Citrus Sinensis ID: 009291

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------54
Protein Sequence
MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL
Secondary Structure (PSIPRED)
ccccccccHHHHHHHHHHHHHHHHHHcccEEEEccccccccccHHHHHHHHHHHcccccccccccccccccccccEEEEEEccccEEEEEccccccccccccccccccccccccccccccccccccHHHHHcccccccccccccccccccccccccccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccEEEEEEcccccEEEEEEEcccEEEEEEEccccccHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEccccccEEEcccccEEEcccccccccccccccccccccccccccHHHHcccccccccccHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccHHHHHHHHHHHHHHHcccEEEEcccccccHHHHHHHHHHHHHHHcccccEEEccccccccccccccEEEccccccEEEccccccccccccccccccccEEEEEccccccccccccEEEEEccccccHHHHHHcccccccccccccccccccEcccccccccccHcccccHHHHHHcccccccEEEEcccccccccEccEEEEEEEEEcccccEEEcccccccccccEEcccccccccccccccccHccccccHHHEEEEEEcccccccEEEEEEEccccEEEEEcccccccHHHHHHHHHHHHHHcccccccEccEEEEEccccccEEEEEcccccEHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccEEcccccHHHEEEcccccEEEccccccEHHHccHHHHccccccccHccHHHHHHccccHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHccccccccccccHHHHHHHHHHccccHHHcccHHHHHHHHHHHcccccccccccccc
Coil and Loop (DISEMBL)
mggttsteEEEFDKQWSECAEHLKDCLnsvvlpigslsVGLCVHRALLFKVLADLINlpcriakgckycrrddassclvqigpdREYLVDLledpgvlskpdsslnrtasvfvssplyhprfkavETVENIRSLAKLYfidnhspkfdldddpsgtaidqdykpdpqalfqraswnvtadrdlqmqnpsgpsthvidssnfikgpllrspvkpfrhrkshetsafstlkpyvtnnhLLMEANLSVmstsnrelyleeeGLEIRWSELLIKKkigegsfgtvyhaewRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMgavteppnlsIVTEYLSRgslykllhipdarvVVDERLRLNMAYDVAKGmnylhqrrppivhrdlkspnllvdstytvkvcdfglsrskpntyissktaagtpewmapevlredpsneksdvfSFGVILWELITlqkpwrnstpsqvisavgfkgrrleipknVNPMVAALIETCwaeepeirpsfpSIMETLQQFLMssvcqplsaqpl
Flexible Loop (DISEMBL)
mggttsteeeeFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGvlskpdsslnRTASVfvssplyhprfKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKpfrhrkshetsafstlkpyvTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKgmnylhqrrppivhrdlkspnllvdSTYTVKVCdfglsrskpntyissktaagtpewmaPEVLREDPSNEKSDVFSFGVILWELITlqkpwrnstpsqvisavgfkgrrleipknVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL
Low Complexity Region (SEG)
MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL
Disordered region (IsUnstruct)
***************WSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVL*********TASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNH*********************************************************************************FSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR*********************************DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM************
Disordered Region (DISOPRED)
*******EEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSK***********************************************************************************************************************************************************EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN*****KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ***************
Disordered Region (DISEMBL)
***************WSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVK**********SAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL
Disordered Region (DISPRO)
*********EEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ*******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	538	2.2.26 [Sep-21-2011]
Q05609	821	Serine/threonine-protein	yes	no	0.931	0.610	0.582	1e-162
Q9FPR3	933	Serine/threonine-protein	no	no	0.483	0.278	0.603	3e-92
Q54TM7	1288	Probable serine/threonine	yes	no	0.483	0.201	0.449	8e-61
Q54H46	642	Probable serine/threonine	no	no	0.486	0.408	0.451	4e-59
Q54H45	690	Probable serine/threonine	no	no	0.501	0.391	0.443	3e-58
Q55GU0	916	Probable serine/threonine	no	no	0.531	0.312	0.418	5e-57
Q54TA1	749	Probable serine/threonine	no	no	0.479	0.344	0.441	1e-56
Q54Y55	506	Dual specificity protein	no	no	0.509	0.541	0.419	4e-53
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.477	0.158	0.4	3e-52
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.501	0.162	0.356	7e-52

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  573 bits (1477), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 310/532 (58%), Positives = 375/532 (70%), Gaps = 31/532 (5%)

Query: 1   MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPC 60
           MGG     E+E    W EC + LK+    VV+PIGSLSVGLC HRALLFKVLAD+I+LPC
Sbjct: 316 MGGPVIMGEDELVPMWKECIDGLKEIF-KVVVPIGSLSVGLCRHRALLFKVLADIIDLPC 374

Query: 61  RIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHP 120
           RIAKGCKYC RDDA+SCLV+ G DREYLVDL+  PG L +PDS LN  +S+ +SSPL  P
Sbjct: 375 RIAKGCKYCNRDDAASCLVRFGLDREYLVDLVGKPGHLWEPDSLLNGPSSISISSPLRFP 434

Query: 121 RFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTAD 180
           R K VE   + R LAK YF D+ S   +L  DP+    D  +     ++F R        
Sbjct: 435 RPKPVEPAVDFRLLAKQYFSDSQS--LNLVFDPASD--DMGF-----SMFHR-------- 477

Query: 181 RDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLME 240
              Q  NP G +  + ++      P    P +    R S++  A     P ++       
Sbjct: 478 ---QYDNPGGENDALAENGGGSLPPSANMPPQNM-MRASNQIEAAPMNAPPISQ------ 527

Query: 241 ANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQE 300
               V + +NREL L+ + ++I W +L IK+KIG GSFGTV+ AEW  SDVAVKIL+EQ+
Sbjct: 528 ---PVPNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQD 584

Query: 301 FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV 360
           FH +R  EFLREVAIMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH   AR 
Sbjct: 585 FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 644

Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
            +DER RL+MAYDVAKGMNYLH R PPIVHRDLKSPNLLVD  YTVKVCDFGLSR K +T
Sbjct: 645 QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAST 704

Query: 421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG 480
           ++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N  P+QV++AVG
Sbjct: 705 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 764

Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
           FK +RLEIP+N+NP VAA+IE CW  EP  RPSF +IM+ L+  + S+V  P
Sbjct: 765 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 816

Acts as a negative regulator in the ethylene response pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  339 bits (870), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 158/262 (60%), Positives = 198/262 (75%), Gaps = 2/262 (0%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI W++L+I ++IG GS+G VYHA+W  ++VAVK  ++Q+F      EF  EV IM+ LR
Sbjct: 663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLR 722

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HPN+V  +GAVT PPNLSIVTE+L RGSLY++LH P + +  DER R+ MA DVA GMN 
Sbjct: 723 HPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHI--DERRRIKMALDVAMGMNC 780

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           LH   P IVHRDLK+PNLLVD+ + VKV DFGLSR K NT++SSK+ AGTPEWMAPEVLR
Sbjct: 781 LHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 840

Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
            +PSNEK DV+SFGVILWEL TL+ PWR   P QV+ AVGF+ RRLEIPK ++P+V  +I
Sbjct: 841 NEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRII 900

Query: 501 ETCWAEEPEIRPSFPSIMETLQ 522
             CW  +P +RPSF  + E L+
Sbjct: 901 LECWQTDPNLRPSFAQLTEVLK 922

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  235 bits (599), Expect = 8e-61,   Method: Compositional matrix adjust.
 Identities = 119/265 (44%), Positives = 167/265 (63%), Gaps = 5/265 (1%)

Query: 261  EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
            E+  SE+ I  +IG G +G V+   WR ++VAVK+L     +     +  +EV ++  LR
Sbjct: 845  EVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKLR 904

Query: 321  HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
            HPNIVL MGA TEP +  IVTEYLSRGSL  +L   D  + +D  LRL + +D A+GM Y
Sbjct: 905  HPNIVLFMGACTEPSSPCIVTEYLSRGSLANILL--DESIEMDWGLRLQLGFDCARGMTY 962

Query: 381  LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
            LH R P I+HRDLK+ NLLVD ++ VKV DFGL+  K +T+  +KT  GT  W+APEVL 
Sbjct: 963  LHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPEVLA 1020

Query: 441  EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
            E+   EK+DV+S+ ++LWEL+T   P+      QV+ ++  +G RL +P    P  AAL+
Sbjct: 1021 EEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSID-RGERLPMPAWCPPKYAALM 1079

Query: 501  ETCWAEEPEIRPSFPSIMETLQQFL 525
              CW  +P  RPSFP I+  ++  +
Sbjct: 1080 NRCWETDPTHRPSFPEILPIMEGMI 1104

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  229 bits (585), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 120/266 (45%), Positives = 162/266 (60%), Gaps = 4/266 (1%)

Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIM 316
           ++G +I   ++ I  +IG+G++G VY   WR S VAVK L     +E+  KEF RE+ +M
Sbjct: 364 KDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLM 423

Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           K LRHPN++  +G+   PP++ I TEY+ RGSLY +LH  D  + +   L + M  D AK
Sbjct: 424 KNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILH--DQALQLQWSLLIKMMIDAAK 481

Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 436
           G+ YLH   P I+HRDLKS NLLVD  + VKV DFGLS  +     ++ TA GTP W +P
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSP 539

Query: 437 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
           EVLR     EK+DV+SFG+ILWE  T Q P+    P QVI AVG +G R  +P+N  P  
Sbjct: 540 EVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKY 599

Query: 497 AALIETCWAEEPEIRPSFPSIMETLQ 522
             L+  C  E P  RP+    +E L+
Sbjct: 600 IQLLIDCLNENPSHRPTMEQCLERLE 625

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  226 bits (576), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 122/275 (44%), Positives = 164/275 (59%), Gaps = 5/275 (1%)

Query: 249 SNRELYLE-EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFK 307
           S R  Y + ++G +I   ++ I  +IG+G+FG VY   WR S VAVK L     +E+  K
Sbjct: 372 SKRSGYTQIKDGKDIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILK 431

Query: 308 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 367
           EF RE+ +MK LRHPN++  +G+    P++ I TEY+ RGSLY +LH  + ++ +   L 
Sbjct: 432 EFHREINLMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILH--NEKIKISWSLV 489

Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 427
             M  D AKG+ YLH   P I+HRDLKS NLLVD  + VKV DFGLS  +     ++ TA
Sbjct: 490 KRMMIDAAKGIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTA 547

Query: 428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE 487
            GTP W +PEVLR     EK+DV+SFG+ILWE  T Q P+    P QVI AVG +G R  
Sbjct: 548 CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPP 607

Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
            PK   P    L++ C  E P  RP+    +E L+
Sbjct: 608 TPKYGPPKYIQLLKDCLNENPSQRPTMEQCLEILE 642

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  222 bits (566), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 123/294 (41%), Positives = 176/294 (59%), Gaps = 8/294 (2%)

Query: 231 YVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD 290
           Y    ++L  +   V   S ++ Y  +  +EI +SEL I  K+GEG+FG VY   WR S 
Sbjct: 628 YNNQGNILKNSGSVVEPPSQQQQYFSD--IEISFSELKISSKLGEGTFGVVYKGLWRGSS 685

Query: 291 VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 349
           VA+K I I ++ +    +EF +E+ I+  LRHPNIVLLM A T PPNL  +TEYL  GSL
Sbjct: 686 VAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSL 745

Query: 350 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 409
           Y  LH    ++ ++ +L   +A  +A+GMNYLH     ++HRD+KS NLL+D    VK+C
Sbjct: 746 YDALH--SKKIKMNMQLYKKLAIQIAQGMNYLHLSG--VIHRDIKSLNLLLDEHMNVKIC 801

Query: 410 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           DFGLS+ K  +   +K + G+P WM+PE+L  +   EK DV++FG+ILWEL T + P+  
Sbjct: 802 DFGLSKLKSKSTEMTK-SIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSG 860

Query: 470 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
               Q+  AV  K  R  IP      ++ LI+ CW ++P  RPSF  I+  L +
Sbjct: 861 LDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNE 914

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1

 Score =  221 bits (563), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 117/265 (44%), Positives = 161/265 (60%), Gaps = 7/265 (2%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLR 320
           I  SE++++ +IG GS   V+   WR   VA+K   +  E  ED   E  +E  IM  LR
Sbjct: 486 IDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELAQEATIMSQLR 545

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HPNI   +G    PP + IV EY+  GSLY++LH  D  + +D     +MA D+AKGMNY
Sbjct: 546 HPNICQFLGTCNNPPEILIVMEYMPLGSLYRILH--DPSISLDWPRMKSMALDIAKGMNY 603

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA---AGTPEWMAPE 437
           LH   P ++HRDLKS NLLVD  Y VK+ DFGLS ++   ++  KTA    GTP W APE
Sbjct: 604 LHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLS-TRFKKHLDKKTAMTPVGTPCWTAPE 662

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           VLR DP  EK+DVFSF ++LWE++T + P++     Q++ +VG    R  +P  V+    
Sbjct: 663 VLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAPFT 722

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQ 522
            LI  CW+E+P+ RPSF  I++ L+
Sbjct: 723 RLITECWSEDPQQRPSFQEIVKRLE 747

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1

 Score =  209 bits (532), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 117/279 (41%), Positives = 160/279 (57%), Gaps = 5/279 (1%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EIR  E+  ++ IG GSFG VY    R   VAVK+L +Q F       F +EV +M  + 
Sbjct: 18  EIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLHKQNFDAATLSAFRKEVHLMSKIY 77

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HPNI L MGA T P    IVTE + +G+L  LLH  D ++ +   LR+ MA D A G+N+
Sbjct: 78  HPNICLFMGACTIPGRCVIVTELVPKGNLETLLH--DQKIQLPLYLRMRMARDAALGINW 135

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS--RSKPNTYISSKTAAGTPEWMAPEV 438
           LH+  P  VHRD+KS NLLVD    VK+CDFGLS  + K        +A GTP +MAPEV
Sbjct: 136 LHESNPVFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQSSAKGTPLYMAPEV 195

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNVNPMVA 497
           +     NE SDV+SFG++LWE++T ++P+ +     +   AV  K  R  IP +    + 
Sbjct: 196 MMFKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPIPNDCLDSLR 255

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQ 536
            LIE CW +EP  RPSF  I+  L   ++ +    L+ +
Sbjct: 256 RLIEKCWDKEPISRPSFKEIISALDHVIIDAAISDLNGR 294

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  206 bits (524), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 106/265 (40%), Positives = 161/265 (60%), Gaps = 8/265 (3%)

Query: 262  IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH 321
            I + E+ I K+IG GS+G V++ +W+  DVAVK  ++Q+  E +  EF  E+A +  L+H
Sbjct: 1359 INYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSELKH 1418

Query: 322  PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
             NIV  +GA  + PN+ IVTEY+  G+L  +L  PD ++    +L+L   Y  A G++YL
Sbjct: 1419 SNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKL--LYGAAMGIDYL 1476

Query: 382  HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
            H   P IVHRD+K  N+LVD  + VK+ DFG +R K +   ++ T  GTP W APEV+R 
Sbjct: 1477 HSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPEVIRG 1534

Query: 442  DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
            +   EK+DVFSFGV++WE++T ++P+      +V S    +G R  IP +     A LI+
Sbjct: 1535 EKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKV-SLDILEGGRPIIPSDCPHEFAKLIK 1593

Query: 502  TCWAEEPEIRPSFPSIMETLQQFLM 526
             CW  +   R   P++ E +QQ ++
Sbjct: 1594 KCWHAKAHKR---PTMTEVVQQLML 1615

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  205 bits (522), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 99/278 (35%), Positives = 168/278 (60%), Gaps = 8/278 (2%)

Query: 250  NRELYLEEEGL---EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRF 306
            N E YL   GL    I + E+ + ++IG GS+G VY  +W+N DVA+K  I+Q+  E+  
Sbjct: 1379 NNERYLTSAGLCSWVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHL 1438

Query: 307  KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 366
                 E+A +K L HPNI+ ++GA  + PN+ IVTEY+++G+L   +     ++   +++
Sbjct: 1439 LGIREEIAFLKKLHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKI 1498

Query: 367  RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            ++    ++AKG++YLH   PPI+HRD+K  N+L+D  + VK+ DFG +R K    I ++ 
Sbjct: 1499 KI--LVNIAKGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTR- 1555

Query: 427  AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 486
              GTP W APE++R D  +EK DVFSFG+++WE++T ++P+  +   ++   +  +  R 
Sbjct: 1556 -CGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRP 1613

Query: 487  EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
            +IP++     A L+  CW  +   RP+   ++  L +F
Sbjct: 1614 KIPQDCPEEFAKLMRKCWHAKSTKRPTMDDVIIVLAKF 1651

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	538
296090398	758	unnamed protein product [Vitis vinifera]	0.992	0.704	0.619	0.0
225449728	767	PREDICTED: serine/threonine-protein kina	0.992	0.696	0.619	0.0
224113505	765	serine/threonine protein kinase 4, CTR4	0.988	0.695	0.586	0.0
255580106	700	map3k delta-1 protein kinase, putative [	0.933	0.717	0.642	0.0
255575367	871	map3k delta-1 protein kinase, putative [	0.986	0.609	0.576	1e-176
359481975	850	PREDICTED: serine/threonine-protein kina	0.994	0.629	0.563	1e-175
237857405	843	serine/threonine protein kinase [Prunus	0.968	0.618	0.578	1e-174
384979221	845	CTR1 [Fragaria x ananassa]	0.975	0.621	0.578	1e-173
224100665	668	serine/threonine protein kinase 3, CTR3	0.934	0.752	0.595	1e-173
350535513	837	CTR1-like protein kinase [Solanum lycope	0.960	0.617	0.599	1e-173

>gi|296090398|emb|CBI40217.3| unnamed protein product [Vitis vinifera]

 Score =  672 bits (1735), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/560 (61%), Positives = 406/560 (72%), Gaps = 26/560 (4%)

Query: 1   MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPC 60
           MGG  S+ E+ F   W E +  LK+ L SVVLPIGSLSVGLCVHRALLFKVLAD++NLPC
Sbjct: 190 MGGAASSGEDGFANHWKEFSGMLKNSLGSVVLPIGSLSVGLCVHRALLFKVLADVVNLPC 249

Query: 61  RIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHP 120
           RIAKGCKYCR + ASSCLV+ GP+REYLVDL+ +PG L  PDS LN T+S+ VSSPL HP
Sbjct: 250 RIAKGCKYCRSNVASSCLVRFGPEREYLVDLMCNPGALCSPDSLLNGTSSILVSSPLCHP 309

Query: 121 RFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQ------------- 167
           RFK VET E+ R LA+LYF D  S     DD  SG A+ QD   D +             
Sbjct: 310 RFKLVETAEDFRILARLYFFDCQSLNIAFDDPSSGAAVGQDDNSDSRFPKPFDRSYTESK 369

Query: 168 ----------ALF--QRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFR 215
                      LF  QR +  V+ DRD QMQN   P  +VI+S + +KG +  S + P  
Sbjct: 370 NLVSTSNNHHELFLPQRTARLVSHDRDPQMQNSFNPLPNVINSKHLVKGAVRPSHILPMG 429

Query: 216 HRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGE 275
           +R       F   +P    N   ME N SV S S+ +  L EE LEI WSEL++K+ IG 
Sbjct: 430 NRDVQPILPFPRPRPGTNKNLGFMEKNHSVTSRSSLKYSLVEEDLEIPWSELVLKENIGA 489

Query: 276 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 335
           GSFGTV+ A+WR+SDVAVKIL+EQ+FH +RF+EFLREVAIMK LRHPNIVL MGAVT+PP
Sbjct: 490 GSFGTVHRAKWRDSDVAVKILMEQDFHAERFEEFLREVAIMKRLRHPNIVLFMGAVTQPP 549

Query: 336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 395
           +LSIVTEYLSRGSLYKLL +PDA +V+DER RLNMAYDVA GMNYLHQ +PPIVHRDLKS
Sbjct: 550 HLSIVTEYLSRGSLYKLLRMPDAGMVLDERRRLNMAYDVAMGMNYLHQLKPPIVHRDLKS 609

Query: 396 PNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 455
           PNLLVD  YTVKVCDFGLSRSK NT++SSKTAAGTPEWMAPEVLR++PSNEKSDV+SFGV
Sbjct: 610 PNLLVDGNYTVKVCDFGLSRSKANTFLSSKTAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 669

Query: 456 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 515
           ILWEL+TLQ+PW++  P+QV++AV FKG+RLEIP  VN  VA LIE CWA EP  RP F 
Sbjct: 670 ILWELVTLQRPWKHLNPAQVVAAVAFKGKRLEIPAEVNHQVAYLIEACWANEPSKRPPFS 729

Query: 516 SIMETLQQFLMSSVCQPLSA 535
            I E LQ  L+SS  QP   
Sbjct: 730 FIKEYLQP-LISSSPQPFQG 748

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225449728|ref|XP_002267382.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera]

 Score =  672 bits (1734), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/560 (61%), Positives = 406/560 (72%), Gaps = 26/560 (4%)

Query: 1   MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPC 60
           MGG  S+ E+ F   W E +  LK+ L SVVLPIGSLSVGLCVHRALLFKVLAD++NLPC
Sbjct: 199 MGGAASSGEDGFANHWKEFSGMLKNSLGSVVLPIGSLSVGLCVHRALLFKVLADVVNLPC 258

Query: 61  RIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHP 120
           RIAKGCKYCR + ASSCLV+ GP+REYLVDL+ +PG L  PDS LN T+S+ VSSPL HP
Sbjct: 259 RIAKGCKYCRSNVASSCLVRFGPEREYLVDLMCNPGALCSPDSLLNGTSSILVSSPLCHP 318

Query: 121 RFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQ------------- 167
           RFK VET E+ R LA+LYF D  S     DD  SG A+ QD   D +             
Sbjct: 319 RFKLVETAEDFRILARLYFFDCQSLNIAFDDPSSGAAVGQDDNSDSRFPKPFDRSYTESK 378

Query: 168 ----------ALF--QRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFR 215
                      LF  QR +  V+ DRD QMQN   P  +VI+S + +KG +  S + P  
Sbjct: 379 NLVSTSNNHHELFLPQRTARLVSHDRDPQMQNSFNPLPNVINSKHLVKGAVRPSHILPMG 438

Query: 216 HRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGE 275
           +R       F   +P    N   ME N SV S S+ +  L EE LEI WSEL++K+ IG 
Sbjct: 439 NRDVQPILPFPRPRPGTNKNLGFMEKNHSVTSRSSLKYSLVEEDLEIPWSELVLKENIGA 498

Query: 276 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 335
           GSFGTV+ A+WR+SDVAVKIL+EQ+FH +RF+EFLREVAIMK LRHPNIVL MGAVT+PP
Sbjct: 499 GSFGTVHRAKWRDSDVAVKILMEQDFHAERFEEFLREVAIMKRLRHPNIVLFMGAVTQPP 558

Query: 336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 395
           +LSIVTEYLSRGSLYKLL +PDA +V+DER RLNMAYDVA GMNYLHQ +PPIVHRDLKS
Sbjct: 559 HLSIVTEYLSRGSLYKLLRMPDAGMVLDERRRLNMAYDVAMGMNYLHQLKPPIVHRDLKS 618

Query: 396 PNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 455
           PNLLVD  YTVKVCDFGLSRSK NT++SSKTAAGTPEWMAPEVLR++PSNEKSDV+SFGV
Sbjct: 619 PNLLVDGNYTVKVCDFGLSRSKANTFLSSKTAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 678

Query: 456 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 515
           ILWEL+TLQ+PW++  P+QV++AV FKG+RLEIP  VN  VA LIE CWA EP  RP F 
Sbjct: 679 ILWELVTLQRPWKHLNPAQVVAAVAFKGKRLEIPAEVNHQVAYLIEACWANEPSKRPPFS 738

Query: 516 SIMETLQQFLMSSVCQPLSA 535
            I E LQ  L+SS  QP   
Sbjct: 739 FIKEYLQP-LISSSPQPFQG 757

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113505|ref|XP_002316514.1| serine/threonine protein kinase 4, CTR4 [Populus trichocarpa] gi|222865554|gb|EEF02685.1| serine/threonine protein kinase 4, CTR4 [Populus trichocarpa]

 Score =  664 bits (1714), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/575 (58%), Positives = 406/575 (70%), Gaps = 43/575 (7%)

Query: 1   MGGTTSTEEEE-FDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLP 59
           MGG    E+++ F K W EC E +K  L SVV+ +GSL++GLCVHRALLFKVLAD INLP
Sbjct: 188 MGGVVFNEDDDTFAKCWKECTEVMKRRLGSVVILVGSLTIGLCVHRALLFKVLADSINLP 247

Query: 60  CRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYH 119
           CRI  GCKYCR+D  SSCLVQ+G DREY VDLL  PG LS+PDSSLN T+S+ VSSPL H
Sbjct: 248 CRIVNGCKYCRKDVVSSCLVQVGDDREYFVDLLGKPGALSQPDSSLNCTSSILVSSPLSH 307

Query: 120 PRFKAVETVENIRSLA-KLYFIDNHSPKFDLDDDPSGTAIDQD----------------- 161
           PRFK+++T E+ R++A KLYF+D        D+  SGT I +D                 
Sbjct: 308 PRFKSIQTTEDFRTMAAKLYFLDCQPLNLVFDNPSSGTTIHEDDRFISRLGKDMKNLPPT 367

Query: 162 ----YKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHR 217
               ++     L Q  + N+  D DLQ  N   P  +V+ + NF++GP + S + P +  
Sbjct: 368 SINKHEASLSPLHQGVAQNIMHDMDLQAPNSYNPFLNVVKTKNFVEGPNVPSSILPVK-- 425

Query: 218 KSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGE-- 275
           K H     S  KP  TNN L ME N +++S SN +L+LEEE  ++ WSELL+KKKIG   
Sbjct: 426 KKHTDPVISNPKPVATNNLLFMEINQTILSKSNNQLHLEEEDFDVPWSELLLKKKIGSVC 485

Query: 276 ----------------GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
                           GSFGTVYHA+WR SDVAVKIL EQEFH +RF+EFL EV+IMK L
Sbjct: 486 EFCEISFMKDTNQCFSGSFGTVYHADWRGSDVAVKILEEQEFHAERFEEFLSEVSIMKRL 545

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           RHPNIVL MGAVT+PPNLSIV EYLSRGSL+KLLH+PDA ++++ER RLNMA DVAKGMN
Sbjct: 546 RHPNIVLFMGAVTQPPNLSIVMEYLSRGSLHKLLHLPDAALILNERRRLNMANDVAKGMN 605

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           YLHQ RPPI+HRDLKS NLLVDS Y VK+CDFGLSRSK  TYISS  AAGTPEWMAPEVL
Sbjct: 606 YLHQFRPPIIHRDLKSLNLLVDSAYKVKICDFGLSRSKAKTYISSTNAAGTPEWMAPEVL 665

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
           R + SNEKSDV+SFGV+LWEL+TLQ PWRN   +Q+I+AVGF G RLEIP NVNP VAAL
Sbjct: 666 RNEQSNEKSDVYSFGVVLWELMTLQHPWRNLKQAQIIAAVGFMGGRLEIPSNVNPSVAAL 725

Query: 500 IETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS 534
           I+ C   EP  RPSF  IM+TLQ+ +  S+ QP++
Sbjct: 726 IKVCLDSEPSKRPSFSYIMKTLQELINDSISQPVA 760

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255580106|ref|XP_002530885.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223529538|gb|EEF31491.1| map3k delta-1 protein kinase, putative [Ricinus communis]

 Score =  657 bits (1695), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/518 (64%), Positives = 399/518 (77%), Gaps = 16/518 (3%)

Query: 1   MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPC 60
           MGG TSTE+  FD  W EC E L++ L SVVLPIG+L VGLCVHRALLFKVLAD INLPC
Sbjct: 181 MGGVTSTEQNTFDMCWKECTEILRNRLGSVVLPIGNLPVGLCVHRALLFKVLADSINLPC 240

Query: 61  RIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHP 120
           RIAKGCK+CRRD A+SCLVQ+G +REYLVDL   PG LS+PDSSLNRT+S+ VSSPL HP
Sbjct: 241 RIAKGCKHCRRDVAASCLVQVGSEREYLVDLFGKPGTLSQPDSSLNRTSSILVSSPLSHP 300

Query: 121 RFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYK------PDPQALFQRAS 174
            FK+++T +++R+LAK +FID+       DD PSGT IDQD K       D + L   +S
Sbjct: 301 SFKSLQTADDLRTLAKHFFIDSQLLNLAFDDTPSGT-IDQDDKNSKTVIKDNKNLIPNSS 359

Query: 175 WNVTADRDLQMQNPSGPST-----HVIDSSNFIKGP----LLRSPVKPFRHRKSHETSAF 225
            +  A     ++  +G  T     H ++SS+         +L +P  P  HR  +  S  
Sbjct: 360 NSHDASTPPLLKRVAGNITNASGLHAVNSSSKSNSLSKDLILPNPALPIMHRDPYSISVT 419

Query: 226 STLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAE 285
           S  KP  TNN L ++AN S +S S+ EL+LEEE L+I WSEL+IK+KIGEGSFGTV+ A+
Sbjct: 420 SNPKPDATNNQLFLDANQSFVSRSSSELHLEEEDLDIPWSELVIKEKIGEGSFGTVHRAD 479

Query: 286 WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 345
           WR SDVAVKIL+EQ++H + F EFLREV IMK LRHPNIVL MGAVT+PP  SIVTEYLS
Sbjct: 480 WRGSDVAVKILMEQDYHAEHFNEFLREVTIMKRLRHPNIVLFMGAVTQPPKFSIVTEYLS 539

Query: 346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 405
           RGSL+KLLH+PDAR+++DE+ RLNMAYDVAKGMNYLHQ RPPIVHRDLKS NLLVDS YT
Sbjct: 540 RGSLHKLLHMPDARIILDEKRRLNMAYDVAKGMNYLHQLRPPIVHRDLKSLNLLVDSQYT 599

Query: 406 VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK 465
           VKVCDFGLSRSK  TY+SSKTAAGTPEWMAPEVLR +PS+EKSDV+SFGVILWEL+TLQ+
Sbjct: 600 VKVCDFGLSRSKAKTYLSSKTAAGTPEWMAPEVLRNEPSDEKSDVYSFGVILWELMTLQQ 659

Query: 466 PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           PWR+   +QV++AVGFK +RLEIP N+NP VAALI+ C
Sbjct: 660 PWRSLNQAQVVAAVGFKNQRLEIPNNINPSVAALIDRC 697

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255575367|ref|XP_002528586.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223531982|gb|EEF33794.1| map3k delta-1 protein kinase, putative [Ricinus communis]

 Score =  624 bits (1608), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 316/548 (57%), Positives = 392/548 (71%), Gaps = 17/548 (3%)

Query: 1   MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPC 60
           MGG+ +  E++F   W EC++ LKDCL S+V+PIGSLSVGLC HRALLFKVLAD I+LPC
Sbjct: 314 MGGSATIGEDDFTNIWRECSDDLKDCLGSIVVPIGSLSVGLCRHRALLFKVLADTIDLPC 373

Query: 61  RIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHP 120
           RIAKGCKYC+RDDASSCLV+ G DREYLVDL+  PG L +PDS LN  +S+ +SSPL  P
Sbjct: 374 RIAKGCKYCKRDDASSCLVRFGLDREYLVDLIGKPGCLCEPDSLLNGPSSISISSPLRFP 433

Query: 121 RFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQA------------ 168
           R K+ E   + RSLAK YF D  S     DD  +GT  ++  K D               
Sbjct: 434 RMKSAEPTVDFRSLAKQYFSDCQSLNLVFDDASAGTIPEKIEKTDIDRINLVPIPSNTNE 493

Query: 169 -----LFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETS 223
                L  + +     DR+  M      S +V  S+N +K  +    +    HR +    
Sbjct: 494 ISQLPLPMKVARTNAQDRNSYMIKSHNGSQNVKQSTNMVKDLIPLKHIPTIEHRDARPLL 553

Query: 224 AFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYH 283
           + S  +   + N    E +  + S  ++E  L+ E L+I WS+L++K++IG GSFGTV+ 
Sbjct: 554 SISDQREDTSKNSKFSEGSQLISSRQSKEFSLDVEDLDIPWSDLVLKERIGAGSFGTVHR 613

Query: 284 AEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 343
           A+W  SDVAVKIL+EQ+FH +RFKEFLREVAIMK LRHPNIVL MGAVT+PPNLSIVTEY
Sbjct: 614 ADWHGSDVAVKILMEQDFHAERFKEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 673

Query: 344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 403
           LSRGSLY+LLH   AR  +DER RL+MAYDVAKGMNYLH+R PPIVHRDLKSPNLLVD  
Sbjct: 674 LSRGSLYRLLHKSGAREALDERRRLSMAYDVAKGMNYLHKRNPPIVHRDLKSPNLLVDKK 733

Query: 404 YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL 463
           YTVKVCDFGLSR K NT++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFGVI+WEL TL
Sbjct: 734 YTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIMWELATL 793

Query: 464 QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           Q+PW N  P+QV++AVGFKGRRLEIP+++NP VA +IE CWA EP  RPSF +IM++L+ 
Sbjct: 794 QQPWGNLNPAQVVAAVGFKGRRLEIPRDLNPQVATIIEACWANEPWKRPSFATIMDSLRL 853

Query: 524 FLMSSVCQ 531
            + + + Q
Sbjct: 854 LIKAPIPQ 861

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359481975|ref|XP_002277360.2| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera]

 Score =  619 bits (1597), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 313/555 (56%), Positives = 391/555 (70%), Gaps = 20/555 (3%)

Query: 1   MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPC 60
           MGG  ST E++F   W EC++  KDCL S+V+PIGSLS GLC HRALLFKVLAD I+L C
Sbjct: 290 MGGAASTGEDDFVSIWRECSDDQKDCLGSIVVPIGSLSFGLCRHRALLFKVLADTIDLRC 349

Query: 61  RIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHP 120
           RIAKGCKYC RDDASSCLV++GPDRE+LVDL+  PG L +PDS LN  AS+ +SSPL  P
Sbjct: 350 RIAKGCKYCTRDDASSCLVRVGPDREFLVDLVGKPGCLCEPDSLLNGPASISISSPLRFP 409

Query: 121 RFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSG-------------------TAIDQD 161
           R K VET  + RSLAK YF +  S     +D   G                     I ++
Sbjct: 410 RSKPVETNIDFRSLAKQYFSECQSLNLVFEDTSVGKIQEKFGYVEKTCTDRTHLVPISRN 469

Query: 162 YKPDPQ-ALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSH 220
               PQ  +  + +W    D+D Q+     P    I  ++ +K P+    +    H    
Sbjct: 470 RGETPQLPMPPKVAWPSAHDQDSQLFKSCNPYQSSISPTDAVKDPIPPKRIPLTGHGDVQ 529

Query: 221 ETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGT 280
            + A S L+     +    +      +   +EL L+ E L+I WS+L++K++IG GSFGT
Sbjct: 530 PSLALSDLRGDTIKDMRFTDGGQLYPNKPCKELSLDVEDLDIPWSDLVLKERIGAGSFGT 589

Query: 281 VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 340
           V+ A+W  SDVAVK+L+EQ+FH +RFKEFLREV+IMK LRHPNIVL MGAVT+PPNLSIV
Sbjct: 590 VHRADWNGSDVAVKVLMEQDFHAERFKEFLREVSIMKRLRHPNIVLFMGAVTQPPNLSIV 649

Query: 341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 400
           TEYLSRGSLY+LLH P AR ++DER RL+MAYDVAKGMNYLH+R PPIVHRDLKSPNLLV
Sbjct: 650 TEYLSRGSLYRLLHKPGAREMLDERRRLSMAYDVAKGMNYLHKRNPPIVHRDLKSPNLLV 709

Query: 401 DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWEL 460
           D  YTVKVCDFGLSR K NT++SSK+AAGTPEWMAPEVLR++ SNEKSD++SFG+ILWEL
Sbjct: 710 DKKYTVKVCDFGLSRFKANTFLSSKSAAGTPEWMAPEVLRDEASNEKSDIYSFGIILWEL 769

Query: 461 ITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 520
            TLQ+PW N  P+QV++AVGFKG+RLEIP+++NP VA++IE CWA EP  RPSF +IME+
Sbjct: 770 ATLQQPWSNLNPAQVVAAVGFKGKRLEIPRDLNPQVASIIEACWANEPWKRPSFFNIMES 829

Query: 521 LQQFLMSSVCQPLSA 535
           L+  +     QP+ A
Sbjct: 830 LKPLIKPPTPQPVRA 844

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|237857405|gb|ACR23642.1| serine/threonine protein kinase [Prunus persica]

 Score =  617 bits (1590), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 322/557 (57%), Positives = 393/557 (70%), Gaps = 36/557 (6%)

Query: 1   MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPC 60
           MGG+ S  E+EF   W E ++ LKDCL SVV+PIGSLSVGLC HRALLFKVLAD I+L C
Sbjct: 289 MGGSASVGEDEFVPIWRESSDDLKDCLGSVVVPIGSLSVGLCRHRALLFKVLADRIDLSC 348

Query: 61  RIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHP 120
           RIAKGCKYC RDDASSCLV+ G DREYLVDL+ +PG L +PDS LN  +S+ +SSPL  P
Sbjct: 349 RIAKGCKYCTRDDASSCLVRFGLDREYLVDLIANPGYLCEPDSLLNGPSSISISSPLRFP 408

Query: 121 RFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKP---------------- 164
           R K VE   + RSLAK YF D  S     D+  +G+A+D+D K                 
Sbjct: 409 RLKPVEPTIDFRSLAKQYFSDCQSLNLVFDEASAGSAVDEDNKEFSMYPKQLDRKITEGN 468

Query: 165 ---------DPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFR 215
                    D  +++ + S     DR+ Q+ NPS    +++ +   +K P+    + P  
Sbjct: 469 NLLLVSSLNDNTSMYAKVSQPSFEDRNPQLFNPS---QNIVHTPGMVKDPIPLKRIPPIG 525

Query: 216 HRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGE 275
           HR   + S   T     T     +E    V S  ++EL  + E L+I W++L++K +IG 
Sbjct: 526 HR---DVSRVDT-----TKGSRFVEGVQLVPSKPSKELTFDIEDLDIPWNDLVLKDRIGA 577

Query: 276 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 335
           GSFGTV+ A+W  SDVAVKIL+EQ+FH +RFKEFLREV IMK LRHPNIVL MGAVT+PP
Sbjct: 578 GSFGTVHRADWHGSDVAVKILMEQDFHAERFKEFLREVTIMKRLRHPNIVLFMGAVTKPP 637

Query: 336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 395
           NLSIVTEYLSRGSLY+LLH P A   +DE+ RLNMAYDVAKGMNYLH+R PPIVHRDLKS
Sbjct: 638 NLSIVTEYLSRGSLYRLLHKPGAMEALDEKRRLNMAYDVAKGMNYLHRRNPPIVHRDLKS 697

Query: 396 PNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 455
           PNLLVD  YTVKVCDFGLSR K NT++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFGV
Sbjct: 698 PNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 757

Query: 456 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 515
           ILWEL TLQ+PW N  P+QV++AVGFK +RLEIP+++NP VA++IE CWA EP  RPSF 
Sbjct: 758 ILWELATLQQPWGNLNPAQVVAAVGFKNKRLEIPRDLNPQVASIIEACWANEPWKRPSFA 817

Query: 516 SIMETLQQFLMSSVCQP 532
           SIME+L   +     QP
Sbjct: 818 SIMESLMPLIKPPATQP 834

Source: Prunus persica

Species: Prunus persica

Genus: Prunus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|384979221|gb|AFI38955.1| CTR1 [Fragaria x ananassa]

 Score =  616 bits (1588), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 318/550 (57%), Positives = 389/550 (70%), Gaps = 25/550 (4%)

Query: 1   MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPC 60
           MGG+ S  E +F   W E ++ LKDCL SVV+PIGSLS+GLC HRALLFKVLAD I+LPC
Sbjct: 300 MGGSASVGEADFFPIWRESSDELKDCLGSVVVPIGSLSIGLCRHRALLFKVLADSIDLPC 359

Query: 61  RIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHP 120
           RIAKGCKYC RDDASSCLV+ G DRE  VDL+ +PG L +PDS LN  +++ +SSPL  P
Sbjct: 360 RIAKGCKYCTRDDASSCLVRFGVDRELFVDLIGNPGCLCEPDSLLNGPSTISISSPLRFP 419

Query: 121 RFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYK----------PDPQALF 170
           R + VE   + R+LAK YF D        D+ P+G+A ++D K           D   LF
Sbjct: 420 RIRTVEPTIDFRTLAKQYFSDCQLLNLVFDEAPAGSAGNEDNKGFSMYPKQKFTDGNNLF 479

Query: 171 QRASWNVTA-----DRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAF 225
             +S +        DR  Q+     PS +++     +K  +    + P  HR   + S  
Sbjct: 480 LDSSLDDDTSMHVDDRSPQLLKSYNPSQNIVHQQTMLKDQIPLKRIPPIGHR---DISRL 536

Query: 226 STLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAE 285
            T     + +    E    V S  N+EL  + + L+I WSEL +K++IG GSFGTV+ A+
Sbjct: 537 DT-----SRDSRFGEGLQVVPSKPNKELTFDVDDLDIPWSELALKERIGAGSFGTVHRAD 591

Query: 286 WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 345
           W  SDVAVKIL+EQEFH +RFKEFLREV IMK LRHPNIVL MGAVT+PPNLSIVTEYLS
Sbjct: 592 WHGSDVAVKILMEQEFHAERFKEFLREVTIMKRLRHPNIVLFMGAVTKPPNLSIVTEYLS 651

Query: 346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 405
           RGSLY+LLH P    V+DER RLNMA+DVAKGMNYLH+R PPIVHRDLKSPNLLVD  YT
Sbjct: 652 RGSLYRLLHKPGP--VLDERRRLNMAHDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYT 709

Query: 406 VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK 465
           VKVCDFGLSR K NT++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+
Sbjct: 710 VKVCDFGLSRLKANTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 769

Query: 466 PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           PW N  P+QV++AVGFK +RLEIP+++NP VA++IE CWA EP  RPSF SIME+L+  +
Sbjct: 770 PWGNLNPAQVVAAVGFKNKRLEIPRDLNPQVASIIEACWANEPWKRPSFASIMESLKPLI 829

Query: 526 MSSVCQPLSA 535
            +   QP  A
Sbjct: 830 KAPTPQPSHA 839

Source: Fragaria x ananassa

Species: Fragaria x ananassa

Genus: Fragaria

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224100665|ref|XP_002311967.1| serine/threonine protein kinase 3, CTR3 [Populus trichocarpa] gi|222851787|gb|EEE89334.1| serine/threonine protein kinase 3, CTR3 [Populus trichocarpa]

 Score =  615 bits (1587), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 320/537 (59%), Positives = 376/537 (70%), Gaps = 34/537 (6%)

Query: 1   MGGTTSTEEEE-FDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLP 59
           MGG    E++  F + W EC E +K    SVVLPIGSLS+GLCVHRALLFKVLAD INLP
Sbjct: 163 MGGVVLNEDDNAFAECWKECTEVMKRRFRSVVLPIGSLSIGLCVHRALLFKVLADSINLP 222

Query: 60  CRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYH 119
           CRI KGCKYCRRD  SSCLVQ+G DREY VDLL +PG LS+PDSSLN ++S+ VSSPL H
Sbjct: 223 CRIVKGCKYCRRDVVSSCLVQVGNDREYFVDLLRNPGALSQPDSSLNCSSSILVSSPLSH 282

Query: 120 PRFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTA 179
           PRFK+ +T E+ R+LAKLYF+D+       D+  SGT ID+D                  
Sbjct: 283 PRFKSNQTTEDFRTLAKLYFLDSQPLNLVFDNSSSGTTIDED------------------ 324

Query: 180 DRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLM 239
             D  +        +++ +S+  +   L S V P R +  +     S  K   TNN L M
Sbjct: 325 --DKFISRLGKDKKNLLPTSSNNRDTSLSSSVLPVRQK--YTDPVVSNPKRVATNNLLFM 380

Query: 240 EANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQ 299
           E N S+      E+   ++             K   GSFGTVYHA+WR SDVAVKIL EQ
Sbjct: 381 ELNQSIPICQLCEISFMKD-----------TDKCFSGSFGTVYHADWRGSDVAVKILEEQ 429

Query: 300 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR 359
           EFH +RF+EFL EVAIMK LRHPNIVL MGAVT+PPNLSIV EYLSRGSL+KLLH+ DA 
Sbjct: 430 EFHAERFEEFLSEVAIMKRLRHPNIVLFMGAVTQPPNLSIVMEYLSRGSLHKLLHMNDAA 489

Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 419
            ++DER RLNMAYDVAKGMNYLHQ RPPIVHRDLKS NLLVDSTYTVK+CDFGLSRSK  
Sbjct: 490 SILDERRRLNMAYDVAKGMNYLHQFRPPIVHRDLKSLNLLVDSTYTVKICDFGLSRSKAK 549

Query: 420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           TYISS  AAG PEWMAPEVLR + SNEKSDV+SFGVILWEL+TLQ+PWRN   +Q+I AV
Sbjct: 550 TYISSTNAAGRPEWMAPEVLRNERSNEKSDVYSFGVILWELMTLQQPWRNLKQAQIIEAV 609

Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQ 536
           GF G+RLEIP +VNP VAALI+ C   EP  RP F  IMETLQ+ + +S+  P++AQ
Sbjct: 610 GFMGQRLEIPSSVNPSVAALIDVCLDNEPSKRPPFSYIMETLQELINNSISHPVAAQ 666

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350535513|ref|NP_001234454.1| CTR1-like protein kinase [Solanum lycopersicum] gi|40781628|gb|AAR89820.1| CTR1-like protein kinase [Solanum lycopersicum] gi|40781634|gb|AAR89823.1| CTR1-like protein kinase [Solanum lycopersicum]

 Score =  614 bits (1584), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 320/534 (59%), Positives = 386/534 (72%), Gaps = 17/534 (3%)

Query: 1   MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPC 60
           MGG TS  E+E    W EC+  LKDCL S VLPIGSLSVGLC HRALLFKVLAD I LPC
Sbjct: 308 MGGATSAGEDELVPLWKECSYELKDCLGSTVLPIGSLSVGLCRHRALLFKVLADAIGLPC 367

Query: 61  RIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHP 120
           RIAKGCKYC R DASSCLV+ GPDREYLVDL+  PG L +PDSSLN  +S+ +SSPL  P
Sbjct: 368 RIAKGCKYCNRADASSCLVRFGPDREYLVDLIGSPGCLCEPDSSLNGPSSISISSPLRFP 427

Query: 121 RFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTAD 180
           RF+ VE   + RSLAK YF D  S     ++  +G A+D D     +   +R S      
Sbjct: 428 RFREVEPTTDFRSLAKQYFSDCQSLNLVFEESSAGAAVDGDAGQTDRNNIERNS------ 481

Query: 181 RDLQMQNPSGPSTHVIDSSNFIKGPLLR--SPVKPFRHRKSHETSAFSTLKPYVTNNHLL 238
                   +GPS    D  + +  P +R  +PVK  R    H  +  S  +    +   L
Sbjct: 482 ------AVTGPSNR--DEVSRLPVPAIRDMAPVKYVRP-VLHGDTQLSDPRDIGNDMRFL 532

Query: 239 MEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIE 298
              +  V S  +R++ LE E  +I W +L++K++IG GSFGTV+ A+W  SDVAVKIL+E
Sbjct: 533 ERGSQLVPSKISRDIALEIEDFDIPWEDLVLKERIGAGSFGTVHRADWNGSDVAVKILME 592

Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA 358
           Q+FH +RFKEFLREVAIMK LRHPNIVL MGAVT+ PNLSIVTEYLSRGSLY+LLH P A
Sbjct: 593 QDFHAERFKEFLREVAIMKRLRHPNIVLFMGAVTQRPNLSIVTEYLSRGSLYRLLHKPGA 652

Query: 359 RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 418
           R V+DER RL+MAYDVAKGMNYLH+R PPIVHRDLKSPNLLVD  YTVKVCDFGLSR K 
Sbjct: 653 REVLDERRRLSMAYDVAKGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA 712

Query: 419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
           NT++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N  P+QV++A
Sbjct: 713 NTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWSNLNPAQVVAA 772

Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
           VGFKG+RL+IP+++ P VA++IE CWA+EP  RPSF +IM+ L+  +   V  P
Sbjct: 773 VGFKGKRLDIPRDLTPQVASIIEACWAKEPWKRPSFAAIMDMLRPLIKPPVTPP 826

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	538
TAIR|locus:2144613	821	CTR1 "CONSTITUTIVE TRIPLE RESP	0.535	0.350	0.711	1.7e-154
TAIR|locus:2025515	933	EDR1 "ENHANCED DISEASE RESISTA	0.565	0.325	0.538	5.7e-107
TAIR|locus:2143009	880	AT5G11850 [Arabidopsis thalian	0.485	0.296	0.596	3.1e-106
TAIR|locus:2194055	992	AT1G18160 [Arabidopsis thalian	0.485	0.263	0.596	5.1e-106
TAIR|locus:2027794	1030	AT1G73660 [Arabidopsis thalian	0.485	0.253	0.596	1.3e-105
TAIR|locus:2200296	765	AT1G67890 [Arabidopsis thalian	0.483	0.339	0.558	2.1e-77
TAIR|locus:2084314	773	AT3G06620 [Arabidopsis thalian	0.514	0.358	0.519	1.1e-76
TAIR|locus:2158019	831	AT5G49470 [Arabidopsis thalian	0.325	0.210	0.557	1.3e-73
TAIR|locus:2084304	671	AT3G06630 [Arabidopsis thalian	0.449	0.360	0.577	2.2e-73
TAIR|locus:2127228	736	AT4G23050 [Arabidopsis thalian	0.511	0.373	0.492	5.9e-73

TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1077 (384.2 bits), Expect = 1.7e-154, Sum P(2) = 1.7e-154
 Identities = 205/288 (71%), Positives = 241/288 (83%)

Query:   245 VMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED 304
             V + +NREL L+ + ++I W +L IK+KIG GSFGTV+ AEW  SDVAVKIL+EQ+FH +
Sbjct:   529 VPNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE 588

Query:   305 RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE 364
             R  EFLREVAIMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH   AR  +DE
Sbjct:   589 RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 648

Query:   365 RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 424
             R RL+MAYDVAKGMNYLH R PPIVHRDLKSPNLLVD  YTVKVCDFGLSR K +T++SS
Sbjct:   649 RRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 708

Query:   425 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR 484
             K+AAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N  P+QV++AVGFK +
Sbjct:   709 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 768

Query:   485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
             RLEIP+N+NP VAA+IE CW  EP  RPSF +IM+ L+  + S+V  P
Sbjct:   769 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 816

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009744 "response to sucrose stimulus" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0010105 "negative regulation of ethylene mediated signaling pathway" evidence=TAS

GO:0010182 "sugar mediated signaling pathway" evidence=TAS

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009686 "gibberellin biosynthetic process" evidence=IMP

GO:0048510 "regulation of timing of transition from vegetative to reproductive phase" evidence=IMP

GO:2000035 "regulation of stem cell division" evidence=IMP

GO:2000069 "regulation of post-embryonic root development" evidence=IMP

GO:0071281 "cellular response to iron ion" evidence=IEP

GO:0009750 "response to fructose stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP

TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 853 (305.3 bits), Expect = 5.7e-107, Sum P(2) = 5.7e-107
 Identities = 167/310 (53%), Positives = 215/310 (69%)

Query:   216 HRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGL---EIRWSELLIKKK 272
             HRK       +   P +  +H    ++L   S  N    L++  +   EI W++L+I ++
Sbjct:   616 HRKYTSDDISTGCDPRL-KDHESTSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAER 674

Query:   273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 332
             IG GS+G VYHA+W  ++VAVK  ++Q+F      EF  EV IM+ LRHPN+V  +GAVT
Sbjct:   675 IGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVT 734

Query:   333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 392
              PPNLSIVTE+L RGSLY++LH P + +  DER R+ MA DVA GMN LH   P IVHRD
Sbjct:   735 RPPNLSIVTEFLPRGSLYRILHRPKSHI--DERRRIKMALDVAMGMNCLHTSTPTIVHRD 792

Query:   393 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 452
             LK+PNLLVD+ + VKV DFGLSR K NT++SSK+ AGTPEWMAPEVLR +PSNEK DV+S
Sbjct:   793 LKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYS 852

Query:   453 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 512
             FGVILWEL TL+ PWR   P QV+ AVGF+ RRLEIPK ++P+V  +I  CW  +P +RP
Sbjct:   853 FGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRP 912

Query:   513 SFPSIMETLQ 522
             SF  + E L+
Sbjct:   913 SFAQLTEVLK 922

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP;NAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0000165 "MAPK cascade" evidence=ISS

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IMP

GO:0009620 "response to fungus" evidence=IMP

GO:1900150 "regulation of defense response to fungus" evidence=IMP

GO:2000031 "regulation of salicylic acid mediated signaling pathway" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0008219 "cell death" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0002229 "defense response to oomycetes" evidence=IMP

GO:0009617 "response to bacterium" evidence=IMP

GO:1900424 "regulation of defense response to bacterium" evidence=IMP

GO:0009788 "negative regulation of abscisic acid mediated signaling pathway" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005769 "early endosome" evidence=IDA

GO:0005783 "endoplasmic reticulum" evidence=IDA

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)]

 Score = 852 (305.0 bits), Expect = 3.1e-106, Sum P(2) = 3.1e-106
 Identities = 157/263 (59%), Positives = 199/263 (75%)

Query:   261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
             EI W +L I ++IG GS+G VY AEW  ++VAVK  ++Q+F  D   +F  E+ IM  LR
Sbjct:   603 EIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEIMLRLR 662

Query:   321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
             HPN+VL MGAVT PPN SI+TE+L RGSLY+LLH P+ ++  DE+ R+ MA DVAKGMNY
Sbjct:   663 HPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQL--DEKRRMRMALDVAKGMNY 720

Query:   381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
             LH   P +VHRDLKSPNLLVD  + VKVCDFGLSR K +TY+SSK+ AGTPEWMAPEVLR
Sbjct:   721 LHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPEVLR 780

Query:   441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
              +P+NEK DV+SFGVILWEL T + PW+   P QV+ AVGF+ RRLEIP +++  VA +I
Sbjct:   781 NEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVAQII 840

Query:   501 ETCWAEEPEIRPSFPSIMETLQQ 523
               CW  EP +RPSF  +M++L++
Sbjct:   841 RECWQTEPHLRPSFTQLMQSLKR 863

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)]

 Score = 840 (300.8 bits), Expect = 5.1e-106, Sum P(2) = 5.1e-106
 Identities = 157/263 (59%), Positives = 199/263 (75%)

Query:   261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
             EI W E+ + ++IG GS+G VY  +W  + VAVK  I+Q+   +  +EF  EV +M+ LR
Sbjct:   709 EILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVRMMRRLR 768

Query:   321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
             HPNIVL MGAVT PPNLSIVTE+L RGSLY+L+H P+ ++  DER RL MA D A+GMNY
Sbjct:   769 HPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQL--DERKRLRMALDAARGMNY 826

Query:   381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
             LH   P IVHRDLKSPNLLVD  + VKVCDFGLSR K +TY+SSK+ AGT EWMAPEVLR
Sbjct:   827 LHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAPEVLR 886

Query:   441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
              +P++EK DV+S+GVILWEL TLQ+PW    P QV+ AVGF+ RRL+IP+ V+P +A +I
Sbjct:   887 NEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGIADII 946

Query:   501 ETCWAEEPEIRPSFPSIMETLQQ 523
               CW  +P +RPSF  IM++L+Q
Sbjct:   947 RKCWQTDPRLRPSFGEIMDSLKQ 969

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)]

 Score = 836 (299.3 bits), Expect = 1.3e-105, Sum P(2) = 1.3e-105
 Identities = 157/263 (59%), Positives = 198/263 (75%)

Query:   261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
             EI W E+ + ++IG GS+G VY  +W  ++VAVK  ++Q+   +  +EF  EV IMK LR
Sbjct:   742 EILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKKLR 801

Query:   321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
             HPNIVL MGAVT PPNLSIVTE+L RGSLY+L+H P+ ++  DER RL MA D A+GMNY
Sbjct:   802 HPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQL--DERRRLRMALDAARGMNY 859

Query:   381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
             LH   P IVHRDLKSPNLLVD  + VKVCDFGLSR K +TY+SSK+ AGT EWMAPEVLR
Sbjct:   860 LHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVLR 919

Query:   441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
              +P++EK DV+S+GVILWEL TLQ+PW    P QV+ AVGF+ RRL+IP  V+P +A LI
Sbjct:   920 NEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAIADLI 979

Query:   501 ETCWAEEPEIRPSFPSIMETLQQ 523
               CW  + ++RPSF  IM +L++
Sbjct:   980 SKCWQTDSKLRPSFAEIMASLKR 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

GO:0009651 "response to salt stress" evidence=IMP

GO:0048573 "photoperiodism, flowering" evidence=RCA

TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)]

 Score = 779 (279.3 bits), Expect = 2.1e-77, P = 2.1e-77
 Identities = 147/263 (55%), Positives = 194/263 (73%)

Query:   261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
             EI W +L I ++IG+GS GTVYH  W  SDVAVK+  +QE+ E+    F +EV++MK LR
Sbjct:   481 EILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLMKRLR 540

Query:   321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
             HPN++L MGAV  P  L IVTE+L RGSL++LL    +++  D R R++MA D+A+GMNY
Sbjct:   541 HPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKL--DLRRRIHMASDIARGMNY 598

Query:   381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
             LH   PPI+HRDLKS NLLVD  +TVKV DFGLSR K  TY+++    GTP+WMAPEVLR
Sbjct:   599 LHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTN-GRGTPQWMAPEVLR 657

Query:   441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
              + ++EKSDV+SFGV+LWEL+T + PW N    QVI AVGF  +RLE+PK+V+P   AL+
Sbjct:   658 NEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQWIALM 717

Query:   501 ETCWAEEPEIRPSFPSIMETLQQ 523
             E+CW  EP+ RPSF  +M+ L++
Sbjct:   718 ESCWHSEPQCRPSFQELMDKLRE 740

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)]

 Score = 772 (276.8 bits), Expect = 1.1e-76, P = 1.1e-76
 Identities = 146/281 (51%), Positives = 202/281 (71%)

Query:   244 SVMSTSNRELYLEEEGLE--IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEF 301
             S  S+   ++  + EGLE  I W +L I +++G+GS GTVYH  W  SDVAVK+  +QE+
Sbjct:   469 STSSSVMNKVDTDSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEY 528

Query:   302 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 361
               +  + F +EV +MK LRHPN++L MGAVT P  L IV+E+L RGSL++LL    +++ 
Sbjct:   529 SAEVIESFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSKL- 587

Query:   362 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 421
              D R R++MA D+A+GMNYLH   PPI+HRDLKS NLLVD  +TVKV DFGLSR K  TY
Sbjct:   588 -DWRRRIHMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETY 646

Query:   422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 481
             ++SK+  GTP+WMAPEVLR + ++EKSD++SFGV+LWEL T + PW      QVI AVGF
Sbjct:   647 LTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGF 706

Query:   482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
               +RLEIPK+++P   +L+E+CW  + ++RP+F  +M+ L+
Sbjct:   707 MDQRLEIPKDIDPRWISLMESCWHSDTKLRPTFQELMDKLR 747

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0000956 "nuclear-transcribed mRNA catabolic process" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)]

 Score = 515 (186.3 bits), Expect = 1.3e-73, Sum P(2) = 1.3e-73
 Identities = 102/183 (55%), Positives = 130/183 (71%)

Query:   343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA--KGMNYLHQRRPPIVHRDLKSPNLLV 400
             Y S  SL +LL++      V   L + + Y  A  +GMNYLH   PPI+HRDLKS NLLV
Sbjct:   630 YYSLDSLIQLLYL------VYNMLHIFLTYFFAQARGMNYLHHCTPPIIHRDLKSSNLLV 683

Query:   401 DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWEL 460
             D  +TVKV DFGLSR K  TY+++KT  GTP+WMAPEVLR + ++EKSDV+SFGVILWEL
Sbjct:   684 DKNWTVKVADFGLSRIKHETYLTTKTGRGTPQWMAPEVLRNEAADEKSDVYSFGVILWEL 743

Query:   461 ITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 520
             +T + PW +    QVI AVGF  +RLE+PKNV+P   +L+E+CW  EP+ RPSF  IME 
Sbjct:   744 VTEKIPWESLNAMQVIGAVGFMNQRLEVPKNVDPQWISLMESCWHSEPQDRPSFQEIMEK 803

Query:   521 LQQ 523
             L++
Sbjct:   804 LRE 806

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)]

 Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
 Identities = 141/244 (57%), Positives = 181/244 (74%)

Query:   261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
             EI W +L I ++IG GS GTVYH  W  SDVAVK+  +QE+ E   K F +EV++MK LR
Sbjct:   428 EILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQEYSESVIKSFEKEVSLMKRLR 487

Query:   321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
             HPN++L MGAVT P  L IV+E++ RGSL++LL    +++  D R R+NMA D+A+GMNY
Sbjct:   488 HPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKL--DWRRRINMALDIARGMNY 545

Query:   381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
             LH   PPI+HRDLKS NLLVD  +TVKV DFGLSR K  TY++SK+  GTP+WMAPEVLR
Sbjct:   546 LHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKGTPQWMAPEVLR 605

Query:   441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
              + ++EKSD++SFGV+LWEL T + PW N    QVI AVGF  +RLEIPK+ +P   +LI
Sbjct:   606 NESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIPKDTDPDWISLI 665

Query:   501 ETCW 504
             E+CW
Sbjct:   666 ESCW 669

GO:0000155 "phosphorelay sensor kinase activity" evidence=IEA

GO:0000160 "phosphorelay signal transduction system" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)]

 Score = 737 (264.5 bits), Expect = 5.9e-73, P = 5.9e-73
 Identities = 137/278 (49%), Positives = 190/278 (68%)

Query:   244 SVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE 303
             S ++  N  L + +   EIRW +L + +++G GSF  V+   W  SDVA+K+  + +++ 
Sbjct:   446 SPVNQRNNRL-VTDSSCEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNA 504

Query:   304 DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVD 363
                 E  +E+ IMK LRHPN++L MGAV      +I+ EY+ RGSL+K+LH  +    +D
Sbjct:   505 MTLTECKKEINIMKKLRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILH--NTNQPLD 562

Query:   364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
             ++ RL MA DVA+GMNYLH+R PPIVHRDLKS NLLVD  + VKV DFGLS+ K  T++S
Sbjct:   563 KKRRLRMALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLS 622

Query:   424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 483
             +K+  GTP+WMAPEVLR +PSNEK DVFSFGVILWEL+T   PW      QV+  VGF  
Sbjct:   623 TKSGKGTPQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMD 682

Query:   484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
             RRL++P+ +NP +A++I+ CW  +P  RPSF  ++  +
Sbjct:   683 RRLDLPEGLNPRIASIIQDCWQTDPAKRPSFEELISQM 720

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q05609	CTR1_ARATH	2, ., 7, ., 1, 1, ., 1	0.5827	0.9312	0.6102	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.10	LOW CONFIDENCE prediction!
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	4.6.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	538
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-86
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-84
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-84
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-79
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-69
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-69
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-64
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-57
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-56
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-54
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-54
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-53
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-52
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-51
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-51
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-50
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-49
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-49
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-49
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-49
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-49
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-47
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-47
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-45
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-45
pfam14381	203	pfam14381, EDR1, Ethylene-responsive protein kinas	6e-45
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-45
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-45
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-44
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-44
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-43
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-43
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-43
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-42
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-42
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-42
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-41
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-41
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-41
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-41
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-40
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-39
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-39
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-39
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-39
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-39
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-38
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-38
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-38
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-38
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-38
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-38
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-37
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-37
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-37
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-37
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-37
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-37
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-37
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-37
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-37
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-37
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-37
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-37
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-37
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-36
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-36
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-36
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-36
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-36
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-36
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-35
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-35
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-35
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-35
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-35
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-35
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-35
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-34
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-34
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-34
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-34
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-34
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-33
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-33
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-33
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-33
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-33
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-33
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-33
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-32
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-32
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-32
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-32
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-32
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-32
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-32
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-32
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-31
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-31
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-31
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-31
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-31
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-30
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-30
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-30
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-30
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-30
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-29
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-29
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-29
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-29
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-28
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-28
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-28
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-27
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-27
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-27
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-27
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-27
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-26
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-26
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-26
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-26
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-25
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-25
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-25
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-25
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-25
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-25
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-25
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-25
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-24
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-24
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-24
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-24
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-24
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-24
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-24
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-24
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-24
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-24
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-24
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-24
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-23
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-23
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-23
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-23
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-23
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-23
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-23
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-23
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-23
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-22
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-22
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-22
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-22
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-22
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-22
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-22
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-21
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-21
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-21
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-21
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-21
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-21
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-21
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-20
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-19
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-19
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-19
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-19
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-19
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-19
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-19
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-19
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-19
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-18
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-18
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-18
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-18
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-18
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-18
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-18
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-17
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-17
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-17
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-17
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-17
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-16
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-15
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-14
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-14
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-14
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-13
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-12
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-10
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	7e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.002

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  265 bits (681), Expect = 7e-86
 Identities = 107/264 (40%), Positives = 146/264 (55%), Gaps = 15/264 (5%)

Query: 267 LLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           L + KK+GEG+FG VY    +         VAVK L E    E+R +EFL E +IMK L 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER-EEFLEEASIMKKLS 59

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HPNIV L+G  T+   L IVTEY+  G L   L     ++ + +   L MA  +AKGM Y
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEY 117

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEV 438
           L  +    VHRDL + N LV     VK+ DFGLSR      Y   +     P +WMAPE 
Sbjct: 118 LESKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 439 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           L++     KSDV+SFGV+LWE+ TL ++P+   +  +V+  +   G RL  P+N    + 
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELY 234

Query: 498 ALIETCWAEEPEIRPSFPSIMETL 521
            L+  CWA +PE RP+F  ++E L
Sbjct: 235 ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  261 bits (670), Expect = 3e-84
 Identities = 104/263 (39%), Positives = 143/263 (54%), Gaps = 14/263 (5%)

Query: 267 LLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           L + KK+GEG+FG VY  + +        +VAVK L E    +   +EFLRE  IM+ L 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI-EEFLREARIMRKLD 59

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HPN+V L+G  TE   L IV EY+  G L   L     R  +     L+ A  +A+GM Y
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR--KNRPKLSLSDLLSFALQIARGMEY 117

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWMAPEVL 439
           L  +    +HRDL + N LV     VK+ DFGLSR   +  Y   +       WMAPE L
Sbjct: 118 LESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175

Query: 440 REDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           +E     KSDV+SFGV+LWE+ TL ++P+   +  +V+  +   G RL  P N  P +  
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYD 234

Query: 499 LIETCWAEEPEIRPSFPSIMETL 521
           L+  CWAE+PE RP+F  ++E L
Sbjct: 235 LMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  260 bits (667), Expect = 7e-84
 Identities = 106/263 (40%), Positives = 143/263 (54%), Gaps = 13/263 (4%)

Query: 267 LLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           L + KK+GEG+FG VY    +        +VAVK L E    +   +EFLRE  IM+ L 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI-EEFLREARIMRKLD 59

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HPNIV L+G  TE   L IV EY+  G L   L        +     L+ A  +A+GM Y
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEY 118

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWMAPEVL 439
           L  +    +HRDL + N LV     VK+ DFGLSR   +  Y   K       WMAPE L
Sbjct: 119 LESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176

Query: 440 REDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           +E     KSDV+SFGV+LWE+ TL ++P+   + ++V+  +  KG RL  P N  P +  
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYK 235

Query: 499 LIETCWAEEPEIRPSFPSIMETL 521
           L+  CWAE+PE RP+F  ++E L
Sbjct: 236 LMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  250 bits (640), Expect = 1e-79
 Identities = 103/266 (38%), Positives = 145/266 (54%), Gaps = 18/266 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           KK+GEG+FG VY  + +       +VAVK L E    E+R K+FL+E  +MK L HPN+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER-KDFLKEARVMKKLGHPNVV 59

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLL------HIPDARVVVDERLRLNMAYDVAKGMN 379
            L+G  TE   L +V EY+  G L   L           +  +  +  L+ A  +AKGM 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPE 437
           YL  ++   VHRDL + N LV     VK+ DFGLSR   +  Y   KT    P  WMAPE
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L++     KSDV+SFGV+LWE+ TL   P+   +  +V+  +  KG RL  P+     +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDEL 236

Query: 497 AALIETCWAEEPEIRPSFPSIMETLQ 522
             L+ +CW  +PE RP+F  ++E L+
Sbjct: 237 YELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  222 bits (569), Expect = 2e-69
 Identities = 87/255 (34%), Positives = 131/255 (51%), Gaps = 11/255 (4%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I +K+GEGSFG VY A  + +   VA+K++ +++  +DR +  LRE+ I+K L+HPNIV 
Sbjct: 3   ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR-ERILREIKILKKLKHPNIVR 61

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L     +   L +V EY   G L+ LL     R  + E         +   + YLH +  
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHSKG- 117

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            IVHRDLK  N+L+D    VK+ DFGL+R          T  GTPE+MAPEVL      +
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFVGTPEYMAPEVLLGKGYGK 175

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCW 504
             D++S GVIL+EL+T + P+        +     K +    P   +++P    LI    
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235

Query: 505 AEEPEIRPSFPSIME 519
            ++PE R +    ++
Sbjct: 236 VKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  222 bits (568), Expect = 4e-69
 Identities = 90/261 (34%), Positives = 138/261 (52%), Gaps = 17/261 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + +K+G GSFGTVY A+ + +   VAVKIL ++     + +   RE+ I++ L HPNIV 
Sbjct: 3   LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L+ A  +  +L +V EY   G L+  L        + E     +A  + +G+ YLH    
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSNG- 118

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSN 445
            I+HRDLK  N+L+D    VK+ DFGL++    +  S  T  GTP +MAPEVL   +   
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 446 EKSDVFSFGVILWELITLQKPWRNS---TPSQVISAVGFKGRRLEIPK----NVNPMVAA 498
            K DV+S GVIL+EL+T + P+         Q+I  +   G  LE  +    + +     
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI--LGPPLEFDEPKWSSGSEEAKD 235

Query: 499 LIETCWAEEPEIRPSFPSIME 519
           LI+ C  ++P  RP+   I++
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  208 bits (532), Expect = 2e-64
 Identities = 94/253 (37%), Positives = 127/253 (50%), Gaps = 42/253 (16%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +GEG FGTVY A  + +   VA+KI I++E      +E LRE+ I+K L HPNIV L G 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKI-IKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
             +  +L +V EY   GSL  LL   +    + E   L +   + +G+ YLH     I+H
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSN--GIIH 115

Query: 391 RDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKS 448
           RDLK  N+L+DS    VK+ DFGLS+   +     KT  GTP +MAPEVL      +EKS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 508
           D++S GVIL+EL  L+                                  LI     ++P
Sbjct: 176 DIWSLGVILYELPELKD---------------------------------LIRKMLQKDP 202

Query: 509 EIRPSFPSIMETL 521
           E RPS   I+E L
Sbjct: 203 EKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  191 bits (487), Expect = 4e-57
 Identities = 96/268 (35%), Positives = 143/268 (53%), Gaps = 14/268 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI    L +++K+G G FG V+   W  +  VAVK L       +    FL+E  IMK L
Sbjct: 2   EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKKL 58

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           RH  +V L    +E   + IVTEY+S+GSL   L   + + +   +L ++MA  +A+GM 
Sbjct: 59  RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-VDMAAQIAEGMA 117

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 438
           YL  R    +HRDL + N+LV      K+ DFGL+R  + + Y + + A    +W APE 
Sbjct: 118 YLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA 175

Query: 439 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
                   KSDV+SFG++L E++T  + P+   T  +V+  V  +G R+  P N    + 
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELY 234

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFL 525
            L+  CW ++PE RP+F    E LQ FL
Sbjct: 235 DLMLQCWDKDPEERPTF----EYLQSFL 258

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  189 bits (483), Expect = 1e-56
 Identities = 96/260 (36%), Positives = 134/260 (51%), Gaps = 14/260 (5%)

Query: 271 KKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           KK+G+GSFG V   EW  S      VAVK L + +   D   +FL+E AIM  L H N++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G V   P L +VTE    GSL   L        +   L  + A  +A GM YL  +R
Sbjct: 60  RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTL-CDYAVQIANGMRYLESKR 117

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAPEVLRED 442
              +HRDL + N+L+ S   VK+ DFGL R+ P     Y+  +       W APE LR  
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 443 PSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             +  SDV+ FGV LWE+ T  ++PW   + SQ++  +  +G RLE P+     +  ++ 
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235

Query: 502 TCWAEEPEIRPSFPSIMETL 521
            CWA  P  RP+F ++ E L
Sbjct: 236 QCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  184 bits (470), Expect = 1e-54
 Identities = 99/266 (37%), Positives = 140/266 (52%), Gaps = 11/266 (4%)

Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
             I   EL +   IG+G FG V   ++R   VAVK L +        + FL E ++M  L
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           RHPN+V L+G V +   L IVTEY+++GSL   L     R V+    +L  A DV +GM 
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGME 116

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           YL ++    VHRDL + N+LV      KV DFGL++       S K      +W APE L
Sbjct: 117 YLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEAL 171

Query: 440 REDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           RE   + KSDV+SFG++LWE+ +  + P+       V+  V  KG R+E P+   P V  
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYK 230

Query: 499 LIETCWAEEPEIRPSFPSIMETLQQF 524
           +++ CW  +P  RP+F  + E L   
Sbjct: 231 VMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  184 bits (469), Expect = 2e-54
 Identities = 82/256 (32%), Positives = 128/256 (50%), Gaps = 24/256 (9%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           + +G GSFG+VY A  +++   +AVK +      E+  +   RE+ I+  L+HPNIV   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 329 GA-VTEPPN-LSIVTEYLSRGSL------YKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           G+   E  N L+I  EY+S GSL      +  L  P  R              + +G+ Y
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY---------TRQILEGLAY 116

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEV 438
           LH     IVHRD+K  N+LVDS   VK+ DFG ++   +      + +  GTP WMAPEV
Sbjct: 117 LHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVA 497
           +R +     +D++S G  + E+ T + PW     P   +  +G  G   EIP++++    
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234

Query: 498 ALIETCWAEEPEIRPS 513
             +  C   +P+ RP+
Sbjct: 235 DFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  181 bits (461), Expect = 2e-53
 Identities = 96/260 (36%), Positives = 140/260 (53%), Gaps = 11/260 (4%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           SEL   K++G G FG V+  +WR   DVA+K++ E    ED   +F+ E  +M  L HPN
Sbjct: 4   SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPN 60

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L G  T+   + IVTEY++ G L   L   + +  +     L+M  DV + M YL  
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLR--ERKGKLGTEWLLDMCSDVCEAMEYL-- 116

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLRED 442
                +HRDL + N LV     VKV DFGL+R    + Y SS+      +W  PEV    
Sbjct: 117 ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS 176

Query: 443 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             + KSDV+SFGV++WE+ +  K P+   + S+V+ +V   G RL  PK     V  ++ 
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMY 235

Query: 502 TCWAEEPEIRPSFPSIMETL 521
           +CW E+PE RP+F  ++  L
Sbjct: 236 SCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  178 bits (454), Expect = 2e-52
 Identities = 99/266 (37%), Positives = 146/266 (54%), Gaps = 11/266 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+  +  VAVK L E        +EFL+E A+MK 
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 58

Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 117

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 118 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175

Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  KG R+E P+   P V
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKV 234

Query: 497 AALIETCWAEEPEIRPSFPSIMETLQ 522
             L+  CW   P  RPSF  I +  +
Sbjct: 235 YELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  175 bits (445), Expect = 6e-51
 Identities = 93/280 (33%), Positives = 150/280 (53%), Gaps = 23/280 (8%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    +        + VA+K + E     +R  EFL E 
Sbjct: 2   ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-IEFLNEA 60

Query: 314 AIMKGLRHPNIVLLMGAV-TEPPNLSIVTEYLSRGSLYKLL--HIPDARV-----VVDER 365
           ++MK     ++V L+G V T  P L +V E +++G L   L    P+A           +
Sbjct: 61  SVMKEFNCHHVVRLLGVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 366 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 425
             + MA ++A GM YL  ++   VHRDL + N +V    TVK+ DFG++R    T    K
Sbjct: 120 KFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177

Query: 426 TAAGT-P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK 482
              G  P  WMAPE L++     KSDV+SFGV+LWE+ TL ++P++  +  +V+  V   
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236

Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           G  L++P+N    +  L+  CW   P++RP+F  I+ +L+
Sbjct: 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  174 bits (444), Expect = 7e-51
 Identities = 91/265 (34%), Positives = 141/265 (53%), Gaps = 14/265 (5%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNS-DVAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHP 322
            E  +++K+G G FG V+   W+N   VA+KIL  +    +    +F +EV  +K LRH 
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ---DFQKEVQALKRLRHK 62

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           +++ L    +    + I+TE + +GSL   L  P+ +V+    L ++MA  VA+GM YL 
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-IDMACQVAEGMAYLE 121

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLR 440
           ++    +HRDL + N+LV      KV DFGL+R  K + Y+SS      P +W APE   
Sbjct: 122 EQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK--IPYKWTAPEAAS 177

Query: 441 EDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
               + KSDV+SFG++L+E+ T  Q P+      +V   +   G R+  P      +  +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI 236

Query: 500 IETCWAEEPEIRPSFPSIMETLQQF 524
           +  CWA EPE RPSF ++ E L   
Sbjct: 237 MLECWAAEPEDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  174 bits (442), Expect = 1e-50
 Identities = 95/265 (35%), Positives = 139/265 (52%), Gaps = 14/265 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           I+K IG G FG V     +       DVA+K L      + R  +FL E +IM    HPN
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQFDHPN 66

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           I+ L G VT+   + I+TEY+  GSL K L   D +  V  +L + M   +A GM YL +
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTV-GQL-VGMLRGIASGMKYLSE 124

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG-TP-EWMAPEVLRE 441
                VHRDL + N+LV+S    KV DFGLSR   ++  +  T  G  P  W APE +  
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182

Query: 442 DPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
                 SDV+SFG+++WE+++  ++P+ + +   VI AV   G RL  P +    +  L+
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSALYQLM 241

Query: 501 ETCWAEEPEIRPSFPSIMETLQQFL 525
             CW ++   RP+F  I+ TL + +
Sbjct: 242 LDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  170 bits (434), Expect = 2e-49
 Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 24/257 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEF-LREVAIMKGLRHPNI 324
           I K+IG+GSFG VY    R SD     +K  I+     ++ +E  L EV I+K L HPNI
Sbjct: 4   IIKQIGKGSFGKVYLVR-RKSDGKLYVLKE-IDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAYDVAK 376
           +    +  E   L IV EY   G L + +          P+ ++       L+    +  
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-------LDWFVQLCL 114

Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 436
            + YLH R+  I+HRD+K  N+ + S   VK+ DFG+S+   +T   +KT  GTP +++P
Sbjct: 115 ALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172

Query: 437 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
           E+ +  P N KSD++S G +L+EL TL+ P+      ++   +  KG+   IP   +  +
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-LKGQYPPIPSQYSSEL 231

Query: 497 AALIETCWAEEPEIRPS 513
             L+ +   ++PE RPS
Sbjct: 232 RNLVSSLLQKDPEERPS 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  170 bits (432), Expect = 3e-49
 Identities = 95/260 (36%), Positives = 141/260 (54%), Gaps = 11/260 (4%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           SEL   K++G G FG V+  +WR    VA+K + E    E+   +F+ E  +M  L HP 
Sbjct: 4   SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPK 60

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L G  T+   L IVTE++  G L   L     +  + + + L+M  DV +GM YL  
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYL-- 116

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEVLRED 442
            R   +HRDL + N LV ST  VKV DFG++R    + Y SS  A    +W  PEV    
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176

Query: 443 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             + KSDV+SFGV++WE+ T  K P+   +  +V+  +  +G RL  PK  +  V  ++ 
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMY 235

Query: 502 TCWAEEPEIRPSFPSIMETL 521
           +CW E+PE RP+F  ++  +
Sbjct: 236 SCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  169 bits (431), Expect = 4e-49
 Identities = 89/266 (33%), Positives = 138/266 (51%), Gaps = 25/266 (9%)

Query: 271 KKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           K++G G+FG+V    +         VAVK L ++     + KEFLRE ++M  L HP IV
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIV 59

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYL 381
            L+G V +   L +V E    G L K L     IP + +         +A+ VA GM YL
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-------KELAHQVAMGMAYL 111

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTP-EWMAPEV 438
             +    VHRDL + N+L+ + +  K+ DFG+SR+    + Y  + TA   P +W APE 
Sbjct: 112 ESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169

Query: 439 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +     + KSDV+S+GV LWE  +   KP+     ++VI+ +   G RL  P+     + 
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIY 228

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQ 523
           +++ +CW   PE RP+F  +  T ++
Sbjct: 229 SIMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  169 bits (430), Expect = 5e-49
 Identities = 96/260 (36%), Positives = 140/260 (53%), Gaps = 11/260 (4%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           +L   K++G G FG V + +WR   DVA+K++ E    ED   EF+ E  +M  L H  +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKL 61

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V L G  T+   + IVTEY+S G L   L     R    + L   M  DV +GM YL  +
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE--MCKDVCEGMAYLESK 119

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEVLREDP 443
           +   +HRDL + N LVD    VKV DFGLSR    + Y SS  +     W  PEVL    
Sbjct: 120 Q--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177

Query: 444 SNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 502
            + KSDV++FGV++WE+ +L K P+     S+ +  V  +G RL  P   +  V A++ +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYS 236

Query: 503 CWAEEPEIRPSFPSIMETLQ 522
           CW E+ E RP+F  ++ +++
Sbjct: 237 CWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  169 bits (430), Expect = 5e-49
 Identities = 91/256 (35%), Positives = 130/256 (50%), Gaps = 10/256 (3%)

Query: 271 KKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           +KIG+G+FG VY    + N++VAVK        + + K FL+E  I+K   HPNIV L+G
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIG 59

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              +   + IV E +  GSL   L     R+ V  +  L M+ D A GM YL  +    +
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKN--CI 115

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP-EWMAPEVLREDPSNEK 447
           HRDL + N LV     +K+ DFG+SR +    Y  S      P +W APE L       +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 448 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 506
           SDV+S+G++LWE  +L   P+   +  Q    +   G R+  P+     +  L+  CWA 
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAY 234

Query: 507 EPEIRPSFPSIMETLQ 522
           +PE RPSF  I   LQ
Sbjct: 235 DPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  168 bits (427), Expect = 3e-48
 Identities = 86/272 (31%), Positives = 138/272 (50%), Gaps = 20/272 (7%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           +EL   K +G G+FGTVY   W          VA+K+L E+   +   KE L E  +M  
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA-NKEILDEAYVMAS 65

Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           + HP++V L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGM
Sbjct: 66  VDHPHVVRLLG-ICLSSQVQLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCVQIAKGM 122

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTP-EWM 434
           +YL ++R  +VHRDL + N+LV +   VK+ DFGL++        Y +       P +WM
Sbjct: 123 SYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA--EGGKVPIKWM 178

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           A E +       KSDV+S+GV +WEL+T   KP+    P+  I  +  KG RL  P    
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGERLPQPPICT 237

Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
             V  ++  CW  + E RP+F  ++    +  
Sbjct: 238 IDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  165 bits (421), Expect = 1e-47
 Identities = 85/253 (33%), Positives = 134/253 (52%), Gaps = 20/253 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I +KIG+G FG VY A  + +   VA+K++  +   +++ ++ + E+ I+K  +HPNIV 
Sbjct: 4   ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNIVK 61

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNYLHQ 383
             G+  +   L IV E+ S GSL  LL        + E     +AY   ++ KG+ YLH 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLK--STNQTLTES---QIAYVCKELLKGLEYLHS 116

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
               I+HRD+K+ N+L+ S   VK+ DFGLS    +T  +  T  GTP WMAPEV+   P
Sbjct: 117 NG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMVGTPYWMAPEVINGKP 173

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALI 500
            + K+D++S G+   EL   + P+    P +    I+  G  G  L  P+  +      +
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG--LRNPEKWSDEFKDFL 231

Query: 501 ETCWAEEPEIRPS 513
           + C  + PE RP+
Sbjct: 232 KKCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  164 bits (418), Expect = 4e-47
 Identities = 96/266 (36%), Positives = 142/266 (53%), Gaps = 16/266 (6%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI  + + + +K+G G FG V+   W N+  VAVK L          K+FL E  IMK L
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKKL 58

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           RHP ++ L    T    + IVTE +  GSL + L     R +   +L ++MA  VA GM 
Sbjct: 59  RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL-IDMAAQVASGMA 117

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPE 437
           YL  +    +HRDL + N+LV      KV DFGL+R  K + Y  ++  A  P +W APE
Sbjct: 118 YLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPE 174

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
               +  + KSDV+SFG++L E++T  + P+   T ++V+  V  +G R+  P      +
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKEL 233

Query: 497 AALIETCWAEEPEIRPSFPSIMETLQ 522
             ++  CW E+P+ RP+F    ETLQ
Sbjct: 234 YDIMLDCWKEDPDDRPTF----ETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  161 bits (408), Expect = 2e-45
 Identities = 93/279 (33%), Positives = 134/279 (48%), Gaps = 32/279 (11%)

Query: 271 KKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           K++GEG FG V    +          VAVK L      E    +F RE+ I++ L H NI
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 325 VLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           V   G   +P   +L ++ EYL  GSL   L     R  ++ +  L  +  + KGM+YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTP-EWMAPEVL 439
            +R   +HRDL + N+LV+S   VK+ DFGL++  P    Y   K    +P  W APE L
Sbjct: 127 SQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK---------------GR 484
           R    +  SDV+SFGV L+EL T   P   S P++ +  +G                 G 
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDP-SQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243

Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           RL  P +    V  L++ CW  EP+ RPSF  ++  + +
Sbjct: 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  158 bits (402), Expect = 5e-45
 Identities = 94/260 (36%), Positives = 138/260 (53%), Gaps = 13/260 (5%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
            +L + + IGEG FG V   E+    VAVK +      +   + FL E A+M  L H N+
Sbjct: 6   QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK----CDVTAQAFLEETAVMTKLHHKNL 61

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V L+G +     L IV E +S+G+L   L     R +V     L  + DVA+GM YL  +
Sbjct: 62  VRLLGVILHN-GLYIVMELMSKGNLVNFLR-TRGRALVSVIQLLQFSLDVAEGMEYLESK 119

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
           +  +VHRDL + N+LV      KV DFGL+R       +SK      +W APE L+    
Sbjct: 120 K--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKHKKF 174

Query: 445 NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           + KSDV+S+GV+LWE+ +  + P+   +  +V   V  KG R+E P+     V  L+ +C
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSC 233

Query: 504 WAEEPEIRPSFPSIMETLQQ 523
           W  EP+ RPSF  + E L++
Sbjct: 234 WETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1

 Score =  156 bits (398), Expect = 6e-45
 Identities = 56/99 (56%), Positives = 66/99 (66%), Gaps = 3/99 (3%)

Query: 1   MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPC 60
           MGG     E    + W EC+  LK+  NS V+P+GSL +GLC HRALLFKVLAD I LPC
Sbjct: 107 MGGPVKDAESMLAR-WKECSNELKE--NSGVVPLGSLKIGLCRHRALLFKVLADSIGLPC 163

Query: 61  RIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLS 99
           R+ KGCKYC  DD +S LV+    REYLVDL+  PG L 
Sbjct: 164 RLVKGCKYCGSDDDASNLVKFDDGREYLVDLMGAPGTLI 202

EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  159 bits (405), Expect = 6e-45
 Identities = 97/288 (33%), Positives = 147/288 (51%), Gaps = 26/288 (9%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
           E+    L + K +GEG+FG V  AE    D       VAVK+L +    E    + + E+
Sbjct: 8   ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEM 66

Query: 314 AIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI---------PDARVVVD 363
            +MK + +H NI+ L+G  T+   L +V EY + G+L   L           PD     +
Sbjct: 67  EMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126

Query: 364 ERLRL----NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 419
           E L      + AY VA+GM +L  ++   +HRDL + N+LV   + +K+ DFGL+R   +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184

Query: 420 TYISSKTAAGT-P-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS 477
                KT  G  P +WMAPE L +     +SDV+SFGV+LWE+ TL        P + + 
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244

Query: 478 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            +  +G R+E P+N    +  L+  CW E P  RP+F  ++E L + L
Sbjct: 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  158 bits (402), Expect = 7e-45
 Identities = 80/248 (32%), Positives = 132/248 (53%), Gaps = 11/248 (4%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I +K+GEGS+G+VY A  + +   VA+K++      ED  +E ++E++I+K    P IV 
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEED-LQEIIKEISILKQCDSPYIVK 62

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
             G+  +  +L IV EY   GS+  ++ I      + E     + Y   KG+ YLH  + 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK- 119

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
             +HRD+K+ N+L++     K+ DFG+S    +T     T  GTP WMAPEV++E   N 
Sbjct: 120 -KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWA 505
           K+D++S G+   E+   + P+ +  P + I  +  K    L  P+  +P     ++ C  
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV 238

Query: 506 EEPEIRPS 513
           ++PE RPS
Sbjct: 239 KDPEERPS 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  158 bits (400), Expect = 1e-44
 Identities = 93/260 (35%), Positives = 139/260 (53%), Gaps = 13/260 (5%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           EL + + IG+G FG V   ++R + VAVK +     ++   + FL E ++M  LRH N+V
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLV 62

Query: 326 LLMGA-VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            L+G  V E   L IVTEY+++GSL   L     R V+     L  + DV + M YL   
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
               VHRDL + N+LV      KV DFGL++   +T  + K      +W APE LRE   
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKF 176

Query: 445 NEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           + KSDV+SFG++LWE+ +  + P+       V+  V  KG +++ P    P+V  +++ C
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQC 235

Query: 504 WAEEPEIRPSFPSIMETLQQ 523
           W  +   RPSF  + E L+ 
Sbjct: 236 WHLDAATRPSFLQLREQLEH 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  158 bits (402), Expect = 1e-44
 Identities = 95/284 (33%), Positives = 138/284 (48%), Gaps = 25/284 (8%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
            ++   +++K+++GEG+FG V+  E  +         VAVK L E   ++ R K+F RE 
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR-KDFEREA 59

Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR---- 367
            ++   +H NIV   G  TE     +V EY+  G L K L  H PDA  +          
Sbjct: 60  ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 368 -----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-Y 421
                L +A  +A GM YL  +    VHRDL + N LV     VK+ DFG+SR    T Y
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177

Query: 422 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAV 479
                    P  WM PE +       +SDV+SFGV+LWE+ T  K PW   +  +VI  +
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237

Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             +GR L+ P+     V  ++  CW  +P+ R +   I E LQ+
Sbjct: 238 T-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  155 bits (392), Expect = 2e-43
 Identities = 91/267 (34%), Positives = 146/267 (54%), Gaps = 11/267 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           E+    L + KK+G G FG V+   +   + VA+K L +     +    FL E  +MK L
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQL 58

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           +HP +V L   VT+ P + I+TEY+  GSL   L  P+   +   +L ++MA  +A+GM 
Sbjct: 59  QHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKL-IDMAAQIAEGMA 116

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEV 438
           ++ ++    +HRDL++ N+LV  T   K+ DFGL+R  + N Y + + A    +W APE 
Sbjct: 117 FIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 174

Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N    + 
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQF 524
            L+  CW E+PE RP+F  +   L+ F
Sbjct: 234 ELMRLCWKEKPEERPTFEYLRSVLEDF 260

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  154 bits (390), Expect = 4e-43
 Identities = 92/265 (34%), Positives = 137/265 (51%), Gaps = 15/265 (5%)

Query: 273 IGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           IG+G FG VYH    +SD      AVK L      E+  ++FL+E  IMK   HPN++ L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFLKEGIIMKDFSHPNVLSL 61

Query: 328 MGAVTEPPNLS-IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           +G          +V  Y+  G L   +        V + +   +   VAKGM YL  ++ 
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASKK- 118

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTP-EWMAPEVLRED 442
             VHRDL + N ++D ++TVKV DFGL+R    K    + + T A  P +WMA E L+  
Sbjct: 119 -FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 502
               KSDV+SFGV+LWEL+T   P      S  I+    +GRRL  P+     +  ++ +
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237

Query: 503 CWAEEPEIRPSFPSIMETLQQFLMS 527
           CW  +PE+RP+F  ++  ++Q   +
Sbjct: 238 CWHPKPEMRPTFSELVSRIEQIFST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  153 bits (388), Expect = 5e-43
 Identities = 93/260 (35%), Positives = 134/260 (51%), Gaps = 11/260 (4%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           SEL + ++IG G FG V+   W     VA+K + E    E+ F E   E  +M  L HP 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPK 60

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L G  TE   + +V E++  G L   L     R    +   L M  DV +GM YL  
Sbjct: 61  LVQLYGVCTERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLES 118

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLRED 442
               ++HRDL + N LV     VKV DFG++R   +   +S T    P +W +PEV    
Sbjct: 119 SN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176

Query: 443 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             + KSDV+SFGV++WE+ +  K P+ N + S+V+  +   G RL  P+  +  V  L++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYELMQ 235

Query: 502 TCWAEEPEIRPSFPSIMETL 521
            CW E PE RPSF  ++  L
Sbjct: 236 HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  152 bits (386), Expect = 1e-42
 Identities = 72/254 (28%), Positives = 131/254 (51%), Gaps = 16/254 (6%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
              +   IG G+FG VY      +   VA+K +  ++  E+  K  ++E+ ++K L+HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMN 379
           IV  +G++    +L I+ EY   GSL +++      P       E L     Y V +G+ 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-------ESLVAVYVYQVLQGLA 113

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           YLH++   ++HRD+K+ N+L      VK+ DFG++    +      +  GTP WMAPEV+
Sbjct: 114 YLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
               ++  SD++S G  + EL+T   P+ +  P   +  +  +     +P+ ++P +   
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDF 230

Query: 500 IETCWAEEPEIRPS 513
           +  C+ ++P +RP+
Sbjct: 231 LMQCFQKDPNLRPT 244

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  152 bits (386), Expect = 4e-42
 Identities = 102/298 (34%), Positives = 139/298 (46%), Gaps = 45/298 (15%)

Query: 265 SELLIKKKIGEGSFGTVY--------------HAEWRNSD----VAVKILIEQEFHEDRF 306
             L   +K+GEG FG V+               AE  N+D    VAVK+L        R 
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR- 63

Query: 307 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDE 364
           ++FL+EV I+  L  PNI  L+G  T  P L ++ EY+  G L + L  H+ +   +   
Sbjct: 64  EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123

Query: 365 RLRL------NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 418
              L       MA  +A GM YL       VHRDL + N LV   YT+K+ DFG+SR   
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR--- 178

Query: 419 NTYIS--SKTAAGTP---EWMAPEVLREDPSNEKSDVFSFGVILWELITL--QKPWRNST 471
           N Y S   +     P    WMA E +       KSDV++FGV LWE++TL  ++P+ + T
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238

Query: 472 PSQVISAVGFKGRR------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             QVI   G   R       L  P N    +  L+  CW  + E RP+F  I   LQ+
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  151 bits (382), Expect = 7e-42
 Identities = 96/274 (35%), Positives = 140/274 (51%), Gaps = 18/274 (6%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 315
           EI+  ++ + + IGEG FG VY   + + +     VAVK          R K FL+E  I
Sbjct: 2   EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYI 60

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M+   HP+IV L+G +TE P + IV E    G L   L +    + +   L L  +Y ++
Sbjct: 61  MRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDL-ASLIL-YSYQLS 117

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP-E 432
             + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR     + Y +SK     P +
Sbjct: 118 TALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK--LPIK 173

Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           WMAPE +        SDV+ FGV +WE++ L  KP++    + VI  +   G RL +P N
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPN 232

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
             P + +L+  CWA +P  RP F  +   L   L
Sbjct: 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  149 bits (377), Expect = 2e-41
 Identities = 102/268 (38%), Positives = 143/268 (53%), Gaps = 15/268 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI    L + KK+G G FG V+   W  N+ VAVK L       +    FL E  IMK L
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKL 58

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           RH  +V L   V+E P + IVTEY+S+GSL   L   + R +    L ++MA  VA GM 
Sbjct: 59  RHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAAQVAAGMA 116

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEV 438
           Y+   R   +HRDL+S N+LV      K+ DFGL+R  + N Y + + A    +W APE 
Sbjct: 117 YIE--RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
                   KSDV+SFG++L EL+T  + P+      +V+  V  +G R+  P++    + 
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLH 233

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFL 525
            L+  CW ++PE RP+F    E LQ FL
Sbjct: 234 ELMLQCWKKDPEERPTF----EYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  149 bits (377), Expect = 3e-41
 Identities = 76/248 (30%), Positives = 124/248 (50%), Gaps = 14/248 (5%)

Query: 273 IGEGSFGTVYHAEWRNSD---VAVK---ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +G GSFG+VY       D    AVK   +  + +  ++  K+  +E+A++  L+HPNIV 
Sbjct: 8   LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            +G   E  NL I  E +  GSL KLL    +     E +       +  G+ YLH R  
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLHDRN- 122

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
             VHRD+K  N+LVD+   VK+ DFG+++ +   +  +K+  G+P WMAPEV+ ++    
Sbjct: 123 -TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
             +D++S G  + E+ T + PW        +  +G       IP +++      I  C  
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240

Query: 506 EEPEIRPS 513
            +P +RP+
Sbjct: 241 RDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  149 bits (379), Expect = 3e-41
 Identities = 79/257 (30%), Positives = 130/257 (50%), Gaps = 32/257 (12%)

Query: 271 KKIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG+ G VY A  R    +VA+K + + +       +  + E+ IMK  +HPNIV  
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRK----QNKELIINEILIMKDCKHPNIVDY 80

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN---MAY---DVAKGMNYL 381
             +      L +V EY+  GSL          ++    +R+N   +AY   +V +G+ YL
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSL--------TDIITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISSKTAAGTPEWMAPE 437
           H +   ++HRD+KS N+L+    +VK+ DFG    L++ K        +  GTP WMAPE
Sbjct: 133 HSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVVGTPYWMAPE 186

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMV 496
           V++      K D++S G++  E+   + P+    P + +  +  KG   L+ P+  +P  
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF 246

Query: 497 AALIETCWAEEPEIRPS 513
              +  C  ++PE RPS
Sbjct: 247 KDFLNKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  147 bits (373), Expect = 6e-41
 Identities = 92/257 (35%), Positives = 134/257 (52%), Gaps = 11/257 (4%)

Query: 271 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           ++IG G+FG V+    R  N+ VAVK   E     D   +FL+E  I+K   HPNIV L+
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLI 59

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
           G  T+   + IV E +  G     L     R+ V E ++  M  + A GM YL  +    
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ--MVENAAAGMEYLESKH--C 115

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-TYISSKTAAGTP-EWMAPEVLREDPSNE 446
           +HRDL + N LV     +K+ DFG+SR + +  Y S+      P +W APE L     + 
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 447 KSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
           +SDV+SFG++LWE  +L   P+ N +  Q   A+  +G RL  P+     V  L+E CW 
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWE 234

Query: 506 EEPEIRPSFPSIMETLQ 522
            +P  RPSF ++ + LQ
Sbjct: 235 YDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  145 bits (367), Expect = 5e-40
 Identities = 90/267 (33%), Positives = 148/267 (55%), Gaps = 10/267 (3%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI    + + KK+G G FG V+   + NS  VAVK L          + FL E  +MK L
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTL 58

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           +H  +V L   VT+   + I+TEY+++GSL   L   +   V+  +L ++ +  +A+GM 
Sbjct: 59  QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMA 117

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 438
           Y+ ++    +HRDL++ N+LV  +   K+ DFGL+R  + N Y + + A    +W APE 
Sbjct: 118 YIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175

Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +       KSDV+SFG++L+E++T  K P+   + S V+SA+  +G R+   +N    + 
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELY 234

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQF 524
            +++TCW E+ E RP+F  +   L  F
Sbjct: 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  144 bits (365), Expect = 1e-39
 Identities = 99/279 (35%), Positives = 139/279 (49%), Gaps = 42/279 (15%)

Query: 273 IGEGSFGTVYHAEWRNSD--------VAVKIL----IEQEFHEDRFKEFLREVAIMKGLR 320
           +G G+FG VY     +          VAVK L     +QE      KEFL+E  +M    
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-----KEFLKEAHLMSNFN 57

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV---------VVDERLRLNMA 371
           HPNIV L+G         I+ E +  G L  L ++ DARV         + +    L++ 
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDL--LSYLRDARVERFGPPLLTLKE---LLDIC 112

Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLV-----DSTYTVKVCDFGLSRS-KPNTYISSK 425
            DVAKG  YL Q     +HRDL + N LV     D+   VK+ DFGL+R    + Y   +
Sbjct: 113 LDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170

Query: 426 TAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
                P  WMAPE L +     +SDV+SFGV++WE++TL Q+P+      +V+  V   G
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG 230

Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
            RL+ P+N    +  L+  CWA++P  RP+F  I E LQ
Sbjct: 231 -RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  144 bits (364), Expect = 3e-39
 Identities = 94/285 (32%), Positives = 150/285 (52%), Gaps = 21/285 (7%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    R+       + VAVK + E     +R  EFL E 
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 60

Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERL 366
           ++MKG    ++V L+G V++     +V E ++ G L   L    P+A     R     + 
Sbjct: 61  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120

Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+ ++   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 121 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 427 AAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WMAPE L++      SD++SFGV+LWE+ +L ++P++  +  QV+  V   G
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 237

Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+ P N    V  L+  CW   P++RP+F  I+  L+  L  S
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  143 bits (362), Expect = 4e-39
 Identities = 99/283 (34%), Positives = 143/283 (50%), Gaps = 27/283 (9%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRN----SD---VAVKILIEQEFHEDRFKEFLREVA 314
           I+  ++++K ++GEG+FG V+ AE  N     D   VAVK L  +E  E   ++F RE  
Sbjct: 2   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAE 59

Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR----- 367
           ++  L+H +IV   G  TE   L +V EY+  G L + L  H PDA+++           
Sbjct: 60  LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119

Query: 368 -----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-Y 421
                L +A  +A GM YL       VHRDL + N LV     VK+ DFG+SR   +T Y
Sbjct: 120 TLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 177

Query: 422 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAV 479
                    P  WM PE +       +SD++SFGV+LWE+ T  K PW   + ++ I  +
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237

Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             +GR LE P+   P V A+++ CW  EP+ R     I   LQ
Sbjct: 238 T-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  143 bits (363), Expect = 7e-39
 Identities = 85/273 (31%), Positives = 133/273 (48%), Gaps = 21/273 (7%)

Query: 267 LLIKKKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L   K +G G+FG V  A             VAVK+L     H    +  + E+ IM  L
Sbjct: 37  LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHL 95

Query: 320 -RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
             H NIV L+GA T    + ++TEY   G L   L        +     L+ +Y VAKGM
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGM 154

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAP 436
            +L  +    +HRDL + N+L+     VK+CDFGL+R     + Y+    A    +WMAP
Sbjct: 155 AFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212

Query: 437 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK----GRRLEIPKNV 492
           E +       +SDV+S+G++LWE+ +L     N  P   + +  +K    G R+  P++ 
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGS---NPYPGMPVDSKFYKLIKEGYRMAQPEHA 269

Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
              +  +++TCW  +P  RP+F  I++ + + L
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  142 bits (359), Expect = 9e-39
 Identities = 90/269 (33%), Positives = 139/269 (51%), Gaps = 19/269 (7%)

Query: 269 IKKKIGEGSFGTVY-----HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           I++ IG G FG V          R   VA+K L +  + E + ++FL E +IM    HPN
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           I+ L G VT+   + I+TE++  G+L   L   D +  V +   + M   +A GM YL +
Sbjct: 67  IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYLSE 124

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSKTAAGTPEWMAPE 437
                VHRDL + N+LV+S    KV DFGLSR      S P TY SS        W APE
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-TYTSSLGGKIPIRWTAPE 181

Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            +        SDV+S+G+++WE+++  ++P+ + +   VI+A+  +  RL  P +    +
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTAL 240

Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFL 525
             L+  CW ++   RP F  I+ TL + +
Sbjct: 241 HQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  142 bits (359), Expect = 2e-38
 Identities = 91/294 (30%), Positives = 153/294 (52%), Gaps = 37/294 (12%)

Query: 267 LLIKKKIGEGSFGTV-----YHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L++ K +GEG FG V     +  + R   + VAVK+L E        ++ L E  ++K +
Sbjct: 2   LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQV 60

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI----------------------PD 357
            HP+++ L GA ++   L ++ EY   GSL   L                        PD
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 358 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS- 416
            R +    L ++ A+ +++GM YL + +  +VHRDL + N+LV     +K+ DFGLSR  
Sbjct: 121 ERALTMGDL-ISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 417 -KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQ 474
            + ++Y+         +WMA E L +     +SDV+SFGV+LWE++TL   P+    P +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237

Query: 475 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
           + + +   G R+E P+N +  +  L+ TCW +EP+ RP+F  I + L++ ++ S
Sbjct: 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  141 bits (357), Expect = 2e-38
 Identities = 83/276 (30%), Positives = 132/276 (47%), Gaps = 20/276 (7%)

Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRH 321
           L + K +GEG FG+V   +    D     VAVK +          +EFL E A MK   H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 322 PNIVLLMG------AVTEPPNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAY 372
           PN++ L+G      ++ + P   ++  ++  G L+  L    +      +  +  L    
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-TYISSKTAAGTP 431
           D+A GM YL  R    +HRDL + N ++    TV V DFGLS+   +  Y      A  P
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 432 -EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIP 489
            +W+A E L +     KSDV++FGV +WE+ T  Q P+      ++   +   G RL+ P
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQP 237

Query: 490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           ++    +  L+ +CW  +P+ RP+F  + E L+  L
Sbjct: 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  140 bits (356), Expect = 3e-38
 Identities = 81/265 (30%), Positives = 132/265 (49%), Gaps = 15/265 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 323
           + + IG+GSFGTV     R SD   KIL+ +E       E      + EV I++ L+HPN
Sbjct: 4   VLETIGKGSFGTVRKVR-RKSDG--KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 324 IVLLMGAVTEPPN--LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNY 380
           IV     + +  N  L IV EY   G L +L+      R  ++E     +   +   +  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 381 LHQRRPP---IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
            H R  P   ++HRDLK  N+ +D+   VK+ DFGL++   +    +KT  GTP +M+PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
            L     +EKSD++S G +++EL  L  P+      Q+ S +  +G+   IP   +  + 
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSELN 239

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQ 522
            +I++    +P+ RPS   +++   
Sbjct: 240 EVIKSMLNVDPDKRPSTEELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 3e-38
 Identities = 80/256 (31%), Positives = 129/256 (50%), Gaps = 20/256 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + ++IG G++G VY A    +   VA+K++  +    D F+   +E++++K  RHPNIV 
Sbjct: 7   LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVA 64

Query: 327 LMGAVTEPPNLSIVTEYLSRGSL---YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             G+      L IV EY   GSL   Y++   P     + E     +  +  KG+ YLH+
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-----LSELQIAYVCRETLKGLAYLHE 119

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL---R 440
                +HRD+K  N+L+     VK+ DFG+S     T    K+  GTP WMAPEV    R
Sbjct: 120 TG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVA 497
           +   + K D+++ G+   EL  LQ P  +  P +    IS   F   +L+  +  +P+  
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237

Query: 498 ALIETCWAEEPEIRPS 513
             I+ C  ++P+ RP+
Sbjct: 238 DFIKKCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  140 bits (355), Expect = 6e-38
 Identities = 99/283 (34%), Positives = 145/283 (51%), Gaps = 28/283 (9%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVA 314
           I+  ++++K+++GEG+FG V+ AE  N         VAVK L +        K+F RE  
Sbjct: 2   IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAE 59

Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR----- 367
           ++  L+H +IV   G   +   L +V EY+  G L K L  H PDA ++VD + R     
Sbjct: 60  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119

Query: 368 ------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 420
                 L++A  +A GM YL  +    VHRDL + N LV +   VK+ DFG+SR   +T 
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177

Query: 421 YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISA 478
           Y         P  WM PE +       +SDV+SFGVILWE+ T  K PW   + ++VI  
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237

Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
           +  +GR LE P+     V  ++  CW  EP+ R +   I + L
Sbjct: 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  139 bits (351), Expect = 9e-38
 Identities = 85/261 (32%), Positives = 141/261 (54%), Gaps = 15/261 (5%)

Query: 272 KIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++G G+FG V    Y    +  DVA+K+L  +     R  E +RE  IM  L +P IV +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR-DEMMREAEIMHQLDNPYIVRM 60

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
           +G V E   L +V E  S G L K L      + V   + L   + V+ GM YL  +   
Sbjct: 61  IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL--MHQVSMGMKYLEGKN-- 115

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTP-EWMAPEVLREDPS 444
            VHRDL + N+L+ + +  K+ DFGLS++    ++Y  +++A   P +W APE +     
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 445 NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           + +SDV+S+G+ +WE  +  QKP++     +V+S +  +G+RL+ P    P + AL++ C
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDC 234

Query: 504 WAEEPEIRPSFPSIMETLQQF 524
           W  + E RP+F  + E ++ +
Sbjct: 235 WIYKWEDRPNFAKVEERMRTY 255

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  139 bits (353), Expect = 1e-37
 Identities = 82/265 (30%), Positives = 132/265 (49%), Gaps = 19/265 (7%)

Query: 275 EGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           EG+FG +++    +       +V VK + +    E +    L+E  ++ GL H NI+ ++
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPIL 74

Query: 329 GAVTEPPNLSIVTE-YLSRGSLYKLLHIP-----DARVVVDERLRLNMAYDVAKGMNYLH 382
               E      V   Y++ G+L   L        +    +  +  ++MA  +A GM+YLH
Sbjct: 75  HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP-EWMAPEVLR 440
           +R   ++H+D+ + N ++D    VK+ D  LSR   P  Y         P +WMA E L 
Sbjct: 135 KRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192

Query: 441 EDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
               +  SDV+SFGV+LWEL+TL Q P+    P + ++A    G RL  P N    + A+
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLAQPINCPDELFAV 251

Query: 500 IETCWAEEPEIRPSFPSIMETLQQF 524
           +  CWA +PE RPSF  +++ L  F
Sbjct: 252 MACCWALDPEERPSFSQLVQCLTDF 276

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  140 bits (354), Expect = 1e-37
 Identities = 97/286 (33%), Positives = 149/286 (52%), Gaps = 30/286 (10%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMK 317
           + W+++  +  IGEG+FG V  A  +      D A+K + E    +D  ++F  E+ ++ 
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLC 62

Query: 318 GL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV--------------- 361
            L  HPNI+ L+GA      L +  EY   G+L   L    +RV+               
Sbjct: 63  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTAST 120

Query: 362 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 421
           +  +  L+ A DVA+GM+YL Q++   +HRDL + N+LV   Y  K+ DFGLSR +   Y
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQ-EVY 177

Query: 422 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAV 479
           +  KT    P  WMA E L        SDV+S+GV+LWE+++L   P+   T +++   +
Sbjct: 178 VK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236

Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
             +G RLE P N +  V  L+  CW E+P  RPSF  I+ +L + L
Sbjct: 237 P-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  138 bits (350), Expect = 2e-37
 Identities = 90/274 (32%), Positives = 137/274 (50%), Gaps = 15/274 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           EI  S +  +K IG G FG V+    +        VA+K L +  + E + ++FL E +I
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASI 59

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M    H NI+ L G VT+     I+TEY+  G+L K L   D      +   + M   +A
Sbjct: 60  MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ--LVGMLRGIA 117

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP---E 432
            GM YL       VHRDL + N+LV+S    KV DFGLSR   +    + T +G      
Sbjct: 118 AGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175

Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE +        SDV+SFG+++WE+++  ++P+ + +  +V+ A+   G RL  P +
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMD 234

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
               V  L+  CW ++   RP F  I+  L + L
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  138 bits (351), Expect = 2e-37
 Identities = 80/254 (31%), Positives = 124/254 (48%), Gaps = 27/254 (10%)

Query: 271 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           + IG+GSFG VY A  +  N  VA+K+ I+ E  ED  ++  +E+  +   R P I    
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
           G+  +   L I+ EY   GS   LL        +DE     +  +V  G+ YLH+     
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEYLHEEGK-- 119

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+K+ N+L+     VK+ DFG+S    +T     T  GTP WMAPEV+++   +EK+
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---------L 499
           D++S G+   EL   + P  +  P +V+           IPKN  P +            
Sbjct: 180 DIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSLEGNKFSKPFKDF 230

Query: 500 IETCWAEEPEIRPS 513
           +  C  ++P+ RPS
Sbjct: 231 VSLCLNKDPKERPS 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 2e-37
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 22/203 (10%)

Query: 270 KKKIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 325
            +K+GEG++G VY A  + +   VA+K I ++ E  E+      LRE++++K L+HPNIV
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIV 61

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+  +     L +V EY     L K L        +   L  ++ Y + +G+ Y H  R
Sbjct: 62  KLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEVLR 440
             I+HRDLK  N+L++    +K+ DFGL+R              T E    W  APE+L 
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEILL 171

Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                  + D++S G I  E+IT
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMIT 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  138 bits (348), Expect = 3e-37
 Identities = 90/270 (33%), Positives = 136/270 (50%), Gaps = 15/270 (5%)

Query: 265 SELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           S + I+K IG G FG V          R   VA+K L +  + E + ++FL E +IM   
Sbjct: 4   SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFLSEASIMGQF 62

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            HPNI+ L G VT+   + IVTEY+  GSL   L   D +  V +   + M   +A GM 
Sbjct: 63  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMK 120

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAP 436
           YL       VHRDL + N+LV+S    KV DFGLSR     P    +++       W AP
Sbjct: 121 YLSDM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178

Query: 437 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           E +        SDV+S+G+++WE+++  ++P+   +   VI A+  +G RL  P +    
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAA 237

Query: 496 VAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  L+  CW ++   RP F  I+  L + +
Sbjct: 238 LHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  139 bits (352), Expect = 3e-37
 Identities = 92/286 (32%), Positives = 149/286 (52%), Gaps = 28/286 (9%)

Query: 267 LLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEFLREVAIMK 317
           L++ K +GEG FG V  AE          +   VAVK+L +    +D   + + E+ +MK
Sbjct: 14  LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-LADLISEMELMK 72

Query: 318 GL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL---------HIPDARVVVDERLR 367
            + +H NI+ L+G  T+   L ++ EY ++G+L + L         +  D   V +E+L 
Sbjct: 73  LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132

Query: 368 ----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
               ++ AY VA+GM YL  RR   +HRDL + N+LV     +K+ DFGL+R   +    
Sbjct: 133 FKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190

Query: 424 SKTAAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 481
            KT+ G    +WMAPE L +     +SDV+SFG+++WE+ TL        P + +  +  
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250

Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
           +G R++ P N    +  L+  CW   P  RP+F  ++E L + L +
Sbjct: 251 EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  138 bits (349), Expect = 3e-37
 Identities = 80/264 (30%), Positives = 132/264 (50%), Gaps = 18/264 (6%)

Query: 273 IGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           +G G FG V+ A+ +  +       V VK L + +  E+   EF RE+ + + L H N+V
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVV 71

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE------RLRLNMAYDVAKGMN 379
            L+G   E     ++ EY   G L + L    ++    +      + ++ +   +A GM+
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWMAPEV 438
           +L   R   VHRDL + N LV S   VKV    LS+   N+ Y   + A     W+APE 
Sbjct: 132 HLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189

Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           ++ED  + KSDV+SFGV++WE+ T  + P+   +  +V++ +      L +P+     + 
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249

Query: 498 ALIETCWAEEPEIRPSFPSIMETL 521
            L+  CWA  P+ RPSF  ++  L
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  137 bits (345), Expect = 6e-37
 Identities = 91/267 (34%), Positives = 142/267 (53%), Gaps = 11/267 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI    L +  K+G+G FG V+   W   + VA+K L       +    FL+E  IMK L
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKKL 58

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           RH  +V L   V+E P + IVTE++ +GSL   L   D + +   +L ++MA  +A GM 
Sbjct: 59  RHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMA 116

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEV 438
           Y+   R   +HRDL++ N+LV      K+ DFGL+R  + N Y + + A    +W APE 
Sbjct: 117 YI--ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
                   KSDV+SFG++L EL+T  + P+      +V+  V  +G R+  P+     + 
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH 233

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQF 524
            L++ CW ++P+ RP+F  I   L+ +
Sbjct: 234 ELMKLCWKKDPDERPTFEYIQSFLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  137 bits (347), Expect = 7e-37
 Identities = 90/269 (33%), Positives = 127/269 (47%), Gaps = 21/269 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           + +G G+FG VY   +R  D       VAVK L E    +D   +FL E  IM    H N
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE-SDFLMEALIMSKFNHQN 70

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----LNMAYDVAKGMN 379
           IV L+G   E     I+ E ++ G L   L     R      L     L  A DVAKG  
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 380 YLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS--KPNTYISSKTAAGTPEWM 434
           YL +     +HRD+ + N L+         K+ DFG++R   + + Y     A    +WM
Sbjct: 131 YLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
            PE   +     K+DV+SFGV+LWE+ +L   P+   T  +V+  V   G RL+ PK   
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGGGRLDPPKGCP 247

Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             V  ++  CW   PE RP+F +I+E +Q
Sbjct: 248 GPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  138 bits (348), Expect = 8e-37
 Identities = 94/303 (31%), Positives = 154/303 (50%), Gaps = 32/303 (10%)

Query: 256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRF 306
           E+   E+    L++ K +GEG FG V  AE          R + VAVK+L + +  E   
Sbjct: 9   EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDL 67

Query: 307 KEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL------------ 353
            + + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L            
Sbjct: 68  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCY 127

Query: 354 ---HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 410
               +P+ ++   + +  + AY VA+GM YL  ++   +HRDL + N+LV     +K+ D
Sbjct: 128 NPTQVPEEQLSFKDLV--SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIAD 183

Query: 411 FGLSRSKPNTYISSKTAAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR 468
           FGL+R   +     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL     
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Query: 469 NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L  +
Sbjct: 244 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303

Query: 529 VCQ 531
             Q
Sbjct: 304 SNQ 306

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  137 bits (346), Expect = 8e-37
 Identities = 80/256 (31%), Positives = 121/256 (47%), Gaps = 14/256 (5%)

Query: 269 IKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + + IG G+   VY A     N  VA+K  I+ E  +    E  +EV  M    HPN+V 
Sbjct: 5   LIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
              +      L +V  YLS GSL  ++     R  +DE +   +  +V KG+ YLH    
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG- 122

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS----KPNTYISSKTAAGTPEWMAPEVLRED 442
             +HRD+K+ N+L+    +VK+ DFG+S S       T    KT  GTP WMAPEV+ + 
Sbjct: 123 -QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181

Query: 443 PS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA-- 498
              + K+D++SFG+   EL T   P+    P +V+          LE   +      +  
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFR 241

Query: 499 -LIETCWAEEPEIRPS 513
            +I  C  ++P  RP+
Sbjct: 242 KMISLCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  137 bits (346), Expect = 8e-37
 Identities = 88/280 (31%), Positives = 148/280 (52%), Gaps = 21/280 (7%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    +        + VA+K + E     +R  EFL E 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 60

Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERL----- 366
           ++MK     ++V L+G V++     ++ E ++RG L   L    P+      +       
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 121 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 427 AAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  +  QV+  V  +G
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-MEG 237

Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  136 bits (344), Expect = 1e-36
 Identities = 98/268 (36%), Positives = 141/268 (52%), Gaps = 15/268 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI    L ++ K+G+G FG V+   W   + VA+K L       +    FL+E  +MK L
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKL 58

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           RH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  +A GM 
Sbjct: 59  RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMA 116

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEV 438
           Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +W APE 
Sbjct: 117 YV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
                   KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P      + 
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH 233

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFL 525
            L+  CW +EPE RP+F    E LQ FL
Sbjct: 234 DLMCQCWRKEPEERPTF----EYLQAFL 257

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  137 bits (346), Expect = 1e-36
 Identities = 95/295 (32%), Positives = 149/295 (50%), Gaps = 28/295 (9%)

Query: 256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRF 306
           E+   E    +L + K +GEG FG V  AE    D         VAVK+L +    +D  
Sbjct: 6   EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-L 64

Query: 307 KEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIP--------- 356
            + + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L            
Sbjct: 65  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124

Query: 357 DARVVVDERLR----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 412
           D   V DE++     ++  Y VA+GM YL  ++   +HRDL + N+LV     +K+ DFG
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFG 182

Query: 413 LSRSKPNTYISSKTAAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS 470
           L+R   N     KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL       
Sbjct: 183 LARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242

Query: 471 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 243 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  135 bits (342), Expect = 3e-36
 Identities = 69/208 (33%), Positives = 113/208 (54%), Gaps = 16/208 (7%)

Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           I+KKIG+G F  VY A        VA+K + I +       ++ L+E+ ++K L HPN++
Sbjct: 6   IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             + +  E   L+IV E    G L +++ H    + ++ ER        +   + ++H +
Sbjct: 66  KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-----GTPEWMAPEVL 439
           R  I+HRD+K  N+ + +T  VK+ D GL R     + SSKT A     GTP +M+PE +
Sbjct: 126 R--IMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERI 178

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPW 467
            E+  N KSD++S G +L+E+  LQ P+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  138 bits (347), Expect = 4e-36
 Identities = 82/239 (34%), Positives = 123/239 (51%), Gaps = 15/239 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHP-NIVL 326
           I +K+GEGSFG VY A      VA+K+L ++   + +  E FLRE+ I+  L HP NIV 
Sbjct: 4   ILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L     +  +L +V EY+  GSL  LL     +  + E   L +   +   + YLH +  
Sbjct: 63  LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG- 121

Query: 387 PIVHRDLKSPNLLVDSTYT-VKVCDFGLSRSKPNTYISS------KTAAGTPEWMAPEVL 439
            I+HRD+K  N+L+D     VK+ DFGL++  P+   +S       T+ GTP +MAPEVL
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 440 R---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
                  ++  SD++S G+ L+EL+T   P+     S   S        L  P   +P+
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239

Length = 384

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  135 bits (341), Expect = 5e-36
 Identities = 98/287 (34%), Positives = 146/287 (50%), Gaps = 25/287 (8%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRN----SD---VAVKILIEQEFHEDRFKEFLREVA 314
           I+   +++K+++GEG+FG V+ AE  N     D   VAVK L  ++  ++  K+F RE  
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAE 59

Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVD--------E 364
           ++  L+H +IV   G   E   L +V EY+  G L K L  H PDA ++ +        +
Sbjct: 60  LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119

Query: 365 RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YIS 423
              L++A  +A GM YL  +    VHRDL + N LV     VK+ DFG+SR   +T Y  
Sbjct: 120 SQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177

Query: 424 SKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGF 481
                  P  WM PE +       +SDV+S GV+LWE+ T  K PW   + ++VI  +  
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 236

Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
           +GR L+ P+     V  L+  CW  EP +R +   I   LQ    +S
Sbjct: 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  134 bits (340), Expect = 7e-36
 Identities = 93/282 (32%), Positives = 135/282 (47%), Gaps = 36/282 (12%)

Query: 271 KKIGEGSFGTV----YHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           +++G+G+FG+V    Y     N+   VAVK L  Q    +  ++F RE+ I+K L+H NI
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 325 VLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           V   G        NL +V EYL  GSL   L     R+  D R  L  A  + KGM YL 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL--DHRKLLLYASQICKGMEYLG 125

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTPE-WMAPEVL 439
            +R   VHRDL + N+LV+S   VK+ DFGL++  P    Y   +    +P  W APE L
Sbjct: 126 SKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGF----------------K 482
            E   +  SDV+SFGV+L+EL T     ++ +P    +  +G                  
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSD--KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241

Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
             RL  P      + A+++ CW  +P  RPSF  +   ++  
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  134 bits (339), Expect = 1e-35
 Identities = 96/281 (34%), Positives = 141/281 (50%), Gaps = 29/281 (10%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAE-----WRNSDVAVKILIEQEFHE-DRFKEFLREVA 314
           EI  S +   +++GEG+FG VY  E      R S  +V I   +E  E    +EF +E  
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR----- 367
           +M  L+HPNIV L+G  T+     ++ EYL+ G L++ L  + P + V  +         
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 368 ------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNT 420
                 L++A  +A GM YL       VHRDL + N LV    TVK+ DFGLSR      
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178

Query: 421 YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTPSQVIS 477
           Y   ++ +  P  WM PE +       +SD++SFGV+LWE+ +  LQ P+   +  +VI 
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ-PYYGFSNQEVIE 237

Query: 478 AVGFKGRR-LEIPKNVNPMVAALIETCWAEEPEIRPSFPSI 517
            +  + R+ L  P++    V AL+  CW E P  RP F  I
Sbjct: 238 MI--RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  133 bits (336), Expect = 2e-35
 Identities = 86/261 (32%), Positives = 139/261 (53%), Gaps = 21/261 (8%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILI---EQEFHEDRFKEFL----REVAIMKGLRHPN 323
           IG GSFG+VY     +S   +AVK +         +DR +  L    RE+A++K L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV  +G+  +  +L+I  EY+  GS+  LL+   A    +E L  N    + KG+NYLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLHN 124

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE------WMAPE 437
           R   I+HRD+K  N+LVD+   +K+ DFG+S+      +S+KT    P       WMAPE
Sbjct: 125 RG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           V+++     K+D++S G ++ E++T + P+ + T  Q I  +G      EIP N++    
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP-EIPSNISSEAI 241

Query: 498 ALIETCWAEEPEIRPSFPSIM 518
             +E  +  +   RP+   ++
Sbjct: 242 DFLEKTFEIDHNKRPTAAELL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  132 bits (334), Expect = 2e-35
 Identities = 83/266 (31%), Positives = 131/266 (49%), Gaps = 23/266 (8%)

Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
            ++G G+FGTV    Y  +     VAVKIL           E LRE  +M+ L +P IV 
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           ++G + E  +  +V E    G L K L    H+ +  +         + + V+ GM YL 
Sbjct: 61  MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-------ELVHQVSMGMKYLE 112

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP-EWMAPEVL 439
           +     VHRDL + N+L+ + +  K+ DFGLS+       Y  +KT    P +W APE +
Sbjct: 113 ETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 440 REDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
                + KSDV+SFGV++WE  +  QKP++    ++V   +   G R+E P+   P +  
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYD 229

Query: 499 LIETCWAEEPEIRPSFPSIMETLQQF 524
           L++ CW    + RP F  +   L+ +
Sbjct: 230 LMKLCWTYGVDERPGFAVVELRLRNY 255

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  132 bits (334), Expect = 2e-35
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 11/267 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW-RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI    L ++KK+G G FG V+ A + +++ VAVK +          + FL E  +MK L
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTL 58

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           +H  +V L   VT+ P + I+TE++++GSL   L   +       +L ++ +  +A+GM 
Sbjct: 59  QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMA 116

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 438
           ++ QR    +HRDL++ N+LV ++   K+ DFGL+R  + N Y + + A    +W APE 
Sbjct: 117 FIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174

Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +       KSDV+SFG++L E++T  + P+   +  +VI A+  +G R+  P+N    + 
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQF 524
            ++  CW   PE RP+F  I   L  F
Sbjct: 234 NIMMRCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  133 bits (336), Expect = 3e-35
 Identities = 95/280 (33%), Positives = 136/280 (48%), Gaps = 33/280 (11%)

Query: 273 IGEGSFGTVYHAEW-------RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           IG+G+FG V+ A           + VAVK+L E E   D   +F RE A+M    HPNIV
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDHPNIV 71

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------------IPDARVVVDERLRLN--- 369
            L+G       + ++ EY++ G L + L                 AR      L L+   
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 370 ---MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISS 424
              +A  VA GM YL +R+   VHRDL + N LV     VK+ DFGLSR+    + Y +S
Sbjct: 132 QLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 425 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
           +  A    WM PE +  +    +SDV+++GV+LWE+ +   +P+      +VI  V   G
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR-DG 248

Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             L  P N    +  L+  CW++ P  RPSF SI   LQ+
Sbjct: 249 NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  132 bits (334), Expect = 6e-35
 Identities = 95/284 (33%), Positives = 141/284 (49%), Gaps = 30/284 (10%)

Query: 264 WSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           W ++  +  IGEG+FG V  A  +      + A+K+L E     D  ++F  E+ ++  L
Sbjct: 1   WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH-RDFAGELEVLCKL 59

Query: 320 -RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV---------------VD 363
             HPNI+ L+GA      L I  EY   G+L   L    +RV+               + 
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR--KSRVLETDPAFAKEHGTASTLT 117

Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
            +  L  A DVA GM YL +++   +HRDL + N+LV      K+ DFGLSR +   Y+ 
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSRGE-EVYVK 174

Query: 424 SKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGF 481
            KT    P  WMA E L       KSDV+SFGV+LWE+++L   P+   T +++   +  
Sbjct: 175 -KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP- 232

Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +G R+E P+N +  V  L+  CW + P  RP F  I   L + L
Sbjct: 233 QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  133 bits (336), Expect = 6e-35
 Identities = 95/290 (32%), Positives = 149/290 (51%), Gaps = 28/290 (9%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLR 311
           E+  + L + K +GEG FG V  AE    D         VAVK+L +    +D   + + 
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD-LSDLVS 66

Query: 312 EVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIP---------DARVV 361
           E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L            D   +
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 362 VDERLR----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 417
            +E+L     ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R  
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 418 PNTYISSKTAAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
            N     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL        P + 
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244

Query: 476 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 245 LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  131 bits (330), Expect = 1e-34
 Identities = 70/250 (28%), Positives = 130/250 (52%), Gaps = 8/250 (3%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIE---QEFHEDRFKEFLREVAIMKGLRHP 322
           +  I  KIG+GSFG V+    R +D  V  + +    + +    +E + E  ++  L   
Sbjct: 1   DFEILNKIGKGSFGVVFKVV-RKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
            I+    +  +   L+IV EY   G L+KLL +   R + ++++       +  G+ +LH
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV-WRFFIQILLGLAHLH 118

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
            ++  I+HRD+KS NL +D+   VK+ D G+++   +    + T  GTP +++PE+  + 
Sbjct: 119 SKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 502
           P NEKSDV++ GV+L+E  T + P+  +    +I  +  +G    + +  +  +A LI+ 
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLIDQ 235

Query: 503 CWAEEPEIRP 512
           C  ++   RP
Sbjct: 236 CLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  130 bits (329), Expect = 2e-34
 Identities = 84/270 (31%), Positives = 131/270 (48%), Gaps = 35/270 (12%)

Query: 263 RWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           RW       KIG G+FG VY A   N D    +AVK +  Q+      KE   E+ +++ 
Sbjct: 1   RWQRG---NKIGGGTFGKVYTA--VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLEL 55

Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH---IPDARVVVDERLRLNMAYDVA 375
           L+HPN+V   G       + I  EY S G+L +LL    I D  V+          Y + 
Sbjct: 56  LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI--------RVYTLQ 107

Query: 376 --KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYI---SSKTAAG 429
             +G+ YLH     IVHRD+K  N+ +D    +K+ DFG + + K NT       ++ AG
Sbjct: 108 LLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165

Query: 430 TPEWMAPEVLREDPSNEK---SDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRR 485
           TP +MAPEV+           +D++S G ++ E+ T ++PW       Q++  VG  G +
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK 224

Query: 486 LEIPKN--VNPMVAALIETCWAEEPEIRPS 513
             IP +  ++P     ++ C   +P+ RP+
Sbjct: 225 PPIPDSLQLSPEGKDFLDRCLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  130 bits (328), Expect = 4e-34
 Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 37/282 (13%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKIL----IEQEFHEDRFKEFLREVAIMKGL-RH 321
             K IGEGSF TV  A+ +  N + A+KIL    + +E      K    E  ++  L  H
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV---KYVKIEKEVLTRLNGH 61

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           P I+ L     +  NL  V EY   G L + +        +DE+     A ++   + YL
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYL 118

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNT----------------Y 421
           H +   I+HRDLK  N+L+D    +K+ DFG    L  +                     
Sbjct: 119 HSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 481
               +  GT E+++PE+L E P+ + SD+++ G I+++++T + P+R S        +  
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI-- 234

Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
                  P N  P    LIE     +P+ R       + L+ 
Sbjct: 235 LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  129 bits (327), Expect = 4e-34
 Identities = 77/261 (29%), Positives = 127/261 (48%), Gaps = 27/261 (10%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQ--------EFHEDRFKEFLR----EVAIMKGLR 320
           IG+G++G VY A   N      + ++Q          H+ R K+ ++    E+  +K L 
Sbjct: 9   IGKGTYGRVYLA--LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           H NIV  +G  T    LSI  EY+  GS+   L         +E+L       V +G+ Y
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAY 123

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEV 438
           LH +   I+HRDLK+ NLLVD+    K+ DFG+S+   + Y + +  +  G+  WMAPEV
Sbjct: 124 LHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 439 LREDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK----NV 492
           +       + K D++S G ++ E+   ++PW +      +  +G K     IP     N+
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241

Query: 493 NPMVAALIETCWAEEPEIRPS 513
           +P+    +  C+   P+ RP+
Sbjct: 242 SPVALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  129 bits (326), Expect = 5e-34
 Identities = 86/269 (31%), Positives = 138/269 (51%), Gaps = 20/269 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           + +G+G FG+V  A+ ++ D     VAVK+L    F     +EFLRE A MK   HPN++
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 326 LLMG------AVTEPPNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAK 376
            L+G      A    P   ++  ++  G L+  L    I +    +  +  +    D+A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWM 434
           GM YL  +    +HRDL + N +++   TV V DFGLS+      Y     A+  P +W+
Sbjct: 125 GMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           A E L ++     SDV++FGV +WE++T  Q P+     S++ + +  KG RL+ P +  
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQPPDCL 241

Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             V  L+  CW+ EP+ RPSF  + + L+
Sbjct: 242 EDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  128 bits (323), Expect = 8e-34
 Identities = 84/252 (33%), Positives = 126/252 (50%), Gaps = 9/252 (3%)

Query: 273 IGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           +G+G+FG V+    ++ + VAVK   E    E + K FL E  I+K   HPNIV L+G  
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGVC 61

Query: 332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 391
           T+   + IV E +  G     L      +   + ++   A D A GM YL  +    +HR
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLESKN--CIHR 117

Query: 392 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDV 450
           DL + N LV     +K+ DFG+SR + +   SS      P +W APE L     + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177

Query: 451 FSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 509
           +S+G++LWE  +L   P+   T  Q    V  KG R+  P+     V  +++ CW  +PE
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPE 236

Query: 510 IRPSFPSIMETL 521
            RP F  + + L
Sbjct: 237 NRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  128 bits (323), Expect = 2e-33
 Identities = 95/301 (31%), Positives = 143/301 (47%), Gaps = 50/301 (16%)

Query: 266 ELLIKKKIGEGSFGTVYHAEW----------------RNSDVAVKILIEQEFHEDRFKEF 309
           +L +K+K+GEG FG V+  E                 +   VAVK+L   +  +    +F
Sbjct: 6   QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARNDF 64

Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-------------HIP 356
           L+E+ IM  L++PNI+ L+G       L ++TEY+  G L + L             +IP
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 357 DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 416
                V     L MA  +A GM YL       VHRDL + N LV + YT+K+ DFG+SR+
Sbjct: 125 S----VSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRN 178

Query: 417 -KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL--QKPWRNSTP 472
                Y   +  A  P  WMA E +        SDV++FGV LWE+ TL  ++P+   + 
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238

Query: 473 SQVISAVG--FKGRRLEIPKNVNPM----VAALIETCWAEEPEIRPSFPSIMETLQQFLM 526
            QVI   G  F+ +  +I  +  P+    V  L+  CW+ + + RP+F      +  FL 
Sbjct: 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF----NKIHHFLR 294

Query: 527 S 527
            
Sbjct: 295 E 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  127 bits (319), Expect = 3e-33
 Identities = 93/274 (33%), Positives = 140/274 (51%), Gaps = 28/274 (10%)

Query: 273 IGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL 327
           IGEG+FG V  A  +      D A+K + E    +D  ++F  E+ ++  L  HPNI+ L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINL 61

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV---------------VDERLRLNMAY 372
           +GA      L +  EY   G+L   L    +RV+               +  +  L+ A 
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE 432
           DVA+GM+YL Q++   +HRDL + N+LV   Y  K+ DFGLSR +   Y+          
Sbjct: 120 DVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKKTMGRLPVR 176

Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           WMA E L        SDV+S+GV+LWE+++L   P+   T +++   +  +G RLE P N
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLN 235

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            +  V  L+  CW E+P  RPSF  I+ +L + L
Sbjct: 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  127 bits (321), Expect = 4e-33
 Identities = 97/294 (32%), Positives = 141/294 (47%), Gaps = 41/294 (13%)

Query: 267 LLIKKKIGEGSFGTVYHAE------WRNSD------------VAVKILIEQEFHEDRFKE 308
           L  K+K+GEG FG V+  E      + + D            VAVK+L E      R  +
Sbjct: 7   LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR-ND 65

Query: 309 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL---------HIPDAR 359
           FL+E+ IM  L+ PNI+ L+        L ++TEY+  G L + L            D  
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--K 417
            +    L   MA  +A GM YL       VHRDL + N LV   YT+K+ DFG+SR+   
Sbjct: 126 TISYSTLI-FMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL--QKPWRNSTPSQV 475
            + Y     A     WM+ E +        SDV++FGV LWE++TL  ++P+   +  QV
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242

Query: 476 ISAVG--FK--GRRLEIPK-NVNP-MVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           I   G  F+  GR++ +PK  + P  +  L+ +CW    + RPSF  I  TL +
Sbjct: 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  126 bits (319), Expect = 4e-33
 Identities = 75/271 (27%), Positives = 132/271 (48%), Gaps = 32/271 (11%)

Query: 271 KKIGEGSFGTVYHAEWRNSDV------AVKILIEQEF----HEDRFKEFLREVAIMKGLR 320
           +++G G+F + Y A     DV      AVK +          E+  +   +E+ +M  L 
Sbjct: 6   QQLGTGAFSSCYQAR----DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HP+I+ ++GA  E  + ++  E+++ GS+  LL    A     E + +N    + +G++Y
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSY 118

Query: 381 LHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRSKPNTYISSK-----TAAGTPEWM 434
           LH+ +  I+HRD+K  NLL+DST   +++ DFG + ++     +          GT  +M
Sbjct: 119 LHENQ--IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGRRLEIPKN 491
           APEVLR +      DV+S G ++ E+ T + PW     S    +I  +        IP++
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           ++P +  +   C   +PE R   P   E L+
Sbjct: 236 LSPGLRDVTLRCLELQPEDR---PPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  126 bits (319), Expect = 5e-33
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 20/260 (7%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMG 329
           I +G++G V+ A+ +++    A+K++ + +   +++  + L E  I+   + P +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
           +     NL +V EYL  G L  LL    +   +DE +      ++   + YLH     I+
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGS---LDEDVARIYIAEIVLALEYLHSNG--II 115

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSR--------SKPNTYISSKTAAGTPEWMAPEVLRE 441
           HRDLK  N+L+DS   +K+ DFGLS+        +  +     K   GTP+++APEV+  
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--L 499
              ++  D +S G IL+E +    P+   TP ++   +     ++E P++V     A  L
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNGKIEWPEDVEVSDEAIDL 233

Query: 500 IETCWAEEPEIRPSFPSIME 519
           I      +PE R    SI E
Sbjct: 234 ISKLLVPDPEKRLGAKSIEE 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 5e-33
 Identities = 77/252 (30%), Positives = 124/252 (49%), Gaps = 15/252 (5%)

Query: 271 KKIGEGSFGTVY--HAEWRNSDVAVK-ILIEQEFHEDR--FKEFLREVAIMKGLRHPNIV 325
           K +G+G+FG VY  +      ++AVK +  + +  E +        E+ ++K L+H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
              G + +   LSI  EY+  GS+   L    A   + E +       + +G+ YLH   
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSNM 124

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS----KTAAGTPEWMAPEVLRE 441
             IVHRD+K  N+L DS   VK+ DFG S+ +  T  SS    K+  GTP WM+PEV+  
Sbjct: 125 --IVHRDIKGANILRDSAGNVKLGDFGASK-RLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
           +    K+DV+S G  + E++T + PW        I  +  +    ++P +V+P     + 
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241

Query: 502 TCWAEEPEIRPS 513
             + E  + RPS
Sbjct: 242 RTFVENAKKRPS 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  126 bits (319), Expect = 6e-33
 Identities = 90/280 (32%), Positives = 141/280 (50%), Gaps = 34/280 (12%)

Query: 271 KKIGEGSFGTV--YHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +GEG FG V  Y  +  N      VAVK L ++E  +     + +E+ I+K L H NI
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINILKTLYHENI 68

Query: 325 VLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           V   G  +E     L ++ EY+  GSL   L  P  ++ + + L    A  + +GM YLH
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLF--AQQICEGMAYLH 124

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTPE-WMAPEVL 439
            +    +HRDL + N+L+D+   VK+ DFGL+++ P  + Y   +    +P  W A E L
Sbjct: 125 SQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF---------------KGR 484
           +E+  +  SDV+SFGV L+EL+T     + S P +    +G                +G 
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQ-SPPKKFEEMIGPKQGQMTVVRLIELLERGM 241

Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
           RL  PKN    V  L++ CW  E + RP+F S++  L++ 
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  125 bits (315), Expect = 1e-32
 Identities = 82/255 (32%), Positives = 138/255 (54%), Gaps = 9/255 (3%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE---FLREVAIMKGLRHPNIV 325
           I KKIGEGSFG +Y A+ + SD    ++ E +  +   KE     +EV ++  ++HPNIV
Sbjct: 4   IIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
               +  E   L IV EY   G L K ++     V+  E   L+    ++ G+ ++H R+
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK 121

Query: 386 PPIVHRDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
             I+HRD+KS N+ +     V K+ DFG++R   ++   + T  GTP +++PE+ +  P 
Sbjct: 122 --ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           N K+D++S G +L+EL TL+ P+  +   Q++  +  +G    I  N +  + +LI   +
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPISPNFSRDLRSLISQLF 238

Query: 505 AEEPEIRPSFPSIME 519
              P  RPS  SI++
Sbjct: 239 KVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  125 bits (315), Expect = 1e-32
 Identities = 76/252 (30%), Positives = 133/252 (52%), Gaps = 8/252 (3%)

Query: 271 KKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           KKIGEGSFG     + +      V  +I I +   ++R +E  +EVA++  ++HPNIV  
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQY 64

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  E  NL IV +Y   G LYK ++     V+  E   L+    +   + ++H R+  
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK-- 121

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           I+HRD+KS N+ +    T+K+ DFG++R   +T   ++T  GTP +++PE+    P N K
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181

Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
           SD+++ G +L+E+ TL+  +       ++  +  +G    +  + +  +  L+   +   
Sbjct: 182 SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-IRGSYPPVSSHYSYDLRNLVSQLFKRN 240

Query: 508 PEIRPSFPSIME 519
           P  RPS  SI+E
Sbjct: 241 PRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  126 bits (317), Expect = 1e-32
 Identities = 89/264 (33%), Positives = 133/264 (50%), Gaps = 14/264 (5%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 315
           ++ +EL   K +G G+FGTVY   W          VA+KIL E    +    EF+ E  I
Sbjct: 4   LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV-EFMDEALI 62

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M  + HP++V L+G V   P + +VT+ +  G L   +H  + +  +  +L LN    +A
Sbjct: 63  MASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIA 119

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EW 433
           KGM YL +RR  +VHRDL + N+LV S   VK+ DFGL+R             G    +W
Sbjct: 120 KGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           MA E +       +SDV+S+GV +WEL+T      +  P++ I  +  KG RL  P    
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICT 237

Query: 494 PMVAALIETCWAEEPEIRPSFPSI 517
             V  ++  CW  + + RP F  +
Sbjct: 238 IDVYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score =  124 bits (312), Expect = 4e-32
 Identities = 81/275 (29%), Positives = 134/275 (48%), Gaps = 19/275 (6%)

Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHP 322
           L + K +GEG FG+V   +    D    VAVK +          ++FL E   MK   HP
Sbjct: 1   LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 323 NIVLLMGAVTEP------PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYD 373
           N++ L+G   +       P+  ++  ++  G L+  L    + D    +  ++ +    D
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTP 431
           +A GM YL  +    +HRDL + N +++    V V DFGLS+   N   Y   + A    
Sbjct: 121 IASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 490
           +W+A E L +     KSDV+SFGV +WE+ T  Q P+     S++   +  +G RL+ P 
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPP 237

Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +    + +L+ +CW   P+ RPSF ++   L++ L
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 5e-32
 Identities = 74/264 (28%), Positives = 139/264 (52%), Gaps = 32/264 (12%)

Query: 273 IGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G+G+FG VY A+ + + +  A KI+  +   E+  ++F+ E+ I+   +HPNIV L  A
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 L I+ E+   G+L  ++ +   R + + ++R      + + +N+LH  +  ++H
Sbjct: 71  YFYENKLWILIEFCDGGALDSIM-LELERGLTEPQIRYVC-RQMLEALNFLHSHK--VIH 126

Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-----REDPSN 445
           RDLK+ N+L+     VK+ DFG+S    +T     T  GTP WMAPEV+     +++P +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA------- 498
            K+D++S G+ L EL  ++ P     P +V+         L+I K+  P +         
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSEPPTLDQPSKWSSS 237

Query: 499 ---LIETCWAEEPEIRPSFPSIME 519
               +++C  ++P+ RP+   +++
Sbjct: 238 FNDFLKSCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 5e-32
 Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 16/253 (6%)

Query: 273 IGEGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +G+GSFG V     +++    A+K+L    I +    +       E  I+  + HP IV 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT---ERNILSRINHPFIVK 57

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  A      L +V EY   G L+   H+       +ER R   A ++   + YLH    
Sbjct: 58  LHYAFQTEEKLYLVLEYAPGGELFS--HLSKEGRFSEERARFYAA-EIVLALEYLHSLG- 113

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            I++RDLK  N+L+D+   +K+ DFGL++   +    + T  GTPE++APEVL      +
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 506
             D +S GV+L+E++T + P+      ++   +      L  P+ ++P    LI     +
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQK 230

Query: 507 EPEIRPSFPSIME 519
           +P  R       E
Sbjct: 231 DPTKRLGSGGAEE 243

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  123 bits (310), Expect = 6e-32
 Identities = 76/259 (29%), Positives = 133/259 (51%), Gaps = 20/259 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--------VAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           + KK+G+GS+G+VY  + R SD        V +  + ++E  +      + E+ I+  + 
Sbjct: 4   VLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKEREDA-----VNEIRILASVN 57

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMN 379
           HPNI+    A  +   L IV EY   G L K +      R ++ E+    +   + +G+ 
Sbjct: 58  HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
            LH+++  I+HRDLKS N+L+ +   VK+ D G+S+        +KT  GTP +MAPEV 
Sbjct: 118 ALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AKTQIGTPHYMAPEVW 173

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
           +  P + KSD++S G +L+E+ T   P+   +   +   V  +G+   IP   +  +   
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-QRGKYPPIPPIYSQDLQNF 232

Query: 500 IETCWAEEPEIRPSFPSIM 518
           I +    +P++RP+   I+
Sbjct: 233 IRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 6e-32
 Identities = 70/208 (33%), Positives = 114/208 (54%), Gaps = 26/208 (12%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH--EDRFKEFLREV-AIMKGLRHPN 323
           + K++G+G+FG+VY A  + +   VA+K +  ++F+  E+     LREV ++ K   HPN
Sbjct: 3   VIKQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMN--LREVKSLRKLNEHPN 59

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV L     E   L  V EY+  G+LY+L+     +   +  +R ++ Y + +G+ ++H 
Sbjct: 60  IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIH- 116

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKP--NTYISSKTAAGTPEWM-APE 437
            +    HRDLK  NLLV     VK+ DFGL+R   S+P    Y+S++       W  APE
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-------WYRAPE 168

Query: 438 VLREDPS-NEKSDVFSFGVILWELITLQ 464
           +L    S +   D+++ G I+ EL TL+
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  123 bits (311), Expect = 7e-32
 Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 8/209 (3%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHP 322
            +L    ++G G+ G V     R +   +AVK  I  E +E   K+ LRE+ I+     P
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKT-IRLEINEAIQKQILRELDILHKCNSP 59

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
            IV   GA     ++SI  EY+  GSL K+L   + +  + ER+   +A  V KG+ YLH
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
           ++   I+HRD+K  N+LV+S   +K+CDFG+S    N+   +KT  GT  +MAPE ++ +
Sbjct: 118 EKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQGN 174

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNST 471
             + KSD++S G+ L EL T + P+    
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPEN 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 1e-31
 Identities = 80/254 (31%), Positives = 126/254 (49%), Gaps = 27/254 (10%)

Query: 273 IGEGSFGTVY---HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH---PNIVL 326
           IG G++G VY   H       VA+KI I  +  +D   +  REVA++  LR    PNI  
Sbjct: 9   IGRGAYGAVYRGKHVP-TGRVVALKI-INLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHI-----PDARVVVDERLRLNMAYDVAKGMNYL 381
             G+  + P L I+ EY   GS+  L+           V++ E L       VA  + Y+
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-------VA--LKYI 117

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
           H  +  ++HRD+K+ N+LV +T  VK+CDFG++           T  GTP WMAPEV+ E
Sbjct: 118 H--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175

Query: 442 DPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-FKGRRLEIPKNVNPMVAAL 499
               + K+D++S G+ ++E+ T   P+ +    + +  +   K  RLE     + ++   
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DNGYSKLLREF 234

Query: 500 IETCWAEEPEIRPS 513
           +  C  EEP+ R S
Sbjct: 235 VAACLDEEPKERLS 248

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  123 bits (309), Expect = 1e-31
 Identities = 91/280 (32%), Positives = 137/280 (48%), Gaps = 30/280 (10%)

Query: 271 KKIGEGSFGTV----YHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +GEG FG V    Y  E  N+   VAVK L + E   +   +  +E+ I++ L H NI
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENI 68

Query: 325 VLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           V   G  TE     I  + E+L  GSL + L  P  +  ++ + +L  A  + KGM+YL 
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPE-WMAPEVL 439
            R+   VHRDL + N+LV+S + VK+ DFGL+++      Y + K    +P  W APE L
Sbjct: 127 SRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 440 REDPSNEKSDVFSFGVILWELIT--------------LQKPWRNSTPSQVISAVGFKGRR 485
            +      SDV+SFGV L+EL+T              +  P         +  V  +G+R
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244

Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P N    V  L+  CW  +P  R +F +++E  +  L
Sbjct: 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  121 bits (306), Expect = 2e-31
 Identities = 66/250 (26%), Positives = 134/250 (53%), Gaps = 8/250 (3%)

Query: 273 IGEGSFG--TVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G+G+FG  T+Y     +S V  K +      E   ++ L E+ I+  L+HPNI+     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 331 VTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
             +   L I  EY + G+LY K++       + +E + L   + +   ++Y+H+    I+
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQ--LFEEEMVLWYLFQIVSAVSYIHKAG--IL 123

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 449
           HRD+K+ N+ +     +K+ DFG+S+   + Y  ++T  GTP +M+PE+ +    N KSD
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSD 183

Query: 450 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 509
           +++ G +L+EL+TL++ +  + P  ++  +  +G    +    +  + +L+ +   ++PE
Sbjct: 184 IWALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHSLLQQDPE 242

Query: 510 IRPSFPSIME 519
            RP+   +++
Sbjct: 243 KRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  122 bits (307), Expect = 4e-31
 Identities = 94/297 (31%), Positives = 135/297 (45%), Gaps = 47/297 (15%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD------------------VAVKILIEQEFHEDRF 306
             LL K+K+GEG FG V+  E  N                    VAVKIL        R 
Sbjct: 5   GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR- 63

Query: 307 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL---HIPDAR---- 359
            +FL+EV I+  L+ PNI+ L+G   +   L ++TEY+  G L + L   H+ D      
Sbjct: 64  NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123

Query: 360 ---------VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 410
                      +     L++A  +A GM YL       VHRDL + N LV    T+K+ D
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIAD 181

Query: 411 FGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL--QKP 466
           FG+SR+     Y   +  A  P  WMA E +        SDV++FGV LWE++ L  ++P
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241

Query: 467 WRNSTPSQVISAVG--FKGRRLEI----PKNVNPMVAALIETCWAEEPEIRPSFPSI 517
           +   T  QVI   G  F+ +  ++    P      +  L+  CW+ +   RPSF  I
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 6e-31
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 18/202 (8%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLM 328
            KIGEG++G VY A  + +   V I  I+  F  +   K  LRE+ ++K L HPNI+ L+
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                  +L +V E++    LYKL  I D +  + E L  +  Y + +G+ + H     I
Sbjct: 65  DVFRHKGDLYLVFEFMDT-DLYKL--IKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--I 119

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEVLREDP 443
           +HRDLK  NLL+++   +K+ DFGL+RS       S     T      W  APE+L  D 
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVTRWYRAPELLLGDK 174

Query: 444 S-NEKSDVFSFGVILWELITLQ 464
             +   D++S G I  EL++ +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  120 bits (302), Expect = 1e-30
 Identities = 80/264 (30%), Positives = 132/264 (50%), Gaps = 25/264 (9%)

Query: 266 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           EL  K ++IG+GSFG VY   + R  +V    +I+ E  ED  ++  +E+ ++     P 
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           I    G+  +   L I+ EYL  GS   LL  P     ++E     +  ++ KG++YLH 
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGP---LEETYIATILREILKGLDYLHS 119

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            R   +HRD+K+ N+L+     VK+ DFG++    +T I   T  GTP WMAPEV+++  
Sbjct: 120 ERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 498
            + K+D++S G+   EL   + P  +  P +V+           IPKN  P +       
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYSKP 228

Query: 499 ---LIETCWAEEPEIRPSFPSIME 519
               +E C  ++P  RP+   +++
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score =  119 bits (300), Expect = 1e-30
 Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 13/272 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHA-----EWRNSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+    + I++ +G G FG +          R   VA+  L      + R + FL E   
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALT 59

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           +    H NIV L G +T    + IVTEY+S G+L   L   + ++V  +   + M   +A
Sbjct: 60  LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ--LMGMLPGLA 117

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG-LSRSKPNTYISSKTAAGTPEWM 434
            GM YL +     VH+ L +  +LV+S    K+  F  L   K     ++ +      W 
Sbjct: 118 SGMKYLSEM--GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE ++    +  SDV+SFG+++WE+++  ++P+ + +   VI AV   G RL  P+N  
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCP 234

Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            ++  L+  CW +E   RP F  I   L + +
Sbjct: 235 NLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  120 bits (301), Expect = 2e-30
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 20/264 (7%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR-----FKEFLREVAIM 316
           ++ +EL   K +G G FGTV+   W     ++KI +  +  +DR     F+E    +  M
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63

Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
             L H  IV L+G +    +L +VT+    GSL  L H+   R  +D +  LN    +AK
Sbjct: 64  GSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAK 120

Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-----SKPNTYISSKTAAGTP 431
           GM YL + R  +VHR+L + N+L+ S   V++ DFG++       K   Y   KT     
Sbjct: 121 GMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI--- 175

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 490
           +WMA E +       +SDV+S+GV +WE+++   +P+    P +V   +  KG RL  P+
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQ 234

Query: 491 NVNPMVAALIETCWAEEPEIRPSF 514
                V  ++  CW  +  +RP+F
Sbjct: 235 ICTIDVYMVMVKCWMIDENVRPTF 258

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  118 bits (298), Expect = 3e-30
 Identities = 86/269 (31%), Positives = 136/269 (50%), Gaps = 16/269 (5%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 315
           ++ +EL   K +G G+FGTVY   W          VA+K+L E    +   KE L E  +
Sbjct: 4   LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAYV 62

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M G+  P +  L+G +     + +VT+ +  G L  L ++ + +  +  +  LN    +A
Sbjct: 63  MAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIA 119

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEW 433
           KGM+YL + R  +VHRDL + N+LV S   VK+ DFGL+R      T   +       +W
Sbjct: 120 KGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177

Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
           MA E +       +SDV+S+GV +WEL+T   KP+ +  P++ I  +  KG RL  P   
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY-DGIPAREIPDLLEKGERLPQPPIC 236

Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETL 521
              V  ++  CW  + E RP F  +++  
Sbjct: 237 TIDVYMIMVKCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  118 bits (297), Expect = 5e-30
 Identities = 88/291 (30%), Positives = 145/291 (49%), Gaps = 35/291 (12%)

Query: 261 EIRWSELLIKKKIGEGSFGTVY----------HAEWRNSDVAVKILIEQEFHEDRFKEFL 310
           E+  S +   +++GE +FG +Y          HA+     VA+K L +   +  ++ EF 
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQL----VAIKTLKDIN-NPQQWGEFQ 55

Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARV-------- 360
           +E ++M  L HPNIV L+G VT+   + ++ EYL++G L++ L +  P + V        
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115

Query: 361 ----VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 416
                +D    L++A  +A GM YL       VH+DL + N+L+     VK+ D GLSR 
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSRE 173

Query: 417 -KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPS 473
                Y   +  +  P  WM PE +     +  SD++SFGV+LWE+ +   +P+   +  
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233

Query: 474 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
           +VI  V  K + L   ++  P + +L+  CW E P  RP F  I   L+ +
Sbjct: 234 EVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  118 bits (298), Expect = 1e-29
 Identities = 83/253 (32%), Positives = 130/253 (51%), Gaps = 16/253 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           K +G G+FGTVY   W          VA+K L E    +   KE L E  +M  + +P++
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHV 71

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL +R
Sbjct: 72  CRLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER 128

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG-TP-EWMAPEVLRED 442
           R  +VHRDL + N+LV +   VK+ DFGL++             G  P +WMA E +   
Sbjct: 129 R--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186

Query: 443 PSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
               +SDV+S+GV +WEL+T   KP+ +  P+  IS++  KG RL  P      V  ++ 
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEKGERLPQPPICTIDVYMIMV 245

Query: 502 TCWAEEPEIRPSF 514
            CW  + + RP F
Sbjct: 246 KCWMIDADSRPKF 258

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  117 bits (294), Expect = 1e-29
 Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 25/264 (9%)

Query: 266 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           EL  K ++IG+GSFG V+   + R   V    +I+ E  ED  ++  +E+ ++     P 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +    G+  +   L I+ EYL  GS   LL         DE     M  ++ KG++YLH 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHS 119

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            +   +HRD+K+ N+L+     VK+ DFG++    +T I   T  GTP WMAPEV+++  
Sbjct: 120 EKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 498
            + K+D++S G+   EL   + P  +  P +V+           IPKN  P +       
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFSKP 228

Query: 499 ---LIETCWAEEPEIRPSFPSIME 519
               I+ C  ++P  RP+   +++
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (293), Expect = 2e-29
 Identities = 77/260 (29%), Positives = 125/260 (48%), Gaps = 22/260 (8%)

Query: 265 SELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRH 321
           S+L   K +G+GS G VY    +      A+K +      ++ F K+ LRE+  ++    
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCES 58

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSL----YKLLHIPDARVVVDERLRLNMAYDVAKG 377
           P +V   GA  +   +SIV EY+  GSL     K+  IP       E +   +A  + KG
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP-------EPVLAYIARQILKG 111

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           ++YLH +R  I+HRD+K  NLL++S   VK+ DFG+S+   NT     T  GT  +M+PE
Sbjct: 112 LDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170

Query: 438 VLREDPSNEKSDVFSFGVILWELIT----LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
            ++ +  +  +D++S G+ L E          P + S    + +        L   +  +
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP-AEEFS 229

Query: 494 PMVAALIETCWAEEPEIRPS 513
           P     I  C  ++P+ RPS
Sbjct: 230 PEFRDFISACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  116 bits (291), Expect = 3e-29
 Identities = 80/264 (30%), Positives = 130/264 (49%), Gaps = 25/264 (9%)

Query: 266 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           EL  K +KIG+GSFG V+   + R   V    +I+ E  ED  ++  +E+ ++     P 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +    G+  +   L I+ EYL  GS   LL  P     +DE     +  ++ KG++YLH 
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGP---LDETQIATILREILKGLDYLHS 119

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            +   +HRD+K+ N+L+     VK+ DFG++    +T I   T  GTP WMAPEV+++  
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 498
            + K+D++S G+   EL   + P     P +V+           IPKN  P +       
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSKP 228

Query: 499 ---LIETCWAEEPEIRPSFPSIME 519
               +E C  +EP  RP+   +++
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  115 bits (290), Expect = 6e-29
 Identities = 81/277 (29%), Positives = 136/277 (49%), Gaps = 26/277 (9%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKI--LIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
            KIGEGS G V  A  +++   VAVK   L +Q+  E  F E    V IM+  +HPNIV 
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNE----VVIMRDYQHPNIVE 80

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           +  +      L +V E+L  G+L  ++        ++E     +   V K +++LH +  
Sbjct: 81  MYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQG- 135

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
            ++HRD+KS ++L+ S   VK+ DFG    +S+  P      K+  GTP WMAPEV+   
Sbjct: 136 -VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR----RKSLVGTPYWMAPEVISRL 190

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-GFKGRRLEIPKNVNPMVAALIE 501
           P   + D++S G+++ E++  + P+ N  P Q +  +      +L+    V+P + + ++
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250

Query: 502 TCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 538
                +P  R    +  E L    ++    P S  PL
Sbjct: 251 RMLVRDPAQR---ATAAELLNHPFLAKAGPPSSIVPL 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  113 bits (285), Expect = 2e-28
 Identities = 75/272 (27%), Positives = 137/272 (50%), Gaps = 22/272 (8%)

Query: 265 SELLIKKKIGEGSFGTVYHAE--WRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRH 321
           +   I+KKIG G F  VY A        VA+K + I +       ++ ++E+ ++K L H
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNY 380
           PN++  + +  E   L+IV E    G L +++ +    + ++ ER        +   + +
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-----GTPEWMA 435
           +H RR  ++HRD+K  N+ + +T  VK+ D GL R     + SSKT A     GTP +M+
Sbjct: 122 MHSRR--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMS 174

Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP----KN 491
           PE + E+  N KSD++S G +L+E+  LQ P+     +  + ++  K  + + P    ++
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEH 232

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
            +  +  L+  C   +P+ RP    + +  +Q
Sbjct: 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  113 bits (284), Expect = 2e-28
 Identities = 73/256 (28%), Positives = 129/256 (50%), Gaps = 18/256 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           + +G G+FG V+    +     V +K +  ++  +D       E  ++K L HPNI+   
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
               E   L IV EY   G+L + +       ++DE   L+    +   ++++H +   I
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFVQILLALHHVHTKL--I 122

Query: 389 VHRDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAA----GTPEWMAPEVLREDP 443
           +HRDLK+ N+L+D    V K+ DFG+S+      +SSK+ A    GTP +++PE+    P
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCEGKP 177

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAALIET 502
            N+KSD+++ G +L+EL +L++ +  +  P+ V+  +   G    I    +P +  LI +
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM--SGTFAPISDRYSPDLRQLILS 235

Query: 503 CWAEEPEIRPSFPSIM 518
               +P  RP    IM
Sbjct: 236 MLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 7e-28
 Identities = 70/227 (30%), Positives = 112/227 (49%), Gaps = 15/227 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRH-PNIVL 326
           K I +G+FG+VY A+ R++    A+K+L + +   +++      E AIM      P +  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +      L +V EYL+ G    L+        + E        +V  G+  LHQR  
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG- 117

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            I+HRD+K  NLL+D T  +K+ DFGLSR   N   + K   GTP+++APE +     ++
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLEN-KKFVGTPDYLAPETILGVGDDK 172

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
            SD +S G +++E +    P+   TP  V   +    RR+  P+ V 
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--LSRRINWPEEVK 217

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  111 bits (278), Expect = 2e-27
 Identities = 75/257 (29%), Positives = 127/257 (49%), Gaps = 22/257 (8%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           I+KKIG G F  VY A      V V   K+ I          + ++E+ ++K L HPN++
Sbjct: 6   IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               +  E   L+IV E    G L +++ H    + ++ E+        +   + ++H R
Sbjct: 66  KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-----GTPEWMAPEVL 439
           R  ++HRD+K  N+ + +T  VK+ D GL R     + SSKT A     GTP +M+PE +
Sbjct: 126 R--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERI 178

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP----KNVNPM 495
            E+  N KSD++S G +L+E+  LQ P+     +  + ++  K  + + P     + +  
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE 236

Query: 496 VAALIETCWAEEPEIRP 512
           +  L+  C   +PE RP
Sbjct: 237 LRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  111 bits (278), Expect = 2e-27
 Identities = 77/248 (31%), Positives = 128/248 (51%), Gaps = 12/248 (4%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILI-EQEFHEDRFKEFL-REVAIMKGLRHPNIVLLMGA 330
           +G+G++G VY A  R+    V+I I E    + R+ + L  E+A+   L+H NIV  +G+
Sbjct: 16  LGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
            +E     I  E +  GSL  LL      +  +E+  +     + +G+ YLH  +  IVH
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVH 131

Query: 391 RDLKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS--NE 446
           RD+K  N+LV+ TY+  VK+ DFG S+        ++T  GT ++MAPEV+ + P     
Sbjct: 132 RDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 447 KSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
            +D++S G  + E+ T + P+     P   +  VG      EIP++++      I  C+ 
Sbjct: 191 PADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFE 250

Query: 506 EEPEIRPS 513
            +P+ R S
Sbjct: 251 PDPDKRAS 258

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  110 bits (277), Expect = 2e-27
 Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 25/257 (9%)

Query: 273 IGEGSFGTVYHAEWRNSD-VAVKILI----EQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G+G++GTVY         +AVK +          E  +++   EV ++K L+H NIV  
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
           +G   +   +SI  E++  GS+  +L+         E +       +  G+ YLH     
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLP---EPVFCKYTKQILDGVAYLHNNC-- 122

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR---------SKPNTYISSKTAAGTPEWMAPEV 438
           +VHRD+K  N+++     +K+ DFG +R         +  N     K+  GTP WMAPEV
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML---KSMHGTPYWMAPEV 179

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMV 496
           + E     KSD++S G  ++E+ T + P  +      +  +G   R L   +P + +   
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAAA 238

Query: 497 AALIETCWAEEPEIRPS 513
              + +C   +   RPS
Sbjct: 239 IDFVTSCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  111 bits (279), Expect = 3e-27
 Identities = 74/257 (28%), Positives = 117/257 (45%), Gaps = 47/257 (18%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL-----IE--QEFHEDRFKEFLREVAI 315
            +    K +G GSFG V     + S    A+KIL     ++  Q  H       L E  I
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH------VLNEKRI 54

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH------IPDARVVVDERLRLN 369
           ++ +RHP +V L G+  +  NL +V EY+  G L+  L        P AR    +     
Sbjct: 55  LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ----- 109

Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAA 428
               V   + YLH     IV+RDLK  NLL+DS   +K+ DFG + R K  TY    T  
Sbjct: 110 ----VVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLC 159

Query: 429 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGR 484
           GTPE++APE++      +  D ++ G++++E++    P+ +  P     +++        
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG------ 213

Query: 485 RLEIPKNVNPMVAALIE 501
           ++  P   +P    LI 
Sbjct: 214 KVRFPSFFSPDAKDLIR 230

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  109 bits (274), Expect = 4e-27
 Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 9/252 (3%)

Query: 271 KKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           + +G+GS+G V    H       V  K+ +      +R K   +E  ++  L+HPNIV  
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAY 64

Query: 328 MGAVT-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
             +   E   L IV  +   G LY  L     +++  E   +     +A  + YLH++  
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLP-ENQVVEWFVQIAMALQYLHEKH- 122

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            I+HRDLK+ N+ +  T  +KV D G++R   N    + T  GTP +M+PE+    P N 
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 506
           KSDV++ G  ++E+ TL+  +     + ++  +  +G+   +PK+ +P +  LI T  ++
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATMLSK 240

Query: 507 EPEIRPSFPSIM 518
            PE RPS  SI+
Sbjct: 241 RPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  110 bits (276), Expect = 4e-27
 Identities = 71/261 (27%), Positives = 127/261 (48%), Gaps = 24/261 (9%)

Query: 272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           ++G+G+FG VY A+ + +       + +   E+  ++++ E+ I+    HP IV L+GA 
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 332 TEPPNLSIVTEYLSRGS-------LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
                L I+ E+   G+       L + L  P  +V+  + L         + + YLH  
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML---------EALQYLHSM 129

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-----L 439
           +  I+HRDLK+ N+L+     +K+ DFG+S     T     +  GTP WMAPEV     +
Sbjct: 130 K--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-FKGRRLEIPKNVNPMVAA 498
           ++ P + K+D++S G+ L E+  ++ P     P +V+  +   +   L  P   +     
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247

Query: 499 LIETCWAEEPEIRPSFPSIME 519
            ++T   + PE RPS   ++E
Sbjct: 248 FLKTALDKHPETRPSAAQLLE 268

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  109 bits (273), Expect = 6e-27
 Identities = 70/253 (27%), Positives = 131/253 (51%), Gaps = 9/253 (3%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           + + +GEGSFG     +  NSD      +I + +       ++  +E  ++  ++HPNIV
Sbjct: 4   VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA--VEDSRKEAVLLAKMKHPNIV 61

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
               +     +L IV EY   G L + + +   ++  ++ + L     +  G+ ++H++R
Sbjct: 62  AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQMCLGVQHIHEKR 120

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+KS N+ +     VK+ DFG +R   +    + T  GTP ++ PE+    P N
Sbjct: 121 --VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
            KSD++S G IL+EL TL+ P++ ++   +I  V  +G    +P + +  + +LI+  + 
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-CQGSYKPLPSHYSYELRSLIKQMFK 237

Query: 506 EEPEIRPSFPSIM 518
             P  RPS  +I+
Sbjct: 238 RNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  109 bits (274), Expect = 1e-26
 Identities = 69/202 (34%), Positives = 108/202 (53%), Gaps = 14/202 (6%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           ++GEG+ G+V     +N+    A+K +     + D  K+ LRE+ I K  + P IV   G
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 330 AVTEPP--NLSIVTEYLSRGSL---YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           A  +    ++ I  EY   GSL   YK +     R+   E++   +A  V KG++YLH R
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI--GEKVLGKIAESVLKGLSYLHSR 124

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
           +  I+HRD+K  N+L+     VK+CDFG+S    N+   + T  GT  +MAPE ++  P 
Sbjct: 125 K--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPY 180

Query: 445 NEKSDVFSFGVILWELITLQKP 466
           +  SDV+S G+ L E+   + P
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  107 bits (269), Expect = 4e-26
 Identities = 74/241 (30%), Positives = 122/241 (50%), Gaps = 32/241 (13%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           I  ++G+G+FG VY A+ + + V     +     E+  ++++ E+ I+    HPNIV L+
Sbjct: 9   IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68

Query: 329 GAVTEPPNLSIVTEYLSRGS-------LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
            A     NL I+ E+ + G+       L + L  P  RVV  + L         + +NYL
Sbjct: 69  DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL---------EALNYL 119

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-- 439
           H+ +  I+HRDLK+ N+L      +K+ DFG+S     T     +  GTP WMAPEV+  
Sbjct: 120 HENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 440 ---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
              ++ P + K+DV+S G+ L E+  ++ P     P +V+         L+I K+  P +
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKSEPPTL 228

Query: 497 A 497
           A
Sbjct: 229 A 229

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  107 bits (268), Expect = 6e-26
 Identities = 78/270 (28%), Positives = 136/270 (50%), Gaps = 19/270 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQ-EFHEDRFKEFL-REVAIMKGLRHPNIVL 326
           +KIG+G+ GTV+ A     DVA   ++ I+Q    +   KE +  E+ +MK L++PNIV 
Sbjct: 25  EKIGQGASGTVFTA----IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            + +      L +V EYL+ GSL  ++        +DE     +  +  + + +LH  + 
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHANQ- 135

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRD+KS N+L+    +VK+ DFG             T  GTP WMAPEV+       
Sbjct: 136 -VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 505
           K D++S G++  E++  + P+ N  P + +  +   G   L+ P+ ++P+    +  C  
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254

Query: 506 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 535
            + E R S   +++    FL   + +PLS+
Sbjct: 255 MDVEKRGSAKELLQ--HPFL--KLAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  106 bits (266), Expect = 8e-26
 Identities = 68/259 (26%), Positives = 122/259 (47%), Gaps = 18/259 (6%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMG 329
           IG+G+FG V   + R++    A+K + +Q+  E    +  L E  I++ L HP +V L  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 330 AVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
           +  +  N+ +V + L  G L Y   H+       +E+++  +  ++   + YLH +   I
Sbjct: 68  SFQDEENMYLVVDLLLGGDLRY---HLSQKVKFSEEQVKFWIC-EIVLALEYLHSKG--I 121

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +HRD+K  N+L+D    V + DF ++    P+T  +S   +GTP +MAPEVL     +  
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPEVLCRQGYSVA 179

Query: 448 SDVFSFGVILWELITLQKPWRN--STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
            D +S GV  +E +  ++P+R    T    I A   +   +  P   +      I     
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QETADVLYPATWSTEAIDAINKLLE 238

Query: 506 EEPEIRPSFPSIMETLQQF 524
            +P+ R      ++ L+  
Sbjct: 239 RDPQKRLGDN--LKDLKNH 255

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  106 bits (268), Expect = 1e-25
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 36/214 (16%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 323
           KK+GEG++  VY A  + +   VA+K +   E  E   K+      LRE+ +++ L+HPN
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA--KDGINFTALREIKLLQELKHPN 63

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA------KG 377
           I+ L+       N+++V E++    L K++         D+ + L  A   +      +G
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEKVIK--------DKSIVLTPADIKSYMLMTLRG 114

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMA 435
           + YLH     I+HRDLK  NLL+ S   +K+ DFGL+RS   PN  ++ +    T  + A
Sbjct: 115 LEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRA 170

Query: 436 PEVLREDPSNEKS---DVFSFGVILWELITLQKP 466
           PE+L    +       D++S G I  EL+ L+ P
Sbjct: 171 PELLFG--ARHYGVGVDMWSVGCIFAELL-LRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score =  107 bits (268), Expect = 1e-25
 Identities = 89/338 (26%), Positives = 143/338 (42%), Gaps = 73/338 (21%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
           E     L + K +G G+FG V  A     +       VAVK+L E     + +K  + E+
Sbjct: 3   EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE-YKALMTEL 61

Query: 314 AIMKGL-RHPNIVLLMGAVTEP--PNLSIV--------TEYL-SRGSLYKLLHIPDAR-- 359
            I+  +  H N+V L+GA T+P  P + IV        + YL S+   +        R  
Sbjct: 62  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKR 121

Query: 360 ---VVVDERLRLN-------------------------------------------MAYD 373
                  ++ RL+                                            ++ 
Sbjct: 122 EMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQ 181

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTP 431
           VA+GM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+    A    
Sbjct: 182 VARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 490
           +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       +G R+  P+
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPE 299

Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              P + +++  CW   PE RP+F  ++E L   L  +
Sbjct: 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  106 bits (267), Expect = 1e-25
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 25/208 (12%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKIL----------IEQEFHEDRFKEFLREVAIMKG 318
           K +G+GSFG V  AE + +D   AVK+L          +E    E R             
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG------- 53

Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
            +HP +  L         L  V EY++ G L  + HI  +    + R R   A ++  G+
Sbjct: 54  -KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARF-YAAEIVLGL 109

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
            +LH+R   I++RDLK  N+L+DS   +K+ DFG+ +      +++ T  GTP+++APE+
Sbjct: 110 QFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI 167

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKP 466
           L   P     D ++ GV+L+E++  Q P
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 27/208 (12%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD----VAVK-ILIEQEFHEDRFK-EFLREVAIMKGLRHP 322
              +IGEG++G VY A  RN      VA+K I +E E  ++ F    +RE+ +++ LRHP
Sbjct: 3   KIAQIGEGTYGQVYKA--RNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHP 58

Query: 323 NIVLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           NIV L   VT     SI  V EY+    L  LL  P+ +    +         + +G+ Y
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCY--MKQLLEGLQY 115

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-A 435
           LH     I+HRD+K  N+L+++   +K+ DFGL+R     Y    +A  T      W   
Sbjct: 116 LHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVITLWYRP 169

Query: 436 PEVLR-EDPSNEKSDVFSFGVILWELIT 462
           PE+L        + D++S G IL EL  
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  107 bits (268), Expect = 2e-25
 Identities = 75/260 (28%), Positives = 124/260 (47%), Gaps = 23/260 (8%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFK-EFLREVAIMKGLRH 321
           SEL    +IG G+ GTVY    R +    A+K++     HED  + +  RE+ I++ + H
Sbjct: 74  SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNH 131

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           PN+V           + ++ E++  GSL       +   + DE+   ++A  +  G+ YL
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSL-------EGTHIADEQFLADVARQILSGIAYL 184

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
           H+R   IVHRD+K  NLL++S   VK+ DFG+SR    T     ++ GT  +M+PE +  
Sbjct: 185 HRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242

Query: 442 DPSNEK-----SDVFSFGVILWELITLQKPW---RNSTPSQVISAVGFKGRRLEIPKNVN 493
           D ++        D++S GV + E    + P+   R    + ++ A+    +  E P   +
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-QPPEAPATAS 301

Query: 494 PMVAALIETCWAEEPEIRPS 513
                 I  C   EP  R S
Sbjct: 302 REFRHFISCCLQREPAKRWS 321

Length = 353

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score =  104 bits (261), Expect = 3e-25
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 28/273 (10%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE---FLREVAIMKGLRHPNIVLL 327
            +IG G FG V   E        ++++++        E   FL+EV   + L HPN++  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV----DERLRLNMAYDVAKGMNYLHQ 383
           +G   E     +V E+   G L   L     R +V     + +   MA +VA G+ +LHQ
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLR--SNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP-EWMAPEVLRE 441
                +H DL   N  + +  +VK+ D+GL+  + P  Y  +K     P  W+APE++  
Sbjct: 119 AD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 442 DPSN-------EKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK-NV 492
              +       +KS+++S GV +WEL T   +P+ + +  QV+  V  + + +++PK  +
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQL 235

Query: 493 NPMVA----ALIETCWAEEPEIRPSFPSIMETL 521
           +   +     +++ CW  +PE RP+   + E L
Sbjct: 236 DLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  104 bits (261), Expect = 4e-25
 Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 41/266 (15%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLR-----------EVAIMK-GLR 320
           +G G+FG VY    +N+   +  L E   H   F +  R           EV I+K  LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAY 372
           HPNIV       E   L IV + +    L +             + R+        N+  
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-------WNIFV 120

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP 431
            +   + YLH+ +  IVHRDL   N+++     V + DFGL++ K P + ++S    GT 
Sbjct: 121 QMVLALRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTI 177

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN----STPSQVISAVGFKGRRLE 487
            +  PE+++ +P  EK+DV++FG IL+++ TLQ P+ +    S  ++++ AV        
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV-----YEP 232

Query: 488 IPKNV-NPMVAALIETCWAEEPEIRP 512
           +P+ + +  V  +I +C   + E RP
Sbjct: 233 LPEGMYSEDVTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score =  105 bits (264), Expect = 4e-25
 Identities = 54/158 (34%), Positives = 89/158 (56%), Gaps = 5/158 (3%)

Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAA 428
           ++ VA+GM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+   +A 
Sbjct: 180 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237

Query: 429 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLE 487
              +WMAPE + +     +SDV+SFGV+LWE+ +L   P+     ++        G R+ 
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297

Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            P+N  P +  ++  CW  +P+ RP+F +++E L   L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  103 bits (259), Expect = 5e-25
 Identities = 74/259 (28%), Positives = 132/259 (50%), Gaps = 12/259 (4%)

Query: 268 LIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLR---EVAIMKGLRHP 322
           ++++++G+GSFGTVY  + + +     +K+L E    E    E ++   E  ++  L HP
Sbjct: 3   ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
            IV    +  E     I+TEY     L  KL  +      + E         +  G++Y+
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
           HQRR  I+HRDLK+ N+ + +   +K+ DFG+SR    +   + T  GTP +M+PE L+ 
Sbjct: 123 HQRR--ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179

Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAALI 500
              + KSD++S G IL+E+  L   +      S V+  V  +G    +P+  +  + +++
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV--EGPTPSLPETYSRQLNSIM 237

Query: 501 ETCWAEEPEIRPSFPSIME 519
           ++   ++P +RPS   I+ 
Sbjct: 238 QSMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 8e-25
 Identities = 75/256 (29%), Positives = 123/256 (48%), Gaps = 20/256 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREV-------AIMKGLRHPN 323
           K +G G+FG VY     ++D   ++ ++Q   +   +E  +EV        ++K LRH  
Sbjct: 8   KLLGRGAFGEVYLC--YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65

Query: 324 IVLLMGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           IV   G + +P    LSI  EY+  GS+   L    A   + E +       + +G++YL
Sbjct: 66  IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYL 122

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEV 438
           H     IVHRD+K  N+L DS   VK+ DFG S+      +S    K+  GTP WM+PEV
Sbjct: 123 HSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           +  +    K+DV+S    + E++T + PW        I  +  +  +  +P  V+     
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240

Query: 499 LIETCWAEEPEIRPSF 514
            ++  + EE + RP+ 
Sbjct: 241 FLKQIFVEE-KRRPTA 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  103 bits (259), Expect = 1e-24
 Identities = 77/270 (28%), Positives = 135/270 (50%), Gaps = 19/270 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQEFHEDRFKEFL--REVAIMKGLRHPNIVL 326
           +KIG+G+ GTVY A     DVA   ++ I+Q   + + K+ L   E+ +M+  +HPNIV 
Sbjct: 25  EKIGQGASGTVYTA----IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            + +      L +V EYL+ GSL  ++        +DE     +  +  + + +LH  + 
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ- 135

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRD+KS N+L+    +VK+ DFG             T  GTP WMAPEV+       
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 505
           K D++S G++  E++  + P+ N  P + +  +   G   L+ P+ ++ +    +  C  
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254

Query: 506 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 535
            + E R S   +++    FL   + +PLS+
Sbjct: 255 MDVEKRGSAKELLQ--HPFL--KIAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  103 bits (258), Expect = 2e-24
 Identities = 77/262 (29%), Positives = 121/262 (46%), Gaps = 20/262 (7%)

Query: 273 IGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREV-AIMKGLRHPNIVLLMG 329
           IG G+FGTV     + S    AVK  I     E   K  L ++  +M+    P IV   G
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVK-RIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 330 AVTEPPNLSIVTEY--LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
           A+    +  I  E   +S    YK ++    + V+ E +   +A    K +NYL +    
Sbjct: 71  ALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYL-KEELK 128

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE- 446
           I+HRD+K  N+L+D    +K+CDFG+S    ++   ++ A   P +MAPE  R DPS   
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPE--RIDPSARD 185

Query: 447 ----KSDVFSFGVILWELITLQKPWR--NSTPSQVISAVGFKGRRL--EIPKNVNPMVAA 498
               +SDV+S G+ L+E+ T + P+   NS   Q+   V      L     +  +P    
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVN 245

Query: 499 LIETCWAEEPEIRPSFPSIMET 520
            I  C  ++   RP +  ++E 
Sbjct: 246 FINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  103 bits (258), Expect = 2e-24
 Identities = 70/244 (28%), Positives = 123/244 (50%), Gaps = 10/244 (4%)

Query: 271 KKIGEGSFGTVYHAEWRNSDV--AVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V     + +    A+KIL  E    +D     + E  +++  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             A      L  V EY + G L+   H+   RV  +ER R   A ++   + YLH R   
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSRD-- 115

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RD+K  NL++D    +K+ DFGL +   +   + KT  GTPE++APEVL ++     
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +  R   P+ ++P   +L+     ++
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKSLLAGLLKKD 233

Query: 508 PEIR 511
           P+ R
Sbjct: 234 PKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 83/285 (29%), Positives = 129/285 (45%), Gaps = 57/285 (20%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIV 325
           + + IGEG++G VY A  + +   VA+KI    +  ED  +E   E  I++    HPNI 
Sbjct: 10  LVEVIGEGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNIA 66

Query: 326 LLMGA------VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM-AY---DVA 375
              GA            L +V E    GS+  L+     +    +RL+    AY   +  
Sbjct: 67  TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK---GKRLKEEWIAYILRETL 123

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSKTAAG 429
           +G+ YLH+ +  ++HRD+K  N+L+     VK+ DFG+S        + NT+I      G
Sbjct: 124 RGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------G 175

Query: 430 TPEWMAPEVLREDPSNE-----KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR 484
           TP WMAPEV+  D   +     +SDV+S G+   EL   + P  +  P + +    FK  
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK-- 229

Query: 485 RLEIPKNVNPMVAA----------LIETCWAEEPEIRPSFPSIME 519
              IP+N  P + +           I  C  +  E RP    ++E
Sbjct: 230 ---IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  103 bits (257), Expect = 2e-24
 Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 14/265 (5%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPN 323
            E+ +  ++G+G++G+VY    R + V + +  I  E  E +F + + E+ I+     P 
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV   GA      + +  EY+  GSL KL     A   + E +   + Y V KG+ +L +
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAAGTPEWMAPEVLRED 442
               I+HRD+K  N+LV+    VK+CDFG+S    N   S +KT  G   +MAPE ++  
Sbjct: 121 EHN-IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKSG 176

Query: 443 PSNE------KSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNP 494
             N+      +SDV+S G+ + E+   + P+   T + + + +     G    +P   + 
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236

Query: 495 MVAALIETCWAEEPEIRPSFPSIME 519
                +  C  + P  RP++  ++E
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 3e-24
 Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 34/211 (16%)

Query: 272 KIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           KIGEG++G VY A  +     VA+K I +E E  E      +RE++++K L HPNIV L+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             V     L +V E+L    L K +   P     +D  L  +  Y + +G+ Y H  R  
Sbjct: 65  DVVHSENKLYLVFEFLDL-DLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----------WM-AP 436
           ++HRDLK  NLL+D    +K+ DFGL+R           A G P           W  AP
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLAR-----------AFGVPVRTYTHEVVTLWYRAP 168

Query: 437 EVLREDPSNEKS-DVFSFGVILWELITLQKP 466
           E+L          D++S G I  E++  ++P
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 3e-24
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLM 328
           ++G+G +G V+ A+ +++   VA+K + +    + +  +  L E  I+   +   +V L+
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            A  +   L +  EY+  G    LL+  +  V+ ++  R  MA      ++ LH+     
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFE-AVDALHEL--GY 122

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRDLK  N L+D++  +K+ DFGLS+        + +  G+P++MAPEVLR    +   
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGYDFTV 179

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQV 475
           D +S G +L+E +    P+  STP++ 
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNET 206

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  101 bits (254), Expect = 4e-24
 Identities = 70/211 (33%), Positives = 106/211 (50%), Gaps = 31/211 (14%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY    + +   V   KI +E E  E      +RE++++K L+HPNIV L
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCL 64

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
              + +   L ++ E+LS   L K L        +D  L  +  Y + +G+ + H RR  
Sbjct: 65  QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-----------WMAP 436
           ++HRDLK  NLL+D+   +K+ DFGL+R           A G P            + AP
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR-----------AFGIPVRVYTHEVVTLWYRAP 170

Query: 437 EVLREDPS-NEKSDVFSFGVILWELITLQKP 466
           EVL   P  +   D++S G I  E+ T +KP
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  101 bits (253), Expect = 6e-24
 Identities = 78/270 (28%), Positives = 134/270 (49%), Gaps = 19/270 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQ-EFHEDRFKEFL-REVAIMKGLRHPNIVL 326
           +KIG+G+ GTVY A     DVA   ++ I Q    +   KE +  E+ +M+  ++PNIV 
Sbjct: 26  EKIGQGASGTVYTA----MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            + +      L +V EYL+ GSL  ++        +DE     +  +  + + +LH  + 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ- 136

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRD+KS N+L+    +VK+ DFG             T  GTP WMAPEV+       
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 505
           K D++S G++  E+I  + P+ N  P + +  +   G   L+ P+ ++ +    +  C  
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 506 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 535
            + E R S   +++   QFL   + +PLS+
Sbjct: 256 MDVEKRGSAKELLQ--HQFL--KIAKPLSS 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  101 bits (252), Expect = 6e-24
 Identities = 84/289 (29%), Positives = 136/289 (47%), Gaps = 31/289 (10%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW-------RNSDVAVKILIEQEFHEDRFKEFLREV 313
           EI  S +   +++GE  FG VY           +   VA+K L ++   E   +E  +  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHE 58

Query: 314 AIMKG-LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARV-------VVD 363
           A+M+  L+HPNIV L+G VT+   LS++  Y S   L++ L +  P + V        V 
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 364 ERLR----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--K 417
             L     +++   +A GM +L      +VH+DL + N+LV     VK+ D GL R    
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVI 476
            + Y     +     WM+PE +     +  SD++S+GV+LWE+ +   +P+   +   VI
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236

Query: 477 SAVGFKGRR-LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
             +  + R+ L  P +    V  L+  CW E P  RP F  I   L+ +
Sbjct: 237 EMI--RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 6e-24
 Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 21/201 (10%)

Query: 272 KIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
            +GEG++G V     RN      VA+K   E E  ED  K  LREV +++ LRH NIV L
Sbjct: 8   VVGEGAYGVVLKC--RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV--VVDERLRLNMAYDVAKGMNYLHQRR 385
             A      L +V EY+ R     LL + +A    +  + +R  + + + + + Y H   
Sbjct: 66  KEAFRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYI-WQLLQAIAYCHSHN 120

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLRED 442
             I+HRD+K  N+LV  +  +K+CDFG +R   ++P + ++   A  T  + APE+L  D
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA--TRWYRAPELLVGD 176

Query: 443 PSNEKS-DVFSFGVILWELIT 462
            +  K  DV++ G I+ EL+ 
Sbjct: 177 TNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  101 bits (254), Expect = 7e-24
 Identities = 72/211 (34%), Positives = 116/211 (54%), Gaps = 13/211 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNI 324
           K IG+GSFG V  A+ R SD    AVK+L ++   + + +  +   R V ++K L+HP +
Sbjct: 1   KVIGKGSFGKVLLAK-RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFL 58

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V L  +      L  V +Y++ G L+   H+   R  ++ R R   A +VA  + YLH  
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVASAIGYLHSL 115

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
              I++RDLK  N+L+DS   V + DFGL +       ++ T  GTPE++APEVLR++P 
Sbjct: 116 N--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
           +   D +  G +L+E++    P+ +   SQ+
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  101 bits (254), Expect = 7e-24
 Identities = 76/274 (27%), Positives = 130/274 (47%), Gaps = 37/274 (13%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREVAI-MKGLRHP 322
           +L    +IG G+ G VY   ++ +    AVK +      E+  K  L ++ + +K    P
Sbjct: 16  DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSHDCP 74

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAKG 377
            IV   G      ++ I  E +S   L KLL      IP       E +   M   + K 
Sbjct: 75  YIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIP-------EDILGKMTVAIVKA 126

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEW 433
           ++YL ++   ++HRD+K  N+L+D++  VK+CDFG+S     SK  T      +AG   +
Sbjct: 127 LHYLKEKHG-VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT-----RSAGCAAY 180

Query: 434 MAPEVLREDPSNEK------SDVFSFGVILWELITLQKPWRN-STPSQVISAV-GFKGRR 485
           MAPE  R DP +        +DV+S G+ L EL T Q P++N  T  +V++ +   +   
Sbjct: 181 MAPE--RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238

Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
           L   +  +P   + ++ C  ++   RP +  +++
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  102 bits (254), Expect = 7e-24
 Identities = 69/244 (28%), Positives = 124/244 (50%), Gaps = 10/244 (4%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V     + S    A+KIL ++    +D     L E  ++K  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +      L  V EY++ G L+   H+   RV  ++R R   A ++   ++YLH  +  
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSGK-- 115

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           IV+RDLK  NL++D    +K+ DFGL +       + KT  GTPE++APEVL ++     
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   ++ P+ ++    +L+     ++
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKSLLSGLLIKD 233

Query: 508 PEIR 511
           P  R
Sbjct: 234 PNKR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  100 bits (250), Expect = 1e-23
 Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 19/259 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           ++IG G++G VY A   N+ ++A   +I+ E  ED F    +E+ +MK  +H NIV   G
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNYLHQRRP 386
           +      L I  E+   GSL  + H      V        +AY   +  +G+ YLH +  
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYH------VTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL---REDP 443
             +HRD+K  N+L+     VK+ DFG+S     T    K+  GTP WMAPEV    R+  
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGRRLEIPKNVNPMVAALI 500
            N+  D+++ G+   EL  LQ P  +  P +   +++   F+  +L+     +      +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245

Query: 501 ETCWAEEPEIRPSFPSIME 519
           +    + P+ RP+   +++
Sbjct: 246 KMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  101 bits (254), Expect = 1e-23
 Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 24/212 (11%)

Query: 269 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + K IG G++G V  A  +     VA+K +          K  LRE+ +++ LRH NI+ 
Sbjct: 4   LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63

Query: 327 LMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           L+  +  PP+        IVTE +    L+K++  P  + + D+ ++  + Y + +G+ Y
Sbjct: 64  LL-DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP--QPLTDDHIQYFL-YQILRGLKY 118

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-A 435
           LH     ++HRDLK  N+LV+S   +K+CDFGL+R         +    T      W  A
Sbjct: 119 LH--SANVIHRDLKPSNILVNSNCDLKICDFGLARG--VDPDEDEKGFLTEYVVTRWYRA 174

Query: 436 PEVLREDPSNEKS-DVFSFGVILWELITLQKP 466
           PE+L       K+ D++S G I  EL+T +KP
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLT-RKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  101 bits (252), Expect = 1e-23
 Identities = 68/244 (27%), Positives = 125/244 (51%), Gaps = 9/244 (3%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V   + + +    A+KIL ++    +D     L E  +++  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +      L  V EY + G L+   H+   RV  ++R R   A ++   ++YLH  +  
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN- 116

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RDLK  NL++D    +K+ DFGL +       + KT  GTPE++APEVL ++     
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +  R   P+ ++P   +L+     ++
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPEAKSLLSGLLKKD 234

Query: 508 PEIR 511
           P+ R
Sbjct: 235 PKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 99.3 bits (247), Expect = 2e-23
 Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 20/255 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA-------IMKGLRHPN 323
           K +G+G+FG VY     ++D   ++ ++Q   +    E  +EV        ++K L H  
Sbjct: 8   KLLGQGAFGRVYLC--YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65

Query: 324 IVLLMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           IV   G + +P    LSI  E++  GS+   L    A   + E +       + +G++YL
Sbjct: 66  IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYL 122

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEV 438
           H     IVHRD+K  N+L DS   VK+ DFG S+      +S    K+  GTP WM+PEV
Sbjct: 123 HSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           +  +    K+D++S G  + E++T + PW        I  +  +     +P +V+     
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240

Query: 499 LIETCWAEEPEIRPS 513
            ++  + E  ++RPS
Sbjct: 241 FLKRIFVEA-KLRPS 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 99.4 bits (247), Expect = 4e-23
 Identities = 72/268 (26%), Positives = 135/268 (50%), Gaps = 15/268 (5%)

Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +KIG+G+ GTVY A       +VA+K +  Q+  + + +  + E+ +M+  ++PNIV  +
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYL 82

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +      L +V EYL+ GSL  ++        +DE     +  +  + +++LH  +  +
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQ--V 136

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+KS N+L+    +VK+ DFG             T  GTP WMAPEV+       K 
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEE 507
           D++S G++  E++  + P+ N  P + +  +   G   L+ P+ ++ +    +  C   +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256

Query: 508 PEIRPSFPSIMETLQQFLMSSVCQPLSA 535
            + R S   +++    FL   + +PLS+
Sbjct: 257 VDRRGSAKELLQ--HPFL--KLAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 99.1 bits (247), Expect = 4e-23
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 11/210 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           ++R  +L     +G G+ G+V   +   +  V  K ++         K+ LRE+ IM   
Sbjct: 1   DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC 60

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKG 377
           R P IV   GA     N+ +  E++  GSL ++     P    ++ +     +A  V +G
Sbjct: 61  RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK-----IAVAVVEG 115

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           + YL+     I+HRD+K  N+LV+S   +K+CDFG+S    N+   + T  GT  +M+PE
Sbjct: 116 LTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPE 172

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPW 467
            ++      KSDV+S G+ + EL   + P+
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPF 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 99.5 bits (248), Expect = 6e-23
 Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 31/271 (11%)

Query: 253 LYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEF 309
           ++ + +    + S+  + + +G GSFG V  A+ + +    A+K L ++E     + +  
Sbjct: 6   MFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHV 65

Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
            +E +I+  L HP IV +M +  +   +  + E++  G L+  L           R    
Sbjct: 66  AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-----------RKAGR 114

Query: 370 MAYDVAK--------GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-T 420
              DVAK           YLH +   I++RDLK  NLL+D+   VKV DFG ++  P+ T
Sbjct: 115 FPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172

Query: 421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG 480
           +    T  GTPE++APEV++     +  D ++ GV+L+E I    P+ + TP ++   + 
Sbjct: 173 F----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI- 227

Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIR 511
             G RL+ P   +     L++     +   R
Sbjct: 228 LAG-RLKFPNWFDGRARDLVKGLLQTDHTKR 257

Length = 329

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 99.7 bits (248), Expect = 7e-23
 Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 5/161 (3%)

Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAA 428
           ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+    A 
Sbjct: 185 SFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242

Query: 429 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLE 487
              +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       +G R+ 
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302

Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
            P    P +   +  CW  EP  RP+F  ++E L   L ++
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 98.6 bits (245), Expect = 7e-23
 Identities = 75/271 (27%), Positives = 129/271 (47%), Gaps = 16/271 (5%)

Query: 272 KIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLM 328
           KIGEGS G V  A  +++   VAVK   + +  + + +E L  EV IM+   H N+V + 
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +      L +V E+L  G+L  ++        ++E     +   V + ++YLH +   +
Sbjct: 86  NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ--GV 139

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+KS ++L+ S   +K+ DFG            K+  GTP WMAPEV+   P   + 
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEE 507
           D++S G+++ E+I  + P+ N  P Q +  +      R++    V+ ++   ++     E
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259

Query: 508 PEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 538
           P  R    +  E LQ   +     P    PL
Sbjct: 260 PSQR---ATAQELLQHPFLKLAGPPSCIVPL 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 97.8 bits (243), Expect = 1e-22
 Identities = 72/257 (28%), Positives = 131/257 (50%), Gaps = 23/257 (8%)

Query: 272 KIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLM 328
           KIGEGS G V  A  ++S   VAVK++   +  + + +E L  EV IM+  +H N+V + 
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +      L ++ E+L  G+L  ++    ++  ++E     +   V + + YLH +   +
Sbjct: 85  KSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQ--GV 138

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+KS ++L+     VK+ DFG            K+  GTP WMAPEV+   P   + 
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP---KN---VNPMVAALIET 502
           D++S G+++ E++  + P+ + +P Q +     K  R   P   KN   ++P++   +E 
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAM-----KRLRDSPPPKLKNAHKISPVLRDFLER 253

Query: 503 CWAEEPEIRPSFPSIME 519
               EP+ R +   +++
Sbjct: 254 MLTREPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 25/202 (12%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           +IGEG+ G V+ A+ R +   VA+K +  +        + LRE+  ++  +HP +V L+ 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
                    +V EY+    L ++L      +P+A+V    +  + M   + KG+ Y+H  
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQV----KSYMRM---LLKGVAYMHAN 118

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL---- 439
              I+HRDLK  NLL+ +   +K+ DFGL+R               T  + APE+L    
Sbjct: 119 G--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176

Query: 440 REDPSNEKSDVFSFGVILWELI 461
           + DP     D+++ G I  EL+
Sbjct: 177 KYDPG---VDLWAVGCIFAELL 195

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 98.6 bits (245), Expect = 3e-22
 Identities = 54/165 (32%), Positives = 89/165 (53%), Gaps = 13/165 (7%)

Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSK 425
           L+  Y VA+GM +L  +    VHRDL + N+L+     VK+CDFGL+R     + Y+S  
Sbjct: 240 LSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK-- 482
           +     +WMAPE + ++     SDV+S+G++LWE+ +L   P+    P  ++ +  +   
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY----PGMIVDSTFYNKI 353

Query: 483 --GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
             G R+  P +    V  ++  CW  EPE RPSF  + + ++  L
Sbjct: 354 KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 98.0 bits (244), Expect = 4e-22
 Identities = 53/165 (32%), Positives = 91/165 (55%), Gaps = 13/165 (7%)

Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSK 425
           L+ +Y VAKGM++L  +    +HRDL + N+L+      K+CDFGL+R   N   Y+   
Sbjct: 217 LSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274

Query: 426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK-- 482
            A    +WMAPE +       +SDV+S+G++LWE+ +L   P+    P   + +  +K  
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY----PGMPVDSKFYKMI 330

Query: 483 --GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
             G R+  P+     +  ++++CW  +P  RP+F  I++ ++Q L
Sbjct: 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 95.9 bits (238), Expect = 4e-22
 Identities = 75/257 (29%), Positives = 122/257 (47%), Gaps = 27/257 (10%)

Query: 271 KKIGEGSFGTVYHAEWRNSDV----AVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           +++G G++G VY A  RN       AVKI+ +E     D F    +E+ ++K  +H NIV
Sbjct: 15  QRVGSGTYGDVYKA--RNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIV 69

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNYLH 382
              G+      L I  EY   GSL  + H      V      L +AY   +  +G+ YLH
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYH------VTGPLSELQIAYVCRETLQGLAYLH 123

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
            +    +HRD+K  N+L+     VK+ DFG++     T    K+  GTP WMAPEV   +
Sbjct: 124 SKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 443 PS---NEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGRRLEIPKNVNPMV 496
            +   N+  D+++ G+   EL  LQ P  +  P +   ++S   F+  +L+     +   
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241

Query: 497 AALIETCWAEEPEIRPS 513
              ++    + P+ RP+
Sbjct: 242 HNFVKISLTKNPKKRPT 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 72/237 (30%), Positives = 121/237 (51%), Gaps = 15/237 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREVA----IMKGLRHPNI 324
           K IG+GSFG V  A+ +      AVK+L  Q+    + KE    +A    ++K ++HP +
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVL--QKKAILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V L  +      L  V +Y++ G L+   H+   R   + R R   A ++A  + YLH  
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGELF--FHLQRERSFPEPRARF-YAAEIASALGYLHSL 115

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
              I++RDLK  N+L+DS   V + DFGL +       ++ T  GTPE++APEVLR+ P 
Sbjct: 116 N--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
           +   D +  G +L+E++    P+ +   +++   +  K   L +  N++     L+E
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLE 228

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 97.8 bits (243), Expect = 6e-22
 Identities = 55/162 (33%), Positives = 88/162 (54%), Gaps = 7/162 (4%)

Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSK 425
           +  +Y VA GM +L  +    VHRDL + N+L+     VK+CDFGL+R   + + YIS  
Sbjct: 242 VGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG 299

Query: 426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGFKG 483
           +     +WMAPE +  +     SDV+SFG++LWE+ TL        P   Q  +A+  +G
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK-RG 358

Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            R+  P + +  +  +++ CW E+ EIRP F  ++  +   L
Sbjct: 359 YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 95.1 bits (237), Expect = 9e-22
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 22/206 (10%)

Query: 272 KIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNIV 325
           KIGEGS+G V+    RN +    VA+K  +E E  +D    K  LRE+ ++K L+HPN+V
Sbjct: 8   KIGEGSYGVVFKC--RNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLV 63

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV-VDERLRLNMAYDVAKGMNYLHQR 384
            L+        L +V EY      + +L+  +     V E L   + +   + +N+ H+ 
Sbjct: 64  NLIEVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLRED 442
               +HRD+K  N+L+     +K+CDFG +R  + P    +   A  T  + APE+L  D
Sbjct: 120 N--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA--TRWYRAPELLVGD 175

Query: 443 PS-NEKSDVFSFGVILWELITLQKPW 467
                  DV++ G +  EL+T Q  W
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLW 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 27/247 (10%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL-------IEQEFHEDRFKEFLREVAI 315
            +L   K +G G+FG V+    R S+   A+K++       ++QE H    K  L+EV  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
                HP I+ L     +   L ++ EY+  G L+  L              L  A ++ 
Sbjct: 59  ----SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEIV 111

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWM 434
             + YLH +   IV+RDLK  N+L+D    +K+ DFG ++  +  T+    T  GTPE++
Sbjct: 112 CALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYL 165

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           APEV++    N+  D ++ G++++E++    P+ +  P  +   +   G +LE P++++ 
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-LAG-KLEFPRHLDL 223

Query: 495 MVAALIE 501
               LI+
Sbjct: 224 YAKDLIK 230

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 71/247 (28%), Positives = 118/247 (47%), Gaps = 17/247 (6%)

Query: 273 IGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLMG 329
           +G G FG V   + ++ +   A+K + ++   E   +E +  E  I++   HP IV L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              +   + ++ EY   G L+ +L     R + DE         V     YLH R   I+
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNRG--II 115

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +RDLK  NLL+DS   VK+ DFG ++   S   T+    T  GTPE++APE++     + 
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW----TFCGTPEYVAPEIILNKGYDF 171

Query: 447 KSDVFSFGVILWELITLQKPWRNS--TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
             D +S G++L+EL+T + P+      P ++ + +     +LE P  ++     LI+   
Sbjct: 172 SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231

Query: 505 AEEPEIR 511
              PE R
Sbjct: 232 RRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 72/255 (28%), Positives = 120/255 (47%), Gaps = 20/255 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA-------IMKGLRHPN 323
           K +G+G+FG VY     + D   ++  +Q   +    E  +EV+       ++K L+H  
Sbjct: 8   KLLGQGAFGRVYLC--YDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65

Query: 324 IVLLMGAVTE--PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           IV   G + +     L+I  EY+  GS+   L    A   + E +       + +GM+YL
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYL 122

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEV 438
           H     IVHRD+K  N+L DS   VK+ DFG S+      +S    ++  GTP WM+PEV
Sbjct: 123 HSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           +  +    K+DV+S G  + E++T + PW        I  +  +    ++P +++     
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240

Query: 499 LIETCWAEEPEIRPS 513
            +   + E    RPS
Sbjct: 241 FLGCIFVEARH-RPS 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 93.8 bits (233), Expect = 2e-21
 Identities = 77/264 (29%), Positives = 130/264 (49%), Gaps = 26/264 (9%)

Query: 271 KKIGEGSFGTVYHAE----WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           K+IG G FG V   E    +  + V VK L      +++ K FL E    + L+H N++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQR 384
            +G  TE     +V E+   G L   L        +  D      MA ++A G+ +LH+ 
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLS--RSKPNTYISSKTAAGTPEWMAPEVLRED 442
               +H DL   N L+ +  TVK+ D+GLS  + K + Y++         W+APE++ E 
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 443 PSN-------EKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
             N       ++S+V+S GV +WEL  L  +P+R+ +  QV++    + ++L++PK    
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQQLKLPKPRLK 236

Query: 495 MVAA-----LIETCWAEEPEIRPS 513
           +  +     +++ CW  +PE RPS
Sbjct: 237 LPLSDRWYEVMQFCWL-QPEQRPS 259

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 16/215 (7%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL----REVAIMKGLRHPNIVL 326
           +G G FG V  AE++ +    A+K L + +       E L    R        RHP +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L        ++  V EY + G L  ++HI     V  E   +  A  V  G+ YLH+ + 
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDL--MMHIHTD--VFSEPRAVFYAACVVLGLQYLHENK- 121

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDPS 444
            IV+RDLK  NLL+D+   VK+ DFGL   K       +T+   GTPE++APEVL E   
Sbjct: 122 -IVYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSY 178

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
               D +  GV+++E++  + P+      +V  ++
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 72/249 (28%), Positives = 119/249 (47%), Gaps = 19/249 (7%)

Query: 271 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE---FLREVAIMKGLRHPNIV 325
           K +G+GSFG V  AE +  N   A+K L +    ED   E     R V  +    HP + 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL-AWEHPFLT 59

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L        +L  V EYL+ G L  + HI  +    + R R   A ++  G+ +LH++ 
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARF-YAAEIICGLQFLHKKG 116

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             I++RDLK  N+L+D    +K+ DFG+ +   N    + T  GTP+++APE+L+    N
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI---PKNVNPMVAALIET 502
           E  D +SFGV+L+E++  Q P+      ++     F     +    P+ ++      +  
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRPHFPRWISKEAKDCLSK 229

Query: 503 CWAEEPEIR 511
            +  +P  R
Sbjct: 230 LFERDPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 68/236 (28%), Positives = 123/236 (52%), Gaps = 13/236 (5%)

Query: 271 KKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNIV 325
           K IG+GSFG V  A  +  +   AVK+L ++   + + ++ +   R V ++K ++HP +V
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLV 59

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L  +      L  V +Y++ G L+   H+   R  ++ R R   A ++A  + YLH   
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARF-YAAEIASALGYLHSLN 116

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             IV+RDLK  N+L+DS   + + DFGL +       ++ T  GTPE++APEVL + P +
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
              D +  G +L+E++    P+ +   +++   +    + L++  N+      L+E
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNSARHLLE 228

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 16/271 (5%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLM 328
           KIGEGS G V  A  ++S   VAVK   + +  + + +E L  EV IM+  +H N+V + 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +      L +V E+L  G+L  ++        ++E     +   V K ++ LH +   +
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLHAQ--GV 137

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+KS ++L+     VK+ DFG            K+  GTP WMAPE++   P   + 
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEE 507
           D++S G+++ E++  + P+ N  P + +  +      +L+    V+P +   ++     +
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 508 PEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 538
           P  R    +  E L+   ++    P    PL
Sbjct: 258 PAQR---ATAAELLKHPFLAKAGPPSCIVPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 95.7 bits (238), Expect = 5e-21
 Identities = 50/164 (30%), Positives = 97/164 (59%), Gaps = 8/164 (4%)

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWM 434
           ++++H +   ++HRD+KS N+L+ S   VK+ DFG S+    T +S    +T  GTP ++
Sbjct: 156 VHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGTPYYV 212

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           APE+ R  P ++K+D+FS GV+L+EL+TL++P+      +V+      GR   +P +++P
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-LAGRYDPLPPSISP 271

Query: 495 MVAALIETCWAEEPEIRPSFPSIMET-LQQFLMSSVCQPLSAQP 537
            +  ++    + +P+ RPS   ++   + +  +S + + +  QP
Sbjct: 272 EMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQP 315

Length = 496

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 6e-21
 Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 31/210 (14%)

Query: 273 IGEGSFGTVYHAEWRNS--DVAVK-ILIEQEFHEDRFKEF-LREVAIMKGLR---HPNIV 325
           IGEG++GTVY A   N+   VA+K + +     E+      LRE+A++K L    HPNIV
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 326 LLMGAVTEPPN-----LSIVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            L+     P       L++V E++ +  + Y L   P     +      ++   + +G++
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQDLATY-LSKCPKP--GLPPETIKDLMRQLLRGVD 121

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM- 434
           +LH  R  IVHRDLK  N+LV S   VK+ DFGL+R      I S   A T      W  
Sbjct: 122 FLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMALTSVVVTLWYR 173

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQ 464
           APEVL +       D++S G I  EL   +
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 93.3 bits (232), Expect = 7e-21
 Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 10/244 (4%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V     + +    A+KIL ++    +D     L E  +++  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +      L  V EY + G L+   H+   RV  ++R R   A ++   + YLH     
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLHSCD-- 115

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RDLK  NL++D    +K+ DFGL +   +   + KT  GTPE++APEVL ++     
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   +  P+ ++P   +L+     ++
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 233

Query: 508 PEIR 511
           P+ R
Sbjct: 234 PKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 92.5 bits (230), Expect = 9e-21
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
            +GEGS+G V   + + +   VA+K  +E E  +   K  +RE+ ++K LRH N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
                  L +V E++    L  L   P+    +DE       + + +G+ + H     I+
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN--II 122

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           HRD+K  N+LV  +  VK+CDFG +R  + P    +   A  T  + APE+L  D    +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYRAPELLVGDTKYGR 180

Query: 448 S-DVFSFGVILWELIT 462
           + D+++ G ++ E++T
Sbjct: 181 AVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 92.6 bits (230), Expect = 3e-20
 Identities = 51/164 (31%), Positives = 91/164 (55%), Gaps = 11/164 (6%)

Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSK 425
           L  +  VA+GM++L  +    +HRD+ + N+L+      K+CDFGL+R   N   Y+   
Sbjct: 215 LRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--- 482
            A    +WMAPE + +     +SDV+S+G++LWE+ +L K   +  P  ++++  +K   
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK---SPYPGILVNSKFYKMVK 329

Query: 483 -GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            G ++  P    P + ++++ CW  EP  RP+F  I + +Q+ L
Sbjct: 330 RGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 72/222 (32%), Positives = 106/222 (47%), Gaps = 32/222 (14%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFK-EFLREVAIMKGLRHPNI 324
           I  K+GEG+FG VY A    +   V   KIL+  E  +D F    LRE+ I+K L+HPN+
Sbjct: 12  ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHPNV 69

Query: 325 VLLMGAVTEPPNLS--------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           V L+    E P+ S        +VT Y+    L  LL  P   V + E         + +
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLE 126

Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS------KPNTYISSKTAAGT 430
           G+NYLH+    I+HRD+K+ N+L+D+   +K+ DFGL+R        P       T   T
Sbjct: 127 GINYLHENH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 431 P----EWM-APE-VLREDPSNEKSDVFSFGVILWELITLQKP 466
                 W   PE +L E       D++  G +  E+ T ++P
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRP 225

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 91.2 bits (226), Expect = 4e-20
 Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 13/197 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNI 324
           K IG+GSFG V  A+ R  D    AVK+L ++     + ++ +   R V ++K ++HP +
Sbjct: 1   KVIGKGSFGKVLLAK-RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFL 58

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V L  +      L  V ++++ G L+   H+   R   + R R   A ++A  + YLH  
Sbjct: 59  VGLHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHSI 115

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
              IV+RDLK  N+L+DS   V + DFGL +       ++ T  GTPE++APEV+R+ P 
Sbjct: 116 N--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 445 NEKSDVFSFGVILWELI 461
           +   D +  G +L+E++
Sbjct: 174 DNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 89.8 bits (223), Expect = 6e-20
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 13/198 (6%)

Query: 271 KKIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +K+GEG++ TVY    R     VA+K I ++ E  E      +RE+++MK L+H NIV L
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRL 63

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
              +     L +V EY+    L K +     R  +D     +  Y + KG+ + H+ R  
Sbjct: 64  HDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           ++HRDLK  NLL++    +K+ DFGL+R+   P    S++    T  + AP+VL    + 
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTY 178

Query: 446 EKS-DVFSFGVILWELIT 462
             S D++S G I+ E+IT
Sbjct: 179 STSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 9/201 (4%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMK-GLRHPNIVL 326
           K +G+GSFG V  AE + +D   A+K+L +     +D     + E  I+    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L         L  V EY++ G L  +  I  +R   + R R   A +V   + +LH+   
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRH-- 115

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            +++RDLK  N+L+D+    K+ DFG+ +      +++ T  GTP+++APE+L+E     
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175

Query: 447 KSDVFSFGVILWELITLQKPW 467
             D ++ GV+++E++  Q P+
Sbjct: 176 SVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 33/206 (16%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K+GEGS+ TVY    + +   VA+K I +E E  E      +RE +++K L+H NIV L 
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLH 69

Query: 329 GAVTEPPNLSIVTEYLSRG-SLY-----KLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
             +     L++V EYL      Y       L + + R+ + + LR         G+ Y H
Sbjct: 70  DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR---------GLAYCH 120

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG---TPEWMAPEVL 439
           QRR  ++HRDLK  NLL+     +K+ DFGL+R+K    + SKT +    T  +  P+VL
Sbjct: 121 QRR--VLHRDLKPQNLLISERGELKLADFGLARAKS---VPSKTYSNEVVTLWYRPPDVL 175

Query: 440 REDPSNEKS---DVFSFGVILWELIT 462
               S E S   D++  G I +E+ T
Sbjct: 176 LG--STEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 19/210 (9%)

Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMK 317
            +I++ E+L     G G+ GTVY A    +   +AVK+ I  +   +  K+ + E+ I+ 
Sbjct: 1   QDIQYQEIL-----GHGNGGTVYKAYHLLTRRILAVKV-IPLDITVELQKQIMSELEILY 54

Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
               P I+   GA      +SI TE++  GSL     IP       E +   +A  V KG
Sbjct: 55  KCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIP-------EHVLGRIAVAVVKG 107

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           + YL   +  I+HRD+K  N+LV++   VK+CDFG+S    N+   +KT  GT  +MAPE
Sbjct: 108 LTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPE 163

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPW 467
            +  +     SDV+S G+   EL   + P+
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 70/201 (34%), Positives = 104/201 (51%), Gaps = 11/201 (5%)

Query: 271 KKIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  R  N  +A+K I +EQE  E      +RE++++K ++H NIV L
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
              V     L +V EYL       +   PD     + RL     Y + +G+ Y H  R  
Sbjct: 67  QDVVHSEKRLYLVFEYLDLDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR-- 122

Query: 388 IVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-N 445
           ++HRDLK  NLL+D  T  +K+ DFGL+R+      +      T  + APE+L      +
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 446 EKSDVFSFGVILWELITLQKP 466
              D++S G I  E++  QKP
Sbjct: 183 TPVDIWSVGCIFAEMVN-QKP 202

Length = 294

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 88.5 bits (219), Expect = 4e-19
 Identities = 70/233 (30%), Positives = 121/233 (51%), Gaps = 26/233 (11%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRH--------- 321
           IG+G+FG VY    +++    A+K+L ++E    +      EVA   G R+         
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54

Query: 322 -PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
            P IV L  +     +L +VT+Y+S G L+   H+       ++R +  +A ++   + +
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELF--WHLQKEGRFSEDRAKFYIA-ELVLALEH 111

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           LH+    IV+RDLK  N+L+D+T  + +CDFGLS++      ++ T  GT E++APEVL 
Sbjct: 112 LHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL 169

Query: 441 EDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
           ++    K  D +S GV+++E+     P+      Q+   + F   ++  PKNV
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFPKNV 220

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 58/199 (29%), Positives = 106/199 (53%), Gaps = 9/199 (4%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMK-GLRHPNIVLLM 328
           +G+GSFG V  AE + +D   A+KIL +     +D  +  + E  ++    + P +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                   L  V EY++ G L  + HI        E   +  A ++A G+ +LH +   I
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKF-KEPHAVFYAAEIAIGLFFLHSK--GI 122

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+++D+   +K+ DFG+ +       +++T  GTP+++APE++   P  +  
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 449 DVFSFGVILWELITLQKPW 467
           D ++FGV+L+E++  Q P+
Sbjct: 183 DWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 85/277 (30%), Positives = 129/277 (46%), Gaps = 42/277 (15%)

Query: 269 IKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIV 325
           I + IG+G++G VY    +   S  AVKIL   +   D  +E   E  I++ L  HPN+V
Sbjct: 26  IIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQSLPNHPNVV 82

Query: 326 LLMGAVTEPPNLS-----IVTEYLSRGS---LYKLLHIPDARVVVDERLRLNMAYDVAKG 377
              G   +   L      +V E  + GS   L K L I   R+  DE +   + Y    G
Sbjct: 83  KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL--DEAMISYILYGALLG 140

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           + +LH  R  I+HRD+K  N+L+ +   VK+ DFG+S    +T +   T+ GTP WMAPE
Sbjct: 141 LQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 438 VL----REDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
           V+    + D S + + DV+S G+   EL     P  +  P + +          +IP+N 
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---------FKIPRNP 249

Query: 493 NPMV----------AALIETCWAEEPEIRPSFPSIME 519
            P +             I  C  ++ E RPS   ++E
Sbjct: 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 87.6 bits (217), Expect = 5e-19
 Identities = 70/251 (27%), Positives = 128/251 (50%), Gaps = 22/251 (8%)

Query: 271 KKIGEGSFGTVYHA-EWRNSDV----AVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNI 324
           K +G+GSFG V+   +    D     A+K+L +      DR +  + E  I+  + HP I
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFI 60

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V L  A      L ++ ++L  G L+  L      +  +E ++  +A ++A  +++LH  
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLH-- 115

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
              I++RDLK  N+L+D    +K+ DFGLS+   +    + +  GT E+MAPEV+     
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175

Query: 445 NEKSDVFSFGVILWELITLQKPW----RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
            + +D +SFGV+++E++T   P+    R  T + ++ A      +L +P+ ++P   +L+
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA------KLGMPQFLSPEAQSLL 229

Query: 501 ETCWAEEPEIR 511
              +   P  R
Sbjct: 230 RALFKRNPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 69/297 (23%), Positives = 137/297 (46%), Gaps = 33/297 (11%)

Query: 242 NLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEF 301
           N+   S  N    +E + ++  ++ +LIK    E    ++Y   + N +V ++    ++F
Sbjct: 2   NIITRSYINDIKCIESDDIDK-YTSVLIK----ENDQNSIYKGIFNNKEVIIRTF--KKF 54

Query: 302 HEDRFK---EFLREVAIMKGLRHPNIVLLMG----AVTEPPNLSIVTEYLSRGSLYKLLH 354
           H+           E+  ++ +   NI+ + G     V + P LS++ EY +RG L ++L 
Sbjct: 55  HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL- 113

Query: 355 IPDARVVVDERLRLNMAYDVAKGMNYLHQ--RRPPIVHRDLKSPNLLVDSTYTVKVCDFG 412
             D    +  + +L+MA D  KG+  L++   +P   +++L S + LV   Y +K+   G
Sbjct: 114 --DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHG 168

Query: 413 LSRSKPNTYISSKTAAGTPEWMA---PEVLRE--DPSNEKSDVFSFGVILWELITLQKPW 467
           L +      I S        +M     ++L +       K D++S GV+LWE+ T + P+
Sbjct: 169 LEK------ILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222

Query: 468 RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
            N T  ++   +  K   L++P +    +  ++E C + +   RP+   I+  L  +
Sbjct: 223 ENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279

Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 86.7 bits (214), Expect = 6e-19
 Identities = 70/270 (25%), Positives = 125/270 (46%), Gaps = 38/270 (14%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 329
           +G G++G VY      +    A+K++   +   D  +E  +E+ ++K    H NI    G
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 330 AVTE--PPNLS----IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           A  +  PP +     +V E+   GS+  L+       + +E +   +  ++ +G+++LHQ
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQ 129

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            +  ++HRD+K  N+L+     VK+ DFG+S     T     T  GTP WMAPEV+  D 
Sbjct: 130 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 444 SNE-----KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA- 497
           + +     KSD++S G+   E+     P  +  P + +           IP+N  P +  
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAPRLKS 238

Query: 498 --------ALIETCWAEEPEIRPSFPSIME 519
                   + IE+C  +    RP+   +M+
Sbjct: 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 87.2 bits (216), Expect = 7e-19
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 37/260 (14%)

Query: 271 KKIGEGSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++IG GSFG VY A + R ++V    K+    +   +++++ ++EV  ++ LRHPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
            G         +V EY   GS   +L +    +   E   +   +   +G+ YLH     
Sbjct: 81  KGCYLREHTAWLVMEY-CLGSASDILEVHKKPLQEVEIAAI--CHGALQGLAYLHSHE-- 135

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEV---LRED 442
            +HRD+K+ N+L+    TVK+ DFG +   S  N+++      GTP WMAPEV   + E 
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEG 189

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---- 498
             + K DV+S G+   EL   + P  N      +SA+        I +N +P +++    
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFN---MNAMSAL------YHIAQNDSPTLSSNDWS 240

Query: 499 -----LIETCWAEEPEIRPS 513
                 +++C  + P+ RPS
Sbjct: 241 DYFRNFVDSCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 18/196 (9%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +GEG++G V     + +   VA+K   + E +E+  +  LRE+ +++ L+  NIV L  A
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 L +V EY+ +  L  L  +P+   V  E++R +  Y + K +++ H+    IVH
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVR-SYIYQLIKAIHWCHKND--IVH 123

Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMA------PEVLREDPS 444
           RD+K  NLL+     +K+CDFG +R+     +S  + A   E++A      PE+L   P 
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARN-----LSEGSNANYTEYVATRWYRSPELLLGAPY 178

Query: 445 NEKSDVFSFGVILWEL 460
            +  D++S G IL EL
Sbjct: 179 GKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 48/231 (20%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVK----ILIEQEFHEDRFK--------EFLREVAIM 316
             +GEG++G V  A    +   VA+K    I I  +  +DR            LRE+ IM
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---- 372
             ++H NI+ L+    E   +++V + ++           D + VVD ++RL  +     
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMAS----------DLKKVVDRKIRLTESQVKCI 124

Query: 373 --DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG- 429
              +  G+N LH+     +HRDL   N+ ++S    K+ DFGL+R       S   +   
Sbjct: 125 LLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 430 --------TPE-----WMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKP 466
                   T +     + APE+L   +  +   D++S G I  EL+T  KP
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKP 232

Length = 335

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 86.3 bits (213), Expect = 2e-18
 Identities = 62/250 (24%), Positives = 132/250 (52%), Gaps = 16/250 (6%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR--EVAIMKGLRHPNIVLLM 328
           IG GS+  V     + ++   A+K++ ++  ++D   ++++  +    +   HP +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                   L  V EY++ G L  + H+   R + +E  R   A +++  +NYLH+R   I
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHER--GI 117

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+L+DS   +K+ D+G+ +       ++ T  GTP ++APE+LR +      
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 449 DVFSFGVILWELITLQKPW----RNSTPSQVISAVGFK---GRRLEIPKNVNPMVAALIE 501
           D ++ GV+++E++  + P+     +  P Q      F+    +++ IP++++   A++++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237

Query: 502 TCWAEEPEIR 511
           +   ++P+ R
Sbjct: 238 SFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 9/201 (4%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVL 326
           K +G+GSFG V+ AE + ++   A+K L +     D   E   + +  +     HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L        NL  V EYL+ G L  + HI         R     A ++  G+ +LH +  
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATF-YAAEIICGLQFLHSK-- 115

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            IV+RDLK  N+L+D+   +K+ DFG+ +        + T  GTP+++APE+L     N 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 447 KSDVFSFGVILWELITLQKPW 467
             D +SFGV+L+E++  Q P+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 66/245 (26%), Positives = 125/245 (51%), Gaps = 15/245 (6%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNIVLL 327
           +G+GSFG V  AE + +D   A+KIL +    +D   E     + V  + G + P +  L
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQL 66

Query: 328 MGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
                    L  V EY++ G L Y++  +   +    E   +  A ++A G+ +LH +  
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFK----EPHAVFYAAEIAIGLFFLHSK-- 120

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            I++RDLK  N+++DS   +K+ DFG+ +      +++KT  GTP+++APE++   P  +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 506
             D ++FGV+L+E++  Q P+      ++  ++      +  PK+++    A+ +    +
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTK 238

Query: 507 EPEIR 511
            P  R
Sbjct: 239 HPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 37/260 (14%)

Query: 271 KKIGEGSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++IG GSFG VY A + RNS+V    K+    +   +++++ ++EV  ++ LRHPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
            G         +V EY   GS   LL +   +  + E     + +   +G+ YLH     
Sbjct: 81  RGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEV---LRED 442
           ++HRD+K+ N+L+     VK+ DFG +   +  N ++      GTP WMAPEV   + E 
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEG 189

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---- 498
             + K DV+S G+   EL   + P  N      +SA+        I +N +P + +    
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFN---MNAMSAL------YHIAQNESPALQSGHWS 240

Query: 499 -----LIETCWAEEPEIRPS 513
                 +++C  + P+ RP+
Sbjct: 241 EYFRNFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 76/275 (27%), Positives = 126/275 (45%), Gaps = 38/275 (13%)

Query: 269 IKKKIGEGSFGTVY--HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIV 325
           I + IG+G++G V+    +   S  AVKIL     H D  +E   E  I+K L  HPN+V
Sbjct: 22  IIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIH-DIDEEIEAEYNILKALSDHPNVV 78

Query: 326 LLMGA-----VTEPPNLSIVTEYLSRGSLYKLLHIPDAR-VVVDERLRLNMAYDVAKGMN 379
              G      V     L +V E  + GS+  L+     R   ++E +   + ++   G+ 
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           +LH  +   +HRD+K  N+L+ +   VK+ DFG+S    +T +   T+ GTP WMAPEV+
Sbjct: 139 HLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 440 R-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
                 +   + + DV+S G+   EL     P  +  P + +          +IP+N  P
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIPRNPPP 247

Query: 495 MVAA----------LIETCWAEEPEIRPSFPSIME 519
            +             I  C  ++ E RP+   +++
Sbjct: 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 326
           +G+G FG V   + + +    K+   ++  + R K+       L E  I++ +    IV 
Sbjct: 1   LGKGGFGEVCACQVKATG---KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  A     +L +V   ++ G L   ++        + R     A  +  G+ +LHQRR 
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQRR- 115

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-----RSKPNTYISSKTAAGTPEWMAPEVLRE 441
            IV+RDLK  N+L+D    V++ D GL+       K          AGTP +MAPEVL+ 
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR------AGTPGYMAPEVLQG 168

Query: 442 DPSNEKSDVFSFGVILWELITLQKPWR 468
           +  +   D F+ G  L+E+I  + P+R
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFR 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 71/260 (27%), Positives = 125/260 (48%), Gaps = 21/260 (8%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAI-MKGLRHPNIVLLMG 329
           +G G++G V       +   +AVK  I    +    K  L ++ I M+ +  P  V   G
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVK-RIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
           A+    ++ I  E +   SL K    + D  + + E +   +A  + K + YLH +   +
Sbjct: 68  ALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-V 125

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA-AGTPEWMAPEVLREDPSNE- 446
           +HRD+K  N+L++    VK+CDFG+S    ++   +KT  AG   +MAPE  R +P    
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPE--RINPELNQ 181

Query: 447 -----KSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKN-VNPMVAAL 499
                KSDV+S G+ + EL T + P+ +  TP Q +  V  +    ++P    +P     
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-VEEPSPQLPAEKFSPEFQDF 240

Query: 500 IETCWAEEPEIRPSFPSIME 519
           +  C  +  + RP++P +++
Sbjct: 241 VNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 85.3 bits (211), Expect = 4e-18
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 52/287 (18%)

Query: 263 RWSELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           R+ +L   + +G G+FG V  A  +    +VA+K +++        K   RE+ ++K LR
Sbjct: 11  RYVDL---QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 321 HPNIVLLMGAVTEP-PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           H NI+ L      P  ++  VTE L    L++LL    +R +  + ++    Y + +G+ 
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLGT-DLHRLL---TSRPLEKQFIQY-FLYQILRGLK 122

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAP 436
           Y+H     +VHRDLK  N+L++    +K+CDFGL+R    +   Y+S      T  + AP
Sbjct: 123 YVHS--AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS------TRYYRAP 174

Query: 437 EV-LREDPSNEKSDVFSFGVILWELITLQK--PWRN-------------STPSQVISAVG 480
           E+ L     + + D++S G I  E++  +   P ++             + P  VI+ + 
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234

Query: 481 FKG---------RRLEIP-----KNVNPMVAALIETCWAEEPEIRPS 513
            +          +R  +P     KN +P    L+E     +P+ R S
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS 281

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 66/196 (33%), Positives = 105/196 (53%), Gaps = 13/196 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +K+GEGS+ TVY  + + +   VA+K++  QE     F   +RE +++KGL+H NIVLL 
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANIVLLH 69

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +     L++V EY+       +   P      + +L L   + + +G++Y+HQR   I
Sbjct: 70  DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL---FQLLRGLSYIHQRY--I 124

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRDLK  NLL+  T  +K+ DFGL+R+K     +      T  +  P+VL    S E S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG--STEYS 182

Query: 449 ---DVFSFGVILWELI 461
              D++  G I  E+I
Sbjct: 183 TCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 36/210 (17%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLM 328
           KIGEG+F  V  A+ R +    A+K +  + F        LRE+  ++ L  HPNI+ L+
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 329 GAVTEPPN--LSIVTEYLSRGSLYKLL-----HIPDARVVVDERLRLNMAYDVAKGMNYL 381
             + +     L++V E L   +LY+L+      +P+ RV        +  Y + K ++++
Sbjct: 65  EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRV-------KSYMYQLLKSLDHM 116

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM-A 435
           H  R  I HRD+K  N+L+     +K+ DFG  R      P T YIS++       W  A
Sbjct: 117 H--RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTR-------WYRA 166

Query: 436 PEVLREDPS-NEKSDVFSFGVILWELITLQ 464
           PE L  D     K D+++ G + +E+++L 
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILSLF 196

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 84.6 bits (209), Expect = 6e-18
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 9/211 (4%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLR-HPNIVLLM 328
           +G+GSFG V  A  + S    AVK+L +     +D  +  + E  I+   R HP +  L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                P  L  V E+++ G L  + HI  +R   + R R   A ++   + +LH +   I
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAA-EITSALMFLHDK--GI 117

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+L+D     K+ DFG+ +       ++ T  GTP+++APE+L+E       
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           D ++ GV+L+E++    P+       +  A+
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 85.8 bits (212), Expect = 8e-18
 Identities = 65/245 (26%), Positives = 125/245 (51%), Gaps = 20/245 (8%)

Query: 287 RNSDVAVKILIE-QEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 344
           R SD   K++ +    +++R   + R E+  +    H  IV           L ++ EY 
Sbjct: 88  RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147

Query: 345 SRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLHQRRPPIVHRDLKSPNL 398
           S G L K +     +  + E L         + Y +   ++ +H R+  ++HRDLKS N+
Sbjct: 148 SGGDLNKQI-----KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANI 200

Query: 399 LVDSTYTVKVCDFGLSRSKPNTYISSKTAA---GTPEWMAPEVLREDPSNEKSDVFSFGV 455
            +  T  +K+ DFG S+   ++ +S   A+   GTP ++APE+      ++K+D++S GV
Sbjct: 201 FLMPTGIIKLGDFGFSKQYSDS-VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259

Query: 456 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 515
           IL+EL+TL +P++  +  +++  V + G+    P  V+  + AL++   ++ P +RP+  
Sbjct: 260 ILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQ 318

Query: 516 SIMET 520
            ++ T
Sbjct: 319 QLLHT 323

Length = 478

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 86.8 bits (215), Expect = 1e-17
 Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 17/198 (8%)

Query: 291 VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV-LLMGAVTEPPNLSIVTEYLSRGS 348
           VA+K+L  +    E +   F RE A+   L HPNIV LL      P  L  V EY+   +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 349 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYT 405
           L ++L   D  +   E  RL M   V   +   H +   IVHRDLK  N++V        
Sbjct: 66  LREVLA-ADGALPAGETGRL-ML-QVLDALACAHNQ--GIVHRDLKPQNIMVSQTGVRPH 120

Query: 406 VKVCDFGLSRSKPNTYISSKTAA-------GTPEWMAPEVLREDPSNEKSDVFSFGVILW 458
            KV DFG+    P    +            GTP + APE LR +P    SD++++G+I  
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 459 ELITLQKPWRNSTPSQVI 476
           E +T Q+  + ++ ++++
Sbjct: 181 ECLTGQRVVQGASVAEIL 198

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 39/237 (16%)

Query: 271 KKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVL 326
           K IG G+FG V+            A+K+L + +  +      +R E  I+     P IV 
Sbjct: 7   KVIGRGAFGEVWLV-RDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  +L +V EY+  G L  LL   D  V  +E  R  +A  V   ++ +H+   
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVL-ALDSVHKLG- 121

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-----------------------------RSK 417
             +HRD+K  N+L+D+   +K+ DFGL                              R  
Sbjct: 122 -FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ 474
               + + +  GTP+++APEVLR  P   + D +S GVIL+E++    P+ + T  +
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 77/260 (29%), Positives = 128/260 (49%), Gaps = 39/260 (15%)

Query: 272 KIGEGSFGTVYHA--EWRNSDVAVKILIE--QEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +IG GSFG VY A     N  VAVK +    ++ +E ++++ ++EV  ++ L+HPN +  
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEY 86

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
            G   +     +V EY   GS   LL +   +  + E     + +   +G+ YLH     
Sbjct: 87  KGCYLKEHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFG-LSRSKP-NTYISSKTAAGTPEWMAPEV---LRED 442
           ++HRD+K+ N+L+     VK+ DFG  S+S P N+++      GTP WMAPEV   + E 
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEG 195

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---- 498
             + K DV+S G+   EL   + P  N      +SA+        I +N +P + +    
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFN---MNAMSAL------YHIAQNDSPTLQSNEWT 246

Query: 499 -----LIETCWAEEPEIRPS 513
                 ++ C  + P+ RP+
Sbjct: 247 DSFRGFVDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 41/273 (15%)

Query: 273 IGEGSFGTVYHAEWRNS----------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP 322
           +G+G+F  +Y    R            +V+V + +    H D    F    ++M  L H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHK 61

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           ++V L G      N+ +V EY+  G L   LH    +  V    +L++A  +A  ++YL 
Sbjct: 62  HLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHR--EKNNVSLHWKLDVAKQLASALHYLE 118

Query: 383 QRRPPIVHRDLKSPNLLV-----DSTYT--VKVCDFG-----LSRSKPNTYISSKTAAGT 430
            ++  +VH ++   N+LV     +  Y   +K+ D G     LSR +    I        
Sbjct: 119 DKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169

Query: 431 PEWMAPEVLREDPSNEKS--DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 488
             W+APE +R   ++     D +SFG  L E+ +  +   ++  S           RL +
Sbjct: 170 --WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM 227

Query: 489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
           P      +A LI  CW  +P  RPSF +I+  L
Sbjct: 228 PDC--AELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 69/253 (27%), Positives = 119/253 (47%), Gaps = 18/253 (7%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 326
           +G+G FG V   + R +    K+   ++ ++ R K+       + E  I+  +    IV 
Sbjct: 1   LGKGGFGEVSACQMRATG---KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57

Query: 327 LMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
           L  A     +L +V   ++ G L Y + ++ +      E         +  G+ +LHQRR
Sbjct: 58  LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             I++RDLK  N+L+D+   V++ D GL+    +    +K  AGTP +MAPE+L+ +  +
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE----IPKNVNPMVAALIE 501
              D F+ GV L+E+I  + P+R     + +     K R L      P   +P   +  E
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFR--ARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233

Query: 502 TCWAEEPEIRPSF 514
              A++PE R  F
Sbjct: 234 ALLAKDPEKRLGF 246

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.1 bits (202), Expect = 4e-17
 Identities = 76/285 (26%), Positives = 140/285 (49%), Gaps = 41/285 (14%)

Query: 252 ELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKE 308
           EL+ +E+  E  +++L   ++IG GSFG VY A + R ++V    K+    +   +++++
Sbjct: 16  ELFFKEDP-EKLFTDL---REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 71

Query: 309 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
            ++EV  ++ ++HPN +   G         +V EY   GS   LL +   +  + E    
Sbjct: 72  IIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIA 128

Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKT 426
            + +   +G+ YLH     ++HRD+K+ N+L+     VK+ DFG +   S  N+++    
Sbjct: 129 AITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV---- 182

Query: 427 AAGTPEWMAPEV---LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 483
             GTP WMAPEV   + E   + K DV+S G+   EL   + P  N      +SA+    
Sbjct: 183 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN---MNAMSAL---- 233

Query: 484 RRLEIPKNVNPMVAA---------LIETCWAEEPEIRPSFPSIME 519
               I +N +P + +          +++C  + P+ RP+   +++
Sbjct: 234 --YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 15/206 (7%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           K+GEG++ TVY    + +D  VA+K  I  E  E      +REV+++K L+H NIV L  
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALK-EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
            +    +L++V EYL +     L    ++  + + +L L   + + +G+NY H+R+  ++
Sbjct: 72  IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFL---FQLLRGLNYCHRRK--VL 126

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG--TPEWMAPE--VLREDPSN 445
           HRDLK  NLL++    +K+ DFGL+R+K    I +KT +      W  P   +L     +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKS---IPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 446 EKSDVFSFGVILWELITLQKPWRNST 471
            + D++  G I +E+ T +  +  ST
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 64

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 65  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 121 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178

Query: 446 EKS-DVFSFGVILWELIT 462
             + D++S G I  E++T
Sbjct: 179 STAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 17/213 (7%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +K+GEGS+ TVY    R +   VA+K+ I  +  E      +RE +++KGL+H NIVLL 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKV-ISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +     L+ V EY+       ++  P    +    +RL M + + +G+ Y+H +   I
Sbjct: 70  DIIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFM-FQLLRGLAYIHGQH--I 124

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSK--PNTYISSKTAAGTPEWMAPEVL--REDPS 444
           +HRDLK  NLL+     +K+ DFGL+R+K  P+   SS+    T  +  P+VL    D S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182

Query: 445 NEKSDVFSFGVILWELITLQK--PWRNSTPSQV 475
           +   D++  G I  E++  Q   P  +    Q+
Sbjct: 183 SA-LDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 12/167 (7%)

Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E  +++ + HP+++ +   +       +V  +     LY  L      + +D+ L + 
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIE 163

Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
               + +G+ YLH +R  I+HRD+K+ N+ ++    V + D G ++     P        
Sbjct: 164 KQ--ILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----G 215

Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 473
            AGT E  APEVL  D  N K+D++S G++L+E++          PS
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPS 262

Length = 357

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.9 bits (200), Expect = 8e-17
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 26/204 (12%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 323
           +IGEG++G VY A    S   VA+K + ++ E      ++      LRE+ ++  LRHPN
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNE------RDGIPISSLREITLLLNLRHPN 67

Query: 324 IVLLMGAVTEPPNLSI--VTEYLSR--GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           IV L   V      SI  V EY  +   SL   +  P +   V       +   + +G+ 
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK-----CLMLQLLRGLQ 122

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           YLH+    I+HRDLK  NLL+     +K+ DFGL+R+             T  + APE+L
Sbjct: 123 YLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180

Query: 440 REDPSNEKS-DVFSFGVILWELIT 462
               +   + D+++ G IL EL+ 
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 81.2 bits (201), Expect = 9e-17
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 25/202 (12%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G V  A    +   VA+K L          K   RE+ ++K + H N++ L+  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 331 VTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T   +L       +VT  +    L  ++     + + D+ ++  + Y + +G+ Y+H  
Sbjct: 83  FTPASSLEDFQDVYLVTHLMGA-DLNNIVKC---QKLSDDHIQF-LVYQILRGLKYIHSA 137

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEV-LR 440
              I+HRDLK  N+ V+    +K+ DFGL+R    +   Y+       T  + APE+ L 
Sbjct: 138 G--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV------ATRWYRAPEIMLN 189

Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLT 211

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 81.2 bits (200), Expect = 9e-17
 Identities = 62/243 (25%), Positives = 123/243 (50%), Gaps = 11/243 (4%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVLLM 328
           +G+GSFG V  AE + +D   A+KIL +    +D   E   + +  +    + P +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                   L  V EY++ G L  + HI        E   +  A +++ G+ +LH+R   I
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKF-KEPQAVFYAAEISVGLFFLHRR--GI 122

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+++DS   +K+ DFG+ +      ++++T  GTP+++APE++   P  +  
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 508
           D +++GV+L+E++  Q P+      ++  ++      +  PK+++    ++ +    + P
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLMTKHP 240

Query: 509 EIR 511
             R
Sbjct: 241 SKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 54/199 (27%), Positives = 108/199 (54%), Gaps = 9/199 (4%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMK-GLRHPNIVLLM 328
           IG GS+  V   E + +    A+K++ ++  ++D   ++++ E  + +    HP +V L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                   L  V E++S G L  + H+   R + +E  R   A +++  +N+LH+R   I
Sbjct: 63  SCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNFLHER--GI 117

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+L+D+   +K+ D+G+ +       ++ T  GTP ++APE+LR +      
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 449 DVFSFGVILWELITLQKPW 467
           D ++ GV+++E++  + P+
Sbjct: 178 DWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 50/151 (33%), Positives = 80/151 (52%), Gaps = 15/151 (9%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           KIGEG++GTV+ A+ R +   VA+K +   +  E      LRE+ ++K L+H NIV L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHI----PDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            +     L++V EY  +  L K         D  +V     +  M + + KG+ + H   
Sbjct: 67  VLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIV-----KSFM-FQLLKGLAFCHSHN 119

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 416
             ++HRDLK  NLL++    +K+ DFGL+R+
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 61/201 (30%), Positives = 109/201 (54%), Gaps = 17/201 (8%)

Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V   + + S  +  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL-RLNMAYDVAKGMNYLHQRRPPIV 389
                 +SI  E++  GSL ++L   +A+ + +E L ++++A  V +G+ YL ++   I+
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLK--EAKRIPEEILGKVSIA--VLRGLAYLREKHQ-IM 126

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           HRD+K  N+LV+S   +K+CDFG+S     S  N+++      GT  +M+PE L+    +
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYS 180

Query: 446 EKSDVFSFGVILWELITLQKP 466
            +SD++S G+ L EL   + P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 16/211 (7%)

Query: 272 KIGEGSFGTVYHA-EWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIV 325
           +IGEG++G V+ A + +N    VA+K +  Q   E      +REVA+++ L    HPN+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 326 LLMGAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
            L    T         L++V E++ +     L  +P+  V   E ++ +M + + +G+++
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT-ETIK-DMMFQLLRGLDF 125

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           LH  R  +VHRDLK  N+LV S+  +K+ DFGL+R        +     T  + APEVL 
Sbjct: 126 LHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLL 182

Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNST 471
           +       D++S G I  E+   +  +R S+
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 38/270 (14%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 329
           +G G++G VY      +    A+K++   +  ED  +E   E+ ++K    H NI    G
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 330 AVTE--PP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           A  +  PP     L +V E+   GS+  L+       + ++ +   +  ++ +G+ +LH 
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLHA 139

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL--RE 441
            +  ++HRD+K  N+L+     VK+ DFG+S     T     T  GTP WMAPEV+   E
Sbjct: 140 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197

Query: 442 DPS---NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           +P    + +SD++S G+   E+     P  +  P + +           IP+N  P + +
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPPPKLKS 248

Query: 499 ---------LIETCWAEEPEIRPSFPSIME 519
                     IE C  +    RPS   +++
Sbjct: 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 23/202 (11%)

Query: 270 KKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
             ++G G+ G V     R S  +  + LI  E       + +RE+ ++     P IV   
Sbjct: 6   LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFY 65

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           GA      +SI  E++  GSL ++L     IP       E +   ++  V +G+ YL ++
Sbjct: 66  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-------ENILGKISIAVLRGLTYLREK 118

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEWMAPEVLR 440
              I+HRD+K  N+LV+S   +K+CDFG+S     S  N+++      GT  +M+PE L+
Sbjct: 119 HK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ 171

Query: 441 EDPSNEKSDVFSFGVILWELIT 462
                 +SD++S G+ L E+  
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAI 193

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 61/196 (31%), Positives = 105/196 (53%), Gaps = 13/196 (6%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           K+GEG++ TV+    + ++  VA+K  I  E  E      +REV+++K L+H NIV L  
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALK-EIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
            +     L++V EYL       L +  +   + + ++ +   + + +G++Y H+R+  I+
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM---FQLLRGLSYCHKRK--IL 125

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS- 448
           HRDLK  NLL++    +K+ DFGL+R+K     +      T  +  P+VL    S E S 
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--STEYST 183

Query: 449 --DVFSFGVILWELIT 462
             D++  G IL+E+ T
Sbjct: 184 PIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 69/238 (28%), Positives = 116/238 (48%), Gaps = 16/238 (6%)

Query: 266 ELLIKKKIGEGSFGTVYHA-EWRNSDV-AVKILI-EQEFHEDRFKEFLREVAIMKGLRHP 322
           +  +K  +G G FG V    E    D+ A+K++       ++    F  E  I+     P
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL-RLNMAYDVAKGMNYL 381
            I  L  A  +  NL +V EY   G L  LL+  + +   DE + +  +A ++   ++ +
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF--DEDMAQFYLA-ELVLAIHSV 118

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLR 440
           HQ     VHRD+K  N+L+D T  +K+ DFG + R   N  ++SK   GTP+++APEVL 
Sbjct: 119 HQM--GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 441 EDPSNEKS------DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
               + K       D +S GVI +E+I  + P+   T ++  + +    R L+ P++ 
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.0 bits (193), Expect = 6e-16
 Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 31/210 (14%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-F----LREVAIMKGLRHPN 323
           +I EG++G VY A  + +   VA+K + +E+E      KE F    LRE+ I+  L+HPN
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLKMEKE------KEGFPITSLREINILLKLQHPN 65

Query: 324 IV----LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           IV    +++G+  +   + +V EY+    L  L+       +  E     +   +  G+ 
Sbjct: 66  IVTVKEVVVGSNLD--KIYMVMEYVEH-DLKSLMETMKQPFLQSEVK--CLMLQLLSGVA 120

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPE 437
           +LH     I+HRDLK+ NLL+++   +K+CDFGL+R    P    +      T  + APE
Sbjct: 121 HLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAPE 176

Query: 438 VLREDPS-NEKSDVFSFGVILWELITLQKP 466
           +L      +   D++S G I  EL+T +KP
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLT-KKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 78.5 bits (193), Expect = 7e-16
 Identities = 53/199 (26%), Positives = 107/199 (53%), Gaps = 9/199 (4%)

Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR--EVAIMKGLRHPNIVLLM 328
           IG GS+  V     + +D   A+K++ ++  H+D   ++++  +    +   +P +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                   L +V EY++ G L  + H+   R + +E  R   A ++   +N+LH+R   I
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARF-YAAEICIALNFLHER--GI 117

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+L+D+   +K+ D+G+ +       ++ T  GTP ++APE+LR +      
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177

Query: 449 DVFSFGVILWELITLQKPW 467
           D ++ GV+++E++  + P+
Sbjct: 178 DWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 70/229 (30%), Positives = 102/229 (44%), Gaps = 27/229 (11%)

Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           K I  G++G VY   H E R      KI  +     ++ ++   E  I+    +P +V +
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +     +L +V EY+  G    LL    A  V  +  R+  A  V   + YLH     
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPV--DMARMYFAETVL-ALEYLHNY--G 121

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR-----SKPNTY----------ISSKTAAGTPE 432
           IVHRDLK  NLL+ S   +K+ DFGLS+        N Y             K   GTPE
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVIS 477
           ++APEV+      +  D ++ G+IL+E +    P+   TP     QVIS
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 78.4 bits (194), Expect = 8e-16
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 39/219 (17%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE--DRFKEFLREVAIMKGLR-HPN 323
           I +K+G+G++G V+ A  R +   VA+K  I   F    D  + F RE+  ++ L  HPN
Sbjct: 11  ILQKLGKGAYGIVWKAIDRRTKEVVALK-KIFDAFRNATDAQRTF-REIMFLQELGDHPN 68

Query: 324 IVLLMGAVTEPPN---LSIVTEYLS-------RGSLYKLLHIPDARVVVDERLRLNMAYD 373
           IV L+  V +  N   + +V EY+        R ++ + +H    R ++         Y 
Sbjct: 69  IVKLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK---RYIM---------YQ 115

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT--- 430
           + K + Y+H     ++HRDLK  N+L++S   VK+ DFGL+RS      + +    T   
Sbjct: 116 LLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 431 -PEWM-APEVLREDPSNEKS-DVFSFGVILWELITLQKP 466
              W  APE+L       K  D++S G IL E++ L KP
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML-LGKP 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 13/195 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +K+GEG++ TV+    + ++  VA+K  I  E  E      +REV+++K L+H NIV L 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALK-EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             V    +L++V EYL +     +    +   + + ++ L   Y + +G+ Y H+R+  +
Sbjct: 71  DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---YQILRGLAYCHRRK--V 125

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRDLK  NLL++    +K+ DFGL+R+K     +      T  +  P+VL    S+E S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--SSEYS 183

Query: 449 ---DVFSFGVILWEL 460
              D++  G I +E+
Sbjct: 184 TQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 44/218 (20%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-F----LREVAIMKGLRHPN 323
           KIG+G+FG V+ A  + +   VA+K +L+E E      KE F    LRE+ I++ L+H N
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENE------KEGFPITALREIKILQLLKHEN 72

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLY-----------KLLHIPDARVVVDERLRLNMAY 372
           +V L+                 +GS Y            LL   + +  + E  +  +  
Sbjct: 73  VVNLIEICRTKAT----PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMK 126

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-------SKPNTYISSK 425
            +  G+ Y+H  R  I+HRD+K+ N+L+     +K+ DFGL+R       SKPN Y +++
Sbjct: 127 MLLNGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY-TNR 183

Query: 426 TAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELIT 462
               T  +  PE+L  +       D++  G I+ E+ T
Sbjct: 184 VV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 73/284 (25%), Positives = 116/284 (40%), Gaps = 61/284 (21%)

Query: 291 VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 350
           V V+I   +   E+  K    EV +    RHPNI+      T    L +++ +++ GS  
Sbjct: 28  VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87

Query: 351 KLL--HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 408
            LL  + P+    + E L  N+ +   +G+NYLHQ     +HR++K+ ++L+     V +
Sbjct: 88  SLLKTYFPEG---MSEALIGNILFGALRGLNYLHQN--GYIHRNIKASHILISGDGLVSL 142

Query: 409 CDFGLSRSKPNTYISSKTAAGTPE-------WMAPEVLREDPS--NEKSDVFSFGVILWE 459
                  S       +K     P+       W++PE+LR+D    N KSD++S G+   E
Sbjct: 143 SGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202

Query: 460 LIT--------------LQK-------PWRNSTPSQ-----------VISAVG------- 480
           L T              LQK       P   +T              V S +G       
Sbjct: 203 LATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAG 262

Query: 481 ----FKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIM 518
                   RL  P  K  +P    L+E C  ++PE RPS  S++
Sbjct: 263 MTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 63/247 (25%), Positives = 107/247 (43%), Gaps = 52/247 (21%)

Query: 272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEF-----------LREVAIMKGLR 320
            IG G++G VY A+ +N     +  I++      FK              RE+A+++ L+
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKK------FKGDKEQYTGISQSACREIALLRELK 60

Query: 321 HPNIVLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHI-----PDARVVVDERLRLNMAYD 373
           H N+V L+    E  + S+  + +Y    + + L  I        RV +   +  ++ + 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSR---SKPNTYISSKT 426
           +  G++YLH     ++HRDLK  N+LV         VK+ D GL+R   +          
Sbjct: 117 ILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174

Query: 427 AAGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 485
              T  + APE+L       K+ D+++ G I  EL+TL+                FKGR 
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI--------------FKGRE 220

Query: 486 LEIPKNV 492
            +I K+ 
Sbjct: 221 AKIKKSN 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 79.4 bits (196), Expect = 2e-15
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 33/231 (14%)

Query: 269 IKKKIGEGSFGTVY--HAEWRNSDVAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNI 324
           I + IG+G  G VY  +    +  VA+K  I ++  E+    K FLRE  I   L HP I
Sbjct: 6   IIRLIGKGGMGEVYLAYDPVCSRRVALK-KIREDLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR--------LNMAYDVAK 376
           V +    ++   +     Y+   +L  LL     +  + + L         L++ + +  
Sbjct: 65  VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK--------------PNTYI 422
            + Y+H +   ++HRDLK  N+L+     V + D+G +  K               N   
Sbjct: 125 TIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 423 SSKTA----AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           SS T      GTP++MAPE L   P++E +D+++ GVIL++++TL  P+R 
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233

Length = 932

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 15/200 (7%)

Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V+    + S  +  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L        + E++   ++  V KG+ YL ++   I+H
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 127

Query: 391 RDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           RD+K  N+LV+S   +K+CDFG+S     S  N+++      GT  +M+PE L+    + 
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSV 181

Query: 447 KSDVFSFGVILWELITLQKP 466
           +SD++S G+ L E+   + P
Sbjct: 182 QSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 7/200 (3%)

Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           E  I++ ++HP IV L+ A      L ++ EYLS G L+  +H+    + +++     ++
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF--MHLEREGIFMEDTACFYLS 107

Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
            +++  + +LHQ+   I++RDLK  N+L+D+   VK+ DFGL +   +    + T  GT 
Sbjct: 108 -EISLALEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTI 164

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           E+MAPE+L      +  D +S G ++++++T   P+      + I  +  KG +L +P  
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI-LKG-KLNLPPY 222

Query: 492 VNPMVAALIETCWAEEPEIR 511
           + P    L++      P  R
Sbjct: 223 LTPEARDLLKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 8e-15
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 21/206 (10%)

Query: 269 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
               IGEG++G V  A  +     VA+K  I    H+   +  LRE+ I++  +H NI+ 
Sbjct: 9   NLSYIGEGAYGMVCSATHKPTGVKVAIK-KISPFEHQTFCQRTLREIKILRRFKHENIIG 67

Query: 327 LMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           ++  +  PP+        IV E +    LYKL+     + + ++ ++    Y + +G+ Y
Sbjct: 68  IL-DIIRPPSFESFNDVYIVQELMET-DLYKLIK---TQHLSNDHIQY-FLYQILRGLKY 121

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA---GTPEWMAPE 437
           +H     ++HRDLK  NLL+++   +K+CDFGL+R     +  +        T  + APE
Sbjct: 122 IHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179

Query: 438 VLREDPSNEKS-DVFSFGVILWELIT 462
           ++       K+ D++S G IL E+++
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLS 205

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 74.6 bits (183), Expect = 9e-15
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 26/210 (12%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVL 326
           +IG G++GTVY A   +S   VA+K +  Q   +      +REVA++K L    HPNIV 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 327 LMGAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           LM             +++V E++ +     L  +P   +   E ++ ++     +G+++L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPA-ETIK-DLMRQFLRGLDFL 124

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-----WMAP 436
           H     IVHRDLK  N+LV S   VK+ DFGL+R      I S   A TP      + AP
Sbjct: 125 HANC--IVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAP 176

Query: 437 EVLREDPSNEKSDVFSFGVILWELITLQKP 466
           EVL +       D++S G I  E+   +KP
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 16/218 (7%)

Query: 268 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           LI K   +     +   +  N+ VAVK +      ++  K   +E+   + L+HPNI+  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
           + +      L +V+  ++ GS   LL  H P+    + E     +  DV   ++Y+H + 
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALDYIHSKG 121

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-------KPNTYISSKTAAGTPEWMAPEV 438
              +HR +K+ ++L+     V +     S S       +   +   K++     W++PEV
Sbjct: 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179

Query: 439 LREDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQ 474
           L+++    NEKSD++S G+   EL     P+++   +Q
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 14/220 (6%)

Query: 256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-RE 312
           +   L+++  +  + K IG G+FG V     ++S    A+K+L + E  +     F   E
Sbjct: 34  KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 313 VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 372
             IM     P +V L  A  +   L +V EY+  G L  L+   D    V E+       
Sbjct: 94  RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTA 149

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP 431
           +V   ++ +H     ++HRD+K  N+L+D    +K+ DFG       T  +   TA GTP
Sbjct: 150 EVVLALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTP 207

Query: 432 EWMAPEVLREDPSN----EKSDVFSFGVILWELITLQKPW 467
           ++++PEVL+    +     + D +S GV L+E++    P+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 17/199 (8%)

Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     +    K   RE+ +MK + H NI+ L+
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV--VVDERL---RLN-MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +  V+   L   R++ + Y +  G+ +LH
Sbjct: 82  NVFTPQKSLEEFQD------VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 135

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 136 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 192

Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 193 GYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 27/206 (13%)

Query: 271 KKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPN 323
           + IG G+FG V    W  +D      VA+K +    F      K   RE+ ++   +H N
Sbjct: 6   RPIGYGAFGVV----WSVTDPRDGKRVALKKMP-NVFQNLVSCKRVFRELKMLCFFKHDN 60

Query: 324 IVLLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
           ++  +  + +PP++       +VTE L +  L+K++  P    +  + +++   Y + +G
Sbjct: 61  VLSALD-ILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQP--LSSDHVKV-FLYQILRG 115

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAP 436
           + YLH     I+HRD+K  NLLV+S   +K+CDFGL+R  +P+          T  + AP
Sbjct: 116 LKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Query: 437 EVLREDPS-NEKSDVFSFGVILWELI 461
           E+L          D++S G I  EL+
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELL 199

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 31/215 (14%)

Query: 271 KKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIV 325
           K++G+G++G V  A    +     VA+K +      +   K  LRE+ +++  R H NI 
Sbjct: 6   KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 326 LLMGAVTEPPNLSIVTEYLSRGS-LYKLLHIPDARVVVDERLRLNMA------YDVAKGM 378
            L        ++ IV         LY+ L   D   ++     L  A      Y +  G+
Sbjct: 66  CLY-------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS------KPNTYISSKTAAGTPE 432
            Y+H     ++HRDLK  NLLV++   +K+CDFGL+R       +   +++   A  T  
Sbjct: 119 KYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA--TRW 174

Query: 433 WMAPEVLREDPSNEKS-DVFSFGVILWELITLQKP 466
           + APE++    S  K+ DV+S G IL EL+   KP
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGR-KP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 68/244 (27%), Positives = 117/244 (47%), Gaps = 29/244 (11%)

Query: 273 IGEGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLREVAIMKGLRH----PNI 324
           IG G FG VY    R +D     A+K L ++     + +       IM  L      P I
Sbjct: 2   IGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V +  A   P  L  + + ++ G L+   H+    V  ++ +R   A ++  G+ ++H R
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRF-YATEIILGLEHMHNR 116

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISSKTAAGTPEWMAPEVLR 440
              +V+RDLK  N+L+D    V++ D GL    S+ KP+       + GT  +MAPEVL+
Sbjct: 117 F--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQ 168

Query: 441 EDPSNEKS-DVFSFGVILWELITLQKPWRN--STPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +  + + S D FS G +L++L+    P+R   +     I  +      +E+P + +P + 
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-VNVELPDSFSPELK 227

Query: 498 ALIE 501
           +L+E
Sbjct: 228 SLLE 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 27/243 (11%)

Query: 273 IGEGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLREVAIMKGLRH----PNI 324
           IG G FG VY    R +D     A+K L ++     + +       IM  L      P I
Sbjct: 2   IGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V +  A   P  LS + + ++ G L+   H+    V  +  +R   A ++  G+ ++H R
Sbjct: 60  VCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEAEMRF-YAAEIILGLEHMHNR 116

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISSKTAAGTPEWMAPEVLR 440
              +V+RDLK  N+L+D    V++ D GL    S+ KP+       + GT  +MAPEVL+
Sbjct: 117 F--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQ 168

Query: 441 EDPSNEKS-DVFSFGVILWELITLQKPWR-NSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           +  + + S D FS G +L++L+    P+R + T  +           +E+P + +P + +
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228

Query: 499 LIE 501
           L+E
Sbjct: 229 LLE 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 14/217 (6%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEF-HEDRFKEFLREVAIM 316
           ++++ +    + +G GSFG V  A ++N D   VA+K   + +   + +      E  I+
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85

Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
             + HP  V L G+  +   L +V E++  G  +  L   + R   D  +    A  +  
Sbjct: 86  NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPND--VGCFYAAQIVL 142

Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMA 435
              YL      IV+RDLK  NLL+D    +K+ DFG ++     TY    T  GTPE++A
Sbjct: 143 IFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY----TLCGTPEYIA 196

Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 472
           PE+L      + +D ++ G+ ++E++    P+  + P
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 74/270 (27%), Positives = 135/270 (50%), Gaps = 39/270 (14%)

Query: 271 KKIGEGSFGTVYHAE-WRNSDVAVKILIEQEFHED--RFKEFLREVAIMKGLRHPNIVLL 327
           ++IG G FG V  +E + ++ VA  ++ E + +       EFL++    + L+HPNI+  
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           +G   E     +V EY   G L   L     H  ++++++ +R    MA ++A G+ ++H
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR----MACEIAAGVTHMH 116

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL--SRSKPNTYISSKTAAGTP-EWMAPEVL 439
           +     +H DL   N  + S  TVKV D+G+  SR K + YI ++     P  W+APE++
Sbjct: 117 KHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELV 173

Query: 440 RE-------DPSNEKSDVFSFGVILWELI-TLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
            E           + S+V++ GV LWEL     +P+ + +  +V++ V  K +++++ K 
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-IKDQQVKLFK- 231

Query: 492 VNPMVA--------ALIETCWAEEPEIRPS 513
             P +          +++ CW   PE R +
Sbjct: 232 --PQLELPYSERWYEVLQFCWL-SPEKRAT 258

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 64/225 (28%), Positives = 110/225 (48%), Gaps = 18/225 (8%)

Query: 271 KKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVL 326
           K +G+GSFG V  AE   +    AVK L +     D   E   + +  +     +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L        +L  V E+L+ G L  + HI D +   D       A ++  G+ +LH +  
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDL--MFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKG- 116

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPEVLREDPS 444
            I++RDLK  N+++D    +K+ DFG+   K N +  ++  T  GTP+++APE+L+    
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKY 173

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 489
               D +SFGV+L+E++  Q P+      ++     F+  R++ P
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTP 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 8/151 (5%)

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           R P +V L  A      L ++ +Y++ G L+   H+       +  +R+ +A ++   ++
Sbjct: 63  RCPFLVTLHYAFQTDTKLHLILDYVNGGELFT--HLYQREHFTESEVRVYIA-EIVLALD 119

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 438
           +LHQ    I++RD+K  N+L+DS   V + DFGLS+         + +  GT E+MAPEV
Sbjct: 120 HLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 439 LREDPS--NEKSDVFSFGVILWELITLQKPW 467
           +R      ++  D +S GV+ +EL+T   P+
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 61/268 (22%), Positives = 120/268 (44%), Gaps = 32/268 (11%)

Query: 273 IGEGSFGTVY---------HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           +G+G+F  ++         + E   ++V +K+L   + H +  + F    ++M  L H +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKH 60

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +VL  G         +V EY+  GSL    ++   + +++   +L +A  +A  +++L  
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLD--TYLKKNKNLINISWKLEVAKQLAWALHFLED 118

Query: 384 RRPPIVHRDLKSPNLLV-----DSTYT---VKVCDFGLSRSKPNTYISSKTAAGTPEWMA 435
           +   + H ++ + N+L+       T     +K+ D G+S     T +  +       W+ 
Sbjct: 119 KG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVP 172

Query: 436 PEVLREDPS-NEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           PE +    + +  +D +SFG  LWE+ +   KP       + +    F   R ++P    
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---FYEDRHQLPAPKW 229

Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETL 521
             +A LI  C   EP+ RPSF +I+  L
Sbjct: 230 TELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 82/295 (27%), Positives = 128/295 (43%), Gaps = 46/295 (15%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVL 326
           +KIGEG++G VY A  +N+   V   K  +E +  E      LRE+++++ L     IV 
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVR 65

Query: 327 LMGAV-----TEPPNLSIVTEYLSRG------SLYKLLHIPDARVVVDERLRLNMAYDVA 375
           L+           P+L +V EYL         S  +    P     +  +   +  Y + 
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-----LPAKTIKSFMYQLL 120

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV-KVCDFGLSR--SKPNTYISSKTAAGTPE 432
           KG+ + H+    ++HRDLK  NLLVD    + K+ D GL R  S P   + S T      
Sbjct: 121 KGVAHCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP---VKSYTHEIVTL 175

Query: 433 WM-APEVLREDPSNEKS-DVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIP 489
           W  APEVL          D++S G I  E+   Q  +  +S   Q++      G   E  
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE-- 233

Query: 490 KNVNPMVAALIETCWAEEPEIRP-----SFPSI----METLQQFLMSSVCQPLSA 535
             V P V+ L +  W E P+ +P     + P +    ++ LQ+ L     + +SA
Sbjct: 234 -QVWPGVSKLRD--WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 28/212 (13%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIV 325
           K IG G+FG V     ++S    A+K+L + E     +  F  F  E  IM       IV
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIV 106

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLL---HIPD--ARVVVDERLRLNMAYDVAKGMNY 380
            L  A  +   L +V EY+  G L  L+    IP+  AR    E   + +A D    M +
Sbjct: 107 QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAE---VVLALDAIHSMGF 163

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVL 439
                   +HRD+K  N+L+D +  +K+ DFG   +   N  +   TA GTP++++PEVL
Sbjct: 164 --------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215

Query: 440 REDPSN----EKSDVFSFGVILWELITLQKPW 467
           +    +     + D +S GV L+E++    P+
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 21/207 (10%)

Query: 271 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNIVL 326
           K IG G++G V  A+    N  VA+K  I   F ++R   K  LRE+ +++ L H N++ 
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIK-KIANAF-DNRIDAKRTLREIKLLRHLDHENVIA 68

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKL----LH--IPDARVVVDERLRLNMAYDVAKGMNY 380
           +   +  P   +    Y+     Y+L    LH  I  ++ + D+  +    Y + +G+ Y
Sbjct: 69  IKDIMPPPHREAFNDVYIV----YELMDTDLHQIIRSSQTLSDDHCQY-FLYQLLRGLKY 123

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           +H     ++HRDLK  NLL+++   +K+CDFGL+R+             T  + APE+L 
Sbjct: 124 IHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 441 EDPSNEKS-DVFSFGVILWELITLQKP 466
                  + DV+S G I  EL+  +KP
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLG-RKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 71.3 bits (174), Expect = 2e-13
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 17/199 (8%)

Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 83  NVFTPQKSLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 137 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 193

Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)

Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200

Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 201 GYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 8/198 (4%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMG 329
           IG+GSFG V     R++     +   ++ H          L E  ++  +  P IV L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
           +   P  L +V  +++ G L+   H+         R R   A ++   +  LH+    ++
Sbjct: 61  SFQSPEKLYLVLAFINGGELFH--HLQREGRFDLSRARFYTA-ELLCALENLHKFN--VI 115

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 449
           +RDLK  N+L+D    + +CDFGL +        + T  GTPE++APE+L      +  D
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175

Query: 450 VFSFGVILWELITLQKPW 467
            ++ GV+L+E++T   P+
Sbjct: 176 WWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 58/251 (23%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLL 327
           K IG G+FG V   + +++    A+K L + E  E      +R E  I+    +P +V L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPD------ARVVVDERLRLNMAYDVAKGMNYL 381
             +  +   L ++ EYL  G +  LL   D       R  + E +   +A D    + Y 
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI---LAIDSIHKLGY- 122

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----------------SRSKPNTYI--- 422
                  +HRD+K  NLL+D+   +K+ DFGL                S + P+ ++   
Sbjct: 123 -------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 423 ----SSK---------------TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL 463
               SSK               +  GTP+++APEV  +   N++ D +S GVI++E++  
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Query: 464 QKPWRNSTPSQ 474
             P+ +  P +
Sbjct: 236 YPPFCSDNPQE 246

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 35/223 (15%)

Query: 271 KKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G  G V+    + +    A+K+L ++E  + ++ K  L E  I+  L HP +  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +      L +V +Y   G L++LL     + + +E  R   A +V   + YLH     
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLL--G 123

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS------------------RSKPNTYISSKTAA- 428
           IV+RDLK  N+L+  +  + + DF LS                  R      I S+T + 
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183

Query: 429 ----------GTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 461
                     GT E++APEV+  D      D ++ G++L+E++
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 20/207 (9%)

Query: 263 RWSELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           R+ +L   K IG G+ G V  A       +VAVK L     ++   K   RE+ ++K + 
Sbjct: 22  RYQQL---KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 78

Query: 321 HPNIVLLMGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           H NI+ L+   T      E  ++ +V E L   +L +++H+      +D      + Y +
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSYLLYQM 132

Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 434
             G+ +LH     I+HRDLK  N++V S  T+K+ DFGL+R+    ++ +     T  + 
Sbjct: 133 LCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV-TRYYR 189

Query: 435 APEVLREDPSNEKSDVFSFGVILWELI 461
           APEV+      E  D++S G I+ EL+
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 40/218 (18%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEF----LREVAIMKGLRHPNIVLLM 328
           IGEG++G VY A  R+ D    + +++   ++  + F    +RE+ I++ L H NIV L 
Sbjct: 15  IGEGTYGQVYKA--RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 329 GAVT----------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
             VT          +     +V EY+    L  LL      V   E    +    + +G+
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLE--SGLVHFSEDHIKSFMKQLLEGL 129

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSKTAAGTPE 432
           NY H++    +HRD+K  N+L+++   +K+ DFGL+R      S+P T         T  
Sbjct: 130 NYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT-----NKVITLW 182

Query: 433 WMAPEVL----REDPSNEKSDVFSFGVILWELITLQKP 466
           +  PE+L    R  P+    DV+S G IL EL T +KP
Sbjct: 183 YRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 30/213 (14%)

Query: 263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF-KEFLREVAIMKGL 319
           R+ +L   K++G G++GTV  A  R +   VA+K L  + F  + F K   RE+ ++K +
Sbjct: 16  RYRDL---KQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHM 71

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYL--------SRGSLYKLLHIPDARVVVDERLRLNMA 371
           +H N++ L+   T   +L    ++           G L K   + + R+         + 
Sbjct: 72  KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LV 124

Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
           Y + KG+ Y+H     I+HRDLK  NL V+    +K+ DFGL+R       S  T     
Sbjct: 125 YQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVT 178

Query: 432 EWM-APEV-LREDPSNEKSDVFSFGVILWELIT 462
            W  APEV L      +  D++S G I+ E++T
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 17/208 (8%)

Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRH 321
           S     + IG G++G V  A    S   VA+K  I   F      K  LRE+ I++  +H
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-KIPHAFDVPTLAKRTLRELKILRHFKH 63

Query: 322 PNIVLLMGAVTEPPNLSI---VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
            NI+ +   +  P        V   L    L+ ++H    + + +E +R  + Y + +G+
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIH--SDQPLTEEHIRYFL-YQLLRGL 120

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWM- 434
            Y+H     ++HRDLK  NLLV+    +++ DFG++R   S P  +    T      W  
Sbjct: 121 KYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 435 APEVLREDPS-NEKSDVFSFGVILWELI 461
           APE+L   P      D++S G I  E++
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 27/204 (13%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV- 331
           IG GSFG VY A     D + K+ I++   + ++K   RE+ IMK L H NI+ L     
Sbjct: 74  IGNGSFGVVYEAIC--IDTSEKVAIKKVLQDPQYKN--RELLIMKNLNHINIIFLKDYYY 129

Query: 332 TEPPN-------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           TE          L++V E++ +     + H       +   L    +Y + + + Y+H +
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189

Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG-----LSRSKPNTYISSKTAAGTPEWMAPEV 438
              I HRDLK  NLL+D +T+T+K+CDFG     L+  +  +YI S+       + APE+
Sbjct: 190 F--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF------YRAPEL 241

Query: 439 -LREDPSNEKSDVFSFGVILWELI 461
            L         D++S G I+ E+I
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 51/204 (25%), Positives = 102/204 (50%), Gaps = 15/204 (7%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 326
           +G+G FG V   + +N+    K+   ++  + R K+       L E  I++ +  P IV 
Sbjct: 1   LGKGGFGEVCAVQVKNTG---KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57

Query: 327 LMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
           L  A     +L +V   ++ G L Y + ++      ++    ++ +  +  G+ +LH   
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD 115

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             IV+RD+K  N+L+D     ++ D GL+    +   +    AGT  +MAPE+L+E+P +
Sbjct: 116 --IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYS 172

Query: 446 EKSDVFSFGVILWELITLQKPWRN 469
              D F+ G  ++E++  + P+++
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 15/203 (7%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 326
           +G+G FG V   + R +    K+   ++  + R K+       L E  I++ +    +V 
Sbjct: 8   LGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 327 LMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
           L  A      L +V   ++ G L + + H+ +A    +E   +  A ++  G+  LHQ R
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF--EEGRAVFYAAEICCGLEDLHQER 122

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             IV+RDLK  N+L+D    +++ D GL+   P    + K   GT  +MAPEV++ +   
Sbjct: 123 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYT 179

Query: 446 EKSDVFSFGVILWELITLQKPWR 468
              D ++ G +L+E+I  Q P++
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 13/233 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 325
           I K IG G+FG V   + +N+D   A+KIL + E         F  E  ++    +  I 
Sbjct: 5   ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWIT 64

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L  A  +  NL +V +Y   G L  LL   + R+  D   R  +A ++   ++ +HQ  
Sbjct: 65  TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA-EMVIAIDSVHQLH 122

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLR--ED 442
              VHRD+K  N+L+D    +++ DFG   +   +  + S  A GTP++++PE+L+  ED
Sbjct: 123 --YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 443 PSNE---KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
              +   + D +S GV ++E++  + P+   +  +    +     R + P  V
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 24/203 (11%)

Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLL 327
           K++G G++G+V  A  +     VA+K L  + F  + F K   RE+ ++K ++H N++ L
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79

Query: 328 MGAVTEPP------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T         +  +V  Y+ +  L K++  P    + +++++  + Y +  G+ Y+
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHP----LSEDKVQY-LVYQMLCGLKYI 133

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM-APEV-L 439
           H     I+HRDLK  NL V+    +K+ DFGL+R       +  T      W  APEV L
Sbjct: 134 H--SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVIL 187

Query: 440 REDPSNEKSDVFSFGVILWELIT 462
                N+  D++S G I+ E++T
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 21/225 (9%)

Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE 308
           R+L ++ E  E+        K IG G+FG V     +++    A+K+L + E  +     
Sbjct: 36  RDLRMKAEDYEV-------VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88

Query: 309 FL-REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 367
           F   E  IM     P +V L  A  +   L +V EY+  G L  L+   D    V E+  
Sbjct: 89  FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWA 144

Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKT 426
                +V   ++ +H      +HRD+K  N+L+D +  +K+ DFG   +      +   T
Sbjct: 145 RFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202

Query: 427 AAGTPEWMAPEVLREDPSN----EKSDVFSFGVILWELITLQKPW 467
           A GTP++++PEVL+    +     + D +S GV L+E++    P+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 58/241 (24%), Positives = 108/241 (44%), Gaps = 30/241 (12%)

Query: 266 ELLIKKKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHEDRFKEFLREVA-IMKGLRH 321
           E++ K K+ +G FG V    H   +   V  KI+  + F+          V  +MK   +
Sbjct: 17  EIVKKLKLIDGKFGKVSVLKHKPTQKLFV-QKIIKAKNFNAIEPM-----VHQLMKD--N 68

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           PN + L  +VT      ++ +Y+  G L+ LL        + E     +   + + +N L
Sbjct: 69  PNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALNDL 125

Query: 382 HQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSK--PNTYISSKTAAGTPEWMAPEV 438
           H+    I+H D+K  N+L D +   + +CD+GL +    P+ Y       GT ++ +PE 
Sbjct: 126 HKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY------DGTLDYFSPEK 177

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---RLEIPKNVNPM 495
           ++    +   D ++ GV+ +EL+T + P++     + +       R   +L   KNV+  
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKED-EDEELDLESLLKRQQKKLPFIKNVSKN 236

Query: 496 V 496
            
Sbjct: 237 A 237

Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 43/247 (17%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLL 327
           K IG G+FG V   + +++    A+KIL + +  E      +R E  I+       +V +
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL ++ E+L  G +  LL   D   + +E  +  +A  V   ++ +HQ    
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVL-AIDSIHQL--G 121

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGL------------------------------SRSK 417
            +HRD+K  NLL+DS   VK+ DFGL                              S+ K
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181

Query: 418 PNTYISSK-----TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 472
             T+  ++     +  GTP+++APEV  +   N+  D +S GVI++E++    P+ + TP
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 473 SQVISAV 479
            +    V
Sbjct: 242 QETYKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 69.0 bits (168), Expect = 3e-12
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 51/289 (17%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E R +E  + KKIG G FG V+  + + +      K +  +   E    + + EV +M+ 
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68

Query: 319 LRHPNIVLLMGAVTEPPN--LSIVTEYLSRGSL-------YKLLHIPDARVVVDERLRLN 369
           L+H NIV  +       N  L I+ E+   G L       YK+    +   +VD   +L 
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128

Query: 370 MAYDVAKGMNYLHQRR-----PPIVHRDLKSPNLLVDSTY-----------------TVK 407
            A      + Y H  +       ++HRDLK  N+ + +                     K
Sbjct: 129 HA------LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182

Query: 408 VCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLREDPS--NEKSDVFSFGVILWELITL 463
           + DFGLS+   N  I S   +  GTP + +PE+L  +    ++KSD+++ G I++EL + 
Sbjct: 183 IGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 464 QKPWRNSTP-SQVISAVGFKGRRLEI---PKNVNPMVAALIETCWAEEP 508
           + P+  +   SQ+IS +  +G  L I    K +N ++  L+     E P
Sbjct: 240 KTPFHKANNFSQLISELK-RGPDLPIKGKSKELNILIKNLLNLSAKERP 287

Length = 1021

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 37/220 (16%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE---------FHEDRFKEFLREVAIMK 317
           I K IG G+FG V   + +N+    A+KIL + E         F E+R      +V ++ 
Sbjct: 5   ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREER------DV-LVN 57

Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY----D 373
           G R   I  L  A  +  NL +V +Y   G L  LL         ++RL  +MA     +
Sbjct: 58  GDRRW-ITNLHYAFQDENNLYLVMDYYVGGDLLTLLS------KFEDRLPEDMARFYLAE 110

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPE 432
           +   ++ +HQ     VHRD+K  N+L+D    +++ DFG   R   +  + S  A GTP+
Sbjct: 111 MVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168

Query: 433 WMAPEVLR--EDPSNE---KSDVFSFGVILWELITLQKPW 467
           +++PE+L+  ED       + D +S GV ++E++  + P+
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 43/247 (17%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLL 327
           K IG G+FG V   + +++    A+KIL + +  E      +R E  I+       +V +
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL ++ E+L  G +  LL   D   + +E  +  +A  V   ++ +HQ    
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVL-AIDAIHQL--G 121

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGL------------------------------SRSK 417
            +HRD+K  NLL+D+   VK+ DFGL                              S+ K
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 418 PNTYISSK-----TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 472
             T+  ++     +  GTP+++APEV  +   N+  D +S GVI++E++    P+ + TP
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 473 SQVISAV 479
            +    V
Sbjct: 242 QETYRKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 49/275 (17%)

Query: 266 ELLIKKKIGEGSFGTVY-----HAEWRNSDVAVKILIEQEF-HEDRFKEFLR-EVAIMKG 318
           ELL  K +G G++G V+              A+K+L +     + +  E  R E  +++ 
Sbjct: 3   ELL--KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 319 LRH-PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
           +R  P +V L  A      L ++ +Y+S G ++   H+       ++ +R     ++   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFT--HLYQRDNFSEDEVRFYSG-EIILA 117

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-----SKPNTYISSKTAAGTPE 432
           + +LH  +  IV+RD+K  N+L+DS   V + DFGLS+      K  TY    +  GT E
Sbjct: 118 LEHLH--KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY----SFCGTIE 171

Query: 433 WMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           +MAPE++R    + K+ D +S G++++EL+T   P+                  LE  +N
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF-----------------TLEGERN 214

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 526
               V+  I  C        P FPS +    Q L+
Sbjct: 215 TQSEVSRRILKC-------DPPFPSFIGPEAQDLL 242

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 8/174 (4%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHP 322
           E +I K I  G+FG VY    +N+    AVK++ + +  +++   +   E   +   + P
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
            IV L  ++    N+ +V EYL  G +  LLHI       DE + +    +VA  ++YLH
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH 121

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 436
             R  I+HRDLK  N+L+ +   +K+ DFGLS+   N  ++      TP    P
Sbjct: 122 --RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 49/287 (17%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I++ IG+GS+G V  A   ++   VA+K + +   H       LRE+ +++ LRHP+IV 
Sbjct: 4   IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 63

Query: 327 LMGAVTEPPN------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           +   +  PP+      + +V E L    L++++   D   +  E  +  + Y + + + Y
Sbjct: 64  IK-HIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDD--LTPEHHQFFL-YQLLRALKY 118

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN---TYISSKTAAGTPEWMAPE 437
           +H     + HRDLK  N+L ++   +K+CDFGL+R   N   T I       T  + APE
Sbjct: 119 IHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Query: 438 VLREDPSNEKS--DVFSFGVILWELITLQK--PWRN-------------STPSQVISAVG 480
           +     S      D++S G I  E++T +   P +N             +   + IS V 
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236

Query: 481 -FKGRR--------LEIP-----KNVNPMVAALIETCWAEEPEIRPS 513
             K RR          +P      N +P+   L+E   A +P+ RP+
Sbjct: 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 15/158 (9%)

Query: 312 EVAIMKGLRHPNIVLLMGAVT-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           E  I++ + HP+I+ L G  T       I+  Y  +  LY  L       + D    L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAICD---ILAI 187

Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKT 426
              V + + YLH+ R  I+HRD+K+ N+ ++    V + DFG +        N Y     
Sbjct: 188 ERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG--- 242

Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ 464
            AGT    APE+L  DP     D++S G++L+E+ T  
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 23/238 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 325
           I K IG G+FG V   + ++++   A+KIL + E         F  E  ++       I 
Sbjct: 5   IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWIT 64

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY----DVAKGMNYL 381
            L  A  +   L +V +Y   G L  LL         ++RL  +MA     ++   ++ +
Sbjct: 65  TLHYAFQDENYLYLVMDYYVGGDLLTLLS------KFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG--LSRSKPNTYISSKTAAGTPEWMAPEVL 439
           HQ     VHRD+K  N+L+D    +++ DFG  L  ++  T + S  A GTP++++PE+L
Sbjct: 119 HQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEIL 175

Query: 440 R--EDPSNE---KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
           +  ED   +   + D +S GV ++E++  + P+   +  +    +     R + P ++
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 20/229 (8%)

Query: 302 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 361
           H D    F    ++M  + H ++  + G         +V E++  G L   L     RV 
Sbjct: 56  HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVP 115

Query: 362 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-------DSTYTVKVCDFGLS 414
           V    ++ +A  +A  ++YL  +   +VH ++ + N+L+        ++  +K+ D G+S
Sbjct: 116 VA--WKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171

Query: 415 RSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWEL-ITLQKPWRNSTP 472
                T +S +       W+APE +    S +  +D +SFG  L E+    + P +  TP
Sbjct: 172 F----TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227

Query: 473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
           S+      F  ++  +P+     +A LI  C   EP  RPSF +I+  L
Sbjct: 228 SE---KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 19/198 (9%)

Query: 273 IGEGSFGTV---YHAEWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +G G++G+V   Y    R   VAVK L    +   H  R     RE+ ++K ++H N++ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQK-VAVKKLSRPFQSLIHARRT---YRELRLLKHMKHENVIG 78

Query: 327 LMGAVTEPPNLSIVTE-YLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           L+   T   ++    E YL    +   L +I   + + DE ++  + Y + +G+ Y+H  
Sbjct: 79  LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLRGLKYIHS- 136

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  N+ V+    +++ DFGL+R   +          T  + APE+ L    
Sbjct: 137 -AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VATRWYRAPEIMLNWMH 192

Query: 444 SNEKSDVFSFGVILWELI 461
            N+  D++S G I+ EL+
Sbjct: 193 YNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 24/210 (11%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV--- 325
           + +G GS G V+ A   + D  VAVK ++  +      K  LRE+ I++ L H NIV   
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVY 68

Query: 326 --LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMN 379
             L         ++  +TE  S   + + +    A V+    L    A    Y + +G+ 
Sbjct: 69  EVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLK 128

Query: 380 YLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSK---TAAGTPEWM- 434
           Y+H     ++HRDLK  N+ +++    +K+ DFGL+R     Y S K   +     +W  
Sbjct: 129 YIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY-SHKGYLSEGLVTKWYR 185

Query: 435 APEVLREDPSN--EKSDVFSFGVILWELIT 462
           +P +L   P+N  +  D+++ G I  E++T
Sbjct: 186 SPRLLLS-PNNYTKAIDMWAAGCIFAEMLT 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 19/199 (9%)

Query: 273 IGEGSFGTVYHA-EWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A + +    VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 331 VTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T   +L       +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 138

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +T         T  + APE+ L    
Sbjct: 139 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 195 YNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 326
           +G+G FG V   + R +    K+   ++  + R K+       L E  I++ +    +V 
Sbjct: 8   LGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 327 LMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
           L  A      L +V   ++ G L + + ++ +     DE   +  A ++  G+  LH+ R
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF--DEERAVFYAAEITCGLEDLHRER 122

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             IV+RDLK  N+L+D    +++ D GL+   P    + +   GT  +MAPEV++ +   
Sbjct: 123 --IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVVKNERYT 179

Query: 446 EKSDVFSFGVILWELITLQKPWR 468
              D +  G +++E+I  + P+R
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 49/206 (23%), Positives = 107/206 (51%), Gaps = 11/206 (5%)

Query: 312 EVAIMKGLRH-PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           E  +++ +R  P +V L  A      L ++ +Y++ G L+   H+       ++ +++  
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFT--HLSQRERFKEQEVQIYS 111

Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAAG 429
             ++   + +LH  +  I++RD+K  N+L+DS   V + DFGLS+      +  + +  G
Sbjct: 112 G-EIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168

Query: 430 TPEWMAPEVLR-EDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE 487
           T E+MAP+++R  D  ++K+ D +S GV+++EL+T   P+         + +  +  + E
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228

Query: 488 --IPKNVNPMVAALIETCWAEEPEIR 511
              P+ ++ +   +I+    ++P+ R
Sbjct: 229 PPYPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 63/261 (24%), Positives = 102/261 (39%), Gaps = 73/261 (27%)

Query: 271 KKIGEGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLR--EVAIMKGLR---- 320
           K IG G+FG V     R  D     A+K L        R  + L   + A +K  R    
Sbjct: 7   KTIGIGAFGEVCLV--RKVDTNALYAMKTL--------RKADVLMRNQAAHVKAERDILA 56

Query: 321 ---HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL-RLNMAYDVAK 376
              +  +V L  +  +  NL  V +Y+  G +  LL       + +E L R  +A ++  
Sbjct: 57  EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIA-ELTC 112

Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----------------------S 414
            +  +H  +   +HRD+K  N+L+D    +K+ DFGL                      S
Sbjct: 113 AIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 415 RSKPNTY---------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
                 +                       + +  GTP ++APEVL      +  D +S 
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 454 GVILWELITLQKPWRNSTPSQ 474
           GVIL+E++  Q P+   TP++
Sbjct: 231 GVILYEMLVGQPPFLADTPAE 251

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 15/203 (7%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 326
           +G+G FG V   + R +    K+   +   + R K+       L E  I++ +    +V 
Sbjct: 8   LGKGGFGEVCACQVRATG---KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRR 385
           L  A      L +V   ++ G L    HI +      +E   L  A ++  G+  LH+  
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
              V+RDLK  N+L+D    +++ D GL+   P    S +   GT  +MAPEVL      
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVLNNQRYT 179

Query: 446 EKSDVFSFGVILWELITLQKPWR 468
              D +  G +++E+I  Q P+R
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 326
           +G+G FG V   + R +    K+   ++  + R K+       L E  I++ +    +V 
Sbjct: 8   LGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRR 385
           L  A      L +V   ++ G L    HI +      DE+  +  A ++  G+  L + R
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             IV+RDLK  N+L+D    +++ D GL+   P    + +   GT  +MAPEV+  +   
Sbjct: 123 --IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYT 179

Query: 446 EKSDVFSFGVILWELITLQKPWR 468
              D +  G +++E+I  Q P+R
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 32/236 (13%)

Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           E+A M  L+HPNIV L+G         ++ EY+   +L ++L     R +  ER R  +A
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWER-RRKIA 786

Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSP-NLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT 430
             +AK + +LH R  P V     SP  +++D      +       S P    +      +
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-----LSLPGLLCTDTKCFIS 841

Query: 431 PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------ 484
             ++APE        EKSD++ FG+IL EL+T + P        V  ++    R      
Sbjct: 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCYSDC 899

Query: 485 ----------RLEIPKNVNPMVAA--LIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
                     R ++  N N +V    L   C A +P  RP    +++TL+    SS
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 22/227 (9%)

Query: 302 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 361
           H D    F    ++M+ + H +IVLL G         +V E++  G L   +H      V
Sbjct: 44  HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDV 101

Query: 362 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-----DSTYT--VKVCDFGLS 414
           +    +  +A  +A  ++YL  +   +VH ++ + N+L+     D      +K+ D G+ 
Sbjct: 102 LTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGI- 158

Query: 415 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK--SDVFSFGVILWEL-ITLQKPWRNST 471
              P T +S +       W+APE + ED  N    +D +SFG  LWE+    + P ++ T
Sbjct: 159 ---PITVLSRQECVERIPWIAPECV-EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214

Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIM 518
              +     F   +  +       +A L+  C   +P  RP F +IM
Sbjct: 215 ---LAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 67/246 (27%), Positives = 105/246 (42%), Gaps = 44/246 (17%)

Query: 269 IKKKIGEGSFGTVY----HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           I   +  GS G V+    H + +   V VK +          K   RE+ I+K + H  I
Sbjct: 96  ILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAI 148

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVD--ERLRLNMAYDVAKGM---- 378
           + L+ A      + +V         YK     D    VD    L L  A  + + +    
Sbjct: 149 INLIHAYRWKSTVCMVMPK------YKC----DLFTYVDRSGPLPLEQAITIQRRLLEAL 198

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG------LSRSKPNTYISSKTAAGTPE 432
            YLH R   I+HRD+K+ N+ +D      + DFG           P  Y      +GT E
Sbjct: 199 AYLHGR--GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY----GWSGTLE 252

Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWEL----ITLQKPWRNSTPSQVISAV-GFKGRRLE 487
             +PE+L  DP   K+D++S G++L+E+    +TL      S+ SQ+ S +   +   LE
Sbjct: 253 TNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312

Query: 488 IPKNVN 493
            P+N +
Sbjct: 313 FPQNGS 318

Length = 392

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 54/238 (22%), Positives = 105/238 (44%), Gaps = 30/238 (12%)

Query: 272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           K+G G++G VY A+ ++     +  ++Q           RE+A+++ L+HPN++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 332 TEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRL------NMAYDVAKGMNYLHQR 384
               +  +   +  +   L+ ++    A     + ++L      ++ Y +  G++YLH  
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 385 RPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWM-APE 437
              ++HRDLK  N+LV         VK+ D G +R  + P   ++         W  APE
Sbjct: 128 W--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 438 VLREDPSNEKS-DVFSFGVILWELITLQ-------------KPWRNSTPSQVISAVGF 481
           +L       K+ D+++ G I  EL+T +              P+ +    ++ S +GF
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 17/206 (8%)

Query: 272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           K+G G++G VY A+ ++        ++Q           RE+A+++ L+HPN++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 332 TEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRL------NMAYDVAKGMNYLHQR 384
               +  +   +  +   L+ ++    A     + ++L      ++ Y +  G++YLH  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 385 RPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWM-APE 437
              ++HRDLK  N+LV         VK+ D G +R  + P   ++         W  APE
Sbjct: 128 W--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 438 VLREDPSNEKS-DVFSFGVILWELIT 462
           +L       K+ D+++ G I  EL+T
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 12/88 (13%)

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL------SRSKPNTYISSKTAAGTP 431
           ++Y+H     I+HRD+K+ N+LV+    + + DFG       S S P  Y      AGT 
Sbjct: 273 IDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY----GIAGTV 326

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWE 459
           +  APEVL  DP     D++S G++++E
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 73/297 (24%), Positives = 117/297 (39%), Gaps = 71/297 (23%)

Query: 271 KKIGEGSFGTVYHAEWRNSDV--AVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G G+FG V  A   ++    A+K L +++  + ++      E  I+    +  +V L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLL----HIPD--ARVVVDERLRLNMAYDVAKGMNYL 381
             +  +  NL  V +Y+  G +  LL      P+  AR  + E   L +A +    M + 
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAE---LTLAIESVHKMGF- 122

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS------------------ 423
                  +HRD+K  N+L+D    +K+ DFGL      T+ S                  
Sbjct: 123 -------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175

Query: 424 -----------------------------SKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 454
                                        + +  GTP ++APEVL      +  D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235

Query: 455 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV--NPMVAALIET--CWAEE 507
           VIL+E++  Q P+   TP++    V      L IP  V  +P    LI    C AEE
Sbjct: 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 53/239 (22%), Positives = 101/239 (42%), Gaps = 55/239 (23%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLL 327
           K IG+G+FG V   + +++    A+K L++ E F +D+      E  ++     P +V L
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +   L ++ E+L  G L  +L   D     ++  R  MA +    +  +H  +  
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMA-ECVLAIEAVH--KLG 121

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS--------------------------------- 414
            +HRD+K  N+L+D    +K+ DFGLS                                 
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181

Query: 415 ---------RSKPNTYISSK-----TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWE 459
                    + +  T+  ++     +  GTP+++APE+  +    ++ D +S G I++E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 48/265 (18%)

Query: 273 IGEG--SFGTVYHAEWRNSDVAVKIL-IEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLM 328
           IG G     TV  A ++ +   V +  I  E   +    FL+ E+ + K   HPNIV   
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAY---DVAKGMNYLHQ 383
                   L +VT +++ GS   L+  H  D          L +AY    V K ++Y+H 
Sbjct: 66  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMS------ELAIAYILQGVLKALDYIHH 119

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-----------SKTAAGTPE 432
                VHR +K+ ++L+  +   KV   GL RS   + I+            K +     
Sbjct: 120 M--GYVHRSVKASHILI--SVDGKVYLSGL-RSN-LSMINHGQRLRVVHDFPKYSVKVLP 173

Query: 433 WMAPEVLREDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 490
           W++PEVL+++    + KSD++S G+   EL     P+++   +Q+          LE   
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---------LLE--- 221

Query: 491 NVNPMVAALIETCW--AEEPEIRPS 513
            +N  V  L++T    AEE  ++PS
Sbjct: 222 KLNGTVPCLLDTTTIPAEELTMKPS 246

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 64/260 (24%), Positives = 102/260 (39%), Gaps = 71/260 (27%)

Query: 271 KKIGEGSFGTVYHAEWRNSDV----AVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FG V  A  R  D     A+K L +++    ++      E  I+    +  +V
Sbjct: 7   KTLGIGAFGEVCLA--RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVV 64

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPD--ARVVVDERLRLNMAYDVAKGMN 379
            L  +  +  NL  V +Y+  G +  LL      P+  AR  + E   L  A +    M 
Sbjct: 65  RLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE---LTCAVESVHKMG 121

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL-------------------------- 413
           +        +HRD+K  N+L+D    +K+ DFGL                          
Sbjct: 122 F--------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173

Query: 414 -------------SRSKPNTYISSK--------TAAGTPEWMAPEVLREDPSNEKSDVFS 452
                         R KP    +++        +  GTP ++APEVL      +  D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233

Query: 453 FGVILWELITLQKPWRNSTP 472
            GVIL+E++  Q P+   TP
Sbjct: 234 VGVILYEMLVGQPPFLAQTP 253

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 9/95 (9%)

Query: 267 LLIKKKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L   K +G G+FG V  A       E     VAVK+L +   H D  +  + E+ I+  L
Sbjct: 40  LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTDEREALMSELKILSHL 98

Query: 320 -RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL 353
            +H NIV L+GA T    + ++TEY   G L   L
Sbjct: 99  GQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 9/102 (8%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFLREV 313
           E+    L++ + +G G+FG V  A             VAVK+L       ++ +  + E+
Sbjct: 33  EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEK-QALMSEL 91

Query: 314 AIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH 354
            IM  L  H NIV L+GA T+   + I+TEY   G L   LH
Sbjct: 92  KIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 32/156 (20%), Positives = 64/156 (41%), Gaps = 33/156 (21%)

Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLR------EVAIMK-----GLRH 321
           I +G+   +Y  ++      +K  + + +      E +R      E  ++      G+  
Sbjct: 2   IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNT 61

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           P +V  +    +P N +IV EY         +     + V++E     +  ++ + +  L
Sbjct: 62  P-VVYDV----DPDNKTIVMEY---------IEGKPLKDVIEEG-NDELLREIGRLVGKL 106

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVC--DFGLSR 415
           H  +  IVH DL + N++V      K+   DFGL +
Sbjct: 107 H--KAGIVHGDLTTSNIIVRDD---KLYLIDFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 19/47 (40%), Positives = 29/47 (61%)

Query: 429 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
           GTP+++APE+L   P     D ++ GV L+E +T   P+ + TP QV
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQV 588

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.9 bits (94), Expect = 0.002
 Identities = 34/158 (21%), Positives = 64/158 (40%), Gaps = 30/158 (18%)

Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLR------EVAIMK-----GL 319
           K I  G+   +Y  ++      +K  I + +      E +R      E  IM      G+
Sbjct: 2   KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE--RLRLNMAYDVAKG 377
             P  V  +    +P N  IV EY+    L         + +++      L ++ ++ + 
Sbjct: 62  NVP-AVYFV----DPENFIIVMEYIEGEPL---------KDLINSNGMEELELSREIGRL 107

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 415
           +  LH     I+H DL + N+++ S   + + DFGL+ 
Sbjct: 108 VGKLHSAG--IIHGDLTTSNMIL-SGGKIYLIDFGLAE 142

Length = 211

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	538
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PF14381	204	EDR1: Ethylene-responsive protein kinase Le-CTR1	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
PRK10345	210	hypothetical protein; Provisional	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
smart00090	237	RIO RIO-like kinase.	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.45
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
KOG1243	690	consensus Protein kinase [General function predict	99.32
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.27
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.25
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.25
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.09
COG4248	637	Uncharacterized protein with protein kinase and he	98.99
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.9
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.87
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.82
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.67
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.6
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.51
PRK09902	216	hypothetical protein; Provisional	98.45
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.44
PF01636	239	APH: Phosphotransferase enzyme family This family	98.33
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.31
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.24
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.15
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.06
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.94
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.93
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.92
PRK10593	297	hypothetical protein; Provisional	97.86
PLN02876	822	acyl-CoA dehydrogenase	97.86
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.86
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.85
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.66
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.65
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.6
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.59
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.49
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.43
smart00460	68	TGc Transglutaminase/protease-like homologues. Tra	97.34
PRK05231	319	homoserine kinase; Provisional	97.31
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.3
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.13
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.09
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.08
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.02
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.82
KOG2270	520	consensus Serine/threonine protein kinase involved	96.74
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.56
PF01841	113	Transglut_core: Transglutaminase-like superfamily;	96.52
PLN02236	344	choline kinase	96.41
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.38
PLN02756	418	S-methyl-5-thioribose kinase	96.29
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.15
COG2334	331	Putative homoserine kinase type II (protein kinase	96.07
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.96
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.73
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.63
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.4
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.32
COG5279	521	CYK3 Uncharacterized protein involved in cytokines	95.24
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.19
PRK12396	409	5-methylribose kinase; Reviewed	94.97
PTZ00384	383	choline kinase; Provisional	93.77

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=413.27  Aligned_cols=270  Identities=49%  Similarity=0.811  Sum_probs=245.2

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCCc-eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC-
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-  335 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~-  335 (538)
                      ..+.+...++.+.+.||+|+||+||+|.++++. +|||++..........+.|.+|+.+|++++|||||+++|++.++. 
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            335677778888888999999999999999999 999999887776666889999999999999999999999999988 


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-cEEEEeeCCC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLS  414 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla  414 (538)
                      .+++||||+++|+|..+++.. ....++...++.|+.||++||+|||++++ ||||||||+|||++.++ ++||+|||++
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccc
Confidence            799999999999999999764 34569999999999999999999999996 99999999999999997 9999999999


Q ss_pred             ccCCCCccccCCCCCCCccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLR--EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~--~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      +.............||+.|||||++.  ...|+.|+||||||+++|||+||+.||......+....+.....+..+|..+
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~  271 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC  271 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            88765433334578999999999999  5699999999999999999999999999999988888888889999999999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ++.+..||.+||..||++||++.+|+..|+.+.....
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            9999999999999999999999999999998887554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-49  Score=415.42  Aligned_cols=248  Identities=29%  Similarity=0.484  Sum_probs=227.7

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..|+.++.||+|+|++||.+++..+  .||+|++.+.... ....+.+.+|++|.+.|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999998544  4999999775443 445678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |+|.+++|..+++   .+..++|.+++.++.||+.||.|||+++  |||||||..|++++++.+|||+|||+|.......
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999997   3457999999999999999999999999  9999999999999999999999999999887666


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                      ....+.+||+.|.|||++.....+..+||||+||++|.|+.|++||...+-.+....+.  .....+|..++.++++||+
T Consensus       173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~  250 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIR  250 (592)
T ss_pred             cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHH
Confidence            66788999999999999999999999999999999999999999999999888888884  4556678899999999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 009291          502 TCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       502 ~cL~~dP~~RPs~~eIl~  519 (538)
                      ++|+.||.+|||+++|++
T Consensus       251 ~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  251 KLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHhcCCcccCCCHHHHhc
Confidence            999999999999999975

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-49  Score=394.73  Aligned_cols=251  Identities=31%  Similarity=0.508  Sum_probs=224.3

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc-
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-  336 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~-  336 (538)
                      ..+..++.+.++.||+|..|+||+++++.++  +|+|++ .-..++...+++.+|++++++.+||+||.+++.|..+.. 
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            4466778889999999999999999998776  899998 444577778899999999999999999999999999884 


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||++|+|.+++...   +.++|....+|+.+|++||.|||+ ++  ||||||||+|||++..|+|||||||.+.
T Consensus       153 isI~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccH
Confidence            99999999999999999744   459999999999999999999996 78  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhhcCcccCCCC
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS-----TPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~  490 (538)
                      ...+.  ...+.+||..|||||.+.+..|+.++||||||++++|+++|+.||...     ...+...+|. ......+|.
T Consensus       228 ~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~  304 (364)
T KOG0581|consen  228 ILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPE  304 (364)
T ss_pred             Hhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCc
Confidence            76655  346789999999999999999999999999999999999999999874     4555666664 445666777


Q ss_pred             C-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          491 N-VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       491 ~-~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      . +|+++++||..||++||.+|||++|++.
T Consensus       305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            6 9999999999999999999999999975

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-48  Score=404.86  Aligned_cols=267  Identities=37%  Similarity=0.645  Sum_probs=240.2

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...+++..+.+++++.||+|.||.||.|.++++ +||+|.++......   +.|.+|+++|++|+|+|||+++++|..+.
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            455778888899999999999999999999987 79999998765443   37889999999999999999999999988


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+||||||+..|+|.++|+.. .+..+...+.+.++.|||+|++||++++  +|||||.++||||+++..+||+|||+|+
T Consensus       275 piyIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccccccc
Confidence            999999999999999999862 3456888999999999999999999999  9999999999999999999999999999


Q ss_pred             cCCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          416 SKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       416 ~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ...+... ......-+..|.|||++....++.||||||||++||||+| |+.||.+.+..+.+..+. .+.|++.|..||
T Consensus       352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP  430 (468)
T KOG0197|consen  352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCP  430 (468)
T ss_pred             ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCC
Confidence            6554433 2334445789999999999999999999999999999998 899999999999998885 788999999999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      ++++++|..||..+|++||||+.+...|+++......
T Consensus       431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~~  467 (468)
T KOG0197|consen  431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTEG  467 (468)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcccC
Confidence            9999999999999999999999999999998876543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-49  Score=383.35  Aligned_cols=260  Identities=28%  Similarity=0.475  Sum_probs=227.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeec-eeccCCc-ce
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG-AVTEPPN-LS  338 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~-~~~~~~~-~~  338 (538)
                      ...+|++.++||+|.||+||++....++  +|.|.+.....+....+.+..|+.+|++|+|||||++++ .|.+++. ++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            3467999999999999999999886554  899999888888888999999999999999999999999 4655555 89


Q ss_pred             EEEeecCCCChhhhhcC-CCCCccccHHHHHHHHHHHHHHHHHHHhCC--CCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          339 IVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRR--PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      +|||||.+|+|..+++. .+.+..++|..+|+++.|++.||..+|++-  ..|+||||||.||+++.+|.|||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            99999999999999943 344567999999999999999999999932  349999999999999999999999999999


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC-CCCcH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNP  494 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~s~  494 (538)
                      ...+......+.+||+.||+||.+.+..|+.+|||||+||++|||+.-+.||.+.+-.+...+|. ++.-.++| ..+|.
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~-qgd~~~~p~~~YS~  255 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE-QGDYPPLPDEHYST  255 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH-cCCCCCCcHHHhhh
Confidence            98877666778899999999999999999999999999999999999999999998888777775 33334466 67899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      .+..||..|+.+||+.||+...++..++.
T Consensus       256 ~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  256 DLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            99999999999999999996555555444

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-48  Score=385.60  Aligned_cols=246  Identities=26%  Similarity=0.422  Sum_probs=221.7

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+..++|++++.||+|+||+||.++.++++  ||+|++++....+ ...+....|..||.+++||.||.++..|++...+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            355689999999999999999999887665  9999998776544 4678899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+|+||+.||.|...|+++   +.++|..+.-++.+|+.||.|||++|  ||||||||+|||++.+|+++|+|||+++..
T Consensus       101 ylVld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEEEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            9999999999999999744   35999999999999999999999999  999999999999999999999999999976


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      -.....+.+.+||+.|||||++.+..|+..+|+||||+++|||++|..||...+.......+.... ....|..++.+.+
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ar  254 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEAR  254 (357)
T ss_pred             ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHH
Confidence            555555677899999999999999999999999999999999999999999999888888885332 3445556999999


Q ss_pred             HHHHHhhhcCCCCCC
Q 009291          498 ALIETCWAEEPEIRP  512 (538)
Q Consensus       498 ~LI~~cL~~dP~~RP  512 (538)
                      ++++++|..||++|.
T Consensus       255 dll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  255 DLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHHHhccCHHHhc
Confidence            999999999999995

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-47  Score=382.48  Aligned_cols=248  Identities=28%  Similarity=0.510  Sum_probs=221.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..+|.+.+.||+|+|++||+|+++.+.  ||||.+.+.....+..+.+..|+.+|+.++|||||.+++++..++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            468999999999999999999987554  999999888778888889999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC------CcEEEEeeCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST------YTVKVCDFGLSR  415 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~------~~vkL~DFGla~  415 (538)
                      |||.||+|.++++..   +.+++..++.++.||+.||++||+++  ||||||||.|||++..      -.+||+|||+|+
T Consensus        89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999999744   36999999999999999999999999  9999999999999764      568999999999


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC-CCCCCcH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-IPKNVNP  494 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~s~  494 (538)
                      ...... ...+.+|++.|||||++...+|+.|+|+||+|+|+|+|++|+.||...+..+....+.......+ ++..++.
T Consensus       164 ~L~~~~-~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~  242 (429)
T KOG0595|consen  164 FLQPGS-MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN  242 (429)
T ss_pred             hCCchh-HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence            987654 34678999999999999999999999999999999999999999999999998887765555444 4455677


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHH
Q 009291          495 MVAALIETCWAEEPEIRPSFPSI  517 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eI  517 (538)
                      ...+|+...++.+|.+|-++.+-
T Consensus       243 ~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             chhhhhhHHHhcCccccCchHHh
Confidence            77899999999999999776654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-47  Score=386.27  Aligned_cols=251  Identities=27%  Similarity=0.407  Sum_probs=212.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHH-----HHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHED-----RFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~-----~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ..+.|.+.+.||+|+||.|-+|..+.+.  ||||++.++.....     ......+|+++|++|+|||||+++++|+.+.
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4577999999999999999999876554  99999977654321     1223569999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC---CcEEEEeeC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFG  412 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~---~~vkL~DFG  412 (538)
                      ..||||||++||.|.+.+-..   +.+.+..-..+++|++.|+.|||++|  |+||||||+|||++.+   -.+||+|||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999999998643   35788888999999999999999999  9999999999999766   689999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhcCcccC-
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLE-  487 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~---~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~-~~~~i~~~~~~~~-  487 (538)
                      +|+..+.. ....+.|||+.|.|||++.+..   +..++|+|||||+||-+++|.+||....... ...++..+..... 
T Consensus       325 lAK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p  403 (475)
T KOG0615|consen  325 LAKVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP  403 (475)
T ss_pred             hhhccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence            99987644 3457889999999999998764   3458999999999999999999998766555 5666654443332 


Q ss_pred             -CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          488 -IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       488 -~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       ....++++..+||.+||..||++|||++++|.
T Consensus       404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  404 LQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             33578999999999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=386.49  Aligned_cols=266  Identities=38%  Similarity=0.664  Sum_probs=238.0

Q ss_pred             hcccccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       256 ~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ..+.|+|..+++.+++.||+|.||+||+|+|.| +||||++.......+..+.|++|+.++++-+|.||+-++|+|..+.
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            347789999999999999999999999999877 7999999999999999999999999999999999999999999988


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      . .||+.+|+|.+|+.+++..+.  .++....+.|++||+.|+.|||.++  |||||||..||++.+++.|||+|||++.
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             e-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEeccccee
Confidence            7 999999999999999987654  5888999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCC--CccccCCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc---ccC
Q 009291          416 SKPN--TYISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---RLE  487 (538)
Q Consensus       416 ~~~~--~~~~~~~~~gt~~Y~aPE~l~~---~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~---~~~  487 (538)
                      ....  .........|...|||||++..   .+|+..+||||||+++|||++|..||...+.++++.++..+..   ...
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~  616 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK  616 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence            6432  2223345568889999999864   4689999999999999999999999998888888888865533   334


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       488 ~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      ...+++.++++|+..||..++++||.+.+|+..|+.++.+
T Consensus       617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            4567889999999999999999999999999999999984

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.3e-45  Score=358.59  Aligned_cols=250  Identities=27%  Similarity=0.443  Sum_probs=215.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      +.|+.+.++|+|+||+||++++++++  ||||++..++.++...+-.+||+++|++|+|+|+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45888999999999999999998877  9999999988778878889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      ||+..-|.++-+..+   -++...+.++++|++.|+.|+|+++  +|||||||+|||++.+|.+||||||+|+....+..
T Consensus        82 ~~dhTvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   82 YCDHTVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             ecchHHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence            999866655544332   2788999999999999999999999  99999999999999999999999999998765444


Q ss_pred             ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------------------
Q 009291          423 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------------  482 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-------------------  482 (538)
                      ..+..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+.|.+.+.-+.+..|...                   
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            5567788999999999988 78999999999999999999999999998876665544321                   


Q ss_pred             CcccCCC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 GRRLEIP----------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ~~~~~~p----------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.+++-|          +.++..+.+|+++||..||++|++.+|++.
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1222222          245567899999999999999999999874

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=379.27  Aligned_cols=252  Identities=28%  Similarity=0.445  Sum_probs=224.1

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~  337 (538)
                      ....+|.+++.||+|+|++|++|+...+.  ||||++.+..+. +..++-+.+|-.+|.+| .||.|++++..|+++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34578999999999999999999887554  999998766543 34456778899999999 899999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+|+||+++|+|.++++.-   +.+++..++.++.||+.||+|||++|  ||||||||+|||++++|++||+|||.|...
T Consensus       150 YFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999999743   56999999999999999999999999  999999999999999999999999999864


Q ss_pred             CCCc-----------ccc--CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc
Q 009291          418 PNTY-----------ISS--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR  484 (538)
Q Consensus       418 ~~~~-----------~~~--~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~  484 (538)
                      ....           ...  .+.+||..|.+||++.....+..+|||+||||+|+|+.|.+||...++.-+..+|  ...
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI--~~l  302 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI--QAL  302 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--HHh
Confidence            4211           111  4578999999999999999999999999999999999999999999998888887  456


Q ss_pred             ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       485 ~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ...+|.+.++.+.+||+++|..||.+|+|++||.+.
T Consensus       303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  303 DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            678899999999999999999999999999998764

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.5e-45  Score=396.65  Aligned_cols=270  Identities=35%  Similarity=0.563  Sum_probs=236.9

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeece
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA  330 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~  330 (538)
                      ...++..++.+..+.||+|+||+||+|+..+       .-||||.++... +.+..++|.+|++++..|+|||||+++|+
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            3457788899999999999999999997642       129999987654 45567899999999999999999999999


Q ss_pred             eccCCcceEEEeecCCCChhhhhcCCC-----------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEE
Q 009291          331 VTEPPNLSIVTEYLSRGSLYKLLHIPD-----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLL  399 (538)
Q Consensus       331 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NIL  399 (538)
                      |.+++.+|||+|||..|+|.+||....           ...+++..+.+.||.||+.|++||-++.  +|||||-++|+|
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCL  635 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCL  635 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhce
Confidence            999999999999999999999994321           1234888999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEEeeCCCccCCCCcccc--CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 009291          400 VDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVI  476 (538)
Q Consensus       400 l~~~~~vkL~DFGla~~~~~~~~~~--~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~  476 (538)
                      |+++..|||+|||+++.........  ....-..+|||||.+..++|+++|||||+||+|||+++ |..||.+...++++
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            9999999999999999765432221  12334779999999999999999999999999999998 89999999999999


Q ss_pred             HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCC
Q 009291          477 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ  531 (538)
Q Consensus       477 ~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~  531 (538)
                      ..+..... ++.|.+||.++++||..||+.+|.+||+|.+|..+|+++.+.+...
T Consensus       716 e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~  769 (774)
T KOG1026|consen  716 ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY  769 (774)
T ss_pred             HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence            99874444 9999999999999999999999999999999999999999887664

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=351.48  Aligned_cols=240  Identities=27%  Similarity=0.459  Sum_probs=220.8

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      ...++|++++.||.|+||+|.+++.+.++  ||+|++.++.. ...+++...+|..+|+.+.||+++++++.|.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            56789999999999999999999987555  99999987654 3466778899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      |||||.+||.|.++++..   +++++..++-++.||+.||+|||+++  |++|||||+|||+|.+|.+||+|||+|....
T Consensus       121 mvmeyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EEEeccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999999744   36999999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      ..   .-+.|||+.|+|||++.+..|..++|+||||+++|||+.|..||...++..+..+|  ......+|+.++..+++
T Consensus       196 ~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--~~~~v~fP~~fs~~~kd  270 (355)
T KOG0616|consen  196 GR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--LEGKVKFPSYFSSDAKD  270 (355)
T ss_pred             Cc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--HhCcccCCcccCHHHHH
Confidence            43   35789999999999999999999999999999999999999999999998888888  45567889999999999


Q ss_pred             HHHHhhhcCCCCC
Q 009291          499 LIETCWAEEPEIR  511 (538)
Q Consensus       499 LI~~cL~~dP~~R  511 (538)
                      ||.++|+.|-.+|
T Consensus       271 Ll~~LL~vD~t~R  283 (355)
T KOG0616|consen  271 LLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHHhhhhHhh
Confidence            9999999999999

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-44  Score=373.57  Aligned_cols=257  Identities=31%  Similarity=0.508  Sum_probs=224.0

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC---HHHHHHHHHHHHHHHcCC-CCceeEeeceeccCC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH---EDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~---~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~  335 (538)
                      ...+.|++++.||+|+||+|++|.+..  ..||+|++..+...   ....+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            446789999999999999999998764  45999976654221   233456778999999998 999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC-CcEEEEeeCCC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLS  414 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla  414 (538)
                      .+++||||+.||+|.+++..   .+++.|..+..++.|++.|++|||++|  |+||||||+|||++.+ +++||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999974   346899999999999999999999999  9999999999999999 99999999999


Q ss_pred             ccCCCCccccCCCCCCCcccccccccCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLREDP-SN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~s-~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      ...........+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||...+.......+  ......+|..+
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~  246 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYL  246 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCc
Confidence            98743334557889999999999999977 75 8899999999999999999999998877777665  56677888888


Q ss_pred             -cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          493 -NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       493 -s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                       ++++++||.+||..||.+|+|+.+|+  ...+++.
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~~  280 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQK  280 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHh--hChhhcc
Confidence             99999999999999999999999998  4444443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1e-43  Score=367.68  Aligned_cols=265  Identities=31%  Similarity=0.584  Sum_probs=218.2

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc-------CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeecee
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV  331 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~  331 (538)
                      +++..++|++.+.||+|+||.||+|.+.       +..||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            5677789999999999999999999752       2349999986442 344556799999999999 899999999988


Q ss_pred             ccCC-cceEEEeecCCCChhhhhcCCCC----------------------------------------------------
Q 009291          332 TEPP-NLSIVTEYLSRGSLYKLLHIPDA----------------------------------------------------  358 (538)
Q Consensus       332 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------  358 (538)
                      .... .++++|||+++|+|.+++.....                                                    
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            7644 58899999999999999864211                                                    


Q ss_pred             -------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC--ccccCCCCC
Q 009291          359 -------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAG  429 (538)
Q Consensus       359 -------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~g  429 (538)
                             ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.....  ........+
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                   124777888999999999999999999  999999999999999999999999999764322  111223445


Q ss_pred             CCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCC
Q 009291          430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP  508 (538)
Q Consensus       430 t~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP  508 (538)
                      +..|+|||++.+..++.++|||||||++|||++ |..||......+........+.....+..+++.+.++|.+||+.||
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  318 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP  318 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence            678999999999999999999999999999997 9999987654443333333445566678889999999999999999


Q ss_pred             CCCCCHHHHHHHHHHHHhh
Q 009291          509 EIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       509 ~~RPs~~eIl~~L~~il~~  527 (538)
                      ++|||+.++++.|++++..
T Consensus       319 ~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         319 KERPTFSALVEILGDLLQE  337 (338)
T ss_pred             hhCcCHHHHHHHHHHHHhc
Confidence            9999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.5e-44  Score=370.97  Aligned_cols=260  Identities=26%  Similarity=0.422  Sum_probs=224.4

Q ss_pred             hhhhcccccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeec
Q 009291          253 LYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMG  329 (538)
Q Consensus       253 ~~~~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~  329 (538)
                      .++......+..++|+++..||+|+||.||+|+-+.++  +|+|+++++.. ...+++.+..|-.+|...++|.||+++.
T Consensus       129 e~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY  208 (550)
T KOG0605|consen  129 EYLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY  208 (550)
T ss_pred             HHHHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence            33455555778899999999999999999999877666  99999988765 3566788999999999999999999999


Q ss_pred             eeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                      .|++..++||||||++||++..+|...   ..+++..+..++.+++.|++.||+.|  +|||||||+|+|||..|++||+
T Consensus       209 sFQD~~~LYLiMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  209 SFQDKEYLYLIMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             EecCCCeeEEEEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeec
Confidence            999999999999999999999999744   46999999999999999999999999  9999999999999999999999


Q ss_pred             eeCCCccCCC-----------------------Ccc-----c-------------------cCCCCCCCcccccccccCC
Q 009291          410 DFGLSRSKPN-----------------------TYI-----S-------------------SKTAAGTPEWMAPEVLRED  442 (538)
Q Consensus       410 DFGla~~~~~-----------------------~~~-----~-------------------~~~~~gt~~Y~aPE~l~~~  442 (538)
                      |||++.-...                       ...     .                   ....+||+.|||||++.+.
T Consensus       284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k  363 (550)
T KOG0605|consen  284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK  363 (550)
T ss_pred             cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence            9999852100                       000     0                   0124599999999999999


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHH
Q 009291          443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPS---FPSI  517 (538)
Q Consensus       443 ~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~~LI~~cL~~dP~~RPs---~~eI  517 (538)
                      .|+..+|+||||||+|||+.|.+||...++.+....+......+.+|.  .+++++.+||.+||+ ||++|..   ++||
T Consensus       364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI  442 (550)
T KOG0605|consen  364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI  442 (550)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence            999999999999999999999999999999999888865555566665  468999999999999 9999965   5555


Q ss_pred             H
Q 009291          518 M  518 (538)
Q Consensus       518 l  518 (538)
                      .
T Consensus       443 K  443 (550)
T KOG0605|consen  443 K  443 (550)
T ss_pred             h
Confidence            3

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-44  Score=378.14  Aligned_cols=248  Identities=29%  Similarity=0.483  Sum_probs=225.1

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecc-ccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQ-EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~-~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +-|++++.||+|+-|.|-+|++..++  +|||++.+. .........+.+|+.||+.+.||||++++++|++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45889999999999999999986554  999998766 555566678899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++|.|.+++-.   ++.+++.+++.++.||+.|+.|+|..+  |+||||||+|+|++..+++||+|||+|.....+.
T Consensus        92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999999963   456999999999999999999999999  9999999999999999999999999998765543


Q ss_pred             cccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                       -..+.||++.|+|||++.+.+| +.++||||.|||||.|++|+.||+..+....+.++  ....+++|.+++.++++||
T Consensus       167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLL  243 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLL  243 (786)
T ss_pred             -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHH
Confidence             3467899999999999999998 68999999999999999999999999999988888  4556778899999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ++||.+||++|.|.++|++.
T Consensus       244 r~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             HHHhccCccccccHHHHhhC
Confidence            99999999999999999764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-44  Score=360.74  Aligned_cols=253  Identities=31%  Similarity=0.518  Sum_probs=213.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC--cceE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP--NLSI  339 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~--~~~l  339 (538)
                      ..+|..++.||+|+||+||++.+..  ...|||.+.......  .+.+.+|+.+|++++|||||++++......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            3467788999999999999999875  559999987653222  678899999999999999999999743333  6999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCCCccCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKP  418 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~  418 (538)
                      +|||+++|+|.+++...+.  .+++..+..+..|+++||+|||++|  ||||||||+|||++. ++.+||+|||++....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9999999999999975443  5999999999999999999999999  999999999999999 7999999999998755


Q ss_pred             C---CccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhcCcccCCCCCCc
Q 009291          419 N---TYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       419 ~---~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      .   .........||+.|||||++..+ ....++|||||||++.||+||..||.. ....+....+........+|..++
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls  249 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS  249 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence            2   11223457899999999999953 334599999999999999999999998 455555555555555568899999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      ++.++||.+|+..+|++|||++++++.-.
T Consensus       250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  250 DEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            99999999999999999999999987653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-44  Score=371.50  Aligned_cols=248  Identities=30%  Similarity=0.527  Sum_probs=222.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ...|....+||+|+.|.||.|....++  ||||.+........  +-+.+|+.+|+..+|+|||++++.+...+.+|+||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            356778899999999999999876554  88888876654433  47889999999999999999999998889999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||++||+|.+.+..    ..++|.++..|+++++.||+|||.+|  |||||||.+|||++.+|.+||+|||++.......
T Consensus       350 Eym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             eecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            99999999999853    34999999999999999999999999  9999999999999999999999999998876665


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~~LI  500 (538)
                      ....+.+||+.|||||++....|+.++||||||++++||+-|++||-..++...+..+...+ ..+..+..+|+++++|+
T Consensus       424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL  503 (550)
T KOG0578|consen  424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL  503 (550)
T ss_pred             CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence            56678899999999999999999999999999999999999999999888877777775443 45677889999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||+.|+++|+++.++|+
T Consensus       504 ~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  504 DRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHhhcchhcCCCHHHHhc
Confidence            9999999999999999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.8e-44  Score=369.38  Aligned_cols=247  Identities=31%  Similarity=0.560  Sum_probs=225.6

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|.+.+.||+|.||+||+|+.+.+.  ||+|.+.+....++..+.+.+|++|++.++||||+.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46888999999999999999877665  9999998888888889999999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.| +|..++...   +.++|+.+..|+.+++.||.|||+.+  |+|||+||.|||+++.|.+|+||||+|+.......
T Consensus        82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence            9987 999999744   45999999999999999999999999  99999999999999999999999999998766544


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      -.....||+-|||||.+.+.+|+..+|.||||||+||+++|++||....-.+.+..|.  ......|.+.+..+.+|+..
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl~g  233 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTASSSFVNFLQG  233 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCcccccHHHHHHHHH
Confidence            4566789999999999999999999999999999999999999999988878877774  44556677999999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIME  519 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~  519 (538)
                      +|.+||.+|.|..+++.
T Consensus       234 LL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  234 LLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HhhcChhhcccHHHHhc
Confidence            99999999999998865

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-43  Score=370.08  Aligned_cols=247  Identities=29%  Similarity=0.477  Sum_probs=222.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCC
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP  335 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~  335 (538)
                      ..+...+|.+++.||+|.||+|++++.++++  ||||++++..+ ....++..+.|.+|+... +||.++.++..|++..
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3566789999999999999999999998766  99999988754 456678888999999877 5999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ++++||||+.||++....+    ...+++..+.-++..|+.||.|||++|  ||+||||.+|||+|.+|++||+|||+++
T Consensus       443 ~l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             eEEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999999544432    235999999999999999999999999  9999999999999999999999999999


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      ........+.+.+||+.|||||++.+..|+..+|+|||||+||||+.|+.||.+.+++++...|  ......+|..++.+
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI--~~d~~~yP~~ls~e  594 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI--VNDEVRYPRFLSKE  594 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--hcCCCCCCCcccHH
Confidence            8665555678899999999999999999999999999999999999999999999999999888  44566778899999


Q ss_pred             HHHHHHHhhhcCCCCCCCH
Q 009291          496 VAALIETCWAEEPEIRPSF  514 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~  514 (538)
                      ..++|+++|.+||++|..+
T Consensus       595 a~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  595 AIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHHHHhccCcccccCC
Confidence            9999999999999999755

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.5e-42  Score=349.39  Aligned_cols=247  Identities=22%  Similarity=0.378  Sum_probs=214.9

Q ss_pred             EEEccCCcEEEEEEEEcCCceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceecc----CCcceEEEeecC
Q 009291          271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNLSIVTEYLS  345 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~----~~~~~lV~E~~~  345 (538)
                      ..||+|++|.||+|.+.++.||||++....... ...+.+.+|+.+|++++||||+++++++.+    ...+++||||++
T Consensus        26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~  105 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT  105 (283)
T ss_pred             eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence            579999999999999999899999987654333 335788899999999999999999999866    346899999999


Q ss_pred             CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc
Q 009291          346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS  424 (538)
Q Consensus       346 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~  424 (538)
                      +|+|.+++...   ..+++...+.++.|++.||.|||+. +  ++||||||+||++++++.+||+|||+++......   
T Consensus       106 ~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        106 RGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            99999999743   3578889999999999999999984 7  8899999999999999999999999987644321   


Q ss_pred             CCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          425 KTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~--~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      ....++..|+|||.+.+  ..++.++|||||||++|||++|..||...+..+....+.....+..+|..+++++++||.+
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~  257 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA  257 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence            24567899999999976  6789999999999999999999999999888777776655566677777899999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      ||+.||++|||+.++++.|+++-
T Consensus       258 cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        258 CTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HhcCCcccCcCHHHHHHHHHHHH
Confidence            99999999999999999998763

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=350.22  Aligned_cols=246  Identities=25%  Similarity=0.432  Sum_probs=213.9

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc--CCceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||.||+|.+.  ++.+|+|++..... .....+.+.+|+.++++++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36899999999999999999987  44599999875433 2234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            999999999998643   35889999999999999999999999  999999999999999999999999998765432 


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                        .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.  .....+|..++..+.+||+
T Consensus       155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~  230 (291)
T cd05612         155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL--AGKLEFPRHLDLYAKDLIK  230 (291)
T ss_pred             --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCcCCCccCCHHHHHHHH
Confidence              234578999999999999989999999999999999999999999888777666653  3345677888999999999


Q ss_pred             HhhhcCCCCCCC-----HHHHHHH
Q 009291          502 TCWAEEPEIRPS-----FPSIMET  520 (538)
Q Consensus       502 ~cL~~dP~~RPs-----~~eIl~~  520 (538)
                      +||+.||.+||+     ++++++.
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcC
Confidence            999999999995     8887654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-43  Score=364.34  Aligned_cols=253  Identities=29%  Similarity=0.502  Sum_probs=231.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc-ceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-LSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~-~~lV  340 (538)
                      .++|..++.+|+|+||.+++++++..+  +++|.+......+......++|+.++++++|||||.+.+.|.+++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            367899999999999999999877544  9999998887777777789999999999999999999999999888 9999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |+||+||++.+.+...+ +..++++.+..++.|++.|+.|||+++  |+|||||+.||++++++.|||+|||+|+.....
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999997554 456999999999999999999999999  999999999999999999999999999998777


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                      .....+..||+.||+||.+.+.+|+.|+|||||||++|||++-+++|...+.......+. ...-.++|..++.++..+|
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-~~~~~Plp~~ys~el~~lv  238 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-RGLYSPLPSMYSSELRSLV  238 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-hccCCCCCccccHHHHHHH
Confidence            655678899999999999999999999999999999999999999999999988888775 3335678899999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +.||..+|+.||++.+++..
T Consensus       239 ~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  239 KSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHhhcCCccCCCHHHHhhC
Confidence            99999999999999999987

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=366.53  Aligned_cols=275  Identities=31%  Similarity=0.545  Sum_probs=244.5

Q ss_pred             chhhhcccccccccceeEEEEEccCCcEEEEEEEEcCC-----c-eEEEEEec-cccCHHHHHHHHHHHHHHHcCCCCce
Q 009291          252 ELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----D-VAVKILIE-QEFHEDRFKEFLREVAIMKGLRHPNI  324 (538)
Q Consensus       252 ~~~~~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~-vavK~~~~-~~~~~~~~~~~~~Ei~il~~L~hpnI  324 (538)
                      ...+..+.|++..++..+.++||+|+||.||+|+.+..     . ||+|..+. .......++++.+|.++|+.++||||
T Consensus       144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV  223 (474)
T KOG0194|consen  144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV  223 (474)
T ss_pred             cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE
Confidence            34556788999999999999999999999999987532     2 78888775 33667888999999999999999999


Q ss_pred             eEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC
Q 009291          325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY  404 (538)
Q Consensus       325 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~  404 (538)
                      |+++|++.....+++|||+|.||+|.++|+....  .++..+...++.+.+.||+|||+++  +|||||-.+|+|++.++
T Consensus       224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~  299 (474)
T KOG0194|consen  224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKG  299 (474)
T ss_pred             EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCC
Confidence            9999999999999999999999999999975543  5888999999999999999999999  99999999999999999


Q ss_pred             cEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcC
Q 009291          405 TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG  483 (538)
Q Consensus       405 ~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~  483 (538)
                      .+||+|||+++.............-+..|+|||.+....|+.++|||||||++||+++ |..||.+....++...+...+
T Consensus       300 ~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~  379 (474)
T KOG0194|consen  300 VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG  379 (474)
T ss_pred             eEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC
Confidence            9999999999876522211112235789999999999999999999999999999999 788999999999999997889


Q ss_pred             cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       484 ~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      .+.+.|...+.++..++.+||..+|++||++.++.+.|+.+.+....
T Consensus       380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            99999999999999999999999999999999999999999877653

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.8e-42  Score=355.46  Aligned_cols=249  Identities=27%  Similarity=0.450  Sum_probs=216.1

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ....++|++.+.||+|+||.||+|++..+  .+|+|++..... .....+.+.+|+.++++++||||+++++++.+++.+
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            34457899999999999999999998654  499999876533 234456788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+.+++|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++...
T Consensus        94 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             EEEEcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            9999999999999998643   35788999999999999999999999  999999999999999999999999999865


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ....   ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.  ..+..+|..++..+.
T Consensus       169 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~  243 (329)
T PTZ00263        169 PDRT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRAR  243 (329)
T ss_pred             CCCc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHH
Confidence            4332   34578999999999999999999999999999999999999999888766666553  345667788999999


Q ss_pred             HHHHHhhhcCCCCCCC-----HHHHHH
Q 009291          498 ALIETCWAEEPEIRPS-----FPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs-----~~eIl~  519 (538)
                      +||.+||+.||++|++     +++++.
T Consensus       244 ~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        244 DLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            9999999999999987     677764

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-43  Score=332.91  Aligned_cols=253  Identities=29%  Similarity=0.503  Sum_probs=227.1

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHH-HHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDR-FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~-~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ....++|++++.||+|.||.||.|+.+.+.  +|+|++.+++..... ...+.+|++|.+.|+||||++++++|.+....
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            344578999999999999999999988777  899998877654433 35688999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+++||..+|.++..|+... ...+++...+.++.|++.||.|+|.++  ||||||||+|+|++..|.+||+|||.+...
T Consensus        98 yLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999999997433 235899999999999999999999999  999999999999999999999999999887


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      +..  ...+.+||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+...++  ...+..+|..++..++
T Consensus       175 p~~--kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--~k~~~~~p~~is~~a~  250 (281)
T KOG0580|consen  175 PSN--KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--RKVDLKFPSTISGGAA  250 (281)
T ss_pred             CCC--CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--HHccccCCcccChhHH
Confidence            633  456889999999999999999999999999999999999999999999877777777  4567788899999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ++|.+|+..+|.+|.+..|+++.
T Consensus       251 dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  251 DLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHHHHhccCccccccHHHHhhh
Confidence            99999999999999999988753

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.1e-41  Score=338.46  Aligned_cols=258  Identities=28%  Similarity=0.506  Sum_probs=218.3

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc-----CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      +...+|++.+.||+|+||.||+|.+.     +..+|+|.+.... .......+.+|+.++++++||||+++++++.....
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            45678999999999999999999764     2248888876543 34445678999999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+++  ++||||||+||+++.++.+|++|||.+..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999999986432  35889999999999999999999999  99999999999999999999999998765


Q ss_pred             CCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          417 KPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       417 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      ...... ......++..|+|||.+.+..++.++|||||||++||+++ |..||......+....+. .....+.+..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPN  235 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCH
Confidence            432211 1122345678999999999999999999999999999875 999999888777666553 3345567788999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      .+.+++.+||+.+|++||++++|++.|.+++
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence            9999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=359.15  Aligned_cols=251  Identities=27%  Similarity=0.444  Sum_probs=211.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCC-cce
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP-NLS  338 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~-~~~  338 (538)
                      ...+|.++++||.|.||.||+|+...+.  ||||.++.+...-++ ..=+||+.-|++|+ ||||+++.+++.+.. .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3468999999999999999999876544  999998876554332 34468999999998 999999999998887 899


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +|||||+. +|+++++..  +..+++..+..|++||+.||+|+|++|  +.|||+||+|||+.....+||+|||+||...
T Consensus        87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccc
Confidence            99999965 999999755  457999999999999999999999999  9999999999999988899999999999865


Q ss_pred             CCccccCCCCCCCccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-C-------------
Q 009291          419 NTYISSKTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-G-------------  483 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~-~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~-------------  483 (538)
                      +.. ..+..+.|.+|+|||++. ...|+.++|+||+|||++|+.+-++.|.+.++.+.+.++... +             
T Consensus       162 Skp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  162 SKP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             cCC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            543 235678899999999875 567899999999999999999999999998887776655321 0             


Q ss_pred             ---cccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          484 ---RRLEIP-----------KNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       484 ---~~~~~p-----------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                         ..+.+|           ++++.++.+||.+||.+||++|||++|.++.
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence               011111           3578899999999999999999999999764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.6e-42  Score=354.60  Aligned_cols=242  Identities=28%  Similarity=0.458  Sum_probs=208.9

Q ss_pred             EEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      +.||+|+||.||++++..+  .||+|++..... .......+.+|+.++++++||||+++++++.+...+++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999988644  499999876432 3344567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCC
Q 009291          348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA  427 (538)
Q Consensus       348 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  427 (538)
                      +|.+++...   ..+++..+..++.||+.||+|||++|  |+||||||+||+++.++.+||+|||+++............
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            999988643   35889999999999999999999999  9999999999999999999999999987543322233456


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 009291          428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE  507 (538)
Q Consensus       428 ~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~d  507 (538)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.  .....+|..+++++.+||.+||+.|
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence            79999999999999999999999999999999999999998887766665553  3345678889999999999999999


Q ss_pred             CCCCC-----CHHHHHH
Q 009291          508 PEIRP-----SFPSIME  519 (538)
Q Consensus       508 P~~RP-----s~~eIl~  519 (538)
                      |++||     ++.++++
T Consensus       234 P~~R~~~~~~~~~~ll~  250 (323)
T cd05571         234 PKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHcCCCCCCCHHHHHc
Confidence            99999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=375.24  Aligned_cols=273  Identities=26%  Similarity=0.417  Sum_probs=226.7

Q ss_pred             ccchhhhcccccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeE
Q 009291          250 NRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVL  326 (538)
Q Consensus       250 ~~~~~~~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~  326 (538)
                      ....+.....+++...+++|.+.|.+|||+.||+|++.+.  .||+|.+...  ++...+.+.+|+++|+.|. |+|||.
T Consensus        22 ~~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~   99 (738)
T KOG1989|consen   22 QSENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVS   99 (738)
T ss_pred             ccccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceee
Confidence            3345555677888999999999999999999999998754  5999998776  6788899999999999996 999999


Q ss_pred             eece-ecc---C---CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEE
Q 009291          327 LMGA-VTE---P---PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLL  399 (538)
Q Consensus       327 l~~~-~~~---~---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NIL  399 (538)
                      +++. ...   .   -.++|.||||.||.|-+++...... .+++.++++|++|+++|+.+||...|||||||||-+|||
T Consensus       100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvL  178 (738)
T KOG1989|consen  100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVL  178 (738)
T ss_pred             EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheE
Confidence            9993 211   1   2368999999999999999644333 399999999999999999999999999999999999999


Q ss_pred             EcCCCcEEEEeeCCCccCCCCccc---------cCCCCCCCcccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 009291          400 VDSTYTVKVCDFGLSRSKPNTYIS---------SKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPW  467 (538)
Q Consensus       400 l~~~~~vkL~DFGla~~~~~~~~~---------~~~~~gt~~Y~aPE~l---~~~~~s~ksDVwSLGvil~eLltg~~Pf  467 (538)
                      |+.+|++||||||.|+........         .-...-|+.|+|||++   .+...++|+|||+|||+||-||+...||
T Consensus       179 ls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PF  258 (738)
T KOG1989|consen  179 LSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPF  258 (738)
T ss_pred             EcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCc
Confidence            999999999999998753322111         1122468999999987   4778899999999999999999999999


Q ss_pred             CCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          468 RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       468 ~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      +......    |......++..+.++..+++||+.||+.||++||++.|+++.+..+.....
T Consensus       259 e~sg~la----Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  259 EESGKLA----ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             CcCccee----EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence            9875432    323444444446899999999999999999999999999999998876544

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=384.74  Aligned_cols=271  Identities=34%  Similarity=0.555  Sum_probs=234.3

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC-----c--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-----D--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      ++.....++.+.||+|+||.||.|...+.     +  ||||.+.+. .+.+...+|++|..+|++++|||||+++|++.+
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            36688899999999999999999976432     2  777776544 356778899999999999999999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCC----CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                      ....++++|||++|+|..+|+...    ....+.....+.++.||++|++||++++  +|||||..+|+|++....|||+
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEc
Confidence            999999999999999999997541    1235888899999999999999999999  9999999999999999999999


Q ss_pred             eeCCCccCCCCccc-cCCC-CCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCccc
Q 009291          410 DFGLSRSKPNTYIS-SKTA-AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRL  486 (538)
Q Consensus       410 DFGla~~~~~~~~~-~~~~-~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~  486 (538)
                      |||+|+-..+.... .... .-...|||||.+....++.|+|||||||++||++| |..||...++.++...+...+ |+
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL  923 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL  923 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence            99999944332222 1112 33568999999999999999999999999999999 899999999988877665444 99


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCCCC
Q 009291          487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA  535 (538)
Q Consensus       487 ~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~~~  535 (538)
                      +.|..|++.++++|..||+.+|++||+|..|++++.++++....++-+.
T Consensus       924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~  972 (1025)
T KOG1095|consen  924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGP  972 (1025)
T ss_pred             CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccc
Confidence            9999999999999999999999999999999999999998887665543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.2e-42  Score=329.92  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=213.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      .+|...+.||+|.||.||+|++..++  ||||+++.....+.......||+..|+.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999987655  9999998776555555678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |++. +|...++...  ..++...+..++.++++||+|||++.  |+||||||.|+|++.+|.+||+|||+|+.......
T Consensus        82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9965 8999987544  46889999999999999999999999  99999999999999999999999999999877665


Q ss_pred             ccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Ccc---------------
Q 009291          423 SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRR---------------  485 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~---------------  485 (538)
                      .....+-|..|.|||.+.|. .|+..+||||.|||+.||+.+.+-|.+.+.-+.+..+-.. +.+               
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            55556889999999998775 6899999999999999999999888888776655443211 000               


Q ss_pred             ----cC------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          486 ----LE------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       486 ----~~------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                          .+      +-..+++.+.+|+.+||..||.+|.++.|.++.
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                00      112456788999999999999999999998754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-42  Score=356.55  Aligned_cols=254  Identities=28%  Similarity=0.376  Sum_probs=215.8

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--Cc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PN  336 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~  336 (538)
                      ....+.|+.+++||+|.||.||+|++..++  ||+|.+......+.......|||.||++|+||||+++.+...+.  ..
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            445678999999999999999999998776  99999988877777778888999999999999999999998776  57


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|||+|||++ +|.-++.....  .+++.++..++.|++.||+|||.+|  |+|||||..|||||++|.+||+|||+|+.
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceee
Confidence            9999999987 88888875543  5999999999999999999999999  99999999999999999999999999996


Q ss_pred             CCCCc-cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Cc-------cc
Q 009291          417 KPNTY-ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR-------RL  486 (538)
Q Consensus       417 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~-------~~  486 (538)
                      ..... ...+..+-|.+|.|||.+.|. .|+.++|+||.||||.||+.|++.|.+.++.+.+..|-.. +.       ..
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            44322 224566779999999999875 6899999999999999999999999999887766554311 00       01


Q ss_pred             CCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 EIP-------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ~~p-------------------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+|                   ..+++...+|+..||+.||++|.|+.+.+.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            111                   245778999999999999999999998764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=365.32  Aligned_cols=252  Identities=37%  Similarity=0.670  Sum_probs=227.8

Q ss_pred             hcccccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       256 ~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      +.+.|+|.++...-++-||.|+.|.||+|+.++..||||+++.-.         ..+|+=|++|+|+||+.|.|+|....
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsP  185 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSP  185 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCc
Confidence            356788999988889999999999999999999999999864321         24677799999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|||||||..|.|+..|+..   ..+.......+..+|+.|+.|||.+.  |||||||.-||||+.+..|||+|||-++
T Consensus       186 cyCIiMEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  186 CYCIIMEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             eeEEeeeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchH
Confidence            999999999999999999744   36889999999999999999999999  9999999999999999999999999988


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      ...+. ...-..+||..|||||++...+.++|+|||||||+||||+||..||.......+++.+......++.|..|++-
T Consensus       261 e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~G  339 (904)
T KOG4721|consen  261 ELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG  339 (904)
T ss_pred             hhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchH
Confidence            76554 22346789999999999999999999999999999999999999999988888887777677788899999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      ++-||++||+..|..||+|.+|+..|.
T Consensus       340 fklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  340 FKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             HHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            999999999999999999999998885

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-41  Score=357.39  Aligned_cols=265  Identities=31%  Similarity=0.522  Sum_probs=219.2

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeec
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG  329 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~  329 (538)
                      ..+.+..++|++.+.||+|+||.||+|.+..       ..||+|++.... .......+.+|+.+++.+ +|+||+++++
T Consensus        31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~  109 (374)
T cd05106          31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLG  109 (374)
T ss_pred             ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence            3456677899999999999999999997632       249999986543 334456788999999999 8999999999


Q ss_pred             eeccCCcceEEEeecCCCChhhhhcCCC----------------------------------------------------
Q 009291          330 AVTEPPNLSIVTEYLSRGSLYKLLHIPD----------------------------------------------------  357 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------  357 (538)
                      ++......++||||+++|+|.+++....                                                    
T Consensus       110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (374)
T cd05106         110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS  189 (374)
T ss_pred             EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence            9999999999999999999999884321                                                    


Q ss_pred             ---------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          358 ---------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       358 ---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                                     ....+++..++.++.|++.||+|||+++  |+||||||+|||+++++.+||+|||+++.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                           0124678889999999999999999999  99999999999999999999999999876433211


Q ss_pred             --ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          423 --SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       423 --~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                        ......++..|+|||++.+..++.++|||||||++|||++ |..||.................+...+..+++++.++
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  347 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI  347 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence              1122335667999999998899999999999999999997 9999987665444444433444555667789999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      |.+||+.+|++|||+.++++.|++++
T Consensus       348 i~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         348 MKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.3e-41  Score=342.70  Aligned_cols=258  Identities=34%  Similarity=0.536  Sum_probs=210.2

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC----------------C--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN----------------S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN  323 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn  323 (538)
                      +..++|++.+.||+|+||.||+|.+..                +  .||+|++.... .......+.+|+.++++++|||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence            345689999999999999999997532                2  38999876543 4455678999999999999999


Q ss_pred             eeEeeceeccCCcceEEEeecCCCChhhhhcCCC----------------CCccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 009291          324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD----------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPP  387 (538)
Q Consensus       324 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~  387 (538)
                      |+++++++.+.+..++||||+.+++|.+++....                ....+++..++.++.|++.||+|||+++  
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--  158 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--  158 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence            9999999999999999999999999999885321                1124677889999999999999999999  


Q ss_pred             EEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh--C
Q 009291          388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--L  463 (538)
Q Consensus       388 iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt--g  463 (538)
                      |+||||||+|||++.++.+||+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++  +
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999999999999999999999976433211  1223445788999999998889999999999999999986  5


Q ss_pred             CCCCCCCCHHHHHHHHhh------cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          464 QKPWRNSTPSQVISAVGF------KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       464 ~~Pf~~~~~~~~~~~i~~------~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      ..||...+..+....+..      .......+..++..+.+||.+||+.+|++|||+.+|.+.|+
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            678887766555443321      11122345678899999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-41  Score=353.53  Aligned_cols=251  Identities=24%  Similarity=0.410  Sum_probs=217.3

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC---ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS---DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ..+..++|++.+.||+|+||.||+|.+.++   .+|+|++..... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            456678999999999999999999987543   489998865432 3344567889999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+.+|+|.+++...   ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++.
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            999999999999999998643   35889999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+.  .....+|..+++.
T Consensus       180 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~  254 (340)
T PTZ00426        180 VVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPKFLDNN  254 (340)
T ss_pred             ecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHH
Confidence            65432   234578999999999999889999999999999999999999999888766666553  3345567889999


Q ss_pred             HHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 009291          496 VAALIETCWAEEPEIRP-----SFPSIMET  520 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RP-----s~~eIl~~  520 (538)
                      +.++|++||+.+|++|+     +++++++.
T Consensus       255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            99999999999999995     88888764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=344.44  Aligned_cols=259  Identities=29%  Similarity=0.452  Sum_probs=218.4

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +..+....++|++.+.||.|.-++||+|+...+  .||||++........ .+.+.+|+..|+.++||||++++..|..+
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~   96 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD   96 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence            456778889999999999999999999988644  499999987765555 78999999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ..+|+||.||.+|++.++++..-.. -++|..+..|.+++++||.|||.+|  .||||||+.||||+.+|.|||+|||.+
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceee
Confidence            9999999999999999999543222 2899999999999999999999999  999999999999999999999999976


Q ss_pred             ccCCCCccc---c-CCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--
Q 009291          415 RSKPNTYIS---S-KTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--  486 (538)
Q Consensus       415 ~~~~~~~~~---~-~~~~gt~~Y~aPE~l~~--~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--  486 (538)
                      ....+....   . .+..||+.|||||++..  ..|+.|+||||||++..||.+|..||....+..++-....+....  
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            543222111   1 45689999999999643  458999999999999999999999999999887765443222110  


Q ss_pred             --CC----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 --EI----PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 --~~----p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                        -+    ....+..+.++|..||..||++|||+.++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              01    1235678999999999999999999999976

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.1e-41  Score=339.51  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=207.7

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      .|++.+.||+|+||.||++.+..  ..||+|++....... .....+.+|+.++++++|+||+.+++++.+++.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            37889999999999999998764  459999886544322 233567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+++|+|.+++.... ...+++..+..++.|++.||+|||+++  |+||||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999988875322 235889999999999999999999999  9999999999999999999999999998654322 


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hcCcccCCCCCCcHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~s~~l~~LI  500 (538)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+.  .......++..+++.+.+||
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            2234578999999999999999999999999999999999999998765432222111  12334456778899999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHHH
Q 009291          501 ETCWAEEPEIRPS-----FPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs-----~~eIl~  519 (538)
                      ++||+.||++||+     ++++++
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhc
Confidence            9999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-42  Score=349.27  Aligned_cols=251  Identities=31%  Similarity=0.483  Sum_probs=209.9

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCH------------HHHHHHHHHHHHHHcCCCCceeEe
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE------------DRFKEFLREVAIMKGLRHPNIVLL  327 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~------------~~~~~~~~Ei~il~~L~hpnIv~l  327 (538)
                      ....+|++++.||+|.||+|-+|.+..++  ||||++.+.....            ..++...+|+.||+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999987554  9999986643321            123578899999999999999999


Q ss_pred             eceeccC--CcceEEEeecCCCChhhhhcCCCCCcc-ccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC
Q 009291          328 MGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVV-VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY  404 (538)
Q Consensus       328 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~  404 (538)
                      +++..++  +.+|||+|||..|.+...-    .... +.+.++++++.+++.||+|||.+|  ||||||||+|+|++++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCC
Confidence            9998765  4699999999988775432    2233 899999999999999999999999  99999999999999999


Q ss_pred             cEEEEeeCCCccCCCC-----ccccCCCCCCCcccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 009291          405 TVKVCDFGLSRSKPNT-----YISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQV  475 (538)
Q Consensus       405 ~vkL~DFGla~~~~~~-----~~~~~~~~gt~~Y~aPE~l~~~~----~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~  475 (538)
                      +|||+|||.+...+.+     ........||+-|+|||...++.    .+.+.||||+||+||.|+.|+.||......+.
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            9999999998865332     11223468999999999987733    36788999999999999999999999999888


Q ss_pred             HHHHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          476 ISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       476 ~~~i~~~~~~~~~p--~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ..+|.  ..++.+|  +.+.+.+++||.+||++||++|.+..+|...
T Consensus       328 ~~KIv--n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  328 FDKIV--NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             HHHHh--cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            88884  4455555  4589999999999999999999998887543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=350.31  Aligned_cols=248  Identities=26%  Similarity=0.408  Sum_probs=212.8

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||.||+|++..  ..||+|++...... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            469999999999999999999864  45999998765332 234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++...   ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++.....  
T Consensus        81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999643   35889999999999999999999999  99999999999999999999999999976543  


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC------CCCcHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP------KNVNPM  495 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p------~~~s~~  495 (538)
                       ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........|      ..++++
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~  232 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE  232 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence             2245678999999999999999999999999999999999999999888777665554322222222      256899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +.+||.+||..+|++||++.++++.
T Consensus       233 ~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         233 AWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHHHhhChhhhcCCHHHHHhC
Confidence            9999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=348.63  Aligned_cols=238  Identities=24%  Similarity=0.409  Sum_probs=204.8

Q ss_pred             EccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCCh
Q 009291          273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL  349 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  349 (538)
                      ||+|+||+||+|++..++  ||+|++..... .......+.+|+.++++++||||+++++++.++...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999987544  99999865432 344566788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCC
Q 009291          350 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG  429 (538)
Q Consensus       350 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~g  429 (538)
                      .+++...   ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++.............|
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            9998643   35889999999999999999999999  999999999999999999999999999764333223345678


Q ss_pred             CCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCC
Q 009291          430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE  509 (538)
Q Consensus       430 t~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~  509 (538)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.  .....+|..+++++.+||.+||+.||+
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~  233 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPT  233 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHH
Confidence            999999999999999999999999999999999999999887766665553  345667888999999999999999999


Q ss_pred             CCCCHHHH
Q 009291          510 IRPSFPSI  517 (538)
Q Consensus       510 ~RPs~~eI  517 (538)
                      +||++..+
T Consensus       234 ~R~~~~~~  241 (312)
T cd05585         234 RRLGYNGA  241 (312)
T ss_pred             HcCCCCCH
Confidence            99864333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.9e-41  Score=355.46  Aligned_cols=262  Identities=31%  Similarity=0.514  Sum_probs=215.6

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc-------CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeecee
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV  331 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~  331 (538)
                      +.+..++|++.+.||+|+||+||+|.+.       +..||||++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            4566678999999999999999999742       2248999886543 233456788999999999 899999999999


Q ss_pred             ccCCcceEEEeecCCCChhhhhcCCCC-----------------------------------------------------
Q 009291          332 TEPPNLSIVTEYLSRGSLYKLLHIPDA-----------------------------------------------------  358 (538)
Q Consensus       332 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------  358 (538)
                      .+....++||||+++|+|.++++....                                                     
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            999999999999999999999853211                                                     


Q ss_pred             -------------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          359 -------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       359 -------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                                         ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                               124678889999999999999999999  99999999999999999999999999976543


Q ss_pred             Ccc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          420 TYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       420 ~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ...  ......++..|+|||.+.+..++.++|||||||++|||++ |..||.................+...|...+.++
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  346 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEM  346 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHH
Confidence            221  1122334667999999999999999999999999999998 8899987655444444333444555566778999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      .+||.+||+.||++|||+.+|++.|++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.2e-41  Score=338.22  Aligned_cols=258  Identities=34%  Similarity=0.573  Sum_probs=218.3

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc-------eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ..++|++.+.||+|+||.||+|...+..       +++|.+.... .......+.+|+.++++++||||+++++++.+..
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            4568999999999999999999875433       8888876443 3445567899999999999999999999999988


Q ss_pred             cceEEEeecCCCChhhhhcCCCC-------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~  402 (538)
                      ..+++|||+++++|.+++.....             ...+++..++.++.|++.||+|||+++  ++|+||||+||++++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~  159 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGE  159 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcC
Confidence            99999999999999999854311             145788899999999999999999999  999999999999999


Q ss_pred             CCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 009291          403 TYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAV  479 (538)
Q Consensus       403 ~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i  479 (538)
                      ++.+||+|||++.......  .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999987543221  11233456788999999988889999999999999999998 99999988877766655


Q ss_pred             hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       480 ~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      . .......+..++.++.+|+.+||+.||++||++++|++.|+++
T Consensus       240 ~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         240 R-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             H-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            4 3444556788999999999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.4e-41  Score=339.05  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=206.0

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||+|+||+||+++++.++  +|+|++..........+.+.+|+.+++.++|+||+++++++.++..+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36999999999999999999987544  9999987665445556778899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |++++.+..+...   ...+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9998777655432   235889999999999999999999999  99999999999999999999999999987543221


Q ss_pred             -ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-----------------
Q 009291          423 -SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-----------------  484 (538)
Q Consensus       423 -~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-----------------  484 (538)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.....                 
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence             22345689999999999988899999999999999999999999987765443332211000                 


Q ss_pred             ccC-------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 RLE-------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ~~~-------------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ...             ....++.++.+||.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000             11236788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.9e-41  Score=347.99  Aligned_cols=242  Identities=27%  Similarity=0.462  Sum_probs=207.8

Q ss_pred             EEEccCCcEEEEEEEEcC--CceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCC
Q 009291          271 KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      +.||+|+||.||++++..  ..||+|++..... .......+.+|+.+++.++||||+++++++.....+++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            369999999999998864  4499999876432 2344567888999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCC
Q 009291          348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA  427 (538)
Q Consensus       348 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  427 (538)
                      +|..++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++.............
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            999888643   35889999999999999999999999  9999999999999999999999999987543322223445


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 009291          428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE  507 (538)
Q Consensus       428 ~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~d  507 (538)
                      .||..|+|||++.+..++.++|||||||++|||++|+.||...+.......+.  .....+|..+++++.+||.+||+.|
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence            78999999999999999999999999999999999999998887766665553  2345577889999999999999999


Q ss_pred             CCCCC-----CHHHHHH
Q 009291          508 PEIRP-----SFPSIME  519 (538)
Q Consensus       508 P~~RP-----s~~eIl~  519 (538)
                      |++|+     ++.++++
T Consensus       234 P~~R~~~~~~~~~~~l~  250 (323)
T cd05595         234 PKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHhCCCCCCCHHHHHc
Confidence            99998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.4e-41  Score=348.34  Aligned_cols=243  Identities=28%  Similarity=0.458  Sum_probs=208.8

Q ss_pred             EEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      +.||+|+||.||++++..+  .+|+|++..... .......+.+|+.+++.++||||+++++++.+...+++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999988644  499999876432 3345577889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCC
Q 009291          348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA  427 (538)
Q Consensus       348 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  427 (538)
                      +|..++...   ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++............
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            999888643   35889999999999999999999999  9999999999999999999999999987543322223445


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 009291          428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE  507 (538)
Q Consensus       428 ~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~d  507 (538)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.  .....+|..+++++.+||++||+.|
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d  233 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKD  233 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCC
Confidence            78999999999999899999999999999999999999998877766655543  3445678889999999999999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 009291          508 PEIRP-----SFPSIMET  520 (538)
Q Consensus       508 P~~RP-----s~~eIl~~  520 (538)
                      |++|+     ++.++++.
T Consensus       234 P~~R~~~~~~~~~~il~h  251 (328)
T cd05593         234 PNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHcCCCCCCCHHHHhcC
Confidence            99997     88988764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=326.23  Aligned_cols=266  Identities=22%  Similarity=0.382  Sum_probs=217.9

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...-|+.++|.+.+.||+|+|+.||+++...++  ||+|.+....  .+..+..++|++..++++||||++++++...+.
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            445678899999999999999999999865444  9999998875  456678999999999999999999999864333


Q ss_pred             -----cceEEEeecCCCChhhhhcCCCCCc-cccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          336 -----NLSIVTEYLSRGSLYKLLHIPDARV-VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       336 -----~~~lV~E~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                           ..|++++|...|+|.+.++....++ .+++.+.+.|+.++++||++||+..|+++||||||.|||+++.+.++|.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                 3899999999999999996654443 7999999999999999999999999999999999999999999999999


Q ss_pred             eeCCCccCCCCccc---------cCCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 009291          410 DFGLSRSKPNTYIS---------SKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS  477 (538)
Q Consensus       410 DFGla~~~~~~~~~---------~~~~~gt~~Y~aPE~l~~---~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~  477 (538)
                      |||.++...-.-..         -.....|..|.|||.+.-   ...++++|||||||+||+|+.|..||.......-.-
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl  251 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL  251 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence            99998764321111         122346899999999864   456899999999999999999999997543322111


Q ss_pred             HHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          478 AVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       478 ~i~~~~~~~~~p--~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      +.......+.+|  ..+|+.+.++|++||++||.+||++.+++..+.+++
T Consensus       252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            222222233333  458999999999999999999999999999998875

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.1e-41  Score=345.48  Aligned_cols=245  Identities=28%  Similarity=0.453  Sum_probs=207.2

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHH---HcCCCCceeEeeceeccCCcceEE
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIM---KGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il---~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      |++.+.||+|+||.||+|.+..+  .||||++..... .....+.+.+|+.++   +.++||||+++++++.+...+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67899999999999999988644  499999875432 233445667776655   566899999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+++++|...++.    ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++......
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999888753    24899999999999999999999999  999999999999999999999999998754332


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                      ........|+..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+..  ....+|..++..+.++|
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li  232 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPRFLSREAISIM  232 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHH
Confidence            2233456789999999999999999999999999999999999999998887776665533  34456788999999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHH
Q 009291          501 ETCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RP-----s~~eIl~  519 (538)
                      .+||+.||++||     ++.++++
T Consensus       233 ~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         233 RRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhh
Confidence            999999999999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-40  Score=330.71  Aligned_cols=258  Identities=33%  Similarity=0.573  Sum_probs=218.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +.+..++|++.++||+|+||.||+|...++ .+|+|.+....   ...+.+.+|+.+++.++|+||+++++.+.+....+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            356778999999999999999999987644 48888865432   23467899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ++|||+++++|.++++... ...+++..++.++.|++.||+|||+.+  ++||||||+||++++++.+||+|||++....
T Consensus        78 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             EEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecC
Confidence            9999999999999986432 235788889999999999999999999  9999999999999999999999999998754


Q ss_pred             CCccc-cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          419 NTYIS-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       419 ~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. ...+.+.+..++.++
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDEL  233 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence            43211 122345678999999998889999999999999999998 999998887766666554 334455556789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      .++|.+||..+|++||+++++++.|+++
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         234 YDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            9999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=351.57  Aligned_cols=250  Identities=28%  Similarity=0.443  Sum_probs=214.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||+||+|++.  +..||+|++....... .....+.+|+.++..++|+||+++++++.++..+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36899999999999999999987  4459999987654322 44567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999998644   35889999999999999999999999  9999999999999999999999999997654332


Q ss_pred             -----------------------------cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 009291          422 -----------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP  472 (538)
Q Consensus       422 -----------------------------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~  472 (538)
                                                   .......||..|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                         122345689999999999999999999999999999999999999998887


Q ss_pred             HHHHHHHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 009291          473 SQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPS-FPSIMET  520 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p--~~~s~~l~~LI~~cL~~dP~~RPs-~~eIl~~  520 (538)
                      ......+........+|  ..+++++.+||.+||. +|++||+ +.++++.
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            76666654422333333  3469999999999998 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.8e-40  Score=346.12  Aligned_cols=249  Identities=28%  Similarity=0.461  Sum_probs=204.3

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      ....++|++++.||+|+||+||+|++..  +.||+|++.... .....+.+.+|+++++.++|+||+++++++.+...++
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            3446788899999999999999998864  459999986543 3444567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++++|....       ...+..+..++.||+.||+|||+++  |+||||||+|||+++++.+||+|||+++...
T Consensus       149 lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        149 VLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            999999999986532       2567788899999999999999999  9999999999999999999999999998654


Q ss_pred             CCccccCCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhhcCcccCCCC
Q 009291          419 NTYISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPK  490 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~-----~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~---~~~i~~~~~~~~~p~  490 (538)
                      ..........||..|+|||.+..     ...+.++|||||||++|||++|+.||......+.   ...+ ........+.
T Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~  298 (353)
T PLN00034        220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMSQPPEAPA  298 (353)
T ss_pred             cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hccCCCCCCC
Confidence            43323345678999999998753     2345689999999999999999999974332221   1112 1233445667


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      .++.++.+||.+||+.||++|||+.++++.
T Consensus       299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        299 TASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            889999999999999999999999999764

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-43  Score=353.47  Aligned_cols=249  Identities=32%  Similarity=0.534  Sum_probs=218.9

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ..|..++.||+|.||.||+|.+..++  ||+|++.... .+..++.+.+|+.+|.+++++||.++|+.+..+..++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            45777799999999999999987655  9999986654 34556788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      ||.||++.++++...   .+++..+.-++.+++.||.|||.++  .+|||||+.||++..+|.|||+|||.+........
T Consensus        92 y~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999997544   3588888889999999999999999  99999999999999999999999999988877766


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      ...+.+||+.|||||++.+..|+.|+||||||++.+||++|.+||....+...+..|. ......+...+++.+++||..
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEA  245 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHH
Confidence            6688999999999999999899999999999999999999999999988855444332 223334455789999999999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~~  520 (538)
                      ||+.||+.||+|.++++.
T Consensus       246 CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  246 CLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HhhcCcccCcCHHHHhhh
Confidence            999999999999999863

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-41  Score=340.72  Aligned_cols=257  Identities=26%  Similarity=0.381  Sum_probs=222.7

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...+..++|++++.||.|.-|+||+++..++.  +|+|++.+.... .+....+..|-+||+.++||.++.+|..|+.+.
T Consensus        71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            34566788999999999999999999998764  999999776544 455677888999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..|++||||+||+|+.+++.+.. ..+++..+.-++.+++-||+|||-.|  ||.|||||+||||.++|++.|+||.++.
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccc
Confidence            99999999999999999976644 46999999999999999999999999  9999999999999999999999999975


Q ss_pred             cCCC---------------------------------C-c----------------------cccCCCCCCCcccccccc
Q 009291          416 SKPN---------------------------------T-Y----------------------ISSKTAAGTPEWMAPEVL  439 (538)
Q Consensus       416 ~~~~---------------------------------~-~----------------------~~~~~~~gt~~Y~aPE~l  439 (538)
                      ....                                 . .                      ..+...+||-+|.|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            3210                                 0 0                      001224589999999999


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCC----HH
Q 009291          440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS----FP  515 (538)
Q Consensus       440 ~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs----~~  515 (538)
                      .+...+.++|+|+||+.+|||++|..||.+.+..+.+..+..+...++-...++..+++||+++|.+||.+|..    +.
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~  387 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA  387 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence            99999999999999999999999999999999999988886555555555578899999999999999999987    66


Q ss_pred             HHH
Q 009291          516 SIM  518 (538)
Q Consensus       516 eIl  518 (538)
                      +|-
T Consensus       388 eIK  390 (459)
T KOG0610|consen  388 EIK  390 (459)
T ss_pred             Hhh
Confidence            664

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.7e-40  Score=329.44  Aligned_cols=258  Identities=38%  Similarity=0.653  Sum_probs=218.9

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      ++...+|.+.+.||+|+||.||+|.+..  +.+++|++...   ....+.+.+|++++++++|+||+++++++..+..++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            4567789999999999999999998764  45899987643   233467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ++|||+++++|.+++.... ...+++..++.++.|++.||+|||+++  ++||||||+||++++++.+||+|||++....
T Consensus        79 lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          79 IITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            9999999999999986432 235788999999999999999999999  9999999999999999999999999988654


Q ss_pred             CCcccc-CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          419 NTYISS-KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       419 ~~~~~~-~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ...... ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. ...+...+..++.++
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (263)
T cd05052         156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKV  234 (263)
T ss_pred             cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHH
Confidence            432211 12234567999999998899999999999999999998 899998877665554443 344566778899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      .++|.+||+.+|++||++.++++.|++++
T Consensus       235 ~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         235 YELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             HHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            99999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.3e-41  Score=344.46  Aligned_cols=242  Identities=24%  Similarity=0.420  Sum_probs=207.5

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCC-CceeEeeceeccCCcceEEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~h-pnIv~l~~~~~~~~~~~lV~  341 (538)
                      +|++++.||+|+||.||+|++.++  .||+|++..... .....+.+..|..++..+.| ++|+.+++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            588999999999999999998765  499999876432 23445678889999999976 46888999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999999988633   34789999999999999999999999  9999999999999999999999999987533222


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                      .......||..|+|||++.+..++.++|||||||++|+|++|+.||......+....+.  .....+|..+++++.++|.
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~  233 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICK  233 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Confidence            23345578999999999999999999999999999999999999999888777766663  3445677889999999999


Q ss_pred             HhhhcCCCCCCCH
Q 009291          502 TCWAEEPEIRPSF  514 (538)
Q Consensus       502 ~cL~~dP~~RPs~  514 (538)
                      +||..||.+|++.
T Consensus       234 ~~l~~~P~~R~~~  246 (324)
T cd05587         234 GLLTKHPAKRLGC  246 (324)
T ss_pred             HHhhcCHHHcCCC
Confidence            9999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.4e-41  Score=338.05  Aligned_cols=250  Identities=25%  Similarity=0.336  Sum_probs=203.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||+||+|.+..+  .||+|++..... ......+.+|+.++++++||||+++++++.++...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            46799999999999999999988644  499998865432 222346778999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+ +|.+++....  ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          83 EYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             eCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            99975 8888875432  24788899999999999999999999  9999999999999999999999999997654333


Q ss_pred             cccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc----------------
Q 009291          422 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------  484 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~----------------  484 (538)
                      .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+....+.....                
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            33345578999999999875 5689999999999999999999999988776555443321000                


Q ss_pred             -ccC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 -RLE-----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 -~~~-----------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       ...           ....++.++.+||.+||+.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             000           11346788999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-42  Score=342.80  Aligned_cols=248  Identities=27%  Similarity=0.464  Sum_probs=219.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc--CCceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .+|++.+.||+|.||+|-+|...  ++.||||.+.+..+ ++...-.+.+|++||+.|+||||+.++++|++.+.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            57888999999999999999775  44599999877665 4555778899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||..+|.|++++..   ++.+++.++..|++||+.|+.|+|+++  ++|||||.+|||++.++++||+|||++....+..
T Consensus       133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999974   346999999999999999999999999  9999999999999999999999999998766543


Q ss_pred             cccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                       ..++.||++-|.+||++.+.+| +..+|-||||++||.|..|..||.+..-...+.++..+..+-   +.-+....-||
T Consensus       208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLI  283 (668)
T KOG0611|consen  208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLI  283 (668)
T ss_pred             -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHH
Confidence             3478899999999999999998 678999999999999999999999998888888886554432   23455678899


Q ss_pred             HHhhhcCCCCCCCHHHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      ++||.+||++|.|+.+|....
T Consensus       284 RwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  284 RWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             HHHHhcCcccchhHHHHhhhh
Confidence            999999999999999997654

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-40  Score=352.91  Aligned_cols=266  Identities=31%  Similarity=0.521  Sum_probs=220.7

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCC-------ceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeec
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMG  329 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~  329 (538)
                      ..+++..++|++++.||+|+||.||+|.+.+.       .||||++.... .....+.+.+|+.+++++. ||||+++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            44667788999999999999999999986421       38999886543 3444578999999999996 999999999


Q ss_pred             eeccCCcceEEEeecCCCChhhhhcCCCC---------------------------------------------------
Q 009291          330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDA---------------------------------------------------  358 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------  358 (538)
                      ++.+....++||||+++|+|.+++.....                                                   
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            99999999999999999999988753210                                                   


Q ss_pred             ------------------------------------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCC
Q 009291          359 ------------------------------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP  396 (538)
Q Consensus       359 ------------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~  396 (538)
                                                                ...+++..++.++.|++.||+|||+.+  |+||||||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~  266 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAAR  266 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChH
Confidence                                                      123677888999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 009291          397 NLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPS  473 (538)
Q Consensus       397 NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~  473 (538)
                      ||++++++.+||+|||+++......  .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            9999999999999999997643321  11223456788999999999889999999999999999997 89999876554


Q ss_pred             HHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 009291          474 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM  526 (538)
Q Consensus       474 ~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~  526 (538)
                      ...........+...+..++..+.++|.+||+.+|++|||+.+|.+.|++++.
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            44433333445566778899999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-40  Score=348.63  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=209.1

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||+||+|++..+  .||+|++..... .......+.+|+.++.+++|+||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4689999999999999999988654  499999876432 2344567888999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999998643   35899999999999999999999999  9999999999999999999999999987532210


Q ss_pred             c-----------------------------------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 009291          422 I-----------------------------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP  466 (538)
Q Consensus       422 ~-----------------------------------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~P  466 (538)
                      .                                   .....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                   01234799999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhhcCcccCCCC--CCcHHHHHHHHHhhhcCCC---CCCCHHHHHHH
Q 009291          467 WRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPE---IRPSFPSIMET  520 (538)
Q Consensus       467 f~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~~LI~~cL~~dP~---~RPs~~eIl~~  520 (538)
                      |...+..+....+........+|.  .+++++.++|.+|+. +|+   .||++++|++.
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            998888777666654334444454  468999999999775 444   45899999775

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.3e-40  Score=327.22  Aligned_cols=251  Identities=36%  Similarity=0.612  Sum_probs=213.4

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +.++|++.+.||+|+||.||++.++.+ .+|+|.+......   .+.+.+|+.++++++||||+++++++.+....++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            346799999999999999999988654 5899987654333   246888999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++|+|.++++...  ..+++..++.++.|++.||+|||+++  ++||||||+||++++++.+||+|||.++......
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            9999999999986432  24788999999999999999999999  9999999999999999999999999987654322


Q ss_pred             cc-cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          422 IS-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       422 ~~-~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      .. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+.. ..+...|...+..+.++
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~l  233 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEV  233 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHH
Confidence            11 122345668999999998889999999999999999999 8999998887777666643 33445566778999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      +.+||+.+|++||++.++++.|
T Consensus       234 i~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         234 MYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHccCCcccCcCHHHHHHhh
Confidence            9999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.4e-41  Score=334.27  Aligned_cols=249  Identities=41%  Similarity=0.717  Sum_probs=209.1

Q ss_pred             eEEEEEccCCcEEEEEEEEc------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          268 LIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       268 ~i~~~LG~G~fg~Vy~a~~~------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++.+.||.|.||.||+|.+.      +..|+||++.. .......+.+.+|++.+++++||||+++++++......++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence            56889999999999999988      33489999854 334555789999999999999999999999999888899999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC-
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-  420 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~-  420 (538)
                      ||+++|+|.+++... ....+++..++.|+.|++.||+|||+++  ++|+||+++||++++++.+||+|||++...... 
T Consensus        81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccc-cccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence            999999999999755 1235889999999999999999999999  999999999999999999999999999876321 


Q ss_pred             -ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          421 -YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       421 -~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                       ............|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ....+...+..++..+.+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYS  236 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHH
Confidence             112234456788999999998889999999999999999999 78999998887777776 466677788889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      +|.+||..+|++|||+.+|++.|
T Consensus       237 li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  237 LIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHhcC
Confidence            99999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.6e-41  Score=345.21  Aligned_cols=242  Identities=26%  Similarity=0.423  Sum_probs=207.2

Q ss_pred             EEEccCCcEEEEEEEEc-----CCceEEEEEecccc--CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          271 KKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEF--HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~--~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +.||+|+||.||+++..     +..||+|++.....  .......+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999763     34499999876432  223345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +.+++|.+++...   ..+.+..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++........
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence            9999999998643   35788889999999999999999999  999999999999999999999999998754332223


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||...+.......+.  .....+|..+++.+.+||.+|
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~  234 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKL  234 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence            345578999999999999889999999999999999999999999888776666553  335567888999999999999


Q ss_pred             hhcCCCCCC-----CHHHHHH
Q 009291          504 WAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       504 L~~dP~~RP-----s~~eIl~  519 (538)
                      |+.+|++||     +++++++
T Consensus       235 l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         235 LKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             cccCHhHcCCCCCCCHHHHhc
Confidence            999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.4e-40  Score=328.56  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=213.8

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccc-cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||.||+|++.  ++.+|+|.+.... ........+.+|+.+++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999875  4559999876432 34455667899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          342 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       342 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      ||+++++|.+++... .....+++..++.++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            999999999888532 22345788999999999999999999999  999999999999999999999999998875543


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      ........++..|+|||.+.+..++.++||||||+++|||++|+.||.....  ......+.........+..++..+.+
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE  239 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            3223345688899999999888899999999999999999999999976533  23333332222222223457889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      +|.+||+.+|++||++.++++.++++
T Consensus       240 li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         240 LVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            99999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.5e-40  Score=340.15  Aligned_cols=251  Identities=24%  Similarity=0.409  Sum_probs=208.6

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      +..++|++.+.||+|+||.||++++..++  +|+|++.... .....+.+.+|++++++++||||+++++++..+..+++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            45678999999999999999999987554  8888876542 34455789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||++ +  |+||||||+||+++.++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          81 CMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EeecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999999999998643   2488999999999999999999985 6  9999999999999999999999999987654


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-----------------
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-----------------  481 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~-----------------  481 (538)
                      ...  .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+..                 
T Consensus       156 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         156 DSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ccc--cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence            322  2345689999999999999999999999999999999999999976655443222110                 


Q ss_pred             ----------------------------cCcccCC-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          482 ----------------------------KGRRLEI-PKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       482 ----------------------------~~~~~~~-p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                                                  ...+... ...+++++.+||.+||..||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                        0001111 12467899999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-41  Score=349.78  Aligned_cols=249  Identities=25%  Similarity=0.394  Sum_probs=210.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||+||+|++..+  .||||++..... .......+.+|+.+++.++|+||+++++++.++..+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4789999999999999999998644  499999876532 2344567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999999998643   35899999999999999999999999  9999999999999999999999999986432110


Q ss_pred             c--------------------------------------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 009291          422 I--------------------------------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL  463 (538)
Q Consensus       422 ~--------------------------------------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg  463 (538)
                      .                                      ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            0                                      01124689999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhhcCcccCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 009291          464 QKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPS---FPSIME  519 (538)
Q Consensus       464 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~~LI~~cL~~dP~~RPs---~~eIl~  519 (538)
                      ..||...+..+....+........+|.  .+++++.+||.+||. +|.+|++   +.++++
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999998887776665543333444444  468999999999997 9999987   888766

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-40  Score=328.30  Aligned_cols=257  Identities=35%  Similarity=0.589  Sum_probs=217.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ..++|++.+.||+|+||+||+|.+..+     .+|+|++.... .......+.+|+.++++++|+||+++++++.+....
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            346799999999999999999987532     38888875443 444556789999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      +++|||+++++|.+++....  ..+++..++.++.|++.||+|||+++  |+|+||||+||++++++.++|+|||+++..
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          81 MIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            99999999999999986533  25889999999999999999999999  999999999999999999999999999876


Q ss_pred             CCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          418 PNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       418 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      ....  .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+.+.+..+++
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  235 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPS  235 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence            4211  11122344678999999998889999999999999999998 999998877766655553 3344556678899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      .+.+++.+||+.+|++||++.++++.|++++
T Consensus       236 ~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         236 ALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            9999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-40  Score=350.26  Aligned_cols=251  Identities=27%  Similarity=0.366  Sum_probs=207.9

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +.|++++.||+|+||+||+|++..++  ||+|++..... .....+.+.+|+.++++++|+||+++++++.+...+++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            36899999999999999999886554  99999876543 3455678899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          81 DYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999998643   35889999999999999999999999  9999999999999999999999999975321000


Q ss_pred             -----------------------------------------------cccCCCCCCCcccccccccCCCCCchhhHHHHH
Q 009291          422 -----------------------------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG  454 (538)
Q Consensus       422 -----------------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLG  454 (538)
                                                                     .......||..|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence                                                           001234699999999999998899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCcHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 009291          455 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWA--EEPEIRPSFPSIMET  520 (538)
Q Consensus       455 vil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~~LI~~cL~--~dP~~RPs~~eIl~~  520 (538)
                      |++|||++|..||...+..+....+........+|  ..+++++.+||.+|++  .++..|+++.+++..
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            99999999999999887766555543333333444  3679999999999665  455559999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.5e-40  Score=335.23  Aligned_cols=268  Identities=32%  Similarity=0.578  Sum_probs=224.0

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcC---------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEee
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM  328 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~---------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~  328 (538)
                      .+++..++|.+++.||+|+||.||++++.+         ..+|+|.+.... .......+.+|+.+++.+ +|+||++++
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL   90 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            456777899999999999999999997642         238888876543 344456788999999999 799999999


Q ss_pred             ceeccCCcceEEEeecCCCChhhhhcCCCC-------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCC
Q 009291          329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS  395 (538)
Q Consensus       329 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp  395 (538)
                      +++......++||||+.+++|.+++.....             ...+++..++.++.|++.||+|||++|  ++||||||
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp  168 (307)
T cd05098          91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA  168 (307)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence            999999999999999999999999964321             124788899999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEEeeCCCccCCCCcccc--CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 009291          396 PNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP  472 (538)
Q Consensus       396 ~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~  472 (538)
                      +||+++.++.+||+|||+++.........  ....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            99999999999999999987654321111  12234568999999998889999999999999999998 8899987776


Q ss_pred             HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      .+....+. ...+...+..++.++.+||.+||..+|++|||+.++++.|++++.....
T Consensus       249 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~  305 (307)
T cd05098         249 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN  305 (307)
T ss_pred             HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence            55555443 4445667788899999999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5e-41  Score=346.26  Aligned_cols=243  Identities=27%  Similarity=0.462  Sum_probs=207.5

Q ss_pred             EEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      +.||+|+||.||++++..+  .+|+|++..... .......+.+|+++++.++||||+++++++.+...+++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999987644  499999876433 2344567788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       348 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      +|..++...   ..+++..+..++.||+.||+|||+ +|  |+||||||+|||++.++.+||+|||++............
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            999888643   358899999999999999999997 78  999999999999999999999999998754322222344


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..||..|+|||++.+..++.++|||||||++|+|++|..||...+.......+.  .....+|..+++++.+||.+||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~  233 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKK  233 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence            579999999999999999999999999999999999999998887766655553  345567788999999999999999


Q ss_pred             CCCCCC-----CHHHHHHH
Q 009291          507 EPEIRP-----SFPSIMET  520 (538)
Q Consensus       507 dP~~RP-----s~~eIl~~  520 (538)
                      ||++|+     ++.++++.
T Consensus       234 dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         234 DPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CHHHhCCCCCCCHHHHhcC
Confidence            999996     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-40  Score=330.04  Aligned_cols=259  Identities=32%  Similarity=0.568  Sum_probs=219.4

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      +++..++|++.+.||+|+||.||+|.+.+       ..+|+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            35667899999999999999999998753       348999875443 3344567889999999999999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCC-------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPD-------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT  405 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~  405 (538)
                      .....++||||+++++|.+++....       ....+++..++.++.|++.||.|||+.+  ++||||||+||+++.++.
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~  157 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCC
Confidence            9999999999999999999985322       1234678899999999999999999999  999999999999999999


Q ss_pred             EEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhc
Q 009291          406 VKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK  482 (538)
Q Consensus       406 vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~  482 (538)
                      +||+|||+++.......  ......++..|+|||.+.+..++.++|||||||++||+++ |..||...+..+....+. .
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~  236 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D  236 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-c
Confidence            99999999876433211  1223456788999999988889999999999999999998 899998888777666654 4


Q ss_pred             CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       483 ~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      ......|..++..+.++|.+||+.+|++|||+.++++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            4556678888999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-40  Score=326.19  Aligned_cols=257  Identities=35%  Similarity=0.569  Sum_probs=217.2

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ++..++|++.+.||+|+||.||+|.+.++ .+|+|.+......   .+.+.+|+.++++++|+||+++++++......++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            45667899999999999999999987554 4899987654322   3568899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      +|||+.+++|.+++.... ...+++..+..++.|++.||.|||+++  ++||||||+||++++++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            999999999999986433 235789999999999999999999999  99999999999999999999999999986543


Q ss_pred             Cccc-cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          420 TYIS-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       420 ~~~~-~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      .... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||...+.......+. .......+..++..+.
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELY  234 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence            2211 111223457999999998889999999999999999999 999999888766666553 3344556678899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      +++.+||+.+|++||++.++.+.|+++
T Consensus       235 ~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         235 DIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6e-40  Score=327.67  Aligned_cols=255  Identities=31%  Similarity=0.559  Sum_probs=212.1

Q ss_pred             eEEEEEccCCcEEEEEEEEcCC----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC------Ccc
Q 009291          268 LIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------PNL  337 (538)
Q Consensus       268 ~i~~~LG~G~fg~Vy~a~~~~~----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~------~~~  337 (538)
                      .+++.||+|+||.||+|.+...    .+|+|.+..........+.+.+|+.+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4678999999999999987654    378888776555566678899999999999999999999976432      246


Q ss_pred             eEEEeecCCCChhhhhcCC---CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          338 SIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      +++|||+.+|+|.+++...   .....+++..++.++.|++.||+|||+++  |+||||||+||++++++.+||+|||++
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCcc
Confidence            8999999999999887321   22345889999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          415 RSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       415 ~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      +.......  ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .......+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  238 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPPD  238 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence            86543221  1123345778999999999999999999999999999999 789998877766655553 3344556778


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      ++..+.++|.+||+.+|++|||+.+|++.|++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            8999999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-40  Score=349.38  Aligned_cols=256  Identities=25%  Similarity=0.370  Sum_probs=215.4

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...+..++|++.+.||+|+||.||++++..+  .+|+|++..... .....+.+.+|+.+++.++||||+++++++.++.
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~  116 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK  116 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3456678999999999999999999988654  499999865432 2233456788999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+++|+|.+++...    .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEecccee
Confidence            999999999999999998632    3788899999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCCc-cccCCCCCCCcccccccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCC
Q 009291          416 SKPNTY-ISSKTAAGTPEWMAPEVLRED----PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       416 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~----~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~  490 (538)
                      ...... .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||...+.......+........+|.
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  270 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD  270 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence            654322 122456799999999998653    378899999999999999999999998887766666644444445554


Q ss_pred             --CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 009291          491 --NVNPMVAALIETCWAEEPEI--RPSFPSIMET  520 (538)
Q Consensus       491 --~~s~~l~~LI~~cL~~dP~~--RPs~~eIl~~  520 (538)
                        .++.++.+||.+||+.+|++  |++++++++.
T Consensus       271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence              57999999999999999988  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.4e-40  Score=330.74  Aligned_cols=258  Identities=31%  Similarity=0.565  Sum_probs=215.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      +..++|++.+.||+|+||+||+|.+.      +..+++|.+.... .......+.+|+.++++++|+||+++++++....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            34578999999999999999999852      2348888876432 3445578889999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCC--------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPD--------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD  401 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~  401 (538)
                      ..+++|||+.+++|.+++....              ....+++..+..++.|++.||+|||+++  ++||||||+||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~  158 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence            9999999999999999984221              1234788889999999999999999999  99999999999999


Q ss_pred             CCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 009291          402 STYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISA  478 (538)
Q Consensus       402 ~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~  478 (538)
                      .++.+||+|||+++......  .......++..|+|||.+.+..++.++||||||+++|||++ |..||...........
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999997643221  11223345678999999988889999999999999999998 8999988777665555


Q ss_pred             HhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       479 i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      +. .......+..+++.+.++|.+||+.+|++||++.+|++.|+.
T Consensus       239 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 VR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            53 344456677899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.9e-40  Score=330.02  Aligned_cols=258  Identities=32%  Similarity=0.582  Sum_probs=214.3

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      ++..++|++.+.||+|+||.||+|.+.+       ..+|+|++.... .......+.+|+.+++.++|+||+++++++.+
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4556789999999999999999998653       238998875432 23445678999999999999999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCC-------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcE
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDA-------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV  406 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~v  406 (538)
                      ....++||||+++++|.+++.....       ...+++..+..++.|++.||+|||+.+  ++||||||+||++++++.+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCE
Confidence            9999999999999999999854221       123567888999999999999999999  9999999999999999999


Q ss_pred             EEEeeCCCccCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcC
Q 009291          407 KVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG  483 (538)
Q Consensus       407 kL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~  483 (538)
                      +|+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ..
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~  237 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EG  237 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence            99999998754332211  122345778999999998889999999999999999999 789998887766555443 33


Q ss_pred             cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       484 ~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      .....+..+++.+.++|.+||+.+|++|||+.++++.|+
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            344567788999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.1e-40  Score=332.44  Aligned_cols=261  Identities=34%  Similarity=0.593  Sum_probs=217.2

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc----eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcce
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~----vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~  338 (538)
                      +++|++.+.||+|+||.||+|....++    +++|.++.. ......+.+.+|+.+++++ +||||+++++++.+...++
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            468999999999999999999876443    577766532 2344456789999999999 7999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc
Q 009291          339 IVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT  405 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~  405 (538)
                      +++||+++++|.+++....             ....+++..++.++.|++.||+|||++|  |+||||||+||+++.++.
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence            9999999999999985422             1134788999999999999999999999  999999999999999999


Q ss_pred             EEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCc
Q 009291          406 VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR  484 (538)
Q Consensus       406 vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~  484 (538)
                      +||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. ...
T Consensus       158 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~  235 (297)
T cd05089         158 SKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY  235 (297)
T ss_pred             EEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCC
Confidence            9999999986432211 1112233557999999998889999999999999999997 999998887766665553 334


Q ss_pred             ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       485 ~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ....+..++..+.+||.+||+.+|.+||+++++++.|++++....
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            455677899999999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-40  Score=342.90  Aligned_cols=237  Identities=25%  Similarity=0.418  Sum_probs=203.4

Q ss_pred             EEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||+||+|+++.+  .||+|++..... .....+.+..|..++..+ +||||+++++++.+...+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999998754  499999875432 234456778888888876 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      |+|.+++...   ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++............
T Consensus        81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            9999888643   35889999999999999999999999  999999999999999999999999998754322223345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.  .....+|..++.++.+||.+||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~  233 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTK  233 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccc
Confidence            578999999999999999999999999999999999999999988877766663  334556778899999999999999


Q ss_pred             CCCCCCCH
Q 009291          507 EPEIRPSF  514 (538)
Q Consensus       507 dP~~RPs~  514 (538)
                      ||++||++
T Consensus       234 dP~~R~~~  241 (320)
T cd05590         234 NPTMRLGS  241 (320)
T ss_pred             CHHHCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-40  Score=328.81  Aligned_cols=257  Identities=33%  Similarity=0.586  Sum_probs=220.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ....+|++.+.||.|+||.||+|.+.+ ..+++|++....  ......+.+|+.+++.++|+||+++++++.+...+++|
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            345678999999999999999998876 448888876543  33345788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+++++|.+++.... ...+++..++.++.|++.||+|||+.+  ++|+||||+||++++++.+||+|||.+......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            99999999999997543 235789999999999999999999999  999999999999999999999999999776543


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. ...+.+.+..+++.+.++
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHH
Confidence            322334456778999999988889999999999999999998 899998887766666554 444566778899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      |.+||+.+|++|||+.+|++.|+++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         237 MLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHHHHhcC
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.2e-40  Score=341.21  Aligned_cols=242  Identities=26%  Similarity=0.433  Sum_probs=207.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +|++.+.||+|+||.||+|++.++  .+|+|++..... .....+.+..|..++..+ +|++|+.+++++.+.+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            588999999999999999988755  499999876432 233445677788888777 5899999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999999888643   34889999999999999999999999  9999999999999999999999999987543322


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.  .....+|..++.++.++|.
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~  233 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICK  233 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHH
Confidence            23345678999999999999999999999999999999999999999888777766653  3445677889999999999


Q ss_pred             HhhhcCCCCCCCH
Q 009291          502 TCWAEEPEIRPSF  514 (538)
Q Consensus       502 ~cL~~dP~~RPs~  514 (538)
                      +||+.+|++|++.
T Consensus       234 ~~l~~~p~~R~~~  246 (323)
T cd05616         234 GLMTKHPGKRLGC  246 (323)
T ss_pred             HHcccCHHhcCCC
Confidence            9999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-40  Score=324.63  Aligned_cols=253  Identities=38%  Similarity=0.666  Sum_probs=219.7

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +...+|++.+.||+|+||.||+|...++.+|+|.+.....   ..+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            4567899999999999999999999988899999865532   4578999999999999999999999999889999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++..... ..+++..++.++.|++.||.|||+++  ++|+||||+||+++.++.+||+|||.++......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            99999999999864432 25889999999999999999999999  9999999999999999999999999998763322


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                         .....+..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+. ...+...+..+++.+.++|
T Consensus       157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li  232 (256)
T cd05039         157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVM  232 (256)
T ss_pred             ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHH
Confidence               13344667999999988889999999999999999997 999998887766655553 3334566778899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      .+||..+|++|||+.++++.|+++
T Consensus       233 ~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         233 KDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHHhccChhhCcCHHHHHHHHhcC
Confidence            999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=350.19  Aligned_cols=250  Identities=22%  Similarity=0.350  Sum_probs=208.0

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++++.||+|+||+||++.+..+  .||+|++..... .....+.+.+|++++++++||||+++++++.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3689999999999999999988644  499999865432 3345577889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999998643   35889999999999999999999999  9999999999999999999999999986321100


Q ss_pred             c-----------------------------------------------ccCCCCCCCcccccccccCCCCCchhhHHHHH
Q 009291          422 I-----------------------------------------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG  454 (538)
Q Consensus       422 ~-----------------------------------------------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLG  454 (538)
                      .                                               ......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0                                               00124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCC--CCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 009291          455 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIR---PSFPSIMET  520 (538)
Q Consensus       455 vil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~~LI~~cL~~dP~~R---Ps~~eIl~~  520 (538)
                      |++|||++|..||......+....+......+.+|.  .++.++.+||.+||. +|.+|   +++.++++.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            999999999999998877666655543333444454  578999999999998 77765   588888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-41  Score=345.68  Aligned_cols=239  Identities=27%  Similarity=0.415  Sum_probs=206.6

Q ss_pred             EEEccCCcEEEEEEEEc-----CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecC
Q 009291          271 KKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  345 (538)
                      +.||+|+||.||++++.     ++.+|+|++............+.+|++++++++||||+++++++.++..+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            57999999999998752     3459999987655444445667889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccC
Q 009291          346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK  425 (538)
Q Consensus       346 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  425 (538)
                      +++|.+++...   ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++...........
T Consensus        82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence            99999998633   35899999999999999999999999  99999999999999999999999999876544333334


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhh
Q 009291          426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA  505 (538)
Q Consensus       426 ~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~  505 (538)
                      ...|+..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.  .....+|..+++.+.+||++||+
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~  234 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFK  234 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhh
Confidence            5678999999999998889999999999999999999999999888776666553  33456778899999999999999


Q ss_pred             cCCCCCCCHHH
Q 009291          506 EEPEIRPSFPS  516 (538)
Q Consensus       506 ~dP~~RPs~~e  516 (538)
                      .||++||++.+
T Consensus       235 ~~P~~R~~a~~  245 (318)
T cd05582         235 RNPANRLGAGP  245 (318)
T ss_pred             cCHhHcCCCCC
Confidence            99999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8e-40  Score=323.20  Aligned_cols=250  Identities=28%  Similarity=0.456  Sum_probs=216.7

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||+|.+..  ..+++|.+..........+.+.+|+.++++++||||+++++++.+...+++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            47889999999999999998864  4499999876665666778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|.+++.... ...+++..++.++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            99999999986532 245889999999999999999999999  999999999999999999999999998865544333


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      .....++..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+. ......++..++..+.++|.+|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQC  236 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHH
Confidence            344568899999999999889999999999999999999999998887666555443 3334455667889999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 009291          504 WAEEPEIRPSFPSIME  519 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~  519 (538)
                      |+.+|++||++.++++
T Consensus       237 l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         237 LTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ccCCcccCcCHHHHhh
Confidence            9999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-40  Score=331.22  Aligned_cols=256  Identities=34%  Similarity=0.564  Sum_probs=216.2

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...+|.+.+.||+|+||.||+|.+.+       ..+|+|++.... ..+..+.+.+|+++++.++|+||+++++++....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            45678899999999999999997643       348999876543 3334578999999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCC-----------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPD-----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY  404 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~  404 (538)
                      ..+++|||+++++|.+++....           ....+++..+..++.|++.||+|||+++  ++||||||+||+++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~  159 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCC
Confidence            9999999999999999986432           2345788899999999999999999999  99999999999999999


Q ss_pred             cEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhh
Q 009291          405 TVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGF  481 (538)
Q Consensus       405 ~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~  481 (538)
                      .+||+|||++.......  .......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. 
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-  238 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-  238 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence            99999999987543221  11223345778999999999999999999999999999998 999998877777666654 


Q ss_pred             cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       482 ~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      .+.....+..++..+.++|.+||+.||++||++.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            33334456678999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-40  Score=326.37  Aligned_cols=256  Identities=31%  Similarity=0.538  Sum_probs=215.4

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC-----CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc-----
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-----  336 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~-----~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~-----  336 (538)
                      |++++.||+|+||.||+|....     ..+|+|.+............+.+|+..++.++|+||+++++++.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998753     349999987665566667789999999999999999999998765544     


Q ss_pred             -ceEEEeecCCCChhhhhcCC---CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          337 -LSIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       337 -~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                       .++++||+++++|..++...   .....+++..++.++.|++.||+|||+.+  ++||||||+||++++++.+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence             79999999999999888432   12235889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCC
Q 009291          413 LSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP  489 (538)
Q Consensus       413 la~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p  489 (538)
                      +++........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. .......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~  237 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQP  237 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence            99864332111  112234678999999988889999999999999999999 899998887766665553 34556677


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      ..++.++.++|.+||+.||++|||+.++++.|++++
T Consensus       238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            889999999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.7e-40  Score=343.06  Aligned_cols=265  Identities=31%  Similarity=0.561  Sum_probs=217.1

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeecee
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV  331 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~  331 (538)
                      |++..++|++.+.||+|+||.||+|...+       +.||+|++.... .....+.+.+|+.++.++ +|+||+++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            55667799999999999999999996533       349999876443 344556788999999999 899999999987


Q ss_pred             cc-CCcceEEEeecCCCChhhhhcCCCC----------------------------------------------------
Q 009291          332 TE-PPNLSIVTEYLSRGSLYKLLHIPDA----------------------------------------------------  358 (538)
Q Consensus       332 ~~-~~~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------  358 (538)
                      .. +..++++|||+++++|.+++.....                                                    
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            54 4568899999999999998853211                                                    


Q ss_pred             ------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCC
Q 009291          359 ------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGT  430 (538)
Q Consensus       359 ------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt  430 (538)
                            ...+++..+..++.||+.||+|||+++  |+||||||+||+++.++.+||+|||++.......  .......++
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                  125788899999999999999999999  9999999999999999999999999998643221  112234456


Q ss_pred             CcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCC
Q 009291          431 PEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE  509 (538)
Q Consensus       431 ~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~  509 (538)
                      ..|+|||++.+..++.++|||||||++|||++ |..||......+..........+...+..+++++.+++.+||+.+|+
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence            78999999999999999999999999999998 99999875544433333234445556677889999999999999999


Q ss_pred             CCCCHHHHHHHHHHHHhh
Q 009291          510 IRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       510 ~RPs~~eIl~~L~~il~~  527 (538)
                      +||++.++++.|++++..
T Consensus       319 ~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         319 DRPTFSELVEILGDLLQE  336 (337)
T ss_pred             hCcCHHHHHHHHHHHHhc
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.2e-40  Score=356.32  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=218.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC--
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP--  335 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~--  335 (538)
                      .+....+|++.+.||+|+||+||+|++.  +..||||++............+.+|+.++..++|+||+++++.+....  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            3444579999999999999999999875  445999999877666777778899999999999999999988764322  


Q ss_pred             ------cceEEEeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEE
Q 009291          336 ------NLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV  408 (538)
Q Consensus       336 ------~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL  408 (538)
                            .+++||||+++|+|.+++... .....+++..++.++.|++.||.|||+++  |+||||||+|||++.++.+||
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEE
Confidence                  268999999999999988532 22346889999999999999999999999  999999999999999999999


Q ss_pred             EeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc
Q 009291          409 CDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL  486 (538)
Q Consensus       409 ~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~  486 (538)
                      +|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~-~~~~~  263 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL-AGRYD  263 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCC
Confidence            9999997643321  12245679999999999999999999999999999999999999999888766665553 33344


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       487 ~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ++|..+++++.++|.+||+.+|++||++.++++.
T Consensus       264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            5778899999999999999999999999999864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.1e-40  Score=340.66  Aligned_cols=241  Identities=28%  Similarity=0.466  Sum_probs=203.7

Q ss_pred             EEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHc-CCCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKG-LRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~-L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||.||+|++.+++  ||+|++..... .....+.+..|..++.. .+||||+++++++.....+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999987554  99999876432 23344556667777765 4899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      |+|..++...   ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++............
T Consensus        81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9999988643   35889999999999999999999999  999999999999999999999999999764333233345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..||..|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+.  .....+|..++.++.+||.+||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFER  233 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccC
Confidence            678999999999999999999999999999999999999999888777666653  344566778999999999999999


Q ss_pred             CCCCCCCHH-HHH
Q 009291          507 EPEIRPSFP-SIM  518 (538)
Q Consensus       507 dP~~RPs~~-eIl  518 (538)
                      +|++||++. +++
T Consensus       234 ~P~~R~~~~~~l~  246 (316)
T cd05592         234 DPTKRLGVDGDIR  246 (316)
T ss_pred             CHHHcCCChHHHH
Confidence            999999875 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-39  Score=329.08  Aligned_cols=262  Identities=34%  Similarity=0.584  Sum_probs=219.7

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc-----CCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR-----NSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +...+|.+.+.||+|+||+||++...     .+.  +|+|.+...  .....+.+.+|+.++++++|+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            45678999999999999999999752     222  777776543  344566899999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCC----------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPD----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY  404 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~  404 (538)
                      ..++++|||+++++|.+++....          ....+++..++.++.|++.||+|||+++  ++||||||+||++++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence            99999999999999999985322          1234889999999999999999999999  99999999999999999


Q ss_pred             cEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhh
Q 009291          405 TVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGF  481 (538)
Q Consensus       405 ~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~  481 (538)
                      .+||+|||+++.......  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. 
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~-  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence            999999999875433211  1122335678999999998889999999999999999998 899998887777666654 


Q ss_pred             cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       482 ~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .......+..++.++.+|+.+||+.||.+|||+.++++.|+++.+..
T Consensus       237 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            33344556778999999999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.3e-40  Score=325.06  Aligned_cols=252  Identities=35%  Similarity=0.586  Sum_probs=213.1

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc-eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..++|++.+.||+|+||+||++++.+.. +|+|.+......   .+.+.+|+.++++++||||+++++++.+....+++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            3467999999999999999999877654 999987654332   246889999999999999999999999988999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+++|.+++.....  .+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||.++......
T Consensus        79 e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          79 EYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            99999999999864332  5889999999999999999999999  9999999999999999999999999987643322


Q ss_pred             c-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          422 I-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       422 ~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ...+...+...++.+.++
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  233 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAI  233 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHH
Confidence            1 1122335678999999988889999999999999999998 999998877766555553 334445566788999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      +.+||+.+|++||++.+|++.|+
T Consensus       234 i~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         234 MYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHcCCCcccCCCHHHHHHhhC
Confidence            99999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.1e-40  Score=335.19  Aligned_cols=260  Identities=31%  Similarity=0.524  Sum_probs=216.9

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--Cc----eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~----vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      +...+|++.+.||+|+||+||+|.+..  ..    ||+|++... ......+.+.+|+.+++.++|+||+++++++... 
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            345689999999999999999998642  22    788887543 2344556888999999999999999999998764 


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..++++||+.+|+|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||++++++.+||+|||+++
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccc
Confidence            5789999999999999987433  24788889999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          416 SKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       416 ~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      ........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ......+.+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~  236 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPIC  236 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCC
Confidence            65432211  122334668999999999999999999999999999997 99999887765554433 344555667788


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +..+.++|.+||..+|++||++.+++..|..+....
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            999999999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.1e-40  Score=331.25  Aligned_cols=263  Identities=33%  Similarity=0.608  Sum_probs=221.9

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeece
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA  330 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~  330 (538)
                      .+++..++|++.+.||+|+||.||++.+.+       ..+|+|.+.... .......+.+|+.+++++ +|+||++++++
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            356777899999999999999999998753       238888876543 344556789999999999 79999999999


Q ss_pred             eccCCcceEEEeecCCCChhhhhcCC-------------CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCC
Q 009291          331 VTEPPNLSIVTEYLSRGSLYKLLHIP-------------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN  397 (538)
Q Consensus       331 ~~~~~~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~N  397 (538)
                      +.....++++|||+.+++|.++++..             .....+++..++.++.|++.||+|||+.+  |+||||||+|
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N  162 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN  162 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence            99999999999999999999998532             22346889999999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEEeeCCCccCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 009291          398 LLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQ  474 (538)
Q Consensus       398 ILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~  474 (538)
                      |++++++.+||+|||+++........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99999999999999999865432211  122334678999999988889999999999999999997 999998877766


Q ss_pred             HHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          475 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       475 ~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      ....+. .......+..++..+.+|+.+||..+|++|||+.++++.|++++
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 LFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            655543 34455667788999999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.2e-40  Score=334.65  Aligned_cols=263  Identities=34%  Similarity=0.616  Sum_probs=217.7

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc----eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~  336 (538)
                      +.+++|++.+.||+|+||.||+|.+..++    +++|.+.. .........+.+|+.++.++ +|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            55778999999999999999999876433    45555432 22344556888999999999 89999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC
Q 009291          337 LSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~  403 (538)
                      +++||||+++++|.++++...             ....+++..++.++.|++.||+|||++|  ++||||||+||+++++
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~  160 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN  160 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence            999999999999999986432             1235789999999999999999999999  9999999999999999


Q ss_pred             CcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhc
Q 009291          404 YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK  482 (538)
Q Consensus       404 ~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~  482 (538)
                      +.+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+. .
T Consensus       161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~  238 (303)
T cd05088         161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q  238 (303)
T ss_pred             CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-c
Confidence            99999999998643221 11122234667999999988889999999999999999998 999998877766555442 3


Q ss_pred             CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       483 ~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ..+...+..+++.+.+||.+||+.+|++||++++++..|.+++....
T Consensus       239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            33445666788999999999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.6e-40  Score=341.91  Aligned_cols=243  Identities=25%  Similarity=0.409  Sum_probs=206.8

Q ss_pred             EEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||.||+|++.++  .||+|++..... .....+.+..|..++..+ +||||+++++++.+...+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            3689999999999998754  499999876432 234456677899998866 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      ++|...+...   ..+++..+..++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++............
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9999888633   35889999999999999999999999  999999999999999999999999998764333323345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..||..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..  ....+|..++.++.++|.+||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH--DDVLYPVWLSKEAVSILKAFMTK  233 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhcc
Confidence            6789999999999999999999999999999999999999999888777766642  33456677899999999999999


Q ss_pred             CCCCCC-------CHHHHHHH
Q 009291          507 EPEIRP-------SFPSIMET  520 (538)
Q Consensus       507 dP~~RP-------s~~eIl~~  520 (538)
                      +|++||       +++++++.
T Consensus       234 dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcC
Confidence            999999       77777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.6e-40  Score=324.67  Aligned_cols=246  Identities=32%  Similarity=0.541  Sum_probs=209.5

Q ss_pred             EEccCCcEEEEEEEEc----CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCC
Q 009291          272 KIGEGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~----~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      .||+|+||.||+|.+.    +..+|+|++..........+.+.+|+.+++.++|+||+++++++.. ...++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753    3349999987665556667889999999999999999999998754 5679999999999


Q ss_pred             ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc---c
Q 009291          348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS---S  424 (538)
Q Consensus       348 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~  424 (538)
                      +|.+++...   ..+++..++.++.|++.||+|||++|  ++||||||.||++++++.+||+|||++.........   .
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999998643   25889999999999999999999999  999999999999999999999999999765433211   1


Q ss_pred             CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          425 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      ....++..|+|||.+....++.++||||||+++|||++ |..||......+....+. .....+.|..+++++.++|.+|
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~  234 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLC  234 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence            22234578999999988889999999999999999998 999999887776666664 3445677888999999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHHH
Q 009291          504 WAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~~L~~i  524 (538)
                      |+.||++||++++|.+.|++.
T Consensus       235 ~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         235 WTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             hccCchhCcCHHHHHHHHhcc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-40  Score=349.97  Aligned_cols=250  Identities=26%  Similarity=0.343  Sum_probs=207.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++++.||+|+||.||+|++..+  .||+|++..... .....+.+.+|+.++++++|+||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            4799999999999999999998654  499999865432 2234567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC-
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-  420 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~-  420 (538)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|...... 
T Consensus        81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999998643   35889999999999999999999999  999999999999999999999999997422100 


Q ss_pred             ------------------------------------------ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHH
Q 009291          421 ------------------------------------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILW  458 (538)
Q Consensus       421 ------------------------------------------~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~  458 (538)
                                                                ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                      00011346899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 009291          459 ELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRP---SFPSIMET  520 (538)
Q Consensus       459 eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~~LI~~cL~~dP~~RP---s~~eIl~~  520 (538)
                      ||++|+.||......+....+........++  ..+++++.++|.+|+ .+|++|+   ++.+++..
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999999888766655554333333333  468899999999976 5999999   88888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=346.45  Aligned_cols=264  Identities=36%  Similarity=0.531  Sum_probs=210.9

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC-cce
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-NLS  338 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~-~~~  338 (538)
                      .-..++|.-...||+|+||.||+|...+ +.||||.+.......  ..+|.+|+.++.+++|||+|+++|||.+.. ..+
T Consensus        71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~  148 (361)
T KOG1187|consen   71 RKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL  148 (361)
T ss_pred             HHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence            3445678788899999999999999887 569999776554332  346999999999999999999999999988 499


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCC-CCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      +|+||+++|+|.+.|+..... .++|..+.+|+.++|+||+|||... |+||||||||+|||+|+++++||+|||+|+..
T Consensus       149 LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG  227 (361)
T ss_pred             EEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence            999999999999999865443 7899999999999999999999854 68999999999999999999999999999766


Q ss_pred             CCCccccCCC-CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH----HHhhcC----cc
Q 009291          418 PNTYISSKTA-AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---PSQVIS----AVGFKG----RR  485 (538)
Q Consensus       418 ~~~~~~~~~~-~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~---~~~~~~----~i~~~~----~~  485 (538)
                      +......... .||..|+|||++..+..+.|+||||||+++.||++|+.+.....   ......    .+....    ..
T Consensus       228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD  307 (361)
T KOG1187|consen  228 PEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD  307 (361)
T ss_pred             CccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence            5411122222 89999999999999999999999999999999999998877542   111111    111110    01


Q ss_pred             cCCC-CCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          486 LEIP-KNVN-----PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       486 ~~~p-~~~s-----~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      ..+. ...+     ..+..+..+|++.+|++||++.|+++.|+.+...
T Consensus       308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            1111 2222     2366778899999999999999999999766554

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9e-40  Score=324.80  Aligned_cols=256  Identities=34%  Similarity=0.614  Sum_probs=216.0

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +++..++|++++.||+|+||.||+|...+ +.+|+|.+......   ...+.+|+.++++++|+||+++++++. ...++
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            35667889999999999999999998754 45999988755433   247889999999999999999999874 45689


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ++|||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            9999999999999986433 235888999999999999999999999  9999999999999999999999999987654


Q ss_pred             CC-ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          419 NT-YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       419 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      .. ........++..|+|||.+.+..++.++||||||+++||+++ |+.||...+..+....+. ...+.+.+..++.++
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  232 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEEL  232 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHH
Confidence            22 111223345678999999998889999999999999999999 999998877766665553 334556677889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      .++|.+||+.+|++||+++++++.|++
T Consensus       233 ~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         233 YELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.6e-40  Score=335.21  Aligned_cols=250  Identities=27%  Similarity=0.360  Sum_probs=198.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||+||+|++..  ..+|+|++...... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            3679999999999999999999864  45999998654322 22345778999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+. ++|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++.......
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          83 EYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             ECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            9996 5777776533  234788899999999999999999999  9999999999999999999999999987644332


Q ss_pred             cccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhc-Cc--------------
Q 009291          422 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFK-GR--------------  484 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~~~-~~--------------  484 (538)
                      .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... +....+... ..              
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            23345678999999999865 45789999999999999999999999875432 222211100 00              


Q ss_pred             ----cc--CCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 ----RL--EIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ----~~--~~p---------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                          ..  ..+         ...+..+.+||.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                00  001         123567899999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-40  Score=324.61  Aligned_cols=251  Identities=37%  Similarity=0.627  Sum_probs=212.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ...+|++.+.||+|+||.||++.+..+ .+|+|++.......   ..+.+|+.+++.++|+||+++++++......++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            345788999999999999999988654 49999876544332   36788999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++....  ..+++..++.++.|++.||+|||+.+  ++||||||+||++++++.+||+|||+++...+..
T Consensus        79 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          79 EYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             ecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            9999999999986433  25889999999999999999999999  9999999999999999999999999987654332


Q ss_pred             ccc-CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          422 ISS-KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       422 ~~~-~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      ... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..++.++.++
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  233 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTI  233 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHH
Confidence            111 12223457999999999899999999999999999999 899998877766665553 344556677889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      +.+||..+|++|||+.++++.|
T Consensus       234 i~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         234 MYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHHh
Confidence            9999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.7e-40  Score=332.61  Aligned_cols=258  Identities=29%  Similarity=0.505  Sum_probs=216.0

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +...+|.+.+.||+|+||+||+|.+.+       ..+|+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            445678889999999999999998753       338999886543 334456788999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD  401 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~  401 (538)
                      ...++++||+.+++|.+++....             ....+++..++.++.|++.||+|||++|  |+||||||+||+++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~  158 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence            99999999999999999984211             1234788889999999999999999999  99999999999999


Q ss_pred             CCCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 009291          402 STYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISA  478 (538)
Q Consensus       402 ~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~  478 (538)
                      +++.+||+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999999876433221  1123345778999999988889999999999999999998 8889988887776666


Q ss_pred             HhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       479 i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      +. .......+..++.++.+|+.+||+.+|++||++++|+..|++
T Consensus       239 i~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 IR-NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HH-cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            54 333445678899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.9e-40  Score=348.19  Aligned_cols=249  Identities=27%  Similarity=0.372  Sum_probs=207.4

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +.|++++.||+|+||+||+|++..++  +|+|++..... .......+.+|+.++++++|+||+++++.+.++..+++||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            36899999999999999999986544  99999876432 2345667889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          81 DYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999998643   35789999999999999999999999  9999999999999999999999999975321000


Q ss_pred             -----------------------------------------------cccCCCCCCCcccccccccCCCCCchhhHHHHH
Q 009291          422 -----------------------------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG  454 (538)
Q Consensus       422 -----------------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLG  454 (538)
                                                                     .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                           001124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 009291          455 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPS---FPSIME  519 (538)
Q Consensus       455 vil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~~LI~~cL~~dP~~RPs---~~eIl~  519 (538)
                      |++|||++|+.||...+..+....+........+|  ..+++++.++|.+|+ .+|++|++   ++++++
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            99999999999999888766665554333334444  467999999999976 59999987   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.9e-40  Score=331.94  Aligned_cols=250  Identities=28%  Similarity=0.379  Sum_probs=200.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC---CceEEEEEeccccCHHHHHHHHHHHHHHHcC---CCCceeEeeceec-----c
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN---SDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVT-----E  333 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~---~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~-----~  333 (538)
                      .+|++.+.||+|+||+||+|++..   ..+|+|++............+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368999999999999999998742   3489998876544433344566777777665   6999999999874     3


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ...+++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 58888886432 234789999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-----cc--
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-----RL--  486 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-----~~--  486 (538)
                      ++..... .......|+..|+|||.+.+..++.++|||||||++|||++|..||...+..+....+.....     ..  
T Consensus       157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         157 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             eEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            9765433 223455689999999999988999999999999999999999999998876655544421100     00  


Q ss_pred             ------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 ------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ------------------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                        .+.+.+++.+.+||.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                              011356788999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.1e-40  Score=339.53  Aligned_cols=242  Identities=27%  Similarity=0.459  Sum_probs=206.4

Q ss_pred             EEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||+||+|.+..+  .||+|++..... .......+.+|..++..+ +||||+++++++.+...+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999988654  499999876532 234456778899999887 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      ++|..++...   ..+++..+..++.|++.||+|||+++  |+||||||+||++++++.+||+|||+++...........
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9999888643   25889999999999999999999999  999999999999999999999999998753322222344


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.  .....+|..+++.+.+||++||..
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~  233 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTK  233 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccC
Confidence            568999999999999999999999999999999999999999887766665553  334556778999999999999999


Q ss_pred             CCCCCCCH-----HHHHH
Q 009291          507 EPEIRPSF-----PSIME  519 (538)
Q Consensus       507 dP~~RPs~-----~eIl~  519 (538)
                      ||++||++     .++++
T Consensus       234 dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CHHHcCCCCCCCHHHHhc
Confidence            99999999     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.6e-40  Score=338.20  Aligned_cols=249  Identities=25%  Similarity=0.404  Sum_probs=198.2

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-----Ccce
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PNLS  338 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-----~~~~  338 (538)
                      +|++.+.||+|+||.||+|.+..+  .||+|++............+.+|+.++++++||||+++++++...     ..++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            589999999999999999988644  499998865433344456788999999999999999999987543     2479


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+. ++|.+++...   ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 6888888643   34889999999999999999999999  9999999999999999999999999997543


Q ss_pred             CCc---cccCCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------------
Q 009291          419 NTY---ISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF------------  481 (538)
Q Consensus       419 ~~~---~~~~~~~gt~~Y~aPE~l~~--~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~------------  481 (538)
                      ...   .......||..|+|||++.+  ..++.++|||||||++|||++|+.||...+.......+..            
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221   11234578999999999876  5789999999999999999999999977654332211100            


Q ss_pred             --------------cCcccCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          482 --------------KGRRLEI---PKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       482 --------------~~~~~~~---p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                                    ......+   .+.+++.+.++|.+||+.||++|||+.++++.
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                          0000010   12467889999999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-40  Score=342.95  Aligned_cols=250  Identities=27%  Similarity=0.391  Sum_probs=210.6

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||+||++++..+  .+|+|++..... .....+.+.+|+.+++.++|+||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            3689999999999999999988644  499999876543 2344567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999986432  35899999999999999999999999  9999999999999999999999999997654322


Q ss_pred             -cccCCCCCCCccccccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCC
Q 009291          422 -ISSKTAAGTPEWMAPEVLR------EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNV  492 (538)
Q Consensus       422 -~~~~~~~gt~~Y~aPE~l~------~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~  492 (538)
                       .......||..|+|||++.      ...++.++|||||||++|||++|+.||...+.......+........+|  ..+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence             1223457899999999986      4567899999999999999999999999887766665554333333333  357


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +..+.+||.+||+ +|++|||+.+++.
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            8999999999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-39  Score=322.91  Aligned_cols=252  Identities=37%  Similarity=0.657  Sum_probs=215.1

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeecee-ccCCcceEE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEPPNLSIV  340 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~-~~~~~~~lV  340 (538)
                      +...+|++.+.||+|+||.||++...++.+++|.+....    ..+.+.+|+.++++++|+||+++++++ .++...+++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            556789999999999999999999998889999875432    245788999999999999999999975 455678999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+++++|.+++.... ...+++..++.++.|++.||+|||++|  ++||||||+||++++++.+||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          79 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999986432 234788999999999999999999999  999999999999999999999999998764332


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      .   ....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+. .......+..+++.+.++
T Consensus       156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  231 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDV  231 (256)
T ss_pred             C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHH
Confidence            2   23345668999999998889999999999999999997 999998877766665553 333455667889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      |.+||+.+|++|||+.++++.|+++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHHHhcC
Confidence            9999999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-39  Score=346.47  Aligned_cols=265  Identities=32%  Similarity=0.541  Sum_probs=221.8

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeec
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMG  329 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~  329 (538)
                      ..+++..++|.+.+.||+|+||.||+|.+.+       ..||+|++.... .....+.+.+|+.+|.++. ||||+++++
T Consensus        30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            3477888899999999999999999998653       249999987543 2334457889999999997 999999999


Q ss_pred             eeccCCcceEEEeecCCCChhhhhcCCCC---------------------------------------------------
Q 009291          330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDA---------------------------------------------------  358 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------  358 (538)
                      ++......++||||+.+|+|.++++....                                                   
T Consensus       109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence            99999999999999999999999854311                                                   


Q ss_pred             --------------------------------------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCC
Q 009291          359 --------------------------------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK  394 (538)
Q Consensus       359 --------------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLK  394 (538)
                                                                  ...+++..++.++.|++.||+|||+.+  ++|||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlk  266 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLA  266 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCC
Confidence                                                        123567778899999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009291          395 SPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST  471 (538)
Q Consensus       395 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~  471 (538)
                      |+|||+++++.+||+|||+++......  .......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999999997543221  11223456788999999998889999999999999999998 899998766


Q ss_pred             HHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       472 ~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      ..+..........+...|..++.++.+||.+||..+|++||++.+|++.|++++
T Consensus       347 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         347 MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            555544444455566677889999999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.7e-39  Score=328.45  Aligned_cols=258  Identities=33%  Similarity=0.602  Sum_probs=215.5

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +|++.+.||+|+||.||+|.+..       ..+++|.+.... .......+.+|+.+++.++||||+++++.+......+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            47889999999999999998643       237777765433 3445578999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCC---------------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCC
Q 009291          339 IVTEYLSRGSLYKLLHIPD---------------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN  397 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~N  397 (538)
                      +++||+.+++|.+++....                     ....+++..++.++.|++.||+|||+.+  ++||||||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n  157 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN  157 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence            9999999999999875321                     1234788899999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 009291          398 LLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQ  474 (538)
Q Consensus       398 ILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~  474 (538)
                      |++++++.+||+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999975432211  1123345678999999988889999999999999999998 999998887766


Q ss_pred             HHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          475 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       475 ~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      ....+. ...+...+..++..+.++|.+||+.+|++||++.++++.|++++..
T Consensus       238 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             HHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            655443 3345556778899999999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.3e-40  Score=339.09  Aligned_cols=241  Identities=25%  Similarity=0.397  Sum_probs=203.0

Q ss_pred             EEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||.||+|++..+  .||+|++..... .......+..|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999998754  499999876432 123345667788888754 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      ++|..++...   ..+++..+..++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++...........
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9999888643   35889999999999999999999999  999999999999999999999999998753322222345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..||..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..  ....+|..++.++.+||.+||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~  233 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFER  233 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccC
Confidence            6789999999999999999999999999999999999999998887766665532  34456777899999999999999


Q ss_pred             CCCCCCCHH-HHH
Q 009291          507 EPEIRPSFP-SIM  518 (538)
Q Consensus       507 dP~~RPs~~-eIl  518 (538)
                      ||++||++. +++
T Consensus       234 dP~~R~~~~~~~~  246 (316)
T cd05620         234 DPTRRLGVVGNIR  246 (316)
T ss_pred             CHHHcCCChHHHH
Confidence            999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.2e-40  Score=346.06  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=213.6

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      ..+..++|++.+.||+|+||.||++++..+  .+|+|++..... .....+.+.+|+.+++.++||||+++++++.++..
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            455678899999999999999999998754  499999865332 23344568899999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +++||||+++|+|.+++...    .+++..+..++.||+.||+|||+++  |+||||||+|||+++++.+||+|||++..
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEeccccee
Confidence            99999999999999998532    3788999999999999999999999  99999999999999999999999999986


Q ss_pred             CCCCc-cccCCCCCCCcccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCC-
Q 009291          417 KPNTY-ISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK-  490 (538)
Q Consensus       417 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~----~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~-  490 (538)
                      ..... .......||+.|+|||++.+..    ++.++|||||||++|+|++|+.||...+.......+........+|. 
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  271 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED  271 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence            54322 1224567999999999987543    78899999999999999999999998887776666654444455554 


Q ss_pred             -CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 009291          491 -NVNPMVAALIETCWAEEPEI--RPSFPSIMET  520 (538)
Q Consensus       491 -~~s~~l~~LI~~cL~~dP~~--RPs~~eIl~~  520 (538)
                       .++..+.++|.+||..++.+  |+++.++++.
T Consensus       272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             56899999999999866554  8899998775

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.9e-39  Score=328.14  Aligned_cols=267  Identities=33%  Similarity=0.568  Sum_probs=219.2

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      |++..++|++.+.||+|+||.||+|..++       ..+|+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            35667899999999999999999997542       248888865443 2334456889999999999999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCC-------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPD-------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT  405 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~  405 (538)
                      +....++||||+++|+|.+++....       .....+...+..++.|++.||.|||+++  |+||||||+||++++++.
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~  157 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence            9999999999999999999995321       1233567788899999999999999999  999999999999999999


Q ss_pred             EEEEeeCCCccCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhc
Q 009291          406 VKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK  482 (538)
Q Consensus       406 vkL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~  482 (538)
                      ++|+|||+++........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. .
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~  236 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-D  236 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence            999999998754332111  122345678999999998889999999999999999998 788998877766555443 3


Q ss_pred             CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       483 ~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      ......+..+++.+.+++.+||+.+|++|||+.++++.|++.+..+..
T Consensus       237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  284 (288)
T cd05061         237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP  284 (288)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence            344456677889999999999999999999999999999998766543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.4e-39  Score=326.75  Aligned_cols=261  Identities=34%  Similarity=0.567  Sum_probs=218.3

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC-----C--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN-----S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +...+|.+.+.||+|+||.||+|++.+     +  .+++|.+...  .....+.+.+|+.++++++|+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            345689999999999999999997543     1  2666765433  334456789999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD  401 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~  401 (538)
                      ...++||||+++++|.+++....             ....+++..++.++.|++.||+|||+++  ++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~  157 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG  157 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence            99999999999999999985432             1234789999999999999999999999  99999999999999


Q ss_pred             CCCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 009291          402 STYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISA  478 (538)
Q Consensus       402 ~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~  478 (538)
                      .++.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999976433211  1223456788999999999999999999999999999998 9999988777666555


Q ss_pred             HhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       479 i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      +. .......+..++..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus       238 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             Hh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            43 3344455667899999999999999999999999999999999775

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.7e-39  Score=321.62  Aligned_cols=250  Identities=28%  Similarity=0.474  Sum_probs=214.2

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||++.+..+  .+++|.+.... .....+.+.+|+.+++.++|+||+++++.+.+...++++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            588999999999999999988644  49999876543 234556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|.+++.... ...+++..++.++.|++.||.|||+++  ++|+||||+||++++++.++|+|||.+.........
T Consensus        80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          80 CDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            99999999885432 234789999999999999999999999  999999999999999999999999998765443333


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      .....++..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. .....+.+..++..+.+||.+|
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~  235 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQM  235 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHH
Confidence            344568889999999999889999999999999999999999999877766655553 3334456778899999999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 009291          504 WAEEPEIRPSFPSIMET  520 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~~  520 (538)
                      |+.||++||++.+++..
T Consensus       236 l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         236 FKRNPRSRPSATTILSR  252 (255)
T ss_pred             HhCCcccCCCHHHHhhc
Confidence            99999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.7e-39  Score=322.45  Aligned_cols=257  Identities=35%  Similarity=0.573  Sum_probs=214.4

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      .+...+|++.+.||+|+||.||+|.+.++ .+|+|++......   .+.+.+|++++++++|+||+++++++.+ ...++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence            34567899999999999999999987654 4899987653332   2468899999999999999999998754 56899


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      ||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+  ++||||||+||++++++.+||+|||.++....
T Consensus        78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            999999999999996432 234788999999999999999999999  99999999999999999999999999976543


Q ss_pred             Ccc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          420 TYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       420 ~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..++..+.
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~  233 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH  233 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHHH
Confidence            221 1123345678999999988889999999999999999999 888998877766655543 3334455677899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      ++|.+||+.+|++||++.++++.|+..+
T Consensus       234 ~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         234 DLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            9999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1e-39  Score=329.18  Aligned_cols=245  Identities=26%  Similarity=0.394  Sum_probs=202.1

Q ss_pred             EccCCcEEEEEEEEcCC--ceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCCh
Q 009291          273 IGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL  349 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  349 (538)
                      ||+|+||+||++.+..+  .+|+|++...... ....+.+..|+.+++.++|+||+++.+++.....+++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999988644  4999998654332 23346778899999999999999999999999999999999999999


Q ss_pred             hhhhcC-CCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCC
Q 009291          350 YKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA  428 (538)
Q Consensus       350 ~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  428 (538)
                      ..++.. ......+++..++.++.|++.||+|||+++  |+||||||+||++++++.+||+|||++..............
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            887743 223346899999999999999999999999  99999999999999999999999999976544333334457


Q ss_pred             CCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          429 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV--GFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       429 gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ||..|+|||.+.+..++.++||||||+++|+|++|+.||...........+  ........++..+++.+.+++.+||+.
T Consensus       159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  238 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK  238 (280)
T ss_pred             CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence            899999999999999999999999999999999999999865432211111  112234456678899999999999999


Q ss_pred             CCCCCC-----CHHHHHH
Q 009291          507 EPEIRP-----SFPSIME  519 (538)
Q Consensus       507 dP~~RP-----s~~eIl~  519 (538)
                      ||++||     +++++++
T Consensus       239 ~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         239 DPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CHHHhcCCCCCCHHHHhc
Confidence            999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.8e-39  Score=323.91  Aligned_cols=260  Identities=32%  Similarity=0.532  Sum_probs=215.8

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCC------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      +...+|++.+.||+|+||+||+|++..+      .||+|++.... .......+.+|+.+++.++|+||+++++++... 
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            3456899999999999999999986433      26888876543 344456788999999999999999999998754 


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..++++||+++|+|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||++++++.+||+|||+++
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCcee
Confidence            5789999999999999986432  35889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          416 SKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       416 ~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      ........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+. .....+.+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPIC  236 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccC
Confidence            65432111  122334678999999998889999999999999999998 899998777655554443 34455667788


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +..+.++|.+||..||++||++.++++.|+++....
T Consensus       237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         237 TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            999999999999999999999999999998886544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.8e-40  Score=337.43  Aligned_cols=241  Identities=28%  Similarity=0.445  Sum_probs=203.1

Q ss_pred             EEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHc-CCCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKG-LRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~-L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||+||+|++.+++  ||+|++..... .......+..|..+++. ++||||+++++++.+...+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999987554  99999876532 12334556778888876 4899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      |+|..++...   ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++............
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9999998632   34788999999999999999999999  999999999999999999999999998754322222345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..||..|+|||++.+..++.++|||||||++|||++|..||...+..+....+...  ...+|..++.++.++|.+||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  233 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVR  233 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhcc
Confidence            57899999999999999999999999999999999999999988877766665432  3446677899999999999999


Q ss_pred             CCCCCCCHH-HHH
Q 009291          507 EPEIRPSFP-SIM  518 (538)
Q Consensus       507 dP~~RPs~~-eIl  518 (538)
                      ||++||++. +++
T Consensus       234 ~P~~R~~~~~~l~  246 (316)
T cd05619         234 EPERRLGVKGDIR  246 (316)
T ss_pred             CHhhcCCChHHHH
Confidence            999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=320.56  Aligned_cols=251  Identities=29%  Similarity=0.483  Sum_probs=213.4

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccC---HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~---~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      +.|++.+.||+|++|.||++.+.  +..+++|++......   ....+.+.+|+.++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46889999999999999999875  455999987654322   2345678899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      ++||+++++|.+++...   ..+++..+..++.|++.||.|||+.+  ++||||+|+||++++++.++|+|||++.....
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999988643   34788999999999999999999999  99999999999999999999999999875432


Q ss_pred             Ccccc---CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          420 TYISS---KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       420 ~~~~~---~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      .....   ....++..|+|||.+.+..++.++||||||+++|||++|+.||...+.......+........++..++..+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence            21111   234578899999999998899999999999999999999999987766655555544455566778899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      .++|.+||..+|++|||+.++++.
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhhC
Confidence            999999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-39  Score=335.93  Aligned_cols=250  Identities=24%  Similarity=0.422  Sum_probs=205.3

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      +..++|++.+.||+|+||.||++.+..++  +|+|++.... .......+.+|++++++++|+||+++++++.++..+++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            45578999999999999999999987554  7888765542 34455678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ||||+.+++|.+++...   ..+++..+..++.|++.||+|||+. +  ++||||||+|||++.++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          81 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            99999999999998643   3478899999999999999999974 7  9999999999999999999999999987543


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------------------
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG------------------  480 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~------------------  480 (538)
                      ...  .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.                  
T Consensus       156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         156 DSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             hhc--cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence            321  234568999999999999889999999999999999999999997655433322110                  


Q ss_pred             -------------------------hcCcccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          481 -------------------------FKGRRLEIP-KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       481 -------------------------~~~~~~~~p-~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                               .......++ ...+.++++||.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                     000111111 135788999999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.9e-40  Score=340.61  Aligned_cols=241  Identities=28%  Similarity=0.443  Sum_probs=200.8

Q ss_pred             EEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHH-HHHHcCCCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREV-AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei-~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||+||+|++..++  +|+|++...... ......+.+|. .+++.++|+||+++++++.+.+.+++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999987544  999998764322 22233444444 456788999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      ++|.+++...   ..+.+..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            9999998643   34778888999999999999999999  999999999999999999999999998754332223345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.  .....++..++..+.++|.+||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~  233 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQK  233 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHccc
Confidence            679999999999999999999999999999999999999999888776665553  234456678999999999999999


Q ss_pred             CCCCCCCHHHHH
Q 009291          507 EPEIRPSFPSIM  518 (538)
Q Consensus       507 dP~~RPs~~eIl  518 (538)
                      +|.+||++.+.+
T Consensus       234 ~p~~R~~~~~~~  245 (325)
T cd05602         234 DRTKRLGAKDDF  245 (325)
T ss_pred             CHHHCCCCCCCH
Confidence            999999887443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=328.01  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=208.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      .|++.+.||+|+||+||++.+..  +.||+|++....... .....+.+|+.+++.++|+||+.+++.+.+++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48899999999999999998764  459999986543322 223567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.+++|.+++.... ...+++..+..++.|++.||+|||+.+  ++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998875432 235889999999999999999999999  9999999999999999999999999987654322 


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hcCcccCCCCCCcHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~s~~l~~LI  500 (538)
                      ......|+..|+|||++.+..++.++||||+||++|||++|+.||...........+.  .......++..+++.+.+||
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            1234578999999999998889999999999999999999999998765533322221  12334455677899999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHHH
Q 009291          501 ETCWAEEPEIRP-----SFPSIMET  520 (538)
Q Consensus       501 ~~cL~~dP~~RP-----s~~eIl~~  520 (538)
                      .+||..||++||     +++++++.
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcC
Confidence            999999999999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.8e-40  Score=338.45  Aligned_cols=247  Identities=24%  Similarity=0.363  Sum_probs=203.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc-----CCceEEEEEecccc--CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEF--HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~--~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~  337 (538)
                      +|++++.||+|+||+||+++..     +..+|+|++.....  .....+.+.+|+.+++.+ +|+||+++++++.++..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4889999999999999999763     34499999875432  223345678899999999 599999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+.+|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            9999999999999998633   35889999999999999999999999  999999999999999999999999999764


Q ss_pred             CCCc-cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhhcCcccCCCCC
Q 009291          418 PNTY-ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       418 ~~~~-~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~  491 (538)
                      .... .......||..|+|||++.+. .++.++|||||||++|||++|..||.....    ......+  ......++..
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~  233 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSF  233 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCC
Confidence            3221 122345789999999999875 478899999999999999999999964322    2222222  2344566778


Q ss_pred             CcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RP-----s~~eIl~  519 (538)
                      +++.+.++|.+||+.||++||     +++++++
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            999999999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.8e-40  Score=336.61  Aligned_cols=242  Identities=24%  Similarity=0.431  Sum_probs=206.5

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +|++.+.||+|+||+||+|+++.+  .||+|++..... .....+.+..|..++..+. |++|+++++++.+...+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477899999999999999988654  499999876432 2334566788899998885 577888999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++|+|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999999988643   35889999999999999999999999  9999999999999999999999999987643332


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                      .......||..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.  .....+|..++.++.+++.
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~  233 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICK  233 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHHHH
Confidence            23345678999999999999899999999999999999999999999888777666653  3345677889999999999


Q ss_pred             HhhhcCCCCCCCH
Q 009291          502 TCWAEEPEIRPSF  514 (538)
Q Consensus       502 ~cL~~dP~~RPs~  514 (538)
                      +||+.+|.+|++.
T Consensus       234 ~~l~~~p~~R~~~  246 (323)
T cd05615         234 GLMTKHPSKRLGC  246 (323)
T ss_pred             HHcccCHhhCCCC
Confidence            9999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.2e-40  Score=343.58  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=213.0

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...+..++|++.+.||+|+||.||++++..++  +|+|++..... .....+.+.+|+.+++.++||||+++++.+.++.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            35566789999999999999999999987554  89999865332 2334456788999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+++|+|.+++...    .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            999999999999999998632    3788899999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCc-cccCCCCCCCcccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC-
Q 009291          416 SKPNTY-ISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-  489 (538)
Q Consensus       416 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~----~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p-  489 (538)
                      ...... .......||+.|+|||++.+..    ++.++|||||||++|||++|..||...+.......+........+| 
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  270 (371)
T cd05622         191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD  270 (371)
T ss_pred             EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence            654322 1224567999999999987543    7889999999999999999999999888777666665443334444 


Q ss_pred             -CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 009291          490 -KNVNPMVAALIETCWAEEPEI--RPSFPSIMET  520 (538)
Q Consensus       490 -~~~s~~l~~LI~~cL~~dP~~--RPs~~eIl~~  520 (538)
                       ..++.++.++|.+||..++.+  |+++.++++.
T Consensus       271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence             468999999999999844443  6888888874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-39  Score=329.19  Aligned_cols=266  Identities=32%  Similarity=0.574  Sum_probs=222.7

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcC---------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEee
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM  328 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~---------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~  328 (538)
                      .+++...+|++.+.||+|+||.||+|+..+         ..+|+|..... ........+.+|+.+++.+ +||||++++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence            356778899999999999999999997521         13788887543 2345567899999999999 899999999


Q ss_pred             ceeccCCcceEEEeecCCCChhhhhcCCCC-------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCC
Q 009291          329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS  395 (538)
Q Consensus       329 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp  395 (538)
                      +++......+++|||+.+++|.+++.....             ...++...++.++.|++.||.|||++|  ++||||||
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp  165 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA  165 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence            999999999999999999999999864321             234778889999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEEeeCCCccCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 009291          396 PNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP  472 (538)
Q Consensus       396 ~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~  472 (538)
                      +||+++.++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999999999999999999865432211  122345678999999998889999999999999999998 7889988877


Q ss_pred             HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .+....+. ...+...+..++..+.+||.+||..+|++|||+.++++.|++++...
T Consensus       246 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         246 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             HHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence            77666553 34455667789999999999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.3e-39  Score=321.89  Aligned_cols=255  Identities=36%  Similarity=0.589  Sum_probs=213.9

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ++..++|++.+.||+|+||.||+|.+.+. .+|+|.+.......   +.+.+|+.++++++|+||+++++++.+ ...++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI   77 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence            45667899999999999999999987643 48888876544332   468899999999999999999998754 56899


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      +|||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+  ++||||||+||++++++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            999999999999986432 234789999999999999999999999  99999999999999999999999999976543


Q ss_pred             Ccc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          420 TYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       420 ~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. .....+.+...+..+.
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLH  233 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence            221 1122335668999999988889999999999999999999 899998877766665553 3345566778899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      +|+.+||..+|++|||+.++.+.|++
T Consensus       234 ~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         234 ELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.7e-40  Score=338.69  Aligned_cols=241  Identities=23%  Similarity=0.422  Sum_probs=200.9

Q ss_pred             EEEccCCcEEEEEEEEcCC--ceEEEEEeccccC-HHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||.||+|++..+  .||+|++...... ....+.+.+|..+++.+ +||||+++++++.+...+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999998654  4999998765432 34456788999999988 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      |+|..++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++............
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            9999888533   35899999999999999999999999  999999999999999999999999998753222223345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH-HHHHHhhcCcccCCCCCCcHHHH
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--------SQ-VISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~--------~~-~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ..||..|+|||++.+..++.++|||||||++|+|++|+.||.....        .+ ....+  ......+|..++..+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~  233 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAS  233 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHH
Confidence            6789999999999999999999999999999999999999963211        11 12222  3345567888999999


Q ss_pred             HHHHHhhhcCCCCCCC------HHHHH
Q 009291          498 ALIETCWAEEPEIRPS------FPSIM  518 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs------~~eIl  518 (538)
                      ++|++||+.||.+|++      +++++
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence            9999999999999997      55665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.4e-40  Score=338.90  Aligned_cols=238  Identities=29%  Similarity=0.447  Sum_probs=200.4

Q ss_pred             EEEccCCcEEEEEEEEcC--CceEEEEEeccccC-HHHHHHHHHHHH-HHHcCCCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVA-IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-~~~~~~~~~Ei~-il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||+||+|.+..  ..||+|++...... ....+.+.+|.. +++.++||||+++++.+.+...+++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            369999999999999864  44999998754322 223345555555 56789999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      |+|..++...   ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++............
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            9999988643   35889999999999999999999999  999999999999999999999999998754333223345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.  .....++..++..+.++|.+||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~  233 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQK  233 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence            578999999999999999999999999999999999999999887766666553  234456678899999999999999


Q ss_pred             CCCCCCCHH
Q 009291          507 EPEIRPSFP  515 (538)
Q Consensus       507 dP~~RPs~~  515 (538)
                      +|++||++.
T Consensus       234 ~p~~R~~~~  242 (323)
T cd05575         234 DRTKRLGAK  242 (323)
T ss_pred             CHHhCCCCC
Confidence            999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5e-39  Score=329.42  Aligned_cols=267  Identities=31%  Similarity=0.588  Sum_probs=222.0

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcC---------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEee
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM  328 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~---------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~  328 (538)
                      .+.+...+|.+.+.||+|+||.||+|++.+         ..+|+|.+.... .......+.+|+.+++++ +||||++++
T Consensus         6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (314)
T cd05099           6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL   84 (314)
T ss_pred             cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence            356667899999999999999999997532         238888876433 345567788999999999 699999999


Q ss_pred             ceeccCCcceEEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCC
Q 009291          329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS  395 (538)
Q Consensus       329 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp  395 (538)
                      +++.+...++++|||+.+++|.+++....             ....+++..+..++.|++.||+|||++|  ++||||||
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp  162 (314)
T cd05099          85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA  162 (314)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence            99999889999999999999999985421             1235788899999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEEeeCCCccCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 009291          396 PNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP  472 (538)
Q Consensus       396 ~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~  472 (538)
                      +||+++.++.+||+|||+++........  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999865432111  112234567999999998889999999999999999999 8999988877


Q ss_pred             HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      .+....+. .......+..++.++.++|.+||..+|++|||+.++++.|+++.....
T Consensus       243 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         243 EELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence            66666553 334456678889999999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.1e-39  Score=319.17  Aligned_cols=246  Identities=35%  Similarity=0.595  Sum_probs=206.0

Q ss_pred             EEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCC
Q 009291          271 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGS  348 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gs  348 (538)
                      +.||+|+||.||+|.+.  ++.+|+|..... ........+.+|++++++++|+||+++++++......++||||+.+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            36899999999999885  445999986543 344555679999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc--CC
Q 009291          349 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KT  426 (538)
Q Consensus       349 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~  426 (538)
                      |.+++....  ..+++..++.++.|++.||+|||+++  ++||||||+||+++.++.+||+|||++..........  ..
T Consensus        80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999986432  34789999999999999999999999  9999999999999999999999999987543321111  11


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhh
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA  505 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~  505 (538)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..||...........+. ...+...+..++..+.+|+.+||+
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~  234 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWE  234 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcC
Confidence            123457999999999889999999999999999998 889998777655554443 334556677889999999999999


Q ss_pred             cCCCCCCCHHHHHHHHH
Q 009291          506 EEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       506 ~dP~~RPs~~eIl~~L~  522 (538)
                      .+|++|||+.++++.|+
T Consensus       235 ~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         235 YDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CChhhCcCHHHHHHHHh
Confidence            99999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-39  Score=350.20  Aligned_cols=251  Identities=24%  Similarity=0.409  Sum_probs=212.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC---ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS---DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ...|.+.+.||+|+||.||+|....+   .+++|.+...  .......+.+|+.+++.++||||+++++++..+..+++|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            34599999999999999999987544   3777765433  344456788899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          341 TEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      |||+++|+|.+++... .....+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            9999999999887532 23346889999999999999999999999  99999999999999999999999999986543


Q ss_pred             Ccc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          420 TYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       420 ~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+... ...++|..++..+.
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~  300 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGMK  300 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHHH
Confidence            221  123456999999999999999999999999999999999999999988877766665433 33356678899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ++|.+||..+|++||++.+++.
T Consensus       301 ~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        301 ALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHHHHhccChhhCcCHHHHHh
Confidence            9999999999999999999864

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-39  Score=319.43  Aligned_cols=256  Identities=35%  Similarity=0.588  Sum_probs=217.1

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ++..++|++.+.||+|+||.||+|.+.++ .+++|.+......   .+.+.+|+.++++++|+||+++++++.+....++
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            46678999999999999999999987654 4899987654433   3578899999999999999999999998889999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      +|||+++++|.+++.... ...+++..+..++.|++.||+|||+++  ++|+||||+||++++++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccc
Confidence            999999999999986532 235788999999999999999999999  99999999999999999999999999876543


Q ss_pred             Ccc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          420 TYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       420 ~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ... .......+..|+|||.+.+..++.++||||||+++|++++ |+.||...+.......+. ...+...+..++.++.
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELY  234 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence            211 1122234568999999998889999999999999999998 999998877766665553 3345566677899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      +++.+||+.+|++||+++++++.|++
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         235 DLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHHHcccCcccCCCHHHHHHHHhc
Confidence            99999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.8e-39  Score=321.83  Aligned_cols=257  Identities=34%  Similarity=0.565  Sum_probs=215.5

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC---C--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN---S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~---~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ...+|++.+.||+|+||.||+|.+..   +  .+|+|.+.... .....+.+.+|+.++++++||||+++++++.++...
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            34679999999999999999998742   1  37888875433 344567899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||+|||+++  ++||||||+||+++.++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999999996543  34788999999999999999999999  999999999999999999999999999865


Q ss_pred             CCCcccc---CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          418 PNTYISS---KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       418 ~~~~~~~---~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      .......   ....++..|+|||.+.+..++.++||||||+++||+++ |..||......+....+. ...+.+.+..++
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCP  235 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCCCCCCCC
Confidence            4322111   11223567999999998889999999999999999886 999998877666555553 334455667789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      +.+.+++.+||+.+|++||++.++++.|++++
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         236 AALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             HHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence            99999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6e-39  Score=318.94  Aligned_cols=257  Identities=28%  Similarity=0.491  Sum_probs=214.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccc-cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||.||+|.+.  +..+|+|.+.... ......+.+.+|++++++++|+||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999886  4459999876433 23444678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          342 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       342 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      ||+++++|..++... .....+++..++.++.|++.||+|||+.|  ++||||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            999999999988532 22345889999999999999999999999  999999999999999999999999998765443


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhhcCcccCCCC-CCcHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGFKGRRLEIPK-NVNPMVA  497 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~--~~~~~~i~~~~~~~~~p~-~~s~~l~  497 (538)
                      ........++..|+|||.+.+..++.++||||||+++|+|++|+.||.....  ......+. .....+.|. .++..+.
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEELR  238 (267)
T ss_pred             CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHHH
Confidence            3233345688899999999988899999999999999999999999965432  22222222 222233443 6788999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      ++|.+||..+|++|||+.+|++.|+++
T Consensus       239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         239 DLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            999999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=344.28  Aligned_cols=264  Identities=38%  Similarity=0.642  Sum_probs=233.6

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ..|++...+..+..+||-|.||.||.|.|+.-.  ||||.++...   -.+++|+.|..+|+.++|||+|+++++|..+.
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            446777788889999999999999999998655  8999987643   34679999999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|||+|||..|+|.++|+..+. .-++....+.++.||..|++||..++  +|||||..+|+|+.++..||++|||+++
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999999999976543 34677788899999999999999999  9999999999999999999999999999


Q ss_pred             cCC-CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          416 SKP-NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       416 ~~~-~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ... +.+.......-...|.|||-+....++.|+|||+|||+|||+.| |-.||.+....++...+ ..+.|+.-|..|+
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-EkgyRM~~PeGCP  492 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-EKGYRMDGPEGCP  492 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-hccccccCCCCCC
Confidence            754 44433334445789999999999999999999999999999998 77899998876666554 4788999999999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +.+++||+.||+++|.+||+|.+|...+++|+.+.
T Consensus       493 pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  493 PKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            99999999999999999999999999999999765

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-39  Score=323.74  Aligned_cols=259  Identities=25%  Similarity=0.460  Sum_probs=213.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc--CCceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||.||++.+.  +..++||.+..... .....+.+.+|+.+++.++|+||+++++++.++...+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57888999999999999999875  44599998765432 3445578899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcC-CCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          342 EYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       342 E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      ||+++++|.+++.. ......+++..++.++.|++.||+|||++|  ++|+||||+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            99999999998853 222346889999999999999999999999  999999999999999999999999998765443


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--QVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      ........++..|+|||.+.+..++.++||||||+++|+|++|..||......  .....+.........+..+++.+.+
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ  239 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence            32233456888999999999888999999999999999999999999765432  2222222111122223457899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      +|.+||..+|++|||+.+|++.++++.
T Consensus       240 li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         240 LVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.5e-39  Score=322.13  Aligned_cols=263  Identities=29%  Similarity=0.495  Sum_probs=219.0

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc-
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-  333 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~-  333 (538)
                      .+..++|++.+.||+|+||.||+|.+..      ..+++|.+.. .......+.+.+|+.++++++|+||+++++++.+ 
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3567889999999999999999998765      3378887653 3355566789999999999999999999998665 


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCC-----ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEE
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDAR-----VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV  408 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL  408 (538)
                      +...++++||+.+++|.+++......     ..+++..++.++.|++.||+|||+++  ++||||||+||++++++.+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEE
Confidence            56789999999999999998643222     45889999999999999999999999  999999999999999999999


Q ss_pred             EeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcc
Q 009291          409 CDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRR  485 (538)
Q Consensus       409 ~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~  485 (538)
                      +|||+++.......  ......++..|+|||.+.+..++.++||||||+++||+++ |+.||...+..+....+. ...+
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~  237 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYR  237 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCCC
Confidence            99999975432211  1122345678999999998889999999999999999999 999998887766555443 3344


Q ss_pred             cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       486 ~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      ...+..+++++.+++.+||..+|++|||+.++++.|+++.+.
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            455667899999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.7e-39  Score=320.30  Aligned_cols=261  Identities=33%  Similarity=0.583  Sum_probs=218.4

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ++...+|.+.+.||+|+||.||+|.+...     .+++|...... .....+.+.+|+.++++++|+||+++++++.+ .
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            34567799999999999999999987543     37888765432 34556789999999999999999999998876 4


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~  155 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSR  155 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceee
Confidence            5789999999999999996432  24789999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          416 SKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       416 ~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ....... ......++..|+|||.+....++.++||||||+++||+++ |..||......+....+. ...+...+..++
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (270)
T cd05056         156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP  234 (270)
T ss_pred             ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCC
Confidence            6543311 1122234568999999988889999999999999999986 999998887766655543 444566778899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .++.++|.+||..+|++|||+.++++.|+++....
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            99999999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.8e-39  Score=328.88  Aligned_cols=263  Identities=32%  Similarity=0.528  Sum_probs=218.6

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeece
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA  330 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~  330 (538)
                      .+++..++|.+.+.||+|+||.||++.+..       ..+|+|++.... .....+.+.+|+.+++++ +|+||++++++
T Consensus        29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            355667889999999999999999997521       238888876443 344456889999999999 79999999999


Q ss_pred             eccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEe
Q 009291          331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD  410 (538)
Q Consensus       331 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~D  410 (538)
                      +......+++|||+.+++|.++++.... ..+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.++|+|
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECC
Confidence            9999999999999999999999864322 23789999999999999999999999  99999999999999999999999


Q ss_pred             eCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccC
Q 009291          411 FGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLE  487 (538)
Q Consensus       411 FGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~  487 (538)
                      ||++........  ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+..........+..
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  264 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA  264 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC
Confidence            999876433211  1122345678999999999889999999999999999998 9999987766554444433444455


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       488 ~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      .+...++++.++|.+||..+|++|||+.++++.|++++
T Consensus       265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            56678899999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.4e-40  Score=337.74  Aligned_cols=237  Identities=24%  Similarity=0.435  Sum_probs=198.1

Q ss_pred             EEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||+||+|++..++  +|+|++..... .....+.+.+|+.++.++ +||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999987544  99999876533 334456788899988876 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      ++|..++...   ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            9998887533   35889999999999999999999999  999999999999999999999999998754332223345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS---------TPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ..||..|+|||++.+..++.++|||||||++|||++|+.||...         ........+  ......+|..++..+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~  233 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAA  233 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHH
Confidence            67899999999999999999999999999999999999999521         111112222  3345667888999999


Q ss_pred             HHHHHhhhcCCCCCCCH
Q 009291          498 ALIETCWAEEPEIRPSF  514 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~  514 (538)
                      ++|.+||+.||++||++
T Consensus       234 ~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         234 SVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHhcCCHHHcCCC
Confidence            99999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-40  Score=326.70  Aligned_cols=251  Identities=26%  Similarity=0.339  Sum_probs=210.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec--cCCcceE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPPNLSI  339 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~--~~~~~~l  339 (538)
                      -++|+.+..|++|+||.||+|+++.++  ||+|.++.....+..--..+||+.+|.+.+|||||.+-.++.  +-+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            467899999999999999999998776  999998876544433456789999999999999999988764  3445999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      |||||+. +|..++....  .++...++.-++.|+++|++|||.+.  |+||||||+|+|++..|.+||+|||+|+..++
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            9999987 8999997544  46889999999999999999999999  99999999999999999999999999999887


Q ss_pred             CccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Cc-------------
Q 009291          420 TYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR-------------  484 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~-------------  484 (538)
                      +....+..+-|.+|.|||.+.+. .|++.+|+||+|||+.||+++++.|.+....+.+..|-.. +.             
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            76555677789999999998875 5899999999999999999999999988776655444211 00             


Q ss_pred             ---ccC------------CCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 ---RLE------------IPK-NVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ---~~~------------~p~-~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                         ...            ++. .+++.-.+|++.+|..||.+|.|+.+.|+
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence               011            111 15688899999999999999999998754

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.3e-39  Score=323.00  Aligned_cols=258  Identities=29%  Similarity=0.482  Sum_probs=212.7

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC--Cc----eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN--SD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~----vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      ...+|++.+.||+|+||+||+|.+..  ..    +++|.+... .......++..|+.++++++||||+++++++.. ..
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~   82 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS   82 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence            45688999999999999999998853  32    566665322 223445678889999999999999999998764 45


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++++||+++|+|.+++....  ..+++..++.++.|++.||+|||+++  ++||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCcccee
Confidence            789999999999999996432  35889999999999999999999999  99999999999999999999999999976


Q ss_pred             CCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          417 KPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       417 ~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ......  ......++..|+|||.+.+..++.++||||||+++||+++ |..||...........+ ..+.....+..++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  237 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQPQICT  237 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCCCCC
Confidence            432211  1223456778999999998889999999999999999998 99999887766554444 3445556667788


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      ..+.+++.+||..+|++|||+.++++.|..+..+
T Consensus       238 ~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         238 IDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            8999999999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6e-39  Score=320.49  Aligned_cols=256  Identities=32%  Similarity=0.566  Sum_probs=215.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      ..+|++.+.||+|+||.||+|.+..+     .||+|++... ........|..|+.+++.++||||+++++++.++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            45789999999999999999987543     3899987543 24555678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  ++|+||||+||+++.++.+||+|||++....
T Consensus        82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999986543  34788999999999999999999999  9999999999999999999999999987543


Q ss_pred             CCccc---cCCCC--CCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          419 NTYIS---SKTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       419 ~~~~~---~~~~~--gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      .....   .....  .+..|+|||.+.+..++.++|||||||++||+++ |..||......+....+. ...+.+.+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~  236 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDC  236 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccC
Confidence            32111   01111  2457999999998899999999999999999886 999998877766666553 33455666788


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      +..+.+++.+||..+|++||++.+|+..|++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            999999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=322.02  Aligned_cols=250  Identities=27%  Similarity=0.439  Sum_probs=218.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|.|+.|++..+..+  ++|+|++..........+++.+|++|-+.|+||||+++.+...+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45788889999999999999876544  4999998777666667789999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGla~~~~  418 (538)
                      |+++|++|..-+-   .+..++|..+-..++||++||.|+|.++  |||||+||+|+++..   .--+||+|||+|....
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999876553   2246889999999999999999999999  999999999999953   3469999999998877


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC--CCCCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~s~~l  496 (538)
                      ++. .....+||+.|||||++...+|+..+|||+.|+|||-|+.|.+||.+.+...+...+.......+  ..++++++.
T Consensus       165 ~g~-~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  165 DGE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             Ccc-ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            443 33567899999999999999999999999999999999999999999888888888865554443  346889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ++||++||..||.+|.|+.|.|+
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhC
Confidence            99999999999999999998764

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.5e-40  Score=341.58  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=207.8

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||+||++.+..+  .||+|++..... .......+.+|+.++..++|+||+++++.+.+...+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            3689999999999999999988654  499999875432 2344567888999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999998643   35889999999999999999999999  9999999999999999999999999986432110


Q ss_pred             -----------------------------------cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 009291          422 -----------------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP  466 (538)
Q Consensus       422 -----------------------------------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~P  466 (538)
                                                         ......+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence                                               001234689999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhhcCcccCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 009291          467 WRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPS---FPSIME  519 (538)
Q Consensus       467 f~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~~LI~~cL~~dP~~RPs---~~eIl~  519 (538)
                      |...+.......+........+|.  .+++++.+||.+|+ .+|++|++   ++++++
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            998888777666644334444444  47899999999977 49999986   455543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.9e-39  Score=317.59  Aligned_cols=255  Identities=34%  Similarity=0.584  Sum_probs=212.4

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ++...+|.+.+.||+|+||.||+|.+.++ .+++|.+.....   ..+.+.+|+.++++++|+|++++++++.. ...++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05069           2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYI   77 (260)
T ss_pred             cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEE
Confidence            34556799999999999999999988665 488888654332   23468889999999999999999998754 56899


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      +|||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+  ++|+||||+||++++++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            999999999999986432 234788899999999999999999999  99999999999999999999999999976543


Q ss_pred             Ccc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          420 TYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       420 ~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+...+..+.
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH  233 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHH
Confidence            221 1122345678999999998889999999999999999999 899998877766555543 3334456677899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      ++|.+||..+|++||+++++++.|++
T Consensus       234 ~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         234 ELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHHccCCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.9e-39  Score=321.94  Aligned_cols=257  Identities=33%  Similarity=0.541  Sum_probs=212.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC-----Cc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN-----SD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +...+|++.+.||+|+||.||+|.+..     +.  +++|.+.... .......+.+|+.+++.++|+||+++++++.+.
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            445779999999999999999998865     33  6777654332 334446789999999999999999999999998


Q ss_pred             CcceEEEeecCCCChhhhhcCCCC----CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC---cEE
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDA----RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVK  407 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~---~vk  407 (538)
                      ...++||||+.+++|.+++.....    ...+++..++.++.||+.||+|||+++  ++||||||+||+++.++   .+|
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence            899999999999999999854321    235889999999999999999999999  99999999999998654   699


Q ss_pred             EEeeCCCccCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCc
Q 009291          408 VCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR  484 (538)
Q Consensus       408 L~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~  484 (538)
                      |+|||+++........  ......+..|+|||++.+..++.++|||||||++|||++ |..||...+.......+. ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~  238 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGG  238 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence            9999999865322111  112233568999999998889999999999999999997 999999877766655543 344


Q ss_pred             ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       485 ~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      +...+..++..+.++|.+||+.+|++|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            56667889999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.7e-39  Score=318.96  Aligned_cols=246  Identities=31%  Similarity=0.558  Sum_probs=206.1

Q ss_pred             EEccCCcEEEEEEEEc--CC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCC
Q 009291          272 KIGEGSFGTVYHAEWR--NS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~--~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      .||+|+||.||+|.+.  ++  .+|+|++.... .....+.+.+|+.++++++|+||+++++++.. ...++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            3899999999999764  22  38888876542 34445679999999999999999999998754 5689999999999


Q ss_pred             ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc---c
Q 009291          348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS---S  424 (538)
Q Consensus       348 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~  424 (538)
                      +|.+++....  ..+++..++.++.|++.||+|||+++  ++||||||+||+++.++.+||+|||++.........   .
T Consensus        80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999986432  35889999999999999999999999  999999999999999999999999998754332111   1


Q ss_pred             CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          425 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      ....++..|+|||.+.+..++.++||||||+++||+++ |..||......+....+. ...+...+..+++++.++|.+|
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c  234 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDC  234 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence            12233578999999988889999999999999999996 999999887766655553 4456677888999999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHHH
Q 009291          504 WAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~~L~~i  524 (538)
                      |..+|++||++.+|.+.|+++
T Consensus       235 ~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         235 WIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             cCCChhhCcCHHHHHHHHhhh
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.3e-39  Score=329.84  Aligned_cols=250  Identities=25%  Similarity=0.358  Sum_probs=202.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||+||+|.+..+  .+|+|++..... ......+.+|+.++++++|+||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            46799999999999999999987644  499998865432 222345778999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+ +|.+++....  ..+++..+..++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++.......
T Consensus        84 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          84 EYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             eCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            99975 7777775332  34788899999999999999999999  9999999999999999999999999997654433


Q ss_pred             cccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-----------------
Q 009291          422 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-----------------  483 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-----------------  483 (538)
                      .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+....+....                 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            33344567899999999865 457899999999999999999999998776654433321100                 


Q ss_pred             ccc-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 RRL-----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ~~~-----------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ...           .....+++++.+||.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000           111356889999999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1e-38  Score=315.76  Aligned_cols=250  Identities=29%  Similarity=0.478  Sum_probs=212.0

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc-CCcceEEEe
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSIVTE  342 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~-~~~~~lV~E  342 (538)
                      .|++.+.||+|++|.||++.+..+  .+++|.+..........+.+.+|++++++++|+|++++++.+.. +..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            488999999999999999987643  49999987665556666788999999999999999999998764 445799999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+++++|.+++.... ...+++..++.++.|++.||++||+.|  ++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999999986432 235889999999999999999999999  99999999999999999999999999876544333


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+. .......+..+++++.++|.+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIAT  236 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHH
Confidence            3345568899999999999999999999999999999999999998777655544442 223334567789999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIME  519 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~  519 (538)
                      ||+.+|++|||+.++++
T Consensus       237 ~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         237 MLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HhccCcccCCCHHHHhc
Confidence            99999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.7e-39  Score=316.78  Aligned_cols=251  Identities=25%  Similarity=0.463  Sum_probs=217.1

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||.|+||.||.++...  ..+++|.+..........+.+.+|++++++++|+||+++++++.+...++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            58899999999999999988764  4489998877666666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|.+++.... ...+++..+..++.|++.||+|||+.+  ++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            99999999986542 345889999999999999999999999  999999999999999999999999998865443323


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.. ......+..++.++.++|.+|
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSL  236 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHH
Confidence            3455689999999999888889999999999999999999999998777666665542 333344567899999999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 009291          504 WAEEPEIRPSFPSIMET  520 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~~  520 (538)
                      |..+|++||++.++++.
T Consensus       237 l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         237 LQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             cccCcccCCCHHHHhhC
Confidence            99999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.6e-40  Score=336.31  Aligned_cols=238  Identities=29%  Similarity=0.445  Sum_probs=200.0

Q ss_pred             EEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHH-HHHcCCCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVA-IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~-il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||.||+|++..+  .+|+|++..... .......+.+|.. +++.++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999998644  499999875432 2233345555554 67889999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      ++|...+...   ..+++..+..++.||+.||+|||+++  |+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            9998887533   34788899999999999999999999  999999999999999999999999998754333223345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|..||...+.......+.  .....+|...+..+.++|.+||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~  233 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHK  233 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccC
Confidence            578999999999999899999999999999999999999999887766655553  345667788899999999999999


Q ss_pred             CCCCCCCHH
Q 009291          507 EPEIRPSFP  515 (538)
Q Consensus       507 dP~~RPs~~  515 (538)
                      +|++||++.
T Consensus       234 ~p~~R~~~~  242 (321)
T cd05603         234 DQRRRLGAK  242 (321)
T ss_pred             CHhhcCCCC
Confidence            999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.6e-39  Score=324.25  Aligned_cols=251  Identities=28%  Similarity=0.382  Sum_probs=204.2

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||+|.+..  ..||+|++..........+.+.+|+.++++++||||+++++++.++..+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            58899999999999999998864  4499998865544444456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +. ++|.+++........+++..++.++.|++.||+|||+++  ++||||||+||+++.++.+||+|||++.........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence            97 588888765444456899999999999999999999999  999999999999999999999999998765433222


Q ss_pred             cCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--------------------
Q 009291          424 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--------------------  482 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~--------------------  482 (538)
                      .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+...                    
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            2344678899999988654 4789999999999999999999999876654333221100                    


Q ss_pred             -------CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 -------GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 -------~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                             .........+++++.++|++||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                   0000112357889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-39  Score=317.41  Aligned_cols=248  Identities=39%  Similarity=0.665  Sum_probs=214.3

Q ss_pred             EEEccCCcEEEEEEEEc-----CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecC
Q 009291          271 KKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  345 (538)
                      +.||+|+||.||+|.+.     +..+++|++....... ..+.+.+|+.+++.++|+||+++++++.+...++++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            36899999999999887     4458999986654333 56789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCC------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          346 RGSLYKLLHIPDA------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       346 ~gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      +++|.+++.....      ...+++..++.++.|++.||+|||+++  ++|+||||+||+++.++.+||+|||.+.....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999975421      256899999999999999999999999  99999999999999999999999999987554


Q ss_pred             Cc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          420 TY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       420 ~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ..  .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..++.++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  236 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDEL  236 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCccCChHH
Confidence            32  22334567889999999988889999999999999999999 699999887777666654 355667788899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      .+++.+||+.+|++|||+.++++.|+
T Consensus       237 ~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         237 YELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHHHccCCcccCcCHHHHHHhhC
Confidence            99999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.8e-39  Score=318.48  Aligned_cols=258  Identities=34%  Similarity=0.549  Sum_probs=215.6

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--C---ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--S---DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~---~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      +...+|+..+.||+|+||.||+|.+..  .   .+++|.+.... .....+.+.+|++++++++|+||+++.+++.+...
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            345678999999999999999998753  2   37888765432 34456788999999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcccee
Confidence            999999999999999986432  35888999999999999999999999  99999999999999999999999999876


Q ss_pred             CCCCcccc---CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          417 KPNTYISS---KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       417 ~~~~~~~~---~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      ........   .....+..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+. ...+.+.+..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~  235 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDC  235 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCC
Confidence            53321111   11223457999999988889999999999999999997 999998877766665554 33455556678


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      +..+.+++.+||+.+|++||++.++++.|++++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.8e-39  Score=326.11  Aligned_cols=257  Identities=36%  Similarity=0.534  Sum_probs=212.5

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC------------------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCce
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS------------------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI  324 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~------------------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnI  324 (538)
                      ...+|++.+.||+|+||.||+|.+...                  .+|+|.+.... .....+.+.+|++++++++|+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence            456899999999999999999986542                  27888876543 33556789999999999999999


Q ss_pred             eEeeceeccCCcceEEEeecCCCChhhhhcCCC--------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCC
Q 009291          325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD--------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP  396 (538)
Q Consensus       325 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~  396 (538)
                      +++++++..+...+++|||+.+++|.+++....        ....+++..++.++.|++.||+|||+++  ++||||||+
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~  159 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATR  159 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchh
Confidence            999999999999999999999999999986432        1125889999999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCH
Q 009291          397 NLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTP  472 (538)
Q Consensus       397 NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt--g~~Pf~~~~~  472 (538)
                      ||++++++.++|+|||+++......  .......++..|+|||.+.+..++.++|||||||++|||++  +..||...+.
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999999987643321  11233456778999999988889999999999999999998  6788987776


Q ss_pred             HHHHHHHhhc------CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          473 SQVISAVGFK------GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       473 ~~~~~~i~~~------~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      .+....+...      ......+..+++++.++|.+||+.+|++|||+.+|++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            6655444321      1123345567899999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-39  Score=334.69  Aligned_cols=265  Identities=31%  Similarity=0.543  Sum_probs=214.7

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc-------CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeecee
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV  331 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~  331 (538)
                      +.+..++|++.+.||+|+||.||+|.+.       ++.||||++.... .......+.+|+.++.++ +|+||+++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            4566788999999999999999999753       2349999986543 334456788999999999 689999999987


Q ss_pred             cc-CCcceEEEeecCCCChhhhhcCCCC----------------------------------------------------
Q 009291          332 TE-PPNLSIVTEYLSRGSLYKLLHIPDA----------------------------------------------------  358 (538)
Q Consensus       332 ~~-~~~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------  358 (538)
                      .. +..++++|||+++|+|.+++.....                                                    
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            55 4467899999999999999853210                                                    


Q ss_pred             ------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc--ccc
Q 009291          359 ------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISS  424 (538)
Q Consensus       359 ------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~  424 (538)
                                  ...+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++.......  ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                        123677788899999999999999999  9999999999999999999999999987643221  111


Q ss_pred             CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          425 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.................+...|..+++++.+++.+|
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c  318 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  318 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence            22345678999999998889999999999999999997 89999765443333333334455566677889999999999


Q ss_pred             hhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          504 WAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      |+.+|++|||+.+|++.|+++++.
T Consensus       319 l~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         319 WHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             ccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.5e-40  Score=337.51  Aligned_cols=239  Identities=27%  Similarity=0.412  Sum_probs=200.7

Q ss_pred             EEEccCCcEEEEEEEEcC--CceEEEEEecccc-CHHHHHHHHHHHH-HHHcCCCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVA-IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~-~~~~~~~~~~Ei~-il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||+||+|++..  ..+|+|++..... .......+.+|.. +++.++||||+++++++..++.+++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            369999999999998864  4499999875432 2233445566655 46778999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      |+|...+...   ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++............
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            9998888633   35889999999999999999999999  999999999999999999999999998754333223345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.  .....+++..+..+.++|++||+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~ll~~  233 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPLVLRPGASLTAWSILEELLEK  233 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH--cCCccCCCCCCHHHHHHHHHHhcc
Confidence            678999999999999999999999999999999999999999887776665553  234455667899999999999999


Q ss_pred             CCCCCCCHHH
Q 009291          507 EPEIRPSFPS  516 (538)
Q Consensus       507 dP~~RPs~~e  516 (538)
                      +|++||++.+
T Consensus       234 ~p~~R~~~~~  243 (325)
T cd05604         234 DRQRRLGAKE  243 (325)
T ss_pred             CHHhcCCCCC
Confidence            9999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=338.45  Aligned_cols=250  Identities=29%  Similarity=0.451  Sum_probs=220.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCH-HHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~l  339 (538)
                      ...|++.+.||+|.||.||+++.+.++  +|+|++.+..... .....+.+|+.+|+++. |||||.++++|++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            457999999999999999999887644  9999997765533 34568899999999998 9999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC----CCcEEEEeeCCCc
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFGLSR  415 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~----~~~vkL~DFGla~  415 (538)
                      |||++.||.|.+.+...    .+++..+..++.|++.|++|||+.|  |+||||||+|+|+..    ++.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999998644    2999999999999999999999999  999999999999953    3579999999999


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC--CCCCCc
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVN  493 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~s  493 (538)
                      .... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||...+.......+......+.  ....++
T Consensus       188 ~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is  266 (382)
T KOG0032|consen  188 FIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS  266 (382)
T ss_pred             EccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence            8776 3345678999999999999999999999999999999999999999999998888877765544333  335679


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +.+++||++||..||.+|+|+.++++.
T Consensus       267 ~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  267 ESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            999999999999999999999999883

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-39  Score=317.51  Aligned_cols=246  Identities=33%  Similarity=0.544  Sum_probs=207.4

Q ss_pred             EEEccCCcEEEEEEEEcC-----CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecC
Q 009291          271 KKIGEGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~-----~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  345 (538)
                      +.||+|+||.||+|.+..     ..+|+|.+...... ...+.+.+|+.+++.+.|+||+++++++.. ..+++||||+.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            469999999999997643     34889987655433 455688999999999999999999998764 56899999999


Q ss_pred             CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc--
Q 009291          346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS--  423 (538)
Q Consensus       346 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~--  423 (538)
                      +++|.+++....   .+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||+++........  
T Consensus        79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999996433   5889999999999999999999999  999999999999999999999999999865332211  


Q ss_pred             -cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          424 -SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       424 -~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                       .....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+. .......+..++..+.++|.
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIML  232 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHH
Confidence             112223467999999998899999999999999999998 999998887766665553 34455677889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHH
Q 009291          502 TCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       502 ~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      +||+.+|++||++.++++.|+++
T Consensus       233 ~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         233 SCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             HHhcCChhhCcCHHHHHHHHHhc
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-39  Score=322.04  Aligned_cols=248  Identities=35%  Similarity=0.580  Sum_probs=208.3

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      |++++.||+|+||+||++++.+++  +|+|++..............+|+.++++++|+||+++++++.+....+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            789999999999999999998775  999999887666555556667999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS  424 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~  424 (538)
                      .+++|.+++.   ....+++..++.++.|+++||++||+++  ++|+||||+||++++++.++|+|||.+..........
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence            9999999997   3345899999999999999999999999  9999999999999999999999999987532222334


Q ss_pred             CCCCCCCccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---hcCccc--CCCCCCcHHHHH
Q 009291          425 KTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG---FKGRRL--EIPKNVNPMVAA  498 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~-~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~---~~~~~~--~~p~~~s~~l~~  498 (538)
                      ....++..|+|||++. +..++.++||||||+++|+|++|..||...........+.   ......  ......++.+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            5667899999999998 8889999999999999999999999999874333332221   111111  111223489999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +|.+||+.||++||++.++++
T Consensus       236 li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7e-39  Score=334.78  Aligned_cols=248  Identities=27%  Similarity=0.345  Sum_probs=199.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      .++|++.+.||+|+||.||++.+..  ..+|+|++............+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            4789999999999999999998764  44999998765555556678889999999999999999999886543      


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+||||+.+ +|...+..     .+++..+..++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            47999999976 56555531     3778889999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------  482 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-------------  482 (538)
                      ...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...             
T Consensus       172 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         172 TACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             ccccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            643322 223457899999999999999999999999999999999999999876543322111000             


Q ss_pred             -------Cccc--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          483 -------GRRL--------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       483 -------~~~~--------------------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                             ..+.                    ......++++.+||.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                   0000                    0111246789999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=319.41  Aligned_cols=249  Identities=35%  Similarity=0.618  Sum_probs=206.4

Q ss_pred             EEccCCcEEEEEEEEcCCc----eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEEeecCC
Q 009291          272 KIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~~~----vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      .||+|+||.||+|.+.+++    +++|.+... ......+.+.+|++++.++ +||||+++++++.....++++|||+++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            5899999999999886543    466665432 2344556888999999999 799999999999999999999999999


Q ss_pred             CChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          347 GSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       347 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ++|.+++....             ....+++..++.++.|++.||+|||+.+  ++||||||+||++++++.+||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCC
Confidence            99999985432             1124788999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      +....... .......+..|+|||++....++.++||||||+++|||++ |..||......+....+. ...+...+..+
T Consensus       159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~  236 (270)
T cd05047         159 SRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC  236 (270)
T ss_pred             ccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCcC
Confidence            86432211 1122234567999999988889999999999999999997 999998877666555543 33445566778


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      +.++.+++.+||..+|.+|||+.+++..|++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         237 DDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            899999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.8e-39  Score=323.11  Aligned_cols=258  Identities=35%  Similarity=0.571  Sum_probs=214.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +...+|++.+.||+|+||.||+|.+.+       ..+|+|++.... .......+.+|+.++++++||||+++++++.++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            345789999999999999999998642       348999876443 344456789999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCC-------------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPD-------------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS  395 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp  395 (538)
                      ..++++|||+.+++|.+++....                   ....+++..++.++.|++.||+|||+++  ++||||||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p  158 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT  158 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence            99999999999999999985321                   1124678889999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 009291          396 PNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP  472 (538)
Q Consensus       396 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~  472 (538)
                      +||++++++.++|+|||++.......  ........+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999987543221  11122334667999999998899999999999999999997 8889988777


Q ss_pred             HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      .+....+. .......+..++.++.+||.+||+.+|++|||+.|+++.|++
T Consensus       239 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 EEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            66665553 333445567889999999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=336.50  Aligned_cols=248  Identities=27%  Similarity=0.446  Sum_probs=222.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEE--cCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~--~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      +-|.+.+.||+|-|..|-+|++  ++..||||++.+...+...-..+.+|++.|+..+|||||++|++......+|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4688899999999999999976  56679999998888777777789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE-cCCCcEEEEeeCCCccCCCCc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-DSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl-~~~~~vkL~DFGla~~~~~~~  421 (538)
                      +-++|+|++|+-..+.  -+.|+.+.+++.||+.|+.|+|+..  +|||||||+|+.+ .+-|.|||+|||++.....+.
T Consensus        98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            9999999999954333  3889999999999999999999999  9999999999966 577899999999998765443


Q ss_pred             cccCCCCCCCcccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s-~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                       ...+.+|+.-|-|||++.+..|+ +++||||||||||.|.+|+.||+..+..+.+.+|  .......|..++.+.++||
T Consensus       174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI  250 (864)
T KOG4717|consen  174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLI  250 (864)
T ss_pred             -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHH
Confidence             34678999999999999999886 5789999999999999999999999988888777  5667788999999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||..||.+|.+.++|..
T Consensus       251 ~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  251 QSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             HHHHhcCchhhccHHHHhc
Confidence            9999999999999888754

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-38  Score=321.42  Aligned_cols=256  Identities=35%  Similarity=0.580  Sum_probs=213.6

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc-------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +.+.+|.+.++||+|+||.||++...       +..+++|.+...  .....+.+.+|+++++.++|+||+++++++.+.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            45678999999999999999999642       223777776533  345567899999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCC------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDA------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~  402 (538)
                      ...+++|||+.+++|.+++.....            ...+++..++.++.|++.||+|||+.+  ++||||||+||++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~  157 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ  157 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence            999999999999999999864321            134788999999999999999999999  999999999999999


Q ss_pred             CCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 009291          403 TYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAV  479 (538)
Q Consensus       403 ~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i  479 (538)
                      ++.+||+|||++........  ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            99999999999875432211  1122335678999999999999999999999999999998 89999887776666555


Q ss_pred             hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       480 ~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      . .......+..+++.+.++|.+||+.+|++||++++|++.|+
T Consensus       238 ~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 T-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            3 33445667789999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=332.40  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=206.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||+||++++..+  .||+|++..... .....+.+.+|+.+++.++|+||+.+++++.++..+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4799999999999999999998654  499999875332 2334566889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+|+|.+++...  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999998642  234889999999999999999999999  9999999999999999999999999987543322


Q ss_pred             c-ccCCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCC---CC
Q 009291          422 I-SSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK---NV  492 (538)
Q Consensus       422 ~-~~~~~~gt~~Y~aPE~l~~-----~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~---~~  492 (538)
                      . ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||...+..+....+........++.   .+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence            1 1223468999999999863     4578899999999999999999999998777666555543333333333   47


Q ss_pred             cHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEI--RPSFPSIMET  520 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~--RPs~~eIl~~  520 (538)
                      ++.+.+||++||+.++++  |+++.++++.
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            899999999999764443  7888888765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-38  Score=329.12  Aligned_cols=266  Identities=32%  Similarity=0.579  Sum_probs=222.0

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcC---------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEee
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM  328 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~---------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~  328 (538)
                      .+++...+|++++.||+|+||.||+|.+.+         ..+|+|++... ......+.+.+|+.+++++ +|+||++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            466777889999999999999999997532         13788876543 3445567899999999999 799999999


Q ss_pred             ceeccCCcceEEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCC
Q 009291          329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS  395 (538)
Q Consensus       329 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp  395 (538)
                      +++......++++||+++++|.+++....             ....++...+..++.|++.||+|||++|  ++||||||
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp  162 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAA  162 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecccccc
Confidence            99999999999999999999999985421             1234777888999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEEeeCCCccCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 009291          396 PNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP  472 (538)
Q Consensus       396 ~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~  472 (538)
                      +||+++.++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++ |..||...+.
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999999998765432111  122334567999999999999999999999999999998 8899988877


Q ss_pred             HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .+....+. .......+..++.++.++|.+||..+|++|||+.++++.|+++...+
T Consensus       243 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         243 EELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            66665553 33455667788999999999999999999999999999999998554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-39  Score=324.73  Aligned_cols=259  Identities=34%  Similarity=0.519  Sum_probs=210.3

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCC----------------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCcee
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNS----------------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV  325 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~----------------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv  325 (538)
                      +...+|++.+.||+|+||.||++.+.+.                .+|+|.+... ........+.+|++++++++|+||+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence            3456899999999999999999876432                2788887543 3445556799999999999999999


Q ss_pred             EeeceeccCCcceEEEeecCCCChhhhhcCCCC---------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCC
Q 009291          326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA---------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP  396 (538)
Q Consensus       326 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~  396 (538)
                      ++++++......++||||+.+++|.+++.....         ...+++..++.++.|++.||+|||+++  ++||||||+
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~  158 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATR  158 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChh
Confidence            999999999999999999999999999854321         123678889999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCH
Q 009291          397 NLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTP  472 (538)
Q Consensus       397 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt--g~~Pf~~~~~  472 (538)
                      ||++++++.+||+|||++........  ......++..|+|||.+.+..++.++||||||+++|+|++  +..||...+.
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            99999999999999999876433211  1122345678999999998889999999999999999998  6788988776


Q ss_pred             HHHHHHHhh------cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          473 SQVISAVGF------KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       473 ~~~~~~i~~------~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      .+....+..      .......+..+++.+.+||.+||..+|++|||+++|++.|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            655443321      111223455678999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-38  Score=320.63  Aligned_cols=251  Identities=33%  Similarity=0.510  Sum_probs=202.9

Q ss_pred             eeEEEEEccCCcEEEEEEEEc------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--Ccce
Q 009291          267 LLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLS  338 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~~~  338 (538)
                      |++.+.||+|+||+||++...      +..+|+|++.... .......+.+|++++++++||||+++++++...  ..++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            488999999999999887532      3348999886543 233456788999999999999999999987553  4588


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ++|||+.+++|.+++...    .+++..++.++.|++.||+|||+++  |+||||||+||++++++.+||+|||++....
T Consensus        85 lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccC
Confidence            999999999999998642    4899999999999999999999999  9999999999999999999999999988654


Q ss_pred             CCccc---cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHHHhh
Q 009291          419 NTYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--------------VISAVGF  481 (538)
Q Consensus       419 ~~~~~---~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~--------------~~~~i~~  481 (538)
                      .....   .....++..|+|||.+.+..++.++||||||+++|||++|..||.......              .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            32211   122345667999999988889999999999999999999999986533210              0011111


Q ss_pred             cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       482 ~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      .....+.+..++.++.+++.+||+.+|++|||++++++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            2223445677899999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.4e-39  Score=321.62  Aligned_cols=250  Identities=27%  Similarity=0.441  Sum_probs=204.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||.||+|++..+  .+|+|++....  ......+.+|+.++++++|+||+++++++..+..+++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            46799999999999999999997544  48999886543  233456789999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.++++..   ..+++..+..++.|++.||+|||+.+  |+||||||+||++++++.+||+|||++.......
T Consensus        86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          86 EYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999999988643   35789999999999999999999999  9999999999999999999999999998654332


Q ss_pred             cccCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc---cCCCCCCcHH
Q 009291          422 ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---LEIPKNVNPM  495 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~---~~~p~~~s~~  495 (538)
                      .......++..|+|||.+.   ...++.++|||||||++|||++|+.||....+......+......   ...+..++..
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence            2233456888999999884   345788999999999999999999999765544332222111111   1122357899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +.+||++||+.+|++|||+++|++.
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcC
Confidence            9999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4e-39  Score=332.68  Aligned_cols=238  Identities=23%  Similarity=0.389  Sum_probs=198.9

Q ss_pred             EEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||+||+|++..+  .+|+|++..... .....+.+.+|+.++.++ +|+||+.+++++.+...+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999988654  499999876543 234566788999999888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      ++|..++...   ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++............
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            9999888633   35899999999999999999999999  999999999999999999999999998753322223345


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST------PSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~------~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                      ..||..|+|||.+.+..++.++|||||||++|||++|..||....      ..+...... ......+|..++..+.++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~li  234 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-LEKPIRIPRFLSVKASHVL  234 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-HhCCCCCCCCCCHHHHHHH
Confidence            678999999999999999999999999999999999999996321      112222221 3345567888999999999


Q ss_pred             HHhhhcCCCCCCCH
Q 009291          501 ETCWAEEPEIRPSF  514 (538)
Q Consensus       501 ~~cL~~dP~~RPs~  514 (538)
                      .+||+.||++|+++
T Consensus       235 ~~~L~~dP~~R~~~  248 (327)
T cd05617         235 KGFLNKDPKERLGC  248 (327)
T ss_pred             HHHhccCHHHcCCC
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=317.93  Aligned_cols=259  Identities=31%  Similarity=0.550  Sum_probs=218.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCC------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      +...+|++.+.||+|+||+||+|.+..+      .+|+|...... .......+.+|+.++++++|+||+++++++.. .
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            4457899999999999999999987532      27888765443 34556788999999999999999999999887 7


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..++||||+.+|+|.+++....  ..+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccc
Confidence            7899999999999999986543  24889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          416 SKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       416 ~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      ........  .....++..|+|||.+....++.++||||||+++||+++ |..||......+....+. .......|..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPIC  236 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCC
Confidence            65432211  112223568999999988889999999999999999998 999999888776665554 44456667778


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      +..+.+++.+||..+|.+||++.++++.|.++.+.
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            89999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.7e-39  Score=345.03  Aligned_cols=248  Identities=25%  Similarity=0.350  Sum_probs=195.7

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-----
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----  334 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-----  334 (538)
                      ....+|++++.||+|+||+||+|.+..  ..||||++....      ....+|+.+++.++|+||+++++++...     
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            345689999999999999999998864  449999875432      1234799999999999999998876332     


Q ss_pred             ---CcceEEEeecCCCChhhhhcC-CCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-cEEEE
Q 009291          335 ---PNLSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVC  409 (538)
Q Consensus       335 ---~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-~vkL~  409 (538)
                         ..+++||||+++ +|.+++.. ......+++..++.++.||+.||+|||+++  |+||||||+|||++.++ .+||+
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence               236789999975 67666532 223346889999999999999999999999  99999999999998654 79999


Q ss_pred             eeCCCccCCCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-C----
Q 009291          410 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-G----  483 (538)
Q Consensus       410 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~----  483 (538)
                      |||+|+...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....+... +    
T Consensus       214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            999998654332 22345789999999998764 6899999999999999999999999887665444332110 0    


Q ss_pred             ----------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 ----------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ----------------------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                            .+..+|...++++.+||.+||+.+|++|||+.+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                                  011234567889999999999999999999999973

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-38  Score=322.72  Aligned_cols=258  Identities=34%  Similarity=0.546  Sum_probs=209.0

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC----------------C--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCce
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN----------------S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI  324 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnI  324 (538)
                      ..++|++.+.||+|+||.||++++.+                +  .+|+|++.... .....+.+.+|+.+++.++|+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence            34679999999999999999986432                1  27888876442 34455789999999999999999


Q ss_pred             eEeeceeccCCcceEEEeecCCCChhhhhcCCCC--------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCC
Q 009291          325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA--------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP  396 (538)
Q Consensus       325 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~  396 (538)
                      +++++++......+++|||+.+++|.+++.....        ...+++..++.++.|++.||+|||+++  ++||||||+
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~  159 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATR  159 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChh
Confidence            9999999999999999999999999999854221        124677889999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCH
Q 009291          397 NLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTP  472 (538)
Q Consensus       397 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt--g~~Pf~~~~~  472 (538)
                      ||+++.++.++|+|||+++.......  ......++..|+|||...+..++.++|||||||++|||++  |..||...+.
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            99999999999999999875432211  1122334678999999888889999999999999999998  7789987766


Q ss_pred             HHHHHHHhh------cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          473 SQVISAVGF------KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       473 ~~~~~~i~~------~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      .+.......      .....+.+..+++.+.+||.+||+.||++||++.+|++.|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            554432211      112234456788999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-38  Score=318.49  Aligned_cols=257  Identities=32%  Similarity=0.536  Sum_probs=215.0

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ..++|++.+.||+|+||.||+|+.+.       ..+++|.+.... .....+.+.+|+.++++++|+||+++++++.+..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            34689999999999999999998642       238888765432 2335678999999999999999999999999989


Q ss_pred             cceEEEeecCCCChhhhhcCCCCC------ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDAR------VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                      ..++||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEc
Confidence            999999999999999999644322      15889999999999999999999999  9999999999999999999999


Q ss_pred             eeCCCccCCCC-ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccC
Q 009291          410 DFGLSRSKPNT-YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLE  487 (538)
Q Consensus       410 DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~  487 (538)
                      |||++...... ........++..|+|||.+.+..++.++||||||+++|++++ |..||...........+........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP  239 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence            99998653322 112233455778999999988888999999999999999998 7889987777666666544444455


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       488 ~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      .+..++..+.++|.+||+.+|++|||+.++++.|.
T Consensus       240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            66778999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-38  Score=315.06  Aligned_cols=249  Identities=37%  Similarity=0.634  Sum_probs=212.0

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ...+|++.+.||+|+||.||++...+..+|+|......    ..+.+.+|+.++++++|+||+++++++..+ ..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            44679999999999999999999888889999975432    235788999999999999999999998664 4799999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.+++|.+++.... ...+++..++.++.|++.||.|||+.|  ++||||||+||+++.++.+||+|||++....... 
T Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          79 LMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            999999999986433 235788999999999999999999999  9999999999999999999999999987643321 


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                        .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+. ...+...+..+++.+.++|.
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  231 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMT  231 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHH
Confidence              22334568999999988889999999999999999997 999998887766655553 33455566778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHH
Q 009291          502 TCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       502 ~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      +||+.+|++||+++++++.|++
T Consensus       232 ~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         232 SCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHcCCChhhCcCHHHHHHHHcc
Confidence            9999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.3e-38  Score=313.46  Aligned_cols=250  Identities=29%  Similarity=0.502  Sum_probs=215.7

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||++....  ..+++|.+..........+.+.+|+.++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            58899999999999999998754  4499999876655556667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +.+++|.+++.... ...+++..++.++.|++.||.|||+++  ++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            99999999886432 224788999999999999999999999  999999999999999999999999999765543333


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      .....|+..|+|||.+.+...+.++|+||||+++|+|++|..||......+....+. .+.....+..++..+.++|.+|
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~  236 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQL  236 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHH
Confidence            334568889999999998889999999999999999999999998877766665553 3334456678899999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 009291          504 WAEEPEIRPSFPSIME  519 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~  519 (538)
                      |+.+|++||++.++++
T Consensus       237 l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         237 FKRNPRDRPSVNSILE  252 (256)
T ss_pred             hhCChhhCcCHHHHhh
Confidence            9999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8e-39  Score=336.04  Aligned_cols=249  Identities=24%  Similarity=0.381  Sum_probs=202.5

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC-----cce
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-----NLS  338 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~-----~~~  338 (538)
                      +|++++.||+|+||.||++.+.  ++.||+|++..........+.+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999875  445999988654444455678899999999999999999999998776     789


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+. ++|.+.+...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999996 5777777532   35889999999999999999999999  9999999999999999999999999998643


Q ss_pred             CCc-cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--------------
Q 009291          419 NTY-ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--------------  482 (538)
Q Consensus       419 ~~~-~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~--------------  482 (538)
                      ... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+...              
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            321 112334678899999998874 4789999999999999999999999887765544332110              


Q ss_pred             ---------Ccc-------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          483 ---------GRR-------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       483 ---------~~~-------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                               ...       ..+....++++.+||.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                     000       12234568899999999999999999999999763

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=340.06  Aligned_cols=263  Identities=34%  Similarity=0.582  Sum_probs=227.4

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcC----Cc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN----SD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~----~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      ++++.....++.+.||.|.||.||+|....    ..  ||||.-+... +.+..+.|+.|..+|+.++||||++++|++.
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~  461 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCV  461 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence            455666777778899999999999997643    22  7777765543 4445789999999999999999999999998


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      +. ..++|||+++-|.|..+|+.+..  .++......+++||+.||+|||+++  +|||||..+|||+....-|||+|||
T Consensus       462 e~-P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  462 EQ-PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             cc-ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccc
Confidence            75 47999999999999999986553  5888899999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCccc-cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCC
Q 009291          413 LSRSKPNTYIS-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       413 la~~~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  490 (538)
                      +++...+.... .....-+..|||||.+.-..++.++|||.|||++||++. |..||.+..+.+++-.+ ..+.|++.|+
T Consensus       537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P~  615 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCPP  615 (974)
T ss_pred             hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCCC
Confidence            99987654322 233345779999999999999999999999999999987 89999998877766555 3788999999


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +||+.++.|+.+||..+|.+||.+.+|...|.++++.+
T Consensus       616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999999988733

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.9e-39  Score=332.53  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=208.1

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||+||++++..++  ||+|++..... .......+.+|..++..++|+||+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999987544  99999865322 2334456888999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+|+|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999996432  35889999999999999999999999  9999999999999999999999999987654322


Q ss_pred             c-ccCCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCC---CC
Q 009291          422 I-SSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK---NV  492 (538)
Q Consensus       422 ~-~~~~~~gt~~Y~aPE~l~~-----~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~---~~  492 (538)
                      . ......||..|+|||++.+     ..++.++|||||||++|+|++|+.||...+..+....+.....+.++|.   .+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence            1 2233568999999999875     4578899999999999999999999998877766666654444454554   46


Q ss_pred             cHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEI--RPSFPSIMET  520 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~--RPs~~eIl~~  520 (538)
                      ++++.++|.+||+.++++  |++++++++.
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            899999999999976654  4678777643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.8e-38  Score=314.33  Aligned_cols=256  Identities=32%  Similarity=0.576  Sum_probs=214.6

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +++..++|++.+.||+|+||.||++.+.+ ..+++|.+...   ....+.+.+|+.++++++|+||+++++++.+ ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            35667889999999999999999998654 44888887543   2334678899999999999999999999887 7789


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            9999999999999986432 235788889999999999999999999  9999999999999999999999999987654


Q ss_pred             CCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          419 NTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       419 ~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      .... ......++..|+|||.+....++.++|+||||+++|++++ |..||...+.......+. .....+.+...+.++
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  232 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEEL  232 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHH
Confidence            3221 1122345677999999998889999999999999999998 899998877666655443 334455667789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      .+++.+||+.+|++||++.++++.|++
T Consensus       233 ~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         233 YNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.6e-39  Score=331.57  Aligned_cols=252  Identities=24%  Similarity=0.374  Sum_probs=208.4

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||+||++++++++  +|+|++.+... .......+.+|+.++..++|+||+++++.+.++..+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36899999999999999999987544  89999865322 2333456888999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC-
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-  420 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~-  420 (538)
                      ||+.+|+|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++...... 
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            9999999999996432  34889999999999999999999999  999999999999999999999999998754322 


Q ss_pred             ccccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCC---CC
Q 009291          421 YISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK---NV  492 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~---~~  492 (538)
                      ........||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+.....+..+|.   .+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence            11223457899999999986     34578899999999999999999999998887777766654444444443   57


Q ss_pred             cHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEI--RPSFPSIMET  520 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~--RPs~~eIl~~  520 (538)
                      ++++.+||++||+.++.+  |+++.++++.
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            899999999999765555  5888888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.8e-38  Score=319.41  Aligned_cols=251  Identities=22%  Similarity=0.294  Sum_probs=207.9

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      .|+..+.||+|+||+||++.+..+  .+|+|.+....... .....+.+|+++++.++|+||+.+.+.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            367889999999999999988644  49999886554332 234567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.+++|.+++.... ...+++..+..++.|++.||.|||+++  |+||||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            999999998885432 235899999999999999999999999  9999999999999999999999999987643321 


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh--cCcccCCCCCCcHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF--KGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~s~~l~~LI  500 (538)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..  ......++..++.++.+|+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            12345789999999999988899999999999999999999999987765443332221  2223345677899999999


Q ss_pred             HHhhhcCCCCCCC-----HHHHHHH
Q 009291          501 ETCWAEEPEIRPS-----FPSIMET  520 (538)
Q Consensus       501 ~~cL~~dP~~RPs-----~~eIl~~  520 (538)
                      .+||+.||++||+     +.+++..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcC
Confidence            9999999999999     7777664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.7e-38  Score=312.94  Aligned_cols=252  Identities=35%  Similarity=0.623  Sum_probs=212.1

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..++|++.+.||+|+||.||++.+. ++.+|+|.+.......   ..+.+|++++++++||||+++++++......+++|
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            3468999999999999999999876 4559999876544333   36888999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+++|.+++....  ..+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          79 EFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            9999999999986432  34788999999999999999999999  9999999999999999999999999987654322


Q ss_pred             cc-cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          422 IS-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       422 ~~-~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      .. .....++..|+|||.+.+..++.++||||||+++|||++ |..||...........+. ...+...+...+..+.+|
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  233 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYEL  233 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCCCCCCCCCCHHHHHH
Confidence            11 122334678999999998889999999999999999998 999998877766666553 233444566678999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      +.+||+.+|++|||+.++++.|+
T Consensus       234 ~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         234 MQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHHcccChhhCCCHHHHHHhhC
Confidence            99999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9e-39  Score=321.76  Aligned_cols=242  Identities=23%  Similarity=0.323  Sum_probs=195.1

Q ss_pred             EccCCcEEEEEEEEcC--CceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCCh
Q 009291          273 IGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL  349 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  349 (538)
                      ||+|+||.||+++...  ..+|+|++....... .....+..|++++++++||||+++++++.++..+++||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6999999999998764  449999886543322 2234566799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCC
Q 009291          350 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG  429 (538)
Q Consensus       350 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~g  429 (538)
                      .+++.... ...+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||++....... ......|
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~  156 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAG  156 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCC
Confidence            98875432 234788899999999999999999999  9999999999999999999999999987654432 2234568


Q ss_pred             CCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh--cCcccC-CCCCCcHHHHHHHHHhhhc
Q 009291          430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF--KGRRLE-IPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       430 t~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~--~~~~~~-~p~~~s~~l~~LI~~cL~~  506 (538)
                      +..|+|||++.+..++.++|||||||++|||++|+.||...........+..  ...... ....+++++.+||.+||+.
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            9999999999998899999999999999999999999976543211111111  111112 2246789999999999999


Q ss_pred             CCCCCCCHHHHH
Q 009291          507 EPEIRPSFPSIM  518 (538)
Q Consensus       507 dP~~RPs~~eIl  518 (538)
                      ||++||++.+++
T Consensus       237 ~P~~R~~~~~~~  248 (277)
T cd05607         237 KPEDRLGSREKN  248 (277)
T ss_pred             CHhhCCCCccch
Confidence            999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-38  Score=319.59  Aligned_cols=247  Identities=28%  Similarity=0.498  Sum_probs=206.4

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      |++.+.||+|+||.||++.+..++  +++|.+...  .....+.+.+|+++++.++|+||+++++++..+...++|+||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            577889999999999999987655  666666433  3455678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS  424 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~  424 (538)
                      .+++|..++...  ...+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++..........
T Consensus        85 ~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          85 AGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            999998887532  235889999999999999999999999  9999999999999999999999999987654433333


Q ss_pred             CCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-CcccCCCCCCcHHHHH
Q 009291          425 KTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAA  498 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~~  498 (538)
                      ....++..|+|||.+.     +..++.++|||||||++|+|++|+.||...+..+....+... ......+..++.++.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence            4456899999999984     345778999999999999999999999887765555444222 2233456678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ||.+||+.+|++||++.++++
T Consensus       241 li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            999999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-38  Score=314.78  Aligned_cols=247  Identities=37%  Similarity=0.613  Sum_probs=210.9

Q ss_pred             EEEccCCcEEEEEEEEcC---C--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecC
Q 009291          271 KKIGEGSFGTVYHAEWRN---S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~---~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  345 (538)
                      +.||+|++|.||+|.+..   +  .+|+|.+...... ...+.+.+|+.++++++|+||+++++++.+ ..++++|||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            368999999999998753   2  3788988665543 566789999999999999999999999888 88999999999


Q ss_pred             CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc---
Q 009291          346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI---  422 (538)
Q Consensus       346 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~---  422 (538)
                      +++|.+++..... ..+++..++.++.|++.||+|||+++  ++|+||||+||+++.++.+||+|||++........   
T Consensus        79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            9999999865432 35889999999999999999999999  99999999999999999999999999986543211   


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.........+..++..+.+++.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML  235 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence            1123456788999999998899999999999999999998 999998888777666665445555566778999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHH
Q 009291          502 TCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       502 ~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      +||+.+|++|||+.++++.|.
T Consensus       236 ~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         236 QCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHCCCCcccCCCHHHHHHHhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-40  Score=350.42  Aligned_cols=263  Identities=35%  Similarity=0.584  Sum_probs=236.0

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC--C---ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN--S---DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~---~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      .+|..+..+|.+.||.|.||.|++|+.+-  +   .||||.++.. ..++....|+.|..||-+++||||+++.|+....
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            46788889999999999999999998762  2   2999998654 4677788999999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ...+||+|||++|+|..||+..+  +.+..-+...|.+.|+.|++||-+++  +|||||..+|||++.+...|++|||++
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccce
Confidence            99999999999999999998665  45888889999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCccccC-CCCC--CCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCC
Q 009291          415 RSKPNTYISSK-TAAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       415 ~~~~~~~~~~~-~~~g--t~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  490 (538)
                      +...+...... +..|  ..+|.|||.+...+++.+|||||+|+++||.++ |..||..+++++++.++. .+.|++.|.
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPm  857 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPM  857 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCC
Confidence            98755432222 2222  578999999999999999999999999999886 999999999999999985 788999999


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +||..+.+||..||++|-.+||.|.||+..|.+++.+-
T Consensus       858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            99999999999999999999999999999999999653

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.5e-38  Score=312.05  Aligned_cols=251  Identities=29%  Similarity=0.482  Sum_probs=214.1

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc--CCcceEEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIVT  341 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--~~~~~lV~  341 (538)
                      +|++.+.||.|+||.||++.+..+  .+++|++..........+.+.+|+++++.++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            488999999999999999987644  48999887766666777889999999999999999999997753  45579999


Q ss_pred             eecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHH-----hCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          342 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLH-----QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       342 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ||+++++|.+++... .....+++..++.++.|++.||+|||     +.+  ++|+||||+||+++.++.+||+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence            999999999998542 22346889999999999999999999     888  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      .............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+. ......++..++..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  237 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSE  237 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHH
Confidence            76554332345578999999999998889999999999999999999999999887655555443 33334567788999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.+++.+||+.+|++||++.+|++
T Consensus       238 ~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         238 LNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhh
Confidence            999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-38  Score=320.88  Aligned_cols=249  Identities=27%  Similarity=0.326  Sum_probs=197.2

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcC---CCCceeEeeceecc-----CC
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVTE-----PP  335 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~~-----~~  335 (538)
                      +|++.+.||+|+||+||+|++..+  .+|+|.+............+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            588999999999999999998754  499998865433322223455677777655   79999999998754     34


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .++++|||+.+ +|.+++.... ...+++..+..++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999975 8888875432 234889999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC---------cc-
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG---------RR-  485 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~---------~~-  485 (538)
                      ...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+....         .. 
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            654322 2234567899999999999899999999999999999999999998776655443332100         00 


Q ss_pred             ---------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ---------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ---------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                     ....+.+++.+.++|.+||+.||++|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                           0112356788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=313.65  Aligned_cols=249  Identities=30%  Similarity=0.510  Sum_probs=209.7

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||+|+||.||+|.+..  ..+++|++.....  ...+.+.+|+.++++++||||+++++++.+...++++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            579999999999999999998764  4499999876532  356788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.+++|.+++....  ..+++..++.++.|++.||+|||+++  ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          81 YCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            999999999886432  35889999999999999999999999  99999999999999999999999999876544322


Q ss_pred             ccCCCCCCCcccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc---ccCCCCCCcHHH
Q 009291          423 SSKTAAGTPEWMAPEVLRED---PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---RLEIPKNVNPMV  496 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~---~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~---~~~~p~~~s~~l  496 (538)
                      ......++..|+|||.+.+.   .++.++||||||+++|+|++|..||...........+.....   ....+..++.++
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence            23445678899999999776   789999999999999999999999988776555444432211   122334567889


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .++|++||..+|.+|||+.+|+.
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhc
Confidence            99999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-38  Score=317.70  Aligned_cols=242  Identities=29%  Similarity=0.446  Sum_probs=200.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||+|.+..+  .+|+|++.... .......+.+|+.++++++||||+++++++......++||||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            678899999999999999987644  49999886543 344456799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            9999997653       3678889999999999999999999  9999999999999999999999999997654332  


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhhcCcccCC-CCCCcHH
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-------QVISAVGFKGRRLEI-PKNVNPM  495 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-------~~~~~i~~~~~~~~~-p~~~s~~  495 (538)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......       .....+. ....... ....+++
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  228 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEK  228 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHH
Confidence            23457899999999999988999999999999999999999999653321       1111111 1111222 3457889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +.++|.+||+.+|++||+++++++.
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHHhcC
Confidence            9999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-38  Score=331.47  Aligned_cols=248  Identities=26%  Similarity=0.339  Sum_probs=200.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC------C
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~------~  335 (538)
                      .++|++.+.||+|+||.||++.+..  ..+|+|++..........+.+.+|+.+++.++|+||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            4789999999999999999998754  4599999876555556667888999999999999999999987543      3


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..++||||+.+ +|...+..     .+++..+..++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccc
Confidence            47999999976 56665532     3778889999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------  482 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-------------  482 (538)
                      ...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||......+....+...             
T Consensus       168 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         168 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             cCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            654432 223457899999999999999999999999999999999999999876643332211100             


Q ss_pred             --------C----ccc---------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          483 --------G----RRL---------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       483 --------~----~~~---------------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                              .    ...               ..+...+.++.+||.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                    0    000               0112245678999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.5e-38  Score=313.20  Aligned_cols=250  Identities=33%  Similarity=0.586  Sum_probs=202.9

Q ss_pred             EEEccCCcEEEEEEEEcC-----CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec-cCCcceEEEeec
Q 009291          271 KKIGEGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-EPPNLSIVTEYL  344 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~-----~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~-~~~~~~lV~E~~  344 (538)
                      +.||+|+||.||+|.+..     ..+|+|.+... ......+.+.+|+.+++.++||||+++++++. .+...+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            368999999999998643     23888876432 23455678889999999999999999999765 455689999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc---
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY---  421 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~---  421 (538)
                      .+++|.+++.....  ..++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++......   
T Consensus        80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999999864322  3567778889999999999999999  9999999999999999999999999987543221   


Q ss_pred             -cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          422 -ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       422 -~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                       .......++..|+|||.+.+..++.++||||||+++|||++| ..||...+..+....+. .......+..+++.+.++
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  234 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEV  234 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHH
Confidence             111233456789999999888899999999999999999995 56677666655554442 334455566788999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 009291          500 IETCWAEEPEIRPSFPSIMETLQQFLM  526 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~L~~il~  526 (538)
                      +.+||..+|++||++.++++.|++++.
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.3e-38  Score=319.45  Aligned_cols=250  Identities=28%  Similarity=0.494  Sum_probs=208.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .+.|++++.||+|+||.||+|++..+  .+++|++...  .....+.+.+|+.+++.++|+||+++++.+..+..+++||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            46799999999999999999998654  4888887543  4555678899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|..++....  ..+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++.......
T Consensus        89 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          89 EFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             ecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            9999999988875332  24889999999999999999999999  9999999999999999999999999987644333


Q ss_pred             cccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cccCCCCCCcHH
Q 009291          422 ISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPM  495 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~  495 (538)
                      .......++..|+|||.+.     ...++.++|||||||++|+|++|..||...+.......+.... .....+..++..
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME  244 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence            2334456788999999985     3456889999999999999999999998876655444442221 123345678899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.++|.+||+.+|++||++.++++
T Consensus       245 ~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         245 FRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhc
Confidence            999999999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.2e-38  Score=320.97  Aligned_cols=248  Identities=27%  Similarity=0.455  Sum_probs=209.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..+|++.+.||+|+||.||+|.+..  ..+++|.+......  ..+.+.+|+.+++.+.|+||+++++.+..+...++||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            3589999999999999999998754  44899988765433  2357889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++...    .+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++.......
T Consensus        97 e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             cccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            999999999998532    3788899999999999999999999  9999999999999999999999999987644332


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-cCcccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-KGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~s~~l~~LI  500 (538)
                      .......++..|+|||.+.+..++.++|||||||++|+|++|+.||.............. .......+..++..+.++|
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (296)
T cd06654         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (296)
T ss_pred             cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHH
Confidence            223345788999999999988899999999999999999999999987776444333221 1223344567889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||..+|++||++.++++
T Consensus       251 ~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         251 NRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HHHCcCCcccCcCHHHHhh
Confidence            9999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-38  Score=317.27  Aligned_cols=250  Identities=26%  Similarity=0.418  Sum_probs=204.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP------  334 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~------  334 (538)
                      .+.|++.+.||+|+||.||+|.+.++  .+|+|++.....   ....+.+|+.+++++ +|+||+++++++...      
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35678889999999999999988654  489998865432   234678899999998 799999999998643      


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ..++++|||+.+++|.+++.... ...+++..+..++.|++.||+|||+++  |+|+||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            45899999999999999986432 235889999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCCccccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP  489 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p  489 (538)
                      ..............|+..|+|||++.     ...++.++|||||||++|||++|..||.................+...+
T Consensus       159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06637         159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  238 (272)
T ss_pred             eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence            76543333334567899999999986     3457889999999999999999999998766655544443333333344


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..++..+.+||.+||..+|.+|||+.++++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            568899999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-38  Score=314.27  Aligned_cols=248  Identities=31%  Similarity=0.548  Sum_probs=208.5

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC-------HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-------~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      +|.+.+.||+|+||.||+|.+..  ..+|+|.+......       ....+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            46788999999999999998754  45999987654322       1234678899999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .+++|||+++++|.+++...   ..+++..+..++.|++.||+|||+++  ++||||+|+||++++++.++|+|||.++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999999643   35788999999999999999999999  99999999999999999999999999876


Q ss_pred             CCCCcc------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCC
Q 009291          417 KPNTYI------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       417 ~~~~~~------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~  490 (538)
                      ......      ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+. ......++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~  234 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPS  234 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCc
Confidence            542111      1122357889999999998889999999999999999999999998776555444432 234456677


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .++..+.++|++||+.+|++||++.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         235 NISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            88999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=317.42  Aligned_cols=247  Identities=30%  Similarity=0.498  Sum_probs=211.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||.|+||.||+|.+..+  .+++|++.... .......+.+|+++++.++|+||+++++++.++..+++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            3688899999999999999988644  49999886543 33445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+++++|.+++...    .+++..++.++.|++.||.|||+++  ++|+||+|+||++++++.++|+|||+++.......
T Consensus        80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            99999999998643    5889999999999999999999999  99999999999999999999999999987654433


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCC-CcHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN-VNPMVAALIE  501 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~s~~l~~LI~  501 (538)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. ......+.. ++..+.+++.
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~  232 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEGNKFSKPFKDFVS  232 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcccccCHHHHHHHH
Confidence            33455688899999999988899999999999999999999999988776555544432 223333444 8899999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 009291          502 TCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       502 ~cL~~dP~~RPs~~eIl~  519 (538)
                      +||..+|++|||++++++
T Consensus       233 ~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         233 LCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HHhhCChhhCcCHHHHhh
Confidence            999999999999999965

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=333.55  Aligned_cols=240  Identities=27%  Similarity=0.424  Sum_probs=198.0

Q ss_pred             EccCCcEEEEEEEEcC--CceEEEEEeccccC-HHHHHHHHHHHHHHHcC---CCCceeEeeceeccCCcceEEEeecCC
Q 009291          273 IGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGL---RHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      ||+|+||+||+|++..  ..||+|++...... ......+..|..++...   +||||+.+++++.+...+++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            6999999999998864  44999998654332 23344556677777655   699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      |+|..++...   ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++............
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            9999888643   35889999999999999999999999  999999999999999999999999998764333333345


Q ss_pred             CCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC-CCCcHHHHHHHHHhh
Q 009291          427 AAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPMVAALIETCW  504 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~s~~l~~LI~~cL  504 (538)
                      ..||..|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.....  .++ ..+++++.+||++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~~L  233 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFPKNVLSDEGRQFVKGLL  233 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHc
Confidence            6799999999998764 478999999999999999999999998887776666643333  333 347899999999999


Q ss_pred             hcCCCCCC----CHHHHHH
Q 009291          505 AEEPEIRP----SFPSIME  519 (538)
Q Consensus       505 ~~dP~~RP----s~~eIl~  519 (538)
                      +.||++||    ++.++++
T Consensus       234 ~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhc
Confidence            99999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-38  Score=318.07  Aligned_cols=249  Identities=27%  Similarity=0.442  Sum_probs=204.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||.||+|.+.+  ..+|+|++....  ......+.+|+.+++.++||||+++++.+.....++++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            3578888999999999999998864  448999886543  233456788999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++...   ..+++..++.++.|++.||+|||+.|  ++|+||||+||+++.++.+||+|||++.......
T Consensus        86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          86 EFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            999999999998643   35889999999999999999999999  9999999999999999999999999987654433


Q ss_pred             cccCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC---CCCCCcHH
Q 009291          422 ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE---IPKNVNPM  495 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~---~p~~~s~~  495 (538)
                      .......|+..|+|||.+.   ...++.++|||||||++|+|++|..||....+...............   ....++..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS  240 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence            3334557899999999974   45578999999999999999999999976655443333221211111   12257789


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.++|.+||..+|++||++++|++
T Consensus       241 ~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         241 FHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhc
Confidence            999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.4e-38  Score=318.92  Aligned_cols=250  Identities=28%  Similarity=0.506  Sum_probs=208.9

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++++.||+|+||.||++.+.  +..+|+|.+... ........+.+|+.++++++|+||+++++.+..+..+++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            36889999999999999999986  444999987654 244556789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |+++++|..++........+++..+..++.|++.||.|||+ .+  ++||||||+||+++.++.+||+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999988654333468999999999999999999996 58  9999999999999999999999999987653322


Q ss_pred             cccCCCCCCCcccccccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hcCcccCCCCCCc
Q 009291          422 ISSKTAAGTPEWMAPEVLREDP------SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVN  493 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~------~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~s  493 (538)
                        .....++..|+|||.+.+..      ++.++|||||||++|+|++|+.||...........+.  .......++..++
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS  235 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence              23456788999999986543      4789999999999999999999997765544333322  1233455677799


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +++.+||.+||+.+|++||++.+++.
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         236 DDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhc
Confidence            99999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3e-38  Score=330.58  Aligned_cols=248  Identities=26%  Similarity=0.320  Sum_probs=201.2

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC------C
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~------~  335 (538)
                      .++|++.+.||+|+||.||++.+..  ..+|||++..........+.+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            4689999999999999999998764  4499999876554555567888999999999999999999987543      3


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+||||+.+ +|...+..     .+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            47999999975 67666642     3778889999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-----------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-----------  484 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-----------  484 (538)
                      ...... ......+|..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.....           
T Consensus       175 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         175 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             ccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            654432 22345789999999999999999999999999999999999999987765544333211000           


Q ss_pred             ---------cc--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          485 ---------RL--------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       485 ---------~~--------------------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                               +.                    ......+..+.+||.+||+.||++|||++++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                     00                    0011134678999999999999999999999773

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.6e-38  Score=316.78  Aligned_cols=250  Identities=27%  Similarity=0.405  Sum_probs=204.4

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||+|+||.||+|.+..  ..+|+|++..........+.+.+|+.++++++|+||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            368999999999999999998864  459999886554333334568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+++++|..+....   ..+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99998888876533   24889999999999999999999999  99999999999999999999999999987654432


Q ss_pred             ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC------------------
Q 009291          423 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------------  483 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~------------------  483 (538)
                      ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+....                  
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            2334567889999999876 457899999999999999999999998776654443321100                  


Q ss_pred             -cccCC----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 -RRLEI----------PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 -~~~~~----------p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       ...+.          -..++..+.+||.+||+.+|++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             00000          1246788999999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-38  Score=334.86  Aligned_cols=245  Identities=23%  Similarity=0.284  Sum_probs=194.9

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      .+....|++.+.||+|+||.||++.+..++  ||+|...        ...+.+|++++++++||||+++++++......+
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            355678999999999999999999986544  8888642        235678999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +|+|++. ++|..++...   ..+++..++.++.|++.||+|||+++  ||||||||+|||++.++.+||+|||+|+...
T Consensus       160 lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EEEecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            9999985 6888887533   34788999999999999999999999  9999999999999999999999999997533


Q ss_pred             CCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHh-hc-------
Q 009291          419 NTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-------SQVISAVG-FK-------  482 (538)
Q Consensus       419 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~-------~~~~~~i~-~~-------  482 (538)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|..||.....       ...+..+. ..       
T Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            221 122345799999999999999999999999999999999999987643211       00110000 00       


Q ss_pred             ----------------CcccCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 ----------------GRRLEIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ----------------~~~~~~p---------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                      ......+         ..++.++.+||.+||+.||++|||+.|+++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                            0000000         134678999999999999999999999975

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-39  Score=335.72  Aligned_cols=256  Identities=24%  Similarity=0.371  Sum_probs=213.2

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCCc-eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCC
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP  335 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~  335 (538)
                      +-+.+....|+++++||+||.+.||++...+.. ||+|.+.....+...+..|.+|+..|.+| .|.+|+++++|-..+.
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            446788899999999999999999999876544 88888888888899999999999999999 4999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+||||||-+ .+|..+|+....  .++.-.+..+..||+.|+.++|+.|  |||.||||.|+|+- .|.+||+|||+|.
T Consensus       434 ~lYmvmE~Gd-~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~  507 (677)
T KOG0596|consen  434 YLYMVMECGD-IDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIAN  507 (677)
T ss_pred             eEEEEeeccc-ccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhc
Confidence            9999999864 599999975432  2333478889999999999999999  99999999999995 4699999999998


Q ss_pred             cCCCC--ccccCCCCCCCcccccccccCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhh
Q 009291          416 SKPNT--YISSKTAAGTPEWMAPEVLREDP-----------SNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGF  481 (538)
Q Consensus       416 ~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~-----------~s~ksDVwSLGvil~eLltg~~Pf~~~~~-~~~~~~i~~  481 (538)
                      .....  .....+.+||..||+||++....           .+.++||||||||||+|++|+.||..... ...+.++..
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~  587 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD  587 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence            75543  33456789999999999986432           35789999999999999999999987653 333444544


Q ss_pred             cCcccCCCCCCcH-HHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          482 KGRRLEIPKNVNP-MVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       482 ~~~~~~~p~~~s~-~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ....+++|..-+. ++.++++.||.+||++||++.++|.
T Consensus       588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            4456677765443 3999999999999999999988864

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.5e-38  Score=318.98  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=205.9

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      .|++.+.||+|+||.||++.+..+  .+|+|.+...... ....+.+.+|+.++++++|+||+.+++.+.+.+.+++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            377889999999999999988754  4999988654433 2334567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.+++|.+++.... ...+++..+..++.|++.||.|||+.+  |+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            999999999885332 224889999999999999999999999  9999999999999999999999999987654322 


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......   ....... .......+..+++++.+|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHH
Confidence            123457899999999999989999999999999999999999999865432   1111111 122334567789999999


Q ss_pred             HHHhhhcCCCCCCC-----HHHHHH
Q 009291          500 IETCWAEEPEIRPS-----FPSIME  519 (538)
Q Consensus       500 I~~cL~~dP~~RPs-----~~eIl~  519 (538)
                      |.+||+.||++|||     ++++++
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHc
Confidence            99999999999999     888877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-39  Score=321.24  Aligned_cols=254  Identities=27%  Similarity=0.384  Sum_probs=208.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc-eeEeeceeccCC-----
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPP-----  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~~-----  335 (538)
                      ...|+.+++||+|+||+||+|+.+.++  ||+|++......+..-....+|+.+|++|+|+| |+.+++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            345777888999999999999887554  999998765443333356789999999999999 999999998877     


Q ss_pred             -cceEEEeecCCCChhhhhcCCCCC-ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          336 -NLSIVTEYLSRGSLYKLLHIPDAR-VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       336 -~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                       .+++|+||++. +|..++...... ..++...+..++.||+.||+|||+++  |+||||||.|||++++|.+||+|||+
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence             78999999965 899988644321 23667899999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Cc-------
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR-------  484 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~-------  484 (538)
                      |+...-+........+|..|.|||++.+. .|+..+||||+|||++||++++..|.+....+.+..+-.. +.       
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            99766554445677899999999999887 6899999999999999999999999998886666554311 00       


Q ss_pred             --------ccCCC------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          485 --------RLEIP------------KNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       485 --------~~~~p------------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                              ...++            +..+....+++.+||+.+|.+|.|+..+++.
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                    00111            1222478999999999999999999998775

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=319.87  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=204.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc-----CCcc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-----PPNL  337 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~-----~~~~  337 (538)
                      ..|..++.||+|+||.|+.+.++.++  ||||++...-......+...+|+.+|++++|+||+.+.+++..     -+.+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            45556899999999999999887554  9999987555566777899999999999999999999998865     3458


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+|+|+| +.+|+..++.++   .+++..+.-+++|+++||+|+|+.+  |+||||||.|++++.+..+||+|||+|+..
T Consensus       102 YiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             EEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeec
Confidence            9999999 559999997443   4899999999999999999999999  999999999999999999999999999986


Q ss_pred             CCC--ccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-------------
Q 009291          418 PNT--YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-------------  481 (538)
Q Consensus       418 ~~~--~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~-------------  481 (538)
                      ...  ...-+..+.|.+|.|||.+.. ..|+..+||||+|||+.||++|+..|.+.+....+..+..             
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            431  112245677999999998754 5689999999999999999999999987655333322210             


Q ss_pred             -----------cCcccC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          482 -----------KGRRLE-----IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       482 -----------~~~~~~-----~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                                 ......     +-++.++.+.+|+.+||..||.+|+|++|.++.
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                       011111     113778999999999999999999999998753

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-38  Score=309.16  Aligned_cols=246  Identities=35%  Similarity=0.582  Sum_probs=207.9

Q ss_pred             EEEccCCcEEEEEEEEc-CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCCh
Q 009291          271 KKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL  349 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  349 (538)
                      +.||+|+||.||++.+. ++.+++|.+...... ...+.+.+|++++++++|+||+++++++.+....++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            36899999999999876 456999987655433 4567899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc--CCC
Q 009291          350 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTA  427 (538)
Q Consensus       350 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~  427 (538)
                      .+++....  ..+++..+..++.|++.||+|||+++  ++||||||+||+++.++.+||+|||++..........  ...
T Consensus        80 ~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          80 LTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99986432  24788899999999999999999999  9999999999999999999999999987654221111  122


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       428 ~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      ..+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. ...+...+..++.++.++|.+||+.
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhcc
Confidence            33567999999988889999999999999999999 889998887665555543 3345556778899999999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 009291          507 EPEIRPSFPSIMETLQ  522 (538)
Q Consensus       507 dP~~RPs~~eIl~~L~  522 (538)
                      +|++||++.++++.|+
T Consensus       235 ~p~~Rp~~~ell~~l~  250 (251)
T cd05041         235 DPENRPSFSEIYNELQ  250 (251)
T ss_pred             ChhhCcCHHHHHHHhh
Confidence            9999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.4e-38  Score=317.70  Aligned_cols=248  Identities=28%  Similarity=0.478  Sum_probs=210.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..+|++.+.||.|+||.||+|.+..  ..+++|.+......  ..+.+.+|+.+++.++|+||+++++++.....+++|+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            3579999999999999999998754  45999988654332  3457889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|..++...    .+++..+..++.|++.||+|||++|  ++||||||+||+++.++.+||+|||++.......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            999999999988532    4789999999999999999999999  9999999999999999999999999987654332


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-CcccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~~LI  500 (538)
                      .......++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+... ......+..+++.+.++|
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  249 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL  249 (296)
T ss_pred             ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence            2233456888999999999888999999999999999999999999887765544443322 223345667899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||..+|++||++.+++.
T Consensus       250 ~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         250 NRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHhhcChhhCCCHHHHhh
Confidence            9999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6e-38  Score=317.45  Aligned_cols=245  Identities=28%  Similarity=0.470  Sum_probs=212.1

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||.||++.+..  ..+|+|++..... .....+.+.+|++++++++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            468999999999999999998864  4499999875443 2344577889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999998644   35889999999999999999999999  999999999999999999999999998875543 


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                        .....++..|+|||.+.+...+.++||||||+++|+|++|..||...........+.  .....+|..++..++++|.
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~  230 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIR  230 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHH
Confidence              234568899999999988888999999999999999999999998877655555443  3456677888999999999


Q ss_pred             HhhhcCCCCCC-----CHHHHHH
Q 009291          502 TCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       502 ~cL~~dP~~RP-----s~~eIl~  519 (538)
                      +||..+|.+|+     +++++++
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHc
Confidence            99999999998     6776653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.3e-38  Score=309.20  Aligned_cols=249  Identities=27%  Similarity=0.455  Sum_probs=212.8

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||++.+..+  .+|+|.+............+.+|+.++++++|+||+++++.+.....+++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588999999999999999987544  499999877665666678899999999999999999999999998999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC-CcEEEEeeCCCccCCCCcc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~~~~~~~~  422 (538)
                      +++++|.+++.... ...+++..++.++.|++.||+|||+++  ++|+||+|+||+++.+ +.+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999996432 234789999999999999999999999  9999999999999854 4689999999987654321


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+. .....+++..++..+.++|.+
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCCCCCCcCHHHHHHHHH
Confidence             234567889999999998888999999999999999999999998877665554443 233445677789999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIME  519 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~  519 (538)
                      ||..+|++|||+.+++.
T Consensus       236 ~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         236 MLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HccCChhhCCCHHHHhh
Confidence            99999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-37  Score=314.13  Aligned_cols=255  Identities=34%  Similarity=0.542  Sum_probs=204.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc--CC
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PP  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--~~  335 (538)
                      ..+|++.+.||+|+||.||++...      +..+|+|.+...  .....+.+.+|+++++.++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            357899999999999999999742      334899987543  34556788999999999999999999998643  34


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  ++||||||+||++++++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccc
Confidence            6899999999999999986432  34889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccc---cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HH
Q 009291          416 SKPNTYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---------------IS  477 (538)
Q Consensus       416 ~~~~~~~~---~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~---------------~~  477 (538)
                      ........   .....++..|+|||.+.+..++.++||||||+++|||++|..|+........               ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            65432211   1122334569999999988899999999999999999998777543321100               00


Q ss_pred             HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          478 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       478 ~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      .......+.+.+..++.++.+||.+||..+|++|||+.+|++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11112334455677899999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-37  Score=307.38  Aligned_cols=246  Identities=33%  Similarity=0.561  Sum_probs=207.1

Q ss_pred             EEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCCh
Q 009291          271 KKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL  349 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  349 (538)
                      +.||+|+||.||+|...+ +.+|+|++.... .......+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            368999999999998654 348998875443 344445788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc-cCCCC
Q 009291          350 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAA  428 (538)
Q Consensus       350 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~  428 (538)
                      .+++....  ..+++..++.++.|++.||.|||++|  ++||||||+||+++.++.+||+|||++......... .....
T Consensus        80 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          80 LSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            99886433  34789999999999999999999999  999999999999999999999999998764432211 11223


Q ss_pred             CCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 009291          429 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE  507 (538)
Q Consensus       429 gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~d  507 (538)
                      ++..|+|||.+.+..++.++||||||+++|++++ |..||...........+. ...+...+..++..+.+++.+||..+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~  234 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYK  234 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccC
Confidence            4567999999998889999999999999999998 999998887766655553 34455667788999999999999999


Q ss_pred             CCCCCCHHHHHHHHH
Q 009291          508 PEIRPSFPSIMETLQ  522 (538)
Q Consensus       508 P~~RPs~~eIl~~L~  522 (538)
                      |++||++.++++.|.
T Consensus       235 p~~Rp~~~~l~~~l~  249 (250)
T cd05085         235 PENRPKFSELQKELA  249 (250)
T ss_pred             cccCCCHHHHHHHhc
Confidence            999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-38  Score=328.78  Aligned_cols=247  Identities=22%  Similarity=0.329  Sum_probs=199.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC------C
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~------~  335 (538)
                      .++|++++.||+|+||+||+|.+..+  .||+|++..........+.+.+|+.++++++|+||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            36799999999999999999987644  499999876544444556788999999999999999999987543      3


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++++|++ +++|..++..    ..+++..+..++.|++.||+|||+++  |+||||||+||++++++.+||+|||+++
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccce
Confidence            468999988 7789888753    24889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc----------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------  484 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~----------  484 (538)
                      .....   .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....          
T Consensus       167 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         167 QADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             ecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            65432   234578999999999877 5688999999999999999999999987665443332211000          


Q ss_pred             -----------ccC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          485 -----------RLE--------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       485 -----------~~~--------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                                 ...        .....++.+.+||.+||+.||++|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                       000        012356778999999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.2e-38  Score=317.45  Aligned_cols=249  Identities=26%  Similarity=0.358  Sum_probs=198.8

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||+|.+..  ..+++|.+............+.+|+.++++++|+||+++++++.+...+++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            48899999999999999999864  4499998876544433445678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +.+ +|.+++...  ...+++..++.++.||+.||.|||+++  ++||||||+||+++.++.+||+|||++.........
T Consensus        81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            975 777776532  235899999999999999999999999  999999999999999999999999998865433323


Q ss_pred             cCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhc----------------C-c
Q 009291          424 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFK----------------G-R  484 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~-~~~~~~~~~i~~~----------------~-~  484 (538)
                      .....++..|+|||.+.+. .++.++|||||||++|+|++|..||.. .+..+....+...                . .
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            3345678899999998764 468999999999999999999888543 3332222211100                0 0


Q ss_pred             -c---------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 -R---------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 -~---------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       .         ......+++++.+||.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             0         0112356789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.9e-38  Score=318.57  Aligned_cols=260  Identities=33%  Similarity=0.575  Sum_probs=213.8

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc------eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~------vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      +...+|+..+.||+|+||.||+|.+..++      +|+|.+.... .......+.+|+.+++.++|+||+++++++... 
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            34567889999999999999999875332      5777765432 334445788999999999999999999998764 


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..++++||+++|+|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||++++++.+||+|||+++
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccc
Confidence            4679999999999999986432  24788899999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          416 SKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       416 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      .......  ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .......+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPIC  236 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCC
Confidence            6543221  1223345678999999998889999999999999999997 899998876655444443 44455566778


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +..+.+++.+||..+|++||++.++++.|+++....
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            899999999999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.6e-38  Score=316.49  Aligned_cols=256  Identities=32%  Similarity=0.505  Sum_probs=206.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--Cc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PN  336 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~  336 (538)
                      ..|++.+.||+|+||.||+++..      +..+|+|.+... ........+.+|+.+++.++|+||+++.+++...  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            35788999999999999999743      334899987543 2344557899999999999999999999988765  56


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  ++||||||+||+++.++.++|+|||+++.
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccc
Confidence            899999999999999986432  24789999999999999999999999  99999999999999999999999999986


Q ss_pred             CCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHHH
Q 009291          417 KPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--------------SQVISAV  479 (538)
Q Consensus       417 ~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~--------------~~~~~~i  479 (538)
                      ......   ......++..|+|||.+.+..++.++||||||+++|||++++.|+.....              .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            543221   11234567789999999888899999999999999999998766432110              0111111


Q ss_pred             hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       480 ~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      .....+.+.+..++..+.+||.+||+.+|++|||+.++++.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            1233445566778999999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.7e-38  Score=311.50  Aligned_cols=249  Identities=27%  Similarity=0.459  Sum_probs=207.5

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc-CCceEEEEEecccc----CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEF----HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~----~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      +|++.+.||+|+||.||+|... ++.+|+|.+.....    .......+.+|++++++++|+||+++++++.+...++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788999999999999999874 44489998765432    233456788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      +||+++++|.+++...   ..+++..+..++.|++.||+|||+.+  |+|+||+|+||++++++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999998643   24789999999999999999999999  999999999999999999999999998754211


Q ss_pred             ------ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-CcccCCCCCCc
Q 009291          421 ------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVN  493 (538)
Q Consensus       421 ------~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s  493 (538)
                            ........++..|+|||.+.+..++.++||||||+++|+|++|..||...........+... .....++..++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS  235 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence                  11112345788999999999888999999999999999999999999876655443333222 23345677889


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .++.++|++||..+|++||++.++++
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            99999999999999999999998874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.4e-38  Score=310.76  Aligned_cols=247  Identities=32%  Similarity=0.559  Sum_probs=209.7

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||+|+||.||+|.+..  ..+++|.+....    ..+.+.+|++++++++|+||+++++++.+...+++++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            578899999999999999999875  448999875432    15789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.+++|.+++....  ..+++..++.++.|++.||.|||+.+  ++|+||+|+||++++++.+||+|||++........
T Consensus        79 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          79 YCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999999986432  35889999999999999999999999  99999999999999999999999999887654432


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-cCcccCCCCCCcHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-KGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~s~~l~~LI~  501 (538)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.. .......+..++..+.++|.
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            33345578899999999988899999999999999999999999987766554433321 11223345567889999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 009291          502 TCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       502 ~cL~~dP~~RPs~~eIl~  519 (538)
                      +||+.+|++|||+.++++
T Consensus       235 ~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHhcChhhCcCHHHHhc
Confidence            999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.1e-38  Score=355.95  Aligned_cols=258  Identities=24%  Similarity=0.399  Sum_probs=208.4

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc--CC
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PP  335 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--~~  335 (538)
                      .+....+|++++.||+|+||+||+|++..+.  +|+|++............+..|+.+++.++||||++++++|.+  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            4456679999999999999999999987654  8899887766666677889999999999999999999998854  35


Q ss_pred             cceEEEeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCC-----CCEEeecCCCCCEEEcC-------
Q 009291          336 NLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRR-----PPIVHRDLKSPNLLVDS-------  402 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~iiHrDLKp~NILl~~-------  402 (538)
                      .+|+||||+.+++|.+++... .....+++..++.|+.||+.||.|||+.+     .+||||||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            689999999999999998532 22346899999999999999999999843     23999999999999954       


Q ss_pred             ----------CCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009291          403 ----------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNS  470 (538)
Q Consensus       403 ----------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~s~ksDVwSLGvil~eLltg~~Pf~~~  470 (538)
                                .+.+||+|||++....... ......||+.|+|||++.+  ..++.++||||||||||+|++|..||...
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                      3459999999998654332 2234578999999999864  45789999999999999999999999866


Q ss_pred             CHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          471 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       471 ~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ...............++ ....+.++.+||.+||..+|++||++.|++.
T Consensus       247 ~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            54433332221222121 2457899999999999999999999999984

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.6e-38  Score=318.79  Aligned_cols=250  Identities=26%  Similarity=0.352  Sum_probs=201.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||.||+|.+..+  .||+|.+..... ......+.+|+.+++.++|+||+++++++..+..+++||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            46899999999999999999988644  489998764432 222345778999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+. ++|.+++....  ..+++..++.++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||++.......
T Consensus        84 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          84 EYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             eccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            9997 58888875432  24788999999999999999999999  9999999999999999999999999987644332


Q ss_pred             cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-----------------
Q 009291          422 ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-----------------  483 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-----------------  483 (538)
                      .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+....                 
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            222345678899999998654 47889999999999999999999998776644433221100                 


Q ss_pred             cccC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 RRLE-----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ~~~~-----------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ....           ....+++.+++||.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0001           11357889999999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-37  Score=309.94  Aligned_cols=249  Identities=28%  Similarity=0.480  Sum_probs=206.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccc---cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--Ccc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQE---FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNL  337 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~---~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~~  337 (538)
                      .+|++.+.||+|+||.||++.+..+  .|++|.+....   ......+.+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4789999999999999999987654  49999875432   1234567889999999999999999999988764  457


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      +++|||+++++|.+++...   ..+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            8999999999999998633   24788889999999999999999999  999999999999999999999999998754


Q ss_pred             CCCc---cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          418 PNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       418 ~~~~---~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      ....   .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.....................|..++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD  236 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence            3211   1122345788999999998888999999999999999999999999877655555444434444556777889


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+.++|.+||. +|++||++++|++
T Consensus       237 ~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            99999999995 9999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=317.29  Aligned_cols=251  Identities=29%  Similarity=0.509  Sum_probs=211.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||.|+||.||++.+..  ..+|+|++...  .....+.+.+|+.++++++|+||+++++++.++...++||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            3568899999999999999998864  44898987643  4455678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++....  ..+++..++.++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          82 EFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            9999999999986432  35889999999999999999999999  9999999999999999999999999987654433


Q ss_pred             cccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cccCCCCCCcHH
Q 009291          422 ISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPM  495 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~  495 (538)
                      .......++..|+|||.+.     ...++.++||||||+++|+|++|+.||...........+.... .....+..++.+
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (280)
T cd06611         158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS  237 (280)
T ss_pred             cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence            3334456889999999975     3446789999999999999999999998877666554443222 123445678999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +.++|.+||+.+|++||++.++++.
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcC
Confidence            9999999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.5e-38  Score=311.82  Aligned_cols=246  Identities=29%  Similarity=0.477  Sum_probs=195.2

Q ss_pred             EEccCCcEEEEEEEEcCC----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCC
Q 009291          272 KIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~~----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      .||+|+||.||+|.....    .+++|.+... ........+.+|+.+++.++|+||+++++.+.+...+++||||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            589999999999975432    3667765433 23444567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCC--CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc--cc
Q 009291          348 SLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--IS  423 (538)
Q Consensus       348 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~--~~  423 (538)
                      +|.+++.....  ....++..+..++.|++.||+|||+++  |+||||||+||++++++.+||+|||++.......  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999864322  233567888999999999999999999  9999999999999999999999999987533221  11


Q ss_pred             cCCCCCCCcccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCc-c---cCCCCC
Q 009291          424 SKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR-R---LEIPKN  491 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~-------~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~-~---~~~p~~  491 (538)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+....+..... .   ...+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            223345678999998743       456889999999999999999 7889988776665544432221 1   223446


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      ++..+.+++..|| .+|++|||+++|++.|
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            7899999999999 5999999999999887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.4e-38  Score=309.99  Aligned_cols=252  Identities=31%  Similarity=0.461  Sum_probs=209.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||.|+||+||+|....+  .+++|++....... ..+.+.+|+.+++.++|+||+++++.+..+..+++++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            4689999999999999999987543  48899886544333 56789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      ++++++|.++++.......+++..+..++.|++.||+|||+.+  ++||||+|+||++++++.++|+|||++........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999999965433346899999999999999999999999  99999999999999999999999999876543321


Q ss_pred             c----cCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cccCCC---CCCc
Q 009291          423 S----SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIP---KNVN  493 (538)
Q Consensus       423 ~----~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p---~~~s  493 (538)
                      .    .....++..|+|||.+... .++.++|+||||+++|+|++|+.||...+............ ......   ..++
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS  237 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence            1    1334588899999998776 78999999999999999999999998876655444432221 111111   2568


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.+.+++.+||..||++||++.+|++
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         238 KSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            89999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.5e-38  Score=315.16  Aligned_cols=251  Identities=25%  Similarity=0.409  Sum_probs=204.0

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceecc------
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE------  333 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~------  333 (538)
                      ..+.|++.+.||+|+||.||+|.+..+  .+|+|++...   ......+..|+.+++++ +|+||+++++++..      
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            346889999999999999999998644  4899987543   23345688899999998 69999999999853      


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ...++++|||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+  |+|+||+|+||++++++.++|+|||+
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcc
Confidence            456899999999999999986432 234788889999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCccccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI  488 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~  488 (538)
                      +..............|+..|+|||.+.     ...++.++|||||||++|||++|..||....+......+.........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  247 (282)
T cd06636         168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK  247 (282)
T ss_pred             hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence            876543322234556889999999986     345788999999999999999999999876655544433322222223


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          489 PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       489 p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +..++.++.+||.+||+.||++|||+.+|++
T Consensus       248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            3468899999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1e-37  Score=314.18  Aligned_cols=255  Identities=28%  Similarity=0.412  Sum_probs=205.1

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceec-----
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT-----  332 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~-----  332 (538)
                      ....++|++.+.||+|+||.||++.+..  +.+|+|++....   .....+.+|+.+++.+ +|+||+++++++.     
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            3456789999999999999999998864  448999875432   1224677899999999 6999999999873     


Q ss_pred             cCCcceEEEeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEee
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF  411 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DF  411 (538)
                      .+..+++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+  ++||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~df  168 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDF  168 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccC
Confidence            345689999999999999987421 22345889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCCccccCCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cc
Q 009291          412 GLSRSKPNTYISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RR  485 (538)
Q Consensus       412 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~  485 (538)
                      |+++.............|+..|+|||.+..     ..++.++|||||||++|||++|+.||................ ..
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (286)
T cd06638         169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT  248 (286)
T ss_pred             CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence            998765443333345578999999999853     447889999999999999999999998776544443332111 12


Q ss_pred             cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       486 ~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ...+..++..+.++|.+||+.+|++|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            33455678899999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=318.39  Aligned_cols=252  Identities=26%  Similarity=0.402  Sum_probs=210.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .+|++.+.||+|+||+||+|.+..  ..+|+|.+....... ...+.+.+|+++++.++|+||+++++.+.+....+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368999999999999999998865  459999987665443 45677899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999986432 245889999999999999999999999  9999999999999999999999999986532211


Q ss_pred             c-----------------------------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 009291          422 I-----------------------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP  472 (538)
Q Consensus       422 ~-----------------------------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~  472 (538)
                      .                             ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            0                             11123578899999999998899999999999999999999999988777


Q ss_pred             HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 009291          473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS----FPSIME  519 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs----~~eIl~  519 (538)
                      ......+.......+....++..+.++|.+||..+|++|||    +.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            66555543233233333347899999999999999999999    777766

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.2e-38  Score=314.54  Aligned_cols=248  Identities=29%  Similarity=0.514  Sum_probs=210.8

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ..|+..+.||+|+||.||+|.+..  ..+|+|++.... .....+.+.+|+.++++++|+||+++++++.++..+++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            357788999999999999998764  448999876543 23456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+++++|.+++...    .+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          83 YLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999999988632    4788899999999999999999999  99999999999999999999999999976544332


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      ......++..|+|||.+.+..++.++|+||||+++|||++|..||...........+. ......++..++..+.++|.+
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDA  235 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHH
Confidence            3334567889999999988889999999999999999999999998877665554432 223344556678899999999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~~  520 (538)
                      ||+.+|++||++.+++..
T Consensus       236 ~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         236 CLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HcccCcccCcCHHHHHhC
Confidence            999999999999999665

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-37  Score=311.06  Aligned_cols=248  Identities=28%  Similarity=0.481  Sum_probs=205.2

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEecccc---CHHHHHHHHHHHHHHHcCCCCceeEeeceecc--CCcce
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLS  338 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~---~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--~~~~~  338 (538)
                      +|++.+.||+|+||.||+|.+..  +.+++|++.....   .......+.+|+.++++++|+||+++++++.+  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            68889999999999999998764  4499998764422   23445678899999999999999999998765  35678


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +++||+++++|.+++....   .+++...+.++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++....
T Consensus        83 l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            9999999999999986432   4788899999999999999999999  9999999999999999999999999987543


Q ss_pred             CCc---cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          419 NTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       419 ~~~---~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      ...   .......++..|+|||.+.+..++.++|||||||++|||++|+.||....................+|..+++.
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH  237 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence            211   11123457889999999998889999999999999999999999998776555554444344455667778899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.++| +||..+|++||++++|++
T Consensus       238 ~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         238 ARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHH-HHhcCChhhCcCHHHHhc
Confidence            99999 688899999999999965

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-37  Score=310.68  Aligned_cols=255  Identities=31%  Similarity=0.565  Sum_probs=210.4

Q ss_pred             eeEEEEEccCCcEEEEEEEEc-----CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          267 LLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      |++.+.||+|+||.||+|.+.     +..+|+|++..........+.+.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999764     234999998776666667788999999999999999999999875432      


Q ss_pred             cceEEEeecCCCChhhhhcCC---CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      ..++++||+.+|+|..++...   .....+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence            247889999999998887422   12234788899999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCC
Q 009291          413 LSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP  489 (538)
Q Consensus       413 la~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p  489 (538)
                      +++.......  ......++..|++||.+....++.++||||||+++|+|++ |..||......+....+. .......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~  237 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQP  237 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence            9886533211  1223345678999999998889999999999999999999 889998877766555443 33344556


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      ..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            67889999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-37  Score=307.92  Aligned_cols=248  Identities=31%  Similarity=0.497  Sum_probs=211.7

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc--CCceEEEEEecccc---CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~---~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      +|+..+.||+|+||.||+|...  +..+++|.+.....   ..+..+.+.+|+.+++.++|+||+++++++.++..++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999886  45599998865432   244567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      +||+++++|.+++...   ..+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999998643   24789999999999999999999999  999999999999999999999999998765433


Q ss_pred             ccccCCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~-~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      . ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...........+........++..+++.+.++
T Consensus       156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  234 (258)
T cd06632         156 S-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF  234 (258)
T ss_pred             c-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHH
Confidence            2 223456888999999987776 89999999999999999999999988776555555543344455677889999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~  519 (538)
                      |.+||+.+|++||++.++++
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhc
Confidence            99999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-37  Score=308.25  Aligned_cols=248  Identities=31%  Similarity=0.548  Sum_probs=208.1

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||+|.+..  ..+++|++..........+.+.+|+.++++++|+||+++++++.+...+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            58899999999999999998753  4599999887765556778999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|.+++...   ..+++..+..++.|++.||+|||+.+  ++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999998643   24788899999999999999999999  999999999999999999999999998765433221


Q ss_pred             c----CCCCCCCcccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhcCcccCCCCC--Cc
Q 009291          424 S----KTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKN--VN  493 (538)
Q Consensus       424 ~----~~~~gt~~Y~aPE~l~~~~---~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~--~s  493 (538)
                      .    ....++..|+|||.+.+..   .+.++||||||+++|++++|+.||...... .....+. ......+|..  ++
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLS  234 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCcccccC
Confidence            1    1346788999999998766   789999999999999999999999765332 2222222 2333444544  48


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..+.++|.+||+.+|++||++.+++.
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhc
Confidence            99999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-39  Score=310.26  Aligned_cols=261  Identities=22%  Similarity=0.368  Sum_probs=219.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc------CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccC
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF------HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP  334 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~------~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~  334 (538)
                      +..|.-.+.||+|..++|-++.++.+  .+|+|++.....      .....++-.+|+.||+++ .||+|+.+.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            45677788999999999999877644  489998754322      123345667899999998 699999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ..+++|+|.|+.|.|.++|.   ....+++.....|+.|+.+|++|||.++  ||||||||+|||++++.++||+|||+|
T Consensus        96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEecccee
Confidence            99999999999999999996   4557999999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCccccCCCCCCCcccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCC
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLRE------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI  488 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~  488 (538)
                      +....+. ..+..+||+.|+|||.+..      ..|+..+|+|++|+|+|.|+.|.+||......-.+..+..+...+.-
T Consensus       171 ~~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s  249 (411)
T KOG0599|consen  171 CQLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS  249 (411)
T ss_pred             eccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence            9877664 3467899999999999864      34788999999999999999999999887776666666555444433


Q ss_pred             --CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHhhhcC
Q 009291          489 --PKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLMSSVC  530 (538)
Q Consensus       489 --p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~--~L~~il~~~~~  530 (538)
                        ..+++..+++||.+||+.||.+|.|+.|.+.  ++.++..+...
T Consensus       250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r  295 (411)
T KOG0599|consen  250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR  295 (411)
T ss_pred             cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence              3578999999999999999999999999985  45666655443

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-37  Score=317.88  Aligned_cols=248  Identities=24%  Similarity=0.411  Sum_probs=204.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||+|+||.||++.+..++  +|+|.+... ........+.+|++++++++||||+++++++.++..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            36899999999999999999987655  777776543 234455678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |+++++|.++++..   ..+++..+..++.|++.||+|||+ .+  ++||||||+||+++.++.+||+|||++.......
T Consensus        80 y~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          80 HMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             ccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            99999999998643   358899999999999999999997 58  9999999999999999999999999987654322


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC------------------
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------------  483 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~------------------  483 (538)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+....                  
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence              234578899999999988889999999999999999999999997655433332221110                  


Q ss_pred             -----------------cccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          484 -----------------RRLEIP-KNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       484 -----------------~~~~~p-~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                                       .....| ..++.++.+||.+||..+|++|||+.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             011111 1367889999999999999999999998765

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.7e-38  Score=352.34  Aligned_cols=262  Identities=26%  Similarity=0.365  Sum_probs=211.6

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||.||+|.+..  +.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            579999999999999999998864  4599999865433 2344567999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCC--------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          342 EYLSRGSLYKLLHIPD--------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ||++|++|.+++....        .....+...++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence            9999999999885311        1123456678899999999999999999  99999999999999999999999999


Q ss_pred             CccCCCC------------------ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 009291          414 SRSKPNT------------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV  475 (538)
Q Consensus       414 a~~~~~~------------------~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~  475 (538)
                      +......                  ........||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            9764110                  0011224689999999999999999999999999999999999999987655433


Q ss_pred             HHHHhhcC-cccCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHhhh
Q 009291          476 ISAVGFKG-RRLEIPKNVNPMVAALIETCWAEEPEIR-PSFPSIMETLQQFLMSS  528 (538)
Q Consensus       476 ~~~i~~~~-~~~~~p~~~s~~l~~LI~~cL~~dP~~R-Ps~~eIl~~L~~il~~~  528 (538)
                      ........ ........+++.+.+++.+||..||++| ++++++++.|+.+++..
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~  294 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS  294 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence            32211111 1111124678999999999999999999 57788888898888753

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.2e-37  Score=308.95  Aligned_cols=254  Identities=28%  Similarity=0.461  Sum_probs=204.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      +..+.+.....||+|+||.||+|.+..++  +++|.+...  .....+.+.+|+.++++++|+||+++++++..+...++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            34445555678999999999999876554  888876544  33445688999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCCCccCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKP  418 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~  418 (538)
                      ++||+++++|.+++.........++..+..++.|++.||+|||+++  |+||||||+||+++. ++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            9999999999999864322212378888899999999999999999  999999999999976 6799999999987654


Q ss_pred             CCccccCCCCCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhcCcccCCCCCCcHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~--~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      ..........++..|+|||.+.+..  ++.++||||||+++|+|++|..||....... .............+|..++++
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE  240 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence            3322233446789999999986643  7889999999999999999999997654322 222222223344567788999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.+|+.+||+.+|++|||+.++++
T Consensus       241 ~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         241 AKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHh
Confidence            999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.1e-38  Score=335.36  Aligned_cols=245  Identities=26%  Similarity=0.336  Sum_probs=205.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCC-C-----CceeEeeceeccCCc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-H-----PNIVLLMGAVTEPPN  336 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-h-----pnIv~l~~~~~~~~~  336 (538)
                      .+|++.+.||+|+||.|.+|.+.+++  ||||+++..   .....+...|+.+|+.|+ |     -|||+++++|...++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            38999999999999999999987665  999998764   345567778999999996 4     389999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC--CcEEEEeeCCC
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST--YTVKVCDFGLS  414 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~--~~vkL~DFGla  414 (538)
                      +|||+|.+. -+|+++++.++-.+ ++...++.|+.||+.||.+||+.+  |||+||||+||||.+.  ..|||+|||.|
T Consensus       263 lciVfELL~-~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccc
Confidence            999999995 59999998766543 889999999999999999999999  9999999999999643  37999999999


Q ss_pred             ccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc------------
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------  482 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~------------  482 (538)
                      +......   .+...+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+.++.+.+..|...            
T Consensus       339 c~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            9876654   2667789999999999999999999999999999999999999888876655433210            


Q ss_pred             --------C------------------------------cccCCCC-----------CCcHHHHHHHHHhhhcCCCCCCC
Q 009291          483 --------G------------------------------RRLEIPK-----------NVNPMVAALIETCWAEEPEIRPS  513 (538)
Q Consensus       483 --------~------------------------------~~~~~p~-----------~~s~~l~~LI~~cL~~dP~~RPs  513 (538)
                              .                              .....|.           .-...+.+||.+||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                    0                              0000110           11246899999999999999999


Q ss_pred             HHHHHH
Q 009291          514 FPSIME  519 (538)
Q Consensus       514 ~~eIl~  519 (538)
                      ..|.++
T Consensus       496 p~qal~  501 (586)
T KOG0667|consen  496 PAQALN  501 (586)
T ss_pred             HHHHhc
Confidence            999875

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.2e-38  Score=318.51  Aligned_cols=248  Identities=27%  Similarity=0.455  Sum_probs=208.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..+|++.+.||+|+||.||++.+.  +..+|+|.+......  ..+.+.+|+.+++.++|+||+++++++..+..+++||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            368999999999999999999875  445999998655433  2356889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++...    .+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||++.......
T Consensus        96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            999999999998532    4788899999999999999999999  9999999999999999999999999987654333


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-CcccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~~LI  500 (538)
                      .......++..|+|||.+.+..++.++||||||+++|++++|..||...+.......+... ......+..++..+.+||
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  249 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL  249 (297)
T ss_pred             cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence            2233456888999999999988999999999999999999999999876654333222211 122334567889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||..+|++||++.++++
T Consensus       250 ~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         250 NRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-37  Score=307.52  Aligned_cols=250  Identities=42%  Similarity=0.707  Sum_probs=211.3

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      +++.+.||.|+||.||++.+..      ..+|+|++.... .....+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            3567899999999999998875      448999985543 233567889999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+++++|.+++...... .+++..+..++.|++.||++||+.+  ++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999998643321 2789999999999999999999999  999999999999999999999999999865543


Q ss_pred             ccccC-CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          421 YISSK-TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       421 ~~~~~-~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      ..... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+. .......+..++..+.+
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  235 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIYK  235 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHH
Confidence            21111 2336789999999988889999999999999999998 789998877766666554 33455667778999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      ++.+||+.+|++|||+.++++.|
T Consensus       236 ~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      236 LMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHCcCChhhCcCHHHHHhhC
Confidence            99999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.7e-37  Score=310.27  Aligned_cols=248  Identities=29%  Similarity=0.441  Sum_probs=196.1

Q ss_pred             EEEccCCcEEEEEEEEcCC----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||.||+|...+.    .+++|.+..... ......+.+|+.++++++||||+++++++.+...+++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            3689999999999986532    378887755442 33345788999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCC--CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc--
Q 009291          347 GSLYKLLHIPD--ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--  422 (538)
Q Consensus       347 gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~--  422 (538)
                      |+|.+++....  .....++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++........  
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999985422  1224567788889999999999999999  99999999999999999999999999875433221  


Q ss_pred             ccCCCCCCCcccccccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhc-CcccC---CCC
Q 009291          423 SSKTAAGTPEWMAPEVLRED-------PSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK-GRRLE---IPK  490 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~-------~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~-~~~~~---~p~  490 (538)
                      ......++..|+|||.+.+.       .++.++||||||+++|||++ |+.||......+........ ..+..   +..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL  237 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence            12234567889999998643       35789999999999999996 99999877665554332211 12222   223


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      ..++.+.++|.+|| .+|++|||+++|++.|+
T Consensus       238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            46788999999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.3e-38  Score=322.36  Aligned_cols=248  Identities=23%  Similarity=0.337  Sum_probs=197.4

Q ss_pred             EEEEEccC--CcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          269 IKKKIGEG--SFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       269 i~~~LG~G--~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      +++.||+|  +|++||++.++.++  ||+|.+............+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78999999886544  999998766555566677888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc--
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--  422 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~--  422 (538)
                      ++++|.+++.... ...+++..++.++.|++.||+|||+++  |+||||||+||+++.++.++++||+.+........  
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999985432 224789999999999999999999999  99999999999999999999999986543221100  


Q ss_pred             -----ccCCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc----------
Q 009291          423 -----SSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------  485 (538)
Q Consensus       423 -----~~~~~~gt~~Y~aPE~l~~--~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------  485 (538)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..................          
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 1122346778999999976  45889999999999999999999999865543332221110000          


Q ss_pred             ----------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ----------------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ----------------------------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                                        .+....+++++.+||.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                                              0011235678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9e-38  Score=313.29  Aligned_cols=256  Identities=33%  Similarity=0.536  Sum_probs=209.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc--CC
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PP  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--~~  335 (538)
                      ..+|++.+.||+|+||.||+|++..      ..+|+|++...... ...+.+.+|+++++.++|+||+++++++..  ..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            3568888999999999999998642      34999998765433 456789999999999999999999999877  55


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..+++|||+++++|.+++.....  .+++..++.++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||.+.
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccc
Confidence            78999999999999999964332  4889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccc---cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Q 009291          416 SKPNTYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--------------VISA  478 (538)
Q Consensus       416 ~~~~~~~~---~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~--------------~~~~  478 (538)
                      ........   .....++..|+|||.+.+..++.++||||||+++|||++|..||.......              ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76532111   112344567999999988889999999999999999999999986532211              1111


Q ss_pred             HhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       479 i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      ......+.+.+..++.++.+++.+||+.+|++|||+.+|+++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1123334455667889999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.3e-38  Score=312.56  Aligned_cols=248  Identities=36%  Similarity=0.592  Sum_probs=206.3

Q ss_pred             EEccCCcEEEEEEEEcC--------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          272 KIGEGSFGTVYHAEWRN--------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~--------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      .||+|+||.||+|++..        ..+++|.+.... .......+.+|+.+++.++||||+++++++......+++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            68999999999998753        238888875432 234456788999999999999999999999998999999999


Q ss_pred             cCCCChhhhhcCCC----CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-----cEEEEeeCCC
Q 009291          344 LSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-----TVKVCDFGLS  414 (538)
Q Consensus       344 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-----~vkL~DFGla  414 (538)
                      +++++|.+++....    ....+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999985321    1234778899999999999999999999  99999999999999877     8999999998


Q ss_pred             ccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          415 RSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       415 ~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      ........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ...+...+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  237 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPEN  237 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCccc
Confidence            75433211  1123345678999999999999999999999999999998 999998877766555543 3345566778


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      ++..+.++|.+||..+|.+||+++++++.|++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            89999999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=313.25  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=206.1

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||+|+||.||+|.+..+  .|++|++..........+.+.+|++++++++|+||+++++++..++.++++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3699999999999999999988644  49999887655455556788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |++++.+..+....   ..+++..++.++.|++.||+|||+.+  ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99987777665432   24789999999999999999999999  99999999999999999999999999887554332


Q ss_pred             -ccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-----------------
Q 009291          423 -SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-----------------  483 (538)
Q Consensus       423 -~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-----------------  483 (538)
                       ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+....                 
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence             22345678899999999888 78999999999999999999999998766544433221100                 


Q ss_pred             c--c-----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 R--R-----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ~--~-----------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .  .           ...+..++.++.+||++||..+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0  0           0123345889999999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.2e-38  Score=316.00  Aligned_cols=246  Identities=30%  Similarity=0.518  Sum_probs=207.6

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      .|+..+.||+|+||.||+|.+..+  .+|+|.+.... .....+.+.+|+.++++++|+||+++++++..+..+++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            456677899999999999987643  48998876443 234557889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+++  ++|+||+|+||++++++.++|+|||++.........
T Consensus        84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            999999998853    24788999999999999999999999  999999999999999999999999998765443322


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||....+......+. ......++..++..+.++|.+|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHH
Confidence            334467889999999999889999999999999999999999998766555444332 2233345566889999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 009291          504 WAEEPEIRPSFPSIME  519 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~  519 (538)
                      |+.+|++||++.+++.
T Consensus       237 l~~~p~~Rp~~~~il~  252 (277)
T cd06642         237 LNKDPRFRPTAKELLK  252 (277)
T ss_pred             ccCCcccCcCHHHHHH
Confidence            9999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-37  Score=328.68  Aligned_cols=246  Identities=24%  Similarity=0.300  Sum_probs=196.2

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC----CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~----~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      +...+|++++.||+|+||.||++...+    ..+++|.+...       ....+|+.++++++|+||+++++++......
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            345679999999999999999997643    33788876543       2345899999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      +++||++. ++|.+++..   ...+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++..
T Consensus       162 ~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            99999986 578888742   345899999999999999999999999  999999999999999999999999999765


Q ss_pred             CCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhh--c--------
Q 009291          418 PNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGF--K--------  482 (538)
Q Consensus       418 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~---~~~~~i~~--~--------  482 (538)
                      .....  ......||..|+|||++.+..++.++|||||||++|||++|+.||.+....   .....+..  .        
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            43221  123456899999999999999999999999999999999999999764321   11111100  0        


Q ss_pred             ---------------Ccc--cCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          483 ---------------GRR--LEIP-----KNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       483 ---------------~~~--~~~p-----~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                                     ..+  ...+     ..++.++.++|.+||..+|++|||+.+++..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                           000  0111     1346788999999999999999999999764

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=310.24  Aligned_cols=252  Identities=29%  Similarity=0.454  Sum_probs=205.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCC----
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP----  335 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~----  335 (538)
                      ..++|++.+.||+|+||.||+|.+..+  .+++|++.....   ..+.+.+|+.+++++ +|+||+++++++.+..    
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            357899999999999999999998644  489998765432   335788999999999 7999999999986544    


Q ss_pred             --cceEEEeecCCCChhhhhcCCC-CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          336 --NLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       336 --~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                        .+++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+  ++|+||+|+||++++++.+||+|||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence              4899999999999999885422 2346889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-ccc
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRL  486 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~  486 (538)
                      ++..............++..|+|||.+..     ..++.++||||||+++|+|++|..||...........+.... ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL  238 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence            98765443333345668899999998754     346788999999999999999999998766555444433221 122


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..+..++..+.+||.+||..||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            333457889999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.2e-38  Score=310.94  Aligned_cols=245  Identities=25%  Similarity=0.391  Sum_probs=209.9

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      +|++.+.||.|+||.||+|.+.  +..+|+|++...... ....+.+.+|++++++++||||+++++.+.++..+++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4889999999999999999986  445999998765433 3556789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.+++|.+++...   ..+++..+..++.|+++||.|||+++  ++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999998643   35889999999999999999999999  9999999999999999999999999988654432 


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....   .......  .......|..++..+.++
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  232 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDA  232 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHH
Confidence            22345688899999999988899999999999999999999999987764   2222222  225566778899999999


Q ss_pred             HHHhhhcCCCCCCCH--HHHH
Q 009291          500 IETCWAEEPEIRPSF--PSIM  518 (538)
Q Consensus       500 I~~cL~~dP~~RPs~--~eIl  518 (538)
                      |.+||+.+|.+||++  ++++
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             HHHHccCChhHcCCccHHHHh
Confidence            999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.8e-37  Score=306.58  Aligned_cols=250  Identities=31%  Similarity=0.521  Sum_probs=211.1

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||+|.++.  ..+|+|.+..........+.+.+|+.+++.++|+||+++++.+.+....++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            48899999999999999998865  4489998866544444556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-cEEEEeeCCCccCCCCcc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~~~  422 (538)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+  ++|+||||+||++++++ .+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999986432 234789999999999999999999999  99999999999998875 469999999887654333


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+. .....+.+..++..+.++|.+
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~  236 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQ  236 (257)
T ss_pred             cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHH
Confidence            3334568889999999988889999999999999999999999998777655554432 233334556788999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIME  519 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~  519 (538)
                      ||..+|++|||+.++++
T Consensus       237 ~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         237 LFKVSPRDRPSITSILK  253 (257)
T ss_pred             HhccChhhCcCHHHHhh
Confidence            99999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3e-37  Score=334.11  Aligned_cols=248  Identities=20%  Similarity=0.274  Sum_probs=192.2

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCC------CCceeEeecee
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR------HPNIVLLMGAV  331 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~------hpnIv~l~~~~  331 (538)
                      +.+...+|++.+.||+|+||+||+|.+..+  .||||++....   .....+..|+.+++.++      |.+++.+++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            345568899999999999999999988644  49999986432   22334556777776664      45688899888


Q ss_pred             ccC-CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCC-----
Q 009291          332 TEP-PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTY-----  404 (538)
Q Consensus       332 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~-----  404 (538)
                      ..+ ..+++|||++ +++|.+++...   ..+++..++.|+.||+.||+|||+ .|  ||||||||+|||++.++     
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccc
Confidence            654 4688999988 66888877532   358899999999999999999997 58  99999999999998765     


Q ss_pred             -----------cEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 009291          405 -----------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS  473 (538)
Q Consensus       405 -----------~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~  473 (538)
                                 .+||+|||.+......   .....||..|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERHS---RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCccc---cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                       4999999988653322   24567999999999999999999999999999999999999999887665


Q ss_pred             HHHHHHhhcCccc-------------------------C-CC--------------CCCcHHHHHHHHHhhhcCCCCCCC
Q 009291          474 QVISAVGFKGRRL-------------------------E-IP--------------KNVNPMVAALIETCWAEEPEIRPS  513 (538)
Q Consensus       474 ~~~~~i~~~~~~~-------------------------~-~p--------------~~~s~~l~~LI~~cL~~dP~~RPs  513 (538)
                      +....+......+                         . .+              ...++.+.+||.+||+.||++|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            4433221110000                         0 00              011356789999999999999999


Q ss_pred             HHHHHH
Q 009291          514 FPSIME  519 (538)
Q Consensus       514 ~~eIl~  519 (538)
                      ++|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999986

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-37  Score=313.54  Aligned_cols=250  Identities=25%  Similarity=0.381  Sum_probs=203.7

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||+|+||.||+|.+.+  ..+|+|++..........+.+.+|+++++.++|+||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            368999999999999999999864  449999876554444445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+++++|..+....   ..+++..++.++.|++.||+|||+.+  ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            99999998876533   23789999999999999999999999  99999999999999999999999999876544332


Q ss_pred             ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC------------------
Q 009291          423 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------------  483 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~------------------  483 (538)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....                  
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            2334567889999999875 346889999999999999999999997665433322211000                  


Q ss_pred             -cc----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 -RR----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 -~~----------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       ..          ....+.++..+.+|+.+||+.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             00          0112357889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.8e-37  Score=309.51  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=210.0

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC---CceEEEEEeccc--------cCHHHHHHHHHHHHHHHc-CCCCceeEeeceecc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN---SDVAVKILIEQE--------FHEDRFKEFLREVAIMKG-LRHPNIVLLMGAVTE  333 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~---~~vavK~~~~~~--------~~~~~~~~~~~Ei~il~~-L~hpnIv~l~~~~~~  333 (538)
                      .|++.+.||+|+||.||+|.+..   ..+|+|.+....        ........+.+|+.++.+ ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999865   348999875432        233445677889988875 799999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEee
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDF  411 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DF  411 (538)
                      +...+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+  ++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999987431 223458899999999999999999996 77  999999999999999999999999


Q ss_pred             CCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          412 GLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       412 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      |.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+............
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM  237 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence            9997654432 224556888999999999888999999999999999999999999887766555554322222222236


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      +++++.++|.+||+.||++||++.++..+++
T Consensus       238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            7899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-38  Score=325.59  Aligned_cols=261  Identities=35%  Similarity=0.544  Sum_probs=222.2

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      .++..+...++++||+|.||.|.+++..+ ..||||+++.... .....+|.+|+++|.+|+||||++++++|..++.++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            35677889999999999999999998876 6799999876543 334589999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +++||+++|+|..++....... ........|+.||+.|++||.+.+  +|||||.++|||+++++++||+|||.++...
T Consensus       612 mI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccc
Confidence            9999999999999997654322 344556679999999999999999  9999999999999999999999999999655


Q ss_pred             CCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhhc------CcccCC
Q 009291          419 NTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTPSQVISAVGFK------GRRLEI  488 (538)
Q Consensus       419 ~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt--g~~Pf~~~~~~~~~~~i~~~------~~~~~~  488 (538)
                      .+...  ....+-+.+|||||.+.-+++++++|||+||+++||+++  ...||...+.++++......      ..-+..
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence            44322  123345789999999999999999999999999999875  68999999888877654311      112446


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       489 p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      |.-|+..++++|.+||..+-++||+++++...|++.
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            778999999999999999999999999999999875

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.1e-37  Score=305.72  Aligned_cols=249  Identities=31%  Similarity=0.487  Sum_probs=212.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      .+|++.+.||+|++|.||+|.+..  ..+++|++...... .....+.+|+.++.+++|+||+++++++.....++++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            368899999999999999998874  44999987665432 456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |+++++|.+++...   ..+++..++.++.|++.||+|||+ .+  ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          80 YMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            99999999999643   458999999999999999999999 99  9999999999999999999999999988655433


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhhcCcccCCCCC-CcHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---PSQVISAVGFKGRRLEIPKN-VNPMVA  497 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~-~s~~l~  497 (538)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++|..||....   ..+....+. .......+.. ++..+.
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~  233 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFR  233 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHH
Confidence            33234567889999999999889999999999999999999999998774   333333332 3334445566 899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ++|.+||..+|++||++.++++.
T Consensus       234 ~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         234 DFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHHHHHccCChhhCCCHHHHHhC
Confidence            99999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.3e-37  Score=314.47  Aligned_cols=254  Identities=26%  Similarity=0.379  Sum_probs=209.9

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .+|++.+.||+|+||.||++.+..+  .|++|.+...... ....+.+.+|+.+++.++||||+++++.+..+..+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            3689999999999999999988754  4999988665432 334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999999643   35889999999999999999999999  9999999999999999999999999986421100


Q ss_pred             ---------------cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc
Q 009291          422 ---------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL  486 (538)
Q Consensus       422 ---------------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~  486 (538)
                                     .......++..|+|||.+.+..++.++||||||+++|||++|..||.+....+....+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                           00112356788999999988889999999999999999999999998887776666554332222


Q ss_pred             -CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          487 -EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       487 -~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                       ..+..++.++.++|.+||+.+|++||++.++.+.|+.
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             2223678999999999999999999997766666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-38  Score=333.09  Aligned_cols=252  Identities=29%  Similarity=0.436  Sum_probs=224.9

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      ......|.+...||+|.|++|.+|.+..  +.||||++.+...+....+.+.+|+++|+.++|||||+++.+......+|
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            3445689999999999999999998864  45999999998888888788999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+.+|.+++++...   +.+.+..+..++.|++.|++|||+++  |||||||++|||++.+.++||+|||++....
T Consensus       132 lV~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeec
Confidence            999999999999999743   35777899999999999999999999  9999999999999999999999999998876


Q ss_pred             CCccccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      .. ...++.+|++.|.|||++.+..| +.++|+||+|+++|.|++|..||.+.+-.+....+....  +.+|.-++.+..
T Consensus       207 ~~-~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk--~rIp~~ms~dce  283 (596)
T KOG0586|consen  207 YG-LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK--YRIPFYMSCDCE  283 (596)
T ss_pred             cc-ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee--ecccceeechhH
Confidence            43 34578899999999999999887 678999999999999999999999988877766664444  445566788999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ++|+++|..+|.+|+++++|.+.
T Consensus       284 ~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  284 DLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             HHHHHhhccCccccCCHHHhhhh
Confidence            99999999999999999999764

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4e-37  Score=309.19  Aligned_cols=249  Identities=25%  Similarity=0.354  Sum_probs=205.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||+|.+.  ++.+++|++..........+.+.+|+.++++++|+||+++++++.++..+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5889999999999999999875  44599999877655455567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc-
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-  422 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-  422 (538)
                      + +++|.+++....  ..+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9 999999986433  35899999999999999999999999  99999999999999999999999999887544321 


Q ss_pred             ccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-----------------
Q 009291          423 SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-----------------  484 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-----------------  484 (538)
                      ......++..|+|||.+.+. .++.++||||||+++|||++|..||...........+.....                 
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            12345688999999998654 468999999999999999999888877665443332211000                 


Q ss_pred             cc-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 RL-----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ~~-----------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..           ....+.+..+.++|.+||+.+|++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00           011346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.3e-37  Score=311.21  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=202.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||.|++|.||+|++..  ..+++|.+..........+.+.+|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            48899999999999999998864  4499998765543444446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +. ++|..++.... ...+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.+||+|||++.........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            96 58888875433 235889999999999999999999999  999999999999999999999999998765433322


Q ss_pred             cCCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Ccc----------------
Q 009291          424 SKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRR----------------  485 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~-~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~----------------  485 (538)
                      .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+... ...                
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            33445788999999887654 588999999999999999999999876654433222110 000                


Q ss_pred             ----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ----------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                ......+++++.++|.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                      0112356788999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-37  Score=314.29  Aligned_cols=250  Identities=27%  Similarity=0.447  Sum_probs=206.8

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ++.++|++.+.||+|+||+||++.+.  +..+|+|++.... .....+.+.+|+++++.++|+||+++++++.....+++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            34578999999999999999999887  4458998876543 34445788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||+ .+  ++||||||+||++++++.++|+|||++....
T Consensus        81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          81 CMEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            99999999999988643   358899999999999999999997 58  9999999999999999999999999986543


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhhcCcccC
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-----------QVISAVGFKGRRLE  487 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-----------~~~~~i~~~~~~~~  487 (538)
                      ...  .....|+..|+|||++.+..++.++|||||||++|++++|+.||......           +....+. ......
T Consensus       156 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  232 (284)
T cd06620         156 NSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPR  232 (284)
T ss_pred             hhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCC
Confidence            221  23456899999999998888999999999999999999999999865542           1111211 111222


Q ss_pred             CCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          488 IPK-NVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       488 ~p~-~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ++. .++.++.+||.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            333 378899999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=335.56  Aligned_cols=254  Identities=35%  Similarity=0.601  Sum_probs=222.9

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc-----eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      |..++..+.++||+|.||.|++|.|+.-.     ||||.+....... ....|++|+.+|.+|+|+|++++||++.+ ..
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            44456677899999999999999997422     8999987654433 67899999999999999999999999988 66


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      ..||||+++.|+|.+.|+. ..+..+.......++.||+.|+.||..++  +|||||-.+|+++-....|||+|||+.+.
T Consensus       185 ~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceec
Confidence            8999999999999999987 45566888889999999999999999999  99999999999999888999999999997


Q ss_pred             CCCCcccc---CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          417 KPNTYISS---KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       417 ~~~~~~~~---~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      .+......   ....-..-|+|||.+....++.++|||++||++|||++ |..||.+....+++..+. .+.+++-|+.|
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~c  340 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYC  340 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCC
Confidence            65443221   12233567999999999999999999999999999998 789999999999999998 88899999999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      ++.+++++..||..+|++||||..|.+.+
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            99999999999999999999999997443

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3e-37  Score=308.13  Aligned_cols=238  Identities=23%  Similarity=0.418  Sum_probs=191.6

Q ss_pred             EEEccCCcEEEEEEEEcCC--------------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          271 KKIGEGSFGTVYHAEWRNS--------------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~--------------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      +.||+|+||.||+|....+              .+++|++...  .....+.+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            3689999999999975321              2677765433  23445678899999999999999999999999899


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc-------EEEE
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-------VKVC  409 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~-------vkL~  409 (538)
                      .+++|||+++++|..++....  ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.       ++++
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeC
Confidence            999999999999998886432  35889999999999999999999999  999999999999986654       8999


Q ss_pred             eeCCCccCCCCccccCCCCCCCccccccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhhcCcccC
Q 009291          410 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELI-TLQKPWRNSTPSQVISAVGFKGRRLE  487 (538)
Q Consensus       410 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~-~~~~s~ksDVwSLGvil~eLl-tg~~Pf~~~~~~~~~~~i~~~~~~~~  487 (538)
                      |||++......    ....++..|+|||.+. +..++.++|||||||++|||+ .|..||......+... .  ......
T Consensus       155 d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~--~~~~~~  227 (262)
T cd05077         155 DPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-F--YEGQCM  227 (262)
T ss_pred             CCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-H--HhcCcc
Confidence            99998654322    2446788899999986 466899999999999999998 5888887665443322 1  112222


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       488 ~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      .....++++.+||.+||+.||++||++.+|++.+
T Consensus       228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            3344568899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.7e-37  Score=308.00  Aligned_cols=247  Identities=30%  Similarity=0.524  Sum_probs=210.3

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      -|++.+.||+|+||.||+|.+..  ..+|+|+..... .....+.+.+|+.++++++|+||+++++++.++..+++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            47788999999999999998754  448999875443 234557889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|.+++..    ..+++..+..++.|++.|++|||+.+  ++|+||+|+||+++.++.++|+|||++.........
T Consensus        84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            999999999863    24789999999999999999999999  999999999999999999999999998765443222


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. ......++..++.++.++|.+|
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHH
Confidence            234567889999999988888999999999999999999999998877655555442 2334445667899999999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 009291          504 WAEEPEIRPSFPSIMET  520 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~~  520 (538)
                      |+.+|++||++.+++..
T Consensus       237 l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         237 LNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ccCChhhCcCHHHHHhC
Confidence            99999999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-39  Score=335.62  Aligned_cols=249  Identities=28%  Similarity=0.516  Sum_probs=218.0

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      +.|.|+..||.|+||+||+|..+.++  .|-|++...  .++.++.|+-|++||...+||+||++++.|..++.++|+.|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            45778999999999999999988777  455665433  46677899999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      ||.||-...++-.-  ...+++.++.-+++|++.||.|||+++  |||||||..|||++-+|.++|+|||.+........
T Consensus       110 FC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             ecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            99999988876432  235999999999999999999999999  99999999999999999999999999877665555


Q ss_pred             ccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-ccCCCCCCcHHH
Q 009291          423 SSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMV  496 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l  496 (538)
                      ...+..||++|||||++.     ..+|+.++||||||++|.||..+.+|-...++..++..+..... .+-.|..++..+
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            567889999999999875     45789999999999999999999999999999888887754332 345678899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+|+.+||..||+.||++.+|++
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhh
Confidence            99999999999999999999875

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-37  Score=305.99  Aligned_cols=236  Identities=26%  Similarity=0.464  Sum_probs=192.6

Q ss_pred             EEEccCCcEEEEEEEEcCCc------------eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          271 KKIGEGSFGTVYHAEWRNSD------------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~~------------vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +.||+|+||.||+|.+..+.            +++|++.....   ....+.+|+.+++.++|+||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            46899999999999886544            56666543321   15788899999999999999999999887 7789


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-------cEEEEee
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-------TVKVCDF  411 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-------~vkL~DF  411 (538)
                      +||||+++++|.+++.....  .+++..+..++.|++.||+|||+++  |+||||||+||+++.++       .+||+||
T Consensus        77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCC
Confidence            99999999999999864332  5888999999999999999999999  99999999999999887       7999999


Q ss_pred             CCCccCCCCccccCCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCC
Q 009291          412 GLSRSKPNTYISSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEI  488 (538)
Q Consensus       412 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~  488 (538)
                      |++.....    .....++..|+|||.+.+.  .++.++||||||+++|+|++ |..||............. .  ....
T Consensus       153 g~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~--~~~~  225 (259)
T cd05037         153 GIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-D--QHRL  225 (259)
T ss_pred             Cccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-c--CCCC
Confidence            99886543    2234567789999999876  78999999999999999999 588887765433322221 1  1222


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       489 p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      +......+.++|.+||..+|++|||+.++++.|
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         226 PMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            333348899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.6e-38  Score=310.72  Aligned_cols=238  Identities=25%  Similarity=0.452  Sum_probs=195.3

Q ss_pred             EEEccCCcEEEEEEEEcCC---------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          271 KKIGEGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~---------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +.||+|+||.||+|.+...         .+++|.....  .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            3689999999999976432         2677776432  2344567889999999999999999999999989999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc--------EEEEeeCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--------VKVCDFGL  413 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~--------vkL~DFGl  413 (538)
                      ||+.+|+|..+++....  .+++..++.++.|++.||+|||+++  |+||||||+||+++.++.        ++++|||+
T Consensus        79 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          79 EYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             ecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999999965432  5788999999999999999999999  999999999999987664        69999998


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      +......    ....++..|+|||.+.+. .++.++||||||+++|||++| ..||...........   ...+..+|..
T Consensus       155 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~  227 (258)
T cd05078         155 SITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF---YEDRHQLPAP  227 (258)
T ss_pred             ccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH---HHccccCCCC
Confidence            8654322    234678899999999864 578999999999999999998 466666555443322   2234556777


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      .+.++.+||.+||+.+|++|||+++|++.|
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         228 KWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.1e-37  Score=301.57  Aligned_cols=251  Identities=32%  Similarity=0.519  Sum_probs=217.8

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||.|+||.||++.+.  +..+++|++..........+.+.+|+++++.++|+|++++.+.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5889999999999999999987  45599999877666666777899999999999999999999999998999999999


Q ss_pred             cCCCChhhhhcCCC-CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          344 LSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       344 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      +++++|.+++.... ....+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            99999999986432 1346899999999999999999999999  99999999999999999999999999987554432


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......+...... ......++..++..+.++|.+
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~  237 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSS  237 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence            3344568889999999998889999999999999999999999998877666555543 333455667889999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIME  519 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~  519 (538)
                      ||..+|++|||+.++++
T Consensus       238 ~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         238 LLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HcCCChhhCcCHHHHhc
Confidence            99999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.5e-37  Score=311.49  Aligned_cols=249  Identities=26%  Similarity=0.318  Sum_probs=203.1

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC---HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~---~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      +|++.+.||+|+||.||+|.+..  +.+++|.+......   ......+.+|+.++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            47889999999999999998764  45999998765443   33345677899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+ +++|.+++....  ..+++..++.++.||++||.|||+++  ++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 889999996543  35889999999999999999999999  999999999999999999999999999876544


Q ss_pred             ccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc---------------
Q 009291          421 YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------------  484 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~---------------  484 (538)
                      ........++..|+|||.+.+ ..++.++|||||||++|+|++|..||......+....+.....               
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            333334456788999998865 4578999999999999999999888876665443332211000               


Q ss_pred             ------cc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 ------RL-----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ------~~-----~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                            ..     ......+.++.++|.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                  00     011345788999999999999999999999977

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-37  Score=309.80  Aligned_cols=246  Identities=33%  Similarity=0.520  Sum_probs=206.0

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||++.+..  ..+++|.+.... .....+.+.+|++++++++||||+++++.+.....+++++||
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            57788999999999999999874  448999876653 235567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      +.+++|.+++....  ..+++..+..++.|++.||+|||+ .+  ++|+||||+||++++++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999999986442  468899999999999999999999 89  99999999999999999999999999876533221


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhhcCcccCCCCC-CcHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-----PSQVISAVGFKGRRLEIPKN-VNPMV  496 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~p~~-~s~~l  496 (538)
                        ....++..|+|||.+.+..++.++||||||+++|+|++|..||....     ..+....+ ........+.. ++.++
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCCCCCChhhcCHHH
Confidence              22668889999999999999999999999999999999999997652     22222222 22333344444 88999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .++|.+||..+|++|||+.+++.
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhh
Confidence            99999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.6e-37  Score=306.47  Aligned_cols=249  Identities=31%  Similarity=0.518  Sum_probs=204.2

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC--------HHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH--------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~--------~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      +|.+.+.||+|+||.||+|....  ..+|+|.+......        ....+.+.+|+.+++.++|+||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            57889999999999999998753  45999987542211        123457889999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..++||||+.+++|.+++...   ..+++..+..++.|++.||.|||+++  ++||||+|+||+++.++.++|+|||++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999998644   35889999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCCcc--ccCCCCCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--
Q 009291          416 SKPNTYI--SSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--  489 (538)
Q Consensus       416 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~--~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--  489 (538)
                      .......  ......++..|+|||.+....  ++.++|+||||+++|++++|..||......+....+........++  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD  236 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence            6543221  122345788999999987654  7899999999999999999999997665554444333232333333  


Q ss_pred             --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          490 --KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       490 --~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                        ..++.++.++|.+||..+|++|||++++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         237 VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence              346899999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.5e-37  Score=308.68  Aligned_cols=249  Identities=26%  Similarity=0.472  Sum_probs=197.8

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHH-HHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAI-MKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~i-l~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++.+.||+|+||.||+|.+..  ..||+|.+......... ..+..|+.+ ++.++|+||+++++++..+...+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            368999999999999999999864  44999988765433333 345556554 66678999999999999999999999


Q ss_pred             eecCCCChhhhhcC-CCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          342 EYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       342 E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      ||++ ++|.+++.. ......+++..++.++.|++.||+|||++ +  ++||||||+||+++.++.+||+|||++.....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9996 588877743 22234689999999999999999999997 8  99999999999999999999999999886543


Q ss_pred             CccccCCCCCCCcccccccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhhcCcccCCC-CCCc
Q 009291          420 TYISSKTAAGTPEWMAPEVLRE----DPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIP-KNVN  493 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~----~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~p-~~~s  493 (538)
                      .. ......++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||..... .+...... ......++ ..++
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (283)
T cd06617         157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS  234 (283)
T ss_pred             cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence            22 1223567889999998865    4468899999999999999999999975432 22222221 22223333 3578


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .++.++|.+||..+|++||++.++++
T Consensus       235 ~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         235 PEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999999976

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.5e-37  Score=308.71  Aligned_cols=252  Identities=31%  Similarity=0.447  Sum_probs=204.4

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccC-----
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP-----  334 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~-----  334 (538)
                      ..++|++.+.||+|+||.||++....  ..+|+|++....   .....+.+|+.++.++ +|+||+++++++...     
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            35789999999999999999998864  448999875432   2234677899999998 799999999988643     


Q ss_pred             CcceEEEeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ..+++||||+++++|.++++.. .....+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~  174 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGV  174 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeeccc
Confidence            3589999999999999988532 12335889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-CcccC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLRED-----PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLE  487 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-----~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~  487 (538)
                      +..............++..|+|||.+...     .++.++|||||||++|||++|+.||...........+... .....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  254 (291)
T cd06639         175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL  254 (291)
T ss_pred             chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence            88654433233445688999999998643     3688999999999999999999999887765555444222 12233


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       488 ~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+..++..+.++|.+||+.+|++||++.+++.
T Consensus       255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            45567789999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=321.98  Aligned_cols=246  Identities=29%  Similarity=0.489  Sum_probs=218.7

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      |.++++||+|+||.||+|.++.++  +|+|.+..    +...+++..|+.||.+.+.++||++|+.+.....+++|||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            567889999999999999888766  77777643    456778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS  424 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~  424 (538)
                      ..|+..+.++...  .++.++++..++...+.||+|||...  =||||||..|||++.+|..||+|||.|....+.....
T Consensus       111 GAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  111 GAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             CCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence            9999999997543  46999999999999999999999988  8999999999999999999999999999888877777


Q ss_pred             CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-ccCCCCCCcHHHHHHHHHh
Q 009291          425 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~~LI~~c  503 (538)
                      .+..||+.|||||++..-.|+.++||||||++..||..|++||....+...+..+..... .+..|..++.++.+||++|
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C  266 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC  266 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence            888999999999999999999999999999999999999999999888776666643322 2345667899999999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 009291          504 WAEEPEIRPSFPSIMET  520 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~~  520 (538)
                      |-.+|++|.|+.++++.
T Consensus       267 LiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  267 LIKKPEERKTALRLCEH  283 (502)
T ss_pred             hcCCHHHHHHHHHHhhh
Confidence            99999999999998763

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=335.93  Aligned_cols=242  Identities=31%  Similarity=0.515  Sum_probs=209.6

Q ss_pred             EEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCCh
Q 009291          272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL  349 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  349 (538)
                      .||+|.||+||.|++..+.  .|||.+...  +....+-+++|+.+.++|+|.|||+++|.+.++..+-|.||-.+||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            6999999999999998887  566665443  455567899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCccc--cHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc-CCCcEEEEeeCCCccCCCCccccCC
Q 009291          350 YKLLHIPDARVVV--DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       350 ~~~l~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      .++++..=  +++  .|..+.-+.+||++||.|||++.  |||||||-+|+|++ -.|.+||+|||-++....-..-+.+
T Consensus       660 SsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  660 SSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             HHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence            99996432  234  67888889999999999999999  99999999999996 5789999999998876654444567


Q ss_pred             CCCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          427 AAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNS-TPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~--~s~ksDVwSLGvil~eLltg~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      ..||..|||||++..++  |+.++|||||||++.||.||++||... +++..-.++.+-....++|..++.+.+.||.+|
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc  815 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC  815 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence            88999999999998654  889999999999999999999999765 444555666666677889999999999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 009291          504 WAEEPEIRPSFPSIME  519 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~  519 (538)
                      +.++|.+||++.+++.
T Consensus       816 Fepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  816 FEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCcccCccHHHhcc
Confidence            9999999999998864

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9e-37  Score=299.92  Aligned_cols=249  Identities=33%  Similarity=0.556  Sum_probs=214.5

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--CcceEEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIVT  341 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~~~lV~  341 (538)
                      +|++.+.||+|++|.||+|.+.  ++.+++|++..........+.+.+|+.++++++|+||+++++.+.+.  ..+++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4788899999999999999987  44599999876655556678899999999999999999999999888  8899999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999986443   6889999999999999999999999  9999999999999999999999999988765543


Q ss_pred             c--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          422 I--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       422 ~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      .  ......++..|+|||.+.+...+.++||||||+++|+|++|..||.... .......+........++..++..+.+
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD  235 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence            2  1344568899999999988889999999999999999999999998776 333333333334555677788999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +|.+||+.+|++||++.+++.
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhh
Confidence            999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=299.98  Aligned_cols=248  Identities=29%  Similarity=0.571  Sum_probs=215.2

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|++|.||++.+..  ..+++|.+..........+.+.+|++++++++|+|++++++++.+...++++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            48889999999999999998764  3499999877665556678899999999999999999999999998999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|.+++...   ..+++..++.++.|++.||.|||+.|  ++||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999998643   35899999999999999999999999  999999999999999999999999999876554333


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      .....++..|+|||.+.+...+.++||||||+++|+|++|..||............. ......++..+++.+.++|.+|
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQC  234 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHH
Confidence            344568889999999988888999999999999999999999998776555444443 2344556778899999999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 009291          504 WAEEPEIRPSFPSIME  519 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~  519 (538)
                      |..+|++|||+.+++.
T Consensus       235 l~~~p~~R~~~~~~l~  250 (254)
T cd06627         235 FQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HhCChhhCcCHHHHhc
Confidence            9999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4e-37  Score=309.47  Aligned_cols=237  Identities=24%  Similarity=0.428  Sum_probs=191.9

Q ss_pred             EEccCCcEEEEEEEEcC--------------------------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCcee
Q 009291          272 KIGEGSFGTVYHAEWRN--------------------------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV  325 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~--------------------------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv  325 (538)
                      .||+|+||.||+|....                          ..+++|++...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            58999999999986421                          12677776433  233446788999999999999999


Q ss_pred             EeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-
Q 009291          326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-  404 (538)
Q Consensus       326 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-  404 (538)
                      ++++++.+....++||||+++++|..++....  ..+++..+..++.|++.||+|||+++  |+||||||+||++++.+ 
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCc
Confidence            99999999999999999999999999886432  35788999999999999999999999  99999999999997643 


Q ss_pred             ------cEEEEeeCCCccCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHH
Q 009291          405 ------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELI-TLQKPWRNSTPSQVI  476 (538)
Q Consensus       405 ------~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLl-tg~~Pf~~~~~~~~~  476 (538)
                            .+||+|||++......    ....++..|+|||.+.+ ..++.++||||||+++||++ +|..||......+..
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             ccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                  4899999987643222    23456788999998865 56899999999999999995 689999877665443


Q ss_pred             HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          477 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       477 ~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      ....   .....+...++.+.++|.+||+.+|++|||+.+|++.|
T Consensus       232 ~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         232 RFYE---KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHH---hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            3221   22334555678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.9e-37  Score=305.03  Aligned_cols=247  Identities=28%  Similarity=0.431  Sum_probs=194.1

Q ss_pred             EEccCCcEEEEEEEEcCC-c---eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCC
Q 009291          272 KIGEGSFGTVYHAEWRNS-D---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~~-~---vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      .||+|+||+||+++.... .   +++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            699999999999975433 2   3445443322 2344578999999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCC-CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC--cccc
Q 009291          348 SLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISS  424 (538)
Q Consensus       348 sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~--~~~~  424 (538)
                      +|.++++.... ....++..++.++.|++.||+|||+++  ++||||||+|||++.++.+||+|||++......  ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999864322 234667788899999999999999999  999999999999999999999999998643221  1112


Q ss_pred             CCCCCCCcccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcC----cccCCCCCC
Q 009291          425 KTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG----RRLEIPKNV  492 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~-------~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~~  492 (538)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||......+....+....    .+..++..+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            34567889999998753       235789999999999999997 577888777665555432221    122334457


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      ++.+.+++..|| .+|++||++++|++.|.
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            889999999999 68999999999988874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.7e-37  Score=314.60  Aligned_cols=243  Identities=23%  Similarity=0.391  Sum_probs=184.7

Q ss_pred             EEEEccCCcEEEEEEEEcC----CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc--CCcceEEEee
Q 009291          270 KKKIGEGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIVTEY  343 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~----~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--~~~~~lV~E~  343 (538)
                      +++||+|+||+||+|++..    ..+|+|.+......    ..+.+|+.++++++||||+++++++..  +..++++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            4689999999999998653    34899987654322    356789999999999999999998854  4558899999


Q ss_pred             cCCCChhhhhcCCC------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE----cCCCcEEEEeeCC
Q 009291          344 LSRGSLYKLLHIPD------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL  413 (538)
Q Consensus       344 ~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl----~~~~~vkL~DFGl  413 (538)
                      +.+ +|.+++....      ....+++..+..++.||+.||+|||++|  |+||||||+|||+    +.++.+||+|||+
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            864 7877764321      1235889999999999999999999999  9999999999999    4567899999999


Q ss_pred             CccCCCCcc---ccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH-
Q 009291          414 SRSKPNTYI---SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPS---------QVISAV-  479 (538)
Q Consensus       414 a~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~---------~~~~~i-  479 (538)
                      ++.......   ......+|..|+|||++.+. .++.++||||+||++|+|++|+.||......         .....+ 
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            986543221   12345789999999998774 5899999999999999999999999754321         000000 


Q ss_pred             hhcCc-------------------------cc----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          480 GFKGR-------------------------RL----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       480 ~~~~~-------------------------~~----------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ...+.                         ..          ......+..+.+||++||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000                         00          000123457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.1e-37  Score=304.50  Aligned_cols=241  Identities=28%  Similarity=0.447  Sum_probs=206.5

Q ss_pred             EccCCcEEEEEEEEc--CCceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCCh
Q 009291          273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL  349 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  349 (538)
                      ||.|+||.||++.+.  +..+++|++...... ....+.+.+|+.+++.++|+||+++++.+.++..+++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999987  455999998765432 34456799999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCC
Q 009291          350 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG  429 (538)
Q Consensus       350 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~g  429 (538)
                      .+++...   ..+++..+..++.|++.||+|||+++  ++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~  154 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCG  154 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccC
Confidence            9999643   24789999999999999999999999  9999999999999999999999999998765432 2234567


Q ss_pred             CCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcC
Q 009291          430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST--PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE  507 (538)
Q Consensus       430 t~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~d  507 (538)
                      +..|++||.+.+..++.++|+||||+++|+|++|..||....  .......+.........|..+++++.++|.+||+.+
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence            889999999988889999999999999999999999998776  444444444335566777778999999999999999


Q ss_pred             CCCCCC-----HHHHHH
Q 009291          508 PEIRPS-----FPSIME  519 (538)
Q Consensus       508 P~~RPs-----~~eIl~  519 (538)
                      |++||+     +.|+++
T Consensus       235 p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         235 PEERLGNLKGGIKDIKK  251 (262)
T ss_pred             hhhCcCCcccCHHHHhc
Confidence            999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.2e-37  Score=302.23  Aligned_cols=249  Identities=29%  Similarity=0.504  Sum_probs=214.2

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|+||.||++.+..+  .+++|.+............+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            488999999999999999987644  489999876655556667888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          344 LSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       344 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      +++++|.+++... .....+++..++.++.|++.||+|||+.|  ++|+||+|+||+++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN--  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence            9999999988542 12345889999999999999999999999  999999999999999999999999999876554  


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+. .......+..++.++.++|.+
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRS  235 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHH
Confidence            2234568889999999999889999999999999999999999999887766555543 233334556788999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIME  519 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~  519 (538)
                      ||+.+|++||++.+++.
T Consensus       236 ~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         236 MLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HcCCCcccCCCHHHHhc
Confidence            99999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.1e-37  Score=314.45  Aligned_cols=247  Identities=28%  Similarity=0.464  Sum_probs=205.3

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      .|.....||+|+||.||++.+..  ..+|+|.+....  ....+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            34445779999999999998754  449999875432  34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|.+++...    .+++..++.++.|++.||+|||+++  |+||||||+||++++++.++|+|||++.........
T Consensus       101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658         101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            9999999988532    4788999999999999999999999  999999999999999999999999998765433322


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-CcccCCCCCCcHHHHHHHHH
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~~LI~~  502 (538)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||...........+... .........++..+.++|.+
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            33456889999999998888999999999999999999999999887765554443221 12222334578899999999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~~  520 (538)
                      ||..+|.+|||+.++++.
T Consensus       255 ~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         255 MLVREPSQRATAQELLQH  272 (292)
T ss_pred             HccCChhHCcCHHHHhhC
Confidence            999999999999999763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=302.89  Aligned_cols=249  Identities=29%  Similarity=0.487  Sum_probs=208.9

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccc---cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--Ccc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQE---FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNL  337 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~---~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~~  337 (538)
                      .+|++.+.||+|+||.||+|.+..  ..+++|++....   ........+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            478999999999999999998764  449999875432   2344567889999999999999999999998654  458


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++++||+++++|.+++...   ..+++..+..++.|++.||.|||+++  ++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            8999999999999988633   24788899999999999999999999  999999999999999999999999999764


Q ss_pred             CCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          418 PNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       418 ~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      .....   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.....+..+|..+++
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~  236 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD  236 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence            32211   112345788999999999888999999999999999999999999887666655555444455667888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ++.++|.+||. +|.+||++.+++.
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHHHHHhc-CcccCccHHHHhc
Confidence            99999999999 5799999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=312.12  Aligned_cols=245  Identities=28%  Similarity=0.464  Sum_probs=217.6

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+..++|..++.||+|.||+|-+++.+.++  ||+|++++.-. ..+.++.-+.|-++|+..+||.+..+-..|+..+.+
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            345678889999999999999999887554  99999877644 456677788899999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+||||..||.|.-.|.+.   ..+++....-+-..|+.||.|||+++  ||.||||.+|+|++++|++||+|||+++..
T Consensus       244 CFVMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhc
Confidence            9999999999998888643   35889999999999999999999999  999999999999999999999999999875


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      -.......+.+||+.|+|||++....|+..+|+|.+||++|||++|+.||...........|  ....+.+|..++++++
T Consensus       319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI--l~ed~kFPr~ls~eAk  396 (516)
T KOG0690|consen  319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI--LMEDLKFPRTLSPEAK  396 (516)
T ss_pred             ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH--HhhhccCCccCCHHHH
Confidence            44444567899999999999999999999999999999999999999999988776666665  3456788999999999


Q ss_pred             HHHHHhhhcCCCCCC
Q 009291          498 ALIETCWAEEPEIRP  512 (538)
Q Consensus       498 ~LI~~cL~~dP~~RP  512 (538)
                      .|+..+|..||.+|.
T Consensus       397 tLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  397 TLLSGLLKKDPKKRL  411 (516)
T ss_pred             HHHHHHhhcChHhhc
Confidence            999999999999994

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.5e-37  Score=305.28  Aligned_cols=249  Identities=29%  Similarity=0.509  Sum_probs=205.0

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC----HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH----EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~----~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      +|+..+.||+|+||.||++.+..  ..+|+|++......    ....+.+.+|+.++++++|+||+++++++.+...+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            47788999999999999998753  45999988653321    2345788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-cEEEEeeCCCccCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKP  418 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~  418 (538)
                      |+||+.+++|.+++...   ..+++..++.++.|++.||+|||++|  ++|+||+|+||+++.++ .+||+|||.+....
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999998643   35789999999999999999999999  99999999999998775 69999999987654


Q ss_pred             CCcc----ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhhcCcccCCCCC
Q 009291          419 NTYI----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGRRLEIPKN  491 (538)
Q Consensus       419 ~~~~----~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~---~~~~i~~~~~~~~~p~~  491 (538)
                      ....    ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......   ..............+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence            3211    1123457889999999988889999999999999999999999997543322   22222222334556677


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +++++.+++.+||..+|++||++.++++
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            8899999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-37  Score=307.85  Aligned_cols=246  Identities=29%  Similarity=0.513  Sum_probs=204.6

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCC---CCceeEeeceeccCCcceEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .|++.+.||+|+||.||+|.+..  ..+++|.+.... .....+.+.+|+.+++.++   |+||+++++++.+...+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            47788999999999999999854  449999876542 3344567889999999986   99999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+++++|.++++..    .+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999999998642    5889999999999999999999999  999999999999999999999999998765544


Q ss_pred             ccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCC-CCcHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK-NVNPMVAA  498 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~s~~l~~  498 (538)
                      ........|+..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.. .....++. .++.++.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  233 (277)
T cd06917         155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDNGYSKLLRE  233 (277)
T ss_pred             ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCcccCCHHHHH
Confidence            3333445688999999998654 468899999999999999999999987766544433321 12222333 37889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +|.+||+.||++||++.++++
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhh
Confidence            999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.6e-37  Score=310.95  Aligned_cols=250  Identities=26%  Similarity=0.341  Sum_probs=203.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--CcceEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIV  340 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~~~lV  340 (538)
                      ++|++.+.||+|+||.||+|.+..+  .+++|.+............+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            5788999999999999999998744  489998876544444445677899999999999999999998777  789999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+.+ +|.+++....  ..+++..++.++.|++.||+|||+++  ++|+||||+||+++.++.+||+|||++......
T Consensus        85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999975 8988886433  25899999999999999999999999  999999999999999999999999998876544


Q ss_pred             ccccCCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----------------
Q 009291          421 YISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-----------------  482 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~-~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-----------------  482 (538)
                      ........++..|+|||.+.+.. ++.++||||||+++|+|++|..||......+....+...                 
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence            32333456788999999987654 689999999999999999999999877665444332100                 


Q ss_pred             ------------CcccCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 ------------GRRLEIPKN-VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ------------~~~~~~p~~-~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                  .....++.. +++.+.++|++||+.+|++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                        000112222 5888999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.7e-38  Score=313.37  Aligned_cols=244  Identities=27%  Similarity=0.413  Sum_probs=194.9

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--C---cce
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--P---NLS  338 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~---~~~  338 (538)
                      .|.-.+.+|.|+||.||.|....+  .+|||..-.....      --+|+++|+.++|||||+++.+|...  .   ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            577789999999999999987654  4999987544322      22799999999999999999987432  1   356


Q ss_pred             EEEeecCCCChhhhhcC-CCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC-CcEEEEeeCCCcc
Q 009291          339 IVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRS  416 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~~  416 (538)
                      +||||++. +|+..++. ...+..++.-.+.-+.+||++||+|||+.|  |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            89999976 88888852 222345777788889999999999999999  9999999999999865 9999999999998


Q ss_pred             CCCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-C-----------
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-G-----------  483 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~-----------  483 (538)
                      ...+..+ .+..-|..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+..+.+..+... +           
T Consensus       176 L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  176 LVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             eccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            6655433 456678999999998875 5899999999999999999999999987765544333211 0           


Q ss_pred             ---cccC------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 ---RRLE------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ---~~~~------------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                         ....            +....+++..+|+.++|..+|.+|.++.|++.
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence               0111            22356789999999999999999999988864

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.4e-37  Score=308.47  Aligned_cols=252  Identities=26%  Similarity=0.296  Sum_probs=199.7

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCc-----
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPN-----  336 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~-----  336 (538)
                      ++|++.+.||+|+||.||+|.+..+  .||+|++............+.+|+.+++.+. |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3689999999999999999998644  4999987654433333457888999999995 6999999999876655     


Q ss_pred             ceEEEeecCCCChhhhhcCCCC--CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCC
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGL  413 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGl  413 (538)
                      .+++|||+++ +|.+++.....  ...+++..++.++.||+.||+|||+++  |+||||||+||+++. ++.+||+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence            8999999986 78887743221  245899999999999999999999999  999999999999998 88999999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc--------
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--------  484 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~--------  484 (538)
                      +..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8765433222234456888999998865 4578999999999999999999999987766554433211000        


Q ss_pred             --------------c----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 --------------R----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 --------------~----~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                    .    ....+.++.++.+||.+||..||.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                          0    0011357889999999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.7e-36  Score=309.46  Aligned_cols=247  Identities=28%  Similarity=0.448  Sum_probs=204.6

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccc-cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..|++.+.||+|+||+||+|.+.  +..||+|++.... ......+.+.+|+.+++.++||||+++.+++.+....++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888999999999999999875  4459999876443 33455678899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+. |++.+++....  ..+++..+..++.|++.||.|||+.+  ++||||+|+||++++++.+||+|||++...... 
T Consensus        95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9997 47777664322  24889999999999999999999999  999999999999999999999999998754322 


Q ss_pred             cccCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                         ....++..|+|||.+.   ...++.++||||||+++|||++|..||...+.......+.........+..++..+.+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN  245 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence               2446788999999874   3567889999999999999999999998877666555443322222223457889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +|.+||+.+|++||++.+|+..
T Consensus       246 li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         246 FVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHHhcCChhhCcCHHHHhcC
Confidence            9999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-37  Score=321.00  Aligned_cols=242  Identities=24%  Similarity=0.356  Sum_probs=190.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ...|++++.||+|+||.||+|.+.+++  ||+|+....        ....|+.++++++|+||+++++++.+....++||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            457999999999999999999987654  888874332        2346899999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |++. ++|.+++....  ..+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++......
T Consensus       137 e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        137 PHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            9995 57888775432  35889999999999999999999999  9999999999999999999999999987533221


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHH----------HHHHHHhh-cCcccCCC
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW-RNSTPS----------QVISAVGF-KGRRLEIP  489 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf-~~~~~~----------~~~~~i~~-~~~~~~~p  489 (538)
                       ......||..|+|||++.+..++.++|||||||++|||+++..|+ ......          .....+.. ......++
T Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence             223456899999999999999999999999999999999865554 321110          01110100 00000011


Q ss_pred             ------------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          490 ------------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       490 ------------------------------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                                    ..++..+.+||.+||+.||++|||+.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                                          134667788999999999999999999875

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.3e-37  Score=306.90  Aligned_cols=250  Identities=27%  Similarity=0.395  Sum_probs=202.5

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||.|++|.||+|++..+  .+|+|++..... ....+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            588999999999999999998644  499998865532 22335677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +.+ +|.+++........+++..+..++.|++.||+|||+++  ++||||||+||++++++.++|+|||++.........
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            985 88888765444456899999999999999999999999  999999999999999999999999999765433222


Q ss_pred             cCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC----------------ccc
Q 009291          424 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------------RRL  486 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~----------------~~~  486 (538)
                      .....++..|++||.+.+. .++.++||||||+++|+|++|..||...+..+....+....                ...
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            3345678899999988664 56899999999999999999999998766554433221100                000


Q ss_pred             C-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 E-----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ~-----------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .           +.+.++..+.++|.+||+.||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0           11245788999999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.1e-36  Score=311.12  Aligned_cols=251  Identities=26%  Similarity=0.345  Sum_probs=202.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--CcceE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSI  339 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~~~l  339 (538)
                      .++|++.+.||+|+||.||+|.+..  ..||+|++............+.+|+.++++++|+||+++++++.+.  +.+++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4689999999999999999998864  4599999875543333334567899999999999999999998654  45899


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      ||||+.+ +|.+++....  ..+++..++.++.|++.||+|||+.+  ++||||||+||++++++.+||+|||++.....
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999965 7888876432  35889999999999999999999999  99999999999999999999999999987554


Q ss_pred             CccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc--------------
Q 009291          420 TYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--------------  484 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~--------------  484 (538)
                      .........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+.....              
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            3222233445788999999865 4578999999999999999999999988877665544332100              


Q ss_pred             ---ccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 ---RLEIP-----------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ---~~~~p-----------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                         ...++           ...++++.+||.+||+.||++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               00111           125788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-36  Score=309.43  Aligned_cols=249  Identities=27%  Similarity=0.468  Sum_probs=207.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||.||++...  +..+++|.+....  ....+.+.+|+.++++++||||+++++.+......++|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            468999999999999999999865  3459999875432  233467889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++...    .+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.++|+|||++.......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            999999999998632    3778899999999999999999999  9999999999999999999999999887554332


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-CcccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~~LI  500 (538)
                      .......++..|+|||.+.+..++.++||||||+++|++++|..||...+.......+... ......+..++..+.++|
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  249 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence            2233446888999999998888999999999999999999999999877654433322211 112233445788999999


Q ss_pred             HHhhhcCCCCCCCHHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ++||..+|++||++.+++..
T Consensus       250 ~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         250 NRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHccCChhhCcCHHHHhcC
Confidence            99999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.7e-36  Score=295.36  Aligned_cols=247  Identities=32%  Similarity=0.564  Sum_probs=208.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|++.+.||+|++|.||++.+.  +..+++|++.....  ...+.+.+|+.+++.++|+||+++++++..+...++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            4788999999999999999986  44489998865433  4557889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|.+++....  ..+++..++.++.|++.||++||+.+  ++||||+|+||++++++.++|+|||.+........ 
T Consensus        79 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          79 CSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999999986542  35899999999999999999999999  99999999999999999999999999887654321 


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-CcccCCCCCCcHHHHHHHHH
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~~LI~~  502 (538)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+........... ......+..++..+.++|.+
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence            34556888999999999888999999999999999999999999887555544443321 11222223348999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIME  519 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~  519 (538)
                      ||+.||++|||+.++++
T Consensus       234 ~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         234 CLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-38  Score=331.64  Aligned_cols=245  Identities=29%  Similarity=0.511  Sum_probs=206.2

Q ss_pred             eEEEEEccCCcEEEEEEEEcCCceEEE--EEeccc--cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc--ceEEE
Q 009291          268 LIKKKIGEGSFGTVYHAEWRNSDVAVK--ILIEQE--FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN--LSIVT  341 (538)
Q Consensus       268 ~i~~~LG~G~fg~Vy~a~~~~~~vavK--~~~~~~--~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~--~~lV~  341 (538)
                      +....||+|+|-+||+|.+..+++.|.  .++...  ..+...+.|..|+.+|+.|+|+||++++++|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            346789999999999999877774432  222221  235556899999999999999999999999987766  77899


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCCCccCCCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~  420 (538)
                      |.+..|+|..|++..   ..+....+..|++||++||.|||++.|||||||||-+||+|+. .|.|||+|+|+|+.....
T Consensus       123 EL~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999999643   3588889999999999999999999999999999999999975 589999999999987655


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      .  .....||+.|||||.+. ..|++.+||||||+++.||+|+.+||.. .++.++..++..+..+-.+..--.+++++|
T Consensus       200 ~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~f  276 (632)
T KOG0584|consen  200 H--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREF  276 (632)
T ss_pred             c--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHH
Confidence            3  24478999999999987 6799999999999999999999999964 677788887765544444444446899999


Q ss_pred             HHHhhhcCCCCCCCHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~  519 (538)
                      |.+||.. .++|||+.++|.
T Consensus       277 IekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHhcC-chhccCHHHHhh
Confidence            9999999 999999999874

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=306.60  Aligned_cols=250  Identities=26%  Similarity=0.357  Sum_probs=197.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||.||+|.++  ++.||+|.+...... .....+.+|+++++.++|+||+++++++.+....++||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            367999999999999999999876  345999998654322 22235678999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+ +|.+++....  ..+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus        83 e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          83 EYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            99975 8988876433  25789999999999999999999999  9999999999999999999999999987643322


Q ss_pred             cccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhhc-C---------------
Q 009291          422 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFK-G---------------  483 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~-~~~~~~~i~~~-~---------------  483 (538)
                      .......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.... ..+....+... .               
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            22233456888999999875 457899999999999999999999997655 22222111100 0               


Q ss_pred             ---ccc---------CCCCCCc--HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 ---RRL---------EIPKNVN--PMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ---~~~---------~~p~~~s--~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                         ...         .....++  ..+.++|.+||+.+|++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               000         0001233  78899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=305.84  Aligned_cols=249  Identities=27%  Similarity=0.371  Sum_probs=201.3

Q ss_pred             eeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      |++.+.||.|++|.||+|.++  ++.+++|++............+.+|+.+++.++|+||+++++++.++...+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567899999999999999875  445999988765444444457888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS  424 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~  424 (538)
                      . ++|.+++..... ..+++..++.++.|++.||+|||+++  ++||||+|+||+++.++.++|+|||++..........
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            5 689888854321 35889999999999999999999999  9999999999999999999999999987654332222


Q ss_pred             CCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC--------------------
Q 009291          425 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG--------------------  483 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~--------------------  483 (538)
                      ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......+....                    
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            334568899999988664 56899999999999999999999998776544332221100                    


Q ss_pred             -------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 -------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 -------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                             ........++..+.++|.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                   000112456789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.1e-36  Score=306.34  Aligned_cols=251  Identities=27%  Similarity=0.400  Sum_probs=201.7

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||+|++|+||+|.+..+  .+++|.+..........+.+.+|++++++++|+||+++++++.+...+++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            5799999999999999999988644  49999876554444445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCCCccCCCCc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~  421 (538)
                      |+. ++|.+.+.... ...+++..++.++.||+.||+|||+++  ++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 47777764332 224678889999999999999999999  999999999999985 5679999999997654332


Q ss_pred             cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Cc---------------
Q 009291          422 ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR---------------  484 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~---------------  484 (538)
                      .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+... ..               
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY  237 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence            222345678899999988664 5789999999999999999999999877665544432110 00               


Q ss_pred             -----cc------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 -----RL------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 -----~~------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                           ..      ...+.+++++.++|.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 00      012456889999999999999999999999976

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-36  Score=306.67  Aligned_cols=249  Identities=30%  Similarity=0.510  Sum_probs=210.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ...|++.+.||+|+||.||+|.+.  +..+++|++.....   ..+.+.+|+++++.++|+||+++++.+......++++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            456888899999999999999987  45599999875433   4567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++....  ..+++..++.++.|++.||+|||+.|  ++|+||+|+||+++.++.++|+|||++.......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999997433  25889999999999999999999999  9999999999999999999999999887554332


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-ccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~~LI  500 (538)
                      .......++..|+|||.+.+..++.++||||||+++|+|++|..||...........+..... ....+..++..+.++|
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL  250 (286)
T ss_pred             hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence            222344578899999999988899999999999999999999999988776555444432221 2223344889999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||+.+|.+||++.++++
T Consensus       251 ~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         251 NKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHhccChhhCcCHHHHhh
Confidence            9999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.8e-37  Score=311.08  Aligned_cols=246  Identities=27%  Similarity=0.473  Sum_probs=205.6

Q ss_pred             eeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      |.....||+|+||.||++.+.  ++.+|+|++.....  ...+.+.+|+.+++.++||||+++++++..+...++++||+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            444557999999999999875  45599999865432  23456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS  424 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~  424 (538)
                      ++++|..++..    ..+++..++.++.|++.||+|||+++  ++||||||+||+++.++.+||+|||++..........
T Consensus       101 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659         101 QGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             CCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence            99999998753    24789999999999999999999999  9999999999999999999999999987554433233


Q ss_pred             CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cccCCCCCCcHHHHHHHHHh
Q 009291          425 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~~LI~~c  503 (538)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+.... .....+..++..+.++|.+|
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence            44568899999999998889999999999999999999999998777655554443211 12233456788999999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 009291          504 WAEEPEIRPSFPSIMET  520 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~~  520 (538)
                      |+.+|++||++.++++.
T Consensus       255 l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         255 LTREPQERATAQELLDH  271 (297)
T ss_pred             hcCCcccCcCHHHHhhC
Confidence            99999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=328.33  Aligned_cols=244  Identities=27%  Similarity=0.454  Sum_probs=210.8

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      |.-++.||.|+||.||-|++..+.  ||||.+..+.- ..+..+.++.|+..|.+++|||++.+-+++..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            445788999999999999886544  89999866543 345568899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      |- |+-.+++....  .++-+..+..|+.+.+.||+|||+.+  .||||||..|||+++.|.|||+|||.|......   
T Consensus       108 Cl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  108 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             Hh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            96 47778775432  35889999999999999999999999  999999999999999999999999998765432   


Q ss_pred             cCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          424 SKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                       .+.+||+.|||||++.   .+.|+-++||||||++..||...++|+...+....+..|.-...+.-...++++.+.+|+
T Consensus       180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv  258 (948)
T KOG0577|consen  180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  258 (948)
T ss_pred             -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence             5789999999999875   577999999999999999999999999999988888777544333333467899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..||+.-|.+|||.+++++
T Consensus       259 d~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  259 DSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHHhhCcccCCcHHHHhh
Confidence            9999999999999998875

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.5e-36  Score=305.21  Aligned_cols=246  Identities=29%  Similarity=0.471  Sum_probs=205.6

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      .|...+.||+|++|.||++.+..  ..+++|++...  .....+.+.+|+.+++.++|+||+++++++......++++||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            45556799999999999998754  44899987543  233446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +.+++|.+++..    ..+++..+..++.|++.||+|||+++  ++||||+|+||+++.++.++|+|||.+.........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          98 LEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            999999999864    24788999999999999999999999  999999999999999999999999988755433222


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-ccCCCCCCcHHHHHHHHH
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIET  502 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~~LI~~  502 (538)
                      .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..... ....+..++..+.++|++
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence            3345688999999999888899999999999999999999999988776655554432211 122233478999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIME  519 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~  519 (538)
                      ||+.+|++||++.++++
T Consensus       252 ~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         252 MLVRDPAQRATAAELLN  268 (285)
T ss_pred             HcccChhhCcCHHHHcc
Confidence            99999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-36  Score=326.04  Aligned_cols=244  Identities=22%  Similarity=0.298  Sum_probs=193.2

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ...|.+.+.||+|+||.||++.+...+  ||||....        ..+.+|++++++++|+||+++++++......++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            457999999999999999999987544  88885321        24568999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |++. ++|..++....  ..+++..++.++.|++.||+|||++|  ||||||||+|||++.++.+||+|||+++......
T Consensus       240 e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        240 PKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             EccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            9995 68888775332  25899999999999999999999999  9999999999999999999999999997643321


Q ss_pred             c--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhhcCcc-cCCC-
Q 009291          422 I--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST--------PSQVISAVGFKGRR-LEIP-  489 (538)
Q Consensus       422 ~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~--------~~~~~~~i~~~~~~-~~~p-  489 (538)
                      .  ......||..|+|||++.+..++.++|||||||++|||++|..|+....        ..++...+...... ..++ 
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            1  1223568999999999999999999999999999999999876543211        12222222111100 0000 


Q ss_pred             ------------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          490 ------------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       490 ------------------------------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                                                    ..++..+.+||.+||+.||++|||+.|+++.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                                          1345688999999999999999999999863

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.3e-36  Score=302.20  Aligned_cols=249  Identities=30%  Similarity=0.480  Sum_probs=200.8

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc--CCcceEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIV  340 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--~~~~~lV  340 (538)
                      ++|+..+.||.|++|.||++.+..+  .+|+|.+..... ......+.+|++++++++|+||+++++++.+  ...+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            3688999999999999999998643  489998765432 3445778999999999999999999998754  3468999


Q ss_pred             EeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          341 TEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      |||+++++|.+++... .....+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999999887431 22345788999999999999999999999  99999999999999999999999999875433


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhhcCcccCCC-----
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-----PSQVISAVGFKGRRLEIP-----  489 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~p-----  489 (538)
                      ..  .....++..|+|||.+.+..++.++||||||+++|+|++|..||....     ..+....+. ......++     
T Consensus       158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (287)
T cd06621         158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDEPGN  234 (287)
T ss_pred             cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccCCCC
Confidence            22  123457889999999998899999999999999999999999997652     222222221 11111111     


Q ss_pred             -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          490 -KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       490 -~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       ..+++.+.++|.+||..+|++|||+.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             234678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.6e-36  Score=304.11  Aligned_cols=250  Identities=26%  Similarity=0.332  Sum_probs=195.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..+|++.+.||+|+||.||+|.+.  +..+++|++..... ......+.+|+.+++.++|+||+++++++.++...++||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            367999999999999999999875  44599999865432 222235678999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+. +++.+++....  ..+.+..+..++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9996 56766654322  24678888899999999999999999  9999999999999999999999999987644332


Q ss_pred             cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhh-cC---------------
Q 009291          422 ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGF-KG---------------  483 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~-~~~i~~-~~---------------  483 (538)
                      .......++..|+|||.+.+. .++.++||||||+++|+|++|..||........ ...+.. .+               
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            233445678899999998764 478899999999999999999999976554211 111100 00               


Q ss_pred             -----cccCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 -----RRLEIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 -----~~~~~p---------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                           .....+         ...+..+.+++.+||..||++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                 000000         012568899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.1e-36  Score=314.07  Aligned_cols=248  Identities=26%  Similarity=0.336  Sum_probs=199.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC------C
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~------~  335 (538)
                      ..+|++.+.||+|+||.||+|.+..  ..+|+|++..........+.+.+|+.++++++|+||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            4679999999999999999998864  4499998865544455566788999999999999999999987643      3


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..|+||||+.+ +|.+.+...     +++..+..++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccce
Confidence            47999999964 787776422     788899999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------  482 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-------------  482 (538)
                      ....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...             
T Consensus       167 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         167 TAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            6544322 23456788999999999999999999999999999999999999876543322221100             


Q ss_pred             -------Cccc--------------CC-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          483 -------GRRL--------------EI-------PKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       483 -------~~~~--------------~~-------p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                             ..+.              ..       +...++.+.++|.+||+.||++|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   0000              00       11346678999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-36  Score=302.50  Aligned_cols=248  Identities=29%  Similarity=0.488  Sum_probs=210.9

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc--CCceEEEEEecccc-CHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ++|++.+.||+|+||.||+|.+.  +..+++|++..+.. .....+.+.+|+.++++++ |+||+++++++..+...++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999885  44599999866433 3344567889999999998 99999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+.+++|.+++....   .+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999996432   5899999999999999999999999  999999999999999999999999998765432


Q ss_pred             cc--------------------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q 009291          421 YI--------------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG  480 (538)
Q Consensus       421 ~~--------------------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~  480 (538)
                      ..                    ......++..|+|||.+.+...+.++||||||+++|++++|+.||...........+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            21                    1123356889999999988889999999999999999999999999877655544442


Q ss_pred             hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 009291          481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF----PSIME  519 (538)
Q Consensus       481 ~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~----~eIl~  519 (538)
                        .....++..+++.+.+||.+||+.+|.+||++    .+++.
T Consensus       236 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         236 --KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              34556778889999999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2e-36  Score=309.50  Aligned_cols=243  Identities=22%  Similarity=0.382  Sum_probs=184.0

Q ss_pred             EEEEccCCcEEEEEEEEcC----CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec--cCCcceEEEee
Q 009291          270 KKKIGEGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPPNLSIVTEY  343 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~----~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~--~~~~~~lV~E~  343 (538)
                      +.+||+|+||+||+|+...    ..+|+|.+.....    ...+.+|+.++++++||||+++++++.  .+..+++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            4689999999999998653    3489998764432    235678999999999999999999874  35568999999


Q ss_pred             cCCCChhhhhcCC------CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE----cCCCcEEEEeeCC
Q 009291          344 LSRGSLYKLLHIP------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL  413 (538)
Q Consensus       344 ~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl----~~~~~vkL~DFGl  413 (538)
                      +.+ +|.+++...      .....+++..++.++.|++.||+|||+++  |+||||||+||++    +.++.+||+|||+
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            865 777766321      12235789999999999999999999999  9999999999999    5667999999999


Q ss_pred             CccCCCCcc---ccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------HHHHH
Q 009291          414 SRSKPNTYI---SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----------VISAV  479 (538)
Q Consensus       414 a~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~----------~~~~i  479 (538)
                      ++.......   ......+|..|+|||.+.+. .++.++|||||||++|||++|+.||.......          .....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            986543321   12345678999999998764 57899999999999999999999997543210          00000


Q ss_pred             hhcC-------------------------ccc----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          480 GFKG-------------------------RRL----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       480 ~~~~-------------------------~~~----------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ...+                         ...          ......+..+.+||.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            0000                         000          001123456889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.3e-36  Score=307.59  Aligned_cols=250  Identities=25%  Similarity=0.425  Sum_probs=207.0

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..|...+.||+|+||.||++++..  ..+|+|++..... .....+.+.+|+++++.++|+|++++++++.++...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            347788999999999999998764  3489998765432 3445567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+ +|.+++...  ...+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.+||+|||++...... 
T Consensus       105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            99975 777776432  234889999999999999999999999  999999999999999999999999988754332 


Q ss_pred             cccCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                         ....++..|+|||.+.   ...++.++|||||||++|||++|..||...........+.........+..+++.+.+
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  255 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN  255 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence               3456788999999974   4568899999999999999999999998876666555554333333344567899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      +|.+||+.+|.+||++.++++.+..
T Consensus       256 li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         256 FVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             HHHHHccCCcccCcCHHHHHhChhh
Confidence            9999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-36  Score=306.25  Aligned_cols=251  Identities=27%  Similarity=0.437  Sum_probs=197.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|+..+.||+|+||.||++.+..+  .+|+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            34667788999999999999988654  4999987654333 44567889999999996 99999999999998999999


Q ss_pred             EeecCCCChhhhhcC--CCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          341 TEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |||+.. ++.++...  ......+++..+..++.|++.||+|||+. +  ++||||||+||+++.++.+||+|||++...
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            999864 65554321  11224589999999999999999999974 8  999999999999999999999999998764


Q ss_pred             CCCccccCCCCCCCcccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhcCccc----CCC
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLRED---PSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRL----EIP  489 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~---~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~----~~p  489 (538)
                      .... ......|+..|+|||.+.+.   .++.++||||||+++|+|++|+.||...... +....+. .....    ..+
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  236 (288)
T cd06616         159 VDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEE  236 (288)
T ss_pred             ccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCC
Confidence            4332 12334678899999999776   6889999999999999999999999866521 1111111 11111    122


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ..++.++.+||.+||+.+|++|||+++|++.
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            3578999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.7e-36  Score=303.09  Aligned_cols=243  Identities=28%  Similarity=0.375  Sum_probs=199.0

Q ss_pred             EccCCcEEEEEEEEcC--CceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCCh
Q 009291          273 IGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL  349 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  349 (538)
                      ||+|+||+||++.+..  ..+|+|++...... ......+.+|+.+++.++||||+++++.+.....+|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6899999999998764  45999988654332 22345677899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCC
Q 009291          350 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG  429 (538)
Q Consensus       350 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~g  429 (538)
                      .+++..... ..+++..++.++.|++.||.|||+++  ++||||+|+||++++++.+||+|||.+...... .......+
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~  156 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAG  156 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccC
Confidence            999864332 35889999999999999999999999  999999999999999999999999998764432 12234567


Q ss_pred             CCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hcCcccCCCCCCcHHHHHHHHHhhhcC
Q 009291          430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNPMVAALIETCWAEE  507 (538)
Q Consensus       430 t~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~s~~l~~LI~~cL~~d  507 (538)
                      +..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.  ........+..+++.+.++|.+||+.+
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            889999999988889999999999999999999999997654421111111  123345567778999999999999999


Q ss_pred             CCCCC-----CHHHHHH
Q 009291          508 PEIRP-----SFPSIME  519 (538)
Q Consensus       508 P~~RP-----s~~eIl~  519 (538)
                      |++||     ++.+++.
T Consensus       237 p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         237 PEKRLGCRGGSADEVRE  253 (277)
T ss_pred             hhHccCCCcccHHHHHh
Confidence            99999     6666754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-36  Score=299.01  Aligned_cols=243  Identities=30%  Similarity=0.486  Sum_probs=204.7

Q ss_pred             EccCCcEEEEEEEEc--CCceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCCh
Q 009291          273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL  349 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  349 (538)
                      ||+|+||.||++++.  +..+++|++..... .....+.+.+|++++++++|+||+++++.+......++++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986  44599998865433 234567889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc-------
Q 009291          350 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-------  422 (538)
Q Consensus       350 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-------  422 (538)
                      .+++....   .+++..++.++.|++.||+|||+.+  ++|+||+|+||++++++.++|+|||++........       
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99986433   5899999999999999999999999  99999999999999999999999999876433211       


Q ss_pred             -ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCC--cHHHHHH
Q 009291          423 -SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV--NPMVAAL  499 (538)
Q Consensus       423 -~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--s~~l~~L  499 (538)
                       ......++..|+|||.+.+...+.++||||||+++|++++|..||......+....+..  .....+..+  +..+.++
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHH
Confidence             22334578899999999888899999999999999999999999998887776665543  233444444  8999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIMETLQ  522 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~L~  522 (538)
                      |.+||+.+|++|||+.++.+.|+
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhc
Confidence            99999999999999966655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-36  Score=311.83  Aligned_cols=266  Identities=24%  Similarity=0.393  Sum_probs=207.6

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-----Ccc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PNL  337 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-----~~~  337 (538)
                      .+|++.+.||+|+||+||+|.+..  ..||+|.+............+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            479999999999999999998864  4499998765433444456778899999999999999999987644     347


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++++||+. ++|.+++...   ..+++..++.++.|++.||+|||+++  ++||||||+||+++.++.+||+|||++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            99999996 6888887633   35899999999999999999999999  999999999999999999999999999865


Q ss_pred             CCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh---------------
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF---------------  481 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~---------------  481 (538)
                      ...........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..               
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            443222344567889999998865 4688999999999999999999999976543322211100               


Q ss_pred             ---------cC--cc---cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHHhhhcCCCCCCCC
Q 009291          482 ---------KG--RR---LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFLMSSVCQPLSAQP  537 (538)
Q Consensus       482 ---------~~--~~---~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~--L~~il~~~~~~~~~~~p  537 (538)
                               ..  .+   ....+.+++++.++|++||+.+|++|||+.++++.  ++.+. .....|+++-|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~-~~~~~~~~~~~  309 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH-DPSDEPVCQTP  309 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc-CcccCccCCCc
Confidence                     00  00   01224678999999999999999999999999876  55443 33344544433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.9e-36  Score=302.30  Aligned_cols=241  Identities=26%  Similarity=0.387  Sum_probs=192.7

Q ss_pred             EEccCCcEEEEEEEEcC--CceEEEEEeccccCH-HHHHHHHHHHHHH---HcCCCCceeEeeceeccCCcceEEEeecC
Q 009291          272 KIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIM---KGLRHPNIVLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~-~~~~~~~~Ei~il---~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  345 (538)
                      .||+|+||.||++.+..  +.+|+|++....... .....+.+|..++   ...+|+||+.+++++..++..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            38999999999998864  459999886544322 1122334444333   34479999999999999899999999999


Q ss_pred             CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccC
Q 009291          346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK  425 (538)
Q Consensus       346 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  425 (538)
                      +++|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+||++++++.++|+|||++.......  ..
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~  153 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PH  153 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--cc
Confidence            99999988633   35899999999999999999999999  9999999999999999999999999987543321  23


Q ss_pred             CCCCCCccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          426 TAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--VISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       426 ~~~gt~~Y~aPE~l~-~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~--~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      ...|+..|+|||.+. +..++.++||||+||++|+|++|..||.......  ..... .......++..++..+.++|.+
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~  232 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEG  232 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHH
Confidence            456899999999986 4568899999999999999999999997543221  11111 1233456677899999999999


Q ss_pred             hhhcCCCCCC-----CHHHHHHH
Q 009291          503 CWAEEPEIRP-----SFPSIMET  520 (538)
Q Consensus       503 cL~~dP~~RP-----s~~eIl~~  520 (538)
                      ||..||++||     |++++++.
T Consensus       233 ~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         233 LLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             HhcCCHHHhcCCCCCCHHHHHhC
Confidence            9999999999     69988874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.8e-36  Score=304.27  Aligned_cols=251  Identities=25%  Similarity=0.344  Sum_probs=196.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      .++|++.+.||+|+||.||+|.+..+  .||+|++............+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            45799999999999999999988644  4999988654433333345678999999999999999999876544      


Q ss_pred             --cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          336 --NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       336 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                        ..++||||+.+ +|.+++....  ..+++..++.++.|++.||+|||+++  ++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCC
Confidence              35999999965 7877775332  35889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCccc----cCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc---
Q 009291          414 SRSKPNTYIS----SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---  485 (538)
Q Consensus       414 a~~~~~~~~~----~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~---  485 (538)
                      +.........    .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+.......+......   
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9764332211    1233567889999988664 4688999999999999999999999887665443322211000   


Q ss_pred             --------------cCCC-------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 --------------LEIP-------------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 --------------~~~p-------------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                    ..++             ...+..+.+||.+||+.||++|||++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                          0011             113567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.4e-36  Score=303.91  Aligned_cols=254  Identities=19%  Similarity=0.260  Sum_probs=188.5

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCH--H-H------HHHHHHHHHHHHcCCCCceeE
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHE--D-R------FKEFLREVAIMKGLRHPNIVL  326 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~--~-~------~~~~~~Ei~il~~L~hpnIv~  326 (538)
                      ++...+|++.+.||+|+||+||+|.+.++     .+++|+........  + .      ......+...+..++|+||++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            45567899999999999999999988765     35666533222110  0 0      012233445566778999999


Q ss_pred             eeceeccCC----cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC
Q 009291          327 LMGAVTEPP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       327 l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~  402 (538)
                      +++++....    ..++++|++. .++.+++...   ...++..++.++.|++.||+|||+++  |+||||||+|||++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~  161 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDG  161 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC
Confidence            998765443    2367778764 3666666432   23567888999999999999999999  999999999999999


Q ss_pred             CCcEEEEeeCCCccCCCCc-------cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Q 009291          403 TYTVKVCDFGLSRSKPNTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-Q  474 (538)
Q Consensus       403 ~~~vkL~DFGla~~~~~~~-------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~  474 (538)
                      ++.++|+|||+|+......       .......||+.|+|||++.+..++.++|||||||++|||++|..||...... .
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            9999999999997643211       1112346899999999999999999999999999999999999999876322 2


Q ss_pred             HHHHHh------hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          475 VISAVG------FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       475 ~~~~i~------~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      ......      ...... ....+++++.+++..||..+|++||++++|++.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGKI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHhHHHHHHHhhhhhh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            111110      011111 2356789999999999999999999999998876

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=292.28  Aligned_cols=254  Identities=25%  Similarity=0.452  Sum_probs=207.6

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCC
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP  335 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~  335 (538)
                      ......++.+++..||.|.-|.||+++.+.++  .|||.+.... ..++.+.++..+.++..- +.|+||+.+|+|..+.
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~  164 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT  164 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence            34455667788999999999999999998765  7888887654 556667888888877665 4899999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ...+.||.|.. .+..++++..  .+++|..+-++...++.||.||.+++ +|||||+||+|||+|+.|++||||||++.
T Consensus       165 dV~IcMelMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsG  240 (391)
T KOG0983|consen  165 DVFICMELMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISG  240 (391)
T ss_pred             hHHHHHHHHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccc
Confidence            99999999853 5666665433  46999999999999999999998754 39999999999999999999999999997


Q ss_pred             cCCCCccccCCCCCCCcccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhhcCcccCCCC-
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRED---PSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPK-  490 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~---~~s~ksDVwSLGvil~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~p~-  490 (538)
                      ...+.. .....+|.+.|||||.+.-.   .|+.++||||||++++||.||+.||.+.+. -+.+..+. ......+|. 
T Consensus       241 rlvdSk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-n~ePP~L~~~  318 (391)
T KOG0983|consen  241 RLVDSK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-NEEPPLLPGH  318 (391)
T ss_pred             eeeccc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-hcCCCCCCcc
Confidence            765543 23456889999999999643   689999999999999999999999988543 44444443 333333443 


Q ss_pred             -CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          491 -NVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       491 -~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       ..|+.+.+|+..||+.|+.+||.+.++++
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence             47999999999999999999999999875

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.5e-36  Score=298.76  Aligned_cols=250  Identities=28%  Similarity=0.486  Sum_probs=205.7

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecc---ccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQ---EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~---~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      +|.+.+.||+|+||.||++.+....  +++|+.+..   .........+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5889999999999999999886543  566665432   22233344677899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          341 TEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      +||+++++|.+++... .....+++..++.++.|++.||+|||+.+  ++|+||+|+||+++. +.+||+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence            9999999999888531 22346899999999999999999999999  999999999999975 5799999999876544


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      .........++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+. .......+..++.++.++
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  236 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI  236 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence            3333344567889999999988888999999999999999999999998766655444442 333444567788999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~  519 (538)
                      |.+||+.+|++||++.++++
T Consensus       237 i~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         237 MQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHHhcCChhhCcCHHHHhh
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-36  Score=297.30  Aligned_cols=242  Identities=30%  Similarity=0.435  Sum_probs=197.2

Q ss_pred             EEEccCCcEEEEEEEEcC--CceEEEEEeccccC-HHHHHHHHHHHHHH-HcCCCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIM-KGLRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-~~~~~~~~~Ei~il-~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.||+|+||.||+|.+..  +.+|+|++...... ......+..|..++ ...+|+||+++++++...+.+++++||+.+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            568999999999998854  45999998654322 22233445555444 455899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      ++|.+++...   ..+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.+||+|||++.....    ...
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~  152 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKK  152 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----ccc
Confidence            9999998643   35889999999999999999999999  99999999999999999999999999876433    234


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc--cCCCCCCcHHHHHHHHHhh
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMVAALIETCW  504 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~s~~l~~LI~~cL  504 (538)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......  ......++..+.++|.+||
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  232 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL  232 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence            56788999999998888899999999999999999999999888776665554322221  2233467899999999999


Q ss_pred             hcCCCCCCCHHHHHHHH
Q 009291          505 AEEPEIRPSFPSIMETL  521 (538)
Q Consensus       505 ~~dP~~RPs~~eIl~~L  521 (538)
                      +.+|++||++.++.+.|
T Consensus       233 ~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         233 CMDPAKRLGANGYQEIK  249 (260)
T ss_pred             cCCHHHccCCCcHHHHH
Confidence            99999999876665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-36  Score=306.46  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=195.6

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC----CceEEEEEeccc-cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--Ccce
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN----SDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLS  338 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~----~~vavK~~~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~~~  338 (538)
                      .|++.+.||+|+||.||+|.+..    ..+|+|.+.... ........+.+|+.+++.++||||+++++++.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47889999999999999999854    459999987643 1122335678899999999999999999999887  7799


Q ss_pred             EEEeecCCCChhhhhcCC--CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC----CCcEEEEeeC
Q 009291          339 IVTEYLSRGSLYKLLHIP--DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFG  412 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~----~~~vkL~DFG  412 (538)
                      +||||+.+ +|.+++...  .....+++..++.++.|++.||+|||+++  |+||||||+||+++.    ++.+||+|||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            99999975 666665322  12236889999999999999999999999  999999999999999    9999999999


Q ss_pred             CCccCCCCcc---ccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHH
Q 009291          413 LSRSKPNTYI---SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---------VISAV  479 (538)
Q Consensus       413 la~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~---------~~~~i  479 (538)
                      ++........   ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.......         ....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9886543221   12334678899999988764 57899999999999999999999997654322         00000


Q ss_pred             -h-----------------------hcCcccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          480 -G-----------------------FKGRRLEIP-----------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       480 -~-----------------------~~~~~~~~p-----------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       .                       ........+           ...+..+.++|.+||+.||++|||+.++++
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             0                       000011111           156678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.3e-36  Score=298.66  Aligned_cols=245  Identities=24%  Similarity=0.352  Sum_probs=194.4

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccC--CcceEEE
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEP--PNLSIVT  341 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~--~~~~lV~  341 (538)
                      |++.+.||+|+||.||+|.+..  ..+|+|++......... ....+|+.+++++. |+||+++++++.+.  ..+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            6788999999999999998864  44999987654323222 34457888898885 99999999999877  7899999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+ +|.+.+....  ..+++..++.++.|++.||+|||+.+  ++||||+|+||+++. +.+||+|||++.......
T Consensus        80 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          80 ELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             ecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            99974 7777775322  35889999999999999999999999  999999999999999 999999999997654332


Q ss_pred             cccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----------------Cc
Q 009291          422 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK----------------GR  484 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~----------------~~  484 (538)
                      . .....++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+....+...                ..
T Consensus       154 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         154 P-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             C-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence            1 123457889999997654 55788999999999999999999999877665443322110                00


Q ss_pred             ccCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 RLEI-----------PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ~~~~-----------p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ...+           ...++..+.++|.+||..+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            1111           1356789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-36  Score=300.05  Aligned_cols=248  Identities=28%  Similarity=0.380  Sum_probs=203.5

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      |++.+.||+|++|.||++.+..  ..+++|.+............+.+|+.++++++|+||+++++++..+...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            5678899999999999998753  44899988766555455678889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS  424 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~  424 (538)
                      .+ +|.+++....  ..+++..++.++.|++.||+|||+.+  |+|+||||+||++++++.++|+|||.+..........
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence            75 8887775432  35889999999999999999999999  9999999999999999999999999987665443222


Q ss_pred             CCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc------------------
Q 009291          425 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR------------------  485 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~------------------  485 (538)
                      ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+......                  
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            345678899999998876 7899999999999999999999999877665443332111000                  


Q ss_pred             ----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ----------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                ......++.++.++|.+||+.+|.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      0112346789999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=333.92  Aligned_cols=265  Identities=35%  Similarity=0.590  Sum_probs=227.4

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEc---------CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEee
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWR---------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM  328 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~---------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~  328 (538)
                      .+++..++.++.+.||+|.||.|++|...         ...||||.++..... ...+.+..|+++|+.+ .|+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            67888888888999999999999999753         123899998776655 7778999999999999 599999999


Q ss_pred             ceeccCCcceEEEeecCCCChhhhhcCCC-----------CC--ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCC
Q 009291          329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPD-----------AR--VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS  395 (538)
Q Consensus       329 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp  395 (538)
                      +++.+...+++|+||+..|+|.++++...           ..  ..+.....+.++.||+.|++||++..  +|||||-.
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa  446 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA  446 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence            99999888999999999999999996443           00  23888899999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEEeeCCCccCCCCcccc-CCCC--CCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009291          396 PNLLVDSTYTVKVCDFGLSRSKPNTYISS-KTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST  471 (538)
Q Consensus       396 ~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~--gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~  471 (538)
                      +|||++++..+||+|||+|+......... ....  -...|||||.+....|+.++||||+|++||||++ |..||.+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999999644432221 2222  2456999999999999999999999999999998 789999866


Q ss_pred             -HHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          472 -PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       472 -~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                       ..+. ......+.++..|..++++++++|+.||+.+|++||++.++.+.+...+..
T Consensus       527 ~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  527 PTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             cHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence             4444 445568889999999999999999999999999999999999999997653

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=344.28  Aligned_cols=256  Identities=27%  Similarity=0.393  Sum_probs=221.6

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      ...+....++|++++.||+|+||.|.+++++.+.  ||+|++.+-..- .....-|..|-.+|..-+.+=|+.++..|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3445677899999999999999999999998766  999998764322 3334568889999998899999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      +.++|+||||++||+|-.++..-.   .++++.+..++..|+.||..||+.|  +|||||||+|||++..|++||+|||.
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchh
Confidence            999999999999999999996443   6999999999999999999999999  99999999999999999999999997


Q ss_pred             CccCC-CCccccCCCCCCCccccccccc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC
Q 009291          414 SRSKP-NTYISSKTAAGTPEWMAPEVLR----E-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE  487 (538)
Q Consensus       414 a~~~~-~~~~~~~~~~gt~~Y~aPE~l~----~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~  487 (538)
                      +-... ++...+...+|||.|.+||++.    + +.|+..+|+||+||++|||++|..||+..+-.+....|..-...+.
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS  301 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence            76544 6666778889999999999985    2 5689999999999999999999999999888888887765556777


Q ss_pred             CC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 009291          488 IP--KNVNPMVAALIETCWAEEPEIRPS---FPSIM  518 (538)
Q Consensus       488 ~p--~~~s~~l~~LI~~cL~~dP~~RPs---~~eIl  518 (538)
                      +|  ..+|+++++||++.++ +|+.|..   ++++.
T Consensus       302 FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  302 FPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             CCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            77  5689999999999887 5677877   66664

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=351.04  Aligned_cols=250  Identities=30%  Similarity=0.481  Sum_probs=215.1

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +++-...||.|.||.||.|.+.+++  .|+|.++.+.......+.+.+|+.++..++|||+|+++++-.+....+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            4566788999999999999887666  89998888777766678889999999999999999999999888899999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc--
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--  421 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~--  421 (538)
                      |++|+|.++++...   ..++.....+..|++.|++|||++|  ||||||||+||+++.+|.+|++|||.|.......  
T Consensus      1316 C~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             hccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            99999999997433   4677778888999999999999999  9999999999999999999999999998765432  


Q ss_pred             --cccCCCCCCCcccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          422 --ISSKTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       422 --~~~~~~~gt~~Y~aPE~l~~~~---~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                        ...+...||+-|||||++.+..   ...+.|||||||++.||+||+.||......-.+....-.+...++|..++.+-
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence              1224567999999999998654   45789999999999999999999988766544444434667788999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      .+||..||..||++|-++.||++.
T Consensus      1471 ~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             HHHHHHHHhcCchhhhHHHHHHHh
Confidence            999999999999999888777653

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-35  Score=301.26  Aligned_cols=253  Identities=26%  Similarity=0.325  Sum_probs=200.7

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC----
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~----  335 (538)
                      ...++|++.+.||+|+||.||+|.+..  +.+|+|++............+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            345689999999999999999999864  44999998655433333456778999999999999999999887654    


Q ss_pred             ------cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          336 ------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       336 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                            .+++|+||+++ ++..++...  ...+++..++.++.|++.||+|||+.+  |+|+||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeC
Confidence                  78999999976 676766533  235889999999999999999999999  9999999999999999999999


Q ss_pred             eeCCCccCCCCcc-ccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc-
Q 009291          410 DFGLSRSKPNTYI-SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL-  486 (538)
Q Consensus       410 DFGla~~~~~~~~-~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~-  486 (538)
                      |||++........ ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+....... 
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9999876543321 11223457789999988653 56889999999999999999999998776655443332110000 


Q ss_pred             ---------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 ---------------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ---------------------------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                                 .....++..+.++|.+||+.+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                                       011246889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-35  Score=300.73  Aligned_cols=257  Identities=25%  Similarity=0.431  Sum_probs=203.5

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceecc
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE  333 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~  333 (538)
                      .+.+.+..++|++.+.||+|+||.||+|.+.  +..+|||.+...... .....+.+|+.++.+. .|+||+++++++.+
T Consensus         7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   85 (296)
T cd06618           7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT   85 (296)
T ss_pred             ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence            4456677889999999999999999999987  455999998765432 3345667777767666 49999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      ....+++|||+. +++.+++....  ..+++..+..++.|++.||+|||+ .+  |+||||+|+||++++++.+||+|||
T Consensus        86 ~~~~~~v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          86 DSDVFICMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             CCeEEEEeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccc
Confidence            999999999985 47777765422  258899999999999999999997 58  9999999999999999999999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhcC-ccc
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKG-RRL  486 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~----~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~~~~-~~~  486 (538)
                      ++........ .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||...... +....+.... ...
T Consensus       161 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T cd06618         161 ISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL  239 (296)
T ss_pred             cchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC
Confidence            9876543321 12345788999999987654    788999999999999999999999764332 2232222111 122


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       487 ~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +....++.++.+||.+||..+|++||++.++++.
T Consensus       240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            2223478999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=307.91  Aligned_cols=261  Identities=25%  Similarity=0.422  Sum_probs=201.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-----Ccc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PNL  337 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-----~~~  337 (538)
                      ++|++.+.||+|+||.||+|.+..  ..||+|++.... .......+.+|+.++++++|+||+++++++...     ...
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            679999999999999999998764  449999875322 233456788899999999999999999886543     347


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++++||+.+ +|..++..    ..+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999999965 78777753    24889999999999999999999999  999999999999999999999999998764


Q ss_pred             CCCcc---ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-c----------
Q 009291          418 PNTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-K----------  482 (538)
Q Consensus       418 ~~~~~---~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~-~----------  482 (538)
                      .....   ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.. .          
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            33211   1123467899999998754 5688999999999999999999999976543322211100 0          


Q ss_pred             ---------------CcccC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHHhhhcCCCCC
Q 009291          483 ---------------GRRLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFLMSSVCQPLS  534 (538)
Q Consensus       483 ---------------~~~~~---~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~--L~~il~~~~~~~~~  534 (538)
                                     ....+   ..+..++++.++|.+||+.+|++|||+.++++.  ++..... ...|.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~-~~~~~~  307 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP-SDEPVA  307 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC-CCcccC
Confidence                           00000   113467889999999999999999999999886  5555443 224444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-36  Score=327.94  Aligned_cols=253  Identities=17%  Similarity=0.236  Sum_probs=187.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc---eEEEE--------------E-eccccCHHHHHHHHHHHHHHHcCCCCcee
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD---VAVKI--------------L-IEQEFHEDRFKEFLREVAIMKGLRHPNIV  325 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~---vavK~--------------~-~~~~~~~~~~~~~~~Ei~il~~L~hpnIv  325 (538)
                      ..+|++++.||+|+||+||++..+...   .+.|.              + +...........+.+|+.+|++++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            468999999999999999998754322   12120              0 00111223345688999999999999999


Q ss_pred             EeeceeccCCcceEEEeecCCCChhhhhcCCCC--CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC
Q 009291          326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       326 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~  403 (538)
                      ++++++.+....|+++|++. ++|.+++.....  ........++.++.||+.||+|||++|  ||||||||+|||++.+
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~  303 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD  303 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence            99999999999999999985 467766643211  122345677889999999999999999  9999999999999999


Q ss_pred             CcEEEEeeCCCccCCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCC--H-HHHHHH
Q 009291          404 YTVKVCDFGLSRSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP-WRNST--P-SQVISA  478 (538)
Q Consensus       404 ~~vkL~DFGla~~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~P-f~~~~--~-~~~~~~  478 (538)
                      +.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|..+ |....  . .+....
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            9999999999986543321 22345789999999999999999999999999999999998754 43322  1 111111


Q ss_pred             HhhcC-cccCC----------------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          479 VGFKG-RRLEI----------------------------PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       479 i~~~~-~~~~~----------------------------p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.... ...++                            ...++..+.++|.+||+.||.+|||+.|++.
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            11000 00000                            0134567888899999999999999999986

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2e-35  Score=297.52  Aligned_cols=241  Identities=26%  Similarity=0.376  Sum_probs=193.2

Q ss_pred             EEccCCcEEEEEEEEcC--CceEEEEEeccccCHHH-HHHHHHHH---HHHHcCCCCceeEeeceeccCCcceEEEeecC
Q 009291          272 KIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDR-FKEFLREV---AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~-~~~~~~Ei---~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  345 (538)
                      .||+|+||.||+|.+..  ..||+|++......... ...+..|.   ..++...|++|+.+++++.+...+++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            37999999999998764  45999998765432111 12233333   44555689999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccC
Q 009291          346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK  425 (538)
Q Consensus       346 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  425 (538)
                      +++|.+++...   ..+++..+..++.|++.||+|||+.+  ++||||||+||++++++.+||+|||++......  ...
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~  153 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPH  153 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCc
Confidence            99999988633   35899999999999999999999999  999999999999999999999999998754332  123


Q ss_pred             CCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhhcCcccCCCCCCcHHHHHHHHHh
Q 009291          426 TAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS-AVGFKGRRLEIPKNVNPMVAALIETC  503 (538)
Q Consensus       426 ~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~-~i~~~~~~~~~p~~~s~~l~~LI~~c  503 (538)
                      ...|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||.......... ..........+|..++..+.++|.+|
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL  233 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHH
Confidence            45789999999998754 58899999999999999999999998663221111 11123345567778899999999999


Q ss_pred             hhcCCCCCC-----CHHHHHH
Q 009291          504 WAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       504 L~~dP~~RP-----s~~eIl~  519 (538)
                      |..+|.+||     ++.++++
T Consensus       234 l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         234 LQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             hhcCHHhccCCCCCCHHHHHh
Confidence            999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=295.85  Aligned_cols=248  Identities=27%  Similarity=0.376  Sum_probs=201.1

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--CcceEEEe
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIVTE  342 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~~~lV~E  342 (538)
                      |++.+.||+|+||.||+|.+.+  ..+|+|++............+.+|+.++++++|+|++++++++.+.  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            6789999999999999998875  4499999887653444456788999999999999999999999887  78999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+++ +|.+++....  ..+++..++.++.|++.||+|||+.+  ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9975 8888875432  35889999999999999999999999  99999999999999999999999999986544321


Q ss_pred             -ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc---------------
Q 009291          423 -SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------------  485 (538)
Q Consensus       423 -~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~---------------  485 (538)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+......               
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence             1223456788999998765 45789999999999999999999999887765544433211000               


Q ss_pred             ------c--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ------L--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ------~--------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                            .        .+...++..+.++|++||+.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  0        001113788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=305.77  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=207.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC-----cce
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-----NLS  338 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~-----~~~  338 (538)
                      +|++.+.||.|+||.||+|.+..  ..+++|++..........+.+.+|+.+++.++|+||+++++++....     .++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58899999999999999999864  45999988765433455678899999999999999999999987765     789


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ++|||+. ++|.+++....   .+++..++.++.|++.||+|||++|  |+||||||+||+++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999997 47888886432   6899999999999999999999999  9999999999999999999999999998755


Q ss_pred             CCc---cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc---------
Q 009291          419 NTY---ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------  485 (538)
Q Consensus       419 ~~~---~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~---------  485 (538)
                      ...   .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+......         
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            432   112344678899999999887 7899999999999999999999999887765443332211000         


Q ss_pred             --------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHHH
Q 009291          486 --------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFL  525 (538)
Q Consensus       486 --------------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~--L~~il  525 (538)
                                          ......++..+.++|.+||+.+|++||++.+++..  ++.+-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                                01123467889999999999999999999999874  45433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-35  Score=306.73  Aligned_cols=254  Identities=27%  Similarity=0.409  Sum_probs=198.6

Q ss_pred             EEEccC--CcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEG--SFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G--~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      ..||+|  +||+||++++.  ++.||+|++..........+.+.+|+.+++.++||||++++++|..+...++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999885  45599999876655566678899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc---
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS---  423 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~---  423 (538)
                      ++|.+++..... ..+++..+..++.|++.||+|||+++  ++||||||+||+++.++.++++||+.+.........   
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            999999865322 24889999999999999999999999  999999999999999999999999865432111000   


Q ss_pred             ----cCCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC--------------
Q 009291          424 ----SKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG--------------  483 (538)
Q Consensus       424 ----~~~~~gt~~Y~aPE~l~~~--~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~--------------  483 (538)
                          .....++..|+|||++.+.  .++.++|||||||++|||++|..||................              
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                1112345679999999764  47899999999999999999999998765443332211000              


Q ss_pred             -------------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHhh
Q 009291          484 -------------------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLMS  527 (538)
Q Consensus       484 -------------------------------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~--~L~~il~~  527 (538)
                                                     .+.+.+..+++.+.+||++||+.||++|||+.++++  .++++.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                           001112346678999999999999999999999963  44555443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.8e-36  Score=304.55  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=198.7

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCC
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.+++.+|.|+++.|+++...+..+|+|++..........+.+.+|+.+++.++|+||+++++++.+....+++|||+.+
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            34556667777777777776677799999887655666778899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc-----
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-----  421 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~-----  421 (538)
                      ++|.+++.... ...+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||.+.......     
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99999986432 224788999999999999999999999  9999999999999999999999999886432211     


Q ss_pred             --cccCCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC--------------
Q 009291          422 --ISSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG--------------  483 (538)
Q Consensus       422 --~~~~~~~gt~~Y~aPE~l~~~--~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~--------------  483 (538)
                        .......++..|+|||.+.+.  .++.++|||||||++|||++|..||................              
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence              112334567789999998763  57899999999999999999999998765543322111000              


Q ss_pred             ------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 ------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ------------------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                        .....+..++..+.+||.+||+.||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                              000111233567899999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.2e-35  Score=299.86  Aligned_cols=245  Identities=27%  Similarity=0.457  Sum_probs=201.6

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC--CceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      |...+.||+|+||+||+|++..  ..+++|++..... .....+.+.+|+.+++.++|+|++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            5667889999999999998754  4489998765433 334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +. +++.+++....  ..+++..++.++.|++.||.|||++|  ++|+||+|+||+++.++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            96 57777775332  34889999999999999999999999  99999999999999999999999998865322    


Q ss_pred             cCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          424 SKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                      .....|+..|+|||.+.   ...++.++||||||+++|+|++|..||...+.......+............++..+.+||
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  253 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV  253 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence            23456788999999984   456888999999999999999999999887765555544333222223345778899999


Q ss_pred             HHhhhcCCCCCCCHHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~~  520 (538)
                      .+||+.+|.+||++.+++..
T Consensus       254 ~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         254 DYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHHccCChhhCcCHHHHhcC
Confidence            99999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-35  Score=307.65  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=199.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc----CCcce
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNLS  338 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~----~~~~~  338 (538)
                      ++|++.+.||+|+||.||+|.+..  ..||+|++..........+.+.+|+.++++++|+||+++++++..    ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            679999999999999999998764  449999887654344455678899999999999999999998753    34689


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+. ++|.+++...   ..+++..++.++.|++.||+|||+++  |+||||||+||++++++.+||+|||++....
T Consensus        85 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            9999995 5888888643   34899999999999999999999999  9999999999999999999999999987543


Q ss_pred             CCccc----cCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------------
Q 009291          419 NTYIS----SKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF------------  481 (538)
Q Consensus       419 ~~~~~----~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~------------  481 (538)
                      .....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..            
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            22111    123468889999999866 4588999999999999999999999977654332221110            


Q ss_pred             ------------cCcccCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          482 ------------KGRRLEI-----PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       482 ------------~~~~~~~-----p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                  .......     ....++++.++|.+||+.+|++|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                        0001111     1456889999999999999999999998876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=289.85  Aligned_cols=237  Identities=29%  Similarity=0.437  Sum_probs=204.3

Q ss_pred             EccCCcEEEEEEEEc--CCceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCCh
Q 009291          273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL  349 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL  349 (538)
                      ||+|+||.||++.+.  +..+++|++...... ......+.+|+.++++++|+||+++++.+..+...+++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999886  445999998765433 33567889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCC
Q 009291          350 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG  429 (538)
Q Consensus       350 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~g  429 (538)
                      .+++....   .+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||.+..............+
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            99986442   4889999999999999999999999  999999999999999999999999998775443223345567


Q ss_pred             CCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCC
Q 009291          430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE  509 (538)
Q Consensus       430 t~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~  509 (538)
                      +..|+|||...+...+.++|+||||+++|++++|..||...........+..  ....++..++..+.++|++||..+|+
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~  233 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPT  233 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence            8899999999888889999999999999999999999987776555555432  55677888899999999999999999


Q ss_pred             CCCCHHH
Q 009291          510 IRPSFPS  516 (538)
Q Consensus       510 ~RPs~~e  516 (538)
                      +||++.+
T Consensus       234 ~R~~~~~  240 (250)
T cd05123         234 KRLGSGG  240 (250)
T ss_pred             hCCCccc
Confidence            9999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.8e-35  Score=302.40  Aligned_cols=247  Identities=27%  Similarity=0.428  Sum_probs=202.1

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccc-cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..|+..+.||+|+||.||+|++..+  .+++|.+.... ........+.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3477788999999999999998644  48999876432 23445567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+. +++.+++....  ..+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.+||+|||++...... 
T Consensus        95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            9996 57777764332  34789999999999999999999999  999999999999999999999999998764332 


Q ss_pred             cccCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                         ....++..|+|||.+.   ...++.++|||||||++|+|++|..||...........+.........+..++..+.+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence               2446788999999974   3457889999999999999999999998776555444443222222234468899999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ||.+||..+|++||++.++++.
T Consensus       246 li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         246 FVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HHHHHhhCCcccCCCHHHHhhC
Confidence            9999999999999999998765

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.9e-35  Score=294.84  Aligned_cols=239  Identities=23%  Similarity=0.397  Sum_probs=191.9

Q ss_pred             cceeEEEEE--ccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceE
Q 009291          265 SELLIKKKI--GEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       265 ~~y~i~~~L--G~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ++|++.+.+  |+|+||.||++....+  .+|+|+.........       |+.....+ +|+||+++++.+..++.+++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            355565555  9999999999987644  488888765432221       22222222 69999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-cEEEEeeCCCccCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKP  418 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~  418 (538)
                      ||||+++++|.+++....   .+++..++.++.|++.||+|||+.+  ++||||||+||+++.++ .++|+|||++....
T Consensus        87 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            999999999999986442   6899999999999999999999999  99999999999999988 99999999987654


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHhhcCcccCCCCCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI--SAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~--~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ..    ....++..|+|||++.+..++.++||||||+++|+|++|..||.........  ............+..+++.+
T Consensus       162 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T PHA03390        162 TP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA  237 (267)
T ss_pred             CC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence            32    2346789999999999988999999999999999999999999865433221  11111233445566789999


Q ss_pred             HHHHHHhhhcCCCCCCC-HHHHHH
Q 009291          497 AALIETCWAEEPEIRPS-FPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs-~~eIl~  519 (538)
                      .+||.+||+.+|.+||+ ++++++
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhc
Confidence            99999999999999996 588763

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-35  Score=303.95  Aligned_cols=251  Identities=25%  Similarity=0.360  Sum_probs=201.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      .++|++.+.||+|+||.||++.+..  ..||+|++............+.+|+.++++++|+||+++++++..+.      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            4679999999999999999998764  44999988654434444567889999999999999999999886554      


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+ +++|.+++..    ..+++..++.++.|++.||+|||+.|  |+||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence            358999998 6789888753    24889999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc---------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------  485 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~---------  485 (538)
                      .....   .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+......         
T Consensus       167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         167 QTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             ccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            65432   123467889999999876 45789999999999999999999999876554333221110000         


Q ss_pred             --------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH--HHHHHH
Q 009291          486 --------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIM--ETLQQF  524 (538)
Q Consensus       486 --------------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl--~~L~~i  524 (538)
                                          ......+++++.++|.+||+.||++|||+.+++  ..++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                                011245788899999999999999999999998  444444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.2e-35  Score=305.37  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=200.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccC--Ccce
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP--PNLS  338 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~--~~~~  338 (538)
                      ..+|++.+.||+|+||.||+|.+..  +.+|+|++............+.+|+.+++++ +|+||+++++++...  ..++
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            3578889999999999999998864  4599998765433444556778899999999 999999999987643  3589


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+. ++|..++...    .+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++....
T Consensus        86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            9999997 5888887532    4788889999999999999999999  9999999999999999999999999987643


Q ss_pred             CCcc-----ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC---------
Q 009291          419 NTYI-----SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG---------  483 (538)
Q Consensus       419 ~~~~-----~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~---------  483 (538)
                      ....     ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+....         
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            3221     1223457889999998765 457889999999999999999999997655443322211100         


Q ss_pred             -----------------cc---cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 009291          484 -----------------RR---LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQF  524 (538)
Q Consensus       484 -----------------~~---~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~--L~~i  524 (538)
                                       ..   ......++.++.++|.+||+.+|++|||+.++++.  ++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                             00   01123478899999999999999999999999875  4444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.2e-35  Score=296.16  Aligned_cols=247  Identities=22%  Similarity=0.378  Sum_probs=200.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc-----CCceEEEEEecccc--CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEF--HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~--~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~  337 (538)
                      +|++.+.||+|+||.||+|++.     +..||+|++.....  .....+.+.+|+.+++++ +|+||+.+++.+..+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4789999999999999999863     45599999865432  123345678899999999 599999999999998999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            9999999999999998643   34788999999999999999999999  999999999999999999999999998765


Q ss_pred             CCCcc-ccCCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhhcCcccCCCC
Q 009291          418 PNTYI-SSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       418 ~~~~~-~~~~~~gt~~Y~aPE~l~~~--~~s~ksDVwSLGvil~eLltg~~Pf~~~~~----~~~~~~i~~~~~~~~~p~  490 (538)
                      ..... ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.....    ......+  .....+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~  233 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQ  233 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCc
Confidence            33221 12245688999999998753  467899999999999999999999974332    2222222  223345667


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 009291          491 NVNPMVAALIETCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RP-----s~~eIl~  519 (538)
                      .++..+.+++.+||..+|++||     ++.++++
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            7899999999999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.6e-35  Score=298.59  Aligned_cols=251  Identities=27%  Similarity=0.411  Sum_probs=195.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      .++|++.+.||+|+||.||+|.+..  ..+++|++............+.+|+++++.++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999864  44999988655433333345678999999999999999999875433      


Q ss_pred             --cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          336 --NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       336 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                        .+++|+||+.+ ++...+...  ...+++..+..++.|+++||+|||++|  ++|+||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCcc
Confidence              46999999965 666666432  235899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCccc-----------cCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh
Q 009291          414 SRSKPNTYIS-----------SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF  481 (538)
Q Consensus       414 a~~~~~~~~~-----------~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~  481 (538)
                      +.........           .....++..|+|||.+.+. .++.++||||||+++|||++|..||...+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9754332111           1123467889999987654 578999999999999999999999987766544433221


Q ss_pred             cCcc---------------------cCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          482 KGRR---------------------LEIP-------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       482 ~~~~---------------------~~~p-------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ....                     ...+       ..+++.+.++|.+||+.+|++|||+.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1000                     0001       234467889999999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=293.77  Aligned_cols=248  Identities=29%  Similarity=0.345  Sum_probs=198.7

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcC---CCCceeEeeceeccCCc-----
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVTEPPN-----  336 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~~~~~-----  336 (538)
                      |++.+.||+|+||.||+|+++.  ..+|+|++............+.+|+.+++++   +|+||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6789999999999999999864  4599999875544444445666788777666   59999999999987766     


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      ++++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 78888764322 24889999999999999999999999  99999999999999999999999999876


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc---c--------
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---R--------  485 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~---~--------  485 (538)
                      ..... ......++..|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+.....   .        
T Consensus       157 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         157 YSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             ccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            54332 12234578899999999998899999999999999999999999988776554443321100   0        


Q ss_pred             --------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 --------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 --------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                    ......+++.+.++|.+||+.||++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                          0001234578899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.5e-35  Score=296.43  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=204.7

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc-----CCceEEEEEeccccC--HHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFH--EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~~--~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~  337 (538)
                      +|++.+.||+|+||.||+++..     ++.+|+|++......  ....+.+.+|+.++.++ +|+||+++++.+..+..+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4789999999999999999753     345999998754322  23345688999999999 599999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+.+++|.+++...   ..+++..++.++.|++.||+|||+.+  ++||||+|+||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            9999999999999988643   34788999999999999999999999  999999999999999999999999998764


Q ss_pred             CCCcc-ccCCCCCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhhcCcccCCCC
Q 009291          418 PNTYI-SSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       418 ~~~~~-~~~~~~gt~~Y~aPE~l~~~~--~s~ksDVwSLGvil~eLltg~~Pf~~~~~----~~~~~~i~~~~~~~~~p~  490 (538)
                      ..... ......++..|+|||.+.+..  .+.++||||||+++|+|++|..||.....    .+....+  .......+.
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~  233 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPK  233 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCc
Confidence            33221 122345788999999987665  68899999999999999999999964322    1222222  223345667


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      .++..+.++|.+||+.+|++|||+.++.+.|+..
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            7899999999999999999999988887766544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4e-35  Score=304.58  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=195.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--------
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--------  334 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--------  334 (538)
                      ++|.+.+.||.|+||.||+|.+..+  .||+|++.....  ...+.+.+|+++++.++||||+++++++...        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            6899999999999999999988654  489998765543  3446788999999999999999999876543        


Q ss_pred             ------CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc-CCCcEE
Q 009291          335 ------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVK  407 (538)
Q Consensus       335 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~-~~~~vk  407 (538)
                            ...++||||+. ++|.+++..    ..+++..++.++.|++.||+|||+.|  ++||||||+||+++ .++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEE
Confidence                  35789999997 588887752    24889999999999999999999999  99999999999997 456789


Q ss_pred             EEeeCCCccCCCCcc---ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-
Q 009291          408 VCDFGLSRSKPNTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-  482 (538)
Q Consensus       408 L~DFGla~~~~~~~~---~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-  482 (538)
                      |+|||.+........   ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+....+... 
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999876432211   1123357889999998754 55788999999999999999999999877654443332110 


Q ss_pred             ----------------------Cccc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 ----------------------GRRL-----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ----------------------~~~~-----~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                            ....     .+...++.++.+||.+||+.||++|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                                  0000     112357789999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-35  Score=303.54  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=200.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      ..+|.+.+.||+|+||.||+|.+.  +..+|+|++............+.+|+.+++.++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            358999999999999999999875  445999988654434444567889999999999999999999886543      


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++|+||+.. +|..+..     ..+++..+..++.|++.||+|||+++  ++||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            46899999864 6766542     24788999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc----------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------  484 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~----------  484 (538)
                      .....   .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+.....          
T Consensus       166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         166 HADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             CCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            64332   123467888999999876 4688999999999999999999999988765443332211000          


Q ss_pred             ------------c----c---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHhh
Q 009291          485 ------------R----L---EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLMS  527 (538)
Q Consensus       485 ------------~----~---~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~--~L~~il~~  527 (538)
                                  .    .   ...+.++..+.+||.+||+.||++||++++++.  .++.+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                        0    0   011246788999999999999999999999984  36665543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=305.54  Aligned_cols=252  Identities=27%  Similarity=0.351  Sum_probs=213.2

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      ..+....|..-+.||+|+||.||-++-..++  ||+|.+.+..... ......++|-.||++++.+.||.+-..|++.+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            4566788999999999999999988766554  8998875544322 223467889999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|+|+..|.||+|.-.+...+. .-+++..+.-++.+|+.||++||+.+  ||.|||||+|||+|+.|+|+|+|+|+|..
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEe
Confidence            9999999999999988865443 35999999999999999999999999  99999999999999999999999999998


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hcCcccCCCCCCcH
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNP  494 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~s~  494 (538)
                      ...+... ...+||..|||||++.+..|+...|+|||||++|||+.|+.||...........+.  ......+++...|+
T Consensus       337 i~~g~~~-~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~  415 (591)
T KOG0986|consen  337 IPEGKPI-RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE  415 (591)
T ss_pred             cCCCCcc-ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence            7765432 45589999999999999999999999999999999999999998765433332221  24455677889999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHH
Q 009291          495 MVAALIETCWAEEPEIRPSFP  515 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~  515 (538)
                      ++++|.+.+|+.||++|....
T Consensus       416 eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  416 EAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHHHHHccCHHHhccCC
Confidence            999999999999999996543

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7e-35  Score=296.16  Aligned_cols=242  Identities=27%  Similarity=0.460  Sum_probs=202.3

Q ss_pred             EEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCC
Q 009291          270 KKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      ...||+|+||.||++....+  .+|+|++...  .......+.+|+.+++.++|+||+++++.+..+...+++|||++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            36799999999999988644  4899987443  2334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCC
Q 009291          348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA  427 (538)
Q Consensus       348 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  427 (538)
                      +|.+++...    .+++..++.++.|++.||+|||+.|  ++|+||+|+||++++++.++|+|||++.............
T Consensus       103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657         103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            999987532    4788999999999999999999999  9999999999999999999999999987654332223345


Q ss_pred             CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-CcccCCCCCCcHHHHHHHHHhhhc
Q 009291          428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       428 ~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|..||......+....+... .........++..+.++|.+||+.
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  256 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR  256 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence            6788999999998888899999999999999999999999877665554443221 122223456789999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 009291          507 EPEIRPSFPSIME  519 (538)
Q Consensus       507 dP~~RPs~~eIl~  519 (538)
                      +|.+||++.++++
T Consensus       257 ~P~~R~~~~~ll~  269 (292)
T cd06657         257 DPAQRATAAELLK  269 (292)
T ss_pred             CcccCcCHHHHhc
Confidence            9999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.8e-35  Score=302.48  Aligned_cols=248  Identities=24%  Similarity=0.288  Sum_probs=196.7

Q ss_pred             cee-EEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHH------------HHHHHHHHHHHHcCCCCceeEeece
Q 009291          266 ELL-IKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDR------------FKEFLREVAIMKGLRHPNIVLLMGA  330 (538)
Q Consensus       266 ~y~-i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~------------~~~~~~Ei~il~~L~hpnIv~l~~~  330 (538)
                      +|. +.+.||+|+||+||+|.+..  +.||+|++.........            ...+.+|+++++.++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            444 45789999999999998764  44999988654322100            1257789999999999999999999


Q ss_pred             eccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEe
Q 009291          331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD  410 (538)
Q Consensus       331 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~D  410 (538)
                      +......+++|||+. ++|.+++..   ...+++.....++.|++.||+|||+++  ++|+||+|+||+++.++.++|+|
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECC
Confidence            999999999999997 588888853   235889999999999999999999999  99999999999999999999999


Q ss_pred             eCCCccCCCC--------------ccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 009291          411 FGLSRSKPNT--------------YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQV  475 (538)
Q Consensus       411 FGla~~~~~~--------------~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~  475 (538)
                      ||++......              ........++..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9998764411              1111233467889999998764 468999999999999999999999988776554


Q ss_pred             HHHHhhcCc---c-----------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          476 ISAVGFKGR---R-----------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       476 ~~~i~~~~~---~-----------------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ...+.....   .                       ......++.++.++|.+||+.+|++|||+++++.
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            443321000   0                       0011345788999999999999999999999975

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-35  Score=304.33  Aligned_cols=246  Identities=24%  Similarity=0.358  Sum_probs=201.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc-----
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-----  336 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~-----  336 (538)
                      .++|++.+.||+|+||.||+|.+..+  .+|+|++..........+.+.+|+.+++.++|+||+++.+++.....     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            56799999999999999999998644  49999876544444455678899999999999999999998766554     


Q ss_pred             -ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          337 -LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       337 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                       .++|+||+ +++|.+++..    ..+++..++.++.|++.||+|||+.|  |+||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccc
Confidence             89999998 5699998863    24899999999999999999999999  9999999999999999999999999988


Q ss_pred             cCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc---------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------  485 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~---------  485 (538)
                      .....   .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......         
T Consensus       167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         167 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             ccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            65432   234567889999999865 36789999999999999999999999877665544433211000         


Q ss_pred             --------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 --------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 --------------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                          ......+++.+.+||.+||+.+|++|||+.+|+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                                0111246889999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=302.66  Aligned_cols=246  Identities=27%  Similarity=0.457  Sum_probs=216.1

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~  336 (538)
                      .+...+|.++..||+|+||+|.+++.+++.  ||||++++.-.. ...++--+.|-++|... +-|.+++++.+|+.-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            567789999999999999999999988877  999998775432 22333445677777766 56889999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|+||||+.||+|-..++.-   +.+.|..+.-++.+|+-||-+||++|  ||.||||.+|||++.+|++||+|||++..
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeeEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccc
Confidence            99999999999998888643   35888999999999999999999999  99999999999999999999999999987


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      .--....+.+.+||+.|+|||++...+|+..+|+||+|++||||+.|+.||.+..+.+....|  ......+|..+|.++
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI--~ehnvsyPKslSkEA  577 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI--MEHNVSYPKSLSKEA  577 (683)
T ss_pred             cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHccCcCcccccHHH
Confidence            555555678899999999999999999999999999999999999999999999998888887  455667899999999


Q ss_pred             HHHHHHhhhcCCCCCCC
Q 009291          497 AALIETCWAEEPEIRPS  513 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs  513 (538)
                      .++++..|...|.+|..
T Consensus       578 v~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  578 VAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHHHHhhcCCccccC
Confidence            99999999999999943

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-35  Score=293.11  Aligned_cols=248  Identities=27%  Similarity=0.371  Sum_probs=202.5

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      |++.+.||+|.||.||+|+...  ..+++|++..........+.+.+|+.+++.++|+||+++++++.+...+++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            5677899999999999998864  45999998766434444567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS  424 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~  424 (538)
                      . ++|.+++....  ..+++..++.++.|++.||+|||+.+  |+||||+|+||++++++.++|+|||++..........
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            7 58999987542  35889999999999999999999999  9999999999999999999999999988654433223


Q ss_pred             CCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC----------------ccc-
Q 009291          425 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------------RRL-  486 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~----------------~~~-  486 (538)
                      ....++..|+|||.+.+. .++.++||||||+++||+++|+.||...+..+....+....                ... 
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            344567889999998776 78899999999999999999999998876554433221100                000 


Q ss_pred             ----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 ----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ----------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                ...+..+..+.++|++||..+|++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                      011234778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.6e-34  Score=298.59  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=197.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc-CCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~-~~~~~lV  340 (538)
                      ..+|++.+.||.|+||.||+|.+..++  +|+|++..........+.+.+|+.+++.++||||+++.+++.. ....+++
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv   88 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV   88 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence            467999999999999999999876544  9999876544344445678899999999999999999998865 5578999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      +||+ +++|..+++..    .+++..+..++.|++.||+|||+++  |+||||+|+||++++++.+||+|||++......
T Consensus        89 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          89 TELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             eehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            9998 56888887532    4778888899999999999999999  999999999999999999999999998754322


Q ss_pred             ccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------------------
Q 009291          421 YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF------------------  481 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~------------------  481 (538)
                         .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+..                  
T Consensus       162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence               133467889999998766 5689999999999999999999999977654322211100                  


Q ss_pred             ------cCcccC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          482 ------KGRRLE-----IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       482 ------~~~~~~-----~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                            ......     ....+++.+.++|.+||+.+|++||++.+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  000011     113567899999999999999999999988543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-34  Score=300.13  Aligned_cols=248  Identities=23%  Similarity=0.335  Sum_probs=197.6

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC------
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------  334 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~------  334 (538)
                      ..++|++.+.||+|+||.||+|.+..  ..||+|++..........+.+.+|+.++++++|+||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            34789999999999999999998754  4499998866443444456788999999999999999999987533      


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ...+++++++ +++|.+++...    .+++..++.++.|++.||+|||+.+  |+||||||+||++++++.+||+|||++
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccc
Confidence            3467888887 77998887532    4889999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc---------
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------  484 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~---------  484 (538)
                      ......   .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.....         
T Consensus       168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         168 RHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             cccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            764332   234567889999999866 4678899999999999999999999976655433322211000         


Q ss_pred             --------------c-c-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          485 --------------R-L-----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       485 --------------~-~-----~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                                    . .     ......++++.+||.+||+.+|++||++.+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                          0 0     0012357889999999999999999999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=292.79  Aligned_cols=245  Identities=25%  Similarity=0.395  Sum_probs=199.2

Q ss_pred             cceeEE-EEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccC----Cc
Q 009291          265 SELLIK-KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP----PN  336 (538)
Q Consensus       265 ~~y~i~-~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~----~~  336 (538)
                      ++|.+- +.||-|-.|+|..+.++.+  ++|+|++....       ...+|+++.-.. .|+|||.+++++.+.    ..
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            345444 6799999999999877644  59999986542       566788866544 699999999988643    45


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeCC
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGL  413 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGl  413 (538)
                      +.+|||.++||.|...++... ...++|.++..|+.||+.|+.|||+.+  |.||||||+|+|.+.   +-.+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccc
Confidence            789999999999999987543 346999999999999999999999999  999999999999964   44799999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhhcCcccCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV----ISAVGFKGRRLEIP  489 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~----~~~i~~~~~~~~~p  489 (538)
                      |+..... ....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......+    ..+|..+...++-|
T Consensus       211 AK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  211 AKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             ccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            9875532 234677889999999999999999999999999999999999999988765332    33443333333322


Q ss_pred             --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          490 --KNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       490 --~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                        ..+|+..+++|+.+|..+|.+|.|++++++.
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence              3578999999999999999999999998753

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=311.86  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=228.3

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +--.+..++++++..||-|+||.|=+++.++..  +|+|++++... +..+.+.+..|-.||...+.|.||++|..|.+.
T Consensus       413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS  492 (732)
T ss_pred             hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence            334566788999999999999999999888776  89999877654 445567788999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ...|+.||-|-||.|+..++   .++.+++..+.-++..+++|++|||++|  ||.|||||+|++++.+|-+||.|||+|
T Consensus       493 kyvYmLmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFA  567 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFA  567 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhH
Confidence            99999999999999999997   4456999999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      +....+. .+-+.+||++|.|||++.+...+..+|.||||+++|||++|.+||.+.++......|..+...+.+|..++.
T Consensus       568 Kki~~g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k  646 (732)
T KOG0614|consen  568 KKIGSGR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITK  646 (732)
T ss_pred             HHhccCC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccch
Confidence            9887664 335789999999999999999999999999999999999999999999999999999888888999999999


Q ss_pred             HHHHHHHHhhhcCCCCCCC
Q 009291          495 MVAALIETCWAEEPEIRPS  513 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs  513 (538)
                      ...+||++++..+|.+|..
T Consensus       647 ~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  647 TATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hHHHHHHHHHhcCcHhhhc
Confidence            9999999999999999976

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=289.49  Aligned_cols=247  Identities=29%  Similarity=0.433  Sum_probs=196.7

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEEEee
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      |++.+.||+|+||+||+|....  ..+++|.+...... .......+|+..+++++ |+||+++++++.++...++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            6788999999999999999864  34899987654332 22234557899999998 99999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      + +++|.+++.... ...+++..++.++.|++.+|.|||+++  ++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~  154 (283)
T cd07830          80 M-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-P  154 (283)
T ss_pred             C-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-C
Confidence            9 779988886443 235889999999999999999999999  9999999999999999999999999987654322 1


Q ss_pred             cCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-----------------cc
Q 009291          424 SKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-----------------RR  485 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-----------------~~  485 (538)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+....                 ..
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            234567889999998754 457899999999999999999999997766544332221000                 00


Q ss_pred             c-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 L-----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ~-----------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .           ......+..+.++|++||+.+|++|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0           011123678999999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=297.60  Aligned_cols=255  Identities=34%  Similarity=0.605  Sum_probs=208.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHc--CCCCceeEeeceeccC----Ccc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLLMGAVTEP----PNL  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~--L~hpnIv~l~~~~~~~----~~~  337 (538)
                      ..+..+.+.||+|.||.||+|++++..||||++...+     .+.+.+|.+|++.  |+|+||+.+++.-..+    .++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            4678899999999999999999999999999985432     2478888888875  5999999999875433    248


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-----CC-CCEEeecCCCCCEEEcCCCcEEEEee
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-----RR-PPIVHRDLKSPNLLVDSTYTVKVCDF  411 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-----~~-~~iiHrDLKp~NILl~~~~~vkL~DF  411 (538)
                      ++|++|.+.|+|+|+|.+.    .++.+..++++..++.||++||-     +| |.|.|||||..|||+.++|..-|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            9999999999999999753    48899999999999999999996     23 78999999999999999999999999


Q ss_pred             CCCccCCCC----ccccCCCCCCCcccccccccCCCC------CchhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 009291          412 GLSRSKPNT----YISSKTAAGTPEWMAPEVLREDPS------NEKSDVFSFGVILWELITL----------QKPWRNST  471 (538)
Q Consensus       412 Gla~~~~~~----~~~~~~~~gt~~Y~aPE~l~~~~~------s~ksDVwSLGvil~eLltg----------~~Pf~~~~  471 (538)
                      |+|......    .......+||.+|||||++.....      -..+||||||.++||++..          +.||....
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            999865433    223456789999999999976432      2468999999999999832          57886543


Q ss_pred             H-----HHHHHHHhhcCcccCCCCCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          472 P-----SQVISAVGFKGRRLEIPKNVN-----PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       472 ~-----~~~~~~i~~~~~~~~~p~~~s-----~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      +     ++....+-....|..+|..+.     ..+..+|+.||..||.-|.|+-.|-+.|.++.++
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            3     344444445566666665543     4578899999999999999999999999998854

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9e-36  Score=317.62  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=209.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------c
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------N  336 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------~  336 (538)
                      ..|...+.||+|+||.||+++++.++  +|||.+.... ....++...+|+++|++|+|+|||++.++-++..      .
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            34667789999999999999987655  9999976543 3445578889999999999999999999865543      4


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc--CCC--cEEEEeeC
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STY--TVKVCDFG  412 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~--~~~--~vkL~DFG  412 (538)
                      ..+|||||.+|+|...+...+...-+++...+.+..+++.||.|||++|  ||||||||.||++-  .+|  ..||+|||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            6899999999999999998888778999999999999999999999999  99999999999983  323  57999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhhc-----
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPS----QVISAVGFK-----  482 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~----~~~~~i~~~-----  482 (538)
                      .|+...++. ...+.+||..|.+||.+.. ..|+..+|.|||||++|+++||..||......    ++...+...     
T Consensus       170 ~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  170 AARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            999887765 4577899999999999984 88999999999999999999999999664333    122222111     


Q ss_pred             --------C------cccCCCCCCc----HHHHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHhhh
Q 009291          483 --------G------RRLEIPKNVN----PMVAALIETCWAEEPEIRP--SFPSIMETLQQFLMSS  528 (538)
Q Consensus       483 --------~------~~~~~p~~~s----~~l~~LI~~cL~~dP~~RP--s~~eIl~~L~~il~~~  528 (538)
                              .      ..+++|-+++    ..+...+..+|..+|++|-  .+.+....+..++.-.
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence                    1      1123333343    3456678889999999997  7788877777777544

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.5e-34  Score=297.10  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=194.3

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCC----ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceecc----CCc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE----PPN  336 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~----~~~  336 (538)
                      +|++.+.||+|+||.||++.+..+    .+|+|.+..........+.+.+|+.+++++ +|+||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            488999999999999999998755    499998765433334456788999999999 59999999987532    245


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +++++||+. ++|.+++...   ..+++..++.++.|++.||+|||++|  ++||||||+||+++.++.+||+|||++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788899885 5888888532   35889999999999999999999999  99999999999999999999999999976


Q ss_pred             CCCCcc----ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc---------
Q 009291          417 KPNTYI----SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK---------  482 (538)
Q Consensus       417 ~~~~~~----~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~---------  482 (538)
                      ......    ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...         
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            443211    1123468899999998765 46899999999999999999999999876543322211100         


Q ss_pred             ----------------C-ccc---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 ----------------G-RRL---EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ----------------~-~~~---~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                      . ...   .....++..+.+||.+||+.+|++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                            0 000   112346789999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=300.04  Aligned_cols=258  Identities=31%  Similarity=0.492  Sum_probs=211.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcC--CCCceeEeeceeccCC----cc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL--RHPNIVLLMGAVTEPP----NL  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L--~hpnIv~l~~~~~~~~----~~  337 (538)
                      ....++.+.+|+|.||.||+|+..++.||||++.     ....+.|.+|-+|++..  +|+||+++++.-....    .+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            3456678899999999999999999999999974     45567899999998864  7999999999876555    79


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC-------CCCEEeecCCCCCEEEcCCCcEEEEe
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-------RPPIVHRDLKSPNLLVDSTYTVKVCD  410 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------~~~iiHrDLKp~NILl~~~~~vkL~D  410 (538)
                      ++|+||.+.|+|.++|...    .+++....+|+..+++||+|||+-       +|+|+|||||..|||+.++++..|+|
T Consensus       284 wLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            9999999999999999754    489999999999999999999983       36899999999999999999999999


Q ss_pred             eCCCccCCCCcc--ccCCCCCCCcccccccccCCCC------CchhhHHHHHHHHHHHHhCC------------CCCC--
Q 009291          411 FGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPS------NEKSDVFSFGVILWELITLQ------------KPWR--  468 (538)
Q Consensus       411 FGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~------s~ksDVwSLGvil~eLltg~------------~Pf~--  468 (538)
                      ||+|.....+..  .....+||.+|||||++.+...      -.+.||||+|.+|||+++..            .||.  
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            999987543221  1234789999999999977532      24689999999999999752            2332  


Q ss_pred             ---CCCHHHHHHHHhhcCcccCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          469 ---NSTPSQVISAVGFKGRRLEIPKNV-----NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       469 ---~~~~~~~~~~i~~~~~~~~~p~~~-----s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                         .-+-.+....+.....|..+|..+     ...+.+.|..||+.||+.|.|+.-+.+++.++.+....
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence               122234445555566777777543     36789999999999999999999999999999987754

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.7e-35  Score=327.89  Aligned_cols=247  Identities=26%  Similarity=0.476  Sum_probs=194.0

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc-------
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-------  333 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~-------  333 (538)
                      ...+|+.++.||+||||.||+++++  ++.||||++.... .......+.+|+..|++|+|||||+++..|.+       
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            4567888999999999999999886  5669999998776 66677889999999999999999999653200       


Q ss_pred             --------------------------------------------------------------------------------
Q 009291          334 --------------------------------------------------------------------------------  333 (538)
Q Consensus       334 --------------------------------------------------------------------------------  333 (538)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHH
Q 009291          334 ------------------------P--------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL  381 (538)
Q Consensus       334 ------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L  381 (538)
                                              +        ..+||=||||+..++.++++.+...  -.....|.+++||++||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence                                    0        1257889999998888888765432  14778999999999999999


Q ss_pred             HhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC------------------CCccccCCCCCCCcccccccccCCC
Q 009291          382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP------------------NTYISSKTAAGTPEWMAPEVLREDP  443 (538)
Q Consensus       382 H~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~------------------~~~~~~~~~~gt~~Y~aPE~l~~~~  443 (538)
                      |++|  ||||||||.||+++.++.|||+|||+|+...                  ......+..+||.-|+|||++.+..
T Consensus       714 H~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  714 HDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             HhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999  9999999999999999999999999998511                  0111335568999999999997665


Q ss_pred             ---CCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhhcCcccCCCCCC----cHHHHHHHHHhhhcCCCCCCCHH
Q 009291          444 ---SNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNV----NPMVAALIETCWAEEPEIRPSFP  515 (538)
Q Consensus       444 ---~s~ksDVwSLGvil~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~----s~~l~~LI~~cL~~dP~~RPs~~  515 (538)
                         |+.|+|+||||++++||+.   ||...-+ ..++..+.  ...++.+..+    -+.-..+|++||+.||.+||||.
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~  866 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT  866 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence               9999999999999999985   4654332 23333332  2233333111    23457799999999999999999


Q ss_pred             HHHH
Q 009291          516 SIME  519 (538)
Q Consensus       516 eIl~  519 (538)
                      |+|.
T Consensus       867 eLL~  870 (1351)
T KOG1035|consen  867 ELLN  870 (1351)
T ss_pred             HHhh
Confidence            9864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-36  Score=301.43  Aligned_cols=255  Identities=28%  Similarity=0.399  Sum_probs=205.5

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEecccc-----CHHHHHHHHHHHHHHHcCCCCceeEeeceec-c
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-----HEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-E  333 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~-----~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~-~  333 (538)
                      .-.++|-++.+||+|+|+.||+|-+.  ++.||||+-.....     .+...+...+|..|.+.|+||.||++|++|. +
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            34567888999999999999999775  34589998543322     2344577889999999999999999999986 4


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc---CCCcEEEEe
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCD  410 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~---~~~~vkL~D  410 (538)
                      .+.+|-|+|||+|.+|.-+|+..   ..+++.++..|+.||+.||.||.+..|||||-||||.|||+-   ..|.+||+|
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence            56689999999999999999744   369999999999999999999999999999999999999994   457899999


Q ss_pred             eCCCccCCCCcc-------ccCCCCCCCcccccccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Q 009291          411 FGLSRSKPNTYI-------SSKTAAGTPEWMAPEVLRED----PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISA  478 (538)
Q Consensus       411 FGla~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~----~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~-~~~~  478 (538)
                      ||++....+...       .....+||.+|++||.+--.    ..+.|+||||+|||+|.+++|+.||......+ ++..
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence            999986543321       22345799999999998533    46889999999999999999999998765443 3322


Q ss_pred             H-hhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          479 V-GFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       479 i-~~~~~~~~~p--~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      - ........+|  +-++.+.++||++||...-++|.+..++..
T Consensus       697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            1 1222333444  568999999999999999999998887753

>PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1

Probab=100.00  E-value=8e-36  Score=283.06  Aligned_cols=97  Identities=55%  Similarity=0.955  Sum_probs=92.8

Q ss_pred             CCCCCCCchhhhhHHHHHHHHHHHhhhCCeEEeceeeccccchhhHHHHHHHhhhcCCCceeecccccCCC-CCCCeEEE
Q 009291            1 MGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRR-DDASSCLV   79 (538)
Q Consensus         1 ~gg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~~-~~~~~~~~   79 (538)
                      |||++++++.. ..+|++++++||+  +++|+|||+|++|+|||||||||||||+||||||||||++||+. +++++|+|
T Consensus       107 MGG~~~~~~~~-~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~iglpCrLvrG~~y~g~~~~~a~~~V  183 (204)
T PF14381_consen  107 MGGPVSDAEDM-LFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADRIGLPCRLVRGCYYCGWDDDDASNLV  183 (204)
T ss_pred             hCCCCCcchhh-hHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHhcCCCceEEeeccCCccCCCCceEEE
Confidence            99999996665 6699999998999  89999999999999999999999999999999999999999999 99999999


Q ss_pred             EeCCCcchhhhccCCCCcccC
Q 009291           80 QIGPDREYLVDLLEDPGVLSK  100 (538)
Q Consensus        80 ~~~~~~~~~~~~~~~~g~~~~  100 (538)
                      ++++++|||||||++||+|+|
T Consensus       184 ~~~~~~eyiVDLm~~PG~L~P  204 (204)
T PF14381_consen  184 KFDDGREYIVDLMGAPGQLIP  204 (204)
T ss_pred             EcCCCcEEEEEcCCCCCCcCC
Confidence            999999999999999999997

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-35  Score=312.09  Aligned_cols=257  Identities=34%  Similarity=0.565  Sum_probs=222.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      .+.+..++||+|+||+||+|.+-..      +||+|++.... ..+..+++++|+-+|.+++|||++++++++.... +.
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            3455678999999999999987432      38999987654 3344578999999999999999999999998765 89


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ||++|++.|+|.++++..  +..+..+..+.|..||++||.|||+++  ++||||-.+|||+..-..|||+|||+++...
T Consensus       774 lvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            999999999999999753  446888999999999999999999999  9999999999999999999999999999765


Q ss_pred             CCcccc--CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          419 NTYISS--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       419 ~~~~~~--~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      ......  ....-.+.|||-|.+....|+.++|||||||++||++| |..||.+....++-..+ ..+.|+..|+.++-.
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-e~geRLsqPpiCtiD  928 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-EKGERLSQPPICTID  928 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-hccccCCCCCCccHH
Confidence            443322  22334678999999999999999999999999999998 89999998887766655 466779999999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          496 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +..++.+||..|+..||+|+++...+.++..+.
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            999999999999999999999999999887654

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.5e-35  Score=287.59  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=196.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc-CCc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPN  336 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~-~~~  336 (538)
                      ...|+++..||+|.||.||+|...++      .+|+|.++.+...........+|+.+++.++||||+.+..+|.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            34688999999999999999954322      38999887653333333567899999999999999999999877 778


Q ss_pred             ceEEEeecCCCChhhhhcC--CCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC----CcEEEEe
Q 009291          337 LSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST----YTVKVCD  410 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~----~~vkL~D  410 (538)
                      +++++||.+. +|...++.  ......++...+..|+.||+.|+.|||++-  |+||||||.|||+..+    |.|||+|
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence            9999999987 78888742  223346889999999999999999999999  9999999999999877    8999999


Q ss_pred             eCCCccCCCCccc---cCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHH
Q 009291          411 FGLSRSKPNTYIS---SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---------VIS  477 (538)
Q Consensus       411 FGla~~~~~~~~~---~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~---------~~~  477 (538)
                      ||+++...+....   ....+-|..|.|||.+.+. .|+.+.||||.|||+.||++-.+.|.+....-         .+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999987654322   2334568999999999875 58999999999999999999888876532210         011


Q ss_pred             HHh-hcCc----ccC----CC--------------C------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          478 AVG-FKGR----RLE----IP--------------K------------NVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       478 ~i~-~~~~----~~~----~p--------------~------------~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +|- ..+.    .++    .|              .            .-++...+|+.+||+.||.+|.|+++.++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            110 0000    000    01              0            123458899999999999999999988654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.4e-33  Score=317.53  Aligned_cols=147  Identities=33%  Similarity=0.521  Sum_probs=131.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++.+.||+|+||+||+|.+.  +..||+|++..... .......+.+|+.+++.++|+||+++++++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            368999999999999999999987  45599999875433 344557788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      |||+.+++|.+++...   ..+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999998643   24788999999999999999999999  9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-35  Score=304.63  Aligned_cols=246  Identities=26%  Similarity=0.369  Sum_probs=204.8

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ..+.+-|..++.||-|+||.|.+++-.++.  ||+|.+.+... ....+...+.|..||..-+++-||+++..|.+.+.+
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            456778999999999999999999766655  99999876543 345677888999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+||+|++||++-.+|-+.   +.++|..+..++.++..|+++.|+.|  +|||||||+|||||.+|++||+|||+++-.
T Consensus       705 YFVMdYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEEeccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccc
Confidence            9999999999999998643   35899999999999999999999999  999999999999999999999999998621


Q ss_pred             C---C------C---------------------------------ccccCCCCCCCcccccccccCCCCCchhhHHHHHH
Q 009291          418 P---N------T---------------------------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV  455 (538)
Q Consensus       418 ~---~------~---------------------------------~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGv  455 (538)
                      .   +      +                                 .......+||+.|+|||++....|+.-+|+||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            0   0      0                                 00011245999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCC--CCCCcHHHHHHHHHhhhcCCCCCC
Q 009291          456 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEI--PKNVNPMVAALIETCWAEEPEIRP  512 (538)
Q Consensus       456 il~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~s~~l~~LI~~cL~~dP~~RP  512 (538)
                      |||||+.|+.||...++.+...++..-..-+.+  -.+++++..+||.++++ +++.|.
T Consensus       860 il~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            999999999999988887665554322223333  35789999999988654 567774

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-35  Score=284.63  Aligned_cols=241  Identities=27%  Similarity=0.455  Sum_probs=197.0

Q ss_pred             EEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEEEeecCC
Q 009291          270 KKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      .+.||+|+|+.|-.+....  ..||||++.++...  ....+.+|++++.+.+ |+||++++++|+++..+|+|||-|.|
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH--sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G  160 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH--SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG  160 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCch--HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence            3579999999999887654  44999999777433  3468899999999984 99999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC---cEEEEeeCCCccCC--C--
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKP--N--  419 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~---~vkL~DFGla~~~~--~--  419 (538)
                      |+|...++.   +..+++.++..++.+|+.||.+||.+|  |.||||||+|||-.+..   -||||||.++.-..  .  
T Consensus       161 GplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  161 GPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             chHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            999988863   335999999999999999999999999  99999999999996554   48999999875321  1  


Q ss_pred             ---CccccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CH--------HHHH
Q 009291          420 ---TYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNS-------TP--------SQVI  476 (538)
Q Consensus       420 ---~~~~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~-------~~--------~~~~  476 (538)
                         ......+.+|+..|||||+..     ...|+.++|.||||+|+|-|++|.+||.+.       +.        ....
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence               111234567899999999863     346899999999999999999999999642       22        1223


Q ss_pred             HHHhhcCcccCCCC----CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          477 SAVGFKGRRLEIPK----NVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       477 ~~i~~~~~~~~~p~----~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..|  +....++|.    .+|.+.+++|..+|..++.+|.++.+++.
T Consensus       316 esI--QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  316 ESI--QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHH--hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            334  334455664    58999999999999999999999988876

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=305.29  Aligned_cols=238  Identities=25%  Similarity=0.356  Sum_probs=198.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ...+|++...+|.|+|+.|-.+.+..+.  +++|++.+...+.      .+|+.++... +||||+++.+.+.++.+.|+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~------~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN------QDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccccc------ccccchhhhhcCCCcceeecceecCCceeee
Confidence            3577888999999999999999876544  9999987763222      2566555554 79999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE-cCCCcEEEEeeCCCccCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-DSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl-~~~~~vkL~DFGla~~~~  418 (538)
                      |||.+.|+-+.+.+....    .....+..|+.+|+.|+.|||++|  +|||||||+|||+ ++.|+++|+|||.++...
T Consensus       394 v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             eehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            999999987777664332    233677789999999999999999  9999999999999 689999999999998765


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhcCcccCCCCCCcHHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ..   ..+.+-|..|.|||++....|++++||||||++||+|++|+.||...... ++..++    ...++...+|+.++
T Consensus       468 ~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AK  540 (612)
T KOG0603|consen  468 RS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAK  540 (612)
T ss_pred             hh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHH
Confidence            54   34567789999999999999999999999999999999999999877665 333333    23334478999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||++||+.||.+||++.++..
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHHHhccCChhhCcChhhhcc
Confidence            9999999999999999999864

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=285.91  Aligned_cols=260  Identities=27%  Similarity=0.390  Sum_probs=205.9

Q ss_pred             hcccccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHH-cCCCCceeEeeceec
Q 009291          256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMK-GLRHPNIVLLMGAVT  332 (538)
Q Consensus       256 ~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~-~L~hpnIv~l~~~~~  332 (538)
                      .....++...+.+-+..||.|+||+|++-.++.++  .|||.+..... +...+.++.|.+... .-+.||||+++|.+.
T Consensus        55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            34556677777888899999999999999888666  78888876654 455677888887554 457999999999988


Q ss_pred             cCCcceEEEeecCCCChhhhhcC--CCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                      .+...|+.||+|+- +|..+.+.  .-.+..++|+.+-.|....+.||.||.+ .+  |||||+||+|||++..|.||||
T Consensus       134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeee
Confidence            88889999999954 66555421  1123358899999999999999999976 45  9999999999999999999999


Q ss_pred             eeCCCccCCCCccccCCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhhcCc-c
Q 009291          410 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGFKGR-R  485 (538)
Q Consensus       410 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~-~~~i~~~~~-~  485 (538)
                      |||++....+.. ..+..+|...|||||.+...  .|+.+|||||||++|||+.||..||..++..-. +..+..+.. .
T Consensus       211 DFGIcGqLv~Si-AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~  289 (361)
T KOG1006|consen  211 DFGICGQLVDSI-AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI  289 (361)
T ss_pred             cccchHhHHHHH-HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe
Confidence            999987655433 33567899999999999643  489999999999999999999999999876322 222322222 2


Q ss_pred             cCCCC---CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          486 LEIPK---NVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       486 ~~~p~---~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +..+.   +++..+..+|.-||.+|-..||.+.+++++
T Consensus       290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            22333   378899999999999999999999998764

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-34  Score=308.98  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=216.8

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceec-----
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT-----  332 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~-----  332 (538)
                      .-..+.|++.+.||+|.+|.||+++..  ++..|+|++......+   +++..|.++|+.+ .|||++.+++++.     
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            344567999999999999999999765  4559999987654333   3666788999888 6999999999874     


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      .++++|+|||||.+|+..++++.-. ...+.|..+.-|++.++.|+.+||+..  +||||||-.|||++.++.|||+|||
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeee
Confidence            4567999999999999999997554 567999999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-cc
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLRED-----PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RL  486 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-----~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~  486 (538)
                      .+.....+.....+..||+.|||||++...     .|+.++|+||||++..||.-|.+|+....+...+..+..... .+
T Consensus       169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL  248 (953)
T KOG0587|consen  169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL  248 (953)
T ss_pred             eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence            999888877777889999999999998643     478899999999999999999999999988777766532221 23


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .-|..++.++.+||..||..|-++||+..++++
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            335678899999999999999999999988864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.1e-33  Score=278.32  Aligned_cols=218  Identities=22%  Similarity=0.251  Sum_probs=180.8

Q ss_pred             CCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCChhhhh
Q 009291          276 GSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL  353 (538)
Q Consensus       276 G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l  353 (538)
                      |.||+||++++..++  +|+|.+....       .+.+|...+....||||+++++++.+....+++|||+++++|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            899999999986544  9999986542       2334555555667999999999999999999999999999999988


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCCCCcc
Q 009291          354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEW  433 (538)
Q Consensus       354 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y  433 (538)
                      ...   ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.++|+|||.+.......   ....++..|
T Consensus        77 ~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y  148 (237)
T cd05576          77 SKF---LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMY  148 (237)
T ss_pred             HHh---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccc
Confidence            643   24889999999999999999999999  9999999999999999999999999876554321   234456789


Q ss_pred             cccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 009291          434 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS  513 (538)
Q Consensus       434 ~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs  513 (538)
                      +|||.+.+..++.++||||+|+++|||++|..||...... .     .......+|..+++.++++|.+||+.||++||+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~  222 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG  222 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence            9999998888999999999999999999999887643221 0     112334567788999999999999999999999


Q ss_pred             H
Q 009291          514 F  514 (538)
Q Consensus       514 ~  514 (538)
                      +
T Consensus       223 ~  223 (237)
T cd05576         223 A  223 (237)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=262.43  Aligned_cols=249  Identities=25%  Similarity=0.348  Sum_probs=205.8

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      +|.-.++||+|.||+||+|++.++.  ||+|.+.....++..-...++|+.+++.++|.|||+++++...++.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556788999999999999987766  99999887776666667889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      |.. +|..++..-  .+.++.+.+..++.|+++||.++|+++  +.||||||.|++++.+|++||+|||+++..+-+..-
T Consensus        83 cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             hhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            965 888887543  345899999999999999999999999  999999999999999999999999999987765444


Q ss_pred             cCCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcc-----c----CCC---
Q 009291          424 SKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRR-----L----EIP---  489 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~-~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~-----~----~~p---  489 (538)
                      ....+-|..|.+|.++.+.+ |++..|+||.|||+.|+.. |++.|.+..-.+.+.++-+.-..     +    .+|   
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            44566799999999998865 7889999999999999997 56668887776666655321110     0    011   


Q ss_pred             ---------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          490 ---------------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       490 ---------------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                     +.++..-+++++++|.-+|.+|.+++..++
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                           122334688999999999999999987654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6e-35  Score=300.37  Aligned_cols=243  Identities=30%  Similarity=0.445  Sum_probs=205.7

Q ss_pred             EEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCC
Q 009291          270 KKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      .+.||.|.||+||-|+++  ++.||||++.+-.+..+....+.+|+.||..+.||.||.+.-.|++.+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999876  455999999887776666678899999999999999999999999999999999999765


Q ss_pred             ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeCCCccCCCCcccc
Q 009291          348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKPNTYISS  424 (538)
Q Consensus       348 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGla~~~~~~~~~~  424 (538)
                      -|.-+|...  .+.+++....-++.||+.||+|||-++  |+|+||||+|||+..   -.++||||||+|+..+... ..
T Consensus       649 MLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FR  723 (888)
T KOG4236|consen  649 MLEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FR  723 (888)
T ss_pred             HHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh-hh
Confidence            555555433  346999999999999999999999999  999999999999964   3589999999999987653 44


Q ss_pred             CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc--cCCCCCCcHHHHHHHHH
Q 009291          425 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMVAALIET  502 (538)
Q Consensus       425 ~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~s~~l~~LI~~  502 (538)
                      ++.+||+-|+|||++.++.|...-|+||+|+|+|--++|..||....  ++..+++.....  .....++++++.+||..
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence            67899999999999999999999999999999999999999998654  344444322222  22335789999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIME  519 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~  519 (538)
                      +|+..-++|-|.++-+.
T Consensus       802 LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  802 LLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             HHHHHHHHhcchHhhcc
Confidence            99999999999887654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.7e-33  Score=328.38  Aligned_cols=244  Identities=24%  Similarity=0.345  Sum_probs=190.9

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      .+...+.||+|+||.||+|++..  ..||+|.+......      ...|++++++++|||||++++++.++...++||||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            45667889999999999998753  45899987543211      12468889999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHH---hCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH---QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      +++|+|.++++      .+++..+..++.|++.||+|||   +.+  |+||||||+||+++.++..++. ||.+..... 
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPA--VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-  834 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCC--eecCCCCHHhEEECCCCceEEE-ecccccccc-
Confidence            99999999985      2788899999999999999999   446  9999999999999998888875 665543221 


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh--hcC--------ccc--
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--QVISAVG--FKG--------RRL--  486 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~--~~~~~i~--~~~--------~~~--  486 (538)
                         .....++..|+|||++.+..++.++|||||||++|||++|+.||......  .......  ...        ...  
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence               12346789999999999999999999999999999999999998543211  1111000  000        000  


Q ss_pred             --CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          487 --EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       487 --~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                        ..+.....++.+++.+||+.+|++|||+.++++.|+++..+.
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence              111112246788999999999999999999999999998754

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=283.23  Aligned_cols=248  Identities=24%  Similarity=0.315  Sum_probs=200.8

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCC-C-C----ceeEeeceecc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-H-P----NIVLLMGAVTE  333 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-h-p----nIv~l~~~~~~  333 (538)
                      +...+|++...+|+|.||.|..+.+..++  +|||+++.   .....+..+-|+++|.++. + |    -+|.+.++|.-
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            34678999999999999999999887654  89998754   2345567788999999993 2 2    37888899999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-----------
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----------  402 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-----------  402 (538)
                      .++.|+|+|.+ |-++++++..++ ..+++...+..|++|+++++++||+.+  ++|.||||+|||+.+           
T Consensus       163 rghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCC
Confidence            99999999988 669999997654 347899999999999999999999999  999999999999831           


Q ss_pred             ---------CCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 009291          403 ---------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS  473 (538)
Q Consensus       403 ---------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~  473 (538)
                               +..|+|+|||.|+......   .+.+.|..|.|||++.+..++.++||||+||||+|+++|...|+.....
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                     3459999999998765543   4567899999999999999999999999999999999999999987766


Q ss_pred             HHHHHHhhcC-------------------cccCCCC-------------------------CCcHHHHHHHHHhhhcCCC
Q 009291          474 QVISAVGFKG-------------------RRLEIPK-------------------------NVNPMVAALIETCWAEEPE  509 (538)
Q Consensus       474 ~~~~~i~~~~-------------------~~~~~p~-------------------------~~s~~l~~LI~~cL~~dP~  509 (538)
                      +.+......-                   .++..+.                         ..-.++.+||++||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            6443322110                   0111111                         0113689999999999999


Q ss_pred             CCCCHHHHHH
Q 009291          510 IRPSFPSIME  519 (538)
Q Consensus       510 ~RPs~~eIl~  519 (538)
                      +|+|+.|++.
T Consensus       396 ~RiTl~EAL~  405 (415)
T KOG0671|consen  396 RRITLREALS  405 (415)
T ss_pred             ccccHHHHhc
Confidence            9999999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-33  Score=276.40  Aligned_cols=268  Identities=28%  Similarity=0.469  Sum_probs=225.5

Q ss_pred             hcccccccccceeEEEEEccCCcEEEEEEEEcCCc-------eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEee
Q 009291          256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM  328 (538)
Q Consensus       256 ~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~  328 (538)
                      ..+.+.+...+++..-.+-+|.||.||.|.+.+.+       +.+|.++... .+-++..++.|-..+..+.|||+..+.
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            34556777788888999999999999999765432       6777765443 455677899999999999999999999


Q ss_pred             ceec-cCCcceEEEeecCCCChhhhhc-----CCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC
Q 009291          329 GAVT-EPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       329 ~~~~-~~~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~  402 (538)
                      +++. +....++++.++.-|+|..++.     .......++..+...++.|++.|++|||+++  +||.||..+|++|++
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehh
Confidence            9864 4556788999999999999997     3333345677788899999999999999999  999999999999999


Q ss_pred             CCcEEEEeeCCCccCCCCccc--cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 009291          403 TYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAV  479 (538)
Q Consensus       403 ~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i  479 (538)
                      ..+|||+|=.+++-.-....+  ......+..||+||.+....|+.++||||||+++|||+| |+.||-..++.+....+
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            999999999999853222111  223345778999999999999999999999999999998 89999999998877666


Q ss_pred             hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       480 ~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                       ..+.|+..|-+||+++..+|.-||...|++||+++|+...|.++-.+
T Consensus       512 -kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  512 -KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             -hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence             47889999999999999999999999999999999999999887543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.4e-32  Score=262.67  Aligned_cols=236  Identities=34%  Similarity=0.531  Sum_probs=196.0

Q ss_pred             CcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCChhhhhc
Q 009291          277 SFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH  354 (538)
Q Consensus       277 ~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~  354 (538)
                      +||.||+|.+.+  ..+++|++........ .+.+.+|++.+++++|+||+++++++......++++||+.+++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            589999999875  4599999866543322 5789999999999999999999999999899999999999999999986


Q ss_pred             CCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCCCCccc
Q 009291          355 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM  434 (538)
Q Consensus       355 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~  434 (538)
                      ...   .+++..++.++.+++.++.+||+.+  ++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus        80 ~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~  153 (244)
T smart00220       80 KRG---RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM  153 (244)
T ss_pred             hcc---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence            433   2788999999999999999999999  9999999999999999999999999998765432 234556788999


Q ss_pred             ccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhcCcccCCCCC-CcHHHHHHHHHhhhcCCCCCC
Q 009291          435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKN-VNPMVAALIETCWAEEPEIRP  512 (538)
Q Consensus       435 aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~-~s~~l~~LI~~cL~~dP~~RP  512 (538)
                      +||.+.+..++.++||||||+++|++++|..||.. ...................... ++..+.+++.+||..+|++||
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            99999988889999999999999999999999987 4444443333222121111111 889999999999999999999


Q ss_pred             CHHHHHH
Q 009291          513 SFPSIME  519 (538)
Q Consensus       513 s~~eIl~  519 (538)
                      ++.++++
T Consensus       234 ~~~~~~~  240 (244)
T smart00220      234 TAEEALQ  240 (244)
T ss_pred             CHHHHhh
Confidence            9999976

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-32  Score=269.70  Aligned_cols=250  Identities=21%  Similarity=0.384  Sum_probs=211.3

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCH-HHHHHHHHHHHHHHcC-CCCceeEeeceecc
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGL-RHPNIVLLMGAVTE  333 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~-~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~  333 (538)
                      ..+.+...+|.+++.||+|+|.+|.++++..+.  ||+|++++....+ +.++=...|-.+..+. +||.+|.+..+|++
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            344567789999999999999999999988766  9999988765543 3344556677777765 79999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ++.+++|.||.+||+|--.+++.   ..++++.+.-+...|+-||.|||+.|  ||.||||.+|+|++..|++||+|+|.
T Consensus       323 esrlffvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccch
Confidence            99999999999999997666533   35899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHhhcCccc
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN-------STPSQVISAVGFKGRRL  486 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~-------~~~~~~~~~i~~~~~~~  486 (538)
                      ++..-.+...+.+.+||+.|.|||++.+..|...+|+|+||++++||+.|+.||.-       .+.++-+.++. ....+
T Consensus       398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-lekqi  476 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-LEKQI  476 (593)
T ss_pred             hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-hhhcc
Confidence            98755444556789999999999999999999999999999999999999999953       22233333332 34567


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 009291          487 EIPKNVNPMVAALIETCWAEEPEIRPS  513 (538)
Q Consensus       487 ~~p~~~s~~l~~LI~~cL~~dP~~RPs  513 (538)
                      .+|..++-....+++..|+.||.+|..
T Consensus       477 riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  477 RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             cccceeehhhHHHHHHhhcCCcHHhcC
Confidence            788999999999999999999999943

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.3e-33  Score=268.57  Aligned_cols=253  Identities=25%  Similarity=0.341  Sum_probs=199.3

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-----
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----  334 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-----  334 (538)
                      ...+.|+-..++|+|.||.||+|+.+++  .||+|++......+..-...++|+.+|..|+|+|++.+++.|...     
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            4456777888999999999999987654  488877654332223334678999999999999999999987432     


Q ss_pred             ---CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEee
Q 009291          335 ---PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF  411 (538)
Q Consensus       335 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DF  411 (538)
                         ..+|+||.+|+. +|..++....  ..++...+.+++.++.+||.|+|+..  |+|||+||+|+||+++|.+||+||
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeecc
Confidence               248999999976 8888886443  45888999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCCc----cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc--
Q 009291          412 GLSRSKPNTY----ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--  484 (538)
Q Consensus       412 Gla~~~~~~~----~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~--  484 (538)
                      |+++......    ...+..+-|..|.+||.+.+. .|+++.|||+.|||+.||+++.+-+.++++.+.+..+...-.  
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            9997543221    112344569999999998775 589999999999999999999999999988776655432100  


Q ss_pred             ---------------cc--C-CCC-------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 ---------------RL--E-IPK-------------NVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ---------------~~--~-~p~-------------~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                     .+  + +|.             .-.++..+|+.++|..||.+|+++++++.
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                           01  0 111             11347889999999999999999999874

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=6.3e-31  Score=289.94  Aligned_cols=250  Identities=18%  Similarity=0.219  Sum_probs=167.6

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeece----
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA----  330 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~----  330 (538)
                      ....++|++.+.||+|+||.||+|.+..+      .+|+|.+......    +....|  .+....+.++..++..    
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            34567899999999999999999998654      4899986543211    111111  1122222233222222    


Q ss_pred             --eccCCcceEEEeecCCCChhhhhcCCCCC-----------------ccccHHHHHHHHHHHHHHHHHHHhCCCCEEee
Q 009291          331 --VTEPPNLSIVTEYLSRGSLYKLLHIPDAR-----------------VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR  391 (538)
Q Consensus       331 --~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHr  391 (538)
                        ...+..+++|+||+.+++|.+++......                 ....+..+..++.|++.||+|||+++  |+||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR  279 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR  279 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence              24556789999999999999998643211                 01123456689999999999999999  9999


Q ss_pred             cCCCCCEEEcC-CCcEEEEeeCCCccCCCCc-cccCCCCCCCcccccccccCC----------------------CCCch
Q 009291          392 DLKSPNLLVDS-TYTVKVCDFGLSRSKPNTY-ISSKTAAGTPEWMAPEVLRED----------------------PSNEK  447 (538)
Q Consensus       392 DLKp~NILl~~-~~~vkL~DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~----------------------~~s~k  447 (538)
                      ||||+|||++. ++.+||+|||+|+...... .......+++.|+|||.+...                      .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999985 6799999999997543221 122456789999999976322                      23456


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc-------------------cCCCCCCcHHHHHHHHHhhhcCC
Q 009291          448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-------------------LEIPKNVNPMVAALIETCWAEEP  508 (538)
Q Consensus       448 sDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~-------------------~~~p~~~s~~l~~LI~~cL~~dP  508 (538)
                      +|||||||++|||+++..++..... .....+......                   ............+||.+||+.||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            7999999999999997766543211 111111100000                   00001112345589999999999


Q ss_pred             CCCCCHHHHHH
Q 009291          509 EIRPSFPSIME  519 (538)
Q Consensus       509 ~~RPs~~eIl~  519 (538)
                      ++|||+.++++
T Consensus       439 ~kR~ta~e~L~  449 (566)
T PLN03225        439 RQRISAKAALA  449 (566)
T ss_pred             ccCCCHHHHhC
Confidence            99999999976

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=7.3e-30  Score=275.99  Aligned_cols=257  Identities=19%  Similarity=0.188  Sum_probs=181.6

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEE------------------cCCceEEEEEeccccCH--H----------HHHHHH
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEW------------------RNSDVAVKILIEQEFHE--D----------RFKEFL  310 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~------------------~~~~vavK~~~~~~~~~--~----------~~~~~~  310 (538)
                      .+..++|++.++||+|+||+||+|..                  .++.||||.+.......  +          ..+...
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            34577899999999999999999964                  12348999876432110  0          012234


Q ss_pred             HHHHHHHcCCCCce-----eEeeceecc--------CCcceEEEeecCCCChhhhhcCCCC-------------------
Q 009291          311 REVAIMKGLRHPNI-----VLLMGAVTE--------PPNLSIVTEYLSRGSLYKLLHIPDA-------------------  358 (538)
Q Consensus       311 ~Ei~il~~L~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~-------------------  358 (538)
                      .|+.++.+++|.++     ++++++|..        ....++||||+.+++|.++++....                   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46677777766554     667777643        3457999999999999998863210                   


Q ss_pred             --CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc-ccCCCCCCCcccc
Q 009291          359 --RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-SSKTAAGTPEWMA  435 (538)
Q Consensus       359 --~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~gt~~Y~a  435 (538)
                        ...+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++........ ......+++.|+|
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence              112456778899999999999999999  99999999999999999999999999975433211 1112234789999


Q ss_pred             cccccCCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCCHHHH-H----------HHHhh
Q 009291          436 PEVLREDP--------------------S--NEKSDVFSFGVILWELITLQK-PWRNSTPSQV-I----------SAVGF  481 (538)
Q Consensus       436 PE~l~~~~--------------------~--s~ksDVwSLGvil~eLltg~~-Pf~~~~~~~~-~----------~~i~~  481 (538)
                      ||.+....                    +  ..+.||||+||++|+|+++.. ||........ .          .....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99885432                    1  134799999999999999875 6653211110 0          01111


Q ss_pred             cCcccCCCCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q 009291          482 KGRRLEIPKNVNPMVAALIETCWAEEP---EIRPSFPSIME  519 (538)
Q Consensus       482 ~~~~~~~p~~~s~~l~~LI~~cL~~dP---~~RPs~~eIl~  519 (538)
                      ....+.....+++...+|+.+||..+|   .+|+|++|+++
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            122233345678999999999999866   78999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=246.40  Aligned_cols=220  Identities=27%  Similarity=0.441  Sum_probs=178.7

Q ss_pred             hcccccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceec
Q 009291          256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT  332 (538)
Q Consensus       256 ~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~  332 (538)
                      ...++++..+...-+..||+|+||.|=+.++..++  .|+|.+.... ..+..+..++|+.+..+. ..|.+|.++|...
T Consensus        37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~  115 (282)
T KOG0984|consen   37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF  115 (282)
T ss_pred             ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence            34447777888888999999999999888887666  7888775543 455567788888877655 7999999999998


Q ss_pred             cCCcceEEEeecCCCChhhhhc-CCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEee
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF  411 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DF  411 (538)
                      .....++.||.|.. +|..+.+ .-.....++|..+-+|+..++.||+|||++- .+||||+||.|||++.+|+||||||
T Consensus       116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEccc
Confidence            88999999999954 7766652 2234456999999999999999999999863 3999999999999999999999999


Q ss_pred             CCCccCCCCccccCCCCCCCcccccccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHH
Q 009291          412 GLSRSKPNTYISSKTAAGTPEWMAPEVLRE----DPSNEKSDVFSFGVILWELITLQKPWRNS-TPSQVISAV  479 (538)
Q Consensus       412 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~----~~~s~ksDVwSLGvil~eLltg~~Pf~~~-~~~~~~~~i  479 (538)
                      |++....+.. ..+...|...|||||.+..    ..|+-++||||||+++.||.+++.||..+ ++-+.+.++
T Consensus       194 GIsG~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv  265 (282)
T KOG0984|consen  194 GISGYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV  265 (282)
T ss_pred             ccceeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence            9998765542 2334678999999999853    46899999999999999999999999876 444555554

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=276.22  Aligned_cols=201  Identities=26%  Similarity=0.454  Sum_probs=172.6

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCH------HHHHHHHHHHHHHHcCC---CCceeEeece
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE------DRFKEFLREVAIMKGLR---HPNIVLLMGA  330 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~------~~~~~~~~Ei~il~~L~---hpnIv~l~~~  330 (538)
                      -.+++|..++.||.|+||.|+++.++...  |+||.+.+...-.      ...-.+..|++||..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34678999999999999999999987655  7888876654321      11223557999999997   9999999999


Q ss_pred             eccCCcceEEEeecC-CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          331 VTEPPNLSIVTEYLS-RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       331 ~~~~~~~~lV~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                      |++++++|++||... +-+|.+++....   .++|.++..|+.|++.|+++||++|  |||||||-+|++++.+|-+||+
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEe
Confidence            999999999999764 458888887543   5999999999999999999999999  9999999999999999999999


Q ss_pred             eeCCCccCCCCccccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 009291          410 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRN  469 (538)
Q Consensus       410 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~  469 (538)
                      |||.|....++  ......||..|.|||++.+.+| +..-|||+||++||.+.+...||+.
T Consensus       713 dfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  713 DFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99998876554  2357789999999999999887 6778999999999999999999864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=4.8e-31  Score=271.69  Aligned_cols=256  Identities=23%  Similarity=0.286  Sum_probs=206.6

Q ss_pred             hcccccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCC------CCceeEe
Q 009291          256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR------HPNIVLL  327 (538)
Q Consensus       256 ~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~------hpnIv~l  327 (538)
                      .....++--++|.+....|+|-||+|.+|.+...  .||||++....   ...+.=+.|++||++|+      .-+++++
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            3344456678999999999999999999988644  49999997653   34456778999999995      3478999


Q ss_pred             eceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC-CcE
Q 009291          328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTV  406 (538)
Q Consensus       328 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~-~~v  406 (538)
                      +..|...+++|||+|.+ ..+|.++|+.-+...-+....+..++.|+.-||..|.++|  |+|.||||+|||+++. ..+
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCccee
Confidence            99999999999999988 4689999976655556788889999999999999999999  9999999999999865 468


Q ss_pred             EEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc
Q 009291          407 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL  486 (538)
Q Consensus       407 kL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~  486 (538)
                      ||||||.|........  +...-+..|.|||++.|.+|+...|+||+||+||||+||+..|.+.+..+++.........+
T Consensus       577 KLCDfGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  577 KLCDFGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             eeccCccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            9999999987665533  33445778999999999999999999999999999999999999888777664321110000


Q ss_pred             C-------------C---------------------------C-----------CCCc-------HHHHHHHHHhhhcCC
Q 009291          487 E-------------I---------------------------P-----------KNVN-------PMVAALIETCWAEEP  508 (538)
Q Consensus       487 ~-------------~---------------------------p-----------~~~s-------~~l~~LI~~cL~~dP  508 (538)
                      +             |                           |           ..++       ..+.+|+.+||..||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence            0             0                           0           0111       358899999999999


Q ss_pred             CCCCCHHHHHH
Q 009291          509 EIRPSFPSIME  519 (538)
Q Consensus       509 ~~RPs~~eIl~  519 (538)
                      ++|.|..|.|.
T Consensus       735 ~KRit~nqAL~  745 (752)
T KOG0670|consen  735 EKRITVNQALK  745 (752)
T ss_pred             hhcCCHHHHhc
Confidence            99999888764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-29  Score=259.99  Aligned_cols=133  Identities=26%  Similarity=0.399  Sum_probs=111.5

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCC-----C---CceeEeece
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-----H---PNIVLLMGA  330 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-----h---pnIv~l~~~  330 (538)
                      .+...+|.+.++||-|-|++||++.+....  ||+|+.+...   ...+..+.||.+|++++     |   ..||+++++
T Consensus        74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            345589999999999999999999987554  9999986542   33457788999999873     2   469999999


Q ss_pred             ec----cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEE
Q 009291          331 VT----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLV  400 (538)
Q Consensus       331 ~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl  400 (538)
                      |.    .+.++|||+|++ |.+|..++.....++ ++...+.+|++||+.||.|||. +|  |||.||||+|||+
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl  221 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL  221 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence            95    456799999998 668888887666554 8899999999999999999997 57  9999999999998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.3e-29  Score=235.04  Aligned_cols=210  Identities=43%  Similarity=0.672  Sum_probs=182.9

Q ss_pred             EccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCChh
Q 009291          273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY  350 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~  350 (538)
                      ||+|.+|.||++...  +..+++|++....... ..+.+.+|++.++.++|++|+++++++......++++|++.+++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999987  5669999986654322 3467889999999999999999999999989999999999999999


Q ss_pred             hhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCCCccCCCCccccCCCCC
Q 009291          351 KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAG  429 (538)
Q Consensus       351 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~g  429 (538)
                      +++....  ..+++..++.++.+++.++.+||+.+  ++|+||+|.||+++. ++.++|+|||.+..............+
T Consensus        80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence            9986432  34788999999999999999999999  999999999999998 899999999999865543212334567


Q ss_pred             CCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCC
Q 009291          430 TPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP  508 (538)
Q Consensus       430 t~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP  508 (538)
                      ...|++||.+... ..+.++|+|++|++++++                                 ..+.+++.+||+.+|
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p  202 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDP  202 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCc
Confidence            8899999999887 788999999999999999                                 678899999999999


Q ss_pred             CCCCCHHHHHHH
Q 009291          509 EIRPSFPSIMET  520 (538)
Q Consensus       509 ~~RPs~~eIl~~  520 (538)
                      ++||++.++++.
T Consensus       203 ~~R~~~~~l~~~  214 (215)
T cd00180         203 EKRPSAKEILEH  214 (215)
T ss_pred             ccCcCHHHHhhC
Confidence            999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-31  Score=283.10  Aligned_cols=242  Identities=29%  Similarity=0.443  Sum_probs=190.1

Q ss_pred             eEEEEEccCCcEE-EEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEEeecC
Q 009291          268 LIKKKIGEGSFGT-VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       268 ~i~~~LG~G~fg~-Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~E~~~  345 (538)
                      .-.+.+|.|+.|+ ||+|...++.||||.+..     +..+-+.+|+..|+.- +|||||++++.-.+....||..|.|.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            3345689999976 589999999999998743     3445677999999887 69999999999999999999999995


Q ss_pred             CCChhhhhcCCCCC-ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-----CCcEEEEeeCCCccCCC
Q 009291          346 RGSLYKLLHIPDAR-VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       346 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-----~~~vkL~DFGla~~~~~  419 (538)
                       .+|.+++...... ........+.+..|++.||++||+.+  ||||||||.||||+.     ...++|+|||+++....
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence             5999999763111 11111345678899999999999999  999999999999965     25799999999988654


Q ss_pred             Ccc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhhcCcc-cCCCCCCcH
Q 009291          420 TYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR-LEIPKNVNP  494 (538)
Q Consensus       420 ~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg-~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~s~  494 (538)
                      +..   ......||..|+|||++....-+.++|||||||++|+.++| .+||...-..+....  ..... ..+......
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--~~~~~L~~L~~~~d~  741 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--TGNYTLVHLEPLPDC  741 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh--cCccceeeeccCchH
Confidence            322   23456799999999999998888999999999999999996 899998765443221  12211 112222222


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ++.+||.+|++.+|..||++.+++.
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            8999999999999999999999963

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=249.20  Aligned_cols=246  Identities=26%  Similarity=0.331  Sum_probs=194.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEE--cCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC------C
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~--~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~------~  335 (538)
                      ..+|.-++.+|.|.- .|..+-+  .+++||+|++..........+...+|..++..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777889999998 6665644  467799998766544445567888999999999999999999988543      3


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..|+|||++.. +|...++.     .++-+.+..|++|++.|++|||+.|  |+||||||+||++..+..+||.|||+|+
T Consensus        95 e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhc
Confidence            47999999965 88887762     2778889999999999999999999  9999999999999999999999999999


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------  482 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-------------  482 (538)
                      ...... ..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+..|.+...-+...++...             
T Consensus       167 ~e~~~~-~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  167 TEDTDF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             ccCccc-ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            876552 335677899999999999999999999999999999999999988764432221111100             


Q ss_pred             ------------CcccC----CCC-----------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 ------------GRRLE----IPK-----------NVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ------------~~~~~----~p~-----------~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                  .....    +|.           .-...+.+++.+||..||++|.|++++|+
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                        00011    111           11256899999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=274.46  Aligned_cols=249  Identities=28%  Similarity=0.480  Sum_probs=215.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++++.+|.|.||.||++++..+.  .|+|+++....+  .++.+..|+-+++..+|+||+.+++.+.....++++|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            468999999999999999999987554  899998765433  3456778999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |||.+|+|++.-+   ..+++++.++...++..+.||+|||++|  =+|||||-.||++++.|.||+.|||.+...+...
T Consensus        92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhh
Confidence            9999999999876   4457999999999999999999999999  8999999999999999999999999998776665


Q ss_pred             cccCCCCCCCcccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc---cCCCCCCcHH
Q 009291          422 ISSKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---LEIPKNVNPM  495 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l---~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~---~~~p~~~s~~  495 (538)
                      .......||+.|||||+.   ..+.|...+|||++|+...|+-.-+.|-....+...+.........   ++-+..+++.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~  246 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF  246 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence            566788999999999986   3566899999999999999999999997777777777665443332   3334568899


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.+|++.+|..+|++||+++.++.
T Consensus       247 fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhhee
Confidence            999999999999999999988764

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.7e-31  Score=251.72  Aligned_cols=246  Identities=26%  Similarity=0.418  Sum_probs=191.3

Q ss_pred             EEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC-----cceEEE
Q 009291          269 IKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-----NLSIVT  341 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~-----~~~lV~  341 (538)
                      -.+.||.|+||.||-+.+..  +.+++|++..-...-...+.+.+|+.+|..++|.||+..++...-..     .+|+++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            35689999999999998753  44888887554334455678999999999999999999988765443     368899


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |.+. .+|..++-..   ..++.+.+.-+.+||++||+|||+.+  |.||||||.|+|++.+-.+||||||+|+......
T Consensus       137 ELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  137 ELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhh
Confidence            9985 4788877533   35788889999999999999999999  9999999999999999999999999999764322


Q ss_pred             -cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----------------
Q 009291          422 -ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-----------------  482 (538)
Q Consensus       422 -~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-----------------  482 (538)
                       ..-+..+-|..|.|||.+.+. .|+.++||||+|||+.||+-.+..|...++-+.+..+...                 
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence             222334568899999999875 5899999999999999999999999877775554433211                 


Q ss_pred             ----CcccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          483 ----GRRLEIP-----------KNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       483 ----~~~~~~p-----------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                          ......|           ..-..+...++..++..+|++|.+..+.+..
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence                0011111           1223577889999999999999887776543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=5.1e-29  Score=234.50  Aligned_cols=242  Identities=22%  Similarity=0.383  Sum_probs=189.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEE--cCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCC--cce
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP--NLS  338 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~--~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~--~~~  338 (538)
                      .++|++.+++|+|.|+.||.|..  .+.+++||+++.     -..+.+.+|+.||..|. ||||+.++++..++.  ...
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            46899999999999999999974  455688998753     34468999999999996 999999999987764  478


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCCCccC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSK  417 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~  417 (538)
                      +++||..+.+...+..      .++.-.+..++.+++.||.|+|++|  |.|||+||.|++++. .-.++|+|+|+|...
T Consensus       112 LiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhc
Confidence            9999999877766653      3667788899999999999999999  999999999999985 457999999999875


Q ss_pred             CCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhh-----------cCc
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWR-NSTPSQVISAVGF-----------KGR  484 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~-~~~~~~~~~~i~~-----------~~~  484 (538)
                      ..+. .....+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||. +....+.+.++..           ...
T Consensus       184 Hp~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  184 HPGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             CCCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            5432 2234556778899999865 457888999999999999999988873 3333222221110           001


Q ss_pred             ccCCC------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 RLEIP------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ~~~~p------------------------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+.++                        .-+++++.+|+.++|..|-.+|+|+.|.+.
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            11111                        124689999999999999999999999865

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.9e-29  Score=239.20  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=194.7

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeece-eccCCcceEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA-VTEPPNLSIV  340 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~-~~~~~~~~lV  340 (538)
                      +.|.|.+.||+|.||.+-++++++++  +++|.+....   ...++|.+|...--.| .|.||+..+++ |+..+.+.++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            67899999999999999999998776  7888876543   3456888988766566 59999998886 6677778899


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc--CCCcEEEEeeCCCccCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCDFGLSRSKP  418 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~--~~~~vkL~DFGla~~~~  418 (538)
                      +||++.|+|.+-+...+    +.|.....++.|++.|+.|||+++  +||||||.+||||-  +...|||||||+.+..+
T Consensus       101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999999886544    678888999999999999999999  99999999999993  34489999999998765


Q ss_pred             CCccccCCCCCCCcccccccccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhhcCcccCCCC
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDP-----SNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGRRLEIPK  490 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~-----~s~ksDVwSLGvil~eLltg~~Pf~~~~~~---~~~~~i~~~~~~~~~p~  490 (538)
                      ....   ....+..|.+||......     ..+.+|||.||+++|.+++|..||+.....   -.......++.....|.
T Consensus       175 ~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  175 TTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             ceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence            5431   223466899999875432     356789999999999999999999843221   11122222334445554


Q ss_pred             ---CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          491 ---NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       491 ---~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                         .+++.+..+.++-|..++++|--..+..++.......
T Consensus       252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence               3678899999999999999996666666665554443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.6e-27  Score=228.10  Aligned_cols=202  Identities=39%  Similarity=0.589  Sum_probs=172.1

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      |.+.+.||.|++|.||++...+  ..+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            5678999999999999999875  55999998765433 35678889999999999999999999999889999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc-cc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-IS  423 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~-~~  423 (538)
                      .+++|.+++.....  .+++..++.++.+++.++.+||+++  ++|+||+|.||+++.++.++|+|||.+....... ..
T Consensus        80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       80 EGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            99999999864332  1788999999999999999999999  9999999999999999999999999988754432 11


Q ss_pred             cCCCCCCCcccccccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHH
Q 009291          424 SKTAAGTPEWMAPEVL-REDPSNEKSDVFSFGVILWELITLQKPWRN-STPS  473 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l-~~~~~s~ksDVwSLGvil~eLltg~~Pf~~-~~~~  473 (538)
                      .....++..|++||.+ ....++.++|||+||+++|+|++|+.||.. .+..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            2345677889999998 666778899999999999999999999977 3443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.1e-25  Score=228.13  Aligned_cols=257  Identities=23%  Similarity=0.258  Sum_probs=203.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCc---eEEEEEeccccCHHHHHHHHHHHHHHHcCCC----CceeEeecee-ccCCcc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLRH----PNIVLLMGAV-TEPPNL  337 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~---vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h----pnIv~l~~~~-~~~~~~  337 (538)
                      +|++.+.||+|+||.||++.+..+.   +|+|+.........  ..+..|..++..+..    .++..+++.. ..+...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            8999999999999999999987653   88888655422211  156778888888863    6899999998 577788


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC-----CcEEEEeeC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-----YTVKVCDFG  412 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~-----~~vkL~DFG  412 (538)
                      ++||+.+ |.+|.++..... ...++..+++.|+.|++.+|++||+.|  ++||||||+|+++...     ..++|.|||
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            9999987 779999886544 456999999999999999999999999  9999999999999754     469999999


Q ss_pred             CCc--cCCCCc----cc----cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc
Q 009291          413 LSR--SKPNTY----IS----SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK  482 (538)
Q Consensus       413 la~--~~~~~~----~~----~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~  482 (538)
                      +++  ......    ..    .....||..|+++.+..+...+.+.|+||++.++.+++.|..||...........+...
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            998  321111    11    12345999999999999999999999999999999999999999776643333222211


Q ss_pred             CcccC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          483 GRRLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       483 ~~~~~---~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .....   .....+.++.++...+-..+...+|.+..+...|++.....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            11111   23445678888888888899999999999999998888765

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=5e-26  Score=213.00  Aligned_cols=165  Identities=19%  Similarity=0.294  Sum_probs=130.7

Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      |+|.++++..  ...+++..++.++.|++.||+|||+++        ||+||+++.++.+|+  ||++......     .
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----Q   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----c
Confidence            6888888643  235899999999999999999999987        999999999999999  9998765432     2


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhcCccc-----CCCCCCcH--HHHH
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRL-----EIPKNVNP--MVAA  498 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~-~~~~i~~~~~~~-----~~p~~~s~--~l~~  498 (538)
                      ..||+.|||||++.+..++.++|||||||++|||++|+.||....... ....+.......     ..+..+++  ++.+
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD  143 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence            368899999999999999999999999999999999999997654322 222221111111     11223334  6999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          499 LIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +|.+||..+|++||++.++++.+..+....
T Consensus       144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      144 FMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             HHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence            999999999999999999999998776554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.3e-26  Score=266.41  Aligned_cols=194  Identities=22%  Similarity=0.251  Sum_probs=140.5

Q ss_pred             cCCC-CceeEeecee-------ccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 009291          318 GLRH-PNIVLLMGAV-------TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV  389 (538)
Q Consensus       318 ~L~h-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~ii  389 (538)
                      .++| .||++++++|       .+...++.++|++ +++|.+++...  ...+++..++.++.||+.||+|||++|  ||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--Iv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG--IV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            3445 5888888877       3334578889987 56999999643  235899999999999999999999999  99


Q ss_pred             eecCCCCCEEEcCCC-------------------cEEEEeeCCCccCCCCc----------------cccCCCCCCCccc
Q 009291          390 HRDLKSPNLLVDSTY-------------------TVKVCDFGLSRSKPNTY----------------ISSKTAAGTPEWM  434 (538)
Q Consensus       390 HrDLKp~NILl~~~~-------------------~vkL~DFGla~~~~~~~----------------~~~~~~~gt~~Y~  434 (538)
                      ||||||+|||++..+                   .+||+|||+++......                .......||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            999999999996544                   45555666554321100                0001235788899


Q ss_pred             ccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 009291          435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF  514 (538)
Q Consensus       435 aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~  514 (538)
                      |||++.+..++.++|||||||+||||++|..|+.....  ....+......... ........+++.+||+.+|.+||++
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~  259 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSM  259 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcCh
Confidence            99999999999999999999999999999888654321  11111111111111 1124556789999999999999999


Q ss_pred             HHHHH
Q 009291          515 PSIME  519 (538)
Q Consensus       515 ~eIl~  519 (538)
                      .++++
T Consensus       260 ~eil~  264 (793)
T PLN00181        260 SELLQ  264 (793)
T ss_pred             HHHhh
Confidence            99975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.2e-23  Score=209.40  Aligned_cols=251  Identities=34%  Similarity=0.506  Sum_probs=203.5

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHH-HHHHHHHHHHHHHcCCCC-ceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED-RFKEFLREVAIMKGLRHP-NIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~-~~~~~~~Ei~il~~L~hp-nIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      |.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+.+.+++......+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            778999999999999999887 6689998876655443 567899999999999988 7999999997777789999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-cEEEEeeCCCccCCCCcc-
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTYI-  422 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~~~-  422 (538)
                      .++++.+++........+.+.....++.|++.+++|+|+.+  ++|||+||+||+++..+ .++++|||.+........ 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            99999977753321135889999999999999999999999  99999999999999988 799999999975443321 


Q ss_pred             -----ccCCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhhcCcc-cC--
Q 009291          423 -----SSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRR-LE--  487 (538)
Q Consensus       423 -----~~~~~~gt~~Y~aPE~l~~---~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~----~~~~~~i~~~~~~-~~--  487 (538)
                           ......|+..|+|||.+.+   .......|+||+|++++++++|..||.....    ......+...... ..  
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 2356789999999999988   5788999999999999999999999887763    3444444333322 11  


Q ss_pred             CCCCC----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          488 IPKNV----NPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       488 ~p~~~----s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      .....    ...+.+++.+|+..+|..|.+..+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11121    2578999999999999999988877664

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=7.1e-26  Score=217.91  Aligned_cols=256  Identities=32%  Similarity=0.621  Sum_probs=220.8

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +..++..++.+|.+...|..|+|++.+.++++|++...+........|.+|.-.|+-+.||||..+++.|..+.++.++.
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            44556677888999999999999999999999999887777666678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEE--eeCCCccCCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC--DFGLSRSKPN  419 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~--DFGla~~~~~  419 (538)
                      .||+.|+|+..++... ....+..++.+++.++++|++|||+..|-|----|....++++++.+.+|+  |--++.    
T Consensus       267 q~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----  341 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----  341 (448)
T ss_pred             eeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee----
Confidence            9999999999998653 456888899999999999999999988544455688999999999887764  211111    


Q ss_pred             CccccCCCCCCCcccccccccCCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSN---EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s---~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                         +.......+-||+||.+...+.+   ..+|+|||++++|||-|...||....+.+.-.++...+.+..+|+.++..+
T Consensus       342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm  418 (448)
T KOG0195|consen  342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM  418 (448)
T ss_pred             ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence               11233457789999999877654   578999999999999999999999999998888888999999999999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      ..||.-|++.||.+||.++.|.-.|++++
T Consensus       419 ~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            99999999999999999999999998875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=2.7e-25  Score=225.74  Aligned_cols=247  Identities=27%  Similarity=0.408  Sum_probs=188.7

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC-----CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccC
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP  334 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~  334 (538)
                      ..-...|.++++||.|.|++||++.+..     ..||+|.+.....    ...+.+|+++|..+ .+.||+++.+++..+
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            3345678899999999999999997644     3499998765432    23578999999999 599999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGL  413 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGl  413 (538)
                      ++..+|+||+++....++..      .++...+..+++.++.||+++|.+|  ||||||||.|++.+. .+.-.|+|||+
T Consensus       108 d~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             CeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechh
Confidence            99999999999988888875      2567888899999999999999999  999999999999974 56789999999


Q ss_pred             Ccc-C----------------CC------------------Ccc---------ccCCCCCCCcccccccccCCC-CCchh
Q 009291          414 SRS-K----------------PN------------------TYI---------SSKTAAGTPEWMAPEVLREDP-SNEKS  448 (538)
Q Consensus       414 a~~-~----------------~~------------------~~~---------~~~~~~gt~~Y~aPE~l~~~~-~s~ks  448 (538)
                      |.. .                ..                  ++.         ......||++|.|||++...+ .++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            961 0                00                  000         011245899999999987654 58899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHH-H-------------HHHHHhhcCc--------------------cc--------
Q 009291          449 DVFSFGVILWELITLQKPWRNSTPS-Q-------------VISAVGFKGR--------------------RL--------  486 (538)
Q Consensus       449 DVwSLGvil~eLltg~~Pf~~~~~~-~-------------~~~~i~~~~~--------------------~~--------  486 (538)
                      ||||.|+|+..+++++.||...... +             +.......+.                    ..        
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999998432210 0             0000000000                    00        


Q ss_pred             -------C-CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 -------E-IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 -------~-~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                             . .....+..+.+|+.+||..||.+|.|+++.|+
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                   0 00123458899999999999999999999875

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-23  Score=198.40  Aligned_cols=257  Identities=21%  Similarity=0.299  Sum_probs=205.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCC-CceeEeeceeccCCcce
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h-pnIv~l~~~~~~~~~~~  338 (538)
                      +....|.++++||.|+||.+|.|....  ..||||+-......+    .+..|..+.+.|++ ..|..+..+..+...-.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            556889999999999999999998754  459999965543332    46678888888864 67788888888888899


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeCCCc
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSR  415 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGla~  415 (538)
                      +||+.+ |.+|.+++.....  .++..+++.++-|++.-++|+|.++  +|||||||+|+|..-   ...+.|+|||+|+
T Consensus        88 lVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchh
Confidence            999998 7799999976654  3888899999999999999999999  999999999999953   3479999999998


Q ss_pred             cCCC-------CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhhcCcc
Q 009291          416 SKPN-------TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI---SAVGFKGRR  485 (538)
Q Consensus       416 ~~~~-------~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~---~~i~~~~~~  485 (538)
                      ..-+       ++.......||..|.+--+..+...+.+.|+-|+|.+|.++.-|..||++.......   +++......
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            6433       223345567999999988888888889999999999999999999999987654433   333222222


Q ss_pred             cC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          486 LE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       486 ~~---~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      .+   +-...|.++.-.+.-|=..--++-|++.-+.+.++-++..
T Consensus       243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence            22   2356789999999999999999999998887777655543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.7e-23  Score=204.33  Aligned_cols=257  Identities=19%  Similarity=0.278  Sum_probs=208.9

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEE--cCCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcce
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~--~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~  338 (538)
                      +..-.|.++++||+|.||..+.|++  ++..||||.-......    -.+.-|.+..+.| ..++|..++.+..++.+-.
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            4456899999999999999999986  4667999985443322    2455677777777 4799999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-----CCcEEEEeeCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGL  413 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-----~~~vkL~DFGl  413 (538)
                      +|+|++ |-+|.+++...+.  .++...++.+|.|++.-++|+|+++  +|.|||||+|+||..     ...+.|+|||+
T Consensus       101 LVidLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccc
Confidence            999998 7799999976654  4899999999999999999999999  999999999999964     34699999999


Q ss_pred             CccCCC-------CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhhcC
Q 009291          414 SRSKPN-------TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFKG  483 (538)
Q Consensus       414 a~~~~~-------~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~---~~~~~~i~~~~  483 (538)
                      |+..-+       ++....+..||.+||+--...+...+.+.|+-|||-++++++-|..||.+...   .+...+|....
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            986433       23334566799999999888899999999999999999999999999988644   34444443332


Q ss_pred             cccC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          484 RRLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       484 ~~~~---~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      ...+   +-.++|.++..-++-.=..+-++-|+++-+...+..++..
T Consensus       256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence            2222   2256889999999999999999999999998888877743

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=5.9e-23  Score=213.77  Aligned_cols=172  Identities=17%  Similarity=0.150  Sum_probs=131.1

Q ss_pred             hhcccccccccceeEEEEEccCCcEEEEEEEEcC---CceEEEEEecccc---CHHHHHHHHHHHHHHHcCCCCceeE-e
Q 009291          255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN---SDVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVL-L  327 (538)
Q Consensus       255 ~~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~vavK~~~~~~~---~~~~~~~~~~Ei~il~~L~hpnIv~-l  327 (538)
                      +...........|.+.+.||+|+||+||+|.+..   ..+|||++.....   .....+.+.+|+++|++++|+||+. +
T Consensus         8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188          8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            3444556667889999999999999999998753   3378988653211   2334567999999999999999985 4


Q ss_pred             eceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecC-CCCCEEEcCCCcE
Q 009291          328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL-KSPNLLVDSTYTV  406 (538)
Q Consensus       328 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDL-Kp~NILl~~~~~v  406 (538)
                      +++    ...++||||++|++|... .  .    ..   ...++.|++.||+|||++|  |+|||| ||+|||++.++.+
T Consensus        88 ~~~----~~~~LVmE~~~G~~L~~~-~--~----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         88 LAT----GKDGLVRGWTEGVPLHLA-R--P----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             EEc----CCcEEEEEccCCCCHHHh-C--c----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCE
Confidence            432    357999999999999732 1  0    11   1457889999999999999  999999 9999999999999


Q ss_pred             EEEeeCCCccCCCCccc--------cCCCCCCCcccccccccCC
Q 009291          407 KVCDFGLSRSKPNTYIS--------SKTAAGTPEWMAPEVLRED  442 (538)
Q Consensus       407 kL~DFGla~~~~~~~~~--------~~~~~gt~~Y~aPE~l~~~  442 (538)
                      ||+|||+|+........        .....++..|+|||.+...
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999999865432111        1234578889999998643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.8e-24  Score=236.21  Aligned_cols=246  Identities=24%  Similarity=0.307  Sum_probs=189.3

Q ss_pred             eEEEEEccCCcEEEEEEEEcC--CceEEEEEe----ccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          268 LIKKKIGEGSFGTVYHAEWRN--SDVAVKILI----EQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       268 ~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~----~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .....+|.|++|.|+.+....  ..++.|...    ...........+..|+.+-..|.|+|++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            356789999999888775432  223443322    22222222333778888999999999999988888777777779


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |||++ +|..++...   ..+....+..++.|++.||+|||+.|  |.|||||++|++++.+|.+||+|||.+.....+.
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 999998643   35788889999999999999999999  9999999999999999999999999987654333


Q ss_pred             c----ccCCCCCCCcccccccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHh-hcC-----cccCCC
Q 009291          422 I----SSKTAAGTPEWMAPEVLREDPSNE-KSDVFSFGVILWELITLQKPWRNSTPSQVI-SAVG-FKG-----RRLEIP  489 (538)
Q Consensus       422 ~----~~~~~~gt~~Y~aPE~l~~~~~s~-ksDVwSLGvil~eLltg~~Pf~~~~~~~~~-~~i~-~~~-----~~~~~p  489 (538)
                      .    .....+|+..|+|||.+.+..|+. ..||||.|+++..|.+|+.||......+.. .... ...     ....+.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL  554 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence            2    234567899999999999999876 579999999999999999999765444332 1111 111     111223


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..++...+.+|.+||+.+|.+|.|+++|++
T Consensus       555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  555 SLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            457788999999999999999999999975

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=4.2e-22  Score=220.90  Aligned_cols=245  Identities=21%  Similarity=0.246  Sum_probs=185.1

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCceEEEEEecccc--CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEF--HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~--~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      ++...+.||.+.|=+|.++++.+..++||++.++..  .-....+-++|++ ...+++||++.+.-+...+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            788899999999999999999888899999877652  3333444555555 5667899999999988888889999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      ..+ +|+|.+.   .+..+..-+..-|+.|++.||..+|+.|  |+|||||.+|||++.-.-+.|+||..-+...-++..
T Consensus       103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            976 8999885   4556777788889999999999999999  999999999999999989999999865432111111


Q ss_pred             -------cCCCCCCCcccccccccCCC-----------CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCc
Q 009291          424 -------SKTAAGTPEWMAPEVLREDP-----------SNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR  484 (538)
Q Consensus       424 -------~~~~~gt~~Y~aPE~l~~~~-----------~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~  484 (538)
                             ..+......|.|||.+....           .+++-||||+||++.||++ |++||.-..   ..........
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---L~aYr~~~~~  253 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---LLAYRSGNAD  253 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---HHhHhccCcc
Confidence                   12333456899999985421           4677899999999999998 788885321   1111100000


Q ss_pred             --ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          485 --RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       485 --~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                        ...+..--+..+++||..|++.+|++|.++++.|+.
T Consensus       254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence              000111123478999999999999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=6.2e-23  Score=218.07  Aligned_cols=232  Identities=26%  Similarity=0.374  Sum_probs=190.6

Q ss_pred             EccCCcEEEEEEE-----EcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEEEeecCC
Q 009291          273 IGEGSFGTVYHAE-----WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       273 LG~G~fg~Vy~a~-----~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +|+|.||.|++++     +.+.-+|+|+.++.............|..++...+ ||.++++...++.+...++++++..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7999999999874     23444899988765443332235556888888886 99999999999999999999999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT  426 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  426 (538)
                      |.|...+...   ..+++.....+...++-|++++|+.+  ++|||+|++||+++.+|++++.|||+++..-...    .
T Consensus        82 g~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----~  152 (612)
T KOG0603|consen   82 GDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----I  152 (612)
T ss_pred             chhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhh----h
Confidence            9888776533   34777778888889999999999999  9999999999999999999999999998654432    2


Q ss_pred             CCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhc
Q 009291          427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE  506 (538)
Q Consensus       427 ~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~  506 (538)
                      .+||..|||||++.  .....+|.||+|++.+||++|..||..    ++...|  ....+..|..++.++++++.+++..
T Consensus       153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKR  224 (612)
T ss_pred             cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhh
Confidence            29999999999998  467889999999999999999999998    333333  3446778899999999999999999


Q ss_pred             CCCCCCCH--HHHHHHH
Q 009291          507 EPEIRPSF--PSIMETL  521 (538)
Q Consensus       507 dP~~RPs~--~eIl~~L  521 (538)
                      +|..|...  +.+.+..
T Consensus       225 ~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  225 NPENRLGAGPDGVDEIK  241 (612)
T ss_pred             CHHHHhccCcchhHHHh
Confidence            99999654  4444444

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=3.4e-21  Score=187.76  Aligned_cols=174  Identities=13%  Similarity=0.127  Sum_probs=135.0

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHH-HHHH------HHHHHHHHHcCCCCceeEeeceeccC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED-RFKE------FLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~-~~~~------~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +-..+|.+.+.||.|+||.||++...+.++|+|++........ ....      +.+|+..+.++.|++|..+.+++...
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            4468999999999999999999887777899999875543332 2233      57899999999999999998875432


Q ss_pred             --------CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcE
Q 009291          335 --------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV  406 (538)
Q Consensus       335 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~v  406 (538)
                              ...+++|||++|.+|.++..       +++.    ...+++.+|..||+.|  ++|||+||+||+++.+| +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-E
Confidence                    35789999999999988742       2232    3559999999999999  99999999999999988 9


Q ss_pred             EEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHH
Q 009291          407 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELI  461 (538)
Q Consensus       407 kL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLl  461 (538)
                      +|+|||..........            .........+..++|+|+||+++..+.
T Consensus       174 ~liDfg~~~~~~e~~a------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKA------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhh------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            9999998765422110            011334445678999999999987654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=7.2e-21  Score=190.76  Aligned_cols=235  Identities=19%  Similarity=0.269  Sum_probs=154.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHHHHHHcCCC----------CceeEeecee
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRH----------PNIVLLMGAV  331 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~h----------pnIv~l~~~~  331 (538)
                      ..+..++.||.|+++.||.+++.+++  +|+|+....... ....+.+.+|.-....+.+          -.++-.++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            45778899999999999999998754  999997665422 3346677777655544322          1222222221


Q ss_pred             ---------ccC---C-----cceEEEeecCCCChhhhhcC----CCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 009291          332 ---------TEP---P-----NLSIVTEYLSRGSLYKLLHI----PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH  390 (538)
Q Consensus       332 ---------~~~---~-----~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiH  390 (538)
                               ...   +     +.+++|+-+ .++|.+++..    ............+.+..|+++.+++||..|  ++|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH  168 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVH  168 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence                     111   1     236677777 4588887632    222233445556677799999999999999  999


Q ss_pred             ecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccC--------CCCCchhhHHHHHHHHHHHHh
Q 009291          391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE--------DPSNEKSDVFSFGVILWELIT  462 (538)
Q Consensus       391 rDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~s~ksDVwSLGvil~eLlt  462 (538)
                      +||+|+|++++.+|.++|+||+.....+.....   ...+..|.+||....        ..++.+.|.|+||+++|.|++
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999999999987766554321   334577999997644        246889999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 009291          463 LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR  511 (538)
Q Consensus       463 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~R  511 (538)
                      ++.||..........      ..+..-.++|+.+++||+.+|+.||++|
T Consensus       246 ~~lPf~~~~~~~~~~------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPE------WDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSG------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCcccccc------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999998765432111      0222223789999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=1.8e-20  Score=179.02  Aligned_cols=140  Identities=21%  Similarity=0.163  Sum_probs=105.4

Q ss_pred             EEEEccCCcEEEEEEEEc-CCceEEEEEeccccCHHH------------------------HHHHHHHHHHHHcCCCCce
Q 009291          270 KKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDR------------------------FKEFLREVAIMKGLRHPNI  324 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~------------------------~~~~~~Ei~il~~L~hpnI  324 (538)
                      .+.||+|+||.||+|.+. +..||+|++.........                        .....+|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999999875 556999998754321110                        1123459999999987766


Q ss_pred             eEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHH-HhCCCCEEeecCCCCCEEEcCC
Q 009291          325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL-HQRRPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       325 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~iiHrDLKp~NILl~~~  403 (538)
                      .....+..  ...++||||++++++......   ...+++..++.++.|++.+|.+| |+.|  |+||||||+|||++ +
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence            43322221  224899999998776554321   23578899999999999999999 7999  99999999999998 4


Q ss_pred             CcEEEEeeCCCccC
Q 009291          404 YTVKVCDFGLSRSK  417 (538)
Q Consensus       404 ~~vkL~DFGla~~~  417 (538)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=9.7e-20  Score=174.35  Aligned_cols=188  Identities=16%  Similarity=0.171  Sum_probs=140.5

Q ss_pred             eEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHH--HHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEEEeec
Q 009291          268 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED--RFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       268 ~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~--~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      .+...|++|+||+|+.+...+.+++.+.+.....-..  ....+.+|+++|++|. |++|++++++    ...+++|||+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            3567899999999998887777787777655443211  2235789999999995 5889999886    3469999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecC-CCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL-KSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDL-Kp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      .|.+|......         . ...++.|++.+|+++|++|  |+|||| ||+|||++.++.++|+|||+|.........
T Consensus        81 ~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         81 AGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             cCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            99888754321         1 1347789999999999999  999999 799999999999999999999854432210


Q ss_pred             -------------cCCCCCCCcccccccccCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 009291          424 -------------SKTAAGTPEWMAPEVLRED-PSN-EKSDVFSFGVILWELITLQKPWRNST  471 (538)
Q Consensus       424 -------------~~~~~gt~~Y~aPE~l~~~-~~s-~ksDVwSLGvil~eLltg~~Pf~~~~  471 (538)
                                   ..-...++.|++|+...-. ..+ .+.++++.|+.+|.++|++.+..+.+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                         0011256777887764332 222 56788899999999999999876544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=5.4e-19  Score=199.77  Aligned_cols=249  Identities=23%  Similarity=0.312  Sum_probs=186.9

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCC---CCceeEeeceec
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVT  332 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~  332 (538)
                      ...+++....|.|.+.||+|+||+||+|...+. .||+|+-+....-+     |.-=.+++.+|+   -+.|..+.....
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHc
Confidence            455678889999999999999999999987654 39999976554332     111223444444   244555555555


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-------CCc
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-------TYT  405 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-------~~~  405 (538)
                      -.+.-++|+||.+.|+|.+++.   ....+++.....++.|++..++.||.++  |||+||||+|+||..       ..-
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             cCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccc
Confidence            5666799999999999999997   3446999999999999999999999999  999999999999942       345


Q ss_pred             EEEEeeCCCcc---CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc
Q 009291          406 VKVCDFGLSRS---KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK  482 (538)
Q Consensus       406 vkL~DFGla~~---~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~  482 (538)
                      ++|+|||.+.-   ..++ ......++|-.+-.+|...|..++..+|.|.|+.+++-|+.|++-=            ...
T Consensus       840 l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------~~~  906 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------VKN  906 (974)
T ss_pred             eEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------hcC
Confidence            99999998853   3333 2334567888999999999999999999999999999999996421            112


Q ss_pred             CcccC----CCCCC-cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          483 GRRLE----IPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       483 ~~~~~----~p~~~-s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +....    +++.+ .+...+|+..+|+.+-..=|...+|...|+.++...
T Consensus       907 g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~  957 (974)
T KOG1166|consen  907 GSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH  957 (974)
T ss_pred             CcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence            22222    22222 245678888999944444489999999988887654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.6e-19  Score=182.22  Aligned_cols=196  Identities=24%  Similarity=0.378  Sum_probs=148.8

Q ss_pred             CCCceeEeeceecc---------------------------CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHH
Q 009291          320 RHPNIVLLMGAVTE---------------------------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY  372 (538)
Q Consensus       320 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  372 (538)
                      +|||||++.++|.+                           +..+|+||..+.. +|..++-...    .+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            59999999887732                           2457899988754 8999985433    55667778899


Q ss_pred             HHHHHHHHHHhCCCCEEeecCCCCCEEEc--CC--CcEEEEeeCCCccCCC-----Ccc-ccCCCCCCCcccccccccCC
Q 009291          373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVD--ST--YTVKVCDFGLSRSKPN-----TYI-SSKTAAGTPEWMAPEVLRED  442 (538)
Q Consensus       373 qi~~aL~~LH~~~~~iiHrDLKp~NILl~--~~--~~vkL~DFGla~~~~~-----~~~-~~~~~~gt~~Y~aPE~l~~~  442 (538)
                      |+++|+.|||++|  |.|||+|.+|||+.  ++  ..+.|+|||++-....     ++. ......|...-||||+....
T Consensus       349 QlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            9999999999999  99999999999993  33  4689999998753222     111 12344577889999998654


Q ss_pred             C------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 009291          443 P------SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPS  516 (538)
Q Consensus       443 ~------~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~e  516 (538)
                      +      .-.|+|.|+.|.+.||++....||+.........+-..+..-..+|..+++.+++++...|+.||.+|++..=
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence            3      2468999999999999999999999854433322222233445678899999999999999999999998765


Q ss_pred             HHHHHH
Q 009291          517 IMETLQ  522 (538)
Q Consensus       517 Il~~L~  522 (538)
                      ....|+
T Consensus       507 AANvl~  512 (598)
T KOG4158|consen  507 AANVLN  512 (598)
T ss_pred             HHhHHH
Confidence            554443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=1.1e-19  Score=173.39  Aligned_cols=141  Identities=21%  Similarity=0.214  Sum_probs=108.5

Q ss_pred             EEEEccCCcEEEEEEEEc-CCceEEEEEeccccCH----------------------HH--HHHHHHHHHHHHcCCCCce
Q 009291          270 KKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHE----------------------DR--FKEFLREVAIMKGLRHPNI  324 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~----------------------~~--~~~~~~Ei~il~~L~hpnI  324 (538)
                      .+.||+|+||.||+|.+. ++.||||++.......                      ..  ...+.+|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            568999999999999875 6669999987653210                      00  1234578999999999887


Q ss_pred             eEeeceeccCCcceEEEeecCCCChhhh-hcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcC
Q 009291          325 VLLMGAVTEPPNLSIVTEYLSRGSLYKL-LHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       325 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~  402 (538)
                      .....+...  ..++||||++++++... +.    ...+++.....++.|++.+|.+||. .|  |+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-
Confidence            544333332  24899999998755433 32    1246788899999999999999999 99  99999999999998 


Q ss_pred             CCcEEEEeeCCCccCCC
Q 009291          403 TYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       403 ~~~vkL~DFGla~~~~~  419 (538)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            78999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.80  E-value=1.1e-19  Score=201.93  Aligned_cols=206  Identities=32%  Similarity=0.461  Sum_probs=153.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|..++.+..|+||.||.++++  .+.+|+|+- ++..       +.+-  ++....+|.+|                
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l-------ilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL-------ILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccc-ccch-------hhhc--cccccCCccee----------------
Confidence            367889999999999999999887  455888553 2211       1110  33333455444                


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC--
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--  419 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~--  419 (538)
                           |+-..+++..+   .++.        +++.+++|||+.+  |+|||+||+|.+|+.-|++|++|||++...-.  
T Consensus       136 -----gDc~tllk~~g---~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 -----GDCATLLKNIG---PLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             -----chhhhhcccCC---CCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                 34444444322   2332        3378999999999  99999999999999999999999999874211  


Q ss_pred             ------Cc-------cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-c
Q 009291          420 ------TY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-R  485 (538)
Q Consensus       420 ------~~-------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-~  485 (538)
                            ++       ......+||+.|.|||++....|.+.+|+|++|+|+||++.|..||.+.++++.+..+..... .
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                  11       112334799999999999999999999999999999999999999999999888876642222 2


Q ss_pred             cCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 009291          486 LEIPKNVNPMVAALIETCWAEEPEIRPS  513 (538)
Q Consensus       486 ~~~p~~~s~~l~~LI~~cL~~dP~~RPs  513 (538)
                      .+-...++++++++|.++|+.+|..|.-
T Consensus       278 pE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  278 PEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             cccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            2223457899999999999999999943

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=9.4e-19  Score=186.01  Aligned_cols=209  Identities=33%  Similarity=0.573  Sum_probs=164.9

Q ss_pred             HHcCCCCceeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCE-EeecCC
Q 009291          316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI-VHRDLK  394 (538)
Q Consensus       316 l~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~i-iHrDLK  394 (538)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.+.+....  ..+++.-...++++++.||+|||..-  | .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            456889999999999999999999999999999999997633  34888888999999999999999876  4 999999


Q ss_pred             CCCEEEcCCCcEEEEeeCCCccCCCC--ccccCCCCCCCcccccccccCCC-------CCchhhHHHHHHHHHHHHhCCC
Q 009291          395 SPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDP-------SNEKSDVFSFGVILWELITLQK  465 (538)
Q Consensus       395 p~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~-------~s~ksDVwSLGvil~eLltg~~  465 (538)
                      ..|++++....+||+|||+.......  ........-..-|.|||.+.+..       .+.+.||||+|++++|+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998765321  11111222345699999987642       3667999999999999999999


Q ss_pred             CCCCC----CHHHHHHHHhhcCcc---cCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          466 PWRNS----TPSQVISAVGFKGRR---LEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       466 Pf~~~----~~~~~~~~i~~~~~~---~~~p--~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ||...    .+.++...+......   ..+.  ...++++..++++||..+|+.||+++++...++.+....
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            99763    223444444331221   1111  145567999999999999999999999999998887654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=7.4e-18  Score=162.67  Aligned_cols=136  Identities=24%  Similarity=0.378  Sum_probs=113.8

Q ss_pred             EEEccCCcEEEEEEEEcCCceEEEEEeccccCH------HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~------~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      +.||+|++|.||+|.+.+..+++|+........      .....+.+|+.++..+.|++|.....++......+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            579999999999999988889999866443221      12245778999999999998877766666777889999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|++|.+++....      . ....++.+++.+|.+||+.+  ++|+|++|.||+++ ++.++|+|||.+..
T Consensus        82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999885321      2 77889999999999999999  99999999999998 78999999998764

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=3.7e-18  Score=165.29  Aligned_cols=133  Identities=21%  Similarity=0.271  Sum_probs=102.6

Q ss_pred             EEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcC-----CCCceeEeeceeccCC---c-ceE
Q 009291          270 KKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL-----RHPNIVLLMGAVTEPP---N-LSI  339 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-----~hpnIv~l~~~~~~~~---~-~~l  339 (538)
                      .+.||+|+||.||.  +... ..+||++.....  ...+.+.+|+.+++.+     .||||++++++++++.   . +.+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            46899999999996  4332 257888765432  2346789999999999     5799999999998874   3 337


Q ss_pred             EEee--cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHH-HHHHhCCCCEEeecCCCCCEEEcC----CCcEEEEeeC
Q 009291          340 VTEY--LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM-NYLHQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFG  412 (538)
Q Consensus       340 V~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~iiHrDLKp~NILl~~----~~~vkL~DFG  412 (538)
                      |+||  +.+++|.+++...    .+++.  ..++.|++.++ +|||+++  ||||||||+|||++.    ++.++|+||+
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            8999  5579999999642    25555  35577888777 9999999  999999999999974    3489999954


Q ss_pred             CC
Q 009291          413 LS  414 (538)
Q Consensus       413 la  414 (538)
                      -+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=1.4e-17  Score=159.31  Aligned_cols=133  Identities=20%  Similarity=0.344  Sum_probs=107.6

Q ss_pred             EEccCCcEEEEEEEEcCCceEEEEEeccccC------HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecC
Q 009291          272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFH------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~------~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  345 (538)
                      .||+|+||+||+|.+.+.++++|+.......      ......+.+|++++..++|+++.....++......+++|||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            3799999999999988888999996543221      1123567889999999988776544444455667799999999


Q ss_pred             CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       346 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |++|.+++....    .      .++.|++.+|.+||+.+  ++|+|++|+||+++ ++.++++|||++...
T Consensus        81 g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999998874321    0      78899999999999999  99999999999998 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.72  E-value=2.3e-18  Score=180.29  Aligned_cols=173  Identities=27%  Similarity=0.413  Sum_probs=133.2

Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+.|++|...+|.+++.........+....+.++.|++.|++|   ++  .+|+|+||.||+...+.++||+|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhee
Confidence            578999999999999999766666667888899999999999999   77  9999999999999999999999999987


Q ss_pred             cCCCCc------cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCC
Q 009291          416 SKPNTY------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEI  488 (538)
Q Consensus       416 ~~~~~~------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~  488 (538)
                      ......      .......||..||+||++.+..|+.++||||||++|+|++. -...|.      ...... ....-.+
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~~t~~-d~r~g~i  477 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------RIATLT-DIRDGII  477 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------HHHhhh-hhhcCCC
Confidence            654432      22345679999999999999999999999999999999997 222222      111111 1111122


Q ss_pred             C----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          489 P----KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       489 p----~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      |    .+.+ +-..|+.+++...|.+||+  .+...+..
T Consensus       478 p~~~~~d~p-~e~~ll~~lls~~p~~RP~--~~~~~~~~  513 (516)
T KOG1033|consen  478 PPEFLQDYP-EEYTLLQQLLSPSPEERPS--AIEVALHE  513 (516)
T ss_pred             ChHHhhcCc-HHHHHHHHhcCCCcccCch--HHHHhhhh
Confidence            2    2333 4468999999999999994  44444443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=4.9e-17  Score=179.21  Aligned_cols=137  Identities=22%  Similarity=0.329  Sum_probs=114.2

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccC------HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFH------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~------~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      .|...+.||+|+||+||++.+.+..+++|+.......      ....+.+.+|+++++.++|++|+....++.+....++
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l  413 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI  413 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence            3456789999999999999988888777765433211      1223568899999999999999887777777777899


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      ||||+++++|.+++.           ....++.|++.+|.+||+.+  ++||||||+||++ +++.++|+|||+++.
T Consensus       414 v~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        414 VMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999999998874           34678999999999999999  9999999999999 677999999999875

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=8.5e-17  Score=158.95  Aligned_cols=145  Identities=21%  Similarity=0.155  Sum_probs=109.6

Q ss_pred             cceeEEEEEccCCcEEEEEEE-E--cCCceEEEEEeccccCH----------------------HHHHHHHHHHHHHHcC
Q 009291          265 SELLIKKKIGEGSFGTVYHAE-W--RNSDVAVKILIEQEFHE----------------------DRFKEFLREVAIMKGL  319 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~-~--~~~~vavK~~~~~~~~~----------------------~~~~~~~~Ei~il~~L  319 (538)
                      .-|.+.+.||+|+||.||+|. +  .+..||+|++.......                      .....+.+|+.+++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357889999999999999998 3  35669999987543210                      0113456899999999


Q ss_pred             CCCc--eeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCC
Q 009291          320 RHPN--IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN  397 (538)
Q Consensus       320 ~hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~N  397 (538)
                      .+..  +.++++.    ...++||||+.+++|......   ...........++.|++.+|.+||++| .++||||||+|
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~N  179 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYN  179 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhh
Confidence            7532  3444443    235899999999887665421   123556667889999999999999987 49999999999


Q ss_pred             EEEcCCCcEEEEeeCCCccCC
Q 009291          398 LLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       398 ILl~~~~~vkL~DFGla~~~~  418 (538)
                      |+++ ++.++|+|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9998 7899999999887543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=1.5e-16  Score=152.72  Aligned_cols=138  Identities=20%  Similarity=0.176  Sum_probs=106.6

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccCH--------------------HHHHHHHHHHHHHHcCCCCc-
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHE--------------------DRFKEFLREVAIMKGLRHPN-  323 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~--------------------~~~~~~~~Ei~il~~L~hpn-  323 (538)
                      .|.+.+.||+|+||.||++... ++.+|||++.......                    .....+.+|+.++..+.|.+ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            3777899999999999999874 5669999876432110                    01123677889998887774 


Q ss_pred             -eeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC
Q 009291          324 -IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       324 -Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~  402 (538)
                       +...++.    ...++||||+++++|..+...         .....++.+++.++.++|+.|  |+||||||+||++++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~  160 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcC
Confidence             4444432    345899999999998765431         234578889999999999999  999999999999999


Q ss_pred             CCcEEEEeeCCCccCC
Q 009291          403 TYTVKVCDFGLSRSKP  418 (538)
Q Consensus       403 ~~~vkL~DFGla~~~~  418 (538)
                      ++.++|+|||.+....
T Consensus       161 ~~~~~liDfg~~~~~~  176 (198)
T cd05144         161 DEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcEEEEECCccccCC
Confidence            9999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=9.7e-18  Score=185.46  Aligned_cols=251  Identities=25%  Similarity=0.353  Sum_probs=193.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc---eEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~---vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ..|.+.+.||+|+|+.|-........   +|+|.+...............|..+-+.+. |.|++.+++...+....+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45677788999999999988664332   555554444323344455566888888886 99999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHH-hCCCCEEeecCCCCCEEEcCCC-cEEEEeeCCCccCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH-QRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKP  418 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~  418 (538)
                      ++|..++++.+.+..... ...+...+..++.|+..++.|+| ..+  +.|+||||+|.+++..+ .+++.|||+|....
T Consensus       100 ~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            999999999888731211 13556667788999999999999 899  99999999999999999 99999999998754


Q ss_pred             C---CccccCCCCC-CCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-c--ccCCCC
Q 009291          419 N---TYISSKTAAG-TPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-R--RLEIPK  490 (538)
Q Consensus       419 ~---~~~~~~~~~g-t~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~--~~~~p~  490 (538)
                      .   ........+| ++.|+|||...+. ......|+||.|+++..+++|..||...........-.... .  ......
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            4   2222345578 9999999999885 45778999999999999999999997655433221111111 1  233445


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIM  518 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl  518 (538)
                      .++....+++.+++..+|..|.+.+++-
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cCChhhhhcccccccCCchhcccccccc
Confidence            6788999999999999999999988764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=2.3e-15  Score=135.18  Aligned_cols=135  Identities=22%  Similarity=0.228  Sum_probs=112.4

Q ss_pred             EEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCC--CceeEeeceeccCCcceEEEeecCC
Q 009291          269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h--pnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      +.+.||+|.++.||++...+..+++|.......    ...+.+|+.+++.++|  .++++++.+....+..+++|||+.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            457899999999999998887899998755432    3578889999999976  5899999888887889999999988


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCC-CCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      +.+..+          +......++.+++.+|++||... .+++|+|++|+||++++.+.++++|||.++..
T Consensus        78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            777543          34556678899999999999842 23999999999999999899999999988643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=1.5e-15  Score=143.62  Aligned_cols=137  Identities=22%  Similarity=0.161  Sum_probs=96.3

Q ss_pred             EEEEccCCcEEEEEEEEc-CCceEEEEEeccccCHHHHHH----------------------HHHHHHHHHcCCCCc--e
Q 009291          270 KKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKE----------------------FLREVAIMKGLRHPN--I  324 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~~~~----------------------~~~Ei~il~~L~hpn--I  324 (538)
                      .+.||+|+||+||+|.+. +..||||++............                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999877 556999998654322211111                      134556666554332  3


Q ss_pred             eEeeceeccCCcceEEEeecCCCChhh-hhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcC
Q 009291          325 VLLMGAVTEPPNLSIVTEYLSRGSLYK-LLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       325 v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~  402 (538)
                      .+.++.    ...++||||++++.+.. .+....    . ...+..++.+++.++.++|. .+  |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-
Confidence            444432    23589999999854321 111100    1 15677899999999999999 99  99999999999999 


Q ss_pred             CCcEEEEeeCCCccCC
Q 009291          403 TYTVKVCDFGLSRSKP  418 (538)
Q Consensus       403 ~~~vkL~DFGla~~~~  418 (538)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=7.7e-15  Score=145.21  Aligned_cols=136  Identities=15%  Similarity=0.186  Sum_probs=104.6

Q ss_pred             EEEc-cCCcEEEEEEEEcCCceEEEEEecccc-----------CHHHHHHHHHHHHHHHcCCCCce--eEeeceeccCCc
Q 009291          271 KKIG-EGSFGTVYHAEWRNSDVAVKILIEQEF-----------HEDRFKEFLREVAIMKGLRHPNI--VLLMGAVTEPPN  336 (538)
Q Consensus       271 ~~LG-~G~fg~Vy~a~~~~~~vavK~~~~~~~-----------~~~~~~~~~~Ei~il~~L~hpnI--v~l~~~~~~~~~  336 (538)
                      ..|| .|+.|+||.+...+..++||.+.....           .......+.+|+.++.+|.|++|  +..+++......
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            4577 788888998888888899998754221           11233567889999999988775  667766433222


Q ss_pred             ----ceEEEeecCC-CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEee
Q 009291          337 ----LSIVTEYLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF  411 (538)
Q Consensus       337 ----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DF  411 (538)
                          .++|||+++| .+|.+++...    .+++.    .+.|++.+|.+||+.|  |+||||||+|||++.++.++|+||
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEEC
Confidence                2599999997 6898887532    24443    3568999999999999  999999999999998889999999


Q ss_pred             CCCcc
Q 009291          412 GLSRS  416 (538)
Q Consensus       412 Gla~~  416 (538)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1.7e-13  Score=146.38  Aligned_cols=251  Identities=25%  Similarity=0.223  Sum_probs=185.0

Q ss_pred             cccccceeEEEEEcc--CCcEEEEEEEE--c--CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceecc
Q 009291          261 EIRWSELLIKKKIGE--GSFGTVYHAEW--R--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE  333 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~--G~fg~Vy~a~~--~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~  333 (538)
                      +..-..+.+.+.+|.  |.+|.||.+..  .  ...+|+|.-+........-..=++|+...+++ .|+|.++.+..|..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            344455677889999  99999999876  3  33488887444333333333445677777777 49999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHH----HHHHHHhCCCCEEeecCCCCCEEEcCC-CcEEE
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK----GMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKV  408 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~iiHrDLKp~NILl~~~-~~vkL  408 (538)
                      .+..++-+|+|. .+|..+.+..  ...+++..++....+...    ||.++|..+  ++|-|+||+||+...+ ...++
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeec
Confidence            999999999985 6787777533  234888899999999999    999999999  9999999999999988 88999


Q ss_pred             EeeCCCccCCCCccccCCC-----CCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhhc
Q 009291          409 CDFGLSRSKPNTYISSKTA-----AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS-TPSQVISAVGFK  482 (538)
Q Consensus       409 ~DFGla~~~~~~~~~~~~~-----~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~-~~~~~~~~i~~~  482 (538)
                      +|||+.....+........     .|...|++||...+. ++...|||+||.++.+-.++..+.... +..-  ..+...
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W--~~~r~~  341 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSW--SQLRQG  341 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCc--cccccc
Confidence            9999998776654332222     678899999987664 788999999999999998886554322 1100  000001


Q ss_pred             CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ....++-...+..+...+..|++.+|..|++++.+..
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1122233345667777999999999999998876643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=3e-13  Score=134.41  Aligned_cols=200  Identities=22%  Similarity=0.340  Sum_probs=141.2

Q ss_pred             HHHcCCCCceeEeeceeccCC-----cceEEEeecCCCChhhhhcCCC-CCccccHHHHHHHHHHHHHHHHHHHhCCCCE
Q 009291          315 IMKGLRHPNIVLLMGAVTEPP-----NLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPI  388 (538)
Q Consensus       315 il~~L~hpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~i  388 (538)
                      .|-.+.|.|+|+++.+|.+..     ...++.||+..|++..+|++.. ....+......+|+-||+.||.|||+..|+|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            344567999999999986543     3688999999999999996533 2345777888899999999999999999999


Q ss_pred             EeecCCCCCEEEcCCCcEEEEeeCCCccCCCC----ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 009291          389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT----YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ  464 (538)
Q Consensus       389 iHrDLKp~NILl~~~~~vkL~DFGla~~~~~~----~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~  464 (538)
                      +|+++..+-|++..+|-+||.--.-.......    ........+-+.|.+||.=.....+.++|||++|....+|.-+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999999998888532211111110    00112334667899999877777788999999999999999876


Q ss_pred             CCCC-CCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          465 KPWR-NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       465 ~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .--. ..........+......+.     ...-+.+|.+|++..|..||++..++.
T Consensus       280 iq~tnseS~~~~ee~ia~~i~~le-----n~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANVIIGLE-----NGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eccCCCcceeehhhhhhhheeecc-----CccccCcCcccccCCCCCCcchhhhhc
Confidence            5322 1111111111111101111     111246899999999999999998764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=3.1e-12  Score=118.77  Aligned_cols=130  Identities=18%  Similarity=0.094  Sum_probs=95.7

Q ss_pred             EEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCce-eEeeceeccCCcceEEEeecCCCC
Q 009291          270 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYLSRGS  348 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnI-v~l~~~~~~~~~~~lV~E~~~~gs  348 (538)
                      ++.|+.|.++.||+++..+..+++|+......   ....+.+|+.+++.+.+.++ .+++.+..  ...++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            46789999999999998888899998654321   11245678888888865444 34554433  33589999999987


Q ss_pred             hhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCC---CEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          349 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP---PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       349 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~---~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +...-        .   ....++.+++++|+.||+.+.   .++|+|++|.||+++ ++.++++|||.+..
T Consensus        78 l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            75430        0   112356789999999999871   249999999999998 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.32  E-value=4.3e-11  Score=129.36  Aligned_cols=162  Identities=19%  Similarity=0.240  Sum_probs=122.2

Q ss_pred             CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHH
Q 009291          288 NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR  367 (538)
Q Consensus       288 ~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~  367 (538)
                      +.++.|.+.+....  .......+-+.-|+.++||||+++++.++.+...|+|+|.+.  .|..+++.      +.....
T Consensus        37 ~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v  106 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV  106 (690)
T ss_pred             CCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence            44577777665543  444566777888999999999999999999999999999885  67777753      335566


Q ss_pred             HHHHHHHHHHHHHHH-hCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCc
Q 009291          368 LNMAYDVAKGMNYLH-QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE  446 (538)
Q Consensus       368 ~~i~~qi~~aL~~LH-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~  446 (538)
                      .-.+.||+.||.||| +++  ++|++|.-+-|+++..|..||++|.++...............-..|..|+.+....  -
T Consensus       107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--c
Confidence            677899999999998 466  99999999999999999999999998865433221111111222456666554332  3


Q ss_pred             hhhHHHHHHHHHHHHhC
Q 009291          447 KSDVFSFGVILWELITL  463 (538)
Q Consensus       447 ksDVwSLGvil~eLltg  463 (538)
                      ..|.|.|||++||++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            46999999999999998

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.32  E-value=9.6e-12  Score=133.61  Aligned_cols=142  Identities=20%  Similarity=0.232  Sum_probs=96.0

Q ss_pred             EEEccCCcEEEEEEEEc-CCceEEEEEeccccCH----------------------------HHH----------HHHHH
Q 009291          271 KKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHE----------------------------DRF----------KEFLR  311 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~----------------------------~~~----------~~~~~  311 (538)
                      +.||.|++|.||+|+.. ++.||||+........                            ...          -.|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            67999999999999885 5669999985431100                            000          02445


Q ss_pred             HHHHHHcC----CCCceeEeece-eccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHH-HHHHHHhCC
Q 009291          312 EVAIMKGL----RHPNIVLLMGA-VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK-GMNYLHQRR  385 (538)
Q Consensus       312 Ei~il~~L----~hpnIv~l~~~-~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~~~  385 (538)
                      |...+.++    +|.+-+.+-.+ +...+..++||||++|++|.++.......  .   ....++.+++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence            55555554    22222222222 22234469999999999998876432111  1   12345666665 478899999


Q ss_pred             CCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       386 ~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                        ++|+|++|.||+++.++.++|+|||++.....
T Consensus       278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             --ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence              99999999999999999999999999876543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=2.2e-12  Score=137.85  Aligned_cols=248  Identities=21%  Similarity=0.201  Sum_probs=183.7

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc---CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCC
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP  335 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~  335 (538)
                      ......+|..+..||.|.|+.|+....+   +..|++|...........-..-+.|+.+...+ .|.+++.+...|....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            4556678999999999999999987644   23388888766554444333444566666665 5999999999999989


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC-CcEEEEeeCCC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLS  414 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla  414 (538)
                      +.|+=.|||.++++.....   ....+++...+.+..|++.++.++|++.  ++|+|+||+||++..+ +..+++|||++
T Consensus       340 ~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccc
Confidence            9999999999988876653   2235778889999999999999999999  9999999999999875 78899999998


Q ss_pred             ccCCCCccccCCCCCCCccc--ccccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          415 RSKPNTYISSKTAAGTPEWM--APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~--aPE~l~~~~~s~ksDVwSLGvil~eLltg~~-Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      ....-.  . ....+..++.  +++......+-.+.|++|||..+.+..++.. ++....-..      ......+....
T Consensus       415 t~~~~~--~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~------i~~~~~p~~~~  485 (524)
T KOG0601|consen  415 TRLAFS--S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT------IRSGDTPNLPG  485 (524)
T ss_pred             ccccee--c-ccccccccccccchhhccccccccccccccccccccccccCcccCccccccee------eecccccCCCc
Confidence            642211  1 1222333344  5666667778899999999999999999854 333222111      12233344445


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      ...+++.+.+.+...++..||.+.++....
T Consensus       486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  486 LKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            558899999999999999999988775443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.27  E-value=1.7e-12  Score=145.40  Aligned_cols=250  Identities=23%  Similarity=0.276  Sum_probs=187.9

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccc-cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ....+.+.+.+.+-+|.++.++.++-.++.  .+.|+..... ......+....+-.++-.-.+|.++.....+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            355678888999999999999988654433  4444433221 1112233344444444445678888777777777789


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      +++++|+.+++|...++...   ..+.+.+...+..+..++++||...  ++|+|++|.|++...+|..+++|||.....
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999999987554   3566667778888999999999998  999999999999999999999999843211


Q ss_pred             CC--------------------------Cc-----cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 009291          418 PN--------------------------TY-----ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP  466 (538)
Q Consensus       418 ~~--------------------------~~-----~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~P  466 (538)
                      ..                          ..     .......+|+.|.+||.+.+......+|+|++|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            00                          00     001223589999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHhhcCccc-CCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 009291          467 WRNSTPSQVISAVGFKGRRL-EIPKNVNPMVAALIETCWAEEPEIRPSFP  515 (538)
Q Consensus       467 f~~~~~~~~~~~i~~~~~~~-~~p~~~s~~l~~LI~~cL~~dP~~RPs~~  515 (538)
                      |...+++.+...+......+ .-+...+.+.++++...+..+|.+|..+.
T Consensus      1035 ~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999988887664332222 23345789999999999999999997654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.25  E-value=4.5e-11  Score=114.24  Aligned_cols=138  Identities=19%  Similarity=0.170  Sum_probs=98.6

Q ss_pred             EEEEccCCcEEEEEEEEcC--------CceEEEEEecccc-----------C---------HHHHHHHH----HHHHHHH
Q 009291          270 KKKIGEGSFGTVYHAEWRN--------SDVAVKILIEQEF-----------H---------EDRFKEFL----REVAIMK  317 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~--------~~vavK~~~~~~~-----------~---------~~~~~~~~----~Ei~il~  317 (538)
                      ...||.|.-+.||.|...+        ..+|||+.+....           +         ....+.+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999997543        4699998754211           0         01122333    8999999


Q ss_pred             cCCC--CceeEeeceeccCCcceEEEeecCCCChhh-hhcCCCCCccccHHHHHHHHHHHHHHHHHH-HhCCCCEEeecC
Q 009291          318 GLRH--PNIVLLMGAVTEPPNLSIVTEYLSRGSLYK-LLHIPDARVVVDERLRLNMAYDVAKGMNYL-HQRRPPIVHRDL  393 (538)
Q Consensus       318 ~L~h--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~iiHrDL  393 (538)
                      ++..  -++...+++    ...++||||+.++.+.. .++.    ..+++.....+..+++.+|..| |+.|  +||+||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence            8853  456666654    44699999997653322 2221    1244556677889999999999 8999  999999


Q ss_pred             CCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          394 KSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       394 Kp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ++.||+++ ++.+.|+|||.+....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999996 4689999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.25  E-value=6.6e-12  Score=136.93  Aligned_cols=146  Identities=19%  Similarity=0.214  Sum_probs=92.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEecccc---------------------------C-H----HHHHH-
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF---------------------------H-E----DRFKE-  308 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~---------------------------~-~----~~~~~-  308 (538)
                      +.+|+. +.||.|++|.||+|+.+  ++.||||++.....                           . .    +..+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            556776 79999999999999986  46699999864310                           0 0    11122 


Q ss_pred             -----HHHHHHHHHcCC----CCceeEeeceec-cCCcceEEEeecCCCChhhhhc--CCC-CCccccHHHHHHHHHHHH
Q 009291          309 -----FLREVAIMKGLR----HPNIVLLMGAVT-EPPNLSIVTEYLSRGSLYKLLH--IPD-ARVVVDERLRLNMAYDVA  375 (538)
Q Consensus       309 -----~~~Ei~il~~L~----hpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~--~~~-~~~~l~~~~~~~i~~qi~  375 (538)
                           +.+|...+.++.    +.+.+.+-.++. -.+..++||||++|+.+.++-.  ..+ ....+.+..+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                 333444443332    333232222221 1344689999999999987532  111 11124444444444544 


Q ss_pred             HHHHHHHhCCCCEEeecCCCCCEEEcCCC----cEEEEeeCCCccCCC
Q 009291          376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGLSRSKPN  419 (538)
Q Consensus       376 ~aL~~LH~~~~~iiHrDLKp~NILl~~~~----~vkL~DFGla~~~~~  419 (538)
                            ...|  ++|+|+||.||+++.+|    .++++|||++.....
T Consensus       277 ------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  4578  99999999999999888    999999999876543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=1e-10  Score=109.00  Aligned_cols=132  Identities=24%  Similarity=0.350  Sum_probs=103.5

Q ss_pred             EEccCCcEEEEEEEEcCCceEEEEEeccccCHHH------HHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecC
Q 009291          272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR------FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~------~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~  345 (538)
                      .+++|+-+.++.+.+.+.++++|.-..+.+....      ...-.+|..++.++.--.|.--+=+..++....++|||++
T Consensus         3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~   82 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE   82 (204)
T ss_pred             hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence            5789999999999888888888875544432222      2345679999988865555544445667777899999999


Q ss_pred             CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       346 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      |..|.+++...          ...++..+-.-+.-||..|  |||+||.++||++.++ .+.++|||++..
T Consensus        83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC-cEEEEECCcccc
Confidence            99999888533          2456778888899999999  9999999999999766 499999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=6.8e-10  Score=107.21  Aligned_cols=141  Identities=18%  Similarity=0.218  Sum_probs=106.4

Q ss_pred             EEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCC--CceeEeeceeccCC---cceEEEeec
Q 009291          271 KKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEPP---NLSIVTEYL  344 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h--pnIv~l~~~~~~~~---~~~lV~E~~  344 (538)
                      +.|+.|.++.||++...+ ..+++|+....... .....+.+|.++++.+.+  .++.+++.+.....   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            678999999999998776 67999986543321 123467889999999865  34566777665532   568999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR---------------------------------------  385 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------  385 (538)
                      +|.++.+.+..    ..+++.....++.+++.+|..||+..                                       
T Consensus        83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99888775531    23667777778888888888888521                                       


Q ss_pred             ---------------CCEEeecCCCCCEEEcC--CCcEEEEeeCCCcc
Q 009291          386 ---------------PPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRS  416 (538)
Q Consensus       386 ---------------~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~  416 (538)
                                     ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           24799999999999988  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.09  E-value=1.1e-09  Score=101.81  Aligned_cols=146  Identities=18%  Similarity=0.202  Sum_probs=106.5

Q ss_pred             EEEEEccCCcEEEEEEEEcCCceEEEEEeccccCH------HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~------~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      .+..+.+|+-++|+++.+.+....||.-....+..      -..+..++|++.|.++.--.|.--.-++.+...-.+.||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            57789999999999999999988888754333221      123456789999988764444333334555566689999


Q ss_pred             ecCC-CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC---cEEEEeeCCCccC
Q 009291          343 YLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSK  417 (538)
Q Consensus       343 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~---~vkL~DFGla~~~  417 (538)
                      |++| .++.+++...... .........++.++-+.+.-||..+  |||+||..+||++..++   .+.|+|||++...
T Consensus        91 ~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9977 4777777433222 1223334788999999999999999  99999999999996544   4589999998653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.99  E-value=2e-08  Score=103.59  Aligned_cols=252  Identities=17%  Similarity=0.221  Sum_probs=164.1

Q ss_pred             EEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeecee-------ccCCcceEE
Q 009291          269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV-------TEPPNLSIV  340 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~-------~~~~~~~lV  340 (538)
                      .++.||+|+.+.+|-...-.+.|| |++.........     ..+..|... .||-+..=+.+=       ......-++
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchhhchhh-eeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            467899999999997654444454 776554322111     122223333 455443311111       112225677


Q ss_pred             EeecCCC-Chhhhhc---CCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          341 TEYLSRG-SLYKLLH---IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       341 ~E~~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      |..+.+. ....++.   +.....-..++-.+..++.++.+.+.||+.|  .+-+|+.++|+|+++++.|.|.|=..-..
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceee
Confidence            8877664 3333332   2223334668889999999999999999999  99999999999999999999998664433


Q ss_pred             CCCCccccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-------HHHH-HHHHhh-
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITL-QKPWRNST-------PSQV-ISAVGF-  481 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg-~~Pf~~~~-------~~~~-~~~i~~-  481 (538)
                      ..++ ......+|..+|.+||.-.     +...+...|-|.||+++++++.| ++||.+..       +.+. +..-.+ 
T Consensus       167 ~~ng-~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         167 NANG-TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             ccCC-ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            3222 2234567899999999754     34457789999999999999987 99996532       2221 110000 


Q ss_pred             -----cCcccCCCC-----CCcHHHHHHHHHhhhcC--CCCCCCHHHHHHHHHHHHhhhc
Q 009291          482 -----KGRRLEIPK-----NVNPMVAALIETCWAEE--PEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       482 -----~~~~~~~p~-----~~s~~l~~LI~~cL~~d--P~~RPs~~eIl~~L~~il~~~~  529 (538)
                           .....+.|.     -+++.++.|..+|+...  +.-|||++..+..|-.+-.+.+
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence                 111122222     35788999999999764  6789999999888877665543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.90  E-value=5.8e-08  Score=102.53  Aligned_cols=214  Identities=16%  Similarity=0.197  Sum_probs=151.4

Q ss_pred             CcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec----cCCcceEEEeecCC-CCh
Q 009291          277 SFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT----EPPNLSIVTEYLSR-GSL  349 (538)
Q Consensus       277 ~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~----~~~~~~lV~E~~~~-gsL  349 (538)
                      .-.+.|++...-  ..|++|.+......  .......-+++++++.|.|||.+.++|.    .+..+++|++|+++ ++|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            446778887653  33777777222111  1113345678899999999999999886    34458999999986 477


Q ss_pred             hhhhcCC------------CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          350 YKLLHIP------------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       350 ~~~l~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      .++.-..            ......+|..+|.++.|+..||.++|+.|  +..+-|.|.+|+++.+.+++|+..|+....
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeee
Confidence            7765211            12335778999999999999999999999  999999999999999989999888765543


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCHHHH-HHHHhhcCcccCCCCCCcHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQV-ISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~-Pf~~~~~~~~-~~~i~~~~~~~~~p~~~s~~  495 (538)
                      ....       +       |-+.   -..+-|.=.||.++..|.||.. -|.....++. ...         +...++.+
T Consensus       444 ~~d~-------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D  497 (655)
T KOG3741|consen  444 QEDP-------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTD  497 (655)
T ss_pred             cCCC-------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHH
Confidence            2211       0       1111   1245688899999999999953 2443333332 222         24567889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      ++++|.-....++++ -++++++.++
T Consensus       498 ~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  498 LRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             HHHHHHHHHhcCccc-ccHHHHHHHH
Confidence            999999999999997 5777776654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.87  E-value=1.9e-08  Score=101.09  Aligned_cols=140  Identities=19%  Similarity=0.093  Sum_probs=96.4

Q ss_pred             EccCCcEEEEEEEEcCCceEEEEEeccccCHHHHH----------HHHHHHHHHHcCCCCce--eEeeceecc-----CC
Q 009291          273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFK----------EFLREVAIMKGLRHPNI--VLLMGAVTE-----PP  335 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~----------~~~~Ei~il~~L~hpnI--v~l~~~~~~-----~~  335 (538)
                      +-......|++++..+..+.||........ ...+          .+.+|...+.++...+|  ...+++...     ..
T Consensus        30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFELAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            333334446677777777888866332211 1111          37789888888743333  333444432     22


Q ss_pred             cceEEEeecCCC-ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-------CCcEE
Q 009291          336 NLSIVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-------TYTVK  407 (538)
Q Consensus       336 ~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-------~~~vk  407 (538)
                      .-++|||++++. +|.+++.... ....+......++.+++..+..||..|  |+|+|+++.|||++.       ++.+.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEE
Confidence            467999999886 7888874211 123556677789999999999999999  999999999999975       46899


Q ss_pred             EEeeCCCcc
Q 009291          408 VCDFGLSRS  416 (538)
Q Consensus       408 L~DFGla~~  416 (538)
                      |+||+.+..
T Consensus       186 LIDl~r~~~  194 (268)
T PRK15123        186 VIDLHRAQI  194 (268)
T ss_pred             EEECCcccc
Confidence            999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=3.3e-08  Score=94.08  Aligned_cols=127  Identities=26%  Similarity=0.251  Sum_probs=81.3

Q ss_pred             EEEEEEEc-CCceEEEEEeccccC------------------------HHHHHHHHHHHHHHHcCCCC--ceeEeeceec
Q 009291          280 TVYHAEWR-NSDVAVKILIEQEFH------------------------EDRFKEFLREVAIMKGLRHP--NIVLLMGAVT  332 (538)
Q Consensus       280 ~Vy~a~~~-~~~vavK~~~~~~~~------------------------~~~~~~~~~Ei~il~~L~hp--nIv~l~~~~~  332 (538)
                      .||.|... +..+|+|+.......                        ........+|.+.|.++...  ++.+.+++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            37888764 445999987542110                        11124567899999999765  466666553 


Q ss_pred             cCCcceEEEeecC--CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHH-HHhCCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          333 EPPNLSIVTEYLS--RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY-LHQRRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       333 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                         ..++||||++  |..+..+....     ++......++.+++..+.. +|+.|  |||+||.+.||+++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEE
Confidence               3489999998  65665544321     1133455677788885555 57999  9999999999999877 89999


Q ss_pred             eeCCCccCC
Q 009291          410 DFGLSRSKP  418 (538)
Q Consensus       410 DFGla~~~~  418 (538)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.76  E-value=3.3e-09  Score=115.40  Aligned_cols=146  Identities=17%  Similarity=0.298  Sum_probs=107.7

Q ss_pred             HHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcccc---------CCCCCCCcccccccccCCC
Q 009291          373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---------KTAAGTPEWMAPEVLREDP  443 (538)
Q Consensus       373 qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~---------~~~~gt~~Y~aPE~l~~~~  443 (538)
                      +++.|+.|+|+.- ++||++|.|++|.++.++.+||+.|+++.....+....         ....-...|.|||.+.+..
T Consensus       107 ~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            5559999999763 49999999999999999999999999886544311110         1112356899999999988


Q ss_pred             CCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHH--HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          444 SNEKSDVFSFGVILWELITL-QKPWRNSTPSQVI--SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       444 ~s~ksDVwSLGvil~eLltg-~~Pf~~~~~~~~~--~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+.++|+||+|+++|.+..| +.-+...+.....  ..-...........+++.++.+=+.+++..++..||++.++..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence            89999999999999999954 4444443222111  1111222334456789999999999999999999998776643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.67  E-value=1.4e-07  Score=93.06  Aligned_cols=136  Identities=24%  Similarity=0.201  Sum_probs=100.0

Q ss_pred             eeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccC--------------------HHHHHHHHHHHHHHHcCCCC--c
Q 009291          267 LLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFH--------------------EDRFKEFLREVAIMKGLRHP--N  323 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~--------------------~~~~~~~~~Ei~il~~L~hp--n  323 (538)
                      ..++..||-|.-|.||.|.+. +.++|||.-......                    .-....+.+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            346789999999999999876 666999974332110                    12235678999999999654  6


Q ss_pred             eeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC
Q 009291          324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       324 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~  403 (538)
                      |.+.+++    +...+|||+++|-.|...-        ++......++..|++-+.-+-..|  |||+|+.+-||+++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecC
Confidence            6666664    5569999999997776542        123334445556666666666788  9999999999999999


Q ss_pred             CcEEEEeeCCCcc
Q 009291          404 YTVKVCDFGLSRS  416 (538)
Q Consensus       404 ~~vkL~DFGla~~  416 (538)
                      |.+.++||--+..
T Consensus       239 g~~~vIDwPQ~v~  251 (304)
T COG0478         239 GDIVVIDWPQAVP  251 (304)
T ss_pred             CCEEEEeCccccc
Confidence            9999999976543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=1.9e-07  Score=90.41  Aligned_cols=105  Identities=24%  Similarity=0.230  Sum_probs=79.9

Q ss_pred             HHHHHHHHHHHcCCCCc--eeEeeceeccC----CcceEEEeecCCC-ChhhhhcCCCCCccccHHHHHHHHHHHHHHHH
Q 009291          307 KEFLREVAIMKGLRHPN--IVLLMGAVTEP----PNLSIVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMN  379 (538)
Q Consensus       307 ~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~  379 (538)
                      ..+.+|...+..|..-.  +...+++....    ...++|+|++++. +|.+++.....   .+......++.+++..++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            35677888777774322  34445544332    2348999999874 79998864222   556677889999999999


Q ss_pred             HHHhCCCCEEeecCCCCCEEEcCCC---cEEEEeeCCCcc
Q 009291          380 YLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS  416 (538)
Q Consensus       380 ~LH~~~~~iiHrDLKp~NILl~~~~---~vkL~DFGla~~  416 (538)
                      -||+.|  |+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       133 ~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999  99999999999998887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.51  E-value=1e-06  Score=85.18  Aligned_cols=142  Identities=20%  Similarity=0.226  Sum_probs=96.6

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHH-HHH------HHHHHHHHHcCCCCceeEe---ece
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR-FKE------FLREVAIMKGLRHPNIVLL---MGA  330 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~-~~~------~~~Ei~il~~L~hpnIv~l---~~~  330 (538)
                      .+...+|.+.+.+-......|.+....+..+.+|.........+. ...      ..+++..+.+++...+..+   +.+
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            345678999999999999999999989999999987554322111 121      2234444444432222221   111


Q ss_pred             -----eccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc
Q 009291          331 -----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT  405 (538)
Q Consensus       331 -----~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~  405 (538)
                           +.-....+++|||++|..|.++..       +++.    ++..+.+++.-||+.|  +.|+|..|.|++++++ .
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e~----~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDED----LAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-------cCHH----HHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC-c
Confidence                 222234578999999988877643       2332    3456778899999999  9999999999999866 4


Q ss_pred             EEEEeeCCCcc
Q 009291          406 VKVCDFGLSRS  416 (538)
Q Consensus       406 vkL~DFGla~~  416 (538)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999986543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.45  E-value=2.4e-06  Score=82.35  Aligned_cols=139  Identities=18%  Similarity=0.120  Sum_probs=99.7

Q ss_pred             ccCCcEEEEEEEEcCCceEEEEEecccc----CHHHHHHHHHHHHHHHcCCCC--ceeEeeceec---cCC--cceEEEe
Q 009291          274 GEGSFGTVYHAEWRNSDVAVKILIEQEF----HEDRFKEFLREVAIMKGLRHP--NIVLLMGAVT---EPP--NLSIVTE  342 (538)
Q Consensus       274 G~G~fg~Vy~a~~~~~~vavK~~~~~~~----~~~~~~~~~~Ei~il~~L~hp--nIv~l~~~~~---~~~--~~~lV~E  342 (538)
                      |+||-+-|+.....+..+-+|.......    .+.-...|.+|+..+.+|...  .+.+.+ ++.   .+.  .-.||+|
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence            5689999999887777777776531110    012235789999999888532  244444 222   111  2578999


Q ss_pred             ecCC-CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc--EEEEeeCCCcc
Q 009291          343 YLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSRS  416 (538)
Q Consensus       343 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~--vkL~DFGla~~  416 (538)
                      -+.+ .+|.+++.... ....++.....++.+++.+++-||+.|  +.|+|+.+.||+++.+|.  ++++||--++.
T Consensus       106 ~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            7764 48888875332 224577777889999999999999999  999999999999986667  99999976653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.44  E-value=2.5e-06  Score=83.74  Aligned_cols=138  Identities=13%  Similarity=0.180  Sum_probs=83.2

Q ss_pred             EEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc--eeEeeceeccCCcceEEEeecCCCC
Q 009291          271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGAVTEPPNLSIVTEYLSRGS  348 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs  348 (538)
                      ..||+|..+.||+.  .+.++++|...... ..   ....+|.++++.+..-.  +.+.+++....+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-DK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC-CH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984  35567888865422 22   34578999998875333  4667777777777889999999863


Q ss_pred             -hhhhh---------------------cCCCC-CccccHHHHHHHHHH----------HHH-HHHHHH--hCCCCEEeec
Q 009291          349 -LYKLL---------------------HIPDA-RVVVDERLRLNMAYD----------VAK-GMNYLH--QRRPPIVHRD  392 (538)
Q Consensus       349 -L~~~l---------------------~~~~~-~~~l~~~~~~~i~~q----------i~~-aL~~LH--~~~~~iiHrD  392 (538)
                       +...+                     +.... ...++. ....+..+          +.. ..++|.  ...+.++|+|
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence             21111                     11100 001110 00001000          011 122222  2223579999


Q ss_pred             CCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          393 LKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       393 LKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +.|.||++++++ +.|+||+.+..
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999888 99999997753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.33  E-value=5.7e-06  Score=80.00  Aligned_cols=142  Identities=19%  Similarity=0.216  Sum_probs=81.8

Q ss_pred             EEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCC--ceeEeeceec---cCCcceEEEeec
Q 009291          270 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGAVT---EPPNLSIVTEYL  344 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hp--nIv~l~~~~~---~~~~~~lV~E~~  344 (538)
                      ++.|+.|..+.||++...++.+++|.....    .....+.+|..+++.+...  .+.+++....   .....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            578999999999999988878999986443    3445677888888877432  3456665332   223368999999


Q ss_pred             CCCChhh----------------hh---cCC-CCCccccH-H--------HHHHH------------HHHHHH-HHHHHH
Q 009291          345 SRGSLYK----------------LL---HIP-DARVVVDE-R--------LRLNM------------AYDVAK-GMNYLH  382 (538)
Q Consensus       345 ~~gsL~~----------------~l---~~~-~~~~~l~~-~--------~~~~i------------~~qi~~-aL~~LH  382 (538)
                      +|..+..                .+   +.. ........ .        .....            ...+.. .++.++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9987777                11   111 00000000 0        00000            111222 233333


Q ss_pred             h-----CCCCEEeecCCCCCEEEc-CCCcEEEEeeCCCc
Q 009291          383 Q-----RRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSR  415 (538)
Q Consensus       383 ~-----~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~  415 (538)
                      +     ....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2     223499999999999999 66677899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.31  E-value=1.2e-05  Score=78.88  Aligned_cols=141  Identities=21%  Similarity=0.132  Sum_probs=95.2

Q ss_pred             EEEEEccCCcEEEEEEEEc-CCceEEEEEeccccCHHHH----------------------HHHHHHHHHHHcCC--CCc
Q 009291          269 IKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRF----------------------KEFLREVAIMKGLR--HPN  323 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~~----------------------~~~~~Ei~il~~L~--hpn  323 (538)
                      +...|..|.-+.||+|... +..+|+|+++........+                      .=...|+..|+++.  +-.
T Consensus        52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            3458889999999999764 5669999986643321111                      11235777777764  334


Q ss_pred             eeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcC
Q 009291          324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       324 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~  402 (538)
                      +.+-+++..    -.+||||+...-.-   ...-....+....+..+..++++.+.-|-. .+  +||+||..-|||+. 
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~p---AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-  201 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLP---APRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-  201 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCC---CCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-
Confidence            445555433    38999999653110   000011223344677788899999998877 78  99999999999998 


Q ss_pred             CCcEEEEeeCCCccCCC
Q 009291          403 TYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       403 ~~~vkL~DFGla~~~~~  419 (538)
                      ++.+.|+|||-|.....
T Consensus       202 ~~~p~iID~~QaV~~~h  218 (268)
T COG1718         202 DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             CCeEEEEECccccccCC
Confidence            77999999998865443

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.24  E-value=1.1e-05  Score=79.77  Aligned_cols=140  Identities=21%  Similarity=0.197  Sum_probs=84.3

Q ss_pred             EEEccCCc-EEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEEEeecCCCC
Q 009291          271 KKIGEGSF-GTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGS  348 (538)
Q Consensus       271 ~~LG~G~f-g~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~~~gs  348 (538)
                      +.|..|.+ ..||+....+.++.+|+.....     ...+.+|+.+++.+. +--+.+++++...+...++|||+++|.+
T Consensus         4 ~~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           4 ERVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             eecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            34556666 8889997666678888864432     234567888887773 3446677777766667899999999877


Q ss_pred             hhhhh-------------------cCCCC-CccccHH--HHHHHHH--------------------HHHHHHHHHHh---
Q 009291          349 LYKLL-------------------HIPDA-RVVVDER--LRLNMAY--------------------DVAKGMNYLHQ---  383 (538)
Q Consensus       349 L~~~l-------------------~~~~~-~~~l~~~--~~~~i~~--------------------qi~~aL~~LH~---  383 (538)
                      +....                   +.... .......  .......                    .+...+..|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            75431                   11100 0011100  0000000                    01111222211   


Q ss_pred             --CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          384 --RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       384 --~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                        ..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence              12348999999999999988778999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.15  E-value=4.5e-07  Score=98.06  Aligned_cols=231  Identities=19%  Similarity=0.211  Sum_probs=154.0

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCce-EEEEEeccccCHHHHHHHHHHHHHHHcCCCCc-eeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSDV-AVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~v-avK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~~~~~lV~E~~  344 (538)
                      +.....+++|+++++++.+...++. ..+.+...       ....-++++|.+.+||| .+..++-++.+...+++++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            3344567899999999887655542 23333222       24446789999999999 777777788888899999999


Q ss_pred             CCC-ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          345 SRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       345 ~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      .++ +......  .....+.+.+...+.+.-++++++||+.-  =+|+|    ||+..+ +..+..||+......... .
T Consensus       317 s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~  386 (829)
T KOG0576|consen  317 STGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-K  386 (829)
T ss_pred             cCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-c
Confidence            876 2222221  12223555566677778888999999874  48998    777755 689999999988766554 4


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCC--CCcHHHH-HHH
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVA-ALI  500 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~s~~l~-~LI  500 (538)
                      ..+..+++.++|||+.....+..+.|+|++|+-..++.-|-.|-..  +......+........+..  ..+.... ++.
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~  464 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFP  464 (829)
T ss_pred             cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCc
Confidence            4677899999999999999999999999999877777777665432  1111111111110111111  1112222 366


Q ss_pred             HHhhhcCCCCCCCHHH
Q 009291          501 ETCWAEEPEIRPSFPS  516 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~e  516 (538)
                      ..|+...|..|+..-.
T Consensus       465 ~~~~~g~P~~pkv~mg  480 (829)
T KOG0576|consen  465 APCLNGLPPTPKVHMG  480 (829)
T ss_pred             ccccCCCCCCCcchhh
Confidence            6777777777776543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.06  E-value=1.6e-05  Score=86.76  Aligned_cols=142  Identities=19%  Similarity=0.240  Sum_probs=89.7

Q ss_pred             EEEccCCcEEEEEEEEc-CCceEEEEEecccc---------------------------C-HHHH----H------HHHH
Q 009291          271 KKIGEGSFGTVYHAEWR-NSDVAVKILIEQEF---------------------------H-EDRF----K------EFLR  311 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~---------------------------~-~~~~----~------~~~~  311 (538)
                      +.|+.++-|.||+|+.. ++.||||+....-.                           . ...+    +      .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68999999999999998 67799999754211                           0 0111    1      1334


Q ss_pred             HHHHHHcC-----CCCceeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHH-HHHHHhCC
Q 009291          312 EVAIMKGL-----RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG-MNYLHQRR  385 (538)
Q Consensus       312 Ei~il~~L-----~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~a-L~~LH~~~  385 (538)
                      |...+.++     +.++|.--.-+++-.+.-.++|||++|..+.+........  .+...   ++..++.+ +..+=..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~---ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKE---LAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHH---HHHHHHHHHHHHHHhcC
Confidence            44444444     2344332222333345568999999999888885322211  33222   22222222 23333468


Q ss_pred             CCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       386 ~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                        ++|.|..|.||+++.+|.+.+.|||+......
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              99999999999999999999999999876543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.94  E-value=0.00011  Score=70.39  Aligned_cols=127  Identities=24%  Similarity=0.307  Sum_probs=91.1

Q ss_pred             cceeEEEEEccCCc-EEEEEEEEcCCceEEEEEec---ccc-------C--H-------HHHHHHHHHHHHHHcCC---C
Q 009291          265 SELLIKKKIGEGSF-GTVYHAEWRNSDVAVKILIE---QEF-------H--E-------DRFKEFLREVAIMKGLR---H  321 (538)
Q Consensus       265 ~~y~i~~~LG~G~f-g~Vy~a~~~~~~vavK~~~~---~~~-------~--~-------~~~~~~~~Ei~il~~L~---h  321 (538)
                      .+++.++.||.|.. |.||+++..+..||+|+...   ...       .  +       ....-|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            67889999999999 99999999999999999322   110       0  0       22345778888777764   4


Q ss_pred             Cce--eEeeceeccC------------------CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHH
Q 009291          322 PNI--VLLMGAVTEP------------------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL  381 (538)
Q Consensus       322 pnI--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L  381 (538)
                      .+.  |+++|+..=.                  ....||.||.+...            .+.    ..-+.+|.+-|..+
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKIL  180 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHH
Confidence            556  8999886211                  12457888776532            111    22345788888999


Q ss_pred             HhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       382 H~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      |+.|  |+-+|+++.|..     .-||+|||.+
T Consensus       181 ~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLG--IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCC--eeeccCcccccc-----CCEEEecccC
Confidence            9999  999999999975     2489999864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.93  E-value=4.5e-05  Score=72.73  Aligned_cols=104  Identities=18%  Similarity=0.169  Sum_probs=80.8

Q ss_pred             HHHHHHHHcCCC-CceeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCC-CC
Q 009291          310 LREVAIMKGLRH-PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PP  387 (538)
Q Consensus       310 ~~Ei~il~~L~h-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~~  387 (538)
                      ..|.-+++.+++ +++.+++|+|-.    .+++||...+++......-..-...++..+.+|+.++++.+++|+..- ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888888875 699999999854    789999987766432110011123679999999999999999998732 13


Q ss_pred             EEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       388 iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      +.-.|++++|+-++++|.+|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            889999999999999999999999977543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.92  E-value=4.4e-05  Score=71.20  Aligned_cols=131  Identities=23%  Similarity=0.273  Sum_probs=92.2

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCcee-EeeceeccCCcceEEEeecC
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV-LLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv-~l~~~~~~~~~~~lV~E~~~  345 (538)
                      ....+.|++|.+|.||++.+.+..+|+|+-....    ....+..|.++|..+.-.++. +++.+-.+    .+.|||+.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            3456789999999999999999999999975443    335678899999998876665 34443332    34599999


Q ss_pred             CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCC-CCCEEEcCCCcEEEEeeCCCccC
Q 009291          346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK-SPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       346 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLK-p~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |-+|.+.....      +..    -...++++---|...|  |-|+.|. |...++.+++.+.|+||..|+..
T Consensus        96 G~~L~~~~~~~------~rk----~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          96 GRPLGKLEIGG------DRK----HLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             Ccchhhhhhcc------cHH----HHHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            98887765321      112    2335556655567778  8888886 44444445558999999988754

>PRK10593 hypothetical protein; Provisional

Probab=97.86  E-value=0.00024  Score=72.69  Aligned_cols=79  Identities=14%  Similarity=0.042  Sum_probs=57.3

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCC---CceeEeeceecc---CCcceEE
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH---PNIVLLMGAVTE---PPNLSIV  340 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h---pnIv~l~~~~~~---~~~~~lV  340 (538)
                      ..-.+.||.|..+.||+....+..+++|..+. ....   ..+.+|...|+.|..   -.|.++++++..   .+..++|
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~~---~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQGNPMPLMARS-FSTP---GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCCCEEEEEecc-cccc---hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            34467899999999999987666778888533 1111   367789999988843   357788877644   3558999


Q ss_pred             EeecCCCCh
Q 009291          341 TEYLSRGSL  349 (538)
Q Consensus       341 ~E~~~~gsL  349 (538)
                      ||++++.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998754

>PLN02876 acyl-CoA dehydrogenase

Probab=97.86  E-value=0.00019  Score=83.48  Aligned_cols=79  Identities=15%  Similarity=0.222  Sum_probs=55.5

Q ss_pred             EEEEccCCcEEEEEEEEcCC----ceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCce--eEeeceeccC---CcceE
Q 009291          270 KKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNI--VLLMGAVTEP---PNLSI  339 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnI--v~l~~~~~~~---~~~~l  339 (538)
                      .+.++.|.+..+|+....+.    .+++|+....... .....+.+|+++|+.+. |.+|  .+++.++.+.   ...++
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            57789999999999876652    4677765332211 12246779999999985 6654  7778777664   35789


Q ss_pred             EEeecCCCCh
Q 009291          340 VTEYLSRGSL  349 (538)
Q Consensus       340 V~E~~~~gsL  349 (538)
                      ||||++|..+
T Consensus       122 VME~v~G~~~  131 (822)
T PLN02876        122 IMEYLEGRIF  131 (822)
T ss_pred             EEEecCCccc
Confidence            9999988643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.86  E-value=0.00021  Score=68.66  Aligned_cols=132  Identities=22%  Similarity=0.341  Sum_probs=92.5

Q ss_pred             EEEEccCCcEEEEEEEEcCCceEEEEEeccc--------------cCHHHHHHHHHHHHHHHcCC------CCceeEeec
Q 009291          270 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQE--------------FHEDRFKEFLREVAIMKGLR------HPNIVLLMG  329 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~--------------~~~~~~~~~~~Ei~il~~L~------hpnIv~l~~  329 (538)
                      ...||+|+.-.||.-- .+...+||+.....              ......++..+|+.....+.      +.+|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            3579999999999532 23347889987655              11123456667777666665      788999999


Q ss_pred             eeccCCcceEEEeecCC------CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC
Q 009291          330 AVTEPPNLSIVTEYLSR------GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~  403 (538)
                      +.+++-..-+|+|.+..      -+|.+++....    +++    .+...+-+-.+||-+.+  |+.+|++|.||++...
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~----~~~~~L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE----ELRQALDEFKRYLLDHH--IVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH----HHHHHHHHHHHHHHHcC--CeecCCCcccEEEEec
Confidence            99999999999998743      35777774332    444    23334445567788888  9999999999999532


Q ss_pred             --C--cEEEEe-eC
Q 009291          404 --Y--TVKVCD-FG  412 (538)
Q Consensus       404 --~--~vkL~D-FG  412 (538)
                        +  .+.|+| ||
T Consensus       155 ~~~~~~lvlIDG~G  168 (199)
T PF10707_consen  155 DSGEFRLVLIDGLG  168 (199)
T ss_pred             CCCceEEEEEeCCC
Confidence              2  577877 44

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.85  E-value=0.00013  Score=71.84  Aligned_cols=74  Identities=12%  Similarity=0.117  Sum_probs=45.4

Q ss_pred             EEEEccCCcE-EEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCC---ceeEeeceeccC---CcceEEEe
Q 009291          270 KKKIGEGSFG-TVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP---NIVLLMGAVTEP---PNLSIVTE  342 (538)
Q Consensus       270 ~~~LG~G~fg-~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hp---nIv~l~~~~~~~---~~~~lV~E  342 (538)
                      ++.|+.|+.. .||+.   +..+++|......    ....+.+|.+++..+...   -+.++++.....   ...+++|+
T Consensus         2 ~~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           2 IEPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             ceeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            3567777776 58976   3457777643321    234678899888877421   344444443332   23488999


Q ss_pred             ecCCCChh
Q 009291          343 YLSRGSLY  350 (538)
Q Consensus       343 ~~~~gsL~  350 (538)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.66  E-value=0.00024  Score=82.13  Aligned_cols=231  Identities=19%  Similarity=0.210  Sum_probs=155.5

Q ss_pred             EccCCcEEEEEEEEcCC------ceEEEEEeccc-cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc----ceEEE
Q 009291          273 IGEGSFGTVYHAEWRNS------DVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN----LSIVT  341 (538)
Q Consensus       273 LG~G~fg~Vy~a~~~~~------~vavK~~~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~----~~lV~  341 (538)
                      +..-.+|+++..++...      .+.++.-..+. .....+.....|...+.++.|+|++.++.+-.+.-.    ..+..
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~  265 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ  265 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence            55667788887765321      12222211111 122444555567788888999999999988644332    34556


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCC---CEEEcCCCcEEEE--eeCCCcc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP---NLLVDSTYTVKVC--DFGLSRS  416 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~---NILl~~~~~vkL~--DFGla~~  416 (538)
                      ++|...++...++.   -..++....+.+..++.+||+|+|+..  ..|.-+...   +--.+..+.+.++  ||+....
T Consensus       266 ~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~  340 (1351)
T KOG1035|consen  266 EICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKP  340 (1351)
T ss_pred             hhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhccccc
Confidence            88888888888763   345788889999999999999999987  666655555   4444566777777  9998877


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCch--hhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhhcCcccCCCCCCc
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEK--SDVFSFGVILWELITLQKPWRNS-TPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~k--sDVwSLGvil~eLltg~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      .++.... ....-+..|.++|......++.+  .|+|.+|..+..+..|..+-... ....            -++....
T Consensus       341 l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~------------~l~~~~~  407 (1351)
T KOG1035|consen  341 LPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVS------------LLDVLST  407 (1351)
T ss_pred             CCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhh------------hhccccc
Confidence            6654322 33444667888888877666544  79999999999998875542211 1100            0111222


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      .+..++..+|+..++++|+++.+++...
T Consensus       408 ~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  408 SELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhhhhhhcchhhhhccchhhhhhch
Confidence            2778899999999999999999988754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.65  E-value=7.9e-06  Score=95.61  Aligned_cols=202  Identities=15%  Similarity=0.096  Sum_probs=134.6

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCc---eEEEEEecccc---CHHHHHHHHHHHHHHHcCCCCceeEeeceec--cCCcc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPPNL  337 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~---vavK~~~~~~~---~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~--~~~~~  337 (538)
                      .+++.=-+|-|.+   +++++....   +.+++.+.-..   .+...+....|...++...|+++.....-..  +....
T Consensus      1230 ~~EV~l~i~~~~~---~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee 1306 (2724)
T KOG1826|consen 1230 HSEVNLGISNHFH---FRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEE 1306 (2724)
T ss_pred             hhheeeeccccee---eccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHH
Confidence            3333333444433   345444333   55555543322   1222333444555555678998887665442  33446


Q ss_pred             eEEEeecCCCChhhhhcCCCC-CccccHHHHHHHHHHHHHHHHHHHhC---CCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQR---RPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      +.+++|+.+|.+.+.+-.+.. ...++.........+.+.+..-+|+.   |...+|++||+.|.+|..+..+|++++|+
T Consensus      1307 ~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gL 1386 (2724)
T KOG1826|consen 1307 YIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGL 1386 (2724)
T ss_pred             HHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccc
Confidence            899999999999998843322 22344444443444446666666653   33579999999999999999999999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS  470 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~  470 (538)
                      .+..+..........+++.|+.|+....-.++.++|+|..|+.+|+...|..+|...
T Consensus      1387 dKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~f 1443 (2724)
T KOG1826|consen 1387 DKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFF 1443 (2724)
T ss_pred             ccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHH
Confidence            995544444456677889999999999989999999999999999999887776543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.60  E-value=0.00071  Score=66.25  Aligned_cols=73  Identities=16%  Similarity=0.188  Sum_probs=46.1

Q ss_pred             EEEEccCCcEEEEEEEEc---CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc-eeEeeceeccCCcceEEEeecC
Q 009291          270 KKKIGEGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~---~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~~~~~lV~E~~~  345 (538)
                      ++.|..|-...+|++...   +..+++|+......   ......+|+.+++.+...+ ..++++.+..    .++|||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence            467888888999999765   35688887543211   1112346888888774322 3444444332    47999998


Q ss_pred             CCCh
Q 009291          346 RGSL  349 (538)
Q Consensus       346 ~gsL  349 (538)
                      |.++
T Consensus        76 G~~l   79 (235)
T cd05157          76 GRTL   79 (235)
T ss_pred             CCcC
Confidence            8665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.59  E-value=0.00028  Score=77.01  Aligned_cols=141  Identities=17%  Similarity=0.226  Sum_probs=87.7

Q ss_pred             EEEEccCCcEEEEEEEEcCCc-eEEEEEeccccC-----------------------------HHHHH------HHHHHH
Q 009291          270 KKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFH-----------------------------EDRFK------EFLREV  313 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~-vavK~~~~~~~~-----------------------------~~~~~------~~~~Ei  313 (538)
                      .+.||.-+.|.||+|+.++.. ||||+.+.....                             ++..+      .|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            368999999999999987644 999997543211                             01111      133444


Q ss_pred             HHHHcC----CCCc------eeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHH-HHHH
Q 009291          314 AIMKGL----RHPN------IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM-NYLH  382 (538)
Q Consensus       314 ~il~~L----~hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH  382 (538)
                      +...+.    .|-+      |.+++..+  .....++|||++|..+.++-.....+  ++...   ++..+.++. +-|=
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~---i~~~l~~~~~~qIf  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG--ISPHD---ILNKLVEAYLEQIF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC--CCHHH---HHHHHHHHHHHHHH
Confidence            433332    3444      34444332  23468999999998887765332222  34333   333333332 2233


Q ss_pred             hCCCCEEeecCCCCCEEEcC----CCcEEEEeeCCCccCCC
Q 009291          383 QRRPPIVHRDLKSPNLLVDS----TYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       383 ~~~~~iiHrDLKp~NILl~~----~~~vkL~DFGla~~~~~  419 (538)
                      ..|  ++|+|=.|.||++..    ++.+.+.|||+......
T Consensus       319 ~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 KTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             hcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            467  999999999999983    67899999999876543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.49  E-value=0.00046  Score=68.75  Aligned_cols=138  Identities=12%  Similarity=0.059  Sum_probs=76.7

Q ss_pred             EEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCce-eEeeceeccCCcceEEEeecCCCChh
Q 009291          272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYLSRGSLY  350 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnI-v~l~~~~~~~~~~~lV~E~~~~gsL~  350 (538)
                      .+..|-...+|+....+..+++|.........  .....+|..+++.+....+ .+++....    -++|+||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEeCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            35568888999988777778888743321110  0124578888887753322 33444332    36899999986653


Q ss_pred             hh-----------------hcCCCC-CccccHH-HHHHHHHHH---------HHHHHHHHhC------CCCEEeecCCCC
Q 009291          351 KL-----------------LHIPDA-RVVVDER-LRLNMAYDV---------AKGMNYLHQR------RPPIVHRDLKSP  396 (538)
Q Consensus       351 ~~-----------------l~~~~~-~~~l~~~-~~~~i~~qi---------~~aL~~LH~~------~~~iiHrDLKp~  396 (538)
                      ..                 ++.... ...++.. ....+..++         ...++.+-..      .+.++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21                 111111 1111111 111111111         1112222211      124899999999


Q ss_pred             CEEEcCCCcEEEEeeCCCcc
Q 009291          397 NLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       397 NILl~~~~~vkL~DFGla~~  416 (538)
                      ||++++++ +.|+||..|..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.43  E-value=0.00096  Score=67.80  Aligned_cols=143  Identities=15%  Similarity=0.120  Sum_probs=84.1

Q ss_pred             EEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCC--ceeEeece------eccCCcceEE
Q 009291          269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGA------VTEPPNLSIV  340 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hp--nIv~l~~~------~~~~~~~~lV  340 (538)
                      -.+.|..|....+|+....+..+++|+...  ...   ..+..|+.++..+.+.  .+.+++..      ...++..+++
T Consensus        18 ~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          18 SFEGISAGIENTNYFVTTDSGRYVLTLFEK--VSA---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             heecccCccccceEEEEeCCCcEEEEEcCC--CCh---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            366788888899999987777899998653  122   3455677777776432  24444432      1223456899


Q ss_pred             EeecCCCChhh----h-------h---cCC--CCC------ccccHHHH----------HHHHHHHHHHHHHHHh-----
Q 009291          341 TEYLSRGSLYK----L-------L---HIP--DAR------VVVDERLR----------LNMAYDVAKGMNYLHQ-----  383 (538)
Q Consensus       341 ~E~~~~gsL~~----~-------l---~~~--~~~------~~l~~~~~----------~~i~~qi~~aL~~LH~-----  383 (538)
                      ++|++|..+..    .       +   +..  ...      ....+...          ......+..++.++.+     
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99998866532    0       0   100  000      00000000          0111123344455543     


Q ss_pred             CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       384 ~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      ....++|+|+.|.||++++++.+.|+||+.+..
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            112399999999999999887778999997754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>smart00460 TGc Transglutaminase/protease-like homologues

Probab=97.34  E-value=0.00021  Score=55.90  Aligned_cols=54  Identities=22%  Similarity=0.236  Sum_probs=44.8

Q ss_pred             eccccchhhHHHHHHHhhhcCCCceeecccccC---------CCCCCCeEEEEeCCCcchhhhc
Q 009291           37 LSVGLCVHRALLFKVLADLINLPCRIAKGCKYC---------RRDDASSCLVQIGPDREYLVDL   91 (538)
Q Consensus        37 ~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~---------~~~~~~~~~~~~~~~~~~~~~~   91 (538)
                      -+.|.|.+.|.||..|+-.+|||||+|.|..-.         ....|.++-|.++ ++++.+|-
T Consensus         4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~-~~W~~~D~   66 (68)
T smart00460        4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLE-GGWVPVDP   66 (68)
T ss_pred             ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEEC-CCeEEEeC
Confidence            367999999999999999999999999993322         2577889999987 68877773

Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events.

>PRK05231 homoserine kinase; Provisional

Probab=97.31  E-value=0.0023  Score=65.79  Aligned_cols=142  Identities=13%  Similarity=0.141  Sum_probs=75.5

Q ss_pred             EEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCC--ceeEeec------eeccCCcceEEE
Q 009291          270 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMG------AVTEPPNLSIVT  341 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hp--nIv~l~~------~~~~~~~~~lV~  341 (538)
                      .+.|+.|....+|+....+..+++|+..  .....   .+..|+.++..|...  .+.+.+.      +....+..++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             cchhccccccceEEEEeCCCcEEEEEec--cCChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            4567788888999998777779999865  22222   233344445444211  1233332      112244578999


Q ss_pred             eecCCCChh-----------hhh---cCCCCC--------ccc-cHHHHH------------HHHHH-HHHHHHHHHh--
Q 009291          342 EYLSRGSLY-----------KLL---HIPDAR--------VVV-DERLRL------------NMAYD-VAKGMNYLHQ--  383 (538)
Q Consensus       342 E~~~~gsL~-----------~~l---~~~~~~--------~~l-~~~~~~------------~i~~q-i~~aL~~LH~--  383 (538)
                      ||++|..+.           ..+   +.....        ..+ .+....            ..+.+ +...++.+.+  
T Consensus       102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            999886431           111   110000        000 000000            01111 1112233321  


Q ss_pred             ---CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          384 ---RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       384 ---~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                         ....+||+|+.|.||+++++...-|+||+.+..
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               112399999999999998765568999998764

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.30  E-value=0.0034  Score=66.70  Aligned_cols=76  Identities=18%  Similarity=0.124  Sum_probs=51.4

Q ss_pred             EEEEccCCcEEEEEEEEcCC--ceEEEEEecc-----ccCHHHHHHHHHHHHHHHcCC---CCceeEeeceeccCCcceE
Q 009291          270 KKKIGEGSFGTVYHAEWRNS--DVAVKILIEQ-----EFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~-----~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~l  339 (538)
                      .+.||.|.+..||++...++  .++||.-...     ..-.-..+.+..|.+.|+.+.   ..++.+++.+  ++...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            47899999999999998765  6888874311     100122345667777777752   3456777766  3355789


Q ss_pred             EEeecCCC
Q 009291          340 VTEYLSRG  347 (538)
Q Consensus       340 V~E~~~~g  347 (538)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.13  E-value=0.0051  Score=63.05  Aligned_cols=147  Identities=20%  Similarity=0.233  Sum_probs=83.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCC--ceeEeecee------ccCCcc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGAV------TEPPNL  337 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hp--nIv~l~~~~------~~~~~~  337 (538)
                      ....++.++.|....+|+++..+..+++|+..... ..   +....|.+++..|...  .+.+++...      ...+..
T Consensus        23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             CceeccccCCccccceEEEEeCCCcEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            34557778888889999988766678888764421 12   2344566666666322  233443321      223457


Q ss_pred             eEEEeecCCCChhh-----------h---hcCCCCC------c--ccc-HHHH-H-----------HHHHHHHHHHHHHH
Q 009291          338 SIVTEYLSRGSLYK-----------L---LHIPDAR------V--VVD-ERLR-L-----------NMAYDVAKGMNYLH  382 (538)
Q Consensus       338 ~lV~E~~~~gsL~~-----------~---l~~~~~~------~--~l~-~~~~-~-----------~i~~qi~~aL~~LH  382 (538)
                      ++++||++|..+..           .   ++.....      .  ... +... .           .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            89999998854321           0   1110000      0  000 0000 0           01112334455554


Q ss_pred             h-----CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          383 Q-----RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       383 ~-----~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .     ....++|+|+.+.||++++++.+.|+||+.+..
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            2     112499999999999999887779999997653

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.09  E-value=0.0005  Score=69.91  Aligned_cols=141  Identities=19%  Similarity=0.171  Sum_probs=97.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccC--------------------HHHHHHHHHHHHHHHc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFH--------------------EDRFKEFLREVAIMKG  318 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~--------------------~~~~~~~~~Ei~il~~  318 (538)
                      +..+..-+.+++.||-|.-+-||.+.+. +++.++|.-......                    .-..-...+|...|+.
T Consensus        87 L~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka  166 (465)
T KOG2268|consen   87 LSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA  166 (465)
T ss_pred             HHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence            3334445678999999999999999876 667887753221110                    1112345678888888


Q ss_pred             CCC-C-ceeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCC
Q 009291          319 LRH-P-NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP  396 (538)
Q Consensus       319 L~h-p-nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~  396 (538)
                      |.. - -|.+.+++    +..++|||++.+-+|...-+..+         ...+...+..-+--|-++|  +||+|..-=
T Consensus       167 L~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d---------~~~ly~~lm~~Iv~la~~G--lIHgDFNEF  231 (465)
T KOG2268|consen  167 LYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVED---------PPTLYDDLMGLIVRLANHG--LIHGDFNEF  231 (465)
T ss_pred             HHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecCC---------hHHHHHHHHHHHHHHHHcC--ceecccchh
Confidence            742 2 23444443    45699999999988877654322         1234455556666778899  999999999


Q ss_pred             CEEEcCCCcEEEEeeCCCc
Q 009291          397 NLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       397 NILl~~~~~vkL~DFGla~  415 (538)
                      ||++.+++.++++||--..
T Consensus       232 Nimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  232 NIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             eeEEecCCCEEEeechHhh
Confidence            9999999999999998543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.08  E-value=0.0043  Score=63.30  Aligned_cols=74  Identities=19%  Similarity=0.281  Sum_probs=45.3

Q ss_pred             EEEEccCCcEEEEEEEEcC--------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc-eeEeeceeccCCcceEE
Q 009291          270 KKKIGEGSFGTVYHAEWRN--------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~--------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~~~~~lV  340 (538)
                      ++.|..|-...+|++...+        ..+++|+.....   .......+|..+++.+.... ..++++++..    .+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            4566667777899887653        468888864432   11234557877777774332 2345555432    358


Q ss_pred             EeecCCCChh
Q 009291          341 TEYLSRGSLY  350 (538)
Q Consensus       341 ~E~~~~gsL~  350 (538)
                      +||++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            8998886654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.02  E-value=0.0069  Score=62.32  Aligned_cols=143  Identities=19%  Similarity=0.209  Sum_probs=88.8

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCC--CceeEeeceeccCC--cceEEE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEPP--NLSIVT  341 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h--pnIv~l~~~~~~~~--~~~lV~  341 (538)
                      ...+.+....|.--.+|.....++.+++. ...............+|+.+++.+.-  --+...++.|.++.  ..+.||
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             CCceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            34455556556556666666666668877 33222233444566788888887743  23445566666665  679999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHH-HHHHHHHHHHhCC-----------------------------------
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAY-DVAKGMNYLHQRR-----------------------------------  385 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~-qi~~aL~~LH~~~-----------------------------------  385 (538)
                      +|++|..+...+....    ..    ..++. .+++.|.-||+-.                                   
T Consensus       105 ~~veGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~  176 (321)
T COG3173         105 EWVEGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR  176 (321)
T ss_pred             EEecceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence            9998854433321111    00    11222 4444455555421                                   


Q ss_pred             ---------------------CCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          386 ---------------------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       386 ---------------------~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                                           +.++|+|+.+.|++++.++-+=+.||+++...
T Consensus       177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                                 16899999999999999888999999998754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.82  E-value=0.0076  Score=61.37  Aligned_cols=76  Identities=16%  Similarity=0.167  Sum_probs=47.7

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC---CCceeEeeceeccCCcceEEEee
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      .+-.+.++-|....+|+....+..+.||+-.....     ..|..|..-|+.|.   --.+.+++++....+..+++|||
T Consensus        19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~-----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR-----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC-----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eeeeEecCCCChhheEEEECCCccEEEEecChhhH-----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            34467899999999999986677799999763321     35667887777773   44577888887776777999999


Q ss_pred             cCCC
Q 009291          344 LSRG  347 (538)
Q Consensus       344 ~~~g  347 (538)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.74  E-value=0.0071  Score=62.71  Aligned_cols=142  Identities=23%  Similarity=0.213  Sum_probs=95.5

Q ss_pred             eEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccC-----------------------HHHHHH-HHHHHHHHHcCCCC
Q 009291          268 LIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFH-----------------------EDRFKE-FLREVAIMKGLRHP  322 (538)
Q Consensus       268 ~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~-----------------------~~~~~~-~~~Ei~il~~L~hp  322 (538)
                      .+-.+|..|.-+.||.|... +..+|||+++-+...                       ...++. ...|++.|++++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            45678999999999999765 445999987543210                       111121 34688888888765


Q ss_pred             ceeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHH-hCCCCEEeecCCCCCEEEc
Q 009291          323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH-QRRPPIVHRDLKSPNLLVD  401 (538)
Q Consensus       323 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~iiHrDLKp~NILl~  401 (538)
                      .|..---+..  ....|||+|+.+.....-   .-....++...+..+-.|++.-+.-|- .++  +||.||.--|+|+.
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE
Confidence            5442211111  234799999964222111   112234677778888899999998884 567  99999999999994


Q ss_pred             CCCcEEEEeeCCCccC
Q 009291          402 STYTVKVCDFGLSRSK  417 (538)
Q Consensus       402 ~~~~vkL~DFGla~~~  417 (538)
                       +|.+.|+|-+-+...
T Consensus       300 -dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 -DGKLYIIDVSQSVEH  314 (520)
T ss_pred             -CCEEEEEEccccccC
Confidence             568999999877543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.56  E-value=0.026  Score=57.20  Aligned_cols=30  Identities=23%  Similarity=0.422  Sum_probs=25.2

Q ss_pred             CEEeecCCCCCEEEcCCCc-EEEEeeCCCcc
Q 009291          387 PIVHRDLKSPNLLVDSTYT-VKVCDFGLSRS  416 (538)
Q Consensus       387 ~iiHrDLKp~NILl~~~~~-vkL~DFGla~~  416 (538)
                      .++|+|++|.||++++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i

Probab=96.52  E-value=0.0013  Score=56.59  Aligned_cols=54  Identities=22%  Similarity=0.252  Sum_probs=42.7

Q ss_pred             eccccchhhHHHHHHHhhhcCCCceeecccccC----------CCCCCCeEEEEeCCCcchhhh
Q 009291           37 LSVGLCVHRALLFKVLADLINLPCRIAKGCKYC----------RRDDASSCLVQIGPDREYLVD   90 (538)
Q Consensus        37 ~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~----------~~~~~~~~~~~~~~~~~~~~~   90 (538)
                      -+.|.|.+-|.||..|+-.+|||||+|.|....          +.+.|+++-|.++...++.+|
T Consensus        49 ~~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~W~~~D  112 (113)
T PF01841_consen   49 SGRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGGWIPLD  112 (113)
T ss_dssp             CEEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTEEEEEE
T ss_pred             cCCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCcEEEcC
Confidence            356999999999999999999999999994332          244588999999777887776

e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B ....

>PLN02236 choline kinase

Probab=96.41  E-value=0.028  Score=58.74  Aligned_cols=140  Identities=19%  Similarity=0.259  Sum_probs=76.8

Q ss_pred             EEEEccCCcEEEEEEEEcC------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCce-eEeeceeccCCcceEEEe
Q 009291          270 KKKIGEGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnI-v~l~~~~~~~~~~~lV~E  342 (538)
                      ++.|-.|-.-.+|++...+      ..+++|+.....  ...+ .-.+|..+++.+..-++ .++++.+...    .|.|
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e  113 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE  113 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence            4456568888999987532      357888764432  1111 22568888887754333 3455555332    5788


Q ss_pred             ecCCCChhhh-----------------hcCCCC---CccccHHHHHHHHHH-----------------HHHHHHHHHh--
Q 009291          343 YLSRGSLYKL-----------------LHIPDA---RVVVDERLRLNMAYD-----------------VAKGMNYLHQ--  383 (538)
Q Consensus       343 ~~~~gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~q-----------------i~~aL~~LH~--  383 (538)
                      |+++.++...                 +|....   ........+..+..+                 +...++.|.+  
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            9877665321                 111110   001112222222211                 1122222221  


Q ss_pred             -C---CCCEEeecCCCCCEEEcC-CCcEEEEeeCCCcc
Q 009291          384 -R---RPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS  416 (538)
Q Consensus       384 -~---~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~  416 (538)
                       .   ...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             1   124899999999999976 46899999987754

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.38  E-value=0.028  Score=57.34  Aligned_cols=29  Identities=28%  Similarity=0.387  Sum_probs=25.1

Q ss_pred             CEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       387 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            4999999999999987 6789999996643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.29  E-value=0.043  Score=58.43  Aligned_cols=76  Identities=14%  Similarity=0.106  Sum_probs=50.2

Q ss_pred             EEEEEccCCcEEEEEEEEcCCceEEEEEec-----cccCHHHHHHHHHHHHHHHcCC---CCceeEeeceeccCCcceEE
Q 009291          269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIE-----QEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~-----~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ..+.||.|....||++...++.++||.-..     ...-+-.......|...|+.+.   ...|.+++.++.+  ..+++
T Consensus        36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            367899999999999988766688887541     1100012233344566665553   3578888887764  35788


Q ss_pred             EeecCC
Q 009291          341 TEYLSR  346 (538)
Q Consensus       341 ~E~~~~  346 (538)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.15  E-value=0.043  Score=56.31  Aligned_cols=30  Identities=23%  Similarity=0.234  Sum_probs=27.1

Q ss_pred             CEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       387 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++|+|+.+.|+++++++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            499999999999999998999999987754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.07  E-value=0.048  Score=56.60  Aligned_cols=142  Identities=20%  Similarity=0.263  Sum_probs=82.6

Q ss_pred             EEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc------eeEe----eceeccCCcceE
Q 009291          270 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN------IVLL----MGAVTEPPNLSI  339 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn------Iv~l----~~~~~~~~~~~l  339 (538)
                      ...|.+ .--.+|+....++.+++|+.... ....   ++..|+..+..|.-..      +...    +.....+.....
T Consensus        31 ~~~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~~---~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~  105 (331)
T COG2334          31 LRGLNS-EENSNFRVQTEDGRYILKIYRPG-WTRA---EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA  105 (331)
T ss_pred             cccccc-ccCceEEEEecCCCeEEEEecCC-CCHH---HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence            344555 55678999888888988887665 3333   4556677776663221      1211    112222236778


Q ss_pred             EEeecCCCChhh-h-----------h---cC---------CCCCccccHH-------------HHHHHHHHHHHHHHHHH
Q 009291          340 VTEYLSRGSLYK-L-----------L---HI---------PDARVVVDER-------------LRLNMAYDVAKGMNYLH  382 (538)
Q Consensus       340 V~E~~~~gsL~~-~-----------l---~~---------~~~~~~l~~~-------------~~~~i~~qi~~aL~~LH  382 (538)
                      +++|++|..+.. .           +   +.         ........+.             .-.....++...++.+.
T Consensus       106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~  185 (331)
T COG2334         106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL  185 (331)
T ss_pred             EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence            999999877762 1           1   00         0001111121             00112334445555555


Q ss_pred             hCC------CC--EEeecCCCCCEEEcCCCc-EEEEeeCCCcc
Q 009291          383 QRR------PP--IVHRDLKSPNLLVDSTYT-VKVCDFGLSRS  416 (538)
Q Consensus       383 ~~~------~~--iiHrDLKp~NILl~~~~~-vkL~DFGla~~  416 (538)
                      +.-      .+  +||+|+.|.||+++.+.. +.++||+.+..
T Consensus       186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            421      12  899999999999998874 99999997754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.96  E-value=0.033  Score=54.18  Aligned_cols=118  Identities=12%  Similarity=0.074  Sum_probs=76.6

Q ss_pred             CCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCCCChhhhhcC
Q 009291          276 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI  355 (538)
Q Consensus       276 G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  355 (538)
                      |+.++.-.++-+-.+..+|++......- ..+-|..+.+++.++.  .|+++..-  +.-.+-++.|+|..-..      
T Consensus        73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccchhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            5566666665444556777765443321 1235677888888763  46666522  33447799999853110      


Q ss_pred             CCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          356 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       356 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                            .    ...++.-=+.+|.-.|+.++..+|+|-.|+|||-++.|.+||.|-+.-
T Consensus       142 ------~----~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 ------N----FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ------c----hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence                  1    111222224678888976556999999999999999999999998753

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.73  E-value=0.071  Score=55.39  Aligned_cols=30  Identities=27%  Similarity=0.351  Sum_probs=25.8

Q ss_pred             CEEeecCCCCCEEEcC-CCcEEEEeeCCCcc
Q 009291          387 PIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS  416 (538)
Q Consensus       387 ~iiHrDLKp~NILl~~-~~~vkL~DFGla~~  416 (538)
                      .++|+|+.+.|||+++ ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4799999999999974 57899999998754

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.63  E-value=0.039  Score=53.95  Aligned_cols=76  Identities=16%  Similarity=0.212  Sum_probs=57.0

Q ss_pred             EEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC---CCceeEeeceeccCCcceEEEeecCC
Q 009291          270 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      .+.+--|---..|...+....+.||+-.     ......|..|+.-|+.|.   --.|.+++.+-.+..+-|+|+||++-
T Consensus        21 r~~v~gG~inea~~v~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          21 REEVSGGDINEAWRLRDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             ccccCCccccceeEeecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            4456667777778888777889999842     334567888887777663   45678888888888999999999987


Q ss_pred             CChh
Q 009291          347 GSLY  350 (538)
Q Consensus       347 gsL~  350 (538)
                      +.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            6664

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.40  E-value=0.094  Score=54.94  Aligned_cols=73  Identities=18%  Similarity=0.170  Sum_probs=43.7

Q ss_pred             EEccCCcEEEEEEEEcCC--ceEEEEEec-----cccCHHHHHHHHHHHHHHHcCC--CC-ceeEeeceeccCCcceEEE
Q 009291          272 KIGEGSFGTVYHAEWRNS--DVAVKILIE-----QEFHEDRFKEFLREVAIMKGLR--HP-NIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~~~~--~vavK~~~~-----~~~~~~~~~~~~~Ei~il~~L~--hp-nIv~l~~~~~~~~~~~lV~  341 (538)
                      .||.|....||++...++  .++||--..     ....+-......-|...|+...  -| .+.+++.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999987653  588875321     1111222234446667776553  23 45555543  445567999


Q ss_pred             eecCC
Q 009291          342 EYLSR  346 (538)
Q Consensus       342 E~~~~  346 (538)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.32  E-value=0.033  Score=60.13  Aligned_cols=177  Identities=21%  Similarity=0.204  Sum_probs=103.5

Q ss_pred             EEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-CcceEEEeecCCCChhhhhcCCCCC
Q 009291          281 VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-PNLSIVTEYLSRGSLYKLLHIPDAR  359 (538)
Q Consensus       281 Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~  359 (538)
                      .+.|+.+..+++..-+...    .....++....+++.+.|+|...++++-... ....+|+|++ +.+|++++......
T Consensus         5 ~~~a~~~~~~~c~nglplt----~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~   79 (725)
T KOG1093|consen    5 TFFAQEKPGDVCSNGLPLT----PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK   79 (725)
T ss_pred             EEehhcCCCccccCCCcCC----CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc
Confidence            3455555555553222211    1224566778999999999999999886433 3367899998 56999988543310


Q ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccc
Q 009291          360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL  439 (538)
Q Consensus       360 ~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l  439 (538)
                         .        .+++       .++  +.|-     |       ..+++| -++...       ....           
T Consensus        80 ---~--------~s~~-------~~~--~~~~-----~-------~~~~td-~~~t~~-------~~~~-----------  108 (725)
T KOG1093|consen   80 ---D--------ESLL-------AHG--VLHL-----N-------IIYITD-HFLTKY-------PSPI-----------  108 (725)
T ss_pred             ---h--------hhhc-------ccc--ccee-----h-------hhhccc-cccccC-------CCCC-----------
Confidence               0        0111       223  3332     1       233333 111100       0111           


Q ss_pred             cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-cc---------CCCCCCcHHHHHHHHHhhhcCCC
Q 009291          440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RL---------EIPKNVNPMVAALIETCWAEEPE  509 (538)
Q Consensus       440 ~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~---------~~p~~~s~~l~~LI~~cL~~dP~  509 (538)
                           ..|+|||++|.++.++..|...|......+....+..-.. ..         .+-..++..+.++..+|+...|.
T Consensus       109 -----~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~  183 (725)
T KOG1093|consen  109 -----GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPI  183 (725)
T ss_pred             -----CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccc
Confidence                 1399999999999999999887766555444433321110 00         11124567788899999999999


Q ss_pred             CCCCHHHHH
Q 009291          510 IRPSFPSIM  518 (538)
Q Consensus       510 ~RPs~~eIl  518 (538)
                      .||...++.
T Consensus       184 ir~l~~~~~  192 (725)
T KOG1093|consen  184 IRPLPMELS  192 (725)
T ss_pred             cccchhHHh
Confidence            998666554

>COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning]

Probab=95.24  E-value=0.017  Score=61.55  Aligned_cols=56  Identities=30%  Similarity=0.460  Sum_probs=46.7

Q ss_pred             ccccchhhHHHHHHHhhhcCCCceeeccccc-----CC--CCCCCeEEEEeCCCcchhhhccCC
Q 009291           38 SVGLCVHRALLFKVLADLINLPCRIAKGCKY-----CR--RDDASSCLVQIGPDREYLVDLLED   94 (538)
Q Consensus        38 ~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~-----~~--~~~~~~~~~~~~~~~~~~~~~~~~   94 (538)
                      --++|--=|.|||.||-..||||-+|+|.--     ..  .-.|+|++|++++ +.|.||.--.
T Consensus       208 heavCtgYa~lfK~lcn~lgIp~~iIegf~k~~~~~~~~~~iNHaWN~VkiD~-~yy~VDtTwg  270 (521)
T COG5279         208 HEAVCTGYAELFKELCNALGIPCEIIEGFLKSPIYYTRDININHAWNIVKIDN-EYYLVDTTWG  270 (521)
T ss_pred             cccccchHHHHHHHHHHhcCCceEEEeecccccccccCCccccceeeEEEECC-eEEEEeeecC
Confidence            4567778889999999999999999999411     22  6689999999988 9999998654

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.19  E-value=0.051  Score=56.51  Aligned_cols=77  Identities=22%  Similarity=0.273  Sum_probs=57.1

Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      +....|++|++. |+++... .      .....++..|+.+.+..+.-+..+ .+.=|||+...||+|+ +|+|.|+||-
T Consensus       297 e~~y~yl~~kdh-gt~is~i-k------~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISII-K------ADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             CceEEEEEEecC-Cceeeee-e------cccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEee
Confidence            334467788765 4454322 1      245677888999888777777655 3589999999999999 8999999999


Q ss_pred             CCccCCC
Q 009291          413 LSRSKPN  419 (538)
Q Consensus       413 la~~~~~  419 (538)
                      +++....
T Consensus       367 lsRl~~~  373 (488)
T COG5072         367 LSRLSYS  373 (488)
T ss_pred             eeecccC
Confidence            9996443

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.97  E-value=0.052  Score=57.52  Aligned_cols=75  Identities=20%  Similarity=0.096  Sum_probs=46.7

Q ss_pred             EEEEccCCcEEEEEEEEc--CCceEEEEEe----ccccCHHHHHHHHHHHHHHHcCC--CC-ceeEeeceeccCCcceEE
Q 009291          270 KKKIGEGSFGTVYHAEWR--NSDVAVKILI----EQEFHEDRFKEFLREVAIMKGLR--HP-NIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~--~~~vavK~~~----~~~~~~~~~~~~~~Ei~il~~L~--hp-nIv~l~~~~~~~~~~~lV  340 (538)
                      .+.||.|.-..||++.+.  ++.++||--.    ....-+-..+...-|.+.|+.+.  -| .+.+++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            678999999999999975  4458887531    11111222345556677776652  33 45555543  44556788


Q ss_pred             EeecCC
Q 009291          341 TEYLSR  346 (538)
Q Consensus       341 ~E~~~~  346 (538)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888853

>PTZ00384 choline kinase; Provisional

Probab=93.77  E-value=0.27  Score=52.21  Aligned_cols=77  Identities=18%  Similarity=0.212  Sum_probs=43.9

Q ss_pred             EEEEccCCcEEEEEEEEcCC---ceEEEE-Eecc-ccCHHHHHHHHHHHHHHHcCCCCce-eEeeceeccCCcceEEEee
Q 009291          270 KKKIGEGSFGTVYHAEWRNS---DVAVKI-LIEQ-EFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~---~vavK~-~~~~-~~~~~~~~~~~~Ei~il~~L~hpnI-v~l~~~~~~~~~~~lV~E~  343 (538)
                      ++.|..|-...+|++...+.   .+.+|. +... .......-.-.+|+.+++.+...++ .++++.+..    +++.||
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            44565688899999875432   232331 1111 0111111123468888888865444 456666543    699999


Q ss_pred             cCCCChh
Q 009291          344 LSRGSLY  350 (538)
Q Consensus       344 ~~~gsL~  350 (538)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9887653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	538
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-116
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-115
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-41
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-40
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-39
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-39
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-39
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-39
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-39
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-39
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-39
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-39
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-39
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-39
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-39
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-38
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-38
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-38
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-38
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-38
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-38
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-38
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-38
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-38
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-38
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-38
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-38
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-38
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-38
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-38
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-38
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-38
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-38
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-38
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-38
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-38
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-38
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-38
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-37
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-37
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-37
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-37
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-37
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-37
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-37
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-37
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-37
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-36
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-36
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-36
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-36
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-36
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-36
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-36
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-35
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-35
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-35
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-35
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-35
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-35
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-35
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-35
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-35
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-35
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-35
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-35
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-35
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-34
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-34
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-34
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-34
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-34
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-34
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-34
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-34
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-34
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-34
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-34
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-34
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-34
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-34
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-34
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-34
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-34
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-34
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-34
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-34
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-34
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-34
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-34
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-33
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-33
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-33
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-33
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-33
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-33
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-33
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-33
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-33
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-33
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-33
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-33
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-33
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-33
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-33
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-33
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-33
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-33
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-33
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-33
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-33
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-33
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-33
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-33
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-33
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-33
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-33
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-33
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-33
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-33
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-33
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-33
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-33
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-33
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-32
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-32
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-32
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-32
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-32
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-32
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-32
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-32
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-32
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-32
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-32
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-32
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-32
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-32
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-32
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-32
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-32
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-32
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-32
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-32
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-32
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-32
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-32
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-32
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-32
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-32
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-32
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-32
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-32
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-32
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-32
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-32
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-32
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-32
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-32
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-32
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-32
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-32
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-32
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-32
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-32
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-32
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-32
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-32
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-32
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-32
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-31
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-31
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-31
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-31
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-31
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-31
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-31
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-31
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-31
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-31
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-31
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-31
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-31
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-31
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-31
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-31
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-31
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-31
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-31
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-31
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-31
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-31
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-31
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-31
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-31
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-31
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-31
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-31
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-31
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-31
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-31
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-30
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-30
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-30
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-30
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-30
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-30
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-30
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-30
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-30
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-30
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-30
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-30
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-30
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-30
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-30
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-30
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-30
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-30
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-30
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-29
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-29
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-29
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-29
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-29
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-29
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-29
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-29
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-29
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-29
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-29
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-29
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-28
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-28
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-28
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-28
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-28
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-28
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-28
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-27
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-27
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-27
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-27
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-27
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-27
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-27
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-27
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-27
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-27
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-27
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-27
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-27
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-27
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-27
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-27
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-27
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-26
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-26
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-26
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-26
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-26
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-26
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-26
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-26
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-26
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-26
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-26
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-26
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-26
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-26
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-26
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-26
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-26
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-26
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-26
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-26
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-26
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-26
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-26
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-26
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-26
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-26
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-26
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-25
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-25
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-25
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-25
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-25
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-25
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-25
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-25
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-25
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-25
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-25
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-25
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-25
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-25
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-25
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-25
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-25
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-25
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-25
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-25
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-25
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-25
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-25
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-25
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-25
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-24
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-24
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-24
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-24
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-24
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-24
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-24
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-24
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-24
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-24
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-24
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-24
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-24
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-24
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-24
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-24
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-24
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-24
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-24
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-24
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-24
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-24
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-24
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-24
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-24
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-24
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-24
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-24
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-24
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-24
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-24
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-24
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-24
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-24
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-24
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-24
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-24
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-24
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-23
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-23
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-23
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-23
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-23
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-23
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-23
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-23
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-23
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-23
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-23
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-23
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-23
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-23
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-23
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-23
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-23
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-23
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-23
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-23
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-23
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-23
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-23
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-23
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-23
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-23
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-23
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-23
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-23
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-23
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-23
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-23
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-23
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-23
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-23
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-23
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-22
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-22
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-22
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-22
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-22
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-22
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-22
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-22
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-22
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-22
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-22
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-22
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-22
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-22
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-22
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-22
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-22
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-22
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-22
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-22
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-22
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-22
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-22
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-22
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-21
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-21
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-21
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-21
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-21
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-21
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-21
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-21
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-21
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-21
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-21
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-21
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-21
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-21
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-21
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-21
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-21
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-21
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-21
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-21
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-21
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-21
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-21
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-21
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-21
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-21
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-21
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-20
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-20
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-20
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-20
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-20
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-20
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-20
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-20
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-20
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-20
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-20
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-20
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-20
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-20
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-20
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-20
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-20
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-20
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-19
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-19
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-19
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-19
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-19
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-19
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-19
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-19
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-19
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-19
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-19
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-19
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-19
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-18
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-18
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-18
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-18
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-18
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-18
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-18
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-17
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-17
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-17
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-17
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-16
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-16
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-16
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-16
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-16
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-16
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-16
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-16
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-16
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-16
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-16
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-16
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-16
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-16
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-16
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-16
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-16
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-16
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-16
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-16
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-16
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-16
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		8e-16
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-16
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-16
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-16
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-15
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-15
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-15
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-15
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-15
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-15
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-15
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-15
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-15
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-15
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-15
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-15
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-15
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-15
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-15
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-15
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-15
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-15
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-14
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-14
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-14
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-14
3soa_A	444	Full-Length Human Camkii Length = 444		2e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-14
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-14
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-14
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-14
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-14
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-14
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-14
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-14
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-14
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-14
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-14
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-14
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-14
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-14
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-14
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-14
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		9e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-13
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-13
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-13
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-13
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-13
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-12
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-12
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-12
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-12
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-12
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-12
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-11
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		8e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-06

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  416 bits (1069), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 198/278 (71%), Positives = 234/278 (84%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA 314
           ++ + ++I W +L IK+KIG GSFGTV+ AEW  SDVAVKIL+EQ+FH +R  EFLREVA
Sbjct: 27  MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           IMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH   AR  +DER RL+MAYDV
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 434
           AKGMNYLH R PPIVHR+LKSPNLLVD  YTVKVCDFGLSR K +T++SSK+AAGTPEWM
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           APEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N  P+QV++AVGFK +RLEIP+N+NP
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
            VAA+IE CW  EP  RPSF +IM+ L+  + S+V  P
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  412 bits (1060), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 197/278 (70%), Positives = 231/278 (83%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA 314
           ++ + ++I W +L IK+KIG GSFGTV+ AEW  SDVAVKIL+EQ+FH +R  EFLREVA
Sbjct: 27  MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVA 86
Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           IMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH   AR  +DER RL+MAYDV
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 434
           AKGMNYLH R PPIVHRDLKSPNLLVD  YTVKVCDFGLSR K + ++ SK AAGTPEWM
Sbjct: 147 AKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWM 206
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           APEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N  P+QV++AVGFK +RLEIP+N+NP
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
            VAA+IE CW  EP  RPSF +IM+ L+  + S+V  P
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/272 (37%), Positives = 165/272 (60%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI  SE+++  +IG GSFGTVY  +W + DVAVKIL   +   ++F+ F  EVA+++  R
Sbjct: 32  EIEASEVMLSTRIGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR 90
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           H NI+L MG +T+  NL+IVT++    SLYK LH+ + +  + +   +++A   A+GM+Y
Sbjct: 91  HVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQ--LIDIARQTAQGMDY 147
Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA--AGTPEWMAPEV 438
           LH +   I+HRD+KS N+ +    TVK+ DFGL+  K     S +     G+  WMAPEV
Sbjct: 148 LHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 439 LR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRR----LEIPK 490
           +R    +P + +SDV+S+G++L+EL+T + P+ + +   Q+I  VG +G       ++ K
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG-RGYASPDLSKLYK 264
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  +  E RP FP I+ +++
Sbjct: 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  164 bits (416), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 105/274 (38%), Positives = 149/274 (54%), Gaps = 19/274 (6%)
Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED---RFKEFLREVAIM 316
           LEI ++EL +++ IG G FG VY A W   +VAVK     +  ED     +   +E  + 
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKA-ARHDPDEDISQTIENVRQEAKLF 60
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
             L+HPNI+ L G   + PNL +V E+   G L ++L     R+  D  + +N A  +A+
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPD--ILVNWAVQIAR 116
Query: 377 GMNYLHQRR-PPIVHRDLKSPNLLVD--------STYTVKVCDFGLSRSKPNTYISSKTA 427
           GMNYLH     PI+HRDLKS N+L+         S   +K+ DFGL+R    T  +  +A
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSA 174
Query: 428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE 487
           AG   WMAPEV+R    ++ SDV+S+GV+LWEL+T + P+R      V   V      L 
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234
Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
           IP       A L+E CW  +P  RPSF +I++ L
Sbjct: 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 157/273 (57%), Gaps = 15/273 (5%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           H NI+L MG  T+P  L+IVT++    SLY  LH  + +   + +  +++A   A+GM+Y
Sbjct: 79  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDY 135
Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPEV 438
           LH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPEV
Sbjct: 136 LHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 439 LREDPSNE---KSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK---N 491
           +R   SN    +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   N
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
               +  L+  C  ++ + RPSFP I+  +++ 
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 156/273 (57%), Gaps = 15/273 (5%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           H NI+L MG  T  P L+IVT++    SLY  LH  + +   + +  +++A   A+GM+Y
Sbjct: 79  HVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDY 135
Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPEV 438
           LH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPEV
Sbjct: 136 LHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 439 LREDPSNE---KSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK---N 491
           +R   SN    +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   N
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
               +  L+  C  ++ + RPSFP I+  +++ 
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 143/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G FG VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 63
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V   + L MA  ++  M
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 122
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR       ++   A  P +W APE
Sbjct: 123 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+    PSQV   +  K  R+E P+     V
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-KDYRMERPEGCPEKV 239
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 240 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  159 bits (402), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 157/273 (57%), Gaps = 15/273 (5%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 8   EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 66
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           H NI+L MG  T+P  L+IVT++    SLY  LH  + +   + +  +++A   A+GM+Y
Sbjct: 67  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDY 123
Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPEV 438
           LH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPEV
Sbjct: 124 LHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 181
Query: 439 LREDPSNE---KSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK---N 491
           +R   SN    +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   N
Sbjct: 182 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 241
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
               +  L+  C  ++ + RPSFP I+  +++ 
Sbjct: 242 CPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  159 bits (401), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 143/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 63
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V   + L MA  ++  M
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 122
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR       ++   A  P +W APE
Sbjct: 123 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE 180
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+    PSQV   +  K  R+E P+     V
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-KDYRMERPEGCPEKV 239
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 240 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  158 bits (400), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/268 (38%), Positives = 144/268 (53%), Gaps = 14/268 (5%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 28  EMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 84
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   IVTEY+  G+L   L   + R  V   + L MA  ++  M
Sbjct: 85  IKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECN-REEVTAVVLLYMATQISSAM 143
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 144 EYLEKKN--FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 201
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  KG R+E P+   P V
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLE-KGYRMEQPEGCPPKV 260
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQF 524
             L+  CW   P  RPSF    ET Q F
Sbjct: 261 YELMRACWKWSPADRPSFA---ETHQAF 285

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  158 bits (400), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 160/272 (58%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 24  EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 82
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL-NMAYDVAKGMN 379
           H NI+L MG  T+P  L+IVT++    SLY  LHI + +    E ++L ++A   A+GM+
Sbjct: 83  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKF---EMIKLIDIARQTAQGMD 138
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPE 437
           YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPE
Sbjct: 139 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 196
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK--- 490
           V+R   ++P + +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   
Sbjct: 197 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 256
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  ++ + RP FP I+ +++
Sbjct: 257 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  158 bits (400), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 160/272 (58%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 90
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL-NMAYDVAKGMN 379
           H NI+L MG  T+P  L+IVT++    SLY  LHI + +    E ++L ++A   A+GM+
Sbjct: 91  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKF---EMIKLIDIARQTAQGMD 146
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPE 437
           YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPE
Sbjct: 147 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 204
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK--- 490
           V+R   ++P + +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   
Sbjct: 205 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 264
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  ++ + RP FP I+ +++
Sbjct: 265 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  158 bits (399), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 160/272 (58%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 67
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL-NMAYDVAKGMN 379
           H NI+L MG  T+P  L+IVT++    SLY  LHI + +    E ++L ++A   A+GM+
Sbjct: 68  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKF---EMIKLIDIARQTAQGMD 123
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPE 437
           YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPE
Sbjct: 124 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK--- 490
           V+R   ++P + +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 241
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  ++ + RP FP I+ +++
Sbjct: 242 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  158 bits (399), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 160/272 (58%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 31  EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 89
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL-NMAYDVAKGMN 379
           H NI+L MG  T+P  L+IVT++    SLY  LHI + +    E ++L ++A   A+GM+
Sbjct: 90  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKF---EMIKLIDIARQTAQGMD 145
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPE 437
           YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPE
Sbjct: 146 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 203
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK--- 490
           V+R   ++P + +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   
Sbjct: 204 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 263
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  ++ + RP FP I+ +++
Sbjct: 264 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  158 bits (399), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 160/272 (58%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL-NMAYDVAKGMN 379
           H NI+L MG  T+P  L+IVT++    SLY  LHI + +    E ++L ++A   A+GM+
Sbjct: 63  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKF---EMIKLIDIARQTAQGMD 118
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPE 437
           YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPE
Sbjct: 119 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 176
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK--- 490
           V+R   ++P + +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  ++ + RP FP I+ +++
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 160/272 (58%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 67
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL-NMAYDVAKGMN 379
           H NI+L MG  T+P  L+IVT++    SLY  LHI + +    E ++L ++A   A+GM+
Sbjct: 68  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKF---EMIKLIDIARQTAQGMD 123
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPE 437
           YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPE
Sbjct: 124 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK--- 490
           V+R   ++P + +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 241
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  ++ + RP FP I+ +++
Sbjct: 242 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 160/272 (58%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 90
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL-NMAYDVAKGMN 379
           H NI+L MG  T+P  L+IVT++    SLY  LHI + +    E ++L ++A   A+GM+
Sbjct: 91  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKF---EMIKLIDIARQTAQGMD 146
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPE 437
           YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPE
Sbjct: 147 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 204
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK--- 490
           V+R   ++P + +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   
Sbjct: 205 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 264
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  ++ + RP FP I+ +++
Sbjct: 265 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 160/272 (58%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL-NMAYDVAKGMN 379
           H NI+L MG  T+P  L+IVT++    SLY  LHI + +    E ++L ++A   A+GM+
Sbjct: 63  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKF---EMIKLIDIARQTAQGMD 118
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPE 437
           YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPE
Sbjct: 119 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK--- 490
           V+R   ++P + +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  ++ + RP FP I+ +++
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 160/272 (58%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 6   EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 64
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL-NMAYDVAKGMN 379
           H NI+L MG  T+P  L+IVT++    SLY  LHI + +    E ++L ++A   A+GM+
Sbjct: 65  HVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKF---EMIKLIDIARQTAQGMD 120
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPE 437
           YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPE
Sbjct: 121 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 178
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK--- 490
           V+R   ++P + +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   
Sbjct: 179 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 238
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  ++ + RP FP I+ +++
Sbjct: 239 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 146/267 (54%), Gaps = 12/267 (4%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH 321
           I + E+ +++ +G G+FG V  A+WR  DVA+K    Q   E   K F+ E+  +  + H
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIK----QIESESERKAFIVELRQLSRVNH 61
Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           PNIV L GA   P  + +V EY   GSLY +LH  +          ++     ++G+ YL
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 382 HQRRP-PIVHRDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           H  +P  ++HRDLK PNLL+ +  TV K+CDFG +        ++K   G+  WMAPEV 
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVF 176
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAA 498
                +EK DVFS+G+ILWE+IT +KP+     P+  I      G R  + KN+   + +
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 236
Query: 499 LIETCWAEEPEIRPSFPSIMETLQQFL 525
           L+  CW+++P  RPS   I++ +   +
Sbjct: 237 LMTRCWSKDPSQRPSMEEIVKIMTHLM 263

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 146/267 (54%), Gaps = 12/267 (4%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH 321
           I + E+ +++ +G G+FG V  A+WR  DVA+K    Q   E   K F+ E+  +  + H
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIK----QIESESERKAFIVELRQLSRVNH 60
Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           PNIV L GA   P  + +V EY   GSLY +LH  +          ++     ++G+ YL
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 382 HQRRP-PIVHRDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           H  +P  ++HRDLK PNLL+ +  TV K+CDFG +        ++K   G+  WMAPEV 
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVF 175
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAA 498
                +EK DVFS+G+ILWE+IT +KP+     P+  I      G R  + KN+   + +
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 499 LIETCWAEEPEIRPSFPSIMETLQQFL 525
           L+  CW+++P  RPS   I++ +   +
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 159/272 (58%), Gaps = 17/272 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W + DVAVK+L        + + F  EV +++  R
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL-NMAYDVAKGMN 379
           H NI+L MG  T  P L+IVT++    SLY  LHI + +    E ++L ++A   A+GM+
Sbjct: 63  HVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKF---EMIKLIDIARQTAQGMD 118
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPE 437
           YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S +    +G+  WMAPE
Sbjct: 119 YLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK--- 490
           V+R   ++P + +SDV++FG++L+EL+T Q P+ N +   Q+I  VG      ++ K   
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           N    +  L+  C  ++ + RP FP I+ +++
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 147/266 (55%), Gaps = 11/266 (4%)
Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           +E++  E+ + K++G G FG V   +W+   DVAVK++ E    ED   EF +E   M  
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMK 59
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           L HP +V   G  ++   + IVTEY+S G L   L     + +   +L L M YDV +GM
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQL-LEMCYDVCEGM 117
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPE 437
            +L   +   +HRDL + N LVD    VKV DFG++R    + Y+SS       +W APE
Sbjct: 118 AFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPE 175
Query: 438 VLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
           V      + KSDV++FG+++WE+ +L K P+   T S+V+  V  +G RL  P   +  +
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTI 234
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQ 522
             ++ +CW E PE RP+F  ++ +++
Sbjct: 235 YQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 144/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 70
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 129
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 130 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 246
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 247 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  156 bits (395), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 142/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 63
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+ E+++ G+L   L   + R  V   + L MA  ++  M
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 122
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR       ++   A  P +W APE
Sbjct: 123 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+    PSQV   +  K  R+E P+     V
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE-KDYRMERPEGCPEKV 239
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 240 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 144/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 22  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 78
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 79  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 137
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 138 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 195
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 196 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 254
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 255 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 286

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 144/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 69
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 128
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 129 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 245
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 144/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 67
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 126
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 127 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 243
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 244 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 144/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 67
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 126
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 127 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 243
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 244 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 144/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 65
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 124
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 125 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 241
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 143/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 70
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V   + L MA  ++  M
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 129
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 130 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 246
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 247 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  155 bits (392), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 144/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKE 66
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 125
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 126 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 183
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 242
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 243 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 274

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  155 bits (392), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 143/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 70
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 129
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR       ++   A  P +W APE
Sbjct: 130 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 187
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 246
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 247 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  155 bits (392), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 144/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 67
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 126
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 127 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 184
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 243
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 244 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  155 bits (392), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 143/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 65
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V   + L MA  ++  M
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 124
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 125 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 241
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  155 bits (392), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 143/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 65
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V   + L MA  ++  M
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 124
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 125 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 241
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  155 bits (391), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 143/269 (53%), Gaps = 11/269 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 70
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 129
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 130 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 246
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFL 525
             L+  CW   P  RPSF  I +  +   
Sbjct: 247 YELMRACWQWNPSDRPSFAEIHQAFETMF 275

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  155 bits (391), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 143/266 (53%), Gaps = 11/266 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 65
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 124
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 125 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 241
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQ 522
             L+  CW   P  RPSF  I +  +
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 144/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 255 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 311
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 312 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 370
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HR+L + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 371 EYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 428
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 429 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 487
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 488 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 519

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  154 bits (388), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 143/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 272
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V   + L MA  ++  M
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 331
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HR+L + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 332 EYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 448
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 449 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 480

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 142/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 65
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+ E+++ G+L   L   + R  V   + L MA  ++  M
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 124
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 125 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 241
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 142/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 65
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+ E+++ G+L   L   + R  V   + L MA  ++  M
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 124
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 125 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 241
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 142/272 (52%), Gaps = 11/272 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 66
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+ E+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 125
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR       ++   A  P +W APE
Sbjct: 126 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 183
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 242
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 243 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 274

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  153 bits (386), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 142/269 (52%), Gaps = 11/269 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 70
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+ E+++ G+L   L   + R  V+  + L MA  ++  M
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 129
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 130 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 246
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFL 525
             L+  CW   P  RPSF  I +  +   
Sbjct: 247 YELMRACWQWNPSDRPSFAEIHQAFETMF 275

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  151 bits (382), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 139/268 (51%), Gaps = 11/268 (4%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           SEL   ++IG G FG V+   W N D VA+K + E    E+   +F+ E  +M  L HP 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 64
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L G   E   + +VTE++  G L   L     R +      L M  DV +GM YL +
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLRED 442
               ++HRDL + N LV     +KV DFG++R   +   +S T    P +W +PEV    
Sbjct: 123 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 443 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             + KSDV+SFGV++WE+ +  K P+ N + S+V+  +   G RL  P+  +  V  ++ 
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMN 239
Query: 502 TCWAEEPEIRPSFPSIMETLQQFLMSSV 529
            CW E PE RP+F  ++  L +   S +
Sbjct: 240 HCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  151 bits (381), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 138/268 (51%), Gaps = 11/268 (4%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           SEL   ++IG G FG V+   W N D VA+K + E    ED   +F+ E  +M  L HP 
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED---DFIEEAEVMMKLSHPK 83
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L G   E   + +V E++  G L   L     R +      L M  DV +GM YL +
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE 141
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLRED 442
               ++HRDL + N LV     +KV DFG++R   +   +S T    P +W +PEV    
Sbjct: 142 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 199
Query: 443 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             + KSDV+SFGV++WE+ +  K P+ N + S+V+  +   G RL  P+  +  V  ++ 
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMN 258
Query: 502 TCWAEEPEIRPSFPSIMETLQQFLMSSV 529
            CW E PE RP+F  ++  L +   S +
Sbjct: 259 HCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/277 (35%), Positives = 152/277 (54%), Gaps = 25/277 (9%)
Query: 265 SELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILI------EQEFHEDRFKEFLREVAIM 316
           +E+  +K+IG+G FG V+        S VA+K LI      E E  E +F+EF REV IM
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE-KFQEFQREVFIM 77
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
             L HPNIV L G +  PP +  V E++  G LY  L   D    +   ++L +  D+A 
Sbjct: 78  SNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIAL 133
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDST-----YTVKVCDFGLSRSKPNTYISSKTAAGTP 431
           G+ Y+  + PPIVHRDL+SPN+ + S         KV DFGLS+   +   S     G  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNF 190
Query: 432 EWMAPEVL--REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV--ISAVGFKGRRLE 487
           +WMAPE +   E+   EK+D +SF +IL+ ++T + P+   +  ++  I+ +  +G R  
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
           IP++  P +  +IE CW+ +P+ RP F  I++ L + 
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 137/268 (51%), Gaps = 11/268 (4%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           SEL   ++IG G FG V+   W N D VA+K + E    E+   +F+ E  +M  L HP 
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 63
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L G   E   + +V E++  G L   L     R +      L M  DV +GM YL +
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLRED 442
               ++HRDL + N LV     +KV DFG++R   +   +S T    P +W +PEV    
Sbjct: 122 --ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 443 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             + KSDV+SFGV++WE+ +  K P+ N + S+V+  +   G RL  P+  +  V  ++ 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMN 238
Query: 502 TCWAEEPEIRPSFPSIMETLQQFLMSSV 529
            CW E PE RP+F  ++  L     S +
Sbjct: 239 HCWKERPEDRPAFSRLLRQLAAIAASGL 266

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 138/268 (51%), Gaps = 11/268 (4%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           SEL   ++IG G FG V+   W N D VA+K + E    E+   +F+ E  +M  L HP 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 61
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L G   E   + +V E++  G L   L     R +      L M  DV +GM YL +
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLRED 442
               ++HRDL + N LV     +KV DFG++R   +   +S T    P +W +PEV    
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 443 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             + KSDV+SFGV++WE+ +  K P+ N + S+V+  +   G RL  P+  +  V  ++ 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMN 236
Query: 502 TCWAEEPEIRPSFPSIMETLQQFLMSSV 529
            CW E PE RP+F  ++  L +   S +
Sbjct: 237 HCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 138/268 (51%), Gaps = 11/268 (4%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           SEL   ++IG G FG V+   W N D VA+K + E    E+   +F+ E  +M  L HP 
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 63
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L G   E   + +V E++  G L   L     R +      L M  DV +GM YL +
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLRED 442
               ++HRDL + N LV     +KV DFG++R   +   +S T    P +W +PEV    
Sbjct: 122 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 443 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             + KSDV+SFGV++WE+ +  K P+ N + S+V+  +   G RL  P+  +  V  ++ 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMN 238
Query: 502 TCWAEEPEIRPSFPSIMETLQQFLMSSV 529
            CW E PE RP+F  ++  L +   S +
Sbjct: 239 HCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 138/268 (51%), Gaps = 11/268 (4%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           SEL   ++IG G FG V+   W N D VA+K + E    E+   +F+ E  +M  L HP 
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 66
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L G   E   + +V E++  G L   L     R +      L M  DV +GM YL +
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE 124
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLRED 442
               ++HRDL + N LV     +KV DFG++R   +   +S T    P +W +PEV    
Sbjct: 125 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 182
Query: 443 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             + KSDV+SFGV++WE+ +  K P+ N + S+V+  +   G RL  P+  +  V  ++ 
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMN 241
Query: 502 TCWAEEPEIRPSFPSIMETLQQFLMSSV 529
            CW E PE RP+F  ++  L +   S +
Sbjct: 242 HCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 98/277 (35%), Positives = 151/277 (54%), Gaps = 25/277 (9%)
Query: 265 SELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILI------EQEFHEDRFKEFLREVAIM 316
           +E+  +K+IG+G FG V+        S VA+K LI      E E  E +F+EF REV IM
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE-KFQEFQREVFIM 77
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
             L HPNIV L G +  PP +  V E++  G LY  L   D    +   ++L +  D+A 
Sbjct: 78  SNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIAL 133
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDST-----YTVKVCDFGLSRSKPNTYISSKTAAGTP 431
           G+ Y+  + PPIVHRDL+SPN+ + S         KV DFG S+   +   S     G  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLLGNF 190
Query: 432 EWMAPEVL--REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV--ISAVGFKGRRLE 487
           +WMAPE +   E+   EK+D +SF +IL+ ++T + P+   +  ++  I+ +  +G R  
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
           IP++  P +  +IE CW+ +P+ RP F  I++ L + 
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  148 bits (374), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 98/277 (35%), Positives = 151/277 (54%), Gaps = 25/277 (9%)
Query: 265 SELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILI------EQEFHEDRFKEFLREVAIM 316
           +E+  +K+IG+G FG V+        S VA+K LI      E E  E +F+EF REV IM
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE-KFQEFQREVFIM 77
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
             L HPNIV L G +  PP +  V E++  G LY  L   D    +   ++L +  D+A 
Sbjct: 78  SNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIAL 133
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDST-----YTVKVCDFGLSRSKPNTYISSKTAAGTP 431
           G+ Y+  + PPIVHRDL+SPN+ + S         KV DF LS+   +   S     G  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH---SVSGLLGNF 190
Query: 432 EWMAPEVL--REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV--ISAVGFKGRRLE 487
           +WMAPE +   E+   EK+D +SF +IL+ ++T + P+   +  ++  I+ +  +G R  
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
           IP++  P +  +IE CW+ +P+ RP F  I++ L + 
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 94/268 (35%), Positives = 141/268 (52%), Gaps = 13/268 (4%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           G  +   EL + + IG+G FG V   ++R + VAVK +     ++   + FL E ++M  
Sbjct: 15  GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQ 70
Query: 319 LRHPNIVLLMGA-VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
           LRH N+V L+G  V E   L IVTEY+++GSL   L     R V+     L  + DV + 
Sbjct: 71  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEA 129
Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           M YL       VHRDL + N+LV      KV DFGL++   +T  + K      +W APE
Sbjct: 130 MEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPE 184
Query: 438 VLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            LRE   + KSDV+SFG++LWE+ +  + P+       V+  V  KG +++ P    P V
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 243
Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQF 524
             +++ CW  +  +RPSF  + E L+  
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 103/313 (32%), Positives = 167/313 (53%), Gaps = 43/313 (13%)
Query: 240 EANLSVMST-------SNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVA 292
           E NLS++S        S   ++L+E   +I + +L I + IG+G FG VYH  W + +VA
Sbjct: 3   EMNLSLLSARSFPRKASQTSIFLQE--WDIPFEQLEIGELIGKGRFGQVYHGRW-HGEVA 59
Query: 293 VKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKL 352
           ++++  +  +ED+ K F REV   +  RH N+VL MGA   PP+L+I+T      +LY +
Sbjct: 60  IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 353 LHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 412
             + DA++V+D      +A ++ KGM YLH +   I+H+DLKS N+  D+   V + DFG
Sbjct: 120 --VRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYDNGKVV-ITDFG 174
Query: 413 LSRSKPNTYISSKTAAGTPE--------W---MAPEVLR-------ED--PSNEKSDVFS 452
           L        IS    AG  E        W   +APE++R       ED  P ++ SDVF+
Sbjct: 175 LFS------ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 453 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK-NVNPMVAALIETCWAEEPEIR 511
            G I +EL   + P++      +I  +G  G +  + +  +   ++ ++  CWA E E R
Sbjct: 229 LGTIWYELHAREWPFKTQPAEAIIWQMG-TGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
Query: 512 PSFPSIMETLQQF 524
           P+F  +M+ L++ 
Sbjct: 288 PTFTKLMDMLEKL 300

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 139/267 (52%), Gaps = 11/267 (4%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           G  +   EL + + IG+G FG V   ++R + VAVK +     ++   + FL E ++M  
Sbjct: 6   GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQ 61
Query: 319 LRHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
           LRH N+V L+G + E    L IVTEY+++GSL   L     R V+     L  + DV + 
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEA 120
Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           M YL       VHRDL + N+LV      KV DFGL++   +T  + K      +W APE
Sbjct: 121 MEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPE 175
Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
            LRE   + KSDV+SFG++LWE+ +  +      P + +     KG +++ P    P V 
Sbjct: 176 ALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 235
Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQF 524
            +++ CW  +  +RPSF  + E L+  
Sbjct: 236 EVMKNCWHLDAAMRPSFLQLREQLEHI 262

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 91/264 (34%), Positives = 142/264 (53%), Gaps = 11/264 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI   +L   K++G G FG V + +WR   DVA+K++ E    ED   EF+ E  +M  L
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 61
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H  +V L G  T+   + I+TEY++ G L  L ++ + R     +  L M  DV + M 
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEV 438
           YL  ++   +HRDL + N LV+    VKV DFGLSR    + Y SS+ +     W  PEV
Sbjct: 120 YLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEV 177
Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           L     + KSD+++FGV++WE+ +L K P+   T S+    +  +G RL  P   +  V 
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVY 236
Query: 498 ALIETCWAEEPEIRPSFPSIMETL 521
            ++ +CW E+ + RP+F  ++  +
Sbjct: 237 TIMYSCWHEKADERPTFKILLSNI 260

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  146 bits (369), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/260 (34%), Positives = 137/260 (52%), Gaps = 11/260 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           EL + + IG+G FG V   ++R + VAVK +     ++   + FL E ++M  LRH N+V
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLV 62
Query: 326 LLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            L+G + E    L IVTEY+++GSL   L     R V+     L  + DV + M YL   
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
               VHRDL + N+LV      KV DFGL++   +T  + K      +W APE LRE   
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKF 176
Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           + KSDV+SFG++LWE+ +  +      P + +     KG +++ P    P V  +++ CW
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 236
Query: 505 AEEPEIRPSFPSIMETLQQF 524
             +  +RPSF  + E L+  
Sbjct: 237 HLDAAMRPSFLQLREQLEHI 256

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 88/259 (33%), Positives = 139/259 (53%), Gaps = 11/259 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           +L   K++G G FG V + +WR   DVA+K++ E    ED   EF+ E  +M  L H  +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKL 61
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V L G  T+   + I+TEY++ G L  L ++ + R     +  L M  DV + M YL  +
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDP 443
           +   +HRDL + N LV+    VKV DFGLSR   +   +S   +  P  W  PEVL    
Sbjct: 120 Q--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 444 SNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 502
            + KSD+++FGV++WE+ +L K P+   T S+    +  +G RL  P   +  V  ++ +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYS 236
Query: 503 CWAEEPEIRPSFPSIMETL 521
           CW E+ + RP+F  ++  +
Sbjct: 237 CWHEKADERPTFKILLSNI 255

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 141/264 (53%), Gaps = 11/264 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI   +L   K++G G FG V + +WR   DVA+K++ E    ED   EF+ E  +M  L
Sbjct: 5   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 61
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H  +V L G  T+   + I+TEY++ G L  L ++ + R     +  L M  DV + M 
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 438
           YL  ++   +HRDL + N LV+    VKV DFGLSR   +   +S   +  P  W  PEV
Sbjct: 120 YLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 177
Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           L     + KSD+++FGV++WE+ +L K P+   T S+    +  +G RL  P   +  V 
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVY 236
Query: 498 ALIETCWAEEPEIRPSFPSIMETL 521
            ++ +CW E+ + RP+F  ++  +
Sbjct: 237 TIMYSCWHEKADERPTFKILLSNI 260

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 141/264 (53%), Gaps = 11/264 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI   +L   K++G G FG V + +WR   DVA+K++ E    ED   EF+ E  +M  L
Sbjct: 4   EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 60
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H  +V L G  T+   + I+TEY++ G L  L ++ + R     +  L M  DV + M 
Sbjct: 61  SHEKLVQLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAME 118
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 438
           YL  ++   +HRDL + N LV+    VKV DFGLSR   +   +S   +  P  W  PEV
Sbjct: 119 YLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 176
Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           L     + KSD+++FGV++WE+ +L K P+   T S+    +  +G RL  P   +  V 
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVY 235
Query: 498 ALIETCWAEEPEIRPSFPSIMETL 521
            ++ +CW E+ + RP+F  ++  +
Sbjct: 236 TIMYSCWHEKADERPTFKILLSNI 259

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 141/264 (53%), Gaps = 11/264 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI   +L   K++G G FG V + +WR   DVA+K++ E    ED   EF+ E  +M  L
Sbjct: 11  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 67
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H  +V L G  T+   + I+TEY++ G L  L ++ + R     +  L M  DV + M 
Sbjct: 68  SHEKLVQLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAME 125
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 438
           YL  ++   +HRDL + N LV+    VKV DFGLSR   +   +S   +  P  W  PEV
Sbjct: 126 YLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 183
Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           L     + KSD+++FGV++WE+ +L K P+   T S+    +  +G RL  P   +  V 
Sbjct: 184 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVY 242
Query: 498 ALIETCWAEEPEIRPSFPSIMETL 521
            ++ +CW E+ + RP+F  ++  +
Sbjct: 243 TIMYSCWHEKADERPTFKILLSNI 266

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 138/267 (51%), Gaps = 11/267 (4%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           G  +   EL + + IG+G FG V   ++R + VAVK +     ++   + FL E ++M  
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQ 242
Query: 319 LRHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
           LRH N+V L+G + E    L IVTEY+++GSL   L     R V+     L  + DV + 
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEA 301
Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           M YL       VHRDL + N+LV      KV DFGL++   +T  + K      +W APE
Sbjct: 302 MEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPE 356
Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
            LRE   + KSDV+SFG++LWE+ +  +      P + +     KG +++ P    P V 
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 416
Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQF 524
            +++ CW  +   RP+F  + E L+  
Sbjct: 417 DVMKNCWHLDAATRPTFLQLREQLEHI 443

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 141/264 (53%), Gaps = 11/264 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI   +L   K++G G FG V + +WR   DVA+K++ E    ED   EF+ E  +M  L
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 76
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H  +V L G  T+   + I+TEY++ G L  L ++ + R     +  L M  DV + M 
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 438
           YL  ++   +HRDL + N LV+    VKV DFGLSR   +   +S   +  P  W  PEV
Sbjct: 135 YLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           L     + KSD+++FGV++WE+ +L K P+   T S+    +  +G RL  P   +  V 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVY 251
Query: 498 ALIETCWAEEPEIRPSFPSIMETL 521
            ++ +CW E+ + RP+F  ++  +
Sbjct: 252 TIMYSCWHEKADERPTFKILLSNI 275

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 99/262 (37%), Positives = 138/262 (52%), Gaps = 11/262 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           +L++ ++IG G+FG V+    R  N+ VAVK   E     D   +FL+E  I+K   HPN
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPN 173
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV L+G  T+   + IV E +  G     L    AR+ V  +  L M  D A GM YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLES 231
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-TYISSKTAAGTP-EWMAPEVLRE 441
           +    +HRDL + N LV     +K+ DFG+SR + +  Y +S      P +W APE L  
Sbjct: 232 K--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 442 DPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
              + +SDV+SFG++LWE  +L   P+ N +  Q    V  KG RL  P+     V  L+
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDAVFRLM 348
Query: 501 ETCWAEEPEIRPSFPSIMETLQ 522
           E CWA EP  RPSF +I + LQ
Sbjct: 349 EQCWAYEPGQRPSFSTIYQELQ 370

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  144 bits (364), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 90/264 (34%), Positives = 141/264 (53%), Gaps = 11/264 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI   +L   K++G G FG V + +WR   DVA+K++ E    ED   EF+ E  +M  L
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNL 76
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H  +V L G  T+   + I+TEY++ G L  L ++ + R     +  L M  DV + M 
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 438
           YL  ++   +HRDL + N LV+    VKV DFGLSR   +   +S   +  P  W  PEV
Sbjct: 135 YLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEV 192
Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           L     + KSD+++FGV++WE+ +L K P+   T S+    +  +G RL  P   +  V 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVY 251
Query: 498 ALIETCWAEEPEIRPSFPSIMETL 521
            ++ +CW E+ + RP+F  ++  +
Sbjct: 252 TIMYSCWHEKADERPTFKILLSNI 275

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 150/278 (53%), Gaps = 11/278 (3%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 15  EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 71
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 72  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 129
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R  + N Y + + A    +W 
Sbjct: 130 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 187
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 188 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 246
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             +  L+  CW E PE RP+F  +   L+ F  ++  Q
Sbjct: 247 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 284

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 93/278 (33%), Positives = 150/278 (53%), Gaps = 11/278 (3%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 13  EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 69
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 70  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 127
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R   +   +++  A  P +W 
Sbjct: 128 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 185
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 186 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 244
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             +  L+  CW E PE RP+F  +   L+ F  ++  Q
Sbjct: 245 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 282

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 100/317 (31%), Positives = 172/317 (54%), Gaps = 17/317 (5%)
Query: 223 SAFSTLKPYV-----TNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGS 277
           S FSTL+  V      N+ L  + ++  MS+  ++ + E++  EI    L ++KK+G G 
Sbjct: 142 STFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPW-EKDAWEIPRESLKLEKKLGAGQ 200
Query: 278 FGTVYHAEW-RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 336
           FG V+ A + +++ VAVK +          + FL E  +MK L+H  +V L   VT+ P 
Sbjct: 201 FGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTKEP- 256
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           + I+TE++++GSL   L   +       +L ++ +  +A+GM ++ QR    +HRDL++ 
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFIEQRN--YIHRDLRAA 313
Query: 397 NLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 455
           N+LV ++   K+ DFGL+R  + N Y + + A    +W APE +       KSDV+SFG+
Sbjct: 314 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 373
Query: 456 ILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           +L E++T  + P+   +  +VI A+  +G R+  P+N    +  ++  CW   PE RP+F
Sbjct: 374 LLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTF 432
Query: 515 PSIMETLQQFLMSSVCQ 531
             I   L  F  ++  Q
Sbjct: 433 EYIQSVLDDFYTATESQ 449

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 93/278 (33%), Positives = 150/278 (53%), Gaps = 11/278 (3%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 14  EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 70
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 71  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 128
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R   +   +++  A  P +W 
Sbjct: 129 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 186
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 187 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 245
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             +  L+  CW E PE RP+F  +   L+ F  ++  Q
Sbjct: 246 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 283

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/278 (33%), Positives = 150/278 (53%), Gaps = 11/278 (3%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 11  EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 67
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 68  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 125
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R   +   +++  A  P +W 
Sbjct: 126 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 183
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 184 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 242
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             +  L+  CW E PE RP+F  +   L+ F  ++  Q
Sbjct: 243 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 280

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/278 (33%), Positives = 150/278 (53%), Gaps = 11/278 (3%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 61
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 119
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R   +   +++  A  P +W 
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 177
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 236
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             +  L+  CW E PE RP+F  +   L+ F  ++  Q
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 149/275 (54%), Gaps = 11/275 (4%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 11  EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 67
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 68  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 125
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R  + N Y + + A    +W 
Sbjct: 126 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 183
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 184 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 242
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             +  L+  CW E PE RP+F  +   L+ F  ++
Sbjct: 243 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 277

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 149/275 (54%), Gaps = 11/275 (4%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 61
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 119
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R  + N Y + + A    +W 
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 236
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             +  L+  CW E PE RP+F  +   L+ F  ++
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 149/275 (54%), Gaps = 11/275 (4%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 10  EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 66
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 67  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 124
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R  + N Y + + A    +W 
Sbjct: 125 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 182
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 183 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 241
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             +  L+  CW E PE RP+F  +   L+ F  ++
Sbjct: 242 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 276

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 92/275 (33%), Positives = 149/275 (54%), Gaps = 11/275 (4%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 6   EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 62
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 63  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 120
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R   +   +++  A  P +W 
Sbjct: 121 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 178
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 179 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 237
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             +  L+  CW E PE RP+F  +   L+ F  ++
Sbjct: 238 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 272

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 92/275 (33%), Positives = 149/275 (54%), Gaps = 11/275 (4%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 7   EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 63
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 64  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 121
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R   +   +++  A  P +W 
Sbjct: 122 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 179
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 180 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 238
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             +  L+  CW E PE RP+F  +   L+ F  ++
Sbjct: 239 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 273

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 92/275 (33%), Positives = 149/275 (54%), Gaps = 11/275 (4%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 61
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 119
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R   +   +++  A  P +W 
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 177
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 236
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             +  L+  CW E PE RP+F  +   L+ F  ++
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 91/264 (34%), Positives = 144/264 (54%), Gaps = 11/264 (4%)
Query: 267 LLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +MK L+H  +V
Sbjct: 10  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV 66
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A+GM ++ +R 
Sbjct: 67  RLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMAFIEERN 124
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLREDPS 444
              +HRDL++ N+LV  T + K+ DFGL+R  + N Y + + A    +W APE +     
Sbjct: 125 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 182
Query: 445 NEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
             KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N    +  L+  C
Sbjct: 183 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLC 241
Query: 504 WAEEPEIRPSFPSIMETLQQFLMS 527
           W E PE RP+F  +   L+ F  +
Sbjct: 242 WKERPEDRPTFDYLRSVLEDFFTA 265

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/280 (34%), Positives = 139/280 (49%), Gaps = 26/280 (9%)
Query: 266 ELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGL 319
           +L + +K+G+GSFG V   EW     +   VAVK L      + +   +F+REV  M  L
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H N++ L G V  PP + +VTE    GSL   L       ++    R   A  VA+GM 
Sbjct: 73  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 129
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAP 436
           YL  +R   +HRDL + NLL+ +   VK+ DFGL R+ P     Y+  +       W AP
Sbjct: 130 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 437 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           E L+    +  SD + FGV LWE+ T  Q+PW     SQ++  +  +G RL  P++    
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 496 VAALIETCWAEEPEIRPSF-----------PSIMETLQQF 524
           +  ++  CWA +PE RP+F           P+ M  LQ F
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQDF 287

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 98/262 (37%), Positives = 137/262 (52%), Gaps = 11/262 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           +L++ ++IG G+FG V+    R  N+ VAVK   E     D   +FL+E  I+K   HPN
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPN 173
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV L+G  T+   + IV E +  G     L    AR+ V  +  L M  D A GM YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLES 231
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-TYISSKTAAGTP-EWMAPEVLRE 441
           +    +HRDL + N LV     +K+ DFG+SR + +    +S      P +W APE L  
Sbjct: 232 K--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNY 289
Query: 442 DPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
              + +SDV+SFG++LWE  +L   P+ N +  Q    V  KG RL  P+     V  L+
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDAVFRLM 348
Query: 501 ETCWAEEPEIRPSFPSIMETLQ 522
           E CWA EP  RPSF +I + LQ
Sbjct: 349 EQCWAYEPGQRPSFSTIYQELQ 370

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/283 (33%), Positives = 145/283 (51%), Gaps = 28/283 (9%)
Query: 264 WSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           W+++  +  IGEG+FG V  A  +      D A+K + E    +D  ++F  E+ ++  L
Sbjct: 24  WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKL 82
Query: 320 -RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV---------------VD 363
             HPNI+ L+GA      L +  EY   G+L   L    +RV+               + 
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLS 140
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
            +  L+ A DVA+GM+YL Q++   +HRDL + N+LV   Y  K+ DFGLSR +   Y+ 
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVK 197
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFK 482
                    WMA E L        SDV+S+GV+LWE+++L   P+   T +++   +  +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 256
Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           G RLE P N +  V  L+  CW E+P  RPSF  I+ +L + L
Sbjct: 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 137/266 (51%), Gaps = 15/266 (5%)
Query: 266 ELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGL 319
           +L + +K+G+GSFG V   EW     +   VAVK L      + +   +F+REV  M  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H N++ L G V  PP + +VTE    GSL   L       ++    R   A  VA+GM 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMG 125
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAP 436
           YL  +R   +HRDL + NLL+ +   VK+ DFGL R+ P     Y+  +       W AP
Sbjct: 126 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 437 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           E L+    +  SD + FGV LWE+ T  Q+PW     SQ++  +  +G RL  P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 496 VAALIETCWAEEPEIRPSFPSIMETL 521
           +  ++  CWA +PE RP+F ++ + L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 137/266 (51%), Gaps = 15/266 (5%)
Query: 266 ELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGL 319
           +L + +K+G+GSFG V   EW     +   VAVK L      + +   +F+REV  M  L
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 72
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H N++ L G V  PP + +VTE    GSL   L       ++    R   A  VA+GM 
Sbjct: 73  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMG 129
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAP 436
           YL  +R   +HRDL + NLL+ +   VK+ DFGL R+ P     Y+  +       W AP
Sbjct: 130 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 437 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           E L+    +  SD + FGV LWE+ T  Q+PW     SQ++  +  +G RL  P++    
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 496 VAALIETCWAEEPEIRPSFPSIMETL 521
           +  ++  CWA +PE RP+F ++ + L
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 137/266 (51%), Gaps = 15/266 (5%)
Query: 266 ELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGL 319
           +L + +K+G+GSFG V   EW     +   VAVK L      + +   +F+REV  M  L
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H N++ L G V  PP + +VTE    GSL   L       ++    R   A  VA+GM 
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAP 436
           YL  +R   +HRDL + NLL+ +   VK+ DFGL R+ P     Y+  +       W AP
Sbjct: 136 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 437 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           E L+    +  SD + FGV LWE+ T  Q+PW     SQ++  +  +G RL  P++    
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 496 VAALIETCWAEEPEIRPSFPSIMETL 521
           +  ++  CWA +PE RP+F ++ + L
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  142 bits (358), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/283 (33%), Positives = 145/283 (51%), Gaps = 28/283 (9%)
Query: 264 WSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           W+++  +  IGEG+FG V  A  +      D A+K + E    +D  ++F  E+ ++  L
Sbjct: 14  WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKL 72
Query: 320 -RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV---------------VD 363
             HPNI+ L+GA      L +  EY   G+L   L    +RV+               + 
Sbjct: 73  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLS 130
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
            +  L+ A DVA+GM+YL Q++   +HRDL + N+LV   Y  K+ DFGLSR +   Y+ 
Sbjct: 131 SQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVK 187
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFK 482
                    WMA E L        SDV+S+GV+LWE+++L   P+   T +++   +  +
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 246
Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           G RLE P N +  V  L+  CW E+P  RPSF  I+ +L + L
Sbjct: 247 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 289

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  142 bits (357), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 137/266 (51%), Gaps = 15/266 (5%)
Query: 266 ELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGL 319
           +L + +K+G+GSFG V   EW     +   VAVK L      + +   +F+REV  M  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H N++ L G V  PP + +VTE    GSL   L       ++    R   A  VA+GM 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMG 125
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAP 436
           YL  +R   +HRDL + NLL+ +   VK+ DFGL R+ P     Y+  +       W AP
Sbjct: 126 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 437 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           E L+    +  SD + FGV LWE+ T  Q+PW     SQ++  +  +G RL  P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 496 VAALIETCWAEEPEIRPSFPSIMETL 521
           +  ++  CWA +PE RP+F ++ + L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  142 bits (357), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 90/265 (33%), Positives = 145/265 (54%), Gaps = 11/265 (4%)
Query: 267 LLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +MK L+H  +V
Sbjct: 11  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLV 67
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A+GM ++ +R 
Sbjct: 68  RLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMAFIEERN 125
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLREDPS 444
              +HR+L++ N+LV  T + K+ DFGL+R  + N Y + + A    +W APE +     
Sbjct: 126 --YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 183
Query: 445 NEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
             KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N    +  L+  C
Sbjct: 184 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLC 242
Query: 504 WAEEPEIRPSFPSIMETLQQFLMSS 528
           W E PE RP+F  +   L+ F  ++
Sbjct: 243 WKERPEDRPTFDYLRSVLEDFFTAT 267

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 149/278 (53%), Gaps = 11/278 (3%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           E+  E+    L + +++G G  G V+   +  ++ VAVK L +     D    FL E  +
Sbjct: 5   EDAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANL 61
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L+H  +V L   VT+ P + I+TEY+  GSL   L  P    +   +L L+MA  +A
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIA 119
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWM 434
           +GM ++ +R    +HRDL++ N+LV  T + K+ DFGL+R   +   +++  A  P +W 
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWT 177
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N  
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 236
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             +  L+  CW E PE RP+F  +   L+ F  ++  Q
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 97/268 (36%), Positives = 144/268 (53%), Gaps = 15/268 (5%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI    L + K++G G FG V+   W  N+ VA+K L       +    FL E  IMK L
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE---SFLEEAQIMKKL 61
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           +H  +V L   V+E P + IVTEY+++GSL   L   + R +    L ++MA  VA GM 
Sbjct: 62  KHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNL-VDMAAQVAAGMA 119
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 438
           Y+   R   +HRDL+S N+LV +    K+ DFGL+R   +   +++  A  P +W APE 
Sbjct: 120 YIE--RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEA 177
Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
                   KSDV+SFG++L EL+T  + P+      +V+  V  +G R+  P++    + 
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLH 236
Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFL 525
            L+  CW ++PE RP+F    E LQ FL
Sbjct: 237 ELMIHCWKKDPEERPTF----EYLQSFL 260

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 145/277 (52%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 257 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 313
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  
Sbjct: 314 QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQ 371
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 372 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 488
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW +EPE RP+F  +   L+ +  S+
Sbjct: 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 145/283 (51%), Gaps = 28/283 (9%)
Query: 264 WSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           W+++  +  IGEG+FG V  A  +      D A+K + E    +D  ++F  E+ ++  L
Sbjct: 21  WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKL 79
Query: 320 -RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV---------------VD 363
             HPNI+ L+GA      L +  EY   G+L   L    +RV+               + 
Sbjct: 80  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLS 137
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
            +  L+ A DVA+GM+YL Q++   +HR+L + N+LV   Y  K+ DFGLSR +   Y+ 
Sbjct: 138 SQQLLHFAADVARGMDYLSQKQ--FIHRNLAARNILVGENYVAKIADFGLSRGQ-EVYVK 194
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFK 482
                    WMA E L        SDV+S+GV+LWE+++L   P+   T +++   +  +
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 253
Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           G RLE P N +  V  L+  CW E+P  RPSF  I+ +L + L
Sbjct: 254 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 296

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 145/277 (52%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 230
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  
Sbjct: 231 QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQ 288
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 289 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 405
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW +EPE RP+F  +   L+ +  S+
Sbjct: 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 98/275 (35%), Positives = 137/275 (49%), Gaps = 13/275 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR---NSDVAVKI-LIEQEFHEDRFKEFLREVAIM 316
           EI  S + I+K IG G  G V +   R     DV V I  ++  + E + ++FL E +IM
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
               HPNI+ L G VT      IVTEY+  GSL   L   D +  + +   + M   V  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGVGA 162
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP---EW 433
           GM YL       VHRDL + N+LVDS    KV DFGLSR   +   ++ T  G      W
Sbjct: 163 GMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRW 220
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
            APE +     +  SDV+SFGV++WE++   ++P+ N T   VIS+V  +G RL  P   
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGC 279
Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
              +  L+  CW ++   RP F  I+  L   + S
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 145/277 (52%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 230
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  
Sbjct: 231 QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQ 288
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 289 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 405
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW +EPE RP+F  +   L+ +  S+
Sbjct: 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 144/266 (54%), Gaps = 17/266 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           + IG+G FG VYH E+ +        A+K L  +     + + FLRE  +M+GL HPN++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 326 LLMGAVTEPPNL-SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            L+G +  P  L  ++  Y+  G L + +  P     V + +   +   VA+GM YL ++
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYLAEQ 143
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTP-EWMAPEVLR 440
           +   VHRDL + N ++D ++TVKV DFGL+R    +    +     A  P +W A E L+
Sbjct: 144 K--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 441 EDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
                 KSDV+SFGV+LWEL+T    P+R+  P  +   +  +GRRL  P+     +  +
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSLYQV 260
Query: 500 IETCWAEEPEIRPSFPSIMETLQQFL 525
           ++ CW  +P +RP+F  ++  ++Q +
Sbjct: 261 MQQCWEADPAVRPTFRVLVGEVEQIV 286

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 158/294 (53%), Gaps = 22/294 (7%)
Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQ 299
           S S  ++Y+ +E  E+   ++ + +++G+GSFG VY    +        + VA+K + E 
Sbjct: 2   SFSAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 300 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----H 354
               +R  EFL E ++MK     ++V L+G V++     ++ E ++RG L   L      
Sbjct: 61  ASMRERI-EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE 119
Query: 355 IPDARVVVDERLR--LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 412
           + +  V+    L   + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG
Sbjct: 120 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 413 LSRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN 469
           ++R    T    K   G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++ 
Sbjct: 178 MTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 237
Query: 470 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
            +  QV+  V  +G  L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 238 LSNEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 101/283 (35%), Positives = 143/283 (50%), Gaps = 27/283 (9%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRN----SD---VAVKILIEQEFHEDRFKEFLREVA 314
           I+  ++++K ++GEG+FG V+ AE  N     D   VAVK L  +E  E   ++F RE  
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAE 95
Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDER------- 365
           ++  L+H +IV   G  TE   L +V EY+  G L + L  H PDA+++           
Sbjct: 96  LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 366 ---LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-Y 421
                L +A  VA GM YL       VHRDL + N LV     VK+ DFG+SR   +T Y
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 422 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAV 479
                    P  WM PE +       +SDV+SFGV+LWE+ T  K PW   + ++ I  +
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273
Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             +GR LE P+   P V A++  CW  EP+ R S   +   LQ
Sbjct: 274 -TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 98/275 (35%), Positives = 137/275 (49%), Gaps = 13/275 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR---NSDVAVKI-LIEQEFHEDRFKEFLREVAIM 316
           EI  S + I+K IG G  G V +   R     DV V I  ++  + E + ++FL E +IM
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
               HPNI+ L G VT      IVTEY+  GSL   L   D +  + +   + M   V  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGVGA 162
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP---EW 433
           GM YL       VHRDL + N+LVDS    KV DFGLSR   +   ++ T  G      W
Sbjct: 163 GMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
            APE +     +  SDV+SFGV++WE++   ++P+ N T   VIS+V  +G RL  P   
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGC 279
Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
              +  L+  CW ++   RP F  I+  L   + S
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 100/283 (35%), Positives = 142/283 (50%), Gaps = 27/283 (9%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVA 314
           I+  ++++K ++GEG+FG V+ AE  N         VAVK L  +E  E   ++F RE  
Sbjct: 15  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAE 72
Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDER------- 365
           ++  L+H +IV   G  TE   L +V EY+  G L + L  H PDA+++           
Sbjct: 73  LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 132
Query: 366 ---LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-Y 421
                L +A  VA GM YL       VHRDL + N LV     VK+ DFG+SR   +T Y
Sbjct: 133 GLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 190
Query: 422 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAV 479
                    P  WM PE +       +SDV+SFGV+LWE+ T  K PW   + ++ I  +
Sbjct: 191 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 250
Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             +GR LE P+   P V A++  CW  EP+ R S   +   LQ
Sbjct: 251 T-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 292

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 138/266 (51%), Gaps = 15/266 (5%)
Query: 266 ELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGL 319
           +L + +K+G+GSFG V   EW     +   VAVK L      + +   +F+REV  M  L
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H N++ L G V  PP + +VTE    GSL   L       ++    R   A  VA+GM 
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTP-EWMAP 436
           YL  +R   +HRDL + NLL+ +   VK+ DFGL R+ P  + +   +     P  W AP
Sbjct: 136 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 437 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           E L+    +  SD + FGV LWE+ T  Q+PW     SQ++  +  +G RL  P++    
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 496 VAALIETCWAEEPEIRPSFPSIMETL 521
           +  ++  CWA +PE RP+F ++ + L
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 100/283 (35%), Positives = 142/283 (50%), Gaps = 27/283 (9%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVA 314
           I+  ++++K ++GEG+FG V+ AE  N         VAVK L  +E  E   ++F RE  
Sbjct: 9   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAE 66
Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDER------- 365
           ++  L+H +IV   G  TE   L +V EY+  G L + L  H PDA+++           
Sbjct: 67  LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 126
Query: 366 ---LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-Y 421
                L +A  VA GM YL       VHRDL + N LV     VK+ DFG+SR   +T Y
Sbjct: 127 GLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 184
Query: 422 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAV 479
                    P  WM PE +       +SDV+SFGV+LWE+ T  K PW   + ++ I  +
Sbjct: 185 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 244
Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             +GR LE P+   P V A++  CW  EP+ R S   +   LQ
Sbjct: 245 T-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 286

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 138/266 (51%), Gaps = 15/266 (5%)
Query: 266 ELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGL 319
           +L + +K+G+GSFG V   EW     +   VAVK L      + +   +F+REV  M  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H N++ L G V  PP + +VTE    GSL   L       ++    R   A  VA+GM 
Sbjct: 69  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMG 125
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTP-EWMAP 436
           YL  +R   +HRDL + NLL+ +   VK+ DFGL R+ P  + +   +     P  W AP
Sbjct: 126 YLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 437 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           E L+    +  SD + FGV LWE+ T  Q+PW     SQ++  +  +G RL  P++    
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 496 VAALIETCWAEEPEIRPSFPSIMETL 521
           +  ++  CWA +PE RP+F ++ + L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 158/294 (53%), Gaps = 22/294 (7%)
Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQ 299
           S S  ++Y+ +E  E+   ++ + +++G+GSFG VY    +        + VA+K + E 
Sbjct: 2   SFSAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 300 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----H 354
               +R  EFL E ++MK     ++V L+G V++     ++ E ++RG L   L      
Sbjct: 61  ASMRERI-EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE 119
Query: 355 IPDARVVVDERLR--LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 412
           + +  V+    L   + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG
Sbjct: 120 MENNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 413 LSRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN 469
           ++R    T    K   G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++ 
Sbjct: 178 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 237
Query: 470 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
            +  QV+  V  +G  L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 238 LSNEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 90/287 (31%), Positives = 147/287 (51%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG+FG V  AE    D         VAVK+L +    ED   + + E+ +M
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEED-LSDLVSEMEMM 94
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 155 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 150/280 (53%), Gaps = 21/280 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    +        + VA+K + E     +R  EFL E 
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 64
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPDARVVVDERLR- 367
           ++MK     ++V L+G V++     ++ E ++RG L   L      + +  V+    L  
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 124
Query: 368 -LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 125 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  +  QV+  V  +G
Sbjct: 183 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 241
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 242 GLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 281

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  139 bits (349), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 145/277 (52%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 1   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 57
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  
Sbjct: 58  QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQ 115
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 116 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 173
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 174 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 232
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW +EPE RP+F  +   L+ +  S+
Sbjct: 233 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 269

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  139 bits (349), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 150/285 (52%), Gaps = 21/285 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    R+       + VAVK + E     +R  EFL E 
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 71
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERL 366
           ++MKG    ++V L+G V++     +V E ++ G L   L    P+A     R     + 
Sbjct: 72  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+ ++   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 132 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WMAPE L++      SD++SFGV+LWE+ +L ++P++  +  QV+  V   G
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 248
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+ P N    V  L+  CW   P++RP+F  I+  L+  L  S
Sbjct: 249 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 150/285 (52%), Gaps = 21/285 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    R+       + VAVK + E     +R  EFL E 
Sbjct: 10  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 68
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERL 366
           ++MKG    ++V L+G V++     +V E ++ G L   L    P+A     R     + 
Sbjct: 69  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 128
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+ ++   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 129 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 186
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WMAPE L++      SD++SFGV+LWE+ +L ++P++  +  QV+  V   G
Sbjct: 187 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 245
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+ P N    V  L+  CW   P++RP+F  I+  L+  L  S
Sbjct: 246 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 290

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 151/279 (54%), Gaps = 10/279 (3%)
Query: 256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVA 314
           +++  EI    + + K++G G FG V+   + NS  VAVK L          + FL E  
Sbjct: 4   DKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEAN 60
Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           +MK L+H  +V L   VT    + I+TEY+++GSL   L   +   V+  +L ++ +  +
Sbjct: 61  LMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQI 119
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEW 433
           A+GM Y+   R   +HRDL++ N+LV  +   K+ DFGL+R  + N Y + + A    +W
Sbjct: 120 AEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 177
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNV 492
            APE +       KSDV+SFG++L+E++T  K P+   T + V++A+  +G R+   +N 
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALS-QGYRMPRVENC 236
Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
              +  +++ CW E+ E RP+F  +   L  F  ++  Q
Sbjct: 237 PDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQ 275

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 150/285 (52%), Gaps = 21/285 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    R+       + VAVK + E     +R  EFL E 
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 71
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERL 366
           ++MKG    ++V L+G V++     +V E ++ G L   L    P+A     R     + 
Sbjct: 72  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+ ++   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 132 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKG 189
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WMAPE L++      SD++SFGV+LWE+ +L ++P++  +  QV+  V   G
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 248
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+ P N    V  L+  CW   P++RP+F  I+  L+  L  S
Sbjct: 249 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 157/292 (53%), Gaps = 22/292 (7%)
Query: 249 SNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEF 301
           S  ++Y+ +E  E+   ++ + +++G+GSFG VY    +        + VA+K + E   
Sbjct: 10  SAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 302 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-----IP 356
             +R  EFL E ++MK     ++V L+G V++     ++ E ++RG L   L      + 
Sbjct: 69  MRERI-EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127
Query: 357 DARVVVDERLR--LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 414
           +  V+    L   + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG++
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 415 RSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNST 471
           R    T    K   G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  +
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             QV+  V  +G  L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 246 NEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 143/270 (52%), Gaps = 15/270 (5%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH 321
           I + +L    K+ E   G ++   W+ +D+ VK+L  +++   + ++F  E   ++   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 322 PNIVLLMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           PN++ ++GA   PP  + +++T ++  GSLY +LH      VVD+   +  A D+A+GM 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMA 125
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           +LH   P I    L S ++++D   T ++   D   S   P    +       P W+APE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA-------PAWVAPE 178
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
            L+   ED +   +D++SF V+LWEL+T + P+ + +  ++   V  +G R  IP  ++P
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQF 524
            V+ L++ C  E+P  RP F  I+  L++ 
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 150/285 (52%), Gaps = 21/285 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    R+       + VAVK + E     +R  EFL E 
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 70
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERL 366
           ++MKG    ++V L+G V++     +V E ++ G L   L    P+A     R     + 
Sbjct: 71  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+ ++   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 131 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WMAPE L++      SD++SFGV+LWE+ +L ++P++  +  QV+  V   G
Sbjct: 189 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 247
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+ P N    V  L+  CW   P++RP+F  I+  L+  L  S
Sbjct: 248 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 292

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 147/287 (51%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG+FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 94
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 155 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 99/317 (31%), Positives = 168/317 (52%), Gaps = 27/317 (8%)
Query: 223 SAFSTLKPYV-----TNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGS 277
           S FSTL+  V      N+ L  + ++  MS+  ++ + E++  EI    L ++KK+G G 
Sbjct: 136 STFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPW-EKDAWEIPRESLKLEKKLGAGQ 194
Query: 278 FGTVYHAEW-RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 336
           FG V+ A + +++ VAVK +          + FL E  +MK L+H  +V L   VT+ P 
Sbjct: 195 FGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTKEP- 250
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           + I+TE++++GSL   L   +       +L ++ +  +A+GM ++ QR    +HRDL++ 
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFIEQRN--YIHRDLRAA 307
Query: 397 NLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGV 455
           N+LV ++   K+ DFGL+R            A  P +W APE +       KSDV+SFG+
Sbjct: 308 NILVSASLVCKIADFGLAR----------VGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 357
Query: 456 ILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           +L E++T  + P+   +  +VI A+  +G R+  P+N    +  ++  CW   PE RP+F
Sbjct: 358 LLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTF 416
Query: 515 PSIMETLQQFLMSSVCQ 531
             I   L  F  ++  Q
Sbjct: 417 EYIQSVLDDFYTATESQ 433

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  138 bits (348), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 149/285 (52%), Gaps = 21/285 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    R+       + VAVK + E     +R  EFL E 
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 71
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERL 366
           ++MKG    ++V L+G V++     +V E ++ G L   L    P+A     R     + 
Sbjct: 72  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+ ++   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 132 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WMAPE L++      SD++SFGV+LWE+ +L ++P++  +  QV+  V   G
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 248
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+ P N    V  L+  CW   P +RP+F  I+  L+  L  S
Sbjct: 249 GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 293

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 248 TSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQE 300
            S  ++Y+ +E  E+   ++ + +++G+GSFG VY    +        + VA+K + E  
Sbjct: 2   VSAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 60
Query: 301 FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HI 355
              +R  EFL E ++MK     ++V L+G V++     ++ E ++RG L   L      +
Sbjct: 61  SMRERI-EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 119
Query: 356 PDARVVVDERLR--LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
            +  V+    L   + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG+
Sbjct: 120 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNS 470
           +R    T    K   G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 237
Query: 471 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           +  QV+  V  +G  L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 238 SNEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 248 TSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQE 300
            S  ++Y+ +E  E+   ++ + +++G+GSFG VY    +        + VA+K + E  
Sbjct: 2   VSAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 60
Query: 301 FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HI 355
              +R  EFL E ++MK     ++V L+G V++     ++ E ++RG L   L      +
Sbjct: 61  SMRERI-EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEM 119
Query: 356 PDARVVVDERLR--LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
            +  V+    L   + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG+
Sbjct: 120 ENNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNS 470
           +R    T    K   G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 237
Query: 471 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           +  QV+  V  +G  L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 238 SNEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  138 bits (347), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 99/285 (34%), Positives = 145/285 (50%), Gaps = 28/285 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
            I+  ++++K+++GEG+FG V+ AE  N         VAVK L +        K+F RE 
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREA 68
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR---- 367
            ++  L+H +IV   G   +   L +V EY+  G L K L  H PDA ++VD + R    
Sbjct: 69  ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 368 -------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
                  L++A  +A GM YL  +    VHRDL + N LV +   VK+ DFG+SR   +T
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 421 -YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVIS 477
            Y         P  WM PE +       +SDV+SFGVILWE+ T  K PW   + ++VI 
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246
Query: 478 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
            +  +GR LE P+     V  ++  CW  EP+ R +   I + L 
Sbjct: 247 CIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  138 bits (347), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 150/280 (53%), Gaps = 21/280 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    +        + VA+K + E     +R  EFL E 
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 69
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLR- 367
           ++MK     ++V L+G V++     ++ E ++RG L   L      + +  V+    L  
Sbjct: 70  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 129
Query: 368 -LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 130 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 187
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  +  QV+  V  +G
Sbjct: 188 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 246
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 247 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 286

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  138 bits (347), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 263 RW----SELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEF 309
           RW      L++ K +GEG+FG V  AE          R + VAVK+L + +  E    + 
Sbjct: 22  RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 80
Query: 310 LREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------------- 353
           + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L               
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPS 140
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P+ ++    +  ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFGL
Sbjct: 141 HNPEEQL--SSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGL 196
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 471
           +R   +     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL        
Sbjct: 197 ARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + +
Sbjct: 257 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  138 bits (347), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 150/285 (52%), Gaps = 21/285 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    R+       + VAVK + E     +R  EFL E 
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 71
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERL 366
           ++MKG    ++V L+G V++     +V E ++ G L   L    P+A     R     + 
Sbjct: 72  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+ ++   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 132 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WMAPE L++      SD++SFGV+LWE+ +L ++P++  +  QV+  V   G
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 248
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+ P N    V  L+  CW   P++RP+F  I+  L+  L  S
Sbjct: 249 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 144/277 (51%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 175 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE---AFLQEA 231
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  
Sbjct: 232 QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQ 289
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL R  + N Y + + A    +
Sbjct: 290 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIK 347
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 348 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 406
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 407 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 443

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 144/277 (51%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 230
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IV EY+S+GSL   L     + +   +L ++MA  
Sbjct: 231 QVMKKLRHEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQ 288
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 289 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 405
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW +EPE RP+F  +   L+ +  S+
Sbjct: 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 263 RW----SELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEF 309
           RW      L++ K +GEG+FG V  AE          R + VAVK+L + +  E    + 
Sbjct: 22  RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 80
Query: 310 LREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------------- 353
           + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L               
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPS 140
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P+ ++    +  ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFGL
Sbjct: 141 HNPEEQL--SSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGL 196
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 471
           +R   +     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL        
Sbjct: 197 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + +
Sbjct: 257 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 150/280 (53%), Gaps = 21/280 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    +        + VA+K + E     +R  EFL E 
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 70
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPDARVVVDERLR- 367
           ++MK     ++V L+G V++     ++ E ++RG L   L      + +  V+    L  
Sbjct: 71  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 130
Query: 368 -LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 131 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  +  QV+  V  +G
Sbjct: 189 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 247
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 248 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 287

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 147/287 (51%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG+FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 94
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 155 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 263 RW----SELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEF 309
           RW      L++ K +GEG+FG V  AE          R + VAVK+L + +  E    + 
Sbjct: 7   RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 65
Query: 310 LREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------------- 353
           + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L               
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPS 125
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P+ ++    +  ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFGL
Sbjct: 126 HNPEEQL--SSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 471
           +R   +     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL        
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + +
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 147/287 (51%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG+FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 94
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 155 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 157/292 (53%), Gaps = 22/292 (7%)
Query: 249 SNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEF 301
           S  ++Y+ +E  E+   ++ + +++G+GSFG VY    +        + VA+K + E   
Sbjct: 10  SAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 302 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIP 356
             +R  EFL E ++MK     ++V L+G V++     ++ E ++RG L   L      + 
Sbjct: 69  MRERI-EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 127
Query: 357 DARVVVDERLR--LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 414
           +  V+    L   + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG++
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 415 RSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNST 471
           R    T    K   G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  +
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             QV+  V  +G  L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 246 NEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 92/292 (31%), Positives = 157/292 (53%), Gaps = 22/292 (7%)
Query: 249 SNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEF 301
           S  ++Y+ +E  E+   ++ + +++G+GSFG VY    +        + VA+K + E   
Sbjct: 32  SAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 90
Query: 302 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIP 356
             +R  EFL E ++MK     ++V L+G V++     ++ E ++RG L   L      + 
Sbjct: 91  MRERI-EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 149
Query: 357 DARVVVDERLR--LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 414
           +  V+    L   + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG++
Sbjct: 150 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMT 207
Query: 415 RSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNST 471
           R    T    K   G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  +
Sbjct: 208 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 267
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             QV+  V  +G  L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 268 NEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 318

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 263 RW----SELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEF 309
           RW      L++ K +GEG+FG V  AE          R + VAVK+L + +  E    + 
Sbjct: 15  RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 73
Query: 310 LREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------------- 353
           + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L               
Sbjct: 74  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 133
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P+ ++    +  ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFGL
Sbjct: 134 HNPEEQL--SSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGL 189
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 471
           +R   +     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL        
Sbjct: 190 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 249
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + +
Sbjct: 250 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 303

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 142/271 (52%), Gaps = 11/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E  +MK L
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKL 60
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           RH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  +A GM 
Sbjct: 61  RHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMA 118
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 438
           Y+   R   VHRDL++ N+LV      KV DFGL+R   +   +++  A  P +W APE 
Sbjct: 119 YVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEA 176
Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
                   KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P      + 
Sbjct: 177 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH 235
Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
            L+  CW +EPE RP+F  +   L+ +  S+
Sbjct: 236 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 266

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 150/280 (53%), Gaps = 21/280 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    +        + VA+K + E     +R  EFL E 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 66
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPDARVVVDERLR- 367
           ++MK     ++V L+G V++     ++ E ++RG L   L      + +  V+    L  
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 368 -LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG++R    T    K 
Sbjct: 127 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  +  QV+  V  +G
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 243
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 244 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 263 RW----SELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEF 309
           RW      L++ K +GEG+FG V  AE          R + VAVK+L + +  E    + 
Sbjct: 22  RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 80
Query: 310 LREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------------- 353
           + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L               
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 140
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P+ ++    +  ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFGL
Sbjct: 141 HNPEEQL--SSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGL 196
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 471
           +R   +     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL        
Sbjct: 197 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + +
Sbjct: 257 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 263 RW----SELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEF 309
           RW      L++ K +GEG+FG V  AE          R + VAVK+L + +  E    + 
Sbjct: 14  RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 72
Query: 310 LREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------------- 353
           + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L               
Sbjct: 73  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 132
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P+ ++    +  ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFGL
Sbjct: 133 HNPEEQL--SSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGL 188
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 471
           +R   +     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL        
Sbjct: 189 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 248
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + +
Sbjct: 249 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 302

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 98/288 (34%), Positives = 146/288 (50%), Gaps = 25/288 (8%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN----SD---VAVKILIEQEFHEDRFKEFLREV 313
            I+   +++K+++GEG+FG V+ AE  N     D   VAVK L  ++  ++  K+F RE 
Sbjct: 9   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREA 66
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVD-------- 363
            ++  L+H +IV   G   E   L +V EY+  G L K L  H PDA ++ +        
Sbjct: 67  ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELT 126
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YI 422
           +   L++A  +A GM YL  +    VHRDL + N LV     VK+ DFG+SR   +T Y 
Sbjct: 127 QSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 184
Query: 423 SSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVG 480
                   P  WM PE +       +SDV+S GV+LWE+ T  K PW   + ++VI  + 
Sbjct: 185 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
            +GR L+ P+     V  L+  CW  EP +R +   I   LQ    +S
Sbjct: 245 -QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 263 RW----SELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEF 309
           RW      L++ K +GEG+FG V  AE          R + VAVK+L + +  E    + 
Sbjct: 22  RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 80
Query: 310 LREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------------- 353
           + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L               
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPS 140
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P+ ++    +  ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFGL
Sbjct: 141 HNPEEQL--SSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGL 196
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 471
           +R   +     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL        
Sbjct: 197 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 256
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + +
Sbjct: 257 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/303 (31%), Positives = 154/303 (50%), Gaps = 36/303 (11%)
Query: 263 RW----SELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEF 309
           RW      L++ K +GEG+FG V  AE          R + VAVK+L + +  E    + 
Sbjct: 63  RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 121
Query: 310 LREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------------- 353
           + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L               
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P+ ++    +  ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFGL
Sbjct: 182 HNPEEQL--SSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGL 237
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 471
           +R   +     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL        
Sbjct: 238 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + +  +  Q
Sbjct: 298 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357
Query: 532 PLS 534
            + 
Sbjct: 358 EMG 360

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 147/287 (51%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG+FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 94
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 155 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 263 RW----SELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEF 309
           RW      L++ K +GEG+FG V  AE          R + VAVK+L + +  E    + 
Sbjct: 11  RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDL 69
Query: 310 LREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------------- 353
           + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L               
Sbjct: 70  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 129
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P+ ++    +  ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFGL
Sbjct: 130 HNPEEQL--SSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGL 185
Query: 414 SRSKPNTYISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 471
           +R   +     KT  G    +WMAPE L +     +SDV+SFGV+LWE+ TL        
Sbjct: 186 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 245
Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P + +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + +
Sbjct: 246 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 299

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 148/293 (50%), Gaps = 32/293 (10%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 23  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 81
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 142 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLTARNVLVTENNVMKIADFGLARDINNI 197
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 198 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 257
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L  +  Q
Sbjct: 258 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNQ 310

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 145/277 (52%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 64
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 123 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 239
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 146/287 (50%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 28  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 86
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 147 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 202
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 203 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 262
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 263 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 145/264 (54%), Gaps = 10/264 (3%)
Query: 271 KKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           KK+G G FG V+   + NS  VAVK L          + FL E  +MK L+H  +V L  
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYA 74
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
            VT+   + I+TE++++GSL   L   +   V+  +L ++ +  +A+GM Y+   R   +
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYIE--RKNYI 131
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           HRDL++ N+LV  +   K+ DFGL+R  + N Y + + A    +W APE +       KS
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 449 DVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
           +V+SFG++L+E++T  K P+   T + V+SA+  +G R+   +N    +  +++ CW E+
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALS-QGYRMPRMENCPDELYDIMKMCWKEK 250
Query: 508 PEIRPSFPSIMETLQQFLMSSVCQ 531
            E RP+F  +   L  F  ++  Q
Sbjct: 251 AEERPTFDYLQSVLDDFYTATEGQ 274

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/272 (32%), Positives = 150/272 (55%), Gaps = 11/272 (4%)
Query: 256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEW-RNSDVAVKILIEQEFHEDRFKEFLREVA 314
           E++  EI    L ++KK+G G FG V+ A + +++ VAVK +          + FL E  
Sbjct: 6   EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEAN 62
Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           +MK L+H  +V L   VT+ P + I+TE++++GSL   L   +       +L ++ +  +
Sbjct: 63  VMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQI 120
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEW 433
           A+GM ++ QR    +HRDL++ N+LV ++   K+ DFGL+R  + N Y + + A    +W
Sbjct: 121 AEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 178
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNV 492
            APE +       KSDV+SFG++L E++T  + P+   +  +VI A+  +G R+  P+N 
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENC 237
Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
              +  ++  CW   PE RP+F  I   L  F
Sbjct: 238 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 269

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 146/287 (50%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 140
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 201 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 146/287 (50%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 25  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 83
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 144 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 199
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 200 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 259
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 260 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 145/277 (52%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 5   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 61
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IVTEY+++GSL   L     + +   +L ++M+  
Sbjct: 62  QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQL-VDMSAQ 119
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 120 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 177
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 236
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW +EPE RP+F  +   L+ +  S+
Sbjct: 237 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 273

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 147/287 (51%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG+FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 94
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +++ DFGL+R   N 
Sbjct: 155 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMRIADFGLARDINNI 210
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 148/287 (51%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG+FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 94
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++ EY S+G+L               Y +  +P+ ++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 155 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 421 -YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
            Y  + T    P +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 211 DYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 149/280 (53%), Gaps = 21/280 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    +        + VA+K + E     +R  EFL E 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 66
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPDARVVVDERLR- 367
           ++MK     ++V L+G V++     ++ E ++RG L   L      + +  V+    L  
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 368 -LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+  +   VHRDL + N  V   +TVK+ DFG++R    T    K 
Sbjct: 127 MIQMAGEIADGMAYLNANK--FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WM+PE L++      SDV+SFGV+LWE+ TL ++P++  +  QV+  V  +G
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 243
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             L+ P N   M+  L+  CW   P++RPSF  I+ ++++
Sbjct: 244 GLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  136 bits (342), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 145/277 (52%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 64
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK +RH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  
Sbjct: 65  QVMKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 123 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 239
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  136 bits (342), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 144/277 (51%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 64
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL + N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 123 IASGMAYVE--RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 239
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 138/274 (50%), Gaps = 15/274 (5%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHEDRFKEFLREVAI 315
           EI  S + I++ IG G FG V          R   VA+K L +  + E + ++FL E +I
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTL-KVGYTEKQRRDFLGEASI 76
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M    HPNI+ L G VT+   + IVTEY+  GSL   L   D +  V +   + M   ++
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQ--LVGMLRGIS 134
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPE 432
            GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++       
Sbjct: 135 AGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 192
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE +        SDV+S+G+++WE+++  ++P+   T   VI AV  +G RL  P +
Sbjct: 193 WTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVE-EGYRLPSPMD 251
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
               +  L+  CW +E   RP F  I+  L + +
Sbjct: 252 CPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 144/277 (51%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 64
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IVTEY+S+G L   L     + +   +L ++MA  
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQL-VDMAAQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 123 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 239
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 94/275 (34%), Positives = 144/275 (52%), Gaps = 11/275 (4%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAI 315
           ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E  +
Sbjct: 1   KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQV 57
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK LRH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  +A
Sbjct: 58  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIA 115
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWM 434
            GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +W 
Sbjct: 116 SGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 173
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P    
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 232
Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             +  L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 233 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 267

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 93/285 (32%), Positives = 149/285 (52%), Gaps = 21/285 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    R+       + VAVK + E     +R  EFL E 
Sbjct: 14  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 72
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERL 366
           ++MKG    ++V L+G V++     +V E ++ G L   L    P+A     R     + 
Sbjct: 73  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 132
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+ ++   VHR+L + N +V   +TVK+ DFG++R    T    K 
Sbjct: 133 MIQMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WMAPE L++      SD++SFGV+LWE+ +L ++P++  +  QV+  V   G
Sbjct: 191 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 249
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+ P N    V  L+  CW   P +RP+F  I+  L+  L  S
Sbjct: 250 GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 294

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 142/271 (52%), Gaps = 11/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E  +MK L
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKL 59
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           RH  +V L   V+E P + IVTEY+S+GSL   L     + +   +L ++MA  +A GM 
Sbjct: 60  RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMA 117
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEV 438
           Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +W APE 
Sbjct: 118 YVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 175
Query: 439 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
                   KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P      + 
Sbjct: 176 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH 234
Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
            L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 235 DLMCQCWRKDPEERPTFEYLQAFLEDYFTST 265

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  135 bits (341), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 93/285 (32%), Positives = 149/285 (52%), Gaps = 21/285 (7%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 313
           E+   ++ + +++G+GSFG VY    R+       + VAVK + E     +R  EFL E 
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 71
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERL 366
           ++MKG    ++V L+G V++     +V E ++ G L   L    P+A     R     + 
Sbjct: 72  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 426
            + MA ++A GM YL+ ++   VHR+L + N +V   +TVK+ DFG++R    T    K 
Sbjct: 132 MIQMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 189
Query: 427 AAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             G     WMAPE L++      SD++SFGV+LWE+ +L ++P++  +  QV+  V   G
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 248
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+ P N    V  L+  CW   P +RP+F  I+  L+  L  S
Sbjct: 249 GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 293

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 138/275 (50%), Gaps = 16/275 (5%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVA 314
           EI  S +  +K IG G FG VY    + S       VA+K L +  + E +  +FL E  
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAG 98
Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           IM    H NI+ L G +++   + I+TEY+  G+L K L   D    V +   + M   +
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ--LVGMLRGI 156
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--- 431
           A GM YL       VHRDL + N+LV+S    KV DFGLSR   +   ++ T +G     
Sbjct: 157 AAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 490
            W APE +        SDV+SFG+++WE++T  ++P+   +  +V+ A+   G RL  P 
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPM 273
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +    +  L+  CW +E   RP F  I+  L + +
Sbjct: 274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 145/277 (52%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 5   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 61
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IVTEY+++GSL   L     + +   +L ++M+  
Sbjct: 62  QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQL-VDMSAQ 119
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-E 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R   +   +++  A  P +
Sbjct: 120 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK 177
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 236
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW +EPE RP+F  +   L+ +  S+
Sbjct: 237 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 273

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 144/277 (51%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 64
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IV EY+S+GSL   L     + +   +L ++MA  
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 123 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 239
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 146/287 (50%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG+FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 94
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++  Y S+G+L               Y +  +P+ ++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 155 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 142/276 (51%), Gaps = 17/276 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           EI  S + I++ IG G FG V     +      S VA+K L +  + E + +EFL E +I
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFLSEASI 68
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M    HPNI+ L G VT    + I+TE++  G+L   L + D +  V +   + M   +A
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ--LVGMLRGIA 126
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-----SKPNTYISSKTAAGT 430
            GM YL +     VHRDL + N+LV+S    KV DFGLSR     S   TY SS      
Sbjct: 127 SGMRYLAEM--SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIP 184
Query: 431 PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIP 489
             W APE +        SD +S+G+++WE+++  ++P+ + +   VI+A+  +  RL  P
Sbjct: 185 IRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE-QDYRLPPP 243
Query: 490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            +    +  L+  CW ++   RP FP ++  L + +
Sbjct: 244 PDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 279

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  135 bits (339), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 146/287 (50%), Gaps = 32/287 (11%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREVAIM 316
           +L + K +GEG+FG V  AE    D         VAVK+L +    +D   + + E+ +M
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMM 94
Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSL---------------YKLLHIPDARV 360
           K + +H NI+ L+GA T+   L ++  Y S+G+L               Y +  +P+ ++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
              + +  +  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N 
Sbjct: 155 TFKDLV--SCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 421 YISSKTAAGT--PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
               KT  G    +WMAPE L +     +SDV+SFGV++WE+ TL        P + +  
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L
Sbjct: 271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  135 bits (339), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 94/277 (33%), Positives = 144/277 (51%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 64
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IV EY+S+GSL   L     + +   +L ++MA  
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 123 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 239
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  134 bits (338), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 94/283 (33%), Positives = 145/283 (51%), Gaps = 19/283 (6%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHEDRFKEF 309
           + E   EI  S + I++ IG G FG V          R   VA+K L +  + E + ++F
Sbjct: 23  VREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDF 81
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPN++ L G VT+   + I+TE++  GSL   L   D +  V +   + 
Sbjct: 82  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ--LVG 139
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYIS 423
           M   +A GM YL       VHRDL + N+LV+S    KV DFGLSR      S P TY S
Sbjct: 140 MLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-TYTS 196
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK 482
           +        W APE ++       SDV+S+G+++WE+++  ++P+ + T   VI+A+  +
Sbjct: 197 ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-Q 255
Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
             RL  P +    +  L+  CW ++   RP F  I+ TL + +
Sbjct: 256 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 298

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 144/277 (51%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 64
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IV EY+S+GSL   L     + +   +L ++MA  
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-E 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R   +   +++  A  P +
Sbjct: 123 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK 180
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 239
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 93
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVG 151
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 152 MLRGIASGMKYLSDM--GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 93/304 (30%), Positives = 154/304 (50%), Gaps = 37/304 (12%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFG-----TVYHAEWRN--SDVAVKILIEQEFHEDRFK 307
           LE+   E     L++ K +GEG FG     T +H + R   + VAVK+L E        +
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELR 71
Query: 308 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH------------- 354
           + L E  ++K + HP+++ L GA ++   L ++ EY   GSL   L              
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 355 ---------IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 405
                     PD R +    L ++ A+ +++GM YL + +  +VHRDL + N+LV     
Sbjct: 132 GSRNSSSLDHPDERALTMGDL-ISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRK 188
Query: 406 VKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL 463
           +K+ DFGLSR   + ++Y+         +WMA E L +     +SDV+SFGV+LWE++TL
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 464 -QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
              P+    P ++ + +   G R+E P N +  +  L+  CW +EP+ RP F  I + L+
Sbjct: 249 GGNPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307
Query: 523 QFLM 526
           + ++
Sbjct: 308 KMMV 311

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 138/274 (50%), Gaps = 15/274 (5%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHEDRFKEFLREVAI 315
           EI  S + I+K IG G FG V          R   VA+K L +  + + + ++FL E +I
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDFLSEASI 62
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M    HPNI+ L G VT+   + I+TEY+  GSL   L   D R  V +   + M   + 
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIG 120
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPE 432
            GM YL       VHRDL + N+LV+S    KV DFG+SR     P    +++       
Sbjct: 121 SGMKYLSDM--SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 178
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE +        SDV+S+G+++WE+++  ++P+ + +   VI A+  +G RL  P +
Sbjct: 179 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-EGYRLPPPMD 237
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
               +  L+  CW +E   RP F  I+  L + +
Sbjct: 238 CPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 271

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 6   VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 64
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + 
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVG 122
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 123 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 239
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 240 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 33  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 91
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + 
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVG 149
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 150 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 207
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 208 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 266
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 267 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHEDRFKEF 309
           + E   EI  S + I+K IG G FG V          R   VA+K L +  + + + ++F
Sbjct: 19  VREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDF 77
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + I+TEY+  GSL   L   D R  V +   + 
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVG 135
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +  GM YL       VHRDL + N+LV+S    KV DFG+SR     P    +++ 
Sbjct: 136 MLRGIGSGMKYLSDMSA--VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 193
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W APE +        SDV+S+G+++WE+++  ++P+ + +   VI A+  +G R
Sbjct: 194 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-EGYR 252
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW +E   RP F  I+  L + +
Sbjct: 253 LPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 292

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 93
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVG 151
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 152 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 93
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVG 151
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 152 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 93
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVG 151
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 152 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 93
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVG 151
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 152 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHEDRFKEF 309
           + E   EI  S + I+K IG G FG V          R   VA+K L +  + + + ++F
Sbjct: 4   VREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL-KAGYTDKQRRDF 62
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + I+TEY+  GSL   L   D R  V +   + 
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVG 120
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +  GM YL       VHRDL + N+LV+S    KV DFG+SR     P    +++ 
Sbjct: 121 MLRGIGSGMKYLSDM--SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 178
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W APE +        SDV+S+G+++WE+++  ++P+ + +   VI A+  +G R
Sbjct: 179 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-EGYR 237
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW +E   RP F  I+  L + +
Sbjct: 238 LPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 277

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 23  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 81
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + 
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVG 139
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 140 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 197
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 198 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 256
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 257 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 296

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 93/288 (32%), Positives = 144/288 (50%), Gaps = 19/288 (6%)
Query: 244 SVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQE 300
             M +S R+  ++ E +E+        + IGEG FG V+   +    N  +AV I   + 
Sbjct: 24  GAMGSSTRDYEIQRERIEL-------GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN 76
Query: 301 FHEDRFKE-FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR 359
              D  +E FL+E   M+   HP+IV L+G +TE P + I+ E  + G L   L +   +
Sbjct: 77  CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RK 133
Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KP 418
             +D    +  AY ++  + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR  + 
Sbjct: 134 YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 191
Query: 419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVIS 477
           +TY  +       +WMAPE +        SDV+ FGV +WE++    KP++    + VI 
Sbjct: 192 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 251
Query: 478 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            +   G RL +P N  P + +L+  CWA +P  RP F  +   L   L
Sbjct: 252 RIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 298

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 93/288 (32%), Positives = 144/288 (50%), Gaps = 19/288 (6%)
Query: 244 SVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQE 300
             M +S R+  ++ E +E+        + IGEG FG V+   +    N  +AV I   + 
Sbjct: 1   GAMGSSTRDYEIQRERIEL-------GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN 53
Query: 301 FHEDRFKE-FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR 359
              D  +E FL+E   M+   HP+IV L+G +TE P + I+ E  + G L   L +   +
Sbjct: 54  CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RK 110
Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KP 418
             +D    +  AY ++  + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR  + 
Sbjct: 111 YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168
Query: 419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVIS 477
           +TY  +       +WMAPE +        SDV+ FGV +WE++    KP++    + VI 
Sbjct: 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228
Query: 478 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            +   G RL +P N  P + +L+  CWA +P  RP F  +   L   L
Sbjct: 229 RIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 93/277 (33%), Positives = 143/277 (51%), Gaps = 11/277 (3%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREV 313
           L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E 
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEA 64
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +MK LRH  +V L   V+E P + IV EY+S+G L   L     + +   +L ++MA  
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQL-VDMAAQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPE 432
           +A GM Y+   R   VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +
Sbjct: 123 IASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 180
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P  
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 239
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW ++PE RP+F  +   L+ +  S+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 140/280 (50%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 93
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVG 151
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGL+R     P    +++ 
Sbjct: 152 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRG 209
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 139/280 (49%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 93
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVG 151
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGL R     P    +++ 
Sbjct: 152 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 139/271 (51%), Gaps = 12/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKE-FLREVAIM 316
           EI+   + + + IGEG FG V+   +    N  +AV I   +    D  +E FL+E   M
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           +   HP+IV L+G +TE P + I+ E  + G L   L +   +  +D    +  AY ++ 
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLST 502
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMA 435
            + YL  +R   VHRD+ + N+LV +T  VK+ DFGLSR  + +TY  +       +WMA
Sbjct: 503 ALAYLESKR--FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           PE +        SDV+ FGV +WE++    KP++    + VI  +   G RL +P N  P
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 619
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            + +L+  CWA +P  RP F  +   L   L
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 139/271 (51%), Gaps = 12/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKE-FLREVAIM 316
           EI+   + + + IGEG FG V+   +    N  +AV I   +    D  +E FL+E   M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           +   HP+IV L+G +TE P + I+ E  + G L   L +   +  +D    +  AY ++ 
Sbjct: 66  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLST 122
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMA 435
            + YL  +R   VHRD+ + N+LV +T  VK+ DFGLSR  + +TY  +       +WMA
Sbjct: 123 ALAYLESKR--FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           PE +        SDV+ FGV +WE++    KP++    + VI  +   G RL +P N  P
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 239
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            + +L+  CWA +P  RP F  +   L   L
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 90/276 (32%), Positives = 141/276 (51%), Gaps = 17/276 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           EI  S + I++ IG G FG V     +      S VA+K L +  + E + +EFL E +I
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFLSEASI 70
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M    HPNI+ L G VT    + I+TE++  G+L   L + D +  V +   + M   +A
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQ--LVGMLRGIA 128
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-----SKPNTYISSKTAAGT 430
            GM YL +     VHRDL + N+LV+S    KV DFGLSR     S   T  SS      
Sbjct: 129 SGMRYLAEM--SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP 186
Query: 431 PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIP 489
             W APE +        SD +S+G+++WE+++  ++P+ + +   VI+A+  +  RL  P
Sbjct: 187 IRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE-QDYRLPPP 245
Query: 490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            +    +  L+  CW ++   RP FP ++  L + +
Sbjct: 246 PDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 281

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 145/295 (49%), Gaps = 28/295 (9%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH 321
            R S+L+  + +G+G FG       R +   + +     F E+  + FL+EV +M+ L H
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           PN++  +G + +   L+ +TEY+  G+L  ++   D++    +  R++ A D+A GM YL
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQ--RVSFAKDIASGMAYL 124
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSK--------TA 427
           H     I+HRDL S N LV     V V DFGL+R      ++P    S K        T 
Sbjct: 125 HSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGR 484
            G P WMAPE++     +EK DVFSFG++L E+I       +  P  +   ++  GF  R
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSI---METLQQFLMSSVCQPLSAQ 536
               P N  P    +   C   +PE RPSF  +   +ETL+  L   +  PL  Q
Sbjct: 243 --YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL--PLGPQ 293

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 142/277 (51%), Gaps = 19/277 (6%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHEDRFKEFLREVAI 315
           EI  S + I++ IG G FG V          R   VA+K L +  + E + ++FL E +I
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASI 61
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M    HPN++ L G VT+   + I+TE++  GSL   L   D +  V +   + M   +A
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ--LVGMLRGIA 119
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSKTAAG 429
            GM YL       VHR L + N+LV+S    KV DFGLSR      S P TY S+     
Sbjct: 120 AGMKYLADMN--YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-TYTSALGGKI 176
Query: 430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEI 488
              W APE ++       SDV+S+G+++WE+++  ++P+ + T   VI+A+  +  RL  
Sbjct: 177 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPP 235
Query: 489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P +    +  L+  CW ++   RP F  I+ TL + +
Sbjct: 236 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKE-FLREVAIM 316
           EI+   + + + IGEG FG V+   +    N  +AV I   +    D  +E FL+E   M
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           +   HP+IV L+G +TE P + I+ E  + G L   L +   +  +D    +  AY ++ 
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLST 502
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMA 435
            + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR  + +TY  +       +WMA
Sbjct: 503 ALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           PE +        SDV+ FGV +WE++    KP++    + VI  +   G RL +P N  P
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 619
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            + +L+  CWA +P  RP F  +   L   L
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKE-FLREVAIM 316
           EI+   + + + IGEG FG V+   +    N  +AV I   +    D  +E FL+E   M
Sbjct: 9   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           +   HP+IV L+G +TE P + I+ E  + G L   L +   +  +D    +  AY ++ 
Sbjct: 69  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLST 125
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMA 435
            + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR  + +TY  +       +WMA
Sbjct: 126 ALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 183
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           PE +        SDV+ FGV +WE++    KP++    + VI  +   G RL +P N  P
Sbjct: 184 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 242
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            + +L+  CWA +P  RP F  +   L   L
Sbjct: 243 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 273

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score =  132 bits (331), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 137/269 (50%), Gaps = 15/269 (5%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH 321
           I + +L    K+ E   G ++   W+ +D+ VK+L  +++   + ++F  E   ++   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 322 PNIVLLMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           PN++ ++GA   PP  + +++T +   GSLY +LH      VVD+   +  A D A+G  
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLH-EGTNFVVDQSQAVKFALDXARGXA 125
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           +LH   P I    L S ++ +D   T ++   D   S   P    +       P W+APE
Sbjct: 126 FLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYA-------PAWVAPE 178
Query: 438 VLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
            L+   ED +   +D +SF V+LWEL+T + P+ + +  ++   V  +G R  IP  ++P
Sbjct: 179 ALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPGISP 238
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQ 523
            V+ L + C  E+P  RP F  I+  L++
Sbjct: 239 HVSKLXKICXNEDPAKRPKFDXIVPILEK 267

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKE-FLREVAIM 316
           EI+   + + + IGEG FG V+   +    N  +AV I   +    D  +E FL+E   M
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           +   HP+IV L+G +TE P + I+ E  + G L   L +   +  +D    +  AY ++ 
Sbjct: 63  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLST 119
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMA 435
            + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR  + +TY  +       +WMA
Sbjct: 120 ALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           PE +        SDV+ FGV +WE++    KP++    + VI  +   G RL +P N  P
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 236
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            + +L+  CWA +P  RP F  +   L   L
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKE-FLREVAIM 316
           EI+   + + + IGEG FG V+   +    N  +AV I   +    D  +E FL+E   M
Sbjct: 8   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           +   HP+IV L+G +TE P + I+ E  + G L   L +   +  +D    +  AY ++ 
Sbjct: 68  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLST 124
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMA 435
            + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR  + +TY  +       +WMA
Sbjct: 125 ALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 182
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           PE +        SDV+ FGV +WE++    KP++    + VI  +   G RL +P N  P
Sbjct: 183 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 241
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            + +L+  CWA +P  RP F  +   L   L
Sbjct: 242 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 272

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKE-FLREVAIM 316
           EI+   + + + IGEG FG V+   +    N  +AV I   +    D  +E FL+E   M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           +   HP+IV L+G +TE P + I+ E  + G L   L +   +  +D    +  AY ++ 
Sbjct: 66  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLST 122
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMA 435
            + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR  + +TY  +       +WMA
Sbjct: 123 ALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           PE +        SDV+ FGV +WE++    KP++    + VI  +   G RL +P N  P
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 239
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            + +L+  CWA +P  RP F  +   L   L
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 137/271 (50%), Gaps = 12/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKE-FLREVAIM 316
           EI+   + + + IGEG FG V+   +    N  +AV I   +    D  +E FL+E   M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           +   HP+IV L+G +TE P + I+ E  + G L   L +   +  +D    +  AY ++ 
Sbjct: 66  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLST 122
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMA 435
            + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR   ++     +    P +WMA
Sbjct: 123 ALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMA 180
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           PE +        SDV+ FGV +WE++    KP++    + VI  +   G RL +P N  P
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 239
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            + +L+  CWA +P  RP F  +   L   L
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 138/271 (50%), Gaps = 12/271 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKE-FLREVAIM 316
           EI+   + + + IGEG FG V+   +    N  +AV I   +    D  +E FL+E   M
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           +   HP+IV L+G +TE P + I+ E  + G L   L +   +  +D    +  AY ++ 
Sbjct: 66  RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLST 122
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMA 435
            + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR  + +TY  +       +WMA
Sbjct: 123 ALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           PE +        SDV+ FGV +WE++    KP++    + VI  +   G RL +P N  P
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 239
Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            + +L+  CWA +P  RP F  +   L   L
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 92/304 (30%), Positives = 153/304 (50%), Gaps = 37/304 (12%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFG-----TVYHAEWRN--SDVAVKILIEQEFHEDRFK 307
           LE+   E     L++ K +GEG FG     T +H + R   + VAVK+L E        +
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELR 71
Query: 308 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH------------- 354
           + L E  ++K + HP+++ L GA ++   L ++ EY   GSL   L              
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 355 ---------IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 405
                     PD R +    L ++ A+ +++GM YL + +  +VHRDL + N+LV     
Sbjct: 132 GSRNSSSLDHPDERALTMGDL-ISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRK 188
Query: 406 VKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL 463
           +K+ DFGLSR   + ++ +         +WMA E L +     +SDV+SFGV+LWE++TL
Sbjct: 189 MKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 464 -QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
              P+    P ++ + +   G R+E P N +  +  L+  CW +EP+ RP F  I + L+
Sbjct: 249 GGNPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307
Query: 523 QFLM 526
           + ++
Sbjct: 308 KMMV 311

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 139/280 (49%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 93
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTE +  GSL   L   DA+  V +   + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVG 151
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 152 MLRGIASGMKYLSDMGA--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 139/280 (49%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 6   VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 64
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTE +  GSL   L   DA+  V +   + 
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVG 122
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 123 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 239
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 240 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/280 (31%), Positives = 139/280 (49%), Gaps = 15/280 (5%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEF 309
           + E   E+  + + I K +G G FG V     +        VA+K L +  + E + ++F
Sbjct: 35  VHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDF 93
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E +IM    HPNI+ L G VT+   + IVTE +  GSL   L   DA+  V +   + 
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVG 151
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 426
           M   +A GM YL       VHRDL + N+L++S    KV DFGLSR     P    +++ 
Sbjct: 152 MLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
                 W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G R
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P +    +  L+  CW ++   RP F  I+  L + +
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 88/273 (32%), Positives = 138/273 (50%), Gaps = 13/273 (4%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR---NSDVAVKI-LIEQEFHEDRFKEFLREVAIM 316
           E+  S + I++ IG G FG V     +     DVAV I  ++  + E + ++FL E +IM
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIM 98
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
               HPN+V L G VT    + IV E++  G+L   L   D +  V +   + M   +A 
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQ--LVGMLRGIAA 156
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEW 433
           GM YL       VHRDL + N+LV+S    KV DFGLSR     P    ++        W
Sbjct: 157 GMRYLADM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRW 214
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
            APE ++       SDV+S+G+++WE+++  ++P+ + +   VI A+  +G RL  P + 
Sbjct: 215 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-EGYRLPAPMDC 273
Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
              +  L+  CW +E   RP F  I+  L + +
Sbjct: 274 PAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 147/293 (50%), Gaps = 27/293 (9%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 8   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 66
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 67  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 126
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 127 HNPTVKDLIGFGLQ------VAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 178
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 179 ARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETL 521
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +
Sbjct: 239 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRI 290

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 92/304 (30%), Positives = 152/304 (50%), Gaps = 37/304 (12%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFG-----TVYHAEWRN--SDVAVKILIEQEFHEDRFK 307
           LE+   E     L++ K +GEG FG     T +H + R   + VAVK+L E        +
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELR 71
Query: 308 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH------------- 354
           + L E  ++K + HP+++ L GA ++   L ++ EY   GSL   L              
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 355 ---------IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 405
                     PD R +    L ++ A+ +++GM YL +    +VHRDL + N+LV     
Sbjct: 132 GSRNSSSLDHPDERALTMGDL-ISFAWQISQGMQYLAEM--SLVHRDLAARNILVAEGRK 188
Query: 406 VKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL 463
           +K+ DFGLSR   + ++ +         +WMA E L +     +SDV+SFGV+LWE++TL
Sbjct: 189 MKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 464 -QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
              P+    P ++ + +   G R+E P N +  +  L+  CW +EP+ RP F  I + L+
Sbjct: 249 GGNPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307
Query: 523 QFLM 526
           + ++
Sbjct: 308 KMMV 311

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 147/293 (50%), Gaps = 27/293 (9%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 27  LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 85
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 86  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 145
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 146 HNPTVKDLIGFGLQ------VAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 197
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 198 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETL 521
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +
Sbjct: 258 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRI 309

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 134/264 (50%), Gaps = 14/264 (5%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 315
           ++ +EL   K +G G+FGTVY   W          VA+KIL E    +    EF+ E  I
Sbjct: 12  LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV-EFMDEALI 70
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M  + HP++V L+G V   P + +VT+ +  G L + +H  + +  +  +L LN    +A
Sbjct: 71  MASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVH--EHKDNIGSQLLLNWCVQIA 127
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EW 433
           KGM YL +RR  +VHRDL + N+LV S   VK+ DFGL+R             G    +W
Sbjct: 128 KGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           MA E +       +SDV+S+GV +WEL+T      +  P++ I  +  KG RL  P    
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICT 245
Query: 494 PMVAALIETCWAEEPEIRPSFPSI 517
             V  ++  CW  + + RP F  +
Sbjct: 246 IDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 147/293 (50%), Gaps = 27/293 (9%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 28  LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 86
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 87  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 146
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 147 HNPTVKDLIGFGLQ------VAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 198
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 199 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 258
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETL 521
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +
Sbjct: 259 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRI 310

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  129 bits (325), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 147/293 (50%), Gaps = 27/293 (9%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 9   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 67
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 68  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 127
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 128 HNPTVKDLIGFGLQ------VAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 180 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETL 521
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +
Sbjct: 240 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRI 291

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 99/301 (32%), Positives = 149/301 (49%), Gaps = 27/301 (8%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 4   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 62
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 63  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 122
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 123 HNPTVKDLIGFGLQ------VAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 174
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +     + 
Sbjct: 235 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRISAIFSTF 293
Query: 529 V 529
           +
Sbjct: 294 I 294

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 99/303 (32%), Positives = 150/303 (49%), Gaps = 27/303 (8%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 7   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 65
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 66  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 125
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 126 HNPTVKDLIGFGLQ------VAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 177
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 178 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +     + 
Sbjct: 238 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRISAIFSTF 296
Query: 529 VCQ 531
           + +
Sbjct: 297 IGE 299

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 147/293 (50%), Gaps = 27/293 (9%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 6   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 64
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 65  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 125 HNPTVKDLIGFGLQ------VAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 176
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 177 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETL 521
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +
Sbjct: 237 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRI 288

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 147/293 (50%), Gaps = 27/293 (9%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 1   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 59
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 60  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 119
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 120 HNPTVKDLIGFGLQ------VAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 171
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 172 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 231
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETL 521
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +
Sbjct: 232 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRI 283

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 147/293 (50%), Gaps = 27/293 (9%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 8   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 66
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 67  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 126
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 127 HNPTVKDLIGFGLQ------VAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 178
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 179 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETL 521
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +
Sbjct: 239 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRI 290

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 147/293 (50%), Gaps = 27/293 (9%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 9   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 67
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 68  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 127
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 128 HNPTVKDLIGFGLQ------VAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 180 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETL 521
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +
Sbjct: 240 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRI 291

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 134/264 (50%), Gaps = 14/264 (5%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 315
           ++ +EL   K +G G+FGTVY   W          VA+KIL E    +    EF+ E  I
Sbjct: 35  LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV-EFMDEALI 93
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M  + HP++V L+G V   P + +VT+ +  G L + +H  + +  +  +L LN    +A
Sbjct: 94  MASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVH--EHKDNIGSQLLLNWCVQIA 150
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EW 433
           KGM YL +RR  +VHRDL + N+LV S   VK+ DFGL+R             G    +W
Sbjct: 151 KGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 208
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           MA E +       +SDV+S+GV +WEL+T      +  P++ I  +  KG RL  P    
Sbjct: 209 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICT 268
Query: 494 PMVAALIETCWAEEPEIRPSFPSI 517
             V  ++  CW  + + RP F  +
Sbjct: 269 IDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  128 bits (321), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 150/303 (49%), Gaps = 27/303 (8%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 68  LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 126
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 127 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 186
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM +L  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 187 HNPTVKDLIGFGLQ------VAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 238
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +     + 
Sbjct: 299 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRISAIFSTF 357
Query: 529 VCQ 531
           + +
Sbjct: 358 IGE 360

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  128 bits (321), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 150/303 (49%), Gaps = 27/303 (8%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 14  LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 72
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 73  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 132
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM +L  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 133 HNPTVKDLIGFGLQ------VAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 184
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 185 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +     + 
Sbjct: 245 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRISAIFSTF 303
Query: 529 VCQ 531
           + +
Sbjct: 304 IGE 306

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 150/303 (49%), Gaps = 27/303 (8%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 10  LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 68
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 69  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 128
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM +L  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 129 HNPTVKDLIGFGLQ------VAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 180
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 181 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +     + 
Sbjct: 241 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRISAIFSTF 299
Query: 529 VCQ 531
           + +
Sbjct: 300 IGE 302

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 98/301 (32%), Positives = 149/301 (49%), Gaps = 27/301 (8%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 7   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 65
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 66  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 125
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM +L  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 126 HNPTVKDLIGFGLQ------VAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 177
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 178 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +     + 
Sbjct: 238 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRISAIFSTF 296
Query: 529 V 529
           +
Sbjct: 297 I 297

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 150/303 (49%), Gaps = 27/303 (8%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 9   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 67
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 68  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 127
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM +L  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 128 HNPTVKDLIGFGLQ------VAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 180 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +     + 
Sbjct: 240 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRISAIFSTF 298
Query: 529 VCQ 531
           + +
Sbjct: 299 IGE 301

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 150/303 (49%), Gaps = 27/303 (8%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 9   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 67
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 68  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 127
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM +L  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 128 HNPTVKDLIGFGLQ------VAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 180 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +     + 
Sbjct: 240 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRISAIFSTF 298
Query: 529 VCQ 531
           + +
Sbjct: 299 IGE 301

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 98/303 (32%), Positives = 150/303 (49%), Gaps = 27/303 (8%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 10  LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 68
Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT-EYLSRGSLYKLL---- 353
           +        +FL E  IMK   HPN++ L+G         +V   Y+  G L   +    
Sbjct: 69  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 128
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
           H P  + ++   L+      VAKGM +L  ++   VHRDL + N ++D  +TVKV DFGL
Sbjct: 129 HNPTVKDLIGFGLQ------VAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGL 180
Query: 414 SRS---KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           +R    K    + +KT A  P +WMA E L+      KSDV+SFGV+LWEL+T   P   
Sbjct: 181 ARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              +  I+    +GRRL  P+   +P+   +++ CW  + E+RPSF  ++  +     + 
Sbjct: 241 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-CWHPKAEMRPSFSELVSRISAIFSTF 299
Query: 529 VCQ 531
           + +
Sbjct: 300 IGE 302

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 157/286 (54%), Gaps = 31/286 (10%)
Query: 250 NRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR----NSDVAVKILIEQEFHEDR 305
           +++L+L+ + L      L+   ++G G+FG+V    +R      DVA+K+L +Q   +  
Sbjct: 1   DKKLFLKRDNL------LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKAD 53
Query: 306 FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPDARV 360
            +E +RE  IM  L +P IV L+G V +   L +V E    G L+K L      IP + V
Sbjct: 54  TEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV 112
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KP 418
                    + + V+ GM YL ++    VHRDL + N+L+ + +  K+ DFGLS++    
Sbjct: 113 A-------ELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163
Query: 419 NTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVI 476
           ++Y ++++A   P +W APE +     + +SDV+S+GV +WE ++  QKP++     +V+
Sbjct: 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 223
Query: 477 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           + +  +G+R+E P    P + AL+  CW  + E RP F ++ + ++
Sbjct: 224 AFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/196 (37%), Positives = 114/196 (58%), Gaps = 9/196 (4%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKIL--IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           K+GEG FG VY     N+ VAVK L  +     E+  ++F +E+ +M   +H N+V L+G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
             ++  +L +V  Y+  GSL   L   D    +   +R  +A   A G+N+LH+     +
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--I 155
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           HRD+KS N+L+D  +T K+ DFGL+R+      T + S+   GT  +MAPE LR + +  
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRI-VGTTAYMAPEALRGEIT-P 213
Query: 447 KSDVFSFGVILWELIT 462
           KSD++SFGV+L E+IT
Sbjct: 214 KSDIYSFGVVLLEIIT 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 73/195 (37%), Positives = 112/195 (57%), Gaps = 7/195 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKIL--IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           K+GEG FG VY     N+ VAVK L  +     E+  ++F +E+ +M   +H N+V L+G
Sbjct: 32  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
             ++  +L +V  Y+  GSL   L   D    +   +R  +A   A G+N+LH+     +
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--I 149
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           HRD+KS N+L+D  +T K+ DFGL+R+  K    +      GT  +MAPE LR + +  K
Sbjct: 150 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEIT-PK 208
Query: 448 SDVFSFGVILWELIT 462
           SD++SFGV+L E+IT
Sbjct: 209 SDIYSFGVVLLEIIT 223

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 73/195 (37%), Positives = 112/195 (57%), Gaps = 7/195 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKIL--IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           K+GEG FG VY     N+ VAVK L  +     E+  ++F +E+ +M   +H N+V L+G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
             ++  +L +V  Y+  GSL   L   D    +   +R  +A   A G+N+LH+     +
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--I 155
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           HRD+KS N+L+D  +T K+ DFGL+R+  K    +      GT  +MAPE LR + +  K
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEIT-PK 214
Query: 448 SDVFSFGVILWELIT 462
           SD++SFGV+L E+IT
Sbjct: 215 SDIYSFGVVLLEIIT 229

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 156/282 (55%), Gaps = 26/282 (9%)
Query: 255 LEEEGLEIRWSELLIKK-KIGEGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEF 309
           L+++ L ++   LLI   ++G G+FG+V    +R      DVA+K+L +Q   +   +E 
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEM 383
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPDARVVVDE 364
           +RE  IM  L +P IV L+G V +   L +V E    G L+K L      IP + V    
Sbjct: 384 MREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA--- 439
Query: 365 RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYI 422
                + + V+ GM YL ++    VHR+L + N+L+ + +  K+ DFGLS++    ++Y 
Sbjct: 440 ----ELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493
Query: 423 SSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG 480
           ++++A   P +W APE +     + +SDV+S+GV +WE ++  QKP++     +V++ + 
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
            +G+R+E P    P + AL+  CW  + E RP F ++ + ++
Sbjct: 554 -QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 93/285 (32%), Positives = 137/285 (48%), Gaps = 35/285 (12%)
Query: 271 KKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           + IGEG+FG V+ A           + VAVK+L ++E   D   +F RE A+M    +PN
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPN 111
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV-------VDERLR--------- 367
           IV L+G       + ++ EY++ G L + L       V       +  R R         
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 368 -----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNT 420
                L +A  VA GM YL +R+   VHRDL + N LV     VK+ DFGLSR+    + 
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAV 479
           Y +    A    WM PE +  +    +SDV+++GV+LWE+ +   +P+      +VI  V
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289
Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
              G  L  P+N    +  L+  CW++ P  RPSF SI   LQ+ 
Sbjct: 290 R-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 140/290 (48%), Gaps = 28/290 (9%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 78
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVV---------VDERLRL 368
             H N+V L+GA T+P   L ++TE+   G+L   L       V           + L L
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 369 N----MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYI 422
                 ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+
Sbjct: 139 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGF 481
               A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 140/290 (48%), Gaps = 28/290 (9%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 78
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVV---------VDERLRL 368
             H N+V L+GA T+P   L ++TE+   G+L   L       V           + L L
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 369 N----MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYI 422
                 ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+
Sbjct: 139 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGF 481
               A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 90/285 (31%), Positives = 141/285 (49%), Gaps = 26/285 (9%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMSELKILIHI 87
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLH------IPDARVVVD----ERLR 367
             H N+V L+GA T+P   L ++ E+   G+L   L       +P   +  D    E L 
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL- 146
Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSK 425
           +  ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+   
Sbjct: 147 ICYSFQVAKGMEFLASRK--XIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 204
Query: 426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGR 484
            A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       +G 
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 264
Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           R+  P    P +   +  CW  EP  RP+F  ++E L   L ++ 
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 91/291 (31%), Positives = 141/291 (48%), Gaps = 30/291 (10%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 31  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 89
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLH------IPDARVVVD-------- 363
             H N+V L+GA T+P   L ++ E+   G+L   L       +P      D        
Sbjct: 90  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTL 149
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTY 421
           E L +  ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y
Sbjct: 150 EHL-ICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG 480
           +    A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +      
Sbjct: 207 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 266
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
            +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 267 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 317

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 149/315 (47%), Gaps = 46/315 (14%)
Query: 247 STSNRELYLE--EEGLEIRWS----ELLIKKKIGEGSFGTVYHAEWR-------NSDVAV 293
           S+ N   Y++  E   +++W      L   K +G G+FG V +A          +  VAV
Sbjct: 21  SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 80
Query: 294 KILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKL 352
           K+L E+    +R +  + E+ +M  L  H NIV L+GA T    + ++ EY   G L   
Sbjct: 81  KMLKEKADSSER-EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 139
Query: 353 LHIPDARVVVDE-------RLR-------------LNMAYDVAKGMNYLHQRRPPIVHRD 392
           L     +   DE       RL              L  AY VAKGM +L  +    VHRD
Sbjct: 140 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRD 197
Query: 393 LKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           L + N+LV     VK+CDFGL+R     + Y+    A    +WMAPE L E     KSDV
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 257
Query: 451 FSFGVILWELITLQKPWRNSTPSQVISAVGFK----GRRLEIPKNVNPMVAALIETCWAE 506
           +S+G++LWE+ +L     N  P   + A  +K    G +++ P      +  ++++CWA 
Sbjct: 258 WSYGILLWEIFSLG---VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 314
Query: 507 EPEIRPSFPSIMETL 521
           +   RPSFP++   L
Sbjct: 315 DSRKRPSFPNLTSFL 329

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  122 bits (306), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 90/290 (31%), Positives = 139/290 (47%), Gaps = 28/290 (9%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 29  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 87
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVV---------VDERLRL 368
             H N+V L+GA T+P   L ++ E+   G+L   L       V           + L L
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 369 N----MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYI 422
                 ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+
Sbjct: 148 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGF 481
               A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 90/290 (31%), Positives = 139/290 (47%), Gaps = 28/290 (9%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 66  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 124
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVV---------VDERLRL 368
             H N+V L+GA T+P   L ++ E+   G+L   L       V           + L L
Sbjct: 125 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 184
Query: 369 N----MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYI 422
                 ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+
Sbjct: 185 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 242
Query: 423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGF 481
               A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       
Sbjct: 243 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302
Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 303 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 352

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 136/275 (49%), Gaps = 31/275 (11%)
Query: 272 KIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++G+G+FG+V    Y     N+   V +   Q    D+ ++F RE+ I+K L    IV  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 328 MGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            G    P   +L +V EYL  G L   L    AR+  D    L  +  + KGM YL  RR
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL--DASRLLLYSSQICKGMEYLGSRR 147
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLRED 442
              VHRDL + N+LV+S   VK+ DFGL++  P   + Y+  +       W APE L ++
Sbjct: 148 --CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFK---------------GRRL 486
             + +SDV+SFGV+L+EL T     ++ +PS + +  +G +               G+RL
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCD--KSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRL 263
Query: 487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
             P      V  L++ CWA  P+ RPSF ++   L
Sbjct: 264 PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/290 (31%), Positives = 139/290 (47%), Gaps = 28/290 (9%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 78
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVV---------VDERLRL 368
             H N+V L+GA T+P   L ++TE+   G+L   L       V           + L L
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 369 N----MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYI 422
                 ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K    +
Sbjct: 139 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGF 481
               A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 136/275 (49%), Gaps = 31/275 (11%)
Query: 272 KIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++G+G+FG+V    Y     N+   V +   Q    D+ ++F RE+ I+K L    IV  
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 328 MGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            G    P   +L +V EYL  G L   L    AR+  D    L  +  + KGM YL  RR
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL--DASRLLLYSSQICKGMEYLGSRR 135
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLRED 442
              VHRDL + N+LV+S   VK+ DFGL++  P   + Y+  +       W APE L ++
Sbjct: 136 --CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFK---------------GRRL 486
             + +SDV+SFGV+L+EL T     ++ +PS + +  +G +               G+RL
Sbjct: 194 IFSRQSDVWSFGVVLYELFTYCD--KSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRL 251
Query: 487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
             P      V  L++ CWA  P+ RPSF ++   L
Sbjct: 252 PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 286

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 141/291 (48%), Gaps = 31/291 (10%)
Query: 258 EGLEIRWSELLIKKKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFL 310
           E  E   + L   K +G G+FG V  A       E     VAVK+L +   H D  +  +
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM 97
Query: 311 REVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-----------IPDA 358
            E+ IM  L +H NIV L+GA T    + ++TEY   G L   L               A
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 359 RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 418
              +  R  L+ +  VA+GM +L  +    +HRD+ + N+L+ + +  K+ DFGL+R   
Sbjct: 158 NSTLSTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 419 N--TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI 476
           N   YI    A    +WMAPE + +     +SDV+S+G++LWE+ +L     N  P  ++
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG---LNPYPGILV 272
Query: 477 SAVGFK----GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           ++  +K    G ++  P      + ++++ CWA EP  RP+F  I   LQ+
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 136/275 (49%), Gaps = 31/275 (11%)
Query: 272 KIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++G+G+FG+V    Y     N+   V +   Q    D+ ++F RE+ I+K L    IV  
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 328 MGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            G    P   +L +V EYL  G L   L    AR+  D    L  +  + KGM YL  RR
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL--DASRLLLYSSQICKGMEYLGSRR 134
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLRED 442
              VHRDL + N+LV+S   VK+ DFGL++  P   + Y+  +       W APE L ++
Sbjct: 135 --CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFK---------------GRRL 486
             + +SDV+SFGV+L+EL T     ++ +PS + +  +G +               G+RL
Sbjct: 193 IFSRQSDVWSFGVVLYELFTYCD--KSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRL 250
Query: 487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
             P      V  L++ CWA  P+ RPSF ++   L
Sbjct: 251 PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 285

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 135/275 (49%), Gaps = 31/275 (11%)
Query: 272 KIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++G+G+FG+V    Y     N+   V +   Q    D+ ++F RE+ I+K L    IV  
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 328 MGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            G    P  P L +V EYL  G L   L    AR+  D    L  +  + KGM YL  RR
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARL--DASRLLLYSSQICKGMEYLGSRR 131
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLRED 442
              VHRDL + N+LV+S   VK+ DFGL++  P   +  +  +       W APE L ++
Sbjct: 132 --CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFK---------------GRRL 486
             + +SDV+SFGV+L+EL T     ++ +PS + +  +G +               G+RL
Sbjct: 190 IFSRQSDVWSFGVVLYELFTYCD--KSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRL 247
Query: 487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
             P      V  L++ CWA  P+ RPSF ++   L
Sbjct: 248 PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 282

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 140/291 (48%), Gaps = 31/291 (10%)
Query: 258 EGLEIRWSELLIKKKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFL 310
           E  E   + L   K +G G+FG V  A       E     VAVK+L +   H D  +  +
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM 97
Query: 311 REVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-----------IPDA 358
            E+ IM  L +H NIV L+GA T    + ++TEY   G L   L               A
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 359 RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 418
                 R  L+ +  VA+GM +L  +    +HRD+ + N+L+ + +  K+ DFGL+R   
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 419 N--TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI 476
           N   YI    A    +WMAPE + +     +SDV+S+G++LWE+ +L     N  P  ++
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG---LNPYPGILV 272
Query: 477 SAVGFK----GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           ++  +K    G ++  P      + ++++ CWA EP  RP+F  I   LQ+
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 137/290 (47%), Gaps = 20/290 (6%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           +  + + +G+G FG+V  A+ +  D     VAVK+L          +EFLRE A MK   
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 321 HPNIVLLMG------AVTEPPNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMA 371
           HP++  L+G      A    P   ++  ++  G L+  L    I +    +  +  +   
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGT 430
            D+A GM YL  R    +HRDL + N ++    TV V DFGLSR      Y     A+  
Sbjct: 144 VDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 431 P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEI 488
           P +W+A E L ++     SDV++FGV +WE++T  Q P+     +++ + +   G RL+ 
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-IGGNRLKQ 260
Query: 489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 538
           P      V  L+  CW+ +P+ RPSF  +   L+  L        S  PL
Sbjct: 261 PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 138/289 (47%), Gaps = 28/289 (9%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 31  LKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMSELKILIHI 89
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVV------------VDER 365
             H N+V L+GA T+P   L ++ E+   G+L   L       V              E 
Sbjct: 90  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEH 149
Query: 366 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYIS 423
           L +  ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K    + 
Sbjct: 150 L-IXYSFQVAKGMEFLASRK--XIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK 482
              A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       +
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 143/288 (49%), Gaps = 29/288 (10%)
Query: 258 EGLEIRWSELLIKKKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFL 310
           E  E   + L   K +G G+FG V  A       E     VAVK+L +   H D  +  +
Sbjct: 31  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM 89
Query: 311 REVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE----- 364
            E+ IM  L +H NIV L+GA T    + ++TEY   G L   L    A   +D+     
Sbjct: 90  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKAEADLDKEDGRP 148
Query: 365 ---RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-- 419
              R  L+ +  VA+GM +L  +    +HRD+ + N+L+ + +  K+ DFGL+R   N  
Sbjct: 149 LELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 206
Query: 420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
            YI    A    +WMAPE + +     +SDV+S+G++LWE+ +L     N  P  ++++ 
Sbjct: 207 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG---LNPYPGILVNSK 263
Query: 480 GFK----GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
            +K    G ++  P      + ++++ CWA EP  RP+F  I   LQ+
Sbjct: 264 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 311

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 142/291 (48%), Gaps = 30/291 (10%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 29  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 87
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLH------IPDARVVVDERLR---- 367
             H N+V L+GA T+P   L ++ E+   G+L   L       +P  +V  ++  +    
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-YKVAPEDLYKDFLT 146
Query: 368 ----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTY 421
               +  ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K    
Sbjct: 147 LEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX 204
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG 480
           +    A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +      
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
            +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 143/294 (48%), Gaps = 35/294 (11%)
Query: 258 EGLEIRWSELLIKKKIGEGSFGTVYHAE---WRNSDVAVKI---LIEQEFHEDRFKEFLR 311
           E  E   + L   K +G G+FG V  A        D  +K+   +++   H D  +  + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 312 EVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL---------------HI 355
           E+ IM  L +H NIV L+GA T    + ++TEY   G L   L               H 
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 356 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 415
           P+ ++    R  L+ +  VA+GM +L  +    +HRD+ + N+L+ + +  K+ DFGL+R
Sbjct: 159 PEEQL--SSRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLAR 214
Query: 416 SKPN--TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 473
              N   YI    A    +WMAPE + +     +SDV+S+G++LWE+ +L     N  P 
Sbjct: 215 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG---LNPYPG 271
Query: 474 QVISAVGFK----GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
            ++++  +K    G ++  P      + ++++ CWA EP  RP+F  I   LQ+
Sbjct: 272 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 325

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 142/291 (48%), Gaps = 30/291 (10%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 29  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 87
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLH------IPDARVVVDERLR---- 367
             H N+V L+GA T+P   L ++ E+   G+L   L       +P  +V  ++  +    
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-YKVAPEDLYKDFLT 146
Query: 368 ----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTY 421
               +  ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K    
Sbjct: 147 LEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG 480
           +    A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +      
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
            +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 143/288 (49%), Gaps = 29/288 (10%)
Query: 258 EGLEIRWSELLIKKKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFL 310
           E  E   + L   K +G G+FG V  A       E     VAVK+L +   H D  +  +
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM 97
Query: 311 REVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE----- 364
            E+ IM  L +H NIV L+GA T    + ++TEY   G L   L    A   +D+     
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKAEADLDKEDGRP 156
Query: 365 ---RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-- 419
              R  L+ +  VA+GM +L  +    +HRD+ + N+L+ + +  K+ DFGL+R   N  
Sbjct: 157 LELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 214
Query: 420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
            YI    A    +WMAPE + +     +SDV+S+G++LWE+ +L     N  P  ++++ 
Sbjct: 215 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG---LNPYPGILVNSK 271
Query: 480 GFK----GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
            +K    G ++  P      + ++++ CWA EP  RP+F  I   LQ+
Sbjct: 272 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 319

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  119 bits (297), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 138/289 (47%), Gaps = 27/289 (9%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 30  LNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 88
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVV--------VDERLRLN 369
             H N+V L+GA T+P   L ++ E+   G+L   L       V          + L L 
Sbjct: 89  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLE 148
Query: 370 ----MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYIS 423
                ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K    + 
Sbjct: 149 HLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK 482
              A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       +
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 138/290 (47%), Gaps = 28/290 (9%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 78
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVV---------VDERLRL 368
             H N+V L+GA T+P   L ++ E+   G+L   L       V           + L L
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 369 N----MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYI 422
                 ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K    +
Sbjct: 139 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGF 481
               A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 306

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 89/285 (31%), Positives = 140/285 (49%), Gaps = 26/285 (9%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH-RALMSELKILIHI 87
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLH------IPDARVVVD----ERLR 367
             H N+V L+GA T+P   L ++ E+   G+L   L       +P   +  D    E L 
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL- 146
Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSK 425
           +  ++ VAKGM +L  R+   +HRDL + N+L+     VK+ DFGL+R   K   Y+   
Sbjct: 147 IXYSFQVAKGMEFLASRK--XIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKG 204
Query: 426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGR 484
            A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       +G 
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGT 264
Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           R+  P    P +   +  CW  EP  RP+F  ++E L   L ++ 
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 144/291 (49%), Gaps = 29/291 (9%)
Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFK 307
           +E+YL+ + L +        K++G G+FGTV   Y+   +        +++ E ++   K
Sbjct: 3   KEVYLDRKLLTLE------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 56
Query: 308 -EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVV 362
            E L E  +M+ L +P IV ++G + E  +  +V E    G L K L    H+ D  ++ 
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 114
Query: 363 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPN 419
                  + + V+ GM YL +     VHRDL + N+L+ + +  K+ DFGLS   R+  N
Sbjct: 115 ------ELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISA 478
            Y +        +W APE +     + KSDV+SFGV++WE  +  QKP+R    S+V +A
Sbjct: 167 XYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA 225
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           +  KG R+  P      +  L+  CW  + E RP F ++   L+ +    V
Sbjct: 226 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 276

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 71/195 (36%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKIL--IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           K GEG FG VY     N+ VAVK L  +     E+  ++F +E+ +    +H N+V L+G
Sbjct: 29  KXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
             ++  +L +V  Y   GSL   L   D    +    R  +A   A G+N+LH+     +
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH--I 146
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           HRD+KS N+L+D  +T K+ DFGL+R+  K    +      GT  + APE LR + +  K
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEIT-PK 205
Query: 448 SDVFSFGVILWELIT 462
           SD++SFGV+L E+IT
Sbjct: 206 SDIYSFGVVLLEIIT 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 144/291 (49%), Gaps = 29/291 (9%)
Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFK 307
           +E+YL+ + L +        K++G G+FGTV   Y+   +        +++ E ++   K
Sbjct: 17  KEVYLDRKLLTLE------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 70
Query: 308 -EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVV 362
            E L E  +M+ L +P IV ++G + E  +  +V E    G L K L    H+ D  ++ 
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 128
Query: 363 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPN 419
                  + + V+ GM YL +     VHRDL + N+L+ + +  K+ DFGLS   R+  N
Sbjct: 129 ------ELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180
Query: 420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISA 478
            Y +        +W APE +     + KSDV+SFGV++WE  +  QKP+R    S+V +A
Sbjct: 181 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA 239
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           +  KG R+  P      +  L+  CW  + E RP F ++   L+ +    V
Sbjct: 240 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 290

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 144/291 (49%), Gaps = 29/291 (9%)
Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFK 307
           +E+YL+ + L +        K++G G+FGTV   Y+   +        +++ E ++   K
Sbjct: 3   KEVYLDRKLLTLE------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 56
Query: 308 -EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVV 362
            E L E  +M+ L +P IV ++G + E  +  +V E    G L K L    H+ D  ++ 
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 114
Query: 363 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPN 419
                  + + V+ GM YL +     VHRDL + N+L+ + +  K+ DFGLS   R+  N
Sbjct: 115 ------ELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISA 478
            Y +        +W APE +     + KSDV+SFGV++WE  +  QKP+R    S+V +A
Sbjct: 167 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA 225
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           +  KG R+  P      +  L+  CW  + E RP F ++   L+ +    V
Sbjct: 226 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 276

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 144/291 (49%), Gaps = 29/291 (9%)
Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFK 307
           +E+YL+ + L +        K++G G+FGTV   Y+   +        +++ E ++   K
Sbjct: 19  KEVYLDRKLLTLE------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 72
Query: 308 -EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVV 362
            E L E  +M+ L +P IV ++G + E  +  +V E    G L K L    H+ D  ++ 
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 130
Query: 363 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPN 419
                  + + V+ GM YL +     VHRDL + N+L+ + +  K+ DFGLS   R+  N
Sbjct: 131 ------ELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISA 478
            Y +        +W APE +     + KSDV+SFGV++WE  +  QKP+R    S+V +A
Sbjct: 183 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA 241
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           +  KG R+  P      +  L+  CW  + E RP F ++   L+ +    V
Sbjct: 242 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 292

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 144/291 (49%), Gaps = 29/291 (9%)
Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFK 307
           +E+YL+ + L +        K++G G+FGTV   Y+   +        +++ E ++   K
Sbjct: 19  KEVYLDRKLLTLE------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 72
Query: 308 -EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVV 362
            E L E  +M+ L +P IV ++G + E  +  +V E    G L K L    H+ D  ++ 
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 130
Query: 363 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPN 419
                  + + V+ GM YL +     VHRDL + N+L+ + +  K+ DFGLS   R+  N
Sbjct: 131 ------ELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISA 478
            Y +        +W APE +     + KSDV+SFGV++WE  +  QKP+R    S+V +A
Sbjct: 183 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA 241
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           +  KG R+  P      +  L+  CW  + E RP F ++   L+ +    V
Sbjct: 242 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 292

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 144/291 (49%), Gaps = 29/291 (9%)
Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFK 307
           +E+YL+ + L +        K++G G+FGTV   Y+   +        +++ E ++   K
Sbjct: 9   KEVYLDRKLLTLE------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 62
Query: 308 -EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVV 362
            E L E  +M+ L +P IV ++G + E  +  +V E    G L K L    H+ D  ++ 
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 120
Query: 363 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPN 419
                  + + V+ GM YL +     VHRDL + N+L+ + +  K+ DFGLS   R+  N
Sbjct: 121 ------ELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISA 478
            Y +        +W APE +     + KSDV+SFGV++WE  +  QKP+R    S+V +A
Sbjct: 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA 231
Query: 479 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           +  KG R+  P      +  L+  CW  + E RP F ++   L+ +    V
Sbjct: 232 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 132/288 (45%), Gaps = 41/288 (14%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRH 321
           L++ K +GEG FG+V     +  D     VAVK +      +   +EFL E A MK   H
Sbjct: 36  LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 322 PNIVLLMGAVTEP-----PNLSIVTEYLSRGSLYKLL----------HIPDARVVVDERL 366
           PN++ L+G   E      P   ++  ++  G L+  L          HIP   +      
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL------ 149
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISS 424
            L    D+A GM YL  R    +HRDL + N ++    TV V DFGLS+     + Y   
Sbjct: 150 -LKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 425 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-----SQVISAV 479
           + A    +W+A E L +     KSDV++FGV +WE+ T     R  TP     +  +   
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT-----RGMTPYPGVQNHEMYDY 261
Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
              G RL+ P++    +  ++ +CW  +P  RP+F  +   L++ L S
Sbjct: 262 LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 145/287 (50%), Gaps = 21/287 (7%)
Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFK 307
           +E+YL+ + L +        K++G G+FGTV   Y+   +        +++ E ++   K
Sbjct: 362 KEVYLDRKLLTLE------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 415
Query: 308 -EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 366
            E L E  +M+ L +P IV ++G + E  +  +V E    G L K L     R V D+ +
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNI 472
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYIS 423
            + + + V+ GM YL +     VHRDL + N+L+ + +  K+ DFGLS   R+  N Y +
Sbjct: 473 -IELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 529
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK 482
                   +W APE +     + KSDV+SFGV++WE  +  QKP+R    S+V +A+  K
Sbjct: 530 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEK 588
Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           G R+  P      +  L+  CW  + E RP F ++   L+ +    V
Sbjct: 589 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 635

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 145/287 (50%), Gaps = 21/287 (7%)
Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFK 307
           +E+YL+ + L +        K++G G+FGTV   Y+   +        +++ E ++   K
Sbjct: 361 KEVYLDRKLLTLE------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 414
Query: 308 -EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 366
            E L E  +M+ L +P IV ++G + E  +  +V E    G L K L     R V D+ +
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNI 471
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYIS 423
            + + + V+ GM YL +     VHRDL + N+L+ + +  K+ DFGLS   R+  N Y +
Sbjct: 472 -IELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK 482
                   +W APE +     + KSDV+SFGV++WE  +  QKP+R    S+V +A+  K
Sbjct: 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEK 587
Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           G R+  P      +  L+  CW  + E RP F ++   L+ +    V
Sbjct: 588 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 141/269 (52%), Gaps = 10/269 (3%)
Query: 271 KKIGEGSFGT---VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEGSFG    V   E     V  +I I +   ++R +E  REVA++  ++HPNIV  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMKHPNIVQY 88
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  E  +L IV +Y   G L+K ++     V+  E   L+    +   + ++H R+  
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK-- 145
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           I+HRD+KS N+ +    TV++ DFG++R   +T   ++   GTP +++PE+    P N K
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK 205
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
           SD+++ G +L+EL TL+  +   +   ++  +   G    +  + +  + +L+   +   
Sbjct: 206 SDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-ISGSFPPVSLHYSYDLRSLVSQLFKRN 264
Query: 508 PEIRPSFPSIMETLQQFLMSSVCQPLSAQ 536
           P  RPS  SI+E  + F+   + + LS Q
Sbjct: 265 PRDRPSVNSILE--KGFIAKRIEKFLSPQ 291

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 23/271 (8%)
Query: 271 KKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVL 326
           K++G G+FGTV   Y+   +        +++ E ++   K E L E  +M+ L +P IV 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           ++G + E  +  +V E    G L K L    H+ D  ++        + + V+ GM YL 
Sbjct: 73  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII-------ELVHQVSMGMKYLE 124
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL 439
           +     VHRDL + N+L+ + +  K+ DFGLS   R+  N Y +        +W APE +
Sbjct: 125 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 440 REDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
                + KSDV+SFGV++WE  +  QKP+R    S+V +A+  KG R+  P      +  
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCPREMYD 241
Query: 499 LIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           L+  CW  + E RP F ++   L+ +    V
Sbjct: 242 LMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 23/271 (8%)
Query: 271 KKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVL 326
           K++G G+FGTV   Y+   +        +++ E ++   K E L E  +M+ L +P IV 
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           ++G + E  +  +V E    G L K L    H+ D  ++        + + V+ GM YL 
Sbjct: 71  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII-------ELVHQVSMGMKYLE 122
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL 439
           +     VHRDL + N+L+ + +  K+ DFGLS   R+  N Y +        +W APE +
Sbjct: 123 ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 440 REDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
                + KSDV+SFGV++WE  +  QKP+R    S+V +A+  KG R+  P      +  
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEKGERMGCPAGCPREMYD 239
Query: 499 LIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           L+  CW  + E RP F ++   L+ +    V
Sbjct: 240 LMNLCWTYDVENRPGFAAVELRLRNYYYDVV 270

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 84  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 141 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKC 258
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 259 WMIDADSRPKFRELI 273

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 91  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 147
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 148 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 205
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 206 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKC 265
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 266 WMIDADSRPKFRELI 280

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 81  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKC 255
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 256 WMIDADSRPKFRELI 270

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 87  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 143
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 144 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 201
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 202 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 261
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 262 WMIDADSRPKFRELI 276

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 84  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 141 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 258
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 259 WMIDADSRPKFRELI 273

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 106 RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 162
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 163 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 220
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 221 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 280
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 281 WMIDADSRPKFRELI 295

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 81  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 255
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 256 WMIDADSRPKFRELI 270

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 75  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 132 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 250 WMIDADSRPKFRELI 264

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 83  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 140 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 257
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 258 WMIDADSRPKFRELI 272

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 84  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 141 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 258
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 259 WMIDADSRPKFRELI 273

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 88  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 145 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 262
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 263 WMIDADSRPKFRELI 277

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 127/257 (49%), Gaps = 12/257 (4%)
Query: 265 SELLIKKKIGEGSFGTVYHAEW----RNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGL 319
           +EL   K +G G+FGTVY   W     N  + V I + +E    +  KE L E  +M G+
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
             P +  L+G +     + +VT+ +  G L  L H+ + R  +  +  LN    +AKGM+
Sbjct: 77  GSPYVSRLLG-ICLTSTVQLVTQLMPYGCL--LDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPE 437
           YL   R  +VHRDL + N+LV S   VK+ DFGL+R      T   +       +WMA E
Sbjct: 134 YLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
            +       +SDV+S+GV +WEL+T      +  P++ I  +  KG RL  P      V 
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 251
Query: 498 ALIETCWAEEPEIRPSF 514
            ++  CW  + E RP F
Sbjct: 252 MIMVKCWMIDSECRPRF 268

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 81  RLLG-ICLTSTVQLITQLMPFGXL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 255
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 256 WMIDADSRPKFRELI 270

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  115 bits (287), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 144/300 (48%), Gaps = 40/300 (13%)
Query: 258 EGLEIRWSELLIKKKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFL 310
           E  E   + L   K +G G+FG V  A       E     VAVK+L +   H D  +  +
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM 82
Query: 311 REVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL---------------H 354
            E+ IM  L +H NIV L+GA T    + ++TEY   G L   L                
Sbjct: 83  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 355 IPDARVVVDER---LR--LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 409
            P+     D R   LR  L+ +  VA+GM +L  +    +HRD+ + N+L+ + +  K+ 
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIG 200
Query: 410 DFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 467
           DFGL+R   N   YI    A    +WMAPE + +     +SDV+S+G++LWE+ +L    
Sbjct: 201 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG--- 257
Query: 468 RNSTPSQVISAVGFK----GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
            N  P  ++++  +K    G ++  P      + ++++ CWA EP  RP+F  I   LQ+
Sbjct: 258 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 317

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +   E  E       KE L E  +M  + +P++ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 115 RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 171
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 172 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 229
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 230 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 289
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 290 WMIDADSRPKFRELI 304

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 127/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +A+GMNYL  RR
Sbjct: 78  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRR 134
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 135 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 192
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 193 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 252
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 253 WMIDADSRPKFRELI 267

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 83  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFG ++             G    +WMA E +    
Sbjct: 140 --LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKC 257
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 258 WMIDADSRPKFRELI 272

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++ + +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 83  RLLG-ICLTSTVQLIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 140 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 257
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 258 WMIDADSRPKFRELI 272

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 136/280 (48%), Gaps = 30/280 (10%)
Query: 271 KKIGEGSFGTV----YHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +GEG FG V    Y  E  N+   VAVK L + E   +   +  +E+ I++ L H NI
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENI 85
Query: 325 VLLMGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           V   G  TE     + ++ E+L  GSL +  ++P  +  ++ + +L  A  + KGM+YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPE-WMAPEVL 439
            R+   VHRDL + N+LV+S + VK+ DFGL+++        + K    +P  W APE L
Sbjct: 144 SRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 440 REDPSNEKSDVFSFGVILWELIT--------------LQKPWRNSTPSQVISAVGFKGRR 485
            +      SDV+SFGV L EL+T              +  P         +     +G+R
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P N    V  L+  CW  +P  R SF +++E  +  L
Sbjct: 262 LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++ + +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 85  RLLG-ICLTSTVQLIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 142 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 200 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 259
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 260 WMIDADSRPKFRELI 274

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 136/280 (48%), Gaps = 30/280 (10%)
Query: 271 KKIGEGSFGTV----YHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +GEG FG V    Y  E  N+   VAVK L + E   +   +  +E+ I++ L H NI
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENI 73
Query: 325 VLLMGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           V   G  TE     + ++ E+L  GSL +  ++P  +  ++ + +L  A  + KGM+YL 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPE-WMAPEVL 439
            R+   VHRDL + N+LV+S + VK+ DFGL+++        + K    +P  W APE L
Sbjct: 132 SRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 440 REDPSNEKSDVFSFGVILWELIT--------------LQKPWRNSTPSQVISAVGFKGRR 485
            +      SDV+SFGV L EL+T              +  P         +     +G+R
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 249
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           L  P N    V  L+  CW  +P  R SF +++E  +  L
Sbjct: 250 LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 289

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++ + +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 84  RLLG-ICLTSTVQLIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 141 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 258
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 259 WMIDADSRPKFRELI 273

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++ + +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 81  RLLG-ICLTSTVQLIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 255
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 256 WMIDADSRPKFRELI 270

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++ + +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 82  RLLG-ICLTSTVQLIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 139 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 256
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 257 WMIDADSRPKFRELI 271

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++ + +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 82  RLLG-ICLTSTVQLIMQLMPFGXL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 139 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 256
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 257 WMIDADSRPKFRELI 271

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 88  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFG ++             G    +WMA E +    
Sbjct: 145 --LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 262
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 263 WMIDADSRPKFRELI 277

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +  G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 81  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 255
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 256 WMIDADSRPKFRELI 270

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 81  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFG ++             G    +WMA E +    
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 255
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 256 WMIDADSRPKFRELI 270

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +  G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++T+ +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 88  RLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 145 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 262
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 263 WMIDADSRPKFRELI 277

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 134/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 99
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+  L H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 100 LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 156
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 157 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 274
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 275 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 127/269 (47%), Gaps = 30/269 (11%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 133
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTP-EWMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P    +   K    +P  W APE L E
Sbjct: 134 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           L  P      +  ++  CW      RPSF
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSF 279

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 132/269 (49%), Gaps = 22/269 (8%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFK---EFLREVAIMKGLRHPNIV 325
           I+KKIG G F  VY A      V V +   Q F     K   + ++E+ ++K L HPN++
Sbjct: 36  IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 95
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               +  E   L+IV E    G L +++ H    + ++ ER        +   + ++H R
Sbjct: 96  KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-----GTPEWMAPEVL 439
           R  ++HRD+K  N+ + +T  VK+ D GL R     + SSKT A     GTP +M+PE +
Sbjct: 156 R--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERI 208
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP----KNVNPM 495
            E+  N KSD++S G +L+E+  LQ P+     +  + ++  K  + + P     + +  
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE 266
Query: 496 VAALIETCWAEEPEIRPSFPSIMETLQQF 524
           +  L+  C   +PE RP    + +  ++ 
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRM 295

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 134/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 85
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+  L H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 86  LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 142
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 143 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 200
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 260
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 261 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++ + +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 83  RLLG-ICLTSTVQLIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFG ++             G    +WMA E +    
Sbjct: 140 --LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKC 257
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 258 WMIDADSRPKFRELI 272

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDEL-DFLMEA 99
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 156
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 157 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 274
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 275 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 134/261 (51%), Gaps = 14/261 (5%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKI-----LIEQEFHEDRFKEFLREVAIMKGL 319
           +EL   K +G G FGTV+   W     ++KI     +IE +     F+     +  +  L
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H +IV L+G +    +L +VT+YL  GSL  L H+   R  +  +L LN    +AKGM 
Sbjct: 73  DHAHIVRLLG-LCPGSSLQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPE 437
           YL +    +VHR+L + N+L+ S   V+V DFG++    P+      + A TP +WMA E
Sbjct: 130 YLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            +       +SDV+S+GV +WEL+T   +P+     ++V   +  KG RL  P+     V
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTIDV 246
Query: 497 AALIETCWAEEPEIRPSFPSI 517
             ++  CW  +  IRP+F  +
Sbjct: 247 YMVMVKCWMIDENIRPTFKEL 267

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 41  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 99
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 156
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 157 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 274
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 275 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 133/258 (51%), Gaps = 14/258 (5%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKI-----LIEQEFHEDRFKEFLREVAIMKGL 319
           +EL   K +G G FGTV+   W     ++KI     +IE +     F+     +  +  L
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            H +IV L+G +    +L +VT+YL  GSL  L H+   R  +  +L LN    +AKGM 
Sbjct: 91  DHAHIVRLLG-LCPGSSLQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQIAKGMY 147
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPE 437
           YL +    +VHR+L + N+L+ S   V+V DFG++    P+      + A TP +WMA E
Sbjct: 148 YLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            +       +SDV+S+GV +WEL+T   +P+     ++V   +  KG RL  P+     V
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTIDV 264
Query: 497 AALIETCWAEEPEIRPSF 514
             ++  CW  +  IRP+F
Sbjct: 265 YMVMVKCWMIDENIRPTF 282

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 84
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 141
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 142 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 260 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 127/269 (47%), Gaps = 30/269 (11%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 134
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTP-EWMAPEVLRE 441
           R   +HR+L + N+LV++   VK+ DFGL++  P    Y   K    +P  W APE L E
Sbjct: 135 R--YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 193 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 251
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           L  P      +  ++  CW      RPSF
Sbjct: 252 LPRPDGCPDEIYMIMTECWNNNVNQRPSF 280

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++ + +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 83  RLLG-ICLTSTVQLIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFG ++             G    +WMA E +    
Sbjct: 140 --LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 257
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 258 WMIDADSRPKFRELI 272

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 17  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY  RG +YK L         DE+       ++A  ++Y H +R
Sbjct: 77  RLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALSYCHSKR 133
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 134 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 189
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 244
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 245 LLKHNPSQRPMLREVLE 261

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +G G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++ + +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 85  RLLG-ICLTSTVQLIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFG ++             G    +WMA E +    
Sbjct: 142 --LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 200 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 259
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 260 WMIDADSRPKFRELI 274

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 44  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 102
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 103 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 159
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   +   Y
Sbjct: 160 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 217
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 218 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 277
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 278 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 43  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 101
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 102 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 158
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 159 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 216
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 217 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 276
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 277 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 18  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 76
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 77  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 133
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 134 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 191
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 192 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 251
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 252 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 125
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 182
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   +   Y
Sbjct: 183 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 301 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 84
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 141
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 142 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 260 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 85
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 142
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 143 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 200
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 260
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 261 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 53  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 111
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 112 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 168
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 169 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 226
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 227 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 286
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 287 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 33  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 91
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 92  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 148
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG++R   + + Y
Sbjct: 149 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 206
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 207 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 266
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 267 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 130/264 (49%), Gaps = 25/264 (9%)
Query: 266 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           EL  K +KIG+GSFG V+   + R   V    +I+ E  ED  ++  +E+ ++     P 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +    G+  +   L I+ EYL  GS   LL  P     +DE     +  ++ KG++YLH 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGP---LDETQIATILREILKGLDYLHS 142
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            +   +HRD+K+ N+L+     VK+ DFG++    +T I   T  GTP WMAPEV+++  
Sbjct: 143 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 200
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 498
            + K+D++S G+   EL   + P     P +V+           IPKN  P +       
Sbjct: 201 YDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSKP 251
Query: 499 ---LIETCWAEEPEIRPSFPSIME 519
               +E C  +EP  RP+   +++
Sbjct: 252 LKEFVEACLNKEPSFRPTAKELLK 275

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 12/255 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIE-QEFHE----DRFKEFLREVAIMKGLRHPNIV 325
           K +  G+FGTVY   W      VKI +  +E  E       KE L E  +M  + +P++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+G +     + ++ + +  G L  L ++ + +  +  +  LN    +AKGMNYL  RR
Sbjct: 88  RLLG-ICLTSTVQLIMQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EWMAPEVLREDP 443
             +VHRDL + N+LV +   VK+ DFGL++             G    +WMA E +    
Sbjct: 145 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
              +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P      V  ++  C
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 262
Query: 504 WAEEPEIRPSFPSIM 518
           W  + + RP F  ++
Sbjct: 263 WMIDADSRPKFRELI 277

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 130/264 (49%), Gaps = 25/264 (9%)
Query: 266 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           EL  K +KIG+GSFG V+   + R   V    +I+ E  ED  ++  +E+ ++     P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +    G+  +   L I+ EYL  GS   LL  P     +DE     +  ++ KG++YLH 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGP---LDETQIATILREILKGLDYLHS 122
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            +   +HRD+K+ N+L+     VK+ DFG++    +T I   T  GTP WMAPEV+++  
Sbjct: 123 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 180
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 498
            + K+D++S G+   EL   + P     P +V+           IPKN  P +       
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSKP 231
Query: 499 ---LIETCWAEEPEIRPSFPSIME 519
               +E C  +EP  RP+   +++
Sbjct: 232 LKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 164
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 165 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           L  P      +  ++  CW      RPSF
Sbjct: 282 LPRPDGCPDEIYMIMTECWNNNVNQRPSF 310

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 132
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 133 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 191 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 249
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           L  P      +  ++  CW      RPSF
Sbjct: 250 LPRPDGCPDEIYMIMTECWNNNVNQRPSF 278

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 131
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 132 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 190 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 248
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           L  P      +  ++  CW      RPSF
Sbjct: 249 LPRPDGCPDEIYMIMTECWNNNVNQRPSF 277

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI--DHIKLLQYTSQICKGMEYLGTK 136
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 137 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           L  P      +  ++  CW      RPSF  +   + Q
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 291

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 136
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 137 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           L  P      +  ++  CW      RPSF  +   + Q
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 291

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 140
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 141 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 199 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 257
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           L  P      +  ++  CW      RPSF  +   + Q
Sbjct: 258 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 295

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 133
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 134 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           L  P      +  ++  CW      RPSF
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSF 279

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 139
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 140 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 198 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 256
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           L  P      +  ++  CW      RPSF  +   + Q
Sbjct: 257 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 294

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 138
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 139 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 197 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 255
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           L  P      +  ++  CW      RPSF  +   + Q
Sbjct: 256 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 293

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 133
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 134 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           L  P      +  ++  CW      RPSF
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSF 279

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 151
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 152 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           L  P      +  ++  CW      RPSF
Sbjct: 269 LPRPDGCPDEIYMIMTECWNNNVNQRPSF 297

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 137
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 138 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 196 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 254
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           L  P      +  ++  CW      RPSF
Sbjct: 255 LPRPDGCPDEIYMIMTECWNNNVNQRPSF 283

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ EYL  GSL   L     R+  D    L     + KGM YL  +
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 151
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 152 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           L  P      +  ++  CW      RPSF
Sbjct: 269 LPRPDGCPDEIYMIMTECWNNNVNQRPSF 297

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 133/282 (47%), Gaps = 27/282 (9%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 27  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEA 85
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------IPDARVVVDERL 366
            I+    H NIV  +G   +     I+ E ++ G L   L         P +  ++D   
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD--- 142
Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS--KPNTY 421
            L++A D+A G  YL +     +HRD+ + N L+         K+ DFG+++   + + Y
Sbjct: 143 LLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYY 200
Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVG 480
                A    +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V 
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 260
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
             G R++ PKN    V  ++  CW  +PE RP+F  I+E ++
Sbjct: 261 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 271 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++G+G+FG+V    Y     N+   V +   Q   E+  ++F RE+ I+K L+H NIV 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 327 LMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             G        NL ++ E+L  GSL + L     R+  D    L     + KGM YL  +
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI--DHIKLLQYTSQICKGMEYLGTK 136
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE---WMAPEVLRE 441
           R   +HRDL + N+LV++   VK+ DFGL++  P      K          W APE L E
Sbjct: 137 R--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------R 485
              +  SDV+SFGV+L+EL T  +  + S P++ +  +G   +                R
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSK-SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           L  P      +  ++  CW      RPSF  +   + Q
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 291

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 137/289 (47%), Gaps = 31/289 (10%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW-------RNSDVAVKILIEQEFHEDRFKEFLREV 313
           EI  S +   +++GE  FG VY           +   VA+K L ++   E   +E  R  
Sbjct: 22  EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHE 79
Query: 314 AIMKG-LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI----PDARVVVDERL-- 366
           A+++  L+HPN+V L+G VT+   LS++  Y S G L++ L +     D     D+R   
Sbjct: 80  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 139
Query: 367 -------RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--K 417
                   +++   +A GM YL      +VH+DL + N+LV     VK+ D GL R    
Sbjct: 140 SALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVI 476
            + Y     +     WMAPE +     +  SD++S+GV+LWE+ +   +P+   +   V+
Sbjct: 198 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257
Query: 477 SAVGFKGRR-LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
             +  + R+ L  P +    V AL+  CW E P  RP F  I   L+ +
Sbjct: 258 EMI--RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 137/289 (47%), Gaps = 31/289 (10%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW-------RNSDVAVKILIEQEFHEDRFKEFLREV 313
           EI  S +   +++GE  FG VY           +   VA+K L ++   E   +E  R  
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHE 62
Query: 314 AIMKG-LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI----PDARVVVDERL-- 366
           A+++  L+HPN+V L+G VT+   LS++  Y S G L++ L +     D     D+R   
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 367 -------RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--K 417
                   +++   +A GM YL      +VH+DL + N+LV     VK+ D GL R    
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVI 476
            + Y     +     WMAPE +     +  SD++S+GV+LWE+ +   +P+   +   V+
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 477 SAVGFKGRR-LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
             +  + R+ L  P +    V AL+  CW E P  RP F  I   L+ +
Sbjct: 241 EMI--RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 17  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY  RG +YK L         DE+       ++A  ++Y H +R
Sbjct: 77  RLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALSYCHSKR 133
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 134 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLXGTLDYLPPEMIEGRMHD 189
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 244
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 245 LLKHNPSQRPMLREVLE 261

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 20/271 (7%)
Query: 257 EEGLEIRWS--ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR- 311
           EE  + +W+  +  I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR 
Sbjct: 24  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           EV I   LRHPNI+ L G   +   + ++ EY   G++Y+ L         DE+      
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYI 140
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
            ++A  ++Y H +R  ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT 
Sbjct: 141 TELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTL 196
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEI 488
           +++ PE++     +EK D++S GV+ +E +  + P+  +T  +    IS V F       
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----F 251
Query: 489 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
           P  V      LI       P  RP    ++E
Sbjct: 252 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 20/271 (7%)
Query: 257 EEGLEIRWS--ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR- 311
           EE  + +W+  +  I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR 
Sbjct: 15  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 74
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           EV I   LRHPNI+ L G   +   + ++ EY   G++Y+ L         DE+      
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYI 131
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
            ++A  ++Y H +R  ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT 
Sbjct: 132 TELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTL 187
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEI 488
           +++ PE++     +EK D++S GV+ +E +  + P+  +T  +    IS V F       
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----F 242
Query: 489 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
           P  V      LI       P  RP    ++E
Sbjct: 243 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 273

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 129/264 (48%), Gaps = 25/264 (9%)
Query: 266 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           EL  K +KIG+GSFG V+   + R   V    +I+ E  ED  ++  +E+ ++     P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +    G+  +   L I+ EYL  GS   LL  P     +DE     +  ++ KG++YLH 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGP---LDETQIATILREILKGLDYLHS 137
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            +   +HRD+K+ N+L+     VK+ DFG++    +T I      GTP WMAPEV+++  
Sbjct: 138 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 195
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 498
            + K+D++S G+   EL   + P     P +V+           IPKN  P +       
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSKP 246
Query: 499 ---LIETCWAEEPEIRPSFPSIME 519
               +E C  +EP  RP+   +++
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLK 270

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 129/264 (48%), Gaps = 25/264 (9%)
Query: 266 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           EL  K +KIG+GSFG V+   + R   V    +I+ E  ED  ++  +E+ ++     P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +    G+  +   L I+ EYL  GS   LL  P     +DE     +  ++ KG++YLH 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGP---LDETQIATILREILKGLDYLHS 122
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            +   +HRD+K+ N+L+     VK+ DFG++    +T I      GTP WMAPEV+++  
Sbjct: 123 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 498
            + K+D++S G+   EL   + P     P +V+           IPKN  P +       
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSKP 231
Query: 499 ---LIETCWAEEPEIRPSFPSIME 519
               +E C  +EP  RP+   +++
Sbjct: 232 LKEFVEACLNKEPSFRPTAKELLK 255

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 132/284 (46%), Gaps = 27/284 (9%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRN---SDVAVKI---LIEQEFHEDRFKEFLREVAIMKG 318
           + L   K +G G+FG V  A       SD A+ +   +++   H    +  + E+ ++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 319 L-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE------------- 364
           L  H NIV L+GA T      ++TEY   G L   L       +  +             
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 365 --RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--T 420
                L+ +Y VAKGM +L  +    +HRDL + N+L+      K+CDFGL+R   N   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAV 479
           Y+    A    +WMAPE +       +SDV+S+G+ LWEL +L   P+           +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             +G R+  P++    +  +++TCW  +P  RP+F  I++ +++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 124/244 (50%), Gaps = 10/244 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V     + +    A+KIL ++    +D     + E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             A      L  V EY + G L+   H+   RV  +ER R   A ++   + YLH R   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSR--D 125
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RD+K  NL++D    +K+ DFGL +   +   + KT  GTPE++APEVL ++     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   +  P+ ++P   +L+     ++
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 243
Query: 508 PEIR 511
           P+ R
Sbjct: 244 PKQR 247

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 124/244 (50%), Gaps = 10/244 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V     + +    A+KIL ++    +D     + E  +++  RHP +  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             A      L  V EY + G L+   H+   RV  +ER R   A ++   + YLH R   
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSR--D 128
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RD+K  NL++D    +K+ DFGL +   +   + KT  GTPE++APEVL ++     
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 188
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   +  P+ ++P   +L+     ++
Sbjct: 189 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 246
Query: 508 PEIR 511
           P+ R
Sbjct: 247 PKQR 250

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 17  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 133
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE +     +
Sbjct: 134 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEXIEGRXHD 189
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 244
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 245 LLKHNPSQRPXLREVLE 261

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 133/269 (49%), Gaps = 20/269 (7%)
Query: 259 GLEIRWS--ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EV 313
           G + +W+  +  I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV
Sbjct: 1   GKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            I   LRHPNI+ L G   +   + ++ EY   G++Y+ L         DE+       +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITE 117
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 433
           +A  ++Y H +R  ++HRD+K  NLL+ S   +K+ DFG S   P++     T +GT ++
Sbjct: 118 LANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSCHAPSS--RRTTLSGTLDY 173
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPK 490
           + PE++     +EK D++S GV+ +E +  + P+  +T  +    IS V F       P 
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPD 228
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIME 519
            V      LI       P  RP    ++E
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 13  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 129
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRDTLCGTLDYLPPEMIEGRMHD 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 240
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 241 LLKHNPSQRPMLREVLE 257

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 12  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 128
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 184
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 240 LLKHNPSQRPMLREVLE 256

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 15  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 131
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 187
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 242
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 243 LLKHNPSQRPMLREVLE 259

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 17  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 133
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 134 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 189
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 244
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 245 LLKHNPSQRPMLREVLE 261

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 124/244 (50%), Gaps = 10/244 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V     + +    A+KIL ++    +D     + E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             A      L  V EY + G L+   H+   RV  +ER R   A ++   + YLH R   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSR--D 125
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RD+K  NL++D    +K+ DFGL +   +   + KT  GTPE++APEVL ++     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   +  P+ ++P   +L+     ++
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 243
Query: 508 PEIR 511
           P+ R
Sbjct: 244 PKQR 247

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 127/262 (48%), Gaps = 12/262 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           ++++ + +GEG FG VY   + N      +VAVK   +++   D  ++F+ E  IMK L 
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLD 71
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HP+IV L+G + E P   I+ E    G L   L      + V   +  ++   + K M Y
Sbjct: 72  HPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAY 128
Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 439
           L       VHRD+   N+LV S   VK+ DFGLSR  +   Y  +       +WM+PE +
Sbjct: 129 LESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 186
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
                   SDV+ F V +WE+++  K       ++ +  V  KG RL  P    P++  L
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 246
Query: 500 IETCWAEEPEIRPSFPSIMETL 521
           +  CW  +P  RP F  ++ +L
Sbjct: 247 MTRCWDYDPSDRPRFTELVCSL 268

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 132/284 (46%), Gaps = 27/284 (9%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRN---SDVAVKI---LIEQEFHEDRFKEFLREVAIMKG 318
           + L   K +G G+FG V  A       SD A+ +   +++   H    +  + E+ ++  
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 319 L-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE------------- 364
           L  H NIV L+GA T      ++TEY   G L   L       +  +             
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 365 --RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--T 420
                L+ +Y VAKGM +L  +    +HRDL + N+L+      K+CDFGL+R   N   
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 218
Query: 421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAV 479
           Y+    A    +WMAPE +       +SDV+S+G+ LWEL +L   P+           +
Sbjct: 219 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 278
Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             +G R+  P++    +  +++TCW  +P  RP+F  I++ +++
Sbjct: 279 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 22/259 (8%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 15  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 131
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDP 443
             ++HRD+K  NLL+ S   +K+ DFG S   P    SS+ AA  GT +++ PE++    
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPPEMIEGRM 185
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALI 500
            +EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLI 240
Query: 501 ETCWAEEPEIRPSFPSIME 519
                  P  RP    ++E
Sbjct: 241 SRLLKHNPSQRPMLREVLE 259

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 127/262 (48%), Gaps = 12/262 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           ++++ + +GEG FG VY   + N      +VAVK   +++   D  ++F+ E  IMK L 
Sbjct: 9   DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLD 67
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HP+IV L+G + E P   I+ E    G L   L      + V   +  ++   + K M Y
Sbjct: 68  HPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAY 124
Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 439
           L       VHRD+   N+LV S   VK+ DFGLSR  +   Y  +       +WM+PE +
Sbjct: 125 LESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 182
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
                   SDV+ F V +WE+++  K       ++ +  V  KG RL  P    P++  L
Sbjct: 183 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 242
Query: 500 IETCWAEEPEIRPSFPSIMETL 521
           +  CW  +P  RP F  ++ +L
Sbjct: 243 MTRCWDYDPSDRPRFTELVCSL 264

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 15  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 131
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 187
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 242
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 243 LLKHNPSQRPMLREVLE 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 11  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 70
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 71  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 127
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 128 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 183
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 238
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 239 LLKHNPSQRPMLREVLE 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 22/259 (8%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 12  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 128
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDP 443
             ++HRD+K  NLL+ S   +K+ DFG S   P    SS+ AA  GT +++ PE++    
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPPEMIEGRM 182
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALI 500
            +EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLI 237
Query: 501 ETCWAEEPEIRPSFPSIME 519
                  P  RP    ++E
Sbjct: 238 SRLLKHNPSQRPMLREVLE 256

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 116/217 (53%), Gaps = 9/217 (4%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           I  ++G+G+FG VY A+ + + V     +     E+  ++++ E+ I+    HPNIV L+
Sbjct: 41  IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            A     NL I+ E+ + G++  ++ +   R + + ++++ +       +NYLH  +  I
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDAVM-LELERPLTESQIQV-VCKQTLDALNYLHDNK--I 156
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-----REDP 443
           +HRDLK+ N+L      +K+ DFG+S     T     +  GTP WMAPEV+     ++ P
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG 480
            + K+DV+S G+ L E+  ++ P     P +V+  + 
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 127/262 (48%), Gaps = 12/262 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           ++++ + +GEG FG VY   + N      +VAVK   +++   D  ++F+ E  IMK L 
Sbjct: 25  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLD 83
Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HP+IV L+G + E P   I+ E    G L   L      + V   +  ++   + K M Y
Sbjct: 84  HPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAY 140
Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 439
           L       VHRD+   N+LV S   VK+ DFGLSR  +   Y  +       +WM+PE +
Sbjct: 141 LESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 198
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
                   SDV+ F V +WE+++  K       ++ +  V  KG RL  P    P++  L
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 258
Query: 500 IETCWAEEPEIRPSFPSIMETL 521
           +  CW  +P  RP F  ++ +L
Sbjct: 259 MTRCWDYDPSDRPRFTELVCSL 280

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 132/265 (49%), Gaps = 27/265 (10%)
Query: 266 ELLIK-KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHP 322
           EL  K  +IG+GSFG VY     ++   VA+KI I+ E  ED  ++  +E+ ++     P
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSP 77
Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
            I    G+  +   L I+ EYL  GS   LL  P     ++E     +  ++ KG++YLH
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALDLLK-PGP---LEETYIATILREILKGLDYLH 133
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
             R   +HRD+K+ N+L+     VK+ DFG++    +T I      GTP WMAPEV+++ 
Sbjct: 134 SERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---- 498
             + K+D++S G+   EL   + P  +  P +V+           IPKN  P +      
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQHSK 242
Query: 499 ----LIETCWAEEPEIRPSFPSIME 519
                +E C  ++P  RP+   +++
Sbjct: 243 PFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 16  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 75
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 132
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 133 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 188
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 243
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 244 LLKHNPSQRPMLREVLE 260

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 22/259 (8%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  +NS   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 12  IGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H ++
Sbjct: 72  RLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKK 128
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDP 443
             ++HRD+K  NLL+ S   +K+ DFG S   P    SS+ AA  GT +++ PE++    
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPPEMIEGRM 182
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALI 500
            +EK D++S GV+ +E +  + P+  +T       IS V F       P  V      LI
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFT-----FPDFVTEGARDLI 237
Query: 501 ETCWAEEPEIRPSFPSIME 519
                  P  RP    ++E
Sbjct: 238 SRLLKHNPSQRPMLREVLE 256

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 128/264 (48%), Gaps = 25/264 (9%)
Query: 266 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           EL  K ++IG+GSFG V+   + R   V    +I+ E  ED  ++  +E+ ++       
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +    G+  +   L I+ EYL  GS   LL         DE     M  ++ KG++YLH 
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHS 138
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            +   +HRD+K+ N+L+     VK+ DFG++    +T I   T  GTP WMAPEV+++  
Sbjct: 139 EKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 196
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 498
            + K+D++S G+   EL   + P  +  P +V+           IPKN  P +       
Sbjct: 197 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLVGDFTKS 247
Query: 499 ---LIETCWAEEPEIRPSFPSIME 519
               I+ C  ++P  RP+   +++
Sbjct: 248 FKEFIDACLNKDPSFRPTAKELLK 271

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 132/284 (46%), Gaps = 27/284 (9%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRN---SDVAVKI---LIEQEFHEDRFKEFLREVAIMKG 318
           + L   K +G G+FG V  A       SD A+ +   +++   H    +  + E+ ++  
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 319 L-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE------------- 364
           L  H NIV L+GA T      ++TEY   G L   L       +  +             
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 365 --RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--T 420
                L+ +Y VAKGM +L  +    +HRDL + N+L+      K+CDFGL+R   N   
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 223
Query: 421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAV 479
           Y+    A    +WMAPE +       +SDV+S+G+ LWEL +L   P+           +
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 283
Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             +G R+  P++    +  +++TCW  +P  RP+F  I++ +++
Sbjct: 284 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 132/284 (46%), Gaps = 27/284 (9%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRN---SDVAVKI---LIEQEFHEDRFKEFLREVAIMKG 318
           + L   K +G G+FG V  A       SD A+ +   +++   H    +  + E+ ++  
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 319 L-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE------------- 364
           L  H NIV L+GA T      ++TEY   G L   L       +  +             
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 365 --RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--T 420
                L+ +Y VAKGM +L  +    +HRDL + N+L+      K+CDFGL+R   N   
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 216
Query: 421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAV 479
           Y+    A    +WMAPE +       +SDV+S+G+ LWEL +L   P+           +
Sbjct: 217 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 276
Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             +G R+  P++    +  +++TCW  +P  RP+F  I++ +++
Sbjct: 277 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 132/284 (46%), Gaps = 27/284 (9%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRN---SDVAVKI---LIEQEFHEDRFKEFLREVAIMKG 318
           + L   K +G G+FG V  A       SD A+ +   +++   H    +  + E+ ++  
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 319 L-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE------------- 364
           L  H NIV L+GA T      ++TEY   G L   L       +  +             
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 365 --RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--T 420
                L+ +Y VAKGM +L  +    +HRDL + N+L+      K+CDFGL+R   N   
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARHIKNDSN 223
Query: 421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAV 479
           Y+    A    +WMAPE +       +SDV+S+G+ LWEL +L   P+           +
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 283
Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
             +G R+  P++    +  +++TCW  +P  RP+F  I++ +++
Sbjct: 284 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 135/276 (48%), Gaps = 26/276 (9%)
Query: 255 LEEEGLEIRWSELL-IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREV 313
           L+E+ L  +  E+  + +K+GEGS+G+VY A  + +   V I  +Q   E   +E ++E+
Sbjct: 18  LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAI--KQVPVESDLQEIIKEI 75
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
           +IM+    P++V   G+  +  +L IV EY   GS+  ++ + +  +  DE     +   
Sbjct: 76  SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA--TILQS 133
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 433
             KG+ YLH  R   +HRD+K+ N+L+++    K+ DFG++    +         GTP W
Sbjct: 134 TLKGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFW 191
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           MAPEV++E   N  +D++S G+   E+   + P+ +  P + I           IP N  
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI---------FMIPTNPP 242
Query: 494 PM----------VAALIETCWAEEPEIRPSFPSIME 519
           P               ++ C  + PE R +   +++
Sbjct: 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 132/271 (48%), Gaps = 20/271 (7%)
Query: 257 EEGLEIRWS--ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR- 311
           EE  + +W+  +  I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR 
Sbjct: 24  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           EV I   LRHPNI+ L G   +   + ++ EY   G++Y+ L         DE+      
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYI 140
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
            ++A  ++Y H +R  ++HRD+K  NLL+ S   +K+ DFG S   P++        GT 
Sbjct: 141 TELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRDDLCGTL 196
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEI 488
           +++ PE++     +EK D++S GV+ +E +  + P+  +T  +    IS V F       
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----F 251
Query: 489 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
           P  V      LI       P  RP    ++E
Sbjct: 252 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 90/340 (26%), Positives = 144/340 (42%), Gaps = 78/340 (22%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 31  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 89
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTE--------------------YLSRGSLYKLLHIPD 357
             H N+V L+GA T+P   L ++ E                    Y ++G+ ++      
Sbjct: 90  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 149
Query: 358 ARVVVDERLRLN-------------------------------------------MAYDV 374
             + VD + RL+                                            ++ V
Sbjct: 150 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQV 209
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPE 432
           AKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+    A    +
Sbjct: 210 AKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 267
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       +G R+  P  
Sbjct: 268 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 327
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 328 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 367

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 90/340 (26%), Positives = 144/340 (42%), Gaps = 78/340 (22%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 29  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 87
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTE--------------------YLSRGSLYKLLHIPD 357
             H N+V L+GA T+P   L ++ E                    Y ++G+ ++      
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 147
Query: 358 ARVVVDERLRLN-------------------------------------------MAYDV 374
             + VD + RL+                                            ++ V
Sbjct: 148 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQV 207
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPE 432
           AKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+    A    +
Sbjct: 208 AKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 265
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       +G R+  P  
Sbjct: 266 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 325
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 326 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 365

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + R   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 9   IGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 68
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 69  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 125
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 126 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 181
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 236
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 237 LLKHNPSQRPMLREVLE 253

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 135/270 (50%), Gaps = 19/270 (7%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVL 326
           +KIG+G+ GTVY A     DVA   ++ I Q   + + K+   + E+ +M+  ++PNIV 
Sbjct: 26  EKIGQGASGTVYTA----MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            + +      L +V EYL+ GSL  ++        +DE     +  +  + + +LH  + 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ- 136
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRD+KS N+L+    +VK+ DFG             T  GTP WMAPEV+       
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 505
           K D++S G++  E+I  + P+ N  P + +  +   G   L+ P+ ++ +    +  C  
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 506 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 535
            + E R S   +++   QFL   + +PLS+
Sbjct: 256 MDVEKRGSAKELLQ--HQFL--KIAKPLSS 281

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 132/257 (51%), Gaps = 10/257 (3%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           I  ++G+G+FG VY A+ + +       + +   E+  ++++ E+ I+    HP IV L+
Sbjct: 15  IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 74
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
           GA      L I+ E+   G++  ++   D R + + ++++ +   + + +N+LH +R  I
Sbjct: 75  GAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQV-VCRQMLEALNFLHSKR--I 130
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-----LREDP 443
           +HRDLK+ N+L+     +++ DFG+S     T     +  GTP WMAPEV     +++ P
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 190
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALIET 502
            + K+D++S G+ L E+  ++ P     P +V+  +       L  P   +      ++ 
Sbjct: 191 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKI 250
Query: 503 CWAEEPEIRPSFPSIME 519
              + PE RPS   ++E
Sbjct: 251 ALDKNPETRPSAAQLLE 267

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 10/244 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V     + +    A+KIL ++    +D     + E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             A      L  V EY + G L+   H+   RV  +ER R   A ++   + YLH R   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSR--D 125
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RD+K  NL++D    +K+ DFGL +   +   + K   GTPE++APEVL ++     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   +  P+ ++P   +L+     ++
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 243
Query: 508 PEIR 511
           P+ R
Sbjct: 244 PKQR 247

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 10/244 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V     + +    A+KIL ++    +D     + E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             A      L  V EY + G L+   H+   RV  +ER R   A ++   + YLH R   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSR--D 125
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RD+K  NL++D    +K+ DFGL +   +   + K   GTPE++APEVL ++     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   +  P+ ++P   +L+     ++
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 243
Query: 508 PEIR 511
           P+ R
Sbjct: 244 PKQR 247

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 14  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 73
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 74  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 130
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 131 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMIEGRMHD 186
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 241
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 242 LLKHNPSQRPMLREVLE 258

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 132/257 (51%), Gaps = 10/257 (3%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           I  ++G+G+FG VY A+ + +       + +   E+  ++++ E+ I+    HP IV L+
Sbjct: 23  IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
           GA      L I+ E+   G++  ++   D R + + ++++ +   + + +N+LH +R  I
Sbjct: 83  GAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQV-VCRQMLEALNFLHSKR--I 138
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-----LREDP 443
           +HRDLK+ N+L+     +++ DFG+S     T     +  GTP WMAPEV     +++ P
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALIET 502
            + K+D++S G+ L E+  ++ P     P +V+  +       L  P   +      ++ 
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKI 258
Query: 503 CWAEEPEIRPSFPSIME 519
              + PE RPS   ++E
Sbjct: 259 ALDKNPETRPSAAQLLE 275

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 14  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 73
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 74  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 130
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ +FG S   P++     T  GT +++ PE++     +
Sbjct: 131 --VIHRDIKPENLLLGSAGELKIANFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 186
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 241
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 242 LLKHNPSQRPMLREVLE 258

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 13  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 129
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHD 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 240
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 241 LLKHNPSQRPMLREVLE 257

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 12  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 128
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTELCGTLDYLPPEMIEGRMHD 184
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 240 LLKHNPSQRPMLREVLE 256

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 10/244 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V     + +    A+KIL ++    +D     + E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             A      L  V EY + G L+   H+   RV  +ER R   A ++   + YLH R   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSR--D 125
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RD+K  NL++D    +K+ DFGL +   +   + K   GTPE++APEVL ++     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRA 185
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   +  P+ ++P   +L+     ++
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 243
Query: 508 PEIR 511
           P+ R
Sbjct: 244 PKQR 247

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 10/244 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V     + +    A+KIL ++    +D     + E  +++  RHP +  L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             A      L  V EY + G L+   H+   RV  +ER R   A ++   + YLH R   
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSR--D 130
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RD+K  NL++D    +K+ DFGL +   +   + K   GTPE++APEVL ++     
Sbjct: 131 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRA 190
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   +  P+ ++P   +L+     ++
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 248
Query: 508 PEIR 511
           P+ R
Sbjct: 249 PKQR 252

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 12  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 128
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHD 184
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 240 LLKHNPSQRPMLREVLE 256

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 15  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 131
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ +FG S   P++     T  GT +++ PE++     +
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIANFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 187
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 242
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 243 LLKHNPSQRPMLREVLE 259

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 115/217 (52%), Gaps = 9/217 (4%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           I  ++G+G+FG VY A+ + + V     +     E+  ++++ E+ I+    HPNIV L+
Sbjct: 41  IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            A     NL I+ E+ + G++  ++ +   R + + ++++ +       +NYLH  +  I
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDAVM-LELERPLTESQIQV-VCKQTLDALNYLHDNK--I 156
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-----REDP 443
           +HRDLK+ N+L      +K+ DFG+S           +  GTP WMAPEV+     ++ P
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG 480
            + K+DV+S G+ L E+  ++ P     P +V+  + 
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 12  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 128
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHD 184
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 240 LLKHNPSQRPMLREVLE 256

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 15  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 131
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMIEGRMHD 187
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 242
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 243 LLKHNPSQRPMLREVLE 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 17  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 76
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 133
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 134 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHD 189
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 244
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 245 LLKHNPSQRPMLREVLE 261

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 12  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 128
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTXLCGTLDYLPPEMIEGRMHD 184
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 240 LLKHNPSQRPMLREVLE 256

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 15  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 74
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 131
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 132 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRDDLCGTLDYLPPEMIEGRMHD 187
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 242
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 243 LLKHNPSQRPMLREVLE 259

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 89/338 (26%), Positives = 143/338 (42%), Gaps = 78/338 (23%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+ I+  +
Sbjct: 24  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHI 82
Query: 320 -RHPNIVLLMGAVTEPPN-LSIVTE--------------------YLSRGSLYKLLHIPD 357
             H N+V L+GA T+P   L ++ E                    Y ++G+ ++      
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 142
Query: 358 ARVVVDERLRLN-------------------------------------------MAYDV 374
             + VD + RL+                                            ++ V
Sbjct: 143 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQV 202
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPE 432
           AKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+    A    +
Sbjct: 203 AKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       +G R+  P  
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 320
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
             P +   +  CW  EP  RP+F  ++E L   L ++ 
Sbjct: 321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 12  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 128
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 129 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRXXLCGTLDYLPPEMIEGRMHD 184
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 240 LLKHNPSQRPMLREVLE 256

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 132/301 (43%), Gaps = 51/301 (16%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPN 323
           ++ + K+IG+G +G V+  +WR   VAVK+    E        + RE  I +   +RH N
Sbjct: 38  QIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHEN 92
Query: 324 IVLLMGAVTEPPN----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           I+  + A  +       L ++T+Y   GSLY  L        +D +  L +AY    G+ 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 380 YLH------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTY-ISSKTAAG 429
           +LH      Q +P I HRDLKS N+LV    T  + D GL+    S  N   I   T  G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 430 TPEWMAPEVLRED------PSNEKSDVFSFGVILWELI----------TLQKPWRNSTPS 473
           T  +M PEVL E        S   +D++SFG+ILWE+             Q P+ +  PS
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
Query: 474 -----QVISAVGFKGRRLEIPKNVNP-----MVAALIETCWAEEPEIRPSFPSIMETLQQ 523
                 +   V  K  R   P   +       +  L+  CWA  P  R +   + +TL +
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 524 F 524
Sbjct: 329 M 329

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 127/256 (49%), Gaps = 9/256 (3%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAI 315
           G  +  +E    K +G+G+FG V   + + +    A+KIL ++    +D     L E  +
Sbjct: 2   GSRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 61
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           ++  RHP +  L  +      L  V EY + G L+   H+   RV  ++R R   A ++ 
Sbjct: 62  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIV 118
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMA 435
             ++YLH  +  +V+RDLK  NL++D    +K+ DFGL +       + K   GTPE++A
Sbjct: 119 SALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 177
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           PEVL ++      D +  GV+++E++  + P+ N    ++   +  +   +  P+ + P 
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPE 235
Query: 496 VAALIETCWAEEPEIR 511
             +L+     ++P+ R
Sbjct: 236 AKSLLSGLLKKDPKQR 251

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 114/217 (52%), Gaps = 9/217 (4%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           I  ++G+G+FG VY A+ + + V     +     E+  ++++ E+ I+    HPNIV L+
Sbjct: 41  IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            A     NL I+ E+ + G++  ++ +   R + + ++++ +       +NYLH  +  I
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDAVM-LELERPLTESQIQV-VCKQTLDALNYLHDNK--I 156
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-----REDP 443
           +HRDLK+ N+L      +K+ DFG+S              GTP WMAPEV+     ++ P
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG 480
            + K+DV+S G+ L E+  ++ P     P +V+  + 
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVL 326
           +KIG+G+ GTVY A     DVA   ++ I Q   + + K+   + E+ +M+  ++PNIV 
Sbjct: 26  EKIGQGASGTVYTA----MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            + +      L +V EYL+ GSL  ++        +DE     +  +  + + +LH  + 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ- 136
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRD+KS N+L+    +VK+ DFG                GTP WMAPEV+       
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 195
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 505
           K D++S G++  E+I  + P+ N  P + +  +   G   L+ P+ ++ +    +  C  
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255
Query: 506 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 535
            + E R S   +++   QFL   + +PLS+
Sbjct: 256 MDVEKRGSAKELLQ--HQFL--KIAKPLSS 281

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 124/244 (50%), Gaps = 9/244 (3%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V   + + +    A+KIL ++    +D     L E  +++  RHP +  L
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +      L  V EY + G L+   H+   RV  ++R R   A ++   ++YLH  +  
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN- 272
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RDLK  NL++D    +K+ DFGL +       + KT  GTPE++APEVL ++     
Sbjct: 273 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 332
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   +  P+ + P   +L+     ++
Sbjct: 333 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEAKSLLSGLLKKD 390
Query: 508 PEIR 511
           P+ R
Sbjct: 391 PKQR 394

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 124/244 (50%), Gaps = 9/244 (3%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +G+G+FG V   + + +    A+KIL ++    +D     L E  +++  RHP +  L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +      L  V EY + G L+   H+   RV  ++R R   A ++   ++YLH  +  
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN- 269
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +V+RDLK  NL++D    +K+ DFGL +       + KT  GTPE++APEVL ++     
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 329
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D +  GV+++E++  + P+ N    ++   +  +   +  P+ + P   +L+     ++
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEAKSLLSGLLKKD 387
Query: 508 PEIR 511
           P+ R
Sbjct: 388 PKQR 391

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 135/270 (50%), Gaps = 19/270 (7%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVL 326
           +KIG+G+ GTVY A     DVA   ++ I Q   + + K+   + E+ +M+  ++PNIV 
Sbjct: 27  EKIGQGASGTVYTA----MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            + +      L +V EYL+ GSL  ++        +DE     +  +  + + +LH  + 
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ- 137
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HR++KS N+L+    +VK+ DFG             T  GTP WMAPEV+       
Sbjct: 138 -VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 196
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 505
           K D++S G++  E+I  + P+ N  P + +  +   G   L+ P+ ++ +    +  C  
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 506 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 535
            + E R S   +++   QFL   + +PLS+
Sbjct: 257 MDVEKRGSAKELIQ--HQFL--KIAKPLSS 282

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVL 326
           +KIG+G+ GTVY A     DVA   ++ I Q   + + K+   + E+ +M+  ++PNIV 
Sbjct: 26  EKIGQGASGTVYTA----MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            + +      L +V EYL+ GSL  ++        +DE     +  +  + + +LH  + 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ- 136
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRD+KS N+L+    +VK+ DFG                GTP WMAPEV+       
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGP 195
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 505
           K D++S G++  E+I  + P+ N  P + +  +   G   L+ P+ ++ +    +  C  
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 506 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 535
            + E R S   +++   QFL   + +PLS+
Sbjct: 256 MDVEKRGSAKELLQ--HQFL--KIAKPLSS 281

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVL 326
           +KIG+G+ GTVY A     DVA   ++ I Q   + + K+   + E+ +M+  ++PNIV 
Sbjct: 27  EKIGQGASGTVYTA----MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            + +      L +V EYL+ GSL  ++        +DE     +  +  + + +LH  + 
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ- 137
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRD+KS N+L+    +VK+ DFG                GTP WMAPEV+       
Sbjct: 138 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 196
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 505
           K D++S G++  E+I  + P+ N  P + +  +   G   L+ P+ ++ +    +  C  
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 506 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 535
            + E R S   +++   QFL   + +PLS+
Sbjct: 257 MDVEKRGSAKELIQ--HQFL--KIAKPLSS 282

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 126/253 (49%), Gaps = 9/253 (3%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKG 318
           +  +E    K +G+G+FG V   + + +    A+KIL ++    +D     L E  +++ 
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
            RHP +  L  +      L  V EY + G L+   H+   RV  ++R R   A ++   +
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSAL 123
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           +YLH  +  +V+RDLK  NL++D    +K+ DFGL +       + K   GTPE++APEV
Sbjct: 124 DYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 182
Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           L ++      D +  GV+++E++  + P+ N    ++   +  +   +  P+ + P   +
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEAKS 240
Query: 499 LIETCWAEEPEIR 511
           L+     ++P+ R
Sbjct: 241 LLSGLLKKDPKQR 253

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 126/253 (49%), Gaps = 9/253 (3%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKG 318
           +  +E    K +G+G+FG V   + + +    A+KIL ++    +D     L E  +++ 
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
            RHP +  L  +      L  V EY + G L+   H+   RV  ++R R   A ++   +
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSAL 122
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           +YLH  +  +V+RDLK  NL++D    +K+ DFGL +       + K   GTPE++APEV
Sbjct: 123 DYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 181
Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           L ++      D +  GV+++E++  + P+ N    ++   +  +   +  P+ + P   +
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEAKS 239
Query: 499 LIETCWAEEPEIR 511
           L+     ++P+ R
Sbjct: 240 LLSGLLKKDPKQR 252

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 114/219 (52%), Gaps = 13/219 (5%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  R S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 16  IGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNIL 75
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSYCHSKR 132
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 133 --VIHRDIKPENLLLGSNGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHD 188
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGF 481
           EK D++S GV+ +E +    P+   T  +    IS V F
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF 227

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 114/219 (52%), Gaps = 13/219 (5%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  R S   +A+K+L + +  +   +  LR EV I   LRHPNI+
Sbjct: 16  IGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNIL 75
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSYCHSKR 132
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE++     +
Sbjct: 133 --VIHRDIKPENLLLGSNGELKIADFGWSVHAPSS--RRDTLCGTLDYLPPEMIEGRMHD 188
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGF 481
           EK D++S GV+ +E +    P+   T  +    IS V F
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF 227

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 51/300 (17%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNI 324
           +++++ IG+G FG V+  +WR  +VAVKI   +E      + + RE  I +   LRH NI
Sbjct: 44  IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENI 98
Query: 325 VLLMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           +  + A  +       L +V++Y   GSL+  L+    R  V     + +A   A G+ +
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAH 154
Query: 381 LH------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTY-ISSKTAAGT 430
           LH      Q +P I HRDLKS N+LV    T  + D GL+    S  +T  I+     GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 431 PEWMAPEVLRED------PSNEKSDVFSFGVILWELIT----------LQKPWRNSTPS- 473
             +MAPEVL +        S +++D+++ G++ WE+             Q P+ +  PS 
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 474 ----QVISAVGFKGRRLEIPKNVNP-----MVAALIETCWAEEPEIRPSFPSIMETLQQF 524
               ++   V  +  R  IP          ++A ++  CW      R +   I +TL Q 
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 51/300 (17%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNI 324
           +++++ IG+G FG V+  +WR  +VAVKI   +E      + + RE  I +   LRH NI
Sbjct: 11  IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENI 65
Query: 325 VLLMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           +  + A  +       L +V++Y   GSL+  L+    R  V     + +A   A G+ +
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAH 121
Query: 381 LH------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTY-ISSKTAAGT 430
           LH      Q +P I HRDLKS N+LV    T  + D GL+    S  +T  I+     GT
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 181
Query: 431 PEWMAPEVLRED------PSNEKSDVFSFGVILWELIT----------LQKPWRNSTPS- 473
             +MAPEVL +        S +++D+++ G++ WE+             Q P+ +  PS 
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 241
Query: 474 ----QVISAVGFKGRRLEIPKNVNP-----MVAALIETCWAEEPEIRPSFPSIMETLQQF 524
               ++   V  +  R  IP          ++A ++  CW      R +   I +TL Q 
Sbjct: 242 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 301

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 51/300 (17%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNI 324
           +++++ IG+G FG V+  +WR  +VAVKI   +E      + + RE  I +   LRH NI
Sbjct: 5   IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENI 59
Query: 325 VLLMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           +  + A  +       L +V++Y   GSL+  L+    R  V     + +A   A G+ +
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAH 115
Query: 381 LH------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTY-ISSKTAAGT 430
           LH      Q +P I HRDLKS N+LV    T  + D GL+    S  +T  I+     GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 431 PEWMAPEVLRED------PSNEKSDVFSFGVILWELIT----------LQKPWRNSTPS- 473
             +MAPEVL +        S +++D+++ G++ WE+             Q P+ +  PS 
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 474 ----QVISAVGFKGRRLEIPKNVNP-----MVAALIETCWAEEPEIRPSFPSIMETLQQF 524
               ++   V  +  R  IP          ++A ++  CW      R +   I +TL Q 
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 51/300 (17%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNI 324
           +++++ IG+G FG V+  +WR  +VAVKI   +E      + + RE  I +   LRH NI
Sbjct: 31  IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENI 85
Query: 325 VLLMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           +  + A  +       L +V++Y   GSL+  L+    R  V     + +A   A G+ +
Sbjct: 86  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAH 141
Query: 381 LH------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTY-ISSKTAAGT 430
           LH      Q +P I HRDLKS N+LV    T  + D GL+    S  +T  I+     GT
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 201
Query: 431 PEWMAPEVLRED------PSNEKSDVFSFGVILWELIT----------LQKPWRNSTPS- 473
             +MAPEVL +        S +++D+++ G++ WE+             Q P+ +  PS 
Sbjct: 202 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 261
Query: 474 ----QVISAVGFKGRRLEIPKNVNP-----MVAALIETCWAEEPEIRPSFPSIMETLQQF 524
               ++   V  +  R  IP          ++A ++  CW      R +   I +TL Q 
Sbjct: 262 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 321

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 51/300 (17%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNI 324
           +++++ IG+G FG V+  +WR  +VAVKI   +E      + + RE  I +   LRH NI
Sbjct: 6   IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENI 60
Query: 325 VLLMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           +  + A  +       L +V++Y   GSL+  L+    R  V     + +A   A G+ +
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAH 116
Query: 381 LH------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTY-ISSKTAAGT 430
           LH      Q +P I HRDLKS N+LV    T  + D GL+    S  +T  I+     GT
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 176
Query: 431 PEWMAPEVLRED------PSNEKSDVFSFGVILWELIT----------LQKPWRNSTPS- 473
             +MAPEVL +        S +++D+++ G++ WE+             Q P+ +  PS 
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 236
Query: 474 ----QVISAVGFKGRRLEIPKNVNP-----MVAALIETCWAEEPEIRPSFPSIMETLQQF 524
               ++   V  +  R  IP          ++A ++  CW      R +   I +TL Q 
Sbjct: 237 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 296

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 51/300 (17%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNI 324
           +++++ IG+G FG V+  +WR  +VAVKI   +E      + + RE  I +   LRH NI
Sbjct: 8   IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENI 62
Query: 325 VLLMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           +  + A  +       L +V++Y   GSL+  L+    R  V     + +A   A G+ +
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAH 118
Query: 381 LH------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTY-ISSKTAAGT 430
           LH      Q +P I HRDLKS N+LV    T  + D GL+    S  +T  I+     GT
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 178
Query: 431 PEWMAPEVLRED------PSNEKSDVFSFGVILWELIT----------LQKPWRNSTPS- 473
             +MAPEVL +        S +++D+++ G++ WE+             Q P+ +  PS 
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 238
Query: 474 ----QVISAVGFKGRRLEIPKNVNP-----MVAALIETCWAEEPEIRPSFPSIMETLQQF 524
               ++   V  +  R  IP          ++A ++  CW      R +   I +TL Q 
Sbjct: 239 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 298

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 127/257 (49%), Gaps = 18/257 (7%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKI----LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +IG GSF TVY     +++  V++    L +++  +   + F  E   +KGL+HPNIV  
Sbjct: 33  EIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 328 MGA----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             +    V     + +VTE  + G+L    ++   +V   + LR +    + KG+ +LH 
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLK--TYLKRFKVXKIKVLR-SWCRQILKGLQFLHT 147
Query: 384 RRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
           R PPI+HRDLK  N+ +   T +VK+ D GL+  K  ++  +K   GTPE+ APE   E+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFXAPEXY-EE 204
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             +E  DV++FG    E  T + P+      +Q+   V    +     K   P V  +IE
Sbjct: 205 KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 502 TCWAEEPEIRPSFPSIM 518
            C  +  + R S   ++
Sbjct: 265 GCIRQNKDERYSIKDLL 281

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 128/245 (52%), Gaps = 10/245 (4%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHED-RFKEFLRE-VAIMKGLRHPNIVLLMGA 330
           +G+G++G VY    R+    V+I I++    D R+ + L E +A+ K L+H NIV  +G+
Sbjct: 30  LGKGTYGIVYAG--RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
            +E   + I  E +  GSL  LL      +  +E+        + +G+ YLH  +  IVH
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVH 145
Query: 391 RDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS--NEK 447
           RD+K  N+L+++   V K+ DFG S+        ++T  GT ++MAPE++ + P    + 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 448 SDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 506
           +D++S G  + E+ T + P+     P   +  VG      EIP++++    A I  C+  
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 265
Query: 507 EPEIR 511
           +P+ R
Sbjct: 266 DPDKR 270

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 129/278 (46%), Gaps = 34/278 (12%)
Query: 271 KKIGEGSFGTV--YHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +GEG FG V  Y  +  N      VAVK L      + R   + +E+ I++ L H +I
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR-SGWKQEIDILRTLYHEHI 95
Query: 325 VLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           +   G   +    +L +V EY+  GSL   L     R  +     L  A  + +GM YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN---TYISSKTAAGTPEWMAPEVL 439
            +    +HRDL + N+L+D+   VK+ DFGL+++ P     Y   +       W APE L
Sbjct: 152 AQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF---------------KGR 484
           +E      SDV+SFGV L+EL+T       S P++ +  +G                +G 
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           RL  P      V  L++ CW  E   RP+F +++  L+
Sbjct: 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 128/245 (52%), Gaps = 10/245 (4%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHED-RFKEFLRE-VAIMKGLRHPNIVLLMGA 330
           +G+G++G VY    R+    V+I I++    D R+ + L E +A+ K L+H NIV  +G+
Sbjct: 16  LGKGTYGIVYAG--RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
            +E   + I  E +  GSL  LL      +  +E+        + +G+ YLH  +  IVH
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVH 131
Query: 391 RDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS--NEK 447
           RD+K  N+L+++   V K+ DFG S+        ++T  GT ++MAPE++ + P    + 
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 191
Query: 448 SDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 506
           +D++S G  + E+ T + P+     P   +  VG      EIP++++    A I  C+  
Sbjct: 192 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 251
Query: 507 EPEIR 511
           +P+ R
Sbjct: 252 DPDKR 256

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 128/255 (50%), Gaps = 17/255 (6%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG+G+F  V  A       +VA+KI+ + + +    ++  REV IMK L HPNIV L 
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +     L ++ EY S G ++  L +   R  + E+   +    +   + Y HQ+R  I
Sbjct: 78  EVIETEKTLYLIMEYASGGEVFDYL-VAHGR--MKEKEARSKFRQIVSAVQYCHQKR--I 132
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-ISSK--TAAGTPEWMAPEVLREDPSN 445
           VHRDLK+ NLL+D+   +K+ DFG S    N + +  K  T  G+P + APE+ +    +
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFS----NEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 446 E-KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
             + DV+S GVIL+ L++   P+      ++   V  +G +  IP  ++     L++   
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRG-KYRIPFYMSTDCENLLKRFL 246
Query: 505 AEEPEIRPSFPSIME 519
              P  R +   IM+
Sbjct: 247 VLNPIKRGTLEQIMK 261

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 128/262 (48%), Gaps = 12/262 (4%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKG 318
           ++    ++   +G G+FG V   E +     VAVKIL  Q+    D   +  RE+  +K 
Sbjct: 8   VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
            RHP+I+ L   ++ P +  +V EY+S G L+  +     RV   E  RL     +   +
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQ--QILSAV 124
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           +Y H  R  +VHRDLK  N+L+D+    K+ DFGLS    +     +T+ G+P + APEV
Sbjct: 125 DYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAPEV 181
Query: 439 LRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +     +  + D++S GVIL+ L+    P+ +     +   +  +G    IP+ +N  VA
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVA 239
Query: 498 ALIETCWAEEPEIRPSFPSIME 519
            L+      +P  R +   I E
Sbjct: 240 TLLMHMLQVDPLKRATIKDIRE 261

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 125/256 (48%), Gaps = 19/256 (7%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG+G+F  V  A       +VAVKI+ + + +    ++  REV IMK L HPNIV L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE-RLRLNMAYDVAKGMNYLHQRRPP 387
             +     L +V EY S G ++  L +   R+   E R +      +   + Y HQ+   
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR---QIVSAVQYCHQKF-- 133
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK---TAAGTPEWMAPEVLREDPS 444
           IVHRDLK+ NLL+D+   +K+ DFG S    N +       T  G+P + APE+ +    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 445 NE-KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           +  + DV+S GVIL+ L++   P+      ++   V  +G +  IP  ++     L++  
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRG-KYRIPFYMSTDCENLLKKF 247
Query: 504 WAEEPEIRPSFPSIME 519
               P  R +   IM+
Sbjct: 248 LILNPSKRGTLEQIMK 263

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 125/256 (48%), Gaps = 19/256 (7%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG+G+F  V  A       +VAVKI+ + + +    ++  REV IMK L HPNIV L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE-RLRLNMAYDVAKGMNYLHQRRPP 387
             +     L +V EY S G ++  L +   R+   E R +      +   + Y HQ+   
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR---QIVSAVQYCHQKF-- 133
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK---TAAGTPEWMAPEVLREDPS 444
           IVHRDLK+ NLL+D+   +K+ DFG S    N +       T  G+P + APE+ +    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 445 NE-KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           +  + DV+S GVIL+ L++   P+      ++   V  +G +  IP  ++     L++  
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRG-KYRIPFYMSTDCENLLKKF 247
Query: 504 WAEEPEIRPSFPSIME 519
               P  R +   IM+
Sbjct: 248 LILNPSKRGTLEQIMK 263

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 126/264 (47%), Gaps = 13/264 (4%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMG 329
           +G+G F   Y     ++    A K++ +    +   KE +  E+AI K L +P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              +   + +V E   R SL   L +   R  V E           +G+ YLH  R  ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VI 164
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 449
           HRDLK  NL ++    VK+ DFGL+          KT  GTP ++APEVL +   + + D
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVD 224
Query: 450 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 509
           ++S G IL+ L+  + P+  S   +  + +  K     +P+++NP+ +ALI      +P 
Sbjct: 225 IWSLGCILYTLLVGKPPFETSCLKE--TYIRIKKNEYSVPRHINPVASALIRRMLHADPT 282
Query: 510 IRPSFPSIMETLQQFLMSSVCQPL 533
           +R   PS+ E L     +S   P+
Sbjct: 283 LR---PSVAELLTDEFFTSGYAPM 303

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 89/277 (32%), Positives = 132/277 (47%), Gaps = 32/277 (11%)
Query: 271 KKIGEGSFGTV--YHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +GEG FG V  Y  +  N      VAVK L E    + R   + RE+ I++ L H +I
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR-SGWQREIEILRTLYHEHI 72
Query: 325 VLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           V   G   +    S+  V EY+  GSL   L     R  V     L  A  + +GM YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTPE-WMAPEVL 439
            +    +HR L + N+L+D+   VK+ DFGL+++ P  + Y   +    +P  W APE L
Sbjct: 129 AQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 440 REDPSNEKSDVFSFGVILWELITL----QKPWR------NSTPSQV----ISAVGFKGRR 485
           +E      SDV+SFGV L+EL+T     Q P          T  Q+    ++ +  +G R
Sbjct: 187 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGER 246
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           L  P      +  L++ CW  E   RP+F +++  LQ
Sbjct: 247 LPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 89/277 (32%), Positives = 132/277 (47%), Gaps = 32/277 (11%)
Query: 271 KKIGEGSFGTV--YHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +GEG FG V  Y  +  N      VAVK L E    + R   + RE+ I++ L H +I
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR-SGWQREIEILRTLYHEHI 73
Query: 325 VLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           V   G   +    S+  V EY+  GSL   L     R  V     L  A  + +GM YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTPE-WMAPEVL 439
            +    +HR L + N+L+D+   VK+ DFGL+++ P  + Y   +    +P  W APE L
Sbjct: 130 AQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 440 REDPSNEKSDVFSFGVILWELITL----QKPWR------NSTPSQV----ISAVGFKGRR 485
           +E      SDV+SFGV L+EL+T     Q P          T  Q+    ++ +  +G R
Sbjct: 188 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGER 247
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           L  P      +  L++ CW  E   RP+F +++  LQ
Sbjct: 248 LPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 132/278 (47%), Gaps = 34/278 (12%)
Query: 271 KKIGEGSFGTV--YHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +GEG FG V  Y  +  N      VAVK L      + R   + +E+ I++ L H +I
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR-SGWKQEIDILRTLYHEHI 78
Query: 325 VLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           +   G   +    +L +V EY+  GSL   L     R  +     L  A  + +GM YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTPE-WMAPEVL 439
            +    +HR+L + N+L+D+   VK+ DFGL+++ P  + Y   +    +P  W APE L
Sbjct: 135 SQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF---------------KGR 484
           +E      SDV+SFGV L+EL+T       S P++ +  +G                +G 
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 251
Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           RL  P      V  L++ CW  E   RP+F +++  L+
Sbjct: 252 RLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 132/278 (47%), Gaps = 34/278 (12%)
Query: 271 KKIGEGSFGTV--YHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +GEG FG V  Y  +  N      VAVK L      + R   + +E+ I++ L H +I
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR-SGWKQEIDILRTLYHEHI 78
Query: 325 VLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           +   G   +    +L +V EY+  GSL   L     R  +     L  A  + +GM YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTPE-WMAPEVL 439
            +    +HR+L + N+L+D+   VK+ DFGL+++ P  + Y   +    +P  W APE L
Sbjct: 135 AQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF---------------KGR 484
           +E      SDV+SFGV L+EL+T       S P++ +  +G                +G 
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 251
Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
           RL  P      V  L++ CW  E   RP+F +++  L+
Sbjct: 252 RLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG+G+F  V  A       +VA+KI+ + + +    ++  REV IMK L HPNIV L 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +     L ++ EY S G ++  L +   R  + E+   +    +   + Y HQ+R  I
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYL-VAHGR--MKEKEARSKFRQIVSAVQYCHQKR--I 135
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-ISSKTAA--GTPEWMAPEVLREDPSN 445
           VHRDLK+ NLL+D+   +K+ DFG S    N + +  K  A  G P + APE+ +    +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFS----NEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 446 E-KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
             + DV+S GVIL+ L++   P+      ++   V  +G +  IP  ++     L++   
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRG-KYRIPFYMSTDCENLLKRFL 249
Query: 505 AEEPEIRPSFPSIME 519
              P  R +   IM+
Sbjct: 250 VLNPIKRGTLEQIMK 264

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 116/225 (51%), Gaps = 23/225 (10%)
Query: 271 KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRF-----------KEFLREVAIMK 317
           +K+G G++G V   + +N  S+ A+K++ + +F + R+           +E   E++++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
            L HPNI+ L     +     +VTE+   G L++ +     R   DE    N+   +  G
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSG 158
Query: 378 MNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 434
           + YLH  +  IVHRD+K  N+L+   +S   +K+ DFGLS      Y   +   GT  ++
Sbjct: 159 ICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAYYI 215
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           APEVL++   NEK DV+S GVI++ L+    P+       +I  V
Sbjct: 216 APEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 122/258 (47%), Gaps = 15/258 (5%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLL 327
           IG GS+G       R SD   KIL+ +E       E      + EV +++ L+HPNIV  
Sbjct: 14  IGTGSYGRCQKIR-RKSDG--KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 328 MGAVTEPPN--LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
              + +  N  L IV EY   G L  ++      R  +DE   L +   +   +   H+R
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 385 RP---PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
                 ++HRDLK  N+ +D    VK+ DFGL+R   +    +KT  GTP +M+PE +  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
              NEKSD++S G +L+EL  L  P+   +  ++   +  +G+   IP   +  +  +I 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEIIT 249
Query: 502 TCWAEEPEIRPSFPSIME 519
                +   RPS   I+E
Sbjct: 250 RMLNLKDYHRPSVEEILE 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 125/256 (48%), Gaps = 19/256 (7%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG+G+F  V  A       +VAV+I+ + + +    ++  REV IMK L HPNIV L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE-RLRLNMAYDVAKGMNYLHQRRPP 387
             +     L +V EY S G ++  L +   R+   E R +      +   + Y HQ+   
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR---QIVSAVQYCHQKF-- 133
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK---TAAGTPEWMAPEVLREDPS 444
           IVHRDLK+ NLL+D+   +K+ DFG S    N +       T  G+P + APE+ +    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 445 NE-KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           +  + DV+S GVIL+ L++   P+      ++   V  +G +  IP  ++     L++  
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRG-KYRIPFYMSTDCENLLKKF 247
Query: 504 WAEEPEIRPSFPSIME 519
               P  R +   IM+
Sbjct: 248 LILNPSKRGTLEQIMK 263

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 142/303 (46%), Gaps = 37/303 (12%)
Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMK 317
           +E+    L +++ + EG F  VY A+   S  + A+K L+  E  E++ +  ++EV  MK
Sbjct: 23  VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMK 80
Query: 318 GLR-HPNIVLLMGAV--------TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
            L  HPNIV    A         T      ++TE L +G L + L   ++R  +     L
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS---KPNTYISSK 425
            + Y   + + ++H+++PPI+HRDLK  NLL+ +  T+K+CDFG + +    P+   S++
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 426 ---------TAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 473
                    T   TP +  PE++      P  EK D+++ G IL+ L   Q P+ +    
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
Query: 474 QVISAVGFKGRRLEIPKNVNPMVA--ALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           ++++       +  IP +        +LI       PE R S   ++  LQ+   +    
Sbjct: 260 RIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313
Query: 532 PLS 534
           P S
Sbjct: 314 PKS 316

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/254 (31%), Positives = 125/254 (49%), Gaps = 15/254 (5%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG+G+F  V  A       +VAVKI+ + + +    ++  REV IMK L HPNIV L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE-RLRLNMAYDVAKGMNYLHQRRPP 387
             +     L +V EY S G ++  L +   R+   E R +      +   + Y HQ+   
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR---QIVSAVQYCHQKF-- 133
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA-AGTPEWMAPEVLREDPSNE 446
           IVHRDLK+ NLL+D+   +K+ DFG S     T+ +   A  G P + APE+ +    + 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNE--FTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 447 -KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
            + DV+S GVIL+ L++   P+      ++   V  +G +  IP  ++     L++    
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRG-KYRIPFYMSTDCENLLKKFLI 249
Query: 506 EEPEIRPSFPSIME 519
             P  R +   IM+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 130/264 (49%), Gaps = 16/264 (6%)
Query: 262 IRWSELLIKKKIGEGSFGTVY--HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKG 318
           ++    ++   +G G+FG V     E     VAVKIL  Q+    D   +  RE+  +K 
Sbjct: 13  VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL 72
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
            RHP+I+ L   ++ P ++ +V EY+S G L+  +   + R+  DE+    +   +  G+
Sbjct: 73  FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRL--DEKESRRLFQQILSGV 129
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           +Y H  R  +VHRDLK  N+L+D+    K+ DFGLS    +     + + G+P + APEV
Sbjct: 130 DYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRXSCGSPNYAAPEV 186
Query: 439 LRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV--GFKGRRLEIPKNVNPM 495
           +     +  + D++S GVIL+ L+    P+ +     +   +  G        P+ +NP 
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----FYTPQYLNPS 242
Query: 496 VAALIETCWAEEPEIRPSFPSIME 519
           V +L++     +P  R +   I E
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIRE 266

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 104/202 (51%), Gaps = 5/202 (2%)
Query: 270 KKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K  +G G FG VY     +   VAVK L E+        +F  EV ++    H N++ L 
Sbjct: 43  KNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL-QFQTEVEMISMAVHRNLLRLR 101
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RP 386
           G    P    +V  Y++ GS+   L   P+++  +D   R  +A   A+G+ YLH    P
Sbjct: 102 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-GTPEWMAPEVLREDPSN 445
            I+HRD+K+ N+L+D  +   V DFGL++           A  GT   +APE L    S+
Sbjct: 162 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSS 221
Query: 446 EKSDVFSFGVILWELITLQKPW 467
           EK+DVF +GV+L ELIT Q+ +
Sbjct: 222 EKTDVFGYGVMLLELITGQRAF 243

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 122/255 (47%), Gaps = 17/255 (6%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG+G+F  V  A       +VAVKI+ + + +    ++  REV IMK L HPNIV L 
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +     L +V EY S G ++  L         + R +      +   + Y HQ+   I
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR---QIVSAVQYCHQKF--I 127
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK---TAAGTPEWMAPEVLREDPSN 445
           VHRDLK+ NLL+D+   +K+ DFG S    N +       T  G+P + APE+ +    +
Sbjct: 128 VHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 446 E-KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
             + DV+S GVIL+ L++   P+      ++   V  +G +  IP  ++     L++   
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRG-KYRIPFYMSTDCENLLKKFL 241
Query: 505 AEEPEIRPSFPSIME 519
              P  R +   IM+
Sbjct: 242 ILNPSKRGTLEQIMK 256

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 126/242 (52%), Gaps = 13/242 (5%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFL---REVAIMKGL 319
           S+    K IG+GSFG V  A  +  +V  AVK+L ++   + + ++ +   R V ++K +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNV 96
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           +HP +V L  +      L  V +Y++ G L+   H+   R  ++ R R   A ++A  + 
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALG 153
Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           YLH     IV+RDLK  N+L+DS   + + DFGL +       ++ T  GTPE++APEVL
Sbjct: 154 YLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
            + P +   D +  G +L+E++    P+ +   +++   +    + L++  N+      L
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNSARHL 269
Query: 500 IE 501
           +E
Sbjct: 270 LE 271

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 15/205 (7%)
Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           ++K IG+G+F  V  A       +VAVKI+ + + +    ++  REV IMK L HPNIV 
Sbjct: 19  LQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE-RLRLNMAYDVAKGMNYLHQRR 385
           L   +     L +V EY S G ++  L +   R+   E R +      +   + Y HQ+ 
Sbjct: 79  LFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQ---IVSAVQYCHQKY 134
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPEVLREDP 443
             IVHRDLK+ NLL+D    +K+ DFG S       + +K  T  G+P + APE+ +   
Sbjct: 135 --IVHRDLKAENLLLDGDMNIKIADFGFSNE---FTVGNKLDTFCGSPPYAAPELFQGKK 189
Query: 444 SNE-KSDVFSFGVILWELITLQKPW 467
            +  + DV+S GVIL+ L++   P+
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 13/264 (4%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMG 329
           +G+G F   Y     ++    A K++ +    +   KE +  E+AI K L +P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              +   + +V E   R SL   L +   R  V E           +G+ YLH  R  ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VI 164
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 449
           HRDLK  NL ++    VK+ DFGL+          K   GTP ++APEVL +   + + D
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVD 224
Query: 450 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 509
           ++S G IL+ L+  + P+  S   +  + +  K     +P+++NP+ +ALI      +P 
Sbjct: 225 IWSLGCILYTLLVGKPPFETSCLKE--TYIRIKKNEYSVPRHINPVASALIRRMLHADPT 282
Query: 510 IRPSFPSIMETLQQFLMSSVCQPL 533
           +R   PS+ E L     +S   P+
Sbjct: 283 LR---PSVAELLTDEFFTSGYAPM 303

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 12/262 (4%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKG 318
           ++    ++   +G G+FG V   E +     VAVKIL  Q+    D   +  RE+  +K 
Sbjct: 8   VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
            RHP+I+ L   ++ P +  +V EY+S G L+  +     RV   E  RL     +   +
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQ--QILSAV 124
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           +Y H  R  +VHRDLK  N+L+D+    K+ DFGLS    +     + + G+P + APEV
Sbjct: 125 DYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRDSCGSPNYAAPEV 181
Query: 439 LRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +     +  + D++S GVIL+ L+    P+ +     +   +  +G    IP+ +N  VA
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVA 239
Query: 498 ALIETCWAEEPEIRPSFPSIME 519
            L+      +P  R +   I E
Sbjct: 240 TLLMHMLQVDPLKRATIKDIRE 261

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 13/264 (4%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMG 329
           +G+G F   Y     ++    A K++ +    +   KE +  E+AI K L +P++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              +   + +V E   R SL   L +   R  V E           +G+ YLH  R  ++
Sbjct: 94  FFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VI 148
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 449
           HRDLK  NL ++    VK+ DFGL+          K   GTP ++APEVL +   + + D
Sbjct: 149 HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVD 208
Query: 450 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 509
           ++S G IL+ L+  + P+  S   +  + +  K     +P+++NP+ +ALI      +P 
Sbjct: 209 IWSLGCILYTLLVGKPPFETSCLKE--TYIRIKKNEYSVPRHINPVASALIRRMLHADPT 266
Query: 510 IRPSFPSIMETLQQFLMSSVCQPL 533
           +R   PS+ E L     +S   P+
Sbjct: 267 LR---PSVAELLTDEFFTSGYAPM 287

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 13/264 (4%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMG 329
           +G+G F   Y     ++    A K++ +    +   KE +  E+AI K L +P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              +   + +V E   R SL   L +   R  V E           +G+ YLH  R  ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VI 164
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 449
           HRDLK  NL ++    VK+ DFGL+          K   GTP ++APEVL +   + + D
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVD 224
Query: 450 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 509
           ++S G IL+ L+  + P+  S   +  + +  K     +P+++NP+ +ALI      +P 
Sbjct: 225 IWSLGCILYTLLVGKPPFETSCLKE--TYIRIKKNEYSVPRHINPVASALIRRMLHADPT 282
Query: 510 IRPSFPSIMETLQQFLMSSVCQPL 533
           +R   PS+ E L     +S   P+
Sbjct: 283 LR---PSVAELLTDEFFTSGYAPM 303

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 85/162 (52%), Gaps = 5/162 (3%)
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAA 428
           ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+    A 
Sbjct: 197 SFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 254
Query: 429 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLE 487
              +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +       +G R+ 
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 314
Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
            P    P +   +  CW  EP  RP+F  ++E L   L ++ 
Sbjct: 315 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 356

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 121/258 (46%), Gaps = 15/258 (5%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLL 327
           IG GS+G       R SD   KIL+ +E       E      + EV +++ L+HPNIV  
Sbjct: 14  IGTGSYGRCQKIR-RKSDG--KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 328 MGAVTEPPN--LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
              + +  N  L IV EY   G L  ++      R  +DE   L +   +   +   H+R
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 385 RP---PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
                 ++HRDLK  N+ +D    VK+ DFGL+R   +    +K   GTP +M+PE +  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
              NEKSD++S G +L+EL  L  P+   +  ++   +  +G+   IP   +  +  +I 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEIIT 249
Query: 502 TCWAEEPEIRPSFPSIME 519
                +   RPS   I+E
Sbjct: 250 RMLNLKDYHRPSVEEILE 267

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 127/256 (49%), Gaps = 14/256 (5%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PN 323
           +L  K++G G F  V     +++  + A K L ++   +D   E L E+A+++  +  P 
Sbjct: 31  ILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           ++ L         + ++ EY + G ++ L  +P+   +V E   + +   + +G+ YLHQ
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 384 RRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
               IVH DLK  N+L+ S Y    +K+ DFG+SR K       +   GTPE++APE+L 
Sbjct: 150 NN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACELREIMGTPEYLAPEILN 206
Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVA 497
            DP    +D+++ G+I + L+T   P+      +    IS V       E   +V+ +  
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-ETFSSVSQLAT 265
Query: 498 ALIETCWAEEPEIRPS 513
             I++   + PE RP+
Sbjct: 266 DFIQSLLVKNPEKRPT 281

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 132/294 (44%), Gaps = 51/294 (17%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLLMGA 330
           +G+G +G V+   W    VAVKI     F     + + RE  I     LRH NI+  + +
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKI-----FSSRDEQSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 331 VTEPPN----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH---- 382
                N    L ++T Y   GSLY  L     R  ++  L L +A   A G+ +LH    
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQ----RQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 383 --QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS--RSKPNTY--ISSKTAAGTPEWMAP 436
             Q +P I HRD KS N+LV S     + D GL+   S+ + Y  I +    GT  +MAP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 437 EVLRED------PSNEKSDVFSFGVILWELI----------TLQKPWRNSTPS-----QV 475
           EVL E        S + +D+++FG++LWE+             + P+ +  P+      +
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDM 246
Query: 476 ISAVGFKGRRLEIPKNV--NPMVAALIET---CWAEEPEIRPSFPSIMETLQQF 524
              V    +   IP  +  +P+++ L +    CW   P  R +   I +TLQ+ 
Sbjct: 247 KKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKI 300

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 130/294 (44%), Gaps = 51/294 (17%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLL--- 327
           +G+G +G V+   W+  +VAVKI     F     K + RE  +     LRH NI+     
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFIAS 99
Query: 328 -MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH---- 382
            M +      L ++T Y   GSLY  L +      +D    L +   +A G+ +LH    
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 383 --QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISSKTAAGTPEWMAP 436
             Q +P I HRDLKS N+LV       + D GL    S+S     + +    GT  +MAP
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 437 EVLRED------PSNEKSDVFSFGVILWELI----------TLQKPWRNSTPS-----QV 475
           EVL E        S ++ D+++FG++LWE+             + P+ +  P+      +
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 275
Query: 476 ISAVGFKGRRLEIPKN--VNPM---VAALIETCWAEEPEIRPSFPSIMETLQQF 524
              V    +R  IP     +P    +A L++ CW + P  R +   I +TL + 
Sbjct: 276 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 329

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 124/256 (48%), Gaps = 19/256 (7%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG+G+F  V  A       +VAV+I+ + + +    ++  REV IMK L HPNIV L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE-RLRLNMAYDVAKGMNYLHQRRPP 387
             +     L +V EY S G ++  L +   R+   E R +      +   + Y HQ+   
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR---QIVSAVQYCHQKF-- 133
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA---AGTPEWMAPEVLREDPS 444
           IVHRDLK+ NLL+D+   +K+ DFG S    N +          G+P + APE+ +    
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 445 NE-KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           +  + DV+S GVIL+ L++   P+      ++   V  +G +  IP  ++     L++  
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRG-KYRIPFYMSTDCENLLKKF 247
Query: 504 WAEEPEIRPSFPSIME 519
               P  R +   IM+
Sbjct: 248 LILNPSKRGTLEQIMK 263

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 123/254 (48%), Gaps = 12/254 (4%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + +   +A+K+L + +  ++  +  LR E+ I   LRHPNI+
Sbjct: 19  IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 78
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            +     +   + ++ E+  RG LYK L         DE+       ++A  ++Y H+R+
Sbjct: 79  RMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+     +K+ DFG S   P+  +  +   GT +++ PE++     +
Sbjct: 136 --VIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRXMCGTLDYLPPEMIEGKTHD 191
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
           EK D++  GV+ +E +    P+   +PS   +        L+ P  ++     LI     
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPF--DSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLR 249
Query: 506 EEPEIRPSFPSIME 519
             P  R     +ME
Sbjct: 250 YHPPQRLPLKGVME 263

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 88/161 (54%), Gaps = 5/161 (3%)
Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSK 425
           ++ ++ VA+GM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K   Y+   
Sbjct: 202 ISYSFQVARGMEFLSSRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGR 484
                 +WMAPE + +   + KSDV+S+GV+LWE+ +L   P+      +   +   +G 
Sbjct: 260 DTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGM 319
Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           R+  P+   P +  ++  CW  +P+ RP F  ++E L   L
Sbjct: 320 RMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDLL 360

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 113/214 (52%), Gaps = 10/214 (4%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   VA+K+L + +  ++  +  LR E+ I   L HPNI+
Sbjct: 27  IGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNIL 86
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L     +   + ++ EY  RG LYK L         DE+    +  ++A  + Y H ++
Sbjct: 87  RLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+     +K+ DFG S   P+  +  KT  GT +++ PE++     N
Sbjct: 144 --VIHRDIKPENLLLGLKGELKIADFGWSVHAPS--LRRKTMCGTLDYLPPEMIEGRMHN 199
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           EK D++  GV+ +EL+    P+ +++ ++    +
Sbjct: 200 EKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 233

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 130/294 (44%), Gaps = 51/294 (17%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLL--- 327
           +G+G +G V+   W+  +VAVKI     F     K + RE  +     LRH NI+     
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 328 -MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH---- 382
            M +      L ++T Y   GSLY  L +      +D    L +   +A G+ +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 383 --QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISSKTAAGTPEWMAP 436
             Q +P I HRDLKS N+LV       + D GL    S+S     + +    GT  +MAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 437 EVLRED------PSNEKSDVFSFGVILWELI----------TLQKPWRNSTPS-----QV 475
           EVL E        S ++ D+++FG++LWE+             + P+ +  P+      +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 476 ISAVGFKGRRLEIPKN--VNPM---VAALIETCWAEEPEIRPSFPSIMETLQQF 524
              V    +R  IP     +P    +A L++ CW + P  R +   I +TL + 
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 127/257 (49%), Gaps = 16/257 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           KK+G G++G V     + + V  A+KI+ +         + L EVA++K L HPNI+ L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 329 GAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
               +  N  +V E    G L+ +++H    R+  +E     +   V  G+ YLH+    
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN-- 156
Query: 388 IVHRDLKSPNLLVDSTYT---VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
           IVHRDLK  NLL++S      +K+ DFGLS    N     K   GT  ++APEVLR+   
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLRK-KY 214
Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIET 502
           +EK DV+S GVIL+ L+    P+   T  +++  V       + P  KNV+     LI+ 
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 503 CWAEEPEIRPSFPSIME 519
               + + R S    +E
Sbjct: 275 MLQFDSQRRISAQQALE 291

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 121/259 (46%), Gaps = 15/259 (5%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLL 327
           IG GS+G       R SD   KIL+ +E       E      + EV +++ L+HPNIV  
Sbjct: 14  IGTGSYGRCQKIR-RKSDG--KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 328 MGAVTEPPN--LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
              + +  N  L IV EY   G L  ++      R  +DE   L +   +   +   H+R
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 385 RP---PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
                 ++HRDLK  N+ +D    VK+ DFGL+R   +    +K   GTP +M+PE +  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNR 190
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
              NEKSD++S G +L+EL  L  P+   +  ++   +  +G+   IP   +  +  +I 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEIIT 249
Query: 502 TCWAEEPEIRPSFPSIMET 520
                +   RPS   I+E 
Sbjct: 250 RMLNLKDYHRPSVEEILEN 268

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 130/294 (44%), Gaps = 51/294 (17%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLL--- 327
           +G+G +G V+   W+  +VAVKI     F     K + RE  +     LRH NI+     
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 328 -MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH---- 382
            M +      L ++T Y   GSLY  L +      +D    L +   +A G+ +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 383 --QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISSKTAAGTPEWMAP 436
             Q +P I HRDLKS N+LV       + D GL    S+S     + +    GT  +MAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 437 EVLRED------PSNEKSDVFSFGVILWELI----------TLQKPWRNSTPS-----QV 475
           EVL E        S ++ D+++FG++LWE+             + P+ +  P+      +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 476 ISAVGFKGRRLEIPKN--VNPM---VAALIETCWAEEPEIRPSFPSIMETLQQF 524
              V    +R  IP     +P    +A L++ CW + P  R +   I +TL + 
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 123/254 (48%), Gaps = 12/254 (4%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + +   +A+K+L + +  ++  +  LR E+ I   LRHPNI+
Sbjct: 18  IVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            +     +   + ++ E+  RG LYK L         DE+       ++A  ++Y H+R+
Sbjct: 78  RMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+     +K+ DFG S   P+  +  +   GT +++ PE++     +
Sbjct: 135 --VIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRXMCGTLDYLPPEMIEGKTHD 190
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
           EK D++  GV+ +E +    P+   +PS   +        L+ P  ++     LI     
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPF--DSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLR 248
Query: 506 EEPEIRPSFPSIME 519
             P  R     +ME
Sbjct: 249 YHPPQRLPLKGVME 262

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 103/202 (50%), Gaps = 5/202 (2%)
Query: 270 KKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K  +G G FG VY     +   VAVK L E+        +F  EV ++    H N++ L 
Sbjct: 35  KNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLR 93
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RP 386
           G    P    +V  Y++ GS+   L   P+++  +D   R  +A   A+G+ YLH    P
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-GTPEWMAPEVLREDPSN 445
            I+HRD+K+ N+L+D  +   V DFGL++           A  G    +APE L    S+
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSS 213
Query: 446 EKSDVFSFGVILWELITLQKPW 467
           EK+DVF +GV+L ELIT Q+ +
Sbjct: 214 EKTDVFGYGVMLLELITGQRAF 235

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKL------LHIPDARVVVDER 365
           E++I + L H ++V   G   +   + +V E   R SL +L      L  P+AR  + + 
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ- 125
Query: 366 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 425
                   +  G  YLH+ R  ++HRDLK  NL ++    VK+ DFGL+          K
Sbjct: 126 --------IVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 175
Query: 426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 485
           T  GTP ++APEVL +   + + DV+S G I++ L+  + P+  S   +  + +  K   
Sbjct: 176 TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKNE 233
Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIM 518
             IPK++NP+ A+LI+     +P  RP+   ++
Sbjct: 234 YSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 6/208 (2%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           KIGEGS G V  A  +++   V +       + R +    EV IM+   H N+V +  + 
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 391
                L +V E+L  G+L  ++        ++E     +   V + ++YLH +   ++HR
Sbjct: 112 LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ--GVIHR 165
Query: 392 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 451
           D+KS ++L+ S   +K+ DFG            K   GTP WMAPEV+   P   + D++
Sbjct: 166 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 452 SFGVILWELITLQKPWRNSTPSQVISAV 479
           S G+++ E+I  + P+ N  P Q +  +
Sbjct: 226 SLGIMVIEMIDGEPPYFNEPPLQAMRRI 253

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 13/213 (6%)
Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           I  K+G G   TVY AE    N  VA+K I I     E+  K F REV     L H NIV
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
            ++    E     +V EY+   +L + +  H P   + VD    +N    +  G+ + H 
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVD--TAINFTNQILDGIKHAHD 129
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAAGTPEWMAPEVLRED 442
            R  IVHRD+K  N+L+DS  T+K+ DFG++++   T ++ +    GT ++ +PE  + +
Sbjct: 130 MR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
            ++E +D++S G++L+E++  + P+   T   +
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 7/207 (3%)
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           E++I + L H ++V   G   +   + +V E   R SL +L     A    + R  L   
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 124
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
             +  G  YLH+ R  ++HRDLK  NL ++    VK+ DFGL+          KT  GTP
Sbjct: 125 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
            ++APEVL +   + + DV+S G I++ L+  + P+  S   +  + +  K     IPK+
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKNEYSIPKH 239
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIM 518
           +NP+ A+LI+     +P  RP+   ++
Sbjct: 240 INPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 7/207 (3%)
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           E++I + L H ++V   G   +   + +V E   R SL +L     A    + R  L   
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 128
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
             +  G  YLH+ R  ++HRDLK  NL ++    VK+ DFGL+          KT  GTP
Sbjct: 129 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP 185
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
            ++APEVL +   + + DV+S G I++ L+  + P+  S   +  + +  K     IPK+
Sbjct: 186 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKNEYSIPKH 243
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIM 518
           +NP+ A+LI+     +P  RP+   ++
Sbjct: 244 INPVAASLIQKMLQTDPTARPTINELL 270

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 110/204 (53%), Gaps = 11/204 (5%)
Query: 268 LIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNI 324
           +I++ +GEGSFG V  A    +   VA+K +  Q   + D      RE++ +K LRHP+I
Sbjct: 12  IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + L   +T P ++ +V EY + G L+  + +   R+  DE  R      +   + Y H  
Sbjct: 72  IKLYDVITTPTDIVMVIEY-AGGELFDYI-VEKKRMTEDEGRRFFQ--QIICAIEYCH-- 125
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-P 443
           R  IVHRDLK  NLL+D    VK+ DFGLS    +     KT+ G+P + APEV+     
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPEVINGKLY 184
Query: 444 SNEKSDVFSFGVILWELITLQKPW 467
           +  + DV+S G++L+ ++  + P+
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 123/259 (47%), Gaps = 17/259 (6%)
Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE--FLREVAI 315
           ++++  + ++ K +G+GSFG V+ AE++  N   A+K L +     D   E   + +  +
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
                HP +  +        NL  V EYL+ G L  + HI         R     A ++ 
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAA-EII 128
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMA 435
            G+ +LH +   IV+RDLK  N+L+D    +K+ DFG+ +        +    GTP+++A
Sbjct: 129 LGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIA 186
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE---IPKNV 492
           PE+L     N   D +SFGV+L+E++  Q P+      ++  ++     R++    P+ +
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-----RMDNPFYPRWL 241
Query: 493 NPMVAALIETCWAEEPEIR 511
                 L+   +  EPE R
Sbjct: 242 EKEAKDLLVKLFVREPEKR 260

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 130/262 (49%), Gaps = 18/262 (6%)
Query: 267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR----FKEFLREVAIMKGLRHP 322
            + K+K+G G+FG V+  E R+S +   I   +  ++DR     ++   E+ ++K L HP
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVI---KTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR-VVVDERLRLNMAYDVAKGMNYL 381
           NI+ +     +  N+ IV E    G L + +    AR   + E     +   +   + Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 382 HQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 437
           H +   +VH+DLK  N+L   T     +K+ DFGL+   K + +  S  AAGT  +MAPE
Sbjct: 141 HSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPE 196
Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPMV 496
           V + D +  K D++S GV+++ L+T   P+  ++  +V     +K     +  + + P  
Sbjct: 197 VFKRDVTF-KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 497 AALIETCWAEEPEIRPSFPSIM 518
             L++    ++PE RPS   ++
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVL 277

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 129/262 (49%), Gaps = 30/262 (11%)
Query: 271 KKIGEGSFGT--VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+FG   +   +     VAVK  IE+    D  +   RE+   + LRHPNIV   
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVK-YIERGAAID--ENVQREIINHRSLRHPNIVRFK 82
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +  P +L+I+ EY S G LY+   I +A    ++  R      +  G++Y H  +  I
Sbjct: 83  EVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDEARFFFQ-QLLSGVSYCHSMQ--I 137
Query: 389 VHRDLKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDPSN 445
            HRDLK  N L+D +    +K+CDFG S+S    +   K+  GTP ++APEV LR++   
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 446 EKSDVFSFGVILWELITLQKPWRN--------STPSQVISAVGFKGRRLEIPKN--VNPM 495
           + +DV+S GV L+ ++    P+ +         T  +++S       +  IP +  ++P 
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV------KYSIPDDIRISPE 250
Query: 496 VAALIETCWAEEPEIRPSFPSI 517
              LI   +  +P  R S P I
Sbjct: 251 CCHLISRIFVADPATRISIPEI 272

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 7/207 (3%)
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           E++I + L H ++V   G   +   + +V E   R SL +L     A    + R  L   
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 122
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
             +  G  YLH+ R  ++HRDLK  NL ++    VK+ DFGL+          K   GTP
Sbjct: 123 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
            ++APEVL +   + + DV+S G I++ L+  + P+  S   +  + +  K     IPK+
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKNEYSIPKH 237
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIM 518
           +NP+ A+LI+     +P  RP+   ++
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELL 264

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 141/271 (52%), Gaps = 26/271 (9%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR--FKEFLREVAIMKGLRHPNIVLLMGA 330
           IG G FG VY    R+     K+ +++   E     +EF  E+  +   RHP++V L+G 
Sbjct: 47  IGHGVFGKVYKGVLRD---GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF 103
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
             E   + ++ +Y+  G+L + L+  D   + +    RL +    A+G++YLH R   I+
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR--AII 161
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLREDPSNE 446
           HRD+KS N+L+D  +  K+ DFG+S+       T++      GT  ++ PE   +    E
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX-VVKGTLGYIDPEYFIKGRLTE 220
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 506
           KSDV+SFGV+L+E++  +     S P ++++   +      +  + N  +  +++   A+
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESHNNGQLEQIVDPNLAD 275
Query: 507 EPEIRPSFPSIMETLQQFLMSSV-CQPLSAQ 536
             +IRP      E+L++F  ++V C  LS++
Sbjct: 276 --KIRP------ESLRKFGDTAVKCLALSSE 298

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG+G+F  V  A       +VAVKI+ + + +    ++  REV I K L HPNIV L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +     L +V EY S G ++  L         + R +      +   + Y HQ+   I
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ---IVSAVQYCHQKF--I 134
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA-AGTPEWMAPEVLREDPSNE- 446
           VHRDLK+ NLL+D+   +K+ DFG S     T+ +   A  G P + APE+ +    +  
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNE--FTFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 447 KSDVFSFGVILWELITLQKPW 467
           + DV+S GVIL+ L++   P+
Sbjct: 193 EVDVWSLGVILYTLVSGSLPF 213

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 141/271 (52%), Gaps = 26/271 (9%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR--FKEFLREVAIMKGLRHPNIVLLMGA 330
           IG G FG VY    R+     K+ +++   E     +EF  E+  +   RHP++V L+G 
Sbjct: 47  IGHGVFGKVYKGVLRD---GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF 103
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
             E   + ++ +Y+  G+L + L+  D   + +    RL +    A+G++YLH R   I+
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR--AII 161
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLREDPSNE 446
           HRD+KS N+L+D  +  K+ DFG+S+       T++      GT  ++ PE   +    E
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXX-VVKGTLGYIDPEYFIKGRLTE 220
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 506
           KSDV+SFGV+L+E++  +     S P ++++   +      +  + N  +  +++   A+
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESHNNGQLEQIVDPNLAD 275
Query: 507 EPEIRPSFPSIMETLQQFLMSSV-CQPLSAQ 536
             +IRP      E+L++F  ++V C  LS++
Sbjct: 276 --KIRP------ESLRKFGDTAVKCLALSSE 298

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 7/207 (3%)
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           E++I + L H ++V   G   +   + +V E   R SL +L     A    + R  L   
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 146
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
             +  G  YLH+ R  ++HRDLK  NL ++    VK+ DFGL+          K   GTP
Sbjct: 147 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 203
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
            ++APEVL +   + + DV+S G I++ L+  + P+  S   +  + +  K     IPK+
Sbjct: 204 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKNEYSIPKH 261
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIM 518
           +NP+ A+LI+     +P  RP+   ++
Sbjct: 262 INPVAASLIQKMLQTDPTARPTINELL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 7/207 (3%)
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           E++I + L H ++V   G   +   + +V E   R SL +L     A    + R  L   
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-- 148
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
             +  G  YLH+ R  ++HRDLK  NL ++    VK+ DFGL+          K   GTP
Sbjct: 149 -QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
            ++APEVL +   + + DV+S G I++ L+  + P+  S   +  + +  K     IPK+
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TYLRIKKNEYSIPKH 263
Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIM 518
           +NP+ A+LI+     +P  RP+   ++
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINELL 290

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 127/256 (49%), Gaps = 18/256 (7%)
Query: 271 KKIGEGSFGT--VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+FG   +   +  N  VAVK +   E  ++  K   RE+   + LRHPNIV   
Sbjct: 24  KDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRHPNIVRFK 80
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +  P +L+IV EY S G L++   I +A    ++  R      +  G++Y H  +  +
Sbjct: 81  EVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF-FFQQLISGVSYCHAMQ--V 135
Query: 389 VHRDLKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDPSN 445
            HRDLK  N L+D +    +K+CDFG S+S    +   K+  GTP ++APEV L+++   
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 446 EKSDVFSFGVILWELITLQKPWRN-STPSQVISAVG-FKGRRLEIPK--NVNPMVAALIE 501
           + +DV+S GV L+ ++    P+ +   P      +      +  IP   +++P    LI 
Sbjct: 195 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 254
Query: 502 TCWAEEPEIRPSFPSI 517
             +  +P  R S P I
Sbjct: 255 RIFVADPAKRISIPEI 270

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 124/255 (48%), Gaps = 16/255 (6%)
Query: 273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G+GSFG V   + R    + AVK++ +           LREV ++K L HPNI+ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
           + +  +  IV E  + G L+  + I   R    +  R+     V  G+ Y+H+    IVH
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARI--IKQVFSGITYMHKHN--IVH 144
Query: 391 RDLKSPNLLVDSTYT---VKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           RDLK  N+L++S      +K+ DFGLS   + NT +  K   GT  ++APEVLR    +E
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVLR-GTYDE 201
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCW 504
           K DV+S GVIL+ L++   P+       ++  V       ++P  + ++     LI    
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 505 AEEPEIRPSFPSIME 519
              P +R +    +E
Sbjct: 262 TFHPSLRITATQCLE 276

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 122/259 (47%), Gaps = 17/259 (6%)
Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE--FLREVAI 315
           ++++  +  + K +G+GSFG V+ AE++  N   A+K L +     D   E   + +  +
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
                HP +  +        NL  V EYL+ G L  + HI         R     A ++ 
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATF-YAAEII 129
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMA 435
            G+ +LH +   IV+RDLK  N+L+D    +K+ DFG+ +        +    GTP+++A
Sbjct: 130 LGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIA 187
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE---IPKNV 492
           PE+L     N   D +SFGV+L+E++  Q P+      ++  ++     R++    P+ +
Sbjct: 188 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-----RMDNPFYPRWL 242
Query: 493 NPMVAALIETCWAEEPEIR 511
                 L+   +  EPE R
Sbjct: 243 EKEAKDLLVKLFVREPEKR 261

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 123/249 (49%), Gaps = 7/249 (2%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           KIGEGS G V  A  ++S   V + +     + R +    EV IM+  +H N+V +  + 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 391
                L ++ E+L  G+L  ++    ++V ++E     +   V + + YLH +   ++HR
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQ--GVIHR 165
Query: 392 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 451
           D+KS ++L+     VK+ DFG            K   GTP WMAPEV+       + D++
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 452 SFGVILWELITLQKPWRNSTPSQVISAV-GFKGRRLEIPKNVNPMVAALIETCWAEEPEI 510
           S G+++ E++  + P+ + +P Q +  +      +L+    V+P++   +E     +P+ 
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQE 285
Query: 511 RPSFPSIME 519
           R +   +++
Sbjct: 286 RATAQELLD 294

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 273 IGEGSFGTVYHA-EWRNS-DVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVLL-- 327
           +G G    V+ A + R+  DVAVK+L      +  F   F RE      L HP IV +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 328 MGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            G    P  P   IV EY+   +L  ++H       +  +  + +  D  + +N+ HQ  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS---KPNTYISSKTAAGTPEWMAPEVLRED 442
             I+HRD+K  N+L+ +T  VKV DFG++R+     N+   +    GT ++++PE  R D
Sbjct: 137 --IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD 194
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
             + +SDV+S G +L+E++T + P+   +P  V
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 15/213 (7%)
Query: 273 IGEGSFGTVYHA-EWRNS-DVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVLL-- 327
           +G G    V+ A + R+  DVAVK+L      +  F   F RE      L HP IV +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 328 MGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            G    P  P   IV EY+   +L  ++H       +  +  + +  D  + +N+ HQ  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAA--GTPEWMAPEVLRED 442
             I+HRD+K  N+++ +T  VKV DFG++R+  ++  S ++TAA  GT ++++PE  R D
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
             + +SDV+S G +L+E++T + P+   +P  V
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSV 227

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 124/255 (48%), Gaps = 16/255 (6%)
Query: 273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G+GSFG V   + R    + AVK++ +           LREV ++K L HPNI+ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
           + +  +  IV E  + G L+  + I   R    +  R+     V  G+ Y+H+    IVH
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARI--IKQVFSGITYMHKHN--IVH 144
Query: 391 RDLKSPNLLVDSTYT---VKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           RDLK  N+L++S      +K+ DFGLS   + NT +  K   GT  ++APEVLR    +E
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVLR-GTYDE 201
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCW 504
           K DV+S GVIL+ L++   P+       ++  V       ++P  + ++     LI    
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 505 AEEPEIRPSFPSIME 519
              P +R +    +E
Sbjct: 262 TFHPSLRITATQCLE 276

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/255 (30%), Positives = 124/255 (48%), Gaps = 16/255 (6%)
Query: 273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G+GSFG V   + R    + AVK++ +           LREV ++K L HPNI+ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
           + +  +  IV E  + G L+  + I   R    +  R+     V  G+ Y+H+    IVH
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARI--IKQVFSGITYMHKHN--IVH 144
Query: 391 RDLKSPNLLVDSTYT---VKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           RDLK  N+L++S      +K+ DFGLS   + NT +  K   GT  ++APEVLR    +E
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVLR-GTYDE 201
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCW 504
           K DV+S GVIL+ L++   P+       ++  V       ++P  + ++     LI    
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 505 AEEPEIRPSFPSIME 519
              P +R +    +E
Sbjct: 262 TFHPSLRITATQCLE 276

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 140/289 (48%), Gaps = 41/289 (14%)
Query: 262 IRWSELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDR-------------- 305
           ++ ++  +K +IG+GS+G V  A  E  N+  A+K+L +++                   
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 306 ----------FKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIVTEYLSRGSLYKLL 353
                      ++  +E+AI+K L HPN+V L+  + +P   +L +V E +++G +   +
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---M 126
Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
            +P  + + +++ R     D+ KG+ YLH ++  I+HRD+K  NLLV     +K+ DFG+
Sbjct: 127 EVPTLKPLSEDQARFYFQ-DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 414 SRSKPNTYISSKTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNS 470
           S     +        GTP +MAPE L E     S +  DV++ GV L+  +  Q P+ + 
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 471 TPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPSFPSI 517
               + S +  K + LE P   ++   +  LI     + PE R   P I
Sbjct: 244 RIMCLHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 104/194 (53%), Gaps = 13/194 (6%)
Query: 290 DVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVLL--MGAVTEP--PNLSIVTEYL 344
           DVAVK+L      +  F   F RE      L HP IV +   G    P  P   IV EY+
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYV 98
Query: 345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 404
              +L  ++H       +  +  + +  D  + +N+ HQ    I+HRD+K  N+++ +T 
Sbjct: 99  DGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATN 153
Query: 405 TVKVCDFGLSRSKPNTYIS-SKTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 461
            VKV DFG++R+  ++  S ++TAA  GT ++++PE  R D  + +SDV+S G +L+E++
Sbjct: 154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 462 TLQKPWRNSTPSQV 475
           T + P+   +P  V
Sbjct: 214 TGEPPFTGDSPVSV 227

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 113/213 (53%), Gaps = 15/213 (7%)
Query: 273 IGEGSFGTVYHA-EWRNS-DVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVLL-- 327
           +G G    V+ A + R+  DVAVK+L      +  F   F RE      L HP IV +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 328 MGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            G    P  P   IV EY+   +L  ++H       +  +  + +  D  + +N+ HQ  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAA--GTPEWMAPEVLRED 442
             I+HRD+K  N+++ +T  VKV DFG++R+  ++  S ++TAA  GT ++++PE  R D
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
             + +SDV+S G +L+E++T + P+   +P  V
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 104/194 (53%), Gaps = 13/194 (6%)
Query: 290 DVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVLL--MGAVTEP--PNLSIVTEYL 344
           DVAVK+L      +  F   F RE      L HP IV +   G    P  P   IV EY+
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 404
              +L  ++H       +  +  + +  D  + +N+ HQ    I+HRD+K  N+++ +T 
Sbjct: 99  DGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATN 153
Query: 405 TVKVCDFGLSRSKPNTYIS-SKTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 461
            VKV DFG++R+  ++  S ++TAA  GT ++++PE  R D  + +SDV+S G +L+E++
Sbjct: 154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 462 TLQKPWRNSTPSQV 475
           T + P+   +P  V
Sbjct: 214 TGEPPFTGDSPVSV 227

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 104/194 (53%), Gaps = 13/194 (6%)
Query: 290 DVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPNIVLL--MGAVTEP--PNLSIVTEYL 344
           DVAVK+L      +  F   F RE      L HP IV +   G    P  P   IV EY+
Sbjct: 56  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 115
Query: 345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 404
              +L  ++H       +  +  + +  D  + +N+ HQ    I+HRD+K  N+++ +T 
Sbjct: 116 DGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATN 170
Query: 405 TVKVCDFGLSRSKPNTYIS-SKTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 461
            VKV DFG++R+  ++  S ++TAA  GT ++++PE  R D  + +SDV+S G +L+E++
Sbjct: 171 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 230
Query: 462 TLQKPWRNSTPSQV 475
           T + P+   +P  V
Sbjct: 231 TGEPPFTGDSPVSV 244

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 125/256 (48%), Gaps = 18/256 (7%)
Query: 271 KKIGEGSFGT--VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+FG   +   +  N  VAVK +   E  E       RE+   + LRHPNIV   
Sbjct: 25  KDIGSGNFGVARLMRDKQSNELVAVKYI---ERGEKIAANVKREIINHRSLRHPNIVRFK 81
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +  P +L+IV EY S G L++   I +A    ++  R      +  G++Y H  +  +
Sbjct: 82  EVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF-FFQQLISGVSYCHAMQ--V 136
Query: 389 VHRDLKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDPSN 445
            HRDLK  N L+D +    +K+CDFG S+S    +   K+  GTP ++APEV L+++   
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 446 EKSDVFSFGVILWELITLQKPWRN-STPSQVISAVG-FKGRRLEIPK--NVNPMVAALIE 501
           + +DV+S GV L+ ++    P+ +   P      +      +  IP   +++P    LI 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 502 TCWAEEPEIRPSFPSI 517
             +  +P  R S P I
Sbjct: 256 RIFVADPAKRISIPEI 271

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 16/271 (5%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLM 328
           KIGEGS G V  A  R+S   VAVK   + +  + + +E L  EV IM+  +H N+V + 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +      L +V E+L  G+L  ++        ++E     +   V + ++ LH +   +
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ--GV 137
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+KS ++L+     VK+ DFG            K   GTP WMAPE++   P   + 
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEE 507
           D++S G+++ E++  + P+ N  P + +  +      RL+    V+P +   ++     +
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 257
Query: 508 PEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 538
           P  R    +  E L+   ++    P S  PL
Sbjct: 258 PAQR---ATAAELLKHPFLAKAGPPASIVPL 285

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 16/271 (5%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLM 328
           KIGEGS G V  A  R+S   VAVK   + +  + + +E L  EV IM+  +H N+V + 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 94
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +      L +V E+L  G+L  ++        ++E     +   V + ++ LH +   +
Sbjct: 95  NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG--V 148
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+KS ++L+     VK+ DFG            K   GTP WMAPE++   P   + 
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEE 507
           D++S G+++ E++  + P+ N  P + +  +      RL+    V+P +   ++     +
Sbjct: 209 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 268
Query: 508 PEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 538
           P  R    +  E L+   ++    P S  PL
Sbjct: 269 PAQR---ATAAELLKHPFLAKAGPPASIVPL 296

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 129/278 (46%), Gaps = 38/278 (13%)
Query: 269 IKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++ IG G+   V  A    +   VA+K  I  E  +    E L+E+  M    HPNIV 
Sbjct: 19  LQEVIGSGATAVVQAAYCAPKKEKVAIK-RINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLL-HI----PDARVVVDERLRLNMAYDVAKGMNYL 381
              +      L +V + LS GS+  ++ HI         V+DE     +  +V +G+ YL
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS----------RSKPNTYISSKTAAGTP 431
           H+     +HRD+K+ N+L+    +V++ DFG+S          R+K       KT  GTP
Sbjct: 138 HKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR-----KTFVGTP 190
Query: 432 EWMAPEVLREDPSNE-KSDVFSFGVILWELITLQKPWRNSTPSQVIS----------AVG 480
            WMAPEV+ +    + K+D++SFG+   EL T   P+    P +V+             G
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIM 518
            + +  E+ K        +I  C  ++PE RP+   ++
Sbjct: 251 VQDK--EMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 138/288 (47%), Gaps = 36/288 (12%)
Query: 248 TSNRE-LYLEEEGLEIRWSELLI------KKKIGEGSFGTVYHAEWR--NSDVAVKILIE 298
           +S RE LY +  G+ ++ S  +       ++ +G+GSFG V   + +    + AVK++ +
Sbjct: 8   SSGRENLYFQGPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 67
Query: 299 QEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY------- 350
           ++  +   KE  LREV ++K L HPNI+ L     +     +V E  + G L+       
Sbjct: 68  RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 127
Query: 351 KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVK 407
           +   +  AR++            V  G+ Y+H+ +  IVHRDLK  NLL++S      ++
Sbjct: 128 RFSEVDAARII----------RQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIR 175
Query: 408 VCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 467
           + DFGLS +        K   GT  ++APEVL     +EK DV+S GVIL+ L++   P+
Sbjct: 176 IIDFGLS-THFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPF 233
Query: 468 RNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPS 513
             +    ++  V       E+P  K V+     LI       P +R S
Sbjct: 234 NGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS 281

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 16/271 (5%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLM 328
           KIGEGS G V  A  R+S   VAVK   + +  + + +E L  EV IM+  +H N+V + 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 87
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +      L +V E+L  G+L  ++        ++E     +   V + ++ LH +   +
Sbjct: 88  NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ--GV 141
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+KS ++L+     VK+ DFG            K   GTP WMAPE++   P   + 
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEE 507
           D++S G+++ E++  + P+ N  P + +  +      RL+    V+P +   ++     +
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 261
Query: 508 PEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 538
           P  R    +  E L+   ++    P S  PL
Sbjct: 262 PAQR---ATAAELLKHPFLAKAGPPASIVPL 289

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 129/278 (46%), Gaps = 38/278 (13%)
Query: 269 IKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++ IG G+   V  A    +   VA+K  I  E  +    E L+E+  M    HPNIV 
Sbjct: 14  LQEVIGSGATAVVQAAYCAPKKEKVAIK-RINLEKCQTSMDELLKEIQAMSQCHHPNIVS 72
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLL-HI----PDARVVVDERLRLNMAYDVAKGMNYL 381
              +      L +V + LS GS+  ++ HI         V+DE     +  +V +G+ YL
Sbjct: 73  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 132
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS----------RSKPNTYISSKTAAGTP 431
           H+     +HRD+K+ N+L+    +V++ DFG+S          R+K       KT  GTP
Sbjct: 133 HKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR-----KTFVGTP 185
Query: 432 EWMAPEVLREDPSNE-KSDVFSFGVILWELITLQKPWRNSTPSQVIS----------AVG 480
            WMAPEV+ +    + K+D++SFG+   EL T   P+    P +V+             G
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 245
Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIM 518
            + +  E+ K        +I  C  ++PE RP+   ++
Sbjct: 246 VQDK--EMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 16/271 (5%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLM 328
           KIGEGS G V  A  R+S   VAVK   + +  + + +E L  EV IM+  +H N+V + 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 92
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +      L +V E+L  G+L  ++        ++E     +   V + ++ LH +   +
Sbjct: 93  NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG--V 146
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+KS ++L+     VK+ DFG            K   GTP WMAPE++   P   + 
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEE 507
           D++S G+++ E++  + P+ N  P + +  +      RL+    V+P +   ++     +
Sbjct: 207 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 266
Query: 508 PEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 538
           P  R    +  E L+   ++    P S  PL
Sbjct: 267 PAQR---ATAAELLKHPFLAKAGPPASIVPL 294

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 10/268 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           KIGEGS G V  A  R+S   V +       + R +    EV IM+  +H N+V +  + 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 391
                L +V E+L  G+L  ++        ++E     +   V + ++ LH +   ++HR
Sbjct: 218 LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG--VIHR 271
Query: 392 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 451
           D+KS ++L+     VK+ DFG            K   GTP WMAPE++   P   + D++
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 452 SFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEEPEI 510
           S G+++ E++  + P+ N  P + +  +      RL+    V+P +   ++     +P  
Sbjct: 332 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 391
Query: 511 RPSFPSIMETLQQFLMSSVCQPLSAQPL 538
           R    +  E L+   ++    P S  PL
Sbjct: 392 R---ATAAELLKHPFLAKAGPPASIVPL 416

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 10/268 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           KIGEGS G V  A  R+S   V +       + R +    EV IM+  +H N+V +  + 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 391
                L +V E+L  G+L  ++        ++E     +   V + ++ LH +   ++HR
Sbjct: 141 LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG--VIHR 194
Query: 392 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVF 451
           D+KS ++L+     VK+ DFG            K   GTP WMAPE++   P   + D++
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 452 SFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEEPEI 510
           S G+++ E++  + P+ N  P + +  +      RL+    V+P +   ++     +P  
Sbjct: 255 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 314
Query: 511 RPSFPSIMETLQQFLMSSVCQPLSAQPL 538
           R    +  E L+   ++    P S  PL
Sbjct: 315 R---ATAAELLKHPFLAKAGPPASIVPL 339

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 122/256 (47%), Gaps = 15/256 (5%)
Query: 269 IKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNI 324
           I K +GEGSFG V   YH       VA+KI+ ++   + D      RE++ ++ LRHP+I
Sbjct: 17  IVKTLGEGSFGKVKLAYHTT-TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 75
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + L   +     + +V EY       +L      R  + E+        +   + Y H  
Sbjct: 76  IKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 129
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-P 443
           R  IVHRDLK  NLL+D    VK+ DFGLS    +     KT+ G+P + APEV+     
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPEVISGKLY 188
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           +  + DV+S GVIL+ ++  + P+ + +   +   +        +PK ++P  A LI+  
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIKRM 246
Query: 504 WAEEPEIRPSFPSIME 519
               P  R S   IM+
Sbjct: 247 LIVNPLNRISIHEIMQ 262

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 15/256 (5%)
Query: 269 IKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNI 324
           I K +GEGSFG V   YH       VA+KI+ ++   + D      RE++ ++ LRHP+I
Sbjct: 12  IVKTLGEGSFGKVKLAYHTT-TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 70
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + L   +     + +V EY       +L      R  + E+        +   + Y H+ 
Sbjct: 71  IKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-P 443
           +  IVHRDLK  NLL+D    VK+ DFGLS    +     KT+ G+P + APEV+     
Sbjct: 127 K--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPEVISGKLY 183
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           +  + DV+S GVIL+ ++  + P+ + +   +   +        +PK ++P  A LI+  
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIKRM 241
Query: 504 WAEEPEIRPSFPSIME 519
               P  R S   IM+
Sbjct: 242 LIVNPLNRISIHEIMQ 257

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 15/256 (5%)
Query: 269 IKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNI 324
           I K +GEGSFG V   YH       VA+KI+ ++   + D      RE++ ++ LRHP+I
Sbjct: 8   IVKTLGEGSFGKVKLAYHTT-TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 66
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + L   +     + +V EY       +L      R  + E+        +   + Y H+ 
Sbjct: 67  IKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-P 443
           +  IVHRDLK  NLL+D    VK+ DFGLS    +     KT+ G+P + APEV+     
Sbjct: 123 K--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPEVISGKLY 179
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           +  + DV+S GVIL+ ++  + P+ + +   +   +        +PK ++P  A LI+  
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIKRM 237
Query: 504 WAEEPEIRPSFPSIME 519
               P  R S   IM+
Sbjct: 238 LIVNPLNRISIHEIMQ 253

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 122/256 (47%), Gaps = 15/256 (5%)
Query: 269 IKKKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNI 324
           I K +GEGSFG V   YH       VA+KI+ ++   + D      RE++ ++ LRHP+I
Sbjct: 18  IVKTLGEGSFGKVKLAYHTT-TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 76
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + L   +     + +V EY       +L      R  + E+        +   + Y H  
Sbjct: 77  IKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 130
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-P 443
           R  IVHRDLK  NLL+D    VK+ DFGLS    +     KT+ G+P + APEV+     
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPEVISGKLY 189
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           +  + DV+S GVIL+ ++  + P+ + +   +   +        +PK ++P  A LI+  
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIKRM 247
Query: 504 WAEEPEIRPSFPSIME 519
               P  R S   IM+
Sbjct: 248 LIVNPLNRISIHEIMQ 263

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 126/256 (49%), Gaps = 18/256 (7%)
Query: 271 KKIGEGSFGT--VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+FG   +   +  N  VAVK +   E  ++  K   RE+   + LRHPNIV   
Sbjct: 25  KDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRHPNIVRFK 81
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +  P +L+IV EY S G L++   I +A    ++  R      +  G++Y H  +  +
Sbjct: 82  EVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF-FFQQLISGVSYCHAMQ--V 136
Query: 389 VHRDLKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDPSN 445
            HRDLK  N L+D +    +K+C FG S+S    +   K+  GTP ++APEV L+++   
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 446 EKSDVFSFGVILWELITLQKPWRN-STPSQVISAVG-FKGRRLEIPK--NVNPMVAALIE 501
           + +DV+S GV L+ ++    P+ +   P      +      +  IP   +++P    LI 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 502 TCWAEEPEIRPSFPSI 517
             +  +P  R S P I
Sbjct: 256 RIFVADPAKRISIPEI 271

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 132/257 (51%), Gaps = 22/257 (8%)
Query: 265 SELLIKKKIGEGSFGTVYHAE-WRNSDV----AVKILIEQEFH-EDRFKEFLREVAIMKG 318
           S+  + K +G+GSFG V+  +    SD     A+K+L +      DR +  + E  I+  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 83
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           + HP IV L  A      L ++ ++L  G L+  L      +  +E ++  +A ++A  +
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALAL 140
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           ++LH     I++RDLK  N+L+D    +K+ DFGLS+   +    + +  GT E+MAPEV
Sbjct: 141 DHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPW----RNSTPSQVISAVGFKGRRLEIPKNVNP 494
           +      + +D +SFGV+++E++T   P+    R  T + ++ A      +L +P+ ++P
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA------KLGMPQFLSP 252
Query: 495 MVAALIETCWAEEPEIR 511
              +L+   +   P  R
Sbjct: 253 EAQSLLRMLFKRNPANR 269

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 29/256 (11%)
Query: 273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMG 329
           +G+GSFG V   + +    + AVK++ +++  +   KE  LREV ++K L HPNI+ L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 330 AVTEPPNLSIVTEYLSRGSLY-------KLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
              +     +V E  + G L+       +   +  AR++            V  G+ Y+H
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII----------RQVLSGITYMH 143
Query: 383 QRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           + +  IVHRDLK  NLL++S      +++ DFGLS +        K   GT  ++APEVL
Sbjct: 144 KNK--IVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMKDKIGTAYYIAPEVL 200
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVA 497
                +EK DV+S GVIL+ L++   P+  +    ++  V       E+P  K V+    
Sbjct: 201 H-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 498 ALIETCWAEEPEIRPS 513
            LI       P +R S
Sbjct: 260 DLIRKMLTYVPSMRIS 275

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 132/257 (51%), Gaps = 22/257 (8%)
Query: 265 SELLIKKKIGEGSFGTVYHAE-WRNSDV----AVKILIEQEFH-EDRFKEFLREVAIMKG 318
           S+  + K +G+GSFG V+  +    SD     A+K+L +      DR +  + E  I+  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           + HP IV L  A      L ++ ++L  G L+  L      +  +E ++  +A ++A  +
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALAL 139
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           ++LH     I++RDLK  N+L+D    +K+ DFGLS+   +    + +  GT E+MAPEV
Sbjct: 140 DHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPW----RNSTPSQVISAVGFKGRRLEIPKNVNP 494
           +      + +D +SFGV+++E++T   P+    R  T + ++ A      +L +P+ ++P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA------KLGMPQFLSP 251
Query: 495 MVAALIETCWAEEPEIR 511
              +L+   +   P  R
Sbjct: 252 EAQSLLRMLFKRNPANR 268

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 132/257 (51%), Gaps = 22/257 (8%)
Query: 265 SELLIKKKIGEGSFGTVYHAE-WRNSDV----AVKILIEQEFH-EDRFKEFLREVAIMKG 318
           S+  + K +G+GSFG V+  +    SD     A+K+L +      DR +  + E  I+  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           + HP IV L  A      L ++ ++L  G L+  L      +  +E ++  +A ++A  +
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALAL 139
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           ++LH     I++RDLK  N+L+D    +K+ DFGLS+   +    + +  GT E+MAPEV
Sbjct: 140 DHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPW----RNSTPSQVISAVGFKGRRLEIPKNVNP 494
           +      + +D +SFGV+++E++T   P+    R  T + ++ A      +L +P+ ++P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA------KLGMPQFLSP 251
Query: 495 MVAALIETCWAEEPEIR 511
              +L+   +   P  R
Sbjct: 252 EAQSLLRMLFKRNPANR 268

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 29/256 (11%)
Query: 273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMG 329
           +G+GSFG V   + +    + AVK++ +++  +   KE  LREV ++K L HPNI+ L  
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 330 AVTEPPNLSIVTEYLSRGSLY-------KLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
              +     +V E  + G L+       +   +  AR++            V  G+ Y+H
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII----------RQVLSGITYMH 167
Query: 383 QRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           + +  IVHRDLK  NLL++S      +++ DFGLS +        K   GT  ++APEVL
Sbjct: 168 KNK--IVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMKDKIGTAYYIAPEVL 224
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVA 497
                +EK DV+S GVIL+ L++   P+  +    ++  V       E+P  K V+    
Sbjct: 225 H-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 283
Query: 498 ALIETCWAEEPEIRPS 513
            LI       P +R S
Sbjct: 284 DLIRKMLTYVPSMRIS 299

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 29/256 (11%)
Query: 273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMG 329
           +G+GSFG V   + +    + AVK++ +++  +   KE  LREV ++K L HPNI+ L  
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 330 AVTEPPNLSIVTEYLSRGSLY-------KLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
              +     +V E  + G L+       +   +  AR++            V  G+ Y+H
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII----------RQVLSGITYMH 166
Query: 383 QRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           + +  IVHRDLK  NLL++S      +++ DFGLS +        K   GT  ++APEVL
Sbjct: 167 KNK--IVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMKDKIGTAYYIAPEVL 223
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVA 497
                +EK DV+S GVIL+ L++   P+  +    ++  V       E+P  K V+    
Sbjct: 224 H-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 282
Query: 498 ALIETCWAEEPEIRPS 513
            LI       P +R S
Sbjct: 283 DLIRKMLTYVPSMRIS 298

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 125/256 (48%), Gaps = 18/256 (7%)
Query: 271 KKIGEGSFGT--VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+FG   +   +  N  VAVK +   E  ++  K   RE+   + LRHPNIV   
Sbjct: 25  KDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK---REIINHRSLRHPNIVRFK 81
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +  P +L+IV EY S G L++   I +A    ++  R      +  G++Y H  +  +
Sbjct: 82  EVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF-FFQQLISGVSYCHAMQ--V 136
Query: 389 VHRDLKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDPSN 445
            HRDLK  N L+D +    +K+C FG S+S    +   K   GTP ++APEV L+++   
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSV-LHSQPKDTVGTPAYIAPEVLLKKEYDG 195
Query: 446 EKSDVFSFGVILWELITLQKPWRN-STPSQVISAVG-FKGRRLEIPK--NVNPMVAALIE 501
           + +DV+S GV L+ ++    P+ +   P      +      +  IP   +++P    LI 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 502 TCWAEEPEIRPSFPSI 517
             +  +P  R S P I
Sbjct: 256 RIFVADPAKRISIPEI 271

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 127/256 (49%), Gaps = 18/256 (7%)
Query: 271 KKIGEGSFGT--VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+FG   +   +  N  VAVK +   E  ++  K   RE+   + LRHPNIV   
Sbjct: 25  KDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVK---REIINHRSLRHPNIVRFK 81
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +  P +L+IV EY S G L++   I +A    ++  R      +  G++Y H  +  +
Sbjct: 82  EVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF-FFQQLISGVSYAHAMQ--V 136
Query: 389 VHRDLKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDPSN 445
            HRDLK  N L+D +    +K+ DFG S++    +   K+A GTP ++APEV L+++   
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASV-LHSQPKSAVGTPAYIAPEVLLKKEYDG 195
Query: 446 EKSDVFSFGVILWELITLQKPWRN-STPSQVISAVG-FKGRRLEIPK--NVNPMVAALIE 501
           + +DV+S GV L+ ++    P+ +   P      +      +  IP   +++P    LI 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 502 TCWAEEPEIRPSFPSI 517
             +  +P  R S P I
Sbjct: 256 RIFVADPAKRISIPEI 271

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 132/250 (52%), Gaps = 16/250 (6%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR--EVAIMKGLRHPNIVLLM 328
           IG GS+  V     + +D   A++++ ++  ++D   ++++  +    +   HP +V L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                   L  V EY++ G L  + H+   R + +E  R   A +++  +NYLH+R   I
Sbjct: 120 SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHER--GI 174
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+L+DS   +K+ D+G+ +       ++ T  GTP ++APE+LR +      
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 234
Query: 449 DVFSFGVILWELITLQKPW----RNSTPSQVISAVGFK---GRRLEIPKNVNPMVAALIE 501
           D ++ GV+++E++  + P+     +  P Q      F+    +++ IP++++   A++++
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 294
Query: 502 TCWAEEPEIR 511
           +   ++P+ R
Sbjct: 295 SFLNKDPKER 304

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           +G G+F  V  AE + +   V I  I +E  E +      E+A++  ++HPNIV L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 391
               +L ++ + +S G L+  +     +    ER    + + V   + YLH     IVHR
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDL--GIVHR 140
Query: 392 DLKSPNLL---VDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           DLK  NLL   +D    + + DFGLS+ + P + +S  TA GTP ++APEVL + P ++ 
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS--TACGTPGYVAPEVLAQKPYSKA 198
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
            D +S GVI + L+    P+ +   +++   +
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/239 (32%), Positives = 118/239 (49%), Gaps = 18/239 (7%)
Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE- 303
           S+    LY +  GL  R+  +   KK+G G++G V   + +   ++ A+KI+ +      
Sbjct: 8   SSGRENLYFQ--GLSDRYQRV---KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTT 62
Query: 304 DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVD 363
                 L EVA++K L HPNI+ L     +  N  +V E    G L+  + +      VD
Sbjct: 63  SNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD 122
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNT 420
             + +     V  G  YLH+    IVHRDLK  NLL++S      +K+ DFGLS +    
Sbjct: 123 AAVIMK---QVLSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLS-AHFEV 176
Query: 421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
               K   GT  ++APEVLR+   +EK DV+S GVIL+ L+    P+   T  +++  V
Sbjct: 177 GGKMKERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 234

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 119/218 (54%), Gaps = 12/218 (5%)
Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDR 305
           S+    LY +  GL  ++ +L   +K+GEG++G VY A + +   VA+K +      E  
Sbjct: 8   SSGRENLYFQ--GLMEKYQKL---EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI 62
Query: 306 FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDER 365
               +RE++++K L HPNIV L+  +     L++V E++ +  L K+L   +   + D +
Sbjct: 63  PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD-ENKTGLQDSQ 120
Query: 366 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 425
           +++ + Y + +G+ + HQ R  I+HRDLK  NLL++S   +K+ DFGL+R+      S  
Sbjct: 121 IKIYL-YQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177
Query: 426 TAAGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELIT 462
               T  + AP+VL        S D++S G I  E+IT
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 119/218 (54%), Gaps = 12/218 (5%)
Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDR 305
           S+    LY +  GL  ++ +L   +K+GEG++G VY A + +   VA+K +      E  
Sbjct: 8   SSGRENLYFQ--GLMEKYQKL---EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI 62
Query: 306 FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDER 365
               +RE++++K L HPNIV L+  +     L++V E++ +  L K+L   +   + D +
Sbjct: 63  PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD-ENKTGLQDSQ 120
Query: 366 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 425
           +++ + Y + +G+ + HQ R  I+HRDLK  NLL++S   +K+ DFGL+R+      S  
Sbjct: 121 IKIYL-YQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177
Query: 426 TAAGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELIT 462
               T  + AP+VL        S D++S G I  E+IT
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           +G G+F  V  AE + +   V I  I +E  E +      E+A++  ++HPNIV L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 391
               +L ++ + +S G L+  +     +    ER    + + V   + YLH     IVHR
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDL--GIVHR 140
Query: 392 DLKSPNLL---VDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           DLK  NLL   +D    + + DFGLS+ + P + +S  TA GTP ++APEVL + P ++ 
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS--TACGTPGYVAPEVLAQKPYSKA 198
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
            D +S GVI + L+    P+ +   +++   +
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           +G G+F  V  AE + +   V I  I +E  E +      E+A++  ++HPNIV L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 391
               +L ++ + +S G L+  +     +    ER    + + V   + YLH     IVHR
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDL--GIVHR 140
Query: 392 DLKSPNLL---VDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           DLK  NLL   +D    + + DFGLS+ + P + +S  TA GTP ++APEVL + P ++ 
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS--TACGTPGYVAPEVLAQKPYSKA 198
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
            D +S GVI + L+    P+ +   +++   +
Sbjct: 199 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 131/250 (52%), Gaps = 16/250 (6%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR--EVAIMKGLRHPNIVLLM 328
           IG GS+  V     + +D   A+K++ ++  ++D   ++++  +    +   HP +V L 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                   L  V EY++ G L  + H+   R + +E  R   A +++  +NYLH+R   I
Sbjct: 88  SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHER--GI 142
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+L+DS   +K+ D+G+ +       ++    GTP ++APE+LR +      
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 202
Query: 449 DVFSFGVILWELITLQKPW----RNSTPSQVISAVGFK---GRRLEIPKNVNPMVAALIE 501
           D ++ GV+++E++  + P+     +  P Q      F+    +++ IP++++   A++++
Sbjct: 203 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVKAASVLK 262
Query: 502 TCWAEEPEIR 511
           +   ++P+ R
Sbjct: 263 SFLNKDPKER 272

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 131/250 (52%), Gaps = 16/250 (6%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR--EVAIMKGLRHPNIVLLM 328
           IG GS+  V     + +D   A+K++ ++  ++D   ++++  +    +   HP +V L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                   L  V EY++ G L  + H+   R + +E  R   A +++  +NYLH+R   I
Sbjct: 73  SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHER--GI 127
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+L+DS   +K+ D+G+ +       ++    GTP ++APE+LR +      
Sbjct: 128 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 187
Query: 449 DVFSFGVILWELITLQKPW----RNSTPSQVISAVGFK---GRRLEIPKNVNPMVAALIE 501
           D ++ GV+++E++  + P+     +  P Q      F+    +++ IP++++   A++++
Sbjct: 188 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 247
Query: 502 TCWAEEPEIR 511
           +   ++P+ R
Sbjct: 248 SFLNKDPKER 257

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 9/211 (4%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLR-HPNIVLLM 328
           +G+GSFG V  A  + +    AVK+L +     +D  +  + E  I+   R HP +  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                P  L  V E+++ G L  + HI  +R   + R R   A ++   + +LH +   I
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARF-YAAEIISALMFLHDK--GI 145
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+L+D     K+ DFG+ +      +++ T  GTP+++APE+L+E       
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAV 205
Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           D ++ GV+L+E++    P+       +  A+
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 131/250 (52%), Gaps = 16/250 (6%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR--EVAIMKGLRHPNIVLLM 328
           IG GS+  V     + +D   A+K++ ++  ++D   ++++  +    +   HP +V L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                   L  V EY++ G L  + H+   R + +E  R   A +++  +NYLH+R   I
Sbjct: 77  SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHER--GI 131
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+L+DS   +K+ D+G+ +       ++    GTP ++APE+LR +      
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 191
Query: 449 DVFSFGVILWELITLQKPW----RNSTPSQVISAVGFK---GRRLEIPKNVNPMVAALIE 501
           D ++ GV+++E++  + P+     +  P Q      F+    +++ IP++++   A++++
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
Query: 502 TCWAEEPEIR 511
           +   ++P+ R
Sbjct: 252 SFLNKDPKER 261

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 123/258 (47%), Gaps = 33/258 (12%)
Query: 271 KKIGEGSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++IG GSFG VY A + RNS+V    K+    +   +++++ ++EV  ++ LRHPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
            G         +V EY   GS   LL +   +  + E     + +   +G+ YLH     
Sbjct: 120 RGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN-- 174
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV---LREDPS 444
           ++HRD+K+ N+L+     VK+ DFG      +    +    GTP WMAPEV   + E   
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANXFVGTPYWMAPEVILAMDEGQY 230
Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA------ 498
           + K DV+S G+   EL   + P  N      +SA+        I +N +P + +      
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMN---AMSAL------YHIAQNESPALQSGHWSEY 281
Query: 499 ---LIETCWAEEPEIRPS 513
               +++C  + P+ RP+
Sbjct: 282 FRNFVDSCLQKIPQDRPT 299

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 125/270 (46%), Gaps = 38/270 (14%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 329
           +G G++G VY      +    A+K++   +   D  +E  +E+ ++K    H NI    G
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 330 AVTE--PPNLS----IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           A  +  PP +     +V E+   GS+  L+       + +E +   +  ++ +G+++LHQ
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQ 147
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            +  ++HRD+K  N+L+     VK+ DFG+S     T     T  GTP WMAPEV+  D 
Sbjct: 148 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 205
Query: 444 SNE-----KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA- 497
           + +     KSD++S G+   E+     P  +  P + +           IP+N  P +  
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAPRLKS 256
Query: 498 --------ALIETCWAEEPEIRPSFPSIME 519
                   + IE+C  +    RP+   +M+
Sbjct: 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 10/202 (4%)
Query: 271 KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +++G+G+F  V     +    + A KI+  ++      ++  RE  I + L+HPNIV L 
Sbjct: 37  EELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 96
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +++E     +V + ++ G L++ +    AR    E    +  + + + +N++HQ    I
Sbjct: 97  DSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIHQILESVNHIHQH--DI 151
Query: 389 VHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           VHRDLK  NLL+ S      VK+ DFGL+        +    AGTP +++PEVLR+DP  
Sbjct: 152 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYG 211
Query: 446 EKSDVFSFGVILWELITLQKPW 467
           +  D+++ GVIL+ L+    P+
Sbjct: 212 KPVDIWACGVILYILLVGYPPF 233

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 110/213 (51%), Gaps = 14/213 (6%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G+F  V  AE + +   VA+K + ++   E +      E+A++  ++HPNIV L   
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-EGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                +L ++ + +S G L+  +     +    ER    + + V   + YLH     IVH
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDL--GIVH 139
Query: 391 RDLKSPNLL---VDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           RDLK  NLL   +D    + + DFGLS+ + P + +S  TA GTP ++APEVL + P ++
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS--TACGTPGYVAPEVLAQKPYSK 197
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D +S GVI + L+    P+ +   +++   +
Sbjct: 198 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 230

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 120/256 (46%), Gaps = 29/256 (11%)
Query: 273 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMG 329
           +G+GSFG V   + +    + AVK++ +++  +   KE  LREV ++K L HPNI  L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 330 AVTEPPNLSIVTEYLSRGSLY-------KLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
              +     +V E  + G L+       +   +  AR++            V  G+ Y H
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII----------RQVLSGITYXH 143
Query: 383 QRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           + +  IVHRDLK  NLL++S      +++ DFGLS +        K   GT  ++APEVL
Sbjct: 144 KNK--IVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKXKDKIGTAYYIAPEVL 200
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVA 497
                +EK DV+S GVIL+ L++   P+  +    ++  V       E+P  K V+    
Sbjct: 201 H-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 498 ALIETCWAEEPEIRPS 513
            LI       P  R S
Sbjct: 260 DLIRKXLTYVPSXRIS 275

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 113/227 (49%), Gaps = 16/227 (7%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAI 315
           GL  R+  +   KK+G G++G V   + +   ++ A+KI+ +            L EVA+
Sbjct: 1   GLSDRYQRV---KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAV 57
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           +K L HPNI+ L     +  N  +V E    G L+  + +      VD  + +     V 
Sbjct: 58  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQ---VL 114
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPE 432
            G  YLH  +  IVHRDLK  NLL++S      +K+ DFGLS +        K   GT  
Sbjct: 115 SGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLS-AHFEVGGKMKERLGTAY 171
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           ++APEVLR+   +EK DV+S GVIL+ L+    P+   T  +++  V
Sbjct: 172 YIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 217

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 127/250 (50%), Gaps = 13/250 (5%)
Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +K+++G+G+F  V     + +  + A KI+  ++     F++  RE  I + L+HPNIV 
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  ++ E     +V + ++ G L++ +    AR    E    +    + + + Y H    
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCHSN-- 124
Query: 387 PIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            IVHR+LK  NLL+ S      VK+ DFGL+  + N   +    AGTP +++PEVL++DP
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIE 501
            ++  D+++ GVIL+ L+    P+ +    ++ + +         P+   V P   +LI+
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 502 TCWAEEPEIR 511
           +     P+ R
Sbjct: 244 SMLTVNPKKR 253

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 127/250 (50%), Gaps = 13/250 (5%)
Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +K+++G+G+F  V     + +  + A KI+  ++     F++  RE  I + L+HPNIV 
Sbjct: 9   VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 68
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  ++ E     +V + ++ G L++ +    AR    E    +    + + + Y H    
Sbjct: 69  LHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCHSN-- 123
Query: 387 PIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            IVHR+LK  NLL+ S      VK+ DFGL+  + N   +    AGTP +++PEVL++DP
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIE 501
            ++  D+++ GVIL+ L+    P+ +    ++ + +         P+   V P   +LI+
Sbjct: 183 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 242
Query: 502 TCWAEEPEIR 511
           +     P+ R
Sbjct: 243 SMLTVNPKKR 252

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 127/250 (50%), Gaps = 13/250 (5%)
Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +K+++G+G+F  V     + +  + A KI+  ++     F++  RE  I + L+HPNIV 
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  ++ E     +V + ++ G L++ +    AR    E    +    + + + Y H    
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCHSN-- 124
Query: 387 PIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            IVHR+LK  NLL+ S      VK+ DFGL+  + N   +    AGTP +++PEVL++DP
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIE 501
            ++  D+++ GVIL+ L+    P+ +    ++ + +         P+   V P   +LI+
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 502 TCWAEEPEIR 511
           +     P+ R
Sbjct: 244 SMLTVNPKKR 253

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 123/258 (47%), Gaps = 33/258 (12%)
Query: 271 KKIGEGSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++IG GSFG VY A + RNS+V    K+    +   +++++ ++EV  ++ LRHPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
            G         +V EY   GS   LL +   +  + E     + +   +G+ YLH     
Sbjct: 81  RGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV---LREDPS 444
           ++HRD+K+ N+L+     VK+ DFG      +    +    GTP WMAPEV   + E   
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA------ 498
           + K DV+S G+   EL   + P  N      +SA+        I +N +P + +      
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMN---AMSAL------YHIAQNESPALQSGHWSEY 242
Query: 499 ---LIETCWAEEPEIRPS 513
               +++C  + P+ RP+
Sbjct: 243 FRNFVDSCLQKIPQDRPT 260

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 118/251 (47%), Gaps = 11/251 (4%)
Query: 273 IGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMG 329
           +G+GSF  VY AE  ++  +VA+K++ ++  ++    + ++ EV I   L+HP+I+ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV-VDERLRLNMAYDVAKGMNYLHQRRPPI 388
              +   + +V E    G + + L     RV    E    +  + +  GM YLH     I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSH--GI 133
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRDL   NLL+     +K+ DFGL+      +    T  GTP +++PE+        +S
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLES 193
Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 508
           DV+S G + + L+  + P+   T    ++ V       E+P  ++     LI       P
Sbjct: 194 DVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFLSIEAKDLIHQLLRRNP 251
Query: 509 EIRPSFPSIME 519
             R S  S+++
Sbjct: 252 ADRLSLSSVLD 262

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           KIGEGS+G V+    R++   VA+K  +E E      K  LRE+ ++K L+HPN+V L+ 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
                  L +V EY     L++L         V E L  ++ +   + +N+ H+     +
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHN--CI 124
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPS-NE 446
           HRD+K  N+L+     +K+CDFG +R  + P+ Y   + A  T  + +PE+L  D     
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWYRSPELLVGDTQYGP 182
Query: 447 KSDVFSFGVILWELITLQKPW 467
             DV++ G +  EL++    W
Sbjct: 183 PVDVWAIGCVFAELLSGVPLW 203

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 127/250 (50%), Gaps = 13/250 (5%)
Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +K+++G+G+F  V     + +  + A KI+  ++     F++  RE  I + L+HPNIV 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  ++ E     +V + ++ G L++ +    AR    E    +    + + + Y H    
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCHSN-- 147
Query: 387 PIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            IVHR+LK  NLL+ S      VK+ DFGL+  + N   +    AGTP +++PEVL++DP
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIE 501
            ++  D+++ GVIL+ L+    P+ +    ++ + +         P+   V P   +LI+
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266
Query: 502 TCWAEEPEIR 511
           +     P+ R
Sbjct: 267 SMLTVNPKKR 276

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 121/244 (49%), Gaps = 13/244 (5%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNIVLL 327
           +G+GSFG V  +E + +D   AVKIL +    +D   E     + V  + G + P +  L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQL 407
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                    L  V EY++ G L  + HI        E   +  A ++A G+ +L  +   
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRF-KEPHAVFYAAEIAIGLFFLQSK--G 462
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           I++RDLK  N+++DS   +K+ DFG+ +      +++K   GTP+++APE++   P  + 
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D ++FGV+L+E++  Q P+      ++  ++      +  PK+++    A+ +    + 
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTKH 580
Query: 508 PEIR 511
           P  R
Sbjct: 581 PGKR 584

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 135/273 (49%), Gaps = 15/273 (5%)
Query: 265 SELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFH-EDRFKEFLREVAIMKG 318
           S   + K +G+GSFG V+              A+K+L +      DR +  + E  I+  
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERDILAD 86
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           + HP +V L  A      L ++ ++L  G L+  L      +  +E ++  +A ++A G+
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALGL 143
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           ++LH     I++RDLK  N+L+D    +K+ DFGLS+   +    + +  GT E+MAPEV
Sbjct: 144 DHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           +     +  +D +S+GV+++E++T   P++     + ++ +     +L +P+ ++    +
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI--LKAKLGMPQFLSTEAQS 259
Query: 499 LIETCWAEEPEIR-PSFPSIMETLQQFLMSSVC 530
           L+   +   P  R  S P   E +++ +  S  
Sbjct: 260 LLRALFKRNPANRLGSGPDGAEEIKRHVFYSTI 292

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 121/244 (49%), Gaps = 13/244 (5%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNIVLL 327
           +G+GSFG V  +E + +D   AVKIL +    +D   E     + V  + G + P +  L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQL 86
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                    L  V EY++ G L  + HI        E   +  A ++A G+ +L  +   
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRF-KEPHAVFYAAEIAIGLFFLQSK--G 141
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           I++RDLK  N+++DS   +K+ DFG+ +      +++K   GTP+++APE++   P  + 
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 507
            D ++FGV+L+E++  Q P+      ++  ++      +  PK+++    A+ +    + 
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTKH 259
Query: 508 PEIR 511
           P  R
Sbjct: 260 PGKR 263

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 111/224 (49%), Gaps = 23/224 (10%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RH 321
            +  I + +G GSFG V+    R++    A+K+L ++     +  E   +  +M  +  H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI------PDARVVVDERLRLNMAYDVA 375
           P I+ + G   +   + ++ +Y+  G L+ LL        P A+           A +V 
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF---------YAAEVC 116
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMA 435
             + YLH +   I++RDLK  N+L+D    +K+ DFG ++  P+    +    GTP+++A
Sbjct: 117 LALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYXLCGTPDYIA 171
Query: 436 PEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           PEV+   P N+  D +SFG++++E++    P+ +S   +    +
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 35/218 (16%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHP--------- 322
           +G+G+FG V  A  RN+  +    I++  H E++    L EV ++  L H          
Sbjct: 14  LGQGAFGQVVKA--RNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 323 ----NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
               N V  M AV +   L I  EY   G+LY L+H  +     DE  RL     + + +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL--FRQILEAL 129
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL--------------SRSKPNTYISS 424
           +Y+H +   I+HRDLK  N+ +D +  VK+ DFGL              S++ P +  + 
Sbjct: 130 SYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 425 KTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELI 461
            +A GT  ++A EVL      NEK D++S G+I +E+I
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 124/243 (51%), Gaps = 11/243 (4%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGL-RHPNIVLLM 328
           +G+GSFG V  A+ + ++   A+KIL +     +D  +  + E  ++  L + P +  L 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
                   L  V EY++ G L  + HI        E   +  A +++ G+ +LH+R   I
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKF-KEPQAVFYAAEISIGLFFLHKRG--I 141
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           ++RDLK  N+++DS   +K+ DFG+ +      ++++   GTP+++APE++   P  +  
Sbjct: 142 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSV 201
Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 508
           D +++GV+L+E++  Q P+      ++  ++      +  PK+++    ++ +    + P
Sbjct: 202 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLMTKHP 259
Query: 509 EIR 511
             R
Sbjct: 260 AKR 262

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
            K+ +G G+F  V  AE + +    AVK + ++   + +      E+A+++ ++H NIV 
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL-KGKESSIENEIAVLRKIKHENIVA 84
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L      P +L +V + +S G L+  +     +    E+    +   V   + YLH  R 
Sbjct: 85  LEDIYESPNHLYLVMQLVSGGELFDRIV---EKGFYTEKDASTLIRQVLDAVYYLH--RM 139
Query: 387 PIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            IVHRDLK  NLL    D    + + DFGLS+ +    + S TA GTP ++APEVL + P
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMS-TACGTPGYVAPEVLAQKP 198
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
            ++  D +S GVI + L+    P+ +   S++   +
Sbjct: 199 YSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQI 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 16/213 (7%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G+F  V+  + R +    A+K + +     D   E   E+A++K ++H NIV L   
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVTLEDI 74
Query: 331 VTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
                +  +V + +S G L+ ++L     R V  E+    +   V   + YLH+    IV
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN--GIV 128
Query: 390 HRDLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           HRDLK  NLL    +    + + DFGLS+ + N  +S  TA GTP ++APEVL + P ++
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS--TACGTPGYVAPEVLAQKPYSK 186
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D +S GVI + L+    P+   T S++   +
Sbjct: 187 AVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 26/206 (12%)
Query: 276 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA----V 331
           G FG V+ A+  N  VAVKI   Q+  +    E+  EV  + G++H NI+  +GA     
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEY--EVYSLPGMKHENILQFIGAEKRGT 91
Query: 332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-------- 383
           +   +L ++T +  +GSL   L    A VV    L  ++A  +A+G+ YLH+        
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL---KANVVSWNEL-CHIAETMARGLAYLHEDIPGLKDG 147
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLRE 441
            +P I HRD+KS N+L+ +  T  + DFGL+        +  T    GT  +MAPEVL  
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 442 DPSNEKS-----DVFSFGVILWELIT 462
             + ++      D+++ G++LWEL +
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 7/206 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V+    + S  V  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 91
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L        + E++   ++  V KG+ YL ++   I+H
Sbjct: 92  FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 147
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           RD+K  N+LV+S   +K+CDFG+S    ++  +S    GT  +M+PE L+    + +SD+
Sbjct: 148 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDI 205
Query: 451 FSFGVILWELITLQKPWRNSTPSQVI 476
           +S G+ L E+   + P  + + S  I
Sbjct: 206 WSMGLSLVEMAVGRYPIGSGSGSMAI 231

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 114/228 (50%), Gaps = 21/228 (9%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKEFLREVAI 315
           G E+   +  I KK  E S G  Y A++   R S  + + +  +E          REV+I
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE--------REVSI 68
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           ++ + HPNI+ L        ++ ++ E +S G L+  L   ++   + E    +    + 
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQIL 125
Query: 376 KGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTP 431
            G+NYLH ++  I H DLK  N +L+D       +K+ DFGL+    +  +  K   GTP
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTP 182
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           E++APE++  +P   ++D++S GVI + L++   P+   T  + ++ +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 104/214 (48%), Gaps = 12/214 (5%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA-------IMKGLRHPNIV 325
           +G+G +G V+           KI   +   +       ++ A       I++ ++HP IV
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+ A      L ++ EYLS G L+  + +    + +++     +A +++  + +LHQ+ 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELF--MQLEREGIFMEDTACFYLA-EISMALGHLHQK- 140
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             I++RDLK  N++++    VK+ DFGL +   +    + T  GT E+MAPE+L     N
Sbjct: 141 -GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
              D +S G ++++++T   P+      + I  +
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 130/254 (51%), Gaps = 23/254 (9%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHA-EWRNSD--VAVKILIEQEFHEDRFKEFLR 311
           +E++GL     +     +IGEG++G V+ A + +N    VA+K +  Q   E      +R
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 312 EVAIMKGLR---HPNIVLLMGAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVD 363
           EVA+++ L    HPN+V L    T         L++V E++ +     L  +P+  V   
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT- 119
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
           E ++ +M + + +G+++LH  R  +VHRDLK  N+LV S+  +K+ DFGL+R    ++  
Sbjct: 120 ETIK-DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQM 174
Query: 424 SKTAAGTPEWM-APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISA 478
           + T+     W  APEVL +       D++S G I  E+   +  +R S+      +++  
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234
Query: 479 VGFKGRRLEIPKNV 492
           +G  G   + P++V
Sbjct: 235 IGLPGEE-DWPRDV 247

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 105/196 (53%), Gaps = 7/196 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V   + R S  +  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 82
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L   +A+ + +E L   ++  V +G+ YL ++   I+H
Sbjct: 83  FYSDGEISICMEHMDGGSLDQVLK--EAKRIPEEILG-KVSIAVLRGLAYLREKHQ-IMH 138
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           RD+K  N+LV+S   +K+CDFG+S    ++  +S    GT  +MAPE L+    + +SD+
Sbjct: 139 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMAPERLQGTHYSVQSDI 196
Query: 451 FSFGVILWELITLQKP 466
           +S G+ L EL   + P
Sbjct: 197 WSMGLSLVELAVGRYP 212

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 113/224 (50%), Gaps = 28/224 (12%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           GL  R S  L++ K   G FG V+ A+  N  VAVKI   Q+    + +   RE+    G
Sbjct: 10  GLVPRGSLQLLEIK-ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSE---REIFSTPG 65
Query: 319 LRHPNIVLLMGAVTEPPNLSI----VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           ++H N++  + A     NL +    +T +  +GSL   L      ++    L  ++A  +
Sbjct: 66  MKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNEL-CHVAETM 121
Query: 375 AKGMNYLHQ---------RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYIS- 423
           ++G++YLH+          +P I HRD KS N+L+ S  T  + DFGL+ R +P      
Sbjct: 122 SRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD 181
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKS-----DVFSFGVILWELIT 462
           +    GT  +MAPEVL    + ++      D+++ G++LWEL++
Sbjct: 182 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 130/254 (51%), Gaps = 23/254 (9%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHA-EWRNSD--VAVKILIEQEFHEDRFKEFLR 311
           +E++GL     +     +IGEG++G V+ A + +N    VA+K +  Q   E      +R
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 312 EVAIMKGLR---HPNIVLLMGAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVD 363
           EVA+++ L    HPN+V L    T         L++V E++ +     L  +P+  V   
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT- 119
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
           E ++ +M + + +G+++LH  R  +VHRDLK  N+LV S+  +K+ DFGL+R    ++  
Sbjct: 120 ETIK-DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQM 174
Query: 424 SKTAAGTPEWM-APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISA 478
           + T+     W  APEVL +       D++S G I  E+   +  +R S+      +++  
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234
Query: 479 VGFKGRRLEIPKNV 492
           +G  G   + P++V
Sbjct: 235 IGLPGEE-DWPRDV 247

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 182
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+    T  GTPE++APE++     N+
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATW----TLCGTPEYLAPEIILSKGYNK 238
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 271

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K IG GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    +KV DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K IG GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    +KV DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 130/254 (51%), Gaps = 23/254 (9%)
Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHA-EWRNSD--VAVKILIEQEFHEDRFKEFLR 311
           +E++GL     +     +IGEG++G V+ A + +N    VA+K +  Q   E      +R
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 312 EVAIMKGLR---HPNIVLLMGAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVD 363
           EVA+++ L    HPN+V L    T         L++V E++ +     L  +P+  V   
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT- 119
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
           E ++ +M + + +G+++LH  R  +VHRDLK  N+LV S+  +K+ DFGL+R    ++  
Sbjct: 120 ETIK-DMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQM 174
Query: 424 SKTAAGTPEWM-APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISA 478
           + T+     W  APEVL +       D++S G I  E+   +  +R S+      +++  
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234
Query: 479 VGFKGRRLEIPKNV 492
           +G  G   + P++V
Sbjct: 235 IGLPGEE-DWPRDV 247

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V+    + S  V  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 134
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L        + E++   ++  V KG+ YL ++   I+H
Sbjct: 135 FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 190
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           RD+K  N+LV+S   +K+CDFG+S    ++  +S    GT  +M+PE L+    + +SD+
Sbjct: 191 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDI 248
Query: 451 FSFGVILWELITLQKP 466
           +S G+ L E+   + P
Sbjct: 249 WSMGLSLVEMAVGRYP 264

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+      AGTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLAGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V+    + S  V  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L        + E++   ++  V KG+ YL ++   I+H
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 128
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           RD+K  N+LV+S   +K+CDFG+S    ++  +S    GT  +M+PE L+    + +SD+
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDI 186
Query: 451 FSFGVILWELITLQKP 466
           +S G+ L E+   + P
Sbjct: 187 WSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V+    + S  V  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L        + E++   ++  V KG+ YL ++   I+H
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 128
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           RD+K  N+LV+S   +K+CDFG+S    ++  +S    GT  +M+PE L+    + +SD+
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDI 186
Query: 451 FSFGVILWELITLQKP 466
           +S G+ L E+   + P
Sbjct: 187 WSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V+    + S  V  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L        + E++   ++  V KG+ YL ++   I+H
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 128
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           RD+K  N+LV+S   +K+CDFG+S    ++  +S    GT  +M+PE L+    + +SD+
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDI 186
Query: 451 FSFGVILWELITLQKP 466
           +S G+ L E+   + P
Sbjct: 187 WSMGLSLVEMAVGRYP 202

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V+    + S  V  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L        + E++   ++  V KG+ YL ++   I+H
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 128
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           RD+K  N+LV+S   +K+CDFG+S    ++  +S    GT  +M+PE L+    + +SD+
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDI 186
Query: 451 FSFGVILWELITLQKP 466
           +S G+ L E+   + P
Sbjct: 187 WSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V+    + S  V  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L        + E++   ++  V KG+ YL ++   I+H
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 128
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           RD+K  N+LV+S   +K+CDFG+S    ++  +S    GT  +M+PE L+    + +SD+
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDI 186
Query: 451 FSFGVILWELITLQKP 466
           +S G+ L E+   + P
Sbjct: 187 WSMGLSLVEMAVGRYP 202

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 126/262 (48%), Gaps = 20/262 (7%)
Query: 271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF----KEFLREVAIMKGLRHPNI 324
           +++G G F  V     + +  + A K + ++     R     +E  REV I++ +RHPNI
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + L        ++ ++ E +S G L+  L   ++ +  DE  +      +  G++YLH +
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQF--LKQILDGVHYLHSK 127
Query: 385 RPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           R  I H DLK  N +L+D       +K+ DFG++  K       K   GTPE++APE++ 
Sbjct: 128 R--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFGTPEFVAPEIVN 184
Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVA 497
            +P   ++D++S GVI + L++   P+   T  +    ISAV +     E   N + +  
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE-EYFSNTSELAK 243
Query: 498 ALIETCWAEEPEIRPSFPSIME 519
             I     ++P+ R +    +E
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLE 265

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V+    + S  V  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L        + E++   ++  V KG+ YL ++   I+H
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 155
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           RD+K  N+LV+S   +K+CDFG+S    ++  +S    GT  +M+PE L+    + +SD+
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDI 213
Query: 451 FSFGVILWELITLQKP 466
           +S G+ L E+   + P
Sbjct: 214 WSMGLSLVEMAVGRYP 229

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K IG GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    +KV DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 35/218 (16%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHP--------- 322
           +G+G+FG V  A  RN+  +    I++  H E++    L EV ++  L H          
Sbjct: 14  LGQGAFGQVVKA--RNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 323 ----NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
               N V  M AV +   L I  EY    +LY L+H  +     DE  RL     + + +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL--FRQILEAL 129
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL--------------SRSKPNTYISS 424
           +Y+H +   I+HRDLK  N+ +D +  VK+ DFGL              S++ P +  + 
Sbjct: 130 SYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 425 KTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELI 461
            +A GT  ++A EVL      NEK D++S G+I +E+I
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 125/262 (47%), Gaps = 20/262 (7%)
Query: 271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF----KEFLREVAIMKGLRHPNI 324
           +++G G F  V     + +  + A K + ++     R     +E  REV I++ +RHPNI
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + L        ++ ++ E +S G L+  L   ++ +  DE  +      +  G++YLH +
Sbjct: 92  ITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQF--LKQILDGVHYLHSK 148
Query: 385 RPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           R  I H DLK  N +L+D       +K+ DFG++  K       K   GTPE++APE++ 
Sbjct: 149 R--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFGTPEFVAPEIVN 205
Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVA 497
            +P   ++D++S GVI + L++   P+   T  +    ISAV +     E   N + +  
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE-EYFSNTSELAK 264
Query: 498 ALIETCWAEEPEIRPSFPSIME 519
             I     ++P+ R      +E
Sbjct: 265 DFIRRLLVKDPKRRMXIAQSLE 286

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 125/262 (47%), Gaps = 20/262 (7%)
Query: 271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF----KEFLREVAIMKGLRHPNI 324
           +++G G F  V     + +  + A K + ++     R     +E  REV I++ +RHPNI
Sbjct: 18  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + L        ++ ++ E +S G L+  L   ++ +  DE  +      +  G++YLH +
Sbjct: 78  ITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQF--LKQILDGVHYLHSK 134
Query: 385 RPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           R  I H DLK  N +L+D       +K+ DFG++  K       K   GTPE++APE++ 
Sbjct: 135 R--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFGTPEFVAPEIVN 191
Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVA 497
            +P   ++D++S GVI + L++   P+   T  +    ISAV +     E   N + +  
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE-EYFSNTSELAK 250
Query: 498 ALIETCWAEEPEIRPSFPSIME 519
             I     ++P+ R      +E
Sbjct: 251 DFIRRLLVKDPKRRMXIAQSLE 272

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFAEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 91
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 146
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+    T  GTPE++APE++     N
Sbjct: 147 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEYLAPEIILSKGYN 202
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 203 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 236

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+    T  GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 120/269 (44%), Gaps = 14/269 (5%)
Query: 254 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFL 310
           +LE + +   W   L  + +G G FG V+  + + +       K+  ++      ++  +
Sbjct: 176 WLEAQPMGEDW--FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLN 369
            E  I+  +    IV L  A     +L +V   ++ G + Y + ++ +      E   + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 429
               +  G+ +LHQR   I++RDLK  N+L+D    V++ D GL+         +K  AG
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-- 487
           TP +MAPE+L  +  +   D F+ GV L+E+I  + P+R     + +     K R LE  
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR--GEKVENKELKQRVLEQA 409
Query: 488 --IPKNVNPMVAALIETCWAEEPEIRPSF 514
              P   +P      E    ++PE R  F
Sbjct: 410 VTYPDKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 120/269 (44%), Gaps = 14/269 (5%)
Query: 254 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFL 310
           +LE + +   W   L  + +G G FG V+  + + +       K+  ++      ++  +
Sbjct: 176 WLEAQPMGEDW--FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLN 369
            E  I+  +    IV L  A     +L +V   ++ G + Y + ++ +      E   + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 429
               +  G+ +LHQR   I++RDLK  N+L+D    V++ D GL+         +K  AG
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-- 487
           TP +MAPE+L  +  +   D F+ GV L+E+I  + P+R     + +     K R LE  
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR--GEKVENKELKQRVLEQA 409
Query: 488 --IPKNVNPMVAALIETCWAEEPEIRPSF 514
              P   +P      E    ++PE R  F
Sbjct: 410 VTYPDKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 103/214 (48%), Gaps = 12/214 (5%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA-------IMKGLRHPNIV 325
           +G+G +G V+           KI   +   +       ++ A       I++ ++HP IV
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+ A      L ++ EYLS G L+  + +    + +++     +A +++  + +LHQ+ 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELF--MQLEREGIFMEDTACFYLA-EISMALGHLHQK- 140
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             I++RDLK  N++++    VK+ DFGL +   +    +    GT E+MAPE+L     N
Sbjct: 141 -GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHN 199
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
              D +S G ++++++T   P+      + I  +
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 120/269 (44%), Gaps = 14/269 (5%)
Query: 254 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFL 310
           +LE + +   W   L  + +G G FG V+  + + +       K+  ++      ++  +
Sbjct: 176 WLEAQPMGEDW--FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLN 369
            E  I+  +    IV L  A     +L +V   ++ G + Y + ++ +      E   + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 429
               +  G+ +LHQR   I++RDLK  N+L+D    V++ D GL+         +K  AG
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-- 487
           TP +MAPE+L  +  +   D F+ GV L+E+I  + P+R     + +     K R LE  
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR--GEKVENKELKQRVLEQA 409
Query: 488 --IPKNVNPMVAALIETCWAEEPEIRPSF 514
              P   +P      E    ++PE R  F
Sbjct: 410 VTYPDKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 120/269 (44%), Gaps = 14/269 (5%)
Query: 254 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFL 310
           +LE + +   W   L  + +G G FG V+  + + +       K+  ++      ++  +
Sbjct: 176 WLEAQPMGEDW--FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLN 369
            E  I+  +    IV L  A     +L +V   ++ G + Y + ++ +      E   + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 429
               +  G+ +LHQR   I++RDLK  N+L+D    V++ D GL+         +K  AG
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-- 487
           TP +MAPE+L  +  +   D F+ GV L+E+I  + P+R     + +     K R LE  
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR--GEKVENKELKQRVLEQA 409
Query: 488 --IPKNVNPMVAALIETCWAEEPEIRPSF 514
              P   +P      E    ++PE R  F
Sbjct: 410 VTYPDKFSPASKDFCEALLQKDPEKRLGF 438

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL--D 182
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 238
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 271

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 120/229 (52%), Gaps = 16/229 (6%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREV 313
           +E  ++ +    I + IG+GSFG V   +  ++    A+K + +Q+  E +  +   +E+
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            IM+GL HP +V L  +  +  ++ +V + L  G L    H+       +E ++L +  +
Sbjct: 67  QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFIC-E 123
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP-NTYISSKTAAGTPE 432
           +   ++YL  +R  I+HRD+K  N+L+D    V + DF ++   P  T I+  T AGT  
Sbjct: 124 LVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT--TMAGTKP 179
Query: 433 WMAPEVLREDPSNEKS---DVFSFGVILWELITLQKPW--RNSTPSQVI 476
           +MAPE+         S   D +S GV  +EL+  ++P+  R+ST S+ I
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 112/211 (53%), Gaps = 22/211 (10%)
Query: 263 RWSELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           R+++L   + IGEG++G V  A    R + VA+K +   E H+   +  LRE+ I+   R
Sbjct: 44  RYTQL---QYIGEGAYGMVSSAYDHVRKTRVAIKKISPFE-HQTYCQRTLREIQILLRFR 99
Query: 321 HPNIV----LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           H N++    +L  +  E      + + L    LYKLL    ++ + ++ +     Y + +
Sbjct: 100 HENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLL---KSQQLSNDHI-CYFLYQILR 155
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR----SKPNTYISSKTAAGTPE 432
           G+ Y+H     ++HRDLK  NLL+++T  +K+CDFGL+R       +T   ++  A T  
Sbjct: 156 GLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA-TRW 212
Query: 433 WMAPEVLREDPSNEKS-DVFSFGVILWELIT 462
           + APE++       KS D++S G IL E+++
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 102 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL--D 156
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 212
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 213 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 245

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 273 IGEGSFGTVYHAEWRNS--DVAVKILIEQEFHED---RFKEFLREVAIMKGLRHPNIVLL 327
           IG+G+F  V     R +    AVKI+   +F        ++  RE +I   L+HP+IV L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 328 MGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           +   +    L +V E++    L ++++   DA  V  E +  +    + + + Y H    
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 387 PIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            I+HRD+K  N+L+ S   +  VK+ DFG++     + + +    GTP +MAPEV++ +P
Sbjct: 151 -IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNS 470
             +  DV+  GVIL+ L++   P+  +
Sbjct: 210 YGKPVDVWGCGVILFILLSGCLPFYGT 236

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 152
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    + +  GT ++++PE+L E  ++
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADEPIQIYEKI 250

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 108 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 162
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 218
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 152
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      + + +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI 246

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 94  EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 148
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 204
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 205 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 237

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 10/207 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           E  + +++G+G+F  V          + A KI+  ++      ++  RE  I + L+HPN
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV L  +++E     +V + ++ G L++ +    AR    E    +    + + +N+ H 
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILESVNHCHL 121
Query: 384 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
               IVHRDLK  NLL+ S      VK+ DFGL+        +    AGTP +++PEVLR
Sbjct: 122 N--GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 441 EDPSNEKSDVFSFGVILWELITLQKPW 467
           +DP  +  D+++ GVIL+ L+    P+
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLXGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 10/207 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           E  + +++G+G+F  V          + A KI+  ++      ++  RE  I + L+HPN
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV L  +++E     +V + ++ G L++ +    AR    E    +    + + +N+ H 
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILESVNHCHL 121
Query: 384 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
               IVHRDLK  NLL+ S      VK+ DFGL+        +    AGTP +++PEVLR
Sbjct: 122 N--GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 441 EDPSNEKSDVFSFGVILWELITLQKPW 467
           +DP  +  D+++ GVIL+ L+    P+
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 152
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      + + +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI 246

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 10/202 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +++G+G+F  V          + A KI+  ++      ++  RE  I + L+HPNIV L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +++E  +  ++ + ++ G L++ +    AR    E    +    + + + + HQ    +
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLHCHQM--GV 142
Query: 389 VHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           VHRDLK  NLL+ S      VK+ DFGL+        +    AGTP +++PEVLR+DP  
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 446 EKSDVFSFGVILWELITLQKPW 467
           +  D+++ GVIL+ L+    P+
Sbjct: 203 KPVDLWACGVILYILLVGYPPF 224

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 125/253 (49%), Gaps = 27/253 (10%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 68
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+LS   L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 69  LDVIHTENKLYLVFEFLSM-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 125 --VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 445 NEKSDVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIPKNVN-PMVAALIET 502
           +   D++S G I  E++T +  +  +S   Q+        R L  P  V  P V ++   
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF----RTLGTPDEVVWPGVTSM--- 235
Query: 503 CWAEEPEIRPSFP 515
                P+ +PSFP
Sbjct: 236 -----PDYKPSFP 243

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+LS   L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 71  LDVIHTENKLYLVFEFLSM-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 127 --VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 105/198 (53%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+++ H  R
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLSFCHSHR 123
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 74
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 75  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 131 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 188
Query: 446 EKS-DVFSFGVILWELIT 462
             + D++S G I  E++T
Sbjct: 189 STAVDIWSLGCIFAEMVT 206

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           ++G G+ G V+    + S  V  + LI  E       + +RE+ ++     P IV   GA
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 75
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                 +SI  E++  GSL ++L        + E++   ++  V KG+ YL ++   I+H
Sbjct: 76  FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 131
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDV 450
           RD+K  N+LV+S   +K+CDFG+S    +    +    GT  +M+PE L+    + +SD+
Sbjct: 132 RDVKPSNILVNSRGEIKLCDFGVSGQLIDEM--ANEFVGTRSYMSPERLQGTHYSVQSDI 189
Query: 451 FSFGVILWELITLQKP 466
           +S G+ L E+   + P
Sbjct: 190 WSMGLSLVEMAVGRYP 205

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 27/205 (13%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ +VT +L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 111 RAPTIEQMKDVYLVT-HLMGADLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 162
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN----TYISSKTAAGTPEWMAPEV 438
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+     +++   A  T  + APE+
Sbjct: 163 AN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRAPEI 218
Query: 439 LREDPSNEKS-DVFSFGVILWELIT 462
           +       KS D++S G IL E+++
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 446 EKS-DVFSFGVILWELIT 462
             + D++S G I  E++T
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 93  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 144
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 145 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLS 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 273 IGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +GEGS+G V   + RN D    VA+K  +E +  +   K  +RE+ ++K LRH N+V L+
Sbjct: 33  VGEGSYGMV--MKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
               +     +V E++    L  L   P+    +D ++     + +  G+ + H     I
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSHN--I 145
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +HRD+K  N+LV  +  VK+CDFG +R+   P      + A  T  + APE+L  D    
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELLVGDVKYG 203
Query: 447 KS-DVFSFGVILWELI 461
           K+ DV++ G ++ E+ 
Sbjct: 204 KAVDVWAIGCLVTEMF 219

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 153
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    + +  GT ++++PE+L E  + 
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 247

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 98
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL-- 153
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 154 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 209
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 210 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 243

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 27/205 (13%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 93  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 144
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN----TYISSKTAAGTPEWMAPEV 438
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+     +++   A  T  + APE+
Sbjct: 145 AN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRAPEI 200
Query: 439 LREDPSNEKS-DVFSFGVILWELIT 462
           +       KS D++S G IL E+++
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+LS      L    DA  +    L L  +Y   + +G+ + H  R
Sbjct: 71  LDVIHTENKLYLVFEFLS----MDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 127 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 15/197 (7%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE-----FLREVAIMKGLRHPNIVLL 327
           +GEG F TVY A  +N++  V I   +  H    K+      LRE+ +++ L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
           + A     N+S+V +++   +  +++   ++ V+    ++  M   + +G+ YLHQ    
Sbjct: 78  LDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYMLMTL-QGLEYLHQHW-- 132
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVL-REDPS 444
           I+HRDLK  NLL+D    +K+ DFGL++S   PN     +    T  + APE+L      
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGARMY 190
Query: 445 NEKSDVFSFGVILWELI 461
               D+++ G IL EL+
Sbjct: 191 GVGVDMWAVGCILAELL 207

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNH-FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNH-FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 98
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 153
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 154 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 209
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 210 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 243

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++++     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYQMAAGYPPFFADQPIQIYEKI 250

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNH-FAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 123/253 (48%), Gaps = 27/253 (10%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 69
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+LS      L    DA  +    L L  +Y   + +G+ + H  R
Sbjct: 70  LDVIHTENKLYLVFEFLS----MDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 126 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 445 NEKSDVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIPKNVN-PMVAALIET 502
           +   D++S G I  E++T +  +  +S   Q+        R L  P  V  P V ++   
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF----RTLGTPDEVVWPGVTSM--- 236
Query: 503 CWAEEPEIRPSFP 515
                P+ +PSFP
Sbjct: 237 -----PDYKPSFP 244

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 13/212 (6%)
Query: 273 IGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G FG V+  E   +   +A KI I+    +D+ +E   E+++M  L H N++ L  A
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKI-IKTRGMKDK-EEVKNEISVMNQLDHANLIQLYDA 154
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
                ++ +V EY+  G L+    I D    + E   +     + +G+ ++HQ    I+H
Sbjct: 155 FESKNDIVLVMEYVDGGELFD--RIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILH 210
Query: 391 RDLKSPNLLV--DSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
            DLK  N+L        +K+ DFGL+R  KP   +  K   GTPE++APEV+  D  +  
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAPEVVNYDFVSFP 268
Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +D++S GVI + L++   P+     ++ ++ +
Sbjct: 269 TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +    +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY   G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NL++D    +KV DFGL+ R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 74
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 75  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 131 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 188
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 189 STAVDIWSLGCIFAEMVT 206

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 125/253 (49%), Gaps = 27/253 (10%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 445 NEKSDVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIPKNVN-PMVAALIET 502
           +   D++S G I  E++T +  +  +S   Q+        R L  P  V  P V ++   
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF----RTLGTPDEVVWPGVTSM--- 234
Query: 503 CWAEEPEIRPSFP 515
                P+ +PSFP
Sbjct: 235 -----PDYKPSFP 242

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 66
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 67  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 71  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 127 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 69
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 70  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 126 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 184 STAVDIWSLGCIFAEMVT 201

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 125/253 (49%), Gaps = 27/253 (10%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 68
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 69  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 125 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 182
Query: 445 NEKSDVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIPKNVN-PMVAALIET 502
           +   D++S G I  E++T +  +  +S   Q+        R L  P  V  P V ++   
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF----RTLGTPDEVVWPGVTSM--- 235
Query: 503 CWAEEPEIRPSFP 515
                P+ +PSFP
Sbjct: 236 -----PDYKPSFP 243

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 125/253 (49%), Gaps = 27/253 (10%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 68
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 69  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 125 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 445 NEKSDVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIPKNVN-PMVAALIET 502
           +   D++S G I  E++T +  +  +S   Q+        R L  P  V  P V ++   
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF----RTLGTPDEVVWPGVTSM--- 235
Query: 503 CWAEEPEIRPSFP 515
                P+ +PSFP
Sbjct: 236 -----PDYKPSFP 243

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY   G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NL++D    +KV DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 125/253 (49%), Gaps = 27/253 (10%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 68
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 69  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 125 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 445 NEKSDVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIPKNVN-PMVAALIET 502
           +   D++S G I  E++T +  +  +S   Q+        R L  P  V  P V ++   
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF----RTLGTPDEVVWPGVTSM--- 235
Query: 503 CWAEEPEIRPSFP 515
                P+ +PSFP
Sbjct: 236 -----PDYKPSFP 243

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 12/236 (5%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 149
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    + +  GT ++++PE+L E  + 
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
           + SD+++ G I+++L+    P+R      +   +       + P+   P    L+E
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 263

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NL++D    ++V DFG + R K  T+       GTPE++APE++     N+
Sbjct: 162 LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIIISKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 66
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 67  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 66
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 67  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 126
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 181
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 182 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 237
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 271

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 150
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 71
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 72  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 128 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 185
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 186 STAVDIWSLGCIFAEMVT 203

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 157
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 218 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 251

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY+  G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 182 STAVDIWSLGCIFAEMVT 199

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 71  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 127 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 66
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 67  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 69
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 70  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 126 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 184 STAVDIWSLGCIFAEMVT 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 71
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 72  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 128 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 186 STAVDIWSLGCIFAEMVT 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 69
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 70  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 126 --VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 184 STAVDIWSLGCIFAEMVT 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 125/253 (49%), Gaps = 27/253 (10%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 68
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 69  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 125 --VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 445 NEKSDVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIPKNVN-PMVAALIET 502
           +   D++S G I  E++T +  +  +S   Q+        R L  P  V  P V ++   
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF----RTLGTPDEVVWPGVTSM--- 235
Query: 503 CWAEEPEIRPSFP 515
                P+ +PSFP
Sbjct: 236 -----PDYKPSFP 243

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 66
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 67  LDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY   G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NL++D    +KV DFG + R K  T+       GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 153
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 247

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 91  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 142
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 143 AN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLS 223

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY   G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NL++D    +KV DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 127
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 188 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 221

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 129
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 190 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 223

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 155
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 216 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 249

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 152
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 130
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 191 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 224

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 152
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 128
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 222

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 150
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 91  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 142
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 143 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLS 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 121/257 (47%), Gaps = 23/257 (8%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+ W+   ++  +G GSFG V+  E + +    AVK +  + F  +       E+    G
Sbjct: 91  EVHWATHQLR--LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------ELMACAG 141
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           L  P IV L GAV E P ++I  E L  GSL +L+     +  + E   L       +G+
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGL 198
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYT-VKVCDFGLSRS-KPN----TYISSKTAAGTPE 432
            YLH RR  I+H D+K+ N+L+ S  +   +CDFG +   +P+    + ++     GT  
Sbjct: 199 EYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET 256
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL-EIPKN 491
            MAPEV+     + K DV+S   ++  ++    PW       +   +  +   + EIP +
Sbjct: 257 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPS 316
Query: 492 VNPMVAALIETCWAEEP 508
             P+ A  I+    +EP
Sbjct: 317 CAPLTAQAIQEGLRKEP 333

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 113/228 (49%), Gaps = 21/228 (9%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKEFLREVAI 315
           G E+   +  I KK  E S G  Y A++   R S  + + +  +E          REV+I
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE--------REVSI 68
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           ++ + H N++ L        ++ ++ E +S G L+  L   ++   + E    +    + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQIL 125
Query: 376 KGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTP 431
            G+NYLH ++  I H DLK  N +L+D       +K+ DFGL+    +  +  K   GTP
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTP 182
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           E++APE++  +P   ++D++S GVI + L++   P+   T  + ++ +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 93  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 144
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 145 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 95  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 146
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 147 AN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 150
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 95  RAPTIEQMKDVYIVQD-LMETDLYKLLKCQHLSNDHICY-------FLYQILRGLKYIHS 146
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 147 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 95  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 146
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 147 AN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 152
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 12/236 (5%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 149
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
           + SD+++ G I+++L+    P+R      +   +       + P+   P    L+E
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 263

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 95  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 146
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 147 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLS 227

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 113/228 (49%), Gaps = 21/228 (9%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQEFHEDRFKEFLREVAI 315
           G E+   +  I KK  E S G  Y A++   R S  + + +  +E          REV+I
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE--------REVSI 68
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           ++ + H N++ L        ++ ++ E +S G L+  L   ++   + E    +    + 
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQIL 125
Query: 376 KGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTP 431
            G+NYLH ++  I H DLK  N +L+D       +K+ DFGL+    +  +  K   GTP
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTP 182
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           E++APE++  +P   ++D++S GVI + L++   P+   T  + ++ +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 91  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 142
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 143 AN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLS 223

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 127
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 186
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 247 VENPSARITIPDI 259

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 123/253 (48%), Gaps = 27/253 (10%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 67
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +     L    DA  +    L L  +Y   + +G+ + H  R
Sbjct: 68  LDVIHTENKLYLVFEFLHQ----DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 124 --VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 445 NEKSDVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIPKNVN-PMVAALIET 502
           +   D++S G I  E++T +  +  +S   Q+        R L  P  V  P V ++   
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF----RTLGTPDEVVWPGVTSM--- 234
Query: 503 CWAEEPEIRPSFP 515
                P+ +PSFP
Sbjct: 235 -----PDYKPSFP 242

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 12/236 (5%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF TV  A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 134
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
           + SD+++ G I+++L+    P+R      +   +       + P+   P    L+E
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 248

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 99  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 150
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 151 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 91  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 142
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 143 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 96  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 147
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 148 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 97  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 148
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 149 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 88  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 139
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 140 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLS 220

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 111 RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 162
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 163 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 95  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 146
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 147 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 125
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 184
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 245 VENPSARITIPDI 257

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 113/221 (51%), Gaps = 16/221 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF----KEFLREVAIMKGLRHP 322
           I +++G G F  V     +++  + A K + +++    R     +E  REV+I++ + H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           N++ L        ++ ++ E +S G L+  L   ++   + E    +    +  G+NYLH
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLH 132
Query: 383 QRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
            ++  I H DLK  N +L+D       +K+ DFGL+    +  +  K   GTPE++APE+
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEI 189
Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  +P   ++D++S GVI + L++   P+   T  + ++ +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 127
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 186
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 247 VENPSARITIPDI 259

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 89  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 140
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 141 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLS 221

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 89  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 140
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R + P+  +    T      W  APE++ 
Sbjct: 141 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE +APE++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEALAPEIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 28/218 (12%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEF-LREVAIMKGL 319
           E+ W  +  + ++G GSFG V+  + + +     +       + R + F + E+    GL
Sbjct: 56  EVHW--MTHQPRVGRGSFGEVHRMKDKQTGFQCAV------KKVRLEVFRVEELVACAGL 107
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH----IPDARVVVDERLRLNMAYDVA 375
             P IV L GAV E P ++I  E L  GSL +L+     +P+ R +      L  A +  
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY----YLGQALE-- 161
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-VKVCDFGLSRS-KPN----TYISSKTAAG 429
            G+ YLH RR  I+H D+K+ N+L+ S  +   +CDFG +   +P+    + ++     G
Sbjct: 162 -GLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 467
           T   MAPEV+   P + K D++S   ++  ++    PW
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 13/213 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 327
           K +G GSFG V   + + S    A+KIL +Q+  +  + +  L E  I++ +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             +  +  NL +V EY++ G ++   H+       +   R   A  +     YLH     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL--D 161
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
           +++RDLK  NLL+D    ++V DFG + R K  T+       GTPE++AP ++     N+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPAIILSKGYNK 217
Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 113/221 (51%), Gaps = 16/221 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF----KEFLREVAIMKGLRHP 322
           I +++G G F  V     +++  + A K + +++    R     +E  REV+I++ + H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           N++ L        ++ ++ E +S G L+  L   ++   + E    +    +  G+NYLH
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLH 132
Query: 383 QRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
            ++  I H DLK  N +L+D       +K+ DFGL+    +  +  K   GTPE++APE+
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEI 189
Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  +P   ++D++S GVI + L++   P+   T  + ++ +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 95  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 146
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R     +  +        T  + APE++ 
Sbjct: 147 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 96  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 147
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEVLR 440
               ++HRDLK  NLL+++T  +K+CDFGL+R     +  +        T  + APE++ 
Sbjct: 148 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLS 228

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 28/218 (12%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEF-LREVAIMKGL 319
           E+ W  +  + ++G GSFG V+  + + +     +       + R + F + E+    GL
Sbjct: 72  EVHW--MTHQPRVGRGSFGEVHRMKDKQTGFQCAV------KKVRLEVFRVEELVACAGL 123
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH----IPDARVVVDERLRLNMAYDVA 375
             P IV L GAV E P ++I  E L  GSL +L+     +P+ R +      L  A +  
Sbjct: 124 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY----YLGQALE-- 177
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-VKVCDFGLSRS-KPN----TYISSKTAAG 429
            G+ YLH RR  I+H D+K+ N+L+ S  +   +CDFG +   +P+    + ++     G
Sbjct: 178 -GLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 234
Query: 430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 467
           T   MAPEV+   P + K D++S   ++  ++    PW
Sbjct: 235 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E+L +     L    DA  +    L L  +Y   + +G+ + H  R
Sbjct: 71  LDVIHTENKLYLVFEFLHQ----DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 127 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 127
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 186
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 247 VENPSARITIPDI 259

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 113/221 (51%), Gaps = 16/221 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF----KEFLREVAIMKGLRHP 322
           I +++G G F  V     +++  + A K + +++    R     +E  REV+I++ + H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           N++ L        ++ ++ E +S G L+  L   ++   + E    +    +  G+NYLH
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLH 132
Query: 383 QRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
            ++  I H DLK  N +L+D       +K+ DFGL+    +  +  K   GTPE++APE+
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEI 189
Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  +P   ++D++S GVI + L++   P+   T  + ++ +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 127
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 186
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 247 VENPSARITIPDI 259

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 127
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 186
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 247 VENPSARITIPDI 259

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 127
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 186
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 247 VENPSARITIPDI 259

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +    +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY   G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NL++D    ++V DFGL+ R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-XGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 99/193 (51%), Gaps = 7/193 (3%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           K+GEG++ TVY  + + +D  V +  I  E  E      +REV+++K L+H NIV L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 390
           +    +L++V EYL +       ++ D   +++        + + +G+ Y H  R  ++H
Sbjct: 69  IHTEKSLTLVFEYLDKDLKQ---YLDDCGNIINMHNVKLFLFQLLRGLAYCH--RQKVLH 123
Query: 391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSD 449
           RDLK  NLL++    +K+ DFGL+R+K     +      T  +  P++L      + + D
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQID 183
Query: 450 VFSFGVILWELIT 462
           ++  G I +E+ T
Sbjct: 184 MWGVGCIFYEMAT 196

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 18/202 (8%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           +K+G G++ TVY    + + V V +  ++ +  E      +RE+++MK L+H NIV L  
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVD--ERLRLNMA----YDVAKGMNYLHQ 383
            +     L++V E++    L K +   D+R V +    L LN+     + + +G+ + H+
Sbjct: 71  VIHTENKLTLVFEFMDN-DLKKYM---DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLRE 441
            +  I+HRDLK  NLL++    +K+ DFGL+R+   P    SS+    T  + AP+VL  
Sbjct: 127 NK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRAPDVLMG 182
Query: 442 DPSNEKS-DVFSFGVILWELIT 462
             +   S D++S G IL E+IT
Sbjct: 183 SRTYSTSIDIWSCGCILAEMIT 204

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 131/266 (49%), Gaps = 27/266 (10%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREV-AIMKGLRHPNIVLLM 328
           +IG G++G+V     + S   +AVK  I     E   K+ L ++  +M+    P IV   
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVK-RIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 329 GAVTEPPNLSIVTEYLSRG--SLYKLLHIPDARVVVDERL-RLNMAYDVAKGMNYLHQRR 385
           GA+    +  I  E +S      YK ++     V+ +E L ++ +A    K +N+L +  
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA--TVKALNHLKENL 145
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS- 444
             I+HRD+K  N+L+D +  +K+CDFG+S    ++   ++ A   P +MAPE  R DPS 
Sbjct: 146 K-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPE--RIDPSA 201
Query: 445 -----NEKSDVFSFGVILWELITLQKPW--RNSTPSQVISAVGFKGRRLEIP----KNVN 493
                + +SDV+S G+ L+EL T + P+   NS   Q+   V  KG   ++     +  +
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV--KGDPPQLSNSEEREFS 259
Query: 494 PMVAALIETCWAEEPEIRPSFPSIME 519
           P     +  C  ++   RP +  +++
Sbjct: 260 PSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-XGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 28/218 (12%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEF-LREVAIMKGL 319
           E+ W  +  + ++G GSFG V+  + + +     +       + R + F + E+    GL
Sbjct: 70  EVHW--MTHQPRLGRGSFGEVHRMKDKQTGFQCAV------KKVRLEVFRVEELVACAGL 121
Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH----IPDARVVVDERLRLNMAYDVA 375
             P IV L GAV E P ++I  E L  GSL +L+     +P+ R +      L  A +  
Sbjct: 122 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY----YLGQALE-- 175
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-VKVCDFGLSRS-KPN----TYISSKTAAG 429
            G+ YLH RR  I+H D+K+ N+L+ S  +   +CDFG +   +P+    + ++     G
Sbjct: 176 -GLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 232
Query: 430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 467
           T   MAPEV+   P + K D++S   ++  ++    PW
Sbjct: 233 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +  
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY   G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFXEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NL++D    +KV DFG + R K  T+       GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           + +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I + +  P +V 
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNH-YAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY   G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NLL+D    +KV DFG + R K  T+       GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +KIGEG++G VY A+  +  +    KI +E+E  E      +RE++I+K L+H NIV L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLY 66
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV--VVDERLRLNMAYDVAKGMNYLHQRRP 386
             +     L +V E+L +  L KLL + +  +  V  +   L +      G+ Y H RR 
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL----NGIAYCHDRR- 120
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRDLK  NLL++    +K+ DFGL+R+             T  + AP+VL       
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 447 KS-DVFSFGVILWELITLQKPWRNSTP 472
            + D++S G I  E++       N TP
Sbjct: 180 TTIDIWSVGCIFAEMV-------NGTP 199

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 127
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-XGTLPYVAPELLKRREFHA 186
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 247 VENPSARITIPDI 259

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-XGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +V 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY   G ++   H+       +   R   A  +     YLH    
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 160
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NL++D    ++V DFG + R K  T+       GTPE++APE++     N
Sbjct: 161 DLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 216
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +KIGEG++G VY A+  +  +    KI +E+E  E      +RE++I+K L+H NIV L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLY 66
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV--VVDERLRLNMAYDVAKGMNYLHQRRP 386
             +     L +V E+L +  L KLL + +  +  V  +   L +      G+ Y H RR 
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL----NGIAYCHDRR- 120
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRDLK  NLL++    +K+ DFGL+R+             T  + AP+VL       
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 447 KS-DVFSFGVILWELIT 462
            + D++S G I  E++ 
Sbjct: 180 TTIDIWSVGCIFAEMVN 196

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 120/257 (46%), Gaps = 23/257 (8%)
Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+ W+   ++  +G GSFG V+  E + +    AVK +  + F  +       E+    G
Sbjct: 72  EVHWATHQLR--LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------ELMACAG 122
Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           L  P IV L GAV E P ++I  E L  GSL +L+     +  + E   L       +G+
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGL 179
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYT-VKVCDFGLSRS-KPNT----YISSKTAAGTPE 432
            YLH RR  I+H D+K+ N+L+ S  +   +CDFG +   +P+      ++     GT  
Sbjct: 180 EYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET 237
Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL-EIPKN 491
            MAPEV+     + K DV+S   ++  ++    PW       +   +  +   + EIP +
Sbjct: 238 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPS 297
Query: 492 VNPMVAALIETCWAEEP 508
             P+ A  I+    +EP
Sbjct: 298 CAPLTAQAIQEGLRKEP 314

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 70
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E++ +  L K +   DA  +    L L  +Y   + +G+ + H  R
Sbjct: 71  LDVIHTENKLYLVFEHVDQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 127 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 185 STAVDIWSLGCIFAEMVT 202

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-XGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +  
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY   G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NL++D    +KV DFG + R K  T+       GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 271 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVL 326
           K +G GSFG V    H E  N   A+KIL +Q+  +  + +  L E  I++ +  P +  
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNH-YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTK 106
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +  +  NL +V EY   G ++   H+       +   R   A  +     YLH    
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFS--HLRRIGRFSEPHARFYAA-QIVLTFEYLHSL-- 161
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +++RDLK  NL++D    +KV DFG + R K  T+       GTPE++APE++     N
Sbjct: 162 DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW----XLCGTPEYLAPEIILSKGYN 217
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           +  D ++ GV+++E+     P+    P Q+   +
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 251

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +KIGEG++G VY A+  +  +    KI +E+E  E      +RE++I+K L+H NIV L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLY 66
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV--VVDERLRLNMAYDVAKGMNYLHQRRP 386
             +     L +V E+L +  L KLL + +  +  V  +   L +      G+ Y H RR 
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL----NGIAYCHDRR- 120
Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRDLK  NLL++    +K+ DFGL+R+             T  + AP+VL       
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 447 KS-DVFSFGVILWELITLQKPWRNSTP 472
            + D++S G I  E++       N TP
Sbjct: 180 TTIDIWSVGCIFAEMV-------NGTP 199

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 10/214 (4%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K +GEGSF T   A     + + A+KIL ++    E++     RE  +M  L HP  V L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   L     Y   G L K +    +    DE        ++   + YLH +   
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK--G 150
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
           I+HRDLK  N+L++    +++ DFG ++  S  +    +    GT ++++PE+L E  + 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           + SD+++ G I+++L+    P+R      +   +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 109/220 (49%), Gaps = 17/220 (7%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +K+ IG GS+        + +++   + I  +   D  +E   E+ +  G +HPNI+ L 
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI--EILLRYG-QHPNIITLK 82
Query: 329 GAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
               +   + +VTE +  G L  K+L     +    ER    + + + K + YLH +   
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ--G 136
Query: 388 IVHRDLKSPNLL-VDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
           +VHRDLK  N+L VD +    ++++CDFG ++          T   T  ++APEVL    
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG 196
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNS---TPSQVISAVG 480
            +   D++S GV+L+ ++T   P+ N    TP ++++ +G
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 106/203 (52%), Gaps = 11/203 (5%)
Query: 269 IKKKIGEGSFGTVYH-AEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           I +++G G+FG V+   E     V V   I   +  D++     E++IM  L HP ++ L
Sbjct: 55  ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT-VKNEISIMNQLHHPKLINL 113
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             A  +   + ++ E+LS G L+  +   D +  + E   +N      +G+ ++H+    
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHEHS-- 169
Query: 388 IVHRDLKSPNLLVDS--TYTVKVCDFGL-SRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
           IVH D+K  N++ ++    +VK+ DFGL ++  P+  +   TA  T E+ APE++  +P 
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAPEIVDREPV 227
Query: 445 NEKSDVFSFGVILWELITLQKPW 467
              +D+++ GV+ + L++   P+
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 15/228 (6%)
Query: 260 LEIRWSELL----IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREV 313
           +EI+   +L    I +++G G+FG V+    R   ++ A K ++    HE   +   +E+
Sbjct: 148 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEI 205
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
             M  LRHP +V L  A  +   + ++ E++S G L++   + D    + E   +     
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQ 263
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTP 431
           V KG+ ++H+     VH DLK  N++  +  +  +K+ DFGL+ +  +   S K   GT 
Sbjct: 264 VCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGTA 320
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           E+ APEV    P    +D++S GV+ + L++   P+      + +  V
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 15/228 (6%)
Query: 260 LEIRWSELL----IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREV 313
           +EI+   +L    I +++G G+FG V+    R   ++ A K ++    HE   +   +E+
Sbjct: 42  VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEI 99
Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
             M  LRHP +V L  A  +   + ++ E++S G L++   + D    + E   +     
Sbjct: 100 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQ 157
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTP 431
           V KG+ ++H+     VH DLK  N++  +  +  +K+ DFGL+ +  +   S K   GT 
Sbjct: 158 VCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVKVTTGTA 214
Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           E+ APEV    P    +D++S GV+ + L++   P+      + +  V
Sbjct: 215 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 262

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 128/256 (50%), Gaps = 28/256 (10%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHED--RFKEFLREVAIMKGLRHPNI 324
           ++  IG GS+G V  A  + + +  A K  I + F ED  RFK+   E+ IMK L HPNI
Sbjct: 30  LENTIGRGSWGEVKIAVQKGTRIRRAAK-KIPKYFVEDVDRFKQ---EIEIMKSLDHPNI 85
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           + L     +  ++ +V E  + G L+ +++H    + V  E     +  DV   + Y H+
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK 141
Query: 384 RRPPIVHRDLKSPN--LLVDSTYT-VKVCDFGL-SRSKPNTYISSKTAAGTPEWMAPEVL 439
               + HRDLK  N   L DS  + +K+ DFGL +R KP   +  +T  GTP +++P+VL
Sbjct: 142 LN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVL 197
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK----NVNPM 495
            E     + D +S GV+++ L+    P+   T  +V+  +  +      P+    NV+P 
Sbjct: 198 -EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI--REGTFTFPEKDWLNVSPQ 254
Query: 496 VAALIETCWAEEPEIR 511
             +LI     + P+ R
Sbjct: 255 AESLIRRLLTKSPKQR 270

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           +G+G+FG V  A  RN+  +    I++  H E++    L EV ++  L H  +V    A 
Sbjct: 14  LGQGAFGQVVKA--RNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAW 71
Query: 332 TEPPN-------------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
            E  N             L I  EY    +LY L+H  +     DE  RL     + + +
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL--FRQILEAL 129
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL--------------SRSKPNTYISS 424
           +Y+H +   I+HR+LK  N+ +D +  VK+ DFGL              S++ P +  + 
Sbjct: 130 SYIHSQ--GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 425 KTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELI 461
            +A GT  ++A EVL      NEK D +S G+I +E I
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 128/256 (50%), Gaps = 28/256 (10%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHED--RFKEFLREVAIMKGLRHPNI 324
           ++  IG GS+G V  A  + + +  A K  I + F ED  RFK+   E+ IMK L HPNI
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRIRRAAK-KIPKYFVEDVDRFKQ---EIEIMKSLDHPNI 68
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           + L     +  ++ +V E  + G L+ +++H    + V  E     +  DV   + Y H+
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK 124
Query: 384 RRPPIVHRDLKSPN--LLVDSTYT-VKVCDFGL-SRSKPNTYISSKTAAGTPEWMAPEVL 439
               + HRDLK  N   L DS  + +K+ DFGL +R KP   +  +T  GTP +++P+VL
Sbjct: 125 LN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVL 180
Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK----NVNPM 495
            E     + D +S GV+++ L+    P+   T  +V+  +  +      P+    NV+P 
Sbjct: 181 -EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI--REGTFTFPEKDWLNVSPQ 237
Query: 496 VAALIETCWAEEPEIR 511
             +LI     + P+ R
Sbjct: 238 AESLIRRLLTKSPKQR 253

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 119/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG++G V  A  R ++ AV + +++ +   D  +   +E+ I   L H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 127
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 186
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 247 VENPSARITIPDI 259

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/253 (29%), Positives = 119/253 (47%), Gaps = 12/253 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           + +GEG+ G V  A  R ++ AV + +++ +   D  +   +E+ I K L H N+V   G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
              E     +  EY S G L+  +  PD  +   +  R    + +  G+ YLH     I 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRF--FHQLMAGVVYLHG--IGIT 126
Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 445
           HRD+K  NLL+D    +K+ DFGL+   R      + +K   GT  ++APE+L R +   
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRREFHA 185
Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+    
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 505 AEEPEIRPSFPSI 517
            E P  R + P I
Sbjct: 246 VENPSARITIPDI 258

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 111/221 (50%), Gaps = 17/221 (7%)
Query: 268 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++K+ IG GS+        + +++   + +  +   D  +E   E+ +  G +HPNI+ L
Sbjct: 30  VVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI--EILLRYG-QHPNIITL 86
Query: 328 MGAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
                +  ++ +VTE +  G L  K+L     +    ER    + + + K + YLH +  
Sbjct: 87  KDVYDDGKHVYLVTELMRGGELLDKILR----QKFFSEREASFVLHTIGKTVEYLHSQ-- 140
Query: 387 PIVHRDLKSPNLL-VDSTYT---VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
            +VHRDLK  N+L VD +     +++CDFG ++          T   T  ++APEVL+  
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQ 200
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNS---TPSQVISAVG 480
             +E  D++S G++L+ ++    P+ N    TP ++++ +G
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIG 241

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 138/291 (47%), Gaps = 29/291 (9%)
Query: 243 LSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQ 299
           ++V    N + Y +  G E+   +  + KK  E S G  Y A++   R +  + + +  +
Sbjct: 1   MTVFRQENVDDYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 59
Query: 300 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR 359
           +          REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++ 
Sbjct: 60  DIE--------REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES- 110
Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSR 415
             + E         +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+ 
Sbjct: 111 --LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
            K +     K   GTPE++APE++  +P   ++D++S GVI + L++   P+   T  + 
Sbjct: 167 -KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225
Query: 476 ---ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              +SAV ++    E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 226 LANVSAVNYEFED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +KIGEG++G VY A  + +   V   KI ++ E  E      +RE++++K L HPNIV L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 66
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 385
           +  +     L +V E++ +     L    DA  +    L L  +Y   + +G+ + H  R
Sbjct: 67  LDVIHTENKLYLVFEHVHQ----DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPS 444
             ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 445 NEKSDVFSFGVILWELIT 462
           +   D++S G I  E++T
Sbjct: 181 STAVDIWSLGCIFAEMVT 198

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 111/221 (50%), Gaps = 17/221 (7%)
Query: 268 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           ++K+ IG GS+        + +++   + +  +   D  +E   E+ +  G +HPNI+ L
Sbjct: 30  VVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI--EILLRYG-QHPNIITL 86
Query: 328 MGAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
                +  ++ +VTE +  G L  K+L     +    ER    + + + K + YLH +  
Sbjct: 87  KDVYDDGKHVYLVTELMRGGELLDKILR----QKFFSEREASFVLHTIGKTVEYLHSQ-- 140
Query: 387 PIVHRDLKSPNLL-VDSTYT---VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
            +VHRDLK  N+L VD +     +++CDFG ++          T   T  ++APEVL+  
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQ 200
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNS---TPSQVISAVG 480
             +E  D++S G++L+ ++    P+ N    TP ++++ +G
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIG 241

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 138/291 (47%), Gaps = 29/291 (9%)
Query: 243 LSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQ 299
           ++V    N + Y +  G E+   +  + KK  E S G  Y A++   R +  + + +  +
Sbjct: 1   MTVFRQENVDDYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 59
Query: 300 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR 359
           +          REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++ 
Sbjct: 60  DIE--------REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES- 110
Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSR 415
             + E         +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+ 
Sbjct: 111 --LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
            K +     K   GTPE++APE++  +P   ++D++S GVI + L++   P+   T  + 
Sbjct: 167 -KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225
Query: 476 ---ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              +SAV ++    E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 226 LANVSAVNYEFED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++   + E      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEF 119
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKT 426
              +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+  K +     K 
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKG 483
             GTPE++APE++  +P   ++D++S GVI + L++   P+   T  +    +SAV ++ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 237 ED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++   + E      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEF 119
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKT 426
              +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+  K +     K 
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKG 483
             GTPE++APE++  +P   ++D++S GVI + L++   P+   T  +    +SAV ++ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 237 ED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++   + E      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEF 119
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKT 426
              +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+  K +     K 
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKG 483
             GTPE++APE++  +P   ++D++S GVI + L++   P+   T  +    +SAV ++ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 237 ED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPN 323
           S+  +K  +GEG++G V  A  + +   V I   + F +  F    LRE+ I+K  +H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 324 IVLLMGAVTEPPNLSIVTE-YLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYL 381
           I+ +   +  P +     E Y+ +  +   LH +   +++ D+ ++    Y   + +  L
Sbjct: 71  IITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-FIYQTLRAVKVL 128
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---------SKPNTYISSKTAAGTPE 432
           H     ++HRDLK  NLL++S   +KVCDFGL+R         S+P    S  T      
Sbjct: 129 HGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 433 WM-APEVLREDPSNEKS-DVFSFGVILWELITLQKP 466
           W  APEV+       ++ DV+S G IL EL  L++P
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRP 221

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++   + E      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEF 119
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKT 426
              +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+  K +     K 
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKG 483
             GTPE++APE++  +P   ++D++S GVI + L++   P+   T  +    +SAV ++ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 237 ED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++   + E      
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEF 118
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKT 426
              +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+  K +     K 
Sbjct: 119 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 175
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKG 483
             GTPE++APE++  +P   ++D++S GVI + L++   P+   T  +    +SAV ++ 
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 236 ED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 271

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++   + E      
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEF 118
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKT 426
              +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+  K +     K 
Sbjct: 119 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 175
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKG 483
             GTPE++APE++  +P   ++D++S GVI + L++   P+   T  +    +SAV ++ 
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 236 ED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 271

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++   + E      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEATEF 119
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKT 426
              +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+  K +     K 
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKG 483
             GTPE++APE++  +P   ++D++S GVI + L++   P+   T  +    +SAV ++ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 237 ED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 138/291 (47%), Gaps = 29/291 (9%)
Query: 243 LSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQ 299
           ++V    N + Y +  G E+   +  + KK  E S G  Y A++   R +  + + +  +
Sbjct: 1   MTVFRQENVDDYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 59
Query: 300 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR 359
           +          REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++ 
Sbjct: 60  DIE--------REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES- 110
Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSR 415
             + E         +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+ 
Sbjct: 111 --LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
            K +     K   GTPE++APE++  +P   ++D++S GVI + L++   P+   T  + 
Sbjct: 167 -KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225
Query: 476 ---ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              +SAV ++    E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 226 LANVSAVNYEFED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 10/207 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           E  + +++G+G+F  V          + A  I+  ++      ++  RE  I + L+HPN
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV L  +++E  +  ++ + ++ G L++ +    AR    E    +    + + + + HQ
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 384 RRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
               +VHR+LK  NLL+ S      VK+ DFGL+        +    AGTP +++PEVLR
Sbjct: 129 M--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 441 EDPSNEKSDVFSFGVILWELITLQKPW 467
           +DP  +  D+++ GVIL+ L+    P+
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           ++ ++G G+   VY  + + +    A+K+L      +   K+ +R E+ ++  L HPNI+
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVL-----KKTVDKKIVRTEIGVLLRLSHPNII 111
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV----VDERLRLNMAYDVAKGMNYL 381
            L      P  +S+V E ++ G L+        R+V      ER   +    + + + YL
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFD-------RIVEKGYYSERDAADAVKQILEAVAYL 164
Query: 382 HQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           H+    IVHRDLK  NLL  +      +K+ DFGLS+   +  +  KT  GTP + APE+
Sbjct: 165 HEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEI 221
Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI 476
           LR      + D++S G+I + L+   +P+ +    Q +
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++   + E      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEF 119
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKT 426
              +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+  K +     K 
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKG 483
             GTPE++APE++  +P   ++D++S GVI + L++   P+   T  +    +SAV ++ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 237 ED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++   + E      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEF 119
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKT 426
              +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+  K +     K 
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKG 483
             GTPE++APE++  +P   ++D++S GVI + L++   P+   T  +    +SAV ++ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 237 ED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPN 323
           S+  +K  +GEG++G V  A  + +   V I   + F +  F    LRE+ I+K  +H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 324 IVLLMGAVTEPPNLSIVTE-YLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYL 381
           I+ +   +  P +     E Y+ +  +   LH +   +++ D+ ++    Y   + +  L
Sbjct: 71  IITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-FIYQTLRAVKVL 128
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---------SKPNTYISSKTAAGTPE 432
           H     ++HRDLK  NLL++S   +KVCDFGL+R         S+P    S  T      
Sbjct: 129 HGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 433 WM-APEVLREDPSNEKS-DVFSFGVILWELITLQKP 466
           W  APEV+       ++ DV+S G IL EL  L++P
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRP 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQ---EFHEDRFKEFLREVAIMKGLRHPNIV 325
           +K+++G G FG  Y   W + D   ++ I+Q   E      + +  E+ IMK L HPN+V
Sbjct: 19  MKERLGTGGFG--YVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 326 LLMGAVTEPPNLS---------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
               A   P  L          +  EY   G L K L+  +    + E     +  D++ 
Sbjct: 77  ---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 433
            + YLH+ R  I+HRDLK  N+++         K+ D G ++      + ++   GT ++
Sbjct: 134 ALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQY 190
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 467
           +APE+L +       D +SFG + +E IT  +P+
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQ---EFHEDRFKEFLREVAIMKGLRHPNIV 325
           +K+++G G FG  Y   W + D   ++ I+Q   E      + +  E+ IMK L HPN+V
Sbjct: 18  MKERLGTGGFG--YVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 326 LLMGAVTEPPNLS---------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
               A   P  L          +  EY   G L K L+  +    + E     +  D++ 
Sbjct: 76  ---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 433
            + YLH+ R  I+HRDLK  N+++         K+ D G ++      + ++   GT ++
Sbjct: 133 ALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQY 189
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 467
           +APE+L +       D +SFG + +E IT  +P+
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
           REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++   + E      
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEF 119
Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSRSKPNTYISSKT 426
              +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+  K +     K 
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKN 176
Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKG 483
             GTPE++APE++  +P   ++D++S GVI + L++   P+   T  +    +SAV ++ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 237 ED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 8/199 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +KIGEG++GTV+ A+ R +   VA+K +   +  E      LRE+ ++K L+H NIV L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +     L++V E+  +  L K  +       +D  +  +  + + KG+ + H R   +
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKK--YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--V 122
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRDLK  NLL++    +K+ DFGL+R+             T  +  P+VL        S
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 449 -DVFSFGVILWELITLQKP 466
            D++S G I  EL    +P
Sbjct: 183 IDMWSAGCIFAELANAARP 201

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 122/272 (44%), Gaps = 44/272 (16%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           ++G G+ G V+   +R +   +AVK +      E+  +  +    ++K    P IV   G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 330 AVTEPPNLSIVTEYLSRGS--LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                 ++ I  E +   +  L K +  P     + ER+   M   + K + YL ++   
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGP-----IPERILGKMTVAIVKALYYLKEKHG- 145
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE- 446
           ++HRD+K  N+L+D    +K+CDFG+S    +     ++ AG   +MAPE  R DP +  
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS-AGCAAYMAPE--RIDPPDPT 202
Query: 447 ------KSDVFSFGVILWELITLQKPWRN-STPSQVISAV------------GFKGRRLE 487
                 ++DV+S G+ L EL T Q P++N  T  +V++ V            GF G    
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD--- 259
Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
                     + ++ C  ++   RP +  ++E
Sbjct: 260 --------FQSFVKDCLTKDHRKRPKYNKLLE 283

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 25/259 (9%)
Query: 268 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           L  K +GEGSF        + S+ A  + I  +  E   ++ +  + + +G  HPNIV L
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKL 71
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +  +  +V E L+ G L++ +     +    E     +   +   ++++H     
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSHMHD--VG 126
Query: 388 IVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
           +VHRDLK  NLL    +    +K+ DFG +R KP      KT   T  + APE+L ++  
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAV-----------GFKGRRLEIPKNV 492
           +E  D++S GVIL+ +++ Q P+++   S    SAV            F+G   E  KNV
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG---EAWKNV 243
Query: 493 NPMVAALIETCWAEEPEIR 511
           +     LI+     +P  R
Sbjct: 244 SQEAKDLIQGLLTVDPNKR 262

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 124/295 (42%), Gaps = 56/295 (18%)
Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHED 304
           S+    LY +   L     +  +K  IG+GS+G V  A    +    A+KI+ + +  + 
Sbjct: 8   SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI 67
Query: 305 RFKEFLR---EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI------ 355
             K+  R   EV +MK L HPNI  L     +   + +V E    G L   L++      
Sbjct: 68  NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127
Query: 356 ---------------PDAR----------------VVVDERLRLNMAYDVAKGMNYLHQR 384
                          P+                   V  E+L  N+   +   ++YLH +
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187
Query: 385 RPPIVHRDLKSPNLL--VDSTYTVKVCDFGLSRS--KPNT--YISSKTAAGTPEWMAPEV 438
              I HRD+K  N L   + ++ +K+ DFGLS+   K N   Y    T AGTP ++APEV
Sbjct: 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 439 LREDPSNE----KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 489
           L  + +NE    K D +S GV+L  L+    P+     +  IS V  K    E P
Sbjct: 246 L--NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP 298

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 21/222 (9%)
Query: 269 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +K+ IG GS+        +  N + AVKI+ + +   D  +E   E+ +  G +HPNI+ 
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK--RDPTEEI--EILLRYG-QHPNIIT 80
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
           L     +   + +VTE    G L  K+L     +    ER    + + + K + YLH + 
Sbjct: 81  LKDVYDDGKYVYVVTELXKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ- 135
Query: 386 PPIVHRDLKSPNLL-VDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
             +VHRDLK  N+L VD +    ++++CDFG ++          T   T  ++APEVL  
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLER 194
Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNS---TPSQVISAVG 480
              +   D++S GV+L+  +T   P+ N    TP ++++ +G
Sbjct: 195 QGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIG 236

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 132/280 (47%), Gaps = 37/280 (13%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           G++ +  EL     IG G FG V+ A+ R  D    ++   +++ ++ +   REV  +  
Sbjct: 10  GMDFKEIEL-----IGSGGFGQVFKAKHR-IDGKTYVIKRVKYNNEKAE---REVKALAK 60
Query: 319 LRHPNIVLLMG----------------AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV 362
           L H NIV   G                + ++   L I  E+  +G+L + +       + 
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL- 119
Query: 363 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 422
           D+ L L +   + KG++Y+H ++  +++RDLK  N+ +  T  VK+ DFGL  S  N   
Sbjct: 120 DKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 482
             + + GT  +M+PE +      ++ D+++ G+IL EL+ +         +   ++  F 
Sbjct: 178 RXR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-------CDTAFETSKFFT 229
Query: 483 GRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETL 521
             R  I  ++ +     L++   +++PE RP+   I+ TL
Sbjct: 230 DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 134/293 (45%), Gaps = 50/293 (17%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           G++ +  EL     IG G FG V+ A+ R  D    ++   +++ ++ +   REV  +  
Sbjct: 11  GMDFKEIEL-----IGSGGFGQVFKAKHR-IDGKTYVIRRVKYNNEKAE---REVKALAK 61
Query: 319 LRHPNIVLLMG------------------AVTEPPN-----------LSIVTEYLSRGSL 349
           L H NIV   G                  +  +P N           L I  E+  +G+L
Sbjct: 62  LDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL 121
Query: 350 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 409
            + +       + D+ L L +   + KG++Y+H ++  ++HRDLK  N+ +  T  VK+ 
Sbjct: 122 EQWIEKRRGEKL-DKVLALELFEQITKGVDYIHSKK--LIHRDLKPSNIFLVDTKQVKIG 178
Query: 410 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           DFGL  S  N    ++ + GT  +M+PE +      ++ D+++ G+IL EL+ +      
Sbjct: 179 DFGLVTSLKNDGKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------ 231
Query: 470 STPSQVISAVGFKGRRLEIPKNV-NPMVAALIETCWAEEPEIRPSFPSIMETL 521
              +   ++  F   R  I  ++ +     L++   +++PE RP+   I+ TL
Sbjct: 232 -CDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 283

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIV-LLMG 329
           IG G +G VY        VAVK+     F     + F+ E  I +   + H NI   ++G
Sbjct: 21  IGRGRYGAVYKGSLDERPVAVKV-----FSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 330 --AVTEPPNLS--IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR- 384
              VT    +   +V EY   GSL K L +  +  V   RL    A+ V +G+ YLH   
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL----AHSVTRGLAYLHTEL 131
Query: 385 ------RPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYI-------SSKTAAGT 430
                 +P I HRDL S N+LV +  T  + DFGLS R   N  +       ++ +  GT
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 431 PEWMAPEV------LREDPSNEKS-DVFSFGVILWELI 461
             +MAPEV      LR+  S  K  D+++ G+I WE+ 
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 128 NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 182 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 238
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 239 GYKENVDIWSVGCIMGEMV 257

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 54  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 109
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE-RLRLNMAYDVAKGMNYLHQ 383
               G   +   L++V +Y+         H   A+  +    ++L M Y + + + Y+H 
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHS 168
Query: 384 RRPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPE 437
               I HRD+K  NLL+D  T  +K+CDFG    L R +PN +YI S+       + APE
Sbjct: 169 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY------YRAPE 220
Query: 438 VLREDPSNEKS-DVFSFGVILWELITLQ 464
           ++        S DV+S G +L EL+  Q
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 124/260 (47%), Gaps = 29/260 (11%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLRE 312
           E  + +  ++  + + IG G FG VY    R +D     A+K L ++     + +     
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALN 238
Query: 313 VAIMKGLRH----PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
             IM  L      P IV +  A   P  LS + + ++ G L+   H+    V  +  +R 
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEADMRF 296
Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISS 424
             A ++  G+ ++H R   +V+RDLK  N+L+D    V++ D GL    S+ KP+     
Sbjct: 297 YAA-EIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----- 348
Query: 425 KTAAGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRN--STPSQVISAVGF 481
             + GT  +MAPEVL++  + + S D FS G +L++L+    P+R   +     I  +  
Sbjct: 349 -ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407
Query: 482 KGRRLEIPKNVNPMVAALIE 501
               +E+P + +P + +L+E
Sbjct: 408 T-MAVELPDSFSPELRSLLE 426

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S GVI+ E+I
Sbjct: 201 GYKENVDIWSVGVIMGEMI 219

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 124/260 (47%), Gaps = 29/260 (11%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLRE 312
           E  + +  ++  + + IG G FG VY    R +D     A+K L ++     + +     
Sbjct: 180 ELNIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALN 237
Query: 313 VAIMKGLRH----PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
             IM  L      P IV +  A   P  LS + + ++ G L+   H+    V  +  +R 
Sbjct: 238 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEADMRF 295
Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISS 424
             A ++  G+ ++H R   +V+RDLK  N+L+D    V++ D GL    S+ KP+     
Sbjct: 296 YAA-EIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----- 347
Query: 425 KTAAGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRN--STPSQVISAVGF 481
             + GT  +MAPEVL++  + + S D FS G +L++L+    P+R   +     I  +  
Sbjct: 348 -ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 406
Query: 482 KGRRLEIPKNVNPMVAALIE 501
               +E+P + +P + +L+E
Sbjct: 407 T-MAVELPDSFSPELRSLLE 425

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 124/260 (47%), Gaps = 29/260 (11%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLRE 312
           E  + +  ++  + + IG G FG VY    R +D     A+K L ++     + +     
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALN 238
Query: 313 VAIMKGLRH----PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
             IM  L      P IV +  A   P  LS + + ++ G L+   H+    V  +  +R 
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEADMRF 296
Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISS 424
             A ++  G+ ++H R   +V+RDLK  N+L+D    V++ D GL    S+ KP+     
Sbjct: 297 YAA-EIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----- 348
Query: 425 KTAAGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRN--STPSQVISAVGF 481
             + GT  +MAPEVL++  + + S D FS G +L++L+    P+R   +     I  +  
Sbjct: 349 -ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407
Query: 482 KGRRLEIPKNVNPMVAALIE 501
               +E+P + +P + +L+E
Sbjct: 408 T-MAVELPDSFSPELRSLLE 426

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 124/260 (47%), Gaps = 29/260 (11%)
Query: 257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLRE 312
           E  + +  ++  + + IG G FG VY    R +D     A+K L ++     + +     
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALN 238
Query: 313 VAIMKGLRH----PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
             IM  L      P IV +  A   P  LS + + ++ G L+   H+    V  +  +R 
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEADMRF 296
Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISS 424
             A ++  G+ ++H R   +V+RDLK  N+L+D    V++ D GL    S+ KP+     
Sbjct: 297 YAA-EIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----- 348
Query: 425 KTAAGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRN--STPSQVISAVGF 481
             + GT  +MAPEVL++  + + S D FS G +L++L+    P+R   +     I  +  
Sbjct: 349 -ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407
Query: 482 KGRRLEIPKNVNPMVAALIE 501
               +E+P + +P + +L+E
Sbjct: 408 T-MAVELPDSFSPELRSLLE 426

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 60  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 115
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN +YI S+       + APE+
Sbjct: 176 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY------YRAPEL 227
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 14/217 (6%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAI 315
           GL+++  +  + K IG G+FG V     + S    A+K+L + E  +     F   E  I
Sbjct: 69  GLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDI 128
Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M     P +V L  A  +   L +V EY+  G L  L+   D    V E+       +V 
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVV 184
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWM 434
             ++ +H     ++HRD+K  N+L+D    +K+ DFG       T  +   TA GTP+++
Sbjct: 185 LALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYI 242
Query: 435 APEVLREDPSN----EKSDVFSFGVILWELITLQKPW 467
           +PEVL+    +     + D +S GV L+E++    P+
Sbjct: 243 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 273 IGEGSFGTVYHAEWRNS--DVAVKILIEQEFHED---RFKEFLREVAIMKGLRHPNIVLL 327
           IG+G F  V     R +    AVKI+   +F        ++  RE +I   L+HP+IV L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 328 MGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           +   +    L +V E++    L ++++   DA  V  E +  +    + + + Y H    
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 152
Query: 387 PIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            I+HRD+K   +L+ S   +  VK+  FG++     + + +    GTP +MAPEV++ +P
Sbjct: 153 -IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP 211
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNS 470
             +  DV+  GVIL+ L++   P+  +
Sbjct: 212 YGKPVDVWGCGVILFILLSGCLPFYGT 238

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKILIEQEFHED------RFKEFLREVAIMKGLRHPNI 324
           +G G+FG V+ A  + +N +V VK + +++  ED      +  +   E+AI+  + H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + ++          +V E    GS   L    D    +DE L   +   +   + YL  R
Sbjct: 92  IKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL--R 147
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISSKTAAGTPEWMAPEVLR 440
              I+HRD+K  N+++   +T+K+ DFG    L R K        T  GT E+ APEVL 
Sbjct: 148 LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-----LFYTFCGTIEYCAPEVLM 202
Query: 441 EDP-SNEKSDVFSFGVILWELITLQKPW 467
            +P    + +++S GV L+ L+  + P+
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 64  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 119
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE-RLRLNMAYDVAKGMNYLHQ 383
               G   +   L++V +Y+         H   A+  +    ++L M Y + + + Y+H 
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHS 178
Query: 384 RRPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPE 437
               I HRD+K  NLL+D  T  +K+CDFG    L R +PN +YI S+       + APE
Sbjct: 179 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY------YRAPE 230
Query: 438 VLREDPSNEKS-DVFSFGVILWELITLQ 464
           ++        S DV+S G +L EL+  Q
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 105 KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 160
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 220
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN +YI S+       + APE+
Sbjct: 221 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY------YRAPEL 272
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 273 IFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 62  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 117
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 177
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN +YI S+       + APE+
Sbjct: 178 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY------YRAPEL 229
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 230 IFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 31  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 86
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 146
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN +YI S+       + APE+
Sbjct: 147 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY------YRAPEL 198
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 199 IFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           IGEG++G V  A    + V V I     F H+   +  LRE+ I+   RH NI+ +   +
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 332 TEP-----PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
             P      ++ IV + L    LYKLL   H+ +  +           Y + +G+ Y+H 
Sbjct: 91  RAPTIEQMKDVYIVQD-LMETDLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHS 142
Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPN-TYISSKTAAGTPEWM-APEVLR 440
               ++HRDLK  NLL+++T  +K+ DFGL+R + P+  +    T      W  APE++ 
Sbjct: 143 AN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 441 EDPSNEKS-DVFSFGVILWELIT 462
                 KS D++S G IL E+++
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 273 IGEGSFGTVYHAEWRNS--DVAVKILIEQEFHED---RFKEFLREVAIMKGLRHPNIVLL 327
           IG+G F  V     R +    AVKI+   +F        ++  RE +I   L+HP+IV L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 328 MGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           +   +    L +V E++    L ++++   DA  V  E +  +    + + + Y H    
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 387 PIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            I+HRD+K   +L+ S   +  VK+  FG++     + + +    GTP +MAPEV++ +P
Sbjct: 151 -IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 444 SNEKSDVFSFGVILWELITLQKPWRNS 470
             +  DV+  GVIL+ L++   P+  +
Sbjct: 210 YGKPVDVWGCGVILFILLSGCLPFYGT 236

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQD------VYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 39  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 94
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 154
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN +YI S+       + APE+
Sbjct: 155 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY------YRAPEL 206
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 207 IFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQD------VYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 83  NVFTPQKTLEEFQD------VYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 136
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 137 S--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 193
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 128 NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 182 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 238
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 239 GYKENVDIWSVGCIMGEMV 257

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFK-EFLREVAIMKGLRHPN 323
           S+  +K  +GEG++G V  A  + +   V I   + F +  F    LRE+ I+K  +H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 324 IVLLMGAVTEPPNLSIVTE-YLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYL 381
           I+ +   +  P +     E Y+ +  +   LH +   +++ D+ ++    Y   + +  L
Sbjct: 71  IITIFN-IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-FIYQTLRAVKVL 128
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---------SKPNTYISSKTAAGTPE 432
           H     ++HRDLK  NLL++S   +KVCDFGL+R         S+P    S         
Sbjct: 129 HGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 433 WM-APEVLREDPSNEKS-DVFSFGVILWELITLQKP 466
           W  APEV+       ++ DV+S G IL EL  L++P
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRP 221

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+  +S   V   I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN +YI S+       + APE+
Sbjct: 142 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY------YRAPEL 193
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S GVI+ E+I
Sbjct: 201 GYKENVDIWSVGVIMGEMI 219

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 201 GYKENVDIWSVGCIMGEMI 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 91  NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 145 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 201
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 202 GYKENVDIWSVGCIMGEMI 220

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 137/291 (47%), Gaps = 29/291 (9%)
Query: 243 LSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW---RNSDVAVKILIEQ 299
           ++V    N + Y +  G E+   +  + KK  E S G  Y A++   R +  + + +  +
Sbjct: 1   MTVFRQENVDDYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 59
Query: 300 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR 359
           +          REV+I+K ++HPN++ L        ++ ++ E ++ G L+  L   ++ 
Sbjct: 60  DIE--------REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES- 110
Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTY---TVKVCDFGLSR 415
             + E         +  G+ YLH  +  I H DLK  N +L+D       +K+ DFGL+ 
Sbjct: 111 --LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
            K +     K   GTP ++APE++  +P   ++D++S GVI + L++   P+   T  + 
Sbjct: 167 -KIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225
Query: 476 ---ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
              +SAV ++    E   N + +    I     ++P+ R    +I ++LQ 
Sbjct: 226 LANVSAVNYEFED-EYFSNTSALAKDFIRRLLVKDPKKR---MTIQDSLQH 272

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 201 GYKENVDIWSVGCIMGEMI 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 29  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 89  NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 142
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 143 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 199
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 200 GYKENVDIWSVGCIMGEMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 83  NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 137 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 193
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 8/199 (4%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +KIGEG++GTV+ A+ R +   VA+K +   +  E      LRE+ ++K L+H NIV L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             +     L++V E+  +  L K  +       +D  +  +  + + KG+ + H R   +
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKK--YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--V 122
Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRDLK  NLL++    +K+ +FGL+R+             T  +  P+VL        S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 449 -DVFSFGVILWELITLQKP 466
            D++S G I  EL    +P
Sbjct: 183 IDMWSAGCIFAELANAGRP 201

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 91  NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 145 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 201
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 202 GYKENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 84  NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 138 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 194
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 195 GYKENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 91  NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 145 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 201
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 202 GYKENVDIWSVGCIMGEMV 220

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQD------VYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A     + +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T    L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 84  NVFTPQKTLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 138 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 194
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 195 GYKENVDIWSVGCIMGEMV 213

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 201 GYKENVDIWSVGCIMGEMI 219

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 130/273 (47%), Gaps = 17/273 (6%)
Query: 258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAI 315
           +  E++  +L    ++G G++G V       S   +AVK  I    +    K  L ++ I
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVK-RIRATVNSQEQKRLLMDLDI 102
Query: 316 -MKGLRHPNIVLLMGAVTEPPNLSIVTEYL--SRGSLYKLLHIPDARVVVDERLRLNMAY 372
            M+ +  P  V   GA+    ++ I  E +  S    YK   + D    + E +   +A 
Sbjct: 103 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYK--QVIDKGQTIPEDILGKIAV 160
Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE 432
            + K + +LH +   ++HRD+K  N+L+++   VK+CDFG+S    ++ ++    AG   
Sbjct: 161 SIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDS-VAKTIDAGCKP 218
Query: 433 WMAPE----VLREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLE 487
           +MAPE     L +   + KSD++S G+ + EL  L+ P+ +  TP Q +  V  +    +
Sbjct: 219 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPSPQ 277
Query: 488 IPKN-VNPMVAALIETCWAEEPEIRPSFPSIME 519
           +P +  +         C  +  + RP++P +M+
Sbjct: 278 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 266 ELLIKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           E  + + IG+G+F  V          + A KI+  ++      ++  RE  I + L+H N
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSN 64
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV L  +++E     +V + ++ G L++ +    AR    E    +    + + + + HQ
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 384 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
               +VHRDLK  NLL+ S      VK+ DFGL+        +    AGTP +++PEVLR
Sbjct: 122 M--GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 441 EDPSNEKSDVFSFGVILWELITLQKPW 467
           ++   +  D+++ GVIL+ L+    P+
Sbjct: 180 KEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 44/230 (19%)
Query: 268 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNIV 325
           +IK  IG GS+G VY A  +N++  V I       ED    K  LRE+ I+  L+   I+
Sbjct: 29  IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYII 88
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV---------VVDERLRLNMAYDVAK 376
            L        +L I  + L    LY +L I D+ +         + +E ++  + Y++  
Sbjct: 89  RLY-------DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK-TILYNLLL 140
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSK-------- 425
           G N++H+    I+HRDLK  N L++   +VKVCDFGL+R   S+ +T I +         
Sbjct: 141 GENFIHES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 426 ----------TAAGTPEWM-APE-VLREDPSNEKSDVFSFGVILWELITL 463
                     T+     W  APE +L ++   +  D++S G I  EL+ +
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 34/267 (12%)
Query: 263 RWSELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           R+ +L   K IG G+ G V  A       +VAVK L     ++   K   RE+ ++K + 
Sbjct: 23  RYQQL---KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 79
Query: 321 HPNIVLLMGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           H NI+ L+   T      E  ++ +V E L   +L +++H+      +D      + Y +
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSYLLYQM 133
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 434
             G+ +LH     I+HRDLK  N++V S  T+K+ DFGL+R+    ++ +     T  + 
Sbjct: 134 LCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVV-TRYYR 190
Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPK 490
           APEV+      E  D++S G I+ EL+     ++ +      ++VI  +G      E   
Sbjct: 191 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA--EFMA 248
Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSI 517
            + P V   +E         RP++P I
Sbjct: 249 ALQPTVRNYVEN--------RPAYPGI 267

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 32  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 92  NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 145
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++       T  + APEV+   
Sbjct: 146 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV-TRYYRAPEVILGM 202
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 203 GYKENVDIWSVGCIMGEMI 221

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++       T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 35  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 95  NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 148
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 149 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 205
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 206 GYKENVDLWSVGCIMGEMV 224

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 201 GYKENVDIWSVGCIMGEMI 219

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 201 GYKENVDIWSVGCIMGEMI 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 24  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 84  NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 138 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 194
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 195 GYKENVDLWSVGCIMGEMV 213

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 129/271 (47%), Gaps = 17/271 (6%)
Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAI-M 316
           +E++  +L    ++G G++G V       S   +AVK  I    +    K  L ++ I M
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVK-RIRATVNSQEQKRLLMDLDISM 60
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYL--SRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           + +  P  V   GA+    ++ I  E +  S    YK   + D    + E +   +A  +
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYK--QVIDKGQTIPEDILGKIAVSI 118
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 434
            K + +LH +   ++HRD+K  N+L+++   VK+CDFG+S    +  ++    AG   +M
Sbjct: 119 VKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYM 176
Query: 435 APE----VLREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIP 489
           APE     L +   + KSD++S G+ + EL  L+ P+ +  TP Q +  V  +    ++P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPSPQLP 235
Query: 490 KN-VNPMVAALIETCWAEEPEIRPSFPSIME 519
            +  +         C  +  + RP++P +M+
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 201 GYKENVDIWSVGCIMGEMI 219

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKE------FLREVAIMK 317
           E ++ K +G G+ G V  A  R +   VA+KI+ +++F     +E         E+ I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YD 373
            L HP I+ +     +  +  IV E +  G L+        +VV ++RL+        Y 
Sbjct: 71  KLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFD-------KVVGNKRLKEATCKLYFYQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGT 430
           +   + YLH+    I+HRDLK  N+L+ S      +K+ DFG S+    T +  +T  GT
Sbjct: 123 MLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGT 179
Query: 431 PEWMAPEVLREDPS---NEKSDVFSFGVILWELITLQKPW 467
           P ++APEVL    +   N   D +S GVIL+  ++   P+
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKE------FLREVAIMK 317
           E ++ K +G G+ G V  A  R +   VA+KI+ +++F     +E         E+ I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YD 373
            L HP I+ +     +  +  IV E +  G L+        +VV ++RL+        Y 
Sbjct: 71  KLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFD-------KVVGNKRLKEATCKLYFYQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGT 430
           +   + YLH+    I+HRDLK  N+L+ S      +K+ DFG S+    T +  +T  GT
Sbjct: 123 MLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGT 179
Query: 431 PEWMAPEVLREDPS---NEKSDVFSFGVILW 458
           P ++APEVL    +   N   D +S GVIL+
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKE------FLREVAIMK 317
           E ++ K +G G+ G V  A  R +   VA+KI+ +++F     +E         E+ I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YD 373
            L HP I+ +     +  +  IV E +  G L+        +VV ++RL+        Y 
Sbjct: 71  KLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFD-------KVVGNKRLKEATCKLYFYQ 122
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGLSRSKPNTYISSKTAAGT 430
           +   + YLH+    I+HRDLK  N+L+ S      +K+ DFG S+    T +  +T  GT
Sbjct: 123 MLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGT 179
Query: 431 PEWMAPEVLREDPS---NEKSDVFSFGVILW 458
           P ++APEVL    +   N   D +S GVIL+
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKE------FLREVAIMK 317
           E ++ K +G G+ G V  A  R +   VA+KI+ +++F     +E         E+ I+K
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YD 373
            L HP I+ +     +  +  IV E +  G L+        +VV ++RL+        Y 
Sbjct: 70  KLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFD-------KVVGNKRLKEATCKLYFYQ 121
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGT 430
           +   + YLH+    I+HRDLK  N+L+ S      +K+ DFG S+    T +  +T  GT
Sbjct: 122 MLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGT 178
Query: 431 PEWMAPEVLREDPS---NEKSDVFSFGVILW 458
           P ++APEVL    +   N   D +S GVIL+
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 209

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKE------FLREVAIMK 317
           E ++ K +G G+ G V  A  R +   VA+KI+ +++F     +E         E+ I+K
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YD 373
            L HP I+ +     +  +  IV E +  G L+        +VV ++RL+        Y 
Sbjct: 77  KLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFD-------KVVGNKRLKEATCKLYFYQ 128
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGT 430
           +   + YLH+    I+HRDLK  N+L+ S      +K+ DFG S+    T +  +T  GT
Sbjct: 129 MLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGT 185
Query: 431 PEWMAPEVLREDPS---NEKSDVFSFGVILWELITLQKPW 467
           P ++APEVL    +   N   D +S GVIL+  ++   P+
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E+I
Sbjct: 201 GYKENVDIWSVGCIMGEMI 219

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 13/233 (5%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 325
           I K IG G+FG V   + +N+D   A+KIL + E         F  E  ++       I 
Sbjct: 78  ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L  A  +  NL +V +Y   G L  LL   + R+  +E  R  +A ++   ++ +HQ  
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-EEMARFYLA-EMVIAIDSVHQLH 195
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
              VHRD+K  N+L+D    +++ DFG   +   +  + S  A GTP++++PE+L+    
Sbjct: 196 --YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 445 NE-----KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
            +     + D +S GV ++E++  + P+   +  +    +     R + P  V
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 271 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG G+ G V  A       +VA+K L     ++   K   RE+ +MK + H NI+ L+
Sbjct: 30  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 382
              T   +L    +      +Y ++ + DA +    ++ L+      + Y +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
                I+HRDLK  N++V S  T+K+ DFGL+R+   +++       T  + APEV+   
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV-TRYYRAPEVILGM 200
Query: 443 PSNEKSDVFSFGVILWELI 461
              E  D++S G I+ E++
Sbjct: 201 GYKENVDLWSVGCIMGEMV 219

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 60  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 115
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + APE+
Sbjct: 176 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRAPEL 227
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+  +S   V   I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + APE+
Sbjct: 142 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRAPEL 193
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 38  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 93
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + APE+
Sbjct: 154 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRAPEL 205
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+  +S   V   I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + APE+
Sbjct: 142 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRAPEL 193
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 38  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 93
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + APE+
Sbjct: 154 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRAPEL 205
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 206 IFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 30  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 85
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 145
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + APE+
Sbjct: 146 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRAPEL 197
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 198 IFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+  +S   V   I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 82
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 142
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + APE+
Sbjct: 143 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRAPEL 194
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 195 IFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 45  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 100
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 160
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + APE+
Sbjct: 161 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRAPEL 212
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 213 IFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+    D    + I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 34  KVIGNGSFGVVYQAKL--CDSGELVAIKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 89
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 149
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + APE+
Sbjct: 150 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRAPEL 201
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 202 IFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 35/218 (16%)
Query: 273 IGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           +G G FG V+ A+ +  D    I  I     E   ++ +REV  +  L HP IV    A 
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 332 TEPPNLSIVTEYLSRGSLYKLLHIP-------------DARVVVDERLR---LNMAYDVA 375
            E       TE L   S    L+I              + R  ++ER R   L++   +A
Sbjct: 73  LEKNT----TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN------------TYIS 423
           + + +LH +   ++HRDLK  N+       VKV DFGL  +                Y  
Sbjct: 129 EAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 461
                GT  +M+PE +  +  + K D+FS G+IL+EL+
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG GSFG VY A+  +S   VA+K +++ +  ++      RE+ IM+ L H NIV L 
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVRLR 79
Query: 329 ------GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
                 G   +   L++V +Y+         H   A+  +         Y + + + Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 383 QRRPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAP 436
                I HRD+K  NLL+D  T  +K+CDFG    L R +PN +YI S+       + AP
Sbjct: 140 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY------YRAP 191
Query: 437 EVLREDPSNEKS-DVFSFGVILWELITLQ 464
           E++        S DV+S G +L EL+  Q
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG VY A+  +S   V   I++   + RFK   RE+ IM+ L H NIV L   
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKN--RELQIMRKLDHCNIVRLRYF 81
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V +Y+         H   A+  +         Y + + + Y+H  
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + APE+
Sbjct: 142 G--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRAPEL 193
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +        S DV+S G +L EL+  Q
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG GSFG VY A+  +S   VA+K +++ +  ++      RE+ IM+ L H NIV L 
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVRLR 79
Query: 329 ------GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
                 G   +   L++V +Y+         H   A+  +         Y + + + Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 383 QRRPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMAP 436
                I HRD+K  NLL+D  T  +K+CDFG    L R +PN +YI S+       + AP
Sbjct: 140 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY------YRAP 191
Query: 437 EVLREDPSNEKS-DVFSFGVILWELITLQ 464
           E++        S DV+S G +L EL+  Q
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKE------FLREVAIMK 317
           E ++ K +G G+ G V  A  R +   VA++I+ +++F     +E         E+ I+K
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YD 373
            L HP I+ +     +  +  IV E +  G L+        +VV ++RL+        Y 
Sbjct: 210 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFD-------KVVGNKRLKEATCKLYFYQ 261
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGT 430
           +   + YLH+    I+HRDLK  N+L+ S      +K+ DFG S+    T +  +T  GT
Sbjct: 262 MLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGT 318
Query: 431 PEWMAPEVLREDPS---NEKSDVFSFGVILWELITLQKPW 467
           P ++APEVL    +   N   D +S GVIL+  ++   P+
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKE------FLREVAIMK 317
           E ++ K +G G+ G V  A  R +   VA++I+ +++F     +E         E+ I+K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YD 373
            L HP I+ +     +  +  IV E +  G L+        +VV ++RL+        Y 
Sbjct: 196 KLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFD-------KVVGNKRLKEATCKLYFYQ 247
Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGT 430
           +   + YLH+    I+HRDLK  N+L+ S      +K+ DFG S+    T +  +T  GT
Sbjct: 248 MLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM-RTLCGT 304
Query: 431 PEWMAPEVLREDPS---NEKSDVFSFGVILWELITLQKPW 467
           P ++APEVL    +   N   D +S GVIL+  ++   P+
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 109/239 (45%), Gaps = 47/239 (19%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNIVL 326
           IK  IG GS+G VY A  +N++  V I       ED    K  LRE+ I+  L+   I+ 
Sbjct: 32  IKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIR 91
Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR--------VVVDERLRLNMAYDVAKGM 378
           L        +L I  + L    LY +L I D+         + + E+    + Y++  G 
Sbjct: 92  LH-------DLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGE 144
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSK---------- 425
            ++H+    I+HRDLK  N L++   +VK+CDFGL+R   S  + +I +           
Sbjct: 145 KFIHE--SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEP 202
Query: 426 -----------TAAGTPEWM-APE--VLREDPSNEKSDVFSFGVILWELITLQKPWRNS 470
                      T+     W  APE  +L+E+ +N   D++S G I  EL+ + K   N+
Sbjct: 203 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNS-IDIWSTGCIFAELLNMMKSHINN 260

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 263 RWSELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           R+ +L   K IG G+ G V  A       +VAVK L     ++   K   RE+ ++K + 
Sbjct: 25  RYQQL---KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 81
Query: 321 HPNIVLLMGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           H NI+ L+   T      E  ++ +V E L   +L +++H+      +D      + Y +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSYLLYQM 135
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 434
             G+ +LH     I+HRDLK  N++V S  T+K+ DFGL+R+    ++ +     T  + 
Sbjct: 136 LCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV-TRYYR 192
Query: 435 APEVLREDPSNEKSDVFSFGVILWELI 461
           APEV+         D++S G I+ EL+
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELV 219

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIM 316
           L ++  +  + K IG G+FG V     +++    A+K+L + E  +     F   E  IM
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 128
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
                P +V L  A  +   L +V EY+  G L  L+   D    V E+       +V  
Sbjct: 129 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVL 184
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMA 435
            ++ +H      +HRD+K  N+L+D +  +K+ DFG   +      +   TA GTP++++
Sbjct: 185 ALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 436 PEVLREDPSN----EKSDVFSFGVILWELITLQKPW 467
           PEVL+    +     + D +S GV L+E++    P+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIM 316
           L ++  +  + K IG G+FG V     +++    A+K+L + E  +     F   E  IM
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 128
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
                P +V L  A  +   L +V EY+  G L  L+   D    V E+       +V  
Sbjct: 129 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVL 184
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMA 435
            ++ +H      +HRD+K  N+L+D +  +K+ DFG   +      +   TA GTP++++
Sbjct: 185 ALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 436 PEVLREDPSN----EKSDVFSFGVILWELITLQKPW 467
           PEVL+    +     + D +S GV L+E++    P+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIM 316
           L ++  +  + K IG G+FG V     +++    A+K+L + E  +     F   E  IM
Sbjct: 64  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 123
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
                P +V L  A  +   L +V EY+  G L  L+   D    V E+       +V  
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVL 179
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMA 435
            ++ +H      +HRD+K  N+L+D +  +K+ DFG   +      +   TA GTP++++
Sbjct: 180 ALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 436 PEVLREDPSN----EKSDVFSFGVILWELITLQKPW 467
           PEVL+    +     + D +S GV L+E++    P+
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 268 LIKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           L  + +GEG++  V  A       + AVKI+ +Q  H  R + F     + +   + NI+
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGH-SRSRVFREVETLYQCQGNKNIL 74
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L+    +     +V E L  GS+  L HI   +   +ER    +  DVA  +++LH + 
Sbjct: 75  ELIEFFEDDTRFYLVFEKLQGGSI--LAHIQKQKHF-NEREASRVVRDVAAALDFLHTK- 130
Query: 386 PPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRS-------KPNTYISSKTAAGTPEWMA 435
             I HRDLK  N+L +S      VK+CDF L           P T     T  G+ E+MA
Sbjct: 131 -GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMA 189
Query: 436 PEVL-----REDPSNEKSDVFSFGVILWELITLQKPW 467
           PEV+     +    +++ D++S GV+L+ +++   P+
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 94/185 (50%), Gaps = 18/185 (9%)
Query: 307 KEFLREVAIMKGLRHPNIVLLMGAVT---EPP--NLSIVTEYLSRGSLYKLLHIPDARVV 361
           K  LRE+ ++    HPNI+ L        EP    L +VTE L R  L +++H  D R+V
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE-LMRTDLAQVIH--DQRIV 130
Query: 362 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 421
           +  +      Y +  G++ LH+    +VHRDL   N+L+     + +CDF L+R   +T 
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNNDITICDFNLARE--DTA 186
Query: 422 ISSKTAAGTPEWM-APEVLREDPSNEK-SDVFSFGVILWELITLQKPWRNST----PSQV 475
            ++KT   T  W  APE++ +     K  D++S G ++ E+   +  +R ST     +++
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246
Query: 476 ISAVG 480
           +  VG
Sbjct: 247 VEVVG 251

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 94/185 (50%), Gaps = 18/185 (9%)
Query: 307 KEFLREVAIMKGLRHPNIVLLMGAVT---EPP--NLSIVTEYLSRGSLYKLLHIPDARVV 361
           K  LRE+ ++    HPNI+ L        EP    L +VTE L R  L +++H  D R+V
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE-LMRTDLAQVIH--DQRIV 130
Query: 362 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 421
           +  +      Y +  G++ LH+    +VHRDL   N+L+     + +CDF L+R   +T 
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNNDITICDFNLARE--DTA 186
Query: 422 ISSKTAAGTPEWM-APEVLREDPSNEK-SDVFSFGVILWELITLQKPWRNST----PSQV 475
            ++KT   T  W  APE++ +     K  D++S G ++ E+   +  +R ST     +++
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246
Query: 476 ISAVG 480
           +  VG
Sbjct: 247 VEVVG 251

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 129/284 (45%), Gaps = 32/284 (11%)
Query: 261 EIRWSELLIKKKIGEGSFGTVY---------HAEWRNSDVAVKILIEQEFHEDRFKEFLR 311
           +IR  +L+  + +G+G+F  ++         + +   ++V +K+L   + H +  + F  
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFE 61
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
             ++M  L H ++VL  G         +V E++  GSL    ++   +  ++   +L +A
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVA 119
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLV--------DSTYTVKVCDFGLSRSKPNTYIS 423
             +A  M++L +    ++H ++ + N+L+         +   +K+ D G+S     T + 
Sbjct: 120 KQLAAAMHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI----TVLP 173
Query: 424 SKTAAGTPEWMAPEVLREDPSNEK--SDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 481
                    W+ PE + E+P N    +D +SFG  LWE+ +      ++  SQ    + F
Sbjct: 174 KDILQERIPWVPPECI-ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQF 230
Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
              R ++P      +A LI  C   EP+ RPSF +I+  L    
Sbjct: 231 YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 13/152 (8%)
Query: 272 KIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 329
           K+GEG++G VY A     N  VA+K +  +   E      +REV+++K L+H NI+ L  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
            +     L ++ EY +   L K +   D    V  R+  +  Y +  G+N+ H RR   +
Sbjct: 101 VIHHNHRLHLIFEY-AENDLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHSRR--CL 154
Query: 390 HRDLKSPNLLV-----DSTYTVKVCDFGLSRS 416
           HRDLK  NLL+       T  +K+ DFGL+R+
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 273 IGEGSFGTVYHA-EWR-NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMG 329
           +G G++G V  A + R  + VA+K L  + F  + F K   RE+ ++K +RH N++ L+ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 330 AVTEPPNLSIVTEYL--------SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
             T    L   T++           G L K   + + R+         + Y + KG+ Y+
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF-------LVYQMLKGLRYI 144
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APEV L 
Sbjct: 145 HA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV---TRWYRAPEVILN 199
Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNS 470
                +  D++S G I+ E+IT +  ++ S
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 31/210 (14%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG GSFG VY A+  +S   VA+K +++ +  ++      RE+ IM+ L H NIV L 
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVRLR 79
Query: 329 ------GAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYL 381
                 G   +   L++V +Y+   ++Y++  H   A+  +         Y + + + Y+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 382 HQRRPPIVHRDLKSPNLLVD-STYTVKVCDFG----LSRSKPN-TYISSKTAAGTPEWMA 435
           H     I HRD+K  NLL+D  T  +K+CDFG    L R +PN + I S+       + A
Sbjct: 139 HSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY------YRA 190
Query: 436 PEVLREDPSNEKS-DVFSFGVILWELITLQ 464
           PE++        S DV+S G +L EL+  Q
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 107/237 (45%), Gaps = 51/237 (21%)
Query: 269 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNI 324
           I+  IG GS+G V  A  +     VA+K ++     ED    K  LRE+AI+  L H ++
Sbjct: 57  IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLNHDHV 114
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR--------VVVDERLRLNMAYDVAK 376
           V ++  V  P ++    E      LY +L I D+         V + E     + Y++  
Sbjct: 115 VKVLDIVI-PKDVEKFDE------LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK------------------- 417
           G+ Y+H     I+HRDLK  N LV+   +VKVCDFGL+R+                    
Sbjct: 168 GVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 418 -----PNTYISSKTAAG---TPEWMAPE-VLREDPSNEKSDVFSFGVILWELITLQK 465
                P+T    +   G   T  + APE +L ++   E  DV+S G I  EL+ + K
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 19/200 (9%)
Query: 271 KKIGEGSFGTV---YHAEWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +G G++G+V   Y A  R   VAVK L    +   H  R     RE+ ++K L+H N+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQK-VAVKKLSRPFQSLIHARRT---YRELRLLKHLKHENV 89
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLY--KLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           + L+   T   ++   +E     +L    L +I  ++ + DE ++  + Y + +G+ Y+H
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LRE 441
                I+HRDLK  N+ V+    +++ DFGL+R + +  ++   A  T  + APE+ L  
Sbjct: 149 S--AGIIHRDLKPSNVAVNEDSELRILDFGLAR-QADEEMTGYVA--TRWYRAPEIMLNW 203
Query: 442 DPSNEKSDVFSFGVILWELI 461
              N+  D++S G I+ EL+
Sbjct: 204 MHYNQTVDIWSVGCIMAELL 223

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 271 KKIGEGSFGTV---YHAEWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +G G++G+V   Y A  R   VAVK L    +   H  R     RE+ ++K L+H N+
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQK-VAVKKLSRPFQSLIHARRT---YRELRLLKHLKHENV 81
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLY--KLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           + L+   T   ++   +E     +L    L +I   + + DE ++  + Y + +G+ Y+H
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH 140
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LRE 441
                I+HRDLK  N+ V+    +++ DFGL+R              T  + APE+ L  
Sbjct: 141 S--AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY---VATRWYRAPEIMLNW 195
Query: 442 DPSNEKSDVFSFGVILWELI 461
              N+  D++S G I+ EL+
Sbjct: 196 MHYNQTVDIWSVGCIMAELL 215

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 129/284 (45%), Gaps = 32/284 (11%)
Query: 261 EIRWSELLIKKKIGEGSFGTVY---------HAEWRNSDVAVKILIEQEFHEDRFKEFLR 311
           +IR  +L+  + +G+G+F  ++         + +   ++V +K+L   + H +  + F  
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFE 61
Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
             ++M  L H ++VL  G         +V E++  GSL    ++   +  ++   +L +A
Sbjct: 62  AASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVA 119
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLV--------DSTYTVKVCDFGLSRSKPNTYIS 423
             +A  M++L +    ++H ++ + N+L+         +   +K+ D G+S     T + 
Sbjct: 120 KQLAWAMHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI----TVLP 173
Query: 424 SKTAAGTPEWMAPEVLREDPSNEK--SDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 481
                    W+ PE + E+P N    +D +SFG  LWE+ +      ++  SQ    + F
Sbjct: 174 KDILQERIPWVPPECI-ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQF 230
Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
              R ++P      +A LI  C   EP+ RPSF +I+  L    
Sbjct: 231 YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 271 KKIGEGSFGTV---YHAEWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +G G++G+V   Y A  R   VAVK L    +   H  R     RE+ ++K L+H N+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQK-VAVKKLSRPFQSLIHARRT---YRELRLLKHLKHENV 89
Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLY--KLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           + L+   T   ++   +E     +L    L +I   + + DE ++  + Y + +G+ Y+H
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LRE 441
                I+HRDLK  N+ V+    +++ DFGL+R + +  ++   A  T  + APE+ L  
Sbjct: 149 S--AGIIHRDLKPSNVAVNEDSELRILDFGLAR-QADEEMTGYVA--TRWYRAPEIMLNW 203
Query: 442 DPSNEKSDVFSFGVILWELI 461
              N+  D++S G I+ EL+
Sbjct: 204 MHYNQTVDIWSVGCIMAELL 223

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 26/225 (11%)
Query: 273 IGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMG 329
           +G G++G+V  A  + S   VA+K L  + F  + F K   RE+ ++K ++H N++ L+ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 330 AVTEPPNLSIVTEY-----LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             T   +L    ++       +  L K++ +  +    +E+++  + Y + KG+ Y+H  
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS----EEKIQY-LVYQMLKGLKYIHS- 144
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM-APEV-LRED 442
              +VHRDLK  NL V+    +K+ DFGL+R       +  T      W  APEV L   
Sbjct: 145 -AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILSWM 199
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNS----TPSQVISAVGFKG 483
             N+  D++S G I+ E++T +  ++        +Q++   G  G
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 118/258 (45%), Gaps = 34/258 (13%)
Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFK 307
           +E+ L  E  EI        K IG G+FG V   + +N++   A+KIL + E        
Sbjct: 67  KEMQLHREDFEI-------IKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETA 119
Query: 308 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPD--ARV 360
            F  E  ++       I  L  A  +  +L +V +Y   G L  LL      +P+  AR 
Sbjct: 120 CFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF 179
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPN 419
            + E +   +A D    ++Y        VHRD+K  N+L+D    +++ DFG   +   +
Sbjct: 180 YIGEMV---LAIDSIHQLHY--------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDD 228
Query: 420 TYISSKTAAGTPEWMAPEVLR--EDPSNE---KSDVFSFGVILWELITLQKPWRNSTPSQ 474
             + S  A GTP++++PE+L+  ED   +   + D +S GV ++E++  + P+   +  +
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288
Query: 475 VISAVGFKGRRLEIPKNV 492
               +     R + P +V
Sbjct: 289 TYGKIMNHEERFQFPSHV 306

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 118/258 (45%), Gaps = 34/258 (13%)
Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFK 307
           +E+ L  E  EI        K IG G+FG V   + +N++   A+KIL + E        
Sbjct: 83  KEMQLHREDFEI-------IKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETA 135
Query: 308 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPD--ARV 360
            F  E  ++       I  L  A  +  +L +V +Y   G L  LL      +P+  AR 
Sbjct: 136 CFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF 195
Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPN 419
            + E +   +A D    ++Y        VHRD+K  N+L+D    +++ DFG   +   +
Sbjct: 196 YIGEMV---LAIDSIHQLHY--------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDD 244
Query: 420 TYISSKTAAGTPEWMAPEVLR--EDPSNE---KSDVFSFGVILWELITLQKPWRNSTPSQ 474
             + S  A GTP++++PE+L+  ED   +   + D +S GV ++E++  + P+   +  +
Sbjct: 245 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 304
Query: 475 VISAVGFKGRRLEIPKNV 492
               +     R + P +V
Sbjct: 305 TYGKIMNHEERFQFPSHV 322

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 26/225 (11%)
Query: 273 IGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLMG 329
           +G G++G+V  A  + S   VA+K L  + F  + F K   RE+ ++K ++H N++ L+ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 108
Query: 330 AVTEPPNLSIVTEY-----LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             T   +L    ++       +  L K++ +  +    +E+++  + Y + KG+ Y+H  
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFS----EEKIQY-LVYQMLKGLKYIHS- 162
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM-APEV-LRED 442
              +VHRDLK  NL V+    +K+ DFGL+R       +  T      W  APEV L   
Sbjct: 163 -AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILSWM 217
Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNS----TPSQVISAVGFKG 483
             N+  D++S G I+ E++T +  ++        +Q++   G  G
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 118/251 (47%), Gaps = 34/251 (13%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           E  I + IG G++G V  A  R     VA+K +          K  LRE+ I+K  +H N
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 324 IVLLMGAV------TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
           I+ +   +       E  ++ +V + L    L++++H   ++ +  E +R  + Y + +G
Sbjct: 116 IIAIKDILRPTVPYGEFKSVYVVLD-LMESDLHQIIH--SSQPLTLEHVRYFL-YQLLRG 171
Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWM 434
           + Y+H  +  ++HRDLK  NLLV+    +K+ DFG++R   + P  +    T      W 
Sbjct: 172 LKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 229
Query: 435 -APE-VLREDPSNEKSDVFSFGVILWELITLQK--PWRN------------STPS-QVIS 477
            APE +L      +  D++S G I  E++  ++  P +N             TPS  VI 
Sbjct: 230 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 289
Query: 478 AVGFKGRRLEI 488
           AVG +  R  I
Sbjct: 290 AVGAERVRAYI 300

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 142/283 (50%), Gaps = 30/283 (10%)
Query: 246 MSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQE 300
           + T+N   + E+ G+E    ELL  K +G G++G V+     +        A+K+L +  
Sbjct: 39  LRTANLTGHAEKVGIE--NFELL--KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 94
Query: 301 F-HEDRFKEFLR-EVAIMKGLRH-PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD 357
              + +  E  R E  +++ +R  P +V L  A      L ++ +Y++ G L+   H+  
Sbjct: 95  IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT--HLSQ 152
Query: 358 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 417
                +  +++ +  ++   + +LH  +  I++RD+K  N+L+DS   V + DFGLS+  
Sbjct: 153 RERFTEHEVQIYVG-EIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE- 208
Query: 418 PNTYISSKTA-----AGTPEWMAPEVLR-EDPSNEKS-DVFSFGVILWELITLQKPWRNS 470
              +++ +T       GT E+MAP+++R  D  ++K+ D +S GV+++EL+T   P+   
Sbjct: 209 ---FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
Query: 471 TPSQVISAVGFKGRRLE--IPKNVNPMVAALIETCWAEEPEIR 511
                 + +  +  + E   P+ ++ +   LI+    ++P+ R
Sbjct: 266 GEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 25/265 (9%)
Query: 270 KKKIGEGSFGT-VYHAEWRNSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 327
           K  +G G+ GT VY   + N DVAVK ++ + F   DR  + LRE        HPN++  
Sbjct: 29  KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD-----EHPNVIRY 83
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +     I  E L   +L + +   D   +  E + L        G+ +LH     
Sbjct: 84  FCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITL--LQQTTSGLAHLHSLN-- 138
Query: 388 IVHRDLKSPNLLVD-----STYTVKVCDFGLSRS---KPNTYISSKTAAGTPEWMAPEVL 439
           IVHRDLK  N+L+            + DFGL +      +++       GT  W+APE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 440 REDPSNEKS---DVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
            ED     +   D+FS G + + +I+    P+  S   Q    +G        P+    +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258
Query: 496 VA-ALIETCWAEEPEIRPSFPSIME 519
           +A  LIE   A +P+ RPS   +++
Sbjct: 259 IARELIEKMIAMDPQKRPSAKHVLK 283

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 AMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           IG G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 91
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 146
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 147 HS--ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 201
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLT 223

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 117/244 (47%), Gaps = 36/244 (14%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           E  I + IG G++G V  A  R     VA+K +          K  LRE+ I+K  +H N
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 324 IVLLMGAV------TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
           I+ +   +       E  ++ +V + L    L++++H   ++ +  E +R  + Y + +G
Sbjct: 115 IIAIKDILRPTVPYGEFKSVYVVLD-LMESDLHQIIH--SSQPLTLEHVRYFL-YQLLRG 170
Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-----KPNTYISSKTAAGTPE 432
           + Y+H  +  ++HRDLK  NLLV+    +K+ DFG++R        + Y  ++  A T  
Sbjct: 171 LKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA-TRW 227
Query: 433 WMAPEV-LREDPSNEKSDVFSFGVILWELITLQK--PWRN------------STPS-QVI 476
           + APE+ L      +  D++S G I  E++  ++  P +N             TPS  VI
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287
Query: 477 SAVG 480
            AVG
Sbjct: 288 QAVG 291

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 104/215 (48%), Gaps = 12/215 (5%)
Query: 311 REVAIMKGLRHPNIVLLMGAV--TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
           +E+ +++ LRH N++ L+  +   E   + +V EY   G    L  +P+ R  V +    
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH-- 112
Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISS-KT 426
                +  G+ YLH +   IVH+D+K  NLL+ +  T+K+   G++ +  P     + +T
Sbjct: 113 GYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 427 AAGTPEWMAPEVLR--EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR 484
           + G+P +  PE+    +  S  K D++S GV L+ + T   P+      ++   +G KG 
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG-KG- 228
Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
              IP +  P ++ L++     EP  R S   I +
Sbjct: 229 SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 97
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 152
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 153 HS--ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 207
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLT 229

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGX---VATRWYRAPEIMLNWMH 199
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L +        K   RE+ ++K ++H N++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 155
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 156 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 211
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 212 YNQTVDIWSVGCIMAELLT 230

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 93
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 148
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +T         T  + APE+ L 
Sbjct: 149 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIMLN 203
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLT 225

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A        VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 163
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 164 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGX---VATRWYRAPEIMLNWMH 219
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 220 YNQTVDIWSVGCIMAELLT 238

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 93
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 148
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +T         T  + APE+ L 
Sbjct: 149 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIMLN 203
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLT 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 91
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 146
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 147 HS--ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 201
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLT 223

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 93
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 148
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +T         T  + APE+ L 
Sbjct: 149 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIMLN 203
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLT 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A        VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A        VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 96
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 97  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 151
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 152 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 206
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLT 228

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A        VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 92
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 147
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 148 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 202
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLT 224

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 88
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 143
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 144 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 198
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLT 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 148
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 149 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 204
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 205 YNQTVDIWSVGCIMAELLT 223

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 97
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 98  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 152
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 153 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 207
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLT 229

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A        VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 163
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 164 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 219
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 220 YNQTVDIWSVGCIMAELLT 238

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A        VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 139
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 195
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 196 YNQTVDIWSVGCIMAELLT 214

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 88
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 143
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 144 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 198
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLT 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 109
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 110 LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 164
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 165 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY---VATRWYRAPEIMLN 219
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLT 241

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 92
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 147
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 148 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 202
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLT 224

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A        VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 162
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 163 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 218
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 219 YNQTVDIWSVGCIMAELLT 237

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 98
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 153
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 154 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 208
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLT 230

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 139
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 195
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 196 YNQTVDIWSVGCIMAELLT 214

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 98
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 99  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 153
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 154 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 208
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLT 230

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 91
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 92  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 146
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 147 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 201
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 85
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 86  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 140
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 141 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 195
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 196 WMHYNQTVDIWSVGCIMAELLT 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 92
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 147
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 148 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 202
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLT 224

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 199
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKXQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 163
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 164 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 219
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 220 YNQTVDIWSVGCIMAELLT 238

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 141
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 142 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 197
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 198 YNQTVDIWSVGCIMAELLT 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 140
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 141 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 196
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 197 YNQTVDIWSVGCIMAELLT 215

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 140
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 141 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 196
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 197 YNQTVDIWSVGCIMAELLT 215

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 88
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 143
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 144 HS--ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 198
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLT 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 93
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 148
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 149 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 203
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLT 225

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 166
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 167 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 222
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 223 YNQTVDIWSVGCIMAELLT 241

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 88
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 89  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 143
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 144 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 198
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLT 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 162
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 163 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 218
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 219 YNQTVDIWSVGCIMAELLT 237

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 92
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 93  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 147
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 148 HS--ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 202
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLT 224

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A        VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +T         T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A        VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +T         T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A        VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 139
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +T         T  + APE+ L    
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 196 YNQTVDIWSVGCIMAELLT 214

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I  ++ + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKSQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKXQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 87/165 (52%), Gaps = 15/165 (9%)
Query: 311 REVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           RE  I++ +  HP+I+ L+ +      + +V + + +G L+  L     +V + E+   +
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRS 204
Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAA 428
           +   + + +++LH     IVHRDLK  N+L+D    +++ DFG S   +P   +  +   
Sbjct: 205 IMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELC 260
Query: 429 GTPEWMAPEVLR-----EDPSNEKS-DVFSFGVILWELITLQKPW 467
           GTP ++APE+L+       P   K  D+++ GVIL+ L+    P+
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 126/283 (44%), Gaps = 15/283 (5%)
Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHED 304
           +T N       E  E++  +L    ++G G++G V       S    AVK  I    +  
Sbjct: 16  TTENLYFQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVK-RIRATVNSQ 74
Query: 305 RFKEFLREVAI-MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVV 362
             K  L ++ I  + +  P  V   GA+    ++ I  E L   SL K    + D    +
Sbjct: 75  EQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTI 133
Query: 363 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 422
            E +   +A  + K + +LH +   ++HRD+K  N+L+++   VK CDFG+S    +  +
Sbjct: 134 PEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKXCDFGISGYLVDD-V 191
Query: 423 SSKTAAGTPEWMAPE----VLREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVIS 477
           +    AG   + APE     L +   + KSD++S G+   EL  L+ P+ +  TP Q + 
Sbjct: 192 AKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLK 251
Query: 478 AVGFKGRRLEIPKN-VNPMVAALIETCWAEEPEIRPSFPSIME 519
            V  +    ++P +  +         C  +  + RP++P + +
Sbjct: 252 QV-VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL-YKLLHI-----PDARVVVD 363
           L E  I++ +    +V L  A      L +V   ++ G L + + H+     P+AR V  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF- 290
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
                  A ++  G+  LH+ R  IV+RDLK  N+L+D    +++ D GL+   P    +
Sbjct: 291 ------YAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 341
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
            K   GT  +MAPEV++ +      D ++ G +L+E+I  Q P++ 
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVL 326
           +IG G++GTVY A   +S   VA+K +      E      +REVA+++ L    HPN+V 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 327 LMGAVTEPPN-----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           LM             +++V E++ +     L   P   +   E ++ ++     +G+++L
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA-ETIK-DLMRQFLRGLDFL 128
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-----WMAP 436
           H     IVHRDLK  N+LV S  TVK+ DFGL+R      I S   A  P      + AP
Sbjct: 129 HANC--IVHRDLKPENILVTSGGTVKLADFGLAR------IYSYQMALAPVVVTLWYRAP 180
Query: 437 EVLREDPSNEKSDVFSFGVILWELI 461
           EVL +       D++S G I  E+ 
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL-YKLLHI-----PDARVVVD 363
           L E  I++ +    +V L  A      L +V   ++ G L + + H+     P+AR V  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF- 290
Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
                  A ++  G+  LH+ R  IV+RDLK  N+L+D    +++ D GL+   P    +
Sbjct: 291 ------YAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 341
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
            K   GT  +MAPEV++ +      D ++ G +L+E+I  Q P++ 
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A        VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I     + D+ ++  + Y + +G+ Y+H  
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCAKLTDDHVQF-LIYQILRGLKYIHS- 139
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 195
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 196 YNQTVDIWSVGCIMAELLT 214

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVL 326
           +IG G++GTVY A   +S   VA+K +      E      +REVA+++ L    HPN+V 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 327 LMGAVTEPPN-----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           LM             +++V E++ +     L   P   +   E ++ ++     +G+++L
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA-ETIK-DLMRQFLRGLDFL 128
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
           H     IVHRDLK  N+LV S  TVK+ DFGL+R   +  ++      T  + APEVL +
Sbjct: 129 HANC--IVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALDPVVVTLWYRAPEVLLQ 185
Query: 442 DPSNEKSDVFSFGVILWELI 461
                  D++S G I  E+ 
Sbjct: 186 STYATPVDMWSVGCIFAEMF 205

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 271 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM-- 328
           K IG GSFG V+ A+   SD   ++ I++   + RFK   RE+ IM+ ++HPN+V L   
Sbjct: 46  KVIGNGSFGVVFQAKLVESD---EVAIKKVLQDKRFKN--RELQIMRIVKHPNVVDLKAF 100
Query: 329 ----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
               G   +   L++V EY+         H    +  +   L     Y + + + Y+H  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 385 RPPIVHRDLKSPNLLVD-STYTVKVCDFGLSR----SKPN-TYISSKTAAGTPEWMAPEV 438
              I HRD+K  NLL+D  +  +K+ DFG ++     +PN + I S+       + APE+
Sbjct: 161 G--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY------YRAPEL 212
Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           +    +   + D++S G ++ EL+  Q
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           KIG+G+FG V+ A  R +   V   K+L+E E  E      LRE+ I++ L+H N+V L+
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLI 83
Query: 329 GAV---TEPPNLSIVTEYL----SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
                   P N    + YL        L  LL     +  + E  R+     +  G+ Y+
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM--LLNGLYYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-------SKPNTYISSKTAAGTPEWM 434
           H  R  I+HRD+K+ N+L+     +K+ DFGL+R       S+PN Y +      T  + 
Sbjct: 142 H--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV---TLWYR 196
Query: 435 APE-VLREDPSNEKSDVFSFGVILWELIT 462
            PE +L E       D++  G I+ E+ T
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ D+GL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 110/230 (47%), Gaps = 32/230 (13%)
Query: 264 WSELLIKKKIGEGSFGTV-----------YHAEWRNSDVAVKILIEQEFHEDRFKEFLRE 312
           + + +I + +G G FG V           Y A++       ++L++            +E
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK------------KE 51
Query: 313 VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 372
           ++I+   RH NI+ L  +      L ++ E++S   +++   I  +   ++ER  ++  +
Sbjct: 52  ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE--RINTSAFELNEREIVSYVH 109
Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRS-KPNTYISSKTAAG 429
            V + + +LH     I H D++  N++  +  + T+K+ +FG +R  KP    + +    
Sbjct: 110 QVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFT 165
Query: 430 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
            PE+ APEV + D  +  +D++S G +++ L++   P+   T  Q+I  +
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVL 326
           +IG G++GTVY A   +S   VA+K +      E      +REVA+++ L    HPN+V 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 327 LMGAVTEPPN-----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           LM             +++V E++ +     L   P   +   E ++ ++     +G+++L
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA-ETIK-DLMRQFLRGLDFL 128
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-----WMAP 436
           H     IVHRDLK  N+LV S  TVK+ DFGL+R      I S   A  P      + AP
Sbjct: 129 HANC--IVHRDLKPENILVTSGGTVKLADFGLAR------IYSYQMALFPVVVTLWYRAP 180
Query: 437 EVLREDPSNEKSDVFSFGVILWELI 461
           EVL +       D++S G I  E+ 
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           KIG+G+FG V+ A  R +   V   K+L+E E  E      LRE+ I++ L+H N+V L+
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLI 83
Query: 329 GAV---TEPPNLSIVTEYL----SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
                   P N    + YL        L  LL     +  + E  R+     +  G+ Y+
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM--LLNGLYYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-------SKPNTYISSKTAAGTPEWM 434
           H  R  I+HRD+K+ N+L+     +K+ DFGL+R       S+PN Y +         W 
Sbjct: 142 H--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL----WY 195
Query: 435 APE--VLREDPSNEKSDVFSFGVILWELIT 462
            P   +L E       D++  G I+ E+ T
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 23/196 (11%)
Query: 288 NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSR 346
           + + AVKI+ +Q  H  R + F REV ++   + H N++ L+    E     +V E +  
Sbjct: 38  SQEYAVKIIEKQPGH-IRSRVF-REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95
Query: 347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---ST 403
           GS+   +H    R   +E     +  DVA  +++LH +   I HRDLK  N+L +     
Sbjct: 96  GSILSHIH---KRRHFNELEASVVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQV 150
Query: 404 YTVKVCDFGLSRS-------KPNTYISSKTAAGTPEWMAPEVLR---EDPS--NEKSDVF 451
             VK+CDFGL           P +     T  G+ E+MAPEV+    E+ S  +++ D++
Sbjct: 151 SPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLW 210
Query: 452 SFGVILWELITLQKPW 467
           S GVIL+ L++   P+
Sbjct: 211 SLGVILYILLSGYPPF 226

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           KIG+G+FG V+ A  R +   V   K+L+E E  E      LRE+ I++ L+H N+V L+
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLI 83
Query: 329 GAV---TEPPNLSIVTEYL----SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
                   P N    + YL        L  LL     +  + E  R+     +  G+ Y+
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM--LLNGLYYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-------SKPNTYISSKTAAGTPEWM 434
           H  R  I+HRD+K+ N+L+     +K+ DFGL+R       S+PN Y +         W 
Sbjct: 142 H--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL----WY 195
Query: 435 APE--VLREDPSNEKSDVFSFGVILWELIT 462
            P   +L E       D++  G I+ E+ T
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           KIG+G+FG V+ A  R +   V   K+L+E E  E      LRE+ I++ L+H N+V L+
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLI 82
Query: 329 GAV---TEPPNLSIVTEYL----SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
                   P N    + YL        L  LL     +  + E  R+     +  G+ Y+
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM--LLNGLYYI 140
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-------SKPNTYISSKTAAGTPEWM 434
           H  R  I+HRD+K+ N+L+     +K+ DFGL+R       S+PN Y +         W 
Sbjct: 141 H--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL----WY 194
Query: 435 APE--VLREDPSNEKSDVFSFGVILWELIT 462
            P   +L E       D++  G I+ E+ T
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  +    S   +AVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 172
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L    
Sbjct: 173 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG---YVATRWYRAPEIMLNWMH 228
Query: 444 SNEKSDVFSFGVILWELIT 462
            N   D++S G I+ EL+T
Sbjct: 229 YNMTVDIWSVGCIMAELLT 247

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 268 LIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           L+   +G+G+   V+    + +    A+K+     F      + +RE  ++K L H NIV
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-MREFEVLKKLNHKNIV 70
Query: 326 LLMGAVTEPPNLS--IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
            L     E       ++ E+   GSLY +L  P     + E   L +  DV  GMN+L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL-- 128
Query: 384 RRPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPE 437
           R   IVHR++K  N++     D     K+ DFG +R   +   ++S     GT E++ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPD 185
Query: 438 -----VLREDPSNEKS---DVFSFGVILWELITLQKPWR 468
                VLR+D   +     D++S GV  +   T   P+R
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 310 LREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
           L+EV I++ +  HPNI+ L           +V + + +G L+  L     +V + E+   
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETR 127
Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTA 427
            +   + + +  LH+    IVHRDLK  N+L+D    +K+ DFG S +  P   +  ++ 
Sbjct: 128 KIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--RSV 183
Query: 428 AGTPEWMAPEVLR-----EDPSNEKS-DVFSFGVILWELITLQKPW 467
            GTP ++APE++        P   K  D++S GVI++ L+    P+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 30/213 (14%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL- 327
           K +G G  G V+ A   + D  VA+K ++  +      K  LRE+ I++ L H NIV + 
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVF 74
Query: 328 -------------MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
                        +G++TE  ++ IV EY+       L ++ +   +++E  RL M Y +
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEHARLFM-YQL 129
Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSR-SKPNTYISSKTAAG-TP 431
            +G+ Y+H     ++HRDLK  NL +++    +K+ DFGL+R   P+       + G   
Sbjct: 130 LRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 432 EWMAPEVLREDPSN--EKSDVFSFGVILWELIT 462
           +W     L   P+N  +  D+++ G I  E++T
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+  FGL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 44/276 (15%)
Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLL 327
           KK+G+G++G V+ +  R +   VAVK + +   +    +   RE+ I+  L  H NIV L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
           +  +    +  +   YL    +   LH      +++   +  + Y + K + YLH     
Sbjct: 75  LNVLRADNDRDV---YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS--GG 129
Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY---------ISSKTA----------- 427
           ++HRD+K  N+L+++   VKV DFGLSRS  N           I+  T            
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 428 -AGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPW--RNSTPSQVISAVGFKG 483
              T  + APE+L       K  D++S G IL E++   KP    +ST +Q+   +G   
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPIFPGSSTMNQLERIIGV-- 246
Query: 484 RRLEIPKNVN------PMVAALIETCWAEEPEIRPS 513
             ++ P N +      P    +IE+   E+ EIR S
Sbjct: 247 --IDFPSNEDVESIQSPFAKTMIESL-KEKVEIRQS 279

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 123/248 (49%), Gaps = 35/248 (14%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIV 325
           +++  G+G+FGTV   + +++ ++V I  ++   + RF+   RE+ IM+ L    HPNIV
Sbjct: 27  VERMAGQGTFGTVQLGKEKSTGMSVAI--KKVIQDPRFRN--RELQIMQDLAVLHHPNIV 82
Query: 326 LLMGAVTEPPN-------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM-AYDVAKG 377
            L                L++V EY+   +L++       R V    + + +  + + + 
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141
Query: 378 MNYLHQRRPPIVHRDLKSPNLLV-DSTYTVKVCDFG----LSRSKPN-TYISSKTAAGTP 431
           +  LH     + HRD+K  N+LV ++  T+K+CDFG    LS S+PN  YI S+      
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY----- 196
Query: 432 EWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNSTPS----QVISAVGFKGRRL 486
            + APE++  +     + D++S G I  E++  +  +R    +    +++  +G   R  
Sbjct: 197 -YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR-- 253
Query: 487 EIPKNVNP 494
           E+ + +NP
Sbjct: 254 EVLRKLNP 261

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHA--EWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A        VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DF L+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 15/166 (9%)
Query: 310 LREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
           L+EV I++ +  HPNI+ L           +V + + +G L+  L     +V + E+   
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETR 127
Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTA 427
            +   + + +  LH+    IVHRDLK  N+L+D    +K+ DFG S +  P   +  +  
Sbjct: 128 KIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REV 183
Query: 428 AGTPEWMAPEVLR-----EDPSNEKS-DVFSFGVILWELITLQKPW 467
            GTP ++APE++        P   K  D++S GVI++ L+    P+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ D GL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 268 LIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           L+   +G+G+   V+    + +    A+K+     F      + +RE  ++K L H NIV
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-MREFEVLKKLNHKNIV 70
Query: 326 LLMGAVTEPPNLS--IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
            L     E       ++ E+   GSLY +L  P     + E   L +  DV  GMN+L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL-- 128
Query: 384 RRPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE-- 437
           R   IVHR++K  N++     D     K+ DFG +R   +         GT E++ P+  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVXLYGTEEYLHPDMY 187
Query: 438 ---VLREDPSNEKS---DVFSFGVILWELITLQKPWR 468
              VLR+D   +     D++S GV  +   T   P+R
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 15/166 (9%)
Query: 310 LREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
           L+EV I++ +  HPNI+ L           +V + + +G L+  L     +V + E+   
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETR 114
Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTA 427
            +   + + +  LH+    IVHRDLK  N+L+D    +K+ DFG S +  P   +  +  
Sbjct: 115 KIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REV 170
Query: 428 AGTPEWMAPEVLR-----EDPSNEKS-DVFSFGVILWELITLQKPW 467
            GTP ++APE++        P   K  D++S GVI++ L+    P+
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +G G++G+V  A    +   VAVK L    +   H  R     RE+ ++K ++H N++ L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMKHENVIGL 86
Query: 328 MGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+
Sbjct: 87  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYI 141
Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ D GL+R   +          T  + APE+ L 
Sbjct: 142 HS--ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY---VATRWYRAPEIMLN 196
Query: 441 EDPSNEKSDVFSFGVILWELIT 462
               N+  D++S G I+ EL+T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 273 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
           +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 331 VT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
            T      E  ++ +VT  +       L +I   + + D+ ++  + Y + +G+ Y+H  
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 143
Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 443
              I+HRDLK  NL V+    +K+ D GL+R   +          T  + APE+ L    
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY---VATRWYRAPEIMLNWMH 199
Query: 444 SNEKSDVFSFGVILWELIT 462
            N+  D++S G I+ EL+T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 272 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFK---EFLREVAIMKGLR---HPN 323
           +IG G++GTVY A   +S   VA+K +                +REVA+++ L    HPN
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 324 IVLLMGAVTEPPN-----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           +V LM             +++V E++ +     L   P   +   E ++ ++     +G+
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA-ETIK-DLMRQFLRGL 133
Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-----W 433
           ++LH     IVHRDLK  N+LV S  TVK+ DFGL+R      I S   A TP      +
Sbjct: 134 DFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR------IYSYQMALTPVVVTLWY 185
Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELI 461
            APEVL +       D++S G I  E+ 
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 23/196 (11%)
Query: 288 NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSR 346
           + + AVKI+ +Q  H  R + F REV ++   + H N++ L+    E     +V E +  
Sbjct: 38  SQEYAVKIIEKQPGH-IRSRVF-REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95
Query: 347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---ST 403
           GS+   +H    R   +E     +  DVA  +++LH +   I HRDLK  N+L +     
Sbjct: 96  GSILSHIH---KRRHFNELEASVVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQV 150
Query: 404 YTVKVCDF----GLSRSKPNTYISSK---TAAGTPEWMAPEVLR---EDPS--NEKSDVF 451
             VK+CDF    G+  +   + IS+    T  G+ E+MAPEV+    E+ S  +++ D++
Sbjct: 151 SPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLW 210
Query: 452 SFGVILWELITLQKPW 467
           S GVIL+ L++   P+
Sbjct: 211 SLGVILYILLSGYPPF 226

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 114/271 (42%), Gaps = 36/271 (13%)
Query: 265 SELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFH-----EDRFKEFLREVAIM 316
           +E  +   +G+G FGTV+ A  R +D   VA+K++            D     L EVA++
Sbjct: 31  AEYRLGPLLGKGGFGTVF-AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALL 88
Query: 317 ----KGLRHPNIVLLMGAVTEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRLNMA 371
                G  HP ++ L+          +V E  L    L+  +     +  + E       
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFF 145
Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFG---LSRSKPNTYISSKTA 427
             V   + + H R   +VHRD+K  N+L+D      K+ DFG   L   +P T       
Sbjct: 146 GQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV 203
Query: 428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE 487
              PEW++       P+     V+S G++L++++    P+      +++ A       L 
Sbjct: 204 YSPPEWISRHQYHALPAT----VWSLGILLYDMVCGDIPFERD--QEILEA------ELH 251
Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIM 518
            P +V+P   ALI  C A +P  RPS   I+
Sbjct: 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 305 RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE 364
           ++ +F  E+ I+  +++   +   G +T    + I+ EY+   S+   L   +   V+D+
Sbjct: 86  KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI---LKFDEYFFVLDK 142
Query: 365 RLRLNMAYDVAK--------GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 416
                +   V K          +Y+H  +  I HRD+K  N+L+D    VK+ DFG S  
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 417 KPNTYISSKTAAGTPEWMAPEVLREDPS--NEKSDVFSFGVILW 458
             +  I  K + GT E+M PE    + S    K D++S G+ L+
Sbjct: 202 MVDKKI--KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 116/258 (44%), Gaps = 48/258 (18%)
Query: 259 GLEIRWSELLIKKKI-GEGSFGTV-YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIM 316
             E     L++ +KI G GS GTV +   ++   VAVK ++      D     L E+ ++
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEIKLL 62
Query: 317 -KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD-- 373
            +   HPN++    + T    L I  E  +      L  + +++ V DE L+L   Y+  
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELCN----LNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 374 -----VAKGMNYLHQRRPPIVHRDLKSPNLLVDST-------------YTVKVCDFGLSR 415
                +A G+ +LH  +  I+HRDLK  N+LV ++               + + DFGL +
Sbjct: 119 SLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 416 SKPNTYISSKTA----AGTPEWMAPEVLREDPSNEKS-------DVFSFGVILWELITLQ 464
              +   S +T     +GT  W APE+L E  + +         D+FS G + + +++  
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 465 K-PW--RNSTPSQVISAV 479
           K P+  + S  S +I  +
Sbjct: 237 KHPFGDKYSRESNIIRGI 254

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 101/232 (43%), Gaps = 15/232 (6%)
Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE---FLREVAIMKGLRHPNIV 325
           I K IG G+F  V   + + +     + I  ++   +  E   F  E  ++       I 
Sbjct: 65  ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L  A  +   L +V EY   G L  LL     R+   E  R  +A ++   ++ +H  R
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA-EMARFYLA-EIVMAIDSVH--R 180
Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLRE--- 441
              VHRD+K  N+L+D    +++ DFG   + + +  + S  A GTP++++PE+L+    
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 442 ----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 489
                    + D ++ GV  +E+   Q P+   + ++    +      L +P
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L I+ E +  G L+  +     +    ER    +  D+   + +LH     I HRD+K  
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFT-EREAAEIMRDIGTAIQFLHSHN--IAHRDVKPE 157
Query: 397 NLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG +  K  T  + +T   TP ++APEVL  +  ++  D++S 
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFA--KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR 484
           GVI++ L+    P+ ++T  Q IS  G K R
Sbjct: 216 GVIMYILLCGFPPFYSNT-GQAISP-GMKRR 244

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L I+ E +  G L+  +     +    ER    +  D+   + +LH     I HRD+K  
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFT-EREAAEIMRDIGTAIQFLHSHN--IAHRDVKPE 138
Query: 397 NLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG +  K  T  + +T   TP ++APEVL  +  ++  D++S 
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFA--KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 196
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR 484
           GVI++ L+    P+ ++T  Q IS  G K R
Sbjct: 197 GVIMYILLCGFPPFYSNT-GQAISP-GMKRR 225

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 44/253 (17%)
Query: 260 LEIRWSELLIKKKI-GEGSFGTV-YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIM- 316
            E     L++ +KI G GS GTV +   ++   VAVK ++      D     L E+ ++ 
Sbjct: 27  FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEIKLLT 81
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD--- 373
           +   HPN++    + T    L I  E  +      L  + +++ V DE L+L   Y+   
Sbjct: 82  ESDDHPNVIRYYCSETTDRFLYIALELCN----LNLQDLVESKNVSDENLKLQKEYNPIS 137
Query: 374 ----VAKGMNYLHQRRPPIVHRDLKSPNLLVDST-------------YTVKVCDFGLSR- 415
               +A G+ +LH  +  I+HRDLK  N+LV ++               + + DFGL + 
Sbjct: 138 LLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 195
Query: 416 ---SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS---DVFSFGVILWELITLQK-PW- 467
               +     +    +GT  W APE+L E      +   D+FS G + + +++  K P+ 
Sbjct: 196 LDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255
Query: 468 -RNSTPSQVISAV 479
            + S  S +I  +
Sbjct: 256 DKYSRESNIIRGI 268

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 44/253 (17%)
Query: 260 LEIRWSELLIKKKI-GEGSFGTV-YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIM- 316
            E     L++ +KI G GS GTV +   ++   VAVK ++      D     L E+ ++ 
Sbjct: 27  FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEIKLLT 81
Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD--- 373
           +   HPN++    + T    L I  E  +      L  + +++ V DE L+L   Y+   
Sbjct: 82  ESDDHPNVIRYYCSETTDRFLYIALELCN----LNLQDLVESKNVSDENLKLQKEYNPIS 137
Query: 374 ----VAKGMNYLHQRRPPIVHRDLKSPNLLVDST-------------YTVKVCDFGLSR- 415
               +A G+ +LH  +  I+HRDLK  N+LV ++               + + DFGL + 
Sbjct: 138 LLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 195
Query: 416 ---SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS---DVFSFGVILWELITLQK-PW- 467
               +     +    +GT  W APE+L E      +   D+FS G + + +++  K P+ 
Sbjct: 196 LDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255
Query: 468 -RNSTPSQVISAV 479
            + S  S +I  +
Sbjct: 256 DKYSRESNIIRGI 268

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 108/209 (51%), Gaps = 31/209 (14%)
Query: 271 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLL 327
           +K+G G +  V+ A     N  V VKIL  +   +++ K   RE+ I++ LR  PNI+ L
Sbjct: 43  RKLGRGKYSEVFEAINITNNEKVVVKIL--KPVKKNKIK---REIKILENLRGGPNIITL 97
Query: 328 MGAVTEPPNLS--IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
              V +P + +  +V E+++     +L      + + D  +R  M Y++ K ++Y H   
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM-YEILKALDYCHSM- 150
Query: 386 PPIVHRDLKSPNLLVDSTY-TVKVCDFGLSR-----SKPNTYISSKTAAGTPEWMAPEVL 439
             I+HRD+K  N+++D  +  +++ D+GL+       + N  ++S+   G      PE+L
Sbjct: 151 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG------PELL 203
Query: 440 REDPSNEKS-DVFSFGVILWELITLQKPW 467
            +    + S D++S G +L  +I  ++P+
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 48/258 (18%)
Query: 259 GLEIRWSELLIKKKI-GEGSFGTV-YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIM 316
             E     L++ +KI G GS GTV +   ++   VAVK ++      D     L E+ ++
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEIKLL 62
Query: 317 -KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD-- 373
            +   HPN++    + T    L I  E  +      L  + +++ V DE L+L   Y+  
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELCN----LNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 374 -----VAKGMNYLHQRRPPIVHRDLKSPNLLVDST-------------YTVKVCDFGLSR 415
                +A G+ +LH  +  I+HRDLK  N+LV ++               + + DFGL +
Sbjct: 119 SLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 416 ----SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS-------DVFSFGVILWELITLQ 464
                +     +    +GT  W APE+L E  + +         D+FS G + + +++  
Sbjct: 177 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 465 K-PW--RNSTPSQVISAV 479
           K P+  + S  S +I  +
Sbjct: 237 KHPFGDKYSRESNIIRGI 254

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 160
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D++S 
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 219
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 220 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 277
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 278 TEPTQRMTITEFM 290

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 150
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D++S 
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 209
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 210 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 267
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 268 TEPTQRMTITEFM 280

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 152
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D++S 
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 211
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 212 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 269
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 270 TEPTQRMTITEFM 282

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 196
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D++S 
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 255
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 256 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 313
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 314 TEPTQRMTITEFM 326

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 151
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D++S 
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 210
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 211 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 268
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 269 TEPTQRMTITEFM 281

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 146
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D++S 
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 206 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 263
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 264 TEPTQRMTITEFM 276

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 145
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D++S 
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 204
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 205 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 262
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 263 TEPTQRMTITEFM 275

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 190
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D++S 
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 250 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 307
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 308 TEPTQRMTITEFM 320

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 144
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D++S 
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 204 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 261
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 262 TEPTQRMTITEFM 274

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 146
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D++S 
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 206 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 263
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 264 TEPTQRMTITEFM 276

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 53/106 (50%), Gaps = 14/106 (13%)
Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-------- 419
           L++   +A+ + +LH +   ++HRDLK  N+       VKV DFGL  +           
Sbjct: 167 LHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 420 ----TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 461
                Y +     GT  +M+PE +  +  + K D+FS G+IL+EL+
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 58/253 (22%)
Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           GLE    +  + K +G GSFG V   E  + +   +  +++   + R+K   RE+ IMK 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIV--CEVFDIESGKRFALKKVLQDPRYKN--RELDIMKV 56
Query: 319 LRHPNIVLLMGAVT----------EPPN----------------------------LSIV 340
           L H NI+ L+              +PP+                            L+++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 341 TEYLSRGSLYKLLH--IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 398
            EY+   +L+K+L   I   R +    + + + Y + + + ++H     I HRD+K  NL
Sbjct: 117 MEYVP-DTLHKVLKSFIRSGRSIPMNLISIYI-YQLFRAVGFIHSLG--ICHRDIKPQNL 172
Query: 399 LVDST-YTVKVCDFGLSR----SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           LV+S   T+K+CDFG ++    S+P+           PE M    L         D++S 
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELM----LGATEYTPSIDLWSI 228
Query: 454 GVILWELITLQKP 466
           G +  ELI L KP
Sbjct: 229 GCVFGELI-LGKP 240

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 26/291 (8%)
Query: 253 LYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL 310
           LY +   + I     L  +K+GEG F  V   E  +     A+K ++  E  +DR +E  
Sbjct: 17  LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDR-EEAQ 74
Query: 311 REVAIMKGLRHPNIVLLMGAVTEPPNLS----IVTEYLSRGSLY-KLLHIPDARVVVDER 365
           RE  + +   HPNI+ L+              ++  +  RG+L+ ++  + D    + E 
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 366 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 425
             L +   + +G+  +H +     HRDLK  N+L+       + D G           S+
Sbjct: 135 QILWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192
Query: 426 TAAGTPEWM---------APEVLREDPS---NEKSDVFSFGVILWELITLQKPWRNSTPS 473
            A    +W          APE+         +E++DV+S G +L+ ++  + P+      
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 474 QVISAVGFKGRRLEIPKNVNPMVA--ALIETCWAEEPEIRPSFPSIMETLQ 522
               A+  +  +L IP++     A   L+ +    +P  RP  P ++  L+
Sbjct: 253 GDSVALAVQ-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 85/193 (44%), Gaps = 17/193 (8%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKSIGEAIQYLHSIN--IAHRDVKPE 144
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S      TP ++APEVL  +  ++  D++S 
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 454 GVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIPK----NVNPMVAALIETCWA 505
           GVI++ L+    P+  S     IS  G K R    + E P      V+  V  LI     
Sbjct: 204 GVIMYILLCGYPPFY-SNHGLAISP-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 261
Query: 506 EEPEIRPSFPSIM 518
            EP  R +    M
Sbjct: 262 TEPTQRMTITEFM 274

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 120/275 (43%), Gaps = 33/275 (12%)
Query: 256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLR---- 311
           E+E LE   S+  +   +G G FG+VY     + ++ V I   +   +DR  ++      
Sbjct: 2   EKEPLE---SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI---KHVEKDRISDWGELPNG 55
Query: 312 -----EVAIMKGLR--HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE 364
                EV ++K +      ++ L+     P +  ++ E +    +  L      R  + E
Sbjct: 56  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERME--PVQDLFDFITERGALQE 113
Query: 365 RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYIS 423
            L  +  + V + + + H     ++HRD+K  N+L+D +   +K+ DFG      +T  +
Sbjct: 114 ELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 171
Query: 424 SKTAAGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 482
                GT  +  PE +R    + +S  V+S G++L++++    P+ +    ++I    F 
Sbjct: 172 D--FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--EEIIRGQVFF 227
Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSI 517
            +R      V+     LI  C A  P  RP+F  I
Sbjct: 228 RQR------VSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 7/134 (5%)
Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
           L IV E L  G L+  +     +    ER    +   + + + YLH     I HRD+K  
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFT-EREASEIXKSIGEAIQYLHSIN--IAHRDVKPE 190
Query: 397 NLLVDS---TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 453
           NLL  S      +K+ DFG ++ +  ++ S  T   TP ++APEVL  +  ++  D +S 
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSL 249
Query: 454 GVILWELITLQKPW 467
           GVI + L+    P+
Sbjct: 250 GVIXYILLCGYPPF 263

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 46/238 (19%)
Query: 269 IKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
           I+ KIGEG+F +VY A  +        +A+K LI    H  R    L+ + +  G    N
Sbjct: 25  IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGG--QDN 81
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           ++ +     +  ++ I   YL   S   +L+    + V +  L L       K +  +HQ
Sbjct: 82  VMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNL------FKALKRIHQ 135
Query: 384 RRPPIVHRDLKSPNLLVDSTYT-VKVCDFGLSRSKPNT------YISSKTA--------- 427
               IVHRD+K  N L +       + DFGL++   +T      ++ S+           
Sbjct: 136 F--GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKC 193
Query: 428 -------------AGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNST 471
                        AGTP + APEVL + P+   + D++S GVI   L++ + P+  ++
Sbjct: 194 SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/238 (22%), Positives = 104/238 (43%), Gaps = 30/238 (12%)
Query: 272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 331
           K+G G++G VY A+ ++        ++Q           RE+A+++ L+HPN++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 332 TEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRL------NMAYDVAKGMNYLHQR 384
               +  +   +  +   L+ ++    A     + ++L      ++ Y +  G++YLH  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 385 RPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWM-APE 437
              ++HRDLK  N+LV         VK+ D G +R  + P   ++         W  APE
Sbjct: 148 W--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
Query: 438 VLREDPSNEKS-DVFSFGVILWELITLQ-------------KPWRNSTPSQVISAVGF 481
           +L       K+ D+++ G I  EL+T +              P+ +    ++ + +GF
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 269 IKKKIGEGSFGTVYHA--EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRHP--- 322
           + K IG+GSFG V  A     +  VA+K++  E+ FH    ++   E+ I++ LR     
Sbjct: 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQDKD 156
Query: 323 ---NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
              N++ ++   T   ++ +  E LS  +LY+L+     +      +R   A+ + + ++
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR-KFAHSILQCLD 214
Query: 380 YLHQRRPPIVHRDLKSPNLLV--DSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWM 434
            LH+ R  I+H DLK  N+L+       +KV DFG S     +  T I S+       + 
Sbjct: 215 ALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF------YR 266
Query: 435 APEVLREDPSNEKSDVFSFGVILWELIT 462
           APEV+         D++S G IL EL+T
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 269 IKKKIGEGSFGTVYHA--EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRHP--- 322
           + K IG+GSFG V  A     +  VA+K++  E+ FH    ++   E+ I++ LR     
Sbjct: 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQDKD 156
Query: 323 ---NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
              N++ ++   T   ++ +  E LS  +LY+L+     +      +R   A+ + + ++
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR-KFAHSILQCLD 214
Query: 380 YLHQRRPPIVHRDLKSPNLLV--DSTYTVKVCDFGLS---RSKPNTYISSKTAAGTPEWM 434
            LH+ R  I+H DLK  N+L+       +KV DFG S     +  T I S+       + 
Sbjct: 215 ALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF------YR 266
Query: 435 APEVLREDPSNEKSDVFSFGVILWELIT 462
           APEV+         D++S G IL EL+T
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 34/283 (12%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKIL-IEQEFHEDRFKEFLR-EVAIMKGLRHPN 323
           ELL     G     TV  A ++ +   V +  I  E   +    FL+ E+ + K   HPN
Sbjct: 12  ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 71
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNY 380
           IV           L +VT +++ GS   L+        +D    L +AY    V K ++Y
Sbjct: 72  IVPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQGVLKALDY 127
Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-------W 433
           +H      VHR +K+ ++L+     V +     + S  +     +     P+       W
Sbjct: 128 IHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 185
Query: 434 MAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           ++PEVL+++    + KSD++S G+   EL     P+++   +Q++         LE    
Sbjct: 186 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML---------LE---K 233
Query: 492 VNPMVAALIETCW--AEEPEIRPSFPSIMETLQQFLMSSVCQP 532
           +N  V  L++T    AEE  + PS       L   L +S  +P
Sbjct: 234 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRP 276

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 34/283 (12%)
Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKIL-IEQEFHEDRFKEFLR-EVAIMKGLRHPN 323
           ELL     G     TV  A ++ +   V +  I  E   +    FL+ E+ + K   HPN
Sbjct: 28  ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 87
Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNY 380
           IV           L +VT +++ GS   L+        +D    L +AY    V K ++Y
Sbjct: 88  IVPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQGVLKALDY 143
Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-------W 433
           +H      VHR +K+ ++L+     V +     + S  +     +     P+       W
Sbjct: 144 IHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 434 MAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           ++PEVL+++    + KSD++S G+   EL     P+++   +Q++             + 
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL------------EK 249
Query: 492 VNPMVAALIETCW--AEEPEIRPSFPSIMETLQQFLMSSVCQP 532
           +N  V  L++T    AEE  + PS       L   L +S  +P
Sbjct: 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRP 292
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	538
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-160
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-142
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-141
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-136
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-134
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-134
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-134
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-133
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-133
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-114
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-112
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-110
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-107
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-106
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-98
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-80
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-80
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-79
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-79
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-78
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-78
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-78
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-78
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-78
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-77
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-77
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-77
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-77
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-77
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-77
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-76
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-76
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-76
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-76
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-76
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-76
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-75
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-75
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-75
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-75
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-75
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-75
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-74
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-74
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-74
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-74
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-74
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-73
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-73
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-73
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-73
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-73
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-72
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-72
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-72
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-72
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-72
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-72
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-72
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-71
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-71
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-71
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-70
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-69
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-69
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-69
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-69
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-67
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-59
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-59
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-59
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-55
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	9e-54
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-53
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-53
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-53
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-53
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-52
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-52
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-52
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-52
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-52
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-51
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-51
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-50
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-49
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-49
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-48
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-47
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-47
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-47
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-46
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-46
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-46
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-46
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-45
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-45
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-45
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-44
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-44
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-44
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-44
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-43
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-43
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-42
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-42
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-42
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-42
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-42
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-41
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-41
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-41
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-41
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-40
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-40
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-40
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-40
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-40
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-40
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-39
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-39
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-39
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-39
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-39
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-39
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-39
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-39
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-39
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-39
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-38
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-38
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-38
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-38
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-38
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-38
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-38
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-37
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-37
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-37
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-37
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-37
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-37
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-37
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-37
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-37
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-37
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-37
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-37
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-37
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-36
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-36
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-36
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-35
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-35
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-35
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-35
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-34
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-06
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-34
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-34
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-33
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-33
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-33
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-32
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-31
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-31
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-31
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-31
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-31
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-31
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-30
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-29
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-29
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-29
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-29
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-29
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-29
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-29
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-28
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-28
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-28
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-28
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-27
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-27
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-26
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-26
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-26
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-26
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-26
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-26
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-26
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-26
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-25
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-25
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-25
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-24
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-24
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-23
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-23
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-23
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-23
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-23
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-23
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-22
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-21
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-21
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-21
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-20
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-19
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-18
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-16
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-15
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-15
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-08

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  456 bits (1176), Expect = e-160
 Identities = 199/297 (67%), Positives = 240/297 (80%)

Query: 236 HLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKI 295
           H + + ++        +  ++ + ++I W +L IK+KIG GSFGTV+ AEW  SDVAVKI
Sbjct: 8   HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKI 67

Query: 296 LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 355
           L+EQ+FH +R  EFLREVAIMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH 
Sbjct: 68  LMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK 127

Query: 356 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 415
             AR  +DER RL+MAYDVAKGMNYLH R PPIVHR+LKSPNLLVD  YTVKVCDFGLSR
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187

Query: 416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
            K +T++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N  P+QV
Sbjct: 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247

Query: 476 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
           ++AVGFK +RLEIP+N+NP VAA+IE CW  EP  RPSF +IM+ L+  + S+V  P
Sbjct: 248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  410 bits (1056), Expect = e-142
 Identities = 77/269 (28%), Positives = 142/269 (52%), Gaps = 11/269 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
            I + +L    K+ E   G ++   W+ +D+ VK+L  +++   + ++F  E   ++   
Sbjct: 6   GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65

Query: 321 HPNIVLLMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           HPN++ ++GA   PP  + +++T ++  GSLY +LH      VVD+   +  A D+A+GM
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGM 124

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
            +LH   P I    L S ++++D   T ++    +  S       S      P W+APE 
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-----QSPGRMYAPAWVAPEA 179

Query: 439 LREDPSN---EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           L++ P +     +D++SF V+LWEL+T + P+ + +  ++   V  +G R  IP  ++P 
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239

Query: 496 VAALIETCWAEEPEIRPSFPSIMETLQQF 524
           V+ L++ C  E+P  RP F  I+  L++ 
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  407 bits (1049), Expect = e-141
 Identities = 100/275 (36%), Positives = 144/275 (52%), Gaps = 17/275 (6%)

Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE--DRFKEFLREVAIMK 317
           LEI ++EL +++ IG G FG VY A W   +VAVK        +     +   +E  +  
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
            L+HPNI+ L G   + PNL +V E+   G L ++L        +   + +N A  +A+G
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARG 117

Query: 378 MNYLHQRRP-PIVHRDLKSPNLLVDSTY--------TVKVCDFGLSRSKPNTYISSKTAA 428
           MNYLH     PI+HRDLKS N+L+             +K+ DFGL+R    T  +  +AA
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAA 175

Query: 429 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 488
           G   WMAPEV+R    ++ SDV+S+GV+LWEL+T + P+R      V   V      L I
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235

Query: 489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
           P       A L+E CW  +P  RPSF +I++ L  
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  395 bits (1018), Expect = e-136
 Identities = 95/280 (33%), Positives = 152/280 (54%), Gaps = 23/280 (8%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHED-----RFKEFLREV 313
            +  +E+  +K+IG+G FG V+        S VA+K LI  +   +     +F+EF REV
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74

Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            IM  L HPNIV L G +  PP   +V E++  G LY  L   D    +   ++L +  D
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLD 130

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGLSRSKPNTYISSKTAA 428
           +A G+ Y+  + PPIVHRDL+SPN+ + S         KV DFGLS+   ++        
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLL 187

Query: 429 GTPEWMAPEVL--REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV--ISAVGFKGR 484
           G  +WMAPE +   E+   EK+D +SF +IL+ ++T + P+   +  ++  I+ +  +G 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247

Query: 485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
           R  IP++  P +  +IE CW+ +P+ RP F  I++ L + 
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  392 bits (1009), Expect = e-134
 Identities = 91/305 (29%), Positives = 153/305 (50%), Gaps = 22/305 (7%)

Query: 235 NHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVK 294
           N  L+ A       S   ++L+E   +I + +L I + IG+G FG VYH  W   +VA++
Sbjct: 5   NLSLLSARSFPRKASQTSIFLQE--WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIR 61

Query: 295 ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH 354
           ++  +  +ED+ K F REV   +  RH N+VL MGA   PP+L+I+T      +LY ++ 
Sbjct: 62  LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121

Query: 355 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 414
               ++V+D      +A ++ KGM YLH +   I+H+DLKS N+  D+   V + DFGL 
Sbjct: 122 DA--KIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYDN-GKVVITDFGLF 176

Query: 415 RSKPNTYISSKT-----AAGTPEWMAPEVLR---------EDPSNEKSDVFSFGVILWEL 460
                     +        G    +APE++R         + P ++ SDVF+ G I +EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

Query: 461 ITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 520
              + P++      +I  +G   +       +   ++ ++  CWA E E RP+F  +M+ 
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

Query: 521 LQQFL 525
           L++  
Sbjct: 297 LEKLP 301

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  390 bits (1004), Expect = e-134
 Identities = 98/288 (34%), Positives = 155/288 (53%), Gaps = 15/288 (5%)

Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRF 306
              +       +  EI   ++ + ++IG GSFGTVY  +W   DVAVK+L        + 
Sbjct: 6   HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQL 64

Query: 307 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 366
           + F  EV +++  RH NI+L MG  T P  L+IVT++    SLY  LH  + +   + + 
Sbjct: 65  QAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETK--FEMKK 121

Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK- 425
            +++A   A+GM+YLH +   I+HRDLKS N+ +    TVK+ DFGL+  K     S + 
Sbjct: 122 LIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179

Query: 426 -TAAGTPEWMAPEVLREDPSN---EKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVG 480
              +G+  WMAPEV+R   SN    +SDV++FG++L+EL+T Q P+ N     Q+I  VG
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239

Query: 481 FKGRR---LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
                    ++  N    +  L+  C  ++ + RPSFP I+  +++  
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  387 bits (997), Expect = e-133
 Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 19/282 (6%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
             R S+L+  + +G+G FG       R +   + +     F E+  + FL+EV +M+ L 
Sbjct: 6   IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HPN++  +G + +   L+ +TEY+  G+L  ++   D++       R++ A D+A GM Y
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAY 123

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--------------SKPNTYISSKT 426
           LH     I+HRDL S N LV     V V DFGL+R               K        T
Sbjct: 124 LHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 427 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRR 485
             G P WMAPE++     +EK DVFSFG++L E+I       +  P  +   +  +    
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241

Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
              P N  P    +   C   +PE RPSF  +   L+   M 
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  387 bits (996), Expect = e-133
 Identities = 94/270 (34%), Positives = 146/270 (54%), Gaps = 12/270 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
            I + E+ +++ +G G+FG V  A+WR  DVA+K +      E   K F+ E+  +  + 
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI----ESESERKAFIVELRQLSRVN 59

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HPNIV L GA   P  + +V EY   GSLY +LH  +          ++     ++G+ Y
Sbjct: 60  HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 381 LHQRRP-PIVHRDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           LH  +P  ++HRDLK PNLL+ +  TV K+CDFG +        ++K   G+  WMAPEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEV 174

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVA 497
                 +EK DVFS+G+ILWE+IT +KP+     P+  I      G R  + KN+   + 
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
           +L+  CW+++P  RPS   I++ +   +  
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  339 bits (872), Expect = e-114
 Identities = 92/330 (27%), Positives = 138/330 (41%), Gaps = 51/330 (15%)

Query: 238 LMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILI 297
           L+E + S  S S   L ++         ++ + K+IG+G +G V+  +WR   VAVK+  
Sbjct: 14  LIEQSQSSGSGSGLPLLVQR----TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFF 69

Query: 298 EQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP----PNLSIVTEYLSRGSLYKLL 353
             E      +    E+     +RH NI+  + A  +       L ++T+Y   GSLY  L
Sbjct: 70  TTEEASWFRE---TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL 126

Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLH------QRRPPIVHRDLKSPNLLVDSTYTVK 407
                   +D +  L +AY    G+ +LH      Q +P I HRDLKS N+LV    T  
Sbjct: 127 K----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182

Query: 408 VCDFGLSR----SKPNTYISSKTAAGTPEWMAPEVLRED------PSNEKSDVFSFGVIL 457
           + D GL+           I   T  GT  +M PEVL E        S   +D++SFG+IL
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242

Query: 458 WELIT----------LQKPWRNSTPSQ-----VISAVGFKGRRLEIPKN-----VNPMVA 497
           WE+             Q P+ +  PS      +   V  K  R   P           + 
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
            L+  CWA  P  R +   + +TL +   S
Sbjct: 303 KLMTECWAHNPASRLTALRVKKTLAKMSES 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  333 bits (856), Expect = e-112
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 51/300 (17%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAI--MKGLRHPN 323
           ++ + + +G+G +G V+   W+  +VAVKI   ++      K + RE  +     LRH N
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE-----KSWFRETELYNTVMLRHEN 63

Query: 324 IVLLMGAVT----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           I+  + +          L ++T Y   GSLY  L        +D    L +   +A G+ 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLA 119

Query: 380 YLH------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY----ISSKTAAG 429
           +LH      Q +P I HRDLKS N+LV       + D GL+     +     + +    G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 430 TPEWMAPEVLREDP------SNEKSDVFSFGVILWELIT----------LQKPWRNSTPS 473
           T  +MAPEVL E        S ++ D+++FG++LWE+             + P+ +  P+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239

Query: 474 Q-----VISAVGFKGRRLEIPKNVN-----PMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
                 +   V    +R  IP           +A L++ CW + P  R +   I +TL +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  323 bits (829), Expect = e-107
 Identities = 88/342 (25%), Positives = 146/342 (42%), Gaps = 48/342 (14%)

Query: 226 STLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAE 285
           S  +P+++    L +  +  M+TS     L           +++++ IG+G FG V+  +
Sbjct: 4   SLDRPFISEGTTLKDL-IYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGK 62

Query: 286 WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT----EPPNLSIVT 341
           WR  +VAVKI   +E      +    E+     LRH NI+  + A          L +V+
Sbjct: 63  WRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119

Query: 342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH------QRRPPIVHRDLKS 395
           +Y   GSL+  L+    R  V     + +A   A G+ +LH      Q +P I HRDLKS
Sbjct: 120 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175

Query: 396 PNLLVDSTYTVKVCDFGLSRSKPNTY----ISSKTAAGTPEWMAPEVLRED------PSN 445
            N+LV    T  + D GL+    +      I+     GT  +MAPEVL +        S 
Sbjct: 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235

Query: 446 EKSDVFSFGVILWELITL----------QKPWRNSTPS-----QVISAVGFKGRRLEIPK 490
           +++D+++ G++ WE+             Q P+ +  PS     ++   V  +  R  IP 
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 295

Query: 491 N-----VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
                    ++A ++  CW      R +   I +TL Q    
Sbjct: 296 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  320 bits (823), Expect = e-106
 Identities = 80/317 (25%), Positives = 135/317 (42%), Gaps = 49/317 (15%)

Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRF 306
            +S  +L  E   L  +   L + +    G FG V+ A+  N  VAVKI   Q+    + 
Sbjct: 8   HSSGVDLGTEN--LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQN 65

Query: 307 KEFLREVAIMKGLRHPNIVLLMGAVTEPPN----LSIVTEYLSRGSLYKLLHIPDARVVV 362
           +    EV  + G++H NI+  +GA     +    L ++T +  +GSL   L       VV
Sbjct: 66  E---YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVV 118

Query: 363 DERLRLNMAYDVAKGMNYLHQ--------RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 414
                 ++A  +A+G+ YLH+         +P I HRD+KS N+L+ +  T  + DFGL+
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

Query: 415 RSKP--NTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKP- 466
                  +   +    GT  +MAPEVL      +  +  + D+++ G++LWEL +     
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 467 ---------------WRNSTPSQVISAVGFKGRRLEIPKNVNP-----MVAALIETCWAE 506
                           ++ +   +   V  K +R  +           M+   IE CW  
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298

Query: 507 EPEIRPSFPSIMETLQQ 523
           + E R S   + E + Q
Sbjct: 299 DAEARLSAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  300 bits (770), Expect = 2e-98
 Identities = 78/331 (23%), Positives = 123/331 (37%), Gaps = 63/331 (19%)

Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMK-- 317
             +    L + + IG G +G VY        VAVK+           + F+ E  I +  
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVP 62

Query: 318 GLRHPNIVLLMGAVTEPP-----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 372
            + H NI   +               +V EY   GSL K L         D      +A+
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAH 118

Query: 373 DVAKGMNYLH-------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY---- 421
            V +G+ YLH         +P I HRDL S N+LV +  T  + DFGLS           
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

Query: 422 ----ISSKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELI---TLQKPW 467
                ++ +  GT  +MAPEVL         + + ++ D+++ G+I WE+    T   P 
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

Query: 468 RNSTPSQV---------------ISAVGFKGRRLEIPKNVNP------MVAALIETCWAE 506
            +    Q+                  V  + +R + P+           +   IE CW +
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298

Query: 507 EPEIRPSFPSIMETLQQFLMSSVCQPLSAQP 537
           + E R +     E + + LM    +  S  P
Sbjct: 299 DAEARLTAQXAEERMAE-LMMIWERNKSVSP 328

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  256 bits (655), Expect = 1e-80
 Identities = 98/270 (36%), Positives = 139/270 (51%), Gaps = 11/270 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKG 318
            +   +L++ ++IG G+FG V+    R  N+ VAVK   E    + +  +FL+E  I+K 
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-AKFLQEARILKQ 168

Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
             HPNIV L+G  T+   + IV E +  G     L    AR+ V   L+  M  D A GM
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQ--MVGDAAAGM 226

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP-NTYISSKTAAGTP-EWMAP 436
            YL  +    +HRDL + N LV     +K+ DFG+SR +    Y +S      P +W AP
Sbjct: 227 EYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284

Query: 437 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           E L     + +SDV+SFG++LWE  +L   P+ N +  Q    V  KG RL  P+     
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343

Query: 496 VAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           V  L+E CWA EP  RPSF +I + LQ   
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  250 bits (642), Expect = 5e-80
 Identities = 92/275 (33%), Positives = 138/275 (50%), Gaps = 13/275 (4%)

Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA 314
               G  +   EL + + IG+G FG V   ++R + VAVK +      +     FL E +
Sbjct: 11  FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEAS 66

Query: 315 IMKGLRHPNIVLLMGAVT-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
           +M  LRH N+V L+G +  E   L IVTEY+++GSL   L      V+  + L L  + D
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-LKFSLD 125

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 433
           V + M YL       VHRDL + N+LV      KV DFGL++       +  T     +W
Sbjct: 126 VCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKW 180

Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
            APE LRE   + KSDV+SFG++LWE+ +  + P+       V+  V  KG +++ P   
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGC 239

Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
            P V  +++ CW  +  +RPSF  + E L+     
Sbjct: 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  249 bits (638), Expect = 3e-79
 Identities = 92/280 (32%), Positives = 137/280 (48%), Gaps = 17/280 (6%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEF-HEDRFKEFLREVA 314
            I   +L + +K+G+GSFG V   EW         VAVK L        +   +F+REV 
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73

Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
            M  L H N++ L G V  PP + +VTE    GSL   L       ++        A  V
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQV 130

Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTP 431
           A+GM YL  +R   +HRDL + NLL+ +   VK+ DFGL R      + Y+        P
Sbjct: 131 AEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ-EHRKVP 187

Query: 432 -EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIP 489
             W APE L+    +  SD + FGV LWE+ T  Q+PW     SQ++  +  +G RL  P
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247

Query: 490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
           ++    +  ++  CWA +PE RP+F ++ + L +   + +
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  250 bits (641), Expect = 3e-79
 Identities = 82/276 (29%), Positives = 128/276 (46%), Gaps = 16/276 (5%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 315
           ++ +E    K +G G+FGTVY   W          VA+K L E        KE L E  +
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYV 70

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M  + +P++  L+G       + ++T+ +  G L   +      +   + L LN    +A
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGS-QYL-LNWCVQIA 127

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EW 433
           KGMNYL  RR  +VHRDL + N+LV +   VK+ DFGL++                P +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
           MA E +       +SDV+S+GV +WEL+T   KP+     S++ S +  KG RL  P   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244

Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              V  ++  CW  + + RP F  ++    +     
Sbjct: 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  248 bits (636), Expect = 1e-78
 Identities = 90/306 (29%), Positives = 143/306 (46%), Gaps = 20/306 (6%)

Query: 250 NRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHED 304
           + EL  + E + I   +  + + +G+G FG+V  A+ +  D     VAVK+L        
Sbjct: 8   SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS 67

Query: 305 RFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPNLSIVTEYLSRGSLYKLL---HI 355
             +EFLRE A MK   HP++  L+G           P   ++  ++  G L+  L    I
Sbjct: 68  DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127

Query: 356 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 415
            +    +  +  +    D+A GM YL  R    +HRDL + N ++    TV V DFGLSR
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSR 185

Query: 416 S-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTP 472
                 Y     A+  P +W+A E L ++     SDV++FGV +WE++T  Q P+     
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245

Query: 473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
           +++ + +   G RL+ P      V  L+  CW+ +P+ RPSF  +   L+  L       
Sbjct: 246 AEIYNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304

Query: 533 LSAQPL 538
            S  PL
Sbjct: 305 TSQDPL 310

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  248 bits (635), Expect = 2e-78
 Identities = 88/312 (28%), Positives = 147/312 (47%), Gaps = 22/312 (7%)

Query: 233 TNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-- 290
           +++H    ++  ++   + EL  + E + I  + L++ K +GEG FG+V     +  D  
Sbjct: 3   SSHHHHHHSS-GLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGT 61

Query: 291 ---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-----PPNLSIVTE 342
              VAVK +      +   +EFL E A MK   HPN++ L+G   E      P   ++  
Sbjct: 62  SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121

Query: 343 YLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 398
           ++  G L+  L         + +  + L L    D+A GM YL  R    +HRDL + N 
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTL-LKFMVDIALGMEYLSNRN--FLHRDLAARNC 178

Query: 399 LVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVI 456
           ++    TV V DFGLS+      Y      A  P +W+A E L +     KSDV++FGV 
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238

Query: 457 LWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 515
           +WE+ T    P+      ++   +   G RL+ P++    +  ++ +CW  +P  RP+F 
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFS 297

Query: 516 SIMETLQQFLMS 527
            +   L++ L S
Sbjct: 298 VLRLQLEKLLES 309

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  245 bits (629), Expect = 5e-78
 Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 11/274 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           E+    L + +++G G FG V+   +     VAVK L +     D    FL E  +MK L
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQL 65

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           +H  +V L   VT+ P   I+TEY+  GSL   L  P    +   +L L+MA  +A+GM 
Sbjct: 66  QHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMA 123

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 438
           ++ +R    +HRDL++ N+LV  T + K+ DFGL+R   +   +++  A  P +W APE 
Sbjct: 124 FIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 439 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +       KSDV+SFG++L E++T  + P+   T  +VI  +  +G R+  P N    + 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELY 240

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
            L+  CW E PE RP+F  +   L+ F  ++  Q
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  251 bits (642), Expect = 8e-78
 Identities = 91/273 (33%), Positives = 137/273 (50%), Gaps = 13/273 (4%)

Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA 314
               G  +   EL + + IG+G FG V   ++R + VAVK +      +     FL E +
Sbjct: 183 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEAS 238

Query: 315 IMKGLRHPNIVLLMGAVT-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
           +M  LRH N+V L+G +  E   L IVTEY+++GSL   L      V+  + L L  + D
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-LKFSLD 297

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 433
           V + M YL       VHRDL + N+LV      KV DFGL++       +  T     +W
Sbjct: 298 VCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKW 352

Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
            APE LRE   + KSDV+SFG++LWE+ +  + P+       V+  V  KG +++ P   
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGC 411

Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            P V  +++ CW  +   RP+F  + E L+   
Sbjct: 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  244 bits (626), Expect = 9e-78
 Identities = 89/268 (33%), Positives = 136/268 (50%), Gaps = 11/268 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
            I  SEL   ++IG G FG V+   W N   VA+K + E    E+   +F+ E  +M  L
Sbjct: 4   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKL 60

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            HP +V L G   E   + +VTE++  G L   L         +    L M  DV +GM 
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET--LLGMCLDVCEGMA 118

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 438
           YL +    ++HRDL + N LV     +KV DFG++R   +   +S T    P +W +PEV
Sbjct: 119 YLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176

Query: 439 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
                 + KSDV+SFGV++WE+ +  + P+ N + S+V+  +   G RL  P+  +  V 
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVY 235

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFL 525
            ++  CW E PE RP+F  ++  L +  
Sbjct: 236 QIMNHCWRERPEDRPAFSRLLRQLAEIA 263

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  250 bits (640), Expect = 1e-77
 Identities = 107/374 (28%), Positives = 173/374 (46%), Gaps = 32/374 (8%)

Query: 179 ADRDLQMQNPSGPSTHVIDSSN---------FIKGPLLRSPVKPFRHRKSH-------ET 222
           ++R L        +  V +S                     VK ++ RK           
Sbjct: 77  SERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSR 136

Query: 223 SAFSTLKPYV---TNNHLLMEANLS--VMSTSNRELYLEEEGLEIRWSELLIKKKIGEGS 277
           + F++L+  V   + +   +   L+    ++  +   L ++  EI    L ++ K+G+G 
Sbjct: 137 TQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGC 196

Query: 278 FGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 336
           FG V+   W  +  VA+K L       +    FL+E  +MK LRH  +V L   V+E P 
Sbjct: 197 FGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAVVSEEPI 253

Query: 337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
             IVTEY+S+GSL   L     + +   +L ++MA  +A GM Y+ +     VHRDL++ 
Sbjct: 254 Y-IVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVERMN--YVHRDLRAA 309

Query: 397 NLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 455
           N+LV      KV DFGL+R  + N Y + + A    +W APE         KSDV+SFG+
Sbjct: 310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369

Query: 456 ILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 514
           +L EL T  + P+      +V+  V  +G R+  P      +  L+  CW +EPE RP+F
Sbjct: 370 LLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 428

Query: 515 PSIMETLQQFLMSS 528
             +   L+ +  S+
Sbjct: 429 EYLQAFLEDYFTST 442

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  244 bits (624), Expect = 2e-77
 Identities = 91/268 (33%), Positives = 142/268 (52%), Gaps = 11/268 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           E++  E+ + K++G G FG V   +W+   DVAVK++ E    ED   EF +E   M  L
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKL 60

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            HP +V   G  ++   + IVTEY+S G L   L      +   +   L M YDV +GM 
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ--LLEMCYDVCEGMA 118

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 438
           +L   +   +HRDL + N LVD    VKV DFG++R   +    S      P +W APEV
Sbjct: 119 FLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176

Query: 439 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
                 + KSDV++FG+++WE+ +L + P+   T S+V+  V  +G RL  P   +  + 
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIY 235

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFL 525
            ++ +CW E PE RP+F  ++ +++   
Sbjct: 236 QIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  243 bits (623), Expect = 3e-77
 Identities = 90/274 (32%), Positives = 140/274 (51%), Gaps = 11/274 (4%)

Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREV 313
           L     EI   +L   K++G G FG V + +WR   DVA+K++ E    ED   EF+ E 
Sbjct: 14  LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEA 70

Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
            +M  L H  +V L G  T+   + I+TEY++ G L   L     R    +   L M  D
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ--LLEMCKD 128

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-E 432
           V + M YL  ++   +HRDL + N LV+    VKV DFGLSR   +   +S   +  P  
Sbjct: 129 VCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186

Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           W  PEVL     + KSD+++FGV++WE+ +L + P+   T S+    +  +G RL  P  
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHL 245

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            +  V  ++ +CW E+ + RP+F  ++  +   +
Sbjct: 246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  250 bits (641), Expect = 4e-77
 Identities = 97/278 (34%), Positives = 144/278 (51%), Gaps = 11/278 (3%)

Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLRE 312
              +  E+  +++ +K K+G G +G VY   W+     VAVK L E     +   EFL+E
Sbjct: 210 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKE 266

Query: 313 VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 372
            A+MK ++HPN+V L+G  T  P   I+TE+++ G+L   L   + + V    L L MA 
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMAT 325

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP 431
            ++  M YL ++    +HR+L + N LV   + VKV DFGLSR    +TY +   A    
Sbjct: 326 QISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 490
           +W APE L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPE 442

Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
                V  L+  CW   P  RPSF  I +  +     S
Sbjct: 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  243 bits (623), Expect = 5e-77
 Identities = 89/296 (30%), Positives = 135/296 (45%), Gaps = 19/296 (6%)

Query: 246 MSTSNRELY--LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL   ++   +      +   + IG G FG VYH    ++D      AVK L  
Sbjct: 4   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63

Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-PNLSIVTEYLSRGSLYKLLHIPD 357
                +   +FL E  IMK   HPN++ L+G       +  +V  Y+  G L   +    
Sbjct: 64  ITDIGEV-SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 122

Query: 358 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS- 416
               V + +       VAKGM YL  ++   VHRDL + N ++D  +TVKV DFGL+R  
Sbjct: 123 HNPTVKDLIG--FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 178

Query: 417 -KPNTYISSKTAAGT-P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTP 472
                Y          P +WMA E L+      KSDV+SFGV+LWEL+T    P+ +   
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238

Query: 473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             +   +  +GRRL  P+     +  ++  CW  + E+RPSF  ++  +     + 
Sbjct: 239 FDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  242 bits (621), Expect = 7e-77
 Identities = 82/272 (30%), Positives = 128/272 (47%), Gaps = 14/272 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 315
            I   ++++ + +GEG FG VY   + N       VAVK   +    +++ ++F+ E  I
Sbjct: 8   GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVI 66

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           MK L HP+IV L+G + E P   I+ E    G L   L      + V     +  +  + 
Sbjct: 67  MKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLT--LVLYSLQIC 123

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWM 434
           K M YL       VHRD+   N+LV S   VK+ DFGLSR   +      +    P +WM
Sbjct: 124 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           +PE +        SDV+ F V +WE+++  ++P+       VI  +  KG RL  P    
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240

Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P++  L+  CW  +P  RP F  ++ +L    
Sbjct: 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  242 bits (620), Expect = 1e-76
 Identities = 97/272 (35%), Positives = 142/272 (52%), Gaps = 11/272 (4%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E     +   EFL+E A+MK 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 65

Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + + V    L L MA  ++  M
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMATQISSAM 124

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPE 437
            YL ++    +HRDL + N LV   + VKV DFGLSR       ++   A  P +W APE
Sbjct: 125 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182

Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            L  +  + KSDV++FGV+LWE+ T    P+     SQV   +  K  R+E P+     V
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 241

Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
             L+  CW   P  RPSF  I +  +     S
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  247 bits (633), Expect = 2e-76
 Identities = 103/335 (30%), Positives = 169/335 (50%), Gaps = 22/335 (6%)

Query: 211 VKPFRHRKS-------HETSAFSTLKPYV---TNNHLLMEANLSV-MSTSNRELYLEEEG 259
           VK ++ R            S FSTL+  V      +  +   LSV   +S  +   E++ 
Sbjct: 123 VKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDA 182

Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKG 318
            EI    L ++KK+G G FG V+ A +     VAVK +       +    FL E  +MK 
Sbjct: 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 239

Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           L+H  +V L   VT+ P   I+TE++++GSL   L   +       +L ++ +  +A+GM
Sbjct: 240 LQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGM 297

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPE 437
            ++ QR    +HRDL++ N+LV ++   K+ DFGL+R  + N Y + + A    +W APE
Sbjct: 298 AFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355

Query: 438 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            +       KSDV+SFG++L E++T  + P+   +  +VI A+  +G R+  P+N    +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEEL 414

Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             ++  CW   PE RP+F  I   L  F  ++  Q
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  241 bits (618), Expect = 3e-76
 Identities = 98/291 (33%), Positives = 149/291 (51%), Gaps = 28/291 (9%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
            I+  ++++K+++GEG+FG V+ AE  N         VAVK L  ++      K+F RE 
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREA 68

Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR---- 367
            ++  L+H +IV   G   +   L +V EY+  G L K L  H PDA ++VD + R    
Sbjct: 69  ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128

Query: 368 -------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
                  L++A  +A GM YL  +    VHRDL + N LV +   VK+ DFG+SR   +T
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186

Query: 421 -YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVIS 477
            Y         P  WM PE +       +SDV+SFGVILWE+ T  ++PW   + ++VI 
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246

Query: 478 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
            +  +GR LE P+     V  ++  CW  EP+ R +   I + L     ++
Sbjct: 247 CIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  242 bits (620), Expect = 4e-76
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 16/277 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVA 314
             + +EL   K +G G FGTV+   W          V +K++ ++   +   +     + 
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-QAVTDHML 67

Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
            +  L H +IV L+G       L +VT+YL  GSL   +      +   + L LN    +
Sbjct: 68  AIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGP-QLL-LNWGVQI 124

Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-E 432
           AKGM YL +    +VHR+L + N+L+ S   V+V DFG++    P+      + A TP +
Sbjct: 125 AKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182

Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           WMA E +       +SDV+S+GV +WEL+T   +P+     ++V   +  KG RL  P+ 
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQI 241

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               V  ++  CW  +  IRP+F  +     +     
Sbjct: 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  241 bits (616), Expect = 7e-76
 Identities = 90/293 (30%), Positives = 149/293 (50%), Gaps = 21/293 (7%)

Query: 250 NRELYLEEEGLEI--RWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFH 302
           +  L  E + + I          + IG+G FG VYH E+ +        A+K L      
Sbjct: 4   DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63

Query: 303 EDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPPNLSIVTEYLSRGSLYKLLHIPDARV 360
           +   + FLRE  +M+GL HPN++ L+G +   E     ++  Y+  G L + +  P    
Sbjct: 64  QQV-EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNP 121

Query: 361 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPN 419
            V + +  +    VA+GM YL +++   VHRDL + N ++D ++TVKV DFGL+R     
Sbjct: 122 TVKDLI--SFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177

Query: 420 TYISSKTAAGT--P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQV 475
            Y S +       P +W A E L+      KSDV+SFGV+LWEL+T    P+R+  P  +
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237

Query: 476 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              +  +GRRL  P+     +  +++ CW  +P +RP+F  ++  ++Q + + 
Sbjct: 238 THFLA-QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  243 bits (622), Expect = 8e-76
 Identities = 101/359 (28%), Positives = 155/359 (43%), Gaps = 23/359 (6%)

Query: 187 NPSGPST--HVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLS 244
           +P G     H    ++   G L+           S E  + S  K   + N     AN  
Sbjct: 5   DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64

Query: 245 V--MSTSNRELY--LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKI 295
              +S  N EL   ++   +      +   + IG G FG VYH    ++D      AVK 
Sbjct: 65  HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124

Query: 296 LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-PNLSIVTEYLSRGSLYKLLH 354
           L       +   +FL E  IMK   HPN++ L+G       +  +V  Y+  G L   + 
Sbjct: 125 LNRITDIGEV-SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 183

Query: 355 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 414
                  V + +       VAKGM +L  ++   VHRDL + N ++D  +TVKV DFGL+
Sbjct: 184 NETHNPTVKDLIG--FGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLA 239

Query: 415 RS-KPNTYISSKTAAGT--P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN 469
           R      + S     G   P +WMA E L+      KSDV+SFGV+LWEL+T    P+ +
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299

Query: 470 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
                +   +  +GRRL  P+     +  ++  CW  + E+RPSF  ++  +     + 
Sbjct: 300 VNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  241 bits (616), Expect = 1e-75
 Identities = 101/311 (32%), Positives = 149/311 (47%), Gaps = 28/311 (9%)

Query: 248 TSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQE 300
             N + + +     I+  ++++K ++GEG+FG V+ AE  N         VAVK L  +E
Sbjct: 24  IENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KE 81

Query: 301 FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDA 358
             E   ++F RE  ++  L+H +IV   G  TE   L +V EY+  G L + L  H PDA
Sbjct: 82  ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141

Query: 359 RVVVDERLR----------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 408
           +++                L +A  VA GM YL       VHRDL + N LV     VK+
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKI 199

Query: 409 CDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QK 465
            DFG+SR   +T Y         P  WM PE +       +SDV+SFGV+LWE+ T  ++
Sbjct: 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259

Query: 466 PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           PW   + ++ I  +  +GR LE P+   P V A++  CW  EP+ R S   +   LQ   
Sbjct: 260 PWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318

Query: 526 -MSSVCQPLSA 535
               V   +  
Sbjct: 319 QAPPVYLDVLG 329

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  241 bits (616), Expect = 1e-75
 Identities = 91/300 (30%), Positives = 154/300 (51%), Gaps = 22/300 (7%)

Query: 249 SNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEF 301
           S  ++Y+ +E  E+   ++ + +++G+GSFG VY    +          VA+K + E   
Sbjct: 10  SAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68

Query: 302 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDAR 359
             +R  EFL E ++MK     ++V L+G V++     ++ E ++RG L   L    P   
Sbjct: 69  MRER-IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127

Query: 360 VVVDERLR-----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 414
                        + MA ++A GM YL+  +   VHRDL + N +V   +TVK+ DFG++
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMT 185

Query: 415 RSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNST 471
           R    T Y         P  WM+PE L++      SDV+SFGV+LWE+ TL ++P++  +
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245

Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             QV+  V  +G  L+ P N   M+  L+  CW   P++RPSF  I+ ++++ +     +
Sbjct: 246 NEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  247 bits (631), Expect = 2e-75
 Identities = 95/278 (34%), Positives = 144/278 (51%), Gaps = 11/278 (3%)

Query: 254 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLRE 312
            L ++  EI    L ++ K+G+G FG V+   W  +  VA+K L       +    FL+E
Sbjct: 256 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQE 312

Query: 313 VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 372
             +MK LRH  +V L   V+E P   IVTEY+S+GSL   L     + +   +L ++MA 
Sbjct: 313 AQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAA 370

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP 431
            +A GM Y+ +     VHRDL++ N+LV      KV DFGL+R  + N Y + + A    
Sbjct: 371 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 428

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 490
           +W APE         KSDV+SFG++L EL T  + P+      +V+  V  +G R+  P 
Sbjct: 429 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPP 487

Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
                +  L+  CW +EPE RP+F  +   L+ +  S+
Sbjct: 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  240 bits (614), Expect = 3e-75
 Identities = 99/312 (31%), Positives = 145/312 (46%), Gaps = 33/312 (10%)

Query: 252 ELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDR 305
           +LY  ++        L    ++G+G+FG+V    +        + VAVK L  Q    D+
Sbjct: 10  QLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQ 67

Query: 306 FKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVD 363
            ++F RE+ I+K L    IV   G    P   +L +V EYL  G L   L    AR+   
Sbjct: 68  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA- 126

Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTY 421
            RL L  +  + KGM YL  RR   VHRDL + N+LV+S   VK+ DFGL++  P    Y
Sbjct: 127 SRL-LLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183

Query: 422 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTP------- 472
              +    +P  W APE L ++  + +SDV+SFGV+L+EL T   K    S         
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 243

Query: 473 -------SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
                  S+++  +  +G+RL  P      V  L++ CWA  P+ RPSF ++   L    
Sbjct: 244 ERDVPALSRLLELLE-EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302

Query: 526 MSSVCQPLSAQP 537
             S      A  
Sbjct: 303 SGSRGCETHAFT 314

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  237 bits (608), Expect = 8e-75
 Identities = 84/292 (28%), Positives = 126/292 (43%), Gaps = 34/292 (11%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVA 314
           +     L   +++G+G+FG+V    +          VAVK L  Q   E+  ++F RE+ 
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63

Query: 315 IMKGLRHPNIVLLMGAVTEPPNLS--IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 372
           I+K L+H NIV   G        +  ++ EYL  GSL   L     R+    +L L    
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-IKL-LQYTS 121

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGT 430
            + KGM YL  +R   +HRDL + N+LV++   VK+ DFGL++  P    +   K    +
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179

Query: 431 P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL----------------QKPWRNSTPS 473
           P  W APE L E   +  SDV+SFGV+L+EL T                           
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239

Query: 474 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            +I  +     RL  P      +  ++  CW      RPSF  +   + Q  
Sbjct: 240 HLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  239 bits (611), Expect = 8e-75
 Identities = 82/276 (29%), Positives = 129/276 (46%), Gaps = 16/276 (5%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 315
           ++ +E    K +G G+FGTVY   W          VA+K L E    +   KE L E  +
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 70

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M  + +P++  L+G       + ++T+ +  G L   +      +   + L LN    +A
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGS-QYL-LNWCVQIA 127

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EW 433
           KGMNYL  RR  +VHRDL + N+LV +   VK+ DFGL++                P +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 492
           MA E +       +SDV+S+GV +WEL+T   KP+     S++ S +  KG RL  P   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244

Query: 493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
              V  ++  CW  + + RP F  ++    +     
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  236 bits (605), Expect = 2e-74
 Identities = 87/287 (30%), Positives = 140/287 (48%), Gaps = 16/287 (5%)

Query: 255 LEEEGLEIRWSEL-LIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEF 309
           +  + + +    L L  K++G G+FGTV    ++       VAVKIL  +        E 
Sbjct: 6   IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65

Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L E  +M+ L +P IV ++G       + +V E    G L K L     R V D+ + + 
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNI-IE 121

Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTA 427
           + + V+ GM YL +     VHRDL + N+L+ + +  K+ DFGLS+       Y  ++T 
Sbjct: 122 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179

Query: 428 AGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 485
              P +W APE +     + KSDV+SFGV++WE  +  QKP+R    S+V + +  KG R
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGER 238

Query: 486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
           +  P      +  L+  CW  + E RP F ++   L+ +    V + 
Sbjct: 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  236 bits (605), Expect = 2e-74
 Identities = 83/280 (29%), Positives = 148/280 (52%), Gaps = 16/280 (5%)

Query: 257 EEGLEIRWSEL-LIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLR 311
           ++ L ++   L +   ++G G+FG+V    +R      DVA+K+L +     D  +E +R
Sbjct: 1   DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMR 59

Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
           E  IM  L +P IV L+G       + +V E    G L+K L      + V       + 
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSN--VAELL 116

Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAG 429
           + V+ GM YL ++    VHRDL + N+L+ + +  K+ DFGLS+     ++Y ++++A  
Sbjct: 117 HQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174

Query: 430 TP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLE 487
            P +W APE +     + +SDV+S+GV +WE ++  QKP++     +V++ +  +G+R+E
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRME 233

Query: 488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
            P    P + AL+  CW  + E RP F ++ + ++    S
Sbjct: 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  237 bits (607), Expect = 3e-74
 Identities = 86/292 (29%), Positives = 126/292 (43%), Gaps = 34/292 (11%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVA 314
           +     L   +++G+G+FG+V    +          VAVK L  Q   E+  ++F RE+ 
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 94

Query: 315 IMKGLRHPNIVLLMGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 372
           I+K L+H NIV   G         L ++ EYL  GSL   L     R+    +L L    
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-IKL-LQYTS 152

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGT 430
            + KGM YL  +R   +HRDL + N+LV++   VK+ DFGL++  P    Y   K    +
Sbjct: 153 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210

Query: 431 P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL----------------QKPWRNSTPS 473
           P  W APE L E   +  SDV+SFGV+L+EL T                           
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270

Query: 474 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            +I  +     RL  P      +  ++  CW      RPSF  +   + Q  
Sbjct: 271 HLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  235 bits (603), Expect = 3e-74
 Identities = 87/272 (31%), Positives = 136/272 (50%), Gaps = 14/272 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 315
           EI+   + + + IGEG FG V+   + + +     VA+K          R ++FL+E   
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALT 69

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M+   HP+IV L+G +TE P   I+ E  + G L   L +    + +     +  AY ++
Sbjct: 70  MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLAS--LILYAYQLS 126

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWM 434
             + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR  + +TY  +       +WM
Sbjct: 127 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +        SDV+ FGV +WE++    KP++    + VI  +   G RL +P N  
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243

Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P + +L+  CWA +P  RP F  +   L   L
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  237 bits (606), Expect = 5e-74
 Identities = 92/275 (33%), Positives = 137/275 (49%), Gaps = 16/275 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVA 314
           EI  S +  +K IG G FG VY    + S       VA+K L      + R  +FL E  
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAG 98

Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           IM    H NI+ L G +++   + I+TEY+  G+L K L   D    V +   + M   +
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ--LVGMLRGI 156

Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT--P- 431
           A GM YL       VHRDL + N+LV+S    KV DFGLSR   +   ++ T +G   P 
Sbjct: 157 AAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 490
            W APE +        SDV+SFG+++WE++T  ++P+   +  +V+ A+   G RL  P 
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPM 273

Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +    +  L+  CW +E   RP F  I+  L + +
Sbjct: 274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  236 bits (603), Expect = 1e-73
 Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 25/299 (8%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEA 84

Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----LN 369
            I+    H NIV  +G   +     I+ E ++ G L   L     R      L     L+
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144

Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNT-YISSK 425
           +A D+A G  YL +     +HRD+ + N L+         K+ DFG++R      Y    
Sbjct: 145 VARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202

Query: 426 TAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             A  P +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   G
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261

Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS----VCQPLSAQPL 538
            R++ PKN    V  ++  CW  +PE RP+F  I+E ++             P+   PL
Sbjct: 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPL 320

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  236 bits (603), Expect = 1e-73
 Identities = 96/323 (29%), Positives = 159/323 (49%), Gaps = 31/323 (9%)

Query: 233 TNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-- 290
           +++H     +  +   S  EL  + +  E    +L + K +GEG+FG V  AE    D  
Sbjct: 4   SHHHHHHSQDPMLAGVSEYELPEDPK-WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKD 62

Query: 291 -------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTE 342
                  VAVK+L + +  E    + + E+ +MK + +H NI+ L+GA T+   L ++ E
Sbjct: 63  KPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 121

Query: 343 YLSRGSLYKLL--HIPDARVVVDERLR-----------LNMAYDVAKGMNYLHQRRPPIV 389
           Y S+G+L + L    P       +  R           ++  Y +A+GM YL  ++   +
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CI 179

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT-P-EWMAPEVLREDPSNEK 447
           HRDL + N+LV     +K+ DFGL+R   N     KT  G  P +WMAPE L +     +
Sbjct: 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 239

Query: 448 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 506
           SDV+SFGV++WE+ TL   P+      ++   +  +G R++ P N    +  ++  CW  
Sbjct: 240 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHA 298

Query: 507 EPEIRPSFPSIMETLQQFLMSSV 529
            P  RP+F  ++E L + L  + 
Sbjct: 299 VPSQRPTFKQLVEDLDRILTLTT 321

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  235 bits (602), Expect = 2e-73
 Identities = 97/277 (35%), Positives = 134/277 (48%), Gaps = 15/277 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAI 315
           EI  S + I+K IG G  G V +   R     +  VA+K L        R ++FL E +I
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASI 103

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M    HPNI+ L G VT      IVTEY+  GSL   L   D +  + +   + M   V 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGVG 161

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPE 432
            GM YL       VHRDL + N+LVDS    KV DFGLSR     P+   ++        
Sbjct: 162 AGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219

Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE +     +  SDV+SFGV++WE++   ++P+ N T   VIS+V  +G RL  P  
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMG 278

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  L+  CW ++   RP F  I+  L   + S 
Sbjct: 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  237 bits (606), Expect = 2e-73
 Identities = 101/365 (27%), Positives = 167/365 (45%), Gaps = 46/365 (12%)

Query: 211 VKPFRHRKSH-------ETSAFSTLKPYVTNNHL--------LMEANLSVMSTSNRELYL 255
           +  + H   H       E   F+ +  Y  ++H          +     +   S  EL  
Sbjct: 1   MGYYHHHHHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPE 60

Query: 256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRF 306
           +    E+    L++ K +GEG+FG V  AE            + VAVK+L      +D  
Sbjct: 61  DPR-WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL- 118

Query: 307 KEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVD 363
            + + E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L    P       
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178

Query: 364 ERLR-----------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 412
                          ++ AY VA+GM YL  ++   +HRDL + N+LV     +K+ DFG
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFG 236

Query: 413 LSRSKPNTYISSKTAAGT-P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN 469
           L+R   +     KT  G  P +WMAPE L +     +SDV+SFGV+LWE+ TL   P+  
Sbjct: 237 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 470 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
               ++   +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + +  + 
Sbjct: 297 VPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355

Query: 530 CQPLS 534
            Q + 
Sbjct: 356 NQEMG 360

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  233 bits (597), Expect = 3e-73
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 27/287 (9%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
           EI  S +   +++GE  FG VY               VA+K L ++     R +EF  E 
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEA 63

Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR---- 367
            +   L+HPN+V L+G VT+   LS++  Y S G L++ L    P + V   +  R    
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123

Query: 368 -------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 420
                  +++   +A GM YL      +VH+DL + N+LV     VK+ D GL R     
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

Query: 421 -YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVIS 477
            Y      +  P  WMAPE +     +  SD++S+GV+LWE+ +   +P+   +   V+ 
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241

Query: 478 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
            +    + L  P +    V AL+  CW E P  RP F  I   L+ +
Sbjct: 242 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  234 bits (600), Expect = 1e-72
 Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 25/299 (8%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
           E+    + + + +G G+FG VY  +            VAVK L E    +D   +FL E 
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEA 125

Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----LN 369
            I+    H NIV  +G   +     I+ E ++ G L   L     R      L     L+
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185

Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNT-YISSK 425
           +A D+A G  YL +     +HRD+ + N L+         K+ DFG++R      Y    
Sbjct: 186 VARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243

Query: 426 TAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 483
             A  P +WM PE   E     K+D +SFGV+LWE+ +L   P+ + +  +V+  V   G
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302

Query: 484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS----VCQPLSAQPL 538
            R++ PKN    V  ++  CW  +PE RP+F  I+E ++             P+   PL
Sbjct: 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPL 361

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  234 bits (600), Expect = 1e-72
 Identities = 102/355 (28%), Positives = 164/355 (46%), Gaps = 33/355 (9%)

Query: 203 KGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEI 262
           K   LR  V       S   S    ++  +T           +   S  EL  + +  E 
Sbjct: 22  KRIPLRRQVTVSAESSSSMNSNTPLVR--ITTRLSSTADTPMLAGVSEYELPEDPK-WEF 78

Query: 263 RWSELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREV 313
              +L + K +GEG FG V  AE    D         VAVK+L + +  E    + + E+
Sbjct: 79  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEM 137

Query: 314 AIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR--- 367
            +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L    P       +  R   
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 368 --------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 419
                   ++  Y +A+GM YL  ++   +HRDL + N+LV     +K+ DFGL+R   N
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 420 TYISSKTAAGT-P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVI 476
                KT  G  P +WMAPE L +     +SDV+SFGV++WE+ TL   P+      ++ 
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315

Query: 477 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + L  +  +
Sbjct: 316 KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  233 bits (597), Expect = 2e-72
 Identities = 92/297 (30%), Positives = 138/297 (46%), Gaps = 35/297 (11%)

Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLRE 312
           LE   + +   + IGEG+FG V+ A             VAVK+L E+   + +  +F RE
Sbjct: 42  LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQRE 100

Query: 313 VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR--- 367
            A+M    +PNIV L+G       + ++ EY++ G L + L    P     +        
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160

Query: 368 ----------------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 411
                           L +A  VA GM YL +R+   VHRDL + N LV     VK+ DF
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADF 218

Query: 412 GLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWR 468
           GLSR+  +  Y  +      P  WM PE +  +    +SDV+++GV+LWE+ +   +P+ 
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278

Query: 469 NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
                +VI  V   G  L  P+N    +  L+  CW++ P  RPSF SI   LQ+  
Sbjct: 279 GMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  232 bits (593), Expect = 2e-72
 Identities = 88/304 (28%), Positives = 140/304 (46%), Gaps = 32/304 (10%)

Query: 248 TSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEF 301
            S ++   E +        L   + +GEG FG V    +          VAVK L  +  
Sbjct: 4   VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG 63

Query: 302 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDAR 359
                 +  +E+ I++ L H NIV   G  TE     + ++ E+L  GSL + L     +
Sbjct: 64  GNHI-ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122

Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP- 418
           + + ++  L  A  + KGM+YL  R+   VHRDL + N+LV+S + VK+ DFGL+++   
Sbjct: 123 INL-KQQ-LKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178

Query: 419 -NTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL------------- 463
              Y + K    +P  W APE L +      SDV+SFGV L EL+T              
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238

Query: 464 --QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
                    T +++++ +  +G+RL  P N    V  L+  CW  +P  R SF +++E  
Sbjct: 239 MIGPTHGQMTVTRLVNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

Query: 522 QQFL 525
           +  L
Sbjct: 298 EALL 301

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  241 bits (617), Expect = 4e-72
 Identities = 95/345 (27%), Positives = 151/345 (43%), Gaps = 27/345 (7%)

Query: 206 LLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLE--------- 256
           L+    + F  R   +    +        N+         +S S  + Y E         
Sbjct: 320 LVNGATQSFIIRP-QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYT 378

Query: 257 ---EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKE 308
                  EI+   + + + IGEG FG V+   + + +     VA+K          R ++
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EK 437

Query: 309 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
           FL+E   M+   HP+IV L+G +TE P   I+ E  + G L   L +    + +     +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLAS--LI 494

Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA 428
             AY ++  + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR   ++     +  
Sbjct: 495 LYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552

Query: 429 GTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRL 486
             P +WMAPE +        SDV+ FGV +WE++    KP++    + VI  +   G RL
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERL 611

Query: 487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
            +P N  P + +L+  CWA +P  RP F  +   L   L     Q
Sbjct: 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  233 bits (595), Expect = 7e-72
 Identities = 88/274 (32%), Positives = 135/274 (49%), Gaps = 15/274 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 315
           E+  + + I K +G G FG V     +        VA+K L      + R ++FL E +I
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASI 99

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M    HPNI+ L G VT+   + IVTEY+  GSL   L   DA+  V +   + M   +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPE 432
            GM YL       VHRDL + N+L++S    KV DFGL R     P    +++       
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215

Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 491
           W +PE +        SDV+S+G++LWE+++  ++P+   +   VI AV  +G RL  P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
               +  L+  CW ++   RP F  I+  L + +
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  230 bits (590), Expect = 8e-72
 Identities = 87/315 (27%), Positives = 148/315 (46%), Gaps = 36/315 (11%)

Query: 245 VMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILI 297
            +S    ++  + +  E     L++ K +GEG FG V  A   +         VAVK+L 
Sbjct: 4   SLSVDAFKILEDPK-WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62

Query: 298 EQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HI 355
           E        ++ L E  ++K + HP+++ L GA ++   L ++ EY   GSL   L    
Sbjct: 63  E-NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121

Query: 356 PDARVVVDERLR-------------------LNMAYDVAKGMNYLHQRRPPIVHRDLKSP 396
                 +                        ++ A+ +++GM YL + +  +VHRDL + 
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAAR 179

Query: 397 NLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFG 454
           N+LV     +K+ DFGLSR          ++    P +WMA E L +     +SDV+SFG
Sbjct: 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239

Query: 455 VILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 513
           V+LWE++TL   P+    P ++ + +   G R+E P N +  +  L+  CW +EP+ RP 
Sbjct: 240 VLLWEIVTLGGNPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298

Query: 514 FPSIMETLQQFLMSS 528
           F  I + L++ ++  
Sbjct: 299 FADISKDLEKMMVKR 313

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  230 bits (589), Expect = 1e-71
 Identities = 93/288 (32%), Positives = 139/288 (48%), Gaps = 26/288 (9%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIM 316
            + W+++  +  IGEG+FG V  A  +        A+K + E    +D  ++F  E+ ++
Sbjct: 21  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVL 79

Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR------ 367
             L  HPNI+ L+GA      L +  EY   G+L   L                      
Sbjct: 80  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139

Query: 368 -----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 422
                L+ A DVA+GM+YL Q++   +HRDL + N+LV   Y  K+ DFGLSR       
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRG--QEVY 195

Query: 423 SSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG 480
             KT    P  WMA E L        SDV+S+GV+LWE+++L   P+   T +++   + 
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255

Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
            +G RLE P N +  V  L+  CW E+P  RPSF  I+ +L + L   
Sbjct: 256 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  228 bits (583), Expect = 4e-71
 Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 34/289 (11%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLR 311
           +IR  +L+  + +G+G+F  ++    R            V +K+L   + H +  + F  
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFE 61

Query: 312 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
             ++M  L H ++VL  G         +V E++  GSL   L      + +    +L +A
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVA 119

Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--------VKVCDFGLSRSKPNTYIS 423
             +A  M++L +    ++H ++ + N+L+             +K+ D G+S       + 
Sbjct: 120 KQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-----TVL 172

Query: 424 SKTAAGTP-EWMAPEVLREDPS-NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG 480
            K        W+ PE +    + N  +D +SFG  LWE+ +   KP       + +    
Sbjct: 173 PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232

Query: 481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
               +L  PK     +A LI  C   EP+ RPSF +I+  L       +
Sbjct: 233 -DRHQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  229 bits (585), Expect = 5e-71
 Identities = 82/301 (27%), Positives = 129/301 (42%), Gaps = 42/301 (13%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVA 314
                 L   + +GEG FG V    +  ++      VAVK L      + R   + +E+ 
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR-SGWKQEID 85

Query: 315 IMKGLRHPNIVLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----L 368
           I++ L H +I+   G   +    +L +V EY+  GSL   L            +     L
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--------RHSIGLAQLL 137

Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKT 426
             A  + +GM YLH +    +HRDL + N+L+D+   VK+ DFGL+++ P    Y   + 
Sbjct: 138 LFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 195

Query: 427 AAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL---------------QKPWRNS 470
              +P  W APE L+E      SDV+SFGV L+EL+T                       
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255

Query: 471 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 530
           T  ++   +  +G RL  P      V  L++ CW  E   RP+F +++  L+        
Sbjct: 256 TVLRLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314

Query: 531 Q 531
           Q
Sbjct: 315 Q 315

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  227 bits (582), Expect = 1e-70
 Identities = 86/312 (27%), Positives = 138/312 (44%), Gaps = 32/312 (10%)

Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQ 299
                +L  + +  E   + L   K +G G+FG V  A             VAVK+L   
Sbjct: 6   YIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 64

Query: 300 EFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIP 356
               +R +  + E+ ++  L  H NIV L+GA T      ++TEY   G L   L     
Sbjct: 65  AHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 357 DARVVVDERLR-------------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 403
                                   L+ +Y VAKGM +L  +    +HRDL + N+L+   
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG 181

Query: 404 YTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELI 461
              K+CDFGL+R   N      K  A  P +WMAPE +       +SDV+S+G+ LWEL 
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

Query: 462 TL-QKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
           +L   P+      S+    +  +G R+  P++    +  +++TCW  +P  RP+F  I++
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIK-EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

Query: 520 TLQQFLMSSVCQ 531
            +++ +  S   
Sbjct: 301 LIEKQISESTNH 312

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  233 bits (595), Expect = 2e-69
 Identities = 90/355 (25%), Positives = 164/355 (46%), Gaps = 20/355 (5%)

Query: 186 QNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNH-----LLME 240
           +     S      +     P   S +   + R     S   T +P    +      + M+
Sbjct: 252 EACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMD 311

Query: 241 ANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKIL 296
            ++     S+ E   +++    R + L+   ++G G+FG+V    +R      DVA+K+L
Sbjct: 312 TSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL 371

Query: 297 IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIP 356
            +     D  +E +RE  IM  L +P IV L+G       + +V E    G L+K L   
Sbjct: 372 KQGTEKADT-EEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK 429

Query: 357 DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR- 415
              + V       + + V+ GM YL ++    VHR+L + N+L+ + +  K+ DFGLS+ 
Sbjct: 430 REEIPVSN--VAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKA 485

Query: 416 --SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTP 472
             +  + Y +        +W APE +     + +SDV+S+GV +WE ++  QKP++    
Sbjct: 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

Query: 473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
            +V++ +  +G+R+E P    P + AL+  CW  + E RP F ++ + ++    S
Sbjct: 546 PEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  224 bits (573), Expect = 3e-69
 Identities = 87/298 (29%), Positives = 135/298 (45%), Gaps = 32/298 (10%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
           E     L + K +G G+FG V  A+    D       VAVK+L E        +  + E+
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE-GATHSEHRALMSEL 81

Query: 314 AIMKGL-RHPNIVLLMGAVT--EPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR- 367
            I+  +  H N+V L+GA T    P L ++ E+   G+L   L     +           
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140

Query: 368 ----------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 417
                     +  ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDI 198

Query: 418 PNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN-STPS 473
                   K  A  P +WMAPE + +     +SDV+SFGV+LWE+ +L   P+       
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258

Query: 474 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
           +    +  +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++  Q
Sbjct: 259 EFCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  224 bits (573), Expect = 4e-69
 Identities = 89/329 (27%), Positives = 148/329 (44%), Gaps = 30/329 (9%)

Query: 229 KPYVTNNHLLMEANLSVMST--SNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW 286
           KP       ++E+      T     +L   E+  E   + L   K +G G+FG V  A  
Sbjct: 9   KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEK-WEFPRNNLQFGKTLGAGAFGKVVEATA 67

Query: 287 RN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS 338
                      VAVK+L      +++ +  + E+ IM  L +H NIV L+GA T    + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126

Query: 339 IVTEYLSRGSLYKLL-------HIPDARVVVDERLR----LNMAYDVAKGMNYLHQRRPP 387
           ++TEY   G L   L           A  + +        L+ +  VA+GM +L  +   
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-- 184

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSN 445
            +HRD+ + N+L+ + +  K+ DFGL+R     + YI    A    +WMAPE + +    
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 244

Query: 446 EKSDVFSFGVILWELITL-QKPWRNS-TPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
            +SDV+S+G++LWE+ +L   P+      S+    V   G ++  P      + ++++ C
Sbjct: 245 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK-DGYQMAQPAFAPKNIYSIMQAC 303

Query: 504 WAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
           WA EP  RP+F  I   LQ+       + 
Sbjct: 304 WALEPTHRPTFQQICSFLQEQAQEDRRER 332

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  224 bits (572), Expect = 7e-69
 Identities = 92/327 (28%), Positives = 142/327 (43%), Gaps = 37/327 (11%)

Query: 234 NNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN----- 288
              +   ++        RE   + +  E     L   K +G G+FG V +A         
Sbjct: 15  MVQVTGSSDNEYFYVDFREYEYDLK-WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTG 73

Query: 289 --SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLS 345
               VAVK+L E +      +  + E+ +M  L  H NIV L+GA T    + ++ EY  
Sbjct: 74  VSIQVAVKMLKE-KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 132

Query: 346 RGSL--------------------YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            G L                     K L   +   V+     L  AY VAKGM +L  + 
Sbjct: 133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDP 443
              VHRDL + N+LV     VK+CDFGL+R   +      +  A  P +WMAPE L E  
Sbjct: 193 --CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 250

Query: 444 SNEKSDVFSFGVILWELITL-QKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
              KSDV+S+G++LWE+ +L   P+      +     +   G +++ P      +  +++
Sbjct: 251 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-NGFKMDQPFYATEEIYIIMQ 309

Query: 502 TCWAEEPEIRPSFPSIMETLQQFLMSS 528
           +CWA +   RPSFP++   L   L  +
Sbjct: 310 SCWAFDSRKRPSFPNLTSFLGCQLADA 336

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  218 bits (557), Expect = 2e-67
 Identities = 79/280 (28%), Positives = 134/280 (47%), Gaps = 20/280 (7%)

Query: 246 MSTSNRELYLEEEGLEI----RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQ 299
               +    LE + + +    R+ +     +IG GSF TVY      +  +VA   L ++
Sbjct: 5   NQQQDDIEELETKAVGMSNDGRFLKF--DIEIGRGSFKTVYKGLDTETTVEVAWCELQDR 62

Query: 300 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGA----VTEPPNLSIVTEYLSRGSLYKLLHI 355
           +  +   + F  E  ++KGL+HPNIV    +    V     + +VTE ++ G+L   L  
Sbjct: 63  KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122

Query: 356 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLS 414
                 +  ++  +    + KG+ +LH R PPI+HRDLK  N+ +     +VK+ D GL+
Sbjct: 123 FKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179

Query: 415 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-S 473
             K  ++  +K   GTPE+MAPE+  E   +E  DV++FG+ + E+ T + P+      +
Sbjct: 180 TLKRASF--AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAA 236

Query: 474 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 513
           Q+   V    +     K   P V  +IE C  +  + R S
Sbjct: 237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  197 bits (504), Expect = 1e-59
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 13/261 (4%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD---VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           +   IG GS+G       R SD   +  K +        ++ +  + EV +++ L+HPNI
Sbjct: 10  VLYTIGTGSYGRCQKIR-RKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNI 67

Query: 325 VLLMGAVTEPPN--LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYL 381
           V     + +  N  L IV EY   G L  ++      R  +DE   L +   +   +   
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 382 HQRRPP---IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           H+R      ++HRDLK  N+ +D    VK+ DFGL+R   +    +KT  GTP +M+PE 
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           +     NEKSD++S G +L+EL  L  P+   +  ++   +  +G+   IP   +  +  
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNE 246

Query: 499 LIETCWAEEPEIRPSFPSIME 519
           +I      +   RPS   I+E
Sbjct: 247 IITRMLNLKDYHRPSVEEILE 267

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  199 bits (509), Expect = 2e-59
 Identities = 71/269 (26%), Positives = 131/269 (48%), Gaps = 12/269 (4%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
             +KIGEGSFG     +         +K +          +E  REVA++  ++HPNIV 
Sbjct: 28  RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
              +  E  +L IV +Y   G L+K ++     V+  E   L+    +   + ++H R+ 
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKHVHDRK- 145

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            I+HRD+KS N+ +    TV++ DFG++R   +T   ++   GTP +++PE+    P N 
Sbjct: 146 -ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 506
           KSD+++ G +L+EL TL+  +   +   ++  +   G    +  + +  + +L+   +  
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQLFKR 263

Query: 507 EPEIRPS------FPSIMETLQQFLMSSV 529
            P  RPS         I + +++FL   +
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEKFLSPQL 292

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  196 bits (501), Expect = 7e-59
 Identities = 72/260 (27%), Positives = 129/260 (49%), Gaps = 14/260 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD---VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           I+KKIG G F  VY A     D   VA+K + I          + ++E+ ++K L HPN+
Sbjct: 36  IEKKIGRGQFSEVYRAA-CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +    +  E   L+IV E    G L +++ H    + ++ ER        +   + ++H 
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
           RR  ++HRD+K  N+ + +T  VK+ D GL R   +   ++ +  GTP +M+PE + E+ 
Sbjct: 155 RR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 212

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK----NVNPMVAAL 499
            N KSD++S G +L+E+  LQ P+     +  + ++  K  + + P     + +  +  L
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEELRQL 270

Query: 500 IETCWAEEPEIRPSFPSIME 519
           +  C   +PE RP    + +
Sbjct: 271 VNMCINPDPEKRPDVTYVYD 290

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  186 bits (474), Expect = 4e-55
 Identities = 65/271 (23%), Positives = 120/271 (44%), Gaps = 34/271 (12%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV- 325
             + IG G FG V+ A+ R       +K  ++        ++  REV  +  L H NIV 
Sbjct: 15  EIELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNN-----EKAEREVKALAKLDHVNIVH 68

Query: 326 ---------------LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
                              + ++   L I  E+  +G+L + +        +D+ L L +
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALEL 127

Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT 430
              + KG++Y+H ++  +++RDLK  N+ +  T  VK+ DFGL  S  N       + GT
Sbjct: 128 FEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKGT 184

Query: 431 PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 490
             +M+PE +      ++ D+++ G+IL EL+ +      +  S+  +      R   I  
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT----DLRDGIISD 238

Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETL 521
             +     L++   +++PE RP+   I+ TL
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  183 bits (466), Expect = 9e-54
 Identities = 83/276 (30%), Positives = 133/276 (48%), Gaps = 26/276 (9%)

Query: 272 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR--FKEFLREVAIMKGLRHPNIVLLMG 329
           K+GEG FG VY     N+ VAVK L            ++F +E+ +M   +H N+V L+G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97

Query: 330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 389
             ++  +L +V  Y+  GSL   L   D    +   +R  +A   A G+N+LH+     +
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHI 155

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLREDPSNE 446
           HRD+KS N+L+D  +T K+ DFGL+R+      T ++S+   GT  +MAPE LR +    
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR-IVGTTAYMAPEALRGE-ITP 213

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV---------- 496
           KSD++SFGV+L E+IT           Q++  +  K    +  K +   +          
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREPQLL--LDIKEEIEDEEKTIEDYIDKKMNDADST 271

Query: 497 -----AALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
                 ++   C  E+   RP    + + LQ+   S
Sbjct: 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  183 bits (466), Expect = 2e-53
 Identities = 78/286 (27%), Positives = 123/286 (43%), Gaps = 27/286 (9%)

Query: 239 MEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVK 294
            E N  V+ T   +    E   E+ W     + ++G GSFG V+    ++       AVK
Sbjct: 34  TEDNEGVLLTEKLKPVDYEYREEVHWMTH--QPRVGRGSFGEVHRM--KDKQTGFQCAVK 89

Query: 295 ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH 354
            +  + F  +       E+    GL  P IV L GAV E P ++I  E L  GSL +L+ 
Sbjct: 90  KVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI- 141

Query: 355 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGL 413
                  + E   L       +G+ YLH RR  I+H D+K+ N+L+ S      +CDFG 
Sbjct: 142 --KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGH 197

Query: 414 SR-----SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR 468
           +          + ++     GT   MAPEV+   P + K D++S   ++  ++    PW 
Sbjct: 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257

Query: 469 NSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPEIRPS 513
                 +   +  +     EIP +  P+ A  I+    +EP  R S
Sbjct: 258 QYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  181 bits (461), Expect = 4e-53
 Identities = 74/279 (26%), Positives = 135/279 (48%), Gaps = 16/279 (5%)

Query: 244 SVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQ 299
           S+ ST   +   +    +  + E   +  +G+G++G VY    R+      +A+K  I +
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAG--RDLSNQVRIAIKE-IPE 57

Query: 300 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR 359
                  +    E+A+ K L+H NIV  +G+ +E   + I  E +  GSL  LL      
Sbjct: 58  RDSRY-SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP 116

Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKP 418
           +  +E+        + +G+ YLH  +  IVHRD+K  N+L+++    +K+ DFG S+   
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174

Query: 419 NTYISSKTAAGTPEWMAPEVLREDPS--NEKSDVFSFG-VILWELITLQKPWRN-STPSQ 474
                ++T  GT ++MAPE++ + P    + +D++S G  I+ E+ T + P+     P  
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQA 233

Query: 475 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 513
            +  VG      EIP++++    A I  C+  +P+ R  
Sbjct: 234 AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  180 bits (460), Expect = 7e-53
 Identities = 58/268 (21%), Positives = 109/268 (40%), Gaps = 24/268 (8%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IV 325
           I K+IG G    V+          A+K +  +E        +  E+A +  L+  +  I+
Sbjct: 32  ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L         + +V E      L   L     +  +D   R +   ++ + ++ +HQ  
Sbjct: 92  RLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG 147

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDP 443
             IVH DLK  N L+     +K+ DFG++       T +   +  GT  +M PE +++  
Sbjct: 148 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 444 S-----------NEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKN 491
           S           + KSDV+S G IL+ +   + P++        + A+      +E P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIME 519
               +  +++ C   +P+ R S P ++ 
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLA 292

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  180 bits (460), Expect = 7e-53
 Identities = 56/253 (22%), Positives = 101/253 (39%), Gaps = 15/253 (5%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL 327
            ++G GS+G V+    +      AVK  +            L EV   + + +HP  V L
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
             A  E   L + TE     SL +  H       + E        D    + +LH +   
Sbjct: 123 EQAWEEGGILYLQTEL-CGPSLQQ--HCEAWGASLPEAQVWGYLRDTLLALAHLHSQG-- 177

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           +VH D+K  N+ +      K+ DFGL      T  + +   G P +MAPE+L+       
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQEGDPRYMAPELLQGSY-GTA 235

Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAE 506
           +DVFS G+ + E+    +        Q +     +G    E    ++  + +++      
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGLSSELRSVLVMMLEP 291

Query: 507 EPEIRPSFPSIME 519
           +P++R +  +++ 
Sbjct: 292 DPKLRATAEALLA 304

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  180 bits (459), Expect = 2e-52
 Identities = 58/268 (21%), Positives = 109/268 (40%), Gaps = 24/268 (8%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IV 325
           I K+IG G    V+          A+K +  +E        +  E+A +  L+  +  I+
Sbjct: 13  ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L         + +V E      L   L     +  +D   R +   ++ + ++ +HQ  
Sbjct: 73  RLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDP 443
             IVH DLK  N L+     +K+ DFG++       T +   +  GT  +M PE +++  
Sbjct: 129 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 444 S-----------NEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKN 491
           S           + KSDV+S G IL+ +   + P++        + A+      +E P  
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIME 519
               +  +++ C   +P+ R S P ++ 
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLA 273

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  179 bits (456), Expect = 4e-52
 Identities = 59/298 (19%), Positives = 114/298 (38%), Gaps = 24/298 (8%)

Query: 247 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHED 304
           S+    LY +   + I     L  +K+GEG F  V   E  +     A+K ++  E  + 
Sbjct: 11  SSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQ 68

Query: 305 RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN----LSIVTEYLSRGSLYKLL-HIPDAR 359
             +E  RE  + +   HPNI+ L+              ++  +  RG+L+  +  + D  
Sbjct: 69  DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG 128

Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 419
             + E   L +   + +G+  +H       HRDLK  N+L+       + D G       
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186

Query: 420 TYISSKTAA---------GTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPW 467
               S+ A           T  + APE+         +E++DV+S G +L+ ++  + P+
Sbjct: 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

Query: 468 R-NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
                    ++        +      +  +  L+ +    +P  RP  P ++  L+  
Sbjct: 247 DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  177 bits (452), Expect = 5e-52
 Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 41/279 (14%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIM 316
              + EL   +KIG G FG+V+             A+K   +        +  LREV   
Sbjct: 10  TTEFHEL---EKIGSGEFGSVFKC--VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64

Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDV 374
             L +H ++V    A  E  ++ I  EY + GSL   +           E    ++   V
Sbjct: 65  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124

Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVD-------------------STYTVKVCDFGLSR 415
            +G+ Y+H     +VH D+K  N+ +                    +    K+ D G   
Sbjct: 125 GRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 416 SKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ 474
              +     +   G   ++A EVL+E+     K+D+F+  + +      +   RN     
Sbjct: 183 RISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238

Query: 475 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 513
            I     +GR   IP+ ++     L++     +PE RPS
Sbjct: 239 EI----RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPS 273

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  181 bits (460), Expect = 5e-52
 Identities = 57/268 (21%), Positives = 108/268 (40%), Gaps = 24/268 (8%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IV 325
           I K+IG G    V+          A+K +  +E        +  E+A +  L+  +  I+
Sbjct: 60  ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L         + +V E      L   L     +  +D   R +   ++ + ++ +HQ  
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG 175

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDP 443
             IVH DLK  N L+     +K+ DFG++       T +   +  G   +M PE +++  
Sbjct: 176 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 444 SN-----------EKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKN 491
           S+            KSDV+S G IL+ +   + P++        + A+      +E P  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIME 519
               +  +++ C   +P+ R S P ++ 
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLA 320

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  178 bits (454), Expect = 7e-52
 Identities = 77/274 (28%), Positives = 129/274 (47%), Gaps = 25/274 (9%)

Query: 272 KIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
            IG G FG VY    R+ + VA+K    +        EF  E+  +   RHP++V L+G 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE--EFETEIETLSFCRHPHLVSLIGF 103

Query: 331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV-DERLRLNMAYDVAKGMNYLHQRRPPIV 389
             E   + ++ +Y+  G+L + L+  D   +      RL +    A+G++YLH     I+
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAII 161

Query: 390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLREDPSNE 446
           HRD+KS N+L+D  +  K+ DFG+S+       T++S+    GT  ++ PE   +    E
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGTLGYIDPEYFIKGRLTE 220

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-----FKGRRLE------IPKNVNP- 494
           KSDV+SFGV+L+E++  +     S P ++++            +LE      +   + P 
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280

Query: 495 ---MVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
                      C A   E RPS   ++  L+  L
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  178 bits (452), Expect = 2e-51
 Identities = 75/291 (25%), Positives = 134/291 (46%), Gaps = 35/291 (12%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIV 325
           +++ + EG F  VY A+      + A+K L+  E  E++ +  ++EV  MK L  HPNIV
Sbjct: 32  VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 326 LLMGAVTEPPNLS-------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
               A +     S       ++   L +G L + L   ++R  +     L + Y   + +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA---------- 428
            ++H+++PPI+HRDLK  NLL+ +  T+K+CDFG + +  +    S +A           
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 429 --GTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 483
              TP +  PE++      P  EK D+++ G IL+ L   Q P+ +    ++++      
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG----- 264

Query: 484 RRLEIPKNVN--PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
            +  IP +     +  +LI       PE R S   ++  LQ+   +    P
Sbjct: 265 -KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  176 bits (449), Expect = 2e-51
 Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 32/277 (11%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
             + +G G FG V+ A+ +  D   A+K  I     E   ++ +REV  +  L HP IV 
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIVR 67

Query: 327 LMGAVTEPPN------------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
              A  E               L I  +   + +L   ++        +  + L++   +
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127

Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA------ 428
           A+ + +LH +   ++HRDLK  N+       VKV DFGL  +                  
Sbjct: 128 AEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 429 ------GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 482
                 GT  +M+PE +  +  + K D+FS G+IL+EL  L          + ++ V   
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQMERVRTLTDVR-N 242

Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
            +   +     P    +++   +  P  RP   +I+E
Sbjct: 243 LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  173 bits (441), Expect = 3e-50
 Identities = 64/285 (22%), Positives = 112/285 (39%), Gaps = 45/285 (15%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
               +G+G+FG V  A         A+K +      E++    L EV ++  L H  +V 
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 327 LMGAVTEPPNLS-------------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
              A  E  N               I  EY   G+LY L  I    +         +   
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL--IHSENLNQQRDEYWRLFRQ 124

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--------- 424
           + + ++Y+H +   I+HRDLK  N+ +D +  VK+ DFGL+++   +             
Sbjct: 125 ILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 425 -----KTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 478
                 +A GT  ++A EVL      NEK D++S G+I +E+  +           ++  
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVNILKK 240

Query: 479 VGFKGRRLEIP----KNVNPMVAALIETCWAEEPEIRPSFPSIME 519
           +  +   +E P     N   +   +I      +P  RP   +++ 
Sbjct: 241 L--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  171 bits (435), Expect = 3e-49
 Identities = 64/287 (22%), Positives = 109/287 (37%), Gaps = 26/287 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +   +G+G+   V+    + +    A+K+              +RE  ++K L H NIV 
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 327 LMGAVTEPP---NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           L  A+ E     +  ++ E+   GSLY +L  P     + E   L +  DV  GMN+L +
Sbjct: 72  LF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 384 RRPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 438
               IVHR++K  N++     D     K+ DFG +R  + +      +  GT E++ P++
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDM 186

Query: 439 LREDPS--------NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 490
                             D++S GV  +   T   P+R     +    V +K    +   
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQP 537
                     E    +     P   S+   LQ  L   +   L A  
Sbjct: 247 --AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  169 bits (431), Expect = 9e-49
 Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 26/255 (10%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
             +KIG+GSFG V+      +   VA+KI I+ E  ED  ++  +E+ ++     P +  
Sbjct: 26  KLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
             G+  +   L I+ EYL  GS   LL        +DE     +  ++ KG++YLH  + 
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK- 139

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
             +HRD+K+ N+L+     VK+ DFG++    +T I   T  GTP WMAPEV+++   + 
Sbjct: 140 -KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA-------- 498
           K+D++S G+   EL   + P     P +V+           IPKN  P +          
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSKPLKE 249

Query: 499 LIETCWAEEPEIRPS 513
            +E C  +EP  RP+
Sbjct: 250 FVEACLNKEPSFRPT 264

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  170 bits (433), Expect = 1e-48
 Identities = 72/208 (34%), Positives = 113/208 (54%), Gaps = 9/208 (4%)

Query: 272 KIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 330
            +G G FG VY     + + VAVK L E E  +    +F  EV ++    H N++ L G 
Sbjct: 37  ILGRGGFGKVYKGRLADGTLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95

Query: 331 VTEPPNLSIVTEYLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPI 388
              P    +V  Y++ GS+   L   P+++  +D   R  +A   A+G+ YLH    P I
Sbjct: 96  CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTA-AGTPEWMAPEVLREDPSN 445
           +HRD+K+ N+L+D  +   V DFGL++     +T+++  TA  GT   +APE L    S+
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSS 213

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPS 473
           EK+DVF +GV+L ELIT Q+ +  +  +
Sbjct: 214 EKTDVFGYGVMLLELITGQRAFDLARLA 241

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  169 bits (429), Expect = 1e-47
 Identities = 62/313 (19%), Positives = 112/313 (35%), Gaps = 51/313 (16%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +   +G+G+   V+    + +    A+K+              +RE  ++K L H NIV 
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 327 LMGAVTEPP---NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           L  A+ E     +  ++ E+   GSLY +L  P     + E   L +  DV  GMN+L +
Sbjct: 72  LF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 384 RRPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 438
               IVHR++K  N++     D     K+ DFG +R  + +      +  GT E++ P++
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDM 186

Query: 439 LREDPS--------NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--- 487
                             D++S GV  +   T   P+R     +    V +K    +   
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 488 ------------------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
                                   + + +  ++  ++      + E    F         
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 524 FLMSSVCQPLSAQ 536
            L   V    S Q
Sbjct: 307 ILHRMVIHVFSLQ 319

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  163 bits (416), Expect = 7e-47
 Identities = 74/257 (28%), Positives = 124/257 (48%), Gaps = 18/257 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + S   +A+K+L + +  +   +    REV I   LRHPNI+
Sbjct: 13  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L G   +   + ++ EY   G++Y+ L         DE+       ++A  ++Y H +R
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKR 129

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+ S   +K+ DFG S   P++        GT +++ PE++     +
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHD 185

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++S GV+ +E +  + P+  +T  +    IS V F       P  V      LI  
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 240

Query: 503 CWAEEPEIRPSFPSIME 519
                P  RP    ++E
Sbjct: 241 LLKHNPSQRPMLREVLE 257

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  166 bits (422), Expect = 7e-47
 Identities = 71/294 (24%), Positives = 127/294 (43%), Gaps = 22/294 (7%)

Query: 238 LMEANLSVMSTSNRELYLEEEG--LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAV 293
           L E  L        E +L ++    E++  +     ++G G+ G V+    + S   +A 
Sbjct: 4   LEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMAR 63

Query: 294 KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL 353
           K+ I  E       + +RE+ ++     P IV   GA      +SI  E++  GSL ++L
Sbjct: 64  KL-IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122

Query: 354 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG- 412
                   + E++   ++  V KG+ YL ++   I+HRD+K  N+LV+S   +K+CDFG 
Sbjct: 123 KKAG---RIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 413 ---LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
              L  S  N+++      GT  +M+PE L+    + +SD++S G+ L E+   + P   
Sbjct: 179 SGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

Query: 470 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
               ++       G ++E      P           +         +I E L  
Sbjct: 233 PDAKELELMF---GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  164 bits (416), Expect = 1e-46
 Identities = 67/246 (27%), Positives = 122/246 (49%), Gaps = 11/246 (4%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           +KIG+G+ GTVY A    +   VA++  +  +  + + +  + E+ +M+  ++PNIV  +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQ-MNLQ-QQPKKELIINEILVMRENKNPNIVNYL 83

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +      L +V EYL+ GSL  ++        +DE     +  +  + + +LH  +  +
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ--V 137

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+KS N+L+    +VK+ DFG             T  GTP WMAPEV+       K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEE 507
           D++S G++  E+I  + P+ N  P + +  +   G   L+ P+ ++ +    +  C   +
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 257

Query: 508 PEIRPS 513
            E R S
Sbjct: 258 VEKRGS 263

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  164 bits (416), Expect = 2e-46
 Identities = 67/246 (27%), Positives = 124/246 (50%), Gaps = 11/246 (4%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
            KIGEGS G V  A  ++S   VAVK+ ++    + R +    EV IM+  +H N+V + 
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKM-MDLR-KQQRRELLFNEVVIMRDYQHFNVVEMY 108

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
            +      L ++ E+L  G+L  ++     +V ++E     +   V + + YLH +   +
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG--V 162

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
           +HRD+KS ++L+     VK+ DFG            K+  GTP WMAPEV+       + 
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEV 222

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEE 507
           D++S G+++ E++  + P+ + +P Q +  +      +L+    V+P++   +E     +
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRD 282

Query: 508 PEIRPS 513
           P+ R +
Sbjct: 283 PQERAT 288

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  161 bits (410), Expect = 6e-46
 Identities = 70/257 (27%), Positives = 126/257 (49%), Gaps = 18/257 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIV 325
           I + +G+G FG VY A  + +   +A+K+L + +  ++  +  L RE+ I   LRHPNI+
Sbjct: 18  IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            +     +   + ++ E+  RG LYK L     R   DE+       ++A  ++Y H+R+
Sbjct: 78  RMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGR--FDEQRSATFMEELADALHYCHERK 134

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             ++HRD+K  NLL+     +K+ DFG S   P+  +  +T  GT +++ PE++     +
Sbjct: 135 --VIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEGKTHD 190

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 502
           EK D++  GV+ +E +    P+ + + ++    I  V  K      P  ++     LI  
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-----FPPFLSDGSKDLISK 245

Query: 503 CWAEEPEIRPSFPSIME 519
                P  R     +ME
Sbjct: 246 LLRYHPPQRLPLKGVME 262

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  163 bits (414), Expect = 7e-46
 Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 25/216 (11%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSDVAVKIL---------------IEQEFHEDRFKEFLREV 313
           I + + +G F  +   E  N   A+K                  ++   + ++ +F  E+
Sbjct: 35  IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 314 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRL 368
            I+  +++   +   G +T    + I+ EY+   S+ K          +    +  ++  
Sbjct: 95  QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA 428
            +   V    +Y+H  +  I HRD+K  N+L+D    VK+ DFG S    +  I  K + 
Sbjct: 155 CIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGSR 211

Query: 429 GTPEWMAPEVL--REDPSNEKSDVFSFGVILWELIT 462
           GT E+M PE        +  K D++S G+ L+ +  
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  169 bits (429), Expect = 1e-45
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 17/233 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +K+++G G FG V     +++   VA+K    QE      + +  E+ IMK L HPN+V 
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQ-CRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 327 LMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
                     L+      +  EY   G L K L+  +    + E     +  D++  + Y
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136

Query: 381 LHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAP 436
           LH+ R  I+HRDLK  N+++         K+ D G ++              GT +++AP
Sbjct: 137 LHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAP 192

Query: 437 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 489
           E+L +       D +SFG + +E IT  +P+  +           +     I 
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  161 bits (409), Expect = 1e-45
 Identities = 76/275 (27%), Positives = 124/275 (45%), Gaps = 42/275 (15%)

Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +++ IG G+   V  A    +   VA+K  I  E  +    E L+E+  M    HPNIV 
Sbjct: 19  LQEVIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQCHHPNIVS 77

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV-----VVDERLRLNMAYDVAKGMNYL 381
              +      L +V + LS GS+  ++    A+      V+DE     +  +V +G+ YL
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISS-KTAAGTPEWMAP 436
           H+     +HRD+K+ N+L+    +V++ DFG    L+     T     KT  GTP WMAP
Sbjct: 138 HKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

Query: 437 EVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           EV+ +    + K+D++SFG+   EL T   P+    P +V+         +   +N  P 
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---------MLTLQNDPPS 246

Query: 496 VAA-----------------LIETCWAEEPEIRPS 513
           +                   +I  C  ++PE RP+
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  160 bits (406), Expect = 4e-45
 Identities = 69/248 (27%), Positives = 126/248 (50%), Gaps = 11/248 (4%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + +K+GEGS+G+VY A  + +   VA+K +      E   +E ++E++IM+    P++V 
Sbjct: 33  VLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDSPHVVK 88

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
             G+  +  +L IV EY   GS+  ++ + +  +   E     +     KG+ YLH  R 
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL--TEDEIATILQSTLKGLEYLHFMR- 145

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
             +HRD+K+ N+L+++    K+ DFG++    +T     T  GTP WMAPEV++E   N 
Sbjct: 146 -KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 505
            +D++S G+   E+   + P+ +  P + I  +          P+  +      ++ C  
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLV 264

Query: 506 EEPEIRPS 513
           + PE R +
Sbjct: 265 KSPEQRAT 272

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  161 bits (409), Expect = 2e-44
 Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 25/266 (9%)

Query: 269 IKKKIGEGSFGTVYHAE-WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVL 326
            K  +G G+ GT+ +   + N DVAVK +       + F    REV +++    HPN++ 
Sbjct: 28  PKDVLGHGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHPNVIR 82

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
                 +     I  E  +  +L + +   D          + +      G+ +LH    
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAH--LGLEPITLLQQTTSGLAHLHSLN- 138

Query: 387 PIVHRDLKSPNLLV-----DSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEV 438
            IVHRDLK  N+L+            + DFGL +      +++       GT  W+APE+
Sbjct: 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 439 LREDPS---NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG-FKGRRLEIPKNVN 493
           L ED         D+FS G + + +I+    P+  S   Q    +G      L   K+ +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257

Query: 494 PMVAALIETCWAEEPEIRPSFPSIME 519
            +   LIE   A +P+ RPS   +++
Sbjct: 258 VIARELIEKMIAMDPQKRPSAKHVLK 283

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  156 bits (397), Expect = 4e-44
 Identities = 63/255 (24%), Positives = 113/255 (44%), Gaps = 15/255 (5%)

Query: 271 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLL 327
             +G+GSF  VY AE  ++  +VA+K++ ++  ++    +    EV I   L+HP+I+ L
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
                +   + +V E    G + + L          E    +  + +  GM YLH     
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYLHSHG-- 132

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 447
           I+HRDL   NLL+     +K+ DFGL+      +    T  GTP +++PE+        +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192

Query: 448 SDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           SDV+S G + + L+  + P+   T       +    ++     +P  ++     LI    
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-----MPSFLSIEAKDLIHQLL 247

Query: 505 AEEPEIRPSFPSIME 519
              P  R S  S+++
Sbjct: 248 RRNPADRLSLSSVLD 262

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  157 bits (399), Expect = 4e-44
 Identities = 71/253 (28%), Positives = 128/253 (50%), Gaps = 14/253 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I  ++G+G+FG VY A+ + +    A K+ IE +  E+  ++++ E+ I+    HP IV 
Sbjct: 23  IVGELGDGAFGKVYKAKNKETGALAAAKV-IETK-SEEELEDYIVEIEILATCDHPYIVK 80

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L+GA      L I+ E+   G++  ++   D  +   E     +   + + +N+LH +R 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL--TEPQIQVVCRQMLEALNFLHSKR- 137

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-----LRE 441
            I+HRDLK+ N+L+     +++ DFG+S     T     +  GTP WMAPEV     +++
Sbjct: 138 -IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196

Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALI 500
            P + K+D++S G+ L E+  ++ P     P +V+  +       L  P   +      +
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256

Query: 501 ETCWAEEPEIRPS 513
           +    + PE RPS
Sbjct: 257 KIALDKNPETRPS 269

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  156 bits (398), Expect = 5e-44
 Identities = 67/258 (25%), Positives = 118/258 (45%), Gaps = 22/258 (8%)

Query: 271 KKIGEGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +G+G F   +     ++    A KI+    + +    ++      E++I + L H ++
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHV 77

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V   G   +   + +V E   R SL +L      R  + E         +  G  YLH+ 
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN 134

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
           R  ++HRDLK  NL ++    VK+ DFGL+          K   GTP ++APEVL +   
Sbjct: 135 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIE 501
           + + DV+S G I++ L+  + P+  S   +    I    +      IPK++NP+ A+LI+
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHINPVAASLIQ 247

Query: 502 TCWAEEPEIRPSFPSIME 519
                +P  RP+   ++ 
Sbjct: 248 KMLQTDPTARPTINELLN 265

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  155 bits (394), Expect = 4e-43
 Identities = 67/255 (26%), Positives = 118/255 (46%), Gaps = 16/255 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + +G+G F   +     ++    A KI+    + +    ++      E++I + L H ++
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHV 103

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V   G   +   + +V E   R SL +L      R  + E         +  G  YLH+ 
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN 160

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
           R  ++HRDLK  NL ++    VK+ DFGL+          K   GTP ++APEVL +   
Sbjct: 161 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           + + DV+S G I++ L+  + P+  S   +    +  K     IPK++NP+ A+LI+   
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAASLIQKML 276

Query: 505 AEEPEIRPSFPSIME 519
             +P  RP+   ++ 
Sbjct: 277 QTDPTARPTINELLN 291

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  154 bits (392), Expect = 9e-43
 Identities = 70/262 (26%), Positives = 121/262 (46%), Gaps = 37/262 (14%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
             ++IG GSFG VY A    +   VA+K +    +   +++++ ++EV  ++ LRHPN +
Sbjct: 58  DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 117

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
              G         +V EY   GS   LL +      + E     + +   +G+ YLH   
Sbjct: 118 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN 174

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLS--RSKPNTYISSKTAAGTPEWMAPEV---LR 440
             ++HRD+K+ N+L+     VK+ DFG +   +  N+++      GTP WMAPEV   + 
Sbjct: 175 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMD 226

Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA-- 498
           E   + K DV+S G+   EL   + P  N      +           I +N +P + +  
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHIAQNESPALQSGH 277

Query: 499 -------LIETCWAEEPEIRPS 513
                   +++C  + P+ RP+
Sbjct: 278 WSEYFRNFVDSCLQKIPQDRPT 299

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  154 bits (390), Expect = 4e-42
 Identities = 52/241 (21%), Positives = 96/241 (39%), Gaps = 29/241 (12%)

Query: 269 IKKKIGEG--SFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           +   IG+G     TV  A        V V+ +  +    +       E+ + K   HPNI
Sbjct: 29  LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           V           L +VT +++ GS   L+  H  D    ++E     +   V K ++Y+H
Sbjct: 89  VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD---GMNELAIAYILQGVLKALDYIH 145

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS------RSKPNT-YISSKTAAGTPEWMA 435
                 VHR +K+ ++L+     V +     +        +    +   K +     W++
Sbjct: 146 HMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 436 PEVLREDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           PEVL+++    + KSD++S G+   EL     P+++   +Q++         LE      
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML---------LEKLNGTV 254

Query: 494 P 494
           P
Sbjct: 255 P 255

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  151 bits (384), Expect = 4e-42
 Identities = 68/278 (24%), Positives = 129/278 (46%), Gaps = 31/278 (11%)

Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAI-M 316
           +E++  +L    ++G G++G V       S   +AVK  I    +    K  L ++ I M
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISM 60

Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVA 375
           + +  P  V   GA+    ++ I  E +   SL K    + D    + E +   +A  + 
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMA 435
           K + +LH +   ++HRD+K  N+L+++   VK+CDFG+S    +  ++    AG   +MA
Sbjct: 120 KALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMA 177

Query: 436 PEVLREDPS----NEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK 490
           PE +  + +    + KSD++S G+ + EL  L+ P+ +  TP Q +           + +
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ---------VVE 228

Query: 491 NVNPMVAA---------LIETCWAEEPEIRPSFPSIME 519
             +P + A             C  +  + RP++P +M+
Sbjct: 229 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  151 bits (383), Expect = 5e-42
 Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 19/198 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +K+++G+G+F  V     + +  + A KI+  ++     F++  RE  I + L+HPNIV 
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 383
           L  ++ E     +V + ++ G L+      +   AR    E    +    + + + Y H 
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESIAYCHS 123

Query: 384 RRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 439
               IVHR+LK  NLL+ S      VK+ DFGL+     +        AGTP +++PEVL
Sbjct: 124 NG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVL 179

Query: 440 REDPSNEKSDVFSFGVIL 457
           ++DP ++  D+++ GVIL
Sbjct: 180 KKDPYSKPVDIWACGVIL 197

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  152 bits (385), Expect = 6e-42
 Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 47/297 (15%)

Query: 246 MSTSNRELYLEEEGL------EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILI 297
           M++ +    L+E  L         +    + + +G G++G VY      +    A+K++ 
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFE---LVELVGNGTYGQVYKGRHVKTGQLAAIKVM- 57

Query: 298 EQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA------VTEPPNLSIVTEYLSRGSLY 350
             +   D  +E  +E+ ++K    H NI    GA            L +V E+   GS+ 
Sbjct: 58  --DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115

Query: 351 KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 410
            L+       +  E     +  ++ +G+++LHQ +  ++HRD+K  N+L+     VK+ D
Sbjct: 116 DLIKNTKGNTL-KEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVD 172

Query: 411 FGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-----NEKSDVFSFGVILWELITLQK 465
           FG+S     T     T  GTP WMAPEV+  D +     + KSD++S G+   E+     
Sbjct: 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

Query: 466 PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL---------IETCWAEEPEIRPS 513
           P  +  P + +    F      IP+N  P + +          IE+C  +    RP+
Sbjct: 233 PLCDMHPMRAL----FL-----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPA 280

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  151 bits (384), Expect = 8e-42
 Identities = 75/259 (28%), Positives = 121/259 (46%), Gaps = 21/259 (8%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + K IG+G+F  V  A       +VA+KI+ + + +    ++  REV IMK L HPNIV 
Sbjct: 19  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYLH 382
           L   +     L ++ EY S G ++  L       V   R++   A      +   + Y H
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYL-------VAHGRMKEKEARSKFRQIVSAVQYCH 131

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLRE 441
           Q+R  IVHRDLK+ NLL+D+   +K+ DFG S        +      G P + APE+ + 
Sbjct: 132 QKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQG 187

Query: 442 DPSN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
              +  + DV+S GVIL+ L++   P+      ++   V     +  IP  ++     L+
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLL 245

Query: 501 ETCWAEEPEIRPSFPSIME 519
           +      P  R +   IM+
Sbjct: 246 KRFLVLNPIKRGTLEQIMK 264

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  150 bits (380), Expect = 2e-41
 Identities = 58/272 (21%), Positives = 117/272 (43%), Gaps = 16/272 (5%)

Query: 252 ELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEF 309
            L +  +  +   ++L    ++G G+ G V+          +AVK  + +  +++  K  
Sbjct: 12  YLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MRRSGNKEENKRI 70

Query: 310 LREVAI-MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 368
           L ++ + +K    P IV   G      ++ I  E +   +      +      + ER+  
Sbjct: 71  LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG---PIPERILG 127

Query: 369 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA 428
            M   + K + YL ++   ++HRD+K  N+L+D    +K+CDFG+S    +   +   +A
Sbjct: 128 KMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSA 185

Query: 429 GTPEWMAPEVLREDPSNE-----KSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGF 481
           G   +MAPE +      +     ++DV+S G+ L EL T Q P++N       +   +  
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245

Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 513
           +   L      +    + ++ C  ++   RP 
Sbjct: 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK 277

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  150 bits (380), Expect = 3e-41
 Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 36/293 (12%)

Query: 243 LSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE 300
           +S+ S+   ++   E+  +    +L    +IG G++G+V     + S   +AVK  I   
Sbjct: 1   MSIESSGKLKI-SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRST 58

Query: 301 FHEDRFKEFLREVAI-MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH--IPD 357
             E   K+ L ++ + M+    P IV   GA+    +  I  E +S  S  K        
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSV 117

Query: 358 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 417
              V+ E +   +     K +N+L +    I+HRD+K  N+L+D +  +K+CDFG+S   
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176

Query: 418 PNTYISSKTAAGTPEWMAPEVLREDPSNE----KSDVFSFGVILWELITLQKPWRN-STP 472
            ++ I+    AG   +MAPE +    S +    +SDV+S G+ L+EL T + P+   ++ 
Sbjct: 177 VDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235

Query: 473 SQVISAVGFKGRRLEIPKNVNPMVAA------------LIETCWAEEPEIRPS 513
              ++          + K   P ++              +  C  ++   RP 
Sbjct: 236 FDQLTQ---------VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK 279

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  150 bits (380), Expect = 7e-41
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 8/238 (3%)

Query: 296 LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 355
            +  +    RF++    V  +       +  +  + +   +  +  + LS     +    
Sbjct: 125 FVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184

Query: 356 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 415
                +  E L +  ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R
Sbjct: 185 LYKDFLTLEHL-ICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 416 S--KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN-ST 471
              K   Y+    A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+     
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301

Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 529
             +    +  +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++ 
Sbjct: 302 DEEFCRRL-KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 43/188 (22%), Positives = 73/188 (38%), Gaps = 19/188 (10%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
           E     L + K +G G+FG V  A+    D       VAVK+L E   H +  +  + E+
Sbjct: 18  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSEL 76

Query: 314 AIMKGL-RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
            I+  +  H N+V L+GA T+P   L ++ E+   G+L   L       V          
Sbjct: 77  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV----PYKTKG 132

Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
               +G +Y+       +  DLK     + S+ +     F   +S  +            
Sbjct: 133 ARFRQGKDYVG-----AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187

Query: 432 EWMAPEVL 439
           +++  E L
Sbjct: 188 DFLTLEHL 195

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  151 bits (383), Expect = 1e-40
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 16/197 (8%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + +++G+G+F  V       +  + A  I+  ++      ++  RE  I + L+HPNIV 
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 383
           L  +++E  +  ++ + ++ G L+      +   AR    E    +    + + + + HQ
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQQILEAVLHCHQ 128

Query: 384 RRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
               +VHR+LK  NLL+ S      VK+ DFGL+        +    AGTP +++PEVLR
Sbjct: 129 MG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186

Query: 441 EDPSNEKSDVFSFGVIL 457
           +DP  +  D+++ GVIL
Sbjct: 187 KDPYGKPVDLWACGVIL 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  149 bits (378), Expect = 1e-40
 Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 19/198 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +K+++G+G+F  V     + +  + A KI+  ++     F++  RE  I + L+HPNIV 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 383
           L  ++ E     +V + ++ G L+      +   AR    E    +    + + + Y H 
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESIAYCHS 146

Query: 384 RRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 439
               IVHR+LK  NLL+ S      VK+ DFGL+     +        AGTP +++PEVL
Sbjct: 147 NG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVL 202

Query: 440 REDPSNEKSDVFSFGVIL 457
           ++DP ++  D+++ GVIL
Sbjct: 203 KKDPYSKPVDIWACGVIL 220

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  148 bits (375), Expect = 4e-40
 Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 13/197 (6%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 323
            +   + +G G FG V+  E   +   +A KI I+    +D+ +E   E+++M  L H N
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKI-IKTRGMKDK-EEVKNEISVMNQLDHAN 147

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           ++ L  A     ++ +V EY+  G L+    I D    + E   +     + +G+ ++HQ
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFD--RIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 384 RRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLR 440
               I+H DLK  N+L  +     +K+ DFGL+R  KP   +  K   GTPE++APEV+ 
Sbjct: 206 MY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAPEVVN 261

Query: 441 EDPSNEKSDVFSFGVIL 457
            D  +  +D++S GVI 
Sbjct: 262 YDFVSFPTDMWSVGVIA 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  146 bits (370), Expect = 7e-40
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 20/201 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRH 321
           I +++G G F  V     +++  + A K               R +E  REV+I++ + H
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR-EEIEREVSILRQVLH 74

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
            N++ L        ++ ++ E +S G L+  L     +  + E    +    +  G+NYL
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYL 131

Query: 382 HQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAP 436
           H ++  I H DLK  N+++         +K+ DFGL+   +       K   GTPE++AP
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAP 187

Query: 437 EVLREDPSNEKSDVFSFGVIL 457
           E++  +P   ++D++S GVI 
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  145 bits (367), Expect = 7e-40
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 20/201 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRH 321
           + +++G G F  V     + +  + A K      L        R +E  REV I++ +RH
Sbjct: 9   MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR-EEIEREVNILREIRH 67

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           PNI+ L        ++ ++ E +S G L+  L     +  + E         +  G++YL
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYL 124

Query: 382 HQRRPPIVHRDLKSPNLLVDST----YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAP 436
           H +R  I H DLK  N+++         +K+ DFG++   +       K   GTPE++AP
Sbjct: 125 HSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAP 180

Query: 437 EVLREDPSNEKSDVFSFGVIL 457
           E++  +P   ++D++S GVI 
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  145 bits (368), Expect = 9e-40
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 22/198 (11%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
             + +G G+F  V+  + R +    A+K I     F +   +    E+A++K ++H NIV
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIV 69

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLH 382
            L        +  +V + +S G L+      D    R V  E+    +   V   + YLH
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELF------DRILERGVYTEKDASLVIQQVLSAVKYLH 123

Query: 383 QRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           +    IVHRDLK  NLL  +      + + DFGLS+ + N  +   TA GTP ++APEVL
Sbjct: 124 ENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPEVL 179

Query: 440 REDPSNEKSDVFSFGVIL 457
            + P ++  D +S GVI 
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  145 bits (367), Expect = 1e-39
 Identities = 70/198 (35%), Positives = 101/198 (51%), Gaps = 20/198 (10%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I   +G+GSFG V   + R +  + AVK++ +           LREV ++K L HPNI+ 
Sbjct: 26  IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 383
           L   + +  +  IV E  + G L+      D    R    E     +   V  G+ Y+H+
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVFSGITYMHK 139

Query: 384 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 439
               IVHRDLK  N+L++S      +K+ DFGLS   + NT +  K   GT  ++APEVL
Sbjct: 140 HN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVL 195

Query: 440 REDPSNEKSDVFSFGVIL 457
           R    +EK DV+S GVIL
Sbjct: 196 RG-TYDEKCDVWSAGVIL 212

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  146 bits (370), Expect = 1e-39
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 20/201 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRH 321
             +++G G F  V     +++    A K               R ++  REV+I+K ++H
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR-EDIEREVSILKEIQH 73

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           PN++ L        ++ ++ E ++ G L+  L     +  + E         +  G+ YL
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL 130

Query: 382 HQRRPPIVHRDLKSPNLLVDST----YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAP 436
           H  +  I H DLK  N+++         +K+ DFGL+           K   GTPE++AP
Sbjct: 131 HSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAP 186

Query: 437 EVLREDPSNEKSDVFSFGVIL 457
           E++  +P   ++D++S GVI 
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  145 bits (367), Expect = 1e-39
 Identities = 82/295 (27%), Positives = 130/295 (44%), Gaps = 63/295 (21%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD----VAVKIL------------------------IEQE 300
           +K +IG+GS+G V  A   N +     A+K+L                            
Sbjct: 17  LKDEIGKGSYGVVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 301 FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN---LSIVTEYLSRGSLYKLLHIPD 357
                 ++  +E+AI+K L HPN+V L+  V + PN   L +V E +++G + +      
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVME------ 127

Query: 358 ARVVVDERLRLNMA----YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
             V   + L  + A     D+ KG+ YLH ++  I+HRD+K  NLLV     +K+ DFG+
Sbjct: 128 --VPTLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 414 SRSKPNTYISS----KTAAGTPEWMAPEVLREDPSN---EKSDVFSFGVILWELITLQKP 466
           S    N +  S        GTP +MAPE L E       +  DV++ GV L+  +  Q P
Sbjct: 184 S----NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

Query: 467 WRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPSFPSIME 519
           + +     + S +  K + LE P   ++   +  LI     + PE R   P I  
Sbjct: 240 FMDERIMCLHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  146 bits (371), Expect = 2e-39
 Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 26/297 (8%)

Query: 178 TADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHL 237
           ++  D +       +   I     +     R+ ++  R   S   +  +  K        
Sbjct: 8   SSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67

Query: 238 LMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKI 295
             E           EL       E    +   K  IG G    V     R +  + AVKI
Sbjct: 68  GTENLYFQSMGPEDELPDWAAAKEFY-QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126

Query: 296 L------IEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGS 348
           +      +  E  E+  +   RE  I++ +  HP+I+ L+ +      + +V + + +G 
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186

Query: 349 LY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 407
           L+  L      +V + E+   ++   + + +++LH     IVHRDLK  N+L+D    ++
Sbjct: 187 LFDYLT----EKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIR 240

Query: 408 VCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPS------NEKSDVFSFGVIL 457
           + DFG S   +P   +  +   GTP ++APE+L+           ++ D+++ GVIL
Sbjct: 241 LSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  146 bits (370), Expect = 2e-39
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRH 321
           I +++G G F  V     +++  + A K               R +E  REV+I++ + H
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR-EEIEREVSILRQVLH 74

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK----G 377
           PNI+ L        ++ ++ E +S G L+         +   E L    A    K    G
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFD-------FLAQKESLSEEEATSFIKQILDG 127

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDST----YTVKVCDFGLSRS-KPNTYISSKTAAGTPE 432
           +NYLH ++  I H DLK  N+++         +K+ DFGL+   +       K   GTPE
Sbjct: 128 VNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPE 183

Query: 433 WMAPEVLREDPSNEKSDVFSFGVIL 457
           ++APE++  +P   ++D++S GVI 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  148 bits (374), Expect = 2e-39
 Identities = 60/285 (21%), Positives = 110/285 (38%), Gaps = 42/285 (14%)

Query: 269 IKKKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVL 326
            +K +G GS GTV     ++   VAVK +       D     L E+ ++     HPN++ 
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRM-----LIDFCDIALMEIKLLTESDDHPNVIR 73

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLH 382
              + T    L I  E  +  +L  L+       +   +  E   +++   +A G+ +LH
Sbjct: 74  YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 383 QRRPPIVHRDLKSPNLLVDST-------------YTVKVCDFGLSR----SKPNTYISSK 425
             +  I+HRDLK  N+LV ++               + + DFGL +     + +   +  
Sbjct: 133 SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 426 TAAGTPEWMAPEVLRED-------PSNEKSDVFSFGVILWELITLQKP--WRNSTPSQVI 476
             +GT  W APE+L E              D+FS G + + +++  K       +    I
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250

Query: 477 --SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
                     +    +++      LI      +P  RP+   ++ 
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  143 bits (364), Expect = 2e-39
 Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 13/196 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
            K+K+G G+FG V+  E R+S  +  +K  I ++  +   ++   E+ ++K L HPNI+ 
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKT-INKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
           +     +  N+ IV E    G L  +++        + E     +   +   + Y H + 
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144

Query: 386 PPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRE 441
             +VH+DLK  N+L   T     +K+ DFGL+   K + +     AAGT  +MAPEV + 
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFKR 200

Query: 442 DPSNEKSDVFSFGVIL 457
           D    K D++S GV++
Sbjct: 201 D-VTFKCDIWSAGVVM 215

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  146 bits (371), Expect = 2e-39
 Identities = 50/194 (25%), Positives = 95/194 (48%), Gaps = 13/194 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I +++G G+FG V+    + +      K  I   +  D+      E++IM  L HP ++ 
Sbjct: 55  ILEELGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDK-YTVKNEISIMNQLHHPKLIN 112

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  A  +   + ++ E+LS G L+    I      + E   +N      +G+ ++H+   
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHEHS- 169

Query: 387 PIVHRDLKSPNLLVDS--TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDP 443
            IVH D+K  N++ ++    +VK+ DFGL+    P+  +  K    T E+ APE++  +P
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREP 226

Query: 444 SNEKSDVFSFGVIL 457
               +D+++ GV+ 
Sbjct: 227 VGFYTDMWAIGVLG 240

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  143 bits (363), Expect = 5e-39
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 30/209 (14%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKI-------LIEQEFHEDRFKEFLREVAIMKGL 319
            K+ +G G    V     + +  + AVKI           E  ++  +  L+EV I++ +
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 320 -RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVA 375
             HPNI+ L           +V + + +G L+      D    +V + E+    +   + 
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELF------DYLTEKVTLSEKETRKIMRALL 134

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWM 434
           + +  LH+    IVHRDLK  N+L+D    +K+ DFG S    P   +  +   GTP ++
Sbjct: 135 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYL 190

Query: 435 APEVLREDPS------NEKSDVFSFGVIL 457
           APE++    +       ++ D++S GVI+
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  147 bits (373), Expect = 7e-39
 Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 14/217 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
             KK+G G++G V     + +    A+KI+ +         + L EVA++K L HPNI+ 
Sbjct: 41  RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L     +  N  +V E    G L+  +     R+  +E     +   V  G+ YLH+   
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVIIKQVLSGVTYLHKHN- 156

Query: 387 PIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRED 442
            IVHRDLK  NLL++S      +K+ DFGLS   +    +  K   GT  ++APEVLR+ 
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVLRK- 212

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             +EK DV+S GVIL+ L+    P+   T  +++  V
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  143 bits (364), Expect = 1e-38
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 13/199 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHP 322
           + + IG+G F  V     R +    AVKI+              ++  RE +I   L+HP
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST-EDLKREASICHMLKHP 86

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +IV L+   +    L +V E++    L  +++   DA  V  E +  +    + + + Y 
Sbjct: 87  HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 382 HQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           H     I+HRD+K   +L+ S      VK+  FG++     + + +    GTP +MAPEV
Sbjct: 147 HDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

Query: 439 LREDPSNEKSDVFSFGVIL 457
           ++ +P  +  DV+  GVIL
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  141 bits (357), Expect = 2e-38
 Identities = 72/261 (27%), Positives = 116/261 (44%), Gaps = 20/261 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + + +GEG++G V  A  R +   VAVKI ++ +   D  +   +E+ I K L H N+V 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYLH 382
             G   E     +  EY S G L+        R+  D  +    A    + +  G+ YLH
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELF-------DRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLR 440
                I HRD+K  NLL+D    +K+ DFGL+                GT  ++APE+L+
Sbjct: 123 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 441 EDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPMVAA 498
                 E  DV+S G++L  ++  + PW   + S    +   + +    P K ++    A
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240

Query: 499 LIETCWAEEPEIRPSFPSIME 519
           L+     E P  R + P I +
Sbjct: 241 LLHKILVENPSARITIPDIKK 261

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  142 bits (359), Expect = 3e-38
 Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 12/197 (6%)

Query: 268 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNI 324
           L  K++G G F  V     +++  + A K L ++   +D   E L E+A+++  +  P +
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + L         + ++ EY + G ++ L  +P+   +V E   + +   + +G+ YLHQ 
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQN 150

Query: 385 RPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLR 440
              IVH DLK  N+L+ S Y    +K+ DFG+SR       +  +   GTPE++APE+L 
Sbjct: 151 N--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILN 206

Query: 441 EDPSNEKSDVFSFGVIL 457
            DP    +D+++ G+I 
Sbjct: 207 YDPITTATDMWNIGIIA 223

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  146 bits (371), Expect = 4e-38
 Identities = 61/288 (21%), Positives = 115/288 (39%), Gaps = 26/288 (9%)

Query: 175 WNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTN 234
           + + A+       P  P+  V+   +  K        +  +  +   T + +        
Sbjct: 80  FRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDI 139

Query: 235 NHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVA 292
                   + +      + Y              I +++G G+FG V+    R +  + A
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYD-------------IHEELGTGAFGVVHRVTERATGNNFA 186

Query: 293 VKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKL 352
            K  +      D+ +   +E+  M  LRHP +V L  A  +   + ++ E++S G L++ 
Sbjct: 187 AKF-VMTPHESDK-ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE- 243

Query: 353 LHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST--YTVKVCD 410
             + D    + E   +     V KG+ ++H+     VH DLK  N++  +     +K+ D
Sbjct: 244 -KVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLID 300

Query: 411 FGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVIL 457
           FGL+    P   +  K   GT E+ APEV    P    +D++S GV+ 
Sbjct: 301 FGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  143 bits (363), Expect = 5e-38
 Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 29/207 (14%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKIL------IEQEFHEDRFKEFLREVAIMKGLR 320
           + K +G G+ G V  A  R +   VA++I+      I      D       E+ I+K L 
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKG 377
           HP I+ +     +  +  IV E +  G L+      D       + E       Y +   
Sbjct: 199 HPCIIKIKNFF-DAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQMLLA 251

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEW 433
           + YLH+    I+HRDLK  N+L+ S      +K+ DFG S+     + +  +T  GTP +
Sbjct: 252 VQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTY 307

Query: 434 MAPEVLREDPS---NEKSDVFSFGVIL 457
           +APEVL    +   N   D +S GVIL
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  145 bits (367), Expect = 5e-38
 Identities = 72/217 (33%), Positives = 110/217 (50%), Gaps = 14/217 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I   +G+GSFG V   + R +  + AVK++ +           LREV ++K L HPNI+ 
Sbjct: 26  IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L   + +  +  IV E  + G L+  +     R    E     +   V  G+ Y+H+   
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKHN- 141

Query: 387 PIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRED 442
            IVHRDLK  N+L++S      +K+ DFGLS   + NT +  K   GT  ++APEVLR  
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVLRG- 197

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
             +EK DV+S GVIL+ L++   P+       ++  V
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  142 bits (358), Expect = 6e-38
 Identities = 38/239 (15%), Positives = 79/239 (33%), Gaps = 30/239 (12%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRH 321
           +   +GEG+F  VY A   + +         +K+       E  F    + +  +K    
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGTQLMERLKPSMQ 126

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMN 379
              +    A        +V E  S G+L   +++       V+ + L ++ A  +   + 
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYT-----------VKVCDFGLSRSK----PNTYISS 424
            +H     I+H D+K  N ++ + +            + + D G S         T    
Sbjct: 187 QVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF-- 242

Query: 425 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 483
                T  +   E+L   P N + D F     ++ ++        +   +      F+ 
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  140 bits (355), Expect = 1e-37
 Identities = 46/194 (23%), Positives = 95/194 (48%), Gaps = 14/194 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I + +G G FG V+     +S      K  ++ +   D+     +E++I+   RH NI+ 
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVK-GTDQ-VLVKKEISILNIARHRNILH 65

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +      L ++ E++S   +++   I  +   ++ER  ++  + V + + +LH    
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFE--RINTSAFELNEREIVSYVHQVCEALQFLHSHN- 122

Query: 387 PIVHRDLKSPNLLVDS--TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDP 443
            I H D++  N++  +  + T+K+ +FG +R  KP      +     PE+ APEV + D 
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179

Query: 444 SNEKSDVFSFGVIL 457
            +  +D++S G ++
Sbjct: 180 VSTATDMWSLGTLV 193

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  139 bits (352), Expect = 1e-37
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 22/198 (11%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           ++  IG GS+G V  A  + +    A K  I + F ED    F +E+ IMK L HPNI+ 
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRIRRAAKK-IPKYFVEDV-DRFKQEIEIMKSLDHPNIIR 70

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 383
           L     +  ++ +V E  + G L+      +    + V  E     +  DV   + Y H+
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELF------ERVVHKRVFRESDAARIMKDVLSAVAYCHK 124

Query: 384 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 439
               + HRDLK  N L  +      +K+ DFGL+   KP   +  +T  GTP +++P+VL
Sbjct: 125 LN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVL 180

Query: 440 REDPSNEKSDVFSFGVIL 457
                  + D +S GV++
Sbjct: 181 EG-LYGPECDEWSAGVMM 197

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  140 bits (355), Expect = 1e-37
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 29/207 (14%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKIL------IEQEFHEDRFKEFLREVAIMKGLR 320
           + K +G G+ G V  A  R +   VA+KI+      I      D       E+ I+K L 
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKG 377
           HP I+ +     +  +  IV E +  G L+      D       + E       Y +   
Sbjct: 74  HPCIIKIKNFF-DAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQMLLA 126

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEW 433
           + YLH+    I+HRDLK  N+L+ S      +K+ DFG S+     + +  +T  GTP +
Sbjct: 127 VQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTY 182

Query: 434 MAPEVLREDPS---NEKSDVFSFGVIL 457
           +APEVL    +   N   D +S GVIL
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  140 bits (354), Expect = 2e-37
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 23/198 (11%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           ++ ++G G+   VY  + + +    A+K+L +    +        E+ ++  L HPNI+ 
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI----VRTEIGVLLRLSHPNIIK 112

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 383
           L      P  +S+V E ++ G L+      D    +    ER   +    + + + YLH+
Sbjct: 113 LKEIFETPTEISLVLELVTGGELF------DRIVEKGYYSERDAADAVKQILEAVAYLHE 166

Query: 384 RRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 439
               IVHRDLK  NLL  +      +K+ DFGLS+  +    +  KT  GTP + APE+L
Sbjct: 167 NG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEIL 222

Query: 440 REDPSNEKSDVFSFGVIL 457
           R      + D++S G+I 
Sbjct: 223 RGCAYGPEVDMWSVGIIT 240

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  139 bits (352), Expect = 3e-37
 Identities = 72/261 (27%), Positives = 114/261 (43%), Gaps = 20/261 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + + +GEG++G V  A  R +   VAVKI ++ +   D  +   +E+ I K L H N+V 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK----GMNYLH 382
             G   E     +  EY S G L+        R+  D  +    A         G+ YLH
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELF-------DRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLR 440
                I HRD+K  NLL+D    +K+ DFGL+                GT  ++APE+L+
Sbjct: 123 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 441 EDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPMVAA 498
                 E  DV+S G++L  ++  + PW   + S    +   + +    P K ++    A
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240

Query: 499 LIETCWAEEPEIRPSFPSIME 519
           L+     E P  R + P I +
Sbjct: 241 LLHKILVENPSARITIPDIKK 261

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  139 bits (352), Expect = 3e-37
 Identities = 63/262 (24%), Positives = 117/262 (44%), Gaps = 26/262 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL------REVAIMKGLR 320
               +G G+FG V+ A  +  N +V VK + +++  ED + E         E+AI+  + 
Sbjct: 28  TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGS-LYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           H NI+ ++          +V E    G  L+  +   D    +DE L   +   +   + 
Sbjct: 88  HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFRQLVSAVG 144

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 438
           YL  +   I+HRD+K  N+++   +T+K+ DFG +   +        T  GT E+ APEV
Sbjct: 145 YLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPEV 200

Query: 439 LREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           L  +P    + +++S GV L+ L+  + P+      + + A       +  P  V+  + 
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCE--LEETVEA------AIHPPYLVSKELM 252

Query: 498 ALIETCWAEEPEIRPSFPSIME 519
           +L+       PE R +   ++ 
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVT 274

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  137 bits (348), Expect = 3e-37
 Identities = 74/262 (28%), Positives = 122/262 (46%), Gaps = 26/262 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIV 325
           +   +G G+FG V   E +     VAVKIL  Q+         + RE+  +K  RHP+I+
Sbjct: 15  LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYL 381
            L   ++ P +  +V EY+S G L+         +    R+    A      +   ++Y 
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELF-------DYICKHGRVEEMEARRLFQQILSAVDYC 127

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEV 438
           H+    +VHRDLK  N+L+D+    K+ DFGLS    N        +T+ G+P + APEV
Sbjct: 128 HRHM--VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLRTSCGSPNYAAPEV 181

Query: 439 LREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +     +  + D++S GVIL+ L+    P+ +     +   +  +G    IP+ +N  VA
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVA 239

Query: 498 ALIETCWAEEPEIRPSFPSIME 519
            L+      +P  R +   I E
Sbjct: 240 TLLMHMLQVDPLKRATIKDIRE 261

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  139 bits (352), Expect = 3e-37
 Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 16/196 (8%)

Query: 268 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNI 324
           L  K +GEGSF        + S    AVKI I +    +      +E+  +K    HPNI
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKI-ISKRMEANTQ----KEITALKLCEGHPNI 68

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V L     +  +  +V E L+ G L++   I   +    E     +   +   ++++H  
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFE--RI-KKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 385 RPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
              +VHRDLK  NLL    +    +K+ DFG +R KP      KT   T  + APE+L +
Sbjct: 126 G--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183

Query: 442 DPSNEKSDVFSFGVIL 457
           +  +E  D++S GVIL
Sbjct: 184 NGYDESCDLWSLGVIL 199

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  142 bits (360), Expect = 3e-37
 Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 15/218 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIV 325
            ++ +G+GSFG V   + + +    AVK++ +++   +   +  LREV ++K L HPNI+
Sbjct: 30  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L     +     +V E  + G L+  +    +R    E     +   V  G+ Y+H+ +
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 386 PPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRE 441
             IVHRDLK  NLL++S      +++ DFGLS   + +  +  K   GT  ++APEVL  
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPEVLHG 202

Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
              +EK DV+S GVIL+ L++   P+  +    ++  V
Sbjct: 203 -TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  138 bits (350), Expect = 4e-37
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)

Query: 268 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNI 324
           L +  +GEG+   V       +  + AVKI IE++    R     REV ++   + H N+
Sbjct: 16  LQEDVLGEGAHARVQTCINLITSQEYAVKI-IEKQPGHIR-SRVFREVEMLYQCQGHRNV 73

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           + L+    E     +V E +  GS+  L HI   R   +E     +  DVA  +++LH +
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSI--LSHI-HKRRHFNELEASVVVQDVASALDFLHNK 130

Query: 385 RPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRS-KPNTYISS------KTAAGTPEWM 434
              I HRDLK  N+L    +    VK+CDF L    K N   S        T  G+ E+M
Sbjct: 131 G--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 435 APEVLREDPSNEKS-----DVFSFGVIL 457
           APEV+              D++S GVIL
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  138 bits (349), Expect = 6e-37
 Identities = 59/283 (20%), Positives = 111/283 (39%), Gaps = 28/283 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRH- 321
           +   +G G FG+VY       N  VA+K +    I              EV ++K +   
Sbjct: 47  VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106

Query: 322 -PNIVLLMGAVTEPPNLSIVTEYLS-RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
              ++ L+     P +  ++ E       L+  +     R  + E L  +  + V + + 
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVR 163

Query: 380 YLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
           + H     ++HRD+K  N+L+D     +K+ DFG      +T        GT  +  PE 
Sbjct: 164 HCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEW 219

Query: 439 LREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +R        + V+S G++L++++    P+ +    ++I        ++   + V+    
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--EEIIRG------QVFFRQRVSSECQ 271

Query: 498 ALIETCWAEEPEIRPSFPSIMET--LQQFLMSSVCQPLSAQPL 538
            LI  C A  P  RP+F  I     +Q  L+      +    L
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 314

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  138 bits (350), Expect = 7e-37
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 18/196 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIM-KGLRHPNIV 325
           +K+ IG GS+        + +  + AVKI+      +   ++   E+ I+ +  +HPNI+
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNII 79

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L     +   + +VTE +  G L   +     +    ER    + + + K + YLH + 
Sbjct: 80  TLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG 136

Query: 386 PPIVHRDLKSPNLLV----DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
             +VHRDLK  N+L      +  ++++CDFG ++          T   T  ++APEVL  
Sbjct: 137 --VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194

Query: 442 DPSNEKSDVFSFGVIL 457
              +   D++S GV+L
Sbjct: 195 QGYDAACDIWSLGVLL 210

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  140 bits (353), Expect = 7e-37
 Identities = 43/297 (14%), Positives = 92/297 (30%), Gaps = 47/297 (15%)

Query: 263 RWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGL 319
           R   L+    +G+        A  + +     V +    +    +  K+   EV  ++ L
Sbjct: 76  RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135

Query: 320 R----------------------HPNIVLLMGAVTEPPNLSIVTEYL----SRGSLYKLL 353
           R                       P    ++    +  ++ +++ +      + +L    
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195

Query: 354 HIPDARVVVDERL----RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 409
            +  +     + L    RL +   V + +  LH     +VH  L+  ++++D    V + 
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLT 253

Query: 410 DFGLSRSKPNTYISSKTAA-GTPEWMAPEVLREDPSNEK-----SDVFSFGVILWELITL 463
            F        + +S        PE  A  +L     +        D ++ G+ ++ +   
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

Query: 464 QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 520
             P  +         +          KN+   V AL+E       E R      MET
Sbjct: 314 DLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  140 bits (355), Expect = 2e-36
 Identities = 65/228 (28%), Positives = 112/228 (49%), Gaps = 25/228 (10%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-----------IEQEFHEDRFKEFLREVAI 315
             +K+G G++G V   + +N     A+K++            + +  E   +E   E+++
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           +K L HPNI+ L     +     +VTE+   G L++ +     R   DE    N+   + 
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQIL 156

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTP 431
            G+ YLH+    IVHRD+K  N+L+++      +K+ DFGLS     +  +  +   GT 
Sbjct: 157 SGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTA 212

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 479
            ++APEVL++   NEK DV+S GVI++ L+    P+       +I  V
Sbjct: 213 YYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  135 bits (343), Expect = 3e-36
 Identities = 64/269 (23%), Positives = 121/269 (44%), Gaps = 30/269 (11%)

Query: 268 LIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEF--HEDRFKEFLREVAIMKGLRH 321
           L+   +GEGS+G V      +S+     AVKIL +++     +      +E+ +++ LRH
Sbjct: 8   LMGDLLGEGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 322 PNIVLL---MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD----V 374
            N++ L   +        + +V EY     + ++L       V ++R  +  A+     +
Sbjct: 66  KNVIQLVDVLYNEE-KQKMYMVMEYCV-CGMQEMLDS-----VPEKRFPVCQAHGYFCQL 118

Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPE 432
             G+ YLH +   IVH+D+K  NLL+ +  T+K+   G++ +          +T+ G+P 
Sbjct: 119 IDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 433 WMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 490
           +  PE+       S  K D++S GV L+ + T   P+      ++   +        IP 
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GKGSYAIPG 234

Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIME 519
           +  P ++ L++     EP  R S   I +
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  135 bits (343), Expect = 3e-36
 Identities = 58/264 (21%), Positives = 103/264 (39%), Gaps = 28/264 (10%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKIL----IEQEFHEDRFKEFLREVAIMKGLR-- 320
           +   +G+G FGTV+          VA+K++    +              EVA++  +   
Sbjct: 35  LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94

Query: 321 --HPNIVLLMGAVTEPPNLSIVTEYLSRGS-LYKLLHIPDARVVVDERLRLNMAYDVAKG 377
             HP ++ L+          +V E       L+  +     +  + E         V   
Sbjct: 95  GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFFGQVVAA 151

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 436
           + + H R   +VHRD+K  N+L+D      K+ DFG      +         GT  +  P
Sbjct: 152 IQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVYSPP 207

Query: 437 EVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
           E +         + V+S G++L++++    P+      +++ A       L  P +V+P 
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--QEILEA------ELHFPAHVSPD 259

Query: 496 VAALIETCWAEEPEIRPSFPSIME 519
             ALI  C A +P  RPS   I+ 
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILL 283

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  134 bits (340), Expect = 7e-36
 Identities = 63/255 (24%), Positives = 121/255 (47%), Gaps = 20/255 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIV 325
           I  K+G G   TVY AE    N  VA+K +      ++   + F REV     L H NIV
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            ++    E     +V EY+   +L + +    +   +     +N    +  G+ + H  R
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR 131

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-SSKTAAGTPEWMAPEVLREDPS 444
             IVHRD+K  N+L+DS  T+K+ DFG++++   T +  +    GT ++ +PE  + + +
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK-------NVNPMVA 497
           +E +D++S G++L+E++  + P+   T      ++  K  +  +P        ++   ++
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETA----VSIAIKHIQDSVPNVTTDVRKDIPQSLS 245

Query: 498 ALIETCWAEEPEIRP 512
            +I     ++   R 
Sbjct: 246 NVILRATEKDKANRY 260

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  134 bits (340), Expect = 2e-35
 Identities = 70/262 (26%), Positives = 103/262 (39%), Gaps = 54/262 (20%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHP 322
           +K  IG+GS+G V  A    +    A+KI+    I Q   +D  +    EV +MK L HP
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV-ERIKTEVRLMKKLHHP 88

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLY-------------------------------- 350
           NI  L     +   + +V E    G L                                 
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 351 -----KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--T 403
                          V  E+L  N+   +   ++YLH +   I HRD+K  N L  +  +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKS 206

Query: 404 YTVKVCDFGLSR----SKPNTYISSKTAAGTPEWMAPEVLR--EDPSNEKSDVFSFGVIL 457
           + +K+ DFGLS+         Y    T AGTP ++APEVL    +    K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 458 WELITLQKPWRNSTPSQVISAV 479
             L+    P+     +  IS V
Sbjct: 267 HLLLMGAVPFPGVNDADTISQV 288

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  135 bits (341), Expect = 2e-35
 Identities = 43/299 (14%), Positives = 87/299 (29%), Gaps = 56/299 (18%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLR-- 320
            L+    +G+        A  + +     V +    E       + ++ EV  ++ LR  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 321 -----------------------HPNIVLLMGAVTEPPNLSIVTEY-LSRGSLYK----L 352
                                     ++ +     +   LS    Y   + +L      L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 353 LHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 412
           L        +    RL +   V + +  LH     +VH  L+  ++++D    V +  F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251

Query: 413 LSRSKPNTYISSKTAAGTPEWMAPEVL-----------REDPSNEKSDVFSFGVILWELI 461
               +         ++ +  +  PE+            R        D ++ G++++ + 
Sbjct: 252 HLV-RDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 462 TLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 520
               P            +          KN+   V AL+E       E R      MET
Sbjct: 308 CADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  135 bits (341), Expect = 2e-35
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 24/204 (11%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
             K IG G+FG       +     VAVK +      ++  +   RE+   + LRHPNIV 
Sbjct: 24  FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVR 80

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD----VAKGMNYLH 382
               +  P +L+I+ EY S G LY        R+    R   + A      +  G++Y H
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELY-------ERICNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 383 QRRPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVL 439
             +  I HRDLK  N L+D +    +K+CDFG S+ S  ++    K+  GTP ++APEVL
Sbjct: 134 SMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVL 189

Query: 440 REDPSN-EKSDVFSFGVILWELIT 462
                + + +DV+S GV L+ ++ 
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLV 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  133 bits (336), Expect = 6e-35
 Identities = 73/260 (28%), Positives = 124/260 (47%), Gaps = 23/260 (8%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIV 325
           I++ +GEGSFG V  A        VA+K +  Q   +      + RE++ +K LRHP+I+
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYL 381
            L   +T P ++ +V EY   G L+  +       V  +R+  +        +   + Y 
Sbjct: 73  KLYDVITTPTDIVMVIEYAG-GELFDYI-------VEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLR 440
           H+ +  IVHRDLK  NLL+D    VK+ DFGLS       ++  KT+ G+P + APEV+ 
Sbjct: 125 HRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEVIN 180

Query: 441 EDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
               +  + DV+S G++L+ ++  + P+ +     +   V        +P  ++P   +L
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSL 238

Query: 500 IETCWAEEPEIRPSFPSIME 519
           I      +P  R +   I  
Sbjct: 239 IRRMIVADPMQRITIQEIRR 258

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  131 bits (331), Expect = 2e-34
 Identities = 55/262 (20%), Positives = 105/262 (40%), Gaps = 36/262 (13%)

Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIV 325
           +++ +G G  G VY AE   R   VA+K++ E    +  F+    RE      L+ P++V
Sbjct: 38  LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 326 LLMGAV----TEPPNLSIVTEYLSRGSLYKLLH----IPDARVVVDERLRLNMAYDVAKG 377
                +         L +    ++   L  +L     +   R V        +   +   
Sbjct: 98  ----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAV-------AIVRQIGSA 146

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-SSKTAAGTPEWMAP 436
           ++  H       HRD+K  N+LV +     + DFG++ +  +  +       GT  +MAP
Sbjct: 147 LDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAP 204

Query: 437 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK------ 490
           E   E  +  ++D+++   +L+E +T   P++    S + + +        IP+      
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-----NQAIPRPSTVRP 259

Query: 491 NVNPMVAALIETCWAEEPEIRP 512
            +     A+I    A+ PE R 
Sbjct: 260 GIPVAFDAVIARGMAKNPEDRY 281

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  132 bits (332), Expect = 3e-34
 Identities = 36/297 (12%), Positives = 67/297 (22%), Gaps = 50/297 (16%)

Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPN 323
           L + + +  G    V+           A+K+  +  E      +           L   +
Sbjct: 64  LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123

Query: 324 IVLLMGA--------------------------VTEPPNLSIVTEYLSRGSLYKLLHIPD 357
                                                 N  ++    S   L  L    D
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD 182

Query: 358 ARVVVDERL----RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 413
              V            +   + +    L  +   +VH      NL +     + + D   
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 414 SRSKPNTYISSKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNS 470
                    +   A+  P   AP               + +  G+ ++ +  L  P+   
Sbjct: 241 LWKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296

Query: 471 TPSQ-------VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 520
           TP          +   G           +   V  LI      +   R      MET
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  130 bits (329), Expect = 4e-34
 Identities = 52/291 (17%), Positives = 99/291 (34%), Gaps = 25/291 (8%)

Query: 246 MSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHE 303
                RE  + E     +     I +             +       +  +         
Sbjct: 43  NRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSP 102

Query: 304 DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVD 363
                   ++  M      N V  +   +    L I  +   + +L   ++   +    +
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162

Query: 364 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 423
             + L++   +A+ + +LH +   ++HRDLK  N+       VKV DFGL  +       
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220

Query: 424 SKTAA------------GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 471
                            GT  +M+PE +  +  + K D+FS G+IL+EL+          
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QME 278

Query: 472 PSQVISAVGFKGRRLEIPK---NVNPMVAALIETCWAEEPEIRPSFPSIME 519
             ++I+ V    R L+ P       P    +++   +  P  RP    I+E
Sbjct: 279 RVRIITDV----RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 18/57 (31%), Positives = 30/57 (52%), Gaps = 3/57 (5%)

Query: 271 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           + +G G FG V+ A+ +  + + A+K  I     E   ++ +REV  +  L HP IV
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIV 67

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  133 bits (337), Expect = 5e-34
 Identities = 72/262 (27%), Positives = 123/262 (46%), Gaps = 26/262 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIV 325
           +   +G G+FG V   +       VAVKIL  Q+         + RE+  +K  RHP+I+
Sbjct: 20  LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYL 381
            L   ++ P ++ +V EY+S G L+         +  + RL    +      +  G++Y 
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELF-------DYICKNGRLDEKESRRLFQQILSGVDYC 132

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEV 438
           H+    +VHRDLK  N+L+D+    K+ DFGLS    N        +T+ G+P + APEV
Sbjct: 133 HRHM--VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLRTSCGSPNYAAPEV 186

Query: 439 LREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           +     +  + D++S GVIL+ L+    P+ +     +   +         P+ +NP V 
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVI 244

Query: 498 ALIETCWAEEPEIRPSFPSIME 519
           +L++     +P  R +   I E
Sbjct: 245 SLLKHMLQVDPMKRATIKDIRE 266

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  130 bits (328), Expect = 7e-34
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 24/201 (11%)

Query: 268 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 324
           L K+ +G G  G V     R +    A+K+L           +  +EV         P+I
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHI 84

Query: 325 VLLMGA----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV-DERLRLNMAYDVAKGMN 379
           V ++            L I+ E +  G L+    I +       ER    +  D+   + 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 436
           +LH     I HRD+K  NLL  S      +K+ DFG ++      +  +T   TP ++AP
Sbjct: 143 FLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYYVAP 198

Query: 437 EVLREDPSNEKSDVFSFGVIL 457
           EVL  +  ++  D++S GVI+
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  127 bits (322), Expect = 3e-33
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEF-----LREVAIMKGLRHPN 323
            KIGEGS+G V+    R++   VA+K     +F E           LRE+ ++K L+HPN
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L+        L +V EY    ++   L     +  V E L  ++ +   + +N+ H+
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDH-TVLHELD--RYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEV 438
                +HRD+K  N+L+     +K+CDFG +R      ++  +     E    W  +PE+
Sbjct: 121 HN--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVATRWYRSPEL 173

Query: 439 LREDPSNEKS-DVFSFGVILWELITLQ 464
           L  D       DV++ G +  EL++  
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  129 bits (327), Expect = 3e-33
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 25/202 (12%)

Query: 268 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 324
           +  + +G G  G V     + +    A+K+L           +  REV +     + P+I
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHI 117

Query: 325 VLLMGA----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV-DERLRLNMAYDVAKGMN 379
           V ++            L IV E L  G L+    I D       ER    +   + + + 
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMA 435
           YLH     I HRD+K  NLL  S      +K+ DFG ++    +  +   T   TP ++A
Sbjct: 176 YLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVA 231

Query: 436 PEVLREDPSNEKSDVFSFGVIL 457
           PEVL  +  ++  D++S GVI+
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  126 bits (319), Expect = 6e-33
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 36/212 (16%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 323
           KIGEG++GTV+ A+ R +   VA+K + ++ +       E      LRE+ ++K L+H N
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKN 62

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV L   +     L++V E+  +  L K          +D  +  +  + + KG+ + H 
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-A 435
           R   ++HRDLK  NLL++    +K+ +FGL+R+       Y        + E    W   
Sbjct: 120 RN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--------SAEVVTLWYRP 169

Query: 436 PEVLREDPS-NEKSDVFSFGVILWELITLQKP 466
           P+VL      +   D++S G I  EL    +P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (320), Expect = 6e-33
 Identities = 70/261 (26%), Positives = 124/261 (47%), Gaps = 27/261 (10%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDR-FKE-FLREVAIMKGLRHPNI 324
           + + +G G    V+ A     + DVAVK+L   +   D  F   F RE      L HP I
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 325 VLL--MGAVTEPPNLS--IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           V +   G    P      IV EY+   +L  ++H       +  +  + +  D  + +N+
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNF 131

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPE 437
            HQ    I+HRD+K  N+++ +T  VKV DFG++R      N+   +    GT ++++PE
Sbjct: 132 SHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP------KN 491
             R D  + +SDV+S G +L+E++T + P+   +P     +V ++  R +        + 
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----VSVAYQHVREDPIPPSARHEG 245

Query: 492 VNPMVAALIETCWAEEPEIRP 512
           ++  + A++    A+ PE R 
Sbjct: 246 LSADLDAVVLKALAKNPENRY 266

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  125 bits (317), Expect = 2e-32
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 34/210 (16%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEF-----LREVAIMKGLRHPN 323
             +GEGS+G V     +++   VA+K     +F E    +      +RE+ ++K LRH N
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +V L+    +     +V E++   ++   L        +D ++     + +  G+ + H 
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDH-TILDDLE--LFPNGLDYQVVQKYLFQIINGIGFCHS 142

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPE----WM-A 435
               I+HRD+K  N+LV  +  VK+CDFG +R   +    Y          E    W  A
Sbjct: 143 HN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--------DDEVATRWYRA 192

Query: 436 PEVLREDPSNEKS-DVFSFGVILWELITLQ 464
           PE+L  D    K+ DV++ G ++ E+   +
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (327), Expect = 4e-32
 Identities = 55/266 (20%), Positives = 96/266 (36%), Gaps = 38/266 (14%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNI 324
           +K  I  G  G +Y A  RN +   V +K L+     +   +   + E   +  + HP+I
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSI 141

Query: 325 VLLMGAVTEPPNLS-----IVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAYDVAKG 377
           V +   V            IV EY+   SL +     +P A         +    ++   
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEA-------IAYLLEILPA 194

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           ++YLH     +V+ DLK  N+++     +K+ D G      +         GTP + APE
Sbjct: 195 LSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPE 247

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           ++R  P+   +D+++ G  L  L              +          L+          
Sbjct: 248 IVRTGPT-VATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----PVLKTY----DSYG 298

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQ 523
            L+      +P  R  F +  E   Q
Sbjct: 299 RLLRRAIDPDPRQR--FTTAEEMSAQ 322

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  125 bits (315), Expect = 1e-31
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 34/211 (16%)

Query: 271 KKIGEGSFGTVYHAEWRNSD-VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           K IG GSFG V+ A+   SD VA+K +L ++ F         RE+ IM+ ++HPN+V L 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-------NRELQIMRIVKHPNVVDLK 98

Query: 329 GAVTEPPN------LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYL 381
                  +      L++V EY+   ++Y+   H    +  +   L     Y + + + Y+
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157

Query: 382 HQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM- 434
           H     I HRD+K  NLL+D  +  +K+ DFG ++     +PN  YI S+       +  
Sbjct: 158 HSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-------YYR 208

Query: 435 APEV-LREDPSNEKSDVFSFGVILWELITLQ 464
           APE+           D++S G ++ EL+  Q
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  123 bits (310), Expect = 1e-31
 Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 12/238 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 325
             K +GEGSF TV  A    +    A+KIL ++    E++     RE  +M  L HP  V
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L     +   L     Y   G L  L +I       +   R   A ++   + YLH + 
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG 150

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDP 443
             I+HRDLK  N+L++    +++ DFG ++        ++  +  GT ++++PE+L E  
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
           + + SD+++ G I+++L+    P+R      +   +       + P+   P    L+E
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 264

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  121 bits (306), Expect = 5e-31
 Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 35/208 (16%)

Query: 271 KKIGEGSFGTVYHAEWRNSD-VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 323
           +K+GEG++G VY A+      VA+K I ++ E       E      +RE++++K L HPN
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE------DEGIPSTAIREISLLKELHHPN 80

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           IV L+  +     L++V E++ +  L K+L   + +  + +       Y + +G+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK-DLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-A 435
            R  I+HRDLK  NLL++S   +K+ DFGL+R+      +Y        T E    W  A
Sbjct: 138 HR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--------THEVVTLWYRA 187

Query: 436 PEVLREDPS-NEKSDVFSFGVILWELIT 462
           P+VL      +   D++S G I  E+IT
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  121 bits (307), Expect = 9e-31
 Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 39/212 (18%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHP 322
             +GEG F TVY A  +N++  VA+K I +    H    K+      LRE+ +++ L HP
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQELSHP 72

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           NI+ L+ A     N+S+V +++    L  ++   D  +V+             +G+ YLH
Sbjct: 73  NIIGLLDAFGHKSNISLVFDFMET-DLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM- 434
           Q    I+HRDLK  NLL+D    +K+ DFGL++S       Y        T +    W  
Sbjct: 130 QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------THQVVTRWYR 179

Query: 435 APEVL---RE-DPSNEKSDVFSFGVILWELIT 462
           APE+L   R         D+++ G IL EL+ 
Sbjct: 180 APELLFGARMYGVG---VDMWAVGCILAELLL 208

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  120 bits (303), Expect = 9e-31
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 35/207 (16%)

Query: 272 KIGEGSFGTVYHAEWR-NSDVAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPNI 324
           KIGEG++G VY A+       A+K I +E+E       E      +RE++I+K L+H NI
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKE------DEGIPSTTIREISILKELKHSNI 62

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V L   +     L +V E+L +  L KLL        ++     +    +  G+ Y H R
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-AP 436
           R  ++HRDLK  NLL++    +K+ DFGL+R+       Y        T E    W  AP
Sbjct: 120 R--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--------THEIVTLWYRAP 169

Query: 437 EVLREDPS-NEKSDVFSFGVILWELIT 462
           +VL      +   D++S G I  E++ 
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  121 bits (305), Expect = 4e-30
 Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 35/212 (16%)

Query: 271 KKIGEGSFGTVYHAEWRNS--DVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           K IG GSFG VY A+  +S   VA+K +L ++     RFK   RE+ IM+ L H NIV L
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFK--NRELQIMRKLDHCNIVRL 112

Query: 328 MGAVTEPPN------LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNY 380
                          L++V +Y+   ++Y++  H   A+  +         Y + + + Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171

Query: 381 LHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM 434
           +H     I HRD+K  NLL+D  T  +K+CDFG ++     +PN  YI S+       + 
Sbjct: 172 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-------YY 222

Query: 435 -APEV-LREDPSNEKSDVFSFGVILWELITLQ 464
            APE+           DV+S G +L EL+  Q
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  118 bits (297), Expect = 1e-29
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 42/213 (19%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 323
           K+GEG++G VY A    ++  VA+K I +E E      +E      +REV+++K L+H N
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE------EEGVPGTAIREVSLLKELQHRN 94

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           I+ L   +     L ++ EY     L K +   D    V  R+  +  Y +  G+N+ H 
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHS 150

Query: 384 RRPPIVHRDLKSPNLLVDSTYT-----VKVCDFGLSRSK---PNTYISSKTAAGTPE--- 432
           RR   +HRDLK  NLL+  +       +K+ DFGL+R+       +        T E   
Sbjct: 151 RR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--------THEIIT 200

Query: 433 -WM-APEVLREDPS-NEKSDVFSFGVILWELIT 462
            W   PE+L      +   D++S   I  E++ 
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  117 bits (295), Expect = 1e-29
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 36/213 (16%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKEF----LREVAIMKGLR---H 321
           +IG G++GTVY A   +S   VA+K + +                +REVA+++ L    H
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNG--GGGGGGLPISTVREVALLRRLEAFEH 73

Query: 322 PNIVLLMGAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           PN+V LM             +++V E++ +  L   L       +  E ++  M     +
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM-RQFLR 131

Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPE-- 432
           G+++LH     IVHRDLK  N+LV S  TVK+ DFGL+R  S             TP   
Sbjct: 132 GLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------TPVVV 181

Query: 433 --WM-APEVLREDPSNEKSDVFSFGVILWELIT 462
             W  APEVL +       D++S G I  E+  
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  119 bits (301), Expect = 2e-29
 Identities = 62/239 (25%), Positives = 112/239 (46%), Gaps = 19/239 (7%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHP 322
           I K IG G+FG V   + +N+D   A+KIL    + +      F+E   E  ++      
Sbjct: 78  ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNGDSK 134

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
            I  L  A  +  NL +V +Y   G L  LL   + R+  +E  R  +A ++   ++ +H
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-EEMARFYLA-EMVIAIDSVH 192

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLRE 441
           Q     VHRD+K  N+L+D    +++ DFG   +   +  + S  A GTP++++PE+L+ 
Sbjct: 193 QLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250

Query: 442 DPSNEKS-----DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 495
               +       D +S GV ++E++  + P+   +  +    +     R + P  V  +
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  117 bits (295), Expect = 2e-29
 Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 44/214 (20%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 323
           K+G G++ TVY    + +   VA+K + ++ E       E      +RE+++MK L+H N
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-------EGTPSTAIREISLMKELKHEN 64

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA------YDVAKG 377
           IV L   +     L++V E++    L K +   D+R V +    L +       + + +G
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDN-DLKKYM---DSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE-- 432
           + + H+ +  I+HRDLK  NLL++    +K+ DFGL+R+     NT+        + E  
Sbjct: 121 LAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--------SSEVV 170

Query: 433 --WM-APEVLREDPS-NEKSDVFSFGVILWELIT 462
             W  AP+VL    + +   D++S G IL E+IT
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  119 bits (300), Expect = 3e-29
 Identities = 69/249 (27%), Positives = 126/249 (50%), Gaps = 11/249 (4%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEF-HEDRFKEFLREVAIMKGLRHP 322
           E L  K +G+G+FG V   + + +    A+KIL ++    +D     L E  +++  RHP
Sbjct: 151 EYL--KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
            +  L  +      L  V EY + G L+   H+   RV  ++R R   A ++   ++YLH
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLH 265

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
             +  +V+RDLK  NL++D    +K+ DFGL +       + KT  GTPE++APEVL ++
Sbjct: 266 SEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 502
                 D +  GV+++E++  + P+ N    ++   +  +   +  P+ + P   +L+  
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEAKSLLSG 382

Query: 503 CWAEEPEIR 511
              ++P+ R
Sbjct: 383 LLKKDPKQR 391

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  116 bits (294), Expect = 3e-29
 Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 29/205 (14%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVL 326
            K+GEG++ TVY  + + +D  VA+K I +E   HE+      +REV+++K L+H NIV 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLE---HEEGAPCTAIREVSLLKDLKHANIVT 64

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L   +    +L++V EYL +  L + L   D   +++        + + +G+ Y H+++ 
Sbjct: 65  LHDIIHTEKSLTLVFEYLDK-DLKQYLD--DCGNIINMHNVKLFLFQLLRGLAYCHRQK- 120

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-APEV 438
            ++HRDLK  NLL++    +K+ DFGL+R+K     TY          E    W   P++
Sbjct: 121 -VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--------DNEVVTLWYRPPDI 171

Query: 439 LREDPS-NEKSDVFSFGVILWELIT 462
           L      + + D++  G I +E+ T
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMAT 196

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  116 bits (294), Expect = 4e-29
 Identities = 68/251 (27%), Positives = 122/251 (48%), Gaps = 16/251 (6%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHP 322
           + L  K +G+G+FG V     + +    A+KIL ++     D     + E  +++  RHP
Sbjct: 8   DYL--KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
            +  L  A      L  V EY + G L+   H+   RV  +ER R   A ++   + YLH
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLH 122

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLR 440
            R   +V+RD+K  NL++D    +K+ DFGL   K      +      GTPE++APEVL 
Sbjct: 123 SRD--VVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
           ++      D +  GV+++E++  + P+ N    ++   +  +   +  P+ ++P   +L+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLL 236

Query: 501 ETCWAEEPEIR 511
                ++P+ R
Sbjct: 237 AGLLKKDPKQR 247

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  116 bits (292), Expect = 2e-28
 Identities = 69/252 (27%), Positives = 125/252 (49%), Gaps = 17/252 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIV 325
           I + IG+GSFG V   +  ++    A+K + +Q+  E +  +   +E+ IM+GL HP +V
Sbjct: 19  ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L  +  +  ++ +V + L  G L    H+       +E ++L +  ++   ++YL  +R
Sbjct: 79  NLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR 135

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPS 444
             I+HRD+K  N+L+D    V + DF ++      T     T AGT  +MAPE+      
Sbjct: 136 --IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKG 191

Query: 445 NEKS---DVFSFGVILWELITLQKPW--RNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
              S   D +S GV  +EL+  ++P+  R+ST S+ I    F+   +  P   +  + +L
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-FETTVVTYPSAWSQEMVSL 250

Query: 500 IETCWAEEPEIR 511
           ++      P+ R
Sbjct: 251 LKKLLEPNPDQR 262

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  115 bits (291), Expect = 2e-28
 Identities = 54/256 (21%), Positives = 110/256 (42%), Gaps = 15/256 (5%)

Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFK 307
             + +  + + ++  +  I K IG G+F  V   + + +    A+KI+ + +        
Sbjct: 47  EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS 106

Query: 308 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 367
            F  E  ++       I  L  A  +   L +V EY   G L  LL     R+  +   R
Sbjct: 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-MAR 165

Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKT 426
             +A ++   ++ +H+     VHRD+K  N+L+D    +++ DFG   + + +  + S  
Sbjct: 166 FYLA-EIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222

Query: 427 AAGTPEWMAPEVLREDPSNEKS-------DVFSFGVILWELITLQKPWRNSTPSQVISAV 479
           A GTP++++PE+L+       +       D ++ GV  +E+   Q P+   + ++    +
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282

Query: 480 GFKGRRLEIPKNVNPM 495
                 L +P     +
Sbjct: 283 VHYKEHLSLPLVDEGV 298

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  113 bits (286), Expect = 4e-28
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 44/216 (20%)

Query: 272 KIGEGSFGTVYHA-EWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLR-- 320
           +IGEG++G V+ A + +N    VA+K + ++        +E      +REVA+++ L   
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG------EEGMPLSTIREVAVLRHLETF 71

Query: 321 -HPNIVLLMGAVT-----EPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYD 373
            HPN+V L    T         L++V E++ +  L   L  +P     V      +M + 
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP--EPGVPTETIKDMMFQ 128

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP 431
           + +G+++LH  R  +VHRDLK  N+LV S+  +K+ DFGL+R  S             T 
Sbjct: 129 LLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------TS 178

Query: 432 E----WM-APEVLREDPSNEKSDVFSFGVILWELIT 462
                W  APEVL +       D++S G I  E+  
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  113 bits (284), Expect = 9e-28
 Identities = 63/266 (23%), Positives = 120/266 (45%), Gaps = 13/266 (4%)

Query: 239 MEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL 296
           ++  L+       + +        +  +    K +G GSFG V   + + S    A+KIL
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74

Query: 297 IEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 355
            +Q+  + +  E  L E  I++ +  P +V L  +  +  NL +V EY++ G ++   H+
Sbjct: 75  DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF--SHL 132

Query: 356 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 415
                  +   R   A  +     YLH     +++RDLK  NLL+D    ++V DFG ++
Sbjct: 133 RRIGRFSEPHARFYAA-QIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK 189

Query: 416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
                   + T  GTPE +APE++     N+  D ++ GV+++E+     P+    P Q+
Sbjct: 190 RVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

Query: 476 ISAVGFKGRRLEIPKNVNPMVAALIE 501
              +     ++  P + +  +  L+ 
Sbjct: 247 YEKIVSG--KVRFPSHFSSDLKDLLR 270

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  113 bits (285), Expect = 1e-27
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 22/237 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 325
           + K IG G+FG V     +++    A+K+L + E         F  E  IM     P +V
Sbjct: 73  VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA--Y--DVAKGMNYL 381
            L  A  +   L +V EY+  G L  L+         +  +    A  Y  +V   ++ +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMS--------NYDVPEKWARFYTAEVVLALDAI 184

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLR 440
           H      +HRD+K  N+L+D +  +K+ DFG   +      +   TA GTP++++PEVL+
Sbjct: 185 HSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242

Query: 441 EDPSNEK----SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
               +       D +S GV L+E++    P+   +     S +      L  P + +
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  111 bits (279), Expect = 4e-27
 Identities = 71/250 (28%), Positives = 118/250 (47%), Gaps = 21/250 (8%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIM-KGLRHPN 323
           K +G+GSFG V+ AE++ ++   A+K L    +  +   D  +  + E  ++     HP 
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPF 79

Query: 324 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
           +  +        NL  V EYL+ G L    HI         R     A ++  G+ +LH 
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDLM--YHIQSCHKFDLSRATFYAA-EIILGLQFLHS 136

Query: 384 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLRE 441
           +   IV+RDLK  N+L+D    +K+ DFG+   K N    +KT    GTP+++APE+L  
Sbjct: 137 KG--IVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLG 192

Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
              N   D +SFGV+L+E++  Q P+      ++  ++         P+ +      L+ 
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLV 250

Query: 502 TCWAEEPEIR 511
             +  EPE R
Sbjct: 251 KLFVREPEKR 260

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  111 bits (280), Expect = 4e-27
 Identities = 57/220 (25%), Positives = 107/220 (48%), Gaps = 41/220 (18%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLR---HP 322
           +++  G+G+FGTV   + +     VA+K +       + RF+   RE+ IM+ L    HP
Sbjct: 27  VERMAGQGTFGTVQLGKEKSTGMSVAIKKV-----IQDPRFR--NRELQIMQDLAVLHHP 79

Query: 323 NIVLLMGAVTEPPN--------LSIVTEYLSRGSLYKLL-HIPDARVVVDERL-RLNMAY 372
           NIV L  +              L++V EY+   +L++   +    +V     L ++ + +
Sbjct: 80  NIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL-F 136

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRS----KPNT-YISSKT 426
            + + +  LH     + HRD+K  N+LV+ +  T+K+CDFG ++     +PN  YI S+ 
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR- 195

Query: 427 AAGTPEWM-APEVLREDPSNEKS-DVFSFGVILWELITLQ 464
                 +  APE++  +     + D++S G I  E++  +
Sbjct: 196 ------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  113 bits (284), Expect = 7e-27
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 16/224 (7%)

Query: 254 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFK 307
           +LE + +   W      + +G G FG V+  + + +    A K L    +++      ++
Sbjct: 176 WLEAQPMGEDWFLDF--RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR---KGYQ 230

Query: 308 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDE-R 365
             + E  I+  +    IV L  A     +L +V   ++ G + Y + ++ +      E R
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290

Query: 366 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 425
                A  +  G+ +LHQR   I++RDLK  N+L+D    V++ D GL+         +K
Sbjct: 291 AIFYTA-QIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347

Query: 426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
             AGTP +MAPE+L  +  +   D F+ GV L+E+I  + P+R 
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  110 bits (277), Expect = 9e-27
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 35/217 (16%)

Query: 272 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-F----LREVAIMKGLRHPN 323
           KIG+G+FG V+ A  R +   VA+K +L+E E      KE F    LRE+ I++ L+H N
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENE------KEGFPITALREIKILQLLKHEN 77

Query: 324 IVLLMGAVTEP--------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           +V L+               ++ +V ++     L  LL      V         +   + 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLL 134

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE--- 432
            G+ Y+H+ +  I+HRD+K+ N+L+     +K+ DFGL+R+  +   +S+    T     
Sbjct: 135 NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAF-SLAKNSQPNRYTNRVVT 191

Query: 433 -WM-APEVLREDPS-NEKSDVFSFGVILWELITLQKP 466
            W   PE+L  +       D++  G I+ E+ T + P
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP 227

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  112 bits (282), Expect = 2e-26
 Identities = 62/235 (26%), Positives = 116/235 (49%), Gaps = 11/235 (4%)

Query: 271 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIM-KGLRHPNIVL 326
             +G+GSFG V  +E + +D   AVKIL +    +D   E    E  ++    + P +  
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L         L  V EY++ G L    HI       +       A ++A G+ +L  +  
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKG- 462

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            I++RDLK  N+++DS   +K+ DFG+ +      +++KT  GTP+++APE++   P  +
Sbjct: 463 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
             D ++FGV+L+E++  Q P+      ++  ++      +  PK+++    A+ +
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICK 574

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  109 bits (274), Expect = 2e-26
 Identities = 64/241 (26%), Positives = 123/241 (51%), Gaps = 14/241 (5%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDV-----AVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           ELL  K +G+GSFG V+  +  +        A+K+L +             E  I+  + 
Sbjct: 27  ELL--KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HP IV L  A      L ++ ++L  G L+    +    +  +E ++  +A ++A  +++
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLF--TRLSKEVMFTEEDVKFYLA-ELALALDH 141

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           LH     I++RDLK  N+L+D    +K+ DFGLS+   +    + +  GT E+MAPEV+ 
Sbjct: 142 LHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199

Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
                + +D +SFGV+++E++T   P++     + ++ +     +L +P+ ++P   +L+
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLL 257

Query: 501 E 501
            
Sbjct: 258 R 258

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  109 bits (274), Expect = 3e-26
 Identities = 74/252 (29%), Positives = 129/252 (51%), Gaps = 17/252 (6%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLR-EVAIM-KGLRH 321
             L  K IG+GSFG V  A  +  +V  AVK+L ++   + + ++ +  E  ++ K ++H
Sbjct: 41  HFL--KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           P +V L  +      L  V +Y++ G L+   H+   R  ++ R R   A ++A  + YL
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYL 155

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVL 439
           H     IV+RDLK  N+L+DS   + + DFGL   K N   +S T+   GTPE++APEVL
Sbjct: 156 HSLN--IVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVL 211

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
            + P +   D +  G +L+E++    P+ +   +++   +  K   L++  N+      L
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHL 269

Query: 500 IETCWAEEPEIR 511
           +E    ++   R
Sbjct: 270 LEGLLQKDRTKR 281

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  109 bits (275), Expect = 3e-26
 Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 29/231 (12%)

Query: 255 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA 314
           L  E   +         K+G G++G VY A+ ++        ++Q           RE+A
Sbjct: 11  LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA 70

Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMA- 371
           +++ L+HPN++ L        +  +  + +Y     L+ ++    A     + ++L    
Sbjct: 71  LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGM 129

Query: 372 -----YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGLSR--SKP-N 419
                Y +  G++YLH     ++HRDLK  N+LV         VK+ D G +R  + P  
Sbjct: 130 VKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 420 TYISSKTAAGTPE----WM-APEVLREDPSNEKS-DVFSFGVILWELITLQ 464
                  A   P     W  APE+L       K+ D+++ G I  EL+T +
Sbjct: 188 PL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  107 bits (269), Expect = 4e-26
 Identities = 45/208 (21%), Positives = 73/208 (35%), Gaps = 58/208 (27%)

Query: 268 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 324
           +  + +G G  G V     + +    A+K+L           +  REV +     + P+I
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHI 73

Query: 325 VLLMGA----VTEPPNLSIVTEYLSRGSLY----KLLHIP----DARVVVDERLRLNMAY 372
           V ++            L IV E L  G L+              +A  ++          
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---------K 124

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAG 429
            + + + YLH     I HRD+K  NLL  S      +K+ DFG                 
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166

Query: 430 TPEWMAPEVLREDPSNEKSDVFSFGVIL 457
                A E   E   ++  D++S GVI+
Sbjct: 167 -----AKETTGE-KYDKSCDMWSLGVIM 188

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  108 bits (271), Expect = 6e-26
 Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 15/215 (6%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIM-KGLRH 321
           +LL  + IG GS+  V     + +D   A+K++ ++  ++ +       E  +  +   H
Sbjct: 12  DLL--RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           P +V L         L  V EY++ G L  + H+   R + +E  R   A +++  +NYL
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYL 126

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVL 439
           H+R   I++RDLK  N+L+DS   +K+ D+G+   K        T+   GTP ++APE+L
Sbjct: 127 HERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEIL 182

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ 474
           R +      D ++ GV+++E++  + P+     S 
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  107 bits (270), Expect = 7e-26
 Identities = 65/252 (25%), Positives = 119/252 (47%), Gaps = 17/252 (6%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIM-KGLRH 321
             L    +G+GSFG V  +E + +D   AVKIL +    + D  +  + E  ++    + 
Sbjct: 23  NFL--MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           P +  L         L  V EY++ G L    HI       +       A ++A G+ +L
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLFFL 137

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVL 439
             +   I++RDLK  N+++DS   +K+ DFG+   K N +    T    GTP+++APE++
Sbjct: 138 QSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYIAPEII 193

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
              P  +  D ++FGV+L+E++  Q P+      ++  ++      +  PK+++    A+
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAI 251

Query: 500 IETCWAEEPEIR 511
            +    + P  R
Sbjct: 252 CKGLMTKHPGKR 263

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  107 bits (270), Expect = 7e-26
 Identities = 66/252 (26%), Positives = 116/252 (46%), Gaps = 17/252 (6%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIM-KGLRH 321
           E +  + +G+GSFG V  A  + +    AVK+L +    +D   E    E  I+     H
Sbjct: 26  EFI--RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           P +  L      P  L  V E+++ G L    HI  +R   + R R   A ++   + +L
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAA-EIISALMFL 140

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVL 439
           H +   I++RDLK  N+L+D     K+ DFG+   K        TA   GTP+++APE+L
Sbjct: 141 HDKG--IIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEIL 196

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 499
           +E       D ++ GV+L+E++    P+       +  A+      +  P  ++     +
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDATGI 254

Query: 500 IETCWAEEPEIR 511
           +++   + P +R
Sbjct: 255 LKSFMTKNPTMR 266

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  110 bits (277), Expect = 7e-26
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 15/222 (6%)

Query: 254 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFK 307
           +LE + +          + +G+G FG V   + R +    A K L    I++        
Sbjct: 175 WLERQPVTKNTFRQY--RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEA 229

Query: 308 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 367
             L E  I++ +    +V L  A      L +V   ++ G L   ++        + R  
Sbjct: 230 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289

Query: 368 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 427
              A ++  G+  LH+ R  IV+RDLK  N+L+D    +++ D GL+   P    + K  
Sbjct: 290 FYAA-EICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGR 345

Query: 428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
            GT  +MAPEV++ +      D ++ G +L+E+I  Q P++ 
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  107 bits (270), Expect = 1e-25
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 15/215 (6%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIM-KGLRH 321
           +LL  + IG GS+  V     + +D   A++++ ++  ++ +       E  +  +   H
Sbjct: 55  DLL--RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112

Query: 322 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           P +V L         L  V EY++ G L  + H+   R + +E  R   A +++  +NYL
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYL 169

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVL 439
           H+R   I++RDLK  N+L+DS   +K+ D+G+   K        T+   GTP ++APE+L
Sbjct: 170 HERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEIL 225

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ 474
           R +      D ++ GV+++E++  + P+     S 
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  106 bits (266), Expect = 2e-25
 Identities = 60/236 (25%), Positives = 117/236 (49%), Gaps = 13/236 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 325
           I + +G GSFG V+    R++    A+K+L ++     +  E    E  ++  + HP I+
Sbjct: 10  ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            + G   +   + ++ +Y+  G L+    +  ++   +   +   A +V   + YLH + 
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELF--SLLRKSQRFPNPVAKFYAA-EVCLALEYLHSKD 126

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             I++RDLK  N+L+D    +K+ DFG ++  P+    + T  GTP+++APEV+   P N
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYN 181

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 501
           +  D +SFG++++E++    P+ +S   +    +      L  P   N  V  L+ 
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLS 235

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  109 bits (275), Expect = 2e-25
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 14/205 (6%)

Query: 271 KKIGEGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           + IG G FG VY     ++    A+K L    I+ +  E         ++++     P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
           V +  A   P  LS + + ++ G L+   H+    V  +  +R   A ++  G+ ++H R
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEADMRFYAA-EIILGLEHMHNR 311

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
              +V+RDLK  N+L+D    V++ D GL+            + GT  +MAPEVL++  +
Sbjct: 312 F--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVA 367

Query: 445 NEKS-DVFSFGVILWELITLQKPWR 468
            + S D FS G +L++L+    P+R
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFR 392

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  105 bits (264), Expect = 3e-25
 Identities = 63/247 (25%), Positives = 121/247 (48%), Gaps = 24/247 (9%)

Query: 266 ELLIKKKIGEGSFGTVY---HAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIM 316
           ELL  + +G+G +G V+        N+    A+K+L    I +  +         E  I+
Sbjct: 20  ELL--RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--NAKDTAHTKAERNIL 75

Query: 317 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 376
           + ++HP IV L+ A      L ++ EYLS G L+  + +    + +++     +A +++ 
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF--MQLEREGIFMEDTACFYLA-EISM 132

Query: 377 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWM 434
            + +LHQ+   I++RDLK  N++++    VK+ DFGL   K + +  + T    GT E+M
Sbjct: 133 ALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCGTIEYM 188

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           APE+L     N   D +S G ++++++T   P+      + I  +     +L +P  +  
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQ 246

Query: 495 MVAALIE 501
               L++
Sbjct: 247 EARDLLK 253

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  104 bits (261), Expect = 4e-25
 Identities = 30/250 (12%), Positives = 70/250 (28%), Gaps = 42/250 (16%)

Query: 272 KIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLM 328
             G       + A     +  VA+  +  Q    D   +  L     +  +  P +  ++
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 388
             V       +V E++  GSL ++    D        +R      +A   +  H+    +
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIR--AMQSLAAAADAAHRA--GV 150

Query: 389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 448
                    + V     V +                                   +N + 
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATMP---------------------------DANPQD 183

Query: 449 DVFSFGVILWELITLQKPWRNSTPSQVISAVGF-KGRRLEIPKNVNPMV----AALIETC 503
           D+   G  L+ L+  + P   +     ++        +   P +++  +    +A+    
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS 243

Query: 504 WAEEPEIRPS 513
              +  IR +
Sbjct: 244 VQGDGGIRSA 253

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  104 bits (262), Expect = 9e-25
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 24/211 (11%)

Query: 269 IKKKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEF---------LREVAIMKG 318
           +++ I  GS+G V    +     VA+K +                      LRE+ ++  
Sbjct: 26  VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85

Query: 319 LRHPNIVLLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 372
             HPNI+ L                 +VTE +    L +++H     V+  + ++  M Y
Sbjct: 86  FHHPNILGLRDIFV-HFEEPAMHKLYLVTELMRT-DLAQVIHDQRI-VISPQHIQYFM-Y 141

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE 432
            +  G++ LH+    +VHRDL   N+L+     + +CDF L+R        +        
Sbjct: 142 HILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-HRW 198

Query: 433 WMAPEVLREDPSNEKS-DVFSFGVILWELIT 462
           + APE++ +     K  D++S G ++ E+  
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  103 bits (260), Expect = 1e-24
 Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 33/211 (15%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIV 325
           + +K+G G +  V+ A    ++  V VKIL        + K+  RE+ I++ LR  PNI+
Sbjct: 40  LVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNII 94

Query: 326 LLMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
            L   V +P     ++V E+++     +L        + D  +R  M Y++ K ++Y H 
Sbjct: 95  TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYM-YEILKALDYCHS 148

Query: 384 RRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKP-----NTYISSKTAAGTPEWM-AP 436
               I+HRD+K  N+++D  +  +++ D+GL+         N  ++S+       +   P
Sbjct: 149 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR-------YFKGP 199

Query: 437 EVLREDPSNEKS-DVFSFGVILWELITLQKP 466
           E+L +    + S D++S G +L  +I  ++P
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  102 bits (257), Expect = 4e-24
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 30/214 (14%)

Query: 269 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 325
           +K  +GEG++G V  A  +     VA+K +  + F +  F    LRE+ I+K  +H NI+
Sbjct: 15  LKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHENII 72

Query: 326 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            +      P +        I+ E +    L++++     +++ D+ ++  + Y   + + 
Sbjct: 73  TIFNIQR-PDSFENFNEVYIIQELMQT-DLHRVIS---TQMLSDDHIQYFI-YQTLRAVK 126

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----- 434
            LH     ++HRDLK  NLL++S   +KVCDFGL+R    +   +    G    M     
Sbjct: 127 VLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184

Query: 435 -----APEVLREDPS-NEKSDVFSFGVILWELIT 462
                APEV+      +   DV+S G IL EL  
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  101 bits (254), Expect = 1e-23
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)

Query: 271 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLL 327
           K IG G+ G V  A       +VA+K  + + F      K   RE+ +MK + H NI+ L
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89

Query: 328 MGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           +   T   +L       IV E +   +L +++ +     +  ER+   + Y +  G+ +L
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME----LDHERMSYLL-YQMLCGIKHL 143

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 441
           H     I+HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+  
Sbjct: 144 HSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILG 200

Query: 442 DPSNEKSDVFSFGVILWELIT 462
               E  D++S G I+ E+I 
Sbjct: 201 MGYKENVDIWSVGCIMGEMIK 221

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  101 bits (254), Expect = 2e-23
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 40/238 (16%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 325
           IK  IG GS+G VY A  +N++  VA+K  + + F +    K  LRE+ I+  L+   I+
Sbjct: 30  IKHLIGRGSYGYVYLAYDKNTEKNVAIK-KVNRMFEDLIDCKRILREITILNRLKSDYII 88

Query: 326 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            L   +  P +L       IV E      L KL   P    + +E ++  + Y++  G N
Sbjct: 89  RLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF--LTEEHIKTIL-YNLLLGEN 143

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----- 434
           ++H+    I+HRDLK  N L++   +VKVCDFGL+R+  +   ++               
Sbjct: 144 FIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201

Query: 435 -----------------APEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQ 474
                            APE++    +  +  D++S G I  EL+ + +   N   ++
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  101 bits (253), Expect = 4e-23
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 29/208 (13%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 325
             K IG G+ G V  A     D  VA+K  + + F      K   RE+ +MK + H NI+
Sbjct: 66  NLKPIGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124

Query: 326 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            L+   T    L       +V E +   +L +++ +     +  ER+   + Y +  G+ 
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME----LDHERMSYLL-YQMLCGIK 178

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----- 434
           +LH     I+HRDLK  N++V S  T+K+ DFGL+R+   +++       TP  +     
Sbjct: 179 HLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRYYR 230

Query: 435 APEVLREDPSNEKSDVFSFGVILWELIT 462
           APEV+      E  D++S G I+ E++ 
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVR 258

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  100 bits (250), Expect = 4e-23
 Identities = 60/247 (24%), Positives = 102/247 (41%), Gaps = 69/247 (27%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
           + K +G GSFG V            A+K +L +      R+K   RE+ IMK L H NI+
Sbjct: 11  LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYK--NRELDIMKVLDHVNII 63

Query: 326 LL--------------------------------MGAVTEPPN------LSIVTEYLSRG 347
            L                                    +   N      L+++ EY+   
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-D 122

Query: 348 SLYKLL-HIPDARVVV-DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TY 404
           +L+K+L     +   +    + + + Y + + + ++H     I HRD+K  NLLV+S   
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYI-YQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDN 179

Query: 405 TVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM-APEVLREDPS-NEKSDVFSFGVIL 457
           T+K+CDFG ++     +P+  YI S+       +  APE++          D++S G + 
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSR-------FYRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 458 WELITLQ 464
            ELI  +
Sbjct: 233 GELILGK 239

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  101 bits (252), Expect = 5e-23
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 45/242 (18%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 325
           I+  IG GS+G V  A  +     VA+K  I + F +    K  LRE+AI+  L H ++V
Sbjct: 57  IRHLIGTGSYGHVCEAYDKLEKRVVAIK-KILRVFEDLIDCKRILREIAILNRLNHDHVV 115

Query: 326 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            ++  +  P ++       +V E        KL   P    + +  ++  + Y++  G+ 
Sbjct: 116 KVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY--LTELHIKTLL-YNLLVGVK 170

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----- 434
           Y+H     I+HRDLK  N LV+   +VKVCDFGL+R+       +     +P        
Sbjct: 171 YVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228

Query: 435 ----------------------APEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNST 471
                                 APE++    +  ++ DV+S G I  EL+ + K      
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288

Query: 472 PS 473
             
Sbjct: 289 AD 290

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 99.3 bits (248), Expect = 7e-23
 Identities = 57/233 (24%), Positives = 111/233 (47%), Gaps = 31/233 (13%)

Query: 246 MSTSNRELYLEEEGLEIRW---SELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQE 300
           +S   ++ + +++  +  W      +    +G G++G+V  A  +     VA+K L    
Sbjct: 2   LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61

Query: 301 FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS------IVTEYLSRGSLYKLLH 354
             E   K   RE+ ++K ++H N++ L+   T   +L       +V  ++    L K++ 
Sbjct: 62  QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG 120

Query: 355 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 414
           +       +E+++  + Y + KG+ Y+H     +VHRDLK  NL V+    +K+ DFGL+
Sbjct: 121 LK----FSEEKIQYLV-YQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLA 173

Query: 415 RSKPNT---YISSKTAAGTPEW-MAPEVLREDPSNEKS-DVFSFGVILWELIT 462
           R        Y+ ++       W  APEV+       ++ D++S G I+ E++T
Sbjct: 174 RHADAEMTGYVVTR-------WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 27/207 (13%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 325
               +G G++G+V  A        VAVK  + + F      K   RE+ ++K ++H N++
Sbjct: 33  NLSPVGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQSIIHAKRTYRELRLLKHMKHENVI 91

Query: 326 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            L+   T   +L       +VT  +    L  ++     + + D+ ++  + Y + +G+ 
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK---CQKLTDDHVQFLI-YQILRGLK 146

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAP 436
           Y+H     I+HRDLK  NL V+    +K+ DFGL+R   +    Y++      T  + AP
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA------TRWYRAP 198

Query: 437 EVLREDPS-NEKSDVFSFGVILWELIT 462
           E++      N+  D++S G I+ EL+T
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLT 225

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 27/205 (13%)

Query: 271 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 328
           + +G G++G V  A      + VA+K L      E   K   RE+ ++K +RH N++ L+
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 329 GAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
              T    L       +V  ++    L KL+       + ++R++  + Y + KG+ Y+H
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLGEDRIQFLV-YQMLKGLRYIH 145

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWM-APEV 438
                I+HRDLK  NL V+    +K+ DFGL+R   +    Y+ ++       W  APEV
Sbjct: 146 AAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-------WYRAPEV 196

Query: 439 LREDPSNEKS-DVFSFGVILWELIT 462
           +       ++ D++S G I+ E+IT
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMIT 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 60/261 (22%), Positives = 118/261 (45%), Gaps = 44/261 (16%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDV-----AVKIL-----------IEQEFHEDRFKEF 309
           ELL  K +G G++G V+     +        A+K+L            E    E   ++ 
Sbjct: 57  ELL--KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE---RQV 111

Query: 310 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
           L  +      + P +V L  A      L ++ +Y++ G L+   H+       +  +++ 
Sbjct: 112 LEHIR-----QSPFLVTLHYAFQTETKLHLILDYINGGELF--THLSQRERFTEHEVQIY 164

Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA- 428
           +  ++   + +LH+    I++RD+K  N+L+DS   V + DFGL  SK      ++ A  
Sbjct: 165 VG-EIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL--SKEFVADETERAYD 219

Query: 429 --GTPEWMAPEVLREDPSNEKSDV--FSFGVILWELITLQKPW----RNSTPSQVISAVG 480
             GT E+MAP+++R   S     V  +S GV+++EL+T   P+      ++ +++   + 
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279

Query: 481 FKGRRLEIPKNVNPMVAALIE 501
                   P+ ++ +   LI+
Sbjct: 280 KS--EPPYPQEMSALAKDLIQ 298

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 38/223 (17%)

Query: 269 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLR-HPNI 324
           + KK+G+G++G V+ +  R     VAVK  I   F      +   RE+ I+  L  H NI
Sbjct: 13  LVKKLGKGAYGIVWKSIDRRTGEVVAVK-KIFDAFQNSTDAQRTFREIMILTELSGHENI 71

Query: 325 VLLMGAVTEPPNLS---IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           V L+  +    N     +V +Y+    L+ ++    A ++     +  + Y + K + YL
Sbjct: 72  VNLLNVLR-ADNDRDVYLVFDYME-TDLHAVIR---ANILEPVHKQYVV-YQLIKVIKYL 125

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM------- 434
           H     ++HRD+K  N+L+++   VKV DFGLSRS  N    +     +           
Sbjct: 126 HSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183

Query: 435 --------------APEVLREDPS-NEKSDVFSFGVILWELIT 462
                         APE+L       +  D++S G IL E++ 
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 32/216 (14%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 325
             K +G G  G V+ A   + D  VA+K ++     + +  K  LRE+ I++ L H NIV
Sbjct: 15  DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIRRLDHDNIV 71

Query: 326 LLMGAVTEPPNLS--------------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 371
            +   +    +                IV EY+    L  +L       +++E  RL M 
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFM- 126

Query: 372 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRSKPNTYISSKTAAG- 429
           Y + +G+ Y+H     ++HRDLK  NL +++    +K+ DFGL+R     Y      +  
Sbjct: 127 YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 430 --TPEWMAPEVLREDPS-NEKSDVFSFGVILWELIT 462
             T  + +P +L    +  +  D+++ G I  E++T
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 38/218 (17%)

Query: 269 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 325
               IGEG++G V  A        VA+K +    F    + +  LRE+ I+   RH NI+
Sbjct: 31  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENII 88

Query: 326 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
            +   +   P +       IV + +    LYKLL     + + ++ +   + Y + +G+ 
Sbjct: 89  GINDIIR-APTIEQMKDVYIVQDLME-TDLYKLLK---TQHLSNDHICYFL-YQILRGLK 142

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----- 434
           Y+H     ++HRDLK  NLL+++T  +K+CDFGL+R        +        ++     
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 193

Query: 435 -----APEVLREDPS-NEKSDVFSFGVILWELITLQKP 466
                APE++       +  D++S G IL E+++  +P
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRP 230

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 49/221 (22%), Positives = 101/221 (45%), Gaps = 40/221 (18%)

Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLR----- 320
           + +K+G G F TV+ A+    N+ VA+KI+   + + E        E+ +++ +      
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE----AAEDEIKLLQRVNDADNT 78

Query: 321 ------HPNIVLLMGAVT----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
                   +I+ L+           ++ +V E L   +L  L+   + R +    ++  +
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVK-QI 136

Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD------STYTVKVCDFGLSRSKPN---TY 421
           +  +  G++Y+H RR  I+H D+K  N+L++      +   +K+ D G +          
Sbjct: 137 SKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195

Query: 422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 462
           I ++      E+ +PEVL   P    +D++S   +++ELIT
Sbjct: 196 IQTR------EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 87.5 bits (217), Expect = 1e-18
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 32/240 (13%)

Query: 242 NLSVMSTSNRELYLEEEG-LEIRWSELL-----IKKKIGEGSFGTVYHA--EWRNSDVAV 293
              +    N   Y +++G       + +     + K IG+GSFG V  A     +  VA+
Sbjct: 68  RQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVAL 127

Query: 294 KILIEQEFHEDRFKEFLREVAIMKGLRH------PNIVLLMGAVTEPPNLSIVTEYLSRG 347
           K++      +   ++   E+ I++ LR        N++ ++   T   ++ +  E LS  
Sbjct: 128 KMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM- 183

Query: 348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTYT- 405
           +LY+L+     +      +R   A+ + + ++ LH+ R  I+H DLK  N LL     + 
Sbjct: 184 NLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSG 240

Query: 406 VKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 462
           +KV DFG S     +  TYI S+       + APEV+         D++S G IL EL+T
Sbjct: 241 IKVIDFGSSCYEHQRVYTYIQSRF------YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 85.1 bits (211), Expect = 4e-18
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 24/207 (11%)

Query: 269 IKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP---- 322
           I   IG+GSFG V  A        VA+KI+      +    +   EV +++ +       
Sbjct: 58  IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEM 114

Query: 323 --NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
              IV L        +L +V E LS  +LY LL   + R V     R   A  +   + +
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLF 172

Query: 381 LHQRRPPIVHRDLKSPN-LLVDSTYT-VKVCDFGLS---RSKPNTYISSKTAAGTPEWMA 435
           L      I+H DLK  N LL +   + +K+ DFG S     +   YI S+       + +
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YRS 226

Query: 436 PEVLREDPSNEKSDVFSFGVILWELIT 462
           PEVL   P +   D++S G IL E+ T
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHT 253

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 66/238 (27%)

Query: 269 IKKKIGEGSFGTVYHA--EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRH---- 321
           + +K+G+G+FG V            AVK++   +++          E  I+K +++    
Sbjct: 39  VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDIN 94

Query: 322 -PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAY 372
             NIV   G      ++ ++ E L   SLY+++        HI D +             
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIK---------LYCI 144

Query: 373 DVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTYT------------------------VK 407
           ++ K +NYL +    + H DLK  N LL D  +                         +K
Sbjct: 145 EILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 408 VCDFG---LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 462
           + DFG          + I+++       + APEV+     +  SD++SFG +L EL T
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 78.0 bits (191), Expect = 8e-16
 Identities = 38/202 (18%), Positives = 68/202 (33%), Gaps = 48/202 (23%)

Query: 262 IRWSELL------IKKKIGEGSFGTVYHAEWRNSDVAVKIL------IEQEFHEDRFKEF 309
           + +S  L        +KIGEG FG V+     ++ VA+KI+      +    H+  F+E 
Sbjct: 11  VPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEI 70

Query: 310 LREVAIMKGL---------RHPNIVLLMGAV----TEPPNLSIVTEY------------- 343
           L E+ I K L         R    + L        + PP L    ++             
Sbjct: 71  LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130

Query: 344 -LSRGSLYKLLHIPDA--------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 394
                 L+ +L               +       ++ + +   +  + +      HRDL 
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL-AVAEASLRFEHRDLH 189

Query: 395 SPNLLVDSTYTVKVCDFGLSRS 416
             N+L+  T   K+      +S
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKS 211

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 62/234 (26%)

Query: 269 IKKKIGEGSFGTVYHA---EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRHP-- 322
           I   +GEG+FG V          S VA+KI+    ++ E        E+ ++K ++    
Sbjct: 23  IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDK 78

Query: 323 ----NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNM 370
                 VL+        ++ I  E L + + ++ L         +P  R         +M
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVR---------HM 128

Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTYT------------------VKVCDF 411
           AY +   + +LH+ +  + H DLK  N L V+S +                   ++V DF
Sbjct: 129 AYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 412 G---LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 462
           G          T ++++       +  PEV+ E    +  DV+S G IL+E   
Sbjct: 187 GSATFDHEHHTTIVATRH------YRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 58/234 (24%), Positives = 88/234 (37%), Gaps = 62/234 (26%)

Query: 269 IKKKIGEGSFGTVYHA---EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRHP-- 322
           I   +GEG+FG V      +     VAVKI+     + E        E+ +++ L     
Sbjct: 18  IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDP 73

Query: 323 ----NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNM 370
                 V ++       ++ IV E L   S Y  +         +   R          M
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIR---------KM 123

Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTYT------------------VKVCDF 411
           AY + K +N+LH  +  + H DLK  N L V S YT                  +KV DF
Sbjct: 124 AYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 412 G---LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 462
           G         +T +S++       + APEV+     ++  DV+S G IL E   
Sbjct: 182 GSATYDDEHHSTLVSTRH------YRAPEVILALGWSQPCDVWSIGCILIEYYL 229

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 50/259 (19%), Positives = 93/259 (35%), Gaps = 76/259 (29%)

Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----H 321
           + +K+G G F TV+ +        VA+K++   E + +       E+ ++K +R      
Sbjct: 41  VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPND 97

Query: 322 PN---IVLLMGAVTEP-PN---LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           PN   +V L+        N   + +V E L    L K +   + + +    ++  +   V
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQV 155

Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLV---------------------------------- 400
            +G++YLH  +  I+H D+K  N+L+                                  
Sbjct: 156 LQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 401 ---------------DSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDP 443
                               VK+ D G +    K  T         T ++ + EVL    
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSG 269

Query: 444 SNEKSDVFSFGVILWELIT 462
            N  +D++S   + +EL T
Sbjct: 270 YNTPADIWSTACMAFELAT 288

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 30/218 (13%)

Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIV 325
           + +KIG GSFG +Y         +VA+K     E  + +  +   E  I K ++    I 
Sbjct: 13  LGRKIGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIP 68

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            +     E     +V E L   SL  L +    +  +   L L  A  +   + Y+H + 
Sbjct: 69  TIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLL--ADQMISRIEYIHSKN 125

Query: 386 PPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTA-----------AGTP 431
              +HRD+K  N L+        V + DFGL++     Y  ++T             GT 
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK----YRDARTHQHIPYRENKNLTGTA 179

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
            + +         + + D+ S G +L        PW+ 
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 38/227 (16%), Positives = 77/227 (33%), Gaps = 28/227 (12%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
           +   IG+G FG +Y A+  +S  V        +           E+   +    P  +  
Sbjct: 39  VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98

Query: 328 MGAVTEPPNLSIVTEYLS-----RGSLYKLLHIP-------DARVVVDERLRLNMAYDVA 375
                +   L +   + S      G  Y+ + +               +R        ++
Sbjct: 99  WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLS 158

Query: 376 KGM----NYLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRS-------KPNTYI 422
             +     Y+H+     VH D+K+ NLL++     +V   D+GL+         K     
Sbjct: 159 LRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
             +   GT E+ + +       + + D+   G  + + +T   PW +
Sbjct: 217 PKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 44/226 (19%)

Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIV 325
           + KKIG G+FG +   +  + N  VA+K+    E  + R  +   E    K L     I 
Sbjct: 13  VGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM----NYL 381
            +          ++V E L   SL  L  +       D    L     +A  +     Y+
Sbjct: 69  QVYYFGPCGKYNAMVLELLGP-SLEDLFDL------CDRTFSLKTVLMIAIQLISRMEYV 121

Query: 382 HQRRPPIVHRDLKSPNLLV-----DSTYTVKVCDFGLSRS--KPNT-----YISSKTAAG 429
           H +   +++RD+K  N L+      +   + + DF L++    P T     Y   K+  G
Sbjct: 122 HSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179

Query: 430 TPEWMAP------EVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
           T  +M+       E  R D      D+ + G +    +    PW+ 
Sbjct: 180 TARYMSINTHLGKEQSRRD------DLEALGHMFMYFLRGSLPWQG 219

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 46/224 (20%), Positives = 80/224 (35%), Gaps = 40/224 (17%)

Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIV 325
           + ++IGEGSFG ++       N  VA+K     E       +   E    K L     I 
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGIP 69

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM----NYL 381
            +     E  +  +V + L   SL  LL +         +  +      AK M      +
Sbjct: 70  NVYYFGQEGLHNVLVIDLLGP-SLEDLLDL------CGRKFSVKTVAMAAKQMLARVQSI 122

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYT-----VKVCDFGLSRSKPNTYISSKTAA-------- 428
           H++   +V+RD+K  N L+    +     + V DFG+ +     Y    T          
Sbjct: 123 HEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF----YRDPVTKQHIPYREKK 176

Query: 429 ---GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
              GT  +M+         + + D+ + G +    +    PW+ 
Sbjct: 177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 51/218 (23%), Positives = 86/218 (39%), Gaps = 30/218 (13%)

Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIV 325
           + +KIG GSFG +Y       N +VA+K     E  + +  + L E  I + L+    I 
Sbjct: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIP 66

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM----NYL 381
            +     E     +V + L   SL  L +          +L L     +A  M     ++
Sbjct: 67  NVRWFGVEGDYNVLVMDLLGP-SLEDLFNF------CSRKLSLKTVLMLADQMINRVEFV 119

Query: 382 HQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRS--KPNT-----YISSKTAAGTP 431
           H +    +HRD+K  N L+        V + DFGL++     +T     Y  +K   GT 
Sbjct: 120 HSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 469
            + +         + + D+ S G +L   +    PW+ 
Sbjct: 178 RYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 36/194 (18%), Positives = 66/194 (34%), Gaps = 32/194 (16%)

Query: 269 IKKKIGEGSFGTVYHAE----------WRNSDVAVKI-------LIEQEFHEDRFKEF-L 310
           +K      + G +Y A            +    ++K+         EQ F +   K   +
Sbjct: 46  LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105

Query: 311 REVAIMKGLRHPNIVLLMG-AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 369
            +   +       I   MG  V +     +V   L R SL   L +   + V+ ER  L 
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSP-KHVLSERSVLQ 163

Query: 370 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRS-------KPNT 420
           +A  +   + +LH+     VH ++ + N+ VD     +V    +G +             
Sbjct: 164 VACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221

Query: 421 YISSKTAAGTPEWM 434
             S     G  E++
Sbjct: 222 EGSRSPHEGDLEFI 235

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 44/193 (22%), Positives = 72/193 (37%), Gaps = 33/193 (17%)

Query: 269 IKKKIGEGSFGTVYHAE--WRNSDVAVKIL-IE-----QEFHEDRFKEFLREVAIMKGLR 320
           + KKIG G FG +Y A    +    A  ++ +E       F E +F + + +   +K   
Sbjct: 41  LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWI 100

Query: 321 HPNIVLLMG-------AVTEPPNLS---IVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 370
               +  +G        +TE    S   +V E L    L K+           +   L +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKIS---GQNGTFKKSTVLQL 156

Query: 371 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRS-------KPNTY 421
              +   + Y+H+     VH D+K+ NLL+      +V   D+GLS         K    
Sbjct: 157 GIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 422 ISSKTAAGTPEWM 434
              K   GT E+ 
Sbjct: 215 NPRKGHNGTIEFT 227

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	538
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.05
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.03
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.88
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.62
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.4
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.39
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.35
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.07
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.03
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.99
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.82
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.73
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.46
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.39
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.34
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.21
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.07
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.94
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.86
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.66
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.56
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.48
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.44
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.04
3isr_A	293	Transglutaminase-like enzymes, putative cysteine;	95.48
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.32
2f4m_A	295	Peptide N-glycanase; glycoproteins, ubiquitin-depe	94.76
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.23
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.81
1x3z_A	335	Peptide: N-glycanase; hydrolase-hydrolase inhibito	84.28
3kd4_A	506	Putative protease; structural genomics, joint cent	81.89
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.45

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-55  Score=448.46  Aligned_cols=263  Identities=37%  Similarity=0.625  Sum_probs=221.8

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ..|++..+++++.+.||+|+||+||+|++++ .||||+++.........+.|.+|+.+|++++|||||++++++.+ +.+
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence            3478899999999999999999999998654 59999988776677778899999999999999999999998865 568


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++|||||++|+|.++++...  ..+++..+..|+.||+.||+|||+++  ||||||||+|||+++++++||+|||+|+..
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            99999999999999996443  35899999999999999999999999  999999999999999999999999999865


Q ss_pred             CCC--ccccCCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc----cCC
Q 009291          418 PNT--YISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----LEI  488 (538)
Q Consensus       418 ~~~--~~~~~~~~gt~~Y~aPE~l~~---~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~----~~~  488 (538)
                      ...  .......+||+.|||||++.+   ..|+.++|||||||++|||+||+.||...+.......+......    ...
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~  262 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL  262 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence            432  222345689999999999864   45899999999999999999999999887665544433323222    235


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 009291          489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM  526 (538)
Q Consensus       489 p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~  526 (538)
                      +.++++++.+||.+||+.||++|||+.+|++.|+.+-.
T Consensus       263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            67899999999999999999999999999999986643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.3e-55  Score=450.99  Aligned_cols=263  Identities=36%  Similarity=0.569  Sum_probs=225.7

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      ..+..++|.+.++||+|+||+||+|++.+       ..||||++...  .....+.|.+|+++|++++|||||++++++.
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            45667889999999999999999998753       34999998643  4566788999999999999999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCC------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPD------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV  400 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl  400 (538)
                      ++..+++|||||++|+|.++++...            ...++++..++.|+.||+.||+|||+++  ||||||||+|||+
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl  191 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV  191 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE
Confidence            9999999999999999999996432            1246899999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 009291          401 DSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVIS  477 (538)
Q Consensus       401 ~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~  477 (538)
                      ++++.+||+|||+|+......  .......||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+...
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999999998654322  22245679999999999999999999999999999999999 899999998888777


Q ss_pred             HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          478 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       478 ~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      .+. .+.+++.|..+++++.+||.+||+.||++|||+.+|++.|+.+.+.
T Consensus       272 ~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 CIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            764 4567888999999999999999999999999999999999999765

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1e-55  Score=449.76  Aligned_cols=263  Identities=34%  Similarity=0.581  Sum_probs=229.8

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      .|..++|.+.+.||+|+||+||+|++.+       ..||||++...  .....+.|.+|+++|++++|||||++++++.+
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            4667899999999999999999998752       34999998653  45566789999999999999999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCC----------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPD----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~  403 (538)
                      ++.+++|||||++|+|.++++...          ....+++..++.|+.||+.||+|||+++  ||||||||+|||++++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence            999999999999999999996432          2346899999999999999999999999  9999999999999999


Q ss_pred             CcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 009291          404 YTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG  480 (538)
Q Consensus       404 ~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~  480 (538)
                      +.+||+|||+|+.......  ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...+..++...+.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999986433221  2233468999999999999999999999999999999998 899999999888877775


Q ss_pred             hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       481 ~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                       .+.+.+.|..+|+++.+||.+||+.||++|||+.+|++.|+++.+..
T Consensus       245 -~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          245 -QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             -HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             -cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence             45567788999999999999999999999999999999999988754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.1e-56  Score=459.42  Aligned_cols=252  Identities=28%  Similarity=0.466  Sum_probs=220.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++++.||+|+||+||+|+++.+  .||||++..........+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            46899999999999999999998744  4999999887777777889999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |||+||+|.+++.... ...+++..++.|+.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+|+......
T Consensus       103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999996432 335789999999999999999999999  9999999999999999999999999998765443


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+... ...+++..+|+++.+||.
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~  258 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVS  258 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHHHHHHH
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccCCHHHHHHHH
Confidence            3334567999999999999999999999999999999999999999999988887777533 334567889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 009291          502 TCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       502 ~cL~~dP~~RPs~~eIl~  519 (538)
                      +||+.||++|||++|+++
T Consensus       259 ~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          259 QLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHTCSSGGGSCCHHHHHT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999976

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-55  Score=448.56  Aligned_cols=261  Identities=31%  Similarity=0.530  Sum_probs=227.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      .++..+++++.+.||+|+||+||+|++.+       +.||||++.... .....+.|.+|+.++++++|||||++++++.
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            35677889999999999999999998742       349999986543 3344578999999999999999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEE
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLL  399 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NIL  399 (538)
                      ++..+++|||||++|+|.+++....             ....+++..++.|+.||+.||+|||+++  ||||||||+|||
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NIL  177 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVL  177 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceE
Confidence            9999999999999999999995432             1345899999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEEeeCCCccCCCC--ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 009291          400 VDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVI  476 (538)
Q Consensus       400 l~~~~~vkL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~  476 (538)
                      +++++++||+|||+|+.....  ........||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..++.
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999999864322  222345679999999999999999999999999999999998 89999999988887


Q ss_pred             HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          477 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       477 ~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      ..+. .+.+.+.|..+++++.+||.+||+.||++|||+.+|++.|+.+
T Consensus       258 ~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 EMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            7775 4566788999999999999999999999999999999999865

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4e-55  Score=446.28  Aligned_cols=248  Identities=25%  Similarity=0.409  Sum_probs=220.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++++.||+|+||+||+|+++.++  ||||++.+... .....+.+.+|+++|++++|||||++++++.+++.+|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            357999999999999999999987554  99999976532 223356789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      ||||+||+|.+++..   .+.+++..++.++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+|+.....
T Consensus       111 mEy~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          111 LSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999999963   346999999999999999999999999  999999999999999999999999999875432


Q ss_pred             --ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          421 --YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       421 --~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                        .....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+..  ....+|..+++++++
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~d  263 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARD  263 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTCCHHHHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCcccCHHHHH
Confidence              2234567899999999999999999999999999999999999999999988888777753  345678899999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIM  518 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl  518 (538)
                      ||.+||+.||++|||++|++
T Consensus       264 li~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGT
T ss_pred             HHHHHccCCHhHCcChHHHc
Confidence            99999999999999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-54  Score=447.59  Aligned_cols=247  Identities=28%  Similarity=0.435  Sum_probs=219.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      +.|+++++||+|+||+||+|+++.+  .||||++.......  .+.+.+|+.+|++++|||||+++++|.+++.+|+|||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5699999999999999999999754  49999987654332  3468899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      ||+||+|.+++..    ..+++..++.++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+|+.......
T Consensus       152 y~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          152 FLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             CCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            9999999999964    24899999999999999999999999  99999999999999999999999999987765544


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cccCCCCCCcHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~~LI~  501 (538)
                      ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+.... ...+.+..+++++++||.
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence            4567899999999999999999999999999999999999999999998888777665332 234445678999999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 009291          502 TCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       502 ~cL~~dP~~RPs~~eIl~  519 (538)
                      +||+.||++|||++|+++
T Consensus       306 ~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHcCCChhHCcCHHHHhc
Confidence            999999999999999865

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-54  Score=451.51  Aligned_cols=271  Identities=31%  Similarity=0.544  Sum_probs=233.0

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCC-------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCC-CceeEee
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLM  328 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h-pnIv~l~  328 (538)
                      ...|+|..++|++++.||+|+||+||+|.+.+.       .||||++.... .....+.|.+|+.+|++++| ||||+++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            345789999999999999999999999998653       38899886543 44556789999999999965 8999999


Q ss_pred             ceeccC-CcceEEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCC
Q 009291          329 GAVTEP-PNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK  394 (538)
Q Consensus       329 ~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLK  394 (538)
                      ++|.++ ..+++|||||++|+|.++++...             ....+++..+..++.||+.||+|||+++  |||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK  212 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA  212 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccC
Confidence            998664 56899999999999999996422             1345889999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEEeeCCCccCCCC--ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009291          395 SPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST  471 (538)
Q Consensus       395 p~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~  471 (538)
                      |+|||+++++.+||+|||+|+.....  ........||+.|||||++.+..|+.++|||||||++|||+| |+.||...+
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999865432  222345678999999999999999999999999999999998 899999876


Q ss_pred             HHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       472 ~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      ..+........+.+++.|..+++++.+||.+||+.||++|||+.+|++.|++++++...
T Consensus       293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~  351 (353)
T 4ase_A          293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ  351 (353)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred             HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence            55555444456678889999999999999999999999999999999999999987654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-54  Score=435.71  Aligned_cols=247  Identities=32%  Similarity=0.524  Sum_probs=213.3

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc----CCcceEE
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNLSIV  340 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~----~~~~~lV  340 (538)
                      |++.++||+|+||+||+|.+..++  ||+|++..........+.|.+|+.+|++++|||||+++++|.+    +..+|+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            478889999999999999997654  9999998777777778899999999999999999999999864    3458999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCCCccCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~  419 (538)
                      ||||++|+|.++++.   ...+++..++.++.||+.||+|||+++++||||||||+|||++. +|.+||+|||+|+....
T Consensus       108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999964   34689999999999999999999999888999999999999974 78999999999986544


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      ..  ..+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ......+........++..+++++.+
T Consensus       185 ~~--~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (290)
T 3fpq_A          185 SF--AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             TS--BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             Cc--cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence            32  346789999999999875 599999999999999999999999976544 44444554444445566778999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ||.+||+.||++|||++|+++
T Consensus       262 li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          262 IIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.7e-54  Score=443.16  Aligned_cols=254  Identities=28%  Similarity=0.415  Sum_probs=220.4

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ....|++.++||+|+||+||+|+++.+  .||||++.....       ..+|+.+++.++|||||++++++.++..+|+|
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            346799999999999999999998754  499999976543       24699999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-cEEEEeeCCCccCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPN  419 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~~  419 (538)
                      ||||+||+|.++++..   ..+++..++.++.||+.||+|||+++  ||||||||+|||++.+| ++||+|||+|+....
T Consensus       129 mEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             ECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            9999999999999643   46999999999999999999999999  99999999999999887 699999999986543


Q ss_pred             Ccc-----ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc-cCCCCCCc
Q 009291          420 TYI-----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-LEIPKNVN  493 (538)
Q Consensus       420 ~~~-----~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~s  493 (538)
                      ...     .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+...... ..+|+.++
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s  283 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA  283 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence            211     123457999999999999999999999999999999999999999987776666666544333 35788999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +++.+||.+||+.||++|||+.||++.|..++...
T Consensus       284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence            99999999999999999999999999999988764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.8e-55  Score=445.09  Aligned_cols=252  Identities=26%  Similarity=0.391  Sum_probs=213.6

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEc-----CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      .+..++|++++.||+|+||+||+|++.     +..||||++............+.+|+++|++++|||||++++++.+++
T Consensus        20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            345578999999999999999999873     234999998765433333346788999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+|||||+||+|.+++...   ..+++..+..++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+|+
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~  174 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSK  174 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccce
Confidence            999999999999999999643   36999999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      ..........+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+..  ....+|..+|++
T Consensus       175 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~  252 (304)
T 3ubd_A          175 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQFLSPE  252 (304)
T ss_dssp             C-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred             eccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCcCCHH
Confidence            755444445677899999999999999999999999999999999999999999998888777743  345678899999


Q ss_pred             HHHHHHHhhhcCCCCCCCH-----HHHHH
Q 009291          496 VAALIETCWAEEPEIRPSF-----PSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~-----~eIl~  519 (538)
                      +.+||.+||+.||++|||+     +|+++
T Consensus       253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          253 AQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            9999999999999999984     56654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-53  Score=428.90  Aligned_cols=246  Identities=30%  Similarity=0.479  Sum_probs=202.8

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++++.||+|+||+||+|++..  +.||+|++....... ...+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            689999999999999999999864  449999997654433 33567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+ +|+|.+++...   ..+++..+..++.||+.||+|||++|  ||||||||+|||+++++++||+|||+|+......
T Consensus        93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 67899988643   35999999999999999999999999  9999999999999999999999999998755432


Q ss_pred             cccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                       ...+.+||+.|||||++.+..+ +.++|||||||++|+|++|+.||...+..+....+..  ....+|..+|+++.+||
T Consensus       167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li  243 (275)
T 3hyh_A          167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--GVYTLPKFLSPGAAGLI  243 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHH
T ss_pred             -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence             2346789999999999998876 5799999999999999999999999888777776643  34567889999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||+.||++|||++|+++
T Consensus       244 ~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHc
Confidence            9999999999999999976

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.7e-53  Score=449.46  Aligned_cols=248  Identities=28%  Similarity=0.442  Sum_probs=220.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .+.|++++.||+|+||+||+|+++.++  ||||++......  ..+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            357999999999999999999997544  999998765432  2356889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |||+||+|.++++..    .+++..++.++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+|+......
T Consensus       228 Ey~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          228 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             ECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             eCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            999999999999632    4899999999999999999999999  9999999999999999999999999998766554


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~~LI  500 (538)
                      ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+.... ..+..+..+++++.+||
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  381 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  381 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence            44567789999999999999999999999999999999999999999998888777765332 23455678999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||+.||++|||+.|+++
T Consensus       382 ~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          382 DRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHcCCChhHCcCHHHHhc
Confidence            9999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-51  Score=418.01  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=193.1

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC-------
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-------  335 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~-------  335 (538)
                      ++|++++.||+|+||+||+|+++.+  .||||++.... .....+.+.+|+.+|++++|||||+++++|.+.+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            5799999999999999999998744  49999987654 4455678999999999999999999999986544       


Q ss_pred             -----cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEe
Q 009291          336 -----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD  410 (538)
Q Consensus       336 -----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~D  410 (538)
                           .+|+|||||++|+|.+++.........++..++.++.||+.||+|||++|  ||||||||+|||++.+|.+||+|
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence                 36899999999999999976544444566778999999999999999999  99999999999999999999999


Q ss_pred             eCCCccCCCCcc------------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH
Q 009291          411 FGLSRSKPNTYI------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VIS  477 (538)
Q Consensus       411 FGla~~~~~~~~------------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~-~~~  477 (538)
                      ||+|+.......            .....+||+.|||||++.+..|+.++|||||||++|||++   ||....... ...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            999986543211            1234579999999999999999999999999999999996   776533221 112


Q ss_pred             HHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          478 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       478 ~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+. .....+.+...++.+.+||.+||+.||++|||+.|+++
T Consensus       239 ~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          239 DVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            221 11111122334567889999999999999999999876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.2e-51  Score=417.63  Aligned_cols=257  Identities=29%  Similarity=0.473  Sum_probs=202.7

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC----cceEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----NLSIV  340 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~----~~~lV  340 (538)
                      .+|.+.+.||+|+||+||+|+++++.||||++....   .....+..|+..+.+++|||||++++++.+++    .+++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            468999999999999999999999899999986542   22123345666667889999999999987654    47999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC------CCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR------RPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ||||++|+|.++++..    .+++..+..++.|++.||+|||++      .++||||||||+|||++.++++||+|||+|
T Consensus        80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999643    488999999999999999999987      123999999999999999999999999999


Q ss_pred             ccCCCCcc----ccCCCCCCCcccccccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCC----------C----
Q 009291          415 RSKPNTYI----SSKTAAGTPEWMAPEVLRED------PSNEKSDVFSFGVILWELITLQKPWRN----------S----  470 (538)
Q Consensus       415 ~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~------~~s~ksDVwSLGvil~eLltg~~Pf~~----------~----  470 (538)
                      +.......    .....+||+.|||||++.+.      .++.++|||||||++|||+||..||..          .    
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            86433211    12345799999999999764      367899999999999999999765532          1    


Q ss_pred             -CHHHHHHHHhhcCcccCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          471 -TPSQVISAVGFKGRRLEIPKN-----VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       471 -~~~~~~~~i~~~~~~~~~p~~-----~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                       ........+.....+..+|..     +++.+.+||.+||+.||++|||+.||++.|+++.++.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence             122333344334445555543     3457899999999999999999999999999988654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.5e-50  Score=409.22  Aligned_cols=279  Identities=71%  Similarity=1.167  Sum_probs=235.9

Q ss_pred             hcccccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       256 ~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ....+++...+|++.+.||+|+||+||+|++.++.||||++..........+.+.+|+.++++++||||+++++++.+..
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            45667888999999999999999999999998888999999887777787889999999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+++++|.+++........+++..++.++.|++.||+|||++|++|+||||||+||+++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            99999999999999999976554445899999999999999999999998789999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      .............||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.....+..++..++++
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (309)
T 3p86_A          188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ  267 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            65554444456789999999999999999999999999999999999999999999888887777677788889999999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCCC
Q 009291          496 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS  534 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~~  534 (538)
                      +.+||.+||+.||++|||+.++++.|+.++++..+.|..
T Consensus       268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~  306 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR  306 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence            999999999999999999999999999999988776654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=417.38  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=210.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc------CCc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPN  336 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~------~~~  336 (538)
                      ++|++++.||+|+||+||+|+++.+  .||||++..........+.+.+|+.+|+.++|||||++++++..      ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999998754  49999998776667777889999999999999999999998753      356


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|+|||||. |+|.+++..   ...+++..+..++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999996 579998864   346999999999999999999999999  99999999999999999999999999986


Q ss_pred             CCCC----ccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc-----
Q 009291          417 KPNT----YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL-----  486 (538)
Q Consensus       417 ~~~~----~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~-----  486 (538)
                      ....    .....+.+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+.......     
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            5332    1223467899999999998875 46999999999999999999999999988877766553211100     


Q ss_pred             -------------------C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 -------------------E-----IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 -------------------~-----~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                         +     ..+.+++++.+||.+||+.||++|||+.|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                               0     11357899999999999999999999999865

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.3e-47  Score=421.09  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=218.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++++.||+|+||+||+|.++.++  ||+|++....  ....+.+.+|+.+|+.++|||||+++++|.++..+|+||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            368999999999999999999987554  9999987643  444567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC--CcEEEEeeCCCccCCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST--YTVKVCDFGLSRSKPN  419 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~--~~vkL~DFGla~~~~~  419 (538)
                      |||+||+|.+++...  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.+  +.+||+|||+|+....
T Consensus       234 E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          234 EFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             ECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             eecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999998643  235999999999999999999999999  9999999999999854  8999999999987654


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--CCCCCCcHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVA  497 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~s~~l~  497 (538)
                      .. .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+......+  ..+..++++++
T Consensus       310 ~~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          310 KQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             TS-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             CC-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            32 2345689999999999999999999999999999999999999999999888887775443332  23357899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||+.|+++
T Consensus       389 dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          389 DFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.6e-47  Score=397.90  Aligned_cols=244  Identities=25%  Similarity=0.344  Sum_probs=197.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc-----CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~  337 (538)
                      .++|++++.||+|+||+||+|+++     +..||+|++.... .   ...+.+|+++|+.+ +||||++++++|.+.+.+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            367999999999999999999874     2349999886543 1   24577899999998 699999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC-CcEEEEeeCCCcc
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRS  416 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~~  416 (538)
                      |+||||+++|+|.++++      .+++..+..++.||+.||+|||++|  ||||||||+|||++.+ +.+||+|||+|+.
T Consensus        96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            99999999999999984      3889999999999999999999999  9999999999999876 8999999999975


Q ss_pred             CCCCcc----------------------------ccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 009291          417 KPNTYI----------------------------SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPW  467 (538)
Q Consensus       417 ~~~~~~----------------------------~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf  467 (538)
                      ..+...                            ...+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            433210                            12345799999999999876 4899999999999999999999999


Q ss_pred             CCCC-HHHHHHHHhhc----------------------------------------------------CcccCCCCCCcH
Q 009291          468 RNST-PSQVISAVGFK----------------------------------------------------GRRLEIPKNVNP  494 (538)
Q Consensus       468 ~~~~-~~~~~~~i~~~----------------------------------------------------~~~~~~p~~~s~  494 (538)
                      ...+ ..+.+..+...                                                    ....+....+++
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            6543 32222221100                                                    000112245789


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ++.+||.+||+.||++|+|++|+++
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhc
Confidence            9999999999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.1e-47  Score=422.56  Aligned_cols=251  Identities=25%  Similarity=0.381  Sum_probs=211.8

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc----CHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF----HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~----~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      ..+..++|++++.||+|+||+||+|+++.++  ||||++.+...    .........+++.+++.++|||||+++++|.+
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            3556789999999999999999999997655  99999976432    22223333445677788899999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      .+.+|+|||||+||+|.+++..   .+.+++..+..++.||+.||+|||++|  ||||||||+|||++.+|++||+|||+
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccce
Confidence            9999999999999999999964   346999999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhhcCcccCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFKGRRLEIP  489 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~---~~~~~~i~~~~~~~~~p  489 (538)
                      |+......  ..+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||...+.   .++...+  ......+|
T Consensus       339 A~~~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p  414 (689)
T 3v5w_A          339 ACDFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELP  414 (689)
T ss_dssp             CEECSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCC
T ss_pred             eeecCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCC
Confidence            98765432  356789999999999964 5799999999999999999999999976432   2333333  33456778


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPS-----FPSIME  519 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs-----~~eIl~  519 (538)
                      ..+|+++++||.+||+.||++|++     +++|++
T Consensus       415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            899999999999999999999998     677754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8e-46  Score=366.95  Aligned_cols=260  Identities=29%  Similarity=0.601  Sum_probs=233.0

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC--Ccc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNL  337 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~--~~~  337 (538)
                      ..+..++|++.+.||+|+||+||+|++.++.+|+|++..........+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            456778999999999999999999999988899999988777777778899999999999999999999999877  778


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+++++|.+++.... ...+++..++.++.|++.||+|||+++++|+||||||+||+++.++.++|+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             EeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            99999999999999997543 23589999999999999999999998888999999999999999999999999987653


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNE---KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~---ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      ..     ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||...+..+....+.....+..++..+++
T Consensus       164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence            22     3457899999999998765544   899999999999999999999999888877777667777888899999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      .+.++|.+||+.||++|||+.++++.|+++.
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            9999999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.8e-46  Score=380.86  Aligned_cols=250  Identities=29%  Similarity=0.466  Sum_probs=222.7

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ...++|++.+.||+|+||.||+|.+.  ++.||||++..........+.+.+|+.+++.++||||+++++++.+...+++
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            34578999999999999999999985  4459999998877777778889999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      ||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++.....
T Consensus        92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            99999999999998633   35899999999999999999999999  99999999999999999999999999976543


Q ss_pred             CccccCCCCCCCcccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s-~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      .. .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..+....+...  ...+|..+++.+.+
T Consensus       167 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~  243 (328)
T 3fe3_A          167 GG-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFYMSTDCEN  243 (328)
T ss_dssp             SC-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHH
T ss_pred             CC-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence            32 23466899999999999888775 7999999999999999999999999888877766433  44567789999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ||++||+.||++|||++|+++
T Consensus       244 li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          244 LLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999976

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-45  Score=383.36  Aligned_cols=266  Identities=32%  Similarity=0.577  Sum_probs=229.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC---------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG  329 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~---------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~  329 (538)
                      +++..++|++++.||+|+||+||+|++.+         ..||||++... ......+.+.+|+.+++++ +||||+++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            46677899999999999999999998742         12899998654 3456677899999999999 8999999999


Q ss_pred             eeccCCcceEEEeecCCCChhhhhcCCCC-------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCC
Q 009291          330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP  396 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~  396 (538)
                      ++.+...+++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||++|  |+||||||+
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~  232 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR  232 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchh
Confidence            99999999999999999999999964321             234788999999999999999999999  999999999


Q ss_pred             CEEEcCCCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 009291          397 NLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPS  473 (538)
Q Consensus       397 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~  473 (538)
                      |||++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999986543221  2233456789999999999999999999999999999999 99999988877


Q ss_pred             HHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          474 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       474 ~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      +....+. ...+...|..+++++.+||.+||+.||++|||+.++++.|++++....
T Consensus       313 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          313 ELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             GHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            6665553 445667788999999999999999999999999999999999987543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=376.87  Aligned_cols=268  Identities=36%  Similarity=0.525  Sum_probs=228.8

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      .++..++|++.+.||+|+||+||+|.+..+     .||||++.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            356678999999999999999999998532     29999986543 455667899999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ..+++||||+++++|.++++...  ..+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLS  198 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcc
Confidence            99999999999999999996432  35899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCC
Q 009291          415 RSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       415 ~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  490 (538)
                      +.......   ......+|..|+|||++.+..++.++||||||+++|||++ |..||......+....+. ...+.+.+.
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~  277 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPM  277 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCT
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCC
Confidence            87543221   1223346778999999998899999999999999999999 999999988887777664 445667788


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL  533 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~  533 (538)
                      .+++.+.+||.+||..||++|||+.+|++.|+.++.+......
T Consensus       278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~  320 (325)
T 3kul_A          278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA  320 (325)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC----
T ss_pred             CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccc
Confidence            9999999999999999999999999999999999987765443

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.9e-46  Score=379.75  Aligned_cols=278  Identities=29%  Similarity=0.503  Sum_probs=214.0

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      +...+..++|++++.||+|+||+||+|++..+     .||||++..........+.+.+|+.++++++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            34567778999999999999999999987643     4899998776555666788999999999999999999999998


Q ss_pred             cCCcc------eEEEeecCCCChhhhhcCC---CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC
Q 009291          333 EPPNL------SIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       333 ~~~~~------~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~  403 (538)
                      .....      ++||||+.+++|.+++...   .....+++..++.++.|++.||+|||++|  |+||||||+||+++++
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED  173 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC
Confidence            77655      9999999999999998432   22225889999999999999999999999  9999999999999999


Q ss_pred             CcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 009291          404 YTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG  480 (538)
Q Consensus       404 ~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~  480 (538)
                      +.+||+|||+++.......  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            9999999999986543221  1223456788999999999999999999999999999999 899999888777666553


Q ss_pred             hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCCCCCCC
Q 009291          481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL  538 (538)
Q Consensus       481 ~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~~~~p~  538 (538)
                       .......+..+++++.+||.+||+.||++|||+.++++.|++++......+.+..||
T Consensus       254 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl  310 (323)
T 3qup_A          254 -GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL  310 (323)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred             -cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence             445667788899999999999999999999999999999999999998888888875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-45  Score=379.41  Aligned_cols=252  Identities=26%  Similarity=0.453  Sum_probs=220.0

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +..++|++++.||+|+||+||+|++..+  .||+|++..... .....+.+.+|+.+++.++||||+++++++.+...++
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            3457899999999999999999998744  499999876432 1223467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++|+|..++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++...
T Consensus        82 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999999998632   35899999999999999999999999  9999999999999999999999999998644


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..  ....+|..+++++.+
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~  234 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKS  234 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred             cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHH
Confidence            333344567899999999999999999999999999999999999999999888777666643  345678889999999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHHHH
Q 009291          499 LIETCWAEEPEIRP-----SFPSIMET  520 (538)
Q Consensus       499 LI~~cL~~dP~~RP-----s~~eIl~~  520 (538)
                      ||.+||+.||++||     +++++++.
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            99999999999999     89988763

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.2e-45  Score=363.16  Aligned_cols=261  Identities=34%  Similarity=0.590  Sum_probs=228.4

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+.+..++|++.+.||+|+||+||+|.+.+ ..||+|++.......   +.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            466788999999999999999999999854 449999987665444   4688999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             EEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccc
Confidence            99999999999999996433  35899999999999999999999999  999999999999999999999999999865


Q ss_pred             CCCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          418 PNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       418 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      .... .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..+++.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  235 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTH  235 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred             cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHH
Confidence            4332 12234556788999999998999999999999999999999 999999988877776664 34456667788999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          496 VAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      +.++|.+||+.||++|||+.++++.|+++..+
T Consensus       236 ~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            99999999999999999999999999999865

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.2e-45  Score=370.86  Aligned_cols=248  Identities=27%  Similarity=0.454  Sum_probs=217.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..+|++.+.||+|+||+||+|.+..  ..||+|++.......  .+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            4679999999999999999998754  449999987654333  356889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+++|.+++...    .+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++.......
T Consensus        97 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            999999999999643    4889999999999999999999999  9999999999999999999999999998765544


Q ss_pred             cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-cCcccCCCCCCcHHHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-KGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~s~~l~~LI  500 (538)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.. .......+..+++.+.+||
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred             cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence            444567899999999999999999999999999999999999999998887766555433 2334556778999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||+.||++|||+.++++
T Consensus       251 ~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHhh
Confidence            9999999999999999975

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.2e-45  Score=363.78  Aligned_cols=259  Identities=39%  Similarity=0.661  Sum_probs=216.3

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccC--HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~--~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      +++..++|++.+.||+|+||+||+|.+.++.+|+|++......  ....+.+.+|+.+++.++||||+++++++.++...
T Consensus         2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CBCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             CccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            3567789999999999999999999999888999998654322  23356788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCC-CCEEeecCCCCCEEEcC--------CCcEEE
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PPIVHRDLKSPNLLVDS--------TYTVKV  408 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~~iiHrDLKp~NILl~~--------~~~vkL  408 (538)
                      ++||||+++++|.+++..    ..+++..++.++.|++.||+|||+++ .+|+||||||+||+++.        ++.+||
T Consensus        82 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             EEEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             EEEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            999999999999999853    25889999999999999999999988 33889999999999985        778999


Q ss_pred             EeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCC
Q 009291          409 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI  488 (538)
Q Consensus       409 ~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~  488 (538)
                      +|||++.......  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+.......+.
T Consensus       158 ~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          158 TDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI  235 (271)
T ss_dssp             CCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred             ccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence            9999998654332  23457899999999999999999999999999999999999999998888777777666677788


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       489 p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      +..+++.+.++|.+||+.||++|||+.++++.|+++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            889999999999999999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.6e-45  Score=379.53  Aligned_cols=269  Identities=31%  Similarity=0.559  Sum_probs=228.8

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEee
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM  328 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~  328 (538)
                      ...+++..++|++++.||+|+||.||+|++.+       ..||||++.... .....+.+.+|+.+++++ +||||++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            34567888999999999999999999998643       339999986543 455567899999999999 799999999


Q ss_pred             ceeccCCc-ceEEEeecCCCChhhhhcCCCC-------------------------------------------------
Q 009291          329 GAVTEPPN-LSIVTEYLSRGSLYKLLHIPDA-------------------------------------------------  358 (538)
Q Consensus       329 ~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------  358 (538)
                      +++.+... +++||||+.+|+|.++++....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99877554 8999999999999999965432                                                 


Q ss_pred             --------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC--cc
Q 009291          359 --------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YI  422 (538)
Q Consensus       359 --------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~--~~  422 (538)
                                    ...+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                          122889999999999999999999999  999999999999999999999999999865332  12


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~  501 (538)
                      ......||..|+|||++.+..++.++||||||+++|||++ |..||......+..............+..+++++.++|.
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  330 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML  330 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            2344567889999999999999999999999999999998 999998877655555554556677788889999999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          502 TCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       502 ~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +||+.||++|||+.++++.|++++.+.
T Consensus       331 ~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            999999999999999999999998754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.7e-45  Score=384.12  Aligned_cols=264  Identities=35%  Similarity=0.568  Sum_probs=229.1

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ..+.+..++|++.+.||+|+||.||+|++.  ++.||||++... ......+.+.+|+.++++++||||+++++++.+..
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            456788899999999999999999999996  445999997644 34555678899999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+++|+|.++++..  ...+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             CcEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            999999999999999999642  235889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCcccc--CCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          416 SKPNTYISS--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       416 ~~~~~~~~~--~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      .........  ....++..|+|||++.+..++.++|||||||++|||++ |..||......+....+. ...+.+.|..+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  340 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELC  340 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTC
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence            654432221  12234678999999998889999999999999999998 999999988877665553 45667788899


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      ++++.+||.+||+.||++|||+.+|++.|+++.+.
T Consensus       341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            99999999999999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=378.08  Aligned_cols=272  Identities=32%  Similarity=0.578  Sum_probs=234.7

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC---------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEe
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL  327 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~---------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l  327 (538)
                      ..+++..++|++++.||+|+||+||+|++.+         ..||+|++... ......+.+.+|+++++++ +||||+++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            3457778899999999999999999998753         23899998654 3556678899999999999 89999999


Q ss_pred             eceeccCCcceEEEeecCCCChhhhhcCCCC-------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCC
Q 009291          328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK  394 (538)
Q Consensus       328 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLK  394 (538)
                      ++++.++...++||||+.+|+|.+++.....             ...+++..++.++.|++.||+|||+++  |+|||||
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk  218 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA  218 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence            9999999999999999999999999964321             235899999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009291          395 SPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST  471 (538)
Q Consensus       395 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~  471 (538)
                      |+|||++.++.+||+|||+++......  .......+|..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999998654322  12234456789999999999999999999999999999999 999999988


Q ss_pred             HHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 009291          472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL  533 (538)
Q Consensus       472 ~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~  533 (538)
                      ..+....+. ...+...+..+++++.+||.+||+.||++|||+.++++.|++++.....+..
T Consensus       299 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  359 (382)
T 3tt0_A          299 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM  359 (382)
T ss_dssp             HHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred             HHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence            877666553 4556677888999999999999999999999999999999999977655543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.1e-45  Score=364.65  Aligned_cols=264  Identities=31%  Similarity=0.552  Sum_probs=216.5

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      .+++..++|++.+.||+|+||.||+|.+..+     .+|+|+.... ......+.+.+|+.++++++||||+++++++. 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   86 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   86 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence            4677788999999999999999999988543     2788876543 24556678999999999999999999999985 


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ++..++||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             cCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccc
Confidence            456899999999999999996432  35889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          414 SRSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       414 a~~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      ++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....+. ...+.+.+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~  241 (281)
T 1mp8_A          163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPN  241 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTT
T ss_pred             ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCC
Confidence            986543221 1233456788999999998899999999999999999997 999999888777666554 3445667889


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      +++.+.++|.+||+.||++|||+.++++.|++++.+..
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence            99999999999999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-44  Score=367.06  Aligned_cols=267  Identities=31%  Similarity=0.585  Sum_probs=230.4

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeec
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG  329 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~  329 (538)
                      ...+++..++|++.+.||+|+||.||+|.+..       ..||+|++.... .....+.+.+|+.++++++||||+++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence            34567788999999999999999999998732       348999986543 4566788999999999999999999999


Q ss_pred             eeccCCcceEEEeecCCCChhhhhcCCCC---------------------CccccHHHHHHHHHHHHHHHHHHHhCCCCE
Q 009291          330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDA---------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPI  388 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~i  388 (538)
                      ++.+....++||||+.+++|.+++.....                     ...+++..++.++.|++.||+|||++|  |
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i  171 (314)
T 2ivs_A           94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--L  171 (314)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred             EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--C
Confidence            99999999999999999999999964332                     234889999999999999999999999  9


Q ss_pred             EeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCC
Q 009291          389 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQK  465 (538)
Q Consensus       389 iHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~  465 (538)
                      +||||||+||+++.++.+||+|||++.......  .......++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998654322  12234456788999999999889999999999999999999 999


Q ss_pred             CCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          466 PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       466 Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      ||...........+. .......+..+++.+.++|.+||+.||++|||+.++++.|++++..
T Consensus       252 p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          252 PYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             SSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            999888776665553 4445667788999999999999999999999999999999999865

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=364.71  Aligned_cols=252  Identities=29%  Similarity=0.450  Sum_probs=210.5

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCH------------------------HHHHHHHHHHHH
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE------------------------DRFKEFLREVAI  315 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~------------------------~~~~~~~~Ei~i  315 (538)
                      +..++|++.+.||+|+||.||+|.+..+  .||||++.......                        ...+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            4467899999999999999999998654  49999987653211                        124578899999


Q ss_pred             HHcCCCCceeEeeceecc--CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecC
Q 009291          316 MKGLRHPNIVLLMGAVTE--PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL  393 (538)
Q Consensus       316 l~~L~hpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDL  393 (538)
                      +++++||||+++++++.+  ...+++||||+++++|.+++..    ..+++..++.++.|++.||+|||++|  |+||||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dl  163 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDI  163 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCC
Confidence            999999999999999876  5678999999999999887542    35899999999999999999999999  999999


Q ss_pred             CCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009291          394 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNS  470 (538)
Q Consensus       394 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~---~s~ksDVwSLGvil~eLltg~~Pf~~~  470 (538)
                      ||+||+++.++.+||+|||+++.............||+.|+|||++.+..   ++.++|||||||++|+|++|+.||...
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99999999999999999999987654433334567999999999998765   378899999999999999999999988


Q ss_pred             CHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          471 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       471 ~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ........+.......+....+++.+.+||.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            8776666665444444445678999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-44  Score=362.01  Aligned_cols=263  Identities=33%  Similarity=0.570  Sum_probs=227.2

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      ..+++..++|++++.||+|+||+||++.+.++ .||+|++.......   +.+.+|+.++++++|+||+++++++.+...
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            45678889999999999999999999998765 49999987665444   468899999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +++||||+.+++|.+++...  ...+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++..
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             eEEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccc
Confidence            99999999999999999642  235899999999999999999999999  99999999999999999999999999986


Q ss_pred             CCCCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          417 KPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       417 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      ..... .......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. ...+...+..+++
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  248 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASE  248 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred             ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCH
Confidence            54322 12234456788999999998899999999999999999998 999999988877766664 4455666778899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .+.++|.+||+.+|++|||+.++++.|++++...
T Consensus       249 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          249 KVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            9999999999999999999999999999998754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.7e-45  Score=389.04  Aligned_cols=262  Identities=35%  Similarity=0.636  Sum_probs=229.0

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC-
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-  335 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~-  335 (538)
                      ...+++..++|++.+.||+|+||.||+|.+.++.||||++....    ..+.+.+|+.+|++++||||+++++++.+.. 
T Consensus       185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred             ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence            45678899999999999999999999999998889999987543    3357899999999999999999999976655 


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+++|+|.++++... ...+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence            7899999999999999996432 224789999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      ......   ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .+.+...|..+++
T Consensus       338 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~  413 (450)
T 1k9a_A          338 EASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP  413 (450)
T ss_dssp             ECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred             cccccc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCH
Confidence            643321   23467889999999999999999999999999999998 999999887777666654 4567788899999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      .+.+||.+||+.||++|||+.++++.|+++.....
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l  448 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL  448 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence            99999999999999999999999999999987654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-44  Score=358.73  Aligned_cols=260  Identities=34%  Similarity=0.625  Sum_probs=226.1

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +++..++|++.+.||+|+||+||+|++.++ .||+|++.......   +.+.+|+.++++++||||+++++++.+....+
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            467788999999999999999999988765 49999987655443   46889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++++|.+++...  ...+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++....
T Consensus        80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred             EEEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecc
Confidence            999999999999999643  234899999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          419 NTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       419 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ... .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .......+..+++.+
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  234 (268)
T 3sxs_A          156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTI  234 (268)
T ss_dssp             TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHH
T ss_pred             hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHH
Confidence            432 22234456778999999998889999999999999999999 999999888877766654 444556677889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      .++|.+||+.||++|||+.++++.|+.+...
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          235 YQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            9999999999999999999999999887543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=385.31  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=220.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++++.||+|+||+||+|.+..+  .+|+|++..........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999998654  4999999877766667788999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc---CCCcEEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla~~~~  418 (538)
                      ||+.+|+|.+.+...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++   +++.+||+|||++....
T Consensus        90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999988643   35899999999999999999999999  99999999999998   46789999999998766


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l  496 (538)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+.+  ..+++++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            54444456789999999999999999999999999999999999999999998888877776554443333  4789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||.+||+.||++|||+.++++
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCCCHHHHhc
Confidence            99999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-45  Score=373.48  Aligned_cols=266  Identities=34%  Similarity=0.542  Sum_probs=227.4

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      +++..++|++++.||+|+||.||+|++.+       ..||+|++.... .....+.+.+|+.++++++||||+++++++.
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            56677899999999999999999999874       449999986543 4555678999999999999999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCC---------------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEee
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDA---------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR  391 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHr  391 (538)
                      +...+++||||+++++|.+++.....                     ...+++..++.++.||+.||+|||++|  |+||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~  198 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR  198 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence            99999999999999999999964321                     146889999999999999999999999  9999


Q ss_pred             cCCCCCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 009291          392 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWR  468 (538)
Q Consensus       392 DLKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~  468 (538)
                      ||||+||+++.++.+||+|||++.......  .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            999999999999999999999997543221  12234567889999999999899999999999999999999 999999


Q ss_pred             CCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          469 NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       469 ~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      .....+....+. .......+..+++.+.+||.+||+.||++|||+.++++.|+++.....
T Consensus       279 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          279 GMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             TSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            988877766654 344556788899999999999999999999999999999999886554

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=380.75  Aligned_cols=252  Identities=24%  Similarity=0.406  Sum_probs=213.3

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~  336 (538)
                      .+..++|++++.||+|+||+||+|+++.+  .||+|++..... .....+.+.+|..+++.+ +||||+++++++.+...
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            35567999999999999999999998754  499999876432 223356788999999988 79999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|+||||+.+|+|..++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++.
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceee
Confidence            99999999999999998643   35899999999999999999999999  99999999999999999999999999986


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ...........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..  ....+|..+++.+
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~  251 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLHEDA  251 (353)
T ss_dssp             SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred             cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHH
Confidence            44443344567899999999999999999999999999999999999999999998887777743  3456778899999


Q ss_pred             HHHHHHhhhcCCCCCCCH------HHHHH
Q 009291          497 AALIETCWAEEPEIRPSF------PSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~------~eIl~  519 (538)
                      .+||++||+.||++||++      +++++
T Consensus       252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          252 TGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            999999999999999998      66654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.3e-45  Score=368.80  Aligned_cols=262  Identities=33%  Similarity=0.525  Sum_probs=218.2

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      .+..++|++++.||+|+||+||+|.+..+  .+|+|++..  ......+.+.+|+.++++++||||+++++++.++...+
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            35568999999999999999999998754  489998744  35666788999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            9999999999999997532  35889999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCccc--------------cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-hcC
Q 009291          419 NTYIS--------------SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-FKG  483 (538)
Q Consensus       419 ~~~~~--------------~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~-~~~  483 (538)
                      .....              .....||+.|+|||++.+..++.++||||||+++|||++|..||............. ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  239 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF  239 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence            32211              114578999999999999999999999999999999999999987543321100000 001


Q ss_pred             cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          484 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       484 ~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .....+..+++.+.++|.+||+.||++|||+.++++.|+++....
T Consensus       240 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            122356788999999999999999999999999999999887654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.7e-44  Score=365.75  Aligned_cols=269  Identities=30%  Similarity=0.501  Sum_probs=229.8

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeec
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG  329 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~  329 (538)
                      ..+++..++|++.+.||+|+||+||+|++.+       ..||+|++.... .....+.+.+|+.+++++ +||||+++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   94 (313)
T 1t46_A           16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (313)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence            4467788899999999999999999998632       349999986543 345567899999999999 9999999999


Q ss_pred             eeccCCcceEEEeecCCCChhhhhcCCCC---------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCC
Q 009291          330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDA---------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK  394 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLK  394 (538)
                      ++.++...++||||+++|+|.+++.....               ...+++..++.++.|++.||+|||++|  |+|||||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk  172 (313)
T 1t46_A           95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA  172 (313)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCc
Confidence            99999999999999999999999964332               224889999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009291          395 SPNLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST  471 (538)
Q Consensus       395 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~  471 (538)
                      |+||+++.++.+||+|||++........  ......+|..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999999999999999999986544321  1234456788999999999999999999999999999999 999998876


Q ss_pred             HHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       472 ~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      .............+...+..+++.+.++|.+||+.||++|||+.++++.|++++.+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            6555544444555566678899999999999999999999999999999999998654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=372.58  Aligned_cols=270  Identities=32%  Similarity=0.498  Sum_probs=224.0

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeec
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG  329 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~  329 (538)
                      ..+++..++|++.+.||+|+||+||+|.+.+       ..||+|++.... .....+.+.+|+.+++++ +||||+++++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3467888999999999999999999999732       239999986543 334457889999999999 8999999999


Q ss_pred             eeccCCcceEEEeecCCCChhhhhcCCCCC--------------------ccccHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 009291          330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDAR--------------------VVVDERLRLNMAYDVAKGMNYLHQRRPPIV  389 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~ii  389 (538)
                      ++.....+++||||+++|+|.+++......                    ..+++..++.++.||+.||+|||++|  |+
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv  194 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV  194 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence            999999999999999999999999654321                    34789999999999999999999999  99


Q ss_pred             eecCCCCCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 009291          390 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKP  466 (538)
Q Consensus       390 HrDLKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~P  466 (538)
                      ||||||+||+++.++.+||+|||++.......  .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999997543221  11234456788999999999999999999999999999998 9999


Q ss_pred             CCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          467 WRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       467 f~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      |.....................+..+++++.+||.+||+.||++|||+.++++.|+.++.....
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            9887765555555445566777888999999999999999999999999999999999876543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-44  Score=357.15  Aligned_cols=269  Identities=30%  Similarity=0.521  Sum_probs=230.4

Q ss_pred             ccccccceeEEE-EEccCCcEEEEEEEEc----CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          260 LEIRWSELLIKK-KIGEGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       260 ~~i~~~~y~i~~-~LG~G~fg~Vy~a~~~----~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +.+..++|.+.+ .||+|+||.||+|.+.    +..||+|++.... .....+.+.+|+.++++++||||+++++++ +.
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~   81 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA   81 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence            456677888887 9999999999999864    3349999986543 456677899999999999999999999999 45


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ...++||||+++++|.+++...  ...+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~  157 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLS  157 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccce
Confidence            6689999999999999998643  235899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCC
Q 009291          415 RSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       415 ~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  490 (538)
                      ........   ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. ...+..++.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~  236 (287)
T 1u59_A          158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPP  236 (287)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCT
T ss_pred             eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCC
Confidence            86543221   1233456889999999998889999999999999999998 999999888777666553 445667788


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCCCC
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA  535 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~~~  535 (538)
                      .+++++.++|.+||+.||++|||+.++++.|++++.+...+...+
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~  281 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH  281 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence            999999999999999999999999999999999999887765544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.5e-44  Score=373.28  Aligned_cols=251  Identities=26%  Similarity=0.452  Sum_probs=219.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||.||+|.+..+  .||+|++..........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46799999999999999999998744  4999999887777777788999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC---CcEEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~---~~vkL~DFGla~~~~  418 (538)
                      ||+.+|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+   +.+||+|||++....
T Consensus       108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999988643   35899999999999999999999999  9999999999999764   459999999998765


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l  496 (538)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.......+.+  ..+++++
T Consensus       183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (362)
T 2bdw_A          183 DSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  261 (362)
T ss_dssp             TCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred             CCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            432 2245679999999999999999999999999999999999999999988877777665444333322  4679999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      .+||.+||+.||++|||+.++++.
T Consensus       262 ~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          262 KSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcC
Confidence            999999999999999999998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.9e-44  Score=373.17  Aligned_cols=250  Identities=24%  Similarity=0.418  Sum_probs=216.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHH----HHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHED----RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~----~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+.|++++.||+|+||+||+|.+..+  .||+|++........    ..+.+.+|+.++++++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            46799999999999999999998744  499999876543221    245788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC----cEEEEeeCC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGL  413 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~----~vkL~DFGl  413 (538)
                      ++||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+||+++.++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999999643   35899999999999999999999999  99999999999998776    799999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--CCCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKN  491 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~  491 (538)
                      +....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......  ..+..
T Consensus       166 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             ceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence            98765432 2345679999999999999999999999999999999999999999988887777664333222  22357


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +++++.+||.+||..||++|||+.++++
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            8999999999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.9e-44  Score=377.53  Aligned_cols=263  Identities=32%  Similarity=0.560  Sum_probs=217.1

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc-----CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      .++..++|++.+.||+|+||.||+|++.     +..||||++.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            3566789999999999999999999875     3349999986543 455667899999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ..+++||||+++++|.++++...  ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccc
Confidence            99999999999999999997433  35889999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCccc---cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCC
Q 009291          415 RSKPNTYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       415 ~~~~~~~~~---~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  490 (538)
                      +........   .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+. ...+.+.+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~  273 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPM  273 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCT
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCc
Confidence            865432211   122235678999999999999999999999999999998 999999988877766654 445566778


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .++..+.++|.+||+.||++||++.++++.|++++...
T Consensus       274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            89999999999999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.8e-44  Score=361.62  Aligned_cols=263  Identities=36%  Similarity=0.635  Sum_probs=212.5

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ...++..++|++.+.||+|+||+||+|++.+ .+|+|++..........+.+.+|+.++++++||||++++++. .....
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            4567888999999999999999999998654 599999987777777788999999999999999999999965 45668


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+.+++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++...
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccc
Confidence            99999999999999996443  35889999999999999999999999  999999999999999999999999999754


Q ss_pred             CCC--ccccCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhhcCcc---cCC
Q 009291          418 PNT--YISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA-VGFKGRR---LEI  488 (538)
Q Consensus       418 ~~~--~~~~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~-i~~~~~~---~~~  488 (538)
                      ...  ........||..|+|||.+.   +..++.++||||||+++|+|++|+.||......+.... +......   ...
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV  250 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence            321  11223456899999999986   56788899999999999999999999988655444433 3222222   223


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 009291          489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM  526 (538)
Q Consensus       489 p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~  526 (538)
                      +..+++.+.+||.+||+.||++|||+.++++.|+++..
T Consensus       251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            45789999999999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-44  Score=361.40  Aligned_cols=266  Identities=30%  Similarity=0.503  Sum_probs=224.0

Q ss_pred             ccccccccceeEEE-EEccCCcEEEEEEEEcC----CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          258 EGLEIRWSELLIKK-KIGEGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       258 ~~~~i~~~~y~i~~-~LG~G~fg~Vy~a~~~~----~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      ....+..++|++.+ .||+|+||+||+|.+..    ..||||++..........+.+.+|+.+++.++||||+++++++ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            34556778999998 99999999999996542    3499999876655555677899999999999999999999999 


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      +...+++||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCC
Confidence            556789999999999999999743   35889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCC
Q 009291          413 LSRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEI  488 (538)
Q Consensus       413 la~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~  488 (538)
                      ++........   ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. ...+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~  241 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGC  241 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCC
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence            9986543321   1223346788999999998889999999999999999999 999999988877666554 4456677


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       489 p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      +..+++.+.++|.+||+.||++|||+.++++.|++++.+...
T Consensus       242 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            889999999999999999999999999999999999987654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-44  Score=353.97  Aligned_cols=260  Identities=34%  Similarity=0.599  Sum_probs=227.1

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +.+..++|++.+.||+|+||.||+|.+.++ .+|+|++.......   +.+.+|+.++++++||||+++++++.+....+
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            567788999999999999999999998644 59999987665443   47889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  ++||||||+||+++.++.+||+|||++....
T Consensus        80 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             EEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccc
Confidence            9999999999999996432  35889999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          419 NTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       419 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ... .......++..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. ...+...+..+++.+
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l  234 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHV  234 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHH
T ss_pred             cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccCcHHH
Confidence            321 12234557789999999998889999999999999999999 899999988877766654 334556677889999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      .++|.+||+.||++|||+.++++.|+++..+
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.6e-45  Score=366.06  Aligned_cols=264  Identities=24%  Similarity=0.432  Sum_probs=213.7

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC---------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeecee
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV  331 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~---------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~  331 (538)
                      ++..++|++.+.||+|+||+||+|.+..+         .||+|++....  ....+.+.+|+.++++++||||+++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            45678999999999999999999987643         38999886543  33446789999999999999999999999


Q ss_pred             ccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc------
Q 009291          332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT------  405 (538)
Q Consensus       332 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~------  405 (538)
                      .++...++||||+.+++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.      
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCccccccc
Confidence            99999999999999999999997432  34889999999999999999999999  999999999999988877      


Q ss_pred             --EEEEeeCCCccCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhh
Q 009291          406 --VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGF  481 (538)
Q Consensus       406 --vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg-~~Pf~~~~~~~~~~~i~~  481 (538)
                        +||+|||++......    ....+|..|+|||++.+ ..++.++||||||+++|||++| ..||............  
T Consensus       158 ~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~--  231 (289)
T 4fvq_A          158 PFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY--  231 (289)
T ss_dssp             CEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--
T ss_pred             ceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh--
Confidence              999999998755332    23356888999999987 6789999999999999999995 5556555554433322  


Q ss_pred             cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCCCCCC
Q 009291          482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQP  537 (538)
Q Consensus       482 ~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~~~~p  537 (538)
                       .....++...++++.+||.+||+.||++|||+.++++.|++++.+....+.+++|
T Consensus       232 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~~~~  286 (289)
T 4fvq_A          232 -EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHH  286 (289)
T ss_dssp             -HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------------
T ss_pred             -hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCcccc
Confidence             2344566777889999999999999999999999999999999999888888776

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-44  Score=367.78  Aligned_cols=248  Identities=25%  Similarity=0.443  Sum_probs=217.6

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +..++|++++.||+|+||+||+|++..  ..||+|++...... ....+.+.+|+.+++.++||||+++++++.+...++
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            345789999999999999999999864  44999998764321 123457789999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++...
T Consensus        83 lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             EEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            999999999999999743   35899999999999999999999999  9999999999999999999999999998754


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      ..   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..  ....+|..+++++.+
T Consensus       158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~  232 (318)
T 1fot_A          158 DV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKD  232 (318)
T ss_dssp             SC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred             Cc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHH
Confidence            42   2456899999999999999999999999999999999999999999888777766643  345677889999999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHHH
Q 009291          499 LIETCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RP-----s~~eIl~  519 (538)
                      ||.+||+.||++||     +++++++
T Consensus       233 li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          233 LLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            99999999999999     8888874

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6e-44  Score=370.05  Aligned_cols=246  Identities=23%  Similarity=0.422  Sum_probs=212.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~  337 (538)
                      +..++|++++.||+|+||+||+|+++.++  ||+|++..... .....+.+.+|..+++++ +||||+++++++.+...+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            45678999999999999999999987554  99999986644 445567888999999988 899999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++..
T Consensus        86 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            9999999999999998642   35899999999999999999999999  999999999999999999999999999864


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhhcCcccCC
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS---------TPSQVISAVGFKGRRLEI  488 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~  488 (538)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||...         ........+.  .....+
T Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~  238 (345)
T 3a8x_A          161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRI  238 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH--HCCCCC
T ss_pred             cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH--cCCCCC
Confidence            43333445678999999999999999999999999999999999999999752         2222333332  335567


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCH
Q 009291          489 PKNVNPMVAALIETCWAEEPEIRPSF  514 (538)
Q Consensus       489 p~~~s~~l~~LI~~cL~~dP~~RPs~  514 (538)
                      |..++.++.+||.+||+.||++||++
T Consensus       239 p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          239 PRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            88999999999999999999999996

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.1e-44  Score=359.35  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=208.4

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++++.||+|+||+||+|++..+  .||+|++..........+.+.+|+.++++++||||+++++++.++..+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5799999999999999999998654  49999998776666666788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.+ ++.+.+...  ...+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            9986 555554322  235899999999999999999999999  99999999999999999999999999987654444


Q ss_pred             ccCCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhhcC-----------------
Q 009291          423 SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKP-WRNSTPSQVISAVGFKG-----------------  483 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~-~s~ksDVwSLGvil~eLltg~~P-f~~~~~~~~~~~i~~~~-----------------  483 (538)
                      ......||..|+|||++.+.. ++.++|||||||++|+|++|..| |...+..+....+....                 
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            445667899999999998766 79999999999999999998877 55555544444432110                 


Q ss_pred             ----------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 ----------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ----------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                ........+++.+.+||.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                      001122457899999999999999999999999865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.4e-44  Score=365.05  Aligned_cols=270  Identities=30%  Similarity=0.539  Sum_probs=227.6

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeec
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG  329 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~  329 (538)
                      ..+++..++|++.+.||+|+||+||+|++.+       ..||+|++.... .....+.+.+|+.+++++ +||||+++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            4466778899999999999999999998642       349999986543 455567899999999999 7999999999


Q ss_pred             eeccCC-cceEEEeecCCCChhhhhcCCCC-------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCC
Q 009291          330 AVTEPP-NLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS  395 (538)
Q Consensus       330 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp  395 (538)
                      ++.... .+++||||+++++|.+++.....             ...+++..++.++.|++.||+|||++|  |+||||||
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp  176 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA  176 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence            987654 48999999999999999965432             223889999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 009291          396 PNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP  472 (538)
Q Consensus       396 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~  472 (538)
                      +||+++.++.+||+|||+++......  .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            99999999999999999998654321  12234457889999999999999999999999999999998 9999988765


Q ss_pred             HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      ................+..+++.+.++|.+||+.||++|||+.++++.|++++++...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  314 (316)
T 2xir_A          257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ  314 (316)
T ss_dssp             SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence            5444444345556677888999999999999999999999999999999999987643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.4e-44  Score=358.22  Aligned_cols=257  Identities=37%  Similarity=0.665  Sum_probs=216.8

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH--HH---HHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE--DR---FKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~--~~---~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      .+..++|++.+.||+|+||+||+|++..  +.||+|++.......  ..   .+.+.+|+.++++++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            4567899999999999999999999864  449999986544322  11   1678999999999999999999999876


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc-----EEE
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-----VKV  408 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~-----vkL  408 (538)
                      ..  ++||||+++++|.+++....  ..+++..++.++.|++.||+|||+++++|+||||||+||+++.++.     +||
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             CC--eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            65  79999999999988886433  3589999999999999999999999877999999999999988776     999


Q ss_pred             EeeCCCccCCCCccccCCCCCCCccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhhcCc
Q 009291          409 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR--EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV--ISAVGFKGR  484 (538)
Q Consensus       409 ~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~--~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~--~~~i~~~~~  484 (538)
                      +|||+++.....   .....||+.|+|||++.  ...++.++||||||+++|+|++|+.||........  ...+.....
T Consensus       171 ~Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          171 ADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             CCCTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             CCCCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            999999864432   24567899999999984  45578999999999999999999999987654433  344444556


Q ss_pred             ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       485 ~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      +..++..+++.+.+||.+||+.||++|||+.++++.|+++
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            6778889999999999999999999999999999999763

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.5e-44  Score=363.66  Aligned_cols=255  Identities=27%  Similarity=0.355  Sum_probs=208.1

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      .+...++|++++.||+|+||+||+|++.. +.||+|++..........+.+.+|+.++++++||||+++++++.++..++
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            34456899999999999999999999854 44999998766545555678899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+.+ +|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++...
T Consensus        96 lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           96 LVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EEEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EEEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            99999985 7777775433  34899999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Ccc-----------
Q 009291          419 NTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRR-----------  485 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~-----------  485 (538)
                      ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+... +..           
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            44434455678999999999876 56899999999999999999999999877665554443210 000           


Q ss_pred             ----------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ----------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ----------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                      ......+++++.+||.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                            0112356789999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3e-44  Score=361.87  Aligned_cols=262  Identities=31%  Similarity=0.505  Sum_probs=215.1

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      .++..++|++++.||+|+||+||+|++.      +..||||++...  .....+.+.+|+.++++++||||+++++++..
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3566789999999999999999999852      334999988644  45666789999999999999999999998854


Q ss_pred             --CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEee
Q 009291          334 --PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF  411 (538)
Q Consensus       334 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DF  411 (538)
                        ...+++||||+++++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+||
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Df  158 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF  158 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccC
Confidence              356899999999999999996443  34889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------------
Q 009291          412 GLSRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--------------  474 (538)
Q Consensus       412 Gla~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~--------------  474 (538)
                      |++........   ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......              
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            99986543221   1233456778999999999999999999999999999999999986532211              


Q ss_pred             -HHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          475 -VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       475 -~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                       ..........+.+.+..+++++.+||.+||+.||++|||+.++++.|+++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence             11112224456677889999999999999999999999999999999998765

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.9e-44  Score=368.04  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=207.8

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc-----CCceEEEEEeccccC--HHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~~--~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      ..+..++|++.+.||+|+||.||+|++.     +..||+|++......  ......+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            3466789999999999999999999873     344999998765432  234456889999999999999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      +...+++||||+++++|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCC
Confidence            999999999999999999998632   35889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      +++.............||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+..  ....+|..+
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~  244 (327)
T 3a62_A          167 LCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPYL  244 (327)
T ss_dssp             CC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCTTS
T ss_pred             cccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCCCC
Confidence            997644333333456799999999999999999999999999999999999999999888777666643  345677889


Q ss_pred             cHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RP-----s~~eIl~  519 (538)
                      ++++.+||.+||..||++||     ++.++++
T Consensus       245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            99999999999999999999     6777765

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.6e-44  Score=360.51  Aligned_cols=263  Identities=25%  Similarity=0.400  Sum_probs=220.2

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +..++|++.+.||+|+||.||+|++..  ..||+|++..... .....+.+.+|+.++++++||||+++++++.+...++
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            345789999999999999999999864  4499999865433 4556678999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++....
T Consensus        88 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999999633   35899999999999999999999999  9999999999999999999999999998654


Q ss_pred             CCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc---ccCCCCCCcH
Q 009291          419 NTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---RLEIPKNVNP  494 (538)
Q Consensus       419 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~---~~~~p~~~s~  494 (538)
                      ... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+.............   ....+..+++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence            332 122345689999999999999999999999999999999999999999887665544432221   1234577899


Q ss_pred             HHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHhhhc
Q 009291          495 MVAALIETCWAEEPEIRP-SFPSIMETLQQFLMSSV  529 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RP-s~~eIl~~L~~il~~~~  529 (538)
                      .+.++|.+||..||++|| +++++.+.|++++....
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            999999999999999998 99999999998876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.5e-44  Score=374.23  Aligned_cols=252  Identities=25%  Similarity=0.427  Sum_probs=217.6

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~  336 (538)
                      .+..++|++++.||+|+||+||+|++..++  ||+|++..... .....+.+.+|..++..+ +||||+++++++.+...
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            456789999999999999999999987654  99999876432 122345788999999988 79999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|+||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++.
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            99999999999999998642   35899999999999999999999999  99999999999999999999999999986


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ...........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+..  ....+|..+++++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~  248 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEA  248 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred             cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHH
Confidence            44333344567899999999999999999999999999999999999999999888877776643  3456788999999


Q ss_pred             HHHHHHhhhcCCCCCCC-----HHHHHH
Q 009291          497 AALIETCWAEEPEIRPS-----FPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs-----~~eIl~  519 (538)
                      .+||.+||+.||++||+     +++|++
T Consensus       249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          249 VAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            99999999999999995     466654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-43  Score=354.50  Aligned_cols=267  Identities=33%  Similarity=0.573  Sum_probs=227.3

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      ..+++..++|++.+.||+|+||.||+|.+.+. .+|+|++......   .+.+.+|+.++++++||||+++++++.+ ..
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence            45778889999999999999999999998765 4999998765433   3478899999999999999999999864 55


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|  |+||||||+||++++++.+||+|||++..
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             cEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            899999999999999986421 125889999999999999999999999  99999999999999999999999999987


Q ss_pred             CCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          417 KPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       417 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+. ...+...+..+++
T Consensus       159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  237 (279)
T 1qpc_A          159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPE  237 (279)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred             ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccH
Confidence            544322 2234456789999999998889999999999999999999 899999888877666553 3445566788999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCC
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP  532 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~  532 (538)
                      ++.++|.+||..||++|||+.++++.|++++.....+.
T Consensus       238 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  275 (279)
T 1qpc_A          238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY  275 (279)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence            99999999999999999999999999999998766543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.3e-44  Score=386.49  Aligned_cols=267  Identities=32%  Similarity=0.573  Sum_probs=230.8

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...+++..++|++.+.||+|+||+||+|.+.+ ..||||++......   .+.+.+|+.+|++++||||+++++++. ..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            45578889999999999999999999999874 45999998765433   458899999999999999999999987 56


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+.+|+|.++++... ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             ccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            7899999999999999996432 224788899999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          416 SKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       416 ~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ....... ......++..|+|||++....++.++||||||+++|||++ |+.||......+....+. ...+.+.|..++
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~  411 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCP  411 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSC
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence            7543221 1233456788999999998899999999999999999999 999999988877776664 445677788999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCC
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ  531 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~  531 (538)
                      +++.+||.+||..||++|||+.+|++.|+++......+
T Consensus       412 ~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~  449 (454)
T 1qcf_A          412 EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ  449 (454)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence            99999999999999999999999999999998765543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-44  Score=375.74  Aligned_cols=251  Identities=27%  Similarity=0.463  Sum_probs=216.7

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~  336 (538)
                      .+..++|++.+.||+|+||+||+|+++.++  ||+|++..... .....+.+.+|..+++.+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            456689999999999999999999987544  99999876432 122345677899999876 89999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|+||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999998642   35899999999999999999999999  99999999999999999999999999986


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ...........+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+...  ...+|..+++++
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~  245 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEA  245 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHH
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHH
Confidence            543333445678999999999999999999999999999999999999999998888777776433  455678899999


Q ss_pred             HHHHHHhhhcCCCCCCCHH-HHH
Q 009291          497 AALIETCWAEEPEIRPSFP-SIM  518 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~-eIl  518 (538)
                      .+||.+||+.||++||++. +|+
T Consensus       246 ~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          246 KDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHHHHHhcCCHhHcCCChHHHH
Confidence            9999999999999999997 654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-43  Score=364.50  Aligned_cols=268  Identities=31%  Similarity=0.575  Sum_probs=230.4

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC---------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEe
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL  327 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~---------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l  327 (538)
                      ..+++..++|++++.||+|+||+||+|++.+         ..||+|++.... .....+.+.+|+.+++++ +||||+++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            3467778999999999999999999998742         348999986543 455677899999999999 89999999


Q ss_pred             eceeccCCcceEEEeecCCCChhhhhcCCCC-------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCC
Q 009291          328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK  394 (538)
Q Consensus       328 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLK  394 (538)
                      ++++.+...+++||||+++++|.+++.....             ...+++..++.++.|++.||+|||++|  |+|||||
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk  184 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA  184 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence            9999999999999999999999999965431             124889999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009291          395 SPNLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST  471 (538)
Q Consensus       395 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~  471 (538)
                      |+||+++.++.+||+|||++........  ......++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            9999999999999999999986544321  2234456788999999998889999999999999999999 999999888


Q ss_pred             HHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       472 ~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ..+....+. ...+...+..++..+.++|.+||+.+|++|||+.++++.|++++....
T Consensus       265 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          265 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            777665553 344566778899999999999999999999999999999999997654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=354.42  Aligned_cols=268  Identities=32%  Similarity=0.612  Sum_probs=224.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc-
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL-  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~-  337 (538)
                      .-.|.+.+.||+|+||+||+|.+..+     .+|+|++... ......+.+.+|+.++++++||||+++++++.+.... 
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            34677889999999999999987433     3888887543 3456678899999999999999999999999776665 


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+.+++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++..
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            99999999999999997533  35889999999999999999999999  999999999999999999999999999865


Q ss_pred             CCCc----cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          418 PNTY----ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       418 ~~~~----~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      ....    .......++..|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....+. .......+..+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  253 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYC  253 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTC
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccc
Confidence            4321    122345678899999999999999999999999999999995 55566666555554443 45566677889


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCCCCCC
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQP  537 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~~~~p  537 (538)
                      ++.+.++|.+||+.||++|||+.++++.|++++.+.......+-|
T Consensus       254 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~~~lp  298 (298)
T 3pls_A          254 PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP  298 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCBCCCC
T ss_pred             hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccchhhCC
Confidence            999999999999999999999999999999999987766554433

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-44  Score=369.57  Aligned_cols=261  Identities=30%  Similarity=0.429  Sum_probs=212.8

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc-
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-  336 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~-  336 (538)
                      .++.+..++|++.+.||+|+||+||+|++.++.||||++....   .....+.+|+.++++++||||+++++++.+... 
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            4466778899999999999999999999998889999986542   333456679999999999999999999877543 


Q ss_pred             ---ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC----------CCCEEeecCCCCCEEEcCC
Q 009291          337 ---LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR----------RPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       337 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~~~iiHrDLKp~NILl~~~  403 (538)
                         +++||||+++|+|.++++..    .+++..++.++.|++.||+|||+.          +  |+||||||+|||++.+
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT
T ss_pred             CceEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC
Confidence               69999999999999999643    388999999999999999999999          8  9999999999999999


Q ss_pred             CcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Q 009291          404 YTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLRED-----PSNEKSDVFSFGVILWELITLQKPWRNST-----  471 (538)
Q Consensus       404 ~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~-----~~s~ksDVwSLGvil~eLltg~~Pf~~~~-----  471 (538)
                      +.+||+|||+++.......  ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||....     
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            9999999999976443221  22346789999999999873     45678999999999999999999997532     


Q ss_pred             -----------HHHHHHHHhhcCcccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          472 -----------PSQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       472 -----------~~~~~~~i~~~~~~~~~p~-----~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                                 .......+.....+..++.     ..++++.+||.+||+.||++|||+.++++.|+++...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                       2222222222222222222     2346699999999999999999999999999998654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.3e-44  Score=376.36  Aligned_cols=247  Identities=22%  Similarity=0.419  Sum_probs=210.7

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~  336 (538)
                      .+..++|++++.||+|+||+||+|+++.++  ||+|++...... ....+.+.+|..++.++ +||||+++++++.+...
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            455678999999999999999999987654  999999876443 33445688899999876 89999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +++||||+++|+|..++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++.
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeee
Confidence            99999999999999998643   35899999999999999999999999  99999999999999999999999999986


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHhhcCcccC
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---------PSQVISAVGFKGRRLE  487 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~---------~~~~~~~i~~~~~~~~  487 (538)
                      ...........+||+.|+|||++.+..++.++|||||||++|||++|+.||....         .......+  ......
T Consensus       203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~  280 (396)
T 4dc2_A          203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIR  280 (396)
T ss_dssp             CCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCC
T ss_pred             cccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccC
Confidence            4443334566789999999999999999999999999999999999999996431         12222333  334567


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 009291          488 IPKNVNPMVAALIETCWAEEPEIRPSF  514 (538)
Q Consensus       488 ~p~~~s~~l~~LI~~cL~~dP~~RPs~  514 (538)
                      +|..+++++.+||++||+.||++||++
T Consensus       281 ~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          281 IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            888999999999999999999999996

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=360.35  Aligned_cols=256  Identities=35%  Similarity=0.663  Sum_probs=213.2

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .+..++|++.+.||+|+||+||+|++.++.||+|++...    ...+.+.+|+.++++++||||+++++++.+  ..++|
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence            356789999999999999999999999888999997532    345678999999999999999999998874  47999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh---CCCCEEeecCCCCCEEEcCCCc-EEEEeeCCCcc
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ---RRPPIVHRDLKSPNLLVDSTYT-VKVCDFGLSRS  416 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~~~iiHrDLKp~NILl~~~~~-vkL~DFGla~~  416 (538)
                      |||+++++|.+++........+++..++.++.|++.||+|||+   ++  |+||||||+||+++.++. +||+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999765544457889999999999999999999   77  999999999999988886 79999999976


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhhcCcccCCCCCCcH
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--VISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~--~~~~i~~~~~~~~~p~~~s~  494 (538)
                      ....   .....||..|+|||++.+..++.++||||||+++|||++|+.||.......  ....+ ....+...+..+++
T Consensus       156 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (307)
T 2eva_A          156 IQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPLIKNLPK  231 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCCCBTTCCH
T ss_pred             cccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCCcccccCH
Confidence            5432   234568999999999999999999999999999999999999998654322  22222 24455666788999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .+.++|.+||+.||++|||+.++++.|+++....
T Consensus       232 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            9999999999999999999999999999998654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=363.58  Aligned_cols=264  Identities=33%  Similarity=0.545  Sum_probs=222.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCc------eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~------vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      .++..++|++.+.||+|+||+||+|.+..+.      ||+|++.... .......+.+|+.++++++||||+++++++.+
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            4677889999999999999999999876432      8999986543 45556789999999999999999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ....++||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~  193 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGL  193 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCc
Confidence            999999999999999999996432  35889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCC
Q 009291          414 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP  489 (538)
Q Consensus       414 a~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p  489 (538)
                      +........   ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. ...+.+.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~  272 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTP  272 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCC
T ss_pred             chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCc
Confidence            986543221   1122345778999999999999999999999999999999 999999888877766654 44556677


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ..+++.+.++|.+||+.||++||++.++++.|++++....
T Consensus       273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            8899999999999999999999999999999999986543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=374.32  Aligned_cols=266  Identities=30%  Similarity=0.493  Sum_probs=226.1

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      .++..++|++++.||+|+||+||+|++.+       ..||||++... ........+.+|+.++++++||||+++++++.
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            35667899999999999999999998543       24999998543 34555667899999999999999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCC----CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC---c
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---T  405 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~---~  405 (538)
                      +....++||||+.+|+|.+++....    ....+++..++.++.||+.||+|||++|  |+||||||+|||++.++   .
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCce
Confidence            9999999999999999999995422    2245889999999999999999999999  99999999999998554   5


Q ss_pred             EEEEeeCCCccCCC--CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhc
Q 009291          406 VKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK  482 (538)
Q Consensus       406 vkL~DFGla~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~  482 (538)
                      +||+|||+++....  .........+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence            99999999974311  1112234567899999999999999999999999999999998 999999988877776664 4


Q ss_pred             CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       483 ~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ..+...+..++..+.+||.+||+.||++|||+.+|++.|+.+.....
T Consensus       302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            45566788899999999999999999999999999999999887653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.3e-44  Score=384.22  Aligned_cols=268  Identities=34%  Similarity=0.555  Sum_probs=227.1

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...+++..++|++.+.||+|+||+||+|.+.++ .||||++......   .+.+.+|+.+|++++||||+++++++.+ .
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            345778889999999999999999999998865 4999998765433   3478999999999999999999999876 6


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             ceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccce
Confidence            7899999999999999996321 234889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          416 SKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       416 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ...... .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .+.+.+.|..++
T Consensus       329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~  407 (452)
T 1fmk_A          329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP  407 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSC
T ss_pred             ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence            654322 12233456789999999998999999999999999999999 999999988877776664 455677888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCC
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP  532 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~  532 (538)
                      +.+.+||.+||+.||++|||+++|++.|++++.+...+.
T Consensus       408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~  446 (452)
T 1fmk_A          408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  446 (452)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence            999999999999999999999999999999987766543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.5e-43  Score=359.75  Aligned_cols=269  Identities=30%  Similarity=0.503  Sum_probs=220.6

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeecee
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV  331 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~  331 (538)
                      ...+.+..++|++.+.||+|+||+||+|.+...     .||+|++..........+.+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            345667789999999999999999999987542     499999877766777778899999999999999999999998


Q ss_pred             ccCCc-----ceEEEeecCCCChhhhhcCC---CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC
Q 009291          332 TEPPN-----LSIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       332 ~~~~~-----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~  403 (538)
                      .+...     .++||||+.+++|.+++...   .....+++..++.++.|++.||.|||++|  |+||||||+||+++.+
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~  183 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD  183 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC
Confidence            76553     59999999999999998422   23346899999999999999999999999  9999999999999999


Q ss_pred             CcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 009291          404 YTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG  480 (538)
Q Consensus       404 ~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~  480 (538)
                      +.+||+|||++.......  .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  263 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL  263 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence            999999999997654322  12234457889999999999999999999999999999999 899999887776665553


Q ss_pred             hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       481 ~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                       ...+...+..+++.+.++|.+||..||++|||+.++++.|++++...
T Consensus       264 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          264 -HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             -TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence             44456777889999999999999999999999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.9e-44  Score=370.94  Aligned_cols=249  Identities=25%  Similarity=0.384  Sum_probs=219.0

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ....++|++++.||+|+||+||+|++..  ..||+|++...... ....+.+.+|+.+++.++||||+++++++.+...+
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            3456899999999999999999999874  44999998764321 23346788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++..
T Consensus       117 ~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceec
Confidence            9999999999999999643   35899999999999999999999999  999999999999999999999999999875


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ...   ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+...  ...+|..+++++.
T Consensus       192 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~  266 (350)
T 1rdq_E          192 KGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLK  266 (350)
T ss_dssp             SSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHH
T ss_pred             cCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence            443   24567999999999999999999999999999999999999999998887777766433  4567888999999


Q ss_pred             HHHHHhhhcCCCCCCC-----HHHHHH
Q 009291          498 ALIETCWAEEPEIRPS-----FPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs-----~~eIl~  519 (538)
                      +||.+||+.||++||+     +++|++
T Consensus       267 ~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          267 DLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            9999999999999998     777764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.1e-43  Score=350.96  Aligned_cols=250  Identities=26%  Similarity=0.453  Sum_probs=219.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||.||+|.+..+  .||+|++..........+.+.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46899999999999999999998744  4999999887777777888999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc---EEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGla~~~~  418 (538)
                      ||+.+++|.+.+...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999998888633   35899999999999999999999999  999999999999976655   9999999997765


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l  496 (538)
                      ... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+.......+.+  ..+++++
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          160 DSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             SSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             cCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            433 2245678999999999999999999999999999999999999999988877777665444433332  4789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||.+||+.||++|||+.++++
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHcccChhhCCCHHHHhc
Confidence            99999999999999999999987

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=362.64  Aligned_cols=250  Identities=23%  Similarity=0.398  Sum_probs=215.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH----HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~----~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+.|++.+.||+|+||.||+|.+..  ..||+|++.......    ...+.+.+|+.++++++||||+++++++.+...+
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3579999999999999999999874  449999987654321    1246788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC----cEEEEeeCC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGL  413 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~----~vkL~DFGl  413 (538)
                      ++||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999999643   35899999999999999999999999  99999999999998877    899999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--CCCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKN  491 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~  491 (538)
                      ++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.......  ..+..
T Consensus       165 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          165 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             CEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            98764332 2345679999999999999999999999999999999999999999888877766654333222  12357


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +++.+.+||.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            8999999999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.2e-44  Score=358.15  Aligned_cols=264  Identities=36%  Similarity=0.619  Sum_probs=229.5

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ..+++..++|++.+.||+|+||+||+|.+..+  .+|+|++....   ...+.+.+|+.++++++||||+++++++.++.
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            35678889999999999999999999998754  48999986543   34567889999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+.+++|.+++.... ...+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++.
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             CEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999999999996532 235889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          416 SKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       416 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ...... .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. ...+...+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  238 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP  238 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCC
Confidence            754332 12233456788999999999999999999999999999999 999999888766665553 445567778899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +.+.+||.+||..||++|||+.++++.|++++...
T Consensus       239 ~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            99999999999999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=364.37  Aligned_cols=248  Identities=20%  Similarity=0.355  Sum_probs=215.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||+||+|.+..++  +|+|++...   ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            468999999999999999999987554  899988643   234457889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC--CCcEEEEeeCCCccCCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~~~~  419 (538)
                      ||+++++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.  ++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999999996432  35899999999999999999999999  999999999999987  78999999999987654


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC--CCCCCcHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMVA  497 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~s~~l~  497 (538)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+........  ....+++++.
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            32 22345689999999999998899999999999999999999999999888877776654333222  1247899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||..||++|||+.++++
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHhc
Confidence            9999999999999999999987

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.6e-44  Score=370.09  Aligned_cols=253  Identities=24%  Similarity=0.360  Sum_probs=210.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC---HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~---~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      .++|++.+.||+|+||+||+|.+..  +.||||++......   ....+.+.+|+.+++.++||||+++++++.+...++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4679999999999999999999864  44999998653211   112457889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc---EEEEeeCCC
Q 009291          339 IVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGLS  414 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGla  414 (538)
                      +||||+++++|.+.+... .....+++..++.++.||+.||+|||+++  |+||||||+|||++.++.   +||+|||++
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999998877432 22335889999999999999999999999  999999999999986554   999999999


Q ss_pred             ccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC--CCCCC
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNV  492 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~  492 (538)
                      ..............||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+........  ....+
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~~  259 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHI  259 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTTS
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCccccccC
Confidence            8766544334566899999999999999999999999999999999999999987543 33333332222111  12578


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ++++.+||.+||+.||++|||+.++++
T Consensus       260 s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          260 SESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            999999999999999999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.9e-44  Score=366.47  Aligned_cols=267  Identities=31%  Similarity=0.499  Sum_probs=227.4

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCC-------ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeece
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA  330 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~  330 (538)
                      .+++..++|++.+.||+|+||+||+|.+.++       .+|+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            4677889999999999999999999998642       38899886543 445567899999999999 89999999999


Q ss_pred             eccCCcceEEEeecCCCChhhhhcCCC-----------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEE
Q 009291          331 VTEPPNLSIVTEYLSRGSLYKLLHIPD-----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLL  399 (538)
Q Consensus       331 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NIL  399 (538)
                      +.+...+++||||+++|+|.+++....           ....+++..++.++.|++.||+|||++|  |+||||||+||+
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl  196 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL  196 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence            999999999999999999999985321           1235789999999999999999999999  999999999999


Q ss_pred             EcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 009291          400 VDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVI  476 (538)
Q Consensus       400 l~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~  476 (538)
                      ++.++.+||+|||++.......  .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            9999999999999997543221  12234456788999999999899999999999999999998 89999887665555


Q ss_pred             HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          477 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       477 ~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ..+.........+..+++.+.++|.+||+.||++|||+.++++.|+++....
T Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            5554455566677888999999999999999999999999999999988654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.5e-44  Score=356.85  Aligned_cols=262  Identities=35%  Similarity=0.640  Sum_probs=219.0

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-C
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-P  335 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-~  335 (538)
                      ...+.+..++|++.+.||+|+||+||++++.++.||+|++....    ..+.+.+|+.++++++||||+++++++.+. .
T Consensus        13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            34567888999999999999999999999998889999986543    345788999999999999999999986544 5


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|  ++||||||+||+++.++.+||+|||++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  165 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK  165 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccc
Confidence            7899999999999999986321 123788999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      ......   ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. ...+...+..+++
T Consensus       166 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  241 (278)
T 1byg_A          166 EASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP  241 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCH
T ss_pred             cccccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCH
Confidence            654332   23467889999999998899999999999999999998 999999887776666553 3445677888999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      .+.++|.+||+.||++|||+.++++.|+++.....
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~  276 (278)
T 1byg_A          242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL  276 (278)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence            99999999999999999999999999999977654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.4e-44  Score=365.16  Aligned_cols=259  Identities=31%  Similarity=0.529  Sum_probs=215.2

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--e----EEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--V----AVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--v----avK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      +..++|++.+.||+|+||+||+|++..++  +    |+|.+.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            45678999999999999999999985443  4    666554322 2344568999999999999999999999998754


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                       .++|+||+.+|+|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCccee
Confidence             789999999999999996533  35889999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          416 SKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       416 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      .......  ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+. ...+...+..+
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  244 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC  244 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTB
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccC
Confidence            6433221  2233456889999999999999999999999999999999 999999888776655553 44566778889


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      +..+.++|.+||+.||++|||+.++++.|+.+..+
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            99999999999999999999999999999998864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.6e-43  Score=353.96  Aligned_cols=263  Identities=30%  Similarity=0.498  Sum_probs=222.2

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCCc-----eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      .+.+..++|++.+.||+|+||+||+|.+.+..     ||+|++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            35667789999999999999999999876432     8999876543 44556789999999999999999999999875


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      + ..++||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             C-CCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCC
Confidence            4 5689999999999999996432  34889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          414 SRSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       414 a~~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      +........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. .....+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  238 (281)
T 3cc6_A          160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDL  238 (281)
T ss_dssp             GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTT
T ss_pred             CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCC
Confidence            986543321 2234456889999999998899999999999999999998 999998777766655543 3445667788


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +++.+.++|.+||+.||++|||+.++++.|++++...
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            9999999999999999999999999999999998764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.2e-44  Score=374.61  Aligned_cols=248  Identities=27%  Similarity=0.433  Sum_probs=208.1

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHHHH-HHcCCCCceeEeeceeccCCcc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAI-MKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei~i-l~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      +..++|++++.||+|+||+||+|+++.++  ||+|++...... ......+.+|..+ ++.++||||+++++++.+...+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            44578999999999999999999987654  899999776543 3344567777776 5678999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++..
T Consensus       115 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            9999999999999998643   35889999999999999999999999  999999999999999999999999999864


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..  ....++..++..+.
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~  267 (373)
T 2r5t_A          190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSAR  267 (373)
T ss_dssp             BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--SCCCCCSSSCHHHH
T ss_pred             ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHH
Confidence            3333344567899999999999999999999999999999999999999999888777776643  34567788999999


Q ss_pred             HHHHHhhhcCCCCCCCHHH
Q 009291          498 ALIETCWAEEPEIRPSFPS  516 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~e  516 (538)
                      +||.+||+.||++||++.+
T Consensus       268 ~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTT
T ss_pred             HHHHHHcccCHHhCCCCCC
Confidence            9999999999999999853

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-43  Score=357.86  Aligned_cols=261  Identities=31%  Similarity=0.493  Sum_probs=215.4

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEE------cCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEW------RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~------~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      .+....|++.+.||+|+||.||+|++      .+..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            45567799999999999999999985      23449999986543 233346788999999999999999999999876


Q ss_pred             --CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          335 --PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       335 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                        ..+++||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccc
Confidence              66899999999999999995332  34889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCc---cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------------CHHHH
Q 009291          413 LSRSKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS--------------TPSQV  475 (538)
Q Consensus       413 la~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~--------------~~~~~  475 (538)
                      ++.......   .......+|..|+|||.+.+..++.++||||||+++|+|++|..||...              .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence            998754432   2234556888899999999999999999999999999999999876422              11222


Q ss_pred             HHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 009291          476 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM  526 (538)
Q Consensus       476 ~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~  526 (538)
                      .........+.+.+..+++.+.+||.+||+.||++|||+.++++.|+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            222223455677788999999999999999999999999999999999874

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.9e-44  Score=358.56  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=205.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      ++|++++.||+|+||+||+|++. +..+|+|++..........+.+.+|+.++++++||||+++++++.+...+++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999985 44599999876544443346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +.+ +|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            976 8888886432  35889999999999999999999999  999999999999999999999999999765433323


Q ss_pred             cCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Ccc----------------
Q 009291          424 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRR----------------  485 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~----------------  485 (538)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+... ...                
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            3455789999999999764 5899999999999999999999999988776655444211 000                


Q ss_pred             ----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ----------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                ..+...+++++.+||.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                      0122457899999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.7e-43  Score=354.07  Aligned_cols=265  Identities=31%  Similarity=0.522  Sum_probs=219.5

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc-----eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeecee-ccC
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEP  334 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~-~~~  334 (538)
                      .....+|++.+.||+|+||+||+|.+..+.     +|+|.+... ......+.+.+|+.++++++||||+++++++ ..+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            334567999999999999999999865332     677776543 3456677899999999999999999999985 556


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ...++||||+.+++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||++++++.+||+|||++
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             CceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECccccc
Confidence            67899999999999999996433  35789999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCcc----ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCC
Q 009291          415 RSKPNTYI----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP  489 (538)
Q Consensus       415 ~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p  489 (538)
                      +.......    ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+. ...+...+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  254 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQP  254 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCC
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCC
Confidence            86544321    1233456788999999999999999999999999999999 566777766655555443 44555667


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCC
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ  531 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~  531 (538)
                      ..+++.+.++|.+||+.||++|||+.++++.|++++.+...+
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~  296 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  296 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            889999999999999999999999999999999999876543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.9e-44  Score=387.62  Aligned_cols=263  Identities=36%  Similarity=0.621  Sum_probs=229.1

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ..+++...+|++.+.||+|+||.||+|.+..  ..||||++......   .+.|.+|+.+|++++||||+++++++.+..
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            3467888999999999999999999999875  44999998765433   457899999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+.+|+|.+++.... ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             cEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccce
Confidence            9999999999999999996432 235889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          416 SKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       416 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ...... .......++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+. ...+...|..++
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  445 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP  445 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence            754332 22234456789999999998899999999999999999999 999999888776665553 456677888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      +.+.+||.+||+.||++|||+.+|++.|+.++..
T Consensus       446 ~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999999988654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.2e-43  Score=352.59  Aligned_cols=262  Identities=27%  Similarity=0.513  Sum_probs=221.4

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+..++|++.+.||+|+||+||+|.+..++  +|+|++....... .....+.+|+.++++++||||+++++++.+....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            445689999999999999999999987655  9999986543222 2245788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++...
T Consensus        85 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccC
Confidence            9999999999999998633   35889999999999999999999999  999999999999999999999999998665


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ....  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......+....+.  .....+|..+++.+.
T Consensus       160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  235 (279)
T 3fdn_A          160 PSSR--RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGAR  235 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHH
T ss_pred             Cccc--ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHH
Confidence            4332  245678999999999999999999999999999999999999999988877766653  334566788999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 009291          498 ALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL  533 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~  533 (538)
                      +||.+||+.||++|||+.++++.  .++++....|.
T Consensus       236 ~li~~~l~~~p~~Rps~~e~l~h--~~~~~~~~~~~  269 (279)
T 3fdn_A          236 DLISRLLKHNPSQRPMLREVLEH--PWITANSSKPS  269 (279)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHC--HHHHHHCSSCC
T ss_pred             HHHHHHhccChhhCCCHHHHhhC--ccccCCccCcc
Confidence            99999999999999999999874  45555544443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=372.17  Aligned_cols=253  Identities=25%  Similarity=0.439  Sum_probs=215.0

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...+..++|++++.||+|+||+||+|++..++  ||+|++..... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            34567789999999999999999999987655  99999875432 2233467889999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+.+|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||++.
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceee
Confidence            999999999999999999743   35899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhhcCcccCCC
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFKGRRLEIP  489 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~---~~~~~~i~~~~~~~~~p  489 (538)
                      ...... .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.....   .+....+  ......+|
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p  240 (384)
T 4fr4_A          164 MLPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYP  240 (384)
T ss_dssp             ECCTTC-CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCC
T ss_pred             eccCCC-ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCC
Confidence            764432 3356789999999999974   4589999999999999999999999975432   2333333  33456678


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPS-FPSIME  519 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs-~~eIl~  519 (538)
                      ..+++.+.+||.+||+.||++||+ ++++++
T Consensus       241 ~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            889999999999999999999998 666654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.9e-44  Score=382.15  Aligned_cols=252  Identities=27%  Similarity=0.456  Sum_probs=210.5

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+..++|++++.||+|+||.||+|++..+  .||||++..... .......+.+|+.+++.++||||+++++++.+...+
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            45567899999999999999999998754  499999876432 334456788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      ++||||+++++|.+++...   ..+++..++.++.||+.||+|||+ +|  ||||||||+|||++.++.+||+|||+++.
T Consensus       224 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEEEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            9999999999999998643   358999999999999999999998 99  99999999999999999999999999986


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ............||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..  ....+|..+++++
T Consensus       299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~  376 (446)
T 4ejn_A          299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEA  376 (446)
T ss_dssp             TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred             ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHH
Confidence            54443344567899999999999999999999999999999999999999999888777766643  3456778899999


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHHH
Q 009291          497 AALIETCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RP-----s~~eIl~  519 (538)
                      .+||.+||+.||++||     ++.++++
T Consensus       377 ~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            9999999999999999     9999976

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.1e-43  Score=356.03  Aligned_cols=270  Identities=25%  Similarity=0.429  Sum_probs=210.2

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccc-cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~-~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++.... ......+.+.+|+.++++++||||+++++++.+....++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3468999999999999999999975  4459999987533 345667789999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          340 VTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ||||+.+++|.+++... .....+++..++.++.|++.||+|||++|  ++||||||+||+++.++.+||+|||++....
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999998531 12345889999999999999999999999  9999999999999999999999999998655


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST--PSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ..........|+..|+|||.+.+..++.++||||||+++|+|++|+.||....  .......+.........+..+++++
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  267 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  267 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence            44333345578999999999999999999999999999999999999997643  2333333332222222346789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCCC
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS  534 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~~  534 (538)
                      .+||.+||+.||++|||+.++++.|+++.......|.+
T Consensus       268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~  305 (310)
T 2wqm_A          268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH  305 (310)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-----
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhh
Confidence            99999999999999999999999999999888776654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.2e-44  Score=363.20  Aligned_cols=266  Identities=31%  Similarity=0.558  Sum_probs=226.5

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEc-------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeece
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA  330 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~  330 (538)
                      ..+++..++|++.+.||+|+||.||+|.+.       +..||+|++.... .......+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            346777889999999999999999999875       3449999986543 44556679999999999999999999999


Q ss_pred             eccCCcceEEEeecCCCChhhhhcCCC-------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC
Q 009291          331 VTEPPNLSIVTEYLSRGSLYKLLHIPD-------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       331 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~  403 (538)
                      +.+....++||||+++++|.+++....       ....+++..++.++.|++.||+|||++|  |+||||||+||+++.+
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED  174 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence            999999999999999999999985321       1134688999999999999999999999  9999999999999999


Q ss_pred             CcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 009291          404 YTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG  480 (538)
Q Consensus       404 ~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~  480 (538)
                      +.+||+|||++.......  .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            999999999997543321  11233456889999999999899999999999999999999 899999888777666553


Q ss_pred             hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       481 ~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                       .......+..+++.+.+||.+||+.||++|||+.++++.|++++..
T Consensus       255 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          255 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             -cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence             3444566788999999999999999999999999999999887643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.4e-44  Score=379.72  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=218.3

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      .+.+..++|++++.||+|+||+||+|++..++  ||+|++...... ....+.+.+|+.+++.++||||+++++++.++.
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            45667889999999999999999999987554  999998653211 111235778999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+||||+++|+|.++++..    .+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeE
Confidence            999999999999999998643    4889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCc-cccCCCCCCCcccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC-
Q 009291          416 SKPNTY-ISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-  489 (538)
Q Consensus       416 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~----~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p-  489 (538)
                      ...... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+..+....+........+| 
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  296 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD  296 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred             eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence            654432 2334678999999999998765    7899999999999999999999999998888777765433334444 


Q ss_pred             -CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 009291          490 -KNVNPMVAALIETCWAEEPEI--RPSFPSIME  519 (538)
Q Consensus       490 -~~~s~~l~~LI~~cL~~dP~~--RPs~~eIl~  519 (538)
                       ..+++++++||++||+.+|++  ||++++|++
T Consensus       297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence             478999999999999999988  999999875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.8e-43  Score=357.45  Aligned_cols=246  Identities=27%  Similarity=0.449  Sum_probs=213.5

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      .|...+.||+|+||.||+|++.  ++.||||++......  ..+.+.+|+.++++++||||+++++++......++||||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            4778889999999999999986  445999998755432  345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +++++|.+++...    .+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++.........
T Consensus       124 ~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          124 LQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             CCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence            9999999998632    4899999999999999999999999  999999999999999999999999999876554334


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-ccCCCCCCcHHHHHHHHH
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIET  502 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~l~~LI~~  502 (538)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+..... ....+..+++.+.+||.+
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  277 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER  277 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence            4566899999999999999999999999999999999999999998887776665543222 223345688999999999


Q ss_pred             hhhcCCCCCCCHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIME  519 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~  519 (538)
                      ||+.||++|||+.++++
T Consensus       278 ~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          278 MLVRDPQERATAQELLD  294 (321)
T ss_dssp             HSCSSTTTSCCHHHHHT
T ss_pred             HccCChhhCcCHHHHhc
Confidence            99999999999999976

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-43  Score=362.22  Aligned_cols=250  Identities=29%  Similarity=0.381  Sum_probs=206.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++++.||+|+||+||+|.+..  +.||+|++..... ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            4689999999999999999999874  4499999865432 223357889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC-
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-  420 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~-  420 (538)
                      ||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++...... 
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999998643   35899999999999999999999999  999999999999999999999999999754321 


Q ss_pred             -ccccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhhcCcccCCCCCCcHHHH
Q 009291          421 -YISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       421 -~~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~-~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                       ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ................+++.+.
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence             112245679999999999988775 7789999999999999999999987655322 2222222223333456899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||+.|+++
T Consensus       240 ~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          240 ALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHccCChhhCcCHHHHhh
Confidence            9999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=356.70  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=207.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++++.||+|+||+||+|.+..  ..||+|++..........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            679999999999999999999874  449999987776666667889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++........
T Consensus        83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            99999999988643   34889999999999999999999999  99999999999999999999999999987654433


Q ss_pred             ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------------------
Q 009291          423 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------------  482 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-------------------  482 (538)
                      ......||..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+...                   
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            3455678999999999976 56899999999999999999999999988776655443211                   


Q ss_pred             CcccCCC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 GRRLEIP----------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ~~~~~~p----------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ....+.+          ..+++.+.+||.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0111111          367889999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.6e-44  Score=364.91  Aligned_cols=261  Identities=30%  Similarity=0.514  Sum_probs=217.7

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc------eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~------vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      .+..++|++.+.||+|+||+||+|.+..++      +|+|++.... .....+.+.+|+.++++++||||+++++++.+ 
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            355678999999999999999999986543      5566553322 22223467789999999999999999999864 


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ...++||||+.+|+|.+++...  ...+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             CccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcc
Confidence            5689999999999999998643  346889999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          415 RSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       415 ~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      +.......  ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~  241 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQI  241 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTT
T ss_pred             cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCc
Confidence            87543321  2234567889999999999999999999999999999999 999999887766665553 4456677788


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ++..+.++|.+||..||++|||+.++++.|+++....
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            9999999999999999999999999999999997643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3e-43  Score=360.29  Aligned_cols=264  Identities=34%  Similarity=0.615  Sum_probs=222.9

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc----eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCC
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP  335 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~  335 (538)
                      .+..++|++.+.||+|+||.||+|++..++    +|+|.+.... .....+.+.+|+.+++++ +||||+++++++.+..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            356789999999999999999999886554    4788776432 334456789999999999 8999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~  402 (538)
                      ..++||||+++++|.+++....             ....+++..++.++.|++.||+|||++|  |+||||||+||+++.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE  177 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcC
Confidence            9999999999999999996542             2346899999999999999999999999  999999999999999


Q ss_pred             CCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhh
Q 009291          403 TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGF  481 (538)
Q Consensus       403 ~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~  481 (538)
                      ++.+||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+. 
T Consensus       178 ~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-  255 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-  255 (327)
T ss_dssp             GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred             CCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-
Confidence            999999999998753322 12234456889999999998889999999999999999998 999999988877766654 


Q ss_pred             cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       482 ~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ...+...+..+++.+.+||.+||..||++|||+.++++.|++++....
T Consensus       256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            344566778899999999999999999999999999999999997764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4e-43  Score=358.47  Aligned_cols=265  Identities=29%  Similarity=0.455  Sum_probs=219.7

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-  334 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-  334 (538)
                      +....|++++.||+|+||+||++.+.      +..||||++... ......+.+.+|+.++++++||||+++++++.+. 
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            44455699999999999999988653      344999998755 3455667899999999999999999999998764 


Q ss_pred             -CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          335 -PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       335 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                       ..+++||||+++++|.+++...    .+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             CceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccc
Confidence             5689999999999999999643    3889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------------HH
Q 009291          414 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--------------VI  476 (538)
Q Consensus       414 a~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~--------------~~  476 (538)
                      +........   ......+|..|+|||.+.+..++.++||||||+++|+|++|..||.......              ..
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            987654321   2234567888999999999889999999999999999999999997543211              11


Q ss_pred             HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 009291          477 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL  533 (538)
Q Consensus       477 ~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~  533 (538)
                      ............+..+++.+.+||.+||+.||++|||+.++++.|+++......++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p  317 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP  317 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence            122234456677888999999999999999999999999999999999988776554

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.1e-43  Score=351.77  Aligned_cols=262  Identities=18%  Similarity=0.222  Sum_probs=217.4

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~  337 (538)
                      .+..++|++.+.||+|+||+||+|.+..  ..||+|++......    +.+.+|+.+++.+ +|+||+++++++.+....
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            3456789999999999999999999754  44999998654322    3577899999999 799999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc-----EEEEeeC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-----VKVCDFG  412 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~-----vkL~DFG  412 (538)
                      ++||||+ +++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.     +||+|||
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            9999999 999999997543  24899999999999999999999999  999999999999987765     9999999


Q ss_pred             CCccCCCCcc-------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhhc
Q 009291          413 LSRSKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---PSQVISAVGFK  482 (538)
Q Consensus       413 la~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~---~~~~~~~i~~~  482 (538)
                      +++.......       ......||..|+|||++.+..++.++||||||+++|||++|+.||....   .......+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            9986543221       1245578999999999999999999999999999999999999998743   33333333211


Q ss_pred             C---cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCC
Q 009291          483 G---RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ  531 (538)
Q Consensus       483 ~---~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~  531 (538)
                      .   ........+++++.+||.+||+.||++|||+++|++.|++++......
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            1   112234578999999999999999999999999999999999876543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-43  Score=355.53  Aligned_cols=252  Identities=30%  Similarity=0.565  Sum_probs=203.5

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHc--CCCCceeEeeceecc----CC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLLMGAVTE----PP  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~--L~hpnIv~l~~~~~~----~~  335 (538)
                      +..++|++.+.||+|+||+||+|++.++.||||++....     ...+.+|.+++..  ++||||+++++++.+    ..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            345789999999999999999999988889999986432     2355566666665  799999999998643    34


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHH--------hCCCCEEeecCCCCCEEEcCCCcEE
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH--------QRRPPIVHRDLKSPNLLVDSTYTVK  407 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~iiHrDLKp~NILl~~~~~vk  407 (538)
                      .+++||||+++|+|.++++..    .+++..++.++.|++.||+|||        +++  |+||||||+|||++.++.+|
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEE
T ss_pred             eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEE
Confidence            589999999999999999533    4899999999999999999999        888  99999999999999999999


Q ss_pred             EEeeCCCccCCCCcc----ccCCCCCCCcccccccccCC------CCCchhhHHHHHHHHHHHHhC----------CCCC
Q 009291          408 VCDFGLSRSKPNTYI----SSKTAAGTPEWMAPEVLRED------PSNEKSDVFSFGVILWELITL----------QKPW  467 (538)
Q Consensus       408 L~DFGla~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~------~~s~ksDVwSLGvil~eLltg----------~~Pf  467 (538)
                      |+|||+++.......    ......||+.|+|||++.+.      .++.++||||||+++|||++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            999999975432211    12344799999999999876      455799999999999999999          8888


Q ss_pred             CCCCH-----HHHHHHHhhcCcccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          468 RNSTP-----SQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       468 ~~~~~-----~~~~~~i~~~~~~~~~p~-----~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      .....     ......+.....+..++.     .+++.+.+||.+||+.||++|||+.++++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            65322     222223323333333432     3567899999999999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.1e-43  Score=351.17  Aligned_cols=251  Identities=26%  Similarity=0.429  Sum_probs=220.4

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ..++|++.+.||+|+||.||++.+..+  .+|+|++..... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            357899999999999999999998754  489999876543 34556788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      ||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++.....
T Consensus        93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999988632   35889999999999999999999999  99999999999999999999999999987654


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      .........||..|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.  .....+|..+++.+.++
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l  245 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASL  245 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHH
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHH
Confidence            3333455678999999999999999999999999999999999999999888776665553  33456778899999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~  520 (538)
                      |.+||+.||++|||+.++++.
T Consensus       246 i~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          246 IQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHcccChhhCcCHHHHhhC
Confidence            999999999999999999863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.4e-44  Score=364.34  Aligned_cols=265  Identities=29%  Similarity=0.446  Sum_probs=216.3

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      ++...++|++.+.||+|+||+||+|.+. +..||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            4445678999999999999999999975 4459999876543  234568899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCC-CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          339 IVTEYLSRGSLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      +||||+++++|.+++..... ...+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++...
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999999999999864432 235889999999999999999999999  999999999999999999999999999764


Q ss_pred             CCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhhcC-----
Q 009291          418 PNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS-------AVGFKG-----  483 (538)
Q Consensus       418 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~-------~i~~~~-----  483 (538)
                      ....  .......||..|+|||++.+..++.++||||||+++|||++|+.||....+.+...       ......     
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            3321  11234458999999999998899999999999999999999999997654322110       000000     


Q ss_pred             ---cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          484 ---RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       484 ---~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                         ....++..++..+.++|.+||+.||++|||+.++++.|+.++...
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence               011122345678999999999999999999999999999998654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.7e-43  Score=366.69  Aligned_cols=257  Identities=21%  Similarity=0.304  Sum_probs=212.6

Q ss_pred             ccccccceeEEEEEccC--CcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          260 LEIRWSELLIKKKIGEG--SFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G--~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      +....++|++++.||+|  +||+||+|++..  ..||||++..........+.+.+|+.+++.++||||+++++++.++.
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            34556789999999999  999999999974  44999999887777777888999999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+++++|.+++.... ...+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||.+.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccce
Confidence            9999999999999999996532 234899999999999999999999999  9999999999999999999999999886


Q ss_pred             cCCCC-------ccccCCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc--
Q 009291          416 SKPNT-------YISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--  484 (538)
Q Consensus       416 ~~~~~-------~~~~~~~~gt~~Y~aPE~l~~--~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~--  484 (538)
                      .....       ........||..|+|||++.+  ..++.++|||||||++|||++|+.||......+....+.....  
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            43211       111233478999999999987  5789999999999999999999999987655444332211100  


Q ss_pred             ------------------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 ------------------------------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ------------------------------------------~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                                                ..+.+..+++.+.+||.+||+.||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                                      11234567899999999999999999999999975

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-43  Score=379.50  Aligned_cols=257  Identities=24%  Similarity=0.362  Sum_probs=218.6

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      .+.+..++|++++.||+|+||+||+|++..++  ||+|++...... ....+.+.+|+.++..++||||+++++++.+..
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            35567789999999999999999999997654  999998653221 111234788999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+||||+.+|+|.+++...  ...+++..++.++.|++.||+|||+++  ||||||||+|||++.++.+||+|||+|+
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence            999999999999999999753  235899999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCCc-cccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC
Q 009291          416 SKPNTY-ISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP  489 (538)
Q Consensus       416 ~~~~~~-~~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p  489 (538)
                      ...... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+.....+..+|
T Consensus       224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p  303 (437)
T 4aw2_A          224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP  303 (437)
T ss_dssp             ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence            654332 2234568999999999987     5568999999999999999999999999998888777765443444555


Q ss_pred             C---CCcHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 009291          490 K---NVNPMVAALIETCWAEEPEI--RPSFPSIME  519 (538)
Q Consensus       490 ~---~~s~~l~~LI~~cL~~dP~~--RPs~~eIl~  519 (538)
                      .   .+++++.+||++||+.+|++  ||+++++++
T Consensus       304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            4   48999999999999988888  999998865

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=361.57  Aligned_cols=260  Identities=31%  Similarity=0.531  Sum_probs=214.3

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--e----EEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--V----AVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--v----avK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      +...+|++++.||+|+||+||+|.+..++  +    ++|.+.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            55688999999999999999999986443  5    555543322 2334567889999999999999999999998754


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                       .++++||+.+|+|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             -ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence             789999999999999996433  35889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          416 SKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       416 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      .......  ......+|..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. .....+.+..+
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  244 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC  244 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTB
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccC
Confidence            6543221  1233456788999999999999999999999999999999 999999888777665553 45566778889


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +.++.+||.+||..||++|||+.++++.|+++....
T Consensus       245 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            999999999999999999999999999999998543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.5e-44  Score=369.29  Aligned_cols=249  Identities=29%  Similarity=0.489  Sum_probs=210.5

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ..++|++.+.||+|+||+||+|.+..  +.||+|++....... .....+.+|+.+++.++||||+++++++.+...+++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            35789999999999999999999854  459999986543221 113468899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      ||||+ +|+|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||++++++.+||+|||++.....
T Consensus        87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            99999 67888887532   35899999999999999999999999  99999999999999999999999999987654


Q ss_pred             CccccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      .. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+  ......+|..+++.+.+
T Consensus       161 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~  237 (336)
T 3h4j_B          161 GN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQS  237 (336)
T ss_dssp             SB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHH
T ss_pred             Cc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHH
Confidence            43 2346689999999999988876 78999999999999999999999876543322222  22345567889999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ||++||+.||++|||++|+++.
T Consensus       238 li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHcCCChhHCcCHHHHHhC
Confidence            9999999999999999999763

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.6e-43  Score=349.96  Aligned_cols=254  Identities=31%  Similarity=0.498  Sum_probs=215.6

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc----
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----  333 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~----  333 (538)
                      .......|++.+.||+|+||+||+|.+..+.  ||+|++..........+.+.+|+.++++++||||+++++++..    
T Consensus        21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (290)
T 1t4h_A           21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred             cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence            4455667999999999999999999987655  8889988777777778899999999999999999999998764    


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc-CCCcEEEEeeC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFG  412 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~-~~~~vkL~DFG  412 (538)
                      ...+++||||+++++|.+++...   ..+++..++.++.|++.||+|||+++++|+||||||+||+++ .++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             CceEEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            45589999999999999999642   358899999999999999999999877799999999999997 78999999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhcCcccCCCCC
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~  491 (538)
                      ++.......  .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... .....+........++..
T Consensus       178 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (290)
T 1t4h_A          178 LATLKRASF--AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV  254 (290)
T ss_dssp             GGGGCCTTS--BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred             Ccccccccc--cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence            997654432  234578999999998875 5899999999999999999999999875444 334444333344456667


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .++++.+||.+||+.||++|||+.++++
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            8899999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=387.74  Aligned_cols=267  Identities=34%  Similarity=0.561  Sum_probs=232.0

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...+++..++|++.+.||+|+||.||+|.+.++ .||||++......   .+.|.+|+.+|++++|+||+++++++.+ .
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            456788899999999999999999999998865 4999998765433   3478999999999999999999999876 6


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+.+|+|.++++... ...+++..++.|+.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             cceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            7899999999999999996321 234889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          416 SKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       416 ~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+. ...+.+.+..++
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~  490 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP  490 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence            7654321 1234456789999999999899999999999999999999 899999988877776664 455677888999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCC
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ  531 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~  531 (538)
                      +.+.+||.+||+.||++|||+.+|++.|++++.+...+
T Consensus       491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  528 (535)
T 2h8h_A          491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  528 (535)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence            99999999999999999999999999999998766554

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=360.63  Aligned_cols=254  Identities=22%  Similarity=0.353  Sum_probs=211.9

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCC--CceeEeeceeccCCc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEPPN  336 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h--pnIv~l~~~~~~~~~  336 (538)
                      +++...+|++.+.||+|+||+||++.+... .||||++..........+.+.+|+.++++++|  +||+++++++.++..
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            466778899999999999999999987543 39999998777777778899999999999976  999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +++|||+ .+++|.+++...   ..+++..++.++.|++.||+|||+++  |+||||||+|||++ ++.+||+|||+++.
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEEEeC-CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccc
Confidence            9999995 578999999743   35889999999999999999999999  99999999999997 57899999999987


Q ss_pred             CCCCcc--ccCCCCCCCcccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhc
Q 009291          417 KPNTYI--SSKTAAGTPEWMAPEVLRE-----------DPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFK  482 (538)
Q Consensus       417 ~~~~~~--~~~~~~gt~~Y~aPE~l~~-----------~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~~~  482 (538)
                      ......  ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||...... .....+...
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  236 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  236 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence            543321  1235679999999999865           66889999999999999999999999875443 333344334


Q ss_pred             CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       483 ~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      .....++...++.+.+||.+||+.||++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            55667788889999999999999999999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.2e-43  Score=361.01  Aligned_cols=255  Identities=29%  Similarity=0.426  Sum_probs=210.0

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc---CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~---~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ..++|++.+.||+|+||+||+|.+..++  +|+|++.....   .....+.+.+|+.++++++||||+++++++.+....
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            3578999999999999999999987554  89999865432   344567899999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCC-------------------------------------CCCccccHHHHHHHHHHHHHHHHH
Q 009291          338 SIVTEYLSRGSLYKLLHIP-------------------------------------DARVVVDERLRLNMAYDVAKGMNY  380 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~-------------------------------------~~~~~l~~~~~~~i~~qi~~aL~~  380 (538)
                      ++||||+++|+|.+++...                                     .....+++..++.++.|++.||+|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            9999999999999998410                                     012235688899999999999999


Q ss_pred             HHhCCCCEEeecCCCCCEEEcCCC--cEEEEeeCCCccCCC----CccccCCCCCCCcccccccccC--CCCCchhhHHH
Q 009291          381 LHQRRPPIVHRDLKSPNLLVDSTY--TVKVCDFGLSRSKPN----TYISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFS  452 (538)
Q Consensus       381 LH~~~~~iiHrDLKp~NILl~~~~--~vkL~DFGla~~~~~----~~~~~~~~~gt~~Y~aPE~l~~--~~~s~ksDVwS  452 (538)
                      ||+++  |+||||||+||+++.++  .+||+|||++.....    .........||+.|+|||++.+  ..++.++||||
T Consensus       184 LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          184 LHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            99999  99999999999998766  899999999975322    1112345678999999999975  67899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          453 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       453 LGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ||+++|||++|+.||...+..+....+.........+  ..+++.+.+||.+||+.||++|||+.++++
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999999988887777665444433332  347899999999999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-43  Score=388.10  Aligned_cols=270  Identities=30%  Similarity=0.513  Sum_probs=226.1

Q ss_pred             cccccccceeEEE-EEccCCcEEEEEEEEcC--C--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          259 GLEIRWSELLIKK-KIGEGSFGTVYHAEWRN--S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       259 ~~~i~~~~y~i~~-~LG~G~fg~Vy~a~~~~--~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      .+.+...++.+.+ .||+|+||.||+|.+..  +  .||||++.... .....+.+.+|+.+|++++||||+++++++.+
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            3455667777777 89999999999998753  2  38999986543 33345789999999999999999999999976


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                       ..+++||||+.+|+|.+++...  ...+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGl  482 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGL  482 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCST
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccC
Confidence             5689999999999999999643  345899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCC
Q 009291          414 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP  489 (538)
Q Consensus       414 a~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p  489 (538)
                      ++.......   ......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+. .+.+...|
T Consensus       483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p  561 (613)
T 2ozo_A          483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECP  561 (613)
T ss_dssp             TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCC
T ss_pred             cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence            987543221   1123345688999999999999999999999999999998 999999988877776664 45677888


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCCCC
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA  535 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~~~  535 (538)
                      ..+++++.+||.+||+.+|++||++.+|++.|++++.+........
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~  607 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG  607 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCS
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCc
Confidence            9999999999999999999999999999999999998876654433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.4e-43  Score=359.12  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=195.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++++.||+|+||+||+|.+..  ..||+|++.... .....+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            4679999999999999999998864  449999987543 2222356789999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCC---CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ||+. ++|.+++...   .....+++..++.++.||+.||+|||++|  |+||||||+||+++.++.+||+|||+++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            9998 5898888432   22235889999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Cc------------
Q 009291          419 NTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR------------  484 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~------------  484 (538)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+... +.            
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            433334456789999999999764 6899999999999999999999999988876665544211 00            


Q ss_pred             -------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 -------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 -------------------~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                         ....+..++.++.+||.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                               01122357889999999999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.3e-43  Score=358.45  Aligned_cols=250  Identities=25%  Similarity=0.379  Sum_probs=201.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      .++|++++.||+|+||.||+|++..  ..||||++.... .....+.+.+|+.++++++||||+++++++.+..      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4689999999999999999999864  449999987654 3344578999999999999999999999885543      


Q ss_pred             ---------------------------------------------------cceEEEeecCCCChhhhhcCCCCCccccH
Q 009291          336 ---------------------------------------------------NLSIVTEYLSRGSLYKLLHIPDARVVVDE  364 (538)
Q Consensus       336 ---------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~  364 (538)
                                                                         .+++||||+++++|.+++.........++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               27999999999999999987665556777


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc------------cccCCCCCCCc
Q 009291          365 RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY------------ISSKTAAGTPE  432 (538)
Q Consensus       365 ~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~------------~~~~~~~gt~~  432 (538)
                      ..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++......            .......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            789999999999999999999  9999999999999999999999999998755431            12234579999


Q ss_pred             ccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 009291          433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP  512 (538)
Q Consensus       433 Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RP  512 (538)
                      |+|||++.+..++.++||||||+++|||++|..|+...  ......+. .......+...++.+.+||.+||+.||++||
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence            99999999999999999999999999999987664321  11111111 1111111234567889999999999999999


Q ss_pred             CHHHHHH
Q 009291          513 SFPSIME  519 (538)
Q Consensus       513 s~~eIl~  519 (538)
                      |+.++++
T Consensus       319 s~~~~l~  325 (332)
T 3qd2_B          319 EATDIIE  325 (332)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhh
Confidence            9999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.4e-43  Score=352.40  Aligned_cols=264  Identities=34%  Similarity=0.570  Sum_probs=216.0

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      ..+..++|++.+.||+|+||+||+|++..+     .||+|++..... .....+.+.+|+.++++++||||+++++++.+
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            345678999999999999999999986432     278888765432 33556789999999999999999999999987


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      +. .++||||+.+++|.+++...  ...+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CC-ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccc
Confidence            65 89999999999999998643  235889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCC
Q 009291          414 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP  489 (538)
Q Consensus       414 a~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p  489 (538)
                      +........   ......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.....+.+.+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  247 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP  247 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC
Confidence            987543321   1234457888999999998889999999999999999999 999999998888877776666667778


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ..+++.+.++|.+||..||++|||+.++++.|+++....
T Consensus       248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            889999999999999999999999999999999886544

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=357.57  Aligned_cols=260  Identities=23%  Similarity=0.364  Sum_probs=210.8

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC--cc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP--NL  337 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~--~~  337 (538)
                      ...++|++.+.||+|+||+||+|.+..  ..||||++..... ....+.+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            345789999999999999999999974  4599999875432 222457789999999999999999999987655  67


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE----cCCCcEEEEeeCC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL  413 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl----~~~~~vkL~DFGl  413 (538)
                      ++||||+++++|.+++........+++..++.++.|++.||+|||++|  |+||||||+||++    +.++.+||+|||+
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            999999999999999976544445899999999999999999999999  9999999999999    7888899999999


Q ss_pred             CccCCCCccccCCCCCCCccccccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhh
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLR--------EDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGF  481 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~--------~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~----~~~~~~i~~  481 (538)
                      ++...... ......||..|+|||++.        +..++.++|||||||++|||++|+.||.....    .+....+..
T Consensus       163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            98765433 224567999999999986        56789999999999999999999999974332    222222221


Q ss_pred             cCc-------------------cc----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          482 KGR-------------------RL----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       482 ~~~-------------------~~----~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      ...                   ..    .++..+++.+.+||++||+.||++|||++|+++...+-.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            110                   01    122334578999999999999999999999998876543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9e-43  Score=358.67  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=219.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++.+.||+|+||.||++.+..+  .+|+|++..... .....+.+.+|+.+++.++|+||+++++++.+...+++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            46899999999999999999998754  489999876543 445667899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+.+++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++......
T Consensus       120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999988632   35889999999999999999999999  999999999999999999999999999876543


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                      ........||..|+|||++.+..++.++||||||+++|+|++|+.||......+....+..  ....++..+++.+.+||
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li  272 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--NEYSIPKHINPVAASLI  272 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHH
T ss_pred             cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc--CCCCCCccCCHHHHHHH
Confidence            3334556789999999999999999999999999999999999999998887766655533  34556788999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||+.||++|||+.++++
T Consensus       273 ~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          273 QKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHTCSSGGGSCCGGGGGG
T ss_pred             HHHccCChhHCcCHHHHhc
Confidence            9999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-43  Score=352.20  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=216.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeecee--ccCCcceE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV--TEPPNLSI  339 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~--~~~~~~~l  339 (538)
                      .++|++.+.||+|+||.||++.+..+  .+|+|++..........+.+.+|+.++++++||||+++++++  .....+++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46899999999999999999998644  499999987776777788999999999999999999999987  44667899


Q ss_pred             EEeecCCCChhhhhcCCC-CCccccHHHHHHHHHHHHHHHHHHHhCC---CCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          340 VTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRR---PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||+++   .+|+||||||+||+++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999985321 2234889999999999999999999976   349999999999999999999999999997


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      .............|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+. ......++..++++
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~  243 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDE  243 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCCCCTTSCHH
T ss_pred             eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-hcccccCCcccCHH
Confidence            65443222234468999999999999999999999999999999999999999988776666554 33344677889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIMETL  521 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~~L  521 (538)
                      +.++|.+||+.||++|||+.++++.+
T Consensus       244 l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          244 LNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            99999999999999999999997643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.1e-43  Score=377.16  Aligned_cols=252  Identities=29%  Similarity=0.501  Sum_probs=219.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      ..+..++|++++.||+|+||.||+|++.  +..||||++....... .....+.+|+.+++.++||||+++++++.+...
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3455689999999999999999999987  4459999987643221 234578899999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +++||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+||+++.++.+||+|||++..
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhh
Confidence            99999999999999998643   35899999999999999999999999  99999999999999999999999999987


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      ..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.  ......|..++++
T Consensus       166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~  242 (476)
T 2y94_A          166 MSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLNPS  242 (476)
T ss_dssp             CCTTC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH--TTCCCCCTTCCHH
T ss_pred             ccccc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCcCCCccCCHH
Confidence            65432 2346689999999999988776 689999999999999999999999888777766663  3345667889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.+||.+||+.||++|||+.++++
T Consensus       243 ~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          243 VISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHh
Confidence            999999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=351.27  Aligned_cols=250  Identities=26%  Similarity=0.419  Sum_probs=190.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++.+.||+|+||.||+|++.  +..||+|++....... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            468999999999999999999985  4459999986543211 2246788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+++++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999987432  35899999999999999999999999  999999999999999999999999999876543


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                      ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+  .......|..++.++.+||
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li  243 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDLI  243 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--CSSCCCCCTTSCHHHHHHH
T ss_pred             CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--hhcccCCccccCHHHHHHH
Confidence            33334567899999999999988999999999999999999999999877655544433  2234456778999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||+.||++|||+.++++
T Consensus       244 ~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          244 HQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHHSCSSGGGSCCHHHHTT
T ss_pred             HHHcccCHhhCCCHHHHhc
Confidence            9999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-43  Score=367.34  Aligned_cols=262  Identities=31%  Similarity=0.525  Sum_probs=211.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec-cCCcc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-EPPNL  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~-~~~~~  337 (538)
                      ...|++.+.||+|+||+||+|.+..+     .+|+|.+... ......+.+.+|+.++++++||||+++++++. .+...
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            34688999999999999999987532     2788877543 34456678999999999999999999999864 45678


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+++|+|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++..
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeeccccccc
Confidence            99999999999999997433  34788999999999999999999999  999999999999999999999999999864


Q ss_pred             CCCcc----ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          418 PNTYI----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       418 ~~~~~----~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      .....    ......+|..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ...+...|..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~  321 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYC  321 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTC
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence            33211    1123456788999999999999999999999999999999 678888776655554443 44556677889


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCC
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ  531 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~  531 (538)
                      ++.+.++|.+||+.||++|||+.++++.|++++.+....
T Consensus       322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence            999999999999999999999999999999999876543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9e-43  Score=363.19  Aligned_cols=251  Identities=29%  Similarity=0.438  Sum_probs=199.9

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      ....++|++++.||+|+||+||++++..+  .||+|++.......   +.+.+|+.+++.++||||+++++++.+...++
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            34567899999999999999999998744  49999987654333   35779999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc--EEEEeeCCCcc
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSRS  416 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~--vkL~DFGla~~  416 (538)
                      +||||+.+|+|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.  +||+|||+++.
T Consensus        93 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           93 IIMEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            999999999999998632   35899999999999999999999999  999999999999987665  99999999975


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhhcCcccCCCCC
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEK-SDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~k-sDVwSLGvil~eLltg~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~  491 (538)
                      ..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.....    ......+.......+....
T Consensus       168 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (361)
T 3uc3_A          168 SVLHS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR  246 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred             ccccC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence            33221 2245679999999999988887665 8999999999999999999987543    2333333323333444446


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +++++.+||.+||+.||++|||+.++++.
T Consensus       247 ~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          247 ISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            89999999999999999999999999764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-42  Score=364.91  Aligned_cols=249  Identities=23%  Similarity=0.393  Sum_probs=214.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||+||+|.+..++  +|+|++....  ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            468999999999999999999987544  8999886543  334457889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc--CCCcEEEEeeCCCccCCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~--~~~~vkL~DFGla~~~~~  419 (538)
                      ||+.+++|.+++....  ..+++..++.++.||+.||+|||++|  |+||||||+|||++  ..+.+||+|||+++....
T Consensus       128 E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          128 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            9999999999986432  35899999999999999999999999  99999999999997  457899999999987654


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc--cCCCCCCcHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMVA  497 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~s~~l~  497 (538)
                      ... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......  ......+++++.
T Consensus       204 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          204 DEI-VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             TSC-EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             Ccc-eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            321 23457899999999999999999999999999999999999999998887776666443322  223457899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||+.++++
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcCCChhHCcCHHHHhh
Confidence            9999999999999999999976

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=374.67  Aligned_cols=256  Identities=22%  Similarity=0.332  Sum_probs=215.2

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...+..++|++++.||+|+||+||+|+++.  +.||+|++.+.... ....+.+.+|..++..++||||+++++++.+..
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            345677899999999999999999999864  44999998754321 222345789999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+||||+++|+|.+++....  ..+++..++.++.||+.||+|||++|  ||||||||+|||++.+|++||+|||+++
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhhe
Confidence            9999999999999999996432  25899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCcc-ccCCCCCCCccccccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC
Q 009291          416 SKPNTYI-SSKTAAGTPEWMAPEVLR-------EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE  487 (538)
Q Consensus       416 ~~~~~~~-~~~~~~gt~~Y~aPE~l~-------~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~  487 (538)
                      ....... .....+||+.|+|||++.       ...++.++|||||||++|||++|+.||...+..+....+........
T Consensus       211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  290 (412)
T 2vd5_A          211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS  290 (412)
T ss_dssp             ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence            6543322 234568999999999997       35689999999999999999999999999888777766643333333


Q ss_pred             CC---CCCcHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 009291          488 IP---KNVNPMVAALIETCWAEEPEIR---PSFPSIME  519 (538)
Q Consensus       488 ~p---~~~s~~l~~LI~~cL~~dP~~R---Ps~~eIl~  519 (538)
                      +|   ..+++++.+||++||+ +|++|   |+++++++
T Consensus       291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            33   5799999999999999 99998   58888754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.5e-43  Score=363.81  Aligned_cols=264  Identities=17%  Similarity=0.216  Sum_probs=209.2

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHH---------HHHHHHHHHHHHcCCCCcee
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDR---------FKEFLREVAIMKGLRHPNIV  325 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~---------~~~~~~Ei~il~~L~hpnIv  325 (538)
                      +..++|++.+.||+|+||+||+|.+..       ..||||++.........         ...+.+|+..++.++|+||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            456789999999999999999998864       34999998765321110         12344566777888999999


Q ss_pred             EeeceeccC----CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc
Q 009291          326 LLMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD  401 (538)
Q Consensus       326 ~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~  401 (538)
                      ++++++...    ...++||||+ +++|.+++....  ..+++..++.++.||+.||+|||+++  |+||||||+|||++
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~  186 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLN  186 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEe
Confidence            999998664    4489999999 999999996532  35899999999999999999999999  99999999999998


Q ss_pred             --CCCcEEEEeeCCCccCCCCcc-------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 009291          402 --STYTVKVCDFGLSRSKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP  472 (538)
Q Consensus       402 --~~~~vkL~DFGla~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~  472 (538)
                        .++.+||+|||+++.......       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              889999999999976433211       11334599999999999999999999999999999999999999985432


Q ss_pred             HHHHHHHhhcCcc---------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          473 SQVISAVGFKGRR---------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       473 ~~~~~~i~~~~~~---------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      .............         ...+..+++++.++|..||..+|++||++.+|++.|++++.....
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            2222111111000         011257899999999999999999999999999999999986543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.8e-43  Score=358.37  Aligned_cols=256  Identities=18%  Similarity=0.241  Sum_probs=211.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ..++|++.+.||+|+||+||+|++..+  .||||++......    +.+.+|+.+++++ +|+||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            457899999999999999999997644  4999998754322    3578899999999 99999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc-----EEEEeeCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-----VKVCDFGLS  414 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~-----vkL~DFGla  414 (538)
                      ||||+ +++|.+++...  ...+++..++.++.|++.||+|||++|  |+||||||+|||++.++.     +||+|||++
T Consensus        83 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            99999 89999999753  235899999999999999999999999  999999999999998887     999999999


Q ss_pred             ccCCCCcc-------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhhcCc
Q 009291          415 RSKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGR  484 (538)
Q Consensus       415 ~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~---~~~~~i~~~~~  484 (538)
                      +.......       ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   +....+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            86433221       124567999999999999999999999999999999999999999875433   22222211111


Q ss_pred             ccC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          485 RLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       485 ~~~---~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ...   ....++ ++.++|.+||+.+|.+||++++|++.|++++...
T Consensus       238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            111   123455 9999999999999999999999999999988654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.9e-42  Score=353.66  Aligned_cols=250  Identities=23%  Similarity=0.399  Sum_probs=215.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH----HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~----~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .++|++.+.||+|+||.||+|.+..  ..||+|++.......    ...+.+.+|+.++++++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4679999999999999999999874  449999987654322    1246788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC----cEEEEeeCC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGL  413 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~----~vkL~DFGl  413 (538)
                      ++||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999743   35899999999999999999999999  99999999999999887    799999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--CCCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKN  491 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~  491 (538)
                      +....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+.......  ..+..
T Consensus       166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (321)
T 2a2a_A          166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH  244 (321)
T ss_dssp             CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             ceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence            98765432 2245578999999999999999999999999999999999999999988877766654332221  12357


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +++.+.+||.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          245 TSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            8999999999999999999999999976

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.3e-43  Score=358.43  Aligned_cols=262  Identities=33%  Similarity=0.506  Sum_probs=216.8

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec--c
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--E  333 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~--~  333 (538)
                      +..++|++.+.||+|+||.||+|++.      +..||+|++...  .....+.+.+|+.++++++|+||+++++++.  +
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            55689999999999999999999852      334999998654  3555678999999999999999999999876  4


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ...+++||||+++++|.+++...  ...+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             CceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccc
Confidence            55689999999999999999642  235899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHH
Q 009291          414 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--------------QVI  476 (538)
Q Consensus       414 a~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~--------------~~~  476 (538)
                      +........   ......+|..|+|||++.+..++.++||||||+++|+|++|..||......              ...
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            986543321   223456788899999999988999999999999999999999998654332              112


Q ss_pred             HHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          477 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       477 ~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ........+.+.+..+++.+.+||.+||+.||++|||+.++++.|+.++....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            22223455667788899999999999999999999999999999999886543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.4e-42  Score=347.70  Aligned_cols=250  Identities=26%  Similarity=0.489  Sum_probs=217.6

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+..++|++.+.||+|+||.||+|++..++  ||+|++....... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            345678999999999999999999987654  8999986543221 1235788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++...
T Consensus        90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            9999999999999998643   35889999999999999999999999  999999999999999999999999998765


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||......+....+.  .....+|..++..+.
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  240 (284)
T 2vgo_A          165 PSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSK  240 (284)
T ss_dssp             SSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHH
T ss_pred             ccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHH
Confidence            433  2245678999999999999999999999999999999999999999888776665553  344567788999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||+.++++
T Consensus       241 ~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          241 DLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhcCHhhCCCHHHHhh
Confidence            9999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-42  Score=360.26  Aligned_cols=247  Identities=27%  Similarity=0.437  Sum_probs=212.7

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..|++.+.||+|+||+||+|++..+  .||||++..... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            5699999999999999999998644  499999876543 3445678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+. |+|.+++...  ...+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++...... 
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            9997 5787777432  235889999999999999999999999  999999999999999999999999999765432 


Q ss_pred             cccCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                         ....||+.|+|||++.   +..++.++|||||||++|||++|+.||...+.......+.........+..+++.+.+
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  284 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  284 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence               3567899999999984   5678999999999999999999999999888777666655444444456678999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      ||.+||+.||++|||+.++++.
T Consensus       285 li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          285 FVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHHcccChhhCcCHHHHhhC
Confidence            9999999999999999999753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.9e-43  Score=355.95  Aligned_cols=270  Identities=27%  Similarity=0.463  Sum_probs=203.6

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeecee--
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAV--  331 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~--  331 (538)
                      ...+++...+|++.+.||+|+||.||+|++.  +..||+|++...  .....+.+.+|+.+++++. ||||+++++++  
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            3445677789999999999999999999985  445999988554  3455678899999999996 99999999988  


Q ss_pred             ------ccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc
Q 009291          332 ------TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT  405 (538)
Q Consensus       332 ------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~  405 (538)
                            .....+++||||+. |+|.+++........+++..++.++.||+.||+|||+++++|+||||||+|||++.++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~  176 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT  176 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence                  33445899999996 68988886433344689999999999999999999998877999999999999999999


Q ss_pred             EEEEeeCCCccCCCCccc------------cCCCCCCCcccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 009291          406 VKVCDFGLSRSKPNTYIS------------SKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNS  470 (538)
Q Consensus       406 vkL~DFGla~~~~~~~~~------------~~~~~gt~~Y~aPE~l---~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~  470 (538)
                      +||+|||++.........            .....||+.|+|||++   .+..++.++||||||+++|+|++|+.||...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            999999999865432111            1144589999999998   5667899999999999999999999999865


Q ss_pred             CHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 009291          471 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL  533 (538)
Q Consensus       471 ~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~  533 (538)
                      .......    .......+..++..+.+||.+||+.||++|||+.++++.|+.+.......+.
T Consensus       257 ~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~  315 (337)
T 3ll6_A          257 AKLRIVN----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK  315 (337)
T ss_dssp             -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTT
T ss_pred             hHHHhhc----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCC
Confidence            5433222    2333445567788899999999999999999999999999999887655443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=359.18  Aligned_cols=261  Identities=27%  Similarity=0.433  Sum_probs=204.2

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHH--HHcCCCCceeEeecee-----c
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAI--MKGLRHPNIVLLMGAV-----T  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~i--l~~L~hpnIv~l~~~~-----~  332 (538)
                      ..+..++|++++.||+|+||+||+|++.++.||||++....     ...+..|.++  +..++|+||+++++.+     .
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            34667899999999999999999999988889999986543     1233444444  4558999999999743     2


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC---------CCCEEeecCCCCCEEEcCC
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR---------RPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~~~iiHrDLKp~NILl~~~  403 (538)
                      ....+++||||+++|+|.+++....    .++..++.++.|++.||+|||++         +  |+||||||+|||++.+
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~  156 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKND  156 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTT
T ss_pred             CCceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCC
Confidence            3345789999999999999996433    57888999999999999999999         8  9999999999999999


Q ss_pred             CcEEEEeeCCCccCCCCc--------cccCCCCCCCcccccccccC-------CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009291          404 YTVKVCDFGLSRSKPNTY--------ISSKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELITLQKPWR  468 (538)
Q Consensus       404 ~~vkL~DFGla~~~~~~~--------~~~~~~~gt~~Y~aPE~l~~-------~~~s~ksDVwSLGvil~eLltg~~Pf~  468 (538)
                      +.+||+|||+++......        .......||..|+|||++.+       ..++.++|||||||++|||++|..||.
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            999999999997654321        11234569999999999987       456778999999999999999977763


Q ss_pred             CCCH------------------HHHHHHHhhcCcccCCCCC------CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          469 NSTP------------------SQVISAVGFKGRRLEIPKN------VNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       469 ~~~~------------------~~~~~~i~~~~~~~~~p~~------~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      ....                  ......+.....+..+|..      +++.+.+||.+||+.||++|||+.++++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            3211                  1222222233344445544      345899999999999999999999999999999


Q ss_pred             HhhhcCC
Q 009291          525 LMSSVCQ  531 (538)
Q Consensus       525 l~~~~~~  531 (538)
                      +......
T Consensus       317 l~~~~~~  323 (336)
T 3g2f_A          317 MMIWERN  323 (336)
T ss_dssp             HHCCCC-
T ss_pred             HHHHHhc
Confidence            9776543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.8e-42  Score=343.99  Aligned_cols=247  Identities=27%  Similarity=0.382  Sum_probs=212.2

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||+||+|.+.++.  +|+|++.......  .+.+.+|+.++++++||||+++++++.+....++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            357999999999999999999987664  8999887654332  457889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE---cCCCcEEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~~  418 (538)
                      ||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||++   +.++.+||+|||++....
T Consensus        86 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           86 ELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             eccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999999988632   35889999999999999999999999  9999999999999   788999999999998654


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCC--CCCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI--PKNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~s~~l  496 (538)
                      ... ......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||......+....+.......+.  ...+++.+
T Consensus       161 ~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          161 PGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             TTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred             Ccc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence            432 23456789999999998765 899999999999999999999999998887777666433322211  12689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||.+||+.||++|||+.++++
T Consensus       239 ~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            99999999999999999999976

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-42  Score=353.81  Aligned_cols=260  Identities=25%  Similarity=0.379  Sum_probs=208.8

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc--
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL--  337 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~--  337 (538)
                      ..++|++.+.||+|+||.||+|++..+  .||+|++..... .....+.+.+|+.++++++||||+++++++......  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            357899999999999999999998644  499999876543 345567899999999999999999999998765544  


Q ss_pred             --eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          338 --SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       338 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                        ++||||+++++|.++++..   ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++.
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence              9999999999999999643   35899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCc---cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--CCCC
Q 009291          416 SKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPK  490 (538)
Q Consensus       416 ~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~  490 (538)
                      ......   .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+............  ..+.
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence            654321   12234568999999999999999999999999999999999999999988877655543332221  2235


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHH-HHHHHHHHHhh
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPS-IMETLQQFLMS  527 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~e-Il~~L~~il~~  527 (538)
                      .+++++.+||.+||+.||++||++.+ +...|.++...
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            68999999999999999999986554 44555555443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-42  Score=356.06  Aligned_cols=267  Identities=29%  Similarity=0.483  Sum_probs=222.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc-------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      .++..++|++.+.||+|+||.||+|++.       +..||||++... ........+.+|+.++++++||||+++++++.
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            3567789999999999999999999843       234999998643 34555678999999999999999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCC----CccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCc
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDA----RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYT  405 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~  405 (538)
                      +....++||||+++++|.+++.....    ...+++..++.++.|++.||+|||++|  |+||||||+||+++.   +..
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcce
Confidence            99999999999999999999964321    235889999999999999999999999  999999999999984   456


Q ss_pred             EEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhc
Q 009291          406 VKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK  482 (538)
Q Consensus       406 vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~  482 (538)
                      +||+|||++.......  .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~  260 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S  260 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-c
Confidence            9999999987432211  12234467889999999998899999999999999999998 999999888777666554 4


Q ss_pred             CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       483 ~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      ......+..+++.+.++|.+||+.||++|||+.++++.|+.+......
T Consensus       261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence            445667788999999999999999999999999999999998876543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.9e-42  Score=348.66  Aligned_cols=248  Identities=29%  Similarity=0.515  Sum_probs=218.1

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ..|++.+.||+|+||.||+|.+..  ..||+|++...... ...+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            569999999999999999998864  44999998765432 345688999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+++++|.+++..    ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++........
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            9999999999863    35889999999999999999999999  99999999999999999999999999987655443


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........+. ......++..++..+.+||.+
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHH
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHH
Confidence            4456678999999999999999999999999999999999999999888776665553 334455677899999999999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 009291          503 CWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~~  520 (538)
                      ||+.||++|||+.++++.
T Consensus       254 ~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          254 CLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             HCCSSGGGSCCHHHHTTC
T ss_pred             HcCCChhhCcCHHHHhhC
Confidence            999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-42  Score=360.06  Aligned_cols=245  Identities=25%  Similarity=0.427  Sum_probs=207.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++.+.||+|+||+||++.++.++  ||+|++......      ..+|++++.++ +||||+++++++.+...+|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            467999999999999999999987554  999998765432      34688888877 799999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC----CcEEEEeeCCCcc
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST----YTVKVCDFGLSRS  416 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~----~~vkL~DFGla~~  416 (538)
                      |||+.+|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||+.+.    +.+||+|||++..
T Consensus        95 ~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           95 TELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             ECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999998643   35899999999999999999999999  9999999999998533    3599999999987


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhhcCcccC--CCCC
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN---STPSQVISAVGFKGRRLE--IPKN  491 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~---~~~~~~~~~i~~~~~~~~--~p~~  491 (538)
                      ...........+||+.|+|||++.+..++.++|||||||++|+|++|..||..   .+..+....+........  .+..
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            55443344567899999999999988899999999999999999999999986   344555555543333222  3357


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +++++.+||.+||..||++|||+.++++
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            8999999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-42  Score=352.88  Aligned_cols=262  Identities=19%  Similarity=0.268  Sum_probs=210.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++.+.||+|+||.||+|.+..+  .||+|++..... .....+.+.+|+.++++++||||+++++++.++..+++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            57899999999999999999998644  499999865533 345567899999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+++++|.+++...   ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++......
T Consensus       113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999999999643   35889999999999999999999999  999999999999999999999999998765433


Q ss_pred             c-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cccCCCCCCcHHHHH
Q 009291          421 Y-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA  498 (538)
Q Consensus       421 ~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~~  498 (538)
                      . .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.... .....+..+++++.+
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence            2 12234578999999999999999999999999999999999999999877654444333222 123456789999999


Q ss_pred             HHHHhhhcCCCCCC-CHHHHHHHHHHHHhhhcC
Q 009291          499 LIETCWAEEPEIRP-SFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       499 LI~~cL~~dP~~RP-s~~eIl~~L~~il~~~~~  530 (538)
                      +|.+||+.||++|| +++++++.|++++.....
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             HHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            99999999999999 999999999998766543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.8e-42  Score=363.25  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=212.2

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCC--CCceeEeeceeccCCc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEPPN  336 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~--hpnIv~l~~~~~~~~~  336 (538)
                      ..+...+|++++.||+|+||+||++.+.. ..||||++..........+.+.+|+.++++++  |+||+++++++..+..
T Consensus        51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            44556789999999999999999998764 34999999877767777889999999999996  5999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +++||| +.+++|.+++....   .+++..++.++.||+.||+|||+++  |+||||||+|||++ ++.+||+|||+++.
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             EEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence            999999 56789999997433   5888899999999999999999999  99999999999995 57999999999987


Q ss_pred             CCCCcc--ccCCCCCCCcccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhc
Q 009291          417 KPNTYI--SSKTAAGTPEWMAPEVLRE-----------DPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFK  482 (538)
Q Consensus       417 ~~~~~~--~~~~~~gt~~Y~aPE~l~~-----------~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~~~  482 (538)
                      ......  ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||...... .....+...
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  283 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  283 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence            543221  2245679999999999865           36889999999999999999999999875433 344444444


Q ss_pred             CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       483 ~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      .....+|...+.++.+||.+||+.||++|||+.++++.
T Consensus       284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            55666778889999999999999999999999999753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=358.63  Aligned_cols=247  Identities=26%  Similarity=0.375  Sum_probs=195.1

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ..+.|++.+.||+|+||+||+|++.++  .||||++....    ..+.+.+|+.++++++||||+++++++.+...+++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            346799999999999999999999754  49999987543    235678899999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeCCCccC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSK  417 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGla~~~  417 (538)
                      |||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.   ++.+||+|||+++..
T Consensus       127 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          127 LELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             ECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999998643   35899999999999999999999999  999999999999975   889999999999865


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhcCccc--CCCCCCcH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRL--EIPKNVNP  494 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~-~~~~i~~~~~~~--~~p~~~s~  494 (538)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+.......  +....++.
T Consensus       202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          202 EHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             Cccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence            4332 2245678999999999999999999999999999999999999998766544 333333222222  22357899


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ++.+||.+||+.||++|||+.++++
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=351.70  Aligned_cols=249  Identities=21%  Similarity=0.246  Sum_probs=203.4

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~  337 (538)
                      ++..++|++.+.||+|+||+||+|++..  +.||||++............+.+|+..+.++ +|+||+++++++.+...+
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            3445789999999999999999999874  4499999876655555556666666666555 899999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+ +++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++...
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            9999999 668888875432  35899999999999999999999999  999999999999999999999999999876


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      .... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....   ...+........++..+++++.
T Consensus       208 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~  282 (311)
T 3p1a_A          208 GTAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELR  282 (311)
T ss_dssp             C-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHH
T ss_pred             ccCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHH
Confidence            5432 2345579999999999876 689999999999999999999776654322   2233223333345577899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||+.++++
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          283 SVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-42  Score=364.49  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=198.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCC--cce
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP--NLS  338 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~--~~~  338 (538)
                      .++|++++.||+|+||.||+|.+..+  .||||++..........+.+.+|+.+++++. ||||+++++++..++  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            46899999999999999999998744  4999998766556677788999999999997 999999999986544  689


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+. ++|..++...    .+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+|+...
T Consensus        88 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            9999997 5898888642    4889999999999999999999999  9999999999999999999999999997543


Q ss_pred             CC---------------------ccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 009291          419 NT---------------------YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI  476 (538)
Q Consensus       419 ~~---------------------~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~  476 (538)
                      ..                     .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            21                     111234579999999999986 67899999999999999999999999988776655


Q ss_pred             HHHhhcCc---------------------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 009291          477 SAVGFKGR---------------------------------------------RLEIPKNVNPMVAALIETCWAEEPEIR  511 (538)
Q Consensus       477 ~~i~~~~~---------------------------------------------~~~~p~~~s~~l~~LI~~cL~~dP~~R  511 (538)
                      ..+.....                                             ....+..+++++.+||.+||+.||++|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            54421000                                             001123678999999999999999999


Q ss_pred             CCHHHHHHH
Q 009291          512 PSFPSIMET  520 (538)
Q Consensus       512 Ps~~eIl~~  520 (538)
                      ||+.|+++.
T Consensus       321 ~t~~e~l~H  329 (388)
T 3oz6_A          321 ISANDALKH  329 (388)
T ss_dssp             CCHHHHTTS
T ss_pred             CCHHHHhCC
Confidence            999998764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.4e-42  Score=347.85  Aligned_cols=256  Identities=24%  Similarity=0.392  Sum_probs=198.1

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      +++..++|++.+.||+|+||+||+|++..  +.||+|++..........+.+.++...++.++||||+++++++.++...
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            45677899999999999999999999854  4499999876544444445556666668889999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcC-CCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          338 SIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ++||||+++ +|.+++.. ......+++..++.++.|++.||+|||++ |  |+||||||+||+++.++.+||+|||++.
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG  158 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence            999999975 88777642 11234689999999999999999999998 9  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhhcCcccCCCC
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVL----REDPSNEKSDVFSFGVILWELITLQKPWRNS-TPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l----~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~-~~~~~~~~i~~~~~~~~~p~  490 (538)
                      ...... ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||... ..................+.
T Consensus       159 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T 3fme_A          159 YLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD  237 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred             cccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence            654432 22345789999999996    5667899999999999999999999999864 33333333333333333445


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+++++.+||.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            78999999999999999999999999987

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=352.99  Aligned_cols=256  Identities=32%  Similarity=0.544  Sum_probs=207.3

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcC--CCCceeEeeceeccC----Cc
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL--RHPNIVLLMGAVTEP----PN  336 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L--~hpnIv~l~~~~~~~----~~  336 (538)
                      ..++|++.+.||+|+||.||+|+++++.||||++....     ...+.+|.+++..+  +||||+++++++.+.    ..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            34689999999999999999999998889999986432     12445566666554  899999999998776    67


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC--------CCCEEeecCCCCCEEEcCCCcEEE
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR--------RPPIVHRDLKSPNLLVDSTYTVKV  408 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~~~iiHrDLKp~NILl~~~~~vkL  408 (538)
                      +++||||+++|+|.++++..    .+++..++.++.|++.||+|||++        +  |+||||||+||+++.++.+||
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEE
Confidence            89999999999999999643    488999999999999999999998        8  999999999999999999999


Q ss_pred             EeeCCCccCCCCccc----cCCCCCCCcccccccccCCCCCch------hhHHHHHHHHHHHHhC----------CCCCC
Q 009291          409 CDFGLSRSKPNTYIS----SKTAAGTPEWMAPEVLREDPSNEK------SDVFSFGVILWELITL----------QKPWR  468 (538)
Q Consensus       409 ~DFGla~~~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~k------sDVwSLGvil~eLltg----------~~Pf~  468 (538)
                      +|||++.........    .....||+.|+|||++.+..++.+      +|||||||++|||++|          +.||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            999999765432211    234579999999999988766654      9999999999999999          77776


Q ss_pred             CCC-----HHHHHHHHhhcCcccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          469 NST-----PSQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       469 ~~~-----~~~~~~~i~~~~~~~~~p~-----~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ...     .......+.....+..++.     .+++++.+||.+||+.||++|||+.++++.|+++..+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            532     1222333333333444443     567889999999999999999999999999999988754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-42  Score=386.41  Aligned_cols=262  Identities=31%  Similarity=0.508  Sum_probs=221.8

Q ss_pred             ccccccceeEE-EEEccCCcEEEEEEEEcC----CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          260 LEIRWSELLIK-KKIGEGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       260 ~~i~~~~y~i~-~~LG~G~fg~Vy~a~~~~----~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      +.+....+.+. +.||+|+||+||+|.+..    ..||||++..........+.+.+|+.+|++++||||+++++++.. 
T Consensus       363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  441 (635)
T 4fl3_A          363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-  441 (635)
T ss_dssp             SBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             ccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            44555566665 489999999999996642    349999998766555566789999999999999999999999865 


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ..+++||||+.+|+|.+++...   ..+++..++.|+.||+.||+|||+++  ||||||||+|||++.++.+||+|||++
T Consensus       442 ~~~~lv~E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla  516 (635)
T 4fl3_A          442 ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLS  516 (635)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred             CCEEEEEEccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence            4588999999999999999643   35889999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCc---cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCC
Q 009291          415 RSKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       415 ~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  490 (538)
                      +......   .......+|..|+|||++.+..++.++|||||||++|||++ |+.||......+....+. ...+...|.
T Consensus       517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~  595 (635)
T 4fl3_A          517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPA  595 (635)
T ss_dssp             HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCT
T ss_pred             cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence            8654322   11233456788999999999999999999999999999998 999999998887776664 455677888


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .+++++.+||.+||+.||++|||+.+|++.|++++.+.
T Consensus       596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999999998764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.6e-42  Score=389.72  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=219.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCC
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP  335 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~  335 (538)
                      ..+..++|++++.||+|+||+||+|++..++  ||||++..... .....+.+.+|..++..+ +|++|+.+++++.+..
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            3456789999999999999999999987655  99999876422 122345778899999988 7999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+||||+++|+|.++++..   ..+++..++.++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+++
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceee
Confidence            999999999999999999743   35899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      ............+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.  .....+|..++++
T Consensus       491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~  568 (674)
T 3pfq_A          491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKE  568 (674)
T ss_dssp             ECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCCCCCTTSCHH
T ss_pred             ccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHH
Confidence            64443334566789999999999999999999999999999999999999999998888877774  3456778899999


Q ss_pred             HHHHHHHhhhcCCCCCCCH-----HHHHH
Q 009291          496 VAALIETCWAEEPEIRPSF-----PSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~-----~eIl~  519 (538)
                      +.+||++||+.||++||++     ++|++
T Consensus       569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          569 AVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            9999999999999999997     56653

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=361.20  Aligned_cols=267  Identities=32%  Similarity=0.553  Sum_probs=219.8

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      ...+++..++|++.+.||+|+||.||+|.+.+ .+|+|++..........+.+.+|+.++++++|+||+++++++.+...
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            45577888999999999999999999998765 59999987654444444567789999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +++||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++ ++.+||+|||+++.
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             eEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            999999999999999996532  35889999999999999999999999  99999999999998 67999999999875


Q ss_pred             CCCC-----ccccCCCCCCCcccccccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc
Q 009291          417 KPNT-----YISSKTAAGTPEWMAPEVLRE---------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK  482 (538)
Q Consensus       417 ~~~~-----~~~~~~~~gt~~Y~aPE~l~~---------~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~  482 (538)
                      ....     ........|+..|+|||.+.+         ..++.++||||||+++|+|++|+.||...........+...
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  258 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG  258 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence            4221     112234458899999999875         34788999999999999999999999998887777666544


Q ss_pred             CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       483 ~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ......+..++.++.++|.+||..||++|||+.++++.|+++.....
T Consensus       259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence            33333445788999999999999999999999999999998876543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.9e-42  Score=373.90  Aligned_cols=255  Identities=31%  Similarity=0.447  Sum_probs=212.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++++.||+|+||+||+|++..+  .+|+|++............+.+|+.+++.++||||+++++++.+...+++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            35799999999999999999998754  4999998766544444567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGla~~~~  418 (538)
                      ||+.+|+|.+.+...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.   ++.+||+|||++....
T Consensus       116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999888532   35889999999999999999999999  999999999999975   4559999999998765


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l  496 (538)
                      ... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+.........+  ..+++.+
T Consensus       191 ~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          191 NQK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             TTB-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             CCc-cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence            432 2345679999999999864 68999999999999999999999999999888887776554443322  5789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH--HHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMET--LQQFL  525 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~--L~~il  525 (538)
                      .+||.+||+.||++|||+.++++.  +++..
T Consensus       269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             HHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence            999999999999999999999853  44443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2e-42  Score=344.87  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=208.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++.+.||+|+||+||+|.+.  +..||+|++............+.+|+..+..+ +||||+++++++.++..+++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            468999999999999999999986  44599999987665666677889999999999 899999999999999999999


Q ss_pred             EeecCCCChhhhhcCCC-CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-----------------
Q 009291          341 TEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----------------  402 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-----------------  402 (538)
                      |||+++++|.+++.... ....+++..++.++.||+.||+|||++|  |+||||||+||+++.                 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            99999999999996421 1145899999999999999999999999  999999999999984                 


Q ss_pred             --CCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 009291          403 --TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV  479 (538)
Q Consensus       403 --~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i  479 (538)
                        ...+||+|||++......    ....||..|+|||.+.+. .++.++||||||+++|+|++|..|+......   ..+
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~  240 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEI  240 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHH
T ss_pred             CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHH
Confidence              447999999999876543    345689999999999876 5668999999999999999998877554322   222


Q ss_pred             hhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       480 ~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       .......++..+++++.+||.+||+.||++|||+.++++
T Consensus       241 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          241 -RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             233445677889999999999999999999999999865

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.2e-43  Score=358.50  Aligned_cols=251  Identities=25%  Similarity=0.307  Sum_probs=198.2

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ..++|++++.||+|+||+||+|.+..++  ||+|++..........+.+.+|+.++++++||||+++++++.+...+++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3568999999999999999999887544  99999876655555567788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE-----cCCCcEEEEeeCCCc
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-----DSTYTVKVCDFGLSR  415 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl-----~~~~~vkL~DFGla~  415 (538)
                      |||+.+ +|.+++....   .+++..++.++.||+.||+|||+++  |+||||||+|||+     +.++.+||+|||+++
T Consensus       112 ~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            999975 8999886433   4889999999999999999999999  9999999999999     455669999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--------  486 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--------  486 (538)
                      .............||..|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.......        
T Consensus       186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            654433334556789999999999875 48999999999999999999999999888776655442110000        


Q ss_pred             --------C------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 --------E------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 --------~------------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                              .            ++..+++++.+||.+||+.||++|||+.|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                    0            01126789999999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.8e-42  Score=374.58  Aligned_cols=250  Identities=30%  Similarity=0.466  Sum_probs=214.2

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||+||+|.+..  ..||||++............+.+|+.++++++||||+++++++.+...+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            3679999999999999999999874  45999998765433334567899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc---CCCcEEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla~~~~  418 (538)
                      ||+.+++|.+.+...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++   .++.+||+|||+++...
T Consensus       101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999988532   35899999999999999999999999  99999999999995   45679999999998654


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l  496 (538)
                      ... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+.........+  ..+++++
T Consensus       176 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  253 (486)
T 3mwu_A          176 QNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (486)
T ss_dssp             CC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred             CCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence            332 2345679999999999976 48999999999999999999999999999888887776554443333  4689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      .+||.+||+.||++|||+.++++.
T Consensus       254 ~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          254 KDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcC
Confidence            999999999999999999999873

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.4e-43  Score=353.34  Aligned_cols=257  Identities=31%  Similarity=0.485  Sum_probs=211.0

Q ss_pred             eeEEEEEccCCcEEEEEEEEcCCceEEEEEeccc--cCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQE--FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~--~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      |..++.||+|+||+||+|.+.++.+|+|++....  ......+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            3446899999999999999888889999986542  23345678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc--
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--  422 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~--  422 (538)
                      ++++|.+++........+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++........  
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            99999999975444456899999999999999999999999  99999999999999999999999999976543221  


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhhc---------CcccCCC
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----VISAVGFK---------GRRLEIP  489 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~----~~~~i~~~---------~~~~~~p  489 (538)
                      ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......    ....+...         ......+
T Consensus       191 ~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD  269 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred             cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence            2234578999999999876 48899999999999999999999997654322    11111111         1111223


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM  526 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~  526 (538)
                      ..+++.+.++|.+||+.+|++|||+.++++.|+++..
T Consensus       270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            3456789999999999999999999999999998754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-42  Score=355.92  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=209.9

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ...++|++++.||+|+||.||+|++..  ..||+|++..........+.+.+|+.++++++||||+++++++.+....++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            346789999999999999999999874  449999988777677777788999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      ||||+.+++|.+++....   .+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++.....
T Consensus       102 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            999999999988875433   4899999999999999999999999  99999999999999999999999999987554


Q ss_pred             CccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----------------
Q 009291          420 TYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK----------------  482 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~----------------  482 (538)
                      .........||..|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+...                
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            43334556789999999999875 6899999999999999999999999988776555433211                


Q ss_pred             ---CcccC----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 ---GRRLE----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ---~~~~~----------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                         ....+          ..+.+++.+.+||.+||+.||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               00000          11357899999999999999999999999875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=359.53  Aligned_cols=246  Identities=25%  Similarity=0.374  Sum_probs=206.2

Q ss_pred             eeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      +...+.||+|+||.||+|.+..  ..||+|++....  ....+.+.+|+.++++++||||+++++++.+...+++||||+
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            4447889999999999999864  449999987643  344568999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE--cCCCcEEEEeeCCCccCCCCcc
Q 009291          345 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV--DSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       345 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl--~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      ++++|.+++...  ...+++..++.++.||+.||+|||+++  |+||||||+|||+  +.++.+||+|||+++...... 
T Consensus       169 ~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-  243 (373)
T 2x4f_A          169 DGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-  243 (373)
T ss_dssp             TTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence            999999888533  235889999999999999999999999  9999999999999  567899999999998765432 


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC--CCCCCcHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMVAALI  500 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~s~~l~~LI  500 (538)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+........  ....+++++.+||
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            23455799999999999999999999999999999999999999999888777766643332222  2256899999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||+.||++|||+.++++
T Consensus       324 ~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          324 SKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HTTSCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhhCCCHHHHhc
Confidence            9999999999999999987

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.9e-42  Score=377.48  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=213.9

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+..++|++.+.||+|+||+||+|+++.  +.||+|++....... ...+.+.+|+.++++++||||+++++++.+...+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            4566899999999999999999999864  449999987643221 2346788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCC-CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          338 SIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      |+||||++||+|.+++.... ....+++..++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|||+++.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeee
Confidence            99999999999999986432 2346899999999999999999999999  99999999999999999999999999987


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhhcCcccCCCCCC
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~----~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      ...........+||+.|+|||++.+..++.++|||||||++|||++|+.||....    ..+....+.  .....+|..+
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~  416 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKF  416 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTS
T ss_pred             ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCccc
Confidence            6554433445689999999999999999999999999999999999999998753    334444432  2345677889


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCH
Q 009291          493 NPMVAALIETCWAEEPEIRPSF  514 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~  514 (538)
                      ++++.+||.+||+.||++||++
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCC
T ss_pred             CHHHHHHHHHhccCCHhHCCCC
Confidence            9999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=347.33  Aligned_cols=256  Identities=27%  Similarity=0.456  Sum_probs=210.1

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ......+|.....||+|+||.||+|.+..+  .||+|++....  ....+.+.+|+.+++.++||||+++++++.+....
T Consensus        17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            344455566667999999999999998654  48999886653  33456789999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCCCcc
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS  416 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~  416 (538)
                      ++||||+++++|.+++........+++..++.++.|++.||+|||++|  |+||||||+||+++. ++.+||+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccc
Confidence            999999999999999975544445778999999999999999999999  999999999999987 89999999999987


Q ss_pred             CCCCccccCCCCCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhcCcccCCCCCCc
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~--~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~s  493 (538)
                      ............|+..|+|||++.+..  ++.++||||||+++|+|++|+.||....... .............++..++
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (295)
T 2clq_A          173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS  252 (295)
T ss_dssp             SCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC
T ss_pred             cCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC
Confidence            654333334567899999999997654  7899999999999999999999997654332 2222223344556788899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +++.+||.+||+.||++|||+.++++
T Consensus       253 ~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          253 AEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            99999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-42  Score=346.12  Aligned_cols=250  Identities=26%  Similarity=0.460  Sum_probs=206.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++.+.||+|+||+||+|.+..+  .+|+|++..... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            5799999999999999999998754  489999876542 2234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE---cCCCcEEEEeeCCCccCC
Q 009291          343 YLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       343 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~~  418 (538)
                      |+++++|.+++... .....+++..++.++.|++.||+|||++|  |+||||||+||++   +.++.+||+|||++....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999999988432 12245899999999999999999999999  9999999999999   456789999999997654


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCC-CCCCcHHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI-PKNVNPMVA  497 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~s~~l~  497 (538)
                      ... ......||..|+|||.+. ..++.++||||||+++|+|++|+.||......+.............. ...+++++.
T Consensus       179 ~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (285)
T 3is5_A          179 SDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV  256 (285)
T ss_dssp             ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred             Ccc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence            432 234567899999999986 46889999999999999999999999998887776665544333322 234789999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||+.|+++
T Consensus       257 ~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          257 DLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.4e-42  Score=342.87  Aligned_cols=252  Identities=29%  Similarity=0.474  Sum_probs=208.9

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      ..+..++|++.+.||+|+||.||+|.+.  +..||+|++...... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            3456789999999999999999999986  445999998654321 1234578899999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++..
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             EEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccc
Confidence            99999999999999998643   34889999999999999999999999  99999999999999999999999999987


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      ..... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+..  ....+|..++..
T Consensus       161 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~  237 (276)
T 2h6d_A          161 MSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG--GVFYIPEYLNRS  237 (276)
T ss_dssp             CCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred             cCCCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--CcccCchhcCHH
Confidence            65432 2235578999999999988765 6899999999999999999999998887776665532  334567788999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.++|.+||+.||++|||+.++++
T Consensus       238 l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          238 VATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHHh
Confidence            999999999999999999999987

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.2e-42  Score=342.22  Aligned_cols=257  Identities=24%  Similarity=0.431  Sum_probs=214.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH----HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~----~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .++|++.+.||+|+||+||+|.+..  +.+|+|++.......    ...+.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            3579999999999999999999874  459999987654322    1246788999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC----cEEEEeeCC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGL  413 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~----~vkL~DFGl  413 (538)
                      ++||||+++++|.+++..   ...+++..++.++.|++.||+|||++|  |+||||||+||+++.++    .+||+|||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            999999999999999863   235899999999999999999999999  99999999999998877    899999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--CCCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKN  491 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~  491 (538)
                      +....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+.......  ..+..
T Consensus       159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T 3bhy_A          159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN  237 (283)
T ss_dssp             CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             ceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence            98654432 2234568999999999999999999999999999999999999999988877666654332221  22357


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHh
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLM  526 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~--~L~~il~  526 (538)
                      +++.+.+||.+||+.||++|||+.++++  .++.+-.
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            8899999999999999999999999987  4555543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-42  Score=356.65  Aligned_cols=246  Identities=26%  Similarity=0.352  Sum_probs=203.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      .++|++.+.||+|+||.||+|.+..  ..||||++..........+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            4689999999999999999999864  44999998766556666788999999999999999999999987653      


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+||||+ +++|.+++..    ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 7899999864    24889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-----------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-----------  483 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-----------  483 (538)
                      .....   .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....           
T Consensus       177 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          177 QADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             ECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             ccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            75443   245678999999999887 678999999999999999999999999887665544332100           


Q ss_pred             ------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 ------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ------------------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                        .-......+++.+.+||.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                              001233567899999999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.2e-43  Score=360.84  Aligned_cols=257  Identities=22%  Similarity=0.269  Sum_probs=202.3

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC-----CceEEEEEeccccCHH---------HHHHHHHHHHHHHcCCCCceeEe
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN-----SDVAVKILIEQEFHED---------RFKEFLREVAIMKGLRHPNIVLL  327 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~vavK~~~~~~~~~~---------~~~~~~~Ei~il~~L~hpnIv~l  327 (538)
                      +..++|++.+.||+|+||+||+|.+..     ..+|+|+.........         ....+.+|+.+++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            456789999999999999999999854     4499999876532111         11346688899999999999999


Q ss_pred             eceecc----CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC
Q 009291          328 MGAVTE----PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST  403 (538)
Q Consensus       328 ~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~  403 (538)
                      ++++.+    ....++||||+ +++|.+++....   .+++..++.++.||+.||+|||+++  |+||||||+|||++.+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence            999877    67799999999 999999986432   6899999999999999999999999  9999999999999887


Q ss_pred             C--cEEEEeeCCCccCCCCc-------cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CH
Q 009291          404 Y--TVKVCDFGLSRSKPNTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS--TP  472 (538)
Q Consensus       404 ~--~vkL~DFGla~~~~~~~-------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~--~~  472 (538)
                      +  .+||+|||+++......       .......||..|+|||++.+..++.++|||||||++|||++|+.||...  ..
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  99999999997643221       1113457899999999999999999999999999999999999999652  22


Q ss_pred             HHHHHHHhhcCcccCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHh
Q 009291          473 SQVISAVGFKGRRLEIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM  526 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p---------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~  526 (538)
                      .......  ......++         ..+++++.++|.+||+.||++|||+.+|++.|+++..
T Consensus       268 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 VAVQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            2221111  11111222         2789999999999999999999999999999987654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=353.88  Aligned_cols=269  Identities=21%  Similarity=0.303  Sum_probs=214.1

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec--
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--  332 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~--  332 (538)
                      ...+.+..++|++.+.||+|+||.||++++..  ..||+|++...  .....+.+.+|+.+++.++||||+++++++.  
T Consensus        21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (317)
T 2buj_A           21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRE   98 (317)
T ss_dssp             EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred             ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence            34456778899999999999999999999854  44999988653  3556678999999999999999999999986  


Q ss_pred             --cCCcceEEEeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          333 --EPPNLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       333 --~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                        .....++||||+.+++|.+++... .....+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+
T Consensus        99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A           99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEEC
T ss_pred             cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEE
Confidence              344689999999999999998541 12346899999999999999999999999  9999999999999999999999


Q ss_pred             eeCCCccCCCCccc---------cCCCCCCCcccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH
Q 009291          410 DFGLSRSKPNTYIS---------SKTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNSTP--SQV  475 (538)
Q Consensus       410 DFGla~~~~~~~~~---------~~~~~gt~~Y~aPE~l~~~~---~s~ksDVwSLGvil~eLltg~~Pf~~~~~--~~~  475 (538)
                      |||++.........         .....||..|+|||.+.+..   ++.++||||||+++|+|++|+.||.....  ...
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  256 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV  256 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence            99998764321110         01234689999999987654   68999999999999999999999954211  111


Q ss_pred             HHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          476 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       476 ~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      ...+ ......+.+..+++.+.++|.+||+.||++|||+.++++.|+++......
T Consensus       257 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          257 ALAV-QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             HHHH-HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             hHHh-hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence            1112 22334455567899999999999999999999999999999987654433

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=349.87  Aligned_cols=253  Identities=26%  Similarity=0.296  Sum_probs=203.1

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC---HHHHHHHHHHHHHHHcC---CCCceeEeeceecc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH---EDRFKEFLREVAIMKGL---RHPNIVLLMGAVTE  333 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~---~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~~  333 (538)
                      +..++|++.+.||+|+||+||+|++..  +.||+|++......   ......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            446789999999999999999999754  44999998654321   11123455677776666   59999999999876


Q ss_pred             CC-----cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEE
Q 009291          334 PP-----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV  408 (538)
Q Consensus       334 ~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL  408 (538)
                      ..     .+++||||+. ++|.+++..... ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEE
Confidence            55     4799999997 599999875432 24899999999999999999999999  999999999999999999999


Q ss_pred             EeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc---
Q 009291          409 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---  485 (538)
Q Consensus       409 ~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~---  485 (538)
                      +|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......   
T Consensus       162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9999998654332 234567899999999999999999999999999999999999999998887766554321000   


Q ss_pred             ----------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ----------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ----------------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                            ......+++.+.+||.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                                  0012367899999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.1e-42  Score=371.73  Aligned_cols=249  Identities=28%  Similarity=0.477  Sum_probs=211.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCH-----------HHHHHHHHHHHHHHcCCCCceeEeece
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE-----------DRFKEFLREVAIMKGLRHPNIVLLMGA  330 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~-----------~~~~~~~~Ei~il~~L~hpnIv~l~~~  330 (538)
                      .++|++++.||+|+||+||+|.+..+  .+|+|++.......           ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            46899999999999999999998754  49999987654322           234678899999999999999999999


Q ss_pred             eccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC---cEE
Q 009291          331 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVK  407 (538)
Q Consensus       331 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~---~vk  407 (538)
                      +.+...+++||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++   .+|
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999999988532   35899999999999999999999999  99999999999998776   699


Q ss_pred             EEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC
Q 009291          408 VCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE  487 (538)
Q Consensus       408 L~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~  487 (538)
                      |+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+........
T Consensus       190 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             ECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99999998765432 2345679999999999874 589999999999999999999999999998888877754443322


Q ss_pred             C--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          488 I--PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       488 ~--p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .  ...+++++.+||.+||+.||.+|||+.++++
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            2  2578999999999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.4e-42  Score=339.31  Aligned_cols=250  Identities=29%  Similarity=0.382  Sum_probs=208.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||.||+|.+..  ..||+|++...... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3679999999999999999999874  45999998755432 34567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++.......
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999998643   35899999999999999999999999  9999999999999999999999999997643221


Q ss_pred             --cccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhcCcccCCCCCCcHHHH
Q 009291          422 --ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       422 --~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                        .......|+..|+|||.+.+..+ +.++||||||+++|+|++|+.||....... .................+++.+.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL  239 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence              12245678999999999988765 778999999999999999999998765432 22222222222333356899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||+.++++
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          240 ALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHCCCCchhCCCHHHHhc
Confidence            9999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-42  Score=349.60  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=208.1

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceecc--
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE--  333 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~--  333 (538)
                      .+....++|++.+.||+|+||.||+|++.  +..||+|++......   .+.+.+|+.+++++ +||||+++++++..  
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            34456789999999999999999999985  445999998755433   24678999999998 79999999999876  


Q ss_pred             ----CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          334 ----PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       334 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                          ...+++||||+++++|.+++.... ...+++..++.++.||+.||+|||++|  |+||||||+||+++.++.+||+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEEC
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEe
Confidence                467899999999999999996432 245889999999999999999999999  9999999999999999999999


Q ss_pred             eeCCCccCCCCccccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc
Q 009291          410 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR  484 (538)
Q Consensus       410 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~  484 (538)
                      |||++..............||..|+|||++.     +..++.++||||||+++|+|++|..||...........+.....
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  251 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA  251 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence            9999987554333334567899999999987     56688999999999999999999999998887766665544444


Q ss_pred             ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ....+..+++.+.+||.+||..||++|||+.++++
T Consensus       252 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            44445678999999999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-42  Score=356.04  Aligned_cols=243  Identities=27%  Similarity=0.409  Sum_probs=184.6

Q ss_pred             cceeEE---EEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcce
Q 009291          265 SELLIK---KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       265 ~~y~i~---~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~  338 (538)
                      .+|++.   +.||+|+||+||+|.+..+  .||||++...     ....+.+|+.+++.+. ||||+++++++.+....+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence            456554   7899999999999998744  4999998653     2346778999999997 999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC---cEEEEeeCCCc
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSR  415 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~---~vkL~DFGla~  415 (538)
                      +||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++   .+||+|||+++
T Consensus        83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            999999999999999743   35899999999999999999999999  99999999999997665   89999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhhcCcccCC
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-------SQVISAVGFKGRRLEI  488 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~  488 (538)
                      .............||+.|+|||++.+..++.++||||||+++|+|++|+.||.....       .+....+..  ....+
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--~~~~~  235 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--GDFSF  235 (325)
T ss_dssp             ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--TCCCC
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--CCCCC
Confidence            765544444566789999999999999999999999999999999999999986443       333444432  22222


Q ss_pred             C----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          489 P----KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       489 p----~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +    ..+++++.+||.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            2    368999999999999999999999999863

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=356.91  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=199.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++++.||+|+||+||+|++..+  .||+|++.... .......+.+|+.++++++||||+++++++.+...+++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            5799999999999999999998744  49999986543 12222245679999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.+ +|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cccc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            9975 8888876432  35889999999999999999999999  99999999999999999999999999986654433


Q ss_pred             ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc----------------
Q 009291          423 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------------  485 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------------  485 (538)
                      ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......                
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            3445678999999999876 56899999999999999999999999998877665544321000                


Q ss_pred             ------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                  ......+++++.+||.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                        0112357889999999999999999999999976

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.5e-42  Score=354.28  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=208.3

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCC-----CCceeEeeceec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----HPNIVLLMGAVT  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-----hpnIv~l~~~~~  332 (538)
                      ..+..++|++++.||+|+||+||+|++..+  .||||++...   ......+.+|+.+++.+.     ||||+++++++.
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            445568999999999999999999998544  4999998642   344567788999999986     999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC----------
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS----------  402 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~----------  402 (538)
                      ....+++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++|  |+||||||+|||++.          
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccch
Confidence            999999999999 8899999965432 24889999999999999999999999  999999999999975          


Q ss_pred             ---------------CCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 009291          403 ---------------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW  467 (538)
Q Consensus       403 ---------------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf  467 (538)
                                     ++.+||+|||+++.....   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence                           789999999999865443   24567899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHhhcCccc------------------------CCCC--------------------CCcHHHHHHHHHh
Q 009291          468 RNSTPSQVISAVGFKGRRL------------------------EIPK--------------------NVNPMVAALIETC  503 (538)
Q Consensus       468 ~~~~~~~~~~~i~~~~~~~------------------------~~p~--------------------~~s~~l~~LI~~c  503 (538)
                      ...+..+....+.......                        ..|.                    ..++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            9887766555443211110                        1111                    1236788999999


Q ss_pred             hhcCCCCCCCHHHHHH
Q 009291          504 WAEEPEIRPSFPSIME  519 (538)
Q Consensus       504 L~~dP~~RPs~~eIl~  519 (538)
                      |+.||++|||+.++++
T Consensus       340 L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          340 LQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCSSGGGSCCHHHHTT
T ss_pred             hcCChhhCCCHHHHhc
Confidence            9999999999999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.6e-42  Score=345.62  Aligned_cols=247  Identities=26%  Similarity=0.400  Sum_probs=211.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||+||++++.  +..||+|++.....  ...+.+.+|+.++++++||||+++++++.+...+++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            468999999999999999999986  44599999875432  23357889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE---cCCCcEEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~~  418 (538)
                      ||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||++   ++++.+||+|||++....
T Consensus        86 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           86 QLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999999988532   35889999999999999999999999  9999999999999   788899999999997654


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--CCCCCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~s~~l  496 (538)
                      ...  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+.......  +.+..+++.+
T Consensus       161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          161 NGI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             CBT--THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             CCc--cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            331  223468999999999999999999999999999999999999999988877766665443332  3446789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||.+||..||++|||+.++++
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHcCCChhHCcCHHHHhc
Confidence            99999999999999999999976

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-43  Score=361.09  Aligned_cols=263  Identities=29%  Similarity=0.414  Sum_probs=209.9

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+.+..++|++.+.||+|+||+||+|++. ++.||||++...... .....+.+|+.+++.++||||+++++++.++...
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            35566788999999999999999999864 455999998654321 1223688999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCC-CCccccHHHHHHHHHHHHHHHHHHHhC---CCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          338 SIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQR---RPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ++||||+.+++|.+++.... ....+++..++.++.|++.||+|||++   |  |+||||||+||+++.++.+||+|||+
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCcc
Confidence            99999999999999996543 334589999999999999999999999   8  99999999999999999999999999


Q ss_pred             CccCCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhh--cC--
Q 009291          414 SRSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS-----TPSQVISAVGF--KG--  483 (538)
Q Consensus       414 a~~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~-----~~~~~~~~i~~--~~--  483 (538)
                      +........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...     ........+..  ..  
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK  260 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred             ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence            986543222 233456899999999999888999999999999999999999999521     10001111100  00  


Q ss_pred             --------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          484 --------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       484 --------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                              .....+...++.+.++|.+||+.||++|||+.++++.|+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence                    01112223447899999999999999999999999999753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.6e-42  Score=370.70  Aligned_cols=247  Identities=26%  Similarity=0.354  Sum_probs=200.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      .++|++++.||+|+||+||+|.+..++  ||||++..........+.+.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999987544  999999877666777788999999999999999999999986553      


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+||||+.++ |.+.+..     .+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            469999999764 6666542     3889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-----------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-----------  484 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-----------  484 (538)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.....           
T Consensus       213 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          213 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ----CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             ecCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            765432 23456899999999999999999999999999999999999999998876655544321100           


Q ss_pred             ---------c-----cC----CCCC-----------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 ---------R-----LE----IPKN-----------VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ---------~-----~~----~p~~-----------~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                               .     ..    ++..           .++++.+||.+||+.||++|||++|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                     0     00    0000           1567999999999999999999999876

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.9e-42  Score=349.84  Aligned_cols=262  Identities=31%  Similarity=0.507  Sum_probs=216.6

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEc------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      ..+..++|++++.||+|+||.||++++.      +..||+|++...  .....+.+.+|+.++++++||||+++++++..
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            4566788999999999999999999852      334999998654  34556789999999999999999999998866


Q ss_pred             CC--cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEee
Q 009291          334 PP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF  411 (538)
Q Consensus       334 ~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DF  411 (538)
                      ..  .+++||||+++++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.+||+||
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Df  189 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF  189 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecC
Confidence            54  6899999999999999996543  34889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------H--
Q 009291          412 GLSRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS------------Q--  474 (538)
Q Consensus       412 Gla~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~------------~--  474 (538)
                      |++........   ......++..|+|||.+.+..++.++||||||+++|+|++|..||......            .  
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence            99987544321   123345778899999999888999999999999999999999988643111            0  


Q ss_pred             -HHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          475 -VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       475 -~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                       ..........+.+.+..+++++.+||.+||+.||++|||+.++++.|+++..+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence             11112223445667788999999999999999999999999999999998765

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=357.37  Aligned_cols=243  Identities=24%  Similarity=0.398  Sum_probs=208.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCH------HHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~------~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      .++|++.+.||+|+||+||+|.+..++  ||||++.......      ...+.+.+|+.++++++||||+++++++.+..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            468999999999999999999886544  9999987654322      13346778999999999999999999999999


Q ss_pred             cceEEEeecCCC-ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          336 NLSIVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       336 ~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      .+++||||+.+| +|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccc
Confidence            999999999776 999998743   35899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCccccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....        ........|..++
T Consensus       178 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~  248 (335)
T 3dls_A          178 AYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVS  248 (335)
T ss_dssp             EECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCC
T ss_pred             eECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccC
Confidence            8765432 2234578999999999988877 7899999999999999999999976432        1233445667789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +++.+||.+||+.||++|||+.++++.
T Consensus       249 ~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          249 KELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            999999999999999999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.5e-41  Score=341.39  Aligned_cols=258  Identities=20%  Similarity=0.267  Sum_probs=210.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeecee-ccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~-~~~~~~~lV  340 (538)
                      .++|++.+.||+|+||.||+|++..  ..||+|++......    +.+.+|+.+++.++|++++..+..+ .+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            4689999999999999999999754  44999998665432    3578999999999988766655554 666778999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE---cCCCcEEEEeeCCCccC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~  417 (538)
                      |||+ +++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||++   +.++.+||+|||++...
T Consensus        84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            9999 899999996432  35899999999999999999999999  9999999999999   48889999999999865


Q ss_pred             CCCcc-------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhh---cCc
Q 009291          418 PNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGF---KGR  484 (538)
Q Consensus       418 ~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~---~~~~~~i~~---~~~  484 (538)
                      .....       ......||..|+|||.+.+..++.++||||||+++|+|++|+.||.....   .+....+..   ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            44321       12455789999999999999999999999999999999999999986432   112222211   111


Q ss_pred             ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       485 ~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      ....+..+++.+.+||.+||+.||++|||+.++++.|++++.....
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            1123467899999999999999999999999999999999987654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.2e-42  Score=351.22  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=213.7

Q ss_pred             cccccceeEE-EEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCc
Q 009291          261 EIRWSELLIK-KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       261 ~i~~~~y~i~-~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~  336 (538)
                      +...+.|.+. +.||+|+||+||+|.+..  +.||+|++............+.+|+.+++.+ .||||+++++++.+...
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3345677777 899999999999999874  4599999887655544456889999999999 46999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeCC
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGL  413 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGl  413 (538)
                      +++||||+.+++|.+++... ....+++..++.++.|++.||+|||++|  |+||||||+||+++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999998543 2345899999999999999999999999  999999999999987   78999999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc--cCCCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKN  491 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~  491 (538)
                      ++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+......  ......
T Consensus       181 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  259 (327)
T 3lm5_A          181 SRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS  259 (327)
T ss_dssp             CEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred             ccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence            98765432 224467999999999999999999999999999999999999999998887776655433322  334457


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +++.+.+||.+||+.||++|||++++++
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          260 VSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            8999999999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-42  Score=353.64  Aligned_cols=252  Identities=26%  Similarity=0.316  Sum_probs=203.1

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCH---HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE---DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~---~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      ..++|++++.||+|+||.||+|.+..  ..||+|++.......   ...+.+.+|+.+++.++||||+++++++.+....
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            35789999999999999999999864  449999986543221   1234688999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+.+ +|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++..
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            999999986 8888876432  35888899999999999999999999  999999999999999999999999999876


Q ss_pred             CCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc----------
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL----------  486 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~----------  486 (538)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.......          
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            5444344566889999999999764 58999999999999999999999999888776655543210000          


Q ss_pred             ----------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 ----------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ----------------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                      .+...+++++.+||.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                            011456789999999999999999999999876

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.8e-42  Score=354.85  Aligned_cols=254  Identities=24%  Similarity=0.373  Sum_probs=212.4

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ...++..++|++.+.||+|+||+||+|.+..  ..||+|++.... .....+.+.+|+.++++++||||+++++++.++.
T Consensus        26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            3346677899999999999999999999974  449999987653 4556678999999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      .+++||||+++++|.+++...   ..+++..++.++.|++.||+|||++ +  |+||||||+||+++.++.+||+|||++
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~  179 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS  179 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             EEEEEEECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCC
Confidence            999999999999999999643   3588999999999999999999996 8  999999999999999999999999998


Q ss_pred             ccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------------
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--------------  480 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~--------------  480 (538)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.              
T Consensus       180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          180 GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             HHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             cccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence            653221  1234578999999999999999999999999999999999999998876654432211              


Q ss_pred             ----------------------------hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          481 ----------------------------FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       481 ----------------------------~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                                  ........+..++.++.+||.+||+.||++|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                                        111111122357899999999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=9.4e-42  Score=360.51  Aligned_cols=246  Identities=25%  Similarity=0.369  Sum_probs=195.6

Q ss_pred             ccceeEE-EEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHH-cCCCCceeEeeceecc----CC
Q 009291          264 WSELLIK-KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMK-GLRHPNIVLLMGAVTE----PP  335 (538)
Q Consensus       264 ~~~y~i~-~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~-~L~hpnIv~l~~~~~~----~~  335 (538)
                      .++|.+. +.||+|+||+||++.+..+  .||||++...       ..+.+|+.++. ..+||||+++++++..    ..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            3567776 7899999999999998754  4999998643       25667888874 4589999999998865    56


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFG  412 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFG  412 (538)
                      .+|+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++|  |+||||||+|||++.   ++.+||+|||
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecc
Confidence            7899999999999999997532 235899999999999999999999999  999999999999987   7899999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhhcCcccCC
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----VISAVGFKGRRLEI  488 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~----~~~~i~~~~~~~~~  488 (538)
                      +++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ....+.......+.
T Consensus       210 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          210 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             cccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            998654332 2345678999999999999999999999999999999999999997654322    22233223222222


Q ss_pred             --CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          489 --PKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       489 --p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                        ...+++++.+||++||+.||++|||+.++++.
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              25689999999999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.4e-42  Score=373.19  Aligned_cols=251  Identities=29%  Similarity=0.450  Sum_probs=216.9

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +..++|++.+.||+|+||+||+|.+..  ..||||++...... ....+.+.+|+.++++++||||+++++++.+...++
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            345689999999999999999999864  44999998765432 334567899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE---cCCCcEEEEeeCCCc
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSR  415 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~  415 (538)
                      +||||+.+++|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||+   +.++.+||+|||+++
T Consensus       103 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EEECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999988643   35899999999999999999999999  9999999999999   567899999999997


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCc
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVN  493 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s  493 (538)
                      ...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+.........+  ..++
T Consensus       178 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  255 (484)
T 3nyv_A          178 HFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS  255 (484)
T ss_dssp             HBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred             Eccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCC
Confidence            654332 2234578999999999876 68999999999999999999999999999888887776554444333  4689


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +++.+||.+||+.||++|||+.++++
T Consensus       256 ~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          256 ESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            99999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-41  Score=342.01  Aligned_cols=258  Identities=20%  Similarity=0.270  Sum_probs=206.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeecee-ccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~-~~~~~~~lV  340 (538)
                      .++|++.+.||+|+||+||+|++..+  .||+|++......    ..+.+|+.+++.++|++++..+..+ .+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            36799999999999999999997544  4999986554322    3577899999999888776666554 667778999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE---cCCCcEEEEeeCCCccC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~  417 (538)
                      |||+ +++|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+||++   +.++.+||+|||+++..
T Consensus        84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            9999 899999986432  24899999999999999999999999  9999999999999   78899999999999865


Q ss_pred             CCCcc-------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhh---cCc
Q 009291          418 PNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGF---KGR  484 (538)
Q Consensus       418 ~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~---~~~~~i~~---~~~  484 (538)
                      .....       ......||..|+|||.+.+..++.++|||||||++|+|++|+.||......   .....+..   ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            43221       223557899999999999999999999999999999999999999764332   11111111   111


Q ss_pred             ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       485 ~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      .......+++.+.+||.+||+.||++|||+.++++.|++++.....
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            1122367899999999999999999999999999999999987654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-42  Score=361.95  Aligned_cols=263  Identities=22%  Similarity=0.354  Sum_probs=213.9

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC--cc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP--NL  337 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~--~~  337 (538)
                      ....+|++.+.||+|+||+||+|.+..  ..||||++..... ....+.+.+|++++++++||||+++++++.+..  ..
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            345789999999999999999999874  4599999875432 222457789999999999999999999987655  67


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE----cCCCcEEEEeeCC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL  413 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl----~~~~~vkL~DFGl  413 (538)
                      ++||||+++++|.+++........+++..++.++.|++.||+|||++|  |+||||||+|||+    +.++.+||+|||+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            999999999999999976544445899999999999999999999999  9999999999999    7788899999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhh
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLRE--------DPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGF  481 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~s~ksDVwSLGvil~eLltg~~Pf~~~~----~~~~~~~i~~  481 (538)
                      ++...... ......||..|+|||++.+        ..++.++|||||||++|||++|+.||....    ..+....+..
T Consensus       163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            98765443 2345679999999999865        567889999999999999999999996422    2233333322


Q ss_pred             cCc-------------------ccC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          482 KGR-------------------RLE----IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       482 ~~~-------------------~~~----~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ...                   ..+    ++..+++.+.++|++||+.||++|||++++++.+++++...
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            111                   011    11234578999999999999999999999999999998653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=343.52  Aligned_cols=250  Identities=27%  Similarity=0.469  Sum_probs=209.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ...++|++.+.||+|+||.||+|.+..  ..||+|++.....    .+.+.+|+.+++.++||||+++++++.+...+++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            345789999999999999999999874  4599999876432    3468899999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      ||||+++++|.+++...  ...+++..++.++.|++.||.|||++|  ++|+||||+||+++.++.+||+|||++.....
T Consensus       102 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             EeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            99999999999998632  235889999999999999999999999  99999999999999999999999999987655


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cccCCCCCCcHHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA  498 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l~~  498 (538)
                      .........|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.... .....+..+++.+.+
T Consensus       178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  257 (314)
T 3com_A          178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD  257 (314)
T ss_dssp             TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence            4434455678999999999999999999999999999999999999999887766555443222 233345668999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ||.+||..||++|||+.++++
T Consensus       258 li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          258 FVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHccCChhhCcCHHHHHh
Confidence            999999999999999999976

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.5e-42  Score=375.29  Aligned_cols=253  Identities=25%  Similarity=0.345  Sum_probs=215.4

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~  337 (538)
                      .+..++|++.+.||+|+||.||+|++..+  .||+|++...... ......+.+|+.+|+.++||||+++++++.+...+
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            46678999999999999999999998644  4999998764321 12245688999999999999999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||++...
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999999986543 234899999999999999999999999  999999999999999999999999999876


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhhcCcccCCCCCCc
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~----~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      .... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....    .......+  ......++..++
T Consensus       337 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s  413 (576)
T 2acx_A          337 PEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFS  413 (576)
T ss_dssp             CTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSC
T ss_pred             ccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCC
Confidence            5432 2234689999999999999999999999999999999999999998753    23333333  233456678899


Q ss_pred             HHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RP-----s~~eIl~  519 (538)
                      +++.+||.+||+.||++||     +++++++
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            9999999999999999999     6788764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.2e-42  Score=350.60  Aligned_cols=256  Identities=30%  Similarity=0.517  Sum_probs=211.3

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHc--CCCCceeEeeceeccCC----c
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLLMGAVTEPP----N  336 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~--L~hpnIv~l~~~~~~~~----~  336 (538)
                      ..++|++.+.||+|+||+||+|++.++.||||++....     ...+.+|+++++.  ++||||+++++++....    .
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            34689999999999999999999988889999985432     3467788888887  78999999999998776    7


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHH--------hCCCCEEeecCCCCCEEEcCCCcEEE
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH--------QRRPPIVHRDLKSPNLLVDSTYTVKV  408 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~iiHrDLKp~NILl~~~~~vkL  408 (538)
                      +++||||+++|+|.+++...    .+++..++.++.|++.||+|||        +++  |+||||||+||+++.++.+||
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEE
T ss_pred             eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEE
Confidence            89999999999999999643    4889999999999999999999        888  999999999999999999999


Q ss_pred             EeeCCCccCCCCcc----ccCCCCCCCcccccccccCCC------CCchhhHHHHHHHHHHHHhC----------CCCCC
Q 009291          409 CDFGLSRSKPNTYI----SSKTAAGTPEWMAPEVLREDP------SNEKSDVFSFGVILWELITL----------QKPWR  468 (538)
Q Consensus       409 ~DFGla~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~~------~s~ksDVwSLGvil~eLltg----------~~Pf~  468 (538)
                      +|||++........    ......||..|+|||++.+..      ++.++||||||+++|||++|          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            99999976433221    224557899999999998763      34689999999999999999          78987


Q ss_pred             CCC-----HHHHHHHHhhcCcccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          469 NST-----PSQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       469 ~~~-----~~~~~~~i~~~~~~~~~p~-----~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ...     .......+.....+..++.     .+++.+.+||.+||+.||++|||+.++++.|+++..+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence            642     2333333333333444443     345789999999999999999999999999999987754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-41  Score=364.44  Aligned_cols=249  Identities=28%  Similarity=0.369  Sum_probs=189.4

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc-----CCcc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-----PPNL  337 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~-----~~~~  337 (538)
                      ++|++++.||+|+||+||+|.+..+  .||||++..........+.+.+|+.+|++++||||+++++++..     ...+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            6899999999999999999988644  49999987766666777889999999999999999999999843     3568


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      |+||||+. ++|.+++...   ..+++..++.++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|+..
T Consensus       133 ~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhc
Confidence            99999984 6899888643   35899999999999999999999999  999999999999999999999999999865


Q ss_pred             CCCc---------------------------cccCCCCCCCcccccccc-cCCCCCchhhHHHHHHHHHHHHh-------
Q 009291          418 PNTY---------------------------ISSKTAAGTPEWMAPEVL-REDPSNEKSDVFSFGVILWELIT-------  462 (538)
Q Consensus       418 ~~~~---------------------------~~~~~~~gt~~Y~aPE~l-~~~~~s~ksDVwSLGvil~eLlt-------  462 (538)
                      ....                           ......+||+.|+|||++ .+..++.++|||||||++|||++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            4221                           012345689999999986 56679999999999999999998       


Q ss_pred             ----CCCCCCCCCH--------------------HHHHHHHh-hcC----------------------------cccCCC
Q 009291          463 ----LQKPWRNSTP--------------------SQVISAVG-FKG----------------------------RRLEIP  489 (538)
Q Consensus       463 ----g~~Pf~~~~~--------------------~~~~~~i~-~~~----------------------------~~~~~p  489 (538)
                          |+.+|.+...                    .+.+..+. ..+                            ......
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                6666655431                    01111000 000                            001122


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.+++++.+||.+||..||++|||++|+++
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            456899999999999999999999999876

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.6e-41  Score=358.53  Aligned_cols=250  Identities=27%  Similarity=0.400  Sum_probs=199.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-----Cc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PN  336 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-----~~  336 (538)
                      .++|++++.||+|+||+||+|.+..++  ||||++..........+.+.+|+.+|++++|+||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999987654  99999977655667778899999999999999999999998766     56


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|+||||+. ++|.+++...   ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999986 5999998643   35899999999999999999999999  99999999999999999999999999987


Q ss_pred             CCCCcc----------------------ccCCCCCCCcccccccc-cCCCCCchhhHHHHHHHHHHHHhCCCC-------
Q 009291          417 KPNTYI----------------------SSKTAAGTPEWMAPEVL-REDPSNEKSDVFSFGVILWELITLQKP-------  466 (538)
Q Consensus       417 ~~~~~~----------------------~~~~~~gt~~Y~aPE~l-~~~~~s~ksDVwSLGvil~eLltg~~P-------  466 (538)
                      ......                      .....+||+.|+|||++ .+..++.++|||||||++|||++|..|       
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            543211                      12456789999999986 566799999999999999999985433       


Q ss_pred             ----CCCCCH-----------------HHHH------------------------HHHhhcCcccC-----CCCCCcHHH
Q 009291          467 ----WRNSTP-----------------SQVI------------------------SAVGFKGRRLE-----IPKNVNPMV  496 (538)
Q Consensus       467 ----f~~~~~-----------------~~~~------------------------~~i~~~~~~~~-----~p~~~s~~l  496 (538)
                          |.+...                 ...+                        ..+........     ..+.+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence                333220                 0000                        01100001111     114689999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||.+||+.||++|||++|+++
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhcCCcccCCCHHHHhc
Confidence            99999999999999999999876

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=342.41  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=208.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccC--HHHHHHHHHHHHHHHcCCCCceeEeecee--ccCCcc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAV--TEPPNL  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~--~~~~~~~~~Ei~il~~L~hpnIv~l~~~~--~~~~~~  337 (538)
                      .++|++++.||+|+||.||++.+..+  .+|+|++......  ....+.+.+|+.++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            36899999999999999999998654  4999998654321  23456789999999999999999999998  445678


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+.++ |.+++.... ...+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 666664332 235889999999999999999999999  999999999999999999999999999865


Q ss_pred             CCC--ccccCCCCCCCcccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          418 PNT--YISSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       418 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~--~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ...  ........||..|+|||++.+..  ++.++||||||+++|+|++|+.||...+..+....+..  ....++..++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~  237 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--GSYAIPGDCG  237 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCCCCCSSSC
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--CCCCCCCccC
Confidence            422  11224556899999999998654  37899999999999999999999999887776666543  3456778899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      +.+.+||.+||+.||++|||+.++++.
T Consensus       238 ~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          238 PPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            999999999999999999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-41  Score=351.83  Aligned_cols=252  Identities=24%  Similarity=0.320  Sum_probs=204.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc-------
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-------  333 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~-------  333 (538)
                      ..++|++++.||+|+||+||+|++..  ..||+|++............+.+|+.+++.++||||+++++++.+       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            35789999999999999999999864  459999986655444444577899999999999999999999876       


Q ss_pred             -CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          334 -PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       334 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                       ...+++||||+.+ +|.+.+....  ..+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccch
Confidence             3468999999976 6766665332  34899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCC----ccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc-
Q 009291          413 LSRSKPNT----YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL-  486 (538)
Q Consensus       413 la~~~~~~----~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~-  486 (538)
                      +++.....    ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....... 
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99765421    112244578999999999876 457999999999999999999999999988776665543211111 


Q ss_pred             -CCCCC----------------------------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 -EIPKN----------------------------VNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 -~~p~~----------------------------~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       ...+.                            .++.+.+||.+||+.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence             11111                            2677999999999999999999999876

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-41  Score=379.50  Aligned_cols=265  Identities=32%  Similarity=0.561  Sum_probs=224.1

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCCc-----eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      ..+++..++|++.+.||+|+||+||+|.+..+.     +|+|++... ......+.+.+|+.++++++||||+++++++.
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            345677789999999999999999999886432     777776543 24555678999999999999999999999985


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      + +..++||||+++|+|.++++...  ..+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus       462 ~-~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          462 E-NPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             c-CceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecC
Confidence            4 56899999999999999997432  34889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCC
Q 009291          413 LSRSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       413 la~~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~  490 (538)
                      +++....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+....+. ...+.+.+.
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~  615 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPP  615 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCT
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCc
Confidence            9987544321 1223456789999999998899999999999999999997 999999988877776664 345667788


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      .+++.+.+||.+||..||++|||+.++++.|++++....
T Consensus       616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~k  654 (656)
T 2j0j_A          616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  654 (656)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence            999999999999999999999999999999999987653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.6e-41  Score=339.16  Aligned_cols=251  Identities=23%  Similarity=0.376  Sum_probs=213.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc---C----HHHHHHHHHHHHHHHcCC-CCceeEeeceec
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF---H----EDRFKEFLREVAIMKGLR-HPNIVLLMGAVT  332 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~---~----~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~  332 (538)
                      ..++|++.+.||+|+||.||+|.+..+  .||+|++.....   .    ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            357899999999999999999998654  499999875431   1    233567889999999995 999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      +....++||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  ++||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999999642   35899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCccccCCCCCCCccccccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLR------EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL  486 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~------~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~  486 (538)
                      ++....... ......|+..|+|||++.      ...++.++||||||+++|+|++|+.||...+.......+.......
T Consensus       170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          170 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  248 (298)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             chhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence            998754432 234567899999999985      4567899999999999999999999999888777666665444333


Q ss_pred             CCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 EIP--KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ~~p--~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..+  ..+++.+.+||.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            322  468899999999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.2e-42  Score=351.77  Aligned_cols=252  Identities=21%  Similarity=0.372  Sum_probs=213.7

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHH---------------HHHHHHHHHHHHHcCCCCcee
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED---------------RFKEFLREVAIMKGLRHPNIV  325 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~---------------~~~~~~~Ei~il~~L~hpnIv  325 (538)
                      .+..++|++.+.||+|+||.||+|.+.+..||+|++........               ..+.+.+|+.++++++||||+
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            34567999999999999999999999777799999875432211               126889999999999999999


Q ss_pred             EeeceeccCCcceEEEeecCCCChhhh------hcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCE
Q 009291          326 LLMGAVTEPPNLSIVTEYLSRGSLYKL------LHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNL  398 (538)
Q Consensus       326 ~l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NI  398 (538)
                      ++++++.+...+++||||+++++|.++      +... ....+++..++.++.|++.||+|||+ +|  |+||||||+||
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni  183 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI  183 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence            999999999999999999999999998      5432 13568999999999999999999999 99  99999999999


Q ss_pred             EEcCCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCH-HHH
Q 009291          399 LVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNE-KSDVFSFGVILWELITLQKPWRNSTP-SQV  475 (538)
Q Consensus       399 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~-ksDVwSLGvil~eLltg~~Pf~~~~~-~~~  475 (538)
                      +++.++.+||+|||++......  ......|+..|+|||++.+. .++. ++||||||+++|+|++|..||..... .+.
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            9999999999999999875443  23456789999999999887 5666 99999999999999999999988776 555


Q ss_pred             HHHHhhcCcccCCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          476 ISAVGFKGRRLEIP-------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       476 ~~~i~~~~~~~~~p-------------------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ...+...  ...+|                   ..+++++.+||.+||+.||++|||+.++++
T Consensus       262 ~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 FNNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            5555322  33333                   568999999999999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.1e-42  Score=353.30  Aligned_cols=258  Identities=17%  Similarity=0.247  Sum_probs=210.8

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC----------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeE------
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN----------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL------  326 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~----------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~------  326 (538)
                      ..++|++.+.||+|+||.||+|++..          ..||+|++...       +.+.+|+.++++++||||++      
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            35789999999999999999999864          45999998754       36789999999999999987      


Q ss_pred             ---------eeceecc-CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCC
Q 009291          327 ---------LMGAVTE-PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP  396 (538)
Q Consensus       327 ---------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~  396 (538)
                               +++++.. +..+++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++|  |+||||||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~  188 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAE  188 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGG
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHH
Confidence                     4555544 67789999999 999999997431 246899999999999999999999999  999999999


Q ss_pred             CEEEcCCC--cEEEEeeCCCccCCCCcc-------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 009291          397 NLLVDSTY--TVKVCDFGLSRSKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW  467 (538)
Q Consensus       397 NILl~~~~--~vkL~DFGla~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf  467 (538)
                      ||+++.++  .+||+|||+++.......       ......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999988  999999999976543211       113447899999999999999999999999999999999999999


Q ss_pred             CCCC--HHHHHHHHh-hcCcccCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCC
Q 009291          468 RNST--PSQVISAVG-FKGRRLEIP------KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ  531 (538)
Q Consensus       468 ~~~~--~~~~~~~i~-~~~~~~~~p------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~  531 (538)
                      ....  ......... .......++      ..+++++.+||.+||+.||++|||+.++++.|++++......
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            8764  222222221 111111111      256899999999999999999999999999999999876543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.9e-42  Score=345.59  Aligned_cols=250  Identities=28%  Similarity=0.507  Sum_probs=206.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||.||+|.+..+  .+|+|++....  ....+.+.+|+.+++.++||||+++++++.++..+++||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            46899999999999999999999744  48999876542  233467889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++....  ..+++..++.++.|++.||+|||++|  ++||||||+||+++.++.+||+|||++.......
T Consensus        96 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999999885422  34889999999999999999999999  9999999999999999999999999875432221


Q ss_pred             cccCCCCCCCcccccccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-ccCCCCCCcHH
Q 009291          422 ISSKTAAGTPEWMAPEVL-----REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPM  495 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l-----~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~s~~  495 (538)
                      .......||..|+|||.+     .+..++.++||||||+++|+|++|..||...+.......+..... ....+..++..
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE  251 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence            222345789999999998     466789999999999999999999999998887766655543322 23345678999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.+||.+||+.||++|||+.++++
T Consensus       252 l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHcccChhhCCCHHHHhc
Confidence            999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.9e-41  Score=349.35  Aligned_cols=250  Identities=24%  Similarity=0.399  Sum_probs=212.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEecccc--C----HHHHHHHHHHHHHHHcC-CCCceeEeeceeccC
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF--H----EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP  334 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~--~----~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~  334 (538)
                      ..+|++.+.||+|+||.||+|.+.  +..||||++.....  .    ....+.+.+|+.+++++ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            467999999999999999999986  44599999876432  1    22346788999999999 799999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ...++||||+++++|.+++..   ...+++..++.++.||+.||+|||+.|  |+||||||+||+++.++.+||+|||++
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~  247 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFS  247 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcc
Confidence            999999999999999999863   235899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCccccCCCCCCCcccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCC
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLRE------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI  488 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~  488 (538)
                      ....... ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||...........+.........
T Consensus       248 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  326 (365)
T 2y7j_A          248 CHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS  326 (365)
T ss_dssp             EECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             cccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            8765432 2345679999999999863      35789999999999999999999999988877766665433333222


Q ss_pred             --CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          489 --PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       489 --p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                        ...++..+.+||.+||+.||++|||+.++++
T Consensus       327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              2468899999999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.3e-41  Score=352.17  Aligned_cols=247  Identities=26%  Similarity=0.319  Sum_probs=198.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      .++|++++.||+|+||+||+|.+..+  .||||++..........+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            47899999999999999999988644  4999999876666677788999999999999999999999987655      


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+.+ +|.+++..     .+++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            67999999975 78777752     3789999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc----------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------  485 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------  485 (538)
                      ...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......          
T Consensus       176 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          176 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            654332 223567899999999999999999999999999999999999999988776655444211000          


Q ss_pred             ----------cC--------------CCC------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ----------LE--------------IPK------NVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ----------~~--------------~p~------~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                ..              +|.      ..++++.+||.+||+.||++|||++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                      00              011      12568999999999999999999999976

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.2e-41  Score=339.84  Aligned_cols=249  Identities=30%  Similarity=0.476  Sum_probs=213.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++.+.||+|+||.||+|++.  +..||+|++..........+.+.+|+.++++++||||+++++++.+...+++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            468999999999999999999986  445999998776554445678899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC---CcEEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~---~~vkL~DFGla~~~~  418 (538)
                      ||+.+++|.+++...   ..+++..++.++.|++.||+|||++|  ++||||||+||+++.+   +.+||+|||++....
T Consensus       101 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            999999999888532   35889999999999999999999999  9999999999999654   479999999987654


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCC--CCCcHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV  496 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~s~~l  496 (538)
                      ... ......++..|+|||.+.+. ++.++||||||+++|+|++|..||...+..+....+.........+  ..+++++
T Consensus       176 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 2wei_A          176 QNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (287)
T ss_dssp             CCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred             CCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence            332 12234578899999998764 8999999999999999999999999988877777665444333333  5789999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||.+||+.||++|||+.++++
T Consensus       254 ~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          254 KDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcccChhhCcCHHHHhc
Confidence            99999999999999999999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-41  Score=344.66  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=198.9

Q ss_pred             ccceeEE-EEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceE
Q 009291          264 WSELLIK-KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       264 ~~~y~i~-~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~l  339 (538)
                      .+.|++. +.||+|+||+||+|.+.  +..||||++......  ..+.+.+|+.+++++ +||||+++++++.+.+.+++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            3568885 78999999999999875  445999998765322  345788999999985 79999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc---EEEEeeCCCcc
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGLSRS  416 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGla~~  416 (538)
                      ||||+++++|.+++...   ..+++..++.++.|++.||+|||+++  |+||||||+||+++.++.   +||+|||++..
T Consensus        89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            99999999999999643   35889999999999999999999999  999999999999987765   99999999875


Q ss_pred             CCCCc-------cccCCCCCCCcccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------
Q 009291          417 KPNTY-------ISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTP------------  472 (538)
Q Consensus       417 ~~~~~-------~~~~~~~gt~~Y~aPE~l~~-----~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~------------  472 (538)
                      .....       .......||..|+|||++.+     ..++.++|||||||++|+|++|+.||.....            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            43211       11123468999999999875     5578999999999999999999999987542            


Q ss_pred             ---HHHHHHHhhcCcccCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          473 ---SQVISAVGFKGRRLEIP----KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       473 ---~~~~~~i~~~~~~~~~p----~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                         ......+...  ...++    ..+++.+.+||.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          244 ACQNMLFESIQEG--KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHhcc--CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence               2223333222  22333    468899999999999999999999999976

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2e-41  Score=337.92  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=208.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc--------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--------  333 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--------  333 (538)
                      ..+|++.+.||+|+||.||+|.+.  +..||+|++....      +.+.+|+.++++++||||+++++++..        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            467999999999999999999987  4559999987543      256789999999999999999998754        


Q ss_pred             --------CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc
Q 009291          334 --------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT  405 (538)
Q Consensus       334 --------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~  405 (538)
                              ...+++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|  |+||||||+||+++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCC
Confidence                    345899999999999999996432 235889999999999999999999999  999999999999999999


Q ss_pred             EEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc
Q 009291          406 VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR  485 (538)
Q Consensus       406 vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~  485 (538)
                      +||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....  .....+.    .
T Consensus       161 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~----~  233 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR----D  233 (284)
T ss_dssp             EEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH----T
T ss_pred             EEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh----c
Confidence            9999999998755432 2245578999999999999999999999999999999999998875321  1122221    2


Q ss_pred             cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       486 ~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      ..++..++..+.++|.+||+.||++|||+.++++.|+.+.++..
T Consensus       234 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            23566789999999999999999999999999999998876543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7e-41  Score=349.73  Aligned_cols=245  Identities=25%  Similarity=0.355  Sum_probs=205.1

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcc----
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL----  337 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~----  337 (538)
                      .++|.+.+.||+|+||+||+|.+..+  .||+|++..........+.+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            36899999999999999999998754  499999987666677778899999999999999999999999877655    


Q ss_pred             --eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          338 --SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       338 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                        ++||||+. ++|.+++..     .+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999997 588887742     3889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc----------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------  484 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~----------  484 (538)
                      .....   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....          
T Consensus       193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          193 HADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             ccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            65433   245678999999999987 6789999999999999999999999998877665544321100          


Q ss_pred             -------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 -------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 -------------------~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                         ....+..+++.+.+||.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                               01123467899999999999999999999999865

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.2e-41  Score=340.74  Aligned_cols=256  Identities=22%  Similarity=0.350  Sum_probs=211.5

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCC--CCceeEeeceeccC
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEP  334 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~--hpnIv~l~~~~~~~  334 (538)
                      +.+++...+|++++.||+|+||.||++.+.. ..||+|++..........+.+.+|+.++++++  |+||+++++++.++
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            4466778899999999999999999998764 34999999877767777889999999999997  59999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ..+++||| +.+++|.+++...   ..+++..++.++.|++.||+|||+++  |+||||||+||++++ +.+||+|||++
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~  173 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIA  173 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred             CEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeecccc
Confidence            99999999 5578999999743   35889999999999999999999999  999999999999964 89999999999


Q ss_pred             ccCCCCcc--ccCCCCCCCcccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHh
Q 009291          415 RSKPNTYI--SSKTAAGTPEWMAPEVLRE-----------DPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVG  480 (538)
Q Consensus       415 ~~~~~~~~--~~~~~~gt~~Y~aPE~l~~-----------~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~  480 (538)
                      ........  ......||..|+|||.+.+           ..++.++||||||+++|+|++|+.||...... .....+.
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            86543221  1234568999999999876           46788999999999999999999999876433 3333343


Q ss_pred             hcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 009291          481 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET  520 (538)
Q Consensus       481 ~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~  520 (538)
                      .......++...++.+.+||.+||+.||++|||+.++++.
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            3445566778889999999999999999999999999764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.5e-41  Score=359.23  Aligned_cols=249  Identities=27%  Similarity=0.396  Sum_probs=195.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccC------HHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~------~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      .++|++.+.||+|+||+||+|.+..+  .||+|++......      ......+.+|+.+|++++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            46899999999999999999998755  4999998765321      2223458899999999999999999999865 4


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC---cEEEEeeC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFG  412 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~---~vkL~DFG  412 (538)
                      .+++||||+++++|.+++...   ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++   .+||+|||
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             ceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence            579999999999999988643   35899999999999999999999999  99999999999997544   59999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhcCcc--c
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRR--L  486 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~-~~~~i~~~~~~--~  486 (538)
                      +++...... ......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||....... ....+......  .
T Consensus       288 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~  366 (419)
T 3i6u_A          288 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  366 (419)
T ss_dssp             TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred             cceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence            998765432 2345679999999999864   567889999999999999999999997654332 22222211111  1


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .....+++.+.+||.+||+.||++|||+.++++
T Consensus       367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            122568999999999999999999999999876

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-41  Score=353.63  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=190.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC------C
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~------~  335 (538)
                      .++|++++.||+|+||.||+|.+..++  ||||++..........+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            378999999999999999999986544  99999876655666778899999999999999999999998654      5


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++|+|++ +++|.+++..    ..+++..++.++.||+.||+|||++|  |+||||||+||+++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 6799888864    34899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Cc---------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR---------  484 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~---------  484 (538)
                      .....   .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+... +.         
T Consensus       181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          181 HTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             ccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            75432   235678999999999887 67899999999999999999999999988776554433210 00         


Q ss_pred             ----------------cc---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 ----------------RL---EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ----------------~~---~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                      ..   .....+++.+.+||.+||+.||++|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                            00   011356889999999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.4e-42  Score=361.44  Aligned_cols=245  Identities=16%  Similarity=0.164  Sum_probs=194.9

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccc-cCHHHHHHHHHHH---HHHHcCCCCceeEee-------
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREV---AIMKGLRHPNIVLLM-------  328 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~-~~~~~~~~~~~Ei---~il~~L~hpnIv~l~-------  328 (538)
                      ...++|++.+.||+|+||+||+|++.  +..||||++.... ......+.+.+|+   .++++++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            34578999999999999999999875  4569999987542 2344567889999   455566899999998       


Q ss_pred             ceeccCC-----------------cceEEEeecCCCChhhhhcCCC----CCccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 009291          329 GAVTEPP-----------------NLSIVTEYLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPP  387 (538)
Q Consensus       329 ~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~  387 (538)
                      +++.+.+                 ..++||||+ +|+|.+++....    ....+++..++.|+.||+.||+|||++|  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  226 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  226 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            4544442                 278999999 679999986321    1223456888899999999999999999  


Q ss_pred             EEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCC-----------CCCchhhHHHHHHH
Q 009291          388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-----------PSNEKSDVFSFGVI  456 (538)
Q Consensus       388 iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-----------~~s~ksDVwSLGvi  456 (538)
                      |+||||||+|||++.++.+||+|||+++.....   .....| +.|+|||++.+.           .++.++|||||||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999999865432   235567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          457 LWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       457 l~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +|||++|+.||..........      .....+..+++++.+||.+||+.||++|||+.++++
T Consensus       303 l~elltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSE------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CCSG------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccchh------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999997655432211      122334678999999999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.1e-41  Score=353.66  Aligned_cols=250  Identities=26%  Similarity=0.350  Sum_probs=200.5

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc----
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----  333 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~----  333 (538)
                      ++....+|++++.||+|+||+||+|.+..  ..||+|++.....      ...+|+.+++.++||||+++++++..    
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            34556789999999999999999999864  4499999865432      22379999999999999999999843    


Q ss_pred             ----------------------------------CCcceEEEeecCCCChhhhhcC-CCCCccccHHHHHHHHHHHHHHH
Q 009291          334 ----------------------------------PPNLSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGM  378 (538)
Q Consensus       334 ----------------------------------~~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL  378 (538)
                                                        ...+++||||+++ +|.+.+.. ......+++..++.++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              3348899999985 77776642 11234589999999999999999


Q ss_pred             HHHHhCCCCEEeecCCCCCEEEc-CCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHH
Q 009291          379 NYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVI  456 (538)
Q Consensus       379 ~~LH~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvi  456 (538)
                      +|||++|  |+||||||+||+++ .++.+||+|||+++...... ......+|..|+|||.+.+. .++.++|||||||+
T Consensus       155 ~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          155 GFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999999  99999999999997 68899999999998654432 23456789999999998875 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHhhc-C--------------------------cccCCCCCCcHHHHHHHHHhhhcCCC
Q 009291          457 LWELITLQKPWRNSTPSQVISAVGFK-G--------------------------RRLEIPKNVNPMVAALIETCWAEEPE  509 (538)
Q Consensus       457 l~eLltg~~Pf~~~~~~~~~~~i~~~-~--------------------------~~~~~p~~~s~~l~~LI~~cL~~dP~  509 (538)
                      +|||++|+.||...+..+....+... +                          .+..++..+++++.+||.+||+.||+
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999999999988776655544210 0                          01114567899999999999999999


Q ss_pred             CCCCHHHHHH
Q 009291          510 IRPSFPSIME  519 (538)
Q Consensus       510 ~RPs~~eIl~  519 (538)
                      +|||+.|+++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999984

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.4e-41  Score=348.17  Aligned_cols=260  Identities=17%  Similarity=0.197  Sum_probs=212.1

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEE-----E--cCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC---CCceeEe
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAE-----W--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLL  327 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~-----~--~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l  327 (538)
                      ..+++..++|++.+.||+|+||+||+|.     +  .+..||+|++....     ...+.+|+.+++.++   |+||+.+
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            4466778899999999999999999994     2  34559999986542     236777888888886   9999999


Q ss_pred             eceeccCCcceEEEeecCCCChhhhhcCC--CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---
Q 009291          328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIP--DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---  402 (538)
Q Consensus       328 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---  402 (538)
                      ++++...+..++||||+++|+|.+++...  .....+++..++.++.||+.||+|||++|  ||||||||+|||++.   
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence            99999999999999999999999999531  12345999999999999999999999999  999999999999988   


Q ss_pred             --------CCcEEEEeeCCCccCC--CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 009291          403 --------TYTVKVCDFGLSRSKP--NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP  472 (538)
Q Consensus       403 --------~~~vkL~DFGla~~~~--~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~  472 (538)
                              ++.+||+|||+|+...  ..........||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    8999999999996432  122233566799999999999999999999999999999999999999965432


Q ss_pred             HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHhhhcC
Q 009291          473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR-PSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~R-Ps~~eIl~~L~~il~~~~~  530 (538)
                      ..      ............++.+.+++..||+.+|.+| |+++++.+.|++++.....
T Consensus       291 ~~------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~  343 (365)
T 3e7e_A          291 GE------CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT  343 (365)
T ss_dssp             TE------EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred             Cc------eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence            11      0000111111347889999999999999999 7899999999999877543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.7e-41  Score=345.49  Aligned_cols=277  Identities=25%  Similarity=0.404  Sum_probs=190.8

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHH-HHHcCCCCceeEeeceecc
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVA-IMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~-il~~L~hpnIv~l~~~~~~  333 (538)
                      ...+.+..++|++.+.||+|+||.||+|.+..  +.||||++.... .......+.+|+. +++.++||||+++++++.+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            44567788999999999999999999999874  449999987654 3344455566665 7778899999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcC--CCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEcCCCcEEEEe
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCD  410 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~~~~~vkL~D  410 (538)
                      +...++||||+.+ +|.+++..  ......+++..++.++.|++.||.|||+. |  |+||||||+||+++.++.+||+|
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~D  169 (327)
T 3aln_A           93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCD  169 (327)
T ss_dssp             SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECC
T ss_pred             CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEcc
Confidence            9999999999985 77777642  11134588999999999999999999998 9  99999999999999999999999


Q ss_pred             eCCCccCCCCccccCCCCCCCcccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc
Q 009291          411 FGLSRSKPNTYISSKTAAGTPEWMAPEVL----REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL  486 (538)
Q Consensus       411 FGla~~~~~~~~~~~~~~gt~~Y~aPE~l----~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~  486 (538)
                      ||+++...... ......||..|+|||++    .+..++.++||||||+++|+|++|+.||...................
T Consensus       170 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (327)
T 3aln_A          170 FGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP  248 (327)
T ss_dssp             CSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred             CCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence            99998654432 22344789999999998    45668999999999999999999999998754322111111112222


Q ss_pred             CC----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH----------------HHHHHhhhcCCCCCCCCC
Q 009291          487 EI----PKNVNPMVAALIETCWAEEPEIRPSFPSIMET----------------LQQFLMSSVCQPLSAQPL  538 (538)
Q Consensus       487 ~~----p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~----------------L~~il~~~~~~~~~~~p~  538 (538)
                      .+    ...+++.+.+||.+||+.||++|||+.++++.                +..++......|.+.+|+
T Consensus       249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (327)
T 3aln_A          249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYV  320 (327)
T ss_dssp             CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHHHHHHC----------
T ss_pred             CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHHHHHHHHHHHHhcCCCCCCCCcee
Confidence            22    24689999999999999999999999998652                244455566666666654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.1e-41  Score=342.99  Aligned_cols=249  Identities=27%  Similarity=0.405  Sum_probs=199.2

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc------CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF------HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~------~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      .++|++.+.||+|+||.||+|.+..+  .||||++.....      .......+.+|+.++++++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            36899999999999999999998754  499999865432      1223346889999999999999999999987655


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc---EEEEeeC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFG  412 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~---vkL~DFG  412 (538)
                       +++||||+++++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.   +||+|||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence             89999999999999988643   35899999999999999999999999  999999999999987654   9999999


Q ss_pred             CCccCCCCccccCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhcCcc--c
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRR--L  486 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~~~~~~--~  486 (538)
                      ++........ .....||..|+|||++.   ...++.++|||||||++|+|++|..||...... .....+......  .
T Consensus       163 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T 2ycf_A          163 HSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  241 (322)
T ss_dssp             TCEECCCCHH-HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred             cceecccccc-cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence            9987644321 12346899999999974   566899999999999999999999999765433 222222211111  1


Q ss_pred             CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..+..+++.+.+||.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            123568999999999999999999999999984

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.5e-41  Score=347.82  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=205.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-----Cc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PN  336 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-----~~  336 (538)
                      ..+|++++.||+|+||.||+|.+..++  ||+|++.... .....+.+.+|+.++++++||||+++++++...     ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            368999999999999999999987554  9999986432 455567899999999999999999999998654     36


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++||||+.+ +|.+++...    .+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++..
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            8999999974 899988643    4889999999999999999999999  99999999999999999999999999986


Q ss_pred             CCCCccc---cCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc--------
Q 009291          417 KPNTYIS---SKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--------  484 (538)
Q Consensus       417 ~~~~~~~---~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~--------  484 (538)
                      .......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....        
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            5433211   234578999999998754 4589999999999999999999999988776555444321000        


Q ss_pred             ----------------c-----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 ----------------R-----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ----------------~-----~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                      .     ......+++++.+||.+||+.||++|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                            0     0112467899999999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=343.50  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=204.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc-----
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-----  336 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~-----  336 (538)
                      .++|.+.+.||+|+||.||+|.+..+  .||||++..........+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36899999999999999999998754  49999987766666667889999999999999999999999987654     


Q ss_pred             -ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          337 -LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       337 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                       +++||||+. ++|.+++..     .+++..++.++.||+.||+|||++|  |+||||||+||+++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999997 588877642     3889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc------------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------  482 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~------------  482 (538)
                      .....   .....+|..|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+...            
T Consensus       175 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          175 HADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             C-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             CCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            65432   234578999999999887 67899999999999999999999999988765554433210            


Q ss_pred             --------------C---cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 --------------G---RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 --------------~---~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                    .   .-......+++.+.+||.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                          0   001233567899999999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-42  Score=354.99  Aligned_cols=253  Identities=23%  Similarity=0.365  Sum_probs=207.4

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEE-----cCCceEEEEEecccc--CHHHHHHHHHHHHHHHcC-CCCceeEeeceec
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEF--HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT  332 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~vavK~~~~~~~--~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~  332 (538)
                      .+..++|++.+.||+|+||+||+|++     .+..||||++.....  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            45567999999999999999999998     345599999865321  112224566899999999 6999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      +...+++||||+++++|.+++...   ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eCceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCC
Confidence            999999999999999999999643   35889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCc-cccCCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhhcCcc
Q 009291          413 LSRSKPNTY-ISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGFKGRR  485 (538)
Q Consensus       413 la~~~~~~~-~~~~~~~gt~~Y~aPE~l~~--~~~s~ksDVwSLGvil~eLltg~~Pf~~~~----~~~~~~~i~~~~~~  485 (538)
                      +++...... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....    .......+  ....
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~  282 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSE  282 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCC
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccC
Confidence            998654322 12234579999999999986  347899999999999999999999997532    22222222  2234


Q ss_pred             cCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 009291          486 LEIPKNVNPMVAALIETCWAEEPEIRP-----SFPSIMET  520 (538)
Q Consensus       486 ~~~p~~~s~~l~~LI~~cL~~dP~~RP-----s~~eIl~~  520 (538)
                      ..++..++..+.+||.+||..||++||     +++++++.
T Consensus       283 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            567788999999999999999999999     89998764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-41  Score=355.07  Aligned_cols=250  Identities=24%  Similarity=0.294  Sum_probs=200.7

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc-eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC----
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----  335 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~----  335 (538)
                      +....+|++.+.||+|+||+||+|++..+. +|+|++......      ..+|+.+++.++||||+++++++....    
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~  109 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD  109 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence            334568999999999999999999986554 888887654321      236999999999999999999985433    


Q ss_pred             --cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc-CCCcEEEEeeC
Q 009291          336 --NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFG  412 (538)
Q Consensus       336 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~-~~~~vkL~DFG  412 (538)
                        .+++||||+.++.+..+.........+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||
T Consensus       110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence              37899999987555444332223346899999999999999999999999  99999999999998 79999999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc---------
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK---------  482 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~---------  482 (538)
                      +++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+...         
T Consensus       188 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          188 SAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998754332 23456789999999998765 5899999999999999999999999988776555443211         


Q ss_pred             ------Ccc------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 ------GRR------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ------~~~------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                            ...            ..++..+++++.+||.+||+.||++|||+.++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                  000            1133458899999999999999999999999975

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.3e-41  Score=341.23  Aligned_cols=256  Identities=28%  Similarity=0.360  Sum_probs=208.1

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEc---CCceEEEEEeccccCHHHHHHHHHHHHHHHcC---CCCceeEeeceec
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVT  332 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~  332 (538)
                      ++....++|++.+.||+|+||+||+|++.   +..||+|++............+.+|+.+++.+   +||||+++++++.
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   84 (326)
T 1blx_A            5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   84 (326)
T ss_dssp             CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence            33445578999999999999999999984   23499999876543332223456677776665   8999999999986


Q ss_pred             -----cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEE
Q 009291          333 -----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK  407 (538)
Q Consensus       333 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vk  407 (538)
                           ....+++||||+. ++|.+++..... ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EEECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred             ecccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEE
Confidence                 5567899999997 599999864332 24889999999999999999999999  99999999999999999999


Q ss_pred             EEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC----
Q 009291          408 VCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----  483 (538)
Q Consensus       408 L~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~----  483 (538)
                      |+|||+++...... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...........+....    
T Consensus       161 l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          161 LADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             ECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EecCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999998654332 2345678999999999999999999999999999999999999999888766655442110    


Q ss_pred             ---------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 ---------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ---------------------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                           ....+...+++.+.+||.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                                 001234568899999999999999999999999974

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9.6e-42  Score=343.49  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=193.6

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      .+.+..++|++.+.||+|+||+||+|.+.  +..||+|++..... ....+.+.+|+.++++++||||+++++++.....
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            35677889999999999999999999874  45599998754432 2345678899999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcC-----CCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEee
Q 009291          337 LSIVTEYLSRGSLYKLLHI-----PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF  411 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DF  411 (538)
                      .++||||+++++|.+++..     ......+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+||
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEec
Confidence            9999999999999999853     112345899999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCCc-----cccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc-
Q 009291          412 GLSRSKPNTY-----ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-  484 (538)
Q Consensus       412 Gla~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~-  484 (538)
                      |++.......     .......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||................. 
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  245 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP  245 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence            9987543321     11234568999999999876 5689999999999999999999999998776555443321111 


Q ss_pred             -------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 -------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 -------~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                             .......+++++.+||.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                   11233567899999999999999999999999976

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7e-41  Score=355.98  Aligned_cols=246  Identities=25%  Similarity=0.316  Sum_probs=196.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc------CC
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PP  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~------~~  335 (538)
                      ..+|++.+.||+|+||+||+|++..  ..||||++.....      ...+|+++++.++||||+++++++..      ..
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            4579999999999999999999864  4499999865431      23479999999999999999998743      22


Q ss_pred             cceEEEeecCCCChhhhhcC-CCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC-CcEEEEeeCC
Q 009291          336 NLSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGL  413 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGl  413 (538)
                      .+++||||+.+ +|.+++.. ......+++..++.++.||+.||+|||++|  |+||||||+|||++.+ +.+||+|||+
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchh
Confidence            36799999986 56555431 122345899999999999999999999999  9999999999999954 6789999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----------
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK----------  482 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~----------  482 (538)
                      ++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..+.+..+...          
T Consensus       204 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          204 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98654332 22456789999999999765 7899999999999999999999999988765554433210          


Q ss_pred             -----CcccC------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 -----GRRLE------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 -----~~~~~------------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                           .....            ++..+++++.+||.+||+.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                 01111            23467899999999999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.6e-40  Score=352.63  Aligned_cols=247  Identities=23%  Similarity=0.288  Sum_probs=205.1

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcC------CCCceeEeeceeccC
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL------RHPNIVLLMGAVTEP  334 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L------~hpnIv~l~~~~~~~  334 (538)
                      ...+|++++.||+|+||+||+|.+..++  ||||++...   ......+.+|+.+++.+      +|+||+++++++...
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            3467999999999999999999987644  999998653   34445677888888776      577999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc--EEEEeeC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFG  412 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~--vkL~DFG  412 (538)
                      ..+++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+++  ||||||||+|||++.++.  +||+|||
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999999996 589888865432 24889999999999999999999999  999999999999999887  9999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc-------
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-------  485 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~-------  485 (538)
                      +++.....   .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+......       
T Consensus       248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          248 SSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            99765443   24567899999999999999999999999999999999999999988876655433211000       


Q ss_pred             --------------------------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 009291          486 --------------------------------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFP  515 (538)
Q Consensus       486 --------------------------------------------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~  515 (538)
                                                                        ..++...++.+.+||.+||+.||++|||+.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                                                              001223478899999999999999999999


Q ss_pred             HHHH
Q 009291          516 SIME  519 (538)
Q Consensus       516 eIl~  519 (538)
                      |+++
T Consensus       405 e~L~  408 (429)
T 3kvw_A          405 QALR  408 (429)
T ss_dssp             HHHT
T ss_pred             HHhC
Confidence            9976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=338.10  Aligned_cols=256  Identities=24%  Similarity=0.407  Sum_probs=193.6

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      ...+....++|++++.||+|+||.||+|.+.  +..||||++..........+.+.++..+++.++||||+++++++.++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            4456677889999999999999999999986  44599999977654444445556666778888999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ..+++||||+ ++.+..+....  ...+++..++.++.|++.||+|||++ |  |+||||||+||+++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CcEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCC
Confidence            9999999999 55666655422  23588999999999999999999995 9  99999999999999999999999999


Q ss_pred             CccCCCCccccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhhcCcccC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLE  487 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~-~~~~~~~i~~~~~~~~  487 (538)
                      +....... ......||..|+|||++.     ...++.++||||||+++|+|++|+.||.... ..+....+. ......
T Consensus       172 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~  249 (318)
T 2dyl_A          172 SGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPL  249 (318)
T ss_dssp             C---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCC
T ss_pred             chhccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCC
Confidence            97654332 223457899999999994     4568899999999999999999999998743 333333332 222222


Q ss_pred             C--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          488 I--PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       488 ~--p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +  ...+++.+.+||.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            2  3468999999999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.8e-40  Score=336.86  Aligned_cols=243  Identities=22%  Similarity=0.344  Sum_probs=199.1

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceecc--CCcc
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTE--PPNL  337 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~--~~~~  337 (538)
                      ..++|++++.||+|+||+||+|.+..  ..||+|++....     .+.+.+|+.++++++ ||||+++++++.+  ....
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            35789999999999999999998864  449999986432     257889999999997 9999999999987  5678


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-cEEEEeeCCCcc
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRS  416 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~  416 (538)
                      ++||||+.+++|.++++      .+++..++.++.|++.||+|||++|  |+||||||+|||++.++ .+||+|||+++.
T Consensus       109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            99999999999999885      3788999999999999999999999  99999999999999776 899999999986


Q ss_pred             CCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhh-------------
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGF-------------  481 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~-~~~~~~~i~~-------------  481 (538)
                      ..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ..+....+..             
T Consensus       181 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          181 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            54432 2345678999999999987 668999999999999999999999995432 2222211100             


Q ss_pred             cCc----------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          482 KGR----------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       482 ~~~----------------------~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ...                      ....+..+++++.+||.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000                      00112237899999999999999999999999976

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.6e-40  Score=339.18  Aligned_cols=249  Identities=22%  Similarity=0.292  Sum_probs=205.1

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEc---CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCC------ceeEeecee
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP------NIVLLMGAV  331 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hp------nIv~l~~~~  331 (538)
                      ++..++|++.+.||+|+||+||+|.+.   +..||+|++...   ....+.+.+|+.+++.++|+      +|+++++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            344679999999999999999999873   334999998643   34456788999999888655      599999999


Q ss_pred             ccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---------
Q 009291          332 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---------  402 (538)
Q Consensus       332 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---------  402 (538)
                      .+...+++||||+ +++|.+++..... ..+++..++.++.|++.||+|||++|  |+||||||+||+++.         
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC-
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999 8899999864432 35889999999999999999999999  999999999999987         


Q ss_pred             ----------CCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 009291          403 ----------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP  472 (538)
Q Consensus       403 ----------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~  472 (538)
                                ++.+||+|||+++.....   .....||..|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                      668999999999875432   2456789999999999999999999999999999999999999998877


Q ss_pred             HHHHHHHhhcCcc------------------------------------------cCCCCCCcHHHHHHHHHhhhcCCCC
Q 009291          473 SQVISAVGFKGRR------------------------------------------LEIPKNVNPMVAALIETCWAEEPEI  510 (538)
Q Consensus       473 ~~~~~~i~~~~~~------------------------------------------~~~p~~~s~~l~~LI~~cL~~dP~~  510 (538)
                      .+....+......                                          ...+...++.+.+||.+||+.||++
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            6554433211000                                          0112234678999999999999999


Q ss_pred             CCCHHHHHH
Q 009291          511 RPSFPSIME  519 (538)
Q Consensus       511 RPs~~eIl~  519 (538)
                      |||+.|+++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.2e-40  Score=340.57  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=203.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-----Cc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PN  336 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-----~~  336 (538)
                      .++|++.+.||+|+||+||+|.+..+  .||||++... ........+.+|+.++++++||||+++++++...     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            47899999999999999999998744  4999998543 2445567788999999999999999999987654     67


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++||||+. ++|.+++..    ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||++..
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            899999997 589988864    24889999999999999999999999  99999999999999999999999999986


Q ss_pred             CCCCcc----------ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-Cc
Q 009291          417 KPNTYI----------SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR  484 (538)
Q Consensus       417 ~~~~~~----------~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~  484 (538)
                      ......          ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+... +.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            543211          1123468999999998764 67899999999999999999999999988765544332110 00


Q ss_pred             c-----------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 R-----------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ~-----------------------------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .                             ......+++++.+||.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0                             0112468899999999999999999999999976

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=335.55  Aligned_cols=247  Identities=23%  Similarity=0.333  Sum_probs=197.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec---------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT---------  332 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~---------  332 (538)
                      .++|++++.||+|+||.||+|.+..+  .||+|++...  .....+.+.+|+.++++++||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            47899999999999999999998754  4999988654  4556678999999999999999999998873         


Q ss_pred             -----cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc-CCCcE
Q 009291          333 -----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTV  406 (538)
Q Consensus       333 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~-~~~~v  406 (538)
                           +....++||||+. |+|.+++..    ..+++..++.++.|++.||+|||++|  |+||||||+||+++ +++.+
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence                 4467899999997 599999863    34889999999999999999999999  99999999999997 56799


Q ss_pred             EEEeeCCCccCCCCcc---ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc
Q 009291          407 KVCDFGLSRSKPNTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK  482 (538)
Q Consensus       407 kL~DFGla~~~~~~~~---~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~  482 (538)
                      ||+|||+++.......   ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999986543211   1233457899999998865 67899999999999999999999999988776554433211


Q ss_pred             Cc----------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 GR----------------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ~~----------------------------~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..                            ....+..+++++.+||.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            10                            00123568999999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-41  Score=352.63  Aligned_cols=248  Identities=15%  Similarity=0.085  Sum_probs=184.6

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHH---HHHHcCCCCceeEeec-------
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREV---AIMKGLRHPNIVLLMG-------  329 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei---~il~~L~hpnIv~l~~-------  329 (538)
                      ...+|++.+.||+|+||+||+|++..++  ||+|++...... ....+.+.+|+   .+|+. +||||++++.       
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence            3456999999999999999999987544  999999876543 34456677785   45555 7999888653       


Q ss_pred             eeccC-----------------CcceEEEeecCCCChhhhhcCCCCCccccHHHH------HHHHHHHHHHHHHHHhCCC
Q 009291          330 AVTEP-----------------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR------LNMAYDVAKGMNYLHQRRP  386 (538)
Q Consensus       330 ~~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~  386 (538)
                      ++...                 ..+++||||++ ++|.+++....  ..+++..+      +.++.||+.||+|||++| 
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-  214 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG-  214 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence            33222                 33799999998 79999996431  12344444      677799999999999999 


Q ss_pred             CEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCC
Q 009291          387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQ  464 (538)
Q Consensus       387 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~s~ksDVwSLGvil~eLltg~  464 (538)
                       |+||||||+|||++.++.+||+|||+++......   ....+|+.|+|||++.+  ..++.++|||||||++|||++|+
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence             9999999999999999999999999998765432   14456799999999987  77999999999999999999999


Q ss_pred             CCCCCCCHHHHHHH-----Hhhc--CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          465 KPWRNSTPSQVISA-----VGFK--GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       465 ~Pf~~~~~~~~~~~-----i~~~--~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .||...........     ....  ....+.+..+++.+.+||.+||+.||++|||+.++++
T Consensus       291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99987643211000     0001  1122233578999999999999999999999999964

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1e-40  Score=348.70  Aligned_cols=248  Identities=21%  Similarity=0.283  Sum_probs=198.1

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCC--------CCceeEeecee
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR--------HPNIVLLMGAV  331 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~--------hpnIv~l~~~~  331 (538)
                      +..++|++.+.||+|+||+||+|++..++  ||||++...   ....+.+.+|+.+++.++        |+||+++++++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            34578999999999999999999887544  999998643   345567889999999885        78899999998


Q ss_pred             c----cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEcCCC--
Q 009291          332 T----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTY--  404 (538)
Q Consensus       332 ~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~~~~--  404 (538)
                      .    +...+++||||+. ++|.+.+.... ...+++..++.++.||+.||+|||++ |  |+||||||+|||++.++  
T Consensus       111 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          111 KISGVNGTHICMVFEVLG-HHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEETTEEEEEEEECCCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHH
T ss_pred             eecCCCCceEEEEEeccC-ccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchh
Confidence            7    5667999999995 45555553322 23589999999999999999999998 9  99999999999998775  


Q ss_pred             -----------------------------------------------cEEEEeeCCCccCCCCccccCCCCCCCcccccc
Q 009291          405 -----------------------------------------------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE  437 (538)
Q Consensus       405 -----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE  437 (538)
                                                                     .+||+|||+++.....   .....||..|+|||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE  263 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence                                                           7999999999875433   24567899999999


Q ss_pred             cccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhh-cCc--------------------------
Q 009291          438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP------SQVISAVGF-KGR--------------------------  484 (538)
Q Consensus       438 ~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~------~~~~~~i~~-~~~--------------------------  484 (538)
                      ++.+..++.++|||||||++|||++|+.||...+.      ......+.. .+.                          
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            99999999999999999999999999999976542      111111100 000                          


Q ss_pred             -------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 -------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 -------------~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                   ....+...++.+.+||.+||+.||++|||+.|+++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                         01122334577899999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.3e-40  Score=342.20  Aligned_cols=254  Identities=23%  Similarity=0.342  Sum_probs=199.8

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-CceEEEEEecccc---------CHHHHHHHHHHHHHHHcCCCCceeEeec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEF---------HEDRFKEFLREVAIMKGLRHPNIVLLMG  329 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~---------~~~~~~~~~~Ei~il~~L~hpnIv~l~~  329 (538)
                      +....++|++.+.||+|+||.||+|.+.. ..||||++.....         .....+.+.+|+.++++++||||+++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            34456889999999999999999998754 4499998855322         2344578999999999999999999999


Q ss_pred             eec-----cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC
Q 009291          330 AVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY  404 (538)
Q Consensus       330 ~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~  404 (538)
                      ++.     ....+++||||+. |+|.+++...  ...+++..++.++.|++.||+|||++|  |+||||||+||+++.++
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~  171 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNN  171 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTC
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCC
Confidence            983     3346899999997 5787777633  335899999999999999999999999  99999999999999999


Q ss_pred             cEEEEeeCCCccCCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC
Q 009291          405 TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG  483 (538)
Q Consensus       405 ~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~  483 (538)
                      .+||+|||++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus       172 ~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (362)
T 3pg1_A          172 DITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV  250 (362)
T ss_dssp             CEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             CEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            99999999997544332 2345578999999999887 678999999999999999999999999887666554432110


Q ss_pred             c------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 R------------------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ~------------------------------~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .                              ....+..+++.+.+||.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            0                              01123467889999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.8e-40  Score=332.07  Aligned_cols=246  Identities=26%  Similarity=0.441  Sum_probs=195.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc--------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--------  333 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--------  333 (538)
                      .++|++.+.||+|+||.||+|++..  ..||+|++...   ....+.+.+|+.++++++||||+++++++.+        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            3579999999999999999999864  44999998643   4556789999999999999999999998754        


Q ss_pred             -----CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEE
Q 009291          334 -----PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV  408 (538)
Q Consensus       334 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL  408 (538)
                           ...+++||||+++++|.+++....  ..+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEE
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEE
Confidence                 345799999999999999997432  35788899999999999999999999  999999999999999999999


Q ss_pred             EeeCCCccCCCCc--------------cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Q 009291          409 CDFGLSRSKPNTY--------------ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTP-  472 (538)
Q Consensus       409 ~DFGla~~~~~~~--------------~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~-  472 (538)
                      +|||++.......              .......||..|+|||++.+. .++.++||||||+++|+|++   ||..... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~  234 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER  234 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence            9999997654221              112345689999999999865 68999999999999999998   5654322 


Q ss_pred             HHHHHHHhhcC--cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          473 SQVISAVGFKG--RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       473 ~~~~~~i~~~~--~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ......+....  ....++...++.+.+||.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            22333332211  122344567788999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.5e-40  Score=356.70  Aligned_cols=256  Identities=20%  Similarity=0.307  Sum_probs=210.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCC-CceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h-pnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++++.||+|+||.||+|++.  +..||||++......    ..+.+|+.+++.++| ++|..+..++.+....++|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            468999999999999999999986  445999987655432    247789999999976 5566666667778889999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE---cCCCcEEEEeeCCCccC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~  417 (538)
                      |||+ +++|.+++....  ..+++..++.|+.||+.||+|||+++  ||||||||+|||+   +.++.+||+|||+++..
T Consensus        82 me~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            9999 899999996432  35899999999999999999999999  9999999999999   68899999999999865


Q ss_pred             CCCcc-------ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhh---cCc
Q 009291          418 PNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGF---KGR  484 (538)
Q Consensus       418 ~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~---~~~~~~i~~---~~~  484 (538)
                      .....       ......||..|+|||++.+..++.++|||||||++|||++|+.||.....   .+....+..   ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            43321       12356799999999999999999999999999999999999999987543   222222211   111


Q ss_pred             ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          485 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       485 ~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ...++..+++++.+||.+||..+|++||++.+|++.|++++...
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            12234678999999999999999999999999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.3e-40  Score=344.33  Aligned_cols=252  Identities=21%  Similarity=0.256  Sum_probs=189.9

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc---
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN---  336 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~---  336 (538)
                      ...++|++.+.||+|+||+||+|++..  ..||||++.......   ..+.+|+..++.++||||+++++++.....   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            345789999999999999999999874  459999886543222   245677888888999999999999855332   


Q ss_pred             ----ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHH--hCCCCEEeecCCCCCEEEcC-CCcEEEE
Q 009291          337 ----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH--QRRPPIVHRDLKSPNLLVDS-TYTVKVC  409 (538)
Q Consensus       337 ----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~iiHrDLKp~NILl~~-~~~vkL~  409 (538)
                          +++||||+.++.+..+.........+++..++.++.|++.||.|||  ++|  |+||||||+|||++. ++.+||+
T Consensus        97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEEC
T ss_pred             cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEe
Confidence                7899999987433333222223446889999999999999999999  888  999999999999996 8999999


Q ss_pred             eeCCCccCCCCccccCCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc----
Q 009291          410 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----  484 (538)
Q Consensus       410 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~----  484 (538)
                      |||+++...... ......||..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.....    
T Consensus       175 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          175 DFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            999998765432 234567899999999987654 89999999999999999999999999887666554421100    


Q ss_pred             --------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 --------------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 --------------------------~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                                ....+..+++++.+||.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                                      01122336789999999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.4e-40  Score=340.22  Aligned_cols=245  Identities=22%  Similarity=0.380  Sum_probs=205.1

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCH----HHHHHHHHHHHHHHcCC--CCceeEeecee
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE----DRFKEFLREVAIMKGLR--HPNIVLLMGAV  331 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~----~~~~~~~~Ei~il~~L~--hpnIv~l~~~~  331 (538)
                      .+...++|++.+.||+|+||.||+|.+..+  .||||++.......    ...+.+.+|+.++++++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            344567899999999999999999998644  49999987654321    12235668999999996  59999999999


Q ss_pred             ccCCcceEEEeecCC-CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc-CCCcEEEE
Q 009291          332 TEPPNLSIVTEYLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVC  409 (538)
Q Consensus       332 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~-~~~~vkL~  409 (538)
                      .++...++|||++.+ ++|.+++..   ...+++..++.++.|++.||+|||+++  |+||||||+||+++ +++.+||+
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEe
Confidence            999999999999976 899999864   235889999999999999999999999  99999999999998 78999999


Q ss_pred             eeCCCccCCCCccccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCC
Q 009291          410 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI  488 (538)
Q Consensus       410 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~  488 (538)
                      |||++.......  .....||..|+|||++.+..+ +.++||||||+++|||++|+.||.....  .      ......+
T Consensus       193 Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~------~~~~~~~  262 (320)
T 3a99_A          193 DFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--I------IRGQVFF  262 (320)
T ss_dssp             CCTTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H------HHCCCCC
T ss_pred             eCcccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--h------hcccccc
Confidence            999998765432  234578999999999987766 6789999999999999999999975421  1      1123456


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          489 PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       489 p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +..+++++.+||.+||+.||++|||+.++++
T Consensus       263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            6789999999999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=335.95  Aligned_cols=244  Identities=25%  Similarity=0.390  Sum_probs=196.8

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCH----HHHHHHHHHHHHHHcC----CCCceeEeece
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE----DRFKEFLREVAIMKGL----RHPNIVLLMGA  330 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~----~~~~~~~~Ei~il~~L----~hpnIv~l~~~  330 (538)
                      +...++|++.+.||+|+||.||+|.+..+  .||+|++.......    .....+.+|+.+++++    +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34457899999999999999999988544  49999986654322    2234566799999888    89999999999


Q ss_pred             eccCCcceEEEee-cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc-CCCcEEE
Q 009291          331 VTEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKV  408 (538)
Q Consensus       331 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~-~~~~vkL  408 (538)
                      +.+....++|||+ +.+++|.+++...   ..+++..++.++.|++.||+|||++|  |+||||||+||+++ .++.+||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEE
Confidence            9999999999999 7889999999642   35899999999999999999999999  99999999999999 8899999


Q ss_pred             EeeCCCccCCCCccccCCCCCCCcccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC
Q 009291          409 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE  487 (538)
Q Consensus       409 ~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s-~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~  487 (538)
                      +|||++.......  .....|+..|+|||++.+..+. .++||||||+++|+|++|+.||.....  .      ......
T Consensus       182 ~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~------~~~~~~  251 (312)
T 2iwi_A          182 IDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--I------LEAELH  251 (312)
T ss_dssp             CCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--H------HHTCCC
T ss_pred             EEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--H------hhhccC
Confidence            9999998765432  2456789999999999877664 589999999999999999999975321  1      123455


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       488 ~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ++..++..+.+||.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            67889999999999999999999999999976

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-39  Score=334.08  Aligned_cols=248  Identities=20%  Similarity=0.257  Sum_probs=201.6

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCC---ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc------eeEeeceec
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNS---DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN------IVLLMGAVT  332 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn------Iv~l~~~~~  332 (538)
                      ...++|++.+.||+|+||+||+|.+..+   .||+|++...   ....+.+.+|+.+++.++|++      ++.+++++.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            3457899999999999999999998643   4999998643   344567888999999887655      899999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE------------
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV------------  400 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl------------  400 (538)
                      ....+++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++|  |+||||||+|||+            
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccc
Confidence            999999999999 556666664332 235889999999999999999999999  9999999999999            


Q ss_pred             -------cCCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 009291          401 -------DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS  473 (538)
Q Consensus       401 -------~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~  473 (538)
                             +.++.+||+|||+++.....   .....||..|+|||++.+..++.++|||||||++|||++|..||......
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                   56789999999999865433   24567899999999999999999999999999999999999999988776


Q ss_pred             HHHHHHhhcCccc------------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCC
Q 009291          474 QVISAVGFKGRRL------------------------------------------EIPKNVNPMVAALIETCWAEEPEIR  511 (538)
Q Consensus       474 ~~~~~i~~~~~~~------------------------------------------~~p~~~s~~l~~LI~~cL~~dP~~R  511 (538)
                      +....+.......                                          ......+.++.+||.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            5544332110000                                          0111235689999999999999999


Q ss_pred             CCHHHHHH
Q 009291          512 PSFPSIME  519 (538)
Q Consensus       512 Ps~~eIl~  519 (538)
                      ||+.++++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999974

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.4e-40  Score=340.51  Aligned_cols=249  Identities=20%  Similarity=0.299  Sum_probs=198.4

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCC-----------CCceeEe
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----------HPNIVLL  327 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-----------hpnIv~l  327 (538)
                      .+..++|++.+.||+|+||+||+|++..+  .||||++...   ....+.+.+|+.++++++           |+||+++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            34567899999999999999999998644  4999998643   334567888999998876           8999999


Q ss_pred             eceeccCC----cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC-CCCEEeecCCCCCEEEc-
Q 009291          328 MGAVTEPP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVD-  401 (538)
Q Consensus       328 ~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~iiHrDLKp~NILl~-  401 (538)
                      ++++....    .+++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++ |  |+||||||+|||++ 
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEI  167 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEE
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEec
Confidence            99987544    689999999 8899999864322 3488999999999999999999998 9  99999999999994 


Q ss_pred             -----CCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Q 009291          402 -----STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---  473 (538)
Q Consensus       402 -----~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~---  473 (538)
                           ..+.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence                 4458999999999865433   23557899999999999999999999999999999999999999865421   


Q ss_pred             ---HHHHHHhh-c---------------------------------------CcccCCCCCCcHHHHHHHHHhhhcCCCC
Q 009291          474 ---QVISAVGF-K---------------------------------------GRRLEIPKNVNPMVAALIETCWAEEPEI  510 (538)
Q Consensus       474 ---~~~~~i~~-~---------------------------------------~~~~~~p~~~s~~l~~LI~~cL~~dP~~  510 (538)
                         .....+.. .                                       .....++..+++++.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence               11111110 0                                       0112234456788999999999999999


Q ss_pred             CCCHHHHHH
Q 009291          511 RPSFPSIME  519 (538)
Q Consensus       511 RPs~~eIl~  519 (538)
                      |||+.++++
T Consensus       325 Rpt~~ell~  333 (373)
T 1q8y_A          325 RADAGGLVN  333 (373)
T ss_dssp             CBCHHHHHT
T ss_pred             cCCHHHHhh
Confidence            999999976

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2e-39  Score=334.24  Aligned_cols=245  Identities=23%  Similarity=0.356  Sum_probs=173.8

Q ss_pred             ccceeEEE-EEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc----CCc
Q 009291          264 WSELLIKK-KIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPN  336 (538)
Q Consensus       264 ~~~y~i~~-~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~----~~~  336 (538)
                      .++|++.+ .||+|+||+||+|.+.  +..||+|++....   ...+   +....++.++||||+++++++..    ...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            46799865 6999999999999987  4459999986532   2111   22334566799999999999865    445


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeCC
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGL  413 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGl  413 (538)
                      +++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++|  |+||||||+||+++.   ++.+||+|||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            899999999999999997543 235899999999999999999999999  999999999999975   45699999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhhcCcc--cC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA----VGFKGRR--LE  487 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~----i~~~~~~--~~  487 (538)
                      +.......  .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........    +......  .+
T Consensus       178 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          178 AKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             ceeccccc--cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence            98654332  2456789999999999888899999999999999999999999987665443211    1111111  12


Q ss_pred             CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          488 IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       488 ~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ....+++++.+||.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            22578999999999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=343.98  Aligned_cols=248  Identities=22%  Similarity=0.372  Sum_probs=181.3

Q ss_pred             cceeE-EEEEccCCcEEEEEEEEc----CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeecee--ccCCcc
Q 009291          265 SELLI-KKKIGEGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV--TEPPNL  337 (538)
Q Consensus       265 ~~y~i-~~~LG~G~fg~Vy~a~~~----~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~--~~~~~~  337 (538)
                      +.|++ +++||+|+||+||+|++.    +..||+|++......    ..+.+|+.+|++++||||+++++++  .....+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            45666 458999999999999976    344999998655433    3577899999999999999999998  456779


Q ss_pred             eEEEeecCCCChhhhhcCC------CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEE----cCCCcEE
Q 009291          338 SIVTEYLSRGSLYKLLHIP------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVK  407 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl----~~~~~vk  407 (538)
                      ++||||+.+ +|.+++...      .....+++..++.++.||+.||+|||++|  |+||||||+|||+    +.++.+|
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence            999999975 777776421      12234889999999999999999999999  9999999999999    6778999


Q ss_pred             EEeeCCCccCCCCc---cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------H
Q 009291          408 VCDFGLSRSKPNTY---ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPS---------Q  474 (538)
Q Consensus       408 L~DFGla~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~---------~  474 (538)
                      |+|||+++......   .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......         +
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            99999998754321   122456789999999999874 5899999999999999999999999765542         1


Q ss_pred             HHHHHh-hcCccc-----------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 009291          475 VISAVG-FKGRRL-----------------------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIM  518 (538)
Q Consensus       475 ~~~~i~-~~~~~~-----------------------------------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl  518 (538)
                      .+..+. ..+...                                   ......++.+.+||.+||+.||++|||+.|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            111111 000000                                   00112367889999999999999999999987


Q ss_pred             H
Q 009291          519 E  519 (538)
Q Consensus       519 ~  519 (538)
                      +
T Consensus       333 ~  333 (405)
T 3rgf_A          333 Q  333 (405)
T ss_dssp             T
T ss_pred             c
Confidence            5

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.8e-39  Score=337.75  Aligned_cols=248  Identities=25%  Similarity=0.265  Sum_probs=201.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCC-CC-----ceeEeeceecc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HP-----NIVLLMGAVTE  333 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hp-----nIv~l~~~~~~  333 (538)
                      ...++|++.+.||+|+||+||+|.+..++  ||||++...   ......+.+|+.+++.++ |+     +|+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            34679999999999999999999987544  999998643   344567778888888774 44     49999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh--CCCCEEeecCCCCCEEEc--CCCcEEEE
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ--RRPPIVHRDLKSPNLLVD--STYTVKVC  409 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~~~iiHrDLKp~NILl~--~~~~vkL~  409 (538)
                      ...+++||||+. ++|.+++..... ..+++..++.++.|++.||.|||.  .|  ||||||||+|||++  .++.+||+
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCEEEC
T ss_pred             CCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999996 599999865432 248899999999999999999994  57  99999999999994  47889999


Q ss_pred             eeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc---
Q 009291          410 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL---  486 (538)
Q Consensus       410 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~---  486 (538)
                      |||+++.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.......   
T Consensus       204 DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          204 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99999876443   245678999999999999999999999999999999999999999888766655443110000   


Q ss_pred             -------------CCC------------------CC----------------------------CcHHHHHHHHHhhhcC
Q 009291          487 -------------EIP------------------KN----------------------------VNPMVAALIETCWAEE  507 (538)
Q Consensus       487 -------------~~p------------------~~----------------------------~s~~l~~LI~~cL~~d  507 (538)
                                   .++                  +.                            .++++.+||.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                         000                  00                            0147899999999999


Q ss_pred             CCCCCCHHHHHH
Q 009291          508 PEIRPSFPSIME  519 (538)
Q Consensus       508 P~~RPs~~eIl~  519 (538)
                      |++|||+.|+++
T Consensus       361 P~~Rpta~e~L~  372 (382)
T 2vx3_A          361 PKTRIQPYYALQ  372 (382)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999865

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=342.64  Aligned_cols=250  Identities=26%  Similarity=0.391  Sum_probs=192.7

Q ss_pred             ccccccceeEEEEEccCCcEEE-EEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcc
Q 009291          260 LEIRWSELLIKKKIGEGSFGTV-YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL  337 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~V-y~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~  337 (538)
                      ..+...+|.+.+.||+|+||+| |++...++.||||++......     .+.+|+.+++++ +||||+++++++.+....
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            4566678999999999999985 445556777999998654322     356899999999 799999999999999999


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-----CCcEEEEeeC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFG  412 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-----~~~vkL~DFG  412 (538)
                      ++||||+. |+|.+++.....  ...+..++.++.||+.||+|||++|  |+||||||+|||++.     ...+||+|||
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             EEEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            99999996 599999865432  2444556789999999999999999  999999999999943     3368899999


Q ss_pred             CCccCCCCc---cccCCCCCCCccccccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcc
Q 009291          413 LSRSKPNTY---ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRR  485 (538)
Q Consensus       413 la~~~~~~~---~~~~~~~gt~~Y~aPE~l~---~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~  485 (538)
                      +++......   .......||+.|+|||++.   ...++.++|||||||++|||++ |..||..................
T Consensus       169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~  248 (432)
T 3p23_A          169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD  248 (432)
T ss_dssp             EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCT
T ss_pred             ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcc
Confidence            998754321   1234467999999999997   4567889999999999999999 89999776655443333211111


Q ss_pred             -cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 -LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 -~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                       ...+...+..+.+||.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             1122334677899999999999999999999983

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-38  Score=319.64  Aligned_cols=233  Identities=15%  Similarity=0.139  Sum_probs=191.7

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +..++|++.+.||+|+||.||+|.+..  +.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            445789999999999999999999874  45999998765443 566688999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++++|.++++..     .....+..++.|++.||+|||++|  |+||||||+|||++.+|.+||+++|      
T Consensus       108 lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc------
Confidence            999999999999998532     345568889999999999999999  9999999999999999999998543      


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hhcCcc----cCCCCCCc
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-GFKGRR----LEIPKNVN  493 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i-~~~~~~----~~~p~~~s  493 (538)
                                    |++       .++.++|||||||++|||++|+.||...+..+..... ......    ...+..++
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP  233 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence                          233       3789999999999999999999999876543211000 000111    12346789


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      +++.+||.+||+.||++| |+.++++.|+++.....
T Consensus       234 ~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          234 FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            999999999999999999 99999999999886553

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.9e-38  Score=336.22  Aligned_cols=245  Identities=24%  Similarity=0.373  Sum_probs=185.6

Q ss_pred             cceeEEEEEccCCcEEEEEEE-EcCCceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAE-WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~-~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      +.|.+.+.||+|+||+||.+. ..+..||||++....     .+.+.+|+.+++++ +||||+++++++.+...+++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            456677899999999997653 345669999986542     24577899999876 89999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCc----cccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCC-------------Cc
Q 009291          343 YLSRGSLYKLLHIPDARV----VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-------------YT  405 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~-------------~~  405 (538)
                      |+. |+|.+++.......    ...+..++.++.||+.||+|||++|  |+||||||+|||++.+             +.
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence            996 59999996543211    1123345789999999999999999  9999999999999654             48


Q ss_pred             EEEEeeCCCccCCCCccc----cCCCCCCCcccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 009291          406 VKVCDFGLSRSKPNTYIS----SKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELIT-LQKPWRNSTPS  473 (538)
Q Consensus       406 vkL~DFGla~~~~~~~~~----~~~~~gt~~Y~aPE~l~~-------~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~  473 (538)
                      +||+|||++.........    .....||+.|+|||++.+       ..++.++|||||||++|||++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            999999999875543211    234579999999999976       568999999999999999999 89999876544


Q ss_pred             HHHHHHhhcCcccCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          474 QVISAVGFKGRRLEI-----PKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       474 ~~~~~i~~~~~~~~~-----p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ...  +.........     +..+++++.+||.+||+.||++|||+.++++
T Consensus       247 ~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 ESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            321  1111111111     1235688999999999999999999999975

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.6e-37  Score=312.48  Aligned_cols=224  Identities=25%  Similarity=0.394  Sum_probs=180.3

Q ss_pred             ccceeEE-EEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHH-HcCCCCceeEeeceecc----CC
Q 009291          264 WSELLIK-KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIM-KGLRHPNIVLLMGAVTE----PP  335 (538)
Q Consensus       264 ~~~y~i~-~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il-~~L~hpnIv~l~~~~~~----~~  335 (538)
                      .++|.+. +.||+|+||.||+|.+..+  .||+|++...       ..+.+|+.++ +.++||||+++++++..    ..
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            3567777 7899999999999998644  4999998643       2566788887 56699999999999876    66


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFG  412 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFG  412 (538)
                      .+++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|  |+||||||+||+++.   ++.+||+|||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             eEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            7899999999999999997532 235899999999999999999999999  999999999999998   7899999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh--cCcccCCC-
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF--KGRRLEIP-  489 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~--~~~~~~~p-  489 (538)
                      ++....                      +..++.++|||||||++|+|++|+.||..............  ......++ 
T Consensus       166 ~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  223 (299)
T 3m2w_A          166 FAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  223 (299)
T ss_dssp             TCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred             cccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence            886432                      23467899999999999999999999987655433221111  11122233 


Q ss_pred             ---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          490 ---KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       490 ---~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                         ..+++++.+||.+||+.||++|||+.++++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               568999999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.2e-38  Score=350.03  Aligned_cols=261  Identities=23%  Similarity=0.325  Sum_probs=206.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc------CC
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PP  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~------~~  335 (538)
                      .++|++.+.||+|+||+||+|.+.  +..||||++... ......+.+.+|+.++++++||||+++++++..      ..
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            368999999999999999999875  445999987654 355667789999999999999999999998765      66


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCc---EEEEeeC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFG  412 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~---vkL~DFG  412 (538)
                      ..++||||+++++|.+++........+++..++.++.|++.||+|||++|  |+||||||+||+++.++.   +||+|||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            78999999999999999976554456889999999999999999999999  999999999999987664   9999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------HHHh-h-
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI---------SAVG-F-  481 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~---------~~i~-~-  481 (538)
                      ++....... ......||..|+|||.+.+..++.++||||||+++|+|++|..||.........         .... . 
T Consensus       170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            998765432 234567899999999999999999999999999999999999999765332211         0000 0 


Q ss_pred             -cCc------ccC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHH-----HHHHHHHHHhhh
Q 009291          482 -KGR------RLE----IPKNVNPMVAALIETCWAEEPEIRPSFPS-----IMETLQQFLMSS  528 (538)
Q Consensus       482 -~~~------~~~----~p~~~s~~l~~LI~~cL~~dP~~RPs~~e-----Il~~L~~il~~~  528 (538)
                       ...      ..+    ++..+++.+.+||.+||..||++|||+.+     ..+.+++++...
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence             000      111    22346789999999999999999999988     567777777544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-37  Score=330.26  Aligned_cols=244  Identities=16%  Similarity=0.134  Sum_probs=187.4

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc--CCceEEEEEecccc-CHHHHHHHHHHHHHHHcCCC-CceeEe----------
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRH-PNIVLL----------  327 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~h-pnIv~l----------  327 (538)
                      ....+|...+.||+|+||+||+|.+.  ++.||||++..... .....+.+.+|+.+++.++| .|+..+          
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            44567899999999999999999987  55699999874332 22335678999999999977 322111          


Q ss_pred             -----------eceecc-----CCcceEEEeecCCCChhhhhcC----CCCCccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 009291          328 -----------MGAVTE-----PPNLSIVTEYLSRGSLYKLLHI----PDARVVVDERLRLNMAYDVAKGMNYLHQRRPP  387 (538)
Q Consensus       328 -----------~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~  387 (538)
                                 ..++..     ...++++|+++ +++|.++++.    ......+++..++.++.|++.||+|||+++  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  231 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  231 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence                       111111     12356777765 6799988841    223456888899999999999999999999  


Q ss_pred             EEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccc----------cCCCCCchhhHHHHHHHH
Q 009291          388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL----------REDPSNEKSDVFSFGVIL  457 (538)
Q Consensus       388 iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l----------~~~~~s~ksDVwSLGvil  457 (538)
                      ||||||||+|||++.++.+||+|||+++.....   .....| +.|+|||++          .+..++.++|||||||++
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            999999999999999999999999999875543   345677 999999999          566688999999999999


Q ss_pred             HHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 009291          458 WELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIM  518 (538)
Q Consensus       458 ~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl  518 (538)
                      |||++|+.||...+......      ........+++.+.+||.+||+.||++|||+.+++
T Consensus       308 ~elltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSE------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSG------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhhHH------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999998765433211      11223357889999999999999999999976663

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.1e-37  Score=348.58  Aligned_cols=243  Identities=22%  Similarity=0.271  Sum_probs=198.0

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcC---CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc--
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRN---SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN--  336 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~--  336 (538)
                      +..++|++.+.||+|+||+||+|.+..   +.||||++... ........+.+|+.++++++||||+++++++.+...  
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            445789999999999999999999863   45999987653 345556788999999999999999999999987665  


Q ss_pred             ---ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          337 ---LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       337 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                         .|+||||+++++|.+++..     .+++..++.++.||+.||+|||++|  ||||||||+|||++.+ .+||+|||+
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEeccc
Confidence               6999999999999887643     4899999999999999999999999  9999999999999875 899999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC-CCCCC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-IPKNV  492 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~  492 (538)
                      ++.....    ....||+.|+|||++.+.. +.++|||||||++|+|++|..||......         ..... .....
T Consensus       228 a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~  293 (681)
T 2pzi_A          228 VSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKT  293 (681)
T ss_dssp             CEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHH
T ss_pred             chhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------ccccccccccc
Confidence            9876443    4567999999999987654 88999999999999999999888753210         00000 00123


Q ss_pred             cHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHhh
Q 009291          493 NPMVAALIETCWAEEPEIRP-SFPSIMETLQQFLMS  527 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RP-s~~eIl~~L~~il~~  527 (538)
                      ++.+.+||.+||+.||++|| +++++...|..++..
T Consensus       294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence            57899999999999999998 577777777776643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.4e-38  Score=325.26  Aligned_cols=240  Identities=20%  Similarity=0.218  Sum_probs=185.3

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEecccc------CHHHHHHHHHHHHHHHcCC---------C-----
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEF------HEDRFKEFLREVAIMKGLR---------H-----  321 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~------~~~~~~~~~~Ei~il~~L~---------h-----  321 (538)
                      +..++|++++.||+|+||+||+|+++++.||||++.....      .....+.+.+|+.+++.++         |     
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            3457899999999999999999999888899999976532      2223457888999888875         4     


Q ss_pred             ------------CceeEeeceecc-------------CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHH
Q 009291          322 ------------PNIVLLMGAVTE-------------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK  376 (538)
Q Consensus       322 ------------pnIv~l~~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~  376 (538)
                                  |||+++++++.+             ...+++||||+++|++.+.+..    ..+++..++.++.||+.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence                        555555555544             6789999999999976666632    34899999999999999


Q ss_pred             HHHHHH-hCCCCEEeecCCCCCEEEcCCC--------------------cEEEEeeCCCccCCCCccccCCCCCCCcccc
Q 009291          377 GMNYLH-QRRPPIVHRDLKSPNLLVDSTY--------------------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMA  435 (538)
Q Consensus       377 aL~~LH-~~~~~iiHrDLKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~a  435 (538)
                      ||+||| +++  ||||||||+|||++.++                    .+||+|||+|+.....     ...||+.|+|
T Consensus       173 aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a  245 (336)
T 2vuw_A          173 SLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred             HHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence            999999 999  99999999999999887                    8999999999865432     3479999999


Q ss_pred             cccccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHhhc-Ccc----cCCCCCCcHHHHHHHHHhhhcCC
Q 009291          436 PEVLREDPSNEKSDVFSFGVI-LWELITLQKPWRNSTP-SQVISAVGFK-GRR----LEIPKNVNPMVAALIETCWAEEP  508 (538)
Q Consensus       436 PE~l~~~~~s~ksDVwSLGvi-l~eLltg~~Pf~~~~~-~~~~~~i~~~-~~~----~~~p~~~s~~l~~LI~~cL~~dP  508 (538)
                      ||++.+.. +.++||||||++ .+++++|..||..... ......+... ...    ...+..+++++.+||.+||+.| 
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-  323 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-  323 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence            99998776 899999998777 7788889999854211 1111111101 111    1112357889999999999977 


Q ss_pred             CCCCCHHHHH
Q 009291          509 EIRPSFPSIM  518 (538)
Q Consensus       509 ~~RPs~~eIl  518 (538)
                          |+.|++
T Consensus       324 ----sa~e~l  329 (336)
T 2vuw_A          324 ----SATDLL  329 (336)
T ss_dssp             ----SHHHHH
T ss_pred             ----CHHHHH
Confidence                888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=8.7e-31  Score=288.63  Aligned_cols=184  Identities=14%  Similarity=0.091  Sum_probs=131.2

Q ss_pred             EEccCCcEEEEEEEE--cCCceEEEEEecccc--------CHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCCcceEE
Q 009291          272 KIGEGSFGTVYHAEW--RNSDVAVKILIEQEF--------HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       272 ~LG~G~fg~Vy~a~~--~~~~vavK~~~~~~~--------~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ..+.|++|.+..++.  -+..+++|++.....        .+...++|.+|+++|+++ .|+||++++++++++..+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            466777777766543  477799999976532        134456799999999999 799999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||++|++|.+++....   .+++.   +|+.||+.||+|||++|  ||||||||+|||++++|++||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999997543   46554   47899999999999999  999999999999999999999999999876655


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ  464 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~  464 (538)
                      .....+.+||+.|||||++.+. +..++|+||+|++++++.++.
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             CccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence            4444566899999999999764 667899999999988776553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=2.4e-27  Score=259.73  Aligned_cols=186  Identities=17%  Similarity=0.237  Sum_probs=147.4

Q ss_pred             eEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCH------HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          268 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       268 ~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~------~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ...+.||+|+||+||++...+..+++|+........      ...+.+.+|++++++++||||+.+..++......++||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            346789999999999998888889999876543321      22456899999999999999996655555677789999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+++++|.+++..           +..++.|++.||+|||+++  |+||||||+|||++.  .+||+|||+++......
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            99999999999864           4578999999999999999  999999999999998  99999999998875532


Q ss_pred             cc-------cCCCCCCCcccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009291          422 IS-------SKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWR  468 (538)
Q Consensus       422 ~~-------~~~~~gt~~Y~aPE~l~~--~~~s~ksDVwSLGvil~eLltg~~Pf~  468 (538)
                      ..       .....||+.|||||++..  ..|+..+|+|+..+-..+-..++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            11       134578999999999987  567888999999988888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=6.4e-23  Score=206.36  Aligned_cols=147  Identities=19%  Similarity=0.161  Sum_probs=115.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccCH----------------HHHHHHHHHHHHHHcCCCCceeE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHE----------------DRFKEFLREVAIMKGLRHPNIVL  326 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~----------------~~~~~~~~Ei~il~~L~hpnIv~  326 (538)
                      ...|.+++.||+|+||.||+|.+. +..||+|++.......                .....+.+|+.++++++  | ++
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            345667799999999999999983 3459999986432211                24567899999999998  4 66


Q ss_pred             eeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcE
Q 009291          327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV  406 (538)
Q Consensus       327 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~v  406 (538)
                      +.+++.. +..++||||+++++|.+ +...         ....++.|++.||+|||++|  |+||||||+|||++ ++.+
T Consensus       166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~---------~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~v  231 (282)
T 1zar_A          166 VPKVYAW-EGNAVLMELIDAKELYR-VRVE---------NPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGI  231 (282)
T ss_dssp             SCCEEEE-ETTEEEEECCCCEEGGG-CCCS---------CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEE
T ss_pred             cCeEEec-cceEEEEEecCCCcHHH-cchh---------hHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcE
Confidence            6665543 56799999999999998 5321         23468999999999999999  99999999999999 9999


Q ss_pred             EEEeeCCCccCCCCccccCCCCCCCccccccccc
Q 009291          407 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR  440 (538)
Q Consensus       407 kL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~  440 (538)
                      ||+|||+|+.             +..|+|||.+.
T Consensus       232 kl~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          232 WIIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             EECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             EEEECCCCeE-------------CCCCCHHHHHH
Confidence            9999999863             33468999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=2.4e-19  Score=177.63  Aligned_cols=138  Identities=19%  Similarity=0.173  Sum_probs=106.0

Q ss_pred             ceeEEEEEccCCcEEEEEEEE--cCCc--eEEEEEeccccC----------------------HHHHHHHHHHHHHHHcC
Q 009291          266 ELLIKKKIGEGSFGTVYHAEW--RNSD--VAVKILIEQEFH----------------------EDRFKEFLREVAIMKGL  319 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~--~~~~--vavK~~~~~~~~----------------------~~~~~~~~~Ei~il~~L  319 (538)
                      -|++.+.||+|+||.||+|.+  .+..  ||||++......                      ......+.+|+.+|+++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478899999999999999988  5667  999997543211                      01123678999999999


Q ss_pred             CCCce--eEeeceeccCCcceEEEeecCC-C----ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHH-hCCCCEEee
Q 009291          320 RHPNI--VLLMGAVTEPPNLSIVTEYLSR-G----SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH-QRRPPIVHR  391 (538)
Q Consensus       320 ~hpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~iiHr  391 (538)
                      .|++|  ..++++    ...++||||+.+ |    +|.++...      .++..+..++.|++.||.||| ++|  ||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g--ivHr  195 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE--LVHA  195 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC--EECS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence            87754  334432    357999999942 3    56665421      234567789999999999999 999  9999


Q ss_pred             cCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          392 DLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       392 DLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ||||+|||++.  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999988  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=6e-16  Score=161.44  Aligned_cols=137  Identities=16%  Similarity=0.158  Sum_probs=99.4

Q ss_pred             ceeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccC---------------H-HH----HHHHHHHHHHHHcCCCCce
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFH---------------E-DR----FKEFLREVAIMKGLRHPNI  324 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~---------------~-~~----~~~~~~Ei~il~~L~hpnI  324 (538)
                      -|.+++.||+|+||.||+|.+. ++.||||+++.....               . ..    .....+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4899999999999999999875 455999997532110               0 00    1123457777777754443


Q ss_pred             e--EeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC
Q 009291          325 V--LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       325 v--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~  402 (538)
                      .  ..++.    ...++||||++|++|..+....         ....++.|++.+|.+||++|  ||||||||.|||+++
T Consensus       176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~~---------~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSVP---------DPASLYADLIALILRLAKHG--LIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEEE----ETTEEEEECCSCEEGGGCCCCS---------CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEE
T ss_pred             CCCeeeec----cCceEEEEecCCccHhhhcccH---------HHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeC
Confidence            2  22222    2347999999998887664321         23567899999999999999  999999999999987


Q ss_pred             CC----------cEEEEeeCCCccC
Q 009291          403 TY----------TVKVCDFGLSRSK  417 (538)
Q Consensus       403 ~~----------~vkL~DFGla~~~  417 (538)
                      +|          .+.|+||+-+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            76          3899999977643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=6.2e-12  Score=123.64  Aligned_cols=141  Identities=15%  Similarity=0.038  Sum_probs=109.6

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEEEee
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      ..|++...++.|+.+.||++...++.+++|+.......  ....+.+|+.+++.+. +..+.++++++.+....++||||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            45888889999999999999877777999997643211  1125778999998884 67788899988888889999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR--------------------------------------  385 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------  385 (538)
                      ++|.+|.+.+..        ......++.+++.+|..||+..                                      
T Consensus        92 i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             CSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             cCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            999998876321        1123467889999999999810                                      


Q ss_pred             -------------------CCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          386 -------------------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       386 -------------------~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                                         +.++|+|++|.||++++++.+.|+||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               238999999999999876566799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.05  E-value=3.9e-10  Score=116.26  Aligned_cols=143  Identities=15%  Similarity=0.180  Sum_probs=106.0

Q ss_pred             eEEEEEccCCcEEEEEEEEcCCceEEEEEe--ccccCHHHHHHHHHHHHHHHcCC--CCceeEeeceeccC---CcceEE
Q 009291          268 LIKKKIGEGSFGTVYHAEWRNSDVAVKILI--EQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEP---PNLSIV  340 (538)
Q Consensus       268 ~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~--~~~~~~~~~~~~~~Ei~il~~L~--hpnIv~l~~~~~~~---~~~~lV  340 (538)
                      ...+.|+.|.++.||++...+..+++|+..  .... ......+.+|+.+++.+.  +..+.+++.++.+.   ...++|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            346789999999999998777778888765  2211 112346778999999886  45578888887766   347999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR------------------------------------  384 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------------------------------------  384 (538)
                      |||++|..+.+..-     ..+++.....++.+++++|..||+.                                    
T Consensus       120 me~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            99999977754211     1256778888999999999999983                                    


Q ss_pred             --------------------CCCEEeecCCCCCEEEcCCCc--EEEEeeCCCcc
Q 009291          385 --------------------RPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSRS  416 (538)
Q Consensus       385 --------------------~~~iiHrDLKp~NILl~~~~~--vkL~DFGla~~  416 (538)
                                          .+.++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                134999999999999987653  69999998875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.03  E-value=3.7e-10  Score=109.90  Aligned_cols=135  Identities=17%  Similarity=0.101  Sum_probs=96.3

Q ss_pred             cceeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc--eeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn--Iv~l~~~~~~~~~~~lV~  341 (538)
                      ..+.+....+.|..+.||++... ++.+++|+.....     ...+.+|+.+++.+.+.+  +.+++++...+...++||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            34555443346667999999754 3459999865431     135678888888885434  556888887777889999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR------------------------------------  385 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------  385 (538)
                      ||++|.+|.  ...      ..   ...++.+++..|..||+..                                    
T Consensus        95 e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999998884  221      11   1246677888888888743                                    


Q ss_pred             --------------------CCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          386 --------------------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       386 --------------------~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                                          ..++|+|++|.||++++++.+.|+|||.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                129999999999999877667799999764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.88  E-value=2.3e-09  Score=107.87  Aligned_cols=186  Identities=19%  Similarity=0.168  Sum_probs=120.9

Q ss_pred             EEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCc--eeEeeceeccCC---cceEEEee
Q 009291          270 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPN--IVLLMGAVTEPP---NLSIVTEY  343 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpn--Iv~l~~~~~~~~---~~~lV~E~  343 (538)
                      .+.++.|....||++.   ..+++|+...    ......+.+|..+|+.+. +..  +.+++.......   ..|+|||+
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            3458999999999873   6788888532    234567889999998773 322  344554443333   34789999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR--------------------------------------  385 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------  385 (538)
                      ++|.++.....     ..++......++.|++..|..||+..                                      
T Consensus        98 i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           98 IKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             cCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99988765321     12567777788888998888888621                                      


Q ss_pred             ------------------CCEEeecCCCCCEEEcC--CCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccC----
Q 009291          386 ------------------PPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE----  441 (538)
Q Consensus       386 ------------------~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~----  441 (538)
                                        +.++|+|++|.||++++  .+.+.|+||+.+........-....... .-..|+....    
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHH
Confidence                              24799999999999988  5568999999987543211000000000 0012222110    


Q ss_pred             -CCC---------CchhhHHHHHHHHHHHHhCCCCCC
Q 009291          442 -DPS---------NEKSDVFSFGVILWELITLQKPWR  468 (538)
Q Consensus       442 -~~~---------s~ksDVwSLGvil~eLltg~~Pf~  468 (538)
                       ...         ....+.|++|.++|.+.+|+.+|.
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence             000         122589999999999999987653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.40  E-value=2.6e-06  Score=85.76  Aligned_cols=135  Identities=19%  Similarity=0.164  Sum_probs=93.8

Q ss_pred             EEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCC---ceeEeeceec-cCCcceEEEeecC
Q 009291          270 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP---NIVLLMGAVT-EPPNLSIVTEYLS  345 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hp---nIv~l~~~~~-~~~~~~lV~E~~~  345 (538)
                      .+.++.|....||+.   +..+++|+-.    .......+.+|..+|+.+.+.   .|.+++.+.. .....++|||+++
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            456889999999988   6778998842    233456788999999988642   3556666553 4455789999999


Q ss_pred             CCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 009291          346 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR----------------------------------------  385 (538)
Q Consensus       346 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------------------------------------  385 (538)
                      |.++....-.     .++......++.++...|..||+..                                        
T Consensus        97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9888663210     1344445555556666666655432                                        


Q ss_pred             ------------------CCEEeecCCCCCEEEcC---CCc-EEEEeeCCCcc
Q 009291          386 ------------------PPIVHRDLKSPNLLVDS---TYT-VKVCDFGLSRS  416 (538)
Q Consensus       386 ------------------~~iiHrDLKp~NILl~~---~~~-vkL~DFGla~~  416 (538)
                                        +.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                              23699999999999987   355 58999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.39  E-value=1.4e-06  Score=85.51  Aligned_cols=132  Identities=16%  Similarity=0.160  Sum_probs=93.5

Q ss_pred             EEccCCcE-EEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEEEeecCCC
Q 009291          272 KIGEGSFG-TVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       272 ~LG~G~fg-~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      .+..|..+ .||+.....  ..+++|+-...     ....+.+|...|+.+. +--|.++++++.+++..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34445444 789876543  34888886432     3456778999988774 334677888888888899999999998


Q ss_pred             ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCC-----------------------------------------
Q 009291          348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP-----------------------------------------  386 (538)
Q Consensus       348 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-----------------------------------------  386 (538)
                      ++.+.....       ......+..++...|..||...+                                         
T Consensus       106 ~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          106 TAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             EHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             cccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            887765311       11233466677777777775321                                         


Q ss_pred             ---------------CEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          387 ---------------PIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       387 ---------------~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                                     .++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           37999999999999987777899999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.07  E-value=4.1e-06  Score=85.66  Aligned_cols=84  Identities=6%  Similarity=-0.035  Sum_probs=54.5

Q ss_pred             eeEEEEE-ccCCcEEEEEEEEc--------CCceEEEEEecccc-CHHHHHHHHHHHHHHHcCC-C--CceeEeeceecc
Q 009291          267 LLIKKKI-GEGSFGTVYHAEWR--------NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLR-H--PNIVLLMGAVTE  333 (538)
Q Consensus       267 y~i~~~L-G~G~fg~Vy~a~~~--------~~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~-h--pnIv~l~~~~~~  333 (538)
                      ....+.| +.|....+|++...        +..+++|+...... .......+.+|+.+++.+. +  -.+.+++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3446788 89999999998765        45688887543220 0000124567888777763 2  346677777655


Q ss_pred             C---CcceEEEeecCCCChh
Q 009291          334 P---PNLSIVTEYLSRGSLY  350 (538)
Q Consensus       334 ~---~~~~lV~E~~~~gsL~  350 (538)
                      .   ...++||||++|.++.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            4   3468999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.03  E-value=1.4e-05  Score=80.50  Aligned_cols=141  Identities=16%  Similarity=0.103  Sum_probs=78.3

Q ss_pred             EEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC--CCceeEeec------eeccCCcceEEE
Q 009291          270 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMG------AVTEPPNLSIVT  341 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~--hpnIv~l~~------~~~~~~~~~lV~  341 (538)
                      .+.|+.|..+.||++...+..+++|+....   ..   .+..|..+++.|.  .-.|.+++.      +.......+++|
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---EK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EEECC----CEEEEEEETTEEEEEEEECSC---HH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCCCEEEEecCCC---HH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            456777788999999877667899987642   22   2334444444442  112333333      112355678999


Q ss_pred             eecCCCChh-----------hh---hcC--CC---C-C-----ccccHHH------------------------------
Q 009291          342 EYLSRGSLY-----------KL---LHI--PD---A-R-----VVVDERL------------------------------  366 (538)
Q Consensus       342 E~~~~gsL~-----------~~---l~~--~~---~-~-----~~l~~~~------------------------------  366 (538)
                      +|++|.++.           ..   ++.  ..   . .     ....+..                              
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999986542           00   110  00   0 0     0001100                              


Q ss_pred             -HHHHHHHHHHHHHHHHh-----------CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          367 -RLNMAYDVAKGMNYLHQ-----------RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       367 -~~~i~~qi~~aL~~LH~-----------~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                       ...+..++..++++|++           ..+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             11122234446666653           123499999999999998778999999997753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.82  E-value=4.2e-05  Score=79.49  Aligned_cols=77  Identities=17%  Similarity=0.138  Sum_probs=47.6

Q ss_pred             EEEEEccCCcEEEEEEEE--cCCceEEEEEecccc--CH---HHHHHHHHHHHHHHcCCC--C-ceeEeeceeccCCcce
Q 009291          269 IKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEF--HE---DRFKEFLREVAIMKGLRH--P-NIVLLMGAVTEPPNLS  338 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~--~~~~vavK~~~~~~~--~~---~~~~~~~~Ei~il~~L~h--p-nIv~l~~~~~~~~~~~  338 (538)
                      ..+.||.|..+.||++..  .+..+++|.......  ..   .....+..|.++++.+..  + .+.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            367899999999999964  345689997543211  00   012345678888877632  3 34455543  334568


Q ss_pred             EEEeecCCC
Q 009291          339 IVTEYLSRG  347 (538)
Q Consensus       339 lV~E~~~~g  347 (538)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.73  E-value=0.00014  Score=73.44  Aligned_cols=77  Identities=19%  Similarity=0.140  Sum_probs=60.2

Q ss_pred             eEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC---CCceeEeeceeccCCcceEEEeec
Q 009291          268 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIVTEYL  344 (538)
Q Consensus       268 ~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~lV~E~~  344 (538)
                      .-.+.|+.|....+|+....+..+++|+....     ....+.+|...|+.|.   ...|.+++.+.......++||||+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            34678999999999999876667999986543     1346778988888773   356778888877777899999999


Q ss_pred             CCCCh
Q 009291          345 SRGSL  349 (538)
Q Consensus       345 ~~gsL  349 (538)
                      ++..+
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            98764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.46  E-value=0.00025  Score=74.35  Aligned_cols=76  Identities=16%  Similarity=0.157  Sum_probs=46.1

Q ss_pred             CEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccCCC-CCCCcccccccccCCC---CCchhhHHHHHHHHHHHHh
Q 009291          387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA-AGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELIT  462 (538)
Q Consensus       387 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~-~gt~~Y~aPE~l~~~~---~s~ksDVwSLGvil~eLlt  462 (538)
                      .++|+|++|.|||++.++ ++|+||+.+........-.... .-...|++|+......   .....++..+...+|+.++
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  311 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLFN  311 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHHH
Confidence            499999999999998876 9999999887543211000000 0013456666543211   1223455677777887775


Q ss_pred             C
Q 009291          463 L  463 (538)
Q Consensus       463 g  463 (538)
                      +
T Consensus       312 ~  312 (420)
T 2pyw_A          312 K  312 (420)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.39  E-value=0.0011  Score=63.05  Aligned_cols=143  Identities=17%  Similarity=0.205  Sum_probs=96.1

Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHH-hCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccccC
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH-QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK  425 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  425 (538)
                      .+|.++|+..+  .+++|+++|.++.|.+.+|.-+- ...  -..+=+.|..|++..+|.|.+.+ +.+.          
T Consensus        33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence            47888886433  46999999999999999987762 222  12333457899999999988864 1110          


Q ss_pred             CCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhh
Q 009291          426 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA  505 (538)
Q Consensus       426 ~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~  505 (538)
                        .....+.|||... ...+.+.=|||||+++|..+--..|                   ..-+..+|+.+.+||..|..
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~  155 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMAN  155 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHh
Confidence              1123456888763 3457889999999999998853322                   12345789999999999986


Q ss_pred             c-------------------------CCCCCCCHHHHHHHHHHHHh
Q 009291          506 E-------------------------EPEIRPSFPSIMETLQQFLM  526 (538)
Q Consensus       506 ~-------------------------dP~~RPs~~eIl~~L~~il~  526 (538)
                      .                         .+..|+++++|++.=..-+.
T Consensus       156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~  201 (229)
T 2yle_A          156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP  201 (229)
T ss_dssp             CCC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred             cccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence            6                         24578999999876554443

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.34  E-value=0.00039  Score=69.62  Aligned_cols=147  Identities=15%  Similarity=0.158  Sum_probs=80.3

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc--eeEeece------eccCCcc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGA------VTEPPNL  337 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn--Iv~l~~~------~~~~~~~  337 (538)
                      ...-.+.|+.|....+|++...+..+++|+..... .   ...+..|+.+++.|...+  +.+++..      .......
T Consensus        23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            34456788889999999998777779999876421 1   123456677666653212  3333321      1123456


Q ss_pred             eEEEeecCCCChhh-----------h---hcC-----CCCC----ccccHHHHHH------------HHHHHHHHHHHHH
Q 009291          338 SIVTEYLSRGSLYK-----------L---LHI-----PDAR----VVVDERLRLN------------MAYDVAKGMNYLH  382 (538)
Q Consensus       338 ~lV~E~~~~gsL~~-----------~---l~~-----~~~~----~~l~~~~~~~------------i~~qi~~aL~~LH  382 (538)
                      +++++|++|..+..           .   ++.     ....    ....+...+.            +...+...++.++
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            89999998865321           0   111     0000    0001111000            0012344555665


Q ss_pred             hC-----CCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          383 QR-----RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       383 ~~-----~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +.     ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            31     12499999999999998876668999987653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.21  E-value=0.00097  Score=66.35  Aligned_cols=71  Identities=14%  Similarity=0.208  Sum_probs=43.0

Q ss_pred             EEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCce-eEeeceeccCCcceEEEeec-CCC
Q 009291          270 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYL-SRG  347 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnI-v~l~~~~~~~~~~~lV~E~~-~~g  347 (538)
                      .+.|+.|....+|++    ..+++|+.....   .......+|..+++.+...++ .+++++.  ...-++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            678999999999998    678888875421   111122357766666532222 3555443  33347899999 654


Q ss_pred             Ch
Q 009291          348 SL  349 (538)
Q Consensus       348 sL  349 (538)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.07  E-value=0.0027  Score=62.63  Aligned_cols=80  Identities=15%  Similarity=0.088  Sum_probs=54.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCC---CceeEeeceeccCCcceE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH---PNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h---pnIv~l~~~~~~~~~~~l  339 (538)
                      ..+..-.+.+|.|..+.||+++.. ++.+++|+........  ...|.+|...|+.|..   --+.+++++.    .-++
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l   87 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL   87 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred             CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence            345667899999999999999876 4569999854332211  1356789888887742   2344555542    2378


Q ss_pred             EEeecCCCCh
Q 009291          340 VTEYLSRGSL  349 (538)
Q Consensus       340 V~E~~~~gsL  349 (538)
                      ||||+.++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999876543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.94  E-value=0.0015  Score=65.78  Aligned_cols=32  Identities=34%  Similarity=0.370  Sum_probs=27.6

Q ss_pred             CEEeecCCCCCEEEcCC----CcEEEEeeCCCccCC
Q 009291          387 PIVHRDLKSPNLLVDST----YTVKVCDFGLSRSKP  418 (538)
Q Consensus       387 ~iiHrDLKp~NILl~~~----~~vkL~DFGla~~~~  418 (538)
                      .++|+|+.+.|||++.+    +.+.|+||+.+....
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            49999999999999874    689999999887643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.86  E-value=0.0024  Score=67.24  Aligned_cols=73  Identities=16%  Similarity=0.233  Sum_probs=47.6

Q ss_pred             EEEEEccCCcEEEEEEEEc---------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc-eeEeeceeccCCcce
Q 009291          269 IKKKIGEGSFGTVYHAEWR---------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLS  338 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~---------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~~~~~  338 (538)
                      -.+.|+.|....+|++...         +..+++|+..... .   ...+.+|..+++.|...+ ..++++.+.+    .
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            3567888999999999865         2458888873321 1   124457888888774333 3566666543    3


Q ss_pred             EEEeecCCCCh
Q 009291          339 IVTEYLSRGSL  349 (538)
Q Consensus       339 lV~E~~~~gsL  349 (538)
                      +|+||++|.++
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999986443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.66  E-value=0.0053  Score=65.18  Aligned_cols=74  Identities=15%  Similarity=0.058  Sum_probs=46.6

Q ss_pred             EEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCce-eEeeceeccCCcceEEEeecC
Q 009291          269 IKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYLS  345 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnI-v~l~~~~~~~~~~~lV~E~~~  345 (538)
                      -.+.|+.|-...+|++...+  ..+++|+.......   .-.-.+|..+++.|...++ .++++.+..    .+|+||++
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~  184 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMD  184 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeC
Confidence            35678889999999998776  56888886432100   0011478888888864444 466766632    35999998


Q ss_pred             CCCh
Q 009291          346 RGSL  349 (538)
Q Consensus       346 ~gsL  349 (538)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.56  E-value=0.0049  Score=63.85  Aligned_cols=139  Identities=14%  Similarity=0.147  Sum_probs=77.9

Q ss_pred             EEEEccCCcEEEEEEEEcC---------CceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceE
Q 009291          270 KKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~---------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~l  339 (538)
                      .+.|..|-...+|++...+         ..+++|+.-...   .......+|..+++.|. +.-..++++.+.+    .+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            3567778888899987632         458888742211   12345568888888774 2223566666654    39


Q ss_pred             EEeecCCCChhhh-----------------hcCCCC--Cccc--cHHHHHHHHHHHH-------------------HHHH
Q 009291          340 VTEYLSRGSLYKL-----------------LHIPDA--RVVV--DERLRLNMAYDVA-------------------KGMN  379 (538)
Q Consensus       340 V~E~~~~gsL~~~-----------------l~~~~~--~~~l--~~~~~~~i~~qi~-------------------~aL~  379 (538)
                      ||||++|.+|..-                 ++....  ....  -+.++..+..++.                   ..++
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999988554311                 111111  1111  1344444443332                   1233


Q ss_pred             HHH----hCC--CCEEeecCCCCCEEEcCC----CcEEEEeeCCCc
Q 009291          380 YLH----QRR--PPIVHRDLKSPNLLVDST----YTVKVCDFGLSR  415 (538)
Q Consensus       380 ~LH----~~~--~~iiHrDLKp~NILl~~~----~~vkL~DFGla~  415 (538)
                      .|.    ..+  ..++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            332    221  248999999999999876    789999998775

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.48  E-value=0.02  Score=57.19  Aligned_cols=74  Identities=11%  Similarity=0.080  Sum_probs=44.6

Q ss_pred             EEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCC--ceeEeece-----eccCCcceEEEe
Q 009291          271 KKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGA-----VTEPPNLSIVTE  342 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hp--nIv~l~~~-----~~~~~~~~lV~E  342 (538)
                      ..|+ |....||++...+ ..+++|+........   ..+..|..+++.+...  .+.+++..     ...++..+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            4566 8888999887644 369999976332222   2455677777666321  23444443     112344578999


Q ss_pred             ecCCCC
Q 009291          343 YLSRGS  348 (538)
Q Consensus       343 ~~~~gs  348 (538)
                      +++|..
T Consensus       108 ~i~G~~  113 (328)
T 1zyl_A          108 SVGGRQ  113 (328)
T ss_dssp             CCCCEE
T ss_pred             ecCCCC
Confidence            998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.44  E-value=0.011  Score=59.91  Aligned_cols=31  Identities=19%  Similarity=0.344  Sum_probs=27.5

Q ss_pred             CEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       387 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      .++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            4999999999999998888999999887653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.04  E-value=0.015  Score=59.44  Aligned_cols=73  Identities=16%  Similarity=0.236  Sum_probs=41.7

Q ss_pred             EEEEccCCcEEEEEEEEcC----------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc-eeEeeceeccCCcce
Q 009291          270 KKKIGEGSFGTVYHAEWRN----------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLS  338 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~----------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~~~~~  338 (538)
                      .+.|+.|..-.+|++...+          ..+++|+.....   ........|..+++.+...+ +.++++.+.    -+
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence            4678888889999998654          457888754321   11112346777777664223 345555442    37


Q ss_pred             EEEeecCCCCh
Q 009291          339 IVTEYLSRGSL  349 (538)
Q Consensus       339 lV~E~~~~gsL  349 (538)
                      +||||++|.++
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999987543

>3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii}

Probab=95.48  E-value=0.0057  Score=60.99  Aligned_cols=54  Identities=22%  Similarity=0.256  Sum_probs=45.7

Q ss_pred             eccccchhhHHHHHHHhhhcCCCceeecccccC--CCCCCCeEEEEeCCCcchhhhc
Q 009291           37 LSVGLCVHRALLFKVLADLINLPCRIAKGCKYC--RRDDASSCLVQIGPDREYLVDL   91 (538)
Q Consensus        37 ~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~--~~~~~~~~~~~~~~~~~~~~~~   91 (538)
                      -+.|+|++-|.||-+|+-.+|||||+|-|--..  ..+.|+|+-|.++. .++-+|-
T Consensus       176 ~~~G~C~d~A~l~val~Ra~GIPAR~VsGy~~~~~~~~~HAW~Evyl~g-gWv~~Dp  231 (293)
T 3isr_A          176 ERAGVCRDFAHLGIALCRALSIPARYFTGYAFKLNPPDFHACFEAYIGG-NWIIFDA  231 (293)
T ss_dssp             HCEECHHHHHHHHHHHHHHTTCCEEEEEEEETTCSSCCEEEEEEEEETT-EEEEECT
T ss_pred             CCcEehHHHHHHHHHHHHHCCCCEEEEEEECCCCCCCCeEEEEEEEECC-cEEEEEC
Confidence            468999999999999999999999999992221  24789999999987 8877774

>2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A*

Probab=94.76  E-value=0.015  Score=57.65  Aligned_cols=51  Identities=20%  Similarity=0.161  Sum_probs=45.0

Q ss_pred             eccccchhhHHHHHHHhhhcCCCceeecccccCCCCCCCeEEEEeCC-Ccchhhhcc
Q 009291           37 LSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGP-DREYLVDLL   92 (538)
Q Consensus        37 ~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~   92 (538)
                      -+.|.|++-|.||-+|+-.+|||||+|-|  |   +.|+|+-|.++. ..++-||--
T Consensus       138 ~r~G~C~d~A~lf~al~Ra~GIpAR~V~G--y---~~HaW~Evy~~g~~gWv~~Dpt  189 (295)
T 2f4m_A          138 TRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPSQQRWLHCDAC  189 (295)
T ss_dssp             HCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETTTTEEEEEETT
T ss_pred             cCCEeeHHHHHHHHHHHHHCCCCEEEEcC--C---CCEEEEEEEECCCCeEEEEeCC
Confidence            47999999999999999999999999999  4   899999999987 477666643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.23  E-value=0.048  Score=57.22  Aligned_cols=74  Identities=12%  Similarity=0.147  Sum_probs=45.6

Q ss_pred             EEEEEccCCcEEEEEEEEc---------CCceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcce
Q 009291          269 IKKKIGEGSFGTVYHAEWR---------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~---------~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~  338 (538)
                      -++.+..|-...+|++...         +..+++++.....   ...-...+|..+++.+. +.-..++++.+.    -+
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~  146 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EG  146 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence            3566777888999999876         4568888853321   11112246777777663 222345555432    27


Q ss_pred             EEEeecCCCCh
Q 009291          339 IVTEYLSRGSL  349 (538)
Q Consensus       339 lV~E~~~~gsL  349 (538)
                      +|+||++|.+|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.81  E-value=0.44  Score=49.22  Aligned_cols=29  Identities=24%  Similarity=0.395  Sum_probs=24.9

Q ss_pred             EEeecCCCCCEEE------cCCCcEEEEeeCCCcc
Q 009291          388 IVHRDLKSPNLLV------DSTYTVKVCDFGLSRS  416 (538)
Q Consensus       388 iiHrDLKp~NILl------~~~~~vkL~DFGla~~  416 (538)
                      ++|+|+.+.|||+      +++..+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567899999998864

>1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A*

Probab=84.28  E-value=0.54  Score=47.07  Aligned_cols=49  Identities=24%  Similarity=0.224  Sum_probs=41.8

Q ss_pred             eccccchhhHHHHHHHhhhcCCCceeecccccCCCCCCCeEEEEeCCC-cchhhh
Q 009291           37 LSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPD-REYLVD   90 (538)
Q Consensus        37 ~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~-~~~~~~   90 (538)
                      -+.|.|.|=|-||-+|+=.+|+|+|+|-|     ..+|+|+-|..+.. ++.=||
T Consensus       179 tr~G~C~e~A~lF~~llRalGi~aR~V~~-----~~~H~W~EV~~~~~~rWv~vD  228 (335)
T 1x3z_A          179 TRKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFLNRWVHVD  228 (335)
T ss_dssp             HCEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTTTEEEEEE
T ss_pred             hCCcChHHHHHHHHHHHHHCCCCeEEEec-----CCCcEEEEEEECCCCCEEEEC
Confidence            35899999999999999999999999987     47899999988764 554455

>3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503}

Probab=81.89  E-value=0.68  Score=49.51  Aligned_cols=53  Identities=11%  Similarity=0.202  Sum_probs=42.3

Q ss_pred             ccccchhhHHHHHHHhhhcCCCceeeccccc------CC--CCCCCeEEEEeCCCcchhhhc
Q 009291           38 SVGLCVHRALLFKVLADLINLPCRIAKGCKY------CR--RDDASSCLVQIGPDREYLVDL   91 (538)
Q Consensus        38 ~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~------~~--~~~~~~~~~~~~~~~~~~~~~   91 (538)
                      +.|.|+-.|+||.+|+-..||||++|-+.-.      .+  .-.|+.+-|.++ +++|.+|-
T Consensus       283 ~~G~C~d~a~Ll~AllRa~GIpA~~v~~~t~~~~~~~~~lp~~nh~i~~v~~~-g~~y~lDa  343 (506)
T 3kd4_A          283 AYGTPLEIAQLLNVMLNAAGIPSEVLAVYPGHLDTDACGLAAIQTLAVKATVD-GKDQYLSA  343 (506)
T ss_dssp             TEECHHHHHHHHHHHHHHTTCCEEEEEEEETTSCGGGCCSTTCCEEEEEEEET-TEEEEESS
T ss_pred             CCcchHHHHHHHHHHHHHCCCCcEEEEEEcCCCCCccCCCCCCCEEEEEEEEC-CEEEEEec
Confidence            4699999999999999999999999988311      11  226778888875 48999986

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.45  E-value=3.1  Score=39.09  Aligned_cols=116  Identities=9%  Similarity=0.045  Sum_probs=76.1

Q ss_pred             CCCceeEeeceeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEE
Q 009291          320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLL  399 (538)
Q Consensus       320 ~hpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NIL  399 (538)
                      .||+++.. .+-.+++.+.+.++.-.  ....+-..    ...+....+.++.+|+....+++ .   =+|--|.|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~~-~---r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI----KSFTKNEKLRYLLNIKNLEEVNR-T---RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG----GGSCHHHHHHHHHHGGGGGGGGG-S---SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH----HhcCHHHHHHHHHHHHHHHHHhc-C---ceEEEEecceEE
Confidence            58888866 45555566666665443  23333221    13678888899999988875543 2   368889999999


Q ss_pred             EcCCCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 009291          400 VDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR  468 (538)
Q Consensus       400 l~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~  468 (538)
                      ++.++.++|.--|+-..                 ++|.     ..+...=.-.+=|++..+++++..|.
T Consensus       112 f~~~~~p~i~~RGik~~-----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNV-----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTT-----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccC-----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999987765321                 2222     12333334467788889999887764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	538
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-83
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-77
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-74
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-74
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-73
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-72
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-72
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-71
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-71
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-71
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-71
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-70
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-70
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-69
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-69
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-69
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-69
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-68
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-68
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-68
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-67
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-67
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-67
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-66
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-65
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-65
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-65
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-63
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-62
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-60
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-59
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-58
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-58
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-58
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-57
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-56
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-54
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-53
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-53
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-53
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-52
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-51
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-50
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-50
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-49
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-47
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-47
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-46
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-42
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-42
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-41
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-39
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-37
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  258 bits (661), Expect = 2e-83
 Identities = 95/276 (34%), Positives = 155/276 (56%), Gaps = 15/276 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           EI   ++ + ++IG GSFGTVY  +W   DVAVK+L        + + F  EV +++  R
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           H NI+L MG  T  P L+IVT++    SLY  LHI + +   +    +++A   A+GM+Y
Sbjct: 63  HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDY 119

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEV 438
           LH +   I+HRDLKS N+ +    TVK+ DFGL+   S+ +     +  +G+  WMAPEV
Sbjct: 120 LHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 439 LR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL----EIPKN 491
           +R   ++P + +SDV++FG++L+EL+T Q P+ N      I  +  +G       ++  N
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
               +  L+  C  ++ + RP FP I+ +++    S
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (618), Expect = 3e-77
 Identities = 93/267 (34%), Positives = 138/267 (51%), Gaps = 13/267 (4%)

Query: 259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG 318
           G  +   EL + + IG+G FG V   ++R + VAVK +      +     FL E ++M  
Sbjct: 1   GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ----AFLAEASVMTQ 56

Query: 319 LRHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
           LRH N+V L+G + E    L IVTEY+++GSL   L     R V+     L  + DV + 
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEA 115

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           M YL       VHRDL + N+LV      KV DFGL++   +T     T     +W APE
Sbjct: 116 MEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPE 170

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 496
            LRE   + KSDV+SFG++LWE+ +  + P+       V+  V  KG +++ P    P V
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 229

Query: 497 AALIETCWAEEPEIRPSFPSIMETLQQ 523
             +++ CW  +  +RPSF  + E L+ 
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQLEH 256

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (600), Expect = 2e-74
 Identities = 87/270 (32%), Positives = 141/270 (52%), Gaps = 9/270 (3%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           E+    L + +++G G FG V+   +  ++ VAVK L +     D    FL E  +MK L
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQL 65

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           +H  +V L   VT+ P + I+TEY+  GSL   L  P   + +     L+MA  +A+GM 
Sbjct: 66  QHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMA 123

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 438
           ++ +R    +HRDL++ N+LV  T + K+ DFGL+R  + N Y + + A    +W APE 
Sbjct: 124 FIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           +       KSDV+SFG++L E++T  +       +  +     +G R+  P N    +  
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241

Query: 499 LIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
           L+  CW E PE RP+F  +   L+ F  ++
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (600), Expect = 3e-74
 Identities = 84/290 (28%), Positives = 148/290 (51%), Gaps = 21/290 (7%)

Query: 251 RELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRF 306
           ++L+L+ + L I         ++G G+FG+V    +R       VA+K+L +Q   +   
Sbjct: 1   KKLFLKRDNLLI------ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADT 53

Query: 307 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 366
           +E +RE  IM  L +P IV L+G V +   L +V E    G L+K L     R  +    
Sbjct: 54  EEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLV--GKREEIPVSN 110

Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYIS 423
              + + V+ GM YL ++    VHRDL + N+L+ + +  K+ DFGLS+   +  + Y +
Sbjct: 111 VAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168

Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK 482
                   +W APE +     + +SDV+S+GV +WE ++  QKP++     +V++ +  +
Sbjct: 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-Q 227

Query: 483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 532
           G+R+E P    P + AL+  CW  + E RP F ++ + ++    S   + 
Sbjct: 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 2e-73
 Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 9/259 (3%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           +   IG GS+G       ++    +  K L      E   +  + EV +++ L+HPNIV 
Sbjct: 8   VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67

Query: 327 LMGAVTEPPN--LSIVTEYLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYLHQ 383
               + +  N  L IV EY   G L  ++      R  +DE   L +   +   +   H+
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 384 R---RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           R      ++HRDLK  N+ +D    VK+ DFGL+R   +    +K   GTP +M+PE + 
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187

Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
               NEKSD++S G +L+EL  L  P+   +  ++   +  +G+   IP   +  +  +I
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDELNEII 246

Query: 501 ETCWAEEPEIRPSFPSIME 519
                 +   RPS   I+E
Sbjct: 247 TRMLNLKDYHRPSVEEILE 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 4e-72
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 15/277 (5%)

Query: 263 RWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           R    L  K++G G+FGTV    ++       VAVKIL  +        E L E  +M+ 
Sbjct: 5   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64

Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           L +P IV ++G + E  +  +V E    G L K L        V ++  + + + V+ GM
Sbjct: 65  LDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGM 120

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMA 435
            YL +     VHRDL + N+L+ + +  K+ DFGLS+   +  N Y +        +W A
Sbjct: 121 KYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 436 PEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 494
           PE +     + KSDV+SFGV++WE  +  QKP+R    S+V + +  KG R+  P     
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPR 237

Query: 495 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
            +  L+  CW  + E RP F ++   L+ +    V +
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (582), Expect = 6e-72
 Identities = 90/265 (33%), Positives = 136/265 (51%), Gaps = 11/265 (4%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           I   +L   K++G G FG V + +WR   DVA+K++ E    ED   EF+ E  +M  L 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           H  +V L G  T+   + I+TEY++ G L   L     R     +  L M  DV + M Y
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEY 115

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 439
           L  +    +HRDL + N LV+    VKV DFGLSR    + Y SS  +     W  PEVL
Sbjct: 116 LESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 440 REDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
                + KSD+++FGV++WE+ +L K P+   T S+    +  +G RL  P   +  V  
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYT 232

Query: 499 LIETCWAEEPEIRPSFPSIMETLQQ 523
           ++ +CW E+ + RP+F  ++  +  
Sbjct: 233 IMYSCWHEKADERPTFKILLSNILD 257

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (580), Expect = 1e-71
 Identities = 91/269 (33%), Positives = 135/269 (50%), Gaps = 11/269 (4%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLR 320
           I  SEL   ++IG G FG V+   W N D VA+K + E    E   ++F+ E  +M  L 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS 58

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HP +V L G   E   + +V E++  G L   L              L M  DV +GM Y
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAY 116

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVL 439
           L +    ++HRDL + N LV     +KV DFG++R    + Y SS       +W +PEV 
Sbjct: 117 LEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 440 REDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
                + KSDV+SFGV++WE+ +  K P+ N + S+V+  +   G RL  P+  +  V  
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ 233

Query: 499 LIETCWAEEPEIRPSFPSIMETLQQFLMS 527
           ++  CW E PE RP+F  ++  L +   S
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 5e-71
 Identities = 79/261 (30%), Positives = 129/261 (49%), Gaps = 14/261 (5%)

Query: 267 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 324
           L    +IG GSF TVY      +   VA   L +++  +   + F  E  ++KGL+HPNI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 325 VLLMGA----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           V    +    V     + +VTE ++ G+L   L       V+  ++  +    + KG+ +
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127

Query: 381 LHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
           LH R PPI+HRDLK  N+ +   T +VK+ D GL+  K  ++  +K   GTPE+MAPE+ 
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMY 185

Query: 440 REDPSNEKSDVFSFGVILWELITLQKPWRNS-TPSQVISAVGFKGRRLEIPKNVNPMVAA 498
            E   +E  DV++FG+ + E+ T + P+      +Q+   V    +     K   P V  
Sbjct: 186 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244

Query: 499 LIETCWAEEPEIRPSFPSIME 519
           +IE C  +  + R S   ++ 
Sbjct: 245 IIEGCIRQNKDERYSIKDLLN 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (581), Expect = 5e-71
 Identities = 89/293 (30%), Positives = 133/293 (45%), Gaps = 34/293 (11%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
           E     L   K +G G+FG V +A             VAVK+L E+    +R +  + E+
Sbjct: 33  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-EALMSEL 91

Query: 314 AIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH------------------ 354
            +M  L  H NIV L+GA T    + ++ EY   G L   L                   
Sbjct: 92  KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 355 --IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 412
               +   V+     L  AY VAKGM +L  +    VHRDL + N+LV     VK+CDFG
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFG 209

Query: 413 LSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRN 469
           L+R     + Y+    A    +WMAPE L E     KSDV+S+G++LWE+ +L   P+  
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269

Query: 470 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 522
                    +   G +++ P      +  ++++CWA +   RPSFP++   L 
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  226 bits (577), Expect = 9e-71
 Identities = 89/276 (32%), Positives = 140/276 (50%), Gaps = 17/276 (6%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 315
           EI  S + I++ IG G FG V     +        VA+K L +  + E + ++FL E +I
Sbjct: 22  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASI 80

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M    HPN++ L G VT+   + I+TE++  GSL   L   D +        + M   +A
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIA 138

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-----TYISSKTAAGT 430
            GM YL       VHRDL + N+LV+S    KV DFGLSR   +     TY S+      
Sbjct: 139 AGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 431 PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIP 489
             W APE ++       SDV+S+G+++WE+++  ++P+ + T   VI+A+  +  RL  P
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP 255

Query: 490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
            +    +  L+  CW ++   RP F  I+ TL + +
Sbjct: 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  224 bits (572), Expect = 4e-70
 Identities = 94/271 (34%), Positives = 138/271 (50%), Gaps = 9/271 (3%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+  +++ +K K+G G +G VY   W+     VAVK L E        +EFL+E A+MK 
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKE 69

Query: 319 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           ++HPN+V L+G  T  P   I+TE+++ G+L   L   + R  V   + L MA  ++  M
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 128

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP-NTYISSKTAAGTPEWMAPE 437
            YL   +   +HRDL + N LV   + VKV DFGLSR    +TY +   A    +W APE
Sbjct: 129 EYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
            L  +  + KSDV++FGV+LWE+ T             +  +  K  R+E P+     V 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246

Query: 498 ALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
            L+  CW   P  RPSF  I +  +     S
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 8e-70
 Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 14/259 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I  ++G+G+FG VY A+ + +    A K++  +   E+  ++++ E+ I+    HPNIV 
Sbjct: 16  IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVK 73

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L+ A     NL I+ E+ + G++  ++   +    + E     +       +NYLH  + 
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHDNK- 130

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-----RE 441
            I+HRDLK+ N+L      +K+ DFG+S     T     +  GTP WMAPEV+     ++
Sbjct: 131 -IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 442 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALI 500
            P + K+DV+S G+ L E+  ++ P     P +V+  +       L  P   +      +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249

Query: 501 ETCWAEEPEIRPSFPSIME 519
           + C  +  + R +   +++
Sbjct: 250 KKCLEKNVDARWTTSQLLQ 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 1e-69
 Identities = 91/284 (32%), Positives = 140/284 (49%), Gaps = 24/284 (8%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIM 316
            + W+++  +  IGEG+FG V  A  +      D A+K  +++   +D  ++F  E+ ++
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 64

Query: 317 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------------IPDARVVV 362
             L  HPNI+ L+GA      L +  EY   G+L   L                     +
Sbjct: 65  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 363 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 422
             +  L+ A DVA+GM+YL Q     +HRDL + N+LV   Y  K+ DFGLSR     Y+
Sbjct: 125 SSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181

Query: 423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGF 481
                     WMA E L        SDV+S+GV+LWE+++L   P+   T +++   +  
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240

Query: 482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           +G RLE P N +  V  L+  CW E+P  RPSF  I+ +L + L
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (568), Expect = 1e-69
 Identities = 90/270 (33%), Positives = 137/270 (50%), Gaps = 9/270 (3%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGL 319
           EI    L ++ K+G+G FG V+   W  +  VA+K L          + FL+E  +MK L
Sbjct: 13  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKL 69

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 379
           RH  +V L   V+E P + IVTEY+S+GSL   L     + +      ++MA  +A GM 
Sbjct: 70  RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMA 127

Query: 380 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 438
           Y+ +     VHRDL++ N+LV      KV DFGL+R  + N Y + + A    +W APE 
Sbjct: 128 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
                   KSDV+SFG++L EL T  +       ++ +     +G R+  P      +  
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245

Query: 499 LIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
           L+  CW +EPE RP+F  +   L+ +  S+
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 2e-69
 Identities = 72/262 (27%), Positives = 126/262 (48%), Gaps = 14/262 (5%)

Query: 263 RWS--ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMK 317
           +W+  +  I + +G+G FG VY A  + S   +A+K+L + +  +     +  REV I  
Sbjct: 2   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
            LRHPNI+ L G   +   + ++ EY   G++Y+ L         DE+       ++A  
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 118

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           ++Y H +R  ++HRD+K  NLL+ S   +K+ DFG S   P++     T  GT +++ PE
Sbjct: 119 LSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPE 174

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
           ++     +EK D++S GV+ +E +  + P+  +T  +    +         P  V     
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGAR 232

Query: 498 ALIETCWAEEPEIRPSFPSIME 519
            LI       P  RP    ++E
Sbjct: 233 DLISRLLKHNPSQRPMLREVLE 254

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 2e-69
 Identities = 92/272 (33%), Positives = 137/272 (50%), Gaps = 15/272 (5%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRF-KEFLREVAI 315
           I   +L + +K+G+GSFG V   EW         VAVK L      +     +F+REV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M  L H N++ L G V  PP + +VTE    GSL   L       ++    R   A  VA
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVA 121

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPE 432
           +GM YL  +R   +HRDL + NLL+ +   VK+ DFGL R+ P   + Y+  +       
Sbjct: 122 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 433 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 491
           W APE L+    +  SD + FGV LWE+ T  + PW     SQ++  +  +G RL  P++
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 523
               +  ++  CWA +PE RP+F ++ + L +
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 3e-68
 Identities = 84/276 (30%), Positives = 128/276 (46%), Gaps = 14/276 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVA 314
           EI  S +  +K IG G FG VY    + S       VA+K L +  + E +  +FL E  
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAG 61

Query: 315 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 374
           IM    H NI+ L G +++   + I+TEY+  G+L K   + +          + M   +
Sbjct: 62  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGI 119

Query: 375 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT---AAGTP 431
           A GM YL       VHRDL + N+LV+S    KV DFGLSR   +   ++ T        
Sbjct: 120 AAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 491
            W APE +        SDV+SFG+++WE++T  +       +  +      G RL  P +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237

Query: 492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 527
               +  L+  CW +E   RP F  I+  L + + +
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 6e-68
 Identities = 86/272 (31%), Positives = 135/272 (49%), Gaps = 14/272 (5%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 315
           EI+   + + + IGEG FG V+   + + +     VA+K          R ++FL+E   
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALT 61

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M+   HP+IV L+G +TE   + I+ E  + G L   L +    +  D    +  AY ++
Sbjct: 62  MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLS 118

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWM 434
             + YL  +R   VHRD+ + N+LV S   VK+ DFGLSR  + +TY  +       +WM
Sbjct: 119 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           APE +        SDV+ FGV +WE++     P++    + VI  +   G RL +P N  
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 235

Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
           P + +L+  CWA +P  RP F  +   L   L
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  218 bits (557), Expect = 8e-68
 Identities = 92/301 (30%), Positives = 138/301 (45%), Gaps = 35/301 (11%)

Query: 256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKE 308
           +   LE   + +   + IGEG+FG V+ A             VAVK+L ++E   D   +
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQAD 62

Query: 309 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------------- 354
           F RE A+M    +PNIV L+G       + ++ EY++ G L + L               
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 355 -------IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 407
                         +    +L +A  VA GM YL +R+   VHRDL + N LV     VK
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVK 180

Query: 408 VCDFGLSRSKP--NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK 465
           + DFGLSR+    + Y +    A    WM PE +  +    +SDV+++GV+LWE+ +   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 466 -PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 524
            P+      +VI  V   G  L  P+N    +  L+  CW++ P  RPSF SI   LQ+ 
Sbjct: 241 QPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

Query: 525 L 525
            
Sbjct: 300 C 300

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 1e-67
 Identities = 91/292 (31%), Positives = 136/292 (46%), Gaps = 17/292 (5%)

Query: 246 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 298
           +S  N EL    + + I  S L++   + IG G FG VYH    ++D      AVK L  
Sbjct: 6   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 64

Query: 299 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPD 357
           +        +FL E  IMK   HPN++ L+G          +V  Y+  G L   +    
Sbjct: 65  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124

Query: 358 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-- 415
               V + +       VAKGM +L       VHRDL + N ++D  +TVKV DFGL+R  
Sbjct: 125 HNPTVKDLIG--FGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 416 --SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 473
              + ++  +   A    +WMA E L+      KSDV+SFGV+LWEL+T   P      +
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240

Query: 474 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
             I+    +GRRL  P+     +  ++  CW  + E+RPSF  ++  +    
Sbjct: 241 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 2e-67
 Identities = 83/294 (28%), Positives = 136/294 (46%), Gaps = 29/294 (9%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
           E   + L   K +G G+FG V  A             VAVK+ ++   H    +  + E+
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77

Query: 314 AIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH---------------IPD 357
            ++  L  H NIV L+GA T      ++TEY   G L   L                + D
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 358 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-- 415
             + +D    L+ +Y VAKGM +L  +    +HRDL + N+L+      K+CDFGL+R  
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-Q 474
              + Y+    A    +WMAPE +       +SDV+S+G+ LWEL +L        P   
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255

Query: 475 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
               +  +G R+  P++    +  +++TCW  +P  RP+F  I++ +++ +  S
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 2e-67
 Identities = 68/254 (26%), Positives = 125/254 (49%), Gaps = 11/254 (4%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
             +KIG+G+ GTVY A    +   VA++ +  Q   + + +  + E+ +M+  ++PNIV 
Sbjct: 24  RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVN 81

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            + +      L +V EYL+ GSL  ++        +DE     +  +  + + +LH  + 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ- 136

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 446
            ++HRD+KS N+L+    +VK+ DFG             T  GTP WMAPEV+       
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 505
           K D++S G++  E+I  + P+ N  P + +  +   G   L+ P+ ++ +    +  C  
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 506 EEPEIRPSFPSIME 519
            + E R S   +++
Sbjct: 256 MDVEKRGSAKELLQ 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  215 bits (548), Expect = 3e-66
 Identities = 63/257 (24%), Positives = 114/257 (44%), Gaps = 15/257 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
             ++IG GSFG VY A    +   VA+K +    +   +++++ ++EV  ++ LRHPN +
Sbjct: 19  DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
              G         +V EY    +   L      +  + E     + +   +G+ YLH   
Sbjct: 79  QYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN 135

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR---ED 442
             ++HRD+K+ N+L+     VK+ DFG +           +  GTP WMAPEV+    E 
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEG 189

Query: 443 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 502
             + K DV+S G+   EL   + P  N      +  +           + +      +++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249

Query: 503 CWAEEPEIRPSFPSIME 519
           C  + P+ RP+   +++
Sbjct: 250 CLQKIPQDRPTSEVLLK 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 1e-65
 Identities = 88/301 (29%), Positives = 151/301 (50%), Gaps = 22/301 (7%)

Query: 249 SNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEF 301
           S  ++Y+ +E  E+   ++ + +++G+GSFG VY    +          VA+K + E   
Sbjct: 5   SAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63

Query: 302 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---- 357
             +R  EFL E ++MK     ++V L+G V++     ++ E ++RG L   L        
Sbjct: 64  MRER-IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122

Query: 358 ---ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 414
                        + MA ++A GM YL+      VHRDL + N +V   +TVK+ DFG++
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMT 180

Query: 415 R--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNST 471
           R   + + Y           WM+PE L++      SDV+SFGV+LWE+ TL + P++  +
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240

Query: 472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 531
             QV+  V  +G  L+ P N   M+  L+  CW   P++RPSF  I+ ++++ +     +
Sbjct: 241 NEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

Query: 532 P 532
            
Sbjct: 300 V 300

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 1e-65
 Identities = 80/272 (29%), Positives = 132/272 (48%), Gaps = 14/272 (5%)

Query: 262 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 315
           ++ +E    K +G G+FGTVY   W          VA+K L E    +   KE L E  +
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 64

Query: 316 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 375
           M  + +P++  L+G       + ++T+ +  G L  L ++ + +  +  +  LN    +A
Sbjct: 65  MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIA 121

Query: 376 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEW 433
           KGMNYL  RR  +VHRDL + N+LV +   VK+ DFGL++          ++      +W
Sbjct: 122 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 434 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 493
           MA E +       +SDV+S+GV +WEL+T      +  P+  IS++  KG RL  P    
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239

Query: 494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
             V  ++  CW  + + RP F  ++    +  
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 4e-65
 Identities = 62/258 (24%), Positives = 117/258 (45%), Gaps = 11/258 (4%)

Query: 260 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMK 317
           +E++  +     ++G G+ G V+    + S   +A K+ I  E       + +RE+ ++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLH 59

Query: 318 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
               P IV   GA      +SI  E++  GSL ++L        + E++   ++  V KG
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKG 116

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           + YL ++   I+HRD+K  N+LV+S   +K+CDFG+S    ++   + +  GT  +M+PE
Sbjct: 117 LTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPE 173

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 497
            L+    + +SD++S G+ L E+   + P       ++     F  +         P   
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDAAETPPRPR 231

Query: 498 ALIETCWAEEPEIRPSFP 515
                  +   + RP   
Sbjct: 232 TPGRPLSSYGMDSRPPMA 249

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 8e-65
 Identities = 89/294 (30%), Positives = 148/294 (50%), Gaps = 29/294 (9%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLR 311
           E+    L++ K +GEG+FG V  AE    D         VAVK+L + +  E    + + 
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS 67

Query: 312 EVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI-------------PD 357
           E+ +MK + +H NI+ L+GA T+   L ++ EY S+G+L + L                +
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 358 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-- 415
               +  +  ++ AY VA+GM YL  +    +HRDL + N+LV     +K+ DFGL+R  
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 475
              + Y  +       +WMAPE L +     +SDV+SFGV+LWE+ TL        P + 
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245

Query: 476 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL-MSS 528
           +  +  +G R++ P N    +  ++  CW   P  RP+F  ++E L + + ++S
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 3e-63
 Identities = 74/257 (28%), Positives = 117/257 (45%), Gaps = 12/257 (4%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + + +GEG++G V  A  R ++  VAVKI ++ +   D  +   +E+ I K L H N+V 
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 67

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
             G   E     +  EY S G L+  +      + + E       + +  G+ YLH    
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG- 123

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDP- 443
            I HRD+K  NLL+D    +K+ DFGL+      N         GT  ++APE+L+    
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIET 502
             E  DV+S G++L  ++  + PW   + S Q  S    K   L   K ++    AL+  
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242

Query: 503 CWAEEPEIRPSFPSIME 519
              E P  R + P I +
Sbjct: 243 ILVENPSARITIPDIKK 259

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 6e-63
 Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 47/298 (15%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
            +++++ IG+G FG V+  +WR  +VAVKI   +E   +R      E+     LRH NI+
Sbjct: 4   TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENIL 60

Query: 326 LLMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
             + A  +       L +V++Y   GSL+  L+    R  V     + +A   A G+ +L
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHL 116

Query: 382 HQ------RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR----SKPNTYISSKTAAGTP 431
           H        +P I HRDLKS N+LV    T  + D GL+     +     I+     GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 432 EWMAPEVLRED------PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----------- 474
            +MAPEVL +        S +++D+++ G++ WE+             Q           
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 475 ----VISAVGFKGRRLEIPKNVNPM-----VAALIETCWAEEPEIRPSFPSIMETLQQ 523
               +   V  +  R  IP           +A ++  CW      R +   I +TL Q
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 7e-62
 Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 26/292 (8%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 313
           E     L + K +G G+FG V  A+    D       VAVK+L E   H +         
Sbjct: 9   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68

Query: 314 AIMKGLRHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLH-------------IPDAR 359
            ++    H N+V L+GA T+P   L ++ E+   G+L   L                  +
Sbjct: 69  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128

Query: 360 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SK 417
             +     +  ++ VAKGM +L  R+   +HRDL + N+L+     VK+CDFGL+R   K
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVI 476
              Y+    A    +WMAPE + +     +SDV+SFGV+LWE+ +L   P+      +  
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246

Query: 477 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
                +G R+  P    P +   +  CW  EP  RP+F  ++E L   L ++
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 6e-60
 Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 12/255 (4%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
             K +GEGSF TV  A    +    A+KIL       E++     RE  +M  L HP  V
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L     +   L     Y   G L K +    +    DE        ++   + YLH   
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH--G 126

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDP 443
             I+HRDLK  N+L++    +++ DFG ++  S  +    + +  GT ++++PE+L E  
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 503
           + + SD+++ G I+++L+    P+R      +   +       + P+   P    L+E  
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVEKL 244

Query: 504 WAEEPEIRPSFPSIM 518
              +   R     + 
Sbjct: 245 LVLDATKRLGCEEME 259

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  197 bits (503), Expect = 3e-59
 Identities = 62/257 (24%), Positives = 114/257 (44%), Gaps = 13/257 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I +++G G+FG V+    R +    A K ++    HE   +   +E+  M  LRHP +V 
Sbjct: 30  IHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVN 87

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  A  +   + ++ E++S G L++   + D    + E   +     V KG+ ++H+   
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144

Query: 387 PIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
             VH DLK  N++  +  +  +K+ DFGL+    +   S K   GT E+ APEV    P 
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEGKPV 202

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAALIET 502
              +D++S GV+ + L++   P+      + +  V      +       ++      I  
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262

Query: 503 CWAEEPEIRPSFPSIME 519
               +P  R +    +E
Sbjct: 263 LLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  196 bits (500), Expect = 1e-58
 Identities = 60/257 (23%), Positives = 118/257 (45%), Gaps = 13/257 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I +++G G+FG V+    + +      K  I   +  D+      E++IM  L HP ++ 
Sbjct: 33  ILEELGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDK-YTVKNEISIMNQLHHPKLIN 90

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  A  +   + ++ E+LS G L+  +   D +  + E   +N      +G+ ++H+   
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHEHS- 147

Query: 387 PIVHRDLKSPNLLVDSTY--TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
            IVH D+K  N++ ++    +VK+ DFGL+       I   T   T E+ APE++  +P 
Sbjct: 148 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEIVDREPV 205

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAALIET 502
              +D+++ GV+ + L++   P+      + +  V         +   +V+P     I+ 
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265

Query: 503 CWAEEPEIRPSFPSIME 519
              +EP  R +    +E
Sbjct: 266 LLQKEPRKRLTVHDALE 282

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  194 bits (494), Expect = 2e-58
 Identities = 69/258 (26%), Positives = 122/258 (47%), Gaps = 14/258 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
            +  +G G+F  V  AE + +   VA+K  I ++  E +      E+A++  ++HPNIV 
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHPNIVA 71

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L        +L ++ + +S G L+  +     +    ER    + + V   + YLH    
Sbjct: 72  LDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD--L 126

Query: 387 PIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 443
            IVHRDLK  NLL    D    + + DFGLS+ +    + S TA GTP ++APEVL + P
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQKP 185

Query: 444 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIE 501
            ++  D +S GVI + L+    P+ +   +++   +       + P   +++      I 
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245

Query: 502 TCWAEEPEIRPSFPSIME 519
               ++PE R +    ++
Sbjct: 246 HLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 7e-58
 Identities = 52/257 (20%), Positives = 118/257 (45%), Gaps = 14/257 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           I + +G G FG V+     +S      K +  +   +   K   +E++I+   RH NI+ 
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILH 65

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L  +      L ++ E++S   +++ ++   +   ++ER  ++  + V + + +LH    
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSHN- 122

Query: 387 PIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
            I H D++  N++  +  + T+K+ +FG +R       + +     PE+ APEV + D  
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVV 180

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAALIET 502
           +  +D++S G +++ L++   P+   T  Q+I  +         E  K ++      ++ 
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 503 CWAEEPEIRPSFPSIME 519
              +E + R +    ++
Sbjct: 241 LLVKERKSRMTASEALQ 257

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-57
 Identities = 66/252 (26%), Positives = 118/252 (46%), Gaps = 11/252 (4%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIM-KGLRHPNI 324
           + K +G+GSFG V+ AE++ ++   A+K L  +    +D  +  + E  ++     HP +
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 384
             +        NL  V EYL+ G L   +    +    D       A ++  G+ +LH +
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 385 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 444
              IV+RDLK  N+L+D    +K+ DFG+ +        + T  GTP+++APE+L     
Sbjct: 123 G--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 445 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 504
           N   D +SFGV+L+E++  Q P+      ++  ++  +      P+ +      L+   +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVKLF 238

Query: 505 AEEPEIRPSFPS 516
             EPE R     
Sbjct: 239 VREPEKRLGVRG 250

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  187 bits (477), Expect = 3e-56
 Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 26/277 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-------IEQEFHEDRFKEFLREVAIMKGL 319
            K+ +G G    V     + +    AVKI+          E  ++  +  L+EV I++ +
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 320 R-HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
             HPNI+ L           +V + + +G L+  L     +V + E+    +   + + +
Sbjct: 67  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVI 123

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
             LH+    IVHRDLK  N+L+D    +K+ DFG S          +   GTP ++APE+
Sbjct: 124 CALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEI 180

Query: 439 LREDPS------NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--K 490
           +    +       ++ D++S GVI++ L+    P+ +     ++  +     +   P   
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFL 525
           + +  V  L+      +P+ R +    +     QQ++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  184 bits (468), Expect = 1e-54
 Identities = 60/260 (23%), Positives = 116/260 (44%), Gaps = 15/260 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIV 325
           I + +G GSFG V+    R++    A+K+L ++     +  E    E  ++  + HP I+
Sbjct: 8   ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            + G   +   + ++ +Y+      +L  +          +    A +V   + YLH   
Sbjct: 68  RMWGTFQDAQQIFMIMDYIEG---GELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH--S 122

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             I++RDLK  N+L+D    +K+ DFG ++  P+      T  GTP+++APEV+   P N
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPYN 179

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
           +  D +SFG++++E++    P+ +S   +    +      L  P   N  V  L+     
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRLIT 237

Query: 506 EEPEIRPSFPSIMETLQQFL 525
            +   R    ++    +   
Sbjct: 238 RDLSQRL--GNLQNGTEDVK 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  180 bits (458), Expect = 1e-53
 Identities = 65/257 (25%), Positives = 115/257 (44%), Gaps = 17/257 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 325
           + + +G G    V+ A        VAVK+L      +  F   F RE      L HP IV
Sbjct: 11  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 326 LLMGAVTEPPNLS----IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
            +               IV EY+   +L  ++H       +  +  + +  D  + +N+ 
Sbjct: 71  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFS 127

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEV 438
           HQ    I+HRD+K  N+++ +T  VKV DFG++R      N+   +    GT ++++PE 
Sbjct: 128 HQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMV 496
            R D  + +SDV+S G +L+E++T + P+   +P  V      +         + ++  +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245

Query: 497 AALIETCWAEEPEIRPS 513
            A++    A+ PE R  
Sbjct: 246 DAVVLKALAKNPENRYQ 262

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-53
 Identities = 64/260 (24%), Positives = 118/260 (45%), Gaps = 12/260 (4%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV 325
             K +G+G+FG V     + +    A+KIL  E    +D     + E  +++  RHP + 
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L  A      L  V EY + G L+  L       V  E        ++   + YLH   
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH--S 123

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             +V+RD+K  NL++D    +K+ DFGL +   +   + KT  GTPE++APEVL ++   
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
              D +  GV+++E++  + P+ N    ++   +      +  P+ ++P   +L+     
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGLLK 241

Query: 506 EEPEIRPSFPSIMETLQQFL 525
           ++P+ R          ++ +
Sbjct: 242 KDPKQRLG--GGPSDAKEVM 259

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  181 bits (460), Expect = 9e-53
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 15/253 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHP 322
           + + IG G FG VY     ++    A+K L    I+ +  E         ++++     P
Sbjct: 8   VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
            IV +  A   P  LS + + ++ G L+  L       V  E      A ++  G+ ++H
Sbjct: 68  FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMH 124

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 442
            R   +V+RDLK  N+L+D    V++ D GL+            + GT  +MAPEVL++ 
Sbjct: 125 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKG 180

Query: 443 -PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS-AVGFKGRRLEIPKNVNPMVAALI 500
              +  +D FS G +L++L+    P+R                  +E+P + +P + +L+
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240

Query: 501 ETCWAEEPEIRPS 513
           E     +   R  
Sbjct: 241 EGLLQRDVNRRLG 253

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-52
 Identities = 62/283 (21%), Positives = 120/283 (42%), Gaps = 25/283 (8%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHP 322
             +++G G F  V     +++    A K +     +        ++  REV+I+K ++HP
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73

Query: 323 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           N++ L        ++ ++ E ++ G L+        +  + E         +  G+ YLH
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 383 QRRPPIVHRDLKSPNLLVDS----TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
                I H DLK  N+++         +K+ DFGL+          K   GTPE++APE+
Sbjct: 131 SL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEI 187

Query: 439 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMV 496
           +  +P   ++D++S GVI + L++   P+   T  + ++ V         E   N + + 
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247

Query: 497 AALIETCWAEEPEIRPSFPSIME-------TLQQFLMSSVCQP 532
              I     ++P+ R +    ++         QQ L S+   P
Sbjct: 248 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHP 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (447), Expect = 1e-51
 Identities = 48/278 (17%), Positives = 97/278 (34%), Gaps = 26/278 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + +KIG GSFG +Y      +   VA+K+   +  H     +   E  I K ++    + 
Sbjct: 11  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIP 66

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            +       + +++   L   SL  L +    +     +  L +A  +   + Y+H +  
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHSKN- 123

Query: 387 PIVHRDLKSPNLLVDST---YTVKVCDFGLSR-------SKPNTYISSKTAAGTPEWMAP 436
             +HRD+K  N L+        V + DFGL++        +   Y  +K   GT  + + 
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 437 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------GFKGRRLEIPK 490
                   + + D+ S G +L        PW+    +                    + K
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242

Query: 491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 528
                 A  +  C +   + +P +  + +  +      
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-50
 Identities = 66/282 (23%), Positives = 116/282 (41%), Gaps = 32/282 (11%)

Query: 259 GLEIRWSELL-----IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR 311
           GL+I+ + ++       + +G G  G V     + +    A+K+L           +  R
Sbjct: 1   GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARR 53

Query: 312 EVAIM-KGLRHPNIVLLMGA----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 366
           EV +  +  + P+IV ++            L IV E L  G L+  +     +    ER 
Sbjct: 54  EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TERE 112

Query: 367 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYIS 423
              +   + + + YLH     I HRD+K  NLL  S      +K+ DFG ++   +   S
Sbjct: 113 ASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-S 169

Query: 424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 483
             T   TP ++APEVL  +  ++  D++S GVI++ L+    P+ ++    +   +  + 
Sbjct: 170 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229

Query: 484 RRLEI------PKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
           R  +          V+  V  LI      EP  R +    M 
Sbjct: 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 4e-50
 Identities = 54/261 (20%), Positives = 102/261 (39%), Gaps = 24/261 (9%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLR-- 320
           +   +G G FG+VY     + +  VA+K +    I              EV ++K +   
Sbjct: 8   VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
              ++ L+     P +  ++ E         L      R  + E L  +  + V + + +
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQD--LFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 381 LHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 439
            H     ++HRD+K  N+L+D +   +K+ DFG      +T        GT  +  PE +
Sbjct: 126 CHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 181

Query: 440 REDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 498
           R        + V+S G++L++++    P+ +               ++   + V+     
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--------GQVFFRQRVSSECQH 233

Query: 499 LIETCWAEEPEIRPSFPSIME 519
           LI  C A  P  RP+F  I  
Sbjct: 234 LIRWCLALRPSDRPTFEEIQN 254

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  168 bits (427), Expect = 7e-49
 Identities = 44/277 (15%), Positives = 93/277 (33%), Gaps = 28/277 (10%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + ++IGEGSFG ++      ++  VA+K    +        +   E    K L     + 
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIP 64

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
            +    +    +++   L   SL  LL +   +  V        A  +   +  +H++  
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIHEKS- 121

Query: 387 PIVHRDLKSPNLLVDSTYT-----VKVCDFGLSR-------SKPNTYISSKTAAGTPEWM 434
            +V+RD+K  N L+    +     + V DFG+ +        +   Y   K  +GT  +M
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 435 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV------ISAVGFKGRRLEI 488
           +         + + D+ + G +    +    PW+    +        I          E+
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 489 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 525
                      +        +  P +  +     + L
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (422), Expect = 1e-47
 Identities = 64/260 (24%), Positives = 115/260 (44%), Gaps = 15/260 (5%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIV 325
             K +G GSFG V   + + S    A+KIL +Q+  + +  E  L E  I++ +  P +V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104

Query: 326 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 385
            L  +  +  NL +V EY++ G ++  L          E      A  +     YLH   
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 386 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 445
             +++RDLK  NLL+D    ++V DFG ++          T  GTPE +APE++     N
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKGYN 216

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 505
           +  D ++ GV+++E+     P+    P Q+   +     ++  P + +  +  L+     
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQ 274

Query: 506 EEPEIRPSFPSIMETLQQFL 525
            +   R  F ++   +    
Sbjct: 275 VDLTKR--FGNLKNGVNDIK 292

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-47
 Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 41/287 (14%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGL---RHP 322
              +IGEG++G V+ A    +    VA+K +  Q   E      +REVA+++ L    HP
Sbjct: 11  CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70

Query: 323 NIVLLMGAVTEPPN-----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 377
           N+V L    T         L++V E++ +     L  +P+  V        +M + + +G
Sbjct: 71  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV--PTETIKDMMFQLLRG 128

Query: 378 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 437
           +++LH  R  +VHRDLK  N+LV S+  +K+ DFGL+R   +  ++  +   T  + APE
Sbjct: 129 LDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPE 185

Query: 438 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------------------ 479
           VL +       D++S G I  E+   +  +R S+    +  +                  
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 480 -------GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
                         +   +++ +   L+  C    P  R S  S + 
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 3e-47
 Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 39/286 (13%)

Query: 266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLR 320
           E L    +GEG F TVY A  +N++  VA+K +      E  +   +  LRE+ +++ L 
Sbjct: 1   EKL--DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 58

Query: 321 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           HPNI+ L+ A     N+S+V +++        + I D  +V+             +G+ Y
Sbjct: 59  HPNIIGLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           LHQ    I+HRDLK  NLL+D    +K+ DFGL++S  +   +      T  + APE+L 
Sbjct: 116 LHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 441 EDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-------------------- 479
                    D+++ G IL EL+         +    ++ +                    
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 480 -----GFKGRRL-EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
                 F G  L  I       +  LI+  +   P  R +    ++
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  163 bits (414), Expect = 4e-47
 Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 34/280 (12%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 327
             +KIGEG++G VY A+    +  A+K +  ++  E      +RE++I+K L+H NIV L
Sbjct: 6   GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 328 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 387
              +     L +V E+L +     L         ++     +    +  G+ Y H RR  
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR-- 120

Query: 388 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NE 446
           ++HRDLK  NLL++    +K+ DFGL+R+             T  + AP+VL      + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 447 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV--------------------------- 479
             D++S G I  E++     +   + +  +  +                           
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 480 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
                     K ++     L+      +P  R +    +E
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 2e-46
 Identities = 58/281 (20%), Positives = 115/281 (40%), Gaps = 34/281 (12%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
             +KIGEG++G VY A  + +   VA+K +      E      +RE++++K L HPNIV 
Sbjct: 6   KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L+  +     L +V E+L +     +       + +         + + +G+ + H    
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH-- 121

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP-SN 445
            ++HRDLK  NLL+++   +K+ DFGL+R+      +      T  + APE+L      +
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-------------------------- 479
              D++S G I  E++T +  +   +    +  +                          
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 480 -GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
              +    ++   ++    +L+      +P  R S  + + 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-43
 Identities = 59/295 (20%), Positives = 98/295 (33%), Gaps = 47/295 (15%)

Query: 261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 318
           E+ +++    K IG GSFG VY A+  +S   VA+K +++ +      +   RE+ IM+ 
Sbjct: 19  EVSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRK 69

Query: 319 LRHPNIVLLMGAVTEP------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 372
           L H NIV L               L++V +Y+         H   A+  +         Y
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129

Query: 373 DVAKGMNYLHQRRPPIVHRDLK-SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 431
            + + + Y+H     I HRD+K    LL   T  +K+CDFG ++       +        
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187

Query: 432 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------------ 479
                 +          DV+S G +L EL+  Q  +   +    +  +            
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247

Query: 480 ---------------GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
                                        P   AL        P  R +      
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 6e-43
 Identities = 62/290 (21%), Positives = 109/290 (37%), Gaps = 46/290 (15%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
               IGEG++G V  A    +   VA+K +   E H+   +  LRE+ I+   RH NI+ 
Sbjct: 12  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIG 70

Query: 327 LMGAVTEPP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 382
           +   +  P         +  +L    LYKLL        +         Y + +G+ Y+H
Sbjct: 71  INDIIRAPTIEQMKDVYLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIH 126

Query: 383 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVL 439
                ++HRDLK  NLL+++T  +K+CDFGL+R      +          T  + APE++
Sbjct: 127 SAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 440 -REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------------------- 479
                  +  D++S G IL E+++ +  +        ++ +                   
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 480 ----------GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
                       K     +  N +     L++      P  R      + 
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-42
 Identities = 58/270 (21%), Positives = 118/270 (43%), Gaps = 20/270 (7%)

Query: 269 IKKKIGEGSFGTVYHAE-----WRNSDVAVKILIEQEFHEDR--FKEFLREVAIMKGLRH 321
           + K +G G++G V+              A+K+L +    +     +    E  +++ +R 
Sbjct: 28  LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87

Query: 322 -PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
            P +V L  A      L ++ +Y++ G L+  L     R    E        ++   + +
Sbjct: 88  SPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEH 144

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 439
           LH+    I++RD+K  N+L+DS   V + DFGLS+    +    +    GT E+MAP+++
Sbjct: 145 LHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 440 REDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPM 495
           R   S  ++  D +S GV+++EL+T   P+         + +  +  +     P+ ++ +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262

Query: 496 VAALIETCWAEEPEIRPSFPSIMETLQQFL 525
              LI+    ++P+ R           +  
Sbjct: 263 AKDLIQRLLMKDPKKRLG--CGPRDADEIK 290

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 6e-42
 Identities = 62/282 (21%), Positives = 111/282 (39%), Gaps = 36/282 (12%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
             +KIGEG++GTV+ A+ R +   VA+K +   +  E      LRE+ ++K L+H NIV 
Sbjct: 6   KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65

Query: 327 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 386
           L   +     L++V E+  +       +       +D  +  +  + + KG+ + H R  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN- 121

Query: 387 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-N 445
            ++HRDLK  NLL++    +K+ +FGL+R+             T  +  P+VL      +
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 446 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG---------------------- 483
              D++S G I  EL    +P              F+                       
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 484 ------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
                   + +   +N     L++      P  R S    ++
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 1e-41
 Identities = 57/296 (19%), Positives = 111/296 (37%), Gaps = 50/296 (16%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
              KIG+G+FG V+ A  R +   VA+K ++ +   E      LRE+ I++ L+H N+V 
Sbjct: 14  KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73

Query: 327 LMGAVTEPP--------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
           L+               ++ +V ++           + +  V         +   +  G+
Sbjct: 74  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLNGL 130

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR----SKPNTYISSKTAAGTPEWM 434
            Y+H+ +  I+HRD+K+ N+L+     +K+ DFGL+R    +K +          T  + 
Sbjct: 131 YYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 435 APEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-------------- 479
            PE+L  +       D++  G I+ E+ T     + +T    ++ +              
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 480 ----------------GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
                             K +        +P    LI+     +P  R      + 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-39
 Identities = 63/289 (21%), Positives = 108/289 (37%), Gaps = 48/289 (16%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
             + +G G++G V  A    +   VA+K L      E   K   RE+ ++K +RH N++ 
Sbjct: 22  DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81

Query: 327 LMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           L+   T    L       +V  ++       + H       + E     + Y + KG+ Y
Sbjct: 82  LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRY 136

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           +H       HRDLK  NL V+    +K+ DFGL+R   +          T  + APEV+ 
Sbjct: 137 IHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVIL 191

Query: 441 ED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF------------------ 481
                 +  D++S G I+ E+IT +  ++ S     +  +                    
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 482 -----------KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 519
                      K     I  N +P+   L+E     + E R +    + 
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-37
 Identities = 61/276 (22%), Positives = 110/276 (39%), Gaps = 18/276 (6%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
             K IG G+ G V  A     D  VA+K L     ++   K   RE+ +MK + H NI+ 
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 327 LMGAVTEPP------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 380
           L+   T         ++ +V E +       +          D      + Y +  G+ +
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKH 134

Query: 381 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 440
           LH      +HRDLK  N++V S  T+K+ DFGL+R+   +++ +     T  + APEV+ 
Sbjct: 135 LHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVIL 191

Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 500
                E  D++S G I+ E++  +  +         + V  +      P+ +  +   + 
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV-IEQLGTPCPEFMKKLQPTVR 250

Query: 501 ETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQ 536
                       +FP +         S   +  ++Q
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 286

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  130 bits (328), Expect = 2e-34
 Identities = 51/231 (22%), Positives = 106/231 (45%), Gaps = 24/231 (10%)

Query: 254 YLEEEGLEIRWS---ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE 308
           Y + E   + W    +  + +K+G G +  V+ A    ++  V VKIL        + K+
Sbjct: 21  YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKK 75

Query: 309 FLREVAIMKGLR-HPNIVLLMGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDER 365
             RE+ I++ LR  PNI+ L   V +P +   ++V E+++     +L         + + 
Sbjct: 76  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDY 129

Query: 366 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISS 424
                 Y++ K ++Y H     I+HRD+K  N+++D     +++ D+GL+    +     
Sbjct: 130 DIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEY 186

Query: 425 KTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQ 474
                +  +  PE+L +    +   D++S G +L  +I  ++P+ +   + 
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 1e-33
 Identities = 62/288 (21%), Positives = 113/288 (39%), Gaps = 46/288 (15%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
               +G G++G+V  A    +   VAVK L          K   RE+ ++K ++H N++ 
Sbjct: 22  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81

Query: 327 LMGAVTEPPNLS-----IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 381
           L+   T   +L       +  +L    L  ++        + +     + Y + +G+ Y+
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYI 137

Query: 382 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 440
           H     I+HRDLK  NL V+    +K+ DFGL+R   +          T  + APE+ L 
Sbjct: 138 HSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLN 192

Query: 441 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI---------------------SAV 479
               N+  D++S G I+ EL+T +  +  +     +                     SA 
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

Query: 480 GFKGRRLEIPK--------NVNPMVAALIETCWAEEPEIRPSFPSIME 519
            +     ++PK          NP+   L+E     + + R +    + 
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (279), Expect = 1e-27
 Identities = 44/221 (19%), Positives = 92/221 (41%), Gaps = 28/221 (12%)

Query: 269 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 326
           + +K+G G F TV+ A+   ++  VA+KI+   + + +  +    E+ +++ +   +   
Sbjct: 17  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTK 73

Query: 327 LMGAVTE-------------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 373
                               P  + +V  +   G     L        +       ++  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 374 VAKGMNYLHQRRPPIVHRDLKSPNLLVDS------TYTVKVCDFGLSRSKPNTYISSKTA 427
           +  G++Y+H+R   I+H D+K  N+L++          +K+ D G +      Y +S   
Sbjct: 134 LLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI-- 190

Query: 428 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR 468
             T E+ +PEVL   P    +D++S   +++ELIT    + 
Sbjct: 191 -QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.0 bits (212), Expect = 4e-20
 Identities = 33/187 (17%), Positives = 53/187 (28%), Gaps = 33/187 (17%)

Query: 269 IKKKIGEGSFGTVYHAEWRNS-DVAVKIL--------IEQEFHEDRFKEFLREVAIMKGL 319
           I K +GEG    V++       +  VK            +E  +     F          
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 320 RHPNIVLLMGAVTEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 378
               +  L G       L++   Y     ++   L        V       +   + + +
Sbjct: 64  EFRALQKLQG-------LAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116

Query: 379 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 438
              + R   IVH DL   N+LV     + + DF  S                 E    E+
Sbjct: 117 AKFYHR--GIVHGDLSQYNVLVSE-EGIWIIDFPQSVE-------------VGEEGWREI 160

Query: 439 LREDPSN 445
           L  D  N
Sbjct: 161 LERDVRN 167

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	538
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.44
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.88
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.14
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.14
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.66
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.65
d2f4ma1	287	Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus)	80.12

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=430.60  Aligned_cols=263  Identities=36%  Similarity=0.614  Sum_probs=221.3

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +|++..++|++++.||+|+||+||+|++++ .||||++..........+.|.+|+.+|++++|||||++++++.+ ..++
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence            478889999999999999999999998544 69999998776666778899999999999999999999998765 5689


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++|+|.+++...+  ..+++..+..|+.||+.||+|||+++  ||||||||+|||++.++.+||+|||+|+...
T Consensus        80 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            9999999999999996433  35899999999999999999999999  9999999999999999999999999998754


Q ss_pred             CCc--cccCCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc----ccCCC
Q 009291          419 NTY--ISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIP  489 (538)
Q Consensus       419 ~~~--~~~~~~~gt~~Y~aPE~l~~---~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~----~~~~p  489 (538)
                      ...  .......||+.|||||++.+   ..++.++|||||||++|||+||+.||...+.............    ....+
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  235 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR  235 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence            322  22345679999999999864   3578999999999999999999999998766554443322222    22456


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      .++++++.+||.+||+.||++|||+++|++.|+.+..+
T Consensus       236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            78999999999999999999999999999999988754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=429.02  Aligned_cols=255  Identities=27%  Similarity=0.422  Sum_probs=210.9

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc--CCcceE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSI  339 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--~~~~~l  339 (538)
                      .++|++++.||+|+||+||+|+++.+  .||+|++......+...+.+.+|++++++++|||||++++++.+  +..+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            46899999999999999999998754  49999998877777778889999999999999999999998854  456899


Q ss_pred             EEeecCCCChhhhhcCC-CCCccccHHHHHHHHHHHHHHHHHHHhCC---CCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          340 VTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRR---PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      |||||++|+|.+++... ..+..+++..++.++.||+.||+|||+++   .+||||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998532 22346999999999999999999999864   249999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHH
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM  495 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~  495 (538)
                      .............||+.|||||++.+..++.++|||||||++|||++|+.||...+..+....+... ....+|..+|++
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~  241 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYRYSDE  241 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHH
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHH
Confidence            7655444445678999999999999999999999999999999999999999999888877776533 334677889999


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          496 VAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       496 l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +.+||.+||+.||++|||++|+++
T Consensus       242 l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHh
Confidence            999999999999999999999874

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=424.45  Aligned_cols=247  Identities=29%  Similarity=0.530  Sum_probs=219.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCH-HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~-~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++++.||+|+||+||+|+++.++  ||+|++....... ...+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            468999999999999999999997544  9999987543222 2345788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      ||||++|+|.+++...   ..+++..++.++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|......
T Consensus        85 mEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             EeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999999632   35899999999999999999999999  999999999999999999999999999876543


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                      .  .....||+.|||||++.+..++.++|||||||++|||++|+.||...+..+....+.  .....+|..+++++.+||
T Consensus       160 ~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li  235 (263)
T d2j4za1         160 R--RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLI  235 (263)
T ss_dssp             C--CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHH
T ss_pred             c--ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHH
Confidence            2  245679999999999999999999999999999999999999999998888777663  345667889999999999


Q ss_pred             HHhhhcCCCCCCCHHHHHH
Q 009291          501 ETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||+.||++|||++|+++
T Consensus       236 ~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         236 SRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHT
T ss_pred             HHHccCCHhHCcCHHHHHc
Confidence            9999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.2e-53  Score=427.59  Aligned_cols=262  Identities=33%  Similarity=0.565  Sum_probs=218.8

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc-----eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ++..++|++.+.||+|+||+||+|+++.++     ||||.+... ......+.|.+|+.+|++++|||||++++++.++.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            466788999999999999999999986432     666665433 34566678999999999999999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++|||||++|+|.+++....  ..+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+|+
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccce
Confidence            9999999999999999887433  35899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccc-----cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCC
Q 009291          416 SKPNTYIS-----SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP  489 (538)
Q Consensus       416 ~~~~~~~~-----~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p  489 (538)
                      ........     .....||+.|||||.+.+..++.++|||||||++|||+| |+.||...+..+....+. ...+.+.|
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~  255 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP  255 (299)
T ss_dssp             -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCC
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence            65432111     122457899999999999999999999999999999998 899999998888777764 45667788


Q ss_pred             CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          490 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       490 ~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ..+++++.+||.+||+.||++|||+.+|++.|++++++.
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence            899999999999999999999999999999999998763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=422.16  Aligned_cols=264  Identities=33%  Similarity=0.597  Sum_probs=228.2

Q ss_pred             cccccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          257 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       257 ~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      ++.+++..++|++++.||+|+||+||+|.++++ .||||++.......   +.|.+|+.++++++|||||++++++.+ +
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~-~   80 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence            466889999999999999999999999998754 59999987654333   478999999999999999999998865 5


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+++||||+++|+|.+++.... ...+++..++.|+.||+.||+|||+++  |+||||||+|||+++++.+||+|||+|+
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CeEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceE
Confidence            6799999999999999875432 235899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          416 SKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       416 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ...... .......||+.|||||++.+..++.++|||||||++|||+|| .+||...+..+....+. ...+...|..++
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~  236 (272)
T d1qpca_         158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP  236 (272)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred             EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccCh
Confidence            765432 233456789999999999988999999999999999999996 45566666666665553 556777889999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      +++.+||.+||+.||++|||+++|++.|+++..++
T Consensus       237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst  271 (272)
T d1qpca_         237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (272)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence            99999999999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-53  Score=429.11  Aligned_cols=263  Identities=36%  Similarity=0.602  Sum_probs=226.9

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      .+++..++|++.+.||+|+||+||+|.++.+  .||||++......   .+.|.+|+++|++++|||||++++++.+++.
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            4788899999999999999999999998754  4999998765433   3578999999999999999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++|  ||||||||+|||+++++.+||+|||+|+.
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             eEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceee
Confidence            999999999999999986432 246899999999999999999999999  99999999999999999999999999987


Q ss_pred             CCCCcc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhhcCcccCCCCCCcH
Q 009291          417 KPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR-NSTPSQVISAVGFKGRRLEIPKNVNP  494 (538)
Q Consensus       417 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~s~  494 (538)
                      ...... ......|+..|+|||++.+..++.++|||||||++|||++|..||. ..+..+....+ ....+.+.|..+++
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~  243 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPE  243 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCH
T ss_pred             cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccchH
Confidence            654322 2234457899999999999999999999999999999999766654 44544444433 45667888899999


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          495 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ++.+||.+||+.||++|||+++|++.|+.++++.
T Consensus       244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999887653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=419.12  Aligned_cols=258  Identities=34%  Similarity=0.603  Sum_probs=215.9

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ++.++|++++.||+|+||+||+|++.++ .||||++.......   +.|.+|++++++++|||||++++++.+++.+++|
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            4567899999999999999999998754 49999987654443   4789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+++|+|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+|||+++++.+||+|||+++.....
T Consensus        79 ~E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             EECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EEecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCC
Confidence            99999999999986433  35889999999999999999999999  999999999999999999999999999865443


Q ss_pred             cc-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          421 YI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       421 ~~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      .. ......||..|+|||++.+..++.++|||||||++|||+|+ .+||...+..+....+. ...+...|..+++++.+
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~  233 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ  233 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHH
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHH
Confidence            22 22345789999999999999999999999999999999995 66677777766666654 45667778899999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          499 LIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      ||.+||+.||++|||+++|++.|+++..+
T Consensus       234 li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         234 IMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            99999999999999999999999998754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-53  Score=424.75  Aligned_cols=247  Identities=27%  Similarity=0.462  Sum_probs=218.8

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++++.||+|+||+||+|++..  ..||||++.......  .+.+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            479999999999999999999864  459999987654332  3578999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      ||++|+|.+++...    .+++..++.++.||+.||+|||++|  ||||||||+|||++.+|++||+|||+|+.......
T Consensus        98 y~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             ecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            99999999988532    4899999999999999999999999  99999999999999999999999999987655444


Q ss_pred             ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-CcccCCCCCCcHHHHHHHH
Q 009291          423 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIE  501 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~s~~l~~LI~  501 (538)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ......+..+++++++||.
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence            456778999999999999999999999999999999999999999988877666555433 3345667789999999999


Q ss_pred             HhhhcCCCCCCCHHHHHH
Q 009291          502 TCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       502 ~cL~~dP~~RPs~~eIl~  519 (538)
                      +||+.||++|||++|+++
T Consensus       252 ~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=419.38  Aligned_cols=266  Identities=30%  Similarity=0.513  Sum_probs=228.4

Q ss_pred             cccccceeEEEE-EccCCcEEEEEEEEcCC----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          261 EIRWSELLIKKK-IGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       261 ~i~~~~y~i~~~-LG~G~fg~Vy~a~~~~~----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      -+..++|.+.+. ||+|+||+||+|.++.+    .||||++... ......+.|.+|+++|++++|||||++++++.+ +
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~   81 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E   81 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence            455678888884 99999999999977532    3899998654 355667889999999999999999999999865 4


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+||||+++|+|.+++...  +..+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+|+
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhh
Confidence            589999999999999987533  235899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCc---cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          416 SKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       416 ~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      ......   .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+. .+.++++|..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~  236 (285)
T d1u59a_         158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE  236 (285)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTT
T ss_pred             cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCc
Confidence            754322   12234568999999999999999999999999999999998 899999888777766664 5667888999


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL  533 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~~~~  533 (538)
                      +|+++.+||.+||+.||++|||+.+|++.|+....+...+..
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~  278 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  278 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence            999999999999999999999999999999998877655443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=429.30  Aligned_cols=262  Identities=33%  Similarity=0.507  Sum_probs=223.2

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCC-------ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeece
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA  330 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~  330 (538)
                      .+++..++|++++.||+|+||+||+|++.+.       .||+|++.... .......+.+|+.+++++ +|||||+++++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~  109 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA  109 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence            4678889999999999999999999988643       27888775433 334456789999999998 89999999999


Q ss_pred             eccCCcceEEEeecCCCChhhhhcCCCC--------------------CccccHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q 009291          331 VTEPPNLSIVTEYLSRGSLYKLLHIPDA--------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH  390 (538)
Q Consensus       331 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiH  390 (538)
                      +.+.+.+++|||||++|+|.++++....                    ...+++..++.++.||+.||+|||+++  |||
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiH  187 (325)
T d1rjba_         110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH  187 (325)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred             EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence            9999999999999999999999964321                    235889999999999999999999999  999


Q ss_pred             ecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 009291          391 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPW  467 (538)
Q Consensus       391 rDLKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf  467 (538)
                      |||||+||+++.++.+||+|||+|+.......  ......||+.|||||++.+..++.++|||||||++|||++ |..||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            99999999999999999999999976433221  2234567999999999999999999999999999999997 89999


Q ss_pred             CCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          468 RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       468 ~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      .+.+..+....+.....+++.|..+|+++.+||.+||+.||++|||++||++.|..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            98776666666656777888899999999999999999999999999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=418.26  Aligned_cols=249  Identities=29%  Similarity=0.387  Sum_probs=208.0

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++++.||+|+||+||+|+++.+  .||||++..... ....+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            5799999999999999999998754  499999876542 2334678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC--
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--  420 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~--  420 (538)
                      |+++|+|.+++...   ..+++..++.++.||+.||+|||++|  ||||||||+|||+++++.+||+|||+|+.....  
T Consensus        84 y~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          84 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999998643   36999999999999999999999999  999999999999999999999999999865322  


Q ss_pred             ccccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhhcCcccCCCCCCcHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~-~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      .......+||+.|||||++.+..+ +.++|||||||++|||++|+.||........ ................+++++.+
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence            222345689999999999988876 5789999999999999999999977654332 22232222333334578999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ||.+||+.||++|||++|+++
T Consensus       239 li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999999865

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-52  Score=414.84  Aligned_cols=248  Identities=31%  Similarity=0.516  Sum_probs=212.6

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc----CCcceE
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNLSI  339 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~----~~~~~l  339 (538)
                      -|++.+.||+|+||+||+|.+..++  ||+|++..........+.+.+|+++|++++|||||++++++.+    ...+++
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            3577889999999999999997654  8999988777777778889999999999999999999999854    345899


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc-CCCcEEEEeeCCCccCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKP  418 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~  418 (538)
                      ||||+++|+|.+++...   ..+++..++.++.||+.||+|||+++++||||||||+|||++ +++.+||+|||+|+...
T Consensus        90 vmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999999633   358999999999999999999999987899999999999996 57899999999998654


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhcCcccCCCCCCcHHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ...  .....||+.|||||++.+ .++.++|||||||++|||++|+.||...... .....+........++..+++++.
T Consensus       167 ~~~--~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  243 (270)
T d1t4ha_         167 ASF--AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK  243 (270)
T ss_dssp             TTS--BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred             CCc--cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHH
Confidence            432  245689999999999876 5999999999999999999999999865544 444455444444556677899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||++|+++
T Consensus       244 ~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         244 EIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHccCCHhHCcCHHHHhC
Confidence            9999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-52  Score=416.14  Aligned_cols=251  Identities=31%  Similarity=0.523  Sum_probs=215.3

Q ss_pred             EEEccCCcEEEEEEEEcCC----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEeecCC
Q 009291          271 KKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR  346 (538)
Q Consensus       271 ~~LG~G~fg~Vy~a~~~~~----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~~~~  346 (538)
                      ++||+|+||+||+|.+..+    .||||++.....+....+.|.+|+.+|++++|||||++++++.+ +.+++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            4799999999999987543    39999987665556667889999999999999999999999865 457899999999


Q ss_pred             CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc---c
Q 009291          347 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI---S  423 (538)
Q Consensus       347 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~---~  423 (538)
                      |+|.++++..   ..+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+|+.......   .
T Consensus        92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9999998743   35899999999999999999999999  99999999999999999999999999986543221   2


Q ss_pred             cCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHH
Q 009291          424 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET  502 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~  502 (538)
                      .....||+.|||||.+.+..++.++|||||||++|||++ |+.||...+..+....+. .+.+++.|..+|+++.+||.+
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~  245 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNL  245 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHH
Confidence            234568999999999999999999999999999999998 899999988877776664 566788899999999999999


Q ss_pred             hhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          503 CWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       503 cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ||+.||++|||+++|++.|+++..+.
T Consensus       246 cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         246 CWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             HTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence            99999999999999999999887553

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-53  Score=424.14  Aligned_cols=250  Identities=25%  Similarity=0.412  Sum_probs=217.4

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~l  339 (538)
                      ..++|++++.||+|+||+||+|+++.+  .||||++..... .....+.+.+|+++|++++||||+++++++.+++.+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            457899999999999999999998744  499999875432 22334678999999999999999999999999999999


Q ss_pred             EEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCC
Q 009291          340 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       340 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~  419 (538)
                      ||||+++|+|.+++...   ..+++..++.++.|++.||+|||++|  ||||||||+|||+++++.+||+|||+|+....
T Consensus        86 vmEy~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999988633   35899999999999999999999999  99999999999999999999999999987543


Q ss_pred             Cc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHH
Q 009291          420 TY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA  497 (538)
Q Consensus       420 ~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~  497 (538)
                      ..  ......+||+.|||||++.+..++.++|||||||++|||++|+.||...+..+....+.  .....+|..+++++.
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~  238 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKAR  238 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHH
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHH
Confidence            22  22345679999999999999999999999999999999999999999998888777764  345677889999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||++|++.
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHHHHHccCCHhHCcCHHHHcC
Confidence            9999999999999999999754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=414.56  Aligned_cols=262  Identities=34%  Similarity=0.549  Sum_probs=219.2

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCC------ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      ++..++|++.+.||+|+||+||+|.++.+      .||||++.... .....+.|.+|+.++++++|||||++++++.+.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            56778999999999999999999987643      38999886543 455567899999999999999999999999999


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      ...++||||+.++++.+++....  ..+++..++.++.|++.||+|||+++  ||||||||+|||++.++.+||+|||+|
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchh
Confidence            99999999999999998875433  35889999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCHHHHHHHHhhcCcccCCCC
Q 009291          415 RSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPK  490 (538)
Q Consensus       415 ~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~-Pf~~~~~~~~~~~i~~~~~~~~~p~  490 (538)
                      +.......   ......||+.|||||++.+..++.++|||||||++|||+++.. ||...+..+....+ ..+.+.+.|.
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~~~  236 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTPM  236 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCT
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-hccCCCCCch
Confidence            86543221   1233468999999999999999999999999999999999655 45556665555555 3566778889


Q ss_pred             CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          491 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       491 ~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .+++++.+||.+||+.||++|||+.+|++.|+.++++.
T Consensus       237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            99999999999999999999999999999999998753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=423.01  Aligned_cols=249  Identities=27%  Similarity=0.492  Sum_probs=216.6

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      +.|++++.||+|+||+||+|++..++  ||||++....  ....+.+.+|+++|++++|||||++++++.+++.+++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            46899999999999999999987554  8999987643  3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      ||++|+|.+++...  ...+++..+..++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|+.......
T Consensus        90 y~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          90 FCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            99999999987532  235899999999999999999999999  99999999999999999999999999976544333


Q ss_pred             ccCCCCCCCccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-cccCCCCCCcHHH
Q 009291          423 SSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMV  496 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~-----~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~s~~l  496 (538)
                      ......||+.|||||++.     +..|+.++|||||||++|||++|+.||...+..+....+.... ..+..+..+++++
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  245 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF  245 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence            345678999999999984     4568899999999999999999999999988887777665433 2345567899999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 009291          497 AALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .+||.+||+.||++|||++|+++
T Consensus       246 ~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            99999999999999999999876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=414.73  Aligned_cols=265  Identities=32%  Similarity=0.559  Sum_probs=218.7

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCCc-----eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE  333 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~  333 (538)
                      +++|..++|++++.||+|+||+||+|.+..++     ||||++.. .......+.+.+|+.++++++||||+++++++.+
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT-TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc-ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            36788899999999999999999999886432     55665533 2345566789999999999999999999999864


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                       +.+++||||+++|+|.+++....  ..+++..++.++.||+.||+|||+++  ||||||||+||+++.++.+||+|||+
T Consensus        80 -~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             -CeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchh
Confidence             67899999999999999875432  35899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          414 SRSKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       414 a~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      |+...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+. .+.+.++|.+
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~  233 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPN  233 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTT
T ss_pred             heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence            98754322 22345568999999999999999999999999999999998 899999988888777764 5566788999


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      +|+++.+||.+||+.||++|||+.+|++.|++++.+...
T Consensus       234 ~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~  272 (273)
T d1mp8a_         234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA  272 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhC
Confidence            999999999999999999999999999999999987643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-52  Score=410.92  Aligned_cols=253  Identities=33%  Similarity=0.577  Sum_probs=224.9

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +.++|+++++||+|+||+||+|+++++ .||||++.......   ++|.+|+.++++++||||+++++++.+++.+++||
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            457899999999999999999998755 59999998765544   47899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      ||+.+|+|..++....  ..+++..++.++.|++.||+|||++|  |+||||||+||++++++.+||+|||+++......
T Consensus        79 Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          79 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             ECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             EccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            9999999999976433  35889999999999999999999999  9999999999999999999999999998654432


Q ss_pred             c-ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHH
Q 009291          422 I-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL  499 (538)
Q Consensus       422 ~-~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~L  499 (538)
                      . ......||..|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....+. ...+...|..+++++.+|
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~l  233 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTI  233 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHH
Confidence            2 2334678999999999999999999999999999999998 899999999888877775 556778889999999999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHHHHH
Q 009291          500 IETCWAEEPEIRPSFPSIMETLQQ  523 (538)
Q Consensus       500 I~~cL~~dP~~RPs~~eIl~~L~~  523 (538)
                      |.+||+.||++|||+++|++.|.+
T Consensus       234 i~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         234 MYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHccCCHhHCcCHHHHHHHhhC
Confidence            999999999999999999998864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=422.82  Aligned_cols=251  Identities=26%  Similarity=0.455  Sum_probs=222.8

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      +..++|++++.||+|+||+||+|+++.+  .||||++.+... .....+.+.+|+.+|++++||||+++++++.++..+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            4567899999999999999999998754  499999976532 2233567889999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      +||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+|+...
T Consensus        82 iv~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             cceeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccc
Confidence            999999999999998643   35899999999999999999999999  9999999999999999999999999998765


Q ss_pred             CCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          419 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       419 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                      .........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+....+..  ....+|..+|+++++
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~d  234 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKS  234 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHH
Confidence            544445567899999999999999999999999999999999999999999998887776643  456788999999999


Q ss_pred             HHHHhhhcCCCCCCC-----HHHHHH
Q 009291          499 LIETCWAEEPEIRPS-----FPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RPs-----~~eIl~  519 (538)
                      ||.+||+.||++|++     ++++++
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHhhccCCchhhcccccccHHHHHc
Confidence            999999999999995     788876

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-51  Score=418.06  Aligned_cols=246  Identities=25%  Similarity=0.405  Sum_probs=216.4

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      ..|++++.||+|+||+||+|++..++  ||||++...... ....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35999999999999999999987555  999998766543 455678999999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |||.+|+|..++..   +..+++..++.++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|+..... 
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            99999999776643   235899999999999999999999999  999999999999999999999999999865432 


Q ss_pred             cccCCCCCCCcccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHH
Q 009291          422 ISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA  498 (538)
Q Consensus       422 ~~~~~~~gt~~Y~aPE~l~~---~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~  498 (538)
                         ....||+.|||||++.+   ..|+.++|||||||++|||++|..||...+..+....+.........+..+|+++.+
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence               45689999999999864   458999999999999999999999999988887777665555444556679999999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHH
Q 009291          499 LIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       499 LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ||.+||+.||++|||++|+++
T Consensus       246 li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHCcCChhHCcCHHHHHh
Confidence            999999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-51  Score=417.28  Aligned_cols=248  Identities=26%  Similarity=0.406  Sum_probs=201.0

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      +.|++++.||+|+||+||+|+++.+  .||||++....... ..+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5699999999999999999998754  49999987655432 33568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc---CCCcEEEEeeCCCccCCC
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla~~~~~  419 (538)
                      ||+||+|.+++...   ..+++..+..++.||+.||+|||++|  ||||||||+||++.   +++.+||+|||+|+....
T Consensus        88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999999643   35999999999999999999999999  99999999999994   578999999999987654


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--CCCCCCcHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVA  497 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~s~~l~  497 (538)
                      .. .....+||+.|||||++.+..++.++|||||||++|||++|+.||...+..+....+.......  +.+..+|+++.
T Consensus       163 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         163 GS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             CC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            32 2345689999999999999999999999999999999999999999988887777765444433  34467999999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||++|+++
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHhc
Confidence            9999999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=412.20  Aligned_cols=267  Identities=33%  Similarity=0.555  Sum_probs=223.1

Q ss_pred             hcccccccccceeEEEEEccCCcEEEEEEEEcCC-ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC
Q 009291          256 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP  334 (538)
Q Consensus       256 ~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~  334 (538)
                      ....++|..++|++++.||+|+||+||+|.++++ .||||++.......   +.|.+|+.++++++|||||++++++.+ 
T Consensus         8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-   83 (285)
T d1fmka3           8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-   83 (285)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence            3456788899999999999999999999998765 49999987654443   478999999999999999999999865 


Q ss_pred             CcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCC
Q 009291          335 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS  414 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla  414 (538)
                      +.+++||||+++|+|..++.... ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++++||+|||+|
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             CCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchh
Confidence            56799999999999998886432 235899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCCc-cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhhcCcccCCCCCC
Q 009291          415 RSKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP-WRNSTPSQVISAVGFKGRRLEIPKNV  492 (538)
Q Consensus       415 ~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~P-f~~~~~~~~~~~i~~~~~~~~~p~~~  492 (538)
                      +...... .......||+.|+|||++.+..++.++|||||||++|||++|..| |......+....+. ...+.+.+..+
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~  239 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPEC  239 (285)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTS
T ss_pred             hhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCccc
Confidence            8754332 223446789999999999999999999999999999999996554 55566666665554 45667788999


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      ++++.+||.+||+.||++|||+++|+++|++++.+..+
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence            99999999999999999999999999999998876654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-52  Score=422.84  Aligned_cols=251  Identities=25%  Similarity=0.419  Sum_probs=209.6

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      ++..++|++++.||+|+||+||+|++..++  ||+|++.... .....+.+.+|+.+|++++|||||+++++|.++..+|
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            566789999999999999999999987554  9999987653 3444568899999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      +||||+++|+|.+++...   ..+++..++.++.|++.||.|||+ +|  ||||||||+|||++.+|.+||+|||+|+..
T Consensus        81 iVmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999999999633   358999999999999999999997 58  999999999999999999999999999864


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-----------------
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-----------------  480 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~-----------------  480 (538)
                      ...  ...+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..+......                 
T Consensus       156 ~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         156 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             HHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             CCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            332  2245689999999999999999999999999999999999999997655432211100                 


Q ss_pred             ------------------------hcCcccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          481 ------------------------FKGRRLEIP-KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       481 ------------------------~~~~~~~~p-~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                              ........+ ..++.++.+||.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                    000111112 236889999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=407.99  Aligned_cols=259  Identities=36%  Similarity=0.647  Sum_probs=221.4

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc-CCcc
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNL  337 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~-~~~~  337 (538)
                      +|++..++|++++.||+|+||.||+|+++++.||||++..+.    ..+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus         1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            478899999999999999999999999999999999986543    23578899999999999999999998854 4668


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccC
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK  417 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~  417 (538)
                      ++||||+++|+|.+++... ....+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~  153 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  153 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceec
Confidence            9999999999999998532 1234889999999999999999999999  999999999999999999999999999865


Q ss_pred             CCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHH
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      ...   .....+|..|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....+. .+.+.++|..+++++
T Consensus       154 ~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~  229 (262)
T d1byga_         154 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV  229 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHH
T ss_pred             CCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHH
Confidence            433   234568899999999999999999999999999999998 788999888888777764 557788899999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      .+||.+||+.||++|||+.+|++.|+++....
T Consensus       230 ~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~  261 (262)
T d1byga_         230 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  261 (262)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999986543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-51  Score=410.19  Aligned_cols=249  Identities=23%  Similarity=0.411  Sum_probs=217.6

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCH----HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcce
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS  338 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~----~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~  338 (538)
                      ++|++++.||+|+||+||+|+++.+  .||||++.......    ...+.+.+|+.+|++++|||||++++++.++..+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5799999999999999999998744  59999987654322    23568999999999999999999999999999999


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC----cEEEEeeCCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGLS  414 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~----~vkL~DFGla  414 (538)
                      +|||||++|+|.+++...   ..+++..++.++.|++.||+|||+++  ||||||||+|||++.++    .+||+|||+|
T Consensus        90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999643   35999999999999999999999999  99999999999998776    5999999999


Q ss_pred             ccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--CCCCCC
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNV  492 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~  492 (538)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......  ..+..+
T Consensus       165 ~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         165 HKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             EECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             hhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence            8765443 2346689999999999999999999999999999999999999999998888777765443322  234678


Q ss_pred             cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          493 NPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       493 s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      |+++.+||.+||+.||++|||++|+++
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.4e-50  Score=416.61  Aligned_cols=249  Identities=24%  Similarity=0.398  Sum_probs=217.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++++.||+|+||+||+|+++.+  .||||++....  ....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35899999999999999999998754  49999986543  445578899999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc--CCCcEEEEeeCCCccCCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~--~~~~vkL~DFGla~~~~~  419 (538)
                      |||++|+|.+++...  ...+++..++.++.||+.||+|||++|  ||||||||+|||++  .++.+||+|||+|+....
T Consensus       103 E~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         103 EFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999998543  235999999999999999999999999  99999999999995  467899999999987654


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC--CCCCCcHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMVA  497 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~s~~l~  497 (538)
                      .. ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......+  ....+++++.
T Consensus       179 ~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         179 KQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cc-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            32 23456899999999999999999999999999999999999999999888887777754443322  2356899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||++|+++
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999976

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4e-50  Score=415.33  Aligned_cols=249  Identities=22%  Similarity=0.381  Sum_probs=217.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      .++|++++.||+|+||+||+|++..+  .||||++....  ....+.+.+|+.+|++++|||||+++++|.++..+|+||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35799999999999999999998644  49999987653  334567889999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc--CCCcEEEEeeCCCccCCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~--~~~~vkL~DFGla~~~~~  419 (538)
                      |||++|+|.+++...  ...+++..++.|+.||+.||+|||++|  ||||||||+|||++  .++.+||+|||+|+....
T Consensus       106 E~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         106 EFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             ECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999999887543  235999999999999999999999999  99999999999997  678999999999987654


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--CCCCCCcHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVA  497 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~s~~l~  497 (538)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......  ..+..+++++.
T Consensus       182 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         182 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            32 2345678999999999999999999999999999999999999999998888777775444332  34467899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||+.||++|||++|+++
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999976

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-50  Score=410.96  Aligned_cols=246  Identities=25%  Similarity=0.448  Sum_probs=218.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccC-HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~-~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++++.||+|+||+||+|+++.+  .||||++...... ....+.+.+|+.++++++||||+++++++.++..+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            46899999999999999999998744  4999998764322 23356788999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+.||+|..++....   .+++..++.++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+|+.....
T Consensus        83 mE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999999886433   4788899999999999999999999  999999999999999999999999999876543


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                      .   ...+||+.|||||++.+..++.++|||||||++|||++|+.||...+..+....+...  ...+|..+++++.++|
T Consensus       158 ~---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li  232 (316)
T d1fota_         158 T---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLL  232 (316)
T ss_dssp             B---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             c---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence            2   4578999999999999999999999999999999999999999999988887776433  4567889999999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHH
Q 009291          501 ETCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RP-----s~~eIl~  519 (538)
                      .+||+.||.+|+     |++++++
T Consensus       233 ~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         233 SRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhhhCHHhccccchhhHHHHHc
Confidence            999999999996     8999876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=407.22  Aligned_cols=267  Identities=31%  Similarity=0.553  Sum_probs=217.1

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcCC-------ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeec
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG  329 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~  329 (538)
                      ..+++..++|++++.||+|+||+||+|++.+.       .||||++.... .....+.+.+|..++.++ +|+||+.+++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            34678889999999999999999999987542       38999876543 344556788888888776 6899999999


Q ss_pred             eeccC-CcceEEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCC
Q 009291          330 AVTEP-PNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS  395 (538)
Q Consensus       330 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp  395 (538)
                      ++.++ ..+++|||||++|+|.++++...             ....+++..++.++.||+.||+|||+++  ||||||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp  162 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA  162 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCc
Confidence            87654 46899999999999999985432             1235889999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCH
Q 009291          396 PNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTP  472 (538)
Q Consensus       396 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg-~~Pf~~~~~  472 (538)
                      +|||+++++++||+|||+|+......  .......||+.|||||++.+..++.++|||||||++|||++| ..||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998644322  223456799999999999999999999999999999999987 567877665


Q ss_pred             HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      .+........+.+++.|..+++++.+||.+||+.||++|||++||++.|++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            5555555456677888899999999999999999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=404.47  Aligned_cols=258  Identities=35%  Similarity=0.580  Sum_probs=215.8

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEcCC-----ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP  335 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~  335 (538)
                      |..++|++.+.||+|+||.||+|++...     .||||++..... ..+..+.|.+|+.+|++++||||+++++++.+ .
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            5567899999999999999999987532     388998765543 34556789999999999999999999999976 4


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      ..++||||+++|++.+++...  ...+++..++.++.|++.||+|||+++  |+||||||+||+++.++++||+|||+++
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             chheeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhh
Confidence            678999999999999887532  235899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCcc---ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCC
Q 009291          416 SKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN  491 (538)
Q Consensus       416 ~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  491 (538)
                      .......   ......|+..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+.....+++.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED  239 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccc
Confidence            7543321   2234467889999999999999999999999999999998 89999999999988888777778888899


Q ss_pred             CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQF  524 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~i  524 (538)
                      +|+.+.+||.+||+.||++|||+.+|++.|++.
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            999999999999999999999999999988764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-50  Score=409.33  Aligned_cols=262  Identities=35%  Similarity=0.561  Sum_probs=226.4

Q ss_pred             ccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceec
Q 009291          260 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT  332 (538)
Q Consensus       260 ~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~  332 (538)
                      +++..++|++++.||+|+||+||+|++++       +.||||++.... .....+.|.+|+.+|++++||||+++++++.
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            66778899999999999999999999864       349999976543 4556678999999999999999999999999


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCC---------------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEee
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPD---------------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR  391 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHr  391 (538)
                      +....+++|||+.+|+|.+++....                     ....+++..++.|+.|++.||+|||+++  ||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHr  164 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR  164 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEee
Confidence            9999999999999999999985321                     1234788899999999999999999999  9999


Q ss_pred             cCCCCCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCC
Q 009291          392 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWR  468 (538)
Q Consensus       392 DLKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~-~Pf~  468 (538)
                      ||||+|||++.++.+||+|||+|+......  .......|++.|+|||.+.+..++.++|||||||++|||++|. .||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999997543321  2223567889999999999999999999999999999999985 6898


Q ss_pred             CCCHHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 009291          469 NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL  525 (538)
Q Consensus       469 ~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il  525 (538)
                      ..+..+....+. .+.+.+.|..+++++.+||.+||+.+|++|||+.||+++|+++.
T Consensus       245 ~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            888888877765 44567788899999999999999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-50  Score=407.47  Aligned_cols=264  Identities=34%  Similarity=0.621  Sum_probs=225.0

Q ss_pred             cccccceeEEEEEccCCcEEEEEEEEcCCc----eEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeeceeccCC
Q 009291          261 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP  335 (538)
Q Consensus       261 ~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~~~~~~~  335 (538)
                      .|++++|++.+.||+|+||+||+|.+++++    ||||.+.... .....+.+.+|+++|+++ +|||||++++++.+++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            467899999999999999999999987653    5666654332 334567899999999999 7999999999999999


Q ss_pred             cceEEEeecCCCChhhhhcCC-------------CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIP-------------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS  402 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~  402 (538)
                      .+++||||+++|+|.++++..             .....+++..++.++.||+.||.|||+++  ||||||||+|||++.
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE  162 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence            999999999999999999643             23456899999999999999999999999  999999999999999


Q ss_pred             CCcEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHhh
Q 009291          403 TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGF  481 (538)
Q Consensus       403 ~~~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~-~Pf~~~~~~~~~~~i~~  481 (538)
                      ++.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|. .||...+..+....+. 
T Consensus       163 ~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-  240 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-  240 (309)
T ss_dssp             GGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred             CCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence            9999999999998654332 223556899999999999999999999999999999999975 5788888888777664 


Q ss_pred             cCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhc
Q 009291          482 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV  529 (538)
Q Consensus       482 ~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~  529 (538)
                      .+.+++.|..+++++.+||.+||+.||++|||+.+|++.|++++.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            456788889999999999999999999999999999999999997654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=402.48  Aligned_cols=265  Identities=32%  Similarity=0.588  Sum_probs=226.5

Q ss_pred             cccccccceeEEEEEccCCcEEEEEEEEcCC---------ceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEee
Q 009291          259 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM  328 (538)
Q Consensus       259 ~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~~---------~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~  328 (538)
                      .+++..++|++++.||+|+||.||+|+..++         .||||++.... .......+.+|...++++ +|||||+++
T Consensus         7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            3778899999999999999999999987543         38999986543 455567889999999888 899999999


Q ss_pred             ceeccCCcceEEEeecCCCChhhhhcCCC-------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCC
Q 009291          329 GAVTEPPNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS  395 (538)
Q Consensus       329 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp  395 (538)
                      +++.++...++||||+++|+|.+++....             ....+++..++.++.||+.||+|||+++  ||||||||
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp  163 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA  163 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence            99999999999999999999999996432             1245899999999999999999999999  99999999


Q ss_pred             CCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 009291          396 PNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP  472 (538)
Q Consensus       396 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~  472 (538)
                      +|||++.++.+||+|||+++......  .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...+.
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            99999999999999999998654322  12344578999999999999999999999999999999998 7889998888


Q ss_pred             HHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          473 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       473 ~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      .+....+. .+.+++.|..+++++.+||.+||+.||++|||+.+|++.|++++..
T Consensus       244 ~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            77766554 5677888999999999999999999999999999999999999754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-50  Score=408.09  Aligned_cols=258  Identities=31%  Similarity=0.528  Sum_probs=216.3

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCCc------eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~------vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      ..++|++++.||+|+||+||+|.+..++      ||+|.+.... .....+.|.+|+.++++++|||||++++++.++ .
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            3467999999999999999999886442      6777765332 333456899999999999999999999999875 5


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .++++|++.+++|.+++....  ..+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+|+.
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             eeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeecccccee
Confidence            678889999999998886443  35899999999999999999999999  99999999999999999999999999987


Q ss_pred             CCCCcc--ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          417 KPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       417 ~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||+| |..||...+..+....+. .+.+++.|..++
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~  239 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICT  239 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBC
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccC
Confidence            543322  2234468999999999999999999999999999999998 799999888777665553 566778889999


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhh
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS  527 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~  527 (538)
                      +++.+||.+||+.||++|||+.+|++.|..+.++
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999988754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.4e-49  Score=395.79  Aligned_cols=257  Identities=25%  Similarity=0.384  Sum_probs=214.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc----
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN----  336 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~----  336 (538)
                      .++|++.+.||+|+||+||+|++..+  .||||++..... +....+.+.+|+.+++.++||||+++++++.....    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            35799999999999999999998744  499999976544 45556789999999999999999999999876443    


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|+||||++|++|.+++...   ..+++..++.++.||+.||+|||++|  ||||||||+|||++.++.++|+|||.+..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhh
Confidence            78999999999999988633   35899999999999999999999999  99999999999999999999999999875


Q ss_pred             CCCCc---cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc--cCCCCC
Q 009291          417 KPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKN  491 (538)
Q Consensus       417 ~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~  491 (538)
                      .....   .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+....+......  ......
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  240 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence            43221   2234567999999999999999999999999999999999999999998887776665443332  234567


Q ss_pred             CcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHH
Q 009291          492 VNPMVAALIETCWAEEPEIRP-SFPSIMETLQQFL  525 (538)
Q Consensus       492 ~s~~l~~LI~~cL~~dP~~RP-s~~eIl~~L~~il  525 (538)
                      +|+++.+||.+||+.||++|| |++++++.|.++.
T Consensus       241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            999999999999999999998 8999999888764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-49  Score=411.98  Aligned_cols=246  Identities=25%  Similarity=0.391  Sum_probs=218.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEecccc-CHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~-~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++++.||+|+||+||+|+++.  +.||||++..... .....+.+.+|+.+|+.++||||+++++++.+...+++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            4689999999999999999999874  4499999865432 223356789999999999999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+.+|+|..++...   ..+++..++.++.||+.||.|||++|  ||||||||+|||++.+|.+||+|||+|+.....
T Consensus       120 ~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999998633   35899999999999999999999999  999999999999999999999999999876543


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                         .....||+.|||||++.+..++.++|||||||++|||++|+.||...+.......+..  ....+|..+++++.+||
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li  269 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHH
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHHHH
Confidence               2456899999999999999999999999999999999999999999988887777743  34566788999999999


Q ss_pred             HHhhhcCCCCCC-----CHHHHHH
Q 009291          501 ETCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RP-----s~~eIl~  519 (538)
                      ++||+.||.+|+     |++++++
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHhhhCHHhccccccccHHHHHc
Confidence            999999999994     8999876

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=402.59  Aligned_cols=268  Identities=31%  Similarity=0.510  Sum_probs=231.8

Q ss_pred             ccccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcC-CCCceeEeec
Q 009291          258 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG  329 (538)
Q Consensus       258 ~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L-~hpnIv~l~~  329 (538)
                      ..+++..++|++++.||+|+||.||+|++.+       +.||||++.... .......+.+|+.+++++ +|||||++++
T Consensus        16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            3477888999999999999999999998743       238999986543 455667899999999999 6999999999


Q ss_pred             eeccCCcceEEEeecCCCChhhhhcCCC---------------CCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCC
Q 009291          330 AVTEPPNLSIVTEYLSRGSLYKLLHIPD---------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK  394 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLK  394 (538)
                      ++.+...+++|||||++|+|.++++...               ....+++..+..++.||+.||+|||+++  +||||||
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLK  172 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA  172 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccc
Confidence            9999999999999999999999985432               2335889999999999999999999999  9999999


Q ss_pred             CCCEEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 009291          395 SPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST  471 (538)
Q Consensus       395 p~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLlt-g~~Pf~~~~  471 (538)
                      |+||+++.++.+||+|||+++......  .......||+.|+|||.+.+..++.++|||||||++|||+| |.+||...+
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999998755432  22345678999999999999999999999999999999999 566677766


Q ss_pred             HHHHHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          472 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       472 ~~~~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ..+....+...+.+...|..+++.+.+||.+||+.||++|||+.+|+++|++++.++
T Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence            666666665567778888899999999999999999999999999999999998774

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.8e-49  Score=394.15  Aligned_cols=250  Identities=23%  Similarity=0.362  Sum_probs=216.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccC-------HHHHHHHHHHHHHHHcCC-CCceeEeeceecc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-------EDRFKEFLREVAIMKGLR-HPNIVLLMGAVTE  333 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~-------~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~  333 (538)
                      .++|++++.||+|+||+||+|++..+  .||||++......       ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            47899999999999999999998654  4999998765432       223456889999999997 9999999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ++.+|+||||+++|+|.++++.   +..+++..++.++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999999963   346899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCccccCCCCCCCcccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC
Q 009291          414 SRSKPNTYISSKTAAGTPEWMAPEVLRE------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE  487 (538)
Q Consensus       414 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~  487 (538)
                      ++...... ......||..|+|||.+.+      ..++.++||||+||++|||++|+.||...+.......+........
T Consensus       157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~  235 (277)
T d1phka_         157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG  235 (277)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            98765543 3355689999999999853      3468899999999999999999999999998887776655444333


Q ss_pred             --CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          488 --IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       488 --~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                        ...++|+++.+||.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              33478999999999999999999999999865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-50  Score=408.85  Aligned_cols=248  Identities=27%  Similarity=0.470  Sum_probs=217.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEecccc-CHHHHHHHHHHHHHHH-cCCCCceeEeeceeccCCcceEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMK-GLRHPNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~-~~~~~~~~~~Ei~il~-~L~hpnIv~l~~~~~~~~~~~lV  340 (538)
                      ++|++++.||+|+||+||+|+++.++  ||||++..... .....+.+.+|..++. .++||||+++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999997554  99999875432 1223456667777665 68999999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT  420 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~  420 (538)
                      |||+++|+|.+++...   ..+++..++.++.||+.||+|||+++  ||||||||+|||+++++.+||+|||+|+.....
T Consensus        82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999999999999633   35889999999999999999999999  999999999999999999999999999876555


Q ss_pred             ccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCcHHHHHHH
Q 009291          421 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI  500 (538)
Q Consensus       421 ~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s~~l~~LI  500 (538)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+..  ....+|..+|+++.+||
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli  234 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDLL  234 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred             cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCccCCHHHHHHH
Confidence            4455667899999999999999999999999999999999999999999998888777743  34577889999999999


Q ss_pred             HHhhhcCCCCCCCHH-HHHH
Q 009291          501 ETCWAEEPEIRPSFP-SIME  519 (538)
Q Consensus       501 ~~cL~~dP~~RPs~~-eIl~  519 (538)
                      .+||+.||++|||+. ++++
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGG
T ss_pred             HHhcccCCCCCcCHHHHHHh
Confidence            999999999999995 6753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-49  Score=402.83  Aligned_cols=248  Identities=20%  Similarity=0.355  Sum_probs=215.7

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~  341 (538)
                      +++|++++.||+|+||+||+|.++.++  ||||++....   .....+.+|+++|+.++|||||++++++.+++.+|+||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            578999999999999999999987554  9999987653   22346789999999999999999999999999999999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC--CCcEEEEeeCCCccCCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPN  419 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~~~~  419 (538)
                      |||+||+|.+++....  ..+++..++.++.||+.||+|||++|  |+||||||+|||++.  ...+||+|||+++....
T Consensus        81 E~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999999996432  35899999999999999999999999  999999999999984  45899999999987654


Q ss_pred             CccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccC--CCCCCcHHHH
Q 009291          420 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMVA  497 (538)
Q Consensus       420 ~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~s~~l~  497 (538)
                      .. ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+......++  .+..+|+++.
T Consensus       157 ~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            32 23456789999999999999999999999999999999999999999998888777754333222  2247899999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHH
Q 009291          498 ALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       498 ~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +||.+||..||++|||++|+++
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-48  Score=405.74  Aligned_cols=250  Identities=25%  Similarity=0.358  Sum_probs=209.3

Q ss_pred             cccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccC----HHHHHHHHHHHHHHHcCCCCceeEeeceeccCCc
Q 009291          263 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH----EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN  336 (538)
Q Consensus       263 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~----~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~  336 (538)
                      ..++|++++.||+|+||+||+|++..+  .||||++......    ........+|+.+++.++|||||++++++.+++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            356899999999999999999998754  4999998654322    2222233445778888899999999999999999


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|+||||+++|+|.+++...   ..+++..++.++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+|+.
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999999643   35889999999999999999999999  99999999999999999999999999987


Q ss_pred             CCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hhcCcccCCCCCCcH
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-GFKGRRLEIPKNVNP  494 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i-~~~~~~~~~p~~~s~  494 (538)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+........ ........+|..+++
T Consensus       157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  234 (364)
T d1omwa3         157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP  234 (364)
T ss_dssp             CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred             cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence            6543  2345689999999999964 56899999999999999999999999876543322222 123455667889999


Q ss_pred             HHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 009291          495 MVAALIETCWAEEPEIRPS-----FPSIME  519 (538)
Q Consensus       495 ~l~~LI~~cL~~dP~~RPs-----~~eIl~  519 (538)
                      ++.+||.+||+.||++|||     ++++++
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            9999999999999999999     688865

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-49  Score=399.60  Aligned_cols=272  Identities=31%  Similarity=0.568  Sum_probs=233.5

Q ss_pred             chhhhcccccccccceeEEEEEccCCcEEEEEEEEcC-------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCce
Q 009291          252 ELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI  324 (538)
Q Consensus       252 ~~~~~~~~~~i~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnI  324 (538)
                      +.+++ +.+++..++|++++.||+|+||+||+|.+++       +.||||++.... .......|.+|+.++++++||||
T Consensus         8 ~~~~~-~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nI   85 (308)
T d1p4oa_           8 DVYVP-DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHV   85 (308)
T ss_dssp             SCCCC-CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTB
T ss_pred             cCcCc-cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCE
Confidence            34443 3589999999999999999999999998753       459999986543 45566789999999999999999


Q ss_pred             eEeeceeccCCcceEEEeecCCCChhhhhcCC-------CCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCC
Q 009291          325 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIP-------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN  397 (538)
Q Consensus       325 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~N  397 (538)
                      +++++++..+...++||||+.+|+|.+++...       .....+++..+..++.|++.||.|||+++  |+||||||+|
T Consensus        86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~N  163 (308)
T d1p4oa_          86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARN  163 (308)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGG
T ss_pred             eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCc
Confidence            99999999999999999999999999988432       12234688899999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEEeeCCCccCCCCc--cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHH
Q 009291          398 LLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQ  474 (538)
Q Consensus       398 ILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg-~~Pf~~~~~~~  474 (538)
                      ||+++++++||+|||+|+......  .......||+.|+|||.+.+..++.++||||||+++|||+|| ..||...+..+
T Consensus       164 iLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~  243 (308)
T d1p4oa_         164 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ  243 (308)
T ss_dssp             EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred             eeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998643322  122344689999999999999999999999999999999998 58898888888


Q ss_pred             HHHHHhhcCcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          475 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       475 ~~~~i~~~~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ....+. .+.+.+.|..+++.+.+||.+||+.||++|||+.+|++.|++.+...
T Consensus       244 ~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         244 VLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             HHHHHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            777664 55667788999999999999999999999999999999998776544

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=394.03  Aligned_cols=257  Identities=32%  Similarity=0.533  Sum_probs=214.3

Q ss_pred             eEEEEEccCCcEEEEEEEEcCC-----ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc-CCcceEEE
Q 009291          268 LIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSIVT  341 (538)
Q Consensus       268 ~i~~~LG~G~fg~Vy~a~~~~~-----~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~-~~~~~lV~  341 (538)
                      .+.+.||+|+||+||+|.+..+     .||||++.. .......+.|.+|+++|++++||||+++++++.+ +..+++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            3468899999999999987543     278888754 3356667899999999999999999999999765 56789999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCc
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY  421 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~  421 (538)
                      |||++|+|.+++....  ..+++..++.++.|++.||.|||+.+  |+||||||+|||+++++.+||+|||+++......
T Consensus       109 E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             ECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999999987543  34778889999999999999999999  9999999999999999999999999998654322


Q ss_pred             c----ccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhhcCcccCCCCCCcHHH
Q 009291          422 I----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNVNPMV  496 (538)
Q Consensus       422 ~----~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~s~~l  496 (538)
                      .    ......||..|+|||.+.+..++.++||||||+++|||++|+.||..... .+....+ ..+.+...|..+++++
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~g~~~~~p~~~~~~l  263 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPL  263 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HTTCCCCCCTTCCHHH
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCcccCcHHH
Confidence            1    12335689999999999999999999999999999999998777765433 3333333 3556778889999999


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          497 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       497 ~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      .+||.+||+.||++|||+.||++.|++++.+...
T Consensus       264 ~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         264 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence            9999999999999999999999999999876433

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=394.30  Aligned_cols=246  Identities=26%  Similarity=0.311  Sum_probs=202.9

Q ss_pred             EEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCH---HHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          269 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE---DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       269 i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~---~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      .++.||+|+||+||+|+++.+  .||||++.......   ...+.+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            478999999999999998654  49999986543322   2235688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +.++++..+...   ...+++..+..++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|+........
T Consensus        82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            998877766542   345889999999999999999999999  999999999999999999999999999877665545


Q ss_pred             cCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc-----------------
Q 009291          424 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-----------------  485 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~-----------------  485 (538)
                      ....+||+.|+|||++.+. .++.++|||||||++|||++|..||...+..+....+......                 
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            5667899999999998754 5799999999999999999999999998887766554311000                 


Q ss_pred             ---------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 ---------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ---------~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                               ......+++++.+||.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                     0011356889999999999999999999999865

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=394.26  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=205.8

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++++.||+|+||+||+|++..  +.||||++..........+.+.+|+++|++++|||||++++++.++..+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            589999999999999999999874  449999987654444446789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      |+.++.+.......  ...+++..++.++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|+.......
T Consensus        82 ~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            99765444333322  235899999999999999999999999  99999999999999999999999999987655544


Q ss_pred             ccCCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-C---------------cc
Q 009291          423 SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-G---------------RR  485 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~-~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-~---------------~~  485 (538)
                      ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..+....+... .               ..
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            556678999999999987765 478999999999999999999999988876655543211 0               00


Q ss_pred             cC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 LE-----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 ~~-----------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..           ....+++++.+||.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00           11256789999999999999999999999976

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-48  Score=395.86  Aligned_cols=245  Identities=26%  Similarity=0.391  Sum_probs=200.9

Q ss_pred             ccceeEEE-EEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHc-CCCCceeEeeceecc----CC
Q 009291          264 WSELLIKK-KIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKG-LRHPNIVLLMGAVTE----PP  335 (538)
Q Consensus       264 ~~~y~i~~-~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~-L~hpnIv~l~~~~~~----~~  335 (538)
                      .++|++.+ .||+|+||+||+|++..+  .||||++...       ..+.+|+.++.+ .+|||||+++++|.+    ..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            35798875 599999999999998754  4999998653       356789988755 589999999999865    46


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC---CCcEEEEeeC
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFG  412 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~---~~~vkL~DFG  412 (538)
                      .+|+|||||+||+|.+++.... ...+++..++.++.||+.||+|||++|  |+||||||+|||+++   .+.+||+|||
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence            6899999999999999997432 235999999999999999999999999  999999999999975   5679999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh--cCcccCCC-
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF--KGRRLEIP-  489 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~--~~~~~~~p-  489 (538)
                      +|+...... ......||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+.......+..  ......+| 
T Consensus       160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            998765433 33567899999999999999999999999999999999999999987665444333221  22233333 


Q ss_pred             ---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          490 ---KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       490 ---~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                         ..+|+++.+||.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               257899999999999999999999999976

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.2e-48  Score=386.08  Aligned_cols=250  Identities=24%  Similarity=0.305  Sum_probs=207.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC-CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEee
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      ++|++++.||+|+||+||+|+++. ..||||++..........+.+.+|+.+|++++||||+++++++.+++..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            589999999999999999999874 4499999976654444457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCccc
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS  423 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~  423 (538)
                      +.++.+..+....   ..+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||.|.........
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            9887777766533   45999999999999999999999999  999999999999999999999999999875554444


Q ss_pred             cCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc------------------
Q 009291          424 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------------------  484 (538)
Q Consensus       424 ~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~------------------  484 (538)
                      .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+.....                  
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            4556789999999998764 568999999999999999999999998887666554321000                  


Q ss_pred             ---------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 ---------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 ---------~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                               .......+++.+.+||++||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     01223567899999999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=387.64  Aligned_cols=251  Identities=27%  Similarity=0.368  Sum_probs=205.3

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC---ceEEEEEeccccCHHHHHHHHHHHHHHHcC---CCCceeEeeceec-----
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS---DVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVT-----  332 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~vavK~~~~~~~~~~~~~~~~~Ei~il~~L---~hpnIv~l~~~~~-----  332 (538)
                      .++|++++.||+|+||+||+|++..+   .||||++............+.+|+.+|+.|   +||||++++++|.     
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            36899999999999999999998633   289999876544433334556777776655   8999999999884     


Q ss_pred             cCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          333 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       333 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      ....++++|||+.++.+.......  ...+++..++.++.|++.||+|||+++  ||||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchh
Confidence            334689999999987766554433  235889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC---------
Q 009291          413 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG---------  483 (538)
Q Consensus       413 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~---------  483 (538)
                      ++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+....         
T Consensus       162 ~~~~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         162 LARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             SCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            988654432 3456789999999999999999999999999999999999999999988777665542110         


Q ss_pred             ----------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 ----------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ----------------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                      ....++..+++++.+||.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                            011234567899999999999999999999999865

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=388.77  Aligned_cols=240  Identities=23%  Similarity=0.397  Sum_probs=202.5

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCH----HHHHHHHHHHHHHHcCC--CCceeEeeceeccCCc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE----DRFKEFLREVAIMKGLR--HPNIVLLMGAVTEPPN  336 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~----~~~~~~~~Ei~il~~L~--hpnIv~l~~~~~~~~~  336 (538)
                      ++|++++.||+|+||+||+|++..+  .||||++.......    .....+.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999998744  49999987643221    11234668999999986  8999999999999999


Q ss_pred             ceEEEeecCC-CChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-CCcEEEEeeCCC
Q 009291          337 LSIVTEYLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLS  414 (538)
Q Consensus       337 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla  414 (538)
                      +++||||+.+ +++.+++..   +..+++..++.++.||+.||+|||++|  ||||||||+|||++. ++.+||+|||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 577777753   235899999999999999999999999  999999999999985 579999999999


Q ss_pred             ccCCCCccccCCCCCCCcccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcccCCCCCCc
Q 009291          415 RSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN  493 (538)
Q Consensus       415 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~s  493 (538)
                      +......  .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+  .    +  ......++..+|
T Consensus       159 ~~~~~~~--~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i--~~~~~~~~~~~s  228 (273)
T d1xwsa_         159 ALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----I--IRGQVFFRQRVS  228 (273)
T ss_dssp             EECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----H--HHCCCCCSSCCC
T ss_pred             eeccccc--ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----H--hhcccCCCCCCC
Confidence            8755432  345689999999999987765 567899999999999999999997632  1    1  123456778899


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          494 PMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       494 ~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      +++.+||.+||+.||++|||++|+++
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            99999999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=381.05  Aligned_cols=255  Identities=29%  Similarity=0.471  Sum_probs=201.6

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC----cceEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----NLSIV  340 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~----~~~lV  340 (538)
                      .+|.+.+.||+|+||+||+|++++..||||++....   ........|+..++.++||||+++++++.++.    .+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            578999999999999999999998899999986442   22122334555556789999999999987544    47999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh--------CCCCEEeecCCCCCEEEcCCCcEEEEeeC
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ--------RRPPIVHRDLKSPNLLVDSTYTVKVCDFG  412 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~~~~iiHrDLKp~NILl~~~~~vkL~DFG  412 (538)
                      |||+++|+|.++++..    .+++..++.++.|++.||+|||+        ++  ||||||||+|||++.++++||+|||
T Consensus        80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEcCCCCeEEEecC
Confidence            9999999999999743    48899999999999999999997        46  9999999999999999999999999


Q ss_pred             CCccCCCCc----cccCCCCCCCcccccccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCC-------------
Q 009291          413 LSRSKPNTY----ISSKTAAGTPEWMAPEVLREDP------SNEKSDVFSFGVILWELITLQKPWRN-------------  469 (538)
Q Consensus       413 la~~~~~~~----~~~~~~~gt~~Y~aPE~l~~~~------~s~ksDVwSLGvil~eLltg~~Pf~~-------------  469 (538)
                      +++......    .......||+.|+|||++.+..      ++.++|||||||++|||+||..||..             
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            998643321    1234567999999999987643      57789999999999999999877632             


Q ss_pred             --CCHHHHHHHHhhcCcccCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          470 --STPSQVISAVGFKGRRLEIPKN-----VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       470 --~~~~~~~~~i~~~~~~~~~p~~-----~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                        .........+.....+..+|..     ....+.+||.+||+.||++|||+.||++.|+++..+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence              1222333333333444444433     2356899999999999999999999999999987654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=380.84  Aligned_cols=246  Identities=26%  Similarity=0.350  Sum_probs=203.6

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------  335 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~------  335 (538)
                      .++|++++.||+|+||+||+|.++.  ..||||++..........+.+.+|+.+|++++|||||+++++|....      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            5789999999999999999999874  44999999876667777789999999999999999999999987654      


Q ss_pred             cceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          336 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       336 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                      .+|+||||+ +.+|..+.+.    ..+++..++.++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhccccccccccccccee
Confidence            479999999 5678777753    34899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcC-----------
Q 009291          416 SKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-----------  483 (538)
Q Consensus       416 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~-----------  483 (538)
                      ......   ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+....           
T Consensus       170 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         170 QADSEM---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             ECCSSC---CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             ccCCcc---ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            765432   456899999999998764 56899999999999999999999999887665543322100           


Q ss_pred             ------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          484 ------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       484 ------------------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                        ........+++++.+||.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                              011233567899999999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=370.37  Aligned_cols=250  Identities=24%  Similarity=0.335  Sum_probs=211.9

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCCcceEEEe
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE  342 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~~~~lV~E  342 (538)
                      ++|++++.||+|+||+||+|++..++  ||||++..........+.+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999987554  9999998776666677899999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCCCCcc
Q 009291          343 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI  422 (538)
Q Consensus       343 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~  422 (538)
                      ++.+++|..++...   ..+++..++.++.|++.||+|||++|  ||||||||+|||++.++.+||+|||.|+.......
T Consensus        82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            99999998887643   35889999999999999999999999  99999999999999999999999999988765544


Q ss_pred             ccCCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhhc------------------
Q 009291          423 SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWR-NSTPSQVISAVGFK------------------  482 (538)
Q Consensus       423 ~~~~~~gt~~Y~aPE~l~~~~-~s~ksDVwSLGvil~eLltg~~Pf~-~~~~~~~~~~i~~~------------------  482 (538)
                      ......++..|+|||.+.+.. ++.++|||||||++|||++|+.||. ..+..+....+...                  
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            455667888999999987665 6899999999999999999999864 44444443332210                  


Q ss_pred             ---------CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 ---------GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ---------~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                               ......+..+++.+.+||++||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     0111233467889999999999999999999999865

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=373.92  Aligned_cols=251  Identities=23%  Similarity=0.316  Sum_probs=200.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc--------
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--------  333 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~--------  333 (538)
                      .++|++++.||+|+||+||+|+++.+  .||||++..........+.+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999998744  49999986665555555678899999999999999999998754        


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ...+++||||+.++.+......   ...+++..++.++.|++.||.|||++|  ||||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecce
Confidence            3458999999988766655432   235889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCCc----cccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCccc--
Q 009291          414 SRSKPNTY----ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--  486 (538)
Q Consensus       414 a~~~~~~~----~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~~--  486 (538)
                      ++......    .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.......  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97654321    122345799999999998765 68999999999999999999999999888766655443211100  


Q ss_pred             CC-------------------C---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          487 EI-------------------P---------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       487 ~~-------------------p---------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      ..                   +         ...++++.+||.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00                   0         012567889999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=376.73  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=200.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC--CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccCC----cce
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----NLS  338 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~~----~~~  338 (538)
                      ++|++++.||+|+||+||+|.++.  +.||||++.... .....+.+.+|+.+|++++||||+++++++..+.    ..+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            569999999999999999999874  449999986543 4556678999999999999999999999986543    235


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCccCC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP  418 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~  418 (538)
                      ++++++.+|+|.+++...    .+++..++.++.|++.||+|||++|  ||||||||+|||+++++.+||+|||+|+...
T Consensus        87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            555667799999999643    4899999999999999999999999  9999999999999999999999999997654


Q ss_pred             CCcc---ccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc------------
Q 009291          419 NTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------  482 (538)
Q Consensus       419 ~~~~---~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~------------  482 (538)
                      ....   ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||...+..+........            
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            3221   2345679999999999854 45789999999999999999999999887765444332110            


Q ss_pred             ------------Ccc-----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 ------------GRR-----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ------------~~~-----~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                  ...     ......+++++.+||.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        000     0122467889999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=378.64  Aligned_cols=245  Identities=25%  Similarity=0.307  Sum_probs=198.6

Q ss_pred             ceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc------CCcc
Q 009291          266 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPNL  337 (538)
Q Consensus       266 ~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~------~~~~  337 (538)
                      +|+.++.||+|+||+||+|++..++  ||||++.....      .+.+|+++|++++|+||++++++|..      ..++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            6899999999999999999997544  99999876532      23479999999999999999999843      3347


Q ss_pred             eEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-cEEEEeeCCCcc
Q 009291          338 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRS  416 (538)
Q Consensus       338 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~  416 (538)
                      ++|||||+++.+..+.........+++..++.++.||+.||+|||++|  ||||||||+|||++.++ .+||+|||+++.
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence            899999987655544432233446899999999999999999999999  99999999999998765 899999999987


Q ss_pred             CCCCccccCCCCCCCcccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------------
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------  482 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~-------------  482 (538)
                      ..... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+...             
T Consensus       173 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         173 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            65432 2345689999999998875 56899999999999999999999999988776655443210             


Q ss_pred             --Cccc------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 --GRRL------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 --~~~~------------~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                        ....            .....+++++.+||.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0001            112357899999999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-44  Score=365.51  Aligned_cols=255  Identities=20%  Similarity=0.274  Sum_probs=202.9

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc-eeEeeceeccCCcceEEE
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIVT  341 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~~~~~lV~  341 (538)
                      ++|++++.||+|+||+||+|++..+  .||||++......    +.+.+|+++++.++|+| |+.+.+++.+....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            4699999999999999999998754  4999998765322    35778999999998766 555566667888899999


Q ss_pred             eecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEc---CCCcEEEEeeCCCccCC
Q 009291          342 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKP  418 (538)
Q Consensus       342 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla~~~~  418 (538)
                      ||+. ++|...+....  ..+++..+..++.|++.||+|||++|  ||||||||+|||++   .+..+||+|||+|+...
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          83 ELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             ECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9995 56666654332  35899999999999999999999999  99999999999986   35579999999998654


Q ss_pred             CCc-------cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------cCcc
Q 009291          419 NTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF------KGRR  485 (538)
Q Consensus       419 ~~~-------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~------~~~~  485 (538)
                      ...       .......||+.|||||++.+..++.++|||||||++|||++|+.||...........+..      ....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            321       123455799999999999999999999999999999999999999987665443322211      1111


Q ss_pred             cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhh
Q 009291          486 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS  528 (538)
Q Consensus       486 ~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~  528 (538)
                      ...+.++|+++.+||.+||+.+|++||++++|.+.|++++...
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            2234689999999999999999999999999999999987654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.2e-44  Score=360.78  Aligned_cols=258  Identities=18%  Similarity=0.221  Sum_probs=211.8

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCC-CceeEeeceeccCCcceEE
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIV  340 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~h-pnIv~l~~~~~~~~~~~lV  340 (538)
                      .++|++++.||+|+||+||+|++..+  .||||++......    ..+.+|+++++.++| +||+.+++++.+....++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            46899999999999999999998754  4999988654322    246678889999965 8999999999999999999


Q ss_pred             EeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcC-----CCcEEEEeeCCCc
Q 009291          341 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGLSR  415 (538)
Q Consensus       341 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~-----~~~vkL~DFGla~  415 (538)
                      |||+ +++|.+++....  ..+++..+..++.|++.||+|||++|  ||||||||+|||++.     ++.+||+|||+|+
T Consensus        80 me~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            9999 679999886443  35889999999999999999999999  999999999999964     5789999999998


Q ss_pred             cCCCCc-------cccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhhc---
Q 009291          416 SKPNTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFK---  482 (538)
Q Consensus       416 ~~~~~~-------~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~---~~~~~~i~~~---  482 (538)
                      ......       .......||+.|||||++.+..++.++|||||||++|||++|..||.....   ......+...   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            643221       123455799999999999999999999999999999999999999975433   2222222111   


Q ss_pred             CcccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHhhhcC
Q 009291          483 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC  530 (538)
Q Consensus       483 ~~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~~L~~il~~~~~  530 (538)
                      .....+...+|+++.+++..||..+|++||+++.+.+.|++++.....
T Consensus       235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~  282 (293)
T d1csna_         235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  282 (293)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence            112234467899999999999999999999999999999999876543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=376.87  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=208.7

Q ss_pred             ccccceeEEEEEccCCcEEEEEEEEc-----CCceEEEEEecccc--CHHHHHHHHHHHHHHHcCCC-CceeEeeceecc
Q 009291          262 IRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEF--HEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTE  333 (538)
Q Consensus       262 i~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~vavK~~~~~~~--~~~~~~~~~~Ei~il~~L~h-pnIv~l~~~~~~  333 (538)
                      +..++|++++.||+|+||+||+|++.     ++.||||++.....  .....+.+.+|++++++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            34588999999999999999999873     33499999865432  12223568899999999976 899999999999


Q ss_pred             CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCC
Q 009291          334 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL  413 (538)
Q Consensus       334 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl  413 (538)
                      ...++++|||+.+|+|.+++....   .+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             CCceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccc
Confidence            999999999999999999986433   4778899999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCC-ccccCCCCCCCcccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh--cCcccCC
Q 009291          414 SRSKPNT-YISSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF--KGRRLEI  488 (538)
Q Consensus       414 a~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~--~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~--~~~~~~~  488 (538)
                      |+..... ........|++.|+|||.+.+.  .++.++|||||||++|||++|+.||...+..+....+..  .....++
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~  255 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  255 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCC
Confidence            9765432 2234566799999999999764  468899999999999999999999977654433333221  2334567


Q ss_pred             CCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 009291          489 PKNVNPMVAALIETCWAEEPEIRP-----SFPSIME  519 (538)
Q Consensus       489 p~~~s~~l~~LI~~cL~~dP~~RP-----s~~eIl~  519 (538)
                      |..+++++.+||.+||+.||++||     |++|+++
T Consensus       256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            788999999999999999999999     4788876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=372.52  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=204.4

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceeccC-----Cc
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PN  336 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~~-----~~  336 (538)
                      .++|++++.||+|+||+||+|++..+  .||||++..........+.+.+|+.+|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            36799999999999999999998754  499999987766777778899999999999999999999998533     34


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      .+++++++.+|+|.+++...    .+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcc
Confidence            56677788899999998643    4899999999999999999999999  99999999999999999999999999976


Q ss_pred             CCCCccccCCCCCCCcccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCcc----------
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------  485 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~~----------  485 (538)
                      ....   .....|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+......          
T Consensus       171 ~~~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         171 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CTGG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             cCcc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            5433   35667899999999877654 689999999999999999999999988776555444211100          


Q ss_pred             -----------cC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          486 -----------LE--------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       486 -----------~~--------~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                                 ..        ....+++++.+||.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                       00        11357899999999999999999999999976

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.1e-44  Score=364.15  Aligned_cols=242  Identities=22%  Similarity=0.344  Sum_probs=196.5

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCCc--eEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceecc--CCcce
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTE--PPNLS  338 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~--~~~~~  338 (538)
                      .++|++++.||+|+||+||+|++..++  ||||++....     .+.+.+|+.+|++++ ||||+++++++..  ...++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            468999999999999999999987544  9999986432     346889999999995 9999999999864  45689


Q ss_pred             EEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCC-cEEEEeeCCCccC
Q 009291          339 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSK  417 (538)
Q Consensus       339 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~  417 (538)
                      +||||+.+++|..+.+      .+++..++.++.||+.||+|||++|  ||||||||+|||++.++ .+||+|||+|+..
T Consensus       109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceec
Confidence            9999999999987643      4899999999999999999999999  99999999999998654 6999999999876


Q ss_pred             CCCccccCCCCCCCcccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhh-------------c
Q 009291          418 PNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGF-------------K  482 (538)
Q Consensus       418 ~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~-~~~~i~~-------------~  482 (538)
                      .... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....... ....+..             .
T Consensus       181 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         181 HPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             cCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            5432 23566789999999998765 47999999999999999999999997654322 1111100             0


Q ss_pred             C----------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          483 G----------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       483 ~----------------------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                      .                      ........+++++.+||++||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0                      000011246889999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=371.83  Aligned_cols=246  Identities=26%  Similarity=0.315  Sum_probs=195.1

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCceeEeeceecc------CCc
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPN  336 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnIv~l~~~~~~------~~~  336 (538)
                      ++|++++.||+|+||+||+|.+..+  .||||++..........+.+.+|+.++++++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999999754  49999998877777778889999999999999999999999853      467


Q ss_pred             ceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEEeeCCCcc
Q 009291          337 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS  416 (538)
Q Consensus       337 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~  416 (538)
                      +|+||||+.++.+..+ .     ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~~~-~-----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-Q-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHH-T-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchHHHHhh-h-----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhc
Confidence            8999999987655544 2     24889999999999999999999999  99999999999999999999999999887


Q ss_pred             CCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcCc------------
Q 009291          417 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------------  484 (538)
Q Consensus       417 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~~~~~i~~~~~------------  484 (538)
                      ..... ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||...+.......+.....            
T Consensus       169 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         169 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            55432 33456789999999999999999999999999999999999999988776554433311000            


Q ss_pred             --------c--------------cCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 009291          485 --------R--------------LEIP------KNVNPMVAALIETCWAEEPEIRPSFPSIME  519 (538)
Q Consensus       485 --------~--------------~~~p------~~~s~~l~~LI~~cL~~dP~~RPs~~eIl~  519 (538)
                              .              ...+      ...++++.+||++||..||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                    0              0000      123567899999999999999999999974

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.5e-39  Score=331.88  Aligned_cols=248  Identities=19%  Similarity=0.288  Sum_probs=187.0

Q ss_pred             ccceeEEEEEccCCcEEEEEEEEcCC--ceEEEEEeccccCHHHHHHHHHHHHHHHcCC-----------CCceeEeece
Q 009291          264 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----------HPNIVLLMGA  330 (538)
Q Consensus       264 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-----------hpnIv~l~~~  330 (538)
                      .++|++++.||+|+||+||+|++..+  .||||++....   ...+.+.+|+.+++.++           |+||++++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            35699999999999999999998754  49999987542   33457788998888775           5789999988


Q ss_pred             ecc--CCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHh-CCCCEEeecCCCCCEEEcCCC---
Q 009291          331 VTE--PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTY---  404 (538)
Q Consensus       331 ~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~iiHrDLKp~NILl~~~~---  404 (538)
                      +..  ....+++++++..+..............+++..++.++.||+.||+|||+ .|  |+||||||+|||++.++   
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTT
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCccc
Confidence            754  34566677766554433333222334468899999999999999999997 88  99999999999998655   


Q ss_pred             ---cEEEEeeCCCccCCCCccccCCCCCCCcccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H
Q 009291          405 ---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ------V  475 (538)
Q Consensus       405 ---~vkL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~ksDVwSLGvil~eLltg~~Pf~~~~~~~------~  475 (538)
                         .++|+|||.+......   .....||+.|+|||++.+..++.++||||+||++++|++|+.||.......      .
T Consensus       167 ~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               3999999999865433   245679999999999999999999999999999999999999997543211      1


Q ss_pred             HHHH-hh-cC--------------------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 009291          476 ISAV-GF-KG--------------------------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFP  515 (538)
Q Consensus       476 ~~~i-~~-~~--------------------------------------~~~~~p~~~s~~l~~LI~~cL~~dP~~RPs~~  515 (538)
                      .... .. ..                                      .....+...++++.+||.+||..||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            1000 00 00                                      01111223467899999999999999999999


Q ss_pred             HHHH
Q 009291          516 SIME  519 (538)
Q Consensus       516 eIl~  519 (538)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=2.5e-23  Score=194.74  Aligned_cols=166  Identities=17%  Similarity=0.126  Sum_probs=119.7

Q ss_pred             eeEEEEEccCCcEEEEEEEEc-CCceEEEEEeccccC----------------HHHHHHHHHHHHHHHcCCCCceeEeec
Q 009291          267 LLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFH----------------EDRFKEFLREVAIMKGLRHPNIVLLMG  329 (538)
Q Consensus       267 y~i~~~LG~G~fg~Vy~a~~~-~~~vavK~~~~~~~~----------------~~~~~~~~~Ei~il~~L~hpnIv~l~~  329 (538)
                      +.++++||+|+||+||+|.+. +..||||++......                ......+.+|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            357899999999999999875 455999987532110                112344567899999999999998886


Q ss_pred             eeccCCcceEEEeecCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCCCEEeecCCCCCEEEcCCCcEEEE
Q 009291          330 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC  409 (538)
Q Consensus       330 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~iiHrDLKp~NILl~~~~~vkL~  409 (538)
                      +..    .+++|||+++..+..          +++..+..++.|++.+|+|||++|  |+||||||+|||++++ .++|+
T Consensus        82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEEC
T ss_pred             ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEE
Confidence            632    389999998865543          223345678999999999999999  9999999999999866 58999


Q ss_pred             eeCCCccCCCCccccCCCCCCCccccc--c---cccCCCCCchhhHHHHHHHH
Q 009291          410 DFGLSRSKPNTYISSKTAAGTPEWMAP--E---VLREDPSNEKSDVFSFGVIL  457 (538)
Q Consensus       410 DFGla~~~~~~~~~~~~~~gt~~Y~aP--E---~l~~~~~s~ksDVwSLGvil  457 (538)
                      |||.|.....+..        ..|...  +   .+....|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9999876543211        112111  0   01235678899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.44  E-value=1.8e-07  Score=88.94  Aligned_cols=141  Identities=14%  Similarity=0.028  Sum_probs=96.0

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC-CCceeEeeceeccCCcceEEEee
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEY  343 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~-hpnIv~l~~~~~~~~~~~lV~E~  343 (538)
                      ..|++.+..+-++.+.||+....+..+++|.........  ...+.+|...+..+. +--+.+++++..+++..++||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            355666655555567999998777778888875432211  124567888777663 33356777777788889999999


Q ss_pred             cCCCChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCCC-------------------------------------
Q 009291          344 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP-------------------------------------  386 (538)
Q Consensus       344 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-------------------------------------  386 (538)
                      ++|.++.+.....        .....++.++...++.||+...                                     
T Consensus        92 l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          92 ADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             CSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             ccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            9998886654211        1122345566666667775321                                     


Q ss_pred             --------------------CEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          387 --------------------PIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       387 --------------------~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                                          .++|+|+.|.||++++++.+-|+||+.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                37999999999999877666799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.88  E-value=2e-05  Score=73.90  Aligned_cols=128  Identities=18%  Similarity=0.146  Sum_probs=81.0

Q ss_pred             EEccCCc-EEEEEEEEcCCc-eEEEEEeccccCHHHHHHHHHHHHHHHcCC--CCceeEeeceeccCCcceEEEeecCCC
Q 009291          272 KIGEGSF-GTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       272 ~LG~G~f-g~Vy~a~~~~~~-vavK~~~~~~~~~~~~~~~~~Ei~il~~L~--hpnIv~l~~~~~~~~~~~lV~E~~~~g  347 (538)
                      .+..|.. +.||+....+.. +++|.-.....     ..+.+|...++.+.  .-.+.+++.+..+++..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            4555553 688999876554 67777543322     23556777776663  233567777777888889999999886


Q ss_pred             ChhhhhcCCCCCccccHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 009291          348 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR------------------------------------------  385 (538)
Q Consensus       348 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------------  385 (538)
                      ++.+..        ...   ..++.++...|+.||+..                                          
T Consensus        92 ~~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (255)
T d1nd4a_          92 DLLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  160 (255)
T ss_dssp             ETTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             cccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence            653321        010   111223333444444211                                          


Q ss_pred             --------------CCEEeecCCCCCEEEcCCCcEEEEeeCCCc
Q 009291          386 --------------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR  415 (538)
Q Consensus       386 --------------~~iiHrDLKp~NILl~~~~~vkL~DFGla~  415 (538)
                                    +.++|+|+.|.|||++++..+-|+||+.+.
T Consensus       161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                          137999999999999887667899998664

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.14  E-value=0.0002  Score=72.16  Aligned_cols=77  Identities=16%  Similarity=0.098  Sum_probs=44.7

Q ss_pred             EEEEccCCcEEEEEEEEcC--CceEEEEEecc-----ccCHHHHHHHHHHHHHHHcCC---CCceeEeeceeccCCcceE
Q 009291          270 KKKIGEGSFGTVYHAEWRN--SDVAVKILIEQ-----EFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSI  339 (538)
Q Consensus       270 ~~~LG~G~fg~Vy~a~~~~--~~vavK~~~~~-----~~~~~~~~~~~~Ei~il~~L~---hpnIv~l~~~~~~~~~~~l  339 (538)
                      .+.||.|....||++....  ..++||.-...     ............|...|+.+.   ...+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            5578999999999997643  34777753211     000011123445777776552   2345566544  3445689


Q ss_pred             EEeecCCCC
Q 009291          340 VTEYLSRGS  348 (538)
Q Consensus       340 V~E~~~~gs  348 (538)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.14  E-value=0.0023  Score=62.13  Aligned_cols=68  Identities=13%  Similarity=0.096  Sum_probs=40.1

Q ss_pred             CcEEEEEEEEc-CCceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCce--eEeec-----eeccCCcceEEEeecCCC
Q 009291          277 SFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI--VLLMG-----AVTEPPNLSIVTEYLSRG  347 (538)
Q Consensus       277 ~fg~Vy~a~~~-~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpnI--v~l~~-----~~~~~~~~~lV~E~~~~g  347 (538)
                      .--.||+++.. ++.+++|+.........   ++..|...+..|...+|  +..+.     .+......+.+++++.|.
T Consensus        34 ~EN~vy~v~~~dg~~~VlK~~rp~~~s~~---~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          34 YENRVYQFQDEDRRRFVVKFYRPERWTAD---QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSSEEEEECCTTCCCEEEEEECTTTSCHH---HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ccceeEEEEcCCCCEEEEEEeCCCCCCHH---HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            34689999865 45699999765433333   45667777776632221  11111     123345578889988763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.66  E-value=0.017  Score=57.21  Aligned_cols=76  Identities=18%  Similarity=0.278  Sum_probs=48.4

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcC---------CceEEEEEeccccCHHHHHHHHHHHHHHHcCCCCc-eeEeeceeccC
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEP  334 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~hpn-Iv~l~~~~~~~  334 (538)
                      +++++ +.|+.|-.=.+|++...+         ..+.+++.-. ....   ....+|..+++.+.-.+ ..++++++.+ 
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~-  116 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE---SHLVAESVIFTLLSERHLGPKLYGIFSG-  116 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence            34444 578889999999998653         2366666542 2121   23457888888774333 3477777654 


Q ss_pred             CcceEEEeecCCCCh
Q 009291          335 PNLSIVTEYLSRGSL  349 (538)
Q Consensus       335 ~~~~lV~E~~~~gsL  349 (538)
                         .+|+||++|..+
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               689999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.65  E-value=0.052  Score=51.47  Aligned_cols=52  Identities=13%  Similarity=0.132  Sum_probs=32.2

Q ss_pred             cceeEEEEEccCCcEEEEEEEEcCCceEEEEEeccccCHHHHHHHHHHHHHHHcCC
Q 009291          265 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR  320 (538)
Q Consensus       265 ~~y~i~~~LG~G~fg~Vy~a~~~~~~vavK~~~~~~~~~~~~~~~~~Ei~il~~L~  320 (538)
                      ++..-.+.|..|.--+.|+++..+..+++|+..... .   .+.+..|+.++..|.
T Consensus        18 g~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~-~---~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1          18 GSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---KNDLPFFLGLMQHLA   69 (316)
T ss_dssp             CCEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHH
T ss_pred             CCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC-C---HHHHHHHHHHHHhhh
Confidence            445556778888889999999888889999975432 1   124445666666653

>d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Cysteine proteinases
superfamily: Cysteine proteinases
family: Transglutaminase core
domain: Peptide:N-glycanase 1, PNG1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=80.12  E-value=0.48  Score=44.34  Aligned_cols=53  Identities=19%  Similarity=0.156  Sum_probs=45.0

Q ss_pred             ceeeccccchhhHHHHHHHhhhcCCCceeecccccCCCCCCCeEEEEeCCC-cchhhhc
Q 009291           34 IGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPD-REYLVDL   91 (538)
Q Consensus        34 ~~~~~~~~~~~~~~l~~~~~d~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~   91 (538)
                      +=.-+.|.|.|=|.+|-.++=.+|+|||.|.|  |   .+|+|+-|..+.. ++.-||-
T Consensus       135 ll~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~--~---~~H~W~Ev~~~~~~rWv~vDp  188 (287)
T d2f4ma1         135 LLETRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPSQQRWLHCDA  188 (287)
T ss_dssp             HHHHCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETTTTEEEEEET
T ss_pred             HHHhcCccHHHHHHHHHHHHHHcCCCeEEEec--C---CcceeEEEEecCCCcEEEecC
Confidence            45678999999999999999999999999998  3   4799999999876 4655664